Citrus Sinensis ID: 002601
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 902 | 2.2.26 [Sep-21-2011] | |||||||
| P32361 | 1115 | Serine/threonine-protein | yes | no | 0.436 | 0.353 | 0.354 | 7e-81 | |
| Q09499 | 967 | Serine/threonine-protein | yes | no | 0.420 | 0.391 | 0.399 | 5e-80 | |
| O94537 | 1072 | Serine/threonine-protein | yes | no | 0.492 | 0.414 | 0.334 | 1e-73 | |
| Q55GJ2 | 984 | Probable serine/threonine | yes | no | 0.442 | 0.405 | 0.366 | 6e-73 | |
| Q76MJ5 | 926 | Serine/threonine-protein | yes | no | 0.430 | 0.419 | 0.351 | 1e-70 | |
| Q9EQY0 | 977 | Serine/threonine-protein | yes | no | 0.425 | 0.393 | 0.329 | 4e-68 | |
| O75460 | 977 | Serine/threonine-protein | no | no | 0.423 | 0.390 | 0.330 | 1e-67 | |
| Q9Z2E3 | 911 | Serine/threonine-protein | no | no | 0.425 | 0.421 | 0.334 | 2e-67 | |
| Q55DJ9 | 1505 | Probable serine/threonine | no | no | 0.424 | 0.254 | 0.298 | 9e-46 | |
| Q559A2 | 1431 | Probable serine/threonine | no | no | 0.424 | 0.267 | 0.299 | 4e-43 |
| >sp|P32361|IRE1_YEAST Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=IRE1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 302 bits (774), Expect = 7e-81, Method: Compositional matrix adjust.
Identities = 169/477 (35%), Positives = 256/477 (53%), Gaps = 83/477 (17%)
Query: 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIV 530
+ LVV K + GS+GTVV +G+++GR VAVKR++ D+AL EI+ L SD HPN++
Sbjct: 670 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 729
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R+Y E+ F+Y++LE C +L DL+ E N +++ L E P+
Sbjct: 730 RYYCSETTDRFLYIALELCNLNLQDLV--------ESKNVSDENLKLQKEYN----PI-- 775
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK-- 648
+ R I SG++HLH + +IHRDLKPQN+L+S F A
Sbjct: 776 -------------------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ 816
Query: 649 ---------LSDMGISKRLQGDMSCLTQNATG-YGSSGWQAPEQLLQG------------ 686
+SD G+ K+L S N G+SGW+APE L +
Sbjct: 817 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQCQVETEHS 876
Query: 687 -------------------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK--- 724
R TR+ID+FS+GC+ ++ ++ GKHP+G+ + R++NI++
Sbjct: 877 SSRHTVVSSDSFYDPFTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIF 936
Query: 725 ---DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 781
+ K L I EA DL ++++D +P RP A VL HP FW +L FL VSDR
Sbjct: 937 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDR 996
Query: 782 VELEDRESDSKLLRALE-GIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIR 840
+E+E+R+ S LL + G V +G W K + F++N+ RYR+Y + DLLR +R
Sbjct: 997 LEIENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYRKYHSSKLMDLLRALR 1056
Query: 841 NKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 897
NK +HF +LP+DI EL+G P+GFY+YF+ RFP LLI VY ++ +++ +++
Sbjct: 1057 NKYHHFMDLPEDIAELMGPVPDGFYDYFTKRFPNLLIGVYMIVKENLSDDQILREFL 1113
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices HAC1 precursor mRNA to produce the mature form which then induces transcription of UPR target genes. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 3EC: .EC: 1EC: .EC: 2EC: 6EC: .EC: - |
| >sp|Q09499|IRE1_CAEEL Serine/threonine-protein kinase/endoribonuclease ire-1 OS=Caenorhabditis elegans GN=ire-1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 300 bits (767), Expect = 5e-80, Method: Compositional matrix adjust.
Identities = 171/428 (39%), Positives = 246/428 (57%), Gaps = 49/428 (11%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD 540
+ G GTVV G ++GR VAVKR+V A +E L SD HP+++R++ +ESD
Sbjct: 524 LGTGCEGTVVYRGTFDGREVAVKRVVSEFVKFAHREADLLRESDTHPHVIRYFCMESDSQ 583
Query: 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 600
F YL+LE C SLND + EQ KE N V I L +M+ D
Sbjct: 584 FRYLALELCIASLNDYV--------EQ---KEVQQN----VTIALRDIMKQATD------ 622
Query: 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKR 657
GL+HLH ++HRD+KPQNVLI S+ A +SD G+ KR
Sbjct: 623 -----------------GLAHLHASKIVHRDMKPQNVLITMASQRGEMRAVISDFGLCKR 665
Query: 658 LQGDMSCLTQN-ATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 715
+Q + +++ A+G G+ GW APE L+ + +D+FSLGCI ++ +T G HP+G+S
Sbjct: 666 VQPGKNSISRGIASGLAGTDGWIAPEVLISASTSYPVDIFSLGCIFYYVLTSGTHPFGKS 725
Query: 716 FERDANIVKDRKDLFLVEHIPE---AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 772
R ANIV L + + + A DL + +L+ P R A VLNHPFFWT++ RL
Sbjct: 726 LHRQANIVNGEYTLNKLADLDDWSLADDLISSMLNVEPLHRLTADAVLNHPFFWTSEKRL 785
Query: 773 SFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNV 832
++ DVSDRVE E E +S ++R +E A + + G W EK+ E++ ++R YK +V
Sbjct: 786 AYFSDVSDRVEKE--EDNSPVVRRIETDARIVVCGGWREKICDALKEDLRKFRTYKSFSV 843
Query: 833 RDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEV 892
RDLLR +RNK +H+RELP+D+++ LG P+ F +YF+ RFP+LL+ VY YC GE V
Sbjct: 844 RDLLRAMRNKKHHYRELPEDVRQSLGDIPDQFLHYFTSRFPRLLLHVYKAT-EYCSGEAV 902
Query: 893 FHKYVTND 900
F +Y ++D
Sbjct: 903 FKRYYSDD 910
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices xbp-1 precursor mRNA to produce the mature form which then induces transcription of UPR target genes. Unfolded protein response (UPR) transcripional activation by ire-1, as well as translational attenuation by pek-1 in a complementary pathway, maintains ER homeostasis. Ire-1 and pek-1 are redundant genes that control a pathway essential for larval development and survival. Caenorhabditis elegans (taxid: 6239) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|O94537|PPK4_SCHPO Serine/threonine-protein kinase ppk4 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=ppk4 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (711), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 172/514 (33%), Positives = 271/514 (52%), Gaps = 70/514 (13%)
Query: 415 RPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKL 474
+ + +N T +NI+ + K TD L + K L +I + + L
Sbjct: 596 QASFEQNQTLDILSENIVEIQDK--STDPLQKSLDSSLKSHLPEATVIQNTDGSVTVNSL 653
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 534
V+ + I GS+GT+V G YE R VAVKR++ +D+A +EI L SD HPNIVR+Y
Sbjct: 654 TVYPEVIGYGSHGTIVYRGVYEDREVAVKRVLMEFYDLASREITLLQQSDNHPNIVRYYC 713
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ F+Y+ +E C C+L+DLI E+ P+ +
Sbjct: 714 KQKSDQFLYIVIELCKCNLSDLI--------------EK-------------PIAYD--- 743
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS-------FCA 647
+L+K S L+ + I G+SHLH + L+HRDLKPQN+L+ + S A
Sbjct: 744 -DLFK-----SIDLVSLLYQIAFGVSHLHSLDLVHRDLKPQNILLVVNNSPNLSKTRVRA 797
Query: 648 KLSDMGISKRLQGDMSCLTQNAT--GYGSSGWQAPEQL------------LQGRQTR--- 690
+SD G+SK+L + S L +N T GS GW++PE L ++ R+ R
Sbjct: 798 LISDFGLSKKLDFNQSSL-RNTTFEAAGSYGWRSPEILSGSLSQQSKEIQVKTREGRIRQ 856
Query: 691 ---AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPE----AVDLFT 743
A D+F+LGCI ++ +TGG HP+G ++ + NI+K L ++ + E A DL
Sbjct: 857 ASHATDIFALGCIFYYTLTGGMHPFGSHYDCEGNILKGNYCLVHLQSLGECGVLAADLIE 916
Query: 744 RLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 803
++ P RP + VLNHP FW +L FL DVSDR E+E+R+ S LL+ LE +
Sbjct: 917 DMIAFEPSKRPTIEVVLNHPLFWDYAKKLDFLIDVSDRFEVEERDPPSPLLQMLENNSKS 976
Query: 804 ALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEG 863
+ W + + ++N+G+YR+Y + D+LRV+RNK +H+++LP+ ++ +LG P+G
Sbjct: 977 VIGENWTTCLHSSLVDNLGKYRKYDGSKILDILRVLRNKRHHYQDLPESVRRVLGDLPDG 1036
Query: 864 FYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 897
F +YF +FP LL+ Y+++ E F +Y+
Sbjct: 1037 FTSYFVEKFPMLLLHCYHLVKDVLYEESQFKRYL 1070
|
Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GJ2|IREA_DICDI Probable serine/threonine-protein kinase ireA OS=Dictyostelium discoideum GN=ireA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 6e-73, Method: Compositional matrix adjust.
Identities = 162/442 (36%), Positives = 249/442 (56%), Gaps = 43/442 (9%)
Query: 470 RIGKL-VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN 528
+IGKL ++ NK + GS GT+V EG EGR VAVKR++ A +E+ LI SD+H N
Sbjct: 569 KIGKLEIITNKILGTGSCGTIVYEGKMEGRKVAVKRMLSQFVKFADREVSILIHSDEHTN 628
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+VR+Y E D +F+YL++ C SL+ +YV + Q++ + S +
Sbjct: 629 VVRYYAKEEDDEFIYLAISFCQKSLD--MYV-QQTLSLQISPTDSPS------------I 673
Query: 589 MENTKDIELWKANGHPSAQLL------KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
+ + N + + Q++ ++ ++ GL HLH + ++HRD+KP NVLI D
Sbjct: 674 QSSNNNGNGNNGNNNNNNQIIIDNKTKQMILELFKGLEHLHSLNIVHRDIKPHNVLI--D 731
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCI 700
+ K+SDMG+ K L D LT + S GWQ P + L G R T+ +D+FSLGC+
Sbjct: 732 PNNRVKISDMGLGKLLDNDDQSLTFTS---DSHGWQ-PAEYLNGTNRNTKKVDIFSLGCV 787
Query: 701 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760
+++ +TG HP+G + R+ N++K + D+ ++H+P+ L ++ P+ RP +
Sbjct: 788 VYYLLTGA-HPFGHRYNREKNVLKGKFDIDQIKHLPDIHQLVHSMIQFEPEKRPDIGECI 846
Query: 761 NHPFFWTADTRLSFLRDVSDRVELE------DRESDSKLLRALEGIALVALNGKWDEKME 814
NHPFFW +LSFL SD +E E + E DS + +G +G W K++
Sbjct: 847 NHPFFWEVHKKLSFLVAASDYLEFEKPTSPLNLEIDSHVDLVTDG------SGDWWLKID 900
Query: 815 TKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPK 874
I+NIGRYR+Y ++RDLLRVIRNK NH+R+L + Q LG P+GF+NYF +FP+
Sbjct: 901 QVLIDNIGRYRKYNGKSIRDLLRVIRNKFNHYRDLSPEEQTCLGILPDGFFNYFDLKFPQ 960
Query: 875 LLIEVYNVIFTYCKGEEVFHKY 896
L I Y I K ++ F +Y
Sbjct: 961 LFIVTYLFILKNLKNDQYFVQY 982
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q76MJ5|ERN2_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Homo sapiens GN=ERN2 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 155/441 (35%), Positives = 233/441 (52%), Gaps = 53/441 (12%)
Query: 471 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 529
+GK+ K++ +G+ GT V G +EGR+VAVKRL++ + +E+Q L SD+HPN+
Sbjct: 515 VGKISFNPKDVLGRGAGGTFVFRGQFEGRAVAVKRLLRECFGLVRREVQLLQESDRHPNV 574
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R++ E F Y++LE C SL + + N L EV
Sbjct: 575 LRYFCTERGPQFHYIALELCRASLQEYVE----------NPDLDRGGLEPEV-------- 616
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC--- 646
V + ++SGL+HLH + ++HRDLKP N+LI+ S
Sbjct: 617 ---------------------VLQQLMSGLAHLHSLHIVHRDLKPGNILITGPDSQGLGR 655
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE--QLLQ-GRQTRAIDLFSLGCILFF 703
LSD G+ K+L + ++ G+ GW APE QLL T A+D+FS GC+ ++
Sbjct: 656 VVLSDFGLCKKLPAGRCSFSLHSGIPGTEGWMAPELLQLLPPDSPTSAVDIFSAGCVFYY 715
Query: 704 CITGGKHPYGESFERDANIVKDRKDL-FLVEHIPEAV---DLFTRLLDPNPDLRPKAQNV 759
++GG HP+G+S R ANI+ L L E + + V DL +L P P RP A V
Sbjct: 716 VLSGGSHPFGDSLYRQANILTGAPCLAHLEEEVHDKVVARDLVGAMLSPLPQPRPSAPQV 775
Query: 760 LNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIE 819
L HPFFW+ +L F +DVSD +E E + L+RALE + W E +
Sbjct: 776 LAHPFFWSRAKQLQFFQDVSDWLEKESEQE--PLVRALEAGGCAVVRDNWHEHISMPLQT 833
Query: 820 NIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEV 879
++ ++R YK +VRDLLR +RNK +H+RELP ++++ LG P+GF YF+ RFP+LL+
Sbjct: 834 DLRKFRSYKGTSVRDLLRAVRNKKHHYRELPVEVRQALGQVPDGFVQYFTNRFPRLLLHT 893
Query: 880 YNVIFTYCKGEEVFHKYVTND 900
+ + + C E +F Y D
Sbjct: 894 HRAMRS-CASESLFLPYYPPD 913
|
Induces translational repression through 28S ribosomal RNA cleavage in response to ER stress. Pro-apoptotic. Appears to play no role in the unfolded-protein response, unlike closely related proteins. Homo sapiens (taxid: 9606) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q9EQY0|ERN1_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Mus musculus GN=Ern1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 260 bits (664), Expect = 4e-68, Method: Compositional matrix adjust.
Identities = 144/437 (32%), Positives = 230/437 (52%), Gaps = 53/437 (12%)
Query: 471 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 529
+GK+ K++ G+ GT+V +G ++ R VAVKR++ A +E+Q L SD+HPN+
Sbjct: 566 VGKISFCPKDVLGHGAEGTIVYKGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV 625
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R++ E D+ F Y+++E C +L + YV F
Sbjct: 626 IRYFCTEKDRQFQYIAIELCAATLQE--YVEQKDF------------------------- 658
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FC 646
H + + + SGL+HLH + ++HRDLKP N+L+S +
Sbjct: 659 ------------AHLGLEPITLLHQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIK 706
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL---LQGRQTRAIDLFSLGCILFF 703
A +SD G+ K+L ++ + G+ GW APE L + T +D+FS GC+ ++
Sbjct: 707 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKDNPTYTVDIFSAGCVFYY 766
Query: 704 CITGGKHPYGESFERDANIV--KDRKDLFLVEHIPEAV--DLFTRLLDPNPDLRPKAQNV 759
I+ G HP+G+S +R ANI+ D F + + + +L +++ +P RP A++V
Sbjct: 767 VISEGNHPFGKSLQRQANILLGACNLDCFHSDKHEDVIARELIEKMIAMDPQQRPSAKHV 826
Query: 760 LNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIE 819
L HPFFW+ + +L F +DVSDR+E E D ++R LE + W E +
Sbjct: 827 LKHPFFWSLEKQLQFFQDVSDRIEKE--ALDGPIVRQLERGGRAVVKMDWRENITVPLQT 884
Query: 820 NIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEV 879
++ ++R YK +VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL
Sbjct: 885 DLRKFRTYKGGSVRDLLRAMRNKKHHYRELPVEVQETLGSIPDDFVRYFTSRFPHLLSHT 944
Query: 880 YNVIFTYCKGEEVFHKY 896
Y + C+ E +F Y
Sbjct: 945 YQAM-ELCRHERLFQTY 960
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices XBP1 mRNA to generate a new C-terminus, converting it into a potent unfolded-protein response transcriptional activator and triggering growth arrest and apoptosis. Mus musculus (taxid: 10090) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|O75460|ERN1_HUMAN Serine/threonine-protein kinase/endoribonuclease IRE1 OS=Homo sapiens GN=ERN1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 259 bits (661), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 145/439 (33%), Positives = 229/439 (52%), Gaps = 57/439 (12%)
Query: 471 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 529
+GK+ K++ G+ GT+V G ++ R VAVKR++ A +E+Q L SD+HPN+
Sbjct: 566 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNV 625
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R++ E D+ F Y+++E C +L + YV F
Sbjct: 626 IRYFCTEKDRQFQYIAIELCAATLQE--YVEQKDF------------------------- 658
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FC 646
H + + + + SGL+HLH + ++HRDLKP N+LIS +
Sbjct: 659 ------------AHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIK 706
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL---LQGRQTRAIDLFSLGCILFF 703
A +SD G+ K+L ++ + G+ GW APE L + T +D+FS GC+ ++
Sbjct: 707 AMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 766
Query: 704 CITGGKHPYGESFERDANIVKDRKDLFLVEHIPE------AVDLFTRLLDPNPDLRPKAQ 757
I+ G HP+G+S +R ANI+ L + PE A +L +++ +P RP A+
Sbjct: 767 VISEGSHPFGKSLQRQANILLGACSLDCLH--PEKHEDVIARELIEKMIAMDPQKRPSAK 824
Query: 758 NVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKF 817
+VL HPFFW+ + +L F +DVSDR+E E D +++ LE + W E +
Sbjct: 825 HVLKHPFFWSLEKQLQFFQDVSDRIEKESL--DGPIVKQLERGGRAVVKMDWRENITVPL 882
Query: 818 IENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLI 877
++ ++R YK +VRDLLR +RNK +H+RELP +++E LGS P+ F YF+ RFP LL
Sbjct: 883 QTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGSLPDDFVCYFTSRFPHLLA 942
Query: 878 EVYNVIFTYCKGEEVFHKY 896
Y + C E +F Y
Sbjct: 943 HTYRAM-ELCSHERLFQPY 960
|
Senses unfolded proteins in the lumen of the endoplasmic reticulum via its N-terminal domain which leads to enzyme auto-activation. The active endoribonuclease domain splices XBP1 mRNA to generate a new C-terminus, converting it into a potent unfolded-protein response transcriptional activator and triggering growth arrest and apoptosis. Homo sapiens (taxid: 9606) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q9Z2E3|ERN2_MOUSE Serine/threonine-protein kinase/endoribonuclease IRE2 OS=Mus musculus GN=Ern2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 258 bits (659), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 146/436 (33%), Positives = 228/436 (52%), Gaps = 52/436 (11%)
Query: 471 IGKLVVFNKEI-AKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 529
+GK+ K++ +G+ GT V G +EGR+VAVKRL++ + +E+Q L SD+HPN+
Sbjct: 503 VGKISFNPKDVLGRGAGGTFVFRGQFEGRAVAVKRLLRECFGLVRREVQLLQESDRHPNV 562
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R++ E F Y++LE C SL + +
Sbjct: 563 LRYFCTEHGPQFHYIALELCQASLQEYV-------------------------------- 590
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK- 648
+ D++ W + V + ++SGL+HLH + ++HRDLKP N+L++ S
Sbjct: 591 -ESPDLDRW------GLEPTTVLQQMMSGLAHLHSLHIVHRDLKPANILMAGPDSQGQGR 643
Query: 649 --LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE--QLLQGRQTRAIDLFSLGCILFFC 704
+SD G+ K+L + ++ G+ GW APE QL T A+D+FS GC+ ++
Sbjct: 644 VVISDFGLCKKLPVGRCSFSLHSGIPGTEGWMAPELLQLPPDSPTSAVDIFSAGCVFYYV 703
Query: 705 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPE----AVDLFTRLLDPNPDLRPKAQNVL 760
++GG HP+GES R ANI+ L ++ A+DL +L P RP A VL
Sbjct: 704 LSGGSHPFGESLYRQANILSGDPCLAQLQEETHDKVVALDLVRAMLSLLPQDRPSAGWVL 763
Query: 761 NHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIEN 820
HP FW+ L F +DVSD +E E + L+ ALE + + W + + +
Sbjct: 764 AHPLFWSRAKELQFFQDVSDWLEKEPDQG--PLVSALEAGSYKVVREDWHKHISAPLQAD 821
Query: 821 IGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVY 880
+ R+R YK +VRDLLR +RNK +H+RELP ++++ LG P GF YF+ RFP+LL+ +
Sbjct: 822 LKRFRSYKGTSVRDLLRAMRNKKHHYRELPAEVRQTLGQLPAGFIQYFTQRFPRLLLHTH 881
Query: 881 NVIFTYCKGEEVFHKY 896
+ T C E +F Y
Sbjct: 882 RAMRT-CASESLFLPY 896
|
Role in expression of the DDIT3 transcription factor, required for the unfolded-protein response, growth arrest and apoptosis. Has no effect on 28S ribosomal RNA cleavage, unlike the corresponding human protein. Mus musculus (taxid: 10090) EC: 3 EC: . EC: 1 EC: . EC: 2 EC: 6 EC: . EC: - |
| >sp|Q55DJ9|IRLD_DICDI Probable serine/threonine-protein kinase irlD OS=Dictyostelium discoideum GN=irlD PE=3 SV=1 | Back alignment and function description |
|---|
Score = 186 bits (471), Expect = 9e-46, Method: Compositional matrix adjust.
Identities = 139/465 (29%), Positives = 225/465 (48%), Gaps = 82/465 (17%)
Query: 471 IGKLVVFNKE---IAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVALKEIQNLIA--SD 524
IGK K+ I +GSNGT+V +G + R VA+K++ K + + KEI+ LI +
Sbjct: 1047 IGKFKFSRKDEFIIGRGSNGTLVFKGIWNDRIPVAIKQMHKAFNPLISKEIEVLITLTNK 1106
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
NIVR+ E D FVYL L C SL +L+ K+ + NL++
Sbjct: 1107 NCNNIVRYIDQEEDDMFVYLGLTLCNGSLQNLV------------EKDLEINLISTSNNE 1154
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+ I +LL++ +DIV G+ LH+ G++H DL P+N+LI D+
Sbjct: 1155 NNNNNKLKNFI-------GSELRLLELIKDIVYGIQFLHQQGIVHNDLNPRNILIKDDRF 1207
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
+SD+G+SK T +A G G+ E LL+ R+T+++D+FS+GCILF+
Sbjct: 1208 I---ISDLGLSKMEVTSSYSFTMHAPT-GQEGFHPAEVLLEKRKTKSVDIFSMGCILFYL 1263
Query: 705 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
+TGG+HP+G+ F R ANI+ D+ L ++H A DL ++++ N RP +N+L HPF
Sbjct: 1264 MTGGQHPFGDKFFRMANILTDKPILEPLKHNLVACDLISQMISKNESDRPTTENILLHPF 1323
Query: 765 FWTADTRLSFLRDVSDRVELEDRESDSKLLRAL------EGIALVA---LNGKWDEKMET 815
FW + ++ F+ + + + SKL + + +G+ + L+ W++ ++
Sbjct: 1324 FWNHEKKVKFIDASLNLFKDSNGLFTSKLNKLINQFQDTDGVNTTSTPFLSKPWNQLIDP 1383
Query: 816 KFIENIG-------------------------RYRRYKYDNVRDLLRVIRNKSNHFRELP 850
IE+I ++ Y Y V+DL+R IRN H +E
Sbjct: 1384 TLIEHITNKQNQLSGGSSIGNNNNNSLTLSGKKFYFYDYSQVKDLVRCIRNTIQHHKE-- 1441
Query: 851 QDIQELLGSHP---------------EGFYNYFSCRFPKLLIEVY 880
IQ L+ P E +YF + P LL+ +Y
Sbjct: 1442 --IQRLISQSPSSSNKQEVLDCLESQELVLSYFEEKVPDLLLFLY 1484
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q559A2|IRLA_DICDI Probable serine/threonine-protein kinase irlA OS=Dictyostelium discoideum GN=irlA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (449), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 133/444 (29%), Positives = 221/444 (49%), Gaps = 61/444 (13%)
Query: 478 NKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVALKEIQNLI--ASDQHPNIVRWYG 534
N I +GSNGT+V G + R VAVK++ K + KEI+ LI S+ N++R+
Sbjct: 990 NNIIGRGSNGTLVFRGIWNDRIPVAVKQMQKAFNPHISKEIEVLIRLTSNNCSNMIRYID 1049
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
E DQ FVYL L C SL DL+ S ++E + E+ + + EN +
Sbjct: 1050 QEEDQLFVYLGLTLCEESLQDLME--SKRYKEFI---EKTTTTNITTTFNNNIIDENLYE 1104
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
++L + +D+++G++ LH ++H DL P+N+L+ K +SD+G+
Sbjct: 1105 -----------QRILSLFKDVINGINFLHCQDIVHNDLNPRNILVHKGNFV---ISDLGL 1150
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
SK +Q + S N G G+ E L + R+T+++D+FSLGCILF+ +T G+HP+G
Sbjct: 1151 SK-MQVETSYSFTNNAPTGQEGYHPIEVLQEKRKTKSVDIFSLGCILFYLLTNGQHPFGN 1209
Query: 715 S-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLS 773
+ R ANIV D+ DL ++ A+DL ++ + RP +LNHP FW+ + ++
Sbjct: 1210 NKLLRVANIVYDKPDLEPLKFNAPALDLVRLMISQDEKKRPTIDTILNHPLFWSTNEKIK 1269
Query: 774 FLRDVSDRVELED--RESDSKLLRALEGI---ALVALNGKWDEKMETKFIENIGRYRR-- 826
F + ++ + + SKLL + ++ L+ W++ ++ I+++
Sbjct: 1270 FYESSLNLLKDPNNSQSKHSKLLNYYQNDNSGGVLFLSKPWNQIIDPFLIDHVENNNNNN 1329
Query: 827 -----------------YKYDNVRDLLRVIRNKSNHFRELPQDI--QELLGSHPEGFYN- 866
Y+YD VRDL+R IRN H +++ + I Q+ L + F N
Sbjct: 1330 NNNNNNKQNSKKLAIVAYQYDQVRDLVRCIRNSLVHHKDILRSITQQQNLPPSSKEFAND 1389
Query: 867 ----------YFSCRFPKLLIEVY 880
YF C+FP LL +Y
Sbjct: 1390 CLKSQESVLLYFECKFPDLLFHLY 1413
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 902 | ||||||
| 225457602 | 925 | PREDICTED: uncharacterized protein LOC10 | 0.962 | 0.938 | 0.531 | 0.0 | |
| 297745578 | 827 | unnamed protein product [Vitis vinifera] | 0.899 | 0.980 | 0.527 | 0.0 | |
| 225438442 | 957 | PREDICTED: uncharacterized protein LOC10 | 0.958 | 0.903 | 0.502 | 0.0 | |
| 224074275 | 822 | predicted protein [Populus trichocarpa] | 0.889 | 0.975 | 0.5 | 0.0 | |
| 224086074 | 496 | predicted protein [Populus trichocarpa] | 0.547 | 0.995 | 0.728 | 0.0 | |
| 10177897 | 939 | unnamed protein product [Arabidopsis tha | 0.902 | 0.866 | 0.477 | 0.0 | |
| 255561453 | 911 | kinase, putative [Ricinus communis] gi|2 | 0.921 | 0.912 | 0.482 | 0.0 | |
| 356495301 | 895 | PREDICTED: uncharacterized protein LOC10 | 0.905 | 0.912 | 0.497 | 0.0 | |
| 297808453 | 871 | hypothetical protein ARALYDRAFT_489300 [ | 0.881 | 0.912 | 0.469 | 0.0 | |
| 15277137 | 881 | Ire1 homolog-1 [Arabidopsis thaliana] | 0.902 | 0.923 | 0.472 | 0.0 |
| >gi|225457602|ref|XP_002272934.1| PREDICTED: uncharacterized protein LOC100247854 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 920 bits (2379), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 504/949 (53%), Positives = 642/949 (67%), Gaps = 81/949 (8%)
Query: 1 MRRALVFLLLSTAIIQSVSSSELSATPPNRYVSEIY-----NSLLPPPLPPEPDVALVAA 55
M+R+L+FLL +I ++ S T S+ + NS++P P+ D+ALVAA
Sbjct: 1 MKRSLIFLLWFISISGVLAISTKPETSLLNLDSKGFDILKANSIVPQA--PKNDIALVAA 58
Query: 56 LDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSN-----ASEFYLDVDEDWELYFHSK 110
LDGTI+LV+ KI WSF +G IYSSYQA + + +++F++D +DWELY H+
Sbjct: 59 LDGTIYLVEASSRKILWSFASGSSIYSSYQAFLDGDNDKQLSTDFFIDCGDDWELYRHNI 118
Query: 111 RFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTP 170
FGK +KL + E+Y+ PY+SKDG VT+G+ KT+VFLVD KSG +++ + D S
Sbjct: 119 SFGKREKLLLTPEKYVEGAPYVSKDG-VTVGSKKTTVFLVDAKSGTIINTFRSDASPLIG 177
Query: 171 GFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYA 230
GFQSDE ++ + EEL+E G +L+++ +YIMRTDYVLQ S SG+VLWNV +A
Sbjct: 178 GFQSDEENPILSREEIEELIEPGDVDLQKVELPLYIMRTDYVLQHFSPTSGKVLWNVKFA 237
Query: 231 DFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSL---- 286
D +A F+C G+E+G + + D+ES P H Q ASVYR+R+ SL
Sbjct: 238 DIEAVFQC-------------PGTEIGSEYMSDIES--PLHCQTRASVYRIREPSLLDSF 282
Query: 287 ------PEFLSVIGKVA----------------------------GWISLPGSSQNSLLG 312
P+ L + ++ +SLP S SL
Sbjct: 283 PMHDRLPKTLPAVEVLSLPASEPKSHSLLDSFPMHDRLPKALPAVEVLSLPASEPKSLSQ 342
Query: 313 PVDR-NSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQSF 371
PV R P L +P LALP +E TL + GG SE++ + I+
Sbjct: 343 PVGRLPGPHHLGQ--GKPLLALPLSEG----TLSVHGGDASEMD----IMSIVSDNIEKL 392
Query: 372 IVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKT-GI-PKKKKSRRPGYNRNTTNSEKMQ 429
+ L I+GF+ Y V+ ++ +K GI PKKKK+R+ N+N ++EK
Sbjct: 393 GIWAAPLLFIVGFIIYQFFAVREPGKSRPKDSKVQGISPKKKKARKSVINKNNASNEKRH 452
Query: 430 NIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTV 489
I +ESKV + +GLS + N K L L D V R+IGK++V KEIAKGSNGT+
Sbjct: 453 GNISHESKVADNNGLSQVERNEIKLELNSNSLADVHVGERKIGKMLVSKKEIAKGSNGTI 512
Query: 490 VLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549
VLEG Y+GR VAVKRLV+THHDVALKEIQNLIASDQHPNIVRW+GVE DQDFVYLSLERC
Sbjct: 513 VLEGIYDGRPVAVKRLVRTHHDVALKEIQNLIASDQHPNIVRWHGVEYDQDFVYLSLERC 572
Query: 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
CSL+DLIY+ S S ++QL ++ DSN+LNE +RL +M+ KD ELWK NG+PS QLL
Sbjct: 573 NCSLSDLIYLCSDS-QDQLVNQDWDSNILNEYIVRLHSIMDPNKDFELWKTNGYPSPQLL 631
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQGDMSCLTQN 668
K+ RD+VSGL+HLHE+G+IHRDLKPQN+LI K KS AKLSDMGISKRL GDMS LT +
Sbjct: 632 KLMRDVVSGLAHLHELGIIHRDLKPQNILIIIKGKSLSAKLSDMGISKRLLGDMSSLTHH 691
Query: 669 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 728
TGYGSSGWQAPEQL GRQTRA+DLFSLGC+LFFC+TGGKHPYG++ ERD NIV +RKD
Sbjct: 692 GTGYGSSGWQAPEQLRHGRQTRAVDLFSLGCVLFFCLTGGKHPYGDNLERDVNIVNNRKD 751
Query: 729 LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRE 788
LFL+E+IPEAVDLF+ LL+P+PDLRPKA +VL+HPFFW+++ RLSFLRDVSDRVELEDRE
Sbjct: 752 LFLIENIPEAVDLFSLLLEPDPDLRPKAMDVLHHPFFWSSEMRLSFLRDVSDRVELEDRE 811
Query: 789 SDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRE 848
++S+LL+ LE I +ALNGKWDEKME FI NIGRYRRYK+D+VRDLLRVIRNK NH+RE
Sbjct: 812 NESQLLKQLESIGTLALNGKWDEKMEGAFINNIGRYRRYKFDSVRDLLRVIRNKLNHYRE 871
Query: 849 LPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYV 897
LP DIQE+LG PEGF YFS RFP+ LIEVY VI T+C+ EE F KY+
Sbjct: 872 LPSDIQEILGPVPEGFNLYFSSRFPRFLIEVYKVIHTHCREEEFFQKYI 920
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745578|emb|CBI40743.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 876 bits (2263), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/908 (52%), Positives = 609/908 (67%), Gaps = 97/908 (10%)
Query: 1 MRRALVFLL--LSTAIIQSVSSS-ELSATPPNRYVSEIYNSLLPPPLPPEPDVALVAALD 57
M+R+L+FLL +S + + ++S+ E S + +I + P P+ D+ALVAALD
Sbjct: 1 MKRSLIFLLWFISISGVLAISTKPETSLLNLDSKGFDILKANSIVPQAPKNDIALVAALD 60
Query: 58 GTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSN-----ASEFYLDVDEDWELYFHSKRF 112
GTI+LV+ KI WSF +G IYSSYQA + + +++F++D +DWELY H+ F
Sbjct: 61 GTIYLVEASSRKILWSFASGSSIYSSYQAFLDGDNDKQLSTDFFIDCGDDWELYRHNISF 120
Query: 113 GKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGF 172
GK +KL + E+Y+ PY+SKDG VT+G+ KT+VFLVD KSG +++ + D S GF
Sbjct: 121 GKREKLLLTPEKYVEGAPYVSKDG-VTVGSKKTTVFLVDAKSGTIINTFRSDASPLIGGF 179
Query: 173 QSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADF 232
QSDE ++ + EEL+E G +L+++ +YIMRTDYVLQ S SG+VLWNV +AD
Sbjct: 180 QSDEENPILSREEIEELIEPGDVDLQKVELPLYIMRTDYVLQHFSPTSGKVLWNVKFADI 239
Query: 233 KAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPEFLSV 292
+A F+C G+E+G + + D+ES L C T+ S
Sbjct: 240 EAVFQC-------------PGTEIGSEYMSDIESPLHCQTRA----------------SP 270
Query: 293 IGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPSTETEIPWTLGMPGGSVS 352
+G+ LPG LG +P LALP +E TL + GG S
Sbjct: 271 VGR------LPGPHH---LGQ-------------GKPLLALPLSEG----TLSVHGGDAS 304
Query: 353 EINKKHAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKT-GI-PKK 410
E++ + I+ + L I+GF+ Y V+ ++ +K GI PKK
Sbjct: 305 EMD----IMSIVSDNIEKLGIWAAPLLFIVGFIIYQFFAVREPGKSRPKDSKVQGISPKK 360
Query: 411 KKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRR 470
KK+R+ N+N ++EK I +ESKV + +GLS + N K L L D V R+
Sbjct: 361 KKARKSVINKNNASNEKRHGNISHESKVADNNGLSQVERNEIKLELNSNSLADVHVGERK 420
Query: 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIV 530
IGK++V KEIAKGSNGT+VLEG Y+GR VAVKRLV+THHDVALKEIQNLIASDQHPNIV
Sbjct: 421 IGKMLVSKKEIAKGSNGTIVLEGIYDGRPVAVKRLVRTHHDVALKEIQNLIASDQHPNIV 480
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
RW+GVE DQDFVYLSLERC CSL+DLIY+ S S ++QL
Sbjct: 481 RWHGVEYDQDFVYLSLERCNCSLSDLIYLCSDS-QDQL---------------------- 517
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKL 649
D ELWK NG+PS QLLK+ RD+VSGL+HLHE+G+IHRDLKPQN+LI K KS AKL
Sbjct: 518 ---DFELWKTNGYPSPQLLKLMRDVVSGLAHLHELGIIHRDLKPQNILIIIKGKSLSAKL 574
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
SDMGISKRL GDMS LT + TGYGSSGWQAPEQL GRQTRA+DLFSLGC+LFFC+TGGK
Sbjct: 575 SDMGISKRLLGDMSSLTHHGTGYGSSGWQAPEQLRHGRQTRAVDLFSLGCVLFFCLTGGK 634
Query: 710 HPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769
HPYG++ ERD NIV +RKDLFL+E+IPEAVDLF+ LL+P+PDLRPKA +VL+HPFFW+++
Sbjct: 635 HPYGDNLERDVNIVNNRKDLFLIENIPEAVDLFSLLLEPDPDLRPKAMDVLHHPFFWSSE 694
Query: 770 TRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKY 829
RLSFLRDVSDRVELEDRE++S+LL+ LE I +ALNGKWDEKME FI NIGRYRRYK+
Sbjct: 695 MRLSFLRDVSDRVELEDRENESQLLKQLESIGTLALNGKWDEKMEGAFINNIGRYRRYKF 754
Query: 830 DNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKG 889
D+VRDLLRVIRNK NH+RELP DIQE+LG PEGF YFS RFP+ LIEVY VI T+C+
Sbjct: 755 DSVRDLLRVIRNKLNHYRELPSDIQEILGPVPEGFNLYFSSRFPRFLIEVYKVIHTHCRE 814
Query: 890 EEVFHKYV 897
EE F KY+
Sbjct: 815 EEFFQKYI 822
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438442|ref|XP_002275036.1| PREDICTED: uncharacterized protein LOC100249111 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2146), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/936 (50%), Positives = 601/936 (64%), Gaps = 71/936 (7%)
Query: 2 RRALVFLLLSTAIIQSVSSSELSATPPNRYV-SEIYNSLLPPPLPPEPDVALVAALDGTI 60
RR+L+ ++ +SV S TP YV I N L + D ALVAAL+GTI
Sbjct: 48 RRSLL------SLPKSVDSPIFLDTPSTVYVLYSICNVLNHGKFLSKNDTALVAALNGTI 101
Query: 61 HLVDTKLGKIRWSFGTGRPIYSSYQASFNSN-----ASEFYLDVDEDWELYFHSKRFGKM 115
HLV++ K+ WSF +G IYSSYQA + + S F++D EDWELY H + FGK+
Sbjct: 102 HLVESNSMKVLWSFTSGPSIYSSYQAPLDQDNATDWGSGFFVDCGEDWELYMHGRHFGKV 161
Query: 116 KKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSD 175
K L +AEE+I P++S+DGGV LG+ +T+VFL++ K+G+++ +Y S TP S+
Sbjct: 162 K-LPMTAEEFISSTPHVSEDGGVILGSKQTTVFLLNAKTGKLIHSYRSLESPPTP--LSN 218
Query: 176 ENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKAE 235
+ + VV EE V+SG NL + +YI RTDY LQS +Q S +VLWN+ A+ A
Sbjct: 219 KEESVVHDKDIEEWVDSGSTNLNIVEPRLYITRTDYSLQSFAQGSDKVLWNMTVAEIGAA 278
Query: 236 FRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDNSLPE------F 289
F CQ FS N G ELG + D E LPC Q A VYR R +++ E
Sbjct: 279 FLCQGTENLFSRPPLNLGCELGPEYNCDFEMPLPC--QSKAVVYRYRGHTMLEPFPRHDR 336
Query: 290 LSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPS-------------T 336
L + + P + P D P +P+ + LPS
Sbjct: 337 LQEAHQEDRLLLQPNIDKTLDFHPQDMMLPAVVPNHM------LPSEPKDEISLNFQDNN 390
Query: 337 ETEIPWTLGMP---GGSVSEINKKHAFVEGFR-----SYIQSFIVLFIAL--------CP 380
++E L P +S+ N + + +G S + S IV + L P
Sbjct: 391 DSEAVLPLSPPKIKNSGISDQNVQMPYNDGLSMFSGGSILFSLIVFIVILLVSVIYCCTP 450
Query: 381 IIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGE 440
+ G +KQ N +P KK+ R N ++ +K ++++ +E+K
Sbjct: 451 VAGEQGEMNKQPNDSDSN-------SVPSKKRKIRKSAKNNISSGKKDEHVL-SENK--- 499
Query: 441 TDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSV 500
DG +HI + +L L+D +GR +GKL V N IAKGSNGT+VLEG +EGRSV
Sbjct: 500 -DGSAHIASDNSPWL-NLNGLVDGDTNGRIVGKLFVSNIVIAKGSNGTIVLEGIHEGRSV 557
Query: 501 AVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVL 560
AVKRLV+ HHDVA KEIQNLIASD+HPNIVRWYGVE DQDFVYLSLERCTCSLNDL+ +
Sbjct: 558 AVKRLVRAHHDVAFKEIQNLIASDRHPNIVRWYGVEYDQDFVYLSLERCTCSLNDLLQIH 617
Query: 561 SGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620
S S + + +Q + + E RI+L V +DI+LWK+NG+PS+ LL + RD+VSGL
Sbjct: 618 SNSSQNPGFSMDQATKAMMEYRIQLDSVKCIVQDIKLWKSNGYPSSVLLSLMRDVVSGLV 677
Query: 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680
HLH++G+IHRDLKPQNVLI K+KS CAKLSDMGISKRL GDMS L +ATGYGSSGWQAP
Sbjct: 678 HLHDLGIIHRDLKPQNVLIIKEKSLCAKLSDMGISKRLVGDMSSLGHHATGYGSSGWQAP 737
Query: 681 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVD 740
EQLL GRQTRA+DLFSLGCILF CITGG+HP+G+ ERD NIVK++ DLFLVE IPEA+D
Sbjct: 738 EQLLHGRQTRAVDLFSLGCILFSCITGGRHPFGDPLERDVNIVKNKPDLFLVEFIPEALD 797
Query: 741 LFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 800
LF RLLDP P+LRPKA VL HP FW+++ RLSFLRD SDRVELEDRES+S +L+ALEG
Sbjct: 798 LFARLLDPKPELRPKASEVLYHPLFWSSELRLSFLRDASDRVELEDRESNSHVLKALEGT 857
Query: 801 ALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSH 860
A AL GKW+EKME F+ +IGRYRRYK+D+VRDLLRVIRNK NH+RELP++IQE+LGS
Sbjct: 858 APTALGGKWNEKMEPAFLADIGRYRRYKFDSVRDLLRVIRNKWNHYRELPREIQEILGSV 917
Query: 861 PEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 896
PEGF +YFS RFP+LLIEVY V+ +CKGEE F KY
Sbjct: 918 PEGFDSYFSSRFPRLLIEVYKVVSRHCKGEECFQKY 953
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074275|ref|XP_002304333.1| predicted protein [Populus trichocarpa] gi|222841765|gb|EEE79312.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/868 (50%), Positives = 567/868 (65%), Gaps = 66/868 (7%)
Query: 52 LVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASE---------FYLDVDED 102
LVA L+GTI+ D GKI WSF +G P YSSYQA ++ + F+LD +D
Sbjct: 1 LVALLNGTIYFKDKISGKILWSFSSGGPTYSSYQAPAKHDSDKEKGPGGLTGFFLDYGDD 60
Query: 103 WELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY- 161
W+LY H K G MK L + E++I+ P++S+DG V LG+ KT+VF+V+ K+GR++ +
Sbjct: 61 WQLYAHYKYSGGMK-LPMNIEDFIKITPHMSEDGAVMLGSKKTTVFVVEAKTGRLIRTFK 119
Query: 162 VLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSG 221
D +S F+ H ++ ++L++SG N Q++YI+RTDY LQ+ +S
Sbjct: 120 SPDSPSSLQSFEEGSGLHD-DLNNNKDLLKSGSSN---TAQVIYILRTDYALQTFGPNSD 175
Query: 222 EVLWNVAYADFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRL 281
+V W+ A A F C++V + SE+ +L +++S P Q V +
Sbjct: 176 KVSWSTKVATIGATFLCKDV---------ENPSEV-FNLSFELDSDTPLSCQSRRIVVQR 225
Query: 282 RDNSLPEFLSVIGKVAGWISLPGSSQNSLLGP---VDRNSPLFLPDKVDRPPLALPSTET 338
+D S ++ S G + G LP S+ N +L V+++ L D R LA PS
Sbjct: 226 QDKS--QYSS--GDIHGEDKLPLSAPNLMLTTQPGVEKS----LDDHHARMLLAAPSEHG 277
Query: 339 EIPWTLGMPGGSVS-EINKKHAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQ 397
+ L +P S + E++ + + + S QSFI LF+ + ++ F+ Y SK+ +
Sbjct: 278 K--EMLALPSASAAGEVHYRFGMLLMW-STTQSFI-LFVGIL-LLCFVLYLSKESFTL-- 330
Query: 398 NEEHITKTGIPKKKKSRR----PGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEK 453
E +T TG+ ++ PG +N + E I P E K
Sbjct: 331 -EGQLTGTGLKASSSKKKKAKKPG--KNNVSVENGNEIAPGEGV--------------NK 373
Query: 454 FLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA 513
L L+D +GRRIGKL V N EIAKGSNGTVVLEG YEGR VAVKRLV+THHDVA
Sbjct: 374 TLSDLNKLVDGGANGRRIGKLFVSNTEIAKGSNGTVVLEGVYEGRLVAVKRLVQTHHDVA 433
Query: 514 LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQ 573
KEIQNLIASD+HPNIVRWYGVE D+DFVYLSLERCTCSL+DLI + S S + K++
Sbjct: 434 WKEIQNLIASDRHPNIVRWYGVEYDEDFVYLSLERCTCSLDDLIQIYSDSSLNPVYGKDR 493
Query: 574 DSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633
S E ++RL V +D+ LWKA GHPS LL + RD+VSGL HLHE+G+IHRDLK
Sbjct: 494 TSRAAIEHKLRLDSVKGVMQDLNLWKATGHPSPLLLTLMRDMVSGLVHLHELGIIHRDLK 553
Query: 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAID 693
PQNVLI K++S CAKLSDMGISKRL GDMS L +ATG GSSGWQAPEQL R+TRA+D
Sbjct: 554 PQNVLIIKERSLCAKLSDMGISKRLLGDMSSLAYHATGSGSSGWQAPEQLHHRRETRAVD 613
Query: 694 LFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
LFSLGC+LF+CITGG+HP+G+ ERD NIVK++KDLFLVE+IPEA DL +RLL+P+P+LR
Sbjct: 614 LFSLGCVLFYCITGGRHPFGDHLERDVNIVKNQKDLFLVEYIPEAEDLISRLLNPDPELR 673
Query: 754 PKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVAL-NGKWDEK 812
PKA VL+HP FW ++ RLSFLRD SDRVELEDR SDS +L+ALEGIA AL GKW+EK
Sbjct: 674 PKALEVLHHPMFWNSELRLSFLRDTSDRVELEDRVSDSDILKALEGIAPTALGGGKWNEK 733
Query: 813 METKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRF 872
ME FI +IGR+RRYK+D +RDLLRVIRNK NH+RELP +IQEL+G PEG+ NYF+ RF
Sbjct: 734 MEPAFITDIGRHRRYKFDGIRDLLRVIRNKLNHYRELPNEIQELVGPVPEGYDNYFASRF 793
Query: 873 PKLLIEVYNVIFTYCKGEEVFHKYVTND 900
PKLLIEVY V+ YC+ EE F KY+ ++
Sbjct: 794 PKLLIEVYKVVRKYCREEEWFQKYIKSN 821
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086074|ref|XP_002307805.1| predicted protein [Populus trichocarpa] gi|222857254|gb|EEE94801.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1952), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/494 (72%), Positives = 424/494 (85%)
Query: 407 IPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRV 466
+PKKKK+RR G N++ N+ K Q + +SKVGE + L+ + + K LLTFTD +D RV
Sbjct: 1 MPKKKKNRRSGNNKSNPNNLKNQKYLSLQSKVGEINELTRVERDERKLLLTFTDHVDGRV 60
Query: 467 DGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQH 526
DGRRIGKL+V NKEIAKGSNGTVVLEG Y+GR VAVKRLV++HHDVALKEIQNLIASDQH
Sbjct: 61 DGRRIGKLLVSNKEIAKGSNGTVVLEGIYDGRHVAVKRLVQSHHDVALKEIQNLIASDQH 120
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
PNIVRWYGVE DQDFVYL+LERCTCSLNDLIYV S SF+ Q+ +K+ DSN L E +RL
Sbjct: 121 PNIVRWYGVEYDQDFVYLALERCTCSLNDLIYVNSESFQNQIPSKDMDSNRLPEYMVRLH 180
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+ E+ +++ELWKANG+PS QLLK+ RD+VSGL+HLHE+G++HRD+KPQNVLI +KSFC
Sbjct: 181 SMPEHNRNVELWKANGYPSVQLLKLMRDVVSGLAHLHELGIVHRDMKPQNVLIISEKSFC 240
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
AKLSDMGISKRL GDMS LTQ+ TGYGSSGWQAPEQLL GRQTRA+DLFSLGC+LFFCIT
Sbjct: 241 AKLSDMGISKRLLGDMSSLTQHPTGYGSSGWQAPEQLLHGRQTRALDLFSLGCVLFFCIT 300
Query: 707 GGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766
GGKHP+G++ ERD NIV DRKDLFLVE+IPEA+DLFT LLDP+P+ RPKAQ VLNHP FW
Sbjct: 301 GGKHPFGDNIERDVNIVNDRKDLFLVENIPEALDLFTCLLDPDPEKRPKAQEVLNHPLFW 360
Query: 767 TADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRR 826
T++ RLSFL+DVSDRVELEDRE+ S+LL LE A +ALNGKWDEKME FI NIGRYRR
Sbjct: 361 TSEKRLSFLQDVSDRVELEDRENASELLDTLESTATMALNGKWDEKMEAAFINNIGRYRR 420
Query: 827 YKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTY 886
YK+D++RDLLRVIRNKS+H+RELPQ+I+ELLGSHPEGF +YFS RFPKLLIEVY VI+ Y
Sbjct: 421 YKFDSIRDLLRVIRNKSHHYRELPQEIKELLGSHPEGFESYFSRRFPKLLIEVYKVIYRY 480
Query: 887 CKGEEVFHKYVTND 900
CK EE F KY+ ++
Sbjct: 481 CKEEEFFRKYIDSN 494
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10177897|dbj|BAB11229.1| unnamed protein product [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/865 (47%), Positives = 536/865 (61%), Gaps = 51/865 (5%)
Query: 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASE----------FY 96
E LV+ +DG+I LVD K+ W+F T PIYSSYQA ++ FY
Sbjct: 105 ESGYVLVSTVDGSISLVDMSSQKLDWTFHTNEPIYSSYQAPHYHYTTDEERSSVLGDDFY 164
Query: 97 LDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGR 156
+D D+DW LY S R GK A E+I +PY S D + LG TSVFL+D K+G+
Sbjct: 165 MDCDKDWRLYNSSVRKGKRVNEIVDASEFIGTLPYTSTDR-IVLGKKDTSVFLLDWKTGK 223
Query: 157 VVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQST 216
+V Y +D S ++D+ K +V L SG + +LVYI R D+ +Q
Sbjct: 224 LVKRYRMDELYSNTVVENDKEKAIVLSKEAPLLFGSGFKKSEDFPELVYIERKDFKIQCI 283
Query: 217 SQDSGEVLWNVAYADFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTA 276
S+ G+VLW+V+YA +A+ + E + SG + G ++ P +
Sbjct: 284 SK-FGDVLWSVSYAKMEAKLQNHESVQFISGLSSSVG-----------KNQFPLSYTTSV 331
Query: 277 SVYRLRDNSLPEFLSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLP-DKVDRPPLALPS 335
+ +LR+ +G + + LP + + + L LP +K L+LP
Sbjct: 332 PMVQLRNVKYETLFPRLGFLDEALYLPFQDRKPNQLAIGDGNQLTLPGNKEAEEVLSLPL 391
Query: 336 TETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQSFIVLFIALC----PIIGFLFYHSKQ 391
ET I + GS + GF S IVL C + G FY +Q
Sbjct: 392 PETVISQITDIIDGSTKQ--------AGFASKFSGLIVLIFGFCVTMLSVCGLFFYRLRQ 443
Query: 392 VKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNG 451
S + E ++++ I KK + +K I G SH N
Sbjct: 444 --SIRIKEPYVSEVPIATPKKKKSKKNGTTKAVHKKENGFIS-----GGNKDPSH-EENE 495
Query: 452 EKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD 511
++ L F L + +G R+GKL V NKEIAKGSNGTVVLEG+YEGR VAVKRLV++HHD
Sbjct: 496 KRLLTAFPGLNNSSAEGYRVGKLFVSNKEIAKGSNGTVVLEGSYEGRLVAVKRLVQSHHD 555
Query: 512 VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 571
VA KEI NL+ASD+H NIVRWYGV+ D+ F+Y+SLE C CSLNDLIY S E + +
Sbjct: 556 VAQKEILNLMASDKHSNIVRWYGVDQDEHFIYISLELCACSLNDLIYASSALLESPMASS 615
Query: 572 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631
S I++ P+ EN K +ELWK NGHPS LLK+ RDIV+GL HLH+IG++HRD
Sbjct: 616 SIHS-------IQINPIFENGKGVELWKENGHPSPVLLKLMRDIVAGLVHLHDIGIVHRD 668
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691
LKPQNVLI K+ S CAKLSDMGISKRL D S LT+N+TG GSSGWQAPEQL RQTRA
Sbjct: 669 LKPQNVLIVKNSSLCAKLSDMGISKRLPADTSALTRNSTGSGSSGWQAPEQLRNERQTRA 728
Query: 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
+DLFSLGC+LFFC+TGGKHPYG+++ERD N++ D+KDLFL+E +PEAV L T LL+P+P+
Sbjct: 729 VDLFSLGCVLFFCMTGGKHPYGDNYERDVNVLNDQKDLFLIESLPEAVHLLTGLLNPDPN 788
Query: 752 LRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDE 811
LRP+AQ+V++HP FW +D RLSFLRD SDRVELE+RE S+LL ALE A V LNG+WDE
Sbjct: 789 LRPRAQDVMHHPLFWNSDMRLSFLRDASDRVELENREEGSQLLAALESTAAVTLNGRWDE 848
Query: 812 KMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCR 871
K+++ F++NIGRYRRYK+D++RDLLRVIRNK NH+RELP+++QELLGS PEGF YFS R
Sbjct: 849 KLDSIFLDNIGRYRRYKFDSIRDLLRVIRNKLNHYRELPKELQELLGSVPEGFERYFSSR 908
Query: 872 FPKLLIEVYNVIFTYCKGEEVFHKY 896
FPKLLI+VY V+F YC EE F KY
Sbjct: 909 FPKLLIQVYTVLFDYCNNEEFFFKY 933
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561453|ref|XP_002521737.1| kinase, putative [Ricinus communis] gi|223539128|gb|EEF40724.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 743 bits (1917), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/864 (48%), Positives = 556/864 (64%), Gaps = 33/864 (3%)
Query: 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSN---------ASEFYL 97
E LVA L+GTI+ +T ++ WSF +G PIYSSYQASFN + ++ F++
Sbjct: 61 EDSTELVALLNGTIYFQETNSERVFWSFSSGAPIYSSYQASFNQDNDGENEFGPSTGFFI 120
Query: 98 DVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRV 157
D +DW+LY H K MK LS + E+++ P++S+DG V LG+ T+VF+V+ K+GR+
Sbjct: 121 DYGDDWQLYAHGKHSSGMK-LSMNIEDFMIITPHVSEDGAVILGSKITTVFVVEAKTGRL 179
Query: 158 VDNY-VLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQST 216
V Y LD +S + +E + + +L+ + + QL+YI RTDY LQ+
Sbjct: 180 VQTYKSLDPPSSLQ--RDEEGNAFLNENRNNDLI---ISDSATSAQLIYITRTDYTLQNF 234
Query: 217 SQDSGEVLWNVAYADFKAEFRCQEV-GKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMT 275
+S ++ WN+ A +A F C++V G+S + S ++ + + ++ T
Sbjct: 235 GPNSDKISWNMKVAMIEAAFLCKDVEGRSNFDMPLSCQSR---RMVVRRQGNPQSSSEAT 291
Query: 276 ASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPS 335
L +L L +V SL + +L + L L KVD P P+
Sbjct: 292 HGDEMLPVPALDLVLPSQPRVGK--SLQDHHEGRMLSGSASDFVLPLQSKVDELPTFHPT 349
Query: 336 TETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQ---SFIVLFIALCPIIGFLFYHSKQV 392
++E L N + AF + I+ + +F + ++GF FY S V
Sbjct: 350 DDSEGMLALPNDSEGFDAHNARVAFDDWLNILIKRSTTLSFMFFIVIILLGFNFYPSNLV 409
Query: 393 KSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGE 452
K E ++ K S+R ++ + K +P E+ G T ++ + +
Sbjct: 410 GKSKVASEGLSSDSSSKASSSKRKKSRKSGKKNGK---DVPFENDDGPT-----LSDSSD 461
Query: 453 KFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV 512
K LL +D V+GRRIGKL V N EIAKGSNGT+VLEG YEGR VAVKRLV+ HH+V
Sbjct: 462 KKLLDLNKHVDRGVNGRRIGKLFVSNAEIAKGSNGTIVLEGIYEGRPVAVKRLVQAHHEV 521
Query: 513 ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKE 572
A KEIQNLIASD+HPNIVRWYGVE+D DFVYLSLERCTCSL+DLI + S Q+ +++
Sbjct: 522 AFKEIQNLIASDRHPNIVRWYGVENDNDFVYLSLERCTCSLDDLIQIYCDSSFNQVFSED 581
Query: 573 QDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632
Q + + ++RL V +D+ LWK+NGHPS +L + RD+V GL HLHE+G+IHRDL
Sbjct: 582 QATRVATNYKLRLNKVKGILQDLNLWKSNGHPSPLMLLLMRDVVCGLVHLHELGIIHRDL 641
Query: 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI 692
KPQNVLI K++S AKLSDMGISKRL GDMS L +ATG GSSGWQAPE LLQGRQTRA+
Sbjct: 642 KPQNVLILKERSLSAKLSDMGISKRLLGDMSSLGYHATGCGSSGWQAPELLLQGRQTRAV 701
Query: 693 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDL 752
DLFSLGC+LFFCITGG+HP+G+ ERD NIVK++ DLFLVE+ PEA DL +RLL+ +P+L
Sbjct: 702 DLFSLGCVLFFCITGGRHPFGDRLERDVNIVKNKMDLFLVEYFPEAGDLISRLLNHDPEL 761
Query: 753 RPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEK 812
RPKA VL+HP FW+++ RLSFLR+ SDRVELEDRES S LL+ALE IA AL GKWDEK
Sbjct: 762 RPKALEVLHHPMFWSSEMRLSFLRETSDRVELEDRESGSVLLKALESIASTALGGKWDEK 821
Query: 813 METKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRF 872
ME FI NIG YRRYKYD+VRDLLRV+RNK NH+RELP++IQEL+G PEG+ YF+ RF
Sbjct: 822 MEPAFITNIGHYRRYKYDSVRDLLRVLRNKLNHYRELPKEIQELVGPIPEGYDGYFASRF 881
Query: 873 PKLLIEVYNVIFTYCKGEEVFHKY 896
PKLLIEVY V++ +C+ E+ FHKY
Sbjct: 882 PKLLIEVYKVVYRFCREEDCFHKY 905
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495301|ref|XP_003516517.1| PREDICTED: uncharacterized protein LOC100785363 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1914), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 444/892 (49%), Positives = 553/892 (61%), Gaps = 75/892 (8%)
Query: 42 PPLPP---EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYS-SYQASFNS---NASE 94
P LP +P ALVAALDGT++LVD+ G++ WSF TG PIY SY+A N N
Sbjct: 37 PSLPAPSLKPATALVAALDGTMYLVDSVSGRVFWSFSTGSPIYHHSYRAPINDPEDNNVT 96
Query: 95 FYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKS 154
++ +DWEL H RFGK +LS S Y+ P +K+G G+ K ++F VD K+
Sbjct: 97 GLIECGDDWELIVHDARFGK-TRLSESIANYVALTPTETKEGASIFGSKKDTMFEVDAKT 155
Query: 155 GRVV-DNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVL 213
G +V +Y LD +AS D+ V ELV+ L L+ I R+DYVL
Sbjct: 156 GALVRTHYDLD-NASNVVLSGDDRLQRVTTTKNNELVDPA--QLDSPEFLLKITRSDYVL 212
Query: 214 QSTSQDSGEVLWNVAYADFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQ 273
+S + +G VLW + A+FKA CQ F++ +D D C
Sbjct: 213 KSLGK-AGIVLWTMNVAEFKARLICQHNENPSGRDSFDAEDGYVVDRGLDFAMPYACWDM 271
Query: 274 MTASVYRLRDNSLPEFLSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRP---- 329
VYR R N L A L G Q +++ P S L LP + D
Sbjct: 272 KLNEVYRQRKNFLLH-------PADPGRLSGIYQENIMLPF-HTSELMLPSQPDMDGFIL 323
Query: 330 --------PL----ALPSTETEI------------PWTLGMPGGSVSEINKKHAFVEGFR 365
PL +LPS + ++ PW L M + E++ K +E
Sbjct: 324 GQGGNMMLPLPISNSLPSLQQKLDFCESNDNVAMLPWPL-MEISTQEEVDPKKV-IEWST 381
Query: 366 SYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNS 425
+ +F+ F+FYH V +K QN E +++ PKKKK+R+ N T ++
Sbjct: 382 TLPLILFTIFLGF-----FVFYHYLVVTNKDQNRELNSRSLPPKKKKARKSVKNNITIDN 436
Query: 426 EKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGS 485
+ + P S E D L+ N + T+T + +VDGRRIGKL V NKEIAKGS
Sbjct: 437 RQDK---PMSS--AEEDKLARKETNTD----TYTQM---QVDGRRIGKLFVSNKEIAKGS 484
Query: 486 NGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545
NGT+V EG YEGR VAVKRLVK HHDVA KEIQNLIASD+HPNIVRWYGVE D DFVYL+
Sbjct: 485 NGTIVFEGTYEGRVVAVKRLVKAHHDVAHKEIQNLIASDRHPNIVRWYGVECDHDFVYLA 544
Query: 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE-LWKANGHP 604
LERCTC+L+DLI++ S E ++Q SN RI + D+ LWKANG P
Sbjct: 545 LERCTCNLDDLIHMYSDISENPTICEDQYSNFFKNARI------DTRNDMRYLWKANGFP 598
Query: 605 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 664
S LLK+ RD+VSGL HLHE+G+IHRDLKPQNVLI K+KS CAKLSDMGISKRL DMS
Sbjct: 599 SPLLLKLMRDVVSGLVHLHELGIIHRDLKPQNVLILKEKSLCAKLSDMGISKRLLEDMSS 658
Query: 665 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK 724
L TG GSSGWQAPEQL+QGRQTRA+DLFSLGC+LFFC+TGG+HP+GE ERD NIVK
Sbjct: 659 LGHTVTGCGSSGWQAPEQLVQGRQTRAVDLFSLGCVLFFCMTGGRHPFGERLERDFNIVK 718
Query: 725 DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVEL 784
++KDLFLVE IPEA DL + LL+PNPDLR A VL+HP FW+++ RLSFLRDVSDRVEL
Sbjct: 719 NQKDLFLVEFIPEADDLISCLLNPNPDLRLTAIEVLHHPLFWSSEMRLSFLRDVSDRVEL 778
Query: 785 EDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSN 844
EDRE DS LL+ALE IA +AL KWDEK++ FI NIGRYRRYKYD+VR LLRV+RNK N
Sbjct: 779 EDREIDSDLLKALESIAPLALGAKWDEKLDPDFITNIGRYRRYKYDSVRHLLRVMRNKLN 838
Query: 845 HFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 896
H+RELPQ+IQEL+G PEGF +YF+ RFP+LLIEVY VI+ CK +E F +Y
Sbjct: 839 HYRELPQEIQELIGPVPEGFNDYFASRFPRLLIEVYKVIYKSCKDDECFQRY 890
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297808453|ref|XP_002872110.1| hypothetical protein ARALYDRAFT_489300 [Arabidopsis lyrata subsp. lyrata] gi|297317947|gb|EFH48369.1| hypothetical protein ARALYDRAFT_489300 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 735 bits (1897), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/876 (46%), Positives = 532/876 (60%), Gaps = 81/876 (9%)
Query: 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASF----------NSNASEFY 96
E LV+ +DG+I LVD K+ W+F T PIYSSYQA ++ +F+
Sbjct: 45 ESGYVLVSTVDGSISLVDMSSQKLDWTFHTNEPIYSSYQAPHYHYTTDEERASALGDDFF 104
Query: 97 LDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGR 156
+D D+DW L+ S R GK A E+I +PY S D + LG TSVFL+D K+G+
Sbjct: 105 MDCDKDWRLFNSSMRKGKRVNEIVDASEFIGTLPYTSTDR-IVLGKKDTSVFLLDWKTGK 163
Query: 157 VVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQST 216
+V Y +D S ++D+ K +V L SG + + +LVYI R D+ +Q
Sbjct: 164 LVKRYRMDELYSNTVVENDKEKAIVLSKEAPILFGSGFKESEDLPELVYIERKDFKIQCI 223
Query: 217 SQDSGEVLWNVAYADFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTA 276
S+ G+VLW+V+YA +A+ + E G + G + ++HLP +
Sbjct: 224 SK-FGDVLWSVSYAKMEAKLQNHESVHLMGGLSSSDGIPIRTSW---GKNHLPLSYTTSV 279
Query: 277 SVYRLRDNSLPEFLSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLPDKVDRPPLALPST 336
V +LR+ + +G + + LP DR P D LALPS
Sbjct: 280 PVVQLRNVNYETLFPRLGFLDEALYLPFQ---------DRKPNRLAPG--DGKHLALPSN 328
Query: 337 ETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQSFIVLFIALC----PIIGFLFYHSKQ- 391
+ +++I GF S IVL C + G F +Q
Sbjct: 329 KE---------AEEITDIIDGSTTQAGFASKFSGLIVLLFGFCVTMLSVCGIFFCRLRQG 379
Query: 392 --VKSKKQNEEHIT--------KTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGET 441
+K +E I K G KK+ G N++ +N E
Sbjct: 380 MWIKDPYVSEVPIAIPKKKKSKKNGTHKKENGLISGGNKDPSNEE--------------- 424
Query: 442 DGLSHITGNGEKFLLTFTDLIDDR-VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSV 500
N ++ L F L ++ +G R+GKL V NKEIAKGSNGTVVLEG+YEGR V
Sbjct: 425 --------NDKRLLTAFPGLNNNSSAEGYRVGKLFVSNKEIAKGSNGTVVLEGSYEGRLV 476
Query: 501 AVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVL 560
AVKRLV++HHDVA KEI NL+ASD+HPNIVRWYGV+ D+ F+Y+SLERC CSLNDLIY
Sbjct: 477 AVKRLVQSHHDVAQKEILNLMASDKHPNIVRWYGVDQDEHFIYISLERCACSLNDLIYAS 536
Query: 561 SGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620
S E + + I+ P+ EN K +ELWK NGHPS LLK+ DIV+GL
Sbjct: 537 SALLESPVASSSIQP-------IQRNPIFENGKGVELWKENGHPSPVLLKLMSDIVAGLV 589
Query: 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680
HLH+IG++HRDLKPQNVLI K+ S CAKLSDMGISKRL D S LT+N+TG GSSGWQAP
Sbjct: 590 HLHDIGIVHRDLKPQNVLIVKNSSVCAKLSDMGISKRLPADTSALTRNSTGSGSSGWQAP 649
Query: 681 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVD 740
EQL RQTRA+DLFSLGC+LFFC+T GKHPYG+++ERD N++ DRKDLFL+E +PEAV
Sbjct: 650 EQLRNERQTRAVDLFSLGCVLFFCMTAGKHPYGDNYERDVNVLNDRKDLFLIESLPEAVH 709
Query: 741 LFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 800
L + LL+P+P+LRP+AQ VL+HP FW +D RLSFLRD SDRVELE+RE S+LL ALE
Sbjct: 710 LLSGLLNPDPNLRPRAQEVLHHPLFWNSDMRLSFLRDASDRVELENREEGSQLLAALEST 769
Query: 801 ALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSH 860
A V LNG+WDEK+++ F++NIGRYRRYK+D++RDLLRVIRNK NH+RELP+++QELLGS
Sbjct: 770 AAVTLNGRWDEKLDSIFLDNIGRYRRYKFDSIRDLLRVIRNKLNHYRELPKELQELLGSV 829
Query: 861 PEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 896
PEGF YFS RFPKLLI+VY V+F YC EE F KY
Sbjct: 830 PEGFERYFSSRFPKLLIQVYTVLFDYCNNEEFFFKY 865
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15277137|dbj|BAB63366.1| Ire1 homolog-1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/867 (47%), Positives = 533/867 (61%), Gaps = 53/867 (6%)
Query: 47 EPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASE----------FY 96
E LV+ +DG+I LVD K+ W+F T PIYSSYQA ++ FY
Sbjct: 45 ESGYVLVSTVDGSISLVDMSSQKLDWTFHTNEPIYSSYQAPHYHYTTDEERSSVLGDDFY 104
Query: 97 LDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGR 156
+D D+DW LY S R GK A E+I +PY S D + LG TSVFL+D K+G+
Sbjct: 105 MDCDKDWRLYNSSVRKGKRVNEIVDASEFIGTLPYTSTDR-IVLGKKDTSVFLLDWKTGK 163
Query: 157 VVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQST 216
+V Y +D S ++D+ K +V L SG + +LVYI R D+ +Q
Sbjct: 164 LVKRYRMDELYSNTVVENDKEKAIVLSKEAPLLFGSGFKKSEDFPELVYIERKDFKIQCI 223
Query: 217 SQDSGEVLWNVAYADFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTA 276
S+ G+VLW+V+YA +A+ + E + SG + G ++ P +
Sbjct: 224 SK-FGDVLWSVSYAKMEAKLQNHESVQFISGLSSSVG-----------KNQFPLSYTTSV 271
Query: 277 SVYRLRDNSLPEFLSVIGKVAGWISLPGSSQNSLLGPVDRNSPLFLP-DKVDRPPLALPS 335
+ +LR+ +G + + LP + + + L LP +K L+LP
Sbjct: 272 PMVQLRNVKYETLFPRLGFLDEALYLPFQDRKPNQLAIGDGNQLTLPGNKEAEEVLSLPL 331
Query: 336 TETEIPWTLGMPGGSVSEINKKHAFVEGFRSYIQSFIVLFIALC----PIIGFLFYHSKQ 391
ET I + GS + GF S IVL C + G FY +Q
Sbjct: 332 PETVISQITDIIDGSTKQ--------AGFASKFSGLIVLIFGFCVTMLSVCGLFFYRLRQ 383
Query: 392 VKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNG 451
S + E ++++ I KK + +K I G SH N
Sbjct: 384 --SIRIKEPYVSEVPIATPKKKKSKKNGTTKAVHKKENGFIS-----GGNKDPSH-EENE 435
Query: 452 EKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD 511
++ L F L + +G R+GKL V NKEIAKGSNGTVVLEG+YEGR VAVKRLV++HHD
Sbjct: 436 KRLLTAFPGLNNSSAEGYRVGKLFVSNKEIAKGSNGTVVLEGSYEGRLVAVKRLVQSHHD 495
Query: 512 VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 571
VA KEI NL+ASD+H NIVRWYGV+ D+ F+Y+SLE C CSLNDLIY S E + +
Sbjct: 496 VAQKEILNLMASDKHSNIVRWYGVDQDEHFIYISLELCACSLNDLIYASSALLESPMASS 555
Query: 572 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631
S I++ P+ EN K +ELWK NGHPS LLK+ RDIV+GL HLH+IG++HRD
Sbjct: 556 SIHS-------IQINPIFENGKGVELWKENGHPSPVLLKLMRDIVAGLVHLHDIGIVHRD 608
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG--WQAPEQLLQGRQT 689
LKPQNVLI K+ S CAKLSDMGISKRL D S LT+N+ G GS WQAPEQL RQT
Sbjct: 609 LKPQNVLIVKNSSLCAKLSDMGISKRLPADTSALTRNSIGLGSGSSGWQAPEQLRNERQT 668
Query: 690 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPN 749
RA+DLFSLGC+LFFC+TGGKHPYG+++ERD N++ D+KDLFL+E +PEAV L T LL+P+
Sbjct: 669 RAVDLFSLGCVLFFCMTGGKHPYGDNYERDVNVLNDQKDLFLIESLPEAVHLLTGLLNPD 728
Query: 750 PDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKW 809
P+LRP+AQ+V++HP FW +D RLSFLRD SDRVELE+RE S+LL ALE A V LNG+W
Sbjct: 729 PNLRPRAQDVMHHPLFWNSDMRLSFLRDASDRVELENREEGSQLLAALESTAAVTLNGRW 788
Query: 810 DEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFS 869
DEK+++ F++NIGRYRRYK+D++RDLLRVIRNK NH+RELP+++QELLGS PEGF YFS
Sbjct: 789 DEKLDSIFLDNIGRYRRYKFDSIRDLLRVIRNKLNHYRELPKELQELLGSVPEGFERYFS 848
Query: 870 CRFPKLLIEVYNVIFTYCKGEEVFHKY 896
RFPKLLI+VY V+F YC EE F KY
Sbjct: 849 SRFPKLLIQVYTVLFDYCNNEEFFFKY 875
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 902 | ||||||
| TAIR|locus:2053928 | 841 | IRE1A [Arabidopsis thaliana (t | 0.534 | 0.573 | 0.616 | 5.6e-176 | |
| WB|WBGene00002147 | 967 | ire-1 [Caenorhabditis elegans | 0.321 | 0.299 | 0.421 | 9.1e-82 | |
| DICTYBASE|DDB_G0267650 | 984 | ireA "IRE family protein kinas | 0.543 | 0.497 | 0.346 | 3.9e-79 | |
| TAIR|locus:2081551 | 554 | AT3G11870 [Arabidopsis thalian | 0.507 | 0.826 | 0.395 | 5.1e-74 | |
| UNIPROTKB|F1NPU5 | 946 | Gga.10887 "Uncharacterized pro | 0.331 | 0.316 | 0.368 | 2.6e-73 | |
| CGD|CAL0001725 | 1224 | IRE1 [Candida albicans (taxid: | 0.253 | 0.187 | 0.394 | 6.5e-72 | |
| UNIPROTKB|Q5A7G9 | 1224 | IRE1 "Likely protein kinase/en | 0.253 | 0.187 | 0.394 | 6.5e-72 | |
| MGI|MGI:1930134 | 977 | Ern1 "endoplasmic reticulum (E | 0.320 | 0.295 | 0.369 | 2e-70 | |
| RGD|1559716 | 963 | Ern1 "endoplasmic reticulum to | 0.320 | 0.300 | 0.369 | 2.1e-70 | |
| UNIPROTKB|E7ETG2 | 874 | ERN2 "Endoribonuclease" [Homo | 0.318 | 0.328 | 0.39 | 9.2e-70 |
| TAIR|locus:2053928 IRE1A [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1523 (541.2 bits), Expect = 5.6e-176, Sum P(3) = 5.6e-176
Identities = 307/498 (61%), Positives = 368/498 (73%)
Query: 404 KTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLID 463
K G KKKK+R+ + TN + +P G+ D I G + LL F +
Sbjct: 357 KAGPSKKKKNRK---SAKDTNRQS----VPR----GQ-DQFELIEGG--QMLLGFNNFQS 402
Query: 464 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS 523
DGR+IGKL + +KEIAKGSNGTVV EG YEGR VAVKRLV++HH+VA KEIQNLIAS
Sbjct: 403 GATDGRKIGKLFLSSKEIAKGSNGTVVFEGIYEGRPVAVKRLVRSHHEVAFKEIQNLIAS 462
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIY-VLSGSFEEQLNAKEQDSNLLNEVR 582
DQH NI+RWYGVE DQDFVYLSLERCTCSL+DLI L S + L + + +
Sbjct: 463 DQHTNIIRWYGVEYDQDFVYLSLERCTCSLDDLIKSYLEFSMTKVLENNDSTEGVA-AYK 521
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
I+L + K WK GHPS +LK+ RDIV G+ HLHE+G++HRDLKPQNVLISKD
Sbjct: 522 IQLDSLEGVIKGNNFWKVGGHPSPLMLKLMRDIVCGIVHLHELGIVHRDLKPQNVLISKD 581
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
+ AKLSDMGISKR+ DMS L ATG GSSGWQAPEQLLQGRQTRA+D+FSLGC++F
Sbjct: 582 MTLSAKLSDMGISKRMSRDMSSLGHLATGSGSSGWQAPEQLLQGRQTRAVDMFSLGCVIF 641
Query: 703 FCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762
+ ITG KHP+G+ ERD NIVK++ DLFLVEH+PEA DL +RLL+P+PDLRP A VL H
Sbjct: 642 YTITGCKHPFGDDLERDVNIVKNKVDLFLVEHVPEASDLISRLLNPDPDLRPSATEVLLH 701
Query: 763 PFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIG 822
P FW ++ RLSFLRD SDRVELE+RE+DS++L+A+E A VA+ GKWDEK+E FI NIG
Sbjct: 702 PMFWNSEMRLSFLRDASDRVELENREADSEILKAMESTAPVAIGGKWDEKLEPVFITNIG 761
Query: 823 RYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNV 882
RYRRYKYD++RDLLRVIRNK NH RELP +IQEL+G+ PEGF YF+ RFPKLLIEVY V
Sbjct: 762 RYRRYKYDSIRDLLRVIRNKLNHHRELPPEIQELVGTVPEGFDEYFAVRFPKLLIEVYRV 821
Query: 883 IFTYCKGEEVFHKYVTND 900
I +C+ EEVF KY D
Sbjct: 822 ISLHCREEEVFRKYFKCD 839
|
|
| WB|WBGene00002147 ire-1 [Caenorhabditis elegans (taxid:6239)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 9.1e-82, Sum P(5) = 9.1e-82
Identities = 127/301 (42%), Positives = 189/301 (62%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI---SKDKSFCAKLSDMGISKRLQGDMSC 664
L + + GL+HLH ++HRD+KPQNVLI S+ A +SD G+ KR+Q +
Sbjct: 613 LRDIMKQATDGLAHLHASKIVHRDMKPQNVLITMASQRGEMRAVISDFGLCKRVQPGKNS 672
Query: 665 LTQN-ATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANI 722
+++ A+G G+ GW APE L+ + +D+FSLGCI ++ +T G HP+G+S R ANI
Sbjct: 673 ISRGIASGLAGTDGWIAPEVLISASTSYPVDIFSLGCIFYYVLTSGTHPFGKSLHRQANI 732
Query: 723 VKDRKDLFLVEHIPE---AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVS 779
V L + + + A DL + +L+ P R A VLNHPFFWT++ RL++ DVS
Sbjct: 733 VNGEYTLNKLADLDDWSLADDLISSMLNVEPLHRLTADAVLNHPFFWTSEKRLAYFSDVS 792
Query: 780 DRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVI 839
DRVE E E +S ++R +E A + + G W EK+ E++ ++R YK +VRDLLR +
Sbjct: 793 DRVEKE--EDNSPVVRRIETDARIVVCGGWREKICDALKEDLRKFRTYKSFSVRDLLRAM 850
Query: 840 RNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTN 899
RNK +H+RELP+D+++ LG P+ F +YF+ RFP+LL+ VY YC GE VF +Y ++
Sbjct: 851 RNKKHHYRELPEDVRQSLGDIPDQFLHYFTSRFPRLLLHVYKAT-EYCSGEAVFKRYYSD 909
Query: 900 D 900
D
Sbjct: 910 D 910
|
|
| DICTYBASE|DDB_G0267650 ireA "IRE family protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 737 (264.5 bits), Expect = 3.9e-79, Sum P(3) = 3.9e-79
Identities = 184/531 (34%), Positives = 286/531 (53%)
Query: 388 HSKQVKSKKQNEEH-ITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSH 446
++ Q ++ N+ + I PKKKK ++ N N E +N I N + + D +
Sbjct: 471 NNNQNNNQNSNQNNNINNKKTPKKKKKKQKNKNNKNNNDEDDENEIENYND-NQNDLIDE 529
Query: 447 -ITGNG--------EKFLLTFTDLIDD---RV---DGR-RIGKL-VVFNKEIAKGSNGTV 489
I+ N ++ L+ ++ I++ ++ +G +IGKL ++ NK + GS GT+
Sbjct: 530 FISTNSVIQQQQQQQQQLINSSNKINNGSGKIILDNGNVKIGKLEIITNKILGTGSCGTI 589
Query: 490 VLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549
V EG EGR VAVKR++ A +E+ LI SD+H N+VR+Y E D +F+YL++ C
Sbjct: 590 VYEGKMEGRKVAVKRMLSQFVKFADREVSILIHSDEHTNVVRYYAKEEDDEFIYLAISFC 649
Query: 550 TCSLNDLIY-VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608
SL+ + LS + Q SN N + ++ N + Q+
Sbjct: 650 QKSLDMYVQQTLSLQISPTDSPSIQSSNNNGNGNNG-----NNNNNNQIIIDN--KTKQM 702
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 668
+ ++ GL HLH + ++HRD+KP NVLI D + K+SDMG+ K L D LT
Sbjct: 703 IL---ELFKGLEHLHSLNIVHRDIKPHNVLI--DPNNRVKISDMGLGKLLDNDDQSLTFT 757
Query: 669 ATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 726
+ S GWQ P + L G R T+ +D+FSLGC++++ +TG HP+G + R+ N++K +
Sbjct: 758 SD---SHGWQ-PAEYLNGTNRNTKKVDIFSLGCVVYYLLTGA-HPFGHRYNREKNVLKGK 812
Query: 727 KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELED 786
D+ ++H+P+ L ++ P+ RP +NHPFFW +LSFL SD +E E
Sbjct: 813 FDIDQIKHLPDIHQLVHSMIQFEPEKRPDIGECINHPFFWEVHKKLSFLVAASDYLEFEK 872
Query: 787 RESDSKLLRALEGIALVAL-NGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNH 845
S L + LV +G W K++ I+NIGRYR+Y ++RDLLRVIRNK NH
Sbjct: 873 PTSPLNL-EIDSHVDLVTDGSGDWWLKIDQVLIDNIGRYRKYNGKSIRDLLRVIRNKFNH 931
Query: 846 FRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 896
+R+L + Q LG P+GF+NYF +FP+L I Y I K ++ F +Y
Sbjct: 932 YRDLSPEEQTCLGILPDGFFNYFDLKFPQLFIVTYLFILKNLKNDQYFVQY 982
|
|
| TAIR|locus:2081551 AT3G11870 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 747 (268.0 bits), Expect = 5.1e-74, P = 5.1e-74
Identities = 200/506 (39%), Positives = 280/506 (55%)
Query: 417 GYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGK-LV 475
G TNSE +P++ + +T L + + E L D ++ G+ + + L+
Sbjct: 69 GEENEKTNSESKVLSVPSDQNINKT--LPVMLPSLE---LRKYD--ENETPGKVVNRRLL 121
Query: 476 VFNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRW 532
V E+ G NG V +G Y RS VAVK L H A EI N D H NI+R+
Sbjct: 122 VSTNEMKYGRNGYEVFQGVYGRRSSVAVKCLDLAHTTEAFIQNEIDNHCLCDDHSNIIRF 181
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+G+E DQ F Y+ LE CSL+DLI + + ++D+ + V L VM
Sbjct: 182 HGLEQDQSFAYICLEPWKCSLDDLIKL-------SVRRTKRDTQAVAPVD-DLEKVM--- 230
Query: 593 KDIELWKANGHPS--AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKL 649
K I+ WK G P +LK+ RD+V GL+HLH++ IHR+L PQNVLI KD + AK+
Sbjct: 231 KRIKFWKEKGKPLPLTPMLKLMRDVVCGLAHLHKLKTIHRNLNPQNVLIIVKDMTLTAKI 290
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA---IDLFSLGCILFFCIT 706
SDM +SK L G S AT GSSGWQAPEQL + ++ + D+F+ GC+L + +
Sbjct: 291 SDMSLSKHLGGKKSSYKHLATCSGSSGWQAPEQLNKDKKKKEDFPADMFNFGCLLHYAVM 350
Query: 707 GGKHPYGESFERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
G HP+G ERD NI + K +L LV ++ EA++L +LL+ PDLRP A VL HP F
Sbjct: 351 G-THPFGSPSERDTNIKTNNKTNLSLVTNL-EAINLIEQLLNYKPDLRPSATQVLLHPLF 408
Query: 766 WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFI---ENIG 822
W ++ RL FLR+ SDR+EL D L + + L + W K+ FI EN+
Sbjct: 409 WDSEKRLFFLREASDRIEL-DITMWGDLNKTIAPRVL-GESKDWASKLGKTFITHIENLA 466
Query: 823 R---------YRR-YKYDNVRDLLRVIRNKSNHFRELPQD--IQELLGSHPEGFYNYFSC 870
+ Y R YKY ++R LLR+IRN +H RE+ D I+E++G PEG +F+
Sbjct: 467 QAQPGQESRQYNRSYKYWSLRHLLRLIRNILSHHREILDDPKIKEMVGKVPEGLDIFFTA 526
Query: 871 RFPKLLIEVYNVIFTYCKGEEVFHKY 896
RFP L++E+Y I +CKGEE F KY
Sbjct: 527 RFPNLMMEIYAFISMHCKGEEAFEKY 552
|
|
| UNIPROTKB|F1NPU5 Gga.10887 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 544 (196.6 bits), Expect = 2.6e-73, Sum P(4) = 2.6e-73
Identities = 115/312 (36%), Positives = 177/312 (56%)
Query: 599 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC---AKLSDMGIS 655
KA H Q + + + SGL++LH + ++HRDLKP N+LIS + A +SD G+
Sbjct: 627 KAFSHHGLQPIALLQQTTSGLAYLHSLSIVHRDLKPHNILISMPNAHGKVKAMISDFGLC 686
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPY 712
K+L ++ + G+ GW APE L + T +D+FS GC+ ++ ++ G HP+
Sbjct: 687 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVVSEGSHPF 746
Query: 713 GESFERDANIVKDRKDL-FLVEHIPEAV---DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768
G+S +R ANI+ L FL E + DL ++++ +P RP A VL HPFFW+
Sbjct: 747 GKSLQRQANILLGAYSLEFLDAGRHEDIVARDLIEQMINMDPQKRPSASCVLKHPFFWSL 806
Query: 769 DTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYK 828
+ +L F +DVSDR+E E D +++ LE + W E + ++ ++R YK
Sbjct: 807 EKQLQFFQDVSDRIEKE--ALDGPIVKQLERGGREVVKMDWREHITVPLQTDLRKFRSYK 864
Query: 829 YDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCK 888
+VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL+ Y+ + C+
Sbjct: 865 GGSVRDLLRAMRNKKHHYRELPPEVQETLGSIPDDFVCYFTARFPHLLLHTYHAMRICCQ 924
Query: 889 GEEVFHKYVTND 900
E +F Y D
Sbjct: 925 -ERLFQHYYQQD 935
|
|
| CGD|CAL0001725 IRE1 [Candida albicans (taxid:5476)] | Back alignment and assigned GO terms |
|---|
Score = 500 (181.1 bits), Expect = 6.5e-72, Sum P(4) = 6.5e-72
Identities = 93/236 (39%), Positives = 147/236 (62%)
Query: 668 NATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 726
N G G++ G++ T+AID+FSLGC+ ++ +TGG HP+G+ + R+ NI+K
Sbjct: 988 NGNGNGATNGSVSNSATSGKRLTKAIDIFSLGCVFYYILTGGYHPFGDRYLREGNIIKGE 1047
Query: 727 KDL-FLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 781
DL L+E P E++DL ++++ +P RP +L HP FW+ RL FL VSDR
Sbjct: 1048 YDLSLLMEKCPNDRYESIDLISKIISHDPSQRPNTGKILKHPLFWSFSKRLEFLLKVSDR 1107
Query: 782 VELEDRESDSKLLRALEGIALVALNGKWDEKM-ETKFIENIGRYRRYKYDNVRDLLRVIR 840
E+E R+ S LL LE A NG W + + + +F++N+G+YR+Y + + DLLR +R
Sbjct: 1108 FEIEKRDPPSPLLLKLEEHAKAVHNGNWHKLLNDDEFMDNLGKYRKYSPEKLMDLLRAMR 1167
Query: 841 NKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 896
NK +H+ ++P+ +Q + P+GFY YF+ +FPKLL+E+Y V+ + E VF +Y
Sbjct: 1168 NKYHHYNDMPESLQLKMAPLPDGFYKYFNDKFPKLLMEIYYVVEENFRNEHVFKEY 1223
|
|
| UNIPROTKB|Q5A7G9 IRE1 "Likely protein kinase/endoribonuclease Ire1" [Candida albicans SC5314 (taxid:237561)] | Back alignment and assigned GO terms |
|---|
Score = 500 (181.1 bits), Expect = 6.5e-72, Sum P(4) = 6.5e-72
Identities = 93/236 (39%), Positives = 147/236 (62%)
Query: 668 NATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 726
N G G++ G++ T+AID+FSLGC+ ++ +TGG HP+G+ + R+ NI+K
Sbjct: 988 NGNGNGATNGSVSNSATSGKRLTKAIDIFSLGCVFYYILTGGYHPFGDRYLREGNIIKGE 1047
Query: 727 KDL-FLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 781
DL L+E P E++DL ++++ +P RP +L HP FW+ RL FL VSDR
Sbjct: 1048 YDLSLLMEKCPNDRYESIDLISKIISHDPSQRPNTGKILKHPLFWSFSKRLEFLLKVSDR 1107
Query: 782 VELEDRESDSKLLRALEGIALVALNGKWDEKM-ETKFIENIGRYRRYKYDNVRDLLRVIR 840
E+E R+ S LL LE A NG W + + + +F++N+G+YR+Y + + DLLR +R
Sbjct: 1108 FEIEKRDPPSPLLLKLEEHAKAVHNGNWHKLLNDDEFMDNLGKYRKYSPEKLMDLLRAMR 1167
Query: 841 NKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 896
NK +H+ ++P+ +Q + P+GFY YF+ +FPKLL+E+Y V+ + E VF +Y
Sbjct: 1168 NKYHHYNDMPESLQLKMAPLPDGFYKYFNDKFPKLLMEIYYVVEENFRNEHVFKEY 1223
|
|
| MGI|MGI:1930134 Ern1 "endoplasmic reticulum (ER) to nucleus signalling 1" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 542 (195.9 bits), Expect = 2.0e-70, Sum P(4) = 2.0e-70
Identities = 113/306 (36%), Positives = 177/306 (57%)
Query: 603 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQ 659
H + + + SGL+HLH + ++HRDLKP N+L+S + A +SD G+ K+L
Sbjct: 660 HLGLEPITLLHQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIKAMISDFGLCKKLA 719
Query: 660 GDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPYGESF 716
++ + G+ GW APE L + T +D+FS GC+ ++ I+ G HP+G+S
Sbjct: 720 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKDNPTYTVDIFSAGCVFYYVISEGNHPFGKSL 779
Query: 717 ERDANIVKD--RKDLFLVEHIPEAV--DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 772
+R ANI+ D F + + + +L +++ +P RP A++VL HPFFW+ + +L
Sbjct: 780 QRQANILLGACNLDCFHSDKHEDVIARELIEKMIAMDPQQRPSAKHVLKHPFFWSLEKQL 839
Query: 773 SFLRDVSDRVELEDRESDSKLLRALE--GIALVALNGKWDEKMETKFIENIGRYRRYKYD 830
F +DVSDR+E E D ++R LE G A+V ++ W E + ++ ++R YK
Sbjct: 840 QFFQDVSDRIEKE--ALDGPIVRQLERGGRAVVKMD--WRENITVPLQTDLRKFRTYKGG 895
Query: 831 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 890
+VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL Y + C+ E
Sbjct: 896 SVRDLLRAMRNKKHHYRELPVEVQETLGSIPDDFVRYFTSRFPHLLSHTYQAM-ELCRHE 954
Query: 891 EVFHKY 896
+F Y
Sbjct: 955 RLFQTY 960
|
|
| RGD|1559716 Ern1 "endoplasmic reticulum to nucleus signaling 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 2.1e-70, Sum P(4) = 2.1e-70
Identities = 113/306 (36%), Positives = 177/306 (57%)
Query: 603 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQ 659
H + + + SGL+HLH + ++HRDLKP N+L+S + A +SD G+ K+L
Sbjct: 646 HLGLEPITLLHQTTSGLAHLHSLNIVHRDLKPHNILLSMPNAHGRIKAMISDFGLCKKLA 705
Query: 660 GDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITGGKHPYGESF 716
++ + G+ GW APE L + T +D+FS GC+ ++ I+ G HP+G+S
Sbjct: 706 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGNHPFGKSL 765
Query: 717 ERDANIVKDR--KDLFLVEHIPEAV--DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 772
+R ANI+ D F + + + +L +++ +P RP A++VL HPFFW+ + +L
Sbjct: 766 QRQANILLGACSLDCFHSDKHEDVIARELIEKMIAMDPQQRPSAKHVLKHPFFWSLEKQL 825
Query: 773 SFLRDVSDRVELEDRESDSKLLRALE--GIALVALNGKWDEKMETKFIENIGRYRRYKYD 830
F +DVSDR+E E D ++R LE G A+V ++ W E + ++ ++R YK
Sbjct: 826 QFFQDVSDRIEKESL--DGPIVRQLERGGRAVVKMD--WRENITVPLQTDLRKFRTYKGG 881
Query: 831 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 890
+VRDLLR +RNK +H+RELP ++QE LGS P+ F YF+ RFP LL Y + C+ E
Sbjct: 882 SVRDLLRAMRNKRHHYRELPLEVQETLGSIPDDFVRYFTSRFPHLLSHTYRAM-ELCRHE 940
Query: 891 EVFHKY 896
+F Y
Sbjct: 941 RLFQTY 946
|
|
| UNIPROTKB|E7ETG2 ERN2 "Endoribonuclease" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 550 (198.7 bits), Expect = 9.2e-70, Sum P(4) = 9.2e-70
Identities = 117/300 (39%), Positives = 174/300 (58%)
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAK--LSDMGISKRLQGDMSCLTQ 667
V + ++SGL+HLH + ++HRDLKP N+LI+ D + LSD G+ K+L +
Sbjct: 565 VLQQLMSGLAHLHSLHIVHRDLKPGNILITGPDSQGLGRVVLSDFGLCKKLPAGRCSFSL 624
Query: 668 NATGYGSSGWQAPE--QLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVK 724
++ G+ GW APE QLL T A+D+FS GC+ ++ ++GG HP+G+S R ANI+
Sbjct: 625 HSGIPGTEGWMAPELLQLLPPDSPTSAVDIFSAGCVFYYVLSGGSHPFGDSLYRQANILT 684
Query: 725 DRKDL-FLVEHIPEAV---DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 780
L L E + + V DL +L P P RP A VL HPFFW+ +L F +DVSD
Sbjct: 685 GAPCLAHLEEEVHDKVVARDLVGAMLSPLPQPRPSAPQVLAHPFFWSRAKQLQFFQDVSD 744
Query: 781 RVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIR 840
+E E + L+RALE + W E + ++ ++R YK +VRDLLR +R
Sbjct: 745 WLEKESEQEP--LVRALEAGGCAVVRDNWHEHISMPLQTDLRKFRSYKGTSVRDLLRAVR 802
Query: 841 NKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTND 900
NK +H+RELP ++++ LG P+GF YF+ RFP+LL+ + + + C E +F Y D
Sbjct: 803 NKKHHYRELPVEVRQALGQVPDGFVQYFTNRFPRLLLHTHRAMRS-CASESLFLPYYPPD 861
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 3.1.26 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00002908001 | SubName- Full=Chromosome chr18 scaffold_137, whole genome shotgun sequence; (852 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 902 | |||
| cd10422 | 129 | cd10422, RNase_Ire1, RNase domain (also known as t | 3e-59 | |
| pfam06479 | 127 | pfam06479, Ribonuc_2-5A, Ribonuclease 2-5A | 3e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 8e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-43 | |
| cd09213 | 312 | cd09213, Luminal_IRE1_like, The Luminal domain, a | 3e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-33 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-28 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-26 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-24 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-21 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-21 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-19 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-19 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-19 | |
| cd09769 | 295 | cd09769, Luminal_IRE1, The Luminal domain, a dimer | 7e-19 | |
| cd10321 | 127 | cd10321, RNase_Ire1_like, RNase domain (also known | 1e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-17 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-17 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-14 | |
| smart00580 | 57 | smart00580, PUG, domain in protein kinases, N-glyc | 5e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-13 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-13 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 9e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 9e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-08 | |
| cd10423 | 119 | cd10423, RNase_RNase-L, RNase domain (also known a | 3e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 9e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-06 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-04 | |
| COG4248 | 637 | COG4248, COG4248, Uncharacterized protein with pro | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.003 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|199217 cd10422, RNase_Ire1, RNase domain (also known as the kinase extension nuclease domain) of Ire1 | Back alignment and domain information |
|---|
Score = 197 bits (504), Expect = 3e-59
Identities = 70/126 (55%), Positives = 87/126 (69%)
Query: 771 RLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYD 830
RLSFL+DVSDR E E R+ S LL ALE A + G W EK++ FI+N+G+YR+YK
Sbjct: 3 RLSFLQDVSDRFEKEPRDPPSPLLLALESGADEVVGGDWREKLDKTFIDNLGKYRKYKGS 62
Query: 831 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 890
+VRDLLR +RNK +H+RELP D+QELLG P+GF YF+ RFP LLI VY + K E
Sbjct: 63 SVRDLLRALRNKKHHYRELPPDVQELLGPLPDGFLRYFTSRFPNLLIHVYRAVSDSLKNE 122
Query: 891 EVFHKY 896
F KY
Sbjct: 123 STFKKY 128
|
The model represents the C-terminal endoribonuclease domain of the multi-functional protein Ire1; Ire1 in addition contains a type I transmembrane serine/threonine protein kinase (STK) domain, and a Luminal dimerization domain. Ire1 is essential for the endoplasmic reticulum (ER) unfolded protein response (UPR), which acts as an ER stress sensor and is the oldest and most conserved component of the UPR in eukaryotes. During ER stress, IRE1 dimerizes through its N-terminal luminal domain and forms oligomers, promoting trans-autophosphorylation by its cytosolic kinase domain. This leads to a conformational change that stimulates its endoribonuclease (RNase) activity and results in the cleavage of its mRNA substrate, Hac1 in yeast and Xbp1 in metazoans, thus promoting a splicing event that enables translation into a transcription factor which activates the UPR. This RNase domain is homologous to the RNase domain of RNase L, and possesses a novel fold for a nuclease and appears to be rigid irrespective of the activation state of IRE1. Structural analysis and mutational studies have revealed that an early stage 'phosphoryl-transfer' competent conformation of IRE1 favors face-to-face dimerization of the kinase domains which precedes and is distinct from the RNase 'active' back-to-back conformation. Furthermore, in yeast IRE1, the flavonol quercetin activates the RNase and potentiates activation of the protein kinase by ADP, hinting at the possible existence of endogenous cytoplasmic ligands that may function along with stress signals from ER lumen in order to modulate IRE1 activity, thus identifying IRE1 as a target for development of ATP-competitive inhibitors to modulate the UPR with specific relevance for multiple myeloma. Length = 129 |
| >gnl|CDD|219051 pfam06479, Ribonuc_2-5A, Ribonuclease 2-5A | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 3e-55
Identities = 65/126 (51%), Positives = 94/126 (74%), Gaps = 1/126 (0%)
Query: 771 RLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYD 830
RLSFL DVSDR E+EDR+ S LL+ LE + + G W +K++ F++++G++R+YK D
Sbjct: 2 RLSFLCDVSDRFEIEDRDPPSPLLKLLERTSRAVVGGDWTKKLDKAFMDDLGKFRKYKGD 61
Query: 831 NVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGE 890
+VRDLLR IRNK +H+RELP++++E+LG P+GF YF+ RFP LLI VY V+ C+ E
Sbjct: 62 SVRDLLRAIRNKKHHYRELPEELKEILGDLPDGFLQYFTERFPDLLIHVYTVLK-NCEYE 120
Query: 891 EVFHKY 896
++F KY
Sbjct: 121 KLFPKY 126
|
This domain is a endoribonuclease. Specifically it cleaves an intron from Hac1 mRNA in humans, which causes it to be much more efficiently translated. Length = 127 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 8e-45
Identities = 90/299 (30%), Positives = 135/299 (45%), Gaps = 61/299 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 533
+++ +GS G V L G+ VA+K + K L+EI+ L HPNIVR Y
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLK-HPNIVRLY 63
Query: 534 GVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V D+D +YL +E C L DL+ + L+E R
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL---------------KKRGRLSEDEAR-------- 100
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
R I+S L +LH G++HRDLKP+N+L+ D+ KL+D
Sbjct: 101 -----------------FYLRQILSALEYLHSKGIVHRDLKPENILL--DEDGHVKLADF 141
Query: 653 GISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G++++L + T + G+ + APE LL +A+D++SLG IL+ +T GK P
Sbjct: 142 GLARQLDP-----GEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLT-GKPP 195
Query: 712 YGESFERDA--NIVKDRKDLFLVEHI---PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+ + + K F PEA DL +LL +P+ R A+ L HPFF
Sbjct: 196 FPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 4e-43
Identities = 85/290 (29%), Positives = 126/290 (43%), Gaps = 82/290 (28%)
Query: 481 IAKGSNGTVVL-EGNYEGRSVAVKRLVK----THHDVALKEIQNLIASDQHPNIVRWYGV 535
+ +G GTV L G+ VA+K + K + + L+EI+ L HPNIV+ YGV
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEIL-KKLNHPNIVKLYGV 59
Query: 536 ESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
D++ +YL +E C SL DL+ G E
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSED--------------------------- 92
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
++L++ I+ GL +LH G+IHRDLKP+N+L+ D + KL+D G+
Sbjct: 93 ------------EILRILLQILEGLEYLHSNGIIHRDLKPENILLDSD-NGKVKLADFGL 139
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYG 713
SK L D S L T G+ + APE LL G + D++SLG IL+
Sbjct: 140 SKLLTSDKSLLK---TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE---------- 186
Query: 714 ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 763
+PE DL ++L +P+ RP A+ +L H
Sbjct: 187 ---------------------LPELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|188873 cd09213, Luminal_IRE1_like, The Luminal domain, a dimerization domain, of Inositol-requiring protein 1-like proteins | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 76/204 (37%), Positives = 109/204 (53%), Gaps = 19/204 (9%)
Query: 50 VALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASE----FYLDVDEDWEL 105
+ LVA LDGTI+ VD G+I+WSF G P+YSSYQ+S + NA +D D L
Sbjct: 1 LLLVATLDGTIYAVDASSGEIQWSFDGGGPLYSSYQSSRDGNAESSSTMLIPSLDGDGNL 60
Query: 106 YFHSKRFGKMKKLSSSAEEYIRRMPYISK---DGGVTLGAMKTSVFLVDVKSGRVVDNYV 162
Y H K G +++L + E+ + P +S D V +G+ +TSVF +D K+G+++ Y
Sbjct: 61 YQHDKGHGSLQRLPLTIEDLVEASPLVSDTNEDDVVVVGSKRTSVFALDAKTGKIIKTYR 120
Query: 163 LDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGE 222
D ST G SD N P + EE +L+YI RTDYVLQ+ SG+
Sbjct: 121 ADGLPSTGGSDSDGNSTPGPDELQEE------------EELLYIGRTDYVLQAIDPRSGK 168
Query: 223 VLWNVAYADFKAEFRCQEVGKSFS 246
LWNV Y +++A + + S
Sbjct: 169 ELWNVTYGEYEALTLDADELGTSS 192
|
The Luminal domain is a dimerization domain present in Inositol-requiring protein 1 (IRE1), eukaryotic translation Initiation Factor 2-Alpha Kinase 3 (EIF2AK3), and similar proteins. IRE1 and EIF2AK3 are serine/threonine protein kinases (STKs) and are type I transmembrane proteins that are localized in the endoplasmic reticulum (ER). They are kinase receptors that are activated through the release of BiP, a chaperone bound to their luminal domains under unstressed conditions. This results in dimerization through their luminal domains, allowing trans-autophosphorylation of their kinase domains and activation. They play roles in the signaling of the unfolded protein response (UPR), which is activated when protein misfolding is detected in the ER in order to decrease the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1, also called Endoplasmic reticulum (ER)-to-nucleus signaling protein (or ERN), contains an endoribonuclease domain in its cytoplasmic side and acts as an ER stress sensor. It is the oldest and most conserved component of the UPR in eukaryotes. Its activation results in the cleavage of its mRNA substrate, HAC1 in yeast and Xbp1 in metazoans, promoting a splicing event that enables translation into a transcription factor which activates the UPR. EIF2AK3, also called PKR-like Endoplasmic Reticulum Kinase (PERK), phosphorylates the alpha subunit of eIF-2, resulting in the downregulation of protein synthesis. It functions as the central regulator of translational control during the UPR pathway. In addition to the eIF-2 alpha subunit, EIF2AK3 also phosphorylates Nrf2, a leucine zipper transcription factor which regulates cellular redox status and promotes cell survival during the UPR. Length = 312 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 9e-40
Identities = 88/307 (28%), Positives = 130/307 (42%), Gaps = 65/307 (21%)
Query: 476 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNI 529
+++ GS GTV + G+ VAVK L K A +EI+ L HPNI
Sbjct: 2 ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRIL-RRLSHPNI 60
Query: 530 VRWYGVESDQDFVYLSLERC-TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
VR D+D +YL +E C L D + G E
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLSED--------------------- 98
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ K+ I+ GL +LH G+IHRDLKP+N+L+ ++ K
Sbjct: 99 ------------------EAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVV--K 138
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 707
++D G++K+L S LT G+ + APE LL G +D++SLG IL + +
Sbjct: 139 IADFGLAKKLLKSSSSLTTFV---GTPWYMAPEVLLGGNGYGPKVDVWSLGVIL-YELLT 194
Query: 708 GKHPYGESFERDANIVKDRKDL---------FLVEHIPEAVDLFTRLLDPNPDLRPKAQN 758
GK P+ D + R+ L EA DL + L+ +P RP A+
Sbjct: 195 GKPPFSGENILDQ-LQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEE 253
Query: 759 VLNHPFF 765
+L HP+F
Sbjct: 254 ILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 90/300 (30%), Positives = 131/300 (43%), Gaps = 58/300 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIA---SDQHPNIVRW 532
+ + +GS G+V L G +AVK V+ D L+ ++ I S QHPNIVR+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKS-VELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 533 YGVESD--QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
YG E D ++ + + LE + SL+ L+ G E + IR
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPV--------------IR----- 104
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
K TR I+ GL++LH G++HRD+K N+L+ D KL
Sbjct: 105 --------------------KYTRQILEGLAYLHSNGIVHRDIKGANILV--DSDGVVKL 142
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
+D G +KRL + G+ W APE + RA D++SLGC + T GK
Sbjct: 143 ADFGCAKRLGDIE-TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GK 200
Query: 710 HPYGESFERDAN---IVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
P+ E A I + + EH+ EA D + L +P RP A +L HPF
Sbjct: 201 PPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 80/308 (25%), Positives = 125/308 (40%), Gaps = 82/308 (26%)
Query: 479 KEIAKGSNGTVVLEGNYEGRS------VAVKRL---VKTHHDVALKEIQNLIASDQHPNI 529
++I KG G V Y+ R VA+K + K + + EIQ ++ +HPNI
Sbjct: 6 EKIGKGGFGEV-----YKARHKRTGKEVAIKVIKLESKEKKEKIINEIQ-ILKKCKHPNI 59
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
V++YG +D +++ +E C+ SL DL+ + + E
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES--------------------- 98
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
Q+ V ++++ GL +LH G+IHRD+K N+L++ D K
Sbjct: 99 ------------------QIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VK 138
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
L D G+S +L + T G+ W APE + D++SLG G
Sbjct: 139 LIDFGLSAQLSDTKARNTM----VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAE-G 193
Query: 709 KHPYGESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLDPNPDLRPKA 756
K PY E + K LF + E D + L NP+ RP A
Sbjct: 194 KPPYSEL-----PPM---KALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTA 245
Query: 757 QNVLNHPF 764
+ +L HPF
Sbjct: 246 EQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 7e-29
Identities = 83/326 (25%), Positives = 139/326 (42%), Gaps = 86/326 (26%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWY 533
K++ G+ G+V L N E G VA+K++ K + + L+E+++L ++HPNIV+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
V + D +Y E +L L+ K++ +E IR
Sbjct: 65 EVFRENDELYFVFEYMEGNLYQLM-------------KDRKGKPFSESVIR--------- 102
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+ I+ GL+H+H+ G HRDLKP+N+L+S K++D G
Sbjct: 103 ----------------SIIYQILQGLAHIHKHGFFHRDLKPENLLVS--GPEVVKIADFG 144
Query: 654 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQT---RAIDLFSLGCIL-------- 701
+++ ++ S T Y S+ W +APE LL R T +D+++LGCI+
Sbjct: 145 LAREIR---SRPPY--TDYVSTRWYRAPEILL--RSTSYSSPVDIWALGCIMAELYTLRP 197
Query: 702 ----------FFCI-----TGGKHPYGESFE--RDANIVKDRKDLFLVEHI-----PEAV 739
+ I T K + E ++ + + + PEA+
Sbjct: 198 LFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAI 257
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFF 765
DL +L +P RP A L HP+F
Sbjct: 258 DLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 85/298 (28%), Positives = 130/298 (43%), Gaps = 62/298 (20%)
Query: 480 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-ALKEIQ---NLIASDQHPNIVRWYG 534
I +G+ G V N E G VA+K++ ALK I +L+ + +HPNIV++ G
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
D +Y+ LE Y +GS L
Sbjct: 67 SIETSDSLYIILE----------YAENGS-------------LRQ--------------- 88
Query: 595 IELWKANGHPSAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+ K G L+ V ++ GL++LHE G+IHRD+K N+L +KD KL+D G
Sbjct: 89 --IIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV--VKLADFG 144
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713
++ +L G+ W APE + + A D++SLGC + +T G PY
Sbjct: 145 VATKLNDVSKDDASVV---GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPY- 199
Query: 714 ESFERDA-----NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
++ + IV+D L E I PE D + +P+LRP A+ +L HP+
Sbjct: 200 --YDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 87/299 (29%), Positives = 132/299 (44%), Gaps = 64/299 (21%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQ---NLIASDQHPNIVRW 532
+ GS G+V N + G AVK + A+K+++ L++ QHPNIV++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G E ++D +Y+ LE V GS + L + E IRL
Sbjct: 68 LGTEREEDNLYIFLE----------LVPGGSLAKLL----KKYGSFPEPVIRLY------ 107
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
TR I+ GL +LH+ +HRD+K N+L+ D + KL+D
Sbjct: 108 -------------------TRQILLGLEYLHDRNTVHRDIKGANILV--DTNGVVKLADF 146
Query: 653 GISKRL--QGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGK 709
G++K++ GS W APE + QG A D++SLGC + T GK
Sbjct: 147 GMAKQVVEFSFAKSFK------GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT-GK 199
Query: 710 HPYGESFERDA--NIVKDRKDLFLV-EHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
P+ + A I + K+L + +H+ EA D + L +P LRP A +L HPF
Sbjct: 200 PPWSQLEGVAAVFKIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 79/323 (24%), Positives = 128/323 (39%), Gaps = 81/323 (25%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNI 529
F K I +GS TVVL + + A+K L K E + L + HP I
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
++ Y D++ +Y LE G + + L+E R
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPN----------GELLQYIR----KYGSLDEKCTRFY--- 107
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+A+ I+ L +LH G+IHRDLKP+N+L+ KD K+
Sbjct: 108 ---------------AAE-------ILLALEYLHSKGIIHRDLKPENILLDKDMH--IKI 143
Query: 650 SDMGISKRLQGD----------MSCLTQNATGY-------GSSGWQAPEQLLQGRQTRAI 692
+D G +K L + + +Q G++ + +PE L + ++
Sbjct: 144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSS 203
Query: 693 DLFSLGCILFFCITGGKHP-YGES----FERDANIVKDRKDLFLVEHIPE-AVDLFTRLL 746
DL++LGCI++ +T GK P G + F++ + + F + P A DL +LL
Sbjct: 204 DLWALGCIIYQMLT-GKPPFRGSNEYLTFQK----ILKLEYSFP-PNFPPDAKDLIEKLL 257
Query: 747 DPNPDLRP----KAQNVLNHPFF 765
+P R + HPFF
Sbjct: 258 VLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 4e-26
Identities = 75/297 (25%), Positives = 127/297 (42%), Gaps = 54/297 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKR-----LVKTHHDVALKEIQNLIASDQHPNIVRW 532
K+I KGS G V L +G+ +K + + + AL E++ ++ HPNI+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVK-ILKKLNHPNIIKY 64
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
Y ++ + + +E Y G +++ ++++ E +I
Sbjct: 65 YESFEEKGKLCIVME----------YADGGDLSQKIKKQKKEGKPFPEEQI--------- 105
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
L + L +LH ++HRD+KPQN+ ++ + KL D
Sbjct: 106 ----------------LDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDF 147
Query: 653 GISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 710
GISK L + T T Y S PE L Q + D++SLGC+L+ T KH
Sbjct: 148 GISKVLSSTVDLAKTVVGTPYYLS----PE-LCQNKPYNYKSDIWSLGCVLYELCT-LKH 201
Query: 711 P-YGESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
P GE+ A I+K + ++ E +L + LL +P+ RP +L PF
Sbjct: 202 PFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-25
Identities = 84/338 (24%), Positives = 131/338 (38%), Gaps = 64/338 (18%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRW 532
+++ +GS G V L + + VA+K L K L+EIQ L + + PNIV+
Sbjct: 6 RKLGEGSFGEVYL--ARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
Y D+ +YL +E YV GS E+ L + L
Sbjct: 64 YDFFQDEGSLYLVME----------YVDGGSLEDLLKKIGRKGPL--------------- 98
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
++ L + I+S L +LH G+IHRD+KP+N+L+ +D KL D
Sbjct: 99 -----------SESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRD-GRVVKLIDF 146
Query: 653 GISKRLQGDMSCLTQNA---TGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCIT 706
G++K L S + A T G+ G+ APE LL + + D++SLG L+ +T
Sbjct: 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206
Query: 707 GGKHPYGESFERDANIV-------------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
G GE + A DL +LL +P R
Sbjct: 207 GLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNR 266
Query: 754 PKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDS 791
+ + L+H + S L D+ +
Sbjct: 267 LSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSL 304
|
Length = 384 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 66/303 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQN---LIASDQ 525
+ K++ +G+ G V +G +G+ VAVK L + + ++E ++
Sbjct: 1 LTLGKKLGEGAFG-EVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HPN+V+ GV ++++ +Y+ +E Y+ G L ++ L
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVME----------YMEGGDLLSYL--RKNRPKL-------- 99
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ LL I G+ +L IHRDL +N L+ ++
Sbjct: 100 ------------------SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-- 139
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
K+SD G+S+ L D Y G W APE L +G+ T D++S G
Sbjct: 140 VVKISDFGLSRDLYDDDY--------YRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGV 191
Query: 700 ILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQ 757
+L+ T G+ PY S E +K+ L + P + DL + +P+ RP
Sbjct: 192 LLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 758 NVL 760
++
Sbjct: 252 ELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 68/303 (22%), Positives = 118/303 (38%), Gaps = 63/303 (20%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 526
+ K++ +G+ G V +G+ + VAVK L + + ++E ++ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
PNIV+ GV ++++ + + +E Y+ G + L
Sbjct: 61 PNIVKLLGVCTEEEPLMIVME----------YMPGGDLLDYL------------------ 92
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+ EL + LL I G+ +L IHRDL +N L+ ++
Sbjct: 93 ---RKNRPKEL------SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL--V 141
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCI 700
K+SD G+S+ L D Y G W APE L +G+ T D++S G +
Sbjct: 142 VKISDFGLSRDLYDDDY--------YKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVL 193
Query: 701 LFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQN 758
L+ T G+ PY S +K L + P + L + +P+ RP
Sbjct: 194 LWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSE 253
Query: 759 VLN 761
++
Sbjct: 254 LVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 87/308 (28%), Positives = 132/308 (42%), Gaps = 61/308 (19%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL-KEIQ------NLI 521
R GKL + +G+ G V L + + GR +AVK++ KE+ L+
Sbjct: 5 RRGKL------LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLL 58
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+ QH IV++YG D + + + +E Y+ GS ++QL A L E
Sbjct: 59 KNLQHERIVQYYGCLRDDETLSIFME----------YMPGGSVKDQLKA----YGALTET 104
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
R K TR I+ G+ +LH ++HRD+K N+L +
Sbjct: 105 VTR-------------------------KYTRQILEGVEYLHSNMIVHRDIKGANIL--R 137
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
D + KL D G SKRLQ S T + G+ W +PE + R D++S+GC +
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTV 197
Query: 702 FFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 757
+T K P+ E FE A I + L H+ P+A + R N RP A+
Sbjct: 198 VEMLT-EKPPWAE-FEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAE 255
Query: 758 NVLNHPFF 765
+L H F
Sbjct: 256 ELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 78/309 (25%), Positives = 121/309 (39%), Gaps = 96/309 (31%)
Query: 506 VKTHHDVALKEIQNLIASD----------------QHPNIVRWYGVESDQDFVYLSLERC 549
KT VALK+I+ + +HPNIV+ V + +YL E C
Sbjct: 21 KKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80
Query: 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
L + G N ++ + QLL
Sbjct: 81 DMDLKKYLDKRPGPLSP------------NLIKSIMY--------------------QLL 108
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN- 668
GL++ H ++HRDLKPQN+LI++D KL+D G+++ + T
Sbjct: 109 -------RGLAYCHSHRILHRDLKPQNILINRDG--VLKLADFGLARAFGIPLRTYTHEV 159
Query: 669 ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP--YGES--------FE 717
T + ++APE LL + + A+D++S+GCI ITG P G+S F+
Sbjct: 160 VTLW----YRAPEILLGSKHYSTAVDIWSVGCIFAEMITG--KPLFPGDSEIDQLFKIFQ 213
Query: 718 ----------RDANIVKDRKDLF-------LVEHIP----EAVDLFTRLLDPNPDLRPKA 756
+ D K F L + +P E +DL +++L NP R A
Sbjct: 214 ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA 273
Query: 757 QNVLNHPFF 765
+ L HP+F
Sbjct: 274 KEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 84/309 (27%), Positives = 137/309 (44%), Gaps = 74/309 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQ---NLIASDQHPNIVRW 532
+I G+ G V N + G +AVK R+ +KEI ++ +HPN+V++
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPK-TIKEIADEMKVLELLKHPNLVKY 64
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
YGVE ++ VY+ +E C+ G+ EE L +L+E IR+
Sbjct: 65 YGVEVHREKVYIFMEYCS----------GGTLEELLEHGR----ILDEHVIRVY------ 104
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ QLL+ GL++LH G++HRD+KP N+ + D + KL D
Sbjct: 105 ------------TLQLLE-------GLAYLHSHGIVHRDIKPANIFL--DHNGVIKLGDF 143
Query: 653 GISKRLQ-GDMSCLTQNATGYGSSGWQAPEQLLQGRQT---RAIDLFSLGCILFFCITGG 708
G + +L+ + + + G+ + APE + G+ RA D++SLGC++ T G
Sbjct: 144 GCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-G 202
Query: 709 KHPYGESFERDANIV-------------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 755
K P+ E + + I+ + PE D R L+ +P RP
Sbjct: 203 KRPWSE-LDNEFQIMFHVGAGHKPPIPDSLQLS-------PEGKDFLDRCLESDPKKRPT 254
Query: 756 AQNVLNHPF 764
A +L HPF
Sbjct: 255 ASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 88/299 (29%), Positives = 133/299 (44%), Gaps = 63/299 (21%)
Query: 481 IAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVR-W 532
+ KGS G V+L G+ A+K L K + KE++ N+++ HP IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
Y + ++ +YL LE +L L +E R R
Sbjct: 60 YAFQ-TEEKLYLVLEYAPG--GELFSHL------------SKEGRFSEERARF------- 97
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ A +IV L +LH +G+I+RDLKP+N+L+ D KL+D
Sbjct: 98 -----YAA-------------EIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDF 137
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 711
G++K L + S G+ + APE LL +A+D +SLG +L+ +T GK P
Sbjct: 138 GLAKELSSEGSRTNTFC---GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLT-GKPPF 193
Query: 712 YGESFER-DANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR---PKAQNVLNHPFF 765
Y E + I+KD L E + PEA DL + LL +P R A+ + HPFF
Sbjct: 194 YAEDRKEIYEKILKD--PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 79/323 (24%), Positives = 134/323 (41%), Gaps = 83/323 (25%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHD----VALKEIQNLIASDQHPNIVRWYG 534
I +G++G V + E G +VA+K++ ++ AL+EI+ L A QHP +V+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLD 66
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V L +E L++++ ++++ L
Sbjct: 67 VFPHGSGFVLVMEYMPSDLSEVL-------------RDEERPL----------------- 96
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
P AQ+ R ++ G++++H G++HRDLKP N+LIS D K++D G+
Sbjct: 97 ---------PEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG--VLKIADFGL 145
Query: 655 SKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY 712
++ + L + + W +APE L R+ +DL+++GCI + G
Sbjct: 146 ARLFSEEEPRLYSHQVA---TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202
Query: 713 GES----------------------FER--DANIV--KDRKDLFLVEHIP----EAVDLF 742
GE+ D N + + K + L E P EA+DL
Sbjct: 203 GENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLL 262
Query: 743 TRLLDPNPDLRPKAQNVLNHPFF 765
LL +P R A L HP+F
Sbjct: 263 KGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 76/318 (23%), Positives = 121/318 (38%), Gaps = 98/318 (30%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ----------------NLIA 522
K + +GS+G V + T ALK+I L +
Sbjct: 7 KVLGQGSSGVV---------YKVRHK--PTGKIYALKKIHVDGDEEFRKQLLRELKTLRS 55
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+ P +V+ YG + + + LE Y+ GS L ++
Sbjct: 56 C-ESPYVVKCYGAFYKEGEISIVLE----------YMDGGS--------------LADLL 90
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISK 641
++ + E L + R I+ GL +LH +IHRD+KP N+LI+
Sbjct: 91 KKVGKIPEP---------------VLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS 135
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
K++D GISK L+ + L Q T G+ + +PE++ + A D++SLG L
Sbjct: 136 KG--EVKIADFGISKVLE---NTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTL 190
Query: 702 FFCITGGKHPYGESFERDANIVKDRKDLF-LVEHI--------------PEAVDLFTRLL 746
C GK P+ + + F L++ I PE D + L
Sbjct: 191 LECAL-GKFPF---------LPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 747 DPNPDLRPKAQNVLNHPF 764
+P RP A +L HPF
Sbjct: 241 QKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 88/306 (28%), Positives = 129/306 (42%), Gaps = 69/306 (22%)
Query: 481 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDV-----------ALKEIQNLIASDQHPN 528
I GS G+V L N G +AVK++ AL L+ QH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
IV++ G D D + + LE YV GS LN + E +R
Sbjct: 68 IVQYLGSSLDADHLNIFLE----------YVPGGSVAALLN----NYGAFEETLVR---- 109
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
R I+ GL++LH G+IHRD+K N+L+ D K
Sbjct: 110 ---------------------NFVRQILKGLNYLHNRGIIHRDIKGANILV--DNKGGIK 146
Query: 649 LSDMGISKRLQGDMSCLTQNA---TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
+SD GISK+L+ + N + GS W APE + Q TR D++SLGC++ +
Sbjct: 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEML 206
Query: 706 TGGKHPYGES------FERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQN 758
T GKHP+ + F+ N + + +I EA+D + + + + RP A
Sbjct: 207 T-GKHPFPDCTQLQAIFKIGENASPE-----IPSNISSEAIDFLEKTFEIDHNKRPTAAE 260
Query: 759 VLNHPF 764
+L HPF
Sbjct: 261 LLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-21
Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 52/298 (17%)
Query: 479 KEIAKGSNGTV----VLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVR 531
K++ +G+ G V + + + VAVK L + + K+ HPN+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
GV ++++ +YL LE Y+ G +LL+ +R
Sbjct: 61 LLGVCTEEEPLYLVLE----------YMEGG-------------DLLDYLRKSRPVFPSP 97
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
K LL I G+ +L +HRDL +N L+ +D K+SD
Sbjct: 98 EKST-------LSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL--VVKISD 148
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
G+S+ + D + + G W APE L G T D++S G +L+ T
Sbjct: 149 FGLSRDVYDDDYYRKK------TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
Query: 707 GGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 762
G PY S E ++ L E+ P+ + +L +P+ RP ++
Sbjct: 203 LGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 56/162 (34%), Positives = 85/162 (52%), Gaps = 14/162 (8%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK-----RLQGDMSCLTQNA 669
IV L +LH G+IHRDLKP N+LI + KL+D G+SK R ++
Sbjct: 102 IVLALEYLHSNGIIHRDLKPDNILIDSNGHL--KLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 670 TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRK 727
G+ + APE +L ++ +D +SLGCIL+ + G P+ + NI+ +
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLV-GIPPFHGETPEEIFQNILNGKI 218
Query: 728 D-LFLVEHIPEAVDLFTRLLDPNPDLRPKA---QNVLNHPFF 765
+ VE EA+DL ++LL P+P+ R A + + NHPFF
Sbjct: 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 84/306 (27%), Positives = 129/306 (42%), Gaps = 65/306 (21%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASD-------QHP 527
I KG+ G V L N G +AVK + HD K++ + S+ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NIV++ G E+ ++++ + LE G FEEQL +R
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL--------------VRFF- 113
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
T ++ GL++LH G++HRDLK N+L+ D C
Sbjct: 114 ------------------------TEQVLEGLAYLHSKGILHRDLKADNLLVDAD-GIC- 147
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-LQGRQTRA-IDLFSLGCILFFCI 705
K+SD GISK+ D+ QN + GS W APE + + A +D++SLGC++ +
Sbjct: 148 KISDFGISKK-SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLE-M 205
Query: 706 TGGKHPYG--ESFERDANIVKDRKDLFLVEHI-----PEAVDLFTRLLDPNPDLRPKAQN 758
G+ P+ E+ + R + + P A+D NPD RP A+
Sbjct: 206 FAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARE 265
Query: 759 VLNHPF 764
+L HPF
Sbjct: 266 LLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 82/306 (26%), Positives = 134/306 (43%), Gaps = 64/306 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA-------SDQHPNIV 530
K I+KG+ G+V L + G A+K L K+ A ++ N+ A + P +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI-AKNQVTNVKAERAIMMIQGESPYVA 60
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ Y +D++YL +E Y+ G L+ +
Sbjct: 61 KLYYSFQSKDYLYLVME----------YLNGGDCAS------------------LIKTL- 91
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
G P + ++V G+ LH+ G+IHRD+KP+N+LI D++ KL+
Sbjct: 92 ----------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI--DQTGHLKLT 139
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G+S+ G N G+ + APE +L + D +SLGC++F + G
Sbjct: 140 DFGLSR--NGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPP 192
Query: 711 PYGESFERD-ANIVKDRKDL--FLVEHI-PEAVDLFTRLLDPNPDLRPKA---QNVLNHP 763
+ E+ + NI+ R + + E PEAVDL RLL +P R A Q + +HP
Sbjct: 193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHP 252
Query: 764 FFWTAD 769
FF + +
Sbjct: 253 FFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 86/323 (26%), Positives = 132/323 (40%), Gaps = 78/323 (24%)
Query: 480 EIAKGSNGTVVLEGN-YEGRSVAVKRL-VKTHHD----VALKEIQNL--IASDQHPNIVR 531
EI +G+ GTV + GR VA+K++ V + L+EI L + S +HPNIVR
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
V +R L V FE +QD L +
Sbjct: 66 LLDV-----CHGPRTDREL----KLTLV----FEHV----DQD----------LATYLSK 98
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
G P + + R ++ G+ LH ++HRDLKPQN+L++ D K++D
Sbjct: 99 CP------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV--KIAD 150
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI---------LF 702
G+++ +M+ + T + ++APE LLQ +D++S+GCI LF
Sbjct: 151 FGLARIYSFEMALTSVVVTLW----YRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206
Query: 703 ------------FCITG----GKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLF 742
F + G + P S R + + K V I E +DL
Sbjct: 207 RGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS--FVPEICEEGLDLL 264
Query: 743 TRLLDPNPDLRPKAQNVLNHPFF 765
++L NP R A L HP+F
Sbjct: 265 KKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 5e-21
Identities = 71/298 (23%), Positives = 119/298 (39%), Gaps = 67/298 (22%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 525
+ K++ +G+ G V +G VAVK L + + L+E +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS- 59
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HPNIVR GV + + +Y+ E Y+ G + L ++ L
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTE----------YMPGGDLLDFL--RKHGEKL-------- 99
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
LL++ I G+ +L +HRDL +N L++++
Sbjct: 100 ------------------TLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENL-- 139
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 698
K+SD G+S+ + D Y G W APE L G+ T D++S G
Sbjct: 140 VVKISDFGLSRDIYEDDY--------YRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFG 191
Query: 699 CILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 754
+L+ T G+ PY G S E +++D L E+ P+ + +L + +P+ RP
Sbjct: 192 VLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELYELMLQCWAYDPEDRP 249
|
Length = 258 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 5e-21
Identities = 83/309 (26%), Positives = 126/309 (40%), Gaps = 90/309 (29%)
Query: 497 GRSVAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552
G+ A+K + K + L+EIQ L HPNI+R + ++ +R T
Sbjct: 24 GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL------IEVLF---DRKTGR 74
Query: 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612
L L++ L D NL ++ R P+ E ++ QLLK
Sbjct: 75 LA-LVFEL------------MDMNLYELIKGRKRPLPEKRVKSYMY--------QLLK-- 111
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT----QN 668
L H+H G+ HRD+KP+N+LI D KL+D G SC
Sbjct: 112 -----SLDHMHRNGIFHRDIKPENILIKDD---ILKLADFG---------SCRGIYSKPP 154
Query: 669 ATGYGSSGW-QAPEQLL-QGRQTRAIDLFSLGCILFFCIT-----GGKH----------- 710
T Y S+ W +APE LL G +D++++GC+ F ++ G +
Sbjct: 155 YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214
Query: 711 ---PYGE-------SFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 756
P E S + N +K L + +P E +DL +LL +PD R A
Sbjct: 215 LGTPDAEVLKKFRKSRHMNYNFPS-KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA 273
Query: 757 QNVLNHPFF 765
+ L HP+F
Sbjct: 274 KQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 77/325 (23%), Positives = 133/325 (40%), Gaps = 84/325 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
+I +G+ G V + G VA+K++ AL+EI+ L+ HPNI++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK-LLKELNHPNIIKL 63
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + +YL E D++L ++ R + E+
Sbjct: 64 LDVFRHKGDLYLVFEFM------------------------DTDLYKLIKDRQRGLPESL 99
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
L+ QLL+ GL+ H G++HRDLKP+N+LI+ + KL+D
Sbjct: 100 IKSYLY--------QLLQ-------GLAFCHSHGILHRDLKPENLLINTEGVL--KLADF 142
Query: 653 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG--- 707
G+++ + T Y + W +APE LL + + +D++S+GCI ++
Sbjct: 143 GLARSFGSPVRPYTH----YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL 198
Query: 708 --GKH--------------------PYGESFERDANI-VKDRKDLFLVEHIP----EAVD 740
GK P S R+ + + L + P +A+D
Sbjct: 199 FPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALD 258
Query: 741 LFTRLLDPNPDLRPKAQNVLNHPFF 765
L +++L +P R A+ L HP+F
Sbjct: 259 LLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 4e-20
Identities = 82/329 (24%), Positives = 126/329 (38%), Gaps = 80/329 (24%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIV 530
K I G+ G V GR VA+K++ D+ L+EI+ L+ +H NI+
Sbjct: 4 LLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK-LLRHLRHENII 62
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ S E ND +Y+++ E L+ + L + I+
Sbjct: 63 GLLDI-----LRPPSPE----DFND-VYIVTELMETDLHKVIKSPQPLTDDHIQYF---- 108
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKL 649
Q+L+ GL +LH +IHRDLKP N+L++ + C K+
Sbjct: 109 --------------LYQILR-------GLKYLHSANVIHRDLKPSNILVNSN---CDLKI 144
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG 707
D G++ R T Y + W +APE LL + T+AID++S+GCI +T
Sbjct: 145 CDFGLA-RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
Query: 708 -----GKH--------------PYGE--SFERDANIVKDRKDLFLVEHIP---------- 736
G+ P E F K L P
Sbjct: 204 KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASP 263
Query: 737 EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
EA+DL ++L +P R A L HP+
Sbjct: 264 EAIDLLEKMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 78/304 (25%), Positives = 126/304 (41%), Gaps = 68/304 (22%)
Query: 481 IAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ-------HPNIVRW 532
+ G G V L + + R+ A+K VK H V Q I S++ HP IV+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKC-VKKRHIVETG-QQEHIFSEKEILEECNHPFIVKL 58
Query: 533 YGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
Y D+ ++Y+ +E C L ++ +D L +E
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTIL---------------RDRGLFDE----------- 92
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+A+ +V +LH G+I+RDLKP+N+L+ D + KL D
Sbjct: 93 ------------YTARFY--IACVVLAFEYLHNRGIIYRDLKPENLLL--DSNGYVKLVD 136
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G +K+L+ + T G+ + APE +L ++D +SLG +L+ +TG P
Sbjct: 137 FGFAKKLKSG----QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRP-P 191
Query: 712 YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQN-----VLN 761
+GE E +I+K L +I A DL +LL NP+ R +
Sbjct: 192 FGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251
Query: 762 HPFF 765
H +F
Sbjct: 252 HKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 85/340 (25%), Positives = 146/340 (42%), Gaps = 76/340 (22%)
Query: 452 EKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTV-VLEGNYEGRSVAVK--RLVKT 508
E+ D++ + G K I +G++G V G+ VA+K RL K
Sbjct: 2 EELKAALKDIVSE---GDPRELYKNLEK-IGEGASGEVYKATDRATGKEVAIKKMRLRKQ 57
Query: 509 HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 568
+ ++ + EI ++ +HPNIV +Y D +++ +E Y+ GS + +
Sbjct: 58 NKELIINEIL-IMKDCKHPNIVDYYDSYLVGDELWVVME----------YMDGGSLTDII 106
Query: 569 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628
+NE Q+ V R+++ GL +LH +I
Sbjct: 107 TQNFVR---MNE-------------------------PQIAYVCREVLQGLEYLHSQNVI 138
Query: 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 688
HRD+K N+L+SKD S KL+D G + +L + S + + G+ W APE + +
Sbjct: 139 HRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDY 193
Query: 689 TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR--KDLFLV--EHIP-------- 736
+D++SLG I+ + G+ PY +++ + LFL+ + IP
Sbjct: 194 GPKVDIWSLG-IMCIEMAEGEPPY----------LREPPLRALFLITTKGIPPLKNPEKW 242
Query: 737 --EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSF 774
E D + L +P+ RP A+ +L HPF A + F
Sbjct: 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEEF 282
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 73/305 (23%), Positives = 128/305 (41%), Gaps = 79/305 (25%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWYGVESD 538
+ +GS G+V + E G+ VA+K + V+ +KEI L D P IV++YG
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYYGSYFK 69
Query: 539 QDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597
+++ +E C S++D++ + + + E+
Sbjct: 70 NTDLWIVMEYCGAGSVSDIMKITNKTLTEE------------------------------ 99
Query: 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
++ + + GL +LH IHRD+K N+L++++ AKL+D G+S +
Sbjct: 100 ---------EIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQ 148
Query: 658 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----GKHPY 712
L M+ + T G+ W APE + + D++SLG IT GK PY
Sbjct: 149 LTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLG------ITAIEMAEGKPPY 199
Query: 713 GESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLDPNPDLRPKAQNVL 760
+ + + +F++ + P E D + L +P+ RP A +L
Sbjct: 200 SD--------IHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL 251
Query: 761 NHPFF 765
HPF
Sbjct: 252 QHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 74/312 (23%), Positives = 117/312 (37%), Gaps = 83/312 (26%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK--------EIQNLIASD------ 524
E+ G++G V T +A+K IQ I +
Sbjct: 7 GELGAGNSGVVSK-----------VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK 55
Query: 525 -QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
P IV +YG + + + +E GS ++ +L EV+
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDG----------GSLDK----------ILKEVQG 95
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKD 642
R+ P L K+ ++ GL++LHE +IHRD+KP N+L++
Sbjct: 96 RI------------------PERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSR 137
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
KL D G+S +L ++ T G+S + APE++ + D++SLG L
Sbjct: 138 GQI--KLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLI 190
Query: 703 FCITGGKHPYGES-------FERDANIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLR 753
TG + PY FE IV + L P+ D L +P R
Sbjct: 191 ELATG-RFPYPPENDPPDGIFELLQYIVNEPPPR-LPSGKFSPDFQDFVNLCLIKDPRER 248
Query: 754 PKAQNVLNHPFF 765
P + +L HPF
Sbjct: 249 PSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 75/303 (24%), Positives = 131/303 (43%), Gaps = 62/303 (20%)
Query: 477 FNKEIAKGSNGTV-VLEGNYEGRSVAVKRLVKTHHDVALKEIQN------LIASDQHPNI 529
+ I KG+ G V +++ + A+K + K V ++N ++ HP +
Sbjct: 4 LLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFL 62
Query: 530 VR-WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
V WY + D++ +YL + DL+ L G L+ K + +E +++
Sbjct: 63 VNLWYSFQ-DEENMYLVV--------DLL--LGGDLRYHLSQKVK----FSEEQVKFWIC 107
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+IV L +LH G+IHRD+KP N+L+ D+
Sbjct: 108 -------------------------EIVLALEYLHSKGIIHRDIKPDNILL--DEQGHVH 140
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
++D I+ ++ D T + G+ G+ APE L + + A+D +SLG + C+ G
Sbjct: 141 ITDFNIATKVTPD----TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR-G 195
Query: 709 KHPY-GESFERDANIV---KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR--PKAQNVLNH 762
K PY G S I + L+ EA+D +LL+ +P R +++ NH
Sbjct: 196 KRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255
Query: 763 PFF 765
P+F
Sbjct: 256 PYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 66/244 (27%), Positives = 104/244 (42%), Gaps = 57/244 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD------QHPN 528
+ I KG G V + G+Y G+ VAVK L K Q +A +HPN
Sbjct: 8 LKLGATIGKGEFGDV-MLGDYRGQKVAVKCL-KDD----STAAQAFLAEASVMTTLRHPN 61
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+V+ GV + +Y+ E Y+ G +L++ +R R V
Sbjct: 62 LVQLLGVVLQGNPLYIVTE----------YMAKG-------------SLVDYLRSRGRAV 98
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ AQ L D+ G+ +L E +HRDL +NVL+S+D AK
Sbjct: 99 IT--------------LAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSED--LVAK 142
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
+SD G++K + Q +G W APE L + + + D++S G +L+ + G
Sbjct: 143 VSDFGLAKE-----ASQGQ-DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196
Query: 709 KHPY 712
+ PY
Sbjct: 197 RVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 23/187 (12%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
G P A+ + I+ GL HLH+ +++RDLKP+NVL+ + ++SD+G++ L+G
Sbjct: 91 GFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGG 148
Query: 662 MSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA 720
+ G G+ G+ APE L ++D F+LGC L+ I G+ P+ + E+
Sbjct: 149 -----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKEKVE 202
Query: 721 NIVKDRKDLFLVEHI-------PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTA 768
++ K L + PEA DL LL +P+ R A V HP F
Sbjct: 203 K--EELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
Query: 769 DTRLSFL 775
+ R
Sbjct: 261 NWRRLEA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|188875 cd09769, Luminal_IRE1, The Luminal domain, a dimerization domain, of the Serine/Threonine protein kinase, Inositol-requiring protein 1 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 15/187 (8%)
Query: 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVD-EDWELYF 107
D+ LV+ +DG +H VD K GKI WS P+ + V+ D LY
Sbjct: 2 DLLLVSTVDGGLHAVDRKTGKILWSLKAEDPLVEV-PHHSTLSIDGPTFIVEPRDGSLYV 60
Query: 108 HSKRFGKMKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSA 167
+ +KKL + + ++ P S DG + G+ +T+ + VD ++G + +
Sbjct: 61 LNPGNEGLKKLPFTIPQLVQSSPCRSSDGILYTGSKQTTWYTVDPRTGEKIQVLGSGGAD 120
Query: 168 STPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNV 227
S V P D + S +YI RT+Y + + E +WNV
Sbjct: 121 SN-----CPESCVDPDDDEQSECSS--------SSTIYIGRTEYTVTIYDSKTREPIWNV 167
Query: 228 AYADFKA 234
Y+D+
Sbjct: 168 TYSDYTP 174
|
The Luminal domain is a dimerization domain present in Inositol-requiring protein 1 (IRE1), a serine/threonine protein kinase (STK) and a type I transmembrane protein that is localized in the endoplasmic reticulum (ER). IRE1, also called Endoplasmic reticulum (ER)-to-nucleus signaling protein (or ERN), is a kinase receptor that also contains an endoribonuclease domain in the cytoplasmic side. It plays roles in the signaling of the unfolded protein response (UPR), which is activated when protein misfolding is detected in the ER in order to decrease the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1 acts as an ER stress sensor and is the oldest and most conserved component of the UPR in eukaryotes. During ER stress, IRE1 dimerizes through its luminal domain and forms oligomers, allowing the kinase domain to undergo trans-autophosphorylation. This leads to a conformational change that stimulates its endoribonuclease activity and results in the cleavage of its mRNA substrate, HAC1 in yeast and Xbp1 in metazoans, promoting a splicing event that enables translation into a transcription factor which activates the UPR. Mammals contain two IRE1 proteins, IRE1alpha (or ERN1) and IRE1beta (or ERN2). IRE1alpha is expressed in all cells and tissues while IRE1beta is found only in intestinal epithelial cells. Length = 295 |
| >gnl|CDD|199216 cd10321, RNase_Ire1_like, RNase domain (also known as the kinase extension nuclease domain) of Ire1 and RNase L | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-18
Identities = 35/123 (28%), Positives = 62/123 (50%), Gaps = 13/123 (10%)
Query: 771 RLSFLRDVSDRVELEDRESDSKLLRALEGI----ALVALNGKWDEKMETKFIENIGRYRR 826
++ F+ V + ++ + S L + L + L+ W+ ++ ++++ + R
Sbjct: 3 KIQFIDAVLNLLKDSN-LPPSTLNKLLNPGSDTVSSSFLSKPWNTLIDKNLMDDLSNFVR 61
Query: 827 --YKYDNVRDLLRVIRNKSNHFRE----LPQDIQELLG--SHPEGFYNYFSCRFPKLLIE 878
Y YD V+DL+R IRN H +E LP+ +E+L + F+NYF RFP LLI
Sbjct: 62 RTYNYDQVKDLIRCIRNTIQHHKEIKNQLPEKNKEILESLKSQDSFFNYFESRFPNLLIF 121
Query: 879 VYN 881
+Y
Sbjct: 122 LYY 124
|
This RNase domain is found in the multi-functional protein Ire1; Ire1 also contains a type I transmembrane serine/threonine protein kinase (STK) domain, and a Luminal dimerization domain. Ire1 is essential for the endoplasmic reticulum (ER) unfolded protein response (UPR). The UPR is activated when protein misfolding is detected in the ER in order to reduce the synthesis of new proteins and increase the capacity of the ER to cope with the stress. IRE1 acts as an ER stress sensor; IRE1 dimerizes through its N-terminal luminal domain and forms oligomers, promoting trans-autophosphorylation by its cytosolic kinase domain which stimulates its endoribonuclease (RNase) activity and results in the cleavage of its mRNA substrate, Hac1 in yeast and Xbp1 in metazoans, thus promoting a splicing event that enables translation into a transcription factor which activates the UPR. This RNase domain is also found in Ribonuclease L (RNase L), sometimes referred to as the 2-5A-dependent RNase. RNase L is a highly regulated, latent endoribonuclease widely expressed in most mammalian tissues. It is involved in the mediation of the antiviral and pro-apoptotic activities of the interferon-inducible 2-5A system; the interferon (IFN)-inducible 2'-5'-oligoadenylate synthetase (OAS)/RNase L pathway blocks infections by certain types of viruses through cleavage of viral and cellular single-stranded RNA. RNase L has been shown to have an impact on the pathogenesis of prostate cancer; the RNase L gene, RNASEL, has been identified as a strong candidate for the hereditary prostate cancer 1 (HPC1) allele. Length = 127 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 76/313 (24%), Positives = 124/313 (39%), Gaps = 86/313 (27%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQ---HPNIVRWYG 534
+ I G+ G V + G VA+K ++K + IQ I+ + HPNIV ++G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+D +++ +E C SL D+ V G E
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL-------------------------- 101
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+ V R+ + GL++LHE G IHRD+K N+L+++D KL+D G
Sbjct: 102 -------------QIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG--DVKLADFG 146
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPE---QLLQGRQTRAIDLFSLGCILFFCITG--- 707
+S +L ++ + + G+ W APE +G D+++LG IT
Sbjct: 147 VSAQLTATIA---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALG------ITAIEL 197
Query: 708 --GKHPYGESFERDANIVKDRKDLFLV------------EHI--PEAVDLFTRLLDPNPD 751
+ P + + + LFL+ + P D + L +P
Sbjct: 198 AELQPPMFD--------LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPK 249
Query: 752 LRPKAQNVLNHPF 764
RP A +L HPF
Sbjct: 250 KRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 6e-18
Identities = 86/323 (26%), Positives = 132/323 (40%), Gaps = 108/323 (33%)
Query: 501 AVKRLVKTHHDVALKEI----QNLIASD---------------QHPNIVRWYGV---ESD 538
A+ R +T VALK+I +N A+D HPNIV+ V E+D
Sbjct: 26 AIDR--RTKEVVALKKIFDAFRN--ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81
Query: 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 598
+D +YL E L+ +I +N+L +V R + ++
Sbjct: 82 KD-IYLVFEYMETDLHAVI----------------RANILEDVHKRYI----------MY 114
Query: 599 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKR 657
QLLK + I SG +IHRDLKP N+L++ D C KL+D G+++
Sbjct: 115 --------QLLKALKYIHSG-------NVIHRDLKPSNILLNSD---CRVKLADFGLARS 156
Query: 658 LQGDMSCLTQNA-TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG------ 708
L T Y ++ W +APE LL + T+ +D++S+GCIL + G
Sbjct: 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216
Query: 709 ------------------------KHPYGESFERDANIVKDRKDL--FLVEHIPEAVDLF 742
K P+ + + RK L L + +A+DL
Sbjct: 217 STLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLP-SRPRKPLDELLPKASDDALDLL 275
Query: 743 TRLLDPNPDLRPKAQNVLNHPFF 765
+LL NP+ R A+ L HP+
Sbjct: 276 KKLLVFNPNKRLTAEEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 59/196 (30%), Positives = 92/196 (46%), Gaps = 29/196 (14%)
Query: 604 PSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM 662
P L K+ IV L +LH + +IHRD+KP NVLI+++ KL D GIS L +
Sbjct: 101 PEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQV--KLCDFGISGYLVDSV 158
Query: 663 SCLTQNATGYGSSGWQAPEQL-----LQGRQTRAIDLFSLGCILFFCITGGKHPY---GE 714
+ T +A G + APE++ +G ++ D++SLG I + G+ PY
Sbjct: 159 A-KTIDA---GCKPYMAPERINPELNQKGYDVKS-DVWSLG-ITMIELATGRFPYDSWKT 212
Query: 715 SFERDANIVKDR-----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769
F++ +V++ + F PE D + L N RP +L HPFF
Sbjct: 213 PFQQLKQVVEEPSPQLPAEKF----SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268
Query: 770 TRLSFLRDVSDRVELE 785
++ + DV+ V L
Sbjct: 269 SKNT---DVASFVSLI 281
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 79/302 (26%), Positives = 131/302 (43%), Gaps = 63/302 (20%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLV--KTHHDVALKEIQ------NLIASDQHPNIVRW 532
+ KG+ GTV +G+ +AVK++ ++ A KE + +L+ S +H NIV++
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G L+ T S+ + +V GS LN R P+
Sbjct: 68 LGT---------CLDDNTISIF-MEFVPGGSISSILN--------------RFGPL---- 99
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
P K T+ I+ G+++LH ++HRD+K NV++ + KL D
Sbjct: 100 -----------PEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG--IIKLIDF 146
Query: 653 GISKRL-----QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
G ++RL G S + ++ +G+ W APE + + R D++S+GC +F TG
Sbjct: 147 GCARRLAWVGLHGTHSNMLKSM--HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204
Query: 708 GKHPYGESFERDANIVKDRKDLFLVEHIPE-----AVDLFTRLLDPNPDLRPKAQNVLNH 762
P S +R A + L+ +P+ A+D T L + RP A +L H
Sbjct: 205 --KPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262
Query: 763 PF 764
F
Sbjct: 263 DF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 80/321 (24%), Positives = 125/321 (38%), Gaps = 109/321 (33%)
Query: 497 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIV--RWYGVESDQDFVYLSLERC 549
G VA+K+L +L+EI L+ QHPNIV + V S+ D +Y+ +E
Sbjct: 30 GEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKIYMVMEYV 88
Query: 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
L L+ + F L +EV+ +L QLL
Sbjct: 89 EHDLKSLMETMKQPF------------LQSEVKCLML--------------------QLL 116
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 669
SG++HLH+ ++HRDLK N+L++ K+ D G+++ + TQ
Sbjct: 117 -------SGVAHLHDNWILHRDLKTSNLLLN--NRGILKICDFGLAREYGSPLKPYTQLV 167
Query: 670 TGYGSSGW-QAPEQLL-QGRQTRAIDLFSLGCI---------LF------------FCIT 706
+ W +APE LL + AID++S+GCI LF F +
Sbjct: 168 V----TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223
Query: 707 GG---------------------KHPYGESFERDANIVKDRKDLFLVEHIPEA-VDLFTR 744
G K+PY + ++ F + + DL R
Sbjct: 224 GTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKK-----------FPALSLSDNGFDLLNR 272
Query: 745 LLDPNPDLRPKAQNVLNHPFF 765
LL +P R A++ L HP+F
Sbjct: 273 LLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-17
Identities = 90/338 (26%), Positives = 138/338 (40%), Gaps = 86/338 (25%)
Query: 484 GSNGTVVLEGNYE-GRSVAVKRLVKTH-HDV--ALKEIQNLIASDQHPNIVRWYGVESDQ 539
GSNG V + + + VAVK++V T V AL+EI+ +I H NIV+ Y V
Sbjct: 16 GSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVYEVLGP- 73
Query: 540 DFVYLSLERCTCSLNDL-----IYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVMENTK 593
S T + L +Y++ E L N EQ L+E RL
Sbjct: 74 -----SGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLF------- 119
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
QLL+ GL ++H ++HRDLKP NV I+ + K+ D G
Sbjct: 120 -----------MYQLLR-------GLKYIHSANVLHRDLKPANVFINTE-DLVLKIGDFG 160
Query: 654 ISKRLQGDMS---CLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-- 707
+++ + S L++ + +++P LL T+AID+++ GCI +TG
Sbjct: 161 LARIVDPHYSHKGYLSEGLV---TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
Query: 708 ---GKH------------PYGESFERD-------ANIVKD----RKDL--FLVEHIPEAV 739
G H P +R+ + + D R+ L L PEA+
Sbjct: 218 LFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL 277
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRD 777
D ++L NP R A+ L HP+ + S D
Sbjct: 278 DFLEQILTFNPMDRLTAEEALMHPYM----SCYSCPFD 311
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 77/308 (25%), Positives = 116/308 (37%), Gaps = 64/308 (20%)
Query: 477 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHP 527
F K++ +G G V L G+ G VAVK L + H +EI+ L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL-RTLDHE 66
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NIV++ GV L L + Y+ SGS + L + +D L
Sbjct: 67 NIVKYKGVCEKPGGRSLRLI--------MEYLPSGSLRDYLQ-RHRDQINL--------- 108
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+LL + I G+ +L IHRDL +N+L+ +
Sbjct: 109 ------------------KRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED--LV 148
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K+SD G++K L D G W APE L + + A D++S G L+ T
Sbjct: 149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTY 208
Query: 708 G---KHPYGESF-----ERDANIV-------KDRKDLFLVEHIPEAV-DLFTRLLDPNPD 751
G + P E + IV K+ + L P+ V DL + P
Sbjct: 209 GDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQ 268
Query: 752 LRPKAQNV 759
RP ++
Sbjct: 269 DRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 6e-16
Identities = 86/301 (28%), Positives = 134/301 (44%), Gaps = 66/301 (21%)
Query: 481 IAKGSNGTVVLEGNYEGR------SVAVKRL-VKTHHDVA-LKEIQNLIASDQHPNIVRW 532
+ KG+ G V Y R +A+K + + V L E L + +H NIV++
Sbjct: 16 LGKGTYGIV-----YAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQY 70
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G +S+ F + +E+ V GS S LL R + P+ +N
Sbjct: 71 LGSDSENGFFKIFMEQ----------VPGGSL----------SALL---RSKWGPLKDNE 107
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ I + T+ I+ GL +LH+ ++HRD+K NVL++ K+SD
Sbjct: 108 QTIIFY-------------TKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVV-KISDF 153
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKH 710
G SKRL G C T+ T G+ + APE + +G + D++SLGC + T GK
Sbjct: 154 GTSKRLAGINPC-TETFT--GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKP 209
Query: 711 PYGESFERDANIVKDRKDLFLVEH--IPEAV-----DLFTRLLDPNPDLRPKAQNVLNHP 763
P+ E E A + K H IPE++ + R +P+PD R A ++L P
Sbjct: 210 PFIELGEPQAAMFKVG---MFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDP 266
Query: 764 F 764
F
Sbjct: 267 F 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-16
Identities = 80/308 (25%), Positives = 130/308 (42%), Gaps = 77/308 (25%)
Query: 480 EIAKGSNGTVVLEGNYE-GRSVAVKRLVK--------THHDVALKEIQNLIASDQHPNIV 530
++ +G G V L + G VA+KR+ K H + ++I + + + +V
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDI---LTTTKSEWLV 64
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ D +++YL++E YV G F LN +L+E R
Sbjct: 65 KLLYAFQDDEYLYLAME----------YVPGGDFRTLLNNL----GVLSEDHARFYMA-- 108
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
++ + LHE+G IHRDLKP+N LI D S KL+
Sbjct: 109 -----------------------EMFEAVDALHELGYIHRDLKPENFLI--DASGHIKLT 143
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-- 707
D G+SK +T + GS + APE +L+G+ +D +SLGC+L+ + G
Sbjct: 144 DFGLSK------GIVTYANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLGCMLYEFLCGFP 196
Query: 708 ---GKHPYGESFERDANIVKDRKDL-------FLVEHIPEAVDLFTRLLDPNPDLRPKAQ 757
G P E++E N+ ++ L EA DL T+L++ +
Sbjct: 197 PFSGSTP-NETWE---NLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLE 252
Query: 758 NVLNHPFF 765
++ NHPFF
Sbjct: 253 DIKNHPFF 260
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 33/195 (16%)
Query: 600 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659
P+ + ++ G++H H+ G++HRDLKPQN+L+ K K K++D+G+ +
Sbjct: 104 GRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLL-KIADLGLGRAFS 162
Query: 660 GDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGES-FE 717
+ T + ++APE LL + +D++S+GCI G+S +
Sbjct: 163 IPVKSYTHEIV---TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
Query: 718 RDANI--------------VKDRKDL------------FLVEHI-PEAVDLFTRLLDPNP 750
+ +I V +D V + PE +DL ++L +P
Sbjct: 220 QLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDP 279
Query: 751 DLRPKAQNVLNHPFF 765
R A+ L HP+F
Sbjct: 280 AKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 74/318 (23%), Positives = 115/318 (36%), Gaps = 103/318 (32%)
Query: 497 GRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYGV--ESDQDFVYLSLER 548
G VA+K+ ++ ++ A++EI+ L+ +HPNIVR + + +Y+ E
Sbjct: 24 GELVALKK-IRMENEKEGFPITAIREIK-LLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81
Query: 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608
L L+ F E K QL
Sbjct: 82 MDHDLTGLLDSPEVKFTES-QIK-------------------------------CYMKQL 109
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----ISKRLQGDMS- 663
L+ GL +LH G++HRD+K N+LI+ D KL+D G +KR D +
Sbjct: 110 LE-------GLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSADYTN 160
Query: 664 ---CLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGG---------- 708
L W P +LL G R +D++S+GCIL G
Sbjct: 161 RVITL-----------WYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE 209
Query: 709 ---------------------KHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLD 747
K P+ E+ + + ++ F P A+DL +LL
Sbjct: 210 QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLT 269
Query: 748 PNPDLRPKAQNVLNHPFF 765
+P R A L H +F
Sbjct: 270 LDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 70/326 (21%), Positives = 122/326 (37%), Gaps = 85/326 (26%)
Query: 480 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 533
+ +G+ G V+ N G VA+K+ ++ D AL+E++ L +H NIV
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLK 66
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+ +YL E +L +L+ E L +R
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELL--------------EASPGGLPPDAVRSY------- 105
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+W QLL+ +++ H +IHRD+KP+N+L+S+ KL D G
Sbjct: 106 ---IW--------QLLQ-------AIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFG 145
Query: 654 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG---- 707
++ L+ T Y ++ W +APE L+ + +D++++GCI+ + G
Sbjct: 146 FARALRARP---ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202
Query: 708 ----------------GKHP--YGESFERDAN----IVKDRKDLFLVEHIPE------AV 739
G P + E F + + +E A+
Sbjct: 203 PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPAL 262
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFF 765
D L +P R +L HP+F
Sbjct: 263 DFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 85/297 (28%), Positives = 131/297 (44%), Gaps = 52/297 (17%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLV------KTHHDVALKEIQ-NLIASDQHPNIV 530
K + +G+ G V L + + GR +A K++ +T +V+ E + L+ + QH IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
++YG D+ L++ + Y+ GS ++QL A L E R
Sbjct: 68 QYYGCLRDRAEKTLTIF--------MEYMPGGSVKDQLKA----YGALTESVTR------ 109
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
K TR I+ G+S+LH ++HRD+K N+L +D + KL
Sbjct: 110 -------------------KYTRQILEGMSYLHSNMIVHRDIKGANIL--RDSAGNVKLG 148
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G SKRLQ T + G+ W +PE + R D++SLGC + +T K
Sbjct: 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKP 207
Query: 711 PYGESFERDANIVK---DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
P+ E +E A I K + L HI E F + RP A+ +L HPF
Sbjct: 208 PWAE-YEAMAAIFKIATQPTNPQLPSHISEHARDFLGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 74/290 (25%), Positives = 121/290 (41%), Gaps = 50/290 (17%)
Query: 479 KEIAKGSNGTVVLEGNYEGR-SVAVK--RLVKTHHDVA--LKEIQNLIASDQHPNIVRWY 533
++I KG+ G V +G +G VAVK R L+E + L D HPNIV+
Sbjct: 1 EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLI 58
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
GV + +Y+ +E V GS L +R
Sbjct: 59 GVCVQKQPIYIVME----------LVPGGSL-------------LTFLRK---------- 85
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
K N +LL+++ D +G+ +L IHRDL +N L+ ++ K+SD G
Sbjct: 86 -----KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVL--KISDFG 138
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 712
+S+ +G + + + W APE L GR T D++S G +L+ + G PY
Sbjct: 139 MSREEEGGIYTV-SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197
Query: 713 GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN 761
G S ++ ++ + + PE + L + +P+ RP + N
Sbjct: 198 GMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 77/317 (24%), Positives = 128/317 (40%), Gaps = 85/317 (26%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQNLIASDQHPNIVRWYGV 535
+ I +G+ G V + + G+ VA+K +++ + +E L HPNI +YG
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 536 ------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ D ++L +E C GS ++L+ +R + +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCG----------GGSV----------TDLVKGLRKKGKRLK 111
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
E + + R+ + GL++LHE +IHRD+K QN+L++K+ KL
Sbjct: 112 EE---------------WIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKN--AEVKL 154
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLGCILFFC 704
D G+S +L S L + T G+ W APE + Q A D++SLG
Sbjct: 155 VDFGVSAQLD---STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG------ 205
Query: 705 ITG-----GKHPYGESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLD 747
IT GK P + + + LF + P + D + L
Sbjct: 206 ITAIELADGKPPLCD--------MHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLI 257
Query: 748 PNPDLRPKAQNVLNHPF 764
N + RP + +L HPF
Sbjct: 258 KNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 54/186 (29%), Positives = 86/186 (46%), Gaps = 46/186 (24%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDMSCLTQNATGYG 673
I+ GL ++H G+IHRDLKP N+ +++D C K+ D G+++ +M TGY
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNED---CELKILDFGLARHTDDEM-------TGYV 176
Query: 674 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKHPY-------------G 713
++ W +APE +L + +D++S+GCI+ +TG G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 714 ESF------ERDANIV--------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 759
E E N + KD K++F P A+DL ++L +PD R A
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEA 295
Query: 760 LNHPFF 765
L HP+
Sbjct: 296 LAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 76/315 (24%), Positives = 119/315 (37%), Gaps = 100/315 (31%)
Query: 497 GRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548
GR VA+K++ + AL+EI+ L+ +HPNI+ V + + L E
Sbjct: 25 GRIVAIKKIKLGERKEAKDGINFTALREIK-LLQELKHPNIIGLLDVFGHKSNINLVFE- 82
Query: 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608
+ E+ ++ + I L P DI+ +
Sbjct: 83 ----------FMETDLEK----------VIKDKSIVLTP-----ADIKSY------MLMT 111
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 668
L+ GL +LH ++HRDLKP N+LI+ D KL+D G+++ +T
Sbjct: 112 LR-------GLEYLHSNWILHRDLKPNNLLIASDG--VLKLADFGLARSFGSPNRKMTHQ 162
Query: 669 ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL--------FFCITGGKHPYGES--- 715
+ W +APE L R +D++S+GCI F G+S
Sbjct: 163 VV----TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFL--------PGDSDID 210
Query: 716 -----F-------ERDANIVKDRKDLFLVEHIP-------------EAVDLFTRLLDPNP 750
F E + V D + P +A+DL RLL NP
Sbjct: 211 QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
Query: 751 DLRPKAQNVLNHPFF 765
+ R A+ L HP+F
Sbjct: 271 NKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 54/177 (30%), Positives = 82/177 (46%), Gaps = 16/177 (9%)
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 670
+ R+++ GL +LHE G IHRD+K N+L+S++ KL+D G+S +L MS + T
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMS---KRNT 157
Query: 671 GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----GKHPYGESFERDANIVKD 725
G+ W APE + Q D++SLG G HP F I K+
Sbjct: 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL----IPKN 213
Query: 726 RKDLFLVEHIPEAVDLFTRL-LDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 781
+ F L L+ +P RP A+ +L H F A + S+L + +R
Sbjct: 214 NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA-KKTSYLTLLIER 269
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 74/297 (24%), Positives = 123/297 (41%), Gaps = 62/297 (20%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAV------KRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 534
+ KG+ G L E S+ V RL + AL EI +++ QHPNI+ +Y
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEI-VILSLLQHPNIIAYYN 66
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
D + + + +E G+ +++ Q L E
Sbjct: 67 HFMDDNTLLIEMEYAN----------GGTLYDKIV--RQKGQLFEE-------------- 100
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+L IVS +S++H+ G++HRD+K N+ ++K KL D GI
Sbjct: 101 -----------EMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG--LIKLGDFGI 147
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-IDLFSLGCILFFCITGGKHPYG 713
SK L + S T G+ + +PE L QG + D+++LGC+L+ +T +
Sbjct: 148 SKILGSEYS---MAETVVGTPYYMSPE-LCQGVKYNFKSDIWALGCVLYELLTLKR---- 199
Query: 714 ESFERD------ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
+F+ IV+ + + E + L LL +P+ RP A VL+ P
Sbjct: 200 -TFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 78/299 (26%), Positives = 128/299 (42%), Gaps = 64/299 (21%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRL------VKTHHDVALKEIQNLIASDQHPNIVR 531
K++ KGS G+V + + + A+K + K D A+ EI+ ++AS HPNI+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERED-AVNEIR-ILASVNHPNIIS 63
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ D + + + +E DL +S ++ L+ E I
Sbjct: 64 YKEAFLDGNKLCIVME--YAPFGDLSKAISKR--------KKKRKLIPEQEI-------- 105
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
W+ QLL+ GL LHE ++HRDLK N+L+ + K+ D
Sbjct: 106 ------WRI----FIQLLR-------GLQALHEQKILHRDLKSANILLVANDLV--KIGD 146
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 710
+GISK L+ +M+ T G+ + APE + +GR + D++SLGC+L+ T
Sbjct: 147 LGISKVLKKNMA-----KTQIGTPHYMAPE-VWKGRPYSYKSDIWSLGCLLYEMAT-FAP 199
Query: 711 PY-GESFERDANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKAQNVLNHP 763
P+ S + V+ K IP + + +L P LRP +L P
Sbjct: 200 PFEARSMQDLRYKVQRGK----YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 52/202 (25%), Positives = 82/202 (40%), Gaps = 38/202 (18%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-----QGDMSCLTQNA 669
+V L +H++G IHRD+KP N+LI D KL+D G+ K++ + + N
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHI--KLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 670 TGY---------------------GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
G+ + APE L D +SLG IL+ + G
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 709 KHPYGESFERDAN-IVKDRKDLFLVEHI---PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
Y ++ + N I+ ++ L PEA+DL RLL D + + +HPF
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGSFEEIKSHPF 287
Query: 765 F----WTADTRLS--FLRDVSD 780
F W F+ ++S
Sbjct: 288 FKGIDWENLRETKPPFVPELSS 309
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-14
Identities = 55/161 (34%), Positives = 86/161 (53%), Gaps = 18/161 (11%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 672
+I L HLH+ G+I+RDLKP+N+L+ D KL+D G+ K + T T
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILL--DAQGHVKLTDFGLCKESIHEG----TVTHTFC 161
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDAN-IVKDRKDL-- 729
G+ + APE L++ +A+D +SLG +++ +TG E+ ++ + I+K + +L
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP 221
Query: 730 FLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 765
+L PEA DL +LL NP R A V +HPFF
Sbjct: 222 YLT---PEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 78/317 (24%), Positives = 135/317 (42%), Gaps = 84/317 (26%)
Query: 477 FNKEIAKGSNGTVVL---EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA------SDQHP 527
F K + GS G V+L +G+ G+ A+K L K V LK++++++ S +HP
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGS--GKYYALKILSK-AKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+V YG D +YL +E YV G L + P
Sbjct: 62 FLVNLYGSFQDDSNLYLVME----------YVPGGELFSHLR------------KSGRFP 99
Query: 588 VMENTKDIELWKANGHPSAQLLKVTR----DIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
V R +V L +LH + +++RDLKP+N+L+ D
Sbjct: 100 ---------------------EPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG 138
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
K++D G +KR++G L G+ + APE +L +A+D ++LG +++
Sbjct: 139 YI--KITDFGFAKRVKGRTYTLC------GTPEYLAPEIILSKGYGKAVDWWALGILIYE 190
Query: 704 CITGGKHP--YGES----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD-----L 752
+ G +P + ++ +E+ I++ + F P+A DL LL + L
Sbjct: 191 MLAG--YPPFFDDNPIQIYEK---ILEGKVR-FPSFFSPDAKDLIRNLLQVDLTKRLGNL 244
Query: 753 RPKAQNVLNHPFFWTAD 769
+ ++ NHP+F D
Sbjct: 245 KNGVNDIKNHPWFAGID 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 17/166 (10%)
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
+ I G+ HLH + +++RD+KP+NVL+ D+ C +LSD+G++ L+ + +TQ A
Sbjct: 101 SAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNC-RLSDLGLAVELKDGKT-ITQRA-- 155
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDR--KD 728
G++G+ APE L + + +D F++GC ++ + G+ P+ + E+ +K R +D
Sbjct: 156 -GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV-AGRTPFKDHKEKVAKEELKRRTLED 213
Query: 729 LFLVEH---IPEAVDLFTRLLDPNPDLR----PKAQNVLNHPFFWT 767
EH E+ D+ L P+ R K + H FF T
Sbjct: 214 EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 69/317 (21%), Positives = 120/317 (37%), Gaps = 89/317 (28%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ----------------NLIA 522
+ I KGS GTV V+R + KEI N++
Sbjct: 6 ETIGKGSFGTVRK----------VRR-KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILR 54
Query: 523 SDQHPNIVRWYG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
+HPNIVR+Y ++ +Y+ +E C DL ++ K++ +
Sbjct: 55 ELKHPNIVRYYDRIIDRSNQTLYIVME--YCEGGDLAQLIQ-------KCKKERKYI--- 102
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-----LIHRDLKPQ 635
+ ++ ++ L H ++HRDLKP
Sbjct: 103 -----------------------EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139
Query: 636 NVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDL 694
N+ + + KL D G++K L D + A Y G+ + +PEQL D+
Sbjct: 140 NIFLDANN--NVKLGDFGLAKILGHD----SSFAKTYVGTPYYMSPEQLNHMSYDEKSDI 193
Query: 695 FSLGCILF-FCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPE--AVDLF---TRLLD 747
+SLGC+++ C P+ + + A+ +K+ K IP + +L +L+
Sbjct: 194 WSLGCLIYELC--ALSPPFTARNQLQLASKIKEGK----FRRIPYRYSSELNEVIKSMLN 247
Query: 748 PNPDLRPKAQNVLNHPF 764
+PD RP + +L P
Sbjct: 248 VDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|197798 smart00580, PUG, domain in protein kinases, N-glycanases and other nuclear proteins | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-14
Identities = 28/55 (50%), Positives = 34/55 (61%), Gaps = 3/55 (5%)
Query: 832 VRDLLRVIRNKSNHFREL--PQDIQELLGSHPEGFYNYFSCRFPKLLI-EVYNVI 883
VRDLLR +RN +H RE I+E LG P GF YF+ FP+LLI EVY +
Sbjct: 2 VRDLLRALRNILHHPREEKGNPAIKERLGPVPGGFELYFTVGFPRLLISEVYTLP 56
|
Length = 57 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-14
Identities = 38/106 (35%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGISKRLQG----DMSCLTQNA 669
++ L+ H G++HRDLKPQN+++S AK+ D GI L G D++ LT+
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 670 TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 715
G+ + APEQL T DL++ G I C+TG + G S
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-14
Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 57/296 (19%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKR--LVKTHH-DVALKEIQNLIASD-QHPNIVRWY 533
+I +GS G V + + GR VAVK+ L K ++ E+ +I D QHPNIV Y
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV--VIMRDYQHPNIVEMY 82
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
D +++ +E ++ G+ ++++ R+
Sbjct: 83 SSYLVGDELWVVME----------FLEGGAL----------TDIVTHTRMN--------- 113
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+ V ++ LS LH G+IHRD+K ++L++ D KLSD G
Sbjct: 114 -----------EEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFG 160
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 712
++ ++ + + G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 161 FCAQVSKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLG-IMVIEMVDGEPPYF 216
Query: 713 GESFERDANIVKDRKDLFLVEHI---PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
E + ++D L P R+L +P R A +LNHPF
Sbjct: 217 NEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 51/234 (21%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQD 540
I +G G V L+G Y G+ VAVK + A E ++ H N+VR GV
Sbjct: 14 IGEGEFGAV-LQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG 72
Query: 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 600
+Y+ +E + NL+N +R R ++
Sbjct: 73 -LYIVMELMS-----------------------KGNLVNFLRTRGRALV----------- 97
Query: 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK--RL 658
QLL+ + D+ G+ +L L+HRDL +N+L+S+D AK+SD G+++ +
Sbjct: 98 ---SVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--VAKVSDFGLARVGSM 152
Query: 659 QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
D S L W APE L + + D++S G +L+ + G+ PY
Sbjct: 153 GVDNSKLPVK--------WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 42/189 (22%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QLLK G++ HE ++HRDLKPQN+LI+K KL+D G+++ ++ +
Sbjct: 108 QLLK-------GIAFCHENRVLHRDLKPQNLLINKRGEL--KLADFGLARAFGIPVNTFS 158
Query: 667 QNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGES---------- 715
+ ++AP+ LL R + +ID++S+GCI+ ITG G +
Sbjct: 159 NEVV---TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215
Query: 716 ------------------FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKA 756
++ + L H P +DL RLL NP+LR A
Sbjct: 216 IMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA 275
Query: 757 QNVLNHPFF 765
+ L HP+F
Sbjct: 276 HDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 57/179 (31%), Positives = 91/179 (50%), Gaps = 26/179 (14%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
G P + T I+SGL HLH+ +I+RDLKP+NVL+ D + ++SD+G++ L+
Sbjct: 93 GFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDG 150
Query: 662 MSCLTQNAT-GY-GSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFER 718
Q+ T GY G+ G+ APE LLQG + ++D F+LG L+ I + P+ E+
Sbjct: 151 -----QSKTKGYAGTPGFMAPE-LLQGEEYDFSVDYFALGVTLYEMI-AARGPFRARGEK 203
Query: 719 DANIVKDRKDLFLVEHI-------PEAVDLFTRLLDPNPDLRPKAQN-----VLNHPFF 765
N K+ K L + + P + LL +P+ R ++ + HP F
Sbjct: 204 VEN--KELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 87/307 (28%), Positives = 139/307 (45%), Gaps = 60/307 (19%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRL------VKTHHDV-ALK-EIQNL 520
R+GKL + +G+ G V L + + GR +AVK++ +T +V AL+ EIQ L
Sbjct: 5 RLGKL------LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQ-L 57
Query: 521 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
+ + +H IV++YG D + LS+ + Y+ GS ++QL A L E
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIF--------VEYMPGGSIKDQLKA----YGALTE 105
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 640
R + TR I+ G+S+LH ++HRD+K N+L
Sbjct: 106 NVTR-------------------------RYTRQILQGVSYLHSNMIVHRDIKGANIL-- 138
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700
+D + KL D G SKR+Q T + G+ W +PE + R D++S+ C
Sbjct: 139 RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACT 198
Query: 701 LFFCITGGKHPYGESFERDANIVK---DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 757
+ +T K P+ E +E A I K L + + +A F + + RP A+
Sbjct: 199 VVEMLT-EKPPWAE-YEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPTAE 256
Query: 758 NVLNHPF 764
+L HPF
Sbjct: 257 FLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 73/292 (25%)
Query: 497 GRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552
VA+KR+ +T D KE+Q ++ HPN+V++Y D ++L + +
Sbjct: 26 NEKVAIKRIDLEKCQTSVDELRKEVQ-AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSG- 83
Query: 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612
GS LL +M+++ + G A + V
Sbjct: 84 ---------GS---------------------LLDIMKSS-----YPRGGLDEAIIATVL 108
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ--GDMSCLTQNAT 670
++++ GL +LH G IHRD+K N+L+ +D S K++D G+S L GD + + T
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRK-T 165
Query: 671 GYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGE--------------- 714
G+ W APE + Q D++S G I + G PY +
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFG-ITAIELATGAAPYSKYPPMKVLMLTLQNDP 224
Query: 715 -SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
S E A+ K K + + L +P RP A+ +L H FF
Sbjct: 225 PSLETGADYKKYSKSF---------RKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 56/173 (32%), Positives = 87/173 (50%), Gaps = 18/173 (10%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I+ GL H+H +++RDLKP N+L+ D+ ++SD+G L D S +A+ G
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLG----LACDFSKKKPHAS-VG 157
Query: 674 SSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 732
+ G+ APE L +G + D FSLGC+LF + G P+ + +D + + V
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAV 216
Query: 733 E----HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADTRLSFLR 776
E PE L LL + + R AQ V HPFF + D ++ FL+
Sbjct: 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 83/327 (25%), Positives = 140/327 (42%), Gaps = 91/327 (27%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYG 534
+ +GS G V+ + E G+ VA+K+ +++ D +A++EI+ ++ +H N+V
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR-MLKQLRHENLVNLIE 67
Query: 535 VESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
V + +YL E + L+DL E+ N L+E R+R
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL---------------EKYPNGLDESRVR--------- 103
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
K I+ G+ H +IHRD+KP+N+L+S +S KL D G
Sbjct: 104 ----------------KYLFQILRGIEFCHSHNIIHRDIKPENILVS--QSGVVKLCDFG 145
Query: 654 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKH 710
++ L + T Y ++ W +APE LL G + RA+D++++GC++ +TG
Sbjct: 146 FARTLAAP----GEVYTDYVATRWYRAPE-LLVGDTKYGRAVDIWAVGCLVTEMLTGEPL 200
Query: 711 PYGES---------------FERDANIVKDRKDLFLVEHIPEA----------------- 738
G+S R I + LF +PE
Sbjct: 201 FPGDSDIDQLYHIIKCLGNLIPRHQEIF-QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLV 259
Query: 739 VDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+DL + L +PD RP + +L+H FF
Sbjct: 260 LDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 92/311 (29%), Positives = 139/311 (44%), Gaps = 68/311 (21%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLV------KTHHDV-ALK-EIQNL 520
R+GKL + +G+ G V L + + GR +AVK++ +T +V AL+ EIQ L
Sbjct: 5 RLGKL------LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQ-L 57
Query: 521 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
+ + H IV++YG D LS+ + ++ GS ++QL + L E
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIF--------MEHMPGGSIKDQLKS----YGALTE 105
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 640
R K TR I+ G+S+LH ++HRD+K N+L
Sbjct: 106 NVTR-------------------------KYTRQILEGVSYLHSNMIVHRDIKGANIL-- 138
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGY----GSSGWQAPEQLLQGRQTRAIDLFS 696
+D KL D G SKRLQ CL+ TG G+ W +PE + R D++S
Sbjct: 139 RDSVGNVKLGDFGASKRLQ--TICLS--GTGMKSVTGTPYWMSPEVISGEGYGRKADIWS 194
Query: 697 LGCILFFCITGGKHPYGESFERDANIVK---DRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
+GC + +T K P+ E FE A I K + L H+ + F + + LR
Sbjct: 195 VGCTVVEMLT-EKPPWAE-FEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFVEAKLR 252
Query: 754 PKAQNVLNHPF 764
P A +L H F
Sbjct: 253 PSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 6e-13
Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 46/188 (24%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKRLQGDMSCLTQNATGYG 673
I+ GL ++H ++HRDLKP N+L++ + C K+ D G++ R+ T T Y
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLLNTN---CDLKICDFGLA-RIADPEHDHTGFLTEYV 170
Query: 674 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKH--------------PY 712
++ W +APE +L + T+AID++S+GCIL ++ GK P
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230
Query: 713 GESFERDANIVKDR----------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 756
E I+ R LF P+A+DL ++L NP R
Sbjct: 231 QEDLN---CIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRITV 286
Query: 757 QNVLNHPF 764
+ L HP+
Sbjct: 287 EEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 43/133 (32%), Positives = 73/133 (54%), Gaps = 4/133 (3%)
Query: 589 MEN-TKDIELWKANGHPSA-QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
MEN + D L K +G + QL+ + R I SG+ +L ++G +HRDL +N+L+ + +
Sbjct: 87 MENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV--NSNLV 144
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
K+SD G+S+ L+ D G W APE + + T A D++S G +++ ++
Sbjct: 145 CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
Query: 707 GGKHPYGESFERD 719
G+ PY E +D
Sbjct: 205 YGERPYWEMSNQD 217
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 21/165 (12%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 672
+IV L HLH++G+I+RD+K +N+L+ + L+D G+SK + + A +
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEE---EERAYSFC 167
Query: 673 GSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF 730
G+ + APE + G +A+D +SLG + F +TG P+ E+ N +
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS-PFTVDGEQ--NSQSEISRRI 224
Query: 731 LVEHIP-------EAVDLFTRLLDPNPDLR---PKAQNVLNHPFF 765
L P EA D +LL+ +P R A + NHPFF
Sbjct: 225 LKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 51/295 (17%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 533
K+I +GS G + L + + +K + T V KE L+A +HPNIV ++
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+ +++ +E C G +++N Q L +E
Sbjct: 66 ASFQENGRLFIVMEYCD----------GGDLMKRIN--RQRGVLFSE------------- 100
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+L I GL H+H+ ++HRD+K QN+ +SK+ AKL D G
Sbjct: 101 ------------DQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN-GMVAKLGDFG 147
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF-FCITGGKHPY 712
I+++L M L T G+ + +PE D++SLGC+L+ C KHP+
Sbjct: 148 IARQLNDSME-LAY--TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL--KHPF 202
Query: 713 -GESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
G + + I + + L ++L +P RP ++L PF
Sbjct: 203 EGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-12
Identities = 86/347 (24%), Positives = 137/347 (39%), Gaps = 94/347 (27%)
Query: 479 KEIAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIV 530
KE+ +G+ G V N E +VA+K++ AL+E++ L H NI
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
Y D D V+ + N+L Y+ +EE + A L+++ IR
Sbjct: 66 CLY----DMDIVFPG------NFNEL-YL----YEELMEAD------LHQI-IR------ 97
Query: 591 NTKDIELWKANGHP--SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+G P A I+ GL ++H ++HRDLKP N+L++ D K
Sbjct: 98 ----------SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD--CELK 145
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL----- 701
+ D G+++ + T Y ++ W +APE +L + T+AID++S+GCIL
Sbjct: 146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG 205
Query: 702 ----------------FFCITGGKHPYGESFERDA------------NIVKDRKDLFLVE 733
+ G P E+ R NI K +
Sbjct: 206 RKPVFKGKDYVDQLNQILQVLGT--PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPN 263
Query: 734 HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 780
P A+DL +LL +P R + L HP+ L+ D D
Sbjct: 264 ANPLALDLLEKLLAFDPTKRISVEEALEHPY-------LAIWHDPDD 303
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 31/178 (17%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
A ++ T ++ GLS+LHE +IHRD+K N+LI +++D G + RL +
Sbjct: 103 AVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQR-LRIADFGAAARLAAKGT-- 159
Query: 666 TQNATG------YGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFER 718
G G+ + APE +L+G Q R+ D++S+GC++ T K P+
Sbjct: 160 ---GAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWNAE--- 211
Query: 719 DANIVKDRKDLFLV----------EHIPEAV-DLFTRLLDPNPDLRPKAQNVLNHPFF 765
+F + EH+ + D+ R L+ P+ RP ++ +L HP F
Sbjct: 212 --KHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 61/206 (29%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA--KLSDMGISKRLQGDMSCLTQNATGY 672
I++G+ +LH ++HRDLKP N+L+ + K+ D+G+++ + L A
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN---APLKPLADLD 173
Query: 673 G---SSGWQAPEQLLQGRQ-TRAIDLFSLGCI---------LFFCITGGKHP----YGES 715
+ ++APE LL R T+AID++++GCI +F +
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ 233
Query: 716 FERDANIVK-----DRKDLFLVEHIPE-------------------------------AV 739
ER I + KD ++ +PE
Sbjct: 234 LER---IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFF 765
DL +LL+ +P R A+ L HP+F
Sbjct: 291 DLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 77/306 (25%), Positives = 130/306 (42%), Gaps = 69/306 (22%)
Query: 476 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRL-----VKTHHDVALKEIQNLIASDQHPNI 529
F + + KGS G V L +G+ +K+L + A +E Q L++ +HPNI
Sbjct: 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQ-LLSQLKHPNI 61
Query: 530 V----RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
V W G E ++ + C DL + L KEQ LL
Sbjct: 62 VAYRESWEG-EDGLLYIVMGF----CEGGDLYHKL----------KEQKGKLL------- 99
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
P Q+++ I L +LHE ++HRDLK QNV ++ ++
Sbjct: 100 ------------------PENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT--RTN 139
Query: 646 CAKLSDMGISKRL--QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
K+ D+GI++ L Q DM+ +T G+ + +PE D+++LGC ++
Sbjct: 140 IIKVGDLGIARVLENQCDMA-----STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYE 194
Query: 704 CITGGKHPYGESFERDAN-----IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 758
T KH + +D N I++ + ++ PE +L +L P+ RP ++
Sbjct: 195 MAT-LKHAFN---AKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKS 250
Query: 759 VLNHPF 764
+L P+
Sbjct: 251 ILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 67/250 (26%)
Query: 477 FNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVKTHHDVALKE---IQ--NLIASDQHPNIV 530
F KE+ G G V L G + G VA+K + + A+ E I+ ++ HPN+V
Sbjct: 8 FLKELGSGQFGVVHL-GKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLV 62
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ YGV + Q +++ E Y+ +G LLN +R R
Sbjct: 63 QLYGVCTKQRPIFIVTE----------YMANGC-------------LLNYLRER--KGKL 97
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
T LL + D+ + +L G IHRDL +N L+ +D K+S
Sbjct: 98 GT-------------EWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED--NVVKVS 142
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 703
D G+++ + D Y SS W PE R + D++S G +++
Sbjct: 143 DFGLARYVLDDQ---------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWE 193
Query: 704 CITGGKHPYG 713
+ GK PY
Sbjct: 194 VFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 37/202 (18%)
Query: 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY--- 672
V L +LH G++HRDLKP N+LI+ KL+D G+SK G MS T G+
Sbjct: 111 VLALEYLHNYGIVHRDLKPDNLLITSMGHI--KLTDFGLSK--IGLMSLTTNLYEGHIEK 166
Query: 673 -----------GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DA 720
G+ + APE +L+ + +D +++G IL+ + G +G++ E
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 226
Query: 721 NIVKDRKDLFLVEH----IPEAVDLFTRLLDPNPDLR---PKAQNVLNHPFF----WTAD 769
++ D D+ E +A DL +RLL NP R A V H FF W
Sbjct: 227 QVISD--DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWN-- 282
Query: 770 TRLSFLRDVSDRVELEDRESDS 791
LR ++ + + E D+
Sbjct: 283 ---GLLRQKAEFIPQLESEDDT 301
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 81/324 (25%), Positives = 133/324 (41%), Gaps = 82/324 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDV---ALKEIQNLIASDQHPNIVRW 532
++I +G+ G V N G VA+K RL V A++EI +L+ HPNIV+
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI-SLLKELNHPNIVKL 64
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V ++ +YL E F Q K D++ L+ +
Sbjct: 65 LDVIHTENKLYLVFE----------------FLHQDLKKFMDASPLSGI----------- 97
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
P + ++ GL+ H ++HRDLKPQN+LI+ + + KL+D
Sbjct: 98 -----------PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI--KLADF 144
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHP 711
G+++ + T + ++APE LL + + A+D++SLGCI +T
Sbjct: 145 GLARAFGVPVRTYTHEVV---TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
Query: 712 YGESFERD-------------------ANIVKDRKDLF-------LVEHIP----EAVDL 741
G+S E D + D K F + +P + DL
Sbjct: 202 PGDS-EIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDL 260
Query: 742 FTRLLDPNPDLRPKAQNVLNHPFF 765
+++L +P+ R A+ L HPFF
Sbjct: 261 LSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 41/297 (13%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 525
+V K + +G G VV L+G +VAVK L + L+++ NL+
Sbjct: 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN 61
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HP++++ YG S + L +E Y GS + L E R ++
Sbjct: 62 HPHVIKLYGACSQDGPLLLIVE----------YAKYGSLR----------SFLRESR-KV 100
Query: 586 LPVMENTKDIELWKANGHPSAQ------LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
P + +P + L+ I G+ +L E+ L+HRDL +NVL+
Sbjct: 101 GPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
++ + K+SD G+S+ + + S + + + G W A E L T D++S G
Sbjct: 161 AEGRK--MKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 700 ILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 754
+L+ +T G +PY G + ER N++K + E+ E + +L PD RP
Sbjct: 218 LLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 83/303 (27%), Positives = 128/303 (42%), Gaps = 60/303 (19%)
Query: 480 EIAKGSNGTV-VLEGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYG 534
EI +G+ GTV + G +AVKR+ + L ++ ++ S P IV++YG
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ ++ +E SL D Y V E K
Sbjct: 71 ALFREGDCWICMELMDISL-DKFYKY---------------------------VYEVLKS 102
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+ P L K+ V L++L E+ +IHRD+KP N+L+ D++ KL D G
Sbjct: 103 V-------IPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL--DRNGNIKLCDFG 153
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL----QGRQTRAIDLFSLGCILFFCITGGK 709
IS +L D T++A G + APE++ G R+ D++SLG I + + GK
Sbjct: 154 ISGQLV-DSIAKTRDA---GCRPYMAPERIDPSARDGYDVRS-DVWSLG-ITLYEVATGK 207
Query: 710 HPY---GESFERDANIVK-DRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762
PY F++ +VK D L E P V+ L + RPK + +L H
Sbjct: 208 FPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
Query: 763 PFF 765
PF
Sbjct: 268 PFI 270
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 55/197 (27%), Positives = 91/197 (46%), Gaps = 24/197 (12%)
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
++L +A Q+ + ++I+ GL +LH IHRD+K NVL+S+ KL+D G+
Sbjct: 90 LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGV 147
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
+ +L + T G+ W APE + Q D++SLG IT + GE
Sbjct: 148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLG------ITAIELAKGE 198
Query: 715 SFERDANIVKDRKDLFLVEHI--PEAVDLFTR--------LLDPNPDLRPKAQNVLNHPF 764
D + + + LFL+ P F++ L+ +P RP A+ +L H F
Sbjct: 199 PPNSDMHPM---RVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
Query: 765 FWTADTRLSFLRDVSDR 781
+ S+L ++ DR
Sbjct: 256 IVKNAKKTSYLTELIDR 272
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 37/114 (32%), Positives = 64/114 (56%), Gaps = 15/114 (13%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QL+ + R I SG+ +L E+ +HRDL +N+L++ + K+SD G+S+RL+
Sbjct: 107 QLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSRRLE------D 158
Query: 667 QNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
AT Y + G W APE + + T A D++S G +++ ++ G+ PY +
Sbjct: 159 SEAT-YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 66/255 (25%), Positives = 108/255 (42%), Gaps = 53/255 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 525
+V +E+ +G+ G V L Y VAVK L +T + A K+ + L+ + Q
Sbjct: 7 IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ 66
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H NIV++YGV ++ D + E Y+ G + L + D+ L
Sbjct: 67 HENIVKFYGVCTEGDPPIMVFE----------YMEHGDLNKFLRSHGPDAAFL------- 109
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
++ EL + QLL++ I SG+ +L +HRDL +N L+ D
Sbjct: 110 --KSPDSPMGELTLS------QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD--L 159
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G+S+ + T Y G W PE ++ + T D++S
Sbjct: 160 VVKIGDFGMSRDVY---------TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210
Query: 698 GCILFFCITGGKHPY 712
G +L+ T GK P+
Sbjct: 211 GVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 52/197 (26%), Positives = 87/197 (44%), Gaps = 24/197 (12%)
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
++L K + + R+I+ GL +LH IHRD+K NVL+S+ KL+D G+
Sbjct: 90 LDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGV 147
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
+ +L + T G+ W APE + Q D++SLG I + G+ P +
Sbjct: 148 AGQLTDTQ---IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLG-ITAIELAKGEPPNSD 203
Query: 715 SFERDANIVKDRKDLFLV----------EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
+ + LFL+ ++ + L+ +P RP A+ +L H F
Sbjct: 204 --------LHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255
Query: 765 FWTADTRLSFLRDVSDR 781
+ SFL ++ DR
Sbjct: 256 ITRYTKKTSFLTELIDR 272
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 51/191 (26%), Positives = 83/191 (43%), Gaps = 49/191 (25%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GL ++H +IHRDLKP N+L+++D ++ D G+++ L + T Y +
Sbjct: 116 LLRGLKYIHSANVIHRDLKPSNLLVNEDCEL--RIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 675 SGW-QAPEQLLQ-GRQTRAIDLFSLGCI---------LFFCITGGKHP------------ 711
+ W +APE LL T AID++S+GCI LF GK+
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF----PGKNYVHQLKLILSVLG 229
Query: 712 -----------------YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP 754
Y ++ R +F PEA+DL +++L +P+ R
Sbjct: 230 SPSEEVLNRIGSDRVRKYIQNLPRKQ--PVPWSKIFPKAS-PEALDLLSQMLQFDPEERI 286
Query: 755 KAQNVLNHPFF 765
+ L HPF
Sbjct: 287 TVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 51/170 (30%), Positives = 83/170 (48%), Gaps = 20/170 (11%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I+ L HLH++G+++RD+K +N+L+ + L+D G+SK + T + G
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVV--LTDFGLSKEFLSEEKERTYSFC--G 168
Query: 674 SSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 732
+ + APE + +G +A+D +SLG ++F +TG P+ ER+ R+ L
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS-PFTLEGERNTQSEVSRRILKCD 227
Query: 733 EHIP-----EAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF----WTA 768
P EA DL +LL +P R A + HPFF W A
Sbjct: 228 PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA 277
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 60/216 (27%), Positives = 104/216 (48%), Gaps = 48/216 (22%)
Query: 585 LLPVMENTKDIELWKANGHPSAQ--LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
++P M+ +L K GHP ++ + + ++ GL ++H G+IHRDLKP N+ +++D
Sbjct: 98 VMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNED 153
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI 700
K+ D G+++ +M TGY + W +APE +L + +D++S+GCI
Sbjct: 154 CEL--KILDFGLARHADAEM-------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCI 204
Query: 701 LFFCITG-----GK--------------HPYGESFER-----DANIVKD-----RKDLFL 731
+ +TG GK P E ++ + +K RKD
Sbjct: 205 MAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST 264
Query: 732 V--EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+ + P+AVDL ++L+ + D R A L HP+F
Sbjct: 265 LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 58/226 (25%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 490 VLEGNYEGRS-VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546
V G + G + VAVK L L+E Q ++ +H +V+ Y V S+++ +Y+
Sbjct: 22 VWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-IMKKLRHDKLVQLYAVCSEEEPIYIVT 80
Query: 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSA 606
E Y+ GS + L K + L LP
Sbjct: 81 E----------YMSKGSLLDFL--KSGEGKKLR------LP------------------- 103
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QL+ + I G+++L IHRDL +N+L+ ++ K++D G+++ ++ D
Sbjct: 104 QLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG--ENLVCKIADFGLARLIEDDEYTAR 161
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ A W APE GR T D++S G +L +T G+ PY
Sbjct: 162 EGAK--FPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 50/178 (28%), Positives = 85/178 (47%), Gaps = 25/178 (14%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
G + + +I GL LH+ +++RDLKP+N+L+ ++SD+G++ +
Sbjct: 98 GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHI--RISDLGLAVHVPEG 155
Query: 662 MSCLTQNATG-YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG------- 713
Q G G+ G+ APE + R T + D ++LGC+L+ I G+ P+
Sbjct: 156 -----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRKKKIK 209
Query: 714 -ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 765
E ER +VK+ ++ + + P+A L LL +P R A+ V HP F
Sbjct: 210 REEVER---LVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 4e-12
Identities = 86/349 (24%), Positives = 137/349 (39%), Gaps = 81/349 (23%)
Query: 432 IPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTV-V 490
+P S + S +G+ + ++L +RV RIG G+ GTV
Sbjct: 47 LPPPSSSSSSSSSSSASGSAPSAAKSLSEL--ERV--NRIGS----------GAGGTVYK 92
Query: 491 LEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVRWYGVESDQDFVYLSLE 547
+ GR A+K + H D ++I I HPN+V+ + + + + LE
Sbjct: 93 VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152
Query: 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607
++ GS E A EQ
Sbjct: 153 ----------FMDGGSLEGTHIADEQ---------------------------------F 169
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLT 666
L V R I+SG+++LH ++HRD+KP N+LI+ K+ K++D G+S+ L M C
Sbjct: 170 LADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPC-- 225
Query: 667 QNATGYGSSGWQAPEQ----LLQGR-QTRAIDLFSLG-CILFFCITGGKHPYGESFERD- 719
N++ G+ + +PE+ L G A D++SLG IL F + G+ P+G + D
Sbjct: 226 -NSS-VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL--GRFPFGVGRQGDW 281
Query: 720 ----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
I + E + L P R A +L HPF
Sbjct: 282 ASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 4e-12
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
T +++ L +LH+ +I+RDLKP+N+L+ D L D G+ K +M + T
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILL--DYQGHIALCDFGLCKL---NMKDDDKTNTF 153
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 731
G+ + APE LL T+A+D ++LG +L+ +TG Y E+ + F
Sbjct: 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213
Query: 732 VEHIPEAVDLFTRLLDPNPDLR---PKAQNVLNHPFF 765
+A DL LL +P R AQ + NHPFF
Sbjct: 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 60/192 (31%), Positives = 90/192 (46%), Gaps = 45/192 (23%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 671
+IV GL LHE G+I+RDLK NVL+ + K++D G+ K L G + +T
Sbjct: 104 EIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHI-KIADFGMCKEGILGGVTT-----STF 156
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF- 730
G+ + APE L A+D ++LG +L + + G+ P FE D D +LF
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSP----FEGD-----DEDELFQ 206
Query: 731 -LVE---HIP-----EAVDLFTRLLDPNPDLR----PKA-QNVLNHPFFWTADTRLSFLR 776
++E P EA + L NP+ R P Q++ HPFF R
Sbjct: 207 SILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF----------R 256
Query: 777 DVSDRVELEDRE 788
++ D +LE +E
Sbjct: 257 EI-DWDKLERKE 267
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-12
Identities = 48/165 (29%), Positives = 83/165 (50%), Gaps = 19/165 (11%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 672
+IV L HLH++G+I+RD+K +N+L+ + L+D G+SK D + A +
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVV--LTDFGLSKEFHEDE---VERAYSFC 167
Query: 673 GSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDL- 729
G+ + AP+ + G +A+D +S+G +++ +TG P+ E+++ R+ L
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS-PFTVDGEKNSQAEISRRILK 226
Query: 730 ----FLVEHIPEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFF 765
+ E A D+ RLL +P R P A + HPFF
Sbjct: 227 SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 58/239 (24%)
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HPNIV+ GV + + +Y+ +E V G F L K+ +
Sbjct: 51 HPNIVKLIGVCTQRQPIYIVME----------LVPGGDFLSFLRKKKDELKT-------- 92
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
QL+K D +G+++L IHRDL +N L+ ++
Sbjct: 93 --------------------KQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVL 132
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 698
K+SD G+S++ + Y SSG W APE L GR + D++S G
Sbjct: 133 --KISDFGMSRQEDDGI---------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYG 181
Query: 699 CILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPK 755
+L+ + G PY G + ++ V+ + + P+ V + R D P+ RPK
Sbjct: 182 ILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPK 240
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 20/175 (11%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660
G P L ++T +V GL L E +IHRD+KP NVL++ + KL D G+S L
Sbjct: 98 GIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVA 155
Query: 661 DMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI------DLFSLGCILFFCITGGKHPY-- 712
++ T G + APE++ G + D++SLG + G++PY
Sbjct: 156 SLA-----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMAL-GRYPYPP 209
Query: 713 ---GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
F + + IV + +A D + L+ P+ RP +L HP+
Sbjct: 210 ETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 73/313 (23%), Positives = 124/313 (39%), Gaps = 91/313 (29%)
Query: 494 NYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548
G VA+K++ D A++EI +L+ HPNIVR V ++ +YL E
Sbjct: 21 KLTGEIVALKKIRLETEDEGVPSTAIREI-SLLKELNHPNIVRLLDVVHSENKLYLVFE- 78
Query: 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608
F + K DS P+ + +
Sbjct: 79 ---------------FLDLDLKKYMDS----------SPLTGLDPPL------------I 101
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 668
++ G+++ H ++HRDLKPQN+LI ++ + KL+D G+++ + T
Sbjct: 102 KSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGAL--KLADFGLARAFGVPVRTYTHE 159
Query: 669 ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANI---- 722
+ W +APE LL RQ + +D++S+GCI + + P F D+ I
Sbjct: 160 VV----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN--RRPL---FPGDSEIDQLF 210
Query: 723 -------------------VKDRKDLF-------LVEHIP----EAVDLFTRLLDPNPDL 752
+ D K F L + +P + +DL +++L +P
Sbjct: 211 RIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAK 270
Query: 753 RPKAQNVLNHPFF 765
R A+ L HP+F
Sbjct: 271 RISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 57/204 (27%), Positives = 92/204 (45%), Gaps = 49/204 (24%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GL ++H G+IHRDLKP N+ +++D K+ D G++++ +M TGY
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCEL--KILDFGLARQTDSEM-------TGYVV 177
Query: 675 SGW-QAPEQLLQG-RQTRAIDLFSLGCILFFCIT------GGKH-------------PYG 713
+ W +APE +L T+ +D++S+GCI+ +T G H P
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237
Query: 714 ESFER----DA-NIVK-----DRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761
E ++ DA N VK +KD L P AV++ ++L + + R A L
Sbjct: 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297
Query: 762 HPFFWTADTRLSFLRDVSDRVELE 785
HP+F D D E
Sbjct: 298 HPYF-------EEFHDPEDETEAP 314
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 66/255 (25%), Positives = 111/255 (43%), Gaps = 55/255 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 525
+V +E+ +G+ G V L Y + VAVK L K D A K+ L+ + Q
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTL-KDASDNARKDFHREAELLTNLQ 65
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H +IV++YGV + D + + E Y+ G + L A D+ L+ E
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFE----------YMKHGDLNKFLRAHGPDAVLMAEGN--- 112
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
E T+ +Q+L + + I +G+ +L +HRDL +N L+ ++
Sbjct: 113 -RPAELTQ------------SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN--L 157
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G+S+ + +T Y G W PE ++ + T D++SL
Sbjct: 158 LVKIGDFGMSRDVY---------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208
Query: 698 GCILFFCITGGKHPY 712
G +L+ T GK P+
Sbjct: 209 GVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 64/231 (27%), Positives = 107/231 (46%), Gaps = 48/231 (20%)
Query: 480 EIAKGSNGTVVLEGNYE--GRSVAVKRL-VKTHHD----VALKEIQNL--IASDQHPNIV 530
EI +G+ G V + + GR VA+KR+ V+T + ++E+ L + + +HPN+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R + V CT S D L+ FE +QD L ++
Sbjct: 68 RLFDV-------------CTVSRTDRETKLTLVFEHV----DQD----------LTTYLD 100
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ G P+ + + ++ GL LH ++HRDLKPQN+L++ KL+
Sbjct: 101 KVPE------PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI--KLA 152
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
D G+++ M+ + T + ++APE LLQ +DL+S+GCI
Sbjct: 153 DFGLARIYSFQMALTSVVVTLW----YRAPEVLLQSSYATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 80/325 (24%), Positives = 127/325 (39%), Gaps = 87/325 (26%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYG 534
I +GS G V N E G+ VA+K+ V++ D +AL+EI+ L +HPN+V
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML-KQLKHPNLVNLIE 67
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V + ++L E C D +LNE+
Sbjct: 68 VFRRKRKLHLVFEYC------------------------DHTVLNELEKN---------- 93
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
G P + K+ + ++ H+ IHRD+KP+N+LI+K KL D G
Sbjct: 94 -----PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQI--KLCDFGF 146
Query: 655 SKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG----- 707
++ L G + T Y ++ W +APE L+ Q +D++++GC+ +TG
Sbjct: 147 ARILTGP----GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP 202
Query: 708 GK----------HPYGESFERDANIVKDRKDLFLVEHIPE-----------------AVD 740
GK G+ R I + F IPE A+
Sbjct: 203 GKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ-FFKGLSIPEPETREPLESKFPNISSPALS 261
Query: 741 LFTRLLDPNPDLRPKAQNVLNHPFF 765
L +P R + +L HP+F
Sbjct: 262 FLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 72/312 (23%), Positives = 122/312 (39%), Gaps = 78/312 (25%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVRW 532
K + G+ G V L + +++ + LK+ Q ++ HP I+R
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ E DQ F+Y+ +E YV G L + SN
Sbjct: 67 FWTEHDQRFLYMLME----------YVPGGELFSYLRNSGRFSNSTG------------- 103
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
L +IV L +LH +++RDLKP+N+L+ K+ KL+D
Sbjct: 104 ----------------LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHI--KLTDF 145
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG----- 707
G +K+L+ + T G+ + APE + +A+D ++LG +++ + G
Sbjct: 146 GFAKKLR------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFF 199
Query: 708 GKHPYG---------ESFERDAN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 757
+P+G F R + KD LV VD RL +++ A
Sbjct: 200 DDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV------VDRTRRL----GNMKNGAD 249
Query: 758 NVLNHPFFWTAD 769
+V NH +F + D
Sbjct: 250 DVKNHRWFKSVD 261
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 59/263 (22%), Positives = 106/263 (40%), Gaps = 70/263 (26%)
Query: 523 SDQHPNIVRWYG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
S + P IV++YG ++ + +++E C GS + ++ +
Sbjct: 55 SCKSPYIVKYYGAFLDESSSSIGIAMEYCE----------GGSLD----------SIYKK 94
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 640
V+ R + E L K+ ++ GLS+LH +IHRD+KP N+L++
Sbjct: 95 VKKRGGRIGEKV---------------LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700
+ KL D G+S L + T G+S + APE++ + D++SLG
Sbjct: 140 RKGQ--VKLCDFGVSGEL-----VNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLT 192
Query: 701 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-----PEAVD--------------L 741
L + + P+ E ++ L+ +I PE D
Sbjct: 193 LLE-VAQNRFPFPPEGEPPLGPIE------LLSYIVNMPNPELKDEPGNGIKWSEEFKDF 245
Query: 742 FTRLLDPNPDLRPKAQNVLNHPF 764
+ L+ +P RP ++L HP+
Sbjct: 246 IKQCLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 82/307 (26%), Positives = 117/307 (38%), Gaps = 75/307 (24%)
Query: 480 EIAKGSNGTVV-LEGNYEGRSVAVKRLVKTHHDVALKEI----QNLIASDQHPNIVRWYG 534
EI G+ G V + G +AVK++ +T + K I ++ S P IV+ YG
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 535 V---ESDQDFVYLSLE---RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+SD V++ +E C L I
Sbjct: 82 YFITDSD---VFICMELMSTCLDKLLKRIQ------------------------------ 108
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCA 647
P L K+T IV L +L E G+IHRD+KP N+L+ D S
Sbjct: 109 ------------GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL--DASGNV 154
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT-----RAIDLFSLGCILF 702
KL D GIS RL + G + + APE++ RA D++SLG L
Sbjct: 155 KLCDFGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRA-DVWSLGISLV 209
Query: 703 FCITGGKHPYGE---SFERDANIVKDR-KDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 757
T G+ PY FE I+++ L E P+ L + RPK +
Sbjct: 210 ELAT-GQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR 268
Query: 758 NVLNHPF 764
+L HPF
Sbjct: 269 ELLQHPF 275
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 86/330 (26%), Positives = 133/330 (40%), Gaps = 93/330 (28%)
Query: 479 KEIAKGSNGTVVLEGNYE--GRSVAVK--RLVKTHHDV---ALKEIQNLIASDQHPNIVR 531
++I +G+ G VV +G + G+ VA+K RL V A++EI +L+ QHPNIV
Sbjct: 6 EKIGEGTYG-VVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREI-SLLKELQHPNIVC 63
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
V + +YL E + L K DS LP
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLK----------------KYLDS----------LP---- 93
Query: 592 TKDIELWKANGHPSAQLLK-VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ A+L+K I+ G+ H ++HRDLKPQN+LI D KL+
Sbjct: 94 --------KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI--DNKGVIKLA 143
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 709
D G+++ + T + ++APE LL R + +D++S+G I F K
Sbjct: 144 DFGLARAFGIPVRVYTHEVV---TLWYRAPEVLLGSPRYSTPVDIWSIGTI--FAEMATK 198
Query: 710 HPYGESFERDANI-----------------------VKDRKDLF-------LVEHIP--- 736
P F D+ I + D K+ F L +
Sbjct: 199 KPL---FHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLD 255
Query: 737 -EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+ +DL ++L +P R A+ LNHP+F
Sbjct: 256 EDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 78/325 (24%), Positives = 125/325 (38%), Gaps = 102/325 (31%)
Query: 497 GRSVAVKR-LVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551
GR VA+K+ L+ D AL+EI+ ++ +HPN+V
Sbjct: 33 GRVVALKKILMHNEKDGFPITALREIK-ILKKLKHPNVVP-------------------- 71
Query: 552 SLNDLIYVLSGSFEEQLNA-------KEQD-SNLLNEVRIRLLPVMENTKDIELWKANGH 603
L D+ + + + + D S LL ++L K L
Sbjct: 72 -LIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKL--TESQIKCYML------ 122
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI-------SK 656
QLL+ G+++LHE ++HRD+K N+LI D K++D G+
Sbjct: 123 ---QLLE-------GINYLHENHILHRDIKAANILI--DNQGILKIADFGLARPYDGPPP 170
Query: 657 RLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL--FFC---ITGGK 709
+G T+ T + W + PE LL R+ T A+D++ +GC+ F I GK
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230
Query: 710 H--------------------------PYGE---SFERDANIVKDRKDLFLVEHIPEAVD 740
P E SF +++R + PE +D
Sbjct: 231 SDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER----FGKLGPEGLD 286
Query: 741 LFTRLLDPNPDLRPKAQNVLNHPFF 765
L ++LL +P R A + L HP+F
Sbjct: 287 LLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 42/235 (17%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVES 537
K++ G G V + VAVK L V A E NL+ + QH +VR Y V +
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597
++ +Y+ E Y+ GS + L + E LL
Sbjct: 72 KEEPIYIITE----------YMAKGSLLDFLKSDEGGKVLL------------------- 102
Query: 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
+L+ + I G++++ IHRDL+ NVL+S +S K++D G+++
Sbjct: 103 --------PKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS--ESLMCKIADFGLARV 152
Query: 658 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
++ + + A W APE + G T D++S G +L+ +T GK PY
Sbjct: 153 IEDNEYTAREGAK--FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 43/163 (26%), Positives = 79/163 (48%), Gaps = 10/163 (6%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P Q+ + I+ GL+HLH ++HRD+K N+ + + K+ D+G++K L D +
Sbjct: 99 PEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLL-SDNT 155
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 723
T G+ + +PE D+++LG +L+ C T GKHP+ ++ + A I+
Sbjct: 156 NFAN--TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT-GKHPF-DANNQGALIL 211
Query: 724 KDRKDLFL---VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 763
K + +F + + L + L + RP +L +P
Sbjct: 212 KIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 79/324 (24%), Positives = 122/324 (37%), Gaps = 84/324 (25%)
Query: 480 EIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 533
+I +G+ GTV N E VA+KR+ D AL+EI L+ +H NIVR Y
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI-CLLKELKHKNIVRLY 65
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
V + L E C L +G + ++ V+ +
Sbjct: 66 DVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI------------VKSFMF------- 106
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
QLLK GL+ H ++HRDLKPQN+LI+K+ KL+D G
Sbjct: 107 -------------QLLK-------GLAFCHSHNVLHRDLKPQNLLINKNGEL--KLADFG 144
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHP 711
+++ + C + + W P +L G + + +ID++S GCI G+
Sbjct: 145 LARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
Query: 712 Y-GESFERDANIV------------------KDRKDLFLV------EHI-----PEAVDL 741
+ G + + D K + ++ DL
Sbjct: 201 FPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDL 260
Query: 742 FTRLLDPNPDLRPKAQNVLNHPFF 765
LL NP R A+ L HP+F
Sbjct: 261 LQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 55/161 (34%), Positives = 85/161 (52%), Gaps = 20/161 (12%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
+V GL +LHE +++RDLK N+L+ + K++D G+ K M + +T G+
Sbjct: 110 VVLGLQYLHENKIVYRDLKLDNLLLDTEGFV--KIADFGLCKE---GMGFGDRTSTFCGT 164
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFER--DANIVKD--RKDL 729
+ APE L + TRA+D + LG +L + + G+ P+ G+ E D+ IV D R
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLG-VLIYEMLVGESPFPGDDEEEVFDS-IVNDEVRYPR 222
Query: 730 FLVEHIPEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFF 765
FL EA+ + RLL NP+ R K A++V PFF
Sbjct: 223 FLSR---EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 69/297 (23%), Positives = 128/297 (43%), Gaps = 61/297 (20%)
Query: 480 EIAKGSNGTVVL-EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASD-QHPNIVRWYG 534
+I +GS G V + + GR VAVK + + ++ E+ +I D QH N+V Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEV--VIMRDYQHQNVVEMYK 85
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ +++ +E ++ G+ ++++++ R+
Sbjct: 86 SYLVGEELWVLME----------FLQGGAL----------TDIVSQTRLN---------- 115
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
Q+ V ++ L +LH G+IHRD+K ++L++ D KLSD G
Sbjct: 116 ----------EEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGF 163
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 713
++ D+ + + G+ W APE + + +D++SLG I+ + G+ PY
Sbjct: 164 CAQISKDVP---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLG-IMVIEMVDGEPPYFS 219
Query: 714 ESFERDANIVKDR-----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+S + ++D K+ + P D R+L P R AQ +L+HPF
Sbjct: 220 DSPVQAMKRLRDSPPPKLKNAHKIS--PVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 65/256 (25%), Positives = 105/256 (41%), Gaps = 73/256 (28%)
Query: 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD-------- 524
K + F KE+ G G VV G + G+ +DVA+K I+ S+
Sbjct: 4 KDLTFLKELGTGQFG-VVKYGKWRGQ-----------YDVAIKMIKEGSMSEDEFIEEAK 51
Query: 525 -----QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
H +V+ YGV + Q +Y+ E Y+ +G N L
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRPIYIVTE----------YMSNGCL----------LNYLR 91
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
E R P +QLL++ +D+ G+++L IHRDL +N L+
Sbjct: 92 EHGKRFQP------------------SQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV 133
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFS 696
D C K+SD G+S+ + D + + GS W PE LL + + D+++
Sbjct: 134 --DDQGCVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWA 186
Query: 697 LGCILFFCITGGKHPY 712
G +++ + GK PY
Sbjct: 187 FGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 53/173 (30%), Positives = 83/173 (47%), Gaps = 22/173 (12%)
Query: 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GS 674
L HLH +G+I+RDLKP+N+L+ D+ KL+D G+SK + Y G+
Sbjct: 110 ALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKE------SIDHEKKAYSFCGT 161
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDAN-IVKDRKDL--FL 731
+ APE + + T++ D +S G ++F +TG G+ + I+K + + FL
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFL 221
Query: 732 VEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADTRLSFLRDVS 779
PEA L L NP R A + + HPFF T D + R++
Sbjct: 222 S---PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIK 271
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 67/255 (26%), Positives = 108/255 (42%), Gaps = 52/255 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLV--KTHHD---VALKEIQ---NLIASDQH 526
+V +E+ +G+ G V L Y K LV K D A K+ Q L+ + QH
Sbjct: 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 66
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
+IV++YGV D D + + E Y+ G + L A D+ +L + + R
Sbjct: 67 EHIVKFYGVCGDGDPLIMVFE----------YMKHGDLNKFLRAHGPDAMILVDGQPR-- 114
Query: 587 PVMENTKDIELWKANGHPS-AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+A G +Q+L + I SG+ +L +HRDL +N L+ +
Sbjct: 115 ------------QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN--L 160
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G+S+ + +T Y G W PE ++ + T D++S
Sbjct: 161 LVKIGDFGMSRDVY---------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211
Query: 698 GCILFFCITGGKHPY 712
G IL+ T GK P+
Sbjct: 212 GVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 53/185 (28%), Positives = 86/185 (46%), Gaps = 24/185 (12%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
Q+ + R+I+ GL +LH IHRD+K NVL+S+ KL+D G++ +L
Sbjct: 102 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQ---I 156
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 726
+ T G+ W APE + Q D++SLG I + G+ P+ E +
Sbjct: 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG-ITAIELAKGEPPHSE--------LHPM 207
Query: 727 KDLFLV-EHIPEAV---------DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLR 776
K LFL+ ++ P + + L+ P RP A+ +L H F + S+L
Sbjct: 208 KVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLT 267
Query: 777 DVSDR 781
++ DR
Sbjct: 268 ELIDR 272
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 45/293 (15%)
Query: 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI---QNLIASDQHPNIVRWYGVE 536
E+ +G+ ++ G+ R VAVK L K D KE +L+++ HPNIV+ GV
Sbjct: 10 EVYEGTATDILGPGSGPIR-VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVC 68
Query: 537 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 596
+ Y+ +E DL+ L + E+ LL + E
Sbjct: 69 LLNEPQYIIMELMEGG--DLLSYLRDARVERFGPP-------------LLTLKE------ 107
Query: 597 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC---AKLSDMG 653
LL + D+ G +L ++ IHRDL +N L+S+ K+ D G
Sbjct: 108 -----------LLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 712
+++ + + G W APE LL G+ T D++S G +++ +T G+ PY
Sbjct: 157 LARDIYKS-DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 713 GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP---KAQNVLN 761
+ + V L E+ P+ + L T +P RP + Q +L
Sbjct: 216 ALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 78/322 (24%), Positives = 129/322 (40%), Gaps = 93/322 (28%)
Query: 477 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH--------HDVALKEIQNLIASD 524
F + + GS G V+L ++ VA+KR K+ H + ++I N I
Sbjct: 34 FIRTLGTGSFGRVILATYKNEDFP--PVAIKRFEKSKIIKQKQVDHVFSERKILNYI--- 88
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
HP V YG D+ ++YL LE +V+ G F L ++ N
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLE----------FVIGGEFFTFLRRNKRFPN-------- 130
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
D+ + A AQ++ + +L + +++RDLKP+N+L+ KD
Sbjct: 131 ---------DVGCFYA-----AQIVLI-------FEYLQSLNIVYRDLKPENLLLDKDGF 169
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
K++D G +K + T+ T G+ + APE LL +A D ++LG ++
Sbjct: 170 I--KMTDFGFAKVVD------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
Query: 705 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPN--------------- 749
+ G Y + L + + I E + F + LD N
Sbjct: 222 LVGCPPFYAN------------EPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTK 269
Query: 750 --PDLRPKAQNVLNHPFFWTAD 769
+L+ AQNV HP+F D
Sbjct: 270 RYGNLKKGAQNVKEHPWFGNID 291
|
Length = 340 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 33/191 (17%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
G P+ + + R + GL LH ++HRDLKP+N+L++ KL+D G+++
Sbjct: 104 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQ 161
Query: 662 MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL--------FFCITGGKHPYG 713
M+ T + ++APE LLQ +D++S+GCI FC G
Sbjct: 162 MALTPVVVTLW----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 217
Query: 714 ESFERDANIVKDR--KDLFLVEH-------------IPE----AVDLFTRLLDPNPDLRP 754
+ F+ +D +D+ L +PE L +L NP R
Sbjct: 218 KIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI 277
Query: 755 KAQNVLNHPFF 765
A L HPFF
Sbjct: 278 SAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 19/181 (10%)
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
G + + +I GL LH +++RDLKP+N+L+ D ++SD+G++ +
Sbjct: 98 GFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL--DDYGHIRISDLGLAVEIPEG 155
Query: 662 MSCLTQNATG-YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP---YGESFE 717
+ G G+ G+ APE + R T + D + LGC+++ I GK P E +
Sbjct: 156 -----ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRKEKVK 209
Query: 718 RDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADT 770
R+ VK+ ++ + + A + +LL +P R A+ V HPFF TA+
Sbjct: 210 REEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269
Query: 771 R 771
+
Sbjct: 270 K 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 62/255 (24%), Positives = 103/255 (40%), Gaps = 53/255 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEG------NYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQ 525
+V E+ +G+ G V L + VAVK L K + A ++ Q L+ Q
Sbjct: 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTVLQ 65
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H +IVR+YGV ++ + + E Y+ G L + D+ +L
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFE----------YMRHGDLNRFLRSHGPDAKILAGGE--- 112
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ L Q+L + I SG+ +L + +HRDL +N L+ +
Sbjct: 113 ---DVAPGQLTL--------GQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG--L 159
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG--------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G+S+ + +T Y G W PE +L + T D++S
Sbjct: 160 VVKIGDFGMSRDIY---------STDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210
Query: 698 GCILFFCITGGKHPY 712
G +L+ T GK P+
Sbjct: 211 GVVLWEIFTYGKQPW 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 47/233 (20%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-ESDQ 539
I KG G V+L G+Y G VAVK + A +++ +H N+V+ GV ++
Sbjct: 14 IGKGEFGDVML-GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 72
Query: 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 599
+Y+ E Y+ GS L++ +R R V+
Sbjct: 73 GGLYIVTE----------YMAKGS-------------LVDYLRSRGRSVLGGDC------ 103
Query: 600 ANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659
LLK + D+ + +L +HRDL +NVL+S+D AK+SD G++K
Sbjct: 104 --------LLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN--VAKVSDFGLTKEAS 153
Query: 660 GDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
TQ+ TG W APE L + + + D++S G +L+ + G+ PY
Sbjct: 154 S-----TQD-TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 44/171 (25%), Positives = 85/171 (49%), Gaps = 18/171 (10%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P L ++ +V GL++L + ++HRD+KP N+L++ KL D G+S +L ++
Sbjct: 93 PEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNSIA 150
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 723
T G++ + APE++ + D++SLG I F + G+ PY + + +++
Sbjct: 151 -----KTYVGTNAYMAPERISGEQYGIHSDVWSLG-ISFMELALGRFPYPQIQKNQGSLM 204
Query: 724 ----------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
+D L + + + V T+ + P RP +N+++HPF
Sbjct: 205 PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 605 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 664
S QL+ + R I +G+ +L ++ +HRDL +N+L+ + + K+SD G+S+ L+ D
Sbjct: 106 SYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV--NSNLECKVSDFGLSRVLEDDPEG 163
Query: 665 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
+ G W APE + + T A D++S G +++ ++ G+ PY +
Sbjct: 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 48/168 (28%), Positives = 82/168 (48%), Gaps = 24/168 (14%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+IVS L +LH +++RDLK +N+++ KD K++D G+ K +S T G
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHI--KITDFGLCKE---GISDGATMKTFCG 157
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
+ + APE L RA+D + LG +++ + G+ P+ + +D + +L L+E
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPF---YNQDHEKL---FELILME 210
Query: 734 HI-------PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTAD 769
I PEA L LL +P R A+ ++ H FF + +
Sbjct: 211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASIN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 45/164 (27%), Positives = 81/164 (49%), Gaps = 21/164 (12%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGY 672
+I+ GL LH ++RDLKP+N+L+ ++SD+G++ ++ +G+
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHI--RISDLGLAVKIPEGESI-----RGRV 162
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER------DANIVKDR 726
G+ G+ APE L R T + D + LGC+++ I G+ P+ E+ D +++
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKVKREEVDRRVLET- 220
Query: 727 KDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 765
++++ + EA + LL +P R A V HPFF
Sbjct: 221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 26/167 (15%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I+ GL LH+ G+I+RDLK NVL+ KD K++D G+ K +M+ + +T G
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLLDKDGHI--KIADFGMCKE---NMNGEGKASTFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--- 730
+ + APE L + ++D +S G +L+ + G +GE D +LF
Sbjct: 159 TPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE----------DEDELFDSI 208
Query: 731 LVE--HIP-----EAVDLFTRLLDPNPDLR-PKAQNVLNHPFFWTAD 769
L + H P EA D ++L + +P R ++ HPFF D
Sbjct: 209 LNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 62/270 (22%), Positives = 116/270 (42%), Gaps = 50/270 (18%)
Query: 498 RSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI 557
+ + V+++ K A E Q ++ HPNI+ +Y + + + +E
Sbjct: 31 KQIPVEQMTKDERLAAQNECQ-VLKLLSHPNIIEYYENFLEDKALMIVME---------- 79
Query: 558 YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617
Y G+ E + ++ ++LL+E I L I+
Sbjct: 80 YAPGGTLAEYIQ--KRCNSLLDEDTI-------------------------LHFFVQILL 112
Query: 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 677
L H+H ++HRDLK QN+L+ K K K+ D GISK L S ++ T G+ +
Sbjct: 113 ALHHVHTKLILHRDLKTQNILLDKHKMV-VKIGDFGISKIL----SSKSKAYTVVGTPCY 167
Query: 678 QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--LVEH 734
+PE L +G+ + D+++LGC+L+ + + + A ++K F + +
Sbjct: 168 ISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP--ALVLKIMSGTFAPISDR 224
Query: 735 I-PEAVDLFTRLLDPNPDLRPKAQNVLNHP 763
P+ L +L+ +P RP+ ++ P
Sbjct: 225 YSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 68/250 (27%), Positives = 100/250 (40%), Gaps = 66/250 (26%)
Query: 479 KEIAKGSNGTV-----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIV 530
K + G+ GTV + EG VA+K L + A KEI + ++AS HP++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
R G+ C S LI + G LL+ VR
Sbjct: 73 RLLGI-------------CLSSQVQLITQLMPLGC-------------LLDYVR------ 100
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ +I S LL I G+S+L E L+HRDL +NVL+ + K
Sbjct: 101 -NHKDNIG--------SQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VK 149
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILF 702
++D G++K L D Y + G W A E +L T D++S G ++
Sbjct: 150 ITDFGLAKLLDVD-------EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVW 202
Query: 703 FCITGGKHPY 712
+T G PY
Sbjct: 203 ELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 63/269 (23%), Positives = 108/269 (40%), Gaps = 33/269 (12%)
Query: 500 VAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 556
VAVK L + + Q L+A HPNIV+ GV + + L E
Sbjct: 38 VAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE--------- 88
Query: 557 IYVLSGSFEEQL---NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613
Y+ G E L + + Q S + R N + + L + +
Sbjct: 89 -YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG--LNPLPLS--------CTEQLCIAK 137
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGY 672
+ +G+++L E +HRDL +N L+ ++ K++D G+S+ + D ++N
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGEN--MVVKIADFGLSRNIYSADYYKASEN--DA 193
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFL 731
W PE + R T D+++ G +L+ + G PY G + E V+D L
Sbjct: 194 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSC 253
Query: 732 VEHIP-EAVDLFTRLLDPNPDLRPKAQNV 759
++ P E +L P RP ++
Sbjct: 254 PDNCPLELYNLMRLCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 37/119 (31%), Positives = 66/119 (55%), Gaps = 12/119 (10%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QL+ + R I +G+ +L E+ +HRDL +N+L+ + + K+SD G+S+ L+ D S
Sbjct: 107 QLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV--NSNLVCKVSDFGLSRFLEDDTS--- 161
Query: 667 QNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 719
+ T S G W APE + + T A D++S G +++ ++ G+ PY + +D
Sbjct: 162 -DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-10
Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 44/185 (23%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GL ++H G+IHRDLKP NV +++D ++ D G++++ +M TGY +
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCEL--RILDFGLARQADDEM-------TGYVA 177
Query: 675 SGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK----HPYGESFERDANIV----- 723
+ W +APE +L + +D++S+GCI+ + G + Y + +R +V
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237
Query: 724 -----------------------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760
+D K +F + P A+DL ++L + D R A L
Sbjct: 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGAN-PLAIDLLEKMLVLDSDKRISASEAL 296
Query: 761 NHPFF 765
HP+F
Sbjct: 297 AHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 62/246 (25%), Positives = 109/246 (44%), Gaps = 38/246 (15%)
Query: 475 VVFNKEIAKGSNGTVV---LEGNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQH 526
+ F I +G+ G V+ ++ + + A+K L + H D A E++ L H
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFA-GELEVLCKLGHH 62
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
PNI+ G ++ ++Y+++E Y G NLL+ +R +
Sbjct: 63 PNIINLLGACENRGYLYIAIE----------YAPYG-------------NLLDFLRKSRV 99
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+ E A+ S QLL+ D+ +G+ +L E IHRDL +NVL+ ++
Sbjct: 100 LETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN--LA 157
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
+K++D G+S+ G+ + G W A E L T D++S G +L+ ++
Sbjct: 158 SKIADFGLSR---GE-EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
Query: 707 GGKHPY 712
G PY
Sbjct: 214 LGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 14/166 (8%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 115 GQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 724
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 725 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFF 765
L PE + D R L+ + D R A+ +L HPF
Sbjct: 229 TNGTPELQN--PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 68/237 (28%)
Query: 481 IAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHD------VALKEIQNLIASDQHPN 528
I +G+ G V Y R VA+K+ V+ ++ +L+EI L+ +HPN
Sbjct: 15 IGEGTYGIV-----YRARDTTSGEIVALKK-VRMDNERDGIPISSLREITLLLNL-RHPN 67
Query: 529 IVRWYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
IV V + D ++L +E C L L+ + F E
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSE-------------------- 107
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+Q+ + ++ GL +LHE +IHRDLK N+L++ DK C
Sbjct: 108 -------------------SQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKG-C 146
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGR-QTRAIDLFSLGCIL 701
K++D G+++ +T + W +APE LL T AID++++GCIL
Sbjct: 147 LKIADFGLARTYGLPAKPMTPKVV----TLWYRAPELLLGCTTYTTAIDMWAVGCIL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 20/174 (11%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I+ GL H+H +++RDLKP N+L+ D+ ++SD+G L D S +A+ G
Sbjct: 105 EIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLG----LACDFSKKKPHAS-VG 157
Query: 674 SSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL- 731
+ G+ APE L +G + D FSLGC+LF + G P+ + +D + + DR L +
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEI-DRMTLTVN 215
Query: 732 VE----HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADTRLSFLR 776
VE PE L LL + R AQ V H FF D + +L+
Sbjct: 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 46/198 (23%)
Query: 605 SAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDM 662
S+ +KV I+ GL +LH G++HRD+KP N+L++ + C K+ D G+++ + D
Sbjct: 101 SSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN---CVLKICDFGLARVEEPDE 157
Query: 663 SC-LTQN-ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK---------- 709
S +TQ T Y ++APE L+ R T A+D++S+GCI F + G +
Sbjct: 158 SKHMTQEVVTQY----YRAPEILMGSRHYTSAVDIWSVGCI-FAELLGRRILFQAQSPIQ 212
Query: 710 ----------HPYGESFE-----------RDANIVKDRKDLFLV--EHIPEAVDLFTRLL 746
P E+ R + L+ + + EAV L R+L
Sbjct: 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRML 272
Query: 747 DPNPDLRPKAQNVLNHPF 764
+PD R A + L HP+
Sbjct: 273 VFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 47/185 (25%), Positives = 85/185 (45%), Gaps = 44/185 (23%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+ GL ++H +IHRDLKP N+ +++D K+ D G+++ +M TGY +
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCEL--KILDFGLARHTDDEM-------TGYVA 179
Query: 675 SGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK-HPYGESFERDANIVK------- 724
+ W +APE +L + +D++S+GCI+ +TG P + ++ I++
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239
Query: 725 ------------------------DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760
+ ++F+ + P AVDL ++L + D R A L
Sbjct: 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGAN-PLAVDLLEKMLVLDSDKRITAAQAL 298
Query: 761 NHPFF 765
H +F
Sbjct: 299 AHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+IVS L +LH +++RD+K +N+++ KD K++D G+ K D + + T G
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHI--KITDFGLCKEGISDGATMK---TFCG 157
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
+ + APE L RA+D + LG +++ + G Y + ER ++ + F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 217
Query: 734 HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 765
PEA L LL +P R A+ V+ H FF
Sbjct: 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 23/180 (12%)
Query: 610 KVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 668
K+ +V GL++L+ + ++HRD+KP N+L++ KL D G+S L ++
Sbjct: 107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQI--KLCDFGVSGELINSIA----- 159
Query: 669 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 728
T G+S + +PE++ G+ T D++SLG + GK P+ S D
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL-GKFPFAFSNIDDDGQDDPMGI 218
Query: 729 LFLVEHI--------------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSF 774
L L++ I + D L +P RP Q + P F A +
Sbjct: 219 LDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 79/301 (26%), Positives = 128/301 (42%), Gaps = 66/301 (21%)
Query: 479 KEIAKGSNGTVV-LEGNYEGRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 530
K+I KG V +GR VA+K++ K D LKEI +L+ HPN++
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQD-CLKEI-DLLKQLDHPNVI 65
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVL----SGSFEEQL-NAKEQDSNLLNEVRIRL 585
++ F+ N+L VL +G + + K+Q RL
Sbjct: 66 KYLA-----SFIEN---------NELNIVLELADAGDLSRMIKHFKKQK---------RL 102
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+P E T +WK + S L H+H ++HRD+KP NV I+
Sbjct: 103 IP--ERT----IWK-----------YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVV 145
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
KL D+G+ + S T + G+ + +PE++ + D++SLGC+L+ +
Sbjct: 146 --KLGDLGLGRFFS---SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE-M 199
Query: 706 TGGKHP-YGES---FERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760
+ P YG+ + I K D L + E DL +R ++P+P+ RP VL
Sbjct: 200 AALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVL 259
Query: 761 N 761
Sbjct: 260 Q 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 6e-10
Identities = 65/209 (31%), Positives = 88/209 (42%), Gaps = 56/209 (26%)
Query: 611 VTR----DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS----------- 655
VTR + V + +H++G IHRD+KP N+LI + KLSD G+S
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHI--KLSDFGLSTGFHKQHDSAY 159
Query: 656 --KRLQGD--------------------MSCLTQNAT--------GYGSSG---WQAPEQ 682
K LQG MS Q AT Y + G + APE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 683 LLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHI---PEA 738
LQ + D +SLG I+F C+ G E S E I+ R+ L+ + I EA
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEA 279
Query: 739 VDLFTRLL-DPNPDL-RPKAQNVLNHPFF 765
DL RL+ + L R A + +HPFF
Sbjct: 280 EDLIRRLITNAENRLGRGGAHEIKSHPFF 308
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 74/297 (24%), Positives = 122/297 (41%), Gaps = 77/297 (25%)
Query: 479 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKT-HHDVALKEIQN--LIASDQHPNI 529
+ I +G+ G V + GR VAVK +T D+ K +Q ++ HPNI
Sbjct: 1 ERIGRGNFGEV-----FSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 55
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE-VRIRLLPV 588
VR GV + + +Y+ +E V G F + L E R+++
Sbjct: 56 VRLIGVCTQKQPIYIVME----------LVQGGDFL---------TFLRTEGPRLKV--- 93
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+L+++ + +G+ +L IHRDL +N L+++ K
Sbjct: 94 -----------------KELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVL--K 134
Query: 649 LSDMGISKRLQGDMSCLTQNATG-YGSSG--------WQAPEQLLQGRQTRAIDLFSLGC 699
+SD G+S+ + G Y S+G W APE L GR + D++S G
Sbjct: 135 ISDFGMSR----------EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGI 184
Query: 700 ILFFCITGGKHPYGE-SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 754
+L+ + G PY S ++ ++ L E P+AV L R + +P RP
Sbjct: 185 LLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRP 241
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 48/176 (27%), Positives = 88/176 (50%), Gaps = 15/176 (8%)
Query: 595 IELWKANGH--PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+E K G Q+ + ++ G+ ++H+ ++HRDLK +N+ + + K+ D
Sbjct: 93 LEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDF 149
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILF-FCITGGKH 710
G+S+ L G T T G+ + +PE L QG +++ D++SLGCIL+ C H
Sbjct: 150 GVSRLLMGSCDLAT---TFTGTPYYMSPEALKHQGYDSKS-DIWSLGCILYEMCCL--AH 203
Query: 711 PY-GESFERDANIVKDRKDLFLVEHIPEAVD-LFTRLLDPNPDLRPKAQNVLNHPF 764
+ G++F + + L E ++ + +L+ +P LRP A +L +PF
Sbjct: 204 AFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 9e-10
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 501 AVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555
A+KR+ + H D A E++ L HPNI+ G + ++YL++E
Sbjct: 38 AIKRMKEYASKDDHRDFA-GELEVLCKLGHHPNIINLLGACEHRGYLYLAIE-------- 88
Query: 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615
Y G NLL+ +R + + I A+ S QLL D+
Sbjct: 89 --YAPHG-------------NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS 675
G+ +L + IHRDL +N+L+ ++ + AK++D G+S+ + G
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFGLSR----GQEVYVKKTMGRLPV 187
Query: 676 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
W A E L T D++S G +L+ ++ G PY
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-10
Identities = 65/242 (26%), Positives = 104/242 (42%), Gaps = 48/242 (19%)
Query: 473 KLVVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK-THHDVALKEIQNLIASDQHPNIV 530
KLV K++ G G V + G Y G VA+K L + + A NL+ QHP +V
Sbjct: 9 KLV---KKLGAGQFGEVWM-GYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R Y V + Q+ +Y+ E Y+ +GS + L E
Sbjct: 65 RLYAVVT-QEPIYIITE----------YMENGSLVDFLKTPE------------------ 95
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ + K L+ + I G++ + IHRDL+ N+L+S ++ C K++
Sbjct: 96 -GIKLTINK--------LIDMAAQIAEGMAFIERKNYIHRDLRAANILVS--ETLCCKIA 144
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G++ RL D + + W APE + G T D++S G +L +T G+
Sbjct: 145 DFGLA-RLIEDNEYTAREGAKFPIK-WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRI 202
Query: 711 PY 712
PY
Sbjct: 203 PY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 69/303 (22%), Positives = 120/303 (39%), Gaps = 67/303 (22%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASD-QHPNIVRWYGV 535
+ I G+ G V N +A +++K D A+ + + ++ D +H NIV ++G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 536 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+D +++ +E C SL D IY ++G E
Sbjct: 75 YLRRDKLWICMEFCGGGSLQD-IYHVTGPLSE---------------------------- 105
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+Q+ V+R+ + GL +LH G +HRD+K N+L++ + KL+D G+
Sbjct: 106 -----------SQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGV 152
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-------------TRAIDLFSLGCIL 701
S ++ + + + + G+ W APE R+ AI+L L +
Sbjct: 153 SAQIT---ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
Query: 702 FFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761
F HP F + + K ++ L NP RP A+ +L
Sbjct: 210 F-----DLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
Query: 762 HPF 764
HPF
Sbjct: 265 HPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 52/194 (26%), Positives = 79/194 (40%), Gaps = 44/194 (22%)
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----ISKRLQGDMSCL 665
KV + +++GL ++H ++HRD+K N+LI+KD KL+D G S +
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGIL--KLADFGLARAFSLSKNSKPNRY 180
Query: 666 TQN-ATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL---------------------- 701
T T + ++ PE LL R ID++ GCI+
Sbjct: 181 TNRVVTLW----YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236
Query: 702 -FFC--ITGGKHPYGESFERDANIV-----KDRKDLFLVEHI--PEAVDLFTRLLDPNPD 751
C IT P + E + K + L ++ P A+DL +LL +P
Sbjct: 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPA 296
Query: 752 LRPKAQNVLNHPFF 765
R A LNH FF
Sbjct: 297 KRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 46/167 (27%), Positives = 81/167 (48%), Gaps = 11/167 (6%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
+++++ +I G+++L+ +HRDL +N +++ D F K+ D G+++ + +
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHD--FTVKIGDFGMTRDIY-ETDYYR 176
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKD 725
+ G W APE L G T + D++S G +L+ + + PY G S E+ V D
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236
Query: 726 RKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN------HPFF 765
L ++ PE V DL NP +RP ++N HP F
Sbjct: 237 GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSF 283
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 66/240 (27%), Positives = 106/240 (44%), Gaps = 46/240 (19%)
Query: 500 VAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555
VAVK L KT + LKEI+ +++ ++PNI+R GV D + + E
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIK-IMSRLKNPNIIRLLGVCVSDDPLCMITE-------- 97
Query: 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPS---AQLLKVT 612
Y+ +G + L+ +E +S AN PS A LL +
Sbjct: 98 --YMENGDLNQFLSQREIESTFT--------------------HANNIPSVSIANLLYMA 135
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG 671
I SG+ +L + +HRDL +N L+ + K++D G+S+ L GD + A
Sbjct: 136 VQIASGMKYLASLNFVHRDLATRNCLV--GNHYTIKIADFGMSRNLYSGDYYRIQGRAV- 192
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK-HPYGESFERDANIVKDRKDLF 730
W A E +L G+ T A D+++ G L+ T K PY S D ++++ + F
Sbjct: 193 -LPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY--SLLSDEQVIENTGEFF 249
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 50/166 (30%), Positives = 80/166 (48%), Gaps = 14/166 (8%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
AQ+ V R+ + L LH +IHRD+K NVL+ D S KL+D G ++ + S
Sbjct: 115 AQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 724
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 725 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFF 765
L PE + D R L+ + + R A+ +L HPF
Sbjct: 229 TNGTPELQN--PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 32/99 (32%), Positives = 60/99 (60%), Gaps = 8/99 (8%)
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 670
+ R+++ L ++H++G+IHRD+K N+L++ + KL D G++ L + S + +T
Sbjct: 106 IIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSS---KRST 160
Query: 671 GYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG 707
G+ W APE + +G+ T+A D++SLG ++ TG
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTKA-DIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 46/167 (27%), Positives = 78/167 (46%), Gaps = 12/167 (7%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
Q+ V ++ LS LH G+IHRD+K ++L++ D KLSD G ++ ++
Sbjct: 117 QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVP--- 171
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 726
+ + G+ W APE + + +D++SLG ++ + G + E + +++D
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231
Query: 727 -----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768
K+L V P RLL +P R A +L HPF A
Sbjct: 232 LPPKLKNLHKVS--PSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 44/194 (22%)
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM---------- 662
I++GL+ LH+ +HRDL P N+ I+ K C K++D G+++R
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFIN-SKGIC-KIADFGLARRYGYPPYSDTLSKDET 183
Query: 663 SCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKHPYGES----- 715
+ T + W +LL G + A+D++S+GCI +TG GE+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243
Query: 716 ------------------------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
E KD K +F +A+DL LL NP
Sbjct: 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNAS-DDAIDLLQSLLKLNPL 302
Query: 752 LRPKAQNVLNHPFF 765
R A+ L H +F
Sbjct: 303 ERISAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 58/298 (19%)
Query: 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----EIQNLIASDQHPNIVRWYGV 535
E+ G+ G V N E ++A ++++T + L+ EI+ ++A+ HP IV+ G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIE-ILATCNHPYIVKLLGA 77
Query: 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
+++ +E C D I + E D L E +I++
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIML------------ELDRGL-TEPQIQV---------- 114
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
+ R ++ L +LH + +IHRDLK NVL++ D KL+D G+S
Sbjct: 115 ---------------ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDI--KLADFGVS 157
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLGCILFFCITGGKH 710
+ ++ L + + G+ W APE ++ D++SLG I + +
Sbjct: 158 AK---NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 213
Query: 711 PYGE--SFERDANIVKDRKDLFLV--EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
P+ E I K + E D LD +P+ RP A +L HPF
Sbjct: 214 PHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 56/233 (24%), Positives = 98/233 (42%), Gaps = 59/233 (25%)
Query: 490 VLEGNYEGRS-VAVKRL---VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545
V EG ++ R VA+K L KE+Q L +H +++ + V
Sbjct: 22 VWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQAL-KRLRHKHLISLFAV---------- 70
Query: 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPS 605
CS+ + +Y+++ +L K L ++LPV
Sbjct: 71 -----CSVGEPVYIIT-----ELMEKGSLLAFLRSPEGQVLPV----------------- 103
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
A L+ + + G+++L E IHRDL +N+L+ +D K++D G+++ ++ D+
Sbjct: 104 ASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGED--LVCKVADFGLARLIKEDV--- 158
Query: 666 TQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Y SS W APE G + D++S G +L+ T G+ PY
Sbjct: 159 ------YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPY 205
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 49/169 (28%), Positives = 80/169 (47%), Gaps = 14/169 (8%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 115 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 170
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 724
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMVEGEPPYLNENPLRALYLIA 228
Query: 725 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768
L PE + D R L+ + + R A+ +L HPF A
Sbjct: 229 TNGTPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 73/308 (23%), Positives = 120/308 (38%), Gaps = 66/308 (21%)
Query: 479 KEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQHPNIV 530
+++ +G G V L EG+ G VAVK L +H LK+ ++ + H NIV
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 531 RWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++ G+ E + + L +E ++ SGS +E L + NL
Sbjct: 70 KYKGICTEDGGNGIKLIME----------FLPSGSLKEYLPRNKNKINL----------- 108
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
Q LK I G+ +L +HRDL +NVL+ + K
Sbjct: 109 -----------------KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VK 149
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT-- 706
+ D G++K ++ D T W APE L+Q + A D++S G L+ +T
Sbjct: 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC 209
Query: 707 -GGKHPYGE------------SFERDANIVKDRKDLFLVEHIPEAVD-LFTRLLDPNPDL 752
P + R ++++ K L + PE V L + + P
Sbjct: 210 DSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSK 269
Query: 753 RPKAQNVL 760
R QN++
Sbjct: 270 RTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 30/204 (14%)
Query: 509 HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 568
H D A E++ L HPNI+ G + ++YL++E Y G
Sbjct: 39 HRDFA-GELEVLCKLGHHPNIINLLGACEHRGYLYLAIE----------YAPHG------ 81
Query: 569 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628
NLL+ +R + + I A+ S QLL D+ G+ +L + I
Sbjct: 82 -------NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI 134
Query: 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 688
HRDL +N+L+ ++ + AK++D G+S+ G + G W A E L
Sbjct: 135 HRDLAARNILVGEN--YVAKIADFGLSR---GQ-EVYVKKTMGRLPVRWMAIESLNYSVY 188
Query: 689 TRAIDLFSLGCILFFCITGGKHPY 712
T D++S G +L+ ++ G PY
Sbjct: 189 TTNSDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QL+ + I G++++ + IHRDL+ N+L+ + K++D G+++ ++ +
Sbjct: 103 QLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN--LVCKIADFGLARLIEDNEYTAR 160
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 726
Q A W APE L GR T D++S G +L +T G+ PY R+ +R
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER 218
Query: 727 K-DLFLVEHIPEAV-DLFTRLLDPNPDLRP 754
+ + PE++ +L +PD RP
Sbjct: 219 GYRMPCPQGCPESLHELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 59/198 (29%), Positives = 86/198 (43%), Gaps = 54/198 (27%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMGISKRLQGDMSCL 665
QLL+ L ++H + HRDLKP+N+L + D C K+ D G+++ D
Sbjct: 111 QLLR-------ALKYIHTANVFHRDLKPKNILANAD---CKLKICDFGLARVAFND---- 156
Query: 666 TQNA---TGYGSSGW-QAPEQL--LQGRQTRAIDLFSLGCILFFCITG-----GKH---- 710
T A T Y ++ W +APE + T AID++S+GCI +TG GK+
Sbjct: 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216
Query: 711 ----------PYGESFERDANIVKDRKDLFLVEHI-------------PEAVDLFTRLLD 747
P E+ R N K R+ L + P A+ L RLL
Sbjct: 217 LDLITDLLGTPSPETISRVRN-EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLA 275
Query: 748 PNPDLRPKAQNVLNHPFF 765
+P RP A+ L P+F
Sbjct: 276 FDPKDRPTAEEALADPYF 293
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 81/346 (23%), Positives = 134/346 (38%), Gaps = 88/346 (25%)
Query: 480 EIAKGSNGTVVLEGN-YEGRSVAVKRLV----KTH---HDVALKEIQNLIASDQHPNIVR 531
EI GS G V N + VAVK++ +T+ D+ +KE++ + +HPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDI-IKEVK-FLQQLKHPNTIE 85
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ G + +L +E C S +DL+ V +E
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE------------------------- 120
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
++ +T + GL++LH +IHRD+K N+L+++ KL+D
Sbjct: 121 --------------VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLAD 164
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITGG 708
G S + + G+ W APE +L +G+ +D++SLG CI
Sbjct: 165 F-------GSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT---CI--- 211
Query: 709 KHPYGESFERDANIVKDRKDLFLVEHIP----------EAVDLFTRLLD----PNPDLRP 754
E ER + + + + HI E D F +D P RP
Sbjct: 212 -----ELAERKPPLF-NMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERP 265
Query: 755 KAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 800
+ +L H F D L D+ R + RE D+ R ++ I
Sbjct: 266 ASAELLRHDFVRR-DRPARVLIDLIQRTKDAVRELDNLQYRKMKKI 310
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 38/250 (15%)
Query: 475 VVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVK--THHDVA--LKEIQNLIA 522
+V K + +G G VV Y + +VAVK L T D+A + E++ +
Sbjct: 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKL 73
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+H NI+ GV + + +Y+ +E Y G+ E L R
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVE----------YAAKGNLREFL-------------R 110
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
R P + T DI L+ + G+ +L IHRDL +NVL+++D
Sbjct: 111 ARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
K++D G+++ + D+ + + G W APE L T D++S G +++
Sbjct: 171 NVM--KIADFGLARGVH-DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227
Query: 703 FCITGGKHPY 712
T G PY
Sbjct: 228 EIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 17/161 (10%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY- 672
++V L HLH+ +++RDLKP+N+L+ L D G+SK + LT N T
Sbjct: 104 ELVLALEHLHKYDIVYRDLKPENILLDATGHIA--LCDFGLSK------ANLTDNKTTNT 155
Query: 673 --GSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDL 729
G++ + APE LL + T+ +D +SLG ++F G Y E ++ + K
Sbjct: 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR 215
Query: 730 FLVEHIPEAVDLFTR-LLDPNPDLR----PKAQNVLNHPFF 765
F + + F + LL+ NP R A + HPFF
Sbjct: 216 FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 52/166 (31%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 672
+IV GL LH G+I+RDLK NV++ +D K++D G+ K + GD + +T
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHI--KIADFGMCKENVFGD----NRASTFC 157
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 732
G+ + APE L + T ++D +S G +L+ + G +G+ + D R D
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD--DEDELFESIRVD---T 212
Query: 733 EHIP-----EAVDLFTRLLDPNPDLRPKAQ-NVLNHPFF----WTA 768
H P E+ D+ +L + +P R N+ HPFF WTA
Sbjct: 213 PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 77/333 (23%), Positives = 123/333 (36%), Gaps = 88/333 (26%)
Query: 470 RIGKLVVFN------------KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI 517
GK ++F+ + I KG+ G V N + S A +++ HD+ +EI
Sbjct: 3 LSGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEI 61
Query: 518 QN----LIASDQHPNIVRWYGVESDQDFV-----YLSLERCTCSLNDLIYVLSGSFEEQL 568
+ L A HPN+V++YG+ +D +L LE C GS + +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCN----------GGSVTDLV 111
Query: 569 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628
+ + E I + + + GL HLH I
Sbjct: 112 KGFLKRGERMEEPIIAY-------------------------ILHEALMGLQHLHVNKTI 146
Query: 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP-----EQL 683
HRD+K N+L++ + KL D G+S +L S + T G+ W AP EQ
Sbjct: 147 HRDVKGNNILLTTEGG--VKLVDFGVSAQL---TSTRLRRNTSVGTPFWMAPEVIACEQQ 201
Query: 684 LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIP------- 736
L D++SLG I + G P + + + LF + P
Sbjct: 202 LDSTYDARCDVWSLG-ITAIELGDGDPPLAD--------LHPMRALFKIPRNPPPTLHQP 252
Query: 737 -----EAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
E D + L + + RP ++L H F
Sbjct: 253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 70/329 (21%), Positives = 127/329 (38%), Gaps = 85/329 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVK-THHDVALKEIQNLIASDQHPNIVRWY 533
+ +EI G G V L E R VA+K + + + E ++ HP +V+ Y
Sbjct: 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
GV +++ + L E ++ G + L A+
Sbjct: 66 GVCTERSPICLVFE----------FMEHGCLSDYLRAQR--------------------- 94
Query: 594 DIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
G S + LL + D+ G+++L +IHRDL +N L+ +++ K+SD
Sbjct: 95 --------GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ--VVKVSDF 144
Query: 653 GISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
G+++ + D Q + G+ W +PE + + D++S G +++ + GK
Sbjct: 145 GMTRFVLDD-----QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199
Query: 710 HPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-QNVLNHPFFWTA 768
PY ++R + +VE I L+ P L ++ ++ H +
Sbjct: 200 TPY-----------ENRSNSEVVETINAGFRLY------KPRLASQSVYELMQHCW---- 238
Query: 769 DTRLSFLRDVSDRVELEDRESDSKLLRAL 797
+ EDR S S LL L
Sbjct: 239 ------------KERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
Q+ V ++ LS+LH G+IHRD+K ++L++ D KLSD G ++ ++
Sbjct: 119 QIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRI--KLSDFGFCAQVSKEVP--- 173
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR 726
+ + G+ W APE + + +D++SLG ++ I G + E + ++D
Sbjct: 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN 233
Query: 727 -----KDLFLVEHIPEA-VDLFTRLLDPNPDLRPKAQNVLNHPFF 765
KD V + +DL +L P R AQ +L HPF
Sbjct: 234 LPPRVKDSHKVSSVLRGFLDL---MLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 49/183 (26%), Positives = 81/183 (44%), Gaps = 42/183 (22%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+ GL ++H G++HRDLKP N+LI+++ K+ D G+++ M TGY S
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDL--KICDFGLARIQDPQM-------TGYVS 167
Query: 675 SG-WQAPEQLLQGRQ-TRAIDLFSLGCILFFCITG-----GKHPYGE------------- 714
+ ++APE +L ++ +D++S GCI + G GK +
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPD 227
Query: 715 ------SFERDANIVKD---RKDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLN 761
E V+ R+ + E P A+DL ++L +P R A L
Sbjct: 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287
Query: 762 HPF 764
HP+
Sbjct: 288 HPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 40/261 (15%)
Query: 500 VAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 556
V VK L KT + E + ++ H N+VR G+ + + Y+ LE
Sbjct: 38 VLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE--------- 88
Query: 557 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616
Y G ++ L A E K + Q + + I
Sbjct: 89 -YTDLGDLKQFLRA--------------------TKSKDEKLKPPPLSTKQKVALCTQIA 127
Query: 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 676
G+ HL +HRDL +N L+S K+S + +SK + +NA
Sbjct: 128 LGMDHLSNARFVHRDLAARNCLVSSQ--REVKVSLLSLSKDVYNSEYYKLRNA--LIPLR 183
Query: 677 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE-SFERDANIVKDRK-DLFLVEH 734
W APE + + + D++S G +++ T G+ P+ S E N ++ K +L + E
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEG 243
Query: 735 IPEAV-DLFTRLLDPNPDLRP 754
P + L TR NP RP
Sbjct: 244 CPSRLYKLMTRCWAVNPKDRP 264
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 52/294 (17%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNIVRW 532
K+I +GS G +L + E G+ +K ++ + + KE+ ++++ +HPNIV++
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVA-VLSNMKHPNIVQY 64
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ +Y+ ++ C G +++NA+
Sbjct: 65 QESFEENGNLYIVMDYCE----------GGDLYKKINAQ--------------------- 93
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ P Q+L I L H+H+ ++HRD+K QN+ ++KD + KL D
Sbjct: 94 ------RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTI--KLGDF 145
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
GI++ L + T G+ + +PE D+++LGC+L+ T KH +
Sbjct: 146 GIARVLNSTVELAR---TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT-LKHAF 201
Query: 713 --GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
G I++ + + +L ++L NP RP ++L F
Sbjct: 202 EAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 38/250 (15%)
Query: 475 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVK--THHDVA--LKEIQNLIA 522
+ K + +G G VV+ + E +VAVK L T D++ + E++ +
Sbjct: 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM 76
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+H NI+ G + +Y+ +E Y G+ E L R
Sbjct: 77 IGKHKNIINLLGACTQDGPLYVIVE----------YASKGNLREYL-------------R 113
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
R P ME + DI L+ T + G+ +L IHRDL +NVL++++
Sbjct: 114 ARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
K++D G+++ + ++ + G W APE L T D++S G +++
Sbjct: 174 NVM--KIADFGLARDVN-NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230
Query: 703 FCITGGKHPY 712
T G PY
Sbjct: 231 EIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 82/332 (24%), Positives = 139/332 (41%), Gaps = 97/332 (29%)
Query: 479 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHD-----VALKEIQNLIASDQHP 527
++I +G+ G V Y+ R ++A+K++ D A++EI +L+ QH
Sbjct: 8 EKIGEGTYGVV-----YKARDRVTNETIALKKIRLEQEDEGVPSTAIREI-SLLKEMQHG 61
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NIVR V + +YL E Y+ L+ K+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFE----------YL-------DLDLKKH-------------- 90
Query: 588 VMENTKDIELWKANGHPSAQLLKV-TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
M+++ D A +L+K I+ G+++ H ++HRDLKPQN+LI + +
Sbjct: 91 -MDSSPDF----AKNP---RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-A 141
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI----- 700
KL+D G+++ + T + ++APE LL R + +D++S+GCI
Sbjct: 142 LKLADFGLARAFGIPVRTFTHEVV---TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198
Query: 701 ----LF------------FCITGGKHPYGESFERDANIVKDRKDLF----------LVEH 734
LF F I G P E++ + D K F +V
Sbjct: 199 NQKPLFPGDSEIDELFKIFRILGT--PNEETW-PGVTSLPDYKSAFPKWPPKDLATVVPT 255
Query: 735 I-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+ P VDL +++L +P R A+ L H +F
Sbjct: 256 LEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 47/186 (25%), Positives = 78/186 (41%), Gaps = 41/186 (22%)
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 672
+ ++ GL++ H+ +HRD+K N+L++ KL+D G+++ + S N
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQI--KLADFGLARLYNSEESRPYTNKV-- 178
Query: 673 GSSGWQAPEQLLQG--RQTRAIDLFSLGCIL--FFC-------------------ITGG- 708
+ W P +LL G R AID++S GCIL F + G
Sbjct: 179 -ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237
Query: 709 ---------KHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQN 758
K PY + + + ++ F IP A+DL +L +P R A+
Sbjct: 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEF--SFIPTPALDLLDHMLTLDPSKRCTAEE 295
Query: 759 VLNHPF 764
LN P+
Sbjct: 296 ALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 54/186 (29%), Positives = 77/186 (41%), Gaps = 44/186 (23%)
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
T ++V L +H +G IHRD+KP N+L+ DKS KL+D G ++ D + + + T
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKM--DANGMVRCDTA 203
Query: 672 YGSSGWQAPEQLLQGRQT----RAIDLFSLGCILFFCITGGKHPYGES------------ 715
G+ + +PE L R D +S+G L+ + G Y +S
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 716 ----FERDANIVKDRKDL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF--- 765
F D I K KDL FL D RL R + +HPFF
Sbjct: 264 NSLTFPDDIEISKQAKDLICAFL-------TDREVRL------GRNGVDEIKSHPFFKND 310
Query: 766 -WTADT 770
WT D
Sbjct: 311 QWTFDN 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D G+++ ++ +
Sbjct: 103 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTAR 160
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Q A W APE L GR T D++S G +L T G+ PY
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 60/229 (26%), Positives = 99/229 (43%), Gaps = 49/229 (21%)
Query: 479 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRW 532
K I G+ G V G +VAVK+L + TH A +E+ L+ H NI+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISL 85
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + Q SLE D+ V+ + D+NL + + L
Sbjct: 86 LNVFTPQK----SLEE----FQDVYLVM----------ELMDANLCQVIHMEL------- 120
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
D E ++ + ++ G+ HLH G+IHRDLKP N+++ D + K+ D
Sbjct: 121 -DHE----------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL--KILDF 167
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
G+++ + T Y ++APE +L +D++S+GCI+
Sbjct: 168 GLARTACTNFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIM 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 58/244 (23%), Positives = 92/244 (37%), Gaps = 53/244 (21%)
Query: 479 KEIAKGSNGTVVLEG---NYEGR--SVAVK-----RLVKTHHDVALKEIQNLIASDQHPN 528
K++ GS G VV G G+ VAVK +L D LKE ++ S H N
Sbjct: 1 KKLGDGSFG-VVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDF-LKEA-AIMHSLDHEN 57
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++R YGV + ++ E GS ++L + + L+
Sbjct: 58 LIRLYGVVLTHPLMMVT-ELAPL----------GSLLDRLR--------KDALGHFLIST 98
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
L + Q I +G+ +L IHRDL +N+L++ D K
Sbjct: 99 --------LC----DYAVQ-------IANGMRYLESKRFIHRDLAARNILLASDDK--VK 137
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
+ D G+ + L + W APE L + A D++ G L+ T G
Sbjct: 138 IGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYG 197
Query: 709 KHPY 712
+ P+
Sbjct: 198 EEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-09
Identities = 53/182 (29%), Positives = 80/182 (43%), Gaps = 30/182 (16%)
Query: 599 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658
K N + + R+I+ GLSHLH+ +IHRD+K QNVL++++ KL D G+S +L
Sbjct: 104 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQL 161
Query: 659 QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLGCILFFCITGGKHPYG 713
D + +N T G+ W APE + A DL+SLG I + G P
Sbjct: 162 --DRTVGRRN-TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAPPLC 217
Query: 714 ESFERDANIVKDRKDLFLVEHIP-----------EAVDLFTRLLDPNPDLRPKAQNVLNH 762
+ + + LFL+ P + L N RP + ++ H
Sbjct: 218 D--------MHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269
Query: 763 PF 764
PF
Sbjct: 270 PF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-09
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 8/158 (5%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR-LQGDMSCLTQNATGY 672
+I+ GL LH G+++RDLK N+L+ D K++D G+ K + GD + T
Sbjct: 104 EIICGLQFLHSKGIVYRDLKLDNILLDTDGHI--KIADFGMCKENMLGD----AKTCTFC 157
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 732
G+ + APE LL + ++D +S G +L+ + G +G E ++ +
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR 217
Query: 733 EHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTAD 769
EA D+ +L P+ R + ++ HPFF D
Sbjct: 218 WLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 63/284 (22%), Positives = 110/284 (38%), Gaps = 59/284 (20%)
Query: 497 GRSVAVKRLVKTHHDVALKEIQNLIASDQ------HPNIVRWYGVESDQDFVYLSLERCT 550
G A+K L K + +K++Q++ HP IV D++ VY LE
Sbjct: 43 GEYYAIKCL-KKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE--- 98
Query: 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610
+V+ G L +R KA P+
Sbjct: 99 -------FVVGGE-------------LFTHLR----------------KAGRFPNDVAKF 122
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 670
++V +LH +I+RDLKP+N+L+ K++D G +K++ + T
Sbjct: 123 YHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHV--KVTDFGFAKKVP------DRTFT 174
Query: 671 GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF 730
G+ + APE + +A+D +++G +L+ I G + ++ R + + F
Sbjct: 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF 234
Query: 731 LVEHIPEAVDLFTRLLDPNP-----DLRPKAQNVLNHPFFWTAD 769
A DL LL + L+ +V NHP+F A+
Sbjct: 235 PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN 278
|
Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 614 DIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY 672
+IVS L +LH E +++RDLK +N+++ KD K++D G+ K D + + T
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI--KITDFGLCKEGIKDGATMK---TFC 157
Query: 673 GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV 732
G+ + APE L RA+D + LG +++ + G Y + E+ ++ + F
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR 217
Query: 733 EHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 765
PEA L + LL +P R A+ ++ H FF
Sbjct: 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 33/102 (32%), Positives = 57/102 (55%), Gaps = 6/102 (5%)
Query: 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660
NG P ++ ++ + H+ ++HRD+KP+N+LIS + KL D G ++ L
Sbjct: 95 NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVL--KLCDFGFARNLSE 152
Query: 661 DMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL 701
+ N T Y ++ W ++PE LL +A+D++S+GCIL
Sbjct: 153 GSNA---NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 64/241 (26%), Positives = 105/241 (43%), Gaps = 59/241 (24%)
Query: 479 KEIAKGSNGTV------VLEGNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHP 527
K I G+ G V +LE R+VA+K+L + TH A +E+ L+ H
Sbjct: 30 KPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHK 83
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NI+ V + Q SLE D+ V+ + D+NL +++ L
Sbjct: 84 NIIGLLNVFTPQK----SLEE----FQDVYIVM----------ELMDANLCQVIQMEL-- 123
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
D E ++ + ++ G+ HLH G+IHRDLKP N+++ D +
Sbjct: 124 ------DHE----------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-- 165
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K+ D G+++ T Y ++APE +L +D++S+GCI+ I G
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
Query: 708 G 708
G
Sbjct: 222 G 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 41/122 (33%), Positives = 65/122 (53%), Gaps = 8/122 (6%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCL 665
QL+ + I G+S+LH+ G+IH+D+ +N +I D+ K++D +S+ L D CL
Sbjct: 118 QLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI--DEELQVKITDNALSRDLFPMDYHCL 175
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE--SFERDANIV 723
N W A E L+ + A D++S G +L+ +T G+ PY E FE A +
Sbjct: 176 GDNE--NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-AAYL 232
Query: 724 KD 725
KD
Sbjct: 233 KD 234
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 38/183 (20%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GLS+ H+ ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLINEKGEL--KLADFGLARA----KSVPTKTYSNEVV 165
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYGESFERDANIV--------- 723
+ W P +L G + ID++ +GCIL+ TG G + + + +++
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225
Query: 724 ----------KDRKDLF-------LVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNH 762
+ R LF L+ H P + +DL + LL R A+ L H
Sbjct: 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285
Query: 763 PFF 765
+F
Sbjct: 286 SYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
L+ + + +G++++ + IHRDL+ N+L+ D C K++D G+++ ++ +
Sbjct: 103 NLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG-DGLVC-KIADFGLARLIEDNEYTAR 160
Query: 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Q A W APE L GR T D++S G +L +T G+ PY
Sbjct: 161 QGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 34/208 (16%)
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
T ++V L +H +GLIHRD+KP N+L+ DK KL+D G ++ D + + + T
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLL--DKHGHLKLADFGTCMKM--DETGMVRCDTA 203
Query: 672 YGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK 727
G+ + +PE L G R D +S+G LF + G Y +S + + D K
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 728 DLFLVEHIPEAVDLFTR--------LLDPNPDL-RPKAQNVLNHPFF----WTADT---- 770
+ + PE V++ L D L R + + HPFF W D
Sbjct: 264 NSL---NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRET 320
Query: 771 ------RLSFLRDVSDRVELEDRESDSK 792
LS D S+ ++ED + D +
Sbjct: 321 AAPVVPELSSDIDSSNFDDIEDDKGDVE 348
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I S L +LH + +I+RDLKP+N+L+ D L+D G+ K + +T G
Sbjct: 104 EIASALGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCKE---GIEHSKTTSTFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR---KDLF 730
+ + APE L + R +D + LG +L+ + G P+ + RD + D K L
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLY-GLPPF---YSRDTAEMYDNILNKPLR 214
Query: 731 LVEHI-PEAVDLFTRLLDPNPDLRPKAQN----VLNHPFF 765
L +I A L LL + R A++ + NH FF
Sbjct: 215 LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 71/297 (23%), Positives = 116/297 (39%), Gaps = 68/297 (22%)
Query: 490 VLEGNYEGR---SVAVKRLVKTHHDVALKEIQN-------LIASDQHPNIVRWYGVESDQ 539
V EG Y GR +V ++ VKT + ++ ++ +++ H NIVR GV ++
Sbjct: 22 VYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81
Query: 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 599
++ LE +++G + K + L E R R
Sbjct: 82 LPRFILLE-----------LMAGG-----DLK----SFLRENRPRP-------------- 107
Query: 600 ANGHPSA----QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMGI 654
PS+ LL RD+ G +L E IHRD+ +N L++ K AK++D G+
Sbjct: 108 --ERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM 165
Query: 655 SKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
++ + A+ Y G W PE L G T D++S G +L+ +
Sbjct: 166 ARDIYR--------ASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217
Query: 708 GKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 762
G PY G + + V L + P V + T P+ RP +L
Sbjct: 218 GYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 65/244 (26%), Positives = 98/244 (40%), Gaps = 51/244 (20%)
Query: 479 KEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEI---QNLIASDQHPNIV 530
KE+ G+ G+VV +G Y +S VAVK L + H KE +++A HP IV
Sbjct: 1 KELGHGNFGSVV-KGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R GV C L+ V+ + L + R +PV
Sbjct: 60 RLIGV---------------CKGEPLMLVMELAPLGPLLKYLKKR--------REIPV-- 94
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
D++ +V G+++L +HRDL +NVL+ AK+S
Sbjct: 95 --SDLKEL---------AHQVAM----GMAYLESKHFVHRDLAARNVLLVNRHQ--AKIS 137
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G+S+ L G W APE + G+ + D++S G L+ + G
Sbjct: 138 DFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197
Query: 711 PYGE 714
PYGE
Sbjct: 198 PYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 72/312 (23%)
Query: 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----EIQNLIASDQHPNIVRWYGV 535
E+ G+ G V + E A ++++ + L+ EI ++++ +HPNIV Y
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEI-DILSECKHPNIVGLYEA 70
Query: 536 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
++ +++ +E C +L+ ++ L E
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTE---------------------------- 102
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
Q+ V R ++ L+ LH +IHRDLK N+L++ D KL+D G+
Sbjct: 103 -----------PQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGV 149
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLL------QGRQTRAIDLFSLGCILFFCITGG 708
S + + S L + T G+ W APE + +A D++SLG IT
Sbjct: 150 SAKNK---STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKA-DIWSLG------ITLI 199
Query: 709 KHPYGESFERDAN-------IVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPKAQNV 759
+ E + N I+K D L +PD RP A +
Sbjct: 200 ELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAEL 259
Query: 760 LNHPFFWTADTR 771
L HPF
Sbjct: 260 LKHPFVSDQSDN 271
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 14/169 (8%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G ++ + S
Sbjct: 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS-- 171
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVK 724
+ +T G+ W APE + + +D++SLG I+ + G+ PY E+ R ++
Sbjct: 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 725 DRKDLFLVEHIPEAV-----DLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768
L PE + D R LD + + R A+ +L H F A
Sbjct: 230 TNGTPELQN--PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 63/263 (23%), Positives = 101/263 (38%), Gaps = 79/263 (30%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQ----------- 525
F KE+ G G V L G + + VA+K I S++
Sbjct: 8 FMKELGSGQFGVVHL-GKW-----------RAQIKVAIKAINEGAMSEEDFIEEAKVMMK 55
Query: 526 --HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
HP +V+ YGV + Q +Y+ E F E + LLN +R
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTE----------------FME-------NGCLLNYLRQ 92
Query: 584 RLLPVMENTKDIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
R G S LL + +D+ G+ +L IHRDL +N L+S
Sbjct: 93 R----------------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS-- 134
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS---GWQAPEQLLQGRQTRAIDLFSLGC 699
+ K+SD G+++ + D + + G+ W PE + + D++S G
Sbjct: 135 STGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189
Query: 700 ILFFCITGGKHPYGESFERDANI 722
+++ T GK P FE+ +N
Sbjct: 190 LMWEVFTEGKMP----FEKKSNY 208
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 55/235 (23%), Positives = 96/235 (40%), Gaps = 63/235 (26%)
Query: 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 530
+EI GS G V + VA+K++ + D+ +KE++ + +HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVR-FLQQLRHPNTI 78
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ G + +L +E C S +D++ V L EV I
Sbjct: 79 EYKGCYLREHTAWLVMEYCLGSASDILEVHKKP--------------LQEVEIA------ 118
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ + GL++LH IHRD+K N+L+++ + KL+
Sbjct: 119 -------------------AICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLA 157
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG--CI 700
D G S ++ + G+ W APE +L +G+ +D++SLG CI
Sbjct: 158 DF-------GSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+IVS L +LH +++RDLK +N+++ KD K++D G+ K D + + T G
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHI--KITDFGLCKEGITDAATMK---TFCG 157
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
+ + APE L RA+D + LG +++ + G Y + E+ ++ F
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRT 217
Query: 734 HIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 765
+A L + LL +P+ R A+ ++ H FF
Sbjct: 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|199218 cd10423, RNase_RNase-L, RNase domain (also known as the kinase extension nuclease domain) of RNase L | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-08
Identities = 33/119 (27%), Positives = 58/119 (48%), Gaps = 11/119 (9%)
Query: 770 TRLSFLRDVSDRVELEDRESDSKLLRAL--EGIALVALNGKWDEKMETKFIENIGRY--- 824
R LR+V + +++ R+ S +LR L W K++ + ++ + ++
Sbjct: 2 NRYRTLRNVGNESDIKTRDDKSDILRLLQAGKSECSRSFPNWTSKIDKEVMDIMNKFYEK 61
Query: 825 RRYKY-DNVRDLLRVIRNKSNHFRELP-QDIQELLGSHPEGFYNYFSCRFPKLLIEVYN 881
+++ Y D V DLL+ IRN H E + ++E++G E YF FP L+I VY
Sbjct: 62 KKFFYQDTVGDLLKFIRNLGEHIDEEKNKRMKEIIGDPSE----YFQKTFPDLVIYVYK 116
|
Ribonuclease L (RNase L), sometimes referred to as the 2-5A-dependent RNase, is a highly regulated, latent endoribonuclease (thus the 'L' in RNase L) and is widely expressed in most mammalian tissues. It is involved in the mediation of the antiviral and pro-apoptotic activities of the interferon-inducible 2-5A system, which blocks infections by certain types of viruses through cleavage of viral and cellular single-stranded RNA. RNase L is unique in that it is composed of three major domains; N-terminus regulatory ankyrin repeat domain (ARD), followed by a linker, a protein kinase (PK)-like domain and a C-terminal ribonuclease (RNase) domain. The RNase domain has homology with IRE1, also containing both a kinase and an endoribonuclease, that functions in the unfolded protein response (UPR). RNase L has been shown to have an impact on the pathogenesis of prostate cancer; the RNase L gene, RNASEL, has been identified as a strong candidate for the hereditary prostate cancer 1 (HPC1) allele. The broad range of biological functions of RNase offers a possibility for RNase L as a therapeutic target. Length = 119 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 38/160 (23%), Positives = 78/160 (48%), Gaps = 5/160 (3%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
+++++ +I G+++L+ +HRDL +N ++++D F K+ D G+++ + +
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIY-ETD 173
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANI 722
+ G W +PE L G T D++S G +L+ T + PY G S E+
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF 233
Query: 723 VKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN 761
V + L ++ P+ + +L NP +RP +++
Sbjct: 234 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 55/231 (23%)
Query: 490 VLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546
V EG + VAVK L D L E Q ++ +HP +++ Y V
Sbjct: 22 VWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQ-IMKKLRHPKLIQLYAV----------- 69
Query: 547 ERCTCSLNDLIYVLS-----GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKAN 601
C+L + IY+++ GS E L R LP
Sbjct: 70 ----CTLEEPIYIVTELMKYGSLLEYLQGGAG--------RALKLP-------------- 103
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
QL+ + + SG+++L IHRDL +NVL+ + + C K++D G+++ ++ D
Sbjct: 104 -----QLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG-ENNIC-KVADFGLARVIKED 156
Query: 662 MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ + A W APE L R + D++S G +L +T G+ PY
Sbjct: 157 IYEAREGAK--FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 38/136 (27%), Positives = 66/136 (48%), Gaps = 9/136 (6%)
Query: 597 LWKANGHPSA-QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
L K G A QL+ + + SG+ +L E+G +H+ L VL++ D K+S
Sbjct: 97 LRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSD--LVCKISGFR-- 152
Query: 656 KRLQGD-MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
RLQ D + +G W APE + + A D++S G +++ ++ G+ PY +
Sbjct: 153 -RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211
Query: 715 SFERDANIVKDRKDLF 730
+D ++K +D F
Sbjct: 212 MSGQD--VIKAVEDGF 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 40/196 (20%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GL++ H ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLINERGEL--KLADFGLARA----KSIPTKTYSNEVV 166
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYGESFERDANIV--------- 723
+ W P +L G + ID++ +GCI + TG G + E + +
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226
Query: 724 ------------------KDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLN 761
K R D L H P + +L ++LL R A+ +
Sbjct: 227 ETWPGILSNEEFKSYNYPKYRADC-LHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285
Query: 762 HPFFWTADTRLSFLRD 777
HP+F R+ L D
Sbjct: 286 HPYFHCLGERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 4e-08
Identities = 63/236 (26%), Positives = 102/236 (43%), Gaps = 63/236 (26%)
Query: 479 KEIAKGSNGTVVLEGNY-EGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRW 532
K I G+ G V + G++VA+K+L + TH A +E+ L+ H NI+
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-LMKLVNHKNIIGL 80
Query: 533 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
V +S ++F VYL +E +L +I + L+ R+ L
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD-----------------LDHERMSYL 123
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
L+ Q+L G+ HLH G+IHRDLKP N+++ KS C
Sbjct: 124 ----------LY--------QML-------CGIKHLHSAGIIHRDLKPSNIVV---KSDC 155
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
K+ D G+++ T Y ++APE +L +D++S+GCI+
Sbjct: 156 TLKILDFGLARTAGTSFMMTPYVVTRY----YRAPEVILGMGYKENVDIWSVGCIM 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 69/308 (22%), Positives = 117/308 (37%), Gaps = 77/308 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQH------ 526
+ +E+ +GS G V YEG K +VK + VA+K + + +
Sbjct: 8 ITLIRELGQGSFGMV-----YEG---LAKGVVKGEPETRVAIKTVNENASMRERIEFLNE 59
Query: 527 ---------PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 577
++VR GV S + +E + G + L ++ +
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVME----------LMAKGDLKSYLRSRRPE--- 106
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQN 636
L P+ Q +++ +I G+++L +HRDL +N
Sbjct: 107 --AENNPGLGP---------------PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARN 149
Query: 637 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQ 688
++++D K+ D G+++ + T Y G G W APE L G
Sbjct: 150 CMVAED--LTVKIGDFGMTRDI---------YETDYYRKGGKGLLPVRWMAPESLKDGVF 198
Query: 689 TRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLL 746
T D++S G +L+ T + PY G S E V D L L E+ P+ + +L
Sbjct: 199 TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCW 258
Query: 747 DPNPDLRP 754
NP +RP
Sbjct: 259 QYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 46/186 (24%), Positives = 81/186 (43%), Gaps = 41/186 (22%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GL+++H ++HRDLKPQN+LIS KL+D G+++ S +Q +
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGEL--KLADFGLAR----AKSIPSQTYSSEVV 165
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKH--------------------PY 712
+ W P +L G + A+D++ GCI + G P
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT 225
Query: 713 GESFERDANIVKDRKDLFL-------------VEHIPEAVDLFTRLLDPNPDLRPKAQNV 759
+++ + + + + FL + P+A DL +++L P R AQ+
Sbjct: 226 EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285
Query: 760 LNHPFF 765
L HP+F
Sbjct: 286 LLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 83/315 (26%), Positives = 122/315 (38%), Gaps = 88/315 (27%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRL-------VKTHHDVALK-EIQNLIASDQHPNIVRW 532
+ G+ G V Y+GR V +L V + +K EI L H NI +
Sbjct: 24 VGNGTYGQV-----YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATY 78
Query: 533 YGV------ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
YG D ++L +E C S+ DL+ G NA ++D
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG------NALKED----------- 121
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
W A + R+I+ GL+HLH +IHRD+K QNVL++++
Sbjct: 122 ------------WIA---------YICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE- 159
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLGCI 700
KL D G+S +L D + +N T G+ W APE + A D++SLG I
Sbjct: 160 -VKLVDFGVSAQL--DRTVGRRN-TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG-I 214
Query: 701 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIP-----------EAVDLFTRLLDPN 749
+ G P + A LFL+ P + +D L N
Sbjct: 215 TAIEMAEGAPPLCDMHPMRA--------LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKN 266
Query: 750 PDLRPKAQNVLNHPF 764
RP + +L HPF
Sbjct: 267 YLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-08
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 6/151 (3%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ + H+H +IHRD+K N+L+ + KL D G SK +S T G+
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNG--LVKLGDFGFSKMYAATVSD-DVGRTFCGT 208
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDAN-IVKDRKDLFLV 732
+ APE + ++ D+FSLG +L+ +T K P+ GE+ E + + R D
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLT-LKRPFDGENMEEVMHKTLAGRYDPLPP 267
Query: 733 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 763
PE ++ T LL +P RP + +LN P
Sbjct: 268 SISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 44/253 (17%)
Query: 475 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS--- 523
+V K + +G G VV+ E VAVK L D K++ +LI+
Sbjct: 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML---KSDATEKDLSDLISEMEM 76
Query: 524 ----DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
+H NI+ G + +Y+ +E Y G+ E L
Sbjct: 77 MKMIGKHKNIINLLGACTQDGPLYVIVE----------YASKGNLREYL----------- 115
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
R R P ME + L+ + G+ +L IHRDL +NVL+
Sbjct: 116 --RARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
++D K++D G+++ + + + G W APE L T D++S G
Sbjct: 174 TEDNVM--KIADFGLARDIH-HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 230
Query: 700 ILFFCITGGKHPY 712
+L+ T G PY
Sbjct: 231 LLWEIFTLGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 6e-08
Identities = 32/109 (29%), Positives = 54/109 (49%), Gaps = 4/109 (3%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
+ LL + I S + +L + IHRDL +N L+ ++ K++D G+S+ + GD
Sbjct: 102 NAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH--LVKVADFGLSRLMTGDT- 158
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
T +A W APE L + + D+++ G +L+ T G PY
Sbjct: 159 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 19/164 (11%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
++V + +H++G +HRD+KP+NVLI D++ KL+D G + RL + ++ G
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLI--DRTGHIKLADFGSAARLTANKMVNSKLPV--G 165
Query: 674 SSGWQAPEQLLQGRQTRA-------IDLFSLGCILFFCITGGKHPYGE--SFERDANIVK 724
+ + APE +L D +SLG I + I G+ P+ E S + NI+
Sbjct: 166 TPDYIAPE-VLTTMNGDGKGTYGVECDWWSLGVIAYEMIY-GRSPFHEGTSAKTYNNIMN 223
Query: 725 DRKDLFLVEHIP---EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
++ L E + +DL LL R + + HPFF
Sbjct: 224 FQRFLKFPEDPKVSSDFLDLIQSLL-CGQKERLGYEGLCCHPFF 266
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 7e-08
Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 43/237 (18%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGV 535
K++ G G V + + VAVK + V A N++ + QH +V+ + V
Sbjct: 10 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
+ + +Y+ E ++ GS + L + E
Sbjct: 70 VTKEP-IYIITE----------FMAKGSLLDFLKSDE----------------------- 95
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
+ P +L+ + I G++ + + IHRDL+ N+L+S S K++D G++
Sbjct: 96 ----GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS--ASLVCKIADFGLA 149
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ ++ + + A W APE + G T D++S G +L +T G+ PY
Sbjct: 150 RVIEDNEYTAREGAK--FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 38/193 (19%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+ GL++ H ++HRDLKPQN+LI++ KL+D G+++ S T+ +
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGEL--KLADFGLARA----KSVPTKTYSNEVV 166
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYGESFERDANIV--------- 723
+ W P +L G + ID++ +GCI F +G G + E + +++
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226
Query: 724 -----------------KDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNH 762
K L+ H P E ++L T+ L R A+ + H
Sbjct: 227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286
Query: 763 PFFWTADTRLSFL 775
+F + TR+ L
Sbjct: 287 AYFRSLGTRIHSL 299
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 40/154 (25%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 662
P L++ DI SG+ +L IHRDL +N +++++ + C ++D G+SK++ GD
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVC--VADFGLSKKIYSGDY 168
Query: 663 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG--ESFERDA 720
Q W A E L T D+++ G ++ +T G+ PY E+ E
Sbjct: 169 --YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN 226
Query: 721 NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP 754
++K + + + + +L + P P RP
Sbjct: 227 YLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRP 260
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 66/278 (23%), Positives = 117/278 (42%), Gaps = 30/278 (10%)
Query: 487 GTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVY 543
G + L G + VA+K L ++ E Q +L+A HPNIV GV + + V
Sbjct: 24 GHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83
Query: 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 603
+ E Y+ G E L + S++ + +D + + H
Sbjct: 84 MLFE----------YLNQGDLHEFLIMRSPHSDV----------GCSSDEDGTVKSSLDH 123
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
L + I +G+ +L +H+DL +N+LI + K+SD+G+S+ +
Sbjct: 124 --GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE--QLHVKISDLGLSREIYSADY 179
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERDANI 722
Q + W PE ++ G+ + D++S G +L+ + G P YG S + +
Sbjct: 180 YRVQPKSLLPIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238
Query: 723 VKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNV 759
V+ R+ L E P + L T P RP+ +++
Sbjct: 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 50/201 (24%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-AKLSDMGISKRLQGDMSCLTQNATGYG 673
++ GL ++H ++HRDLKP N+L++ + C K+ D G+++ +T+ Y
Sbjct: 117 LLRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARTTSEKGDFMTE----YV 169
Query: 674 SSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGK--------------------HP 711
+ W +APE LL + T AID++S+GCI F + G K P
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCI-FAELLGRKPLFPGKDYVHQLKLITELLGSP 228
Query: 712 YGES--FERDANIVKDRKDLFLVEHI----------PEAVDLFTRLLDPNPDLRPKAQNV 759
E F R+ + + L P A+DL ++L +P R +
Sbjct: 229 SEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEA 288
Query: 760 LNHPFFWTADTRLSFLRDVSD 780
L HP+ L+ L D SD
Sbjct: 289 LAHPY-------LASLHDPSD 302
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 74/309 (23%), Positives = 126/309 (40%), Gaps = 57/309 (18%)
Query: 475 VVFNKEIAKGSNGTV------VLEGNYEGRSVAVKRLVKTHHDVALK-EIQN---LIASD 524
V F +E+ +G+ G V SVA+K L K + + ++ E + L++
Sbjct: 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-KENAEPKVQQEFRQEAELMSDL 65
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDL-IYVLSGSFEEQLNAKEQDSNLLNEVRI 583
QHPNIV GV + + + E + DL +++ S + A+ D
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFE--YLAHGDLHEFLVRNSPHSDVGAESGD--------- 114
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
E K L + L + I +G+ +L +HRDL +N L+ +
Sbjct: 115 ------ETVKSS-LD------CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161
Query: 644 SFCAKLSDMGISK--------RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 695
+ K+SD G+S+ R+Q S L W PE +L G+ T D++
Sbjct: 162 T--VKISDFGLSRDIYSADYYRVQSK-SLLPVR--------WMPPEAILYGKFTTESDIW 210
Query: 696 SLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
S G +L+ + G PY G S + +++ R+ L E P V L + P R
Sbjct: 211 SFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARR 270
Query: 754 PKAQNVLNH 762
P+ +++
Sbjct: 271 PRFKDIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-07
Identities = 46/189 (24%), Positives = 72/189 (38%), Gaps = 51/189 (26%)
Query: 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ-------------------GDM 662
+H++G IHRD+KP N+L+ D KLSD G+ L+ D
Sbjct: 117 IHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174
Query: 663 SCLTQNATGYGSSGWQ-----------------APEQLLQGRQTRAIDLFSLGCILFFCI 705
++ + W+ APE LQ + D +SLG I++ +
Sbjct: 175 ISKPMSSKRKAET-WKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 706 TGGKHP---YGESFERDANIVKDRKDLFLVEHIP---EAVDLFTRLLDPNPDLR---PKA 756
G +P E I+ ++ L + +P EA DL RL + R
Sbjct: 234 VG--YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGV 290
Query: 757 QNVLNHPFF 765
+ +HPFF
Sbjct: 291 NEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 34/114 (29%), Positives = 60/114 (52%), Gaps = 9/114 (7%)
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFCAK 648
N K ++L P + + I+ G+ +LH ++HRDLKP N+L+ + + K
Sbjct: 99 NKKPVQL------PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 152
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 701
++DMG ++ + L + ++APE LL R T+AID++++GCI
Sbjct: 153 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 31/101 (30%), Positives = 56/101 (55%), Gaps = 3/101 (2%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFCAKLSDMGISKRLQGD 661
P + + + I+ G+ +LH ++HRDLKP N+L+ + + K++DMG ++
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 662 MSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCIL 701
+ L + ++APE LL R T+AID++++GCI
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 30/109 (27%), Positives = 53/109 (48%), Gaps = 2/109 (1%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
+ ++++ + G+ +L +HRDL +NVL+ AK+SD G+SK L D S
Sbjct: 93 TVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDS 150
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ G W APE + + + D++S G ++ + G+ PY
Sbjct: 151 YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 43/150 (28%), Positives = 64/150 (42%), Gaps = 30/150 (20%)
Query: 605 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 664
S LL I G+S+L E+ L+HRDL +NVL+ K++D G+++ L D
Sbjct: 108 SQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDID--- 162
Query: 665 LTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER 718
T Y + G W A E +L R T D++S G ++ +T G PY
Sbjct: 163 ----ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY------ 212
Query: 719 DANIVKDRKDLFLVEHIPEAVDLFTRLLDP 748
D IP+ ++ RL P
Sbjct: 213 ---------DGIPAREIPDLLEKGERLPQP 233
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 18/165 (10%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
++V + +H++G +HRD+KP NVL+ DK+ +L+D G RL D + Q+ G
Sbjct: 110 EMVLAIDSVHQLGYVHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGT--VQSNVAVG 165
Query: 674 SSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 728
+ + +PE L +GR D +SLG ++ + G Y ES + + K+
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 729 LF----LVEHIPE-AVDLFTRLLDPNPDLR---PKAQNVLNHPFF 765
F V + E A DL RL+ P+ R Q+ +HPFF
Sbjct: 226 HFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 5/110 (4%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 662
P+ L+K DI SG+ +L IHRDL +N +++++ + C ++D G+SK++ GD
Sbjct: 110 PTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVC--VADFGLSKKIYNGDY 167
Query: 663 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Q W A E L T D++S G ++ T G+ PY
Sbjct: 168 --YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ G+ HLH G+IHRDLKP N+++ D + K+ D G+++ T Y
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL--KILDFGLARTAGTSFMMTPYVVTRY-- 183
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCIL 701
++APE +L +D++S+GCI+
Sbjct: 184 --YRAPEVILGMGYKENVDIWSVGCIM 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 65/304 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHH----DVALKEIQNLIAS 523
+ F K + G+ G VV E G S VAVK L T H + + E++ +
Sbjct: 37 LSFGKTLGAGAFGKVV-EATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
H NIV G + + + E C Y +LLN +R
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCC-------Y----------------GDLLNFLR- 131
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
R +D LL + + G++ L IHRDL +NVL++ K
Sbjct: 132 RKRESFLTLED-------------LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK 178
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGC 699
K+ D G+++ + D N G++ W APE + T D++S G
Sbjct: 179 --IVKICDFGLARDIMND-----SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231
Query: 700 ILFFCITGGKHPYGESFERDANIVKDRKDLFLV---EHIPEAV-DLFTRLLDPNPDLRPK 755
+L+ + G +PY D+ K K+ + + EH P + D+ D +P RP
Sbjct: 232 LLWEIFSLGSNPY-PGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPT 290
Query: 756 AQNV 759
+ +
Sbjct: 291 FKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 9/100 (9%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
AQ+ V R ++S + ++H G+IHRD+K +NVL++ + C L D G + +G S
Sbjct: 260 AQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC--LGDFGAACFARGSWS-- 315
Query: 666 TQNATGYGSSG---WQAPEQLLQGRQTRAIDLFSLGCILF 702
YG +G APE L T ++D++S G ++F
Sbjct: 316 --TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 2/95 (2%)
Query: 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGW 677
G+ +L E +HRDL +NVL+ AK+SD G+SK L D + G W
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 678 QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
APE + + + D++S G +++ + G+ PY
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 19/162 (11%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I S L LH+ G+I+RDLK NVL+ + C KL+D G+ K + T +T G
Sbjct: 104 EITSALMFLHDKGIIYRDLKLDNVLLDHE-GHC-KLADFGMCKEGIFN-GKTT--STFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDR--KDL 729
+ + APE L + ++D +++G +L + + G P+ E D I+ D
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMG-VLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT 217
Query: 730 FLVEHIPEAVDLFTRLLDPNPDLRPKA------QNVLNHPFF 765
+L + +AVD+ + NP +R + + +L HPFF
Sbjct: 218 WLSQ---DAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 77/334 (23%), Positives = 120/334 (35%), Gaps = 95/334 (28%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVK--------THHDVALKEIQNLIASDQHPNI 529
K + KG G V L G+ A+K L K L E + L D HP +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR--VLTEQEILATLD-HPFL 63
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
Y + ++ L ++ C +L +L + Q L+E R
Sbjct: 64 PTLYASFQTETYLCLVMD--YCPGGELFRLL----------QRQPGKCLSEEVARF---- 107
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+ A +++ L +LH +G+++RDLKP+N+L+ + L
Sbjct: 108 --------YAA-------------EVLLALEYLHLLGIVYRDLKPENILLHESGHI--ML 144
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQ---------------------------APEQ 682
SD +SK+ A GS APE
Sbjct: 145 SDFDLSKQS-DVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV 203
Query: 683 LLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDA---NIVKDRKDLFLVEHIP-- 736
+ A+D ++LG IL + + G P+ G + RD NI+K K++ P
Sbjct: 204 ISGDGHGSAVDWWTLG-ILLYEMLYGTTPFKGSN--RDETFSNILK--KEVTFPGSPPVS 258
Query: 737 -EAVDLFTRLLDPNPDLR----PKAQNVLNHPFF 765
A DL +LL +P R A + HPFF
Sbjct: 259 SSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 8/106 (7%)
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDM 652
D L KA P L K++ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 87 DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEI--KLCDF 144
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
G+S +L M+ + G+ + +PE+L T D++SLG
Sbjct: 145 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYTVQSDIWSLG 185
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 63/225 (28%), Positives = 89/225 (39%), Gaps = 44/225 (19%)
Query: 579 NEVRIRLLPVMENT-----KDIELWKANGHPSAQLLK--VTRDIVSGLSHLHEIGLIHRD 631
NE I L VME K ++ + N H L + + L+++H + HRD
Sbjct: 136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRD 195
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ-T 689
LKPQN+LI + KL D G +K L Q + Y S ++APE +L T
Sbjct: 196 LKPQNLLIDP-NTHTLKLCDFGSAKNLLAG-----QRSVSYICSRFYRAPELMLGATNYT 249
Query: 690 RAIDLFSLGCILFFCITGGKHPYGESF--------------------ERDANIV------ 723
IDL+SLGCI+ I G G+S E + N
Sbjct: 250 THIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPD 309
Query: 724 ---KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
KD K +F +A++ ++ L P R L PFF
Sbjct: 310 VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 66/297 (22%), Positives = 117/297 (39%), Gaps = 56/297 (18%)
Query: 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVE 536
E+ G+ G V N E +A +++ T + L++ +++AS HPNIV+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 537 SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIE 596
++ +++ +E C D + +E
Sbjct: 72 YYENNLWILIEFCAGGAVDAVM------------------------------------LE 95
Query: 597 LWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656
L + P ++ V + + L++LHE +IHRDLK N+L + D KL+D G+S
Sbjct: 96 LERPLTEPQIRV--VCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDI--KLADFGVSA 151
Query: 657 RLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTR----AIDLFSLGCILFFCITGGKHP 711
+ + + + + G+ W APE ++ + + R D++SLG I + + P
Sbjct: 152 K---NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLG-ITLIEMAQIEPP 207
Query: 712 YGE--SFERDANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
+ E I K E D + L+ N D R +L HPF
Sbjct: 208 HHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 53/201 (26%), Positives = 81/201 (40%), Gaps = 47/201 (23%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
++ GLS++H+ ++HRDLKPQN+LIS KL+D G+++ S + +
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLISDTGEL--KLADFGLARA----KSVPSHTYSNEVV 165
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG-----GKHPYGESFER--------- 718
+ W P +L G + +D++ +GCI I G G + ER
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPN 225
Query: 719 ----------------------DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 756
N+ + L V H A DL ++LL P R A
Sbjct: 226 EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNH---AEDLASKLLQCFPKNRLSA 282
Query: 757 QNVLNHPFFWTADTRLSFLRD 777
Q L+H +F RL L D
Sbjct: 283 QAALSHEYFSDLPPRLWELTD 303
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 82/347 (23%), Positives = 136/347 (39%), Gaps = 76/347 (21%)
Query: 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSV-AVKRLV-------KTHHDVALKEIQNLIASD 524
KL +EI GS G V + V A+K++ + D+ +KE++ +
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-IKEVR-FLQKL 72
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
+HPN +++ G + +L +E C S +DL+ EV +
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLL----------------------EVHKK 110
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
L +E + VT + GL++LH +IHRD+K N+L+S+
Sbjct: 111 PLQEVE-----------------IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 153
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCIL 701
KL D G S + G+ W APE +L +G+ +D++SLG
Sbjct: 154 --VKLGDF-------GSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT- 203
Query: 702 FFCITGG--KHPYGESFERDA-----NIVKDRKDLFLVEHIPEAVDLFT-RLLDPNPDLR 753
CI K P F +A +I ++ H E F L P R
Sbjct: 204 --CIELAERKPPL---FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
Query: 754 PKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 800
P ++ +L H F + + + D+ R + RE D+ R ++ I
Sbjct: 259 PTSEVLLKHRFV-LRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 50/210 (23%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIAS-DQHPNIVRWYGV- 535
I KG+ G V N + S+A +++ DV +EI+ N++ S HPN+V++YG+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 536 -ESDQ---DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
++D+ ++L LE C GS E + L+E I +
Sbjct: 89 YKADKLVGGQLWLVLELCN----------GGSVTELVKGLLICGQRLDEAMISYI----- 133
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
L+ A + GL HLH +IHRD+K N+L++ + KL D
Sbjct: 134 -----LYGA---------------LLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVD 171
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPE 681
G+S +L S + T G+ W APE
Sbjct: 172 FGVSAQL---TSTRLRRNTSVGTPFWMAPE 198
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 55/210 (26%), Positives = 84/210 (40%), Gaps = 45/210 (21%)
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
T ++V L +H +G IHRD+KP N+L+ DKS KL+D G ++ + + + T
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKE--GMVRCDTA 203
Query: 672 YGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITGGKHPYGES------------ 715
G+ + +PE L G R D +S+G L+ + G Y +S
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263
Query: 716 ----FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF----WT 767
F D +I K+ K+L V L R + + H FF W
Sbjct: 264 NSLTFPDDNDISKEAKNLICAFLTDREVRLG----------RNGVEEIKRHLFFKNDQWA 313
Query: 768 ----ADTRLSFLRDVS---DRVELEDRESD 790
DT + D+S D +D E D
Sbjct: 314 WETLRDTVAPVVPDLSSDIDTSNFDDIEED 343
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-07
Identities = 63/252 (25%), Positives = 108/252 (42%), Gaps = 61/252 (24%)
Query: 481 IAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHDVA------LKEIQNLIASD-QHPNIV 530
I KG G V L Y+ R VA+K++ + + L+E + IA+D HP IV
Sbjct: 10 IGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLKKRFLREAK--IAADLIHPGIV 65
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVM 589
Y + SD D VY ++ Y+ + + L + +++S L
Sbjct: 66 PVYSICSDGDPVYYTMP----------YIEGYTLKSLLKSVWQKES----------LS-- 103
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
K++ A L + I + + ++H G++HRDLKP N+L+ +
Sbjct: 104 ---KEL----AEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVI 154
Query: 650 SDMG--ISKRLQGD-------------MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 694
D G I K+L+ + S +T G+ + APE+LL + + D+
Sbjct: 155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI 214
Query: 695 FSLGCILFFCIT 706
++LG IL+ +T
Sbjct: 215 YALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-07
Identities = 54/188 (28%), Positives = 90/188 (47%), Gaps = 11/188 (5%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
IV L +H ++HRDLK N+ + + KL D G SK+ +S L ++ G+
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLM--PTGIIKLGDFGFSKQYSDSVS-LDVASSFCGT 234
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLV 732
+ APE + R ++ D++SLG IL+ +T + P+ +R+ ++ + D F
Sbjct: 235 PYYLAPELWERKRYSKKADMWSLGVILYELLTLHR-PFKGPSQREIMQQVLYGKYDPFPC 293
Query: 733 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF-WTADTRLSFLRDVSDRVELEDRESDS 791
L LL NP LRP Q +L+ F + A+ +R S+ + DRE
Sbjct: 294 PVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDIVRH-SETISPHDRE--- 349
Query: 792 KLLRALEG 799
++LR L+
Sbjct: 350 EILRQLQE 357
|
Length = 478 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 67/230 (29%), Positives = 103/230 (44%), Gaps = 39/230 (16%)
Query: 496 EGRS--VAVKRL----VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549
+GR VAVK L K + LKE++ +++ + PNI+R GV D+D + + E
Sbjct: 43 KGRPLLVAVKILRPDANKNARNDFLKEVK-ILSRLKDPNIIRLLGVCVDEDPLCMITEYM 101
Query: 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
DL LS L+ KE++ N L + + S LL
Sbjct: 102 ENG--DLNQFLS---SHHLDDKEENGNDAVPPAHCLPAI-------------SYSS--LL 141
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQN 668
V I SG+ +L + +HRDL +N L+ ++ K++D G+S+ L GD +
Sbjct: 142 HVALQIASGMKYLSSLNFVHRDLATRNCLVGEN--LTIKIADFGMSRNLYAGDYYRIQGR 199
Query: 669 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC----ILFFCITGGKHPYGE 714
A W A E +L G+ T A D+++ G IL C + PYGE
Sbjct: 200 AV--LPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC---KEQPYGE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 36/170 (21%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 671
+I GL LH G+I+RDLK NV++ + K++D G+ K G + T
Sbjct: 109 EIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI--KIADFGMCKENIFGGKTTR-----TF 161
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF 730
G+ + APE + +++D ++ G +L + + G+ P+ GE D +LF
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQPPFDGE----------DEDELF 210
Query: 731 --LVEHIP--------EAVDLFTRLLDPNPDLR----PKA-QNVLNHPFF 765
++EH EAV + LL +P R P +++ H FF
Sbjct: 211 QSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 44/253 (17%)
Query: 475 VVFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALKEIQNLIAS--- 523
+ K + +G G VV+ + + +VAVK L D K++ +L++
Sbjct: 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML---KDDATDKDLSDLVSEMEM 70
Query: 524 ----DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
+H NI+ G + +Y+ +E Y G+ E L
Sbjct: 71 MKMIGKHKNIINLLGACTQDGPLYVLVE----------YASKGNLREYL----------- 109
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
R R P M+ + D L+ + G+ +L IHRDL +NVL+
Sbjct: 110 --RARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
++D K++D G+++ + ++ + G W APE L T D++S G
Sbjct: 168 TEDNVM--KIADFGLARDVH-NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 224
Query: 700 ILFFCITGGKHPY 712
+L+ T G PY
Sbjct: 225 LLWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P + K + S + H+H ++HRD+KP NV I+ + KL D+G+ + S
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFS---S 158
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES---FERDA 720
T + G+ + +PE++ + D++SLGC+L+ YG+ F
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ 218
Query: 721 NIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 754
I + EH E + +L + + P+PD RP
Sbjct: 219 KIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 70/277 (25%), Positives = 124/277 (44%), Gaps = 37/277 (13%)
Query: 498 RSVAVKRLVKTHHDVALKEI----QNLIASDQHPNIVRWYG-VESDQDFVYLSLERCTCS 552
++VA+K L K + L+E + + QHPNIV G V +Q LS+ CS
Sbjct: 36 QAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP---LSMIFSYCS 91
Query: 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612
+DL E L + S++ +T D + K+ P A + +
Sbjct: 92 HSDL--------HEFLVMRSPHSDV------------GSTDDDKTVKSTLEP-ADFVHIV 130
Query: 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG 671
I +G+ L ++H+DL +NVL+ DK K+SD+G+ + + D L N+
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVF-DK-LNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF 730
W +PE ++ G+ + D++S G +L+ + G PY G S + ++++R+ L
Sbjct: 189 --PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLP 246
Query: 731 LVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNHPFFW 766
+ P V L + P RP+ +++ + W
Sbjct: 247 CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 56/230 (24%)
Query: 500 VAVKRLVKTHHDVALKEIQNLIAS-------DQHPNIVRWYGVESDQDFVYLSLERCTCS 552
VAVK L + K++ +L++ +H NI+ GV + + +Y+ +E
Sbjct: 45 VAVKMLKDDATE---KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYA--- 98
Query: 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612
NL + +R R P + D P + L
Sbjct: 99 --------------------AHGNLRDFLRARRPPGEYASPDDP------RPPEETLT-Q 131
Query: 613 RDIVS-------GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
+D+VS G+ L IHRDL +NVL+++D K++D G+++ D+ +
Sbjct: 132 KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED--HVMKIADFGLAR----DIHHI 185
Query: 666 ---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ G W APE L T D++S G +L+ T G PY
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
LL T + G+ L +HRDL +NVL+++ K K+ D G+++ + D + +++
Sbjct: 239 LLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK--IVKICDFGLARDIMHDSNYVSK 296
Query: 668 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-----GESFERDANI 722
+T + W APE + T D++S G +L+ + G PY +F N
Sbjct: 297 GST-FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---YNK 352
Query: 723 VKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 754
+K + +H + V D+ + + P+ RP
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRP 385
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 9e-07
Identities = 55/202 (27%), Positives = 93/202 (46%), Gaps = 24/202 (11%)
Query: 584 RLLPVME--NTKDI--ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
RL VME N D+ ++ ++ + ++ L LH G+I+RDLK N+L+
Sbjct: 70 RLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
+ C KL+D G+ K +G ++ +T T G+ + APE L + ++D ++LG
Sbjct: 130 DAE-GHC-KLADFGMCK--EGILNGVT-TTTFCGTPDYIAPEILQELEYGPSVDWWALG- 183
Query: 700 ILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR---- 753
+L + + G+ P+ E D +I+ D L+ V EAV + + NP+ R
Sbjct: 184 VLMYEMMAGQPPFEADNEDDLFESILHD-DVLYPVWLSKEAVSILKAFMTKNPNKRLGCV 242
Query: 754 ---PKAQNVLNHPFF----WTA 768
+ HPFF W
Sbjct: 243 ASQGGEDAIKQHPFFKEIDWVL 264
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 62/247 (25%), Positives = 92/247 (37%), Gaps = 79/247 (31%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ-GD-- 661
++ + +H++G IHRD+KP N+LI +D KL+D G+ SK Q GD
Sbjct: 109 ELTCAIESVHKMGFIHRDIKPDNILIDRDGHI--KLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 662 ------------------------------MSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691
CL + G + + APE LL+ T+
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--YIAPEVLLRTGYTQL 224
Query: 692 IDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIP-------EAVDLF 742
D +S+G IL+ + G+ P+ E ++ L HIP EA DL
Sbjct: 225 CDWWSVGVILYEMLV-GQPPFLADTPAETQLKVINWETTL----HIPSQAKLSREASDLI 279
Query: 743 TRLLDPNPDLR---PKAQNVLNHPFFWTAD-------------TRLSFLRDVS--DRVEL 784
RL + R A + HPFF D +++ D S D V+
Sbjct: 280 LRLC-CGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDP 338
Query: 785 EDRESDS 791
E SD
Sbjct: 339 EKLRSDD 345
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-06
Identities = 44/194 (22%), Positives = 77/194 (39%), Gaps = 48/194 (24%)
Query: 607 QLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT 666
QLL+ GL++ H+ ++HRDLKPQN+LIS+ KL+D G+++ S +
Sbjct: 111 QLLR-------GLAYCHQRRVLHRDLKPQNLLISERGEL--KLADFGLARA----KSVPS 157
Query: 667 QNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITG----------------- 707
+ + + W P +L G + ++D++ +GCI + TG
Sbjct: 158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKI 217
Query: 708 ---------GKHPYGESFE--RDANIVKDRKDLFL-----VEHIPEAVDLFTRLLDPNPD 751
P S + + + ++ IP +L + L P
Sbjct: 218 FRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPK 277
Query: 752 LRPKAQNVLNHPFF 765
R A + HP+F
Sbjct: 278 KRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 43/163 (26%), Positives = 78/163 (47%), Gaps = 19/163 (11%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATG- 671
++ GL L +++RDLKP+N+L+ D ++SD+G++ ++ +G + G
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILL--DDRGHIRISDLGLAVQIPEG------ETVRGR 161
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK--HPYGESFERDA--NIVKDRK 727
G+ G+ APE + + T + D + LGC+++ I G E +R+ VK+ +
Sbjct: 162 VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ 221
Query: 728 DLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 765
+ + + +A + LL NP R A V HP F
Sbjct: 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 58/261 (22%), Positives = 103/261 (39%), Gaps = 48/261 (18%)
Query: 504 RLVKTHHDV--ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLS 561
RL K+ V + KE L+A +HPNIV + +Y+ +E C
Sbjct: 34 RLPKSSSAVEDSRKEAV-LLAKMKHPNIVAFKESFEADGHLYIVMEYC------------ 80
Query: 562 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621
+L+ + I+L + P +L+ + G+ H
Sbjct: 81 -----------DGGDLMQK--------------IKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 681
+HE ++HRD+K +N+ ++++ KL D G ++ L + T G+ + PE
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGA---YACTYVGTPYYVPPE 170
Query: 682 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAV 739
D++SLGCIL+ T KHP+ + ++ + + + E
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCT-LKHPFQANSWKNLILKVCQGSYKPLPSHYSYELR 229
Query: 740 DLFTRLLDPNPDLRPKAQNVL 760
L ++ NP RP A +L
Sbjct: 230 SLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 33/122 (27%), Positives = 53/122 (43%), Gaps = 20/122 (16%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
+L + R ++ + +LHE +IHRD+K +N+ I+ C L D G +
Sbjct: 180 AICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC--LGDFG--------AA 229
Query: 664 CLTQNATGYGSSGW------QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 717
C + GW APE L + A+D++S G +LF T + FE
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC----HDSLFE 285
Query: 718 RD 719
+D
Sbjct: 286 KD 287
|
Length = 391 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 69/253 (27%), Positives = 101/253 (39%), Gaps = 52/253 (20%)
Query: 470 RIGKLVVFNKE--IAKGSNGTV-----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN--- 519
RI K F K + G+ GTV + EG VA+K L + A KEI +
Sbjct: 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 520 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
++AS +P++ R G+ C S LI L LL+
Sbjct: 62 VMASVDNPHVCRLLGI-------------CLTSTVQLITQLMPF-----------GCLLD 97
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
VR E+ +I S LL I G+++L E L+HRDL +NVL+
Sbjct: 98 YVR-------EHKDNI--------GSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV 142
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
+ K++D G++K L D G W A E +L T D++S G
Sbjct: 143 KTPQH--VKITDFGLAKLLGADEKEY-HAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 199
Query: 700 ILFFCITGGKHPY 712
++ +T G PY
Sbjct: 200 TVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 12/102 (11%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P Q L + + I+ GL +LH +IHRD+K +N+ I+ C + D+G ++
Sbjct: 155 PIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVC--IGDLGAAQ------- 205
Query: 664 CLTQNATGYGSSG---WQAPEQLLQGRQTRAIDLFSLGCILF 702
G +G APE L + + D++S G +LF
Sbjct: 206 FPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247
|
Length = 357 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P + K + S L H+H ++HRD+KP NV I+ + KL D+G+ + S
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT--ATGVVKLGDLGLGRFFS---S 158
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 723
T + G+ + +PE++ + D++SLGC+L+ YG+ N+
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLY 214
Query: 724 KDRKDLFLVEHIPEAVDLFTRLL--------DPNPDLRP 754
K + ++ P D ++ L +P+P+ RP
Sbjct: 215 SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 63/301 (20%), Positives = 109/301 (36%), Gaps = 59/301 (19%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASD------QHPNIVRW 532
+EI G G V+L Y VA + + + + KE + QHPNI++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G + L E C L DL LS
Sbjct: 61 LGQCVEAIPYLLVFE--YCELGDLKSYLSQ------------------------------ 88
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
E W L ++ +I +G++H+H+ +H DL +N ++ D K+ D
Sbjct: 89 ---EQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSD--LTVKVGDY 143
Query: 653 GIS-KRLQGDMSCLTQNATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFC 704
GI R + D + W APE L+ QT+ ++++LG L+
Sbjct: 144 GIGPSRYKEDY--IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
Query: 705 ITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAV-DLFTRLLD---PNPDLRPKAQN 758
PY +R+ +++KD++ + + + +L +P+ R A+
Sbjct: 202 FENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRATAEE 261
Query: 759 V 759
V
Sbjct: 262 V 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 61/231 (26%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-------VKTHHDVALKEIQNLIASDQHPNIV 530
+EI GS G V + VA+K++ + D+ +KE++ + +HPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVK-FLQRIKHPNSI 88
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ G + +L +E C S +DL+ V +E
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE------------------------ 124
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
++ +T + GL++LH +IHRD+K N+L+++ KL+
Sbjct: 125 ---------------VEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLA 167
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLG 698
D G S + + G+ W APE +L +G+ +D++SLG
Sbjct: 168 DF-------GSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 72/349 (20%), Positives = 123/349 (35%), Gaps = 118/349 (33%)
Query: 480 EIAKG-SNGTVVLEGNYE--GRSVAVKRL---VKTHHDVALKEIQNLI---ASDQHPNIV 530
I K + +V ++ VAVK++ + D LK +Q I QHPNI+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKED--LKLLQQEIITSRQLQHPNIL 62
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLS-----GSFEEQLNAKEQDSNLLNEVRIRL 585
+ F+ + +YV+S GS E+ L K L E+ I
Sbjct: 63 PYV-----TSFIV----------DSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAF 105
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ +D+++ L ++H G IHR +K ++L+S D
Sbjct: 106 -------------------------ILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK- 139
Query: 646 CAKLSDMGIS-------KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFS 696
LS + S KR Q + +++ + W +PE L Q Q D++S
Sbjct: 140 -VVLSGLRYSVSMIKHGKR-QRVVHDFPKSSV--KNLPWLSPEVLQQNLQGYNEKSDIYS 195
Query: 697 LGCILFFCIT-----GGKHPYGE----------------------SFERDANIVKDRKDL 729
+G IT G P+ + ++ + + +
Sbjct: 196 VG------ITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSS 249
Query: 730 FLVEHIPEAVD-LFTRLLDP------------NPDLRPKAQNVLNHPFF 765
+ ++VD +TR +P+ RP A +LNH FF
Sbjct: 250 NEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 51/236 (21%)
Query: 477 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQHPN 528
F +++ KG+ G+V L + G VAVK+L H +EI+ L S QH N
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEIL-KSLQHDN 66
Query: 529 IVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
IV++ GV + + + L +E Y+ GS + L + R+
Sbjct: 67 IVKYKGVCYSAGRRNLRLVME----------YLPYGSLRDYLQK--------HRERLD-- 106
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
H LL I G+ +L +HRDL +N+L+ +
Sbjct: 107 ----------------HRK--LLLYASQICKGMEYLGSKRYVHRDLATRNILVESE--NR 146
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
K+ D G++K L D G W APE L + + + A D++S G +L+
Sbjct: 147 VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 2/101 (1%)
Query: 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL 665
AQLL + I G+++LH IHRDL +NVL+ D+ K+ D G++K +
Sbjct: 107 AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR--LVKIGDFGLAKAVPEGHEYY 164
Query: 666 TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
G W A E L + + + A D++S G L+ +T
Sbjct: 165 RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 57/207 (27%), Positives = 85/207 (41%), Gaps = 54/207 (26%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ----- 659
++ + +H++G IHRD+KP N+LI D KL+D G+ SK Q
Sbjct: 109 ELTLAIESVHKMGFIHRDIKPDNILIDLDGHI--KLTDFGLCTGFRWTHNSKYYQKGSHI 166
Query: 660 -------------------GD-MSCLTQNATG----------YGSSGWQAPEQLLQGRQT 689
GD + L Q AT G+ + APE LL+ T
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT 226
Query: 690 RAIDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHI---PEAVDLFTR 744
+ D +S+G ILF + G+ P+ E ++ L + + PEAVDL T+
Sbjct: 227 QLCDWWSVGVILFEMLV-GQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITK 285
Query: 745 LLDPNPDL--RPKAQNVLNHPFFWTAD 769
L + R A ++ HPFF D
Sbjct: 286 LCCSAEERLGRNGADDIKAHPFFSEVD 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 45/207 (21%), Positives = 86/207 (41%), Gaps = 49/207 (23%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGV 535
+ + G+ G V N +A +++K IQ ++ +H NIV ++G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 536 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
++ +++ +E C SL D IY ++G E
Sbjct: 75 YLSREKLWICMEYCGGGSLQD-IYHVTGPLSE---------------------------- 105
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
Q+ V R+ + GL++LH G +HRD+K N+L++ + KL+D G+
Sbjct: 106 -----------LQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGV 152
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPE 681
+ ++ ++ + + G+ W APE
Sbjct: 153 AAKITATIA---KRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 4e-06
Identities = 48/179 (26%), Positives = 90/179 (50%), Gaps = 20/179 (11%)
Query: 596 ELWKANGH-PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL--ISKDKSFCAKLSDM 652
+L K G A++ K+ R +V L+ LH+ +IH D+K +NVL +KD+ + L D
Sbjct: 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIY---LCDY 154
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
G+ K + G SC G+ + +PE++ + D +++G +L + + GKHP+
Sbjct: 155 GLCKII-GTPSCYD------GTLDYFSPEKIKGHNYDVSFDWWAVG-VLTYELLTGKHPF 206
Query: 713 GESFERDANI--VKDR--KDLFLVEHIPE-AVDLFTRLLDPNPDLR-PKAQNVLNHPFF 765
E + + ++ + R K L ++++ + A D +L N + R ++ HPF
Sbjct: 207 KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 31/107 (28%), Positives = 55/107 (51%), Gaps = 3/107 (2%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
L+ + + +G+ L +HRDL +NVLI + K K+ D G+++ + D + +++
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK--LVKICDFGLARDIMRDSNYISK 298
Query: 668 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714
+T + W APE + T D++S G +L+ T G PY E
Sbjct: 299 GST-FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 54/209 (25%), Positives = 85/209 (40%), Gaps = 58/209 (27%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI---------SKRLQ----- 659
++ + +H++G IHRD+KP N+LI +D KL+D G+ SK Q
Sbjct: 109 ELTCAVESVHKMGFIHRDIKPDNILIDRDGHI--KLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 660 -----------GDMS---------------------CLTQNATGYGSSGWQAPEQLLQGR 687
GD + CL + G+ + APE LL+
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLV--GTPNYIAPEVLLRTG 224
Query: 688 QTRAIDLFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFL---VEHIPEAVDLF 742
T+ D +S+G IL+ + G+ P+ E ++ + L + + PEA DL
Sbjct: 225 YTQLCDWWSVGVILYEMLV-GQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283
Query: 743 TRLL-DPNPDL-RPKAQNVLNHPFFWTAD 769
+L P L + A + HPFF T D
Sbjct: 284 IKLCRGPEDRLGKNGADEIKAHPFFKTID 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 17/160 (10%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I S L +LH I +++RDLKP+N+L+ D L+D G+ K ++ T G
Sbjct: 104 EIASALGYLHSINIVYRDLKPENILL--DSQGHVVLTDFGLCKE---GIAQSDTTTTFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKD---RKDLF 730
+ + APE + + +D + LG +L+ + G P+ + RD + D K L
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLY-GLPPF---YCRDVAEMYDNILHKPLV 214
Query: 731 LVEHIPEAV-DLFTRLLDPNPDLRPKAQN----VLNHPFF 765
L + LL+ + R A+ + HPFF
Sbjct: 215 LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 73/305 (23%), Positives = 115/305 (37%), Gaps = 66/305 (21%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVA---VKRLVKT----HHDVALKEIQNLIASDQHPNIVR 531
EI G G V+L + G S A VK L + + L+E+Q HPN+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQ 59
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
G + L LE C L DL L + ++D
Sbjct: 60 CLGQCIESIPYLLVLE--FCPLGDLKNYLRSNRGMVAQMAQKDV---------------- 101
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
L ++ ++ SGL LH+ IH DL +N ++ D S K+ D
Sbjct: 102 ----------------LQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGD 143
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFC 704
G++ + +T++ W APE LL QT+ +++SLG ++
Sbjct: 144 YGLALEQYPEDYYITKDCHAVPLR-WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
Query: 705 ITGGKHPYGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP 754
T PY + E+D + K + DL + E V F L +P+ RP
Sbjct: 203 FTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE-VMQFCWL---DPETRP 258
Query: 755 KAQNV 759
A+ V
Sbjct: 259 TAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 38/128 (29%), Positives = 65/128 (50%), Gaps = 18/128 (14%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 671
+I L+ LHE G+I+RDLK NVL+ D KL+D G+ K GD + +T
Sbjct: 104 EICIALNFLHERGIIYRDLKLDNVLLDADGHI--KLTDYGMCKEGLGPGDTT-----STF 156
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 731
G+ + APE L ++D ++LG +L F + G+ P+ +I+ D D+
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALG-VLMFEMMAGRSPF--------DIITDNPDMNT 207
Query: 732 VEHIPEAV 739
+++ + +
Sbjct: 208 EDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I S L +LH + +++RDLKP+N+L+ D L+D G+ K ++ +T G
Sbjct: 104 EIASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKE---NIEHNGTTSTFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
+ + APE L + R +D + LG +L+ + G
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 28/94 (29%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
++ S + +LH + +I+RDLKP+N+L+ D L+D G+ K + +T G
Sbjct: 104 EVASAIGYLHSLNIIYRDLKPENILL--DSQGHVVLTDFGLCKE---GVEPEETTSTFCG 158
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
+ + APE L + R +D + LG +L+ + G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 3/105 (2%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
LL I G+ +L E ++HR+L +N+L+ D +++D G++ L D
Sbjct: 111 LLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSD--SIVQIADFGVADLLYPDDKKYFY 168
Query: 668 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ W A E +L GR T D++S G ++ ++ G PY
Sbjct: 169 SEHK-TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 3/108 (2%)
Query: 605 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC 664
S LL I G+ +L E L+HRDL +NVL+ K++D G+++ L+GD
Sbjct: 108 SQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKE 165
Query: 665 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ G W A E + + T D++S G ++ +T G PY
Sbjct: 166 YNADG-GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 16/168 (9%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
++V + +H++ +HRD+KP N+L+ D + +L+D G +L D + Q++ G
Sbjct: 110 EMVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGT--VQSSVAVG 165
Query: 674 SSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKD 728
+ + +PE L +G+ D +SLG ++ + G Y ES + + K+
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 729 LF----LVEHIPE-AVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 769
F V + E A DL RL+ + ++ HPFF D
Sbjct: 226 RFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 52/175 (29%), Positives = 84/175 (48%), Gaps = 28/175 (16%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 671
+I L+ LHE G+I+RDLK NVL+ + KL+D G+ K GD + +T
Sbjct: 104 EISLALNFLHERGIIYRDLKLDNVLLDAEGHI--KLTDYGMCKEGIRPGDTT-----STF 156
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY---GESFERDANIVKDRKD 728
G+ + APE L ++D ++LG +L F + G+ P+ G S D N +D
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVGMSDNPDQN-TEDYLF 214
Query: 729 LFLVE---HIP-----EAVDLFTRLLDPNPDLR----PKA--QNVLNHPFFWTAD 769
++E IP +A + L+ +P R P+ +++ +HPFF D
Sbjct: 215 QVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 21/140 (15%)
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 652
D L KA P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 91 DQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI--KLCDF 148
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 711
G+S +L M+ + G+ + +PE+L + D++S+G L + G++P
Sbjct: 149 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE-MAIGRYPI 202
Query: 712 -----------YGESFERDA 720
+G E D
Sbjct: 203 PPPDAKELELMFGCPVEGDP 222
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
++V + +H++ +HRD+KP NVL+ D + +L+D G ++ D + Q++ G
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLL--DMNGHIRLADFGSCLKMNQDGT--VQSSVAVG 165
Query: 674 SSGWQAPEQLLQ------GRQTRAIDLFSLGCILFFCITGGKHPYGESF-ERDANIVKDR 726
+ + +PE +LQ G+ D +SLG ++ + G Y ES E I+
Sbjct: 166 TPDYISPE-ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHE 224
Query: 727 KDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLN----HPFF----WTADTRLS- 773
+ HI EA DL RL+ R QN + H FF W L
Sbjct: 225 ERFQFPSHITDVSEEAKDLIQRLICSRE--RRLGQNGIEDFKKHAFFEGIDWENIRNLEA 282
Query: 774 -FLRDVSDRVELEDRESDSKLLRALE 798
++ DVS + + + D +LR E
Sbjct: 283 PYIPDVSSPSDTSNFDVDDDVLRNPE 308
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 55/259 (21%), Positives = 98/259 (37%), Gaps = 74/259 (28%)
Query: 473 KLVVFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHHDVALKE--------IQN 519
+ + + I +G G V +G Y E +VAVK K +++E ++
Sbjct: 6 EDITLGRCIGEGQFGDV-YQGVYMSPENEKIAVAVK-TCKNCTSPSVREKFLQEAYIMRQ 63
Query: 520 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
HP+IV+ GV ++ V++ +E G L + + L
Sbjct: 64 F----DHPHIVKLIGVITENP-VWIVMELAP----------LGELRSYL---QVNKYSL- 104
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
A L+ + + + L++L +HRD+ +NVL+
Sbjct: 105 ------------------------DLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS------GWQAPEQLLQGRQTRAID 693
S C KL D G+S+ L+ + + Y +S W APE + R T A D
Sbjct: 141 SSPD--CVKLGDFGLSRYLEDE--------SYYKASKGKLPIKWMAPESINFRRFTSASD 190
Query: 694 LFSLGCILFFCITGGKHPY 712
++ G ++ + G P+
Sbjct: 191 VWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 42/186 (22%), Positives = 71/186 (38%), Gaps = 33/186 (17%)
Query: 588 VMENTK----DIELWKANGHPSAQ-LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
V E K D+ L + + S L V + + S L +L + L+H ++ +N+L+++
Sbjct: 78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY 137
Query: 643 K-----SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL--LQGRQTRAIDLF 695
KLSD GI + + + W APE + Q T A D +
Sbjct: 138 GLNEGYVPFIKLSDPGIPITVLSREERVER-------IPWIAPECIRNGQASLTIAADKW 190
Query: 696 SLGCILFFCITGGKHPYG-------ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDP 748
S G L + G+ P E F +D + + + E +L +
Sbjct: 191 SFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLP-------MPDCAELANLINQCWTY 243
Query: 749 NPDLRP 754
+P RP
Sbjct: 244 DPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 50/174 (28%), Positives = 80/174 (45%), Gaps = 26/174 (14%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR--LQGDMSCLTQNATG 671
+I L++LHE G+I+RDLK NVL+ + KL+D G+ K GD + +T
Sbjct: 104 EISLALNYLHERGIIYRDLKLDNVLLDSEGHI--KLTDYGMCKEGLRPGDTT-----STF 156
Query: 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY---GESFERDANIVKDRKD 728
G+ + APE L ++D ++LG +L F + G+ P+ G S D N
Sbjct: 157 CGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 729 LFLVEHIP-------EAVDLFTRLLDPNPDLR----PKA--QNVLNHPFFWTAD 769
+ L + I +A + L+ +P R P+ ++ HPFF D
Sbjct: 216 VILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 3e-05
Identities = 54/230 (23%), Positives = 91/230 (39%), Gaps = 57/230 (24%)
Query: 500 VAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 556
VAVK L D A ++ +++ PNI R GV + + + +E
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIME--------- 99
Query: 557 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIV 616
Y+ +G + L +++ L N+K + + LL + I
Sbjct: 100 -YMENGDLNQFLQKHVAETSGLAC----------NSKSL--------SFSTLLYMATQIA 140
Query: 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGYGSS 675
SG+ +L + +HRDL +N L+ K++ K++D G+S+ L D Y
Sbjct: 141 SGMRYLESLNFVHRDLATRNCLV--GKNYTIKIADFGMSRNLYSSDY---------YRVQ 189
Query: 676 G-------WQAPEQLLQGRQTRAIDLFSLGC----ILFFCITGGKHPYGE 714
G W A E +L G+ T D+++ G IL C + PY
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC---REQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 34/110 (30%), Positives = 52/110 (47%), Gaps = 5/110 (4%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDM 662
P LLK DI G+ +L IHRDL +N ++ +D + C ++D G+SK++ GD
Sbjct: 111 PLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC--VADFGLSKKIYSGDY 168
Query: 663 SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
Q W A E L T D+++ G ++ T G+ PY
Sbjct: 169 --YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 22/48 (45%), Positives = 31/48 (64%), Gaps = 2/48 (4%)
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656
+K ++ L +LH G+IHRDLKP N+LIS + KL+D G+SK
Sbjct: 107 VKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHI--KLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 53/237 (22%), Positives = 92/237 (38%), Gaps = 54/237 (22%)
Query: 526 HPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
HPNIVR+Y + D +Y+ ++ L + L KE+ E
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSL----------KEKKQRFTEE---- 113
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDK 643
+W + +V L +LH E ++HRDL P N+++ +D
Sbjct: 114 -----------RIWN-----------IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD 151
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
++D G++K+ + S LT G+ + PE + D+++ GCIL+
Sbjct: 152 K--VTITDFGLAKQ-KQPESKLTSVV---GTILYSCPEIVKNEPYGEKADVWAFGCILYQ 205
Query: 704 CITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV------DLFTRLLDPNPDLRP 754
T Y + A + + E +PE + D+ T L P+ + RP
Sbjct: 206 MCTLQPPFYSTNMLSLATKIVEAV----YEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 50/178 (28%), Positives = 74/178 (41%), Gaps = 39/178 (21%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG------ISKR 657
P + + ++V L LH G++ RDL P N+L L D G S+
Sbjct: 83 PEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL----------LDDRGHIQLTYFSRW 132
Query: 658 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK----HPYG 713
+ + SC + + + APE +T A D +SLG ILF +TG HP G
Sbjct: 133 SEVEDSCDGEAV----ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG 188
Query: 714 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKA-----QNVLNHPFF 765
+ L + E + EA L +LL NP R A +++ +HPFF
Sbjct: 189 ---------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 7/141 (4%)
Query: 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG-SSG 676
G+ +L +HRDL +N ++ D+SF K++D G+++ + N TG
Sbjct: 110 GMEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 677 WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE--SFERDANIVKDRKDLFLVEH 734
W A E L + T D++S G +L+ +T G PY + SF+ +++ R+ L E+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR-LLQPEY 226
Query: 735 IPEAV-DLFTRLLDPNPDLRP 754
P+ + ++ P P++RP
Sbjct: 227 CPDPLYEVMLSCWHPKPEMRP 247
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-05
Identities = 19/45 (42%), Positives = 28/45 (62%), Gaps = 3/45 (6%)
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKSFCAKLSDMG 653
+ R I+ L LH G++HRD+KPQN++ S SF K+ D+G
Sbjct: 259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSF--KIIDLG 301
|
Length = 566 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 8e-05
Identities = 31/109 (28%), Positives = 53/109 (48%), Gaps = 11/109 (10%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
LL+ + + G+ L IHRD+ +NVL++ + AK+ D G+++ + D
Sbjct: 214 LLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR--VAKICDFGLARDIMND-----S 266
Query: 668 NATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
N G++ W APE + T D++S G +L+ + GK PY
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 19/43 (44%), Positives = 30/43 (69%), Gaps = 2/43 (4%)
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
V R +++GL LH IG++HRD+KP+N+L++ D K+ D G
Sbjct: 314 VMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFG 354
|
Length = 507 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 8/109 (7%)
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 652
D L +A P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 91 DQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEI--KLCDF 148
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
G+S +L M+ + G+ + +PE+L + D++S+G L
Sbjct: 149 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSL 192
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 41/155 (26%), Positives = 68/155 (43%), Gaps = 16/155 (10%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
LL + + G+S L IHRDL +N+L++ + K+ D G+++ ++ D
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR--ITKICDFGLARDIRND-----S 268
Query: 668 NATGYGSS----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 723
N G++ W APE + T D++S G +L+ + G PY D+
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-PGMPVDSKFY 327
Query: 724 KDRKD---LFLVEHIP-EAVDLFTRLLDPNPDLRP 754
K K+ + E P E D+ D +P RP
Sbjct: 328 KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRP 362
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 39/221 (17%)
Query: 500 VAVKRLV----KTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555
VAVK L K + LKEI+ +++ + PNI+R V D + + E
Sbjct: 49 VAVKMLREDANKNARNDFLKEIK-IMSRLKDPNIIRLLAVCITSDPLCMITE-------- 99
Query: 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615
Y+ +G + L+ E + I + L+ + I
Sbjct: 100 --YMENGDLNQFLSRHEPQEA----------AEKADVVTISY--------STLIFMATQI 139
Query: 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL-QGDMSCLTQNATGYGS 674
SG+ +L + +HRDL +N L+ K+ + K++D G+S+ L GD + A
Sbjct: 140 ASGMKYLSSLNFVHRDLATRNCLVGKN--YTIKIADFGMSRNLYSGDYYRIQGRAV--LP 195
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK-HPYGE 714
W + E +L G+ T A D+++ G L+ +T K PY +
Sbjct: 196 IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 33/112 (29%), Positives = 53/112 (47%), Gaps = 10/112 (8%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
L ++ +I GL HLH+ IH DL +N L++ D + K+ D G+S + +T
Sbjct: 102 LQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVTP 159
Query: 668 NATGYGSSGWQAPE-------QLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ + W APE LL QT+ +++SLG ++ G PY
Sbjct: 160 DQL-WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 5/100 (5%)
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P Q + + R ++ L++LH G+IHRD+K +N+ + D+ A L D G + +L D
Sbjct: 183 PLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL--DEPENAVLGDFGAACKL--DAH 238
Query: 664 CLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
T G+ G+ +PE L D++S G +LF
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLF 278
|
Length = 392 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 32/172 (18%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
+I GL LH G+I+RDLK NV++ + K++D G+ K D T G
Sbjct: 109 EISVGLFFLHRRGIIYRDLKLDNVMLDSEGHI--KIADFGMCKEHMVDGVT---TRTFCG 163
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GESFERDANIVKDRKDLF-- 730
+ + APE + +++D ++ G +L + + G+ P+ GE D +LF
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYG-VLLYEMLAGQPPFDGE----------DEDELFQS 212
Query: 731 LVEH--------IPEAVDLFTRLLDPNPDLR----PKAQ-NVLNHPFFWTAD 769
++EH EAV + L+ +P R P+ + ++ H FF D
Sbjct: 213 IMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 6e-04
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 37/184 (20%)
Query: 608 LLKVTRDIVSGLSHLHEIG-------LIHRDLKPQNVLISK---------------DKSF 645
++ +TR ++ L++ H + ++HRDLKPQN+ +S +
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 646 CAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT--RAIDLFSLGCI 700
AK+ D G+SK + + SC+ G+ + +PE LL ++ D+++LGCI
Sbjct: 180 IAKIGDFGLSKNIGIESMAHSCV-------GTPYYWSPELLLHETKSYDDKSDMWALGCI 232
Query: 701 LFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 758
++ + GK P+ +F + + +K DL + E L LL+ + RP A
Sbjct: 233 IYE-LCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQ 291
Query: 759 VLNH 762
L +
Sbjct: 292 CLGY 295
|
Length = 1021 |
| >gnl|CDD|226699 COG4248, COG4248, Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 31/119 (26%), Positives = 47/119 (39%), Gaps = 29/119 (24%)
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
LL+V R++ S + LHE G + D+ + L+S D + D +
Sbjct: 119 LLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD----------SKVVLVDSDSFQINA 168
Query: 668 NATGY----GSSGWQAPEQLLQGRQTRAI----------DLFSLGCILFFCITGGKHPY 712
N T + G S + PE QT D F L ++F + GG+HPY
Sbjct: 169 NGTLHLCPVGVSEFTPPE-----LQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPY 222
|
Length = 637 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 28/102 (27%), Positives = 49/102 (48%), Gaps = 11/102 (10%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
+ G+ L IHRDL +N+L+S++ K+ D G+++ + D + + GS
Sbjct: 183 VARGMEFLASRKCIHRDLAARNILLSENN--VVKICDFGLARDIYKDPDYVRK-----GS 235
Query: 675 S----GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ W APE + T D++S G +L+ + G PY
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 46/194 (23%), Positives = 76/194 (39%), Gaps = 40/194 (20%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ-------------- 659
+ V + +H++G IHRD+KP N+L+ D KLSD G+ L+
Sbjct: 109 ETVLAIDAIHQLGFIHRDIKPDNLLL--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 660 --GDMSCLTQNA----------------TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
D S N+ + G+ + APE +Q + D +SLG I+
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 702 FFCITGGKHPYGESFERDANIVKD-RKDLFLVEHIP---EAVDLFTRLL--DPNPDLRPK 755
+ + G E+ + V + ++ L +P +A DL R N
Sbjct: 227 YEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNG 286
Query: 756 AQNVLNHPFFWTAD 769
+ + +HPFF D
Sbjct: 287 VEEIKSHPFFEGVD 300
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.004
Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 34/126 (26%)
Query: 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG----------------ISKR 657
+ V + +H++G IHRD+KP N+L+ D KLSD G ++
Sbjct: 109 ETVLAIDSIHQLGFIHRDIKPDNLLL--DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166
Query: 658 LQGDMSCLTQNA----------------TGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
L D + N+ + G+ + APE +Q + D +SLG I+
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 702 FFCITG 707
+ + G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 902 | |||
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.98 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| PF06479 | 129 | Ribonuc_2-5A: Ribonuclease 2-5A; InterPro: IPR0105 | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.8 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.71 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.7 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.7 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.63 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.62 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.55 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.49 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.49 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.48 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.47 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.43 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.32 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.26 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.13 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.93 | |
| smart00580 | 58 | PUG domain in protein kinases, N-glycanases and ot | 98.92 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.92 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.84 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.74 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.73 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.58 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.53 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.41 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.35 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.3 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.28 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.04 | |
| PRK11138 | 394 | outer membrane biogenesis protein BamB; Provisiona | 97.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 97.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 97.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.7 | |
| PF13360 | 238 | PQQ_2: PQQ-like domain; PDB: 3HXJ_B 1YIQ_A 1KV9_A | 97.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.5 | |
| PRK11138 | 394 | outer membrane biogenesis protein BamB; Provisiona | 97.39 | |
| TIGR03300 | 377 | assembly_YfgL outer membrane assembly lipoprotein | 97.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.29 | |
| PF01011 | 38 | PQQ: PQQ enzyme repeat family.; InterPro: IPR00237 | 97.19 | |
| PF13360 | 238 | PQQ_2: PQQ-like domain; PDB: 3HXJ_B 1YIQ_A 1KV9_A | 97.17 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.16 | |
| TIGR03300 | 377 | assembly_YfgL outer membrane assembly lipoprotein | 97.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.1 | |
| cd00216 | 488 | PQQ_DH Dehydrogenases with pyrrolo-quinoline quino | 97.0 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.91 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.79 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 96.66 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.61 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.54 | |
| cd00216 | 488 | PQQ_DH Dehydrogenases with pyrrolo-quinoline quino | 96.38 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.13 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 95.9 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.84 | |
| TIGR03074 | 764 | PQQ_membr_DH membrane-bound PQQ-dependent dehydrog | 95.73 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.69 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 95.6 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 95.54 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 95.26 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.25 | |
| smart00564 | 33 | PQQ beta-propeller repeat. Beta-propeller repeat o | 95.08 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 95.04 | |
| PF14593 | 104 | PH_3: PH domain; PDB: 1W1H_D 1W1D_A 1W1G_A 2VKI_A. | 95.01 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.85 | |
| TIGR03075 | 527 | PQQ_enz_alc_DH PQQ-dependent dehydrogenase, methan | 94.8 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.67 | |
| COG1520 | 370 | FOG: WD40-like repeat [Function unknown] | 94.48 | |
| KOG4547 | 541 | consensus WD40 repeat-containing protein [General | 94.33 | |
| COG1520 | 370 | FOG: WD40-like repeat [Function unknown] | 94.28 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.03 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.64 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 93.46 |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-92 Score=813.38 Aligned_cols=385 Identities=53% Similarity=0.948 Sum_probs=357.1
Q ss_pred eeeecccCceEEEEEEeeCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChhhHH
Q 002601 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI 557 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~dli 557 (902)
.+.+|.|+.|+|+..+.++|+.||||++.....+.+.+|+..++.+..||||||+||...++.+.||+.|+|.|+|.|++
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dli 593 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLI 593 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHH
Confidence 45799999999998899999999999999888889999999999999999999999999999999999999999999999
Q ss_pred HHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccccccee
Q 002601 558 YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637 (902)
Q Consensus 558 y~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NI 637 (902)
... + .+..... ....+.++.|++.||+|||+.+||||||||+||
T Consensus 594 e~~-~--~d~~~~~---------------------------------~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNI 637 (903)
T KOG1027|consen 594 ESS-G--LDVEMQS---------------------------------DIDPISVLSQIASGLAHLHSLKIVHRDLKPQNI 637 (903)
T ss_pred hcc-c--cchhhcc---------------------------------cccHHHHHHHHHHHHHHHHhcccccccCCCceE
Confidence 654 1 1111000 012367889999999999999999999999999
Q ss_pred Eecc---CCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCC
Q 002601 638 LISK---DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714 (902)
Q Consensus 638 LL~~---d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~ 714 (902)
||+. ++.++++|+|||+++++..+.+......+..||.||+|||++.....+.++||||+||++|++++||.+||++
T Consensus 638 LI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 638 LISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred EEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 9976 6778999999999999998888777778888999999999999999999999999999999999999999999
Q ss_pred chhhHHHHHhhccccccccCCh--HHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcchhhhhhhhcccchhhccccchHH
Q 002601 715 SFERDANIVKDRKDLFLVEHIP--EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSK 792 (902)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~--e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~~~~~l~~~s~~~e~~~~~~~~~ 792 (902)
..+++.+|+.........+..+ ++.|||.+|+++||..||++.+||.|||||+.++|++|+++++|++|++.++..++
T Consensus 718 ~~~R~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~s~ 797 (903)
T KOG1027|consen 718 SLERQANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSPSE 797 (903)
T ss_pred hHHhhhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCchH
Confidence 9999999999888776666556 99999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhhhcccchHHHhHHHHHhhhhcccCCcchHHHHHHHhccccCcccCCCHHHHHHhCCCCCcccccccccC
Q 002601 793 LLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNYFSCRF 872 (902)
Q Consensus 793 ll~~le~~~~~~~~~~w~~~~~~~l~~~~~~~R~y~~~~vrdLLr~irnk~~h~~el~~~~~~~~G~~p~~f~~yf~~~f 872 (902)
+++++|..+..+..++|++++++.++++|++||+|++++||||||+||||+|||+|+|+++|+++|++|+||..||++||
T Consensus 798 lL~~le~~~~~vv~~~W~~kl~~~~~~~l~kyR~Yk~~svrDLLR~iRNk~hHyrELp~~v~ellG~vPdgF~~YFt~RF 877 (903)
T KOG1027|consen 798 LLRALEAGARVVVSGDWTEKLDKTFMDNLRKYRSYKGSSVRDLLRAIRNKKHHYRELPPEVRELLGDVPDGFDLYFTKRF 877 (903)
T ss_pred HHHhhccCCceEecCchhhhhCHHHHHHHHHhcCcccccHHHHHHHHHhhhhhhhhcCHHHHHhcCCCCcHHHHHHHHhh
Confidence 99999998888889999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CchHHHHHHHHHHhhccchhhhccccC
Q 002601 873 PKLLIEVYNVIFTYCKGEEVFHKYVTN 899 (902)
Q Consensus 873 P~ll~~~y~~~~~~~~~e~~~~~y~~~ 899 (902)
|+||||||.+++. |+.|+.|++||..
T Consensus 878 P~Lli~vY~~~~~-c~~E~~F~~Y~~~ 903 (903)
T KOG1027|consen 878 PNLLIHVYTVLSD-CSGEEIFKKYYSP 903 (903)
T ss_pred hHHHHHHHHHHHH-ccchhhhhhccCC
Confidence 9999999999998 9999999999963
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=438.07 Aligned_cols=383 Identities=26% Similarity=0.378 Sum_probs=293.2
Q ss_pred ccccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccc
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~ 541 (902)
.+-..+|+|++.||+|+|.+|++| ...+++++|||++.+... ....+|-..|...-.||.||+||..|+|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 444577999999999999999998 556799999999866431 2223333333333399999999999999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
+|+|+| |+++|+|.++++. .+.|++.+++.++.+|+.||+|
T Consensus 149 LYFvLe----------~A~nGdll~~i~K-----------------------------~Gsfde~caR~YAAeIldAley 189 (604)
T KOG0592|consen 149 LYFVLE----------YAPNGDLLDLIKK-----------------------------YGSFDETCARFYAAEILDALEY 189 (604)
T ss_pred eEEEEE----------ecCCCcHHHHHHH-----------------------------hCcchHHHHHHHHHHHHHHHHH
Confidence 999999 8888888888743 3557888889999999999999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCcc----------ccccccCCCCccccCchhhccCCCCCc
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----------LTQNATGYGSSGWQAPEQLLQGRQTRA 691 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~----------~~~~~~~~Gt~~Y~APE~l~~~~~s~k 691 (902)
||++|||||||||+||||+.||+ +||+|||.|+.+.+.... ..+..+++||..|++||+|..+..+..
T Consensus 190 lH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~ 267 (604)
T KOG0592|consen 190 LHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS 267 (604)
T ss_pred HHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc
Confidence 99999999999999999988876 999999999988643221 112255789999999999999999999
Q ss_pred chhhhhHHHHHHHHhCCCCCCCCchhhH-HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcch
Q 002601 692 IDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 770 (902)
Q Consensus 692 sDVwSlGviL~elltG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~ 770 (902)
+|+|+||||+|.|+.| .+||....+.. .+.+......++..+++++.|||+++|..||.+|+|++++.+||||.+.++
T Consensus 268 sDiWAlGCilyQmlaG-~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 268 SDLWALGCILYQMLAG-QPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred cchHHHHHHHHHHhcC-CCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 9999999999999998 88998776654 345555566788899999999999999999999999999999999944221
Q ss_pred h----------hhhhhhcccchh----h-------cc---------------ccc-----hHHH----------------
Q 002601 771 R----------LSFLRDVSDRVE----L-------ED---------------RES-----DSKL---------------- 793 (902)
Q Consensus 771 ~----------~~~l~~~s~~~e----~-------~~---------------~~~-----~~~l---------------- 793 (902)
. ..+....+-..+ . .+ ... ..+.
T Consensus 347 ~nlw~~~PP~l~py~p~~~~s~e~~s~~~~~~~~~~~~~~~~~~~~~S~s~~~psn~~~~~~~~~~~~~~~~~~s~~~~~ 426 (604)
T KOG0592|consen 347 ENLWQQTPPKLQPYKPATSISPEYYSAYTPLEPGLDERALFQVPSSASQSSALPSNVTHNGDKVAQPVAPSASSSESKND 426 (604)
T ss_pred hhhhhcCCCcccCCCCcccCCcccCcccccccCCccccccccccccccccccCCCcccccccchhhccccccccccCcch
Confidence 1 111111100000 0 00 000 0000
Q ss_pred HHHHHHHHHhhhcccchHHHhHHHHHhhhhc--ccCCcchHHHHHHHhccccCcccCCCHHHHHHhCCCC---------C
Q 002601 794 LRALEGIALVALNGKWDEKMETKFIENIGRY--RRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHP---------E 862 (902)
Q Consensus 794 l~~le~~~~~~~~~~w~~~~~~~l~~~~~~~--R~y~~~~vrdLLr~irnk~~h~~el~~~~~~~~G~~p---------~ 862 (902)
-..+..+........|+...+..++.+++.. |+..++..|++|.+-.. |+-++++...++.|++| +
T Consensus 427 ~~R~q~le~~~~~~~w~~f~~~~~i~k~~~l~k~~~lf~rkr~lllTn~~---rll~~~~~~~~lk~eip~~~~~~~e~~ 503 (604)
T KOG0592|consen 427 TARLQSLESQSKDNPWHQFLEGSLILKEGALEKRQGLFARKRMLLLTNGP---RLLYVDPQNLVLKGEIPWSPDLRVELK 503 (604)
T ss_pred hhhhhhccccccCccHHHhhhhhhHHhHHHHHhhhhhhhceeEEEecCCC---eEEEEecccceeccccccCcccceeec
Confidence 0111222333456679999998777777633 55677777777666555 88888999999999999 8
Q ss_pred cccccccccCCc---hHHHHHHHHHHhhcc-chhhhccc
Q 002601 863 GFYNYFSCRFPK---LLIEVYNVIFTYCKG-EEVFHKYV 897 (902)
Q Consensus 863 ~f~~yf~~~fP~---ll~~~y~~~~~~~~~-e~~~~~y~ 897 (902)
++..+|.+ +|+ +|++.-+.+..||++ +.+..+|.
T Consensus 504 n~~~~~i~-TP~k~~~l~d~~~~as~w~~ai~~~~~~~~ 541 (604)
T KOG0592|consen 504 NSSTFFIH-TPNKVYYLEDPEQRASVWCKAIETVRKRYS 541 (604)
T ss_pred cCcceEEE-CCccceeccCcccchhHHHHhhhhhhhccc
Confidence 99999999 999 899999999999999 77754444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=421.11 Aligned_cols=248 Identities=33% Similarity=0.531 Sum_probs=217.3
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccC------CchHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
+.|..++.||+|+|++||.+.. .+|..||+|++.+. ..+...+||+ +.+.++|||||+++++|+|.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIe-IHr~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIE-IHRSLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHH-HHHhcCCCcEEeeeeEeecCCceEEE
Confidence 6788899999999999999866 88999999998652 2345677875 77999999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
+|+|. +|+|.+++. +.+.+++.+++.+++||+.||.|||++
T Consensus 97 LELC~----------~~sL~el~K-----------------------------rrk~ltEpEary~l~QIv~GlkYLH~~ 137 (592)
T KOG0575|consen 97 LELCH----------RGSLMELLK-----------------------------RRKPLTEPEARYFLRQIVEGLKYLHSL 137 (592)
T ss_pred EEecC----------CccHHHHHH-----------------------------hcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 99775 566655542 235688999999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+|+|||||-.|++|+++. .+||+|||||..+..+. .+..+.||||.|+|||++....++..+||||+||+||-||
T Consensus 138 ~IiHRDLKLGNlfL~~~~--~VKIgDFGLAt~le~~~---Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL 212 (592)
T KOG0575|consen 138 GIIHRDLKLGNLFLNENM--NVKIGDFGLATQLEYDG---ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLL 212 (592)
T ss_pred CceecccchhheeecCcC--cEEecccceeeeecCcc---cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhh
Confidence 999999999999997764 49999999999987542 3457899999999999999999999999999999999999
Q ss_pred hCCCCCCCCc-hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 706 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 706 tG~~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
.| +|||... .....+.++.....+|...+.+++|||.+||++||.+|||+++||.|+||.
T Consensus 213 ~G-~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 213 VG-RPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred hC-CCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 98 8899876 566667777777788889999999999999999999999999999999993
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=409.54 Aligned_cols=256 Identities=31% Similarity=0.506 Sum_probs=209.7
Q ss_pred ccccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCc---------h-HHHHHHHHHHHhCCCCCeeEeccccc
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH---------D-VALKEIQNLIASDQHPNIVRWYGVES 537 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~---------~-~~~~Ei~~ll~~l~HpNIV~l~g~~~ 537 (902)
+.+.+.|...+.||+|+||.|-+| ...+|+.||||++.+... . ...+|+ +++++++|||||++++++.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~Ei-eILkkL~HP~IV~~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEI-EILKKLSHPNIVRIKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHH-HHHHhcCCCCEEEEeeeee
Confidence 345677889999999999999988 567899999999965421 1 123454 5789999999999999999
Q ss_pred CccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhc
Q 002601 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (902)
Q Consensus 538 d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~ 617 (902)
+.+..||||| |+.+|.|.+++-.+. .+.+.....+++|++.
T Consensus 247 ~~ds~YmVlE----------~v~GGeLfd~vv~nk-----------------------------~l~ed~~K~~f~Qll~ 287 (475)
T KOG0615|consen 247 VPDSSYMVLE----------YVEGGELFDKVVANK-----------------------------YLREDLGKLLFKQLLT 287 (475)
T ss_pred cCCceEEEEE----------EecCccHHHHHHhcc-----------------------------ccccchhHHHHHHHHH
Confidence 9999999999 888999988875432 2344455789999999
Q ss_pred cccccccccccccccccceeEeccC-CCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCC---CCcch
Q 002601 618 GLSHLHEIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAID 693 (902)
Q Consensus 618 gL~yLH~~~IvHrDLKp~NILL~~d-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---s~ksD 693 (902)
|+.|||+.||+||||||+|||+..+ ..+.+||+|||+|+.... .....+.||||.|.|||++....+ ..++|
T Consensus 288 avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVD 363 (475)
T KOG0615|consen 288 AVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVD 363 (475)
T ss_pred HHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc----ceehhhhcCCccccChhheecCCeecccchhe
Confidence 9999999999999999999999766 456799999999998763 245678999999999999987653 45889
Q ss_pred hhhhHHHHHHHHhCCCCCCCCchhhH---HHHHhhccc---cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 694 LFSLGCILFFCITGGKHPYGESFERD---ANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 694 VwSlGviL~elltG~~~Pf~~~~~~~---~~~~~~~~~---~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+||+||+||-|++| .+||.+..... .++.++... ....+.++++++||.+||..||++||++.|+|+||||..
T Consensus 364 iWSlGcvLfvcLsG-~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 364 IWSLGCVLFVCLSG-YPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred eeeccceEEEEecc-CCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 99999999999998 88998765433 244444432 233456789999999999999999999999999999976
Q ss_pred cc
Q 002601 768 AD 769 (902)
Q Consensus 768 ~~ 769 (902)
.+
T Consensus 443 ~~ 444 (475)
T KOG0615|consen 443 AP 444 (475)
T ss_pred cc
Confidence 55
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=390.19 Aligned_cols=245 Identities=30% Similarity=0.450 Sum_probs=208.1
Q ss_pred EeeeecccCceEEEEE-EeeCCcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCcc-ceeeeecccc
Q 002601 477 FNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSLERCT 550 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~-~~yLV~E~c~ 550 (902)
..+.||+|..|+||++ +..+++.+|+|.+.... ..+..+|++.+ ...+||+||.+||.|.++. .++|+||
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il-~~~~spyIV~~ygaF~~~~~~isI~mE--- 158 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEIL-RSCQSPYIVGFYGAFYSNGEEISICME--- 158 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHH-hhCCCCCeeeEeEEEEeCCceEEeehh---
Confidence 3467999999999998 56679999999994332 34667888754 5569999999999999988 4999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc-ccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIH 629 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~-~~IvH 629 (902)
||.+|||+..+.. .+.+++..+.+|+.+|++||.|||+ ++|||
T Consensus 159 -------YMDgGSLd~~~k~-----------------------------~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIH 202 (364)
T KOG0581|consen 159 -------YMDGGSLDDILKR-----------------------------VGRIPEPVLGKIARAVLRGLSYLHEERKIIH 202 (364)
T ss_pred -------hcCCCCHHHHHhh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHhhccCeee
Confidence 8899999887632 2457889999999999999999995 89999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
|||||+||||+..|+ +||||||.++.+.+. ...+.+||..|||||.+.+..|+.++||||||+.++||.+| +
T Consensus 203 RDIKPsNlLvNskGe--VKicDFGVS~~lvnS-----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~G-r 274 (364)
T KOG0581|consen 203 RDIKPSNLLVNSKGE--VKICDFGVSGILVNS-----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIG-R 274 (364)
T ss_pred ccCCHHHeeeccCCC--EEeccccccHHhhhh-----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhC-C
Confidence 999999999999987 999999999988753 45778899999999999999999999999999999999998 6
Q ss_pred CCCCCc-------hhhHHHHHhhcccccccc-CChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 710 HPYGES-------FERDANIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 710 ~Pf~~~-------~~~~~~~~~~~~~~~~~~-~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
.||... .+-...|+....+..+.. +++|++++|..||++||.+||++.|+++|||+...+
T Consensus 275 fP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 275 FPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 676553 222335566566666665 899999999999999999999999999999986543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=385.55 Aligned_cols=260 Identities=30% Similarity=0.380 Sum_probs=213.5
Q ss_pred cceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
.++|.+.++||+|+||+|+... ..+++.+|+|++++... .....|. .++..++||.||+++..|++.+.+||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er-~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAER-NILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHH-HHHHhCCCCcEeeeEEecccCCeEEE
Confidence 3567888999999999999874 46699999999976531 2233444 46777999999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
|+| |+.+|.|..+|.. .+.+++..++-++..|+.||.|||+
T Consensus 103 Vld----------~~~GGeLf~hL~~-----------------------------eg~F~E~~arfYlaEi~lAL~~LH~ 143 (357)
T KOG0598|consen 103 VLD----------YLNGGELFYHLQR-----------------------------EGRFSEDRARFYLAEIVLALGYLHS 143 (357)
T ss_pred EEe----------ccCCccHHHHHHh-----------------------------cCCcchhHHHHHHHHHHHHHHHHHh
Confidence 999 9999999988853 2457888899999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
+|||||||||+||||+.+|+ ++|+|||||+..-.. ...+.+.|||+.|||||++.+..|+.++|+||||+++|||
T Consensus 144 ~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~---~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeM 218 (357)
T KOG0598|consen 144 KGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKD---GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEM 218 (357)
T ss_pred CCeeeccCCHHHeeecCCCc--EEEeccccchhcccC---CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHH
Confidence 99999999999999999988 999999999965432 2345678999999999999999999999999999999999
Q ss_pred HhCCCCCCC-CchhhHHHHHhhcc-ccccccCChHHHHHHHcccCCCCCCCc----CHHHHHcCCCCCCcchhhhhhhh
Q 002601 705 ITGGKHPYG-ESFERDANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRP----KAQNVLNHPFFWTADTRLSFLRD 777 (902)
Q Consensus 705 ltG~~~Pf~-~~~~~~~~~~~~~~-~~~~~~~~~e~~dLI~~~L~~dP~~Rp----t~~elL~HPfF~~~~~~~~~l~~ 777 (902)
++| .+||. ++.......+...+ ...+.-.+++++|+++++|..||++|. ++.++.+||||...++..-+.+.
T Consensus 219 L~G-~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~ 296 (357)
T KOG0598|consen 219 LTG-KPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKK 296 (357)
T ss_pred hhC-CCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcC
Confidence 998 55554 44444444444444 444444789999999999999999995 68899999999776655443333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=384.01 Aligned_cols=252 Identities=31% Similarity=0.516 Sum_probs=205.2
Q ss_pred ceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
..|...++||+|+||+||+|. ..++.+||||.+.+.. .+...+|+. +++.++|||||+|++++.+++++||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~-iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIK-ILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHH-HHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 345667779999999999984 4568999999986552 334567776 678999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
|||. +|+|..+++. .+.+++..++.++.||+.||++||+++
T Consensus 89 EyC~----------gGDLs~yi~~-----------------------------~~~l~e~t~r~Fm~QLA~alq~L~~~~ 129 (429)
T KOG0595|consen 89 EYCN----------GGDLSDYIRR-----------------------------RGRLPEATARHFMQQLASALQFLHENN 129 (429)
T ss_pred EeCC----------CCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9887 3455555432 235788899999999999999999999
Q ss_pred ccccccccceeEeccC-CC---ceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 627 LIHRDLKPQNVLISKD-KS---FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 627 IvHrDLKp~NILL~~d-~~---~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
||||||||+||||+.. +. .++||+|||+|+.+... ....+.||++-|||||++..++|+.|+|+||+|+|+|
T Consensus 130 IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~----~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ily 205 (429)
T KOG0595|consen 130 IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG----SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILY 205 (429)
T ss_pred eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch----hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHH
Confidence 9999999999999764 33 67999999999998753 3346789999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCchhhH-HHHHhhcc---ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 703 FCITGGKHPYGESFERD-ANIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-~~~~~~~~---~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
+|++| ++||......+ ...++... ...+...++...+|+...++.+|..|.+..+...|+|.|...
T Consensus 206 q~l~g-~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 206 QCLTG-KPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred HHHhC-CCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 99998 88888643332 22222221 223344566788999999999999999999999999997654
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=365.56 Aligned_cols=251 Identities=27% Similarity=0.415 Sum_probs=213.4
Q ss_pred ceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
++|.+.+.||.|+||+|.+. ...+|..+|+|++.+... +....| ..+++.+.||+++++++.|.|.+++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nE-k~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNE-KRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhH-HHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 44566788999999999997 455689999999976532 122333 3577888999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+++|.|..+|+ +.+.++++.++.++.||+.||+|||++
T Consensus 123 me----------yv~GGElFS~Lr-----------------------------k~~rF~e~~arFYAAeivlAleylH~~ 163 (355)
T KOG0616|consen 123 ME----------YVPGGELFSYLR-----------------------------KSGRFSEPHARFYAAEIVLALEYLHSL 163 (355)
T ss_pred Ee----------ccCCccHHHHHH-----------------------------hcCCCCchhHHHHHHHHHHHHHHHHhc
Confidence 99 899999999884 345688999999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+|++|||||+||||+++|. +||+|||+|+...+ .+.+.||||.|+|||++....+..++|+|||||++|||+
T Consensus 164 ~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~------rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMl 235 (355)
T KOG0616|consen 164 DIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSG------RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEML 235 (355)
T ss_pred CeeeccCChHHeeeccCCc--EEEEeccceEEecC------cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHH
Confidence 9999999999999999988 99999999998864 357889999999999999999999999999999999999
Q ss_pred hCCCCCCCCc-hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCC-----cCHHHHHcCCCCCCcchhh
Q 002601 706 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTADTRL 772 (902)
Q Consensus 706 tG~~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~R-----pt~~elL~HPfF~~~~~~~ 772 (902)
.| .+||... .......+...+..+|...+++++|||+++|+.|-.+| ....++.+||||.+-++..
T Consensus 236 aG-~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 236 AG-YPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred cC-CCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 98 5666554 43344445555667888999999999999999999999 4677999999998766543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=438.27 Aligned_cols=232 Identities=25% Similarity=0.366 Sum_probs=173.0
Q ss_pred EEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChh
Q 002601 476 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~ 554 (902)
...+.||+|+||.||+|.. .+|+.||||++..... ...+|+ ..++.++|||||+++|+|.+++..|+|||
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~-~~l~~l~HpnIv~~~~~~~~~~~~~lv~E------- 763 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEI-ADMGKLQHPNIVKLIGLCRSEKGAYLIHE------- 763 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHH-HHHhhCCCCCcceEEEEEEcCCCCEEEEe-------
Confidence 3456799999999999865 6799999999865432 223344 45688899999999999999999999999
Q ss_pred hHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc---cccccccc
Q 002601 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH---EIGLIHRD 631 (902)
Q Consensus 555 dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH---~~~IvHrD 631 (902)
|+++|+|.++++ .+++..+.+|+.||++||+||| +.+|+|||
T Consensus 764 ---y~~~g~L~~~l~--------------------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~d 808 (968)
T PLN00113 764 ---YIEGKNLSEVLR--------------------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808 (968)
T ss_pred ---CCCCCcHHHHHh--------------------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCC
Confidence 777888877763 1456677899999999999999 66999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+||+++.++. +++. ||........ ....||+.|+|||++.+..++.++|||||||++|||+|| +.|
T Consensus 809 lkp~Nil~~~~~~--~~~~-~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg-~~p 877 (968)
T PLN00113 809 LSPEKIIIDGKDE--PHLR-LSLPGLLCTD-------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG-KSP 877 (968)
T ss_pred CCHHhEEECCCCc--eEEE-eccccccccC-------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC-CCC
Confidence 9999999987765 4443 5544332211 223578999999999999999999999999999999998 667
Q ss_pred CCCchhhHHHHH---h----hc------ccc------ccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 712 YGESFERDANIV---K----DR------KDL------FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 712 f~~~~~~~~~~~---~----~~------~~~------~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
|.........+. . .. ... ...+...++.+++.+||+.||++||+++|+++.
T Consensus 878 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 643211100000 0 00 000 001112357789999999999999999999754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=390.22 Aligned_cols=249 Identities=31% Similarity=0.443 Sum_probs=215.7
Q ss_pred eEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
-+++++.||+|+-|.|-+| +..+|+.+|||++.+.. .....+|+. +|+.+.|||++++|++++++.++|+|+
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIv-iMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIV-IMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhH-HHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3678899999999999998 56789999999997641 234577886 679999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|.|+++|- ..+++++.++.++++||+.|+.|||..+
T Consensus 92 E----------yv~gGELFdylv-----------------------------~kG~l~e~eaa~ff~QIi~gv~yCH~~~ 132 (786)
T KOG0588|consen 92 E----------YVPGGELFDYLV-----------------------------RKGPLPEREAAHFFRQILDGVSYCHAFN 132 (786)
T ss_pred E----------ecCCchhHHHHH-----------------------------hhCCCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 9 888999988873 3466889999999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCC-CCcchhhhhHHHHHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 705 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGviL~ell 705 (902)
|+||||||+|+||+..++ +||+|||+|..-.++ .-..+.||+|.|.|||++.+.+| +.++||||+|||||.||
T Consensus 133 icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~g----klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALL 206 (786)
T KOG0588|consen 133 ICHRDLKPENLLLDVKNN--IKIADFGMASLEVPG----KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALL 206 (786)
T ss_pred ceeccCCchhhhhhcccC--EeeeccceeecccCC----ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHH
Confidence 999999999999988877 999999999865543 33467899999999999999998 68999999999999999
Q ss_pred hCCCCCCCCchhhH-HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 706 TGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 706 tG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
|| +.||++..-+. ...++......|...++++++||.+||..||++|.|++||++|||+....
T Consensus 207 tG-~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 207 TG-KLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred hC-CCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 98 88998765443 34555555566788899999999999999999999999999999996643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=356.89 Aligned_cols=244 Identities=27% Similarity=0.419 Sum_probs=192.4
Q ss_pred eeecccCceEEEEEE-eeCCcEEEEEEeccCCch-----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 479 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
.++|+|+||+||++. ..+|+.||||++....++ .+++|+. |++.++|+|+|.|+.+|.....++||+|||+.+
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIr-mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIR-MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHH-HHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 469999999999984 457999999999876553 4677876 789999999999999999999999999999976
Q ss_pred hh-hHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 553 LN-DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 553 L~-dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
+. ++-. ..++++...+.+++.|++.|+.|+|+++|||||
T Consensus 87 vL~eLe~----------------------------------------~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRD 126 (396)
T KOG0593|consen 87 VLHELER----------------------------------------YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRD 126 (396)
T ss_pred HHHHHHh----------------------------------------ccCCCCHHHHHHHHHHHHHHhhhhhhcCeeccc
Confidence 43 3322 235677888899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
|||+||||+..|. +||||||+|+.+.......+ .-+.|..|.|||.+.+ .+|+..+||||+||++.||++|...
T Consensus 127 IKPENILit~~gv--vKLCDFGFAR~L~~pgd~YT---DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL 201 (396)
T KOG0593|consen 127 IKPENILITQNGV--VKLCDFGFARTLSAPGDNYT---DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPL 201 (396)
T ss_pred CChhheEEecCCc--EEeccchhhHhhcCCcchhh---hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcC
Confidence 9999999998876 99999999998874333222 2346899999999987 6799999999999999999998443
Q ss_pred CCCCchhh-HHHHHhhccc------------c-c-----------------cccCChHHHHHHHcccCCCCCCCcCHHHH
Q 002601 711 PYGESFER-DANIVKDRKD------------L-F-----------------LVEHIPEAVDLFTRLLDPNPDLRPKAQNV 759 (902)
Q Consensus 711 Pf~~~~~~-~~~~~~~~~~------------~-~-----------------~~~~~~e~~dLI~~~L~~dP~~Rpt~~el 759 (902)
.-+.+.-. ...|.+.... . | ....+..+.|+++.||+.||.+|++.+|+
T Consensus 202 ~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql 281 (396)
T KOG0593|consen 202 WPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL 281 (396)
T ss_pred CCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence 33333222 2222111100 0 0 01123467899999999999999999999
Q ss_pred HcCCCCCCc
Q 002601 760 LNHPFFWTA 768 (902)
Q Consensus 760 L~HPfF~~~ 768 (902)
+.||||.+.
T Consensus 282 l~H~yFd~~ 290 (396)
T KOG0593|consen 282 LHHPYFDGF 290 (396)
T ss_pred hcChHHHHH
Confidence 999999543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=376.82 Aligned_cols=250 Identities=30% Similarity=0.485 Sum_probs=196.0
Q ss_pred ceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC----chHHHHHHHHHHHhCC-CCCeeEecccccCcc-ceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQ-HPNIVRWYGVESDQD-FVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~d~~-~~yLV 545 (902)
++|...++||.|+||.||+| ...+|..||||++++.. +-..+||+..+ .+++ |||||++..++.|.+ .+|+|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL-~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSL-RKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHH-HhcCCCCcchhhHHHhhccCceEeee
Confidence 44556688999999999998 55679999999997653 23468899866 5555 999999999999988 99999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|||++|+|.+++. -+.+.+++..++.|+.||++||+|+|.+
T Consensus 89 fE~Md~NLYqLmK---------------------------------------~R~r~fse~~irnim~QilqGL~hiHk~ 129 (538)
T KOG0661|consen 89 FEFMDCNLYQLMK---------------------------------------DRNRLFSESDIRNIMYQILQGLAHIHKH 129 (538)
T ss_pred HHhhhhhHHHHHh---------------------------------------hcCCcCCHHHHHHHHHHHHHHHHHHHhc
Confidence 9999999887762 1135688999999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~el 704 (902)
|+.||||||+|||+.. ...+||+|||+|+.+.+... -..-+-|..|+|||++.. +.|+.++||||+|||++|+
T Consensus 130 GfFHRDlKPENiLi~~--~~~iKiaDFGLARev~SkpP----YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl 203 (538)
T KOG0661|consen 130 GFFHRDLKPENILISG--NDVIKIADFGLAREVRSKPP----YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAEL 203 (538)
T ss_pred CcccccCChhheEecc--cceeEecccccccccccCCC----cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHH
Confidence 9999999999999964 34599999999998875422 122346899999999875 5689999999999999999
Q ss_pred HhCCCCCCCCchhhH-HHHHhh---------------------ccc--------cccccCChHHHHHHHcccCCCCCCCc
Q 002601 705 ITGGKHPYGESFERD-ANIVKD---------------------RKD--------LFLVEHIPEAVDLFTRLLDPNPDLRP 754 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~-~~~~~~---------------------~~~--------~~~~~~~~e~~dLI~~~L~~dP~~Rp 754 (902)
.+-+..+-+.+...+ .++..- ... ......++++.++|.+||..||.+||
T Consensus 204 ~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp 283 (538)
T KOG0661|consen 204 YSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP 283 (538)
T ss_pred HHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc
Confidence 997443334332221 111110 000 00122567999999999999999999
Q ss_pred CHHHHHcCCCCCCc
Q 002601 755 KAQNVLNHPFFWTA 768 (902)
Q Consensus 755 t~~elL~HPfF~~~ 768 (902)
||+|+++||||...
T Consensus 284 TA~~al~~pffq~~ 297 (538)
T KOG0661|consen 284 TASQALQHPFFQVG 297 (538)
T ss_pred cHHHHhcCcccccc
Confidence 99999999999654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=374.86 Aligned_cols=269 Identities=30% Similarity=0.439 Sum_probs=210.5
Q ss_pred cceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
.+.|...+.||+|+||.||++.. .+|..+|+|+|++... ....+-+..++....+|+||+||..|+|.+++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 35677889999999999999954 5699999999987531 11233334566778999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+|+|++..+|.. ...+++..++.++.+++.|++-||+.
T Consensus 220 ME----------ylPGGD~mTLL~~-----------------------------~~~L~e~~arfYiaE~vlAI~~iH~~ 260 (550)
T KOG0605|consen 220 ME----------YLPGGDMMTLLMR-----------------------------KDTLTEDWARFYIAETVLAIESIHQL 260 (550)
T ss_pred EE----------ecCCccHHHHHHh-----------------------------cCcCchHHHHHHHHHHHHHHHHHHHc
Confidence 99 9999999888743 35678889999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCC---------------------Cccc-----c-------------
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD---------------------MSCL-----T------------- 666 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~---------------------~~~~-----~------------- 666 (902)
|+|||||||+|+||+..|+ +||+|||||..+... .... .
T Consensus 261 gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~ 338 (550)
T KOG0605|consen 261 GYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWK 338 (550)
T ss_pred CcccccCChhheeecCCCC--EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHH
Confidence 9999999999999999998 999999999644210 0000 0
Q ss_pred -----ccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchh-h-HHHHHhhcccc-c--cccCCh
Q 002601 667 -----QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE-R-DANIVKDRKDL-F--LVEHIP 736 (902)
Q Consensus 667 -----~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~-~-~~~~~~~~~~~-~--~~~~~~ 736 (902)
.....+|||.|||||++.+..|+..+|+||||||+||||.| .+||..... . ..+++.+.... + ....++
T Consensus 339 ~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvG-yPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~ 417 (550)
T KOG0605|consen 339 RNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVG-YPPFCSETPQETYRKIVNWRETLKFPEEVDLSD 417 (550)
T ss_pred hhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhhhccCCCcCcccH
Confidence 01234799999999999999999999999999999999998 667765432 2 23455444222 2 234568
Q ss_pred HHHHHHHcccCCCCCCCcC---HHHHHcCCCCCCcch------hhhhhhhcccchh
Q 002601 737 EAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTADT------RLSFLRDVSDRVE 783 (902)
Q Consensus 737 e~~dLI~~~L~~dP~~Rpt---~~elL~HPfF~~~~~------~~~~l~~~s~~~e 783 (902)
+++|||.+||. ||++|.. ++||.+||||.+.++ ..+|...+.+..+
T Consensus 418 eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~D 472 (550)
T KOG0605|consen 418 EAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELD 472 (550)
T ss_pred HHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcchhhcCCCCCCCCCCCccc
Confidence 99999999999 9999974 899999999966432 2345555554443
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=383.02 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=212.0
Q ss_pred cceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
-+.|++.++||+|+||+|+++.. .+++.+|||++++... +....|...+...-+||.+++|+++|+.++++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 36789999999999999999854 4688999999987531 2233343322223379999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||| |..+|++..+.+ .+.+++..++.++..|+.||+|||+
T Consensus 447 vme----------y~~Ggdm~~~~~------------------------------~~~F~e~rarfyaAev~l~L~fLH~ 486 (694)
T KOG0694|consen 447 VME----------YVAGGDLMHHIH------------------------------TDVFSEPRARFYAAEVVLGLQFLHE 486 (694)
T ss_pred EEE----------ecCCCcEEEEEe------------------------------cccccHHHHHHHHHHHHHHHHHHHh
Confidence 999 666776332221 2457888899999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
+||||||||-+||||+.+|+ +||+|||+++..-. ....+.+.||||.|||||++.+..|+.++|+|||||+||||
T Consensus 487 ~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~---~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeM 561 (694)
T KOG0694|consen 487 NGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMG---QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEM 561 (694)
T ss_pred cCceeeecchhheEEcccCc--EEecccccccccCC---CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHH
Confidence 99999999999999999998 99999999997543 23467899999999999999999999999999999999999
Q ss_pred HhCCCCCCC-CchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH-----HHHHcCCCCCCcchh
Q 002601 705 ITGGKHPYG-ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADTR 771 (902)
Q Consensus 705 ltG~~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~-----~elL~HPfF~~~~~~ 771 (902)
|.| ..||. ++.+.....+......+|...+.|+.++++++|.++|++|..+ .+|..||||.+.++.
T Consensus 562 L~G-q~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~ 633 (694)
T KOG0694|consen 562 LVG-ESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWD 633 (694)
T ss_pred HcC-CCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHH
Confidence 998 66776 5555566777777788999999999999999999999999875 689999999876543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=366.39 Aligned_cols=253 Identities=30% Similarity=0.497 Sum_probs=201.2
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC---chHHHHHHHHHHHhCCCCCeeEecccccCcc--ceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQD--FVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~--~~yLV~E~ 548 (902)
+..++.||+|+||+||++... +|...|||.....+ .+...+|+. ++..++|||||+++|.....+ .+++.||
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~-iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE- 96 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIR-ILSRLNHPNIVQYYGSSSSRENDEYNIFME- 96 (313)
T ss_pred hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHH-HHHhCCCCCEEeeCCccccccCeeeEeeee-
Confidence 345678999999999998554 49999999886543 223566665 678888999999999865555 6899999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|.+++.... ..++++.++++.+||++||+|||++||+
T Consensus 97 ---------y~~~GsL~~~~~~~g----------------------------~~l~E~~v~~ytr~iL~GL~ylHs~g~v 139 (313)
T KOG0198|consen 97 ---------YAPGGSLSDLIKRYG----------------------------GKLPEPLVRRYTRQILEGLAYLHSKGIV 139 (313)
T ss_pred ---------ccCCCcHHHHHHHcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 888899888774321 1478999999999999999999999999
Q ss_pred ccccccceeEecc-CCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-CCCcchhhhhHHHHHHHHh
Q 002601 629 HRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 629 HrDLKp~NILL~~-d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~ellt 706 (902)
||||||+||||+. ++. +||+|||+++................||+.|||||++..+. ...++|||||||++.||+|
T Consensus 140 H~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T 217 (313)
T KOG0198|consen 140 HCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT 217 (313)
T ss_pred ccCcccceEEEeCCCCe--EEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence 9999999999987 455 99999999998775222333345567999999999998643 3459999999999999999
Q ss_pred CCCCCCCCc---hhhHHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 707 GGKHPYGES---FERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 707 G~~~Pf~~~---~~~~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
| .+||.+. .+....+.... .+..+...++++++++.+|+..||++||||+++|+|||.....
T Consensus 218 g-~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 218 G-KPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred C-CCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 8 8898873 22222333222 3355667788999999999999999999999999999985543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=373.57 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=205.8
Q ss_pred cceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccC--------CchHHHHHHHHHHHhCC-CCCeeEecccccCccc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT--------HHDVALKEIQNLIASDQ-HPNIVRWYGVESDQDF 541 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~--------~~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~d~~~ 541 (902)
...|.+++.||+|+||+|++| ...+|..||||++.+. ......+|+. +++.++ ||||++++.++.....
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~-~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREIS-ILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHH-HHHHhccCCCEeEEEEEEecCCe
Confidence 356788999999999999998 5667899999976543 1223456775 556666 9999999999999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
+|+|||||. +|+|.+++.. .+.+.+..++++++|++.|++|
T Consensus 95 ~~ivmEy~~----------gGdL~~~i~~-----------------------------~g~l~E~~ar~~F~Qlisav~y 135 (370)
T KOG0583|consen 95 IYIVMEYCS----------GGDLFDYIVN-----------------------------KGRLKEDEARKYFRQLISAVAY 135 (370)
T ss_pred EEEEEEecC----------CccHHHHHHH-----------------------------cCCCChHHHHHHHHHHHHHHHH
Confidence 999999554 4666665532 2446777889999999999999
Q ss_pred cccccccccccccceeEeccC-CCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-CC-CcchhhhhH
Q 002601 622 LHEIGLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QT-RAIDLFSLG 698 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s-~ksDVwSlG 698 (902)
||++||+||||||+|||++.+ ++ +||+|||++..... ......+.|||+.|+|||++.+.. |+ .++||||+|
T Consensus 136 ~H~~gi~HRDLK~ENilld~~~~~--~Kl~DFG~s~~~~~---~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~G 210 (370)
T KOG0583|consen 136 CHSRGIVHRDLKPENILLDGNEGN--LKLSDFGLSAISPG---EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLG 210 (370)
T ss_pred HHhCCEeeCCCCHHHEEecCCCCC--EEEeccccccccCC---CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhH
Confidence 999999999999999999877 55 99999999997741 224557889999999999999877 74 899999999
Q ss_pred HHHHHHHhCCCCCCCCch-hhHHHHHhhccccccccC-ChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 699 CILFFCITGGKHPYGESF-ERDANIVKDRKDLFLVEH-IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~-~~~~~~~~~~~~~~~~~~-~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
|+||.|++| ..||.+.. ......+......++... ++++++|+.+||+.||.+|+++.++++||||..
T Consensus 211 ViLy~ml~G-~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 211 VILYVLLCG-RLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHhC-CCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999998 77888643 333344455555667777 999999999999999999999999999999976
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=374.22 Aligned_cols=246 Identities=27% Similarity=0.397 Sum_probs=204.3
Q ss_pred EEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCchH-----HHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~~~-----~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+-+.||+|+||+||+| ..++.+.||+|.+.+..... ..+|+ ++++.++|||||.++.+|+...++++|.||
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev-~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEV-RILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHH-HHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 445578999999999998 56789999999987653322 34455 478999999999999999999999999998
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|.++|..++ . ....+|++.++.|+.+++.||.|||+++|+
T Consensus 83 a~g~L~~il-----------~-----------------------------~d~~lpEe~v~~~a~~LVsaL~yLhs~ril 122 (808)
T KOG0597|consen 83 AVGDLFTIL-----------E-----------------------------QDGKLPEEQVRAIAYDLVSALYYLHSNRIL 122 (808)
T ss_pred hhhhHHHHH-----------H-----------------------------hccCCCHHHHHHHHHHHHHHHHHHHhcCcc
Confidence 876555443 2 124589999999999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|||+||+||||...|. +|+||||+|+-...+.... ....|||-|||||.+.++.|+..+|+||+|||+|||++|
T Consensus 123 hrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vl---tsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G- 196 (808)
T KOG0597|consen 123 HRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVL---TSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVG- 196 (808)
T ss_pred cccCCcceeeecCCCc--eeechhhhhhhcccCceee---eeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcC-
Confidence 9999999999977765 9999999999876543222 334599999999999999999999999999999999998
Q ss_pred CCCCC-CchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 709 KHPYG-ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 709 ~~Pf~-~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+|||- .........+.......+...+.++..++..+|.+||.+|.+..+++.|||..+
T Consensus 197 ~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 197 QPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred CCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 55554 444444555555556677788999999999999999999999999999999744
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=369.75 Aligned_cols=240 Identities=28% Similarity=0.450 Sum_probs=195.4
Q ss_pred EeeeecccCceEEEEEEeeCCcE-EEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCcc-ceeeeeccc
Q 002601 477 FNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-FVYLSLERC 549 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~~~g~~-VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~-~~yLV~E~c 549 (902)
+.+.||+|+||+||++ .+.|.. ||||++.... .....+|+ .++.+++|||||+++|+|.+.. .++||||
T Consensus 45 ~~~~iG~G~~g~V~~~-~~~g~~~vavK~~~~~~~~~~~~~~f~~E~-~il~~l~HpNIV~f~G~~~~~~~~~~iVtE-- 120 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKG-KWRGTDVVAVKIISDPDFDDESRKAFRREA-SLLSRLRHPNIVQFYGACTSPPGSLCIVTE-- 120 (362)
T ss_pred hhhhcccCCceeEEEE-EeCCceeEEEEEecchhcChHHHHHHHHHH-HHHHhCCCCCeeeEEEEEcCCCCceEEEEE--
Confidence 4456999999999974 556666 9999997543 12344455 5778899999999999999988 7999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc-cc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LI 628 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~-Iv 628 (902)
|+++|+|.++|+.. ....+++..+++|+.|||+||+|||+++ ||
T Consensus 121 --------y~~~GsL~~~l~~~---------------------------~~~~l~~~~~l~~aldiArGm~YLH~~~~iI 165 (362)
T KOG0192|consen 121 --------YMPGGSLSVLLHKK---------------------------RKRKLPLKVRLRIALDIARGMEYLHSEGPII 165 (362)
T ss_pred --------eCCCCcHHHHHhhc---------------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCee
Confidence 99999999999753 1245788889999999999999999999 99
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc--cCCCCCcchhhhhHHHHHHHHh
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL--QGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~--~~~~s~ksDVwSlGviL~ellt 706 (902)
||||||+||||+.+. ..+||+|||+++...... .......||+.|||||++. ...|+.|+||||||+++|||+|
T Consensus 166 HrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t 241 (362)
T KOG0192|consen 166 HRDLKSDNILVDLKG-KTLKIADFGLSREKVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLT 241 (362)
T ss_pred ecccChhhEEEcCCC-CEEEECCCccceeecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHH
Confidence 999999999997775 259999999998765421 1112256999999999999 5689999999999999999999
Q ss_pred CCCCCCCCchhhH--HHH-HhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 707 GGKHPYGESFERD--ANI-VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 707 G~~~Pf~~~~~~~--~~~-~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
| +.||.+..... ..+ ........+....+.+..++.+||+.||.+||+..+++
T Consensus 242 ~-~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 242 G-EIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred C-CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 8 77888765422 222 23445555666888999999999999999999999876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=372.01 Aligned_cols=247 Identities=29% Similarity=0.455 Sum_probs=206.4
Q ss_pred ceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC---chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 473 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
..|.-.++||+|+-|.||.| ...+++.||||++.... .+..+.|+. +|+..+|+|||+++..|.-++.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~-Vm~~~~H~NiVnfl~Sylv~deLWVVME- 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEIL-VMRDLHHPNIVNFLDSYLVGDELWVVME- 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHH-HHHhccchHHHHHHHHhcccceeEEEEe-
Confidence 34555678999999999998 56678999999986432 345677876 5688899999999999988899999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
||.+|+|.+.+.. ..+++.++..|++++++||+|||.+||+
T Consensus 351 ---------ym~ggsLTDvVt~------------------------------~~~~E~qIA~Icre~l~aL~fLH~~gIi 391 (550)
T KOG0578|consen 351 ---------YMEGGSLTDVVTK------------------------------TRMTEGQIAAICREILQGLKFLHARGII 391 (550)
T ss_pred ---------ecCCCchhhhhhc------------------------------ccccHHHHHHHHHHHHHHHHHHHhccee
Confidence 8888998776531 2367889999999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|||||.+|||++.+|. +||+|||+|..+..... ...+.+|||.|||||++....|+.++||||||++++||+.|
T Consensus 392 HrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~---KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG- 465 (550)
T KOG0578|consen 392 HRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQS---KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG- 465 (550)
T ss_pred eeccccceeEeccCCc--EEEeeeeeeeccccccC---ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC-
Confidence 9999999999999987 99999999998876432 55678899999999999999999999999999999999998
Q ss_pred CCCCC-CchhhHHH-HHhhcc--ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 709 KHPYG-ESFERDAN-IVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 709 ~~Pf~-~~~~~~~~-~~~~~~--~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
.+||- +..-+... +..+.. ...+...+++++|++.+||+.|+++|+++.|+|+||||.
T Consensus 466 EPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 466 EPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred CCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 56664 44333332 222222 233556789999999999999999999999999999994
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=354.28 Aligned_cols=260 Identities=25% Similarity=0.346 Sum_probs=209.3
Q ss_pred ccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
..+.|.+.++||.|.-++||+| ....+..||||++.-... +...+|++ .++.++|||||+++..|..+..+|+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~-~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQ-TMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHH-HhhhcCCCCcceEEEEEEecceeEEe
Confidence 3567888999999999999998 456789999999954332 33456665 56889999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|. ||..||+.+.+... -..++++..+..|++++++||.|||.+
T Consensus 103 mp----------fMa~GS~ldIik~~---------------------------~~~Gl~E~~Ia~iLre~LkaL~YLH~~ 145 (516)
T KOG0582|consen 103 MP----------FMAGGSLLDIIKTY---------------------------YPDGLEEASIATILREVLKALDYLHQN 145 (516)
T ss_pred eh----------hhcCCcHHHHHHHH---------------------------ccccccHHHHHHHHHHHHHHHHHHHhc
Confidence 99 99999998887532 234688999999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCcccccc-ccCCCCccccCchhhcc--CCCCCcchhhhhHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-ATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILF 702 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~-~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGviL~ 702 (902)
|.||||||+.||||+.+|. +||+|||.+..+.......... .+.+||+.|||||++.. ..|+.|+||||||++..
T Consensus 146 G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 146 GHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITAC 223 (516)
T ss_pred CceecccccccEEEcCCCc--EEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHH
Confidence 9999999999999999988 9999999887665433222222 67789999999999654 35899999999999999
Q ss_pred HHHhCCCCCCCCchhhHHHHHhhccccc-----------cccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcchh
Q 002601 703 FCITGGKHPYGESFERDANIVKDRKDLF-----------LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 771 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~~~~~~~~~~~~-----------~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~~ 771 (902)
||.+| ..||.+......-.++-..... .......++.+|..||+.||.+|||++++++|+||+....+
T Consensus 224 ELA~G-~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 224 ELAHG-HAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred HHhcC-CCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 99998 8899875543332222211111 11234578899999999999999999999999999775543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=339.93 Aligned_cols=256 Identities=26% Similarity=0.381 Sum_probs=201.8
Q ss_pred cceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccC----CchHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 472 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.+.|.+.++||+|.|..||+. ...+|+.+|+|++.-. +.-+.++++..+...++|||||+|.....+..+.|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 345666788999999999975 5677888998876321 22233444445788999999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| .|.+|.|..-+-.+ ..+++..+..+++||+.||.|+|.++
T Consensus 90 e----------~m~G~dl~~eIV~R-----------------------------~~ySEa~aSH~~rQiLeal~yCH~n~ 130 (355)
T KOG0033|consen 90 D----------LVTGGELFEDIVAR-----------------------------EFYSEADASHCIQQILEALAYCHSNG 130 (355)
T ss_pred e----------cccchHHHHHHHHH-----------------------------HHHHHHHHHHHHHHHHHHHHHHHhcC
Confidence 9 66677665544222 12355667889999999999999999
Q ss_pred ccccccccceeEecc-CCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 627 LIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 627 IvHrDLKp~NILL~~-d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
|||||+||+|+||-. +...-+||+|||+|..+.++ ..-...+|||+|||||++...+|+..+|||+.|||||-++
T Consensus 131 IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g----~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 131 IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG----EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 206 (355)
T ss_pred ceeccCChhheeeeeccCCCceeecccceEEEeCCc----cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence 999999999999953 33345999999999988743 2224567999999999999999999999999999999999
Q ss_pred hCCCCCCCCchhhHHHHHhhccccc----cccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcch
Q 002601 706 TGGKHPYGESFERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 770 (902)
Q Consensus 706 tG~~~Pf~~~~~~~~~~~~~~~~~~----~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~ 770 (902)
.|..|+|+++..+....+......+ ....++++++||++||..||.+|.|+.|+|+|||..+.+.
T Consensus 207 ~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 207 VGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred hCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 9855555557777665444433332 3346789999999999999999999999999999876543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=353.41 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=198.6
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----c-hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+.+.||+|+||+||++.. .+|+.||||++.... . ....+|+ .++..++||||+++++++.+++..|+||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK-RVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHH-HHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 466788999999999999855 468999999986432 1 1233444 4778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++.. .+.+++..+..++.||+.||+|||++|
T Consensus 81 e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ 121 (291)
T cd05612 81 E----------YVPGGELFSYLRN-----------------------------SGRFSNSTGLFYASEIVCALEYLHSKE 121 (291)
T ss_pred e----------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 6666777666532 123567778899999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
|+||||||+|||++.++. +||+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 122 i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~ 193 (291)
T cd05612 122 IVYRDLKPENILLDKEGH--IKLTDFGFAKKLRDR------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLV 193 (291)
T ss_pred eeecCCCHHHeEECCCCC--EEEEecCcchhccCC------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999988776 999999999876432 224568999999999998889999999999999999999
Q ss_pred CCCCCCCCch-hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCcc
Q 002601 707 GGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 769 (902)
Q Consensus 707 G~~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~~ 769 (902)
| ..||.... ......+......++...+++++++|++||+.||.+||+ ++++++||||...+
T Consensus 194 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 261 (291)
T cd05612 194 G-YPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVD 261 (291)
T ss_pred C-CCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCC
Confidence 8 66775543 222333333344455667889999999999999999995 99999999996543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=359.95 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=197.1
Q ss_pred eeecccCceEEEEEE-eeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++. ..+|+.||||++.+.. .....+|+. ++..++||||+++++++.+++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e---- 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR-VLQNTRHPFLTALKYSFQTHDRLCFVME---- 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHH-HHHhCCCCCCCCEEEEEEcCCEEEEEEe----
Confidence 369999999999985 4578999999986531 112334544 6688899999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.||+|||
T Consensus 76 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrD 120 (323)
T cd05571 76 ------YANGGELFFHLSR-----------------------------ERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120 (323)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 6666777666532 23467788899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 121 lkp~NIll~~~~~--~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P 194 (323)
T cd05571 121 LKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (323)
T ss_pred CCHHHEEECCCCC--EEEeeCCCCcccccCC---CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcC-CCC
Confidence 9999999988776 8999999987543211 122345699999999999999999999999999999999998 666
Q ss_pred CCC-chhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcch
Q 002601 712 YGE-SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 770 (902)
Q Consensus 712 f~~-~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~~ 770 (902)
|.. ........+......++...++++.++|.+||+.||++|| ++.++++||||.+.+.
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~ 259 (323)
T cd05571 195 FYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259 (323)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 654 3333334443444455667889999999999999999999 8999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=359.61 Aligned_cols=249 Identities=26% Similarity=0.364 Sum_probs=199.7
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .+...+|+. ++..++||||+++++++.+++..|+|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKS-ILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHH-HHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 4577889999999999999855 468999999986432 122344554 67888999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+++|+|.+++.. ...+++..+..++.||+.||+|||++
T Consensus 97 ~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~ 137 (329)
T PTZ00263 97 LE----------FVVGGELFTHLRK-----------------------------AGRFPNDVAKFYHAELVLAFEYLHSK 137 (329)
T ss_pred Ec----------CCCCChHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 5556666665532 13456777889999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+|+||||||+|||++.++. +||+|||+++..... ..+.+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 138 ~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 209 (329)
T PTZ00263 138 DIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPDR------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209 (329)
T ss_pred CeeecCCCHHHEEECCCCC--EEEeeccCceEcCCC------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH
Confidence 9999999999999988876 999999999876432 12456999999999999999999999999999999999
Q ss_pred hCCCCCCCCc-hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCcch
Q 002601 706 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 770 (902)
Q Consensus 706 tG~~~Pf~~~-~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~~~ 770 (902)
+| ..||... .......+......++...++++.+||.+||+.||.+|++ ++++++||||.+.+.
T Consensus 210 tg-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~ 279 (329)
T PTZ00263 210 AG-YPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANW 279 (329)
T ss_pred cC-CCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCH
Confidence 98 6676543 2222333333333455567789999999999999999987 799999999976443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=332.41 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=196.7
Q ss_pred EEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|...++||+|.||.||+| +..+|+.||||+++... ...+.+|+. +++.++|+||+.++++|.+.+.+-||+||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK-~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIK-LLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHH-HHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 344578999999999998 56789999999986543 346899997 56888999999999999999999999998
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
++.+|+..|. -+...+...++..++.++++||+|||++.|+
T Consensus 83 m~tdLe~vIk---------------------------------------d~~i~l~pa~iK~y~~m~LkGl~y~H~~~Il 123 (318)
T KOG0659|consen 83 MPTDLEVVIK---------------------------------------DKNIILSPADIKSYMLMTLKGLAYCHSKWIL 123 (318)
T ss_pred ccccHHHHhc---------------------------------------ccccccCHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 8888776651 1123466778899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG 707 (902)
||||||.|+||+.+|. +||+|||+|+.+........ ..+-|..|.|||.+.+. .|+..+||||.|||+.||+-|
T Consensus 124 HRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~~---~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr 198 (318)
T KOG0659|consen 124 HRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQT---HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR 198 (318)
T ss_pred cccCCccceEEcCCCc--EEeecccchhccCCCCcccc---cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc
Confidence 9999999999999987 99999999998875433222 22569999999998875 589999999999999999987
Q ss_pred CCCCCCC-chhhHHHHH-hh---------------------c--c----ccccccCChHHHHHHHcccCCCCCCCcCHHH
Q 002601 708 GKHPYGE-SFERDANIV-KD---------------------R--K----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 758 (902)
Q Consensus 708 ~~~Pf~~-~~~~~~~~~-~~---------------------~--~----~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~e 758 (902)
.|.|.+ +.-.+..++ .. . . .......++++.||+.+||..||.+|++++|
T Consensus 199 -~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~q 277 (318)
T KOG0659|consen 199 -VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQ 277 (318)
T ss_pred -CCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHH
Confidence 544443 222221111 10 0 0 0011223567899999999999999999999
Q ss_pred HHcCCCCCCc
Q 002601 759 VLNHPFFWTA 768 (902)
Q Consensus 759 lL~HPfF~~~ 768 (902)
+++||||.+.
T Consensus 278 aL~~~yf~~~ 287 (318)
T KOG0659|consen 278 ALKHPYFKSL 287 (318)
T ss_pred HhcchhhhcC
Confidence 9999999763
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=353.87 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=215.9
Q ss_pred ccccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccce
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~ 542 (902)
.+|...|.+.+.||+|.|..|-+| +.++|..||||++.++.. ...++|+.+ |+.++|||||+||.+......+
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRC-MKLVQHpNiVRLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRC-MKLVQHPNIVRLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHH-HHHhcCcCeeeeeehhcccceE
Confidence 466778899999999999999887 678999999999987653 356888875 5889999999999999999999
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|||+|+-+ +|+|++++... ..++.+..+.+++.||+.|+.|+
T Consensus 93 yLiLELGD----------~GDl~DyImKH----------------------------e~Gl~E~La~kYF~QI~~AI~YC 134 (864)
T KOG4717|consen 93 YLILELGD----------GGDLFDYIMKH----------------------------EEGLNEDLAKKYFAQIVHAISYC 134 (864)
T ss_pred EEEEEecC----------CchHHHHHHhh----------------------------hccccHHHHHHHHHHHHHHHHHH
Confidence 99999554 45555555332 24577788899999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCC-CcchhhhhHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT-RAIDLFSLGCIL 701 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGviL 701 (902)
|+.++|||||||+||.+-+.-. -+||+|||++..+..+ .+..+.||+..|.|||++.+..|+ +++|||||||||
T Consensus 135 HqLHVVHRDLKPENVVFFEKlG-lVKLTDFGFSNkf~PG----~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVIL 209 (864)
T KOG4717|consen 135 HQLHVVHRDLKPENVVFFEKLG-LVKLTDFGFSNKFQPG----KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVIL 209 (864)
T ss_pred hhhhhhcccCCcceeEEeeecC-ceEeeeccccccCCCc----chhhcccchhhccCchhhhcCccCCcchhhhHHHHHH
Confidence 9999999999999998876543 3899999999887754 455788999999999999999985 799999999999
Q ss_pred HHHHhCCCCCCCCchhhH-HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcchh
Q 002601 702 FFCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 771 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~~ 771 (902)
|.|++| .+||.+..+.+ ..++..-+...|...+.|++|||..||+.||.+|.+++|+..|+|++..+.-
T Consensus 210 yMLVCG-q~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 210 YMLVCG-QPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHhC-CCccccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 999987 88998754433 3444455556777888999999999999999999999999999999765543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=342.84 Aligned_cols=242 Identities=23% Similarity=0.373 Sum_probs=190.6
Q ss_pred eEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecc-cccCccc-eeee
Q 002601 474 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYG-VESDQDF-VYLS 545 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g-~~~d~~~-~yLV 545 (902)
.|.+.++||+|+||+||++ .+.+|..||.|.+.=.. .+...+|+. +++.++|||||++++ .+.+++. ++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~-lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEIS-LLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHH-HHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3455678999999999997 67899999999875221 234566765 789999999999999 4555555 8999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc-
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE- 624 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~- 624 (902)
||+|. .|+|.+.+.... -..+.+|++.+++++.|+++||+++|+
T Consensus 99 mE~c~----------~GDLsqmIk~~K-------------------------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~ 143 (375)
T KOG0591|consen 99 MELCD----------AGDLSQMIKHFK-------------------------KQKRLIPEKTVWKYFVQLCRALYHCHSK 143 (375)
T ss_pred HHhhc----------ccCHHHHHHHHH-------------------------hccccCchHHHHHHHHHHHHHHHHHhcc
Confidence 99554 567766653221 123558999999999999999999999
Q ss_pred -cc--ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHH
Q 002601 625 -IG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 625 -~~--IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL 701 (902)
.. |+||||||.||+|+.+|. +||+||||++.+.... ....+.+|||.||+||.+...+|+.++||||+||++
T Consensus 144 ~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r~l~s~~---tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCll 218 (375)
T KOG0591|consen 144 IPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGRFLSSKT---TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLL 218 (375)
T ss_pred ccccceeeccCcchheEEcCCCc--eeeccchhHhHhcchh---HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHH
Confidence 44 999999999999988876 9999999999987643 334567899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchhhH-HHHHhhcccccc-ccCChHHHHHHHcccCCCCCCCcCH
Q 002601 702 FFCITGGKHPYGESFERD-ANIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKA 756 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~-~~~~~~~~~~~~-~~~~~e~~dLI~~~L~~dP~~Rpt~ 756 (902)
|||+.-..|+++++.... .+|........+ ...+.++..||..|+.+||+.||+.
T Consensus 219 yEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 219 YEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 999997444444443333 344444333344 4567899999999999999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=332.51 Aligned_cols=248 Identities=26% Similarity=0.388 Sum_probs=209.1
Q ss_pred ceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
+.|..++.||+|-||.||+|. ..++-.||+|++.+.+. .+..+|++ +.+.++||||+++|++|.|+...||+
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiE-Iqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIE-IQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeE-eecccCCccHHhhhhheeccceeEEE
Confidence 446678899999999999984 45678999999976532 23445554 77899999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
+| |.++|++...|... +...+++.....++.|+|.||.|+|..
T Consensus 101 lE----------ya~~gel~k~L~~~---------------------------~~~~f~e~~~a~Yi~q~A~Al~y~h~k 143 (281)
T KOG0580|consen 101 LE----------YAPRGELYKDLQEG---------------------------RMKRFDEQRAATYIKQLANALLYCHLK 143 (281)
T ss_pred EE----------ecCCchHHHHHHhc---------------------------ccccccccchhHHHHHHHHHHHHhccC
Confidence 99 88999998887422 224467777889999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+||||||||+|+|++.++. +||+|||-+...+ .....+.|||..|.+||+..+..++..+|+|++|++.||++
T Consensus 144 ~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl 216 (281)
T KOG0580|consen 144 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL 216 (281)
T ss_pred CcccCCCCHHHhccCCCCC--eeccCCCceeecC-----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH
Confidence 9999999999999998887 8999999887654 23557889999999999999999999999999999999999
Q ss_pred hCCCCCCCCchhhH-HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 706 TGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 706 tG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
.| .+||....... ...+......++...+.++.|+|.+||..+|.+|.+..|++.|||..
T Consensus 217 vg-~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 217 VG-LPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred hc-CCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 98 78887654332 34444444556777889999999999999999999999999999973
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=346.77 Aligned_cols=250 Identities=24% Similarity=0.372 Sum_probs=197.5
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|...+.||+|+||+||++.. .+|+.||||.+.+... ....+|+ .++..++|+||+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-RILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHH-HHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 45668899999999999854 6799999999864321 1233454 46788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|..++... ....+++..+..++.|++.||+|||+.+|
T Consensus 81 ----------~~~~g~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05631 81 ----------IMNGGDLKFHIYNM---------------------------GNPGFDEQRAIFYAAELCCGLEDLQRERI 123 (285)
T ss_pred ----------ecCCCcHHHHHHhh---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 66667766554311 11246778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+|||++.++. +||+|||++....... ......||..|+|||++.+..++.++|||||||++|||++|
T Consensus 124 iH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 197 (285)
T cd05631 124 VYRDLKPENILLDDRGH--IRISDLGLAVQIPEGE----TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG 197 (285)
T ss_pred EeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCC----eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhC
Confidence 99999999999987765 8999999998754321 11234689999999999999999999999999999999997
Q ss_pred CCCCCCCchhh-----HHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCcc
Q 002601 708 GKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 769 (902)
Q Consensus 708 ~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~~ 769 (902)
.+||...... ....+......++...++++.+||++||+.||.+||+ ++++++||||.+.+
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 198 -QSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred -CCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 7788654321 1122222233445567889999999999999999997 89999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=344.01 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=188.8
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
.|.+.+.||+|+||+||++.. .+++.||+|++.... .....+|+. +++.++||||+++++++.+++..|+|||+
T Consensus 6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS-LLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHH-HHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 467789999999999999854 468999999986432 224456765 66889999999999999999999999997
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|.++|.+++ .. ....+++..+..++.||+.||+|||++||+
T Consensus 85 ~~~~l~~~l-----------~~----------------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 125 (288)
T cd07871 85 LDSDLKQYL-----------DN----------------------------CGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125 (288)
T ss_pred CCcCHHHHH-----------Hh----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 766555443 11 012346677889999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHhC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~elltG 707 (902)
||||||+|||++.++. +||+|||+++....... ......|++.|+|||++.+ ..++.++||||+||++|+|++|
T Consensus 126 H~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g 200 (288)
T cd07871 126 HRDLKPQNLLINEKGE--LKLADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATG 200 (288)
T ss_pred cCCCCHHHEEECCCCC--EEECcCcceeeccCCCc---cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhC
Confidence 9999999999988876 99999999976543211 1233458999999999875 4689999999999999999998
Q ss_pred CCCCCCCchh-hHHH-HHhhc------------------cccc-----------cccCChHHHHHHHcccCCCCCCCcCH
Q 002601 708 GKHPYGESFE-RDAN-IVKDR------------------KDLF-----------LVEHIPEAVDLFTRLLDPNPDLRPKA 756 (902)
Q Consensus 708 ~~~Pf~~~~~-~~~~-~~~~~------------------~~~~-----------~~~~~~e~~dLI~~~L~~dP~~Rpt~ 756 (902)
.+||..... .... +.... ...+ ....+++++|||.+||+.||.+|||+
T Consensus 201 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~ 279 (288)
T cd07871 201 -RPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA 279 (288)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH
Confidence 667754322 1111 10000 0000 11345789999999999999999999
Q ss_pred HHHHcCCCC
Q 002601 757 QNVLNHPFF 765 (902)
Q Consensus 757 ~elL~HPfF 765 (902)
+|+++||||
T Consensus 280 ~~~l~hp~f 288 (288)
T cd07871 280 EAALRHSYF 288 (288)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=347.33 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=192.2
Q ss_pred ceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+.|.+.+.||+|+||+||++... +|+.||||++.... .....+|+. +++.++||||+++++++.+.+..|+|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS-LLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHH-HHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 45778899999999999998554 78999999986432 123455654 6688999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
||.++|.+++. . ....+++..+..++.||+.||+|||+++|
T Consensus 84 ~~~~~l~~~~~-----------~----------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i 124 (303)
T cd07869 84 YVHTDLCQYMD-----------K----------------------------HPGGLHPENVKLFLFQLLRGLSYIHQRYI 124 (303)
T ss_pred CCCcCHHHHHH-----------h----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 77766554431 1 11235677789999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHh
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ellt 706 (902)
+||||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 125 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 199 (303)
T cd07869 125 LHRDLKPQNLLISDTGE--LKLADFGLARAKSVPS---HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199 (303)
T ss_pred ecCCCCHHHEEECCCCC--EEECCCCcceeccCCC---ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999988776 8999999987543221 112334689999999998754 57899999999999999999
Q ss_pred CCCCCCCCchhhH--H-HHHh---hcc---------------cc-------------ccccCChHHHHHHHcccCCCCCC
Q 002601 707 GGKHPYGESFERD--A-NIVK---DRK---------------DL-------------FLVEHIPEAVDLFTRLLDPNPDL 752 (902)
Q Consensus 707 G~~~Pf~~~~~~~--~-~~~~---~~~---------------~~-------------~~~~~~~e~~dLI~~~L~~dP~~ 752 (902)
| .+||....... . .+.. ... .. .....++++.+|+.+||+.||++
T Consensus 200 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~ 278 (303)
T cd07869 200 G-VAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKN 278 (303)
T ss_pred C-CCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchh
Confidence 8 77886532111 1 1100 000 00 00113467899999999999999
Q ss_pred CcCHHHHHcCCCCCCcchh
Q 002601 753 RPKAQNVLNHPFFWTADTR 771 (902)
Q Consensus 753 Rpt~~elL~HPfF~~~~~~ 771 (902)
|||++|+++||||.+...+
T Consensus 279 R~s~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 279 RLSAQAALSHEYFSDLPPR 297 (303)
T ss_pred ccCHHHHhcCcccccCChh
Confidence 9999999999999765543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=361.90 Aligned_cols=255 Identities=31% Similarity=0.434 Sum_probs=194.9
Q ss_pred eeeeccccccccccccccceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeE
Q 002601 455 LLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVR 531 (902)
Q Consensus 455 ~~~~~el~~~~~~~~~i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~ 531 (902)
.+++.++ +.+++.|.-.+.||+|+||+||+|.+.+|+.||||++..... .+...|+. ++.+++|||+|+
T Consensus 64 ~fs~~el-------~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~-~ls~l~H~Nlv~ 135 (361)
T KOG1187|consen 64 SFSYDEL-------RKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVE-ILSRLRHPNLVK 135 (361)
T ss_pred eeeHHHH-------HHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHH-HHhcCCCcCccc
Confidence 4555555 344566777789999999999999999999999999976543 34555654 778999999999
Q ss_pred ecccccCcc-ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHH
Q 002601 532 WYGVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610 (902)
Q Consensus 532 l~g~~~d~~-~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~ 610 (902)
|+|||.+.+ +.+|||| ||+||+|.++|+..... .++|.++++
T Consensus 136 LlGyC~e~~~~~~LVYE----------ym~nGsL~d~L~~~~~~---------------------------~L~W~~R~k 178 (361)
T KOG1187|consen 136 LLGYCLEGGEHRLLVYE----------YMPNGSLEDHLHGKKGE---------------------------PLDWETRLK 178 (361)
T ss_pred EEEEEecCCceEEEEEE----------ccCCCCHHHHhCCCCCC---------------------------CCCHHHHHH
Confidence 999999999 5999999 99999999999864320 467888899
Q ss_pred HHHhhhccccccccc---cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccC-CCCccccCchhhccC
Q 002601 611 VTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG-YGSSGWQAPEQLLQG 686 (902)
Q Consensus 611 I~~qIa~gL~yLH~~---~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~-~Gt~~Y~APE~l~~~ 686 (902)
|+.++|+||+|||+. .||||||||+|||||++ +.+||+|||+|+..... .....+. .||.+|+|||+...+
T Consensus 179 Ia~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~--~~aKlsDFGLa~~~~~~---~~~~~~~~~gt~gY~~PEy~~~g 253 (361)
T KOG1187|consen 179 IALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED--FNAKLSDFGLAKLGPEG---DTSVSTTVMGTFGYLAPEYASTG 253 (361)
T ss_pred HHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC--CCEEccCccCcccCCcc---ccceeeecCCCCccCChhhhccC
Confidence 999999999999986 49999999999999766 55999999999765431 1111222 699999999999999
Q ss_pred CCCCcchhhhhHHHHHHHHhCCCCCCCCch----hhHH----HHHhhc------ccccc-ccCC-----hHHHHHHHccc
Q 002601 687 RQTRAIDLFSLGCILFFCITGGKHPYGESF----ERDA----NIVKDR------KDLFL-VEHI-----PEAVDLFTRLL 746 (902)
Q Consensus 687 ~~s~ksDVwSlGviL~elltG~~~Pf~~~~----~~~~----~~~~~~------~~~~~-~~~~-----~e~~dLI~~~L 746 (902)
..+.|+|||||||+|.|++||++ +.+... .... ..+... ..... .... ..+..+..+|+
T Consensus 254 ~lt~KsDVySFGVvllElitgr~-~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~ 332 (361)
T KOG1187|consen 254 KLTEKSDVYSFGVVLLELITGRK-AVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCL 332 (361)
T ss_pred CcCcccccccchHHHHHHHhCCc-ccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHc
Confidence 99999999999999999999954 443221 0000 111110 00000 1112 23557888999
Q ss_pred CCCCCCCcCHHHHH
Q 002601 747 DPNPDLRPKAQNVL 760 (902)
Q Consensus 747 ~~dP~~Rpt~~elL 760 (902)
+.+|..||+|.||+
T Consensus 333 ~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 333 RPDPKERPTMSQVV 346 (361)
T ss_pred CcCCCcCcCHHHHH
Confidence 99999999999974
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=355.41 Aligned_cols=249 Identities=28% Similarity=0.383 Sum_probs=199.1
Q ss_pred ceEEEeeeecccCceEEEEEEeeC--CcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~--g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
+.|.+.+.||+|+||.||+|.... +..||||++.+.. .....+|+ .++..++|||||++++++.+++..|+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER-KILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHH-HHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457788999999999999986433 3689999985421 12233454 47788999999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||| |+++|+|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 109 v~E----------y~~~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~ 149 (340)
T PTZ00426 109 VLE----------FVIGGEFFTFLRR-----------------------------NKRFPNDVGCFYAAQIVLIFEYLQS 149 (340)
T ss_pred EEe----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 5566777666532 1346777889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
.+|+||||||+|||++.++. +||+|||+++..... ..+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus 150 ~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 221 (340)
T PTZ00426 150 LNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDTR------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221 (340)
T ss_pred CCeEccCCCHHHEEECCCCC--EEEecCCCCeecCCC------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHH
Confidence 99999999999999988776 999999999865432 2345699999999999988899999999999999999
Q ss_pred HhCCCCCCCCchh-hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcch
Q 002601 705 ITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 770 (902)
Q Consensus 705 ltG~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~~ 770 (902)
++| .+||..... .....+......++...++++.++|++||+.||++|+ +++++++||||.+.+.
T Consensus 222 l~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~ 292 (340)
T PTZ00426 222 LVG-CPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW 292 (340)
T ss_pred hcC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence 998 667765432 2233333333345666788999999999999999995 8999999999976543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=350.44 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=188.2
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCc-----ccee
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFVY 543 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~-----~~~y 543 (902)
|.+.+.||+|+||.||++. ..+|+.||||++.... .....+|+. +++.++||||+++++++... ...|
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK-LLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHH-HHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6778999999999999985 4578999999986421 123456665 66889999999999987533 3479
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+|||||.++|.+++ . ....+++..+..++.||+.||+|||
T Consensus 81 lv~e~~~~~L~~~l-----------~-----------------------------~~~~~~~~~~~~i~~qi~~aL~~LH 120 (338)
T cd07859 81 VVFELMESDLHQVI-----------K-----------------------------ANDDLTPEHHQFFLYQLLRALKYIH 120 (338)
T ss_pred EEEecCCCCHHHHH-----------H-----------------------------hcccCCHHHHHHHHHHHHHHHHHHH
Confidence 99997766555443 1 1123677788999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc--CCCCCcchhhhhHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCIL 701 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGviL 701 (902)
+++|+||||||+|||++.++. +||+|||+++................||+.|+|||++.+ ..++.++|||||||++
T Consensus 121 ~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl 198 (338)
T cd07859 121 TANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 198 (338)
T ss_pred HCCeecCCCCHHHeEECCCCc--EEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHH
Confidence 999999999999999988776 999999999865432221112234568999999999876 5789999999999999
Q ss_pred HHHHhCCCCCCCCchhh-HHHH------------------------Hhh---cc-cc---ccccCChHHHHHHHcccCCC
Q 002601 702 FFCITGGKHPYGESFER-DANI------------------------VKD---RK-DL---FLVEHIPEAVDLFTRLLDPN 749 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~-~~~~------------------------~~~---~~-~~---~~~~~~~e~~dLI~~~L~~d 749 (902)
|||++| ++||...... .... ... .. .. .....++++.++|.+||+.|
T Consensus 199 ~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 277 (338)
T cd07859 199 AEVLTG-KPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFD 277 (338)
T ss_pred HHHHcC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcC
Confidence 999998 6777543211 0000 000 00 00 01234578899999999999
Q ss_pred CCCCcCHHHHHcCCCCCCcc
Q 002601 750 PDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 750 P~~Rpt~~elL~HPfF~~~~ 769 (902)
|++||+++|+++||||....
T Consensus 278 P~~Rpt~~e~l~hp~f~~~~ 297 (338)
T cd07859 278 PKDRPTAEEALADPYFKGLA 297 (338)
T ss_pred cccCCCHHHHhcCchhhhcC
Confidence 99999999999999996533
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=349.83 Aligned_cols=258 Identities=29% Similarity=0.425 Sum_probs=201.0
Q ss_pred ccccccccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC-----------------chHHHHHHHHHHHhCCC
Q 002601 465 RVDGRRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----------------HDVALKEIQNLIASDQH 526 (902)
Q Consensus 465 ~~~~~~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~-----------------~~~~~~Ei~~ll~~l~H 526 (902)
..+.+..-++|.+.+.||+|.||.|-+|. ..+++.||||++.+.. .+...+||. +++++.|
T Consensus 89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIa-ilKkl~H 167 (576)
T KOG0585|consen 89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIA-ILKKLHH 167 (576)
T ss_pred CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHH-HHHhcCC
Confidence 34456667889999999999999999984 4579999999996532 134567776 6799999
Q ss_pred CCeeEecccccC--ccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCC-C
Q 002601 527 PNIVRWYGVESD--QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANG-H 603 (902)
Q Consensus 527 pNIV~l~g~~~d--~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~-l 603 (902)
||||+|+.+..| .+.+|||+|||. .|.+...= .... +
T Consensus 168 ~nVV~LiEvLDDP~s~~~YlVley~s----------~G~v~w~p------------------------------~d~~el 207 (576)
T KOG0585|consen 168 PNVVKLIEVLDDPESDKLYLVLEYCS----------KGEVKWCP------------------------------PDKPEL 207 (576)
T ss_pred cCeeEEEEeecCcccCceEEEEEecc----------CCccccCC------------------------------CCcccc
Confidence 999999999876 567999999664 34332110 0012 6
Q ss_pred CHHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCC--ccccccccCCCCccccCch
Q 002601 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM--SCLTQNATGYGSSGWQAPE 681 (902)
Q Consensus 604 ~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~--~~~~~~~~~~Gt~~Y~APE 681 (902)
.+.++++|+++++.||+|||.+|||||||||+|+||+.+|. +||+|||.+..+.... ....+....+|||.|+|||
T Consensus 208 s~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE 285 (576)
T KOG0585|consen 208 SEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPE 285 (576)
T ss_pred cHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeeccceeeecccCCccccHHHHhhcCCCccccchH
Confidence 77899999999999999999999999999999999998876 9999999998774321 1122233467999999999
Q ss_pred hhccCC----CCCcchhhhhHHHHHHHHhCCCCCCCCc-hhhHHHHHhhcccccccc--CChHHHHHHHcccCCCCCCCc
Q 002601 682 QLLQGR----QTRAIDLFSLGCILFFCITGGKHPYGES-FERDANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRP 754 (902)
Q Consensus 682 ~l~~~~----~s~ksDVwSlGviL~elltG~~~Pf~~~-~~~~~~~~~~~~~~~~~~--~~~e~~dLI~~~L~~dP~~Rp 754 (902)
.+..+. .+.+.||||+||+||.|+.| ..||-+. .......+......++.. ..++++|||.+||++||++|.
T Consensus 286 ~c~~~~~~~~~g~a~DiWalGVTLYCllfG-~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri 364 (576)
T KOG0585|consen 286 LCSGGNSFSYSGFALDIWALGVTLYCLLFG-QLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRI 364 (576)
T ss_pred hhcCCCCccccchhhhhhhhhhhHHHhhhc-cCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhhee
Confidence 998743 36899999999999999998 5555544 334445555554455543 578999999999999999999
Q ss_pred CHHHHHcCCCCC
Q 002601 755 KAQNVLNHPFFW 766 (902)
Q Consensus 755 t~~elL~HPfF~ 766 (902)
++.++..|||..
T Consensus 365 ~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 365 TLPDIKLHPWVT 376 (576)
T ss_pred ehhhheecceec
Confidence 999999999974
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=333.80 Aligned_cols=247 Identities=25% Similarity=0.408 Sum_probs=199.3
Q ss_pred eEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC-----------chHHHHHHHHHHHhCCCCCeeEecccccCccc
Q 002601 474 LVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----------HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~-----------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~ 541 (902)
.|.-.+.||+|..++|.+. ...+|.+.|||++.... .+...+|+..+.+...||||+.+.++++.+.+
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 3445578999999988775 56789999999985321 12345677777788899999999999999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
+++|+| .|+.|.|.++|... ..++++..++||+|+..|++|
T Consensus 98 ~FlVFd----------l~prGELFDyLts~-----------------------------VtlSEK~tR~iMrqlfegVey 138 (411)
T KOG0599|consen 98 VFLVFD----------LMPRGELFDYLTSK-----------------------------VTLSEKETRRIMRQLFEGVEY 138 (411)
T ss_pred hhhhhh----------hcccchHHHHhhhh-----------------------------eeecHHHHHHHHHHHHHHHHH
Confidence 999999 77889999988543 236778889999999999999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc------CCCCCcchhh
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ------GRQTRAIDLF 695 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~------~~~s~ksDVw 695 (902)
||.++||||||||+|||++++.+ +||+|||+|+.+..+ ......||||+|.|||.+.. ..|+..+|+|
T Consensus 139 lHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~~G----ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~W 212 (411)
T KOG0599|consen 139 LHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLEPG----EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEW 212 (411)
T ss_pred HHHhhhhhcccChhheeeccccc--eEEeccceeeccCCc----hhHHHhcCCCcccChhheeeecccCCCCccchhhHH
Confidence 99999999999999999976655 999999999998764 33456789999999999864 3578899999
Q ss_pred hhHHHHHHHHhCCCCCCCCchh-hHHHHHhhccccc----cccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 696 SLGCILFFCITGGKHPYGESFE-RDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 696 SlGviL~elltG~~~Pf~~~~~-~~~~~~~~~~~~~----~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
|+|||||-++.| -+||....+ -...++...+..| ..+.+.+++|||.+||+.||.+|.|++|+|.||||.
T Consensus 213 a~GVImyTLLaG-cpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 213 ACGVIMYTLLAG-CPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHHHHHHHHcC-CCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 999999999998 555544322 2333333333333 234567899999999999999999999999999993
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=349.38 Aligned_cols=242 Identities=29% Similarity=0.387 Sum_probs=192.9
Q ss_pred ecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 481 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 481 LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
||+|+||+||++.. .+++.||+|++.+.. .....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e------ 73 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERT-VLAQVNCPFIVPLKFSFQSPEKLYLVLA------ 73 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhCCCCcEeceeeEEecCCeEEEEEc------
Confidence 79999999999854 468899999986421 112334544 6678899999999999999999999999
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+|||||
T Consensus 74 ----~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlk 120 (312)
T cd05585 74 ----FINGGELFHHLQR-----------------------------EGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120 (312)
T ss_pred ----CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCC
Confidence 5666777666532 1236677889999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
|+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+||.
T Consensus 121 p~Nili~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~pf~ 194 (312)
T cd05585 121 PENILLDYQGH--IALCDFGLCKLNMKDD---DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG-LPPFY 194 (312)
T ss_pred HHHeEECCCCc--EEEEECcccccCccCC---CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhC-CCCcC
Confidence 99999988776 9999999998643221 122345699999999999999999999999999999999998 66775
Q ss_pred Cc-hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc---CHHHHHcCCCCCCc
Q 002601 714 ES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP---KAQNVLNHPFFWTA 768 (902)
Q Consensus 714 ~~-~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp---t~~elL~HPfF~~~ 768 (902)
.. .......+......++...++++.++|.+||+.||.+|| ++.|+++||||...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 195 DENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 43 333333333334445666788999999999999999997 58999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=352.80 Aligned_cols=246 Identities=26% Similarity=0.361 Sum_probs=196.2
Q ss_pred eeecccCceEEEEEE-eeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++. ..+|+.||||++.+.. .....+|+ .+++.++||||+++++++.+++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~iv~~~~~~~~~~~~~lv~E---- 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTES-RVLKNTRHPFLTSLKYSFQTKDRLCFVME---- 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCcceEEEEEcCCEEEEEEe----
Confidence 369999999999984 4578999999986532 11234454 46788999999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. ...+++.++..++.||+.||+|||+++|+|||
T Consensus 76 ------y~~~g~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 120 (328)
T cd05593 76 ------YVNGGELFFHLSR-----------------------------ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120 (328)
T ss_pred ------CCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence 6667777665532 23467788899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++| ..|
T Consensus 121 ikp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG-~~P 194 (328)
T cd05593 121 LKLENLMLDKDGH--IKITDFGLCKEGITDA---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (328)
T ss_pred cCHHHeEECCCCc--EEEecCcCCccCCCcc---cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC-CCC
Confidence 9999999988776 8999999987543221 122345699999999999988999999999999999999998 667
Q ss_pred CCCc-hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcch
Q 002601 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 770 (902)
Q Consensus 712 f~~~-~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~~ 770 (902)
|... .......+......++...++++.++|.+||+.||.+|+ ++.++++||||...+.
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~ 259 (328)
T cd05593 195 FYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259 (328)
T ss_pred CCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 7543 333333333334445667788999999999999999997 8999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.15 Aligned_cols=243 Identities=26% Similarity=0.407 Sum_probs=197.5
Q ss_pred EEeeeecccCceEEEEEEeeCCcEEEEEEeccCC-c-hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 476 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~-~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
.+.+.||+|-||.||++.......||||.++... . +...+|+ .+|..++|+|||+|+|+|..++.+|||||
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea-~iMk~L~H~~lV~l~gV~~~~~piyIVtE------ 281 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREA-QIMKKLRHEKLVKLYGVCTKQEPIYIVTE------ 281 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHH-HHHHhCcccCeEEEEEEEecCCceEEEEE------
Confidence 3557899999999999766666699999997643 2 3444455 57899999999999999999999999999
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
||++|+|.++|...+. ..+...+++.++.|||+|++||+++++|||||.
T Consensus 282 ----~m~~GsLl~yLr~~~~---------------------------~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLA 330 (468)
T KOG0197|consen 282 ----YMPKGSLLDYLRTREG---------------------------GLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLA 330 (468)
T ss_pred ----ecccCcHHHHhhhcCC---------------------------CccchHHHHHHHHHHHHHHHHHHhCCccchhhh
Confidence 9999999999965222 345677889999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
++||||+++. ++||+|||||+...++. ........-...|.|||.+..+.++.|||||||||+||||+|-|+.||.
T Consensus 331 ARNiLV~~~~--~vKIsDFGLAr~~~d~~--Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 331 ARNILVDEDL--VVKISDFGLARLIGDDE--YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred hhheeeccCc--eEEEcccccccccCCCc--eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 9999997764 69999999999554432 2222222245679999999999999999999999999999999999988
Q ss_pred Cchh-hHHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 714 ESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 714 ~~~~-~~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
.... +....++.. .-..|..+++++-+++..||+.+|++|||.+.+.
T Consensus 407 ~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 407 GMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 7543 333444443 4445667888999999999999999999998653
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=351.61 Aligned_cols=246 Identities=27% Similarity=0.379 Sum_probs=196.0
Q ss_pred eeecccCceEEEEEE-eeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++. ..+|+.||+|++.+.. .....+|+ .++..++||||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~i~~~~~~~~~~~~~~lv~E---- 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES-RVLQNTRHPFLTALKYAFQTHDRLCFVME---- 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHH-HHHHhCCCCCCcceeeEEecCCEEEEEEe----
Confidence 369999999999985 4578999999986531 11223444 46788899999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. ...+++..++.++.||+.||+|||++||+|||
T Consensus 76 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 120 (323)
T cd05595 76 ------YANGGELFFHLSR-----------------------------ERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120 (323)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 6667777665532 23467788899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 121 lkp~NIll~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g-~~P 194 (323)
T cd05595 121 IKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLP 194 (323)
T ss_pred CCHHHEEEcCCCC--EEecccHHhccccCCC---CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhC-CCC
Confidence 9999999988776 9999999987543221 112345699999999999988999999999999999999998 667
Q ss_pred CCCc-hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcch
Q 002601 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 770 (902)
Q Consensus 712 f~~~-~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~~ 770 (902)
|... .......+......++...++++.++|.+||+.||.+|+ ++.++++||||.+.+.
T Consensus 195 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~ 259 (323)
T cd05595 195 FYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 259 (323)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCH
Confidence 6543 333333333333345667789999999999999999998 8999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=352.50 Aligned_cols=249 Identities=26% Similarity=0.381 Sum_probs=194.9
Q ss_pred EEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCc--cceeeee
Q 002601 475 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSL 546 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~--~~~yLV~ 546 (902)
|...++||+|.||.||+| ...+|+.||+|++.-.. ...+.+||. ++++++|||||+|.+...+. ..+|||+
T Consensus 119 feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~-ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 119 FEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIK-ILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHH-HHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 344568999999999998 56789999999985433 235788997 67999999999999987766 7899999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
||++.+|.-++. ...-.|++.++..+++|++.||+|||++|
T Consensus 198 eYMdhDL~GLl~---------------------------------------~p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 198 EYMDHDLSGLLS---------------------------------------SPGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred ecccchhhhhhc---------------------------------------CCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 977765544431 11134788899999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ell 705 (902)
|+|||||.+||||+.+|. +||+|||||+.+...... .....+-|..|.|||.+.+. .|+.++|+||.||||.||+
T Consensus 239 vlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~~--~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~ 314 (560)
T KOG0600|consen 239 VLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGSA--PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELF 314 (560)
T ss_pred eeeccccccceEEcCCCC--EEeccccceeeccCCCCc--ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHH
Confidence 999999999999988876 999999999987754322 22344569999999999875 6999999999999999999
Q ss_pred hCCCCCCCCchhhH-H-HHHhh---cc-------c------------------cccccCChHHHHHHHcccCCCCCCCcC
Q 002601 706 TGGKHPYGESFERD-A-NIVKD---RK-------D------------------LFLVEHIPEAVDLFTRLLDPNPDLRPK 755 (902)
Q Consensus 706 tG~~~Pf~~~~~~~-~-~~~~~---~~-------~------------------~~~~~~~~e~~dLI~~~L~~dP~~Rpt 755 (902)
+| ++.|....+.. . .|.+. .. . .....+++.+.+|+..||..||.+|.|
T Consensus 315 ~g-kPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t 393 (560)
T KOG0600|consen 315 LG-KPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT 393 (560)
T ss_pred cC-CCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc
Confidence 98 66776543321 1 11110 00 0 001234567899999999999999999
Q ss_pred HHHHHcCCCCCCc
Q 002601 756 AQNVLNHPFFWTA 768 (902)
Q Consensus 756 ~~elL~HPfF~~~ 768 (902)
+.++|+|+||+..
T Consensus 394 A~~aL~seyF~t~ 406 (560)
T KOG0600|consen 394 ASSALQSEYFTTE 406 (560)
T ss_pred HHHHhcCcccccC
Confidence 9999999999543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=370.98 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=205.3
Q ss_pred eEEEeeeecccCceEEEEEEeeC------CcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~~------g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
.+++.++||+|.||.||+|..+. ...||||.|++.... +.|+.+.++++.++|||||+|+|+|.+++.+|+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 45678899999999999985542 468999999876544 234444468999999999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
|+| ||..|+|.++|........... .+.+ ....+...+.+.|+.|||.|++||-+
T Consensus 567 vFE----------Ym~~GDL~eFLra~sP~a~~~~-----------~g~~----~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 567 VFE----------YMDHGDLHEFLRARSPKADKLA-----------SGQD----TPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred EEE----------ecccccHHHHHHhhCCcccccc-----------CCCC----CCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 8999999999976544322110 0111 13457888999999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
+.+|||||..+|+||.++ +.+||+||||++..-...... ......-..+||+||.+..+++|.++|||||||+|||+
T Consensus 622 ~~FVHRDLATRNCLVge~--l~VKIsDfGLsRdiYssDYYk-~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEI 698 (774)
T KOG1026|consen 622 HHFVHRDLATRNCLVGEN--LVVKISDFGLSRDIYSSDYYK-VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEI 698 (774)
T ss_pred Ccccccchhhhhceeccc--eEEEecccccchhhhhhhhhc-ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhh
Confidence 999999999999999655 679999999999876432222 22122346789999999999999999999999999999
Q ss_pred HhCCCCCCCCc-hhhHHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHH
Q 002601 705 ITGGKHPYGES-FERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 759 (902)
Q Consensus 705 ltG~~~Pf~~~-~~~~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~el 759 (902)
++-|+.||.+. .++....+... --..+..++.++.+|+..||+..|.+||+.+|+
T Consensus 699 FsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 699 FSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred hccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 99889898764 33344444443 344567788899999999999999999999987
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=349.94 Aligned_cols=246 Identities=27% Similarity=0.410 Sum_probs=194.4
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+++.||||++.+.. .....+|+..+....+||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~E---- 76 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVME---- 76 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEc----
Confidence 3699999999999854 468999999986431 12334565545455689999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. ...+++..+..++.|++.||+|||+++|+|||
T Consensus 77 ------y~~~g~L~~~i~~-----------------------------~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~d 121 (320)
T cd05590 77 ------FVNGGDLMFHIQK-----------------------------SRRFDEARARFYAAEITSALMFLHDKGIIYRD 121 (320)
T ss_pred ------CCCCchHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 5566676655532 23467778899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~NIli~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~P 195 (320)
T cd05590 122 LKLDNVLLDHEGH--CKLADFGMCKEGIFNG---KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG-HAP 195 (320)
T ss_pred CCHHHeEECCCCc--EEEeeCCCCeecCcCC---CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhC-CCC
Confidence 9999999988876 8999999987543211 122345699999999999988999999999999999999997 678
Q ss_pred CCCchhh-HHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH------HHHHcCCCCCCcc
Q 002601 712 YGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA------QNVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~~~~-~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~------~elL~HPfF~~~~ 769 (902)
|...... ....+.......+...++++.++|.+||+.||.+||++ +++++||||....
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 196 FEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 7654332 23333333334555678899999999999999999998 8999999996543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=348.19 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=193.1
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||.||++.. .+|+.||||++.+.. ......|+..+....+||||+++++++.++++.|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E---- 76 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVME---- 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEEC----
Confidence 3699999999999854 468999999986531 12344555545456799999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+.+|+|..++.. ...+++..+..++.||+.||+|||++||+|||
T Consensus 77 ------~~~~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrD 121 (316)
T cd05620 77 ------FLNGGDLMFHIQD-----------------------------KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121 (316)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 5556666555432 12356778889999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g-~~P 195 (316)
T cd05620 122 LKLDNVMLDRDGH--IKIADFGMCKENVFGD---NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHeEECCCCC--EEeCccCCCeecccCC---CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhC-CCC
Confidence 9999999988775 9999999987532211 122345699999999999999999999999999999999997 667
Q ss_pred CCCch-hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH-HHHHcCCCCCCcc
Q 002601 712 YGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-QNVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~~-~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~-~elL~HPfF~~~~ 769 (902)
|.... ......+.......+...++++.++|.+||+.||++||++ +++++||||...+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 196 FHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred CCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 75433 2223333333344555678899999999999999999998 5899999996644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=347.97 Aligned_cols=246 Identities=26% Similarity=0.408 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+++.||||++.... .+....|...+....+||||+++++++.+++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e---- 76 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVME---- 76 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc----
Confidence 3699999999999854 468899999986431 12234455444455689999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 77 ------~~~gg~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~d 121 (316)
T cd05592 77 ------YLNGGDLMFHIQS-----------------------------SGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121 (316)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 5666777665532 12467778899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nill~~~~~--~kL~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G-~~P 195 (316)
T cd05592 122 LKLDNVLLDKDGH--IKIADFGMCKENMNGE---GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHeEECCCCC--EEEccCcCCeECCCCC---CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhC-CCC
Confidence 9999999988776 8999999997653321 222345699999999999988999999999999999999997 677
Q ss_pred CCCch-hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHH-HHHcCCCCCCcc
Q 002601 712 YGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~~-~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~-elL~HPfF~~~~ 769 (902)
|.... ......+......++...++++.++|.+||+.||.+||++. ++++||||...+
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 196 FHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 76543 22233333333445556778999999999999999999865 888999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=339.73 Aligned_cols=247 Identities=25% Similarity=0.372 Sum_probs=190.3
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|.+.+.||+|+||+||++.. .+++.||||++.... .....+|+. ++..++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELK-MLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHH-HHHhCCCccccchhhhEecCCEEEEEEe
Confidence 467789999999999999855 468899999986532 123455665 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
||.+++.+.+ . .....+++..++.++.|++.||+|||+.+|
T Consensus 81 ~~~~~~l~~~----------~-----------------------------~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 121 (287)
T cd07848 81 YVEKNMLELL----------E-----------------------------EMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121 (287)
T ss_pred cCCCCHHHHH----------H-----------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 6665433221 1 011346777889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+||+++.++. +||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 122 ~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 197 (287)
T cd07848 122 VHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSN--ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197 (287)
T ss_pred ecCCCCHHHEEEcCCCc--EEEeeccCccccccccc--ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence 99999999999987775 99999999987653221 112234689999999999988899999999999999999998
Q ss_pred CCCCCCCchhhHH--HHHhhc-------------c-----c-------------cccccCChHHHHHHHcccCCCCCCCc
Q 002601 708 GKHPYGESFERDA--NIVKDR-------------K-----D-------------LFLVEHIPEAVDLFTRLLDPNPDLRP 754 (902)
Q Consensus 708 ~~~Pf~~~~~~~~--~~~~~~-------------~-----~-------------~~~~~~~~e~~dLI~~~L~~dP~~Rp 754 (902)
.+||........ .+.... . . ......++++.++|++||+.||++||
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~ 276 (287)
T cd07848 198 -QPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY 276 (287)
T ss_pred -CCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC
Confidence 678865322110 100000 0 0 00112456799999999999999999
Q ss_pred CHHHHHcCCCC
Q 002601 755 KAQNVLNHPFF 765 (902)
Q Consensus 755 t~~elL~HPfF 765 (902)
|++|+++||||
T Consensus 277 s~~~~l~hp~f 287 (287)
T cd07848 277 LTEQCLNHPAF 287 (287)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=347.95 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=193.2
Q ss_pred EEEeeeecccCceEEEEEEe----eCCcEEEEEEeccCC-------chHHHHHHHHHHHhC-CCCCeeEecccccCccce
Q 002601 475 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~----~~g~~VAVKrl~~~~-------~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~~~ 542 (902)
|.+.+.||+|+||+||++.. .+|+.||+|++.+.. .+...+|+. ++..+ +||||+++++++.+++..
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERN-VLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHH-HHHhccCCCCcccEEEEEecCCEE
Confidence 56788999999999998754 368999999986421 112334554 44555 699999999999999999
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+||| |+++|+|.+++.. ...+++..+..++.||+.||+||
T Consensus 81 ~lv~e----------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~l 121 (332)
T cd05614 81 HLILD----------YVSGGEMFTHLYQ-----------------------------RDNFSEDEVRFYSGEIILALEHL 121 (332)
T ss_pred EEEEe----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 5566777666532 23467788899999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-CCCcchhhhhHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCIL 701 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGviL 701 (902)
|+++|+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus 122 H~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 197 (332)
T cd05614 122 HKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSEEK--ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILI 197 (332)
T ss_pred HHCCcEecCCCHHHeEECCCCC--EEEeeCcCCccccccCC--CccccccCCccccCHHHhcCCCCCCCccccccchhhh
Confidence 9999999999999999988876 99999999986543211 1223456999999999998654 78999999999999
Q ss_pred HHHHhCCCCCCCCch-----hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCc
Q 002601 702 FFCITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTA 768 (902)
Q Consensus 702 ~elltG~~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~ 768 (902)
|||++| ..||.... ......+.......+...++++.++|.+||+.||++|| +++++++||||...
T Consensus 198 ~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 198 FELLTG-ASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred hhhhcC-CCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999998 77875321 11112222223344556778999999999999999999 88899999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=349.11 Aligned_cols=246 Identities=27% Similarity=0.370 Sum_probs=194.3
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+|+.||||++.+.. ......|+..+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e---- 76 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLD---- 76 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEc----
Confidence 3699999999999854 478999999986431 12334555556788999999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. ...+++..+..++.||+.||+|||++||+|||
T Consensus 77 ------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~givH~d 121 (323)
T cd05575 77 ------YVNGGELFFHLQR-----------------------------ERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121 (323)
T ss_pred ------CCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 5666777665532 12466778889999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~NIll~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~p 195 (323)
T cd05575 122 LKPENILLDSQGH--VVLTDFGLCKEGIEHS---KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG-LPP 195 (323)
T ss_pred CCHHHeEECCCCc--EEEeccCCCcccccCC---CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcC-CCC
Confidence 9999999988776 8999999987543211 122345699999999999998999999999999999999998 667
Q ss_pred CCCc-hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH----HHHHcCCCCCCcc
Q 002601 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~-~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~----~elL~HPfF~~~~ 769 (902)
|... .......+.......+...++++.++|.+||+.||.+||++ .++++||||.+..
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 196 FYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 7543 33322323233333445568899999999999999999987 6999999996543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=350.81 Aligned_cols=253 Identities=29% Similarity=0.436 Sum_probs=197.5
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|.+.+.||+|+||+||++.. .+|+.||||++.+.. ....++++..++..++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 467789999999999999854 468999999986431 12234444457788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++... ..+++..++.++.||+.||+|||+.||
T Consensus 82 ----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~i~~qi~~aL~~LH~~gi 122 (350)
T cd05573 82 ----------YMPGGDLMNLLIRK-----------------------------DVFPEETARFYIAELVLALDSVHKLGF 122 (350)
T ss_pred ----------CCCCCCHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 55667776665321 346778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCc--------------------------cccccccCCCCccccCch
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--------------------------CLTQNATGYGSSGWQAPE 681 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~--------------------------~~~~~~~~~Gt~~Y~APE 681 (902)
+||||||+|||++.++. +||+|||+++....... .........||+.|+|||
T Consensus 123 iH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 200 (350)
T cd05573 123 IHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE 200 (350)
T ss_pred eccCCCHHHeEECCCCC--EEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence 99999999999988876 89999999987654320 001223456999999999
Q ss_pred hhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhh-HH-HHHhh-ccccccc--cCChHHHHHHHcccCCCCCCCcC-
Q 002601 682 QLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DA-NIVKD-RKDLFLV--EHIPEAVDLFTRLLDPNPDLRPK- 755 (902)
Q Consensus 682 ~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~-~~-~~~~~-~~~~~~~--~~~~e~~dLI~~~L~~dP~~Rpt- 755 (902)
++.+..++.++|||||||++|||++| .+||...... .. .+... .....+. ..++++.++|.+||. ||.+||+
T Consensus 201 ~~~~~~~~~~~DiwSlG~il~ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s 278 (350)
T cd05573 201 VLRGTPYGLECDWWSLGVILYEMLYG-FPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS 278 (350)
T ss_pred HHcCCCCCCceeeEecchhhhhhccC-CCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCC
Confidence 99999999999999999999999998 6677654322 22 22221 1111222 247899999999997 9999999
Q ss_pred HHHHHcCCCCCCcc
Q 002601 756 AQNVLNHPFFWTAD 769 (902)
Q Consensus 756 ~~elL~HPfF~~~~ 769 (902)
++++++||||...+
T Consensus 279 ~~~ll~hp~~~~~~ 292 (350)
T cd05573 279 FEEIKSHPFFKGID 292 (350)
T ss_pred HHHHhcCCCcCCCC
Confidence 99999999996543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=345.94 Aligned_cols=255 Identities=25% Similarity=0.349 Sum_probs=186.3
Q ss_pred eeeecccCceEEEEEEee---CCcEEEEEEeccCCc-hHHHHHHHHHHHhCCCCCeeEecccccC--ccceeeeeccccC
Q 002601 478 NKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSLERCTC 551 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~---~g~~VAVKrl~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~d--~~~~yLV~E~c~~ 551 (902)
+++||+|+||+||+|... +++.||+|.+..... ....+|+. +++.++||||+++++++.+ +...|++||++.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIA-LLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHH-HHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 457999999999998643 568999999875432 34566765 6788999999999998754 4568999998887
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
+|.+++........ .-+...+++..++.++.||+.||+|||+.+|+|||
T Consensus 85 ~l~~~~~~~~~~~~-------------------------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrD 133 (317)
T cd07868 85 DLWHIIKFHRASKA-------------------------------NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 133 (317)
T ss_pred CHHHHHHhcccccc-------------------------------cCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 77666532211100 01123478888999999999999999999999999
Q ss_pred cccceeEeccC--CCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhCC
Q 002601 632 LKPQNVLISKD--KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 632 LKp~NILL~~d--~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG~ 708 (902)
|||+|||++.+ ....+||+|||+++................||+.|+|||++.+. .++.++||||+||++|||++|
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g- 212 (317)
T cd07868 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS- 212 (317)
T ss_pred CCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhC-
Confidence 99999999432 12349999999998765432222233445689999999998774 589999999999999999998
Q ss_pred CCCCCCchhh-----------HHHHHhhc-------------------------ccc------------ccccCChHHHH
Q 002601 709 KHPYGESFER-----------DANIVKDR-------------------------KDL------------FLVEHIPEAVD 740 (902)
Q Consensus 709 ~~Pf~~~~~~-----------~~~~~~~~-------------------------~~~------------~~~~~~~e~~d 740 (902)
.+||...... ...+.... ... ......+++.+
T Consensus 213 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 292 (317)
T cd07868 213 EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 292 (317)
T ss_pred CCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHH
Confidence 6677532110 00000000 000 00112356889
Q ss_pred HHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 741 LFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 741 LI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
||.+||+.||.+|||++|+++||||
T Consensus 293 li~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 293 LLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=338.25 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=191.0
Q ss_pred cceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccC-----CchHHHHHHHHHHHhCCCCCeeEecccccC-----cc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESD-----QD 540 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d-----~~ 540 (902)
...|...+.||+|+||.|..| ...+|+.||||++.+. .....++|+. +++.++|+||+.+++.+.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElk-lLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELK-LLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHH-HHHHhcCCCcceEEeecccccccccc
Confidence 344555688999999999987 5567999999998632 2346788886 6788899999999998765 35
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
.+|+|+|+++.+|...+. ....+....+..++.||++||.
T Consensus 100 DvYiV~elMetDL~~iik----------------------------------------~~~~L~d~H~q~f~YQiLrgLK 139 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIK----------------------------------------SQQDLTDDHAQYFLYQILRGLK 139 (359)
T ss_pred eeEEehhHHhhHHHHHHH----------------------------------------cCccccHHHHHHHHHHHHHhcc
Confidence 689999977666655541 1122566777889999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 699 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGv 699 (902)
|+|+.+|+||||||+|+|++.+.. +||+|||+|+..... .........+-|..|.|||++.. ..|+.++||||.||
T Consensus 140 yiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~-~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGC 216 (359)
T KOG0660|consen 140 YIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKF-FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGC 216 (359)
T ss_pred hhhcccccccccchhheeeccCCC--EEeccccceeecccc-CcccchhcceeeeeecCHHHHhccccccchhhhhhhhH
Confidence 999999999999999999987755 899999999988643 22222234457999999998864 56999999999999
Q ss_pred HHHHHHhCCCCCCCCchhhHHHH------------------------Hhhccc-------cccccCChHHHHHHHcccCC
Q 002601 700 ILFFCITGGKHPYGESFERDANI------------------------VKDRKD-------LFLVEHIPEAVDLFTRLLDP 748 (902)
Q Consensus 700 iL~elltG~~~Pf~~~~~~~~~~------------------------~~~~~~-------~~~~~~~~e~~dLI~~~L~~ 748 (902)
|+.||++|+..+-+...-.+... ++.... .......+++.||+++||..
T Consensus 217 I~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~f 296 (359)
T KOG0660|consen 217 ILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVF 296 (359)
T ss_pred HHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhcc
Confidence 99999998544433322111110 110000 01124568999999999999
Q ss_pred CCCCCcCHHHHHcCCCCCC
Q 002601 749 NPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 749 dP~~Rpt~~elL~HPfF~~ 767 (902)
||.+|+|++|+|.|||+..
T Consensus 297 dP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 297 DPKKRITAEEALAHPYLAP 315 (359)
T ss_pred CccccCCHHHHhcChhhhh
Confidence 9999999999999999854
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=347.48 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=193.4
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+|+.||||++.+.. ......|...+....+||||+++++++.+++..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E---- 76 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVME---- 76 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEe----
Confidence 3599999999999854 458899999986531 11234455444445689999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. .+.+++..+..++.||+.||+|||+++|+|||
T Consensus 77 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 121 (321)
T cd05591 77 ------YVNGGDLMFQIQR-----------------------------SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121 (321)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 5556666655532 23467778899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg-~~P 195 (321)
T cd05591 122 LKLDNILLDAEGH--CKLADFGMCKEGILNG---VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG-QPP 195 (321)
T ss_pred CCHHHeEECCCCC--EEEeecccceecccCC---ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcC-CCC
Confidence 9999999988876 8999999987543221 122345689999999999998999999999999999999997 778
Q ss_pred CCCchhh-HHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-------CHHHHHcCCCCCCcc
Q 002601 712 YGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-------KAQNVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~~~~-~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-------t~~elL~HPfF~~~~ 769 (902)
|...... ....+......++...++++.++|.+||+.||++|+ +++++++||||...+
T Consensus 196 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~ 261 (321)
T cd05591 196 FEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEID 261 (321)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence 8654332 223333333345556788999999999999999999 899999999996543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=349.41 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=193.0
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+++.||+|++.+... ....+|+..+....+||||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E---- 76 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE---- 76 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEe----
Confidence 3699999999999854 5688999999875311 1234555545455689999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. ...+++..++.++.||+.||+|||+++|+|||
T Consensus 77 ------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~D 121 (329)
T cd05618 77 ------YVNGGDLMFHMQR-----------------------------QRKLPEEHARFYSAEISLALNYLHERGIIYRD 121 (329)
T ss_pred ------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence 6666777655421 23467888899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 ikp~Nili~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~P 195 (329)
T cd05618 122 LKLDNVLLDSEGH--IKLTDYGMCKEGLRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSP 195 (329)
T ss_pred CCHHHEEECCCCC--EEEeeCCccccccCCC---CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhC-CCC
Confidence 9999999988876 9999999987543211 122345699999999999999999999999999999999998 778
Q ss_pred CCCc----------hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC------HHHHHcCCCCCCcc
Q 002601 712 YGES----------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~----------~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt------~~elL~HPfF~~~~ 769 (902)
|... .......+.......+...++++.++|.+||+.||.+||+ +.++++||||.+.+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 269 (329)
T cd05618 196 FDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 269 (329)
T ss_pred CccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 7421 0111222233333456667889999999999999999998 58999999997654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=350.95 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=193.0
Q ss_pred eEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|.+.+.||+|+||+||++. ..+|+.||||++.+... ...++++..++..++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 46678899999999999984 45689999999865321 1223333346788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++.. ...+++..++.++.|++.||+|||++||
T Consensus 82 ----------~~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~gi 122 (363)
T cd05628 82 ----------FLPGGDMMTLLMK-----------------------------KDTLTEEETQFYIAETVLAIDSIHQLGF 122 (363)
T ss_pred ----------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5566777666532 2346778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCcc--------------------------------ccccccCCCCc
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--------------------------------LTQNATGYGSS 675 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~--------------------------------~~~~~~~~Gt~ 675 (902)
+||||||+|||++.++. +||+|||+++.+...... .......+||+
T Consensus 123 vHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 200 (363)
T cd05628 123 IHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP 200 (363)
T ss_pred EecCCCHHHeEECCCCC--EEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence 99999999999988876 899999999765321100 00012457999
Q ss_pred cccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchh-hHH-HHHhhc-cccccc--cCChHHHHHHHcccCCCC
Q 002601 676 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE-RDA-NIVKDR-KDLFLV--EHIPEAVDLFTRLLDPNP 750 (902)
Q Consensus 676 ~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~-~~~-~~~~~~-~~~~~~--~~~~e~~dLI~~~L~~dP 750 (902)
.|+|||++.+..++.++|||||||++|||++| .+||..... ... .+.... ...++. ..+++++++|.+|+. +|
T Consensus 201 ~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~ 278 (363)
T cd05628 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG-YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EW 278 (363)
T ss_pred cccCHHHHcCCCCCCchhhhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Ch
Confidence 99999999999999999999999999999998 778865432 222 222211 112222 356899999999765 44
Q ss_pred C---CCcCHHHHHcCCCCCCcch
Q 002601 751 D---LRPKAQNVLNHPFFWTADT 770 (902)
Q Consensus 751 ~---~Rpt~~elL~HPfF~~~~~ 770 (902)
. .||+++|+++||||.+.+.
T Consensus 279 ~~r~~r~~~~ei~~hp~f~~~~~ 301 (363)
T cd05628 279 EHRIGAPGVEEIKTNPFFEGVDW 301 (363)
T ss_pred hhcCCCCCHHHHhCCCCCCCCCH
Confidence 4 4689999999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=350.07 Aligned_cols=245 Identities=27% Similarity=0.371 Sum_probs=194.9
Q ss_pred eeecccCceEEEEEE-eeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++. ..+|+.||||++.+.. .....+|+ .++..++||||+++++++.+++..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~-~~l~~~~hp~i~~~~~~~~~~~~~~lv~E---- 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN-RVLQNSRHPFLTALKYSFQTHDRLCFVME---- 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCCceEEEEEcCCEEEEEEe----
Confidence 369999999999974 4678999999986531 11223344 36678899999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc-cccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHR 630 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~-~~IvHr 630 (902)
|+++|+|..++.. ...+++..+..++.||+.||+|||+ .||+||
T Consensus 76 ------~~~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHr 120 (325)
T cd05594 76 ------YANGGELFFHLSR-----------------------------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120 (325)
T ss_pred ------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEec
Confidence 5566777655532 2346778889999999999999997 799999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..
T Consensus 121 Dikp~NIll~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG-~~ 194 (325)
T cd05594 121 DLKLENLMLDKDGH--IKITDFGLCKEGIKDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RL 194 (325)
T ss_pred CCCCCeEEECCCCC--EEEecCCCCeecCCCC---cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccC-CC
Confidence 99999999988876 9999999987543221 112345699999999999998999999999999999999998 66
Q ss_pred CCCCc-hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcc
Q 002601 711 PYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 769 (902)
Q Consensus 711 Pf~~~-~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~ 769 (902)
||... .+.....+......++...++++.++|.+||+.||.+|+ ++.++++||||.+..
T Consensus 195 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 195 PFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 77543 333333333344445667789999999999999999997 899999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.19 Aligned_cols=247 Identities=28% Similarity=0.408 Sum_probs=186.3
Q ss_pred eEEEeeeecccCceEEEEEEe--eCCcEEEEEEeccCC-----chHHHHHHHHH--HHhCCCCCeeEeccccc-----Cc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTH-----HDVALKEIQNL--IASDQHPNIVRWYGVES-----DQ 539 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~--~~g~~VAVKrl~~~~-----~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~-----d~ 539 (902)
.|.+.+.||+|+||+||++.. .+|+.||||++.... .....+|+..+ +..+.||||++++++|. ..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 466788999999999999864 347889999886432 12344555432 23457999999999874 34
Q ss_pred cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccc
Q 002601 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (902)
Q Consensus 540 ~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL 619 (902)
...++|||++.++|.+++ ... ....+++..+..++.||+.||
T Consensus 82 ~~~~lv~e~~~~~l~~~~-----------~~~---------------------------~~~~~~~~~~~~i~~qi~~aL 123 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYL-----------DKV---------------------------PEPGVPTETIKDMMFQLLRGL 123 (290)
T ss_pred CcEEEEEccCCCCHHHHH-----------HhC---------------------------CCCCCCHHHHHHHHHHHHHHH
Confidence 568999997766555543 111 112467788899999999999
Q ss_pred cccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHH
Q 002601 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (902)
Q Consensus 620 ~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGv 699 (902)
+|||+.+|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++|||||||
T Consensus 124 ~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 197 (290)
T cd07862 124 DFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGC 197 (290)
T ss_pred HHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccceEeccCC----cccccccccccccChHHHhCCCCCCccchHHHHH
Confidence 9999999999999999999988776 999999999865432 1223456899999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCchhh--HHHHHhhccc--------------------------cccccCChHHHHHHHcccCCCCC
Q 002601 700 ILFFCITGGKHPYGESFER--DANIVKDRKD--------------------------LFLVEHIPEAVDLFTRLLDPNPD 751 (902)
Q Consensus 700 iL~elltG~~~Pf~~~~~~--~~~~~~~~~~--------------------------~~~~~~~~e~~dLI~~~L~~dP~ 751 (902)
++|||++| .+||...... ...+...... ......+++++++|.+||+.||+
T Consensus 198 il~el~~g-~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (290)
T cd07862 198 IFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276 (290)
T ss_pred HHHHHHcC-CCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch
Confidence 99999997 7788654321 1122111000 00123456789999999999999
Q ss_pred CCcCHHHHHcCCCC
Q 002601 752 LRPKAQNVLNHPFF 765 (902)
Q Consensus 752 ~Rpt~~elL~HPfF 765 (902)
+|||+.|+++||||
T Consensus 277 ~R~s~~~~l~hp~f 290 (290)
T cd07862 277 KRISAYSALSHPYF 290 (290)
T ss_pred hcCCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=345.39 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=196.5
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHH--HHHHhCCCCCeeEecccccCccceeee
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQ--NLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~--~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
|.+.+.||+|+||+||++.. .+|+.||||++.+.. .+...+|.. .++..++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 34678899999999999854 568999999986432 112233333 233567899999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+++|+|...++. ..+++..+..++.||+.||+|||+.
T Consensus 81 ~E----------~~~~~~L~~~~~~------------------------------~~l~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05589 81 ME----------YAAGGDLMMHIHT------------------------------DVFSEPRAVFYAACVVLGLQYLHEN 120 (324)
T ss_pred Ec----------CCCCCcHHHHhhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 5556666554421 2467788899999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
||+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 121 ~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 195 (324)
T cd05589 121 KIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFG---DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195 (324)
T ss_pred CeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCC---CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHH
Confidence 9999999999999988876 9999999987543211 1223457999999999999989999999999999999999
Q ss_pred hCCCCCCCCchh-hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcch
Q 002601 706 TGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 770 (902)
Q Consensus 706 tG~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~~ 770 (902)
+| ..||..... .....+......++...++++.++|.+||+.||.+|| ++.++++||||.+.+.
T Consensus 196 ~G-~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~ 265 (324)
T cd05589 196 VG-ESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINW 265 (324)
T ss_pred hC-CCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCH
Confidence 97 678765432 2223333334445666788999999999999999999 6999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=347.91 Aligned_cols=246 Identities=24% Similarity=0.339 Sum_probs=191.2
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+++.||||++.+... ....+|...+....+||||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e---- 76 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIE---- 76 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEe----
Confidence 3699999999999854 5689999999975321 1233444433334489999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. .+.+++..++.++.||+.||+|||+++|+|||
T Consensus 77 ------~~~~g~L~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~d 121 (329)
T cd05588 77 ------FVSGGDLMFHMQR-----------------------------QRKLPEEHARFYSAEISLALNFLHERGIIYRD 121 (329)
T ss_pred ------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 5566777655421 23478888999999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++| ..|
T Consensus 122 lkp~Nili~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~P 195 (329)
T cd05588 122 LKLDNVLLDAEGH--IKLTDYGMCKEGIRPG---DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSP 195 (329)
T ss_pred CCHHHeEECCCCC--EEECcCccccccccCC---CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHC-CCC
Confidence 9999999988776 9999999987532211 122345799999999999999999999999999999999997 778
Q ss_pred CCCch----------hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC------HHHHHcCCCCCCcc
Q 002601 712 YGESF----------ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~~----------~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt------~~elL~HPfF~~~~ 769 (902)
|.... ......+.......+...++++.++|.+||+.||.+|++ ++++++||||.+.+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~ 269 (329)
T cd05588 196 FDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNID 269 (329)
T ss_pred cccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence 85210 111222223333445567789999999999999999987 78999999996543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=355.97 Aligned_cols=247 Identities=21% Similarity=0.272 Sum_probs=189.6
Q ss_pred ceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
..|.+.+.||+|+||.||++. ..+++.||+|.... ....+|+. +++.++|||||++++++..++..++|+|++.+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~ 167 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---GGTATEAH-ILRAINHPSIIQLKGTFTYNKFTCLILPRYKT 167 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---hhhHHHHH-HHHhCCCCCCCCEeEEEEECCeeEEEEecCCC
Confidence 458889999999999999984 45789999997543 33456665 67889999999999999999999999997655
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
+|.+++ . ....+++..++.|+.||+.||+|||+++|+|||
T Consensus 168 ~L~~~l-----------~-----------------------------~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrD 207 (391)
T PHA03212 168 DLYCYL-----------A-----------------------------AKRNIAICDILAIERSVLRAIQYLHENRIIHRD 207 (391)
T ss_pred CHHHHH-----------H-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 444332 1 113467778899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... .......+||+.|+|||++.+..++.++|||||||++|||++|..++
T Consensus 208 iKP~NIll~~~~~--vkL~DFG~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 208 IKAENIFINHPGD--VCLGDFGAACFPVDIN--ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred CChHhEEEcCCCC--EEEEeCCccccccccc--ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 9999999988876 8999999997543211 11223456999999999999989999999999999999999986555
Q ss_pred CCCch-------hhHH-HHHhh-------------------------ccccc---------cccCChHHHHHHHcccCCC
Q 002601 712 YGESF-------ERDA-NIVKD-------------------------RKDLF---------LVEHIPEAVDLFTRLLDPN 749 (902)
Q Consensus 712 f~~~~-------~~~~-~~~~~-------------------------~~~~~---------~~~~~~e~~dLI~~~L~~d 749 (902)
|.... .... .++.. ..... ....+.++.+||.+||+.|
T Consensus 284 ~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~d 363 (391)
T PHA03212 284 FEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363 (391)
T ss_pred CCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCC
Confidence 54210 0000 00000 00000 0122457889999999999
Q ss_pred CCCCcCHHHHHcCCCCCC
Q 002601 750 PDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 750 P~~Rpt~~elL~HPfF~~ 767 (902)
|.+|||++|+|+||||..
T Consensus 364 P~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 364 AHHRPSAEALLDFAAFQD 381 (391)
T ss_pred hhhCCCHHHHhcChhhcc
Confidence 999999999999999965
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=344.52 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=194.5
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCC-CCeeEecccccCccceeeee
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQH-PNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~H-pNIV~l~g~~~d~~~~yLV~ 546 (902)
|.+.+.||+|+||.||++.. .+++.||||++.+.. .+....|.. ++..+.| ++|+++++++.+.+.+|+||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKR-VLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 56788999999999999854 457899999986431 122344544 4455554 56889999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++.. ...+++..+..++.||+.||+|||+++
T Consensus 81 E----------~~~~g~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (324)
T cd05587 81 E----------YVNGGDLMYHIQQ-----------------------------VGKFKEPHAVFYAAEIAIGLFFLHSKG 121 (324)
T ss_pred c----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 5556676665532 123567788999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
|+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 122 ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 196 (324)
T cd05587 122 IIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGG---KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196 (324)
T ss_pred eEecCCCHHHeEEcCCCC--EEEeecCcceecCCCC---CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh
Confidence 999999999999988776 8999999987533211 12234569999999999999999999999999999999999
Q ss_pred CCCCCCCCchh-hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH-----HHHHcCCCCCCcch
Q 002601 707 GGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADT 770 (902)
Q Consensus 707 G~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~-----~elL~HPfF~~~~~ 770 (902)
| .+||..... .....+......++...++++.+++.+||+.||.+|++. +++++||||...+.
T Consensus 197 G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~ 265 (324)
T cd05587 197 G-QPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265 (324)
T ss_pred C-CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 7 778765432 222333333444566678899999999999999999986 89999999976443
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=360.01 Aligned_cols=253 Identities=24% Similarity=0.304 Sum_probs=191.2
Q ss_pred ccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccC--------ccc
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD--------QDF 541 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d--------~~~ 541 (902)
..+.|.+.+.||+|+||+||+|.. .+++.||||++.... ....+|+. +++.++|||||++++++.. ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~-il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELL-IMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-chHHHHHH-HHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 346789999999999999999854 568999999886532 23345654 6788999999999887532 235
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
+++|||||+++|.+++.. .. .....+++..++.++.||+.||+|
T Consensus 142 l~lvmE~~~~~l~~~~~~-----------~~-------------------------~~~~~l~~~~~~~~~~qi~~gL~y 185 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKH-----------YA-------------------------RNNHALPLFLVKLYSYQLCRALAY 185 (440)
T ss_pred EEEEEecCCccHHHHHHH-----------Hh-------------------------hcCCCCCHHHHHHHHHHHHHHHHH
Confidence 789999887766554411 00 112346788889999999999999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHH
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCI 700 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvi 700 (902)
||+.+|+||||||+||||+.++. .+||+|||+|+.+.... ......||+.|+|||++.+. .++.++|||||||+
T Consensus 186 LH~~~IiHrDLKp~NILl~~~~~-~vkL~DFGla~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvi 260 (440)
T PTZ00036 186 IHSKFICHRDLKPQNLLIDPNTH-TLKLCDFGSAKNLLAGQ----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCI 260 (440)
T ss_pred HHHCCEecCCcCHHHEEEcCCCC-ceeeeccccchhccCCC----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHH
Confidence 99999999999999999986542 48999999998765321 22344689999999998764 68999999999999
Q ss_pred HHHHHhCCCCCCCCchhh--HHHHHhhc----------------------------cccccccCChHHHHHHHcccCCCC
Q 002601 701 LFFCITGGKHPYGESFER--DANIVKDR----------------------------KDLFLVEHIPEAVDLFTRLLDPNP 750 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~~--~~~~~~~~----------------------------~~~~~~~~~~e~~dLI~~~L~~dP 750 (902)
+|||++| .+||...... ...++... ...++...++++.+||.+||+.||
T Consensus 261 l~elltG-~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP 339 (440)
T PTZ00036 261 IAEMILG-YPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339 (440)
T ss_pred HHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCCh
Confidence 9999998 6777643211 11111100 001223456789999999999999
Q ss_pred CCCcCHHHHHcCCCCCC
Q 002601 751 DLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 751 ~~Rpt~~elL~HPfF~~ 767 (902)
.+|||+.|+++||||..
T Consensus 340 ~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 340 LKRLNPIEALADPFFDD 356 (440)
T ss_pred hHCcCHHHHhCChhHHh
Confidence 99999999999999965
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=349.03 Aligned_cols=246 Identities=25% Similarity=0.371 Sum_probs=193.8
Q ss_pred eeecccCceEEEEEE-eeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++. ..+|+.||||++.+.. .....+|...+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e---- 76 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLD---- 76 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEc----
Confidence 369999999999984 4578999999986431 12334555556788999999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. ...+++..+..++.||+.||+|||+.||+|||
T Consensus 77 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~givH~D 121 (325)
T cd05604 77 ------FVNGGELFFHLQR-----------------------------ERSFPEPRARFYAAEIASALGYLHSINIVYRD 121 (325)
T ss_pred ------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 5566676655431 23467788899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G-~~p 195 (325)
T cd05604 122 LKPENILLDSQGH--VVLTDFGLCKEGIAQS---DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG-LPP 195 (325)
T ss_pred CCHHHeEECCCCC--EEEeecCCcccCCCCC---CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcC-CCC
Confidence 9999999988876 8999999987543211 122345699999999999999999999999999999999998 667
Q ss_pred CCCc-hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH----HHHHcCCCCCCcc
Q 002601 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~-~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~----~elL~HPfF~~~~ 769 (902)
|... .......+...........+.++.++|.+||+.||.+||++ .++++||||....
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~ 258 (325)
T cd05604 196 FYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLS 258 (325)
T ss_pred CCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence 6543 23332333333333344567899999999999999999976 5899999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=344.81 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=193.9
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+++.||||++.+.. ......|...+....+||||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~e---- 76 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVME---- 76 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEe----
Confidence 3699999999999854 457899999986531 12344555544445799999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|.+++.. ...+++.++..++.|++.||+|||+.+|+|||
T Consensus 77 ------y~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrd 121 (316)
T cd05619 77 ------YLNGGDLMFHIQS-----------------------------CHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121 (316)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCC
Confidence 6667777666532 12456778889999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 ikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G-~~p 195 (316)
T cd05619 122 LKLDNILLDTDGH--IKIADFGMCKENMLGD---AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG-QSP 195 (316)
T ss_pred CCHHHEEECCCCC--EEEccCCcceECCCCC---CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhC-CCC
Confidence 9999999988876 9999999987543211 112345689999999999988999999999999999999998 667
Q ss_pred CCCchh-hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHH-HHHcCCCCCCcc
Q 002601 712 YGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~~~-~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~-elL~HPfF~~~~ 769 (902)
|..... .....+......++...+.++.++|.+||+.||.+||++. ++++||||....
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 196 FHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred CCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 765432 2223333333344556778999999999999999999997 899999996643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=346.79 Aligned_cols=247 Identities=29% Similarity=0.455 Sum_probs=196.3
Q ss_pred eEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+.+.||+|+||.||++... +|+.||||++.+.. .....+|+ .++..++||||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTER-DILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHH-HHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 4677899999999999998654 58999999986532 11233454 4667888999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++.. ...+++..++.++.||+.||+|||+.+
T Consensus 81 e----------~~~g~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~ 121 (333)
T cd05600 81 E----------YVPGGDFRTLLNN-----------------------------LGVLSEDHARFYMAEMFEAVDALHELG 121 (333)
T ss_pred e----------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 6666777766632 124667788999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
|+||||||+|||++.++. +||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 122 ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~ 193 (333)
T cd05600 122 YIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLC 193 (333)
T ss_pred ccccCCCHHHEEECCCCC--EEEEeCcCCccccc------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhh
Confidence 999999999999988876 99999999986543 2234569999999999999999999999999999999999
Q ss_pred CCCCCCCCchhhH-HHHHhh-cc----cccc---ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 707 GGKHPYGESFERD-ANIVKD-RK----DLFL---VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 707 G~~~Pf~~~~~~~-~~~~~~-~~----~~~~---~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
| .+||....... ...+.. .. .... ...++++.++|.+||..+|.+||+++++++||||....
T Consensus 194 g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 194 G-FPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred C-CCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 8 67876543222 111111 11 0111 13478999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=343.89 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=196.7
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|.+.+.||+|+||+||++.. .+++.||||++.+... .....|...+.....|++|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 56778999999999999854 4678999999865321 1233444444444578999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+.+.. ...+++..+..++.||+.||+|||+++|
T Consensus 82 ----------~~~~g~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~i 122 (323)
T cd05616 82 ----------YVNGGDLMYQIQQ-----------------------------VGRFKEPHAVFYAAEIAIGLFFLHSKGI 122 (323)
T ss_pred ----------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 5666777665532 1346777889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 123 vHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg 197 (323)
T cd05616 123 IYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (323)
T ss_pred EecCCCHHHeEECCCCc--EEEccCCCceecCCCC---CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhC
Confidence 99999999999988876 9999999997543211 122345699999999999999999999999999999999997
Q ss_pred CCCCCCCchh-hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH-----HHHHcCCCCCCcc
Q 002601 708 GKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTAD 769 (902)
Q Consensus 708 ~~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~-----~elL~HPfF~~~~ 769 (902)
.+||..... .....+......++...++++.+++.+||+.||.+|+++ .++++||||...+
T Consensus 198 -~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 198 -QAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 778765432 223333334445566788999999999999999999984 8999999996543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=330.61 Aligned_cols=247 Identities=27% Similarity=0.392 Sum_probs=190.4
Q ss_pred EEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEeccccc--Cccceeeee
Q 002601 475 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVES--DQDFVYLSL 546 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~--d~~~~yLV~ 546 (902)
|...++|++|+||.||+| +..+++.||+|+++-... -..++||. ++...+|||||.+..+.. +-+.+||||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIn-iLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREIN-ILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHH-HHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 445578999999999998 556789999999965432 25689997 556777999999988754 446799999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
|||+.+|..++.. ...++...++..++.|+++||+|||.+.
T Consensus 157 e~~EhDLksl~d~---------------------------------------m~q~F~~~evK~L~~QlL~glk~lH~~w 197 (419)
T KOG0663|consen 157 EYVEHDLKSLMET---------------------------------------MKQPFLPGEVKTLMLQLLRGLKHLHDNW 197 (419)
T ss_pred HHHHhhHHHHHHh---------------------------------------ccCCCchHHHHHHHHHHHHHHHHHhhce
Confidence 9998776655510 1135677788999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ell 705 (902)
|+||||||+|+|++.+|. +||+|||+|+.+....... ...+-|..|.|||.+.+. .|+.++|+||+|||+.||+
T Consensus 198 ilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k~~---T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l 272 (419)
T KOG0663|consen 198 ILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLKPY---TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELL 272 (419)
T ss_pred eEecccchhheeeccCCc--EEecccchhhhhcCCcccC---cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHH
Confidence 999999999999988876 9999999999987653322 234469999999999875 4899999999999999999
Q ss_pred hCCCCCCCC-chhhHHH-HHhh---c---------------------------ccccccc-CChHHHHHHHcccCCCCCC
Q 002601 706 TGGKHPYGE-SFERDAN-IVKD---R---------------------------KDLFLVE-HIPEAVDLFTRLLDPNPDL 752 (902)
Q Consensus 706 tG~~~Pf~~-~~~~~~~-~~~~---~---------------------------~~~~~~~-~~~e~~dLI~~~L~~dP~~ 752 (902)
++ ++-|.+ ....+.+ |... . ...|... .++...+|+..+|..||.+
T Consensus 273 ~~-kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~k 351 (419)
T KOG0663|consen 273 TQ-KPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGK 351 (419)
T ss_pred hc-CCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccc
Confidence 98 544443 3222211 1110 0 0001111 3367889999999999999
Q ss_pred CcCHHHHHcCCCCCC
Q 002601 753 RPKAQNVLNHPFFWT 767 (902)
Q Consensus 753 Rpt~~elL~HPfF~~ 767 (902)
|.|++|.|+|.||..
T Consensus 352 R~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 352 RITAEDGLKHEYFRE 366 (419)
T ss_pred cccHHHhhccccccc
Confidence 999999999999976
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=341.39 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=185.2
Q ss_pred eeeecccCceEEEEEEee---CCcEEEEEEeccCCch-HHHHHHHHHHHhCCCCCeeEeccccc--CccceeeeeccccC
Q 002601 478 NKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHD-VALKEIQNLIASDQHPNIVRWYGVES--DQDFVYLSLERCTC 551 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~---~g~~VAVKrl~~~~~~-~~~~Ei~~ll~~l~HpNIV~l~g~~~--d~~~~yLV~E~c~~ 551 (902)
+.+||+|+||+||+|... +++.||+|++...... ...+|+. +++.++||||+++++++. ++...|+||||+.+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIA-LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHH-HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 467999999999998654 4578999998765433 3455654 678899999999999874 45678999998887
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
+|.+++........ ......+++..+..++.||+.||+|||+.+|+|||
T Consensus 85 ~l~~~~~~~~~~~~-------------------------------~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~D 133 (317)
T cd07867 85 DLWHIIKFHRASKA-------------------------------NKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRD 133 (317)
T ss_pred cHHHHHHhhhcccc-------------------------------CCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCC
Confidence 77666532111100 01123467888899999999999999999999999
Q ss_pred cccceeEeccC--CCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhCC
Q 002601 632 LKPQNVLISKD--KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 632 LKp~NILL~~d--~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG~ 708 (902)
|||+|||+..+ ....+||+|||+++................||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 134 lkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg- 212 (317)
T cd07867 134 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS- 212 (317)
T ss_pred CCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhC-
Confidence 99999999422 12349999999998765433222223345689999999998764 579999999999999999998
Q ss_pred CCCCCCchhhH-----------HHHHhh--------------c-----------c------------ccccccCChHHHH
Q 002601 709 KHPYGESFERD-----------ANIVKD--------------R-----------K------------DLFLVEHIPEAVD 740 (902)
Q Consensus 709 ~~Pf~~~~~~~-----------~~~~~~--------------~-----------~------------~~~~~~~~~e~~d 740 (902)
.+||....+.. ..+... . . ..........+.+
T Consensus 213 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (317)
T cd07867 213 EPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFL 292 (317)
T ss_pred CCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHH
Confidence 67775321110 000000 0 0 0000112346889
Q ss_pred HHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 741 LFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 741 LI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
||.+||+.||.+|||++|+++||||
T Consensus 293 ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 293 LLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHhccCcccccCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=351.71 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=191.4
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|.+.+.||+|+||+||++. ..+++.||||++.+... ....+|+ .++..++|||||++++++.+.+..|+|||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAER-DILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHH-HHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5677899999999999984 45689999999865321 1223344 46788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++... ..+++..++.++.||+.||+|||+.||
T Consensus 82 ----------~~~gg~L~~~l~~~-----------------------------~~~~e~~~~~~~~qi~~aL~~LH~~gi 122 (381)
T cd05626 82 ----------YIPGGDMMSLLIRM-----------------------------EVFPEVLARFYIAELTLAIESVHKMGF 122 (381)
T ss_pred ----------cCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 56667776665321 236777888999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCcc-------------------------------------------
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------------------------------------------- 664 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~------------------------------------------- 664 (902)
+||||||+||||+.++. +||+|||+++.+......
T Consensus 123 vHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (381)
T cd05626 123 IHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQH 200 (381)
T ss_pred eecCCcHHHEEECCCCC--EEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccc
Confidence 99999999999988775 899999998643210000
Q ss_pred -ccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhH--HHHHhhcc-ccc--cccCChHH
Q 002601 665 -LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRK-DLF--LVEHIPEA 738 (902)
Q Consensus 665 -~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~--~~~~~~~~-~~~--~~~~~~e~ 738 (902)
.....+.+||+.|+|||++.+..++.++|||||||++|||++| .+||....... ..+..... ... ....++++
T Consensus 201 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 279 (381)
T cd05626 201 QRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG-QPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEA 279 (381)
T ss_pred cccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhC-CCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHH
Confidence 0011235799999999999988899999999999999999998 67886543222 22322111 112 22467899
Q ss_pred HHHHHccc--CCCCCCCcCHHHHHcCCCCCCcc
Q 002601 739 VDLFTRLL--DPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 739 ~dLI~~~L--~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
.++|.+|+ ..+|..|++++++++||||....
T Consensus 280 ~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 280 VDLITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 99999955 45566699999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=344.05 Aligned_cols=245 Identities=30% Similarity=0.426 Sum_probs=193.2
Q ss_pred eeecccCceEEEEEEe----eCCcEEEEEEeccCCc-------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 479 KEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~----~~g~~VAVKrl~~~~~-------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+.||+|+||.||++.. .+++.||||++.+... .....|+ .++..++||||+++++++.+++..|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAER-NILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHH-HHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 5799999999999754 4688999999864311 1223444 46788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++... ..+++..+..++.||+.||+|||+++|
T Consensus 81 ----------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (323)
T cd05584 81 ----------YLSGGELFMHLERE-----------------------------GIFMEDTACFYLSEISLALEHLHQQGI 121 (323)
T ss_pred ----------CCCCchHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 55667776665321 235667778899999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 122 vH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G 196 (323)
T cd05584 122 IYRDLKPENILLDAQGH--VKLTDFGLCKESIHEG---TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196 (323)
T ss_pred ecCCCCHHHeEECCCCC--EEEeeCcCCeecccCC---CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcC
Confidence 99999999999988776 9999999987543221 122345699999999999988899999999999999999998
Q ss_pred CCCCCCCchhh-HHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcc
Q 002601 708 GKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 769 (902)
Q Consensus 708 ~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~ 769 (902)
.+||...... ....+.......+...++++.++|.+||+.||++|| +++++++||||....
T Consensus 197 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~ 263 (323)
T cd05584 197 -APPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN 263 (323)
T ss_pred -CCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence 6787654322 222222233344556788999999999999999999 899999999996543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.52 Aligned_cols=253 Identities=30% Similarity=0.455 Sum_probs=196.0
Q ss_pred eeeecccCceEEEEE-EeeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCC-eeEecccccCcc------ceee
Q 002601 478 NKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPN-IVRWYGVESDQD------FVYL 544 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpN-IV~l~g~~~d~~------~~yL 544 (902)
.++||+|+||+||+| ...+|+.||+|++.-... ..+.+|+. ++..++|+| ||+|++++...+ .+|+
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREis-llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREIS-LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHH-HHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 356999999999998 556799999999864432 35789987 779999999 999999998877 7999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
|+|+++.+|..|+-.... ...+++...++.+++||++||+|||+
T Consensus 95 vfe~~d~DL~~ymd~~~~------------------------------------~~~g~~~~~ik~~m~Qll~gl~~~H~ 138 (323)
T KOG0594|consen 95 VFEFLDRDLKKYMDSLPK------------------------------------KPQGLPPRLIKSFMRQLLRGLAFLHS 138 (323)
T ss_pred EEEeecccHHHHHHhccc------------------------------------cccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999888887622110 00345667889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFF 703 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~e 703 (902)
++|+||||||+||||+++|. +||+|||+|+...-.... ....++|..|.|||++.+. .|+..+||||+|||+.|
T Consensus 139 ~~IlHRDLKPQNlLi~~~G~--lKlaDFGlAra~~ip~~~---yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 139 HGILHRDLKPQNLLISSSGV--LKLADFGLARAFSIPMRT---YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred CCeecccCCcceEEECCCCc--EeeeccchHHHhcCCccc---ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHH
Confidence 99999999999999999887 899999999966532221 2345689999999999987 68999999999999999
Q ss_pred HHhCCCCCCCCchhhHH-HHHhh-----------------ccccccc------------cCChHHHHHHHcccCCCCCCC
Q 002601 704 CITGGKHPYGESFERDA-NIVKD-----------------RKDLFLV------------EHIPEAVDLFTRLLDPNPDLR 753 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~~-~~~~~-----------------~~~~~~~------------~~~~e~~dLI~~~L~~dP~~R 753 (902)
|+++..++-+++...+. .+... .+..++. ...++..|++.+||+.+|.+|
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R 293 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR 293 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence 99975444444332221 11110 0001111 112578999999999999999
Q ss_pred cCHHHHHcCCCCCCcchhh
Q 002601 754 PKAQNVLNHPFFWTADTRL 772 (902)
Q Consensus 754 pt~~elL~HPfF~~~~~~~ 772 (902)
.|++.+|.||||...+.+.
T Consensus 294 ~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 294 ISAKGALTHPYFSELPEKS 312 (323)
T ss_pred cCHHHHhcChhhcccccch
Confidence 9999999999997654443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=349.72 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=194.7
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chH-HHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDV-ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~-~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+.+.||+|+||+||++.. .+|+.||||++.+.. ... ..+|+ .++..++||||+++++++.+++..|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAER-DILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 466789999999999999854 568999999986531 111 23344 4678889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++.. ...+++..++.++.||+.||+|||+++
T Consensus 81 E----------~~~~g~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~ 121 (364)
T cd05599 81 E----------YLPGGDMMTLLMK-----------------------------KDTFTEEETRFYIAETILAIDSIHKLG 121 (364)
T ss_pred C----------CCCCcHHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 5566777666532 134677888999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccc-----------------------------------cccccC
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-----------------------------------TQNATG 671 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~-----------------------------------~~~~~~ 671 (902)
|+||||||+|||++.++. +||+|||+++.+....... ......
T Consensus 122 ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (364)
T cd05599 122 YIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYST 199 (364)
T ss_pred eEeccCCHHHeEECCCCC--EEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccc
Confidence 999999999999988876 8999999987653211000 011134
Q ss_pred CCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhH--HHHHhhccc-ccc--ccCChHHHHHHHccc
Q 002601 672 YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKD-LFL--VEHIPEAVDLFTRLL 746 (902)
Q Consensus 672 ~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~--~~~~~~~~~-~~~--~~~~~e~~dLI~~~L 746 (902)
+||+.|+|||++....++.++|||||||++|||++| .+||....... ..+...... .++ ...++++.++|.+|+
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll 278 (364)
T cd05599 200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG-YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC 278 (364)
T ss_pred ccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC-CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHc
Confidence 699999999999998999999999999999999998 67776543222 222222211 112 235789999999999
Q ss_pred CCCCCCCcC---HHHHHcCCCCCCcc
Q 002601 747 DPNPDLRPK---AQNVLNHPFFWTAD 769 (902)
Q Consensus 747 ~~dP~~Rpt---~~elL~HPfF~~~~ 769 (902)
. +|.+|++ +.+++.||||...+
T Consensus 279 ~-~p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 279 C-EAERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred c-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 7 9999998 99999999997654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=349.53 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=197.2
Q ss_pred cceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
.+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. ....+.++..+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 45678889999999999999854 568999999986421 112233334577889999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+++|+|.+++.. ..+++..+..++.||+.||+|||++
T Consensus 122 ~E----------y~~gg~L~~~l~~------------------------------~~l~~~~~~~~~~qi~~aL~~LH~~ 161 (370)
T cd05596 122 ME----------YMPGGDLVNLMSN------------------------------YDIPEKWARFYTAEVVLALDAIHSM 161 (370)
T ss_pred Ec----------CCCCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 6666777666532 2356667788999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC----CCCCcchhhhhHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG----RQTRAIDLFSLGCIL 701 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~----~~s~ksDVwSlGviL 701 (902)
+|+||||||+|||++.++. +||+|||++....... .......+||+.|+|||++... .++.++|||||||++
T Consensus 162 ~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvil 237 (370)
T cd05596 162 GFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237 (370)
T ss_pred CeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCC--cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHH
Confidence 9999999999999988876 9999999998764321 1122345799999999998754 378999999999999
Q ss_pred HHHHhCCCCCCCCch-hhHH-HHHhhc-cccccc--cCChHHHHHHHcccCCCCCC--CcCHHHHHcCCCCCCcchh
Q 002601 702 FFCITGGKHPYGESF-ERDA-NIVKDR-KDLFLV--EHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTADTR 771 (902)
Q Consensus 702 ~elltG~~~Pf~~~~-~~~~-~~~~~~-~~~~~~--~~~~e~~dLI~~~L~~dP~~--Rpt~~elL~HPfF~~~~~~ 771 (902)
|||++| .+||.... .... .+.... ...++. ..++++.++|.+||+.+|.+ |++++++++||||++.+..
T Consensus 238 yelltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 238 YEMLVG-DTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHhC-CCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 999998 66776532 2222 222221 112222 45789999999999999988 9999999999999765443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=342.20 Aligned_cols=246 Identities=27% Similarity=0.377 Sum_probs=193.0
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+++.||||++.+.. .....+|+..+....+||||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e---- 76 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVME---- 76 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEc----
Confidence 3699999999999854 458899999987531 12234455434334489999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 77 ------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~d 121 (318)
T cd05570 77 ------YVNGGDLMFHIQR-----------------------------SGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121 (318)
T ss_pred ------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccC
Confidence 5556666555421 23467888899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++| ..|
T Consensus 122 lkp~Nill~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G-~~p 195 (318)
T cd05570 122 LKLDNVLLDSEGH--IKIADFGMCKEGILGG---VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG-QSP 195 (318)
T ss_pred CCHHHeEECCCCc--EEecccCCCeecCcCC---CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC-CCC
Confidence 9999999988876 9999999987532211 122344689999999999999999999999999999999997 677
Q ss_pred CCCchh-hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH-----HHHHcCCCCCCcc
Q 002601 712 YGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~~~-~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~-----~elL~HPfF~~~~ 769 (902)
|..... .....+......++...++++.++|.+||+.||.+||++ .++++||||...+
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 196 FEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 765432 222333333344555678899999999999999999999 9999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=344.76 Aligned_cols=245 Identities=26% Similarity=0.343 Sum_probs=192.3
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+++.||+|++.+.. .....+|+..+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e---- 76 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD---- 76 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEe----
Confidence 3699999999999854 467899999986432 12334555556778899999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++||+|||
T Consensus 77 ------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrD 121 (325)
T cd05602 77 ------YINGGELFYHLQR-----------------------------ERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121 (325)
T ss_pred ------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 5556666665532 12356677788999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++| .+|
T Consensus 122 lkp~Nili~~~~~--~kl~DfG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p 195 (325)
T cd05602 122 LKPENILLDSQGH--IVLTDFGLCKENIEHN---GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG-LPP 195 (325)
T ss_pred CCHHHeEECCCCC--EEEccCCCCcccccCC---CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcC-CCC
Confidence 9999999988776 8999999997543221 122345699999999999999999999999999999999998 667
Q ss_pred CCCch-hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHH----HHHcCCCCCCc
Q 002601 712 YGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ----NVLNHPFFWTA 768 (902)
Q Consensus 712 f~~~~-~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~----elL~HPfF~~~ 768 (902)
|.... ......+...........++++.++|.+||+.||.+|+++. ++++|+||...
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 196 FYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred CCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 75432 22223332333334456778999999999999999999876 89999999553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=342.97 Aligned_cols=246 Identities=26% Similarity=0.353 Sum_probs=193.3
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+|+.||+|++.+.. .....+|+..+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e---- 76 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLD---- 76 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEc----
Confidence 3699999999999855 568999999986432 12344565556788999999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. ...+++..+..++.||+.||+|||+.+|+|||
T Consensus 77 ------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~D 121 (321)
T cd05603 77 ------YVNGGELFFHLQR-----------------------------ERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121 (321)
T ss_pred ------CCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 5556666555421 12356777888999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+||||+.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 122 lkp~NIll~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~p 195 (321)
T cd05603 122 LKPENILLDSQGH--VVLTDFGLCKEGVEPE---ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG-LPP 195 (321)
T ss_pred CCHHHeEECCCCC--EEEccCCCCccCCCCC---CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcC-CCC
Confidence 9999999988876 9999999987542211 122345699999999999988899999999999999999998 667
Q ss_pred CCCc-hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH----HHHHcCCCCCCcc
Q 002601 712 YGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~-~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~----~elL~HPfF~~~~ 769 (902)
|... .......+.......+...+.++.++|.+||+.||.+|+++ .++++||||...+
T Consensus 196 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 196 FYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 7543 22223333333334455667899999999999999999875 5999999996544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=350.30 Aligned_cols=252 Identities=29% Similarity=0.433 Sum_probs=191.3
Q ss_pred eEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+.+.||+|+||+||++. ..+|+.||||++.+... ....+|+ .++..++|||||++++++.+.++.|+||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~-~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAER-DVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHH-HHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46678999999999999984 45789999999864321 1223344 4678899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++.. ...+++..++.++.|++.||+|||+.|
T Consensus 81 E----------~~~gg~L~~~l~~-----------------------------~~~~~~~~~~~~~~ql~~aL~~LH~~g 121 (377)
T cd05629 81 E----------FLPGGDLMTMLIK-----------------------------YDTFSEDVTRFYMAECVLAIEAVHKLG 121 (377)
T ss_pred e----------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 5566777666532 134677788899999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCc------------cc-----------------------------
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS------------CL----------------------------- 665 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~------------~~----------------------------- 665 (902)
|+||||||+|||++.++. +||+|||+++.+..... ..
T Consensus 122 ivHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (377)
T cd05629 122 FIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK 199 (377)
T ss_pred eeccCCCHHHEEECCCCC--EEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 999999999999988776 99999999964321100 00
Q ss_pred ---cccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhH--HHHHhhcc-ccccc--cCChH
Q 002601 666 ---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRK-DLFLV--EHIPE 737 (902)
Q Consensus 666 ---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~--~~~~~~~~-~~~~~--~~~~e 737 (902)
......+||+.|+|||++.+..++.++|||||||++|||++| .+||....... ..+..... ..++. ..+++
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 278 (377)
T cd05629 200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIG-WPPFCSENSHETYRKIINWRETLYFPDDIHLSVE 278 (377)
T ss_pred cccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcC-CCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHH
Confidence 000124699999999999998999999999999999999998 77886543222 22222211 11222 35689
Q ss_pred HHHHHHcccCCCCCCC---cCHHHHHcCCCCCCcc
Q 002601 738 AVDLFTRLLDPNPDLR---PKAQNVLNHPFFWTAD 769 (902)
Q Consensus 738 ~~dLI~~~L~~dP~~R---pt~~elL~HPfF~~~~ 769 (902)
+.++|.+||. +|.+| +++.|++.||||.+.+
T Consensus 279 ~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 279 AEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred HHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9999999998 67665 6999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=350.53 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=192.2
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|...+.||+|+||+||++. ..+++.||||++.+... ...+.++..+++.++|||||++++++.+++.+|+|||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E- 81 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD- 81 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe-
Confidence 5677899999999999985 45689999999865321 1122333347788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|.+++.. .+.+++..++.++.||+.||+|||+++|+
T Consensus 82 ---------~~~gg~L~~~l~~-----------------------------~~~~~e~~~~~~~~qi~~al~~lH~~~iv 123 (382)
T cd05625 82 ---------YIPGGDMMSLLIR-----------------------------MGIFPEDLARFYIAELTCAVESVHKMGFI 123 (382)
T ss_pred ---------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 5566777666532 12357778889999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCc--------------------------------------------c
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--------------------------------------------C 664 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~--------------------------------------------~ 664 (902)
||||||+|||++.++. +||+|||++..+..... .
T Consensus 124 HrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (382)
T cd05625 124 HRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQ 201 (382)
T ss_pred cCCCCHHHEEECCCCC--EEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccc
Confidence 9999999999988876 89999999864321000 0
Q ss_pred ccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhh--HHHHHhhcc-ccc--cccCChHHH
Q 002601 665 LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKDRK-DLF--LVEHIPEAV 739 (902)
Q Consensus 665 ~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~--~~~~~~~~~-~~~--~~~~~~e~~ 739 (902)
.....+.+||+.|+|||++.+..++.++|||||||++|||++| .+||...... ...+..... ... ....++++.
T Consensus 202 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 280 (382)
T cd05625 202 RCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG-QPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEAS 280 (382)
T ss_pred cccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhC-CCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHH
Confidence 0011234699999999999999999999999999999999997 7787654322 222222111 111 234678999
Q ss_pred HHHHcccCCCCCCCcC---HHHHHcCCCCCCcc
Q 002601 740 DLFTRLLDPNPDLRPK---AQNVLNHPFFWTAD 769 (902)
Q Consensus 740 dLI~~~L~~dP~~Rpt---~~elL~HPfF~~~~ 769 (902)
++|.+|+ .+|++|++ ++++++||||...+
T Consensus 281 ~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 281 DLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred HHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 9999986 59999987 99999999996543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=352.64 Aligned_cols=252 Identities=29% Similarity=0.334 Sum_probs=197.0
Q ss_pred cccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC--chHHHHHHHHHHHhCC-C-----CCeeEecccccCcc
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ-H-----PNIVRWYGVESDQD 540 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~-H-----pNIV~l~g~~~d~~ 540 (902)
.++-.|.+.+.||+|+||.|.+| +..+++.||||++++.. ..++..|+. ++..++ | -|+|+++++|...+
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~-iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIR-ILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHH-HHHHHhccCCCCCeeEEEeeecccccc
Confidence 34457888999999999999998 55679999999997643 345566665 445554 4 38999999999999
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
++|||+|++..+|.+++.. .+-.+++...++.|+.||+.||.
T Consensus 262 HlciVfELL~~NLYellK~--------------------------------------n~f~Glsl~~ir~~~~Qil~~L~ 303 (586)
T KOG0667|consen 262 HLCIVFELLSTNLYELLKN--------------------------------------NKFRGLSLPLVRKFAQQILTALL 303 (586)
T ss_pred ceeeeehhhhhhHHHHHHh--------------------------------------cCCCCCCHHHHHHHHHHHHHHHH
Confidence 9999999999888887621 12356889999999999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvi 700 (902)
+||+.+|||+||||+||||...+...+||+|||.|........ +-+-+..|+|||++.+.+|+.+.||||||||
T Consensus 304 ~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCI 377 (586)
T KOG0667|consen 304 FLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCI 377 (586)
T ss_pred HHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce------eeeeccccccchhhccCCCCCccceeehhhh
Confidence 9999999999999999999877777899999999987664322 3345778999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchh-hHH-HHHh---------------------h------------------------------cc
Q 002601 701 LFFCITGGKHPYGESFE-RDA-NIVK---------------------D------------------------------RK 727 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~-~~~-~~~~---------------------~------------------------------~~ 727 (902)
+.||++| .+-|.+..+ .+. .|++ . ..
T Consensus 378 lAEL~tG-~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~ 456 (586)
T KOG0667|consen 378 LAELFTG-EPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLE 456 (586)
T ss_pred HHhHhcC-ccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhccc
Confidence 9999998 544443222 111 0100 0 00
Q ss_pred cccc-c----------cCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 728 DLFL-V----------EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 728 ~~~~-~----------~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
...+ . .....+.|+|++||..||.+|+|+.++|+||||..
T Consensus 457 ~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 457 RRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred ccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCccccc
Confidence 0001 0 00135789999999999999999999999999963
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=332.89 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=191.8
Q ss_pred ecccCceEEEEEE-eeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 481 IAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 481 LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
||+|+||+||++. ..+|+.||||.+.+... +....|+. +++.++||||+++.+++.+++..|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e------ 73 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKR-ILAKVHSRFIVSLAYAFQTKTDLCLVMT------ 73 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHH-HHHhCCCCcEeeeeEEEcCCCeEEEEEe------
Confidence 7999999999975 45789999999865321 12234444 6788899999999999999999999999
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
|+++|+|..++..... ....+++..+..++.||+.||+|||+.+|+|||||
T Consensus 74 ----~~~~g~L~~~~~~~~~-------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 124 (280)
T cd05608 74 ----IMNGGDLRYHIYNVDE-------------------------ENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLK 124 (280)
T ss_pred ----CCCCCCHHHHHHhccc-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 6667777665532111 11346788889999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
|+||+++.++. ++|+|||++..+..... ......||+.|+|||++.+..++.++|||||||++|||++| ..||.
T Consensus 125 p~Nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~pf~ 198 (280)
T cd05608 125 PENVLLDNDGN--VRISDLGLAVELKDGQS---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA-RGPFR 198 (280)
T ss_pred HHHEEECCCCC--EEEeeCccceecCCCCc---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhC-CCCCC
Confidence 99999987765 89999999987654321 12334689999999999999999999999999999999997 77886
Q ss_pred Cchhh--H---HHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCc
Q 002601 714 ESFER--D---ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTA 768 (902)
Q Consensus 714 ~~~~~--~---~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~ 768 (902)
..... . ...+.......+...++++.+++.+||+.||++|| +++++++||||...
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 199 ARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred CCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 43211 1 11111122233455778999999999999999999 88999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=332.22 Aligned_cols=255 Identities=29% Similarity=0.408 Sum_probs=189.8
Q ss_pred ccccceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCc-----cce
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFV 542 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~-----~~~ 542 (902)
+...-.|.-.+.+|.|+||.||.|... ++..||||+..... ...-+|++ +|+.+.|||||+|..+|... -++
T Consensus 20 ~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~-im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 20 KKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQ-IMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred cceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHH-HHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 344455667789999999999998654 47999999875432 23345665 45699999999999876532 256
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
.+||||++.+|.+++. ... .....+|...++-++.||++||+||
T Consensus 98 nlVleymP~tL~~~~r-----------~~~-------------------------~~~~~mp~~~iKLYt~Qlfrgl~yL 141 (364)
T KOG0658|consen 98 NLVLEYMPETLYRVIR-----------HYT-------------------------RANQRMPLLEIKLYTYQLFRGLAYL 141 (364)
T ss_pred HHHHHhchHHHHHHHH-----------HHh-------------------------hcCCCCceeeeHHHHHHHHHHHHHH
Confidence 7899988777766551 000 1123456667788999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCIL 701 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL 701 (902)
|+.||+||||||+|+|+|.+.. .+||||||.|+.+..+... .+-..|..|+|||.+.+. .|+.+.||||.||++
T Consensus 142 h~~~IcHRDIKPqNlLvD~~tg-~LKicDFGSAK~L~~~epn----iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~ 216 (364)
T KOG0658|consen 142 HSHGICHRDIKPQNLLVDPDTG-VLKICDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVM 216 (364)
T ss_pred HhcCcccCCCChheEEEcCCCC-eEEeccCCcceeeccCCCc----eeEEEeccccCHHHHcCccccCceeEEhhhhHHH
Confidence 9999999999999999998753 5999999999988754322 222357889999998875 589999999999999
Q ss_pred HHHHhCCCCCCCCchhhHH-HHHh--------------hc--------------cccccccCChHHHHHHHcccCCCCCC
Q 002601 702 FFCITGGKHPYGESFERDA-NIVK--------------DR--------------KDLFLVEHIPEAVDLFTRLLDPNPDL 752 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~~-~~~~--------------~~--------------~~~~~~~~~~e~~dLI~~~L~~dP~~ 752 (902)
.||+-|+..+-+++...+. .+++ .. ...+.....+++.||+.++|+.+|.+
T Consensus 217 aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~ 296 (364)
T KOG0658|consen 217 AELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSK 296 (364)
T ss_pred HHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhh
Confidence 9999985544444332221 1110 00 00123345689999999999999999
Q ss_pred CcCHHHHHcCCCCC
Q 002601 753 RPKAQNVLNHPFFW 766 (902)
Q Consensus 753 Rpt~~elL~HPfF~ 766 (902)
|.++.|++.||||.
T Consensus 297 R~~~~~~l~h~fFd 310 (364)
T KOG0658|consen 297 RLSALEALAHPFFD 310 (364)
T ss_pred cCCHHHHhcchhhH
Confidence 99999999999994
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=346.61 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=194.9
Q ss_pred ccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
..+.|.+.+.||+|+||.||++.. .+++.||+|++.+.. ....+.++..+++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 345688889999999999999854 468899999986421 12234455567888999999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||| |+++|+|.+++.. ..+++..+..++.||+.||+|||+
T Consensus 121 v~E----------y~~gg~L~~~l~~------------------------------~~~~~~~~~~~~~qil~aL~~LH~ 160 (370)
T cd05621 121 VME----------YMPGGDLVNLMSN------------------------------YDVPEKWAKFYTAEVVLALDAIHS 160 (370)
T ss_pred EEc----------CCCCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 5666777666531 235667788999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC----CCCcchhhhhHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLGCI 700 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSlGvi 700 (902)
++|+||||||+|||++.++. +||+|||++....... .....+.+||+.|+|||++.... ++.++|||||||+
T Consensus 161 ~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~i 236 (370)
T cd05621 161 MGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236 (370)
T ss_pred CCeEecCCCHHHEEECCCCC--EEEEecccceecccCC--ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHH
Confidence 99999999999999988876 9999999998764321 11224567999999999997643 7889999999999
Q ss_pred HHHHHhCCCCCCCCch-hhHH-HHHhhcc-cccc--ccCChHHHHHHHcccCCCCCC--CcCHHHHHcCCCCCCc
Q 002601 701 LFFCITGGKHPYGESF-ERDA-NIVKDRK-DLFL--VEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTA 768 (902)
Q Consensus 701 L~elltG~~~Pf~~~~-~~~~-~~~~~~~-~~~~--~~~~~e~~dLI~~~L~~dP~~--Rpt~~elL~HPfF~~~ 768 (902)
+|||++| .+||.... .... .+..... ..++ ...++.++++|.+||..++.+ |++++|+++||||...
T Consensus 237 lyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 237 LFEMLVG-DTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHhC-CCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 9999998 66775432 2222 2222211 1222 235778999999999866544 8999999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.16 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=202.3
Q ss_pred EEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 475 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
|...+.||+|+||.||+| ...+++.||+|++.-... +...+|+. ++...+|+||.++||.+..+..++++||
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~-~Ls~~~~~~it~yygsyl~g~~LwiiMe-- 91 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEIS-VLSQCDSPNITEYYGSYLKGTKLWIIME-- 91 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHH-HHHhcCcchHHhhhhheeecccHHHHHH--
Confidence 344478999999999998 556799999999864432 23344554 6788999999999999999999999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+.+|++.+.|... ..+++..+.-|+++++.||.|||.++.+|
T Consensus 92 --------y~~gGsv~~lL~~~-----------------------------~~~~E~~i~~ilre~l~~l~ylH~~~kiH 134 (467)
T KOG0201|consen 92 --------YCGGGSVLDLLKSG-----------------------------NILDEFEIAVILREVLKGLDYLHSEKKIH 134 (467)
T ss_pred --------HhcCcchhhhhccC-----------------------------CCCccceeeeehHHHHHHhhhhhhcceec
Confidence 66677777666322 11245566779999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
||||+.|||+..+|. +|++|||.+..+.... ....+++||+.|||||++....|+.|+||||||++.+||.+| .
T Consensus 135 rDIKaanil~s~~g~--vkl~DfgVa~ql~~~~---~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~G-e 208 (467)
T KOG0201|consen 135 RDIKAANILLSESGD--VKLADFGVAGQLTNTV---KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKG-E 208 (467)
T ss_pred ccccccceeEeccCc--EEEEecceeeeeechh---hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcC-C
Confidence 999999999998876 9999999998887542 334788999999999999988999999999999999999998 8
Q ss_pred CCCCCchhhH--HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 710 HPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 710 ~Pf~~~~~~~--~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
+|+.+..+.. ..|.+...+.....+++.++++|..||+.||+.||+|.++|+|+|.+..
T Consensus 209 PP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 209 PPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred CCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 8988754421 1233333333444677889999999999999999999999999999773
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=335.08 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=205.1
Q ss_pred cceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc--h----HHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH--D----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~--~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
..+|.+.+.||+|.||.|-+|. ...|++||||.+++... + ...+||. +|+.++||||+.+|.+|+..+.+.|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIe-IMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIE-IMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHH-HHhhcCCCceeehhhhhcCCceEEE
Confidence 3456677889999999999884 47899999998876432 1 2456665 7799999999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||| |..+|.|++++.. .+.+++.+++.+++||+.|+.|+|.
T Consensus 131 vME----------YaS~GeLYDYiSe-----------------------------r~~LsErEaRhfFRQIvSAVhYCHk 171 (668)
T KOG0611|consen 131 VME----------YASGGELYDYISE-----------------------------RGSLSEREARHFFRQIVSAVHYCHK 171 (668)
T ss_pred EEE----------ecCCccHHHHHHH-----------------------------hccccHHHHHHHHHHHHHHHHHHhh
Confidence 999 7788888888743 3457888999999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCC-CCcchhhhhHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFF 703 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGviL~e 703 (902)
++++|||||.+||||+.+++ +||+||||+..+... ....++||+|-|.+||++.+.+| ++.+|-|||||+||-
T Consensus 172 nrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~----kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYt 245 (668)
T KOG0611|consen 172 NRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADK----KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYT 245 (668)
T ss_pred ccceecccchhheeecCCCC--eeeeccchhhhhccc----cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHH
Confidence 99999999999999988877 999999999887653 34467899999999999999998 589999999999999
Q ss_pred HHhCCCCCCCCch-hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 704 CITGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 704 lltG~~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
|+.| ..||++.. .+....+.... ....+.+.++.-||+.||-.+|++|.|++++..|-|.
T Consensus 246 LVyG-tMPFDG~Dhk~lvrQIs~Ga-YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWv 306 (668)
T KOG0611|consen 246 LVYG-TMPFDGRDHKRLVRQISRGA-YREPETPSDASGLIRWMLMVNPERRATIEDIASHWWV 306 (668)
T ss_pred Hhhc-ccccCCchHHHHHHHhhccc-ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhee
Confidence 9997 78887643 33333333332 2233456789999999999999999999999999887
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=346.10 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=191.5
Q ss_pred ccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
.+..|.+.+.||+|+||.||++.. ..++.||||.... ....+|+. +++.++|+|||++++++..++..++|||++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---~~~~~E~~-iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---ASSVHEAR-LLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---cCHHHHHH-HHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 355688899999999999999854 4578999996432 22456664 678899999999999999999999999966
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
.++|.++ +.. ....+++.+++.|+.||+.||+|||++||+|
T Consensus 243 ~~~L~~~-----------l~~----------------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvH 283 (461)
T PHA03211 243 RSDLYTY-----------LGA----------------------------RLRPLGLAQVTAVARQLLSAIDYIHGEGIIH 283 (461)
T ss_pred CCCHHHH-----------HHh----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Confidence 5544433 211 1124678888999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
|||||+||||+.++. +||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 284 rDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~ 360 (461)
T PHA03211 284 RDIKTENVLVNGPED--ICLGDFGAACFARGSWST-PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360 (461)
T ss_pred CcCCHHHEEECCCCC--EEEcccCCceeccccccc-ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCC
Confidence 999999999987766 899999999876532211 11224569999999999999999999999999999999999866
Q ss_pred CCCCCch--------hhHHHHHhhcc---cccc-------------------------------ccCChHHHHHHHcccC
Q 002601 710 HPYGESF--------ERDANIVKDRK---DLFL-------------------------------VEHIPEAVDLFTRLLD 747 (902)
Q Consensus 710 ~Pf~~~~--------~~~~~~~~~~~---~~~~-------------------------------~~~~~e~~dLI~~~L~ 747 (902)
+.|.... .....++.... ..++ ....+++.+||.+||+
T Consensus 361 ~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~ 440 (461)
T PHA03211 361 SLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALT 440 (461)
T ss_pred CcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcc
Confidence 5554321 11112211100 0000 0234578999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCC
Q 002601 748 PNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 748 ~dP~~Rpt~~elL~HPfF~~ 767 (902)
.||.+|||+.|+|+||||.+
T Consensus 441 ~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 441 FDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cChhhCcCHHHHhhCcccCC
Confidence 99999999999999999964
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=340.96 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=192.0
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||+||++.. .+++.||||++.+... ....+|+..+....+||||+++++++.+.+..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e---- 76 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIE---- 76 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEe----
Confidence 3699999999999854 5678999999975321 1233455444444579999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. .+.+++..++.++.||+.||+|||+++|+|||
T Consensus 77 ------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrD 121 (327)
T cd05617 77 ------YVNGGDLMFHMQR-----------------------------QRKLPEEHARFYAAEICIALNFLHERGIIYRD 121 (327)
T ss_pred ------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 5566777655421 23477888899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 122 lkp~Nili~~~~~--~kl~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g-~~p 195 (327)
T cd05617 122 LKLDNVLLDADGH--IKLTDYGMCKEGLGPG---DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG-RSP 195 (327)
T ss_pred CCHHHEEEeCCCC--EEEeccccceeccCCC---CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhC-CCC
Confidence 9999999988876 9999999987533211 122345799999999999999999999999999999999998 678
Q ss_pred CCCc--------hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC------HHHHHcCCCCCCcc
Q 002601 712 YGES--------FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTAD 769 (902)
Q Consensus 712 f~~~--------~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt------~~elL~HPfF~~~~ 769 (902)
|... .......+.......+...++++.++|.+||+.||.+|++ ++++++||||...+
T Consensus 196 f~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 196 FDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred CCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 7421 1112223333333455567789999999999999999998 56999999997644
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.67 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=194.6
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|.+.+.||+|+||+||++. ..+|+.||||++.+.. ......|...+....+|++|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 4567899999999999985 4568999999986431 11233455444334456788899999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++.. ...+++.+++.++.||+.||+|||++||
T Consensus 82 ----------y~~~g~L~~~i~~-----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~i 122 (323)
T cd05615 82 ----------YVNGGDLMYHIQQ-----------------------------VGKFKEPQAVFYAAEISVGLFFLHRRGI 122 (323)
T ss_pred ----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 5566777665532 1346788889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 123 vHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 197 (323)
T cd05615 123 IYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDG---VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197 (323)
T ss_pred eccCCCHHHeEECCCCC--EEEeccccccccCCCC---ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhC
Confidence 99999999999988876 8999999987543221 112345689999999999988899999999999999999997
Q ss_pred CCCCCCCchhh-HHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCcc
Q 002601 708 GKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 769 (902)
Q Consensus 708 ~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~~ 769 (902)
.+||...... ....+.......+...++++.+++.+||+.||.+|++ .+++++||||...+
T Consensus 198 -~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 198 -QPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 6787654332 2233333333455667889999999999999999997 57899999997643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=345.43 Aligned_cols=245 Identities=28% Similarity=0.414 Sum_probs=187.4
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
|...+.||+|+||+||++.. .+|+.||||++...... ...+|+. ++..++|+||+++++++.+++.+|+|||
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e-- 152 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE-ILRDVNHPNVVKCHDMFDHNGEIQVLLE-- 152 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHH-HHHhCCCCCcceeeeEeccCCeEEEEEe--
Confidence 34557899999999999854 46899999998654322 2344554 6788999999999999999999999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+.+|+|.... ..++..+..++.||+.||+|||+++|+|
T Consensus 153 --------~~~~~~L~~~~---------------------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivH 191 (353)
T PLN00034 153 --------FMDGGSLEGTH---------------------------------IADEQFLADVARQILSGIAYLHRRHIVH 191 (353)
T ss_pred --------cCCCCcccccc---------------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 55556653321 1234456789999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-----CCCCcchhhhhHHHHHHH
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-----RQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSlGviL~el 704 (902)
|||||+|||++.++. +||+|||+++.+.... .......||..|+|||++... ..+.++|||||||++|||
T Consensus 192 rDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el 266 (353)
T PLN00034 192 RDIKPSNLLINSAKN--VKIADFGVSRILAQTM---DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266 (353)
T ss_pred cCCCHHHEEEcCCCC--EEEcccccceeccccc---ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHH
Confidence 999999999988776 8999999998765321 112345699999999987532 235689999999999999
Q ss_pred HhCCCCCCCCchhhH-----HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 705 ITGGKHPYGESFERD-----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
++| +.||....... ..+........+...++++.+||.+||+.||++||++.|+++||||....
T Consensus 267 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 267 YLG-RFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HhC-CCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 998 77886322111 11111222233445678999999999999999999999999999997643
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=343.01 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=196.1
Q ss_pred eEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|.+.+.||+|+||+||++. ..+|+.||||++.+.. ....++++..++..++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 46788999999999999984 4578999999986532 12334555567788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++... ...+++..+..++.||+.||+|||+.+|
T Consensus 82 ----------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~i 123 (330)
T cd05601 82 ----------YQPGGDLLSLLNRY----------------------------EDQFDEDMAQFYLAELVLAIHSVHQMGY 123 (330)
T ss_pred ----------CCCCCCHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 66667777666321 1346778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc------cCCCCCcchhhhhHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL------QGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~------~~~~s~ksDVwSlGviL 701 (902)
+||||||+|||++.++. +||+|||++..+...... ......||+.|+|||++. ...++.++|||||||++
T Consensus 124 ~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 124 VHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred EcccCchHheEECCCCC--EEeccCCCCeECCCCCce--eeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 99999999999988876 999999999876543221 123346899999999987 45678999999999999
Q ss_pred HHHHhCCCCCCCCchh-hHH-HHHhhcc-cccc--ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 702 FFCITGGKHPYGESFE-RDA-NIVKDRK-DLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~-~~~-~~~~~~~-~~~~--~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
|||++| ..||..... ... .+..... ..++ ...++++.+||.+||+ +|.+||+++++++||||...
T Consensus 200 ~el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 200 YEMIYG-RSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred eeeccC-CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 999998 677765322 222 2222211 1122 2457899999999998 99999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=339.48 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=193.7
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+.|...+.||+|+||.||++.. .+|..||+|.+..... ....+|+. ++..++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4577788999999999999854 4688999999865322 23445554 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc-c
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-G 626 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~-~ 626 (902)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +
T Consensus 84 ----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 124 (331)
T cd06649 84 ----------HMDGGSLDQVLKE-----------------------------AKRIPEEILGKVSIAVLRGLAYLREKHQ 124 (331)
T ss_pred ----------cCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 6667777766532 12467778899999999999999986 6
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
|+||||||+|||++.++. +||+|||++...... ......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 125 ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 197 (331)
T cd06649 125 IMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI 197 (331)
T ss_pred EEcCCCChhhEEEcCCCc--EEEccCccccccccc-----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999999988876 899999999866432 1233468999999999998899999999999999999999
Q ss_pred CCCCCCCCchhhHH-HHHh-----------------------------------------------hcccc-ccccCChH
Q 002601 707 GGKHPYGESFERDA-NIVK-----------------------------------------------DRKDL-FLVEHIPE 737 (902)
Q Consensus 707 G~~~Pf~~~~~~~~-~~~~-----------------------------------------------~~~~~-~~~~~~~e 737 (902)
| +.||........ .++. ..... .....+++
T Consensus 198 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (331)
T cd06649 198 G-RYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPD 276 (331)
T ss_pred C-CCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHH
Confidence 8 667754222111 0000 00000 01124678
Q ss_pred HHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 738 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 738 ~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
+++||.+||+.||++|||+.++++||||...
T Consensus 277 l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 277 FQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred HHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 9999999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=343.31 Aligned_cols=254 Identities=27% Similarity=0.393 Sum_probs=203.6
Q ss_pred ccccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCC-CCCeeEecccccCcc
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQ-HPNIVRWYGVESDQD 540 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~-HpNIV~l~g~~~d~~ 540 (902)
..+...|.+.+.||+|.||.||++.. .+|+.+|+|.+.+... +...+|+. +++.+. |||||.+++++++.+
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~-il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVA-ILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHH-HHHhccCCCCEEEEEEEEEcCC
Confidence 44567788999999999999999854 4599999999976532 35667776 456665 999999999999999
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
.+|+|||+|. +|.|.+.+... .+++..+..+++||+.|++
T Consensus 110 ~~~lvmEL~~----------GGeLfd~i~~~------------------------------~~sE~da~~~~~~il~av~ 149 (382)
T KOG0032|consen 110 SVYLVMELCE----------GGELFDRIVKK------------------------------HYSERDAAGIIRQILEAVK 149 (382)
T ss_pred eEEEEEEecC----------CchHHHHHHHc------------------------------cCCHHHHHHHHHHHHHHHH
Confidence 9999999665 55665554211 2677788999999999999
Q ss_pred ccccccccccccccceeEeccCC--CceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~--~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 698 (902)
|||+.||+||||||+|+|+.... ...+|++|||++..... .......+||+.|+|||++....|+..+||||+|
T Consensus 150 ~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~G 225 (382)
T KOG0032|consen 150 YLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIG 225 (382)
T ss_pred HHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC----CceEeeecCCccccCchhhcCCCCCcccchhHHH
Confidence 99999999999999999996543 24699999999998775 2344677899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC-chhhHHHHHhhccc----cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 699 CILFFCITGGKHPYGE-SFERDANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 699 viL~elltG~~~Pf~~-~~~~~~~~~~~~~~----~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
|++|.|++| .+||.. ........+..... ......+..++++|.+||..||.+|+|+.++|+|||+.+.
T Consensus 226 vi~yiLL~G-~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 226 VILYILLSG-VPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHhhC-CCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999998 556654 33333333322222 2233457899999999999999999999999999998764
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=341.53 Aligned_cols=245 Identities=28% Similarity=0.399 Sum_probs=194.7
Q ss_pred eeecccCceEEEEEEe----eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 479 KEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~----~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
+.||+|+||+||++.. .+|+.||||++.+... ....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e-- 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD-ILAEVNHPFIVKLHYAFQTEGKLYLILD-- 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHH-HHHhCCCCCcccEEEEEEcCCEEEEEEc--
Confidence 5699999999998743 4689999999865321 12344554 6788999999999999999999999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+|+|
T Consensus 79 --------~~~~~~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 121 (318)
T cd05582 79 --------FLRGGDLFTRLSK-----------------------------EVMFTEEDVKFYLAELALALDHLHSLGIIY 121 (318)
T ss_pred --------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 5566777666532 134677888999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
|||||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++| .
T Consensus 122 ~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~ 195 (318)
T cd05582 122 RDLKPENILLDEEGH--IKLTDFGLSKESIDHE---KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG-S 195 (318)
T ss_pred CCCCHHHeEECCCCc--EEEeeccCCcccCCCC---CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccC-C
Confidence 999999999988776 8999999987654321 122345699999999999988899999999999999999997 7
Q ss_pred CCCCCchh-hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCcc
Q 002601 710 HPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 769 (902)
Q Consensus 710 ~Pf~~~~~-~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~~ 769 (902)
.||..... .....+.......+...++++.++|.+||+.||.+||+ +.+++.||||...+
T Consensus 196 ~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~ 261 (318)
T cd05582 196 LPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTID 261 (318)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence 78865432 22222222333445567889999999999999999999 77799999997644
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=343.66 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=193.3
Q ss_pred ccceEEEeeeecccCceEEEEEEe---eCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~---~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+...|.+.+.||+|+||+||++.. ..++.||||.+... ....+|+. +++.++|||||++++++.+.+..|+|||
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~-il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREID-ILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHH-HHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 345688999999999999999743 34678999998654 23456665 6688999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
++.++|.+++ . ....+++..++.|+.||+.||+|||++||
T Consensus 167 ~~~~~l~~~l-----------~-----------------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~gi 206 (392)
T PHA03207 167 KYKCDLFTYV-----------D-----------------------------RSGPLPLEQAITIQRRLLEALAYLHGRGI 206 (392)
T ss_pred hcCCCHHHHH-----------H-----------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 7765554433 1 11346778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+|||++.++. ++|+|||+++....... ........||+.|+|||++....++.++|||||||++|||++|
T Consensus 207 vHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g 283 (392)
T PHA03207 207 IHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPD-TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVK 283 (392)
T ss_pred cccCCCHHHEEEcCCCC--EEEccCccccccCcccc-cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999988776 89999999987654321 1122345699999999999999999999999999999999998
Q ss_pred CCCCCCCchhh----HHHHHhh---c-----------------------cccc-------cccCChHHHHHHHcccCCCC
Q 002601 708 GKHPYGESFER----DANIVKD---R-----------------------KDLF-------LVEHIPEAVDLFTRLLDPNP 750 (902)
Q Consensus 708 ~~~Pf~~~~~~----~~~~~~~---~-----------------------~~~~-------~~~~~~e~~dLI~~~L~~dP 750 (902)
+.++++..... ...++.. . ...+ ......++.++|.+||+.||
T Consensus 284 ~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp 363 (392)
T PHA03207 284 NVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ 363 (392)
T ss_pred CCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccCh
Confidence 55544432110 1111100 0 0000 01234578899999999999
Q ss_pred CCCcCHHHHHcCCCCCCcc
Q 002601 751 DLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 751 ~~Rpt~~elL~HPfF~~~~ 769 (902)
.+||++.|++.||||...+
T Consensus 364 ~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 364 EFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred hhCCCHHHHhhCchhhccc
Confidence 9999999999999996533
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=330.66 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=197.1
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|...+.||+|+||+||++.. .+++.||||++..... ....+|+. +++.++||||+++++++.+++..++|||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQ-ILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHH-HHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 45668899999999999854 5689999999864321 12345654 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|..++... ....+++..+..++.|++.||+|||+.+|
T Consensus 81 ----------~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05605 81 ----------LMNGGDLKFHIYNM---------------------------GNPGFDEERAVFYAAEITCGLEDLHRERI 123 (285)
T ss_pred ----------ccCCCcHHHHHHhc---------------------------CcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 66666776555321 11346788889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+||++++++. ++|+|||++....... ......|++.|+|||++.+..++.++||||+||++|||++|
T Consensus 124 vH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g 197 (285)
T cd05605 124 VYRDLKPENILLDDYGH--IRISDLGLAVEIPEGE----TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG 197 (285)
T ss_pred EecCCCHHHEEECCCCC--EEEeeCCCceecCCCC----ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHC
Confidence 99999999999987765 8999999998754321 11234689999999999988899999999999999999997
Q ss_pred CCCCCCCchhhH-----HHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcc
Q 002601 708 GKHPYGESFERD-----ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 769 (902)
Q Consensus 708 ~~~Pf~~~~~~~-----~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~ 769 (902)
..||....... ...+......++...++.+.++|.+||+.||.+|| +++++++||||...+
T Consensus 198 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05605 198 -KSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268 (285)
T ss_pred -CCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence 77886532211 11222223334455778999999999999999999 899999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=340.65 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=187.6
Q ss_pred ccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCcc----
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD---- 540 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~---- 540 (902)
+.+.|...+.||+|+||+||++.. .+|+.||||++.... .....+|+. ++..++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELV-LLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHH-HHHhCCCCCEeeeeeeeccCCCccc
Confidence 446788899999999999999854 568999999986432 123455654 678899999999999876443
Q ss_pred --ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 541 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 541 --~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
..|+|||||.++|.+.+ + ..+++..+..++.||+.|
T Consensus 98 ~~~~~lv~e~~~~~l~~~~-----------~-------------------------------~~~~~~~~~~~~~qi~~~ 135 (359)
T cd07876 98 FQDVYLVMELMDANLCQVI-----------H-------------------------------MELDHERMSYLLYQMLCG 135 (359)
T ss_pred cceeEEEEeCCCcCHHHHH-----------h-------------------------------ccCCHHHHHHHHHHHHHH
Confidence 47999997765544332 1 124566778899999999
Q ss_pred ccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhH
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 619 L~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 698 (902)
|+|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..++.++||||||
T Consensus 136 L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 209 (359)
T cd07876 136 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209 (359)
T ss_pred HHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccccCc----cCCCCcccCCCCCchhccCCCCCcchhhHHHH
Confidence 99999999999999999999988876 9999999997654321 12334689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchhhHH--H----------------------HHhhccc--------c-----------ccccCC
Q 002601 699 CILFFCITGGKHPYGESFERDA--N----------------------IVKDRKD--------L-----------FLVEHI 735 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~~--~----------------------~~~~~~~--------~-----------~~~~~~ 735 (902)
|++|+|++| .+||........ . ....... . .....+
T Consensus 210 ~il~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (359)
T cd07876 210 CIMGELVKG-SVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKT 288 (359)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccc
Confidence 999999998 778864321110 0 0000000 0 001124
Q ss_pred hHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 736 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 736 ~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+++++||.+||+.||++|||+.|+++||||..
T Consensus 289 ~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 289 SQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred hhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 67899999999999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=343.70 Aligned_cols=254 Identities=23% Similarity=0.350 Sum_probs=193.9
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|...+.||+|+||+||++.. .+|+.||||++.+.. ....++++..++..++||||+++++++.+++.+|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 466778999999999999854 568999999986421 11222333346678899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++.. ...+++..++.++.|++.||+|||+.||
T Consensus 82 ----------~~~gg~L~~~l~~-----------------------------~~~l~~~~~~~~~~qi~~~L~~lH~~gi 122 (360)
T cd05627 82 ----------FLPGGDMMTLLMK-----------------------------KDTLSEEATQFYIAETVLAIDAIHQLGF 122 (360)
T ss_pred ----------CCCCccHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 6666777666532 2346778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCcc--------------------------------ccccccCCCCc
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC--------------------------------LTQNATGYGSS 675 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~--------------------------------~~~~~~~~Gt~ 675 (902)
+||||||+|||++.++. +||+|||+++.+...... .......+||+
T Consensus 123 vHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 200 (360)
T cd05627 123 IHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTP 200 (360)
T ss_pred EccCCCHHHEEECCCCC--EEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCc
Confidence 99999999999988876 899999998765321100 00112347999
Q ss_pred cccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhh-HH-HHHhhc-cccccc--cCChHHHHHHHcccCCCC
Q 002601 676 GWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DA-NIVKDR-KDLFLV--EHIPEAVDLFTRLLDPNP 750 (902)
Q Consensus 676 ~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~-~~-~~~~~~-~~~~~~--~~~~e~~dLI~~~L~~dP 750 (902)
.|+|||++.+..++.++|||||||++|||++| .+||...... .. .+.... ...++. ..+++++++|.+|+. ||
T Consensus 201 ~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p 278 (360)
T cd05627 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG-YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DS 278 (360)
T ss_pred cccCHHHHcCCCCCCcceeccccceeeecccC-CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-Ch
Confidence 99999999999999999999999999999998 6787654322 22 222211 112222 357899999999875 99
Q ss_pred CCCc---CHHHHHcCCCCCCcch
Q 002601 751 DLRP---KAQNVLNHPFFWTADT 770 (902)
Q Consensus 751 ~~Rp---t~~elL~HPfF~~~~~ 770 (902)
.+|+ +++++++||||.+.+.
T Consensus 279 ~~R~~~~~~~ei~~hp~f~~~~~ 301 (360)
T cd05627 279 ENRIGSNGVEEIKSHPFFEGVDW 301 (360)
T ss_pred hhcCCCCCHHHHhcCCCCCCCCH
Confidence 9998 4899999999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=351.25 Aligned_cols=248 Identities=31% Similarity=0.451 Sum_probs=205.7
Q ss_pred eecccCceEEEEEE-eeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChhhH
Q 002601 480 EIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDL 556 (902)
Q Consensus 480 ~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~dl 556 (902)
+||+|.||+||-|. ..+...+|||-+..... .+.+.|+..+.+.++|.|||+++|.+.+++++-|.||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFME--------- 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFME--------- 652 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEee---------
Confidence 59999999999874 45567899999865432 3456666678899999999999999999999999999
Q ss_pred HHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccce
Q 002601 557 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 636 (902)
Q Consensus 557 iy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~N 636 (902)
.+|+|+|.+.|..+ |..-.-.+..+-.+.+||++||.|||++.|||||||-+|
T Consensus 653 -qVPGGSLSsLLrsk--------------------------WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDN 705 (1226)
T KOG4279|consen 653 -QVPGGSLSSLLRSK--------------------------WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDN 705 (1226)
T ss_pred -cCCCCcHHHHHHhc--------------------------cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCc
Confidence 99999999998643 332223567788899999999999999999999999999
Q ss_pred eEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC--CCCcchhhhhHHHHHHHHhCCCCCCCC
Q 002601 637 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPYGE 714 (902)
Q Consensus 637 ILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGviL~elltG~~~Pf~~ 714 (902)
|||+.-.. .+||+|||-++++.+-.. -+.++.||..|||||++..++ |+.++|||||||++.||.|| +|||.+
T Consensus 706 VLvNTySG-vlKISDFGTsKRLAginP---~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATG-rPPF~E 780 (1226)
T KOG4279|consen 706 VLVNTYSG-VLKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATG-RPPFVE 780 (1226)
T ss_pred EEEeeccc-eEEecccccchhhccCCc---cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccC-CCCeee
Confidence 99976543 589999999999876432 235667999999999998764 88999999999999999998 889987
Q ss_pred chhhHHHHHhhc----cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 715 SFERDANIVKDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 715 ~~~~~~~~~~~~----~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
....+..+.+-. .+..|.+.+.+++.+|.+|+.+||..||+++++|..||+...
T Consensus 781 lgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 781 LGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 655555443322 344566777899999999999999999999999999999654
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=347.02 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=192.6
Q ss_pred eEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+.+.||+|+||+||++. ..+|+.||||++.+.. .....+|+ .++..++||||+++++.+.+++.+|+||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~-~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAER-DILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHH-HHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 46778999999999999985 4568999999986421 11233454 4778899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++.. ...+++..+..++.||+.||+|||+++
T Consensus 81 E----------~~~~g~L~~~i~~-----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ 121 (376)
T cd05598 81 D----------YIPGGDMMSLLIR-----------------------------LGIFEEDLARFYIAELTCAIESVHKMG 121 (376)
T ss_pred e----------CCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 5556666666532 133567778899999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCc----------------------------------------ccc
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS----------------------------------------CLT 666 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~----------------------------------------~~~ 666 (902)
|+||||||+|||++.++. +||+|||+|..+..... ...
T Consensus 122 ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (376)
T cd05598 122 FIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC 199 (376)
T ss_pred eEeCCCCHHHEEECCCCC--EEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccc
Confidence 999999999999988876 89999999853310000 000
Q ss_pred ccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhH--HHHHhhccc---cccccCChHHHHH
Q 002601 667 QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRKD---LFLVEHIPEAVDL 741 (902)
Q Consensus 667 ~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~--~~~~~~~~~---~~~~~~~~e~~dL 741 (902)
.....+||+.|+|||++.+..++.++|||||||++|||++| .+||....... ..+...... ......++++.++
T Consensus 200 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 278 (376)
T cd05598 200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG-QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDL 278 (376)
T ss_pred cccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC-CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHH
Confidence 01234699999999999999999999999999999999997 77886543322 122221111 1123467899999
Q ss_pred HHcccCCCCCCCc---CHHHHHcCCCCCCcc
Q 002601 742 FTRLLDPNPDLRP---KAQNVLNHPFFWTAD 769 (902)
Q Consensus 742 I~~~L~~dP~~Rp---t~~elL~HPfF~~~~ 769 (902)
|.+|+ .+|.+|+ ++.++++||||...+
T Consensus 279 i~~l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 279 ILRLC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred HHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 99976 5999999 999999999997644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=344.02 Aligned_cols=246 Identities=22% Similarity=0.309 Sum_probs=188.8
Q ss_pred ceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
..|.+.+.||+|+||.||++... +++.||+|...+. ....|+. ++..++||||+++++++.+.+..++|||++.+
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 141 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---TTLIEAM-LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS 141 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---ccHHHHH-HHHhCCCCCCcChhheEEeCCeeEEEEEccCC
Confidence 34788899999999999998554 5789999975443 2345654 67889999999999999999999999997765
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
+|.+++ .. ....+++..++.|+.||+.||+|||+++|+|||
T Consensus 142 ~l~~~l-----------~~----------------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrD 182 (357)
T PHA03209 142 DLYTYL-----------TK----------------------------RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRD 182 (357)
T ss_pred cHHHHH-----------Hh----------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 554433 11 113467788899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|||++.++. +||+|||+++..... .......||..|+|||++.+..++.++|||||||++|||++++.++
T Consensus 183 lkp~Nill~~~~~--~kl~DfG~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 183 VKTENIFINDVDQ--VCIGDLGAAQFPVVA----PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCHHHEEECCCCC--EEEecCccccccccC----cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999999988776 899999998754321 1122345899999999999999999999999999999999987777
Q ss_pred CCCchhh-----------HHHHHhhc---ccccc------------------------------ccCChHHHHHHHcccC
Q 002601 712 YGESFER-----------DANIVKDR---KDLFL------------------------------VEHIPEAVDLFTRLLD 747 (902)
Q Consensus 712 f~~~~~~-----------~~~~~~~~---~~~~~------------------------------~~~~~e~~dLI~~~L~ 747 (902)
|...... ...++... ...++ ...+.++.++|.+||+
T Consensus 257 f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 336 (357)
T PHA03209 257 FEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLT 336 (357)
T ss_pred ccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHc
Confidence 6542111 00111000 00000 1234567789999999
Q ss_pred CCCCCCcCHHHHHcCCCCCC
Q 002601 748 PNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 748 ~dP~~Rpt~~elL~HPfF~~ 767 (902)
.||.+|||+.|+++||||.+
T Consensus 337 ~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 337 FDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCcccCcCHHHHhcCchhcc
Confidence 99999999999999999964
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=344.14 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=196.4
Q ss_pred ccccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccce
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~ 542 (902)
+...+.|.+.+.||+|+||+||++.. .+++.||+|++.+.. ....+.++..+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34457788999999999999999854 468899999985421 122344445577889999999999999999999
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+||| |+++|+|.+++.. ..+++..+..++.||+.||+||
T Consensus 119 ~lv~E----------y~~gg~L~~~~~~------------------------------~~~~~~~~~~~~~qi~~aL~~L 158 (371)
T cd05622 119 YMVME----------YMPGGDLVNLMSN------------------------------YDVPEKWARFYTAEVVLALDAI 158 (371)
T ss_pred EEEEc----------CCCCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 5556666665421 2356677788999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC----CCCcchhhhhH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLG 698 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSlG 698 (902)
|+++|+||||||+|||++.++. +||+|||+++...... .....+.+||+.|+|||++.... ++.++||||||
T Consensus 159 H~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlG 234 (371)
T cd05622 159 HSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (371)
T ss_pred HHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCC--cccccCcccCccccCHHHHhccCCCccCCCccceeehh
Confidence 9999999999999999988876 9999999998765321 11223557999999999987543 78999999999
Q ss_pred HHHHHHHhCCCCCCCCchh-hHH-HHHhhcc-cccc--ccCChHHHHHHHcccCCCCCC--CcCHHHHHcCCCCCCcch
Q 002601 699 CILFFCITGGKHPYGESFE-RDA-NIVKDRK-DLFL--VEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTADT 770 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~-~~~-~~~~~~~-~~~~--~~~~~e~~dLI~~~L~~dP~~--Rpt~~elL~HPfF~~~~~ 770 (902)
|++|||++| .+||..... ... .+..... ..++ ...+++++++|.+||..++.+ |++++++++||||++.+.
T Consensus 235 vilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 235 VFLYEMLVG-DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 999999998 677765432 222 2222211 1122 246789999999999844433 789999999999977544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=342.23 Aligned_cols=244 Identities=27% Similarity=0.344 Sum_probs=186.7
Q ss_pred ecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhC--CCCCeeEecccccCccceeeeeccccC
Q 002601 481 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASD--QHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 481 LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l--~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
||+|+||+||++.. .+|+.||||++.+... .....|...+.... .||||+++++++.+.+..|+|||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e---- 76 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTD---- 76 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEc----
Confidence 79999999999854 5689999999864321 12233443333333 79999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|..++.. ...+++..+..++.||+.||+|||+++|+|||
T Consensus 77 ------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qil~al~~LH~~~ivHrD 121 (330)
T cd05586 77 ------YMSGGELFWHLQK-----------------------------EGRFSEDRAKFYIAELVLALEHLHKYDIVYRD 121 (330)
T ss_pred ------CCCCChHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 5566777665532 23467788899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG~~~ 710 (902)
|||+|||++.++. +||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|+|++| ..
T Consensus 122 lkp~Nili~~~~~--~kl~Dfg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG-~~ 195 (330)
T cd05586 122 LKPENILLDATGH--IALCDFGLSKANLTDN---KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG-WS 195 (330)
T ss_pred CCHHHeEECCCCC--EEEecCCcCcCCCCCC---CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccC-CC
Confidence 9999999988876 8999999987543221 122345799999999998765 479999999999999999998 56
Q ss_pred CCCCc-hhhHHHHHhhcccccc-ccCChHHHHHHHcccCCCCCCCc----CHHHHHcCCCCCCcc
Q 002601 711 PYGES-FERDANIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRP----KAQNVLNHPFFWTAD 769 (902)
Q Consensus 711 Pf~~~-~~~~~~~~~~~~~~~~-~~~~~e~~dLI~~~L~~dP~~Rp----t~~elL~HPfF~~~~ 769 (902)
||... .......+......++ ...++++.++|.+||+.||.+|| ++.++++||||....
T Consensus 196 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 196 PFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 66543 3322222222222222 23578999999999999999998 789999999997644
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=326.60 Aligned_cols=246 Identities=28% Similarity=0.412 Sum_probs=184.4
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHH--HHhCCCCCeeEecccccC-----ccc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNL--IASDQHPNIVRWYGVESD-----QDF 541 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~l--l~~l~HpNIV~l~g~~~d-----~~~ 541 (902)
|...+.||+|+||+||++.. .+|+.||+|.+.... .....+|+..+ +..++||||+++++++.+ ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 56678999999999999854 568999999886431 12344555432 334579999999998764 345
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.++|||++.++|.+++ ... ....+++..+..++.|++.||+|
T Consensus 82 ~~lv~e~~~~~l~~~~-----------~~~---------------------------~~~~~~~~~~~~~~~qi~~al~~ 123 (288)
T cd07863 82 VTLVFEHVDQDLRTYL-----------DKV---------------------------PPPGLPAETIKDLMRQFLRGLDF 123 (288)
T ss_pred EEEEEcccccCHHHHH-----------Hhc---------------------------CCCCCCHHHHHHHHHHHHHHHHH
Confidence 8999997765554443 111 11246788889999999999999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHH
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL 701 (902)
||+.||+||||||+|||++.++. +||+|||+++...... ......||..|+|||++.+..++.++|||||||++
T Consensus 124 lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l 197 (288)
T cd07863 124 LHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQM----ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197 (288)
T ss_pred HHhCCeecCCCCHHHEEECCCCC--EEECccCccccccCcc----cCCCccccccccCchHhhCCCCCCcchhhhHHHHH
Confidence 99999999999999999988876 8999999998664321 11234589999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCchhhH-H-HHHhhc---------------cc-----------cccccCChHHHHHHHcccCCCCCCC
Q 002601 702 FFCITGGKHPYGESFERD-A-NIVKDR---------------KD-----------LFLVEHIPEAVDLFTRLLDPNPDLR 753 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~-~-~~~~~~---------------~~-----------~~~~~~~~e~~dLI~~~L~~dP~~R 753 (902)
|+|++| .+||....... . .+.... .. .......+++.++|.+||+.||++|
T Consensus 198 ~~l~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (288)
T cd07863 198 AEMFRR-KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKR 276 (288)
T ss_pred HHHHhC-CcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccC
Confidence 999987 67775432211 1 111100 00 0112345678999999999999999
Q ss_pred cCHHHHHcCCCC
Q 002601 754 PKAQNVLNHPFF 765 (902)
Q Consensus 754 pt~~elL~HPfF 765 (902)
||+.|++.||||
T Consensus 277 ~t~~~~l~hp~f 288 (288)
T cd07863 277 ISAFRALQHPFF 288 (288)
T ss_pred CCHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.48 Aligned_cols=275 Identities=22% Similarity=0.333 Sum_probs=190.8
Q ss_pred ceEEEeeeecccCceEEEEEEe------eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCc-cc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ-DF 541 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~-~~ 541 (902)
+.|.+.+.||+|+||+||++.. .+++.||||++..... ....+|+..+....+|||||+++++|.+. +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 4577889999999999999853 3457899999865322 23456665444444899999999988764 46
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchh----HHHHhhh-------------------------cc-----
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLL----NEVRIRL-------------------------LP----- 587 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l----~~~~~r~-------------------------~~----- 587 (902)
+|+||| |+++|+|.+++.......... ...+.+. .+
T Consensus 87 ~~lv~e----------y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (338)
T cd05102 87 LMVIVE----------FCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS 156 (338)
T ss_pred eEEEEe----------cCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence 899999 555666666654321100000 0000000 00
Q ss_pred ccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccc
Q 002601 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667 (902)
Q Consensus 588 ~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~ 667 (902)
..........| ...+++..+.+++.||++||+|||+.+|+||||||+|||++.++. +||+|||+++........ ..
T Consensus 157 ~~~~~~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~-~~ 232 (338)
T cd05102 157 TNPPQETDDLW-KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDY-VR 232 (338)
T ss_pred cccchhccccc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc--EEEeecccccccccCcch-hc
Confidence 00000001112 235788899999999999999999999999999999999987765 999999999876432211 11
Q ss_pred cccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhh--HHHHHhh-ccccccccCChHHHHHHHc
Q 002601 668 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKD-RKDLFLVEHIPEAVDLFTR 744 (902)
Q Consensus 668 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~--~~~~~~~-~~~~~~~~~~~e~~dLI~~ 744 (902)
.....+++.|+|||++.+..++.++|||||||++|||++.+.+||...... ....+.. .....+...++++.+++.+
T Consensus 233 ~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 312 (338)
T cd05102 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLA 312 (338)
T ss_pred ccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 223346788999999999899999999999999999998558888753221 1222222 2222344567889999999
Q ss_pred ccCCCCCCCcCHHHHHc
Q 002601 745 LLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 745 ~L~~dP~~Rpt~~elL~ 761 (902)
||+.||.+||++.|+++
T Consensus 313 cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 313 CWQGDPKERPTFSALVE 329 (338)
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=343.49 Aligned_cols=248 Identities=24% Similarity=0.394 Sum_probs=188.6
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCcc-----cee
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD-----FVY 543 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~-----~~y 543 (902)
|...+.||+|+||+||++.. .+|+.||||++..... ....+|+. ++..++||||+++++++.+.+ ..|
T Consensus 2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELK-MLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHH-HHHhCCCCCcCCHhheecCCCccccceEE
Confidence 34568899999999999854 5799999999865321 23455654 668889999999999998776 789
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+|+||+.++|.+++ . ....+++..+..++.||+.||+|||
T Consensus 81 lv~e~~~~~l~~~~-----------~-----------------------------~~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 81 VVTELMQSDLHKII-----------V-----------------------------SPQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred EEeeccccCHHHHH-----------h-----------------------------cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99997665544433 1 1134677788999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 702 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ 702 (902)
+.+|+||||||+|||++.++. +||+|||+++....... .......+|+.|+|||++.+. .++.++|||||||++|
T Consensus 121 ~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 196 (372)
T cd07853 121 SAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDES--KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196 (372)
T ss_pred hCCeeCCCCChHHEEECCCCC--EEeccccceeecccCcc--ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHH
Confidence 999999999999999988765 99999999986543211 112234578999999998874 4789999999999999
Q ss_pred HHHhCCCCCCCCchhhH-HHHHh------------------------hccc--------cccccCChHHHHHHHcccCCC
Q 002601 703 FCITGGKHPYGESFERD-ANIVK------------------------DRKD--------LFLVEHIPEAVDLFTRLLDPN 749 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-~~~~~------------------------~~~~--------~~~~~~~~e~~dLI~~~L~~d 749 (902)
||++| ++||....... ...+. .... ......++++.+||.+||+.|
T Consensus 197 el~~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 275 (372)
T cd07853 197 ELLGR-RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFD 275 (372)
T ss_pred HHHcC-CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCC
Confidence 99997 77876432211 11000 0000 111234678999999999999
Q ss_pred CCCCcCHHHHHcCCCCCCc
Q 002601 750 PDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 750 P~~Rpt~~elL~HPfF~~~ 768 (902)
|.+|||+.|+++||||...
T Consensus 276 P~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 276 PDKRISAADALAHPYLDEG 294 (372)
T ss_pred hhhCcCHHHHhcCHhhCCC
Confidence 9999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=332.14 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=191.4
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+.|...+.||+|+||+||++.. .+++.||||++..... ....+|+. +++.++||||+++++++.+++..|+|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHH-HHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 3467789999999999999854 4688999999864321 23455665 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+.++|.+++.. . ...+++..+..++.||+.||+|||++||
T Consensus 85 ~~~~~l~~~~~~-----------~----------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~i 125 (309)
T cd07872 85 YLDKDLKQYMDD-----------C----------------------------GNIMSMHNVKIFLYQILRGLAYCHRRKV 125 (309)
T ss_pred CCCCCHHHHHHh-----------c----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 877655544311 0 1224566778899999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHh
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ellt 706 (902)
+||||||+|||++.++. +||+|||+++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 126 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t 200 (309)
T cd07872 126 LHRDLKPQNLLINERGE--LKLADFGLARAKSVPTK---TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200 (309)
T ss_pred ecCCCCHHHEEECCCCC--EEECccccceecCCCcc---ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999988776 89999999876543211 1123457899999999865 457899999999999999999
Q ss_pred CCCCCCCCchhhH-HH-HHhh---------------------cccc--------ccccCChHHHHHHHcccCCCCCCCcC
Q 002601 707 GGKHPYGESFERD-AN-IVKD---------------------RKDL--------FLVEHIPEAVDLFTRLLDPNPDLRPK 755 (902)
Q Consensus 707 G~~~Pf~~~~~~~-~~-~~~~---------------------~~~~--------~~~~~~~e~~dLI~~~L~~dP~~Rpt 755 (902)
| .+||......+ .. +... .... .....+++++++|.+||+.||.+|||
T Consensus 201 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t 279 (309)
T cd07872 201 G-RPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS 279 (309)
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC
Confidence 8 67775432211 11 1000 0000 01134678999999999999999999
Q ss_pred HHHHHcCCCCCCcchh
Q 002601 756 AQNVLNHPFFWTADTR 771 (902)
Q Consensus 756 ~~elL~HPfF~~~~~~ 771 (902)
++|+++||||.....+
T Consensus 280 ~~e~l~h~~~~~~~~~ 295 (309)
T cd07872 280 AEEAMKHAYFRSLGTR 295 (309)
T ss_pred HHHHhcChhhhhcccc
Confidence 9999999999765443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=349.38 Aligned_cols=250 Identities=20% Similarity=0.246 Sum_probs=183.4
Q ss_pred ccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC--chHHHHHHHHHHHh------CCCCCeeEecccccCc-c
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIAS------DQHPNIVRWYGVESDQ-D 540 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~------l~HpNIV~l~g~~~d~-~ 540 (902)
..+.|.+.+.||+|+||+||++.. ..++.||||++.... ......|+. ++.. ..|.+|+++++++.++ +
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQ-FMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHH-HHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 356789999999999999999854 568899999986432 122233443 2233 3456799999887654 5
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
+.|+|||++.++|.+++ . +...+++..+..|+.||+.||+
T Consensus 206 ~~~iv~~~~g~~l~~~l-----------~-----------------------------~~~~l~~~~~~~i~~qi~~aL~ 245 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWI-----------M-----------------------------KHGPFSHRHLAQIIFQTGVALD 245 (467)
T ss_pred eEEEEEeccCCCHHHHH-----------H-----------------------------HcCCCCHHHHHHHHHHHHHHHH
Confidence 78999997766555543 1 1134677788999999999999
Q ss_pred cccc-ccccccccccceeEeccCCC--------------ceEEEccCCccccccCCCccccccccCCCCccccCchhhcc
Q 002601 621 HLHE-IGLIHRDLKPQNVLISKDKS--------------FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ 685 (902)
Q Consensus 621 yLH~-~~IvHrDLKp~NILL~~d~~--------------~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~ 685 (902)
|||+ .||+||||||+|||++.++. +.+||+|||++..... .....+||+.|+|||++.+
T Consensus 246 yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~------~~~~~~gt~~Y~APE~~~~ 319 (467)
T PTZ00284 246 YFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH------SRTAIVSTRHYRSPEVVLG 319 (467)
T ss_pred HHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc------ccccccCCccccCcHHhhc
Confidence 9998 59999999999999976653 2489999998764321 1234579999999999999
Q ss_pred CCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhH-HHHHhhccc---------------------------c-c------
Q 002601 686 GRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKD---------------------------L-F------ 730 (902)
Q Consensus 686 ~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~-~~~~~~~~~---------------------------~-~------ 730 (902)
..++.++|||||||++|||++| ++||....... ...+..... . .
T Consensus 320 ~~~~~~~DiwSlGvil~elltG-~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 398 (467)
T PTZ00284 320 LGWMYSTDMWSMGCIIYELYTG-KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLAR 398 (467)
T ss_pred CCCCcHHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHh
Confidence 9999999999999999999998 77886432211 111000000 0 0
Q ss_pred --------cccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 731 --------LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 731 --------~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
.....+.++|||.+||+.||++|||++|+|+||||...
T Consensus 399 ~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 399 IARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred hhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 00013467899999999999999999999999999653
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=351.80 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=201.6
Q ss_pred ccccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCcc--
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD-- 540 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~-- 540 (902)
+..++.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. .+..++|+||++++..+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~-~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVC-CLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHH-HHhcCCCCcEEEeecceeccccc
Confidence 3445788999999999999999985 45799999999864321 12344544 557789999999988765332
Q ss_pred ------ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHh
Q 002601 541 ------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614 (902)
Q Consensus 541 ------~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~q 614 (902)
.+++||| |+++|+|.+++..... ....+++..+..++.|
T Consensus 107 ~~~~~~~i~lV~E----------y~~~gsL~~~l~~~~~-------------------------~~~~l~e~~~~~i~~q 151 (496)
T PTZ00283 107 NPENVLMIALVLD----------YANAGDLRQEIKSRAK-------------------------TNRTFREHEAGLLFIQ 151 (496)
T ss_pred CcccceEEEEEEe----------CCCCCcHHHHHHHhhc-------------------------cCCCCCHHHHHHHHHH
Confidence 3689999 6777888777753211 1235678888999999
Q ss_pred hhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchh
Q 002601 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDL 694 (902)
Q Consensus 615 Ia~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDV 694 (902)
++.||+|||+.+|+||||||+|||++.++. +||+|||+++.+...... ....+.+||+.|+|||++.+..++.++||
T Consensus 152 ll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DV 228 (496)
T PTZ00283 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRRKPYSKKADM 228 (496)
T ss_pred HHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecccCeeccccccc-cccccccCCcceeCHHHhCCCCCCcHHHH
Confidence 999999999999999999999999988765 999999999876532211 12234579999999999999999999999
Q ss_pred hhhHHHHHHHHhCCCCCCCCchhh-HH-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 695 FSLGCILFFCITGGKHPYGESFER-DA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 695 wSlGviL~elltG~~~Pf~~~~~~-~~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
|||||++|||++| ..||...... .. .+........+...++++.+++.+||+.||.+||++.++++|||+..
T Consensus 229 wSlGvilyeLltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 229 FSLGVLLYELLTL-KRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred HHHHHHHHHHHHC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 9999999999997 6787654322 22 22333333445567889999999999999999999999999999854
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=338.82 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=187.2
Q ss_pred ccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCc-----
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~----- 539 (902)
+.+.|.+.+.||+|+||.||++. ...++.||||++.... .....+|+. +++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHH-HHHhcCCCCccccceeecccccccc
Confidence 34678888999999999999985 4568999999986432 123445554 67889999999999987543
Q ss_pred -cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 540 -~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
...|+||||+.++|.+++. ..+++..+..++.|++.|
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~------------------------------------------~~~~~~~~~~~~~qi~~a 138 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQ------------------------------------------MELDHERMSYLLYQMLCG 138 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHH------------------------------------------hcCCHHHHHHHHHHHHHH
Confidence 3579999987766544331 124556678899999999
Q ss_pred ccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhH
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 619 L~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 698 (902)
|+|||++||+||||||+|||++.++. +||+|||+++...... ......||..|+|||++.+..++.++||||||
T Consensus 139 L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG 212 (364)
T cd07875 139 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 212 (364)
T ss_pred HHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccCCCC----cccCCcccCCcCCHHHHhCCCCCchhhHHhHH
Confidence 99999999999999999999988765 9999999998654321 12334689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchhhH--HHHHh----------------------hccc-------------------cccccCC
Q 002601 699 CILFFCITGGKHPYGESFERD--ANIVK----------------------DRKD-------------------LFLVEHI 735 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~--~~~~~----------------------~~~~-------------------~~~~~~~ 735 (902)
|++|+|++| ..||....... ..++. .... .......
T Consensus 213 ~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (364)
T cd07875 213 CIMGEMIKG-GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 291 (364)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccccccccccccc
Confidence 999999998 66775432111 01110 0000 0000123
Q ss_pred hHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 736 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 736 ~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
++++++|.+||+.||.+|||+.|+++||||..
T Consensus 292 ~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 292 SQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 57899999999999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=351.93 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=200.2
Q ss_pred ceEEEeeeecccCceEEEEEEee-C-CcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-E-GRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~-g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
..|.+.+.||+|+||.||+|... + +..||+|.+...... ...+|+ .+++.++|||||++++++.+++..|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~-~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSEL-HCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHH-HHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 34788899999999999998443 3 678888876443222 233454 46788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++..... ....+++..+..++.||+.||+|||+.+|
T Consensus 146 ----------~~~gg~L~~~l~~~~~-------------------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~i 190 (478)
T PTZ00267 146 ----------YGSGGDLNKQIKQRLK-------------------------EHLPFQEYEVGLLFYQIVLALDEVHSRKM 190 (478)
T ss_pred ----------CCCCCCHHHHHHHHHh-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 6677777776643211 12346778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+||||+.++. +||+|||+++.+..... .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 191 vHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg 267 (478)
T PTZ00267 191 MHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVS-LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267 (478)
T ss_pred EECCcCHHhEEECCCCc--EEEEeCcCceecCCccc-cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhC
Confidence 99999999999988775 99999999987654321 1123455799999999999998999999999999999999997
Q ss_pred CCCCCCCchhhH-H-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 708 GKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 708 ~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
..||....... . .+........+...++++.++|.+||+.||++||++++++.|||+..
T Consensus 268 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 268 -HRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred -CCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 66776543222 2 22223333344567789999999999999999999999999999854
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=323.04 Aligned_cols=245 Identities=33% Similarity=0.544 Sum_probs=188.8
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCchHHH-----HHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~~~~-----~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|++.+.||+|+||+||++.. .+++.||+|++......... +|+. .+..++||||+++++++.+.+..++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIK-ILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHH-HHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhh-ccccccccccccccccccccccccccccc
Confidence 56789999999999999855 45679999999876543322 2444 56677999999999999999999999996
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|.+ |+|.+++. +...+++..+..++.||++||++||+.+|+
T Consensus 80 ~~~----------~~L~~~l~-----------------------------~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~ 120 (260)
T PF00069_consen 80 CPG----------GSLQDYLQ-----------------------------KNKPLSEEEILKIAYQILEALAYLHSKGIV 120 (260)
T ss_dssp ETT----------EBHHHHHH-----------------------------HHSSBBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ccc----------cccccccc-----------------------------cccccccccccccccccccccccccccccc
Confidence 654 44444442 123457778899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc-cCCCCCcchhhhhHHHHHHHHhC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSlGviL~elltG 707 (902)
|+||||+||+++.++. ++|+|||.+...... ........++..|+|||++. ...++.++||||+|+++|+|++|
T Consensus 121 H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~ 195 (260)
T PF00069_consen 121 HRDIKPENILLDENGE--VKLIDFGSSVKLSEN---NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTG 195 (260)
T ss_dssp ESSBSGGGEEESTTSE--EEESSGTTTEESTST---TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHS
T ss_pred cccccccccccccccc--ccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987765 899999999764211 12234456899999999998 77889999999999999999998
Q ss_pred CCCCCCCch-hhHHHHHh-hc--cccc----cccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 708 GKHPYGESF-ERDANIVK-DR--KDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 708 ~~~Pf~~~~-~~~~~~~~-~~--~~~~----~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||.+.. ........ .. .... .....+++.++|.+||+.||++||++.++++||||
T Consensus 196 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 196 -KLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp -SSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred -ccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 66777651 11111111 11 0001 11123789999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=339.09 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=186.5
Q ss_pred ccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCc-----
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~----- 539 (902)
+.+.|...+.||+|+||.||++. ...++.||||++..... ....+|+. +++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHH-HHHHhCCCchhceeeeeeccccccc
Confidence 34678888999999999999984 35689999999865321 23445554 66888999999999987543
Q ss_pred -cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 540 -~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
...|+|||||.+++.+++ . ..+++..+..++.|++.|
T Consensus 94 ~~~~~lv~e~~~~~l~~~~-----------~-------------------------------~~l~~~~~~~~~~qi~~a 131 (355)
T cd07874 94 FQDVYLVMELMDANLCQVI-----------Q-------------------------------MELDHERMSYLLYQMLCG 131 (355)
T ss_pred cceeEEEhhhhcccHHHHH-----------h-------------------------------hcCCHHHHHHHHHHHHHH
Confidence 357999997765543332 1 124566778899999999
Q ss_pred ccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhH
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 619 L~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 698 (902)
|+|||+.||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+..++.++||||||
T Consensus 132 L~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG 205 (355)
T cd07874 132 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205 (355)
T ss_pred HHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCCCcc----ccCCccccCCccCHHHHcCCCCCchhhHHHHH
Confidence 99999999999999999999988776 9999999998654321 12334689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCchhhH-H-HHH----------------------hhcc-------------------ccccccCC
Q 002601 699 CILFFCITGGKHPYGESFERD-A-NIV----------------------KDRK-------------------DLFLVEHI 735 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~-~-~~~----------------------~~~~-------------------~~~~~~~~ 735 (902)
|++|+|++| ..||....... . ..+ .... ........
T Consensus 206 ~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (355)
T cd07874 206 CIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284 (355)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccc
Confidence 999999998 66775432110 0 000 0000 00001123
Q ss_pred hHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 736 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 736 ~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
.+++++|.+||+.||++|||+.|+++||||..
T Consensus 285 ~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 285 SQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred hHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 57899999999999999999999999999953
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.39 Aligned_cols=256 Identities=24% Similarity=0.328 Sum_probs=201.9
Q ss_pred EEEeeeecccCceEEEEEEeeC-CcEEEEEEeccCCch-----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~~-g~~VAVKrl~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||.|.-|+||++...+ +..+|+|++.+.... ...+-++++++.+.||.+..||+.++.+++.|+||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 4455789999999999997654 589999999764321 1112223577999999999999999999999999995
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
| ++|+|+..++... .+.+++..++.++..++-||+|||-.|||
T Consensus 159 C----------pGGdL~~LrqkQp---------------------------~~~fse~~aRFYaAEvl~ALEYLHmlGiv 201 (459)
T KOG0610|consen 159 C----------PGGDLHSLRQKQP---------------------------GKRFSESAARFYAAEVLLALEYLHMLGIV 201 (459)
T ss_pred C----------CCccHHHHHhhCC---------------------------CCccchhhHHHHHHHHHHHHHHHHhhcee
Confidence 5 5677776654322 24588899999999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCC---------------------------------c------------
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM---------------------------------S------------ 663 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~---------------------------------~------------ 663 (902)
+|||||+||||.++|+ +.|+||.|+....... .
T Consensus 202 YRDLKPENILvredGH--IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~ 279 (459)
T KOG0610|consen 202 YRDLKPENILVREDGH--IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRS 279 (459)
T ss_pred eccCCcceeEEecCCc--EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccccc
Confidence 9999999999999998 8899999986542100 0
Q ss_pred --------cccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhh--HHHHHhhccccccc-
Q 002601 664 --------CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKDRKDLFLV- 732 (902)
Q Consensus 664 --------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~--~~~~~~~~~~~~~~- 732 (902)
...+....+||-.|+|||++.+...+.++|+|+||+++|||+.| ..||.+...+ ..+++... ..++.
T Consensus 280 ~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG-~TPFKG~~~~~Tl~NIv~~~-l~Fp~~ 357 (459)
T KOG0610|consen 280 LPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYG-TTPFKGSNNKETLRNIVGQP-LKFPEE 357 (459)
T ss_pred chhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhC-CCCcCCCCchhhHHHHhcCC-CcCCCC
Confidence 00122345799999999999999999999999999999999998 6677654332 23444333 23333
Q ss_pred -cCChHHHHHHHcccCCCCCCCcC----HHHHHcCCCCCCcchh
Q 002601 733 -EHIPEAVDLFTRLLDPNPDLRPK----AQNVLNHPFFWTADTR 771 (902)
Q Consensus 733 -~~~~e~~dLI~~~L~~dP~~Rpt----~~elL~HPfF~~~~~~ 771 (902)
..+..++|||+++|.+||.+|.. +.||.+||||.+-++.
T Consensus 358 ~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 358 PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 34578999999999999999998 9999999999876654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=333.92 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=192.0
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|.+.+.||+|+||+||++.. .+++.||||++.+.. ....++++..++..++|+||+++++++.++++.|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 467789999999999999854 568999999986421 12234455557788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++... ...+++..+..++.||+.||+|||+++|
T Consensus 82 ----------~~~g~~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (331)
T cd05597 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYLAEMVLAIDSVHQLGY 123 (331)
T ss_pred ----------cCCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 66677777766321 1246778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-----CCCCCcchhhhhHHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILF 702 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGviL~ 702 (902)
+||||||+|||++.++. +||+|||++..+..... ......+||+.|+|||++.. ..++.++|||||||++|
T Consensus 124 vH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~ 199 (331)
T cd05597 124 VHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY 199 (331)
T ss_pred EECCCCHHHEEECCCCC--EEEEECCceeecCCCCC--ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHH
Confidence 99999999999988876 89999999876653221 11123468999999999873 45788999999999999
Q ss_pred HHHhCCCCCCCCch-hhHH-HHHhhcc-cc---ccccCChHHHHHHHcccCCCCCC--CcCHHHHHcCCCCCCcc
Q 002601 703 FCITGGKHPYGESF-ERDA-NIVKDRK-DL---FLVEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 703 elltG~~~Pf~~~~-~~~~-~~~~~~~-~~---~~~~~~~e~~dLI~~~L~~dP~~--Rpt~~elL~HPfF~~~~ 769 (902)
||++| ..||.... .... .+..... .. .....+++++++|++||..++.+ |++++++++||||.+.+
T Consensus 200 el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 200 EMLYG-ETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred HHhhC-CCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 99997 66775432 2222 2222111 11 11235778999999988664443 88999999999996643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=325.75 Aligned_cols=244 Identities=24% Similarity=0.435 Sum_probs=188.5
Q ss_pred ecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 481 IAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 481 LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
||+|+||+||++.. .+|+.||+|++.... ......|+. ++..++||||+++++++.++...|+|||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~-il~~l~hp~i~~~~~~~~~~~~~~lv~e------ 73 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE-ILEKVNSPFIVNLAYAFESKTHLCLVMS------ 73 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHH-HHHhcCCCcEEEEEEEEecCCeEEEEEe------
Confidence 79999999999854 569999999985421 112334544 6788899999999999999999999999
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
|+++|+|..++... ....+++..+..++.||+.||+|||+.+|+|||||
T Consensus 74 ----~~~g~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik 122 (277)
T cd05607 74 ----LMNGGDLKYHIYNV---------------------------GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMK 122 (277)
T ss_pred ----cCCCCCHHHHHHhc---------------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCC
Confidence 66667776655321 12346677888999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
|+||+++.++. ++|+|||++....... ......|+..|+|||++.+..++.++||||+||++|||++| ..||.
T Consensus 123 p~Nili~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g-~~p~~ 195 (277)
T cd05607 123 PENVLLDDQGN--CRLSDLGLAVELKDGK----TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAG-RTPFK 195 (277)
T ss_pred hHhEEEcCCCC--EEEeeceeeeecCCCc----eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhC-CCCCC
Confidence 99999988766 8999999998765321 11234589999999999988899999999999999999997 67876
Q ss_pred Cchhh--HHHH----HhhccccccccCChHHHHHHHcccCCCCCCCcCH----HHHHcCCCCCCcc
Q 002601 714 ESFER--DANI----VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHPFFWTAD 769 (902)
Q Consensus 714 ~~~~~--~~~~----~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~----~elL~HPfF~~~~ 769 (902)
..... ...+ ............+++++++|.+||+.||++||++ +++++||||...+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 196 DHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred CCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 43221 1111 1111111123467899999999999999999999 6788999996643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=326.37 Aligned_cols=249 Identities=25% Similarity=0.400 Sum_probs=195.9
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|...+.||+|+||+||++. ..+++.||||.+..... ....+|+. ++..++|+||+++++.+.+++..|+|||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQ-ILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHH-HHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3456789999999999974 45789999999864321 12345654 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+|
T Consensus 81 ----------~~~g~~L~~~l~~~---------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05630 81 ----------LMNGGDLKFHIYHM---------------------------GEAGFEEGRAVFYAAEICCGLEDLHQERI 123 (285)
T ss_pred ----------ecCCCcHHHHHHHh---------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 66677776665321 12346778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+||+++.++. ++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|
T Consensus 124 iH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 197 (285)
T cd05630 124 VYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQ----TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 197 (285)
T ss_pred EeCCCCHHHEEECCCCC--EEEeeccceeecCCCc----cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhC
Confidence 99999999999988766 8999999987654321 11234689999999999998999999999999999999997
Q ss_pred CCCCCCCchhh-----HHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCc
Q 002601 708 GKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTA 768 (902)
Q Consensus 708 ~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~ 768 (902)
.+||...... ............+...++++.+|+.+||+.||++||| ++|+++||||...
T Consensus 198 -~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 198 -QSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -CCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 7788653211 1112222222344557789999999999999999999 8999999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=318.92 Aligned_cols=249 Identities=30% Similarity=0.409 Sum_probs=193.3
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc--------hHHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
.|...+.||+|++|.||++.. .+++.||+|.+..... ....+|+ .++..++||||+++++++.+++..|+
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEI-QLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHH-HHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 466778999999999999854 5689999998864321 1233444 46788999999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
|+| |+++|+|.+++.. ...+++..+.+++.|++.||+|||+
T Consensus 82 v~e----------~~~~~~l~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~ 122 (263)
T cd06625 82 FME----------YMPGGSVKDQLKA-----------------------------YGALTETVTRKYTRQILEGVEYLHS 122 (263)
T ss_pred EEE----------ECCCCcHHHHHHH-----------------------------hCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 5556666665532 1235667788999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
.+|+||||||+||+++.++. ++|+|||+++................|+..|+|||++.+..++.++|||||||++|||
T Consensus 123 ~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 200 (263)
T cd06625 123 NMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200 (263)
T ss_pred CCeecCCCCHHHEEEcCCCC--EEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999987766 9999999998664322111111234578899999999998899999999999999999
Q ss_pred HhCCCCCCCCchhhH--HHHHhh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 705 ITGGKHPYGESFERD--ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~--~~~~~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
++| +.||....... ...... .....+...++++.++|.+||..+|.+||++.++++||||
T Consensus 201 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 201 LTE-KPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HhC-CCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 998 67776532211 111111 1223445567899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=332.72 Aligned_cols=253 Identities=22% Similarity=0.368 Sum_probs=192.8
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|.+.+.||+|+||+||++.. .+++.||+|++.+.. ....++++..++...+|+||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 467789999999999999854 457899999986421 12234444557788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++... ...+++..++.++.||+.||+|||+.+|
T Consensus 82 ----------y~~~g~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~al~~lH~~~i 123 (332)
T cd05623 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYLAEMVIAIDSVHQLHY 123 (332)
T ss_pred ----------ccCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 67778887776431 1236777889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc-----cCCCCCcchhhhhHHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGviL~ 702 (902)
+||||||+|||++.++. +||+|||++........ ......+||+.|+|||++. ...++.++|||||||++|
T Consensus 124 iHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ 199 (332)
T cd05623 124 VHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGT--VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMY 199 (332)
T ss_pred EecCCCHHHEEECCCCC--EEEeecchheecccCCc--ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHH
Confidence 99999999999987766 89999999976543211 1123356999999999986 345789999999999999
Q ss_pred HHHhCCCCCCCCc-hhhHHHHHhhcc--ccc---cccCChHHHHHHHcccCCCCCC--CcCHHHHHcCCCCCCcc
Q 002601 703 FCITGGKHPYGES-FERDANIVKDRK--DLF---LVEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 703 elltG~~~Pf~~~-~~~~~~~~~~~~--~~~---~~~~~~e~~dLI~~~L~~dP~~--Rpt~~elL~HPfF~~~~ 769 (902)
||++| ..||... .......+.... ..+ ....+++++++|.+||..++.+ |++++++++||||.+.+
T Consensus 200 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 200 EMLYG-ETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred HHhcC-CCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 99998 6677543 222222222211 111 2345789999999999765544 68999999999997643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=333.34 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=193.8
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|.+.+.||+|+||+||++.. .+++.||||++.+.. ....++++..++....|+||+++++++.+++..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 467889999999999999854 468899999986421 12234555567788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++... ...+++..+..++.|++.||+|||+++|
T Consensus 82 ----------y~~gg~L~~~l~~~----------------------------~~~l~~~~~~~~~~qi~~~L~~lH~~~i 123 (331)
T cd05624 82 ----------YYVGGDLLTLLSKF----------------------------EDRLPEDMARFYIAEMVLAIHSIHQLHY 123 (331)
T ss_pred ----------CCCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 66677777776421 1246777888999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-----CCCCCcchhhhhHHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILF 702 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGviL~ 702 (902)
+||||||+|||++.++. +||+|||+++....... ......+||+.|+|||++.+ +.++.++|||||||++|
T Consensus 124 iHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ 199 (331)
T cd05624 124 VHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMY 199 (331)
T ss_pred eeccCchHHEEEcCCCC--EEEEeccceeeccCCCc--eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhh
Confidence 99999999999988776 89999999987654321 11233569999999999875 46789999999999999
Q ss_pred HHHhCCCCCCCCchh-hHH-HHHhhc-cccc---cccCChHHHHHHHcccCCCCCC--CcCHHHHHcCCCCCCcc
Q 002601 703 FCITGGKHPYGESFE-RDA-NIVKDR-KDLF---LVEHIPEAVDLFTRLLDPNPDL--RPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 703 elltG~~~Pf~~~~~-~~~-~~~~~~-~~~~---~~~~~~e~~dLI~~~L~~dP~~--Rpt~~elL~HPfF~~~~ 769 (902)
||++| ..||..... ... .+.... ...+ ....+++++++|.+||..++.+ |++++++++||||...+
T Consensus 200 ell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~ 273 (331)
T cd05624 200 EMLYG-ETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID 273 (331)
T ss_pred hhhhC-CCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence 99998 667754322 222 222211 1111 1235689999999999876654 57899999999996543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=323.99 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=190.6
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+.|.+.+.||+|+||.||++.. .+++.||+|.+.... .....+|+. +++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVS-LLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHH-HHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 3477889999999999999854 468899999986432 123445554 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
||.++|.+++ ... ...+++..+..++.||+.||+|||+.+|
T Consensus 85 ~~~~~l~~~l-----------~~~----------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~i 125 (301)
T cd07873 85 YLDKDLKQYL-----------DDC----------------------------GNSINMHNVKLFLFQLLRGLNYCHRRKV 125 (301)
T ss_pred ccccCHHHHH-----------Hhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 7765554443 111 1235667788999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHh
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ellt 706 (902)
+||||||+|||++.++. +||+|||++........ ......+++.|+|||++.+. .++.++|||||||++|||++
T Consensus 126 ~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t 200 (301)
T cd07873 126 LHRDLKPQNLLINERGE--LKLADFGLARAKSIPTK---TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200 (301)
T ss_pred eCCCCCHHHEEECCCCc--EEECcCcchhccCCCCC---cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh
Confidence 99999999999988876 89999999876542211 11233578899999998754 47889999999999999999
Q ss_pred CCCCCCCCchhh-HHH-HHh---------------hc------ccc--------ccccCChHHHHHHHcccCCCCCCCcC
Q 002601 707 GGKHPYGESFER-DAN-IVK---------------DR------KDL--------FLVEHIPEAVDLFTRLLDPNPDLRPK 755 (902)
Q Consensus 707 G~~~Pf~~~~~~-~~~-~~~---------------~~------~~~--------~~~~~~~e~~dLI~~~L~~dP~~Rpt 755 (902)
| .+||...... ... +.. .. ... .....++++++||.+||+.||.+|||
T Consensus 201 g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t 279 (301)
T cd07873 201 G-RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS 279 (301)
T ss_pred C-CCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 8 6777643221 110 000 00 000 01234678899999999999999999
Q ss_pred HHHHHcCCCCCCcchh
Q 002601 756 AQNVLNHPFFWTADTR 771 (902)
Q Consensus 756 ~~elL~HPfF~~~~~~ 771 (902)
++|+++||||.....+
T Consensus 280 ~~eil~h~~f~~~~~~ 295 (301)
T cd07873 280 AEEAMKHPYFHCLGER 295 (301)
T ss_pred HHHHhcCcccccccch
Confidence 9999999999765543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=333.40 Aligned_cols=246 Identities=24% Similarity=0.394 Sum_probs=187.3
Q ss_pred ccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCc-----
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~----- 539 (902)
+.+.|...+.||+|+||+||++. ..+++.||||++..... ....+|+. ++..++||||+++++++.+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR-LLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHH-HHHhcCCCchhhhhhhhcccccccc
Confidence 44667788999999999999985 45788999999865321 23445654 67888999999999987543
Q ss_pred -cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 540 -~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
...|+++|++.++|.+++ +...+++..+..++.||+.|
T Consensus 92 ~~~~~~~~~~~~~~l~~~~-----------------------------------------~~~~l~~~~~~~i~~qi~~a 130 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIV-----------------------------------------KCQKLSDEHVQFLIYQLLRG 130 (343)
T ss_pred cCcEEEEeecCCCCHHHHH-----------------------------------------hcCCCCHHHHHHHHHHHHHH
Confidence 457999997665554332 11236777889999999999
Q ss_pred ccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhh
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 697 (902)
Q Consensus 619 L~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSl 697 (902)
|+|||+++|+||||||+|||++.++. +||+|||+++..... .....||+.|+|||++.+ ..++.++|||||
T Consensus 131 L~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 202 (343)
T cd07878 131 LKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202 (343)
T ss_pred HHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCCC------cCCccccccccCchHhcCCccCCchhhhHhH
Confidence 99999999999999999999988876 899999999876432 223468999999999876 468999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhh-HH-HHHhhc----------------------cc--------cccccCChHHHHHHHcc
Q 002601 698 GCILFFCITGGKHPYGESFER-DA-NIVKDR----------------------KD--------LFLVEHIPEAVDLFTRL 745 (902)
Q Consensus 698 GviL~elltG~~~Pf~~~~~~-~~-~~~~~~----------------------~~--------~~~~~~~~e~~dLI~~~ 745 (902)
||++|+|++| ..||...... .. .+.... .. .......+.+.+||.+|
T Consensus 203 G~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 281 (343)
T cd07878 203 GCIMAELLKG-KALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281 (343)
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHH
Confidence 9999999998 6777543211 10 110000 00 00112356788999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCC
Q 002601 746 LDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 746 L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
|+.||.+|||+.|+++||||..
T Consensus 282 L~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 282 LVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred cCCChhhCCCHHHHhcCcchhc
Confidence 9999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=320.10 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=188.7
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC--chHHHHHHHHHHHhCCCCCeeEecccccCc------ccee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQ------DFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~------~~~y 543 (902)
..|...+.||+|+||+||++.. .+++.||+|++.... .....+|+..+....+||||+++++++.+. ...|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 3455667899999999999854 468899999986443 234566766454444799999999998653 4689
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+||| |+++|+|.+++... +...+++..+..++.|++.||+|||
T Consensus 86 iv~e----------~~~~~~L~~~l~~~---------------------------~~~~l~~~~~~~~~~qi~~~l~~LH 128 (272)
T cd06637 86 LVME----------FCGAGSVTDLIKNT---------------------------KGNTLKEEWIAYICREILRGLSHLH 128 (272)
T ss_pred EEEE----------cCCCCcHHHHHHhc---------------------------cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 56667776665421 1134677788999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc-----cCCCCCcchhhhhH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLG 698 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlG 698 (902)
+.+|+||||||+||++++++. ++|+|||++....... .......|+..|+|||++. ...++.++||||||
T Consensus 129 ~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG 203 (272)
T cd06637 129 QHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 203 (272)
T ss_pred HCCCccCCCCHHHEEECCCCC--EEEccCCCceeccccc---ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHH
Confidence 999999999999999988765 9999999998654321 2223456899999999986 33578899999999
Q ss_pred HHHHHHHhCCCCCCCCchhhHHHH-Hhhc--cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 699 CILFFCITGGKHPYGESFERDANI-VKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~~~~-~~~~--~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
|++|||++| ..||.......... .... ........+.++.+++.+||+.||.+||++.++++||||
T Consensus 204 v~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 204 ITAIEMAEG-APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHhC-CCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 999999998 56765432222111 1111 111223456799999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.13 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=190.8
Q ss_pred ceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+.|...+.||+|+||+||++... +|..||+|++..... ....+|+. ++..++||||+++++++.++++.|+|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 45677889999999999998544 688999998765322 23445554 6678899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc-c
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-G 626 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~-~ 626 (902)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+. +
T Consensus 84 ----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 124 (333)
T cd06650 84 ----------HMDGGSLDQVLKK-----------------------------AGRIPEQILGKVSIAVIKGLTYLREKHK 124 (333)
T ss_pred ----------cCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 5566677666532 12356677889999999999999975 7
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
|+||||||+|||++.++. +||+|||++....... .....||..|+|||++.+..++.++|||||||++|+|++
T Consensus 125 ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 197 (333)
T cd06650 125 IMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDSM-----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI 197 (333)
T ss_pred EEecCCChhhEEEcCCCC--EEEeeCCcchhhhhhc-----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999988776 8999999987654321 123468999999999998889999999999999999999
Q ss_pred CCCCCCCCchhhHHH-HH---------------------------------------------hhccccc-cccCChHHH
Q 002601 707 GGKHPYGESFERDAN-IV---------------------------------------------KDRKDLF-LVEHIPEAV 739 (902)
Q Consensus 707 G~~~Pf~~~~~~~~~-~~---------------------------------------------~~~~~~~-~~~~~~e~~ 739 (902)
| ..||......... .. ....... ....+++++
T Consensus 198 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T cd06650 198 G-RYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQ 276 (333)
T ss_pred C-CCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHH
Confidence 8 6677543221110 00 0000000 012456889
Q ss_pred HHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 740 DLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 740 dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+||.+||+.||++|||++|++.||||..
T Consensus 277 ~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 277 DFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred HHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 9999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=320.67 Aligned_cols=261 Identities=26% Similarity=0.366 Sum_probs=217.6
Q ss_pred ceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCc----hHH--HHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH----DVA--LKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~----~~~--~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
+.|.+-++||+|.||.|.+. ...+|+.+|+|++++.-. +.+ +-| ...+...+||.+..|--.|+.++.+++|
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE-~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTE-NRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhH-HHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 45677789999999999986 566899999999977421 111 222 2467788999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+.+|.|.-+|.. .+.+++...+.+...|+.||.|||+.
T Consensus 247 Me----------yanGGeLf~HLsr-----------------------------er~FsE~RtRFYGaEIvsAL~YLHs~ 287 (516)
T KOG0690|consen 247 ME----------YANGGELFFHLSR-----------------------------ERVFSEDRTRFYGAEIVSALGYLHSR 287 (516)
T ss_pred EE----------EccCceEeeehhh-----------------------------hhcccchhhhhhhHHHHHHhhhhhhC
Confidence 99 8888998887743 24467777788999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+||.||||.+|.||++||+ +||+||||++.-- .......+.||||.|.|||++....|+.++|+|.+||++|||+
T Consensus 288 ~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I---~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMm 362 (516)
T KOG0690|consen 288 NIVYRDLKLENLLLDKDGH--IKITDFGLCKEEI---KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMM 362 (516)
T ss_pred CeeeeechhhhheeccCCc--eEeeecccchhcc---cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHH
Confidence 9999999999999999998 9999999998543 2345567899999999999999999999999999999999999
Q ss_pred hCCCCCCCCchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcchhhhhhhhc
Q 002601 706 TGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTRLSFLRDV 778 (902)
Q Consensus 706 tG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~~~~~~l~~~ 778 (902)
+|+.|+|....+.....+......+|...+++++.|+..+|.+||.+|. .+.|+++|+||.+.++...+.+.+
T Consensus 363 CGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki 440 (516)
T KOG0690|consen 363 CGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKI 440 (516)
T ss_pred hccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhcc
Confidence 9855555555666666666666778999999999999999999999996 488999999998877665544444
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=320.33 Aligned_cols=246 Identities=27% Similarity=0.375 Sum_probs=187.7
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||+|+||.||++.. .+|+.||+|++..... ....+|+. +++.++||||+++++++.+.+..|+|+||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHH-HHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 56678899999999999854 4689999999864321 23455664 66888999999999999999999999998
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|.++|.+++. . ....+++..++.++.||++||+|||+.+|+
T Consensus 81 ~~~~l~~~~~-----------~----------------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~ 121 (284)
T cd07839 81 CDQDLKKYFD-----------S----------------------------CNGDIDPEIVKSFMFQLLKGLAFCHSHNVL 121 (284)
T ss_pred CCCCHHHHHH-----------h----------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 7765544431 1 012357778899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-CCCcchhhhhHHHHHHHHhC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~elltG 707 (902)
||||||+||+++.++. +||+|||+++....... ......++..|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 122 H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg 196 (284)
T cd07839 122 HRDLKPQNLLINKNGE--LKLADFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196 (284)
T ss_pred cCCCCHHHEEEcCCCc--EEECccchhhccCCCCC---CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhc
Confidence 9999999999988776 89999999986543211 112345788999999987654 68999999999999999998
Q ss_pred CCCCCCCchh-hHHH-HHhh-----------------c--c---------ccccccCChHHHHHHHcccCCCCCCCcCHH
Q 002601 708 GKHPYGESFE-RDAN-IVKD-----------------R--K---------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 757 (902)
Q Consensus 708 ~~~Pf~~~~~-~~~~-~~~~-----------------~--~---------~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~ 757 (902)
+.++|..... .... +... . . .......++++.++|.+||+.||.+|||++
T Consensus 197 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ 276 (284)
T cd07839 197 GRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE 276 (284)
T ss_pred CCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHH
Confidence 7665543321 1111 1000 0 0 001123467899999999999999999999
Q ss_pred HHHcCCCC
Q 002601 758 NVLNHPFF 765 (902)
Q Consensus 758 elL~HPfF 765 (902)
++++||||
T Consensus 277 ~il~h~~f 284 (284)
T cd07839 277 EALQHPYF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=336.74 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=206.9
Q ss_pred ceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccc-eeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF-VYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~-~yLV 545 (902)
+.|...+.+|+|+||.+++. +..+++.+++|.+.-.. ...+.+|+. +++++.|||||.+.+.|.+++. ++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~-lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMD-LLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHH-HHHhccCCCeeeeccchhcCCceEEEE
Confidence 34556788999999999875 56678899999885332 235677775 7788999999999999999988 9999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|+|| .+|++.+.+... +..-++++.+..++.|++.||.|||++
T Consensus 83 m~Y~----------eGg~l~~~i~~~---------------------------k~~~f~E~~i~~~~~Q~~~av~ylH~~ 125 (426)
T KOG0589|consen 83 MEYC----------EGGDLAQLIKEQ---------------------------KGVLFPEERILKWFVQILLAVNYLHEN 125 (426)
T ss_pred Eeec----------CCCCHHHHHHHH---------------------------hhccccHHHHHHHHHHHHHHHHHHHhh
Confidence 9955 566776665432 224578899999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+|+|||||+.||++++++. +||+|||+|+.+.... ....+.+||+.||.||.+.+.+|..|+|||||||++|||+
T Consensus 126 ~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~---~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~ 200 (426)
T KOG0589|consen 126 RVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPED---SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC 200 (426)
T ss_pred hhhcccchhhhhhccccCc--eeecchhhhhhcCCch---hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH
Confidence 9999999999999999987 7999999999988653 2345678999999999999999999999999999999999
Q ss_pred hCCCCCCCCchh-h-HHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 706 TGGKHPYGESFE-R-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 706 tG~~~Pf~~~~~-~-~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
+- +++|..... . ...+........+...+.+++.+|+.||..+|..||++.++|.+|...
T Consensus 201 ~l-k~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 201 TL-KPAFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred hc-ccccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 96 778875432 2 234444555566777889999999999999999999999999998763
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=319.22 Aligned_cols=247 Identities=28% Similarity=0.381 Sum_probs=187.2
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||+|++|+||++.. .+|..||||++.... .....+|+. ++..++||||+++++++.+++..|+||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREIS-LLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHH-HHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 56678899999999999865 468999999985432 123455654 66888999999999999999999999997
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|.++|.+++ .... ....+++..+..++.||+.||+|||+.+|+
T Consensus 81 ~~~~l~~~~-----------~~~~--------------------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~ 123 (285)
T cd07861 81 LSMDLKKYL-----------DSLP--------------------------KGQYMDAELVKSYLYQILQGILFCHSRRVL 123 (285)
T ss_pred CCCCHHHHH-----------hcCC--------------------------CCCcCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 665554443 1110 113467788899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG 707 (902)
||||||+|||++.++. +||+|||++....... .......+++.|+|||++.+. .++.++|||||||++|+|+||
T Consensus 124 H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 198 (285)
T cd07861 124 HRDLKPQNLLIDNKGV--IKLADFGLARAFGIPV---RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK 198 (285)
T ss_pred ecCCCHHHEEEcCCCc--EEECcccceeecCCCc---ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHC
Confidence 9999999999988876 8999999997654321 111233578899999988754 468999999999999999998
Q ss_pred CCCCCCCchhhHH--HHHhh-----------------c-----------cccccccCChHHHHHHHcccCCCCCCCcCHH
Q 002601 708 GKHPYGESFERDA--NIVKD-----------------R-----------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 757 (902)
Q Consensus 708 ~~~Pf~~~~~~~~--~~~~~-----------------~-----------~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~ 757 (902)
.+||....+... ..... . ........+++++++|.+||+.||.+|||+.
T Consensus 199 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 277 (285)
T cd07861 199 -KPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277 (285)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 667764322110 00000 0 0001123567899999999999999999999
Q ss_pred HHHcCCCC
Q 002601 758 NVLNHPFF 765 (902)
Q Consensus 758 elL~HPfF 765 (902)
++++||||
T Consensus 278 ~ll~~~~~ 285 (285)
T cd07861 278 KALNHPYF 285 (285)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.79 Aligned_cols=248 Identities=28% Similarity=0.385 Sum_probs=192.8
Q ss_pred EEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc---------hHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
|...+.||+|+||+||++...+|+.||||.+..... ....+|+ ..++.++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEV-DLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHH-HHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 455678999999999998777899999998753211 1233344 467888999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
+| |+++|+|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 81 ~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (265)
T cd06631 81 ME----------FVPGGSISSILNR-----------------------------FGPLPEPVFCKYTKQILDGVAYLHNN 121 (265)
T ss_pred Ee----------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 6666777666532 12356778889999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCc---cccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS---CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
+|+|+||+|+||+++.++. ++|+|||++........ .........|+..|+|||++.+..++.++|||||||++|
T Consensus 122 ~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~ 199 (265)
T cd06631 122 CVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199 (265)
T ss_pred CcccCCcCHHhEEECCCCe--EEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHH
Confidence 9999999999999987765 89999999886532111 111122345899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCchhhH--HHHHhh--ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 703 FCITGGKHPYGESFERD--ANIVKD--RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~--~~~~~~--~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
+|++| ..||....... ..+... .....+...++++.++|.+||+.+|.+||++.++++||||
T Consensus 200 ~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 200 EMATG-KPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHhC-CCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99997 67876532221 111111 1122344567789999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.75 Aligned_cols=250 Identities=26% Similarity=0.397 Sum_probs=196.2
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|...+.||+|+||+||++.. .+|+.||+|.+..... ....+|+. ++..++|+||+++++++.+++..++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~-il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQ-ILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHH-HHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 44567899999999999854 5789999999864321 12345554 6778899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|..++... ....+++..+..++.|++.||+|||+.+|
T Consensus 81 ----------~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 123 (285)
T cd05632 81 ----------IMNGGDLKFHIYNM---------------------------GNPGFEEERALFYAAEILCGLEDLHRENT 123 (285)
T ss_pred ----------eccCccHHHHHHHh---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 66666666555321 12357888999999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+||+++.++. ++|+|||++....... ......|+..|+|||++.+..++.++|+|||||++|||++|
T Consensus 124 iH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~----~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 197 (285)
T cd05632 124 VYRDLKPENILLDDYGH--IRISDLGLAVKIPEGE----SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEG 197 (285)
T ss_pred eecCCCHHHEEECCCCC--EEEecCCcceecCCCC----cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhC
Confidence 99999999999987765 9999999987654321 12334689999999999988899999999999999999997
Q ss_pred CCCCCCCchhhH--H---HHHhhccccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCcc
Q 002601 708 GKHPYGESFERD--A---NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 769 (902)
Q Consensus 708 ~~~Pf~~~~~~~--~---~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~~ 769 (902)
.+||....... . ..+......+....++++.+++.+||+.||++||+ +.++++||||....
T Consensus 198 -~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~ 268 (285)
T cd05632 198 -QSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMN 268 (285)
T ss_pred -CCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCC
Confidence 77886543221 1 11122222344556788999999999999999999 88999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=333.81 Aligned_cols=233 Identities=27% Similarity=0.426 Sum_probs=188.4
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChhhHHH
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIY 558 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~dliy 558 (902)
+-||.|+.|.|+++. ..+++||||+++.. ..-+|. .++.++||||+.|.|+|....+++||||||.
T Consensus 130 eWlGSGaQGAVF~Gr-l~netVAVKKV~el----kETdIK-HLRkLkH~NII~FkGVCtqsPcyCIiMEfCa-------- 195 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGR-LHNETVAVKKVREL----KETDIK-HLRKLKHPNIITFKGVCTQSPCYCIIMEFCA-------- 195 (904)
T ss_pred hhhccCcccceeeee-ccCceehhHHHhhh----hhhhHH-HHHhccCcceeeEeeeecCCceeEEeeeccc--------
Confidence 349999999999855 45689999987532 223444 5688999999999999999999999999654
Q ss_pred HhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeE
Q 002601 559 VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 638 (902)
Q Consensus 559 ~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NIL 638 (902)
.|.|++.|... +.+....+..|..+||.|+.|||.+.|||||||+-|||
T Consensus 196 --~GqL~~VLka~-----------------------------~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiL 244 (904)
T KOG4721|consen 196 --QGQLYEVLKAG-----------------------------RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNIL 244 (904)
T ss_pred --cccHHHHHhcc-----------------------------CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceE
Confidence 57777766432 34566677899999999999999999999999999999
Q ss_pred eccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhh
Q 002601 639 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER 718 (902)
Q Consensus 639 L~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~ 718 (902)
|+.+.. +||+|||-++.+... .....++||..|||||++...+.++|+||||||||||||||| ..||.+-...
T Consensus 245 Is~~d~--VKIsDFGTS~e~~~~----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~-EiPYkdVdss 317 (904)
T KOG4721|consen 245 ISYDDV--VKISDFGTSKELSDK----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTG-EIPYKDVDSS 317 (904)
T ss_pred eeccce--EEeccccchHhhhhh----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhc-CCCccccchh
Confidence 988765 999999999877643 334567899999999999999999999999999999999998 8898763321
Q ss_pred HH--HHHhh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCC
Q 002601 719 DA--NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 763 (902)
Q Consensus 719 ~~--~~~~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HP 763 (902)
.. ..-.+ .....+..++..++=||++||+..|..||+..+++.|-
T Consensus 318 AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 318 AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred eeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 11 00001 12344566777899999999999999999999999994
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=316.60 Aligned_cols=253 Identities=28% Similarity=0.397 Sum_probs=194.0
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
.|.+.+.||+|+||.||++.. .+|+.||+|++.... ....+.|+..+++...||||+++++++.+++..|+||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 466788999999999999854 469999999986542 224556666667888999999999999999999999996
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc-cc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GL 627 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~-~I 627 (902)
++++| .+++..... ....+++..+..++.||+.||+|||++ ++
T Consensus 82 ~~~~l-----------~~~l~~~~~-------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i 125 (283)
T cd06617 82 MDTSL-----------DKFYKKVYD-------------------------KGLTIPEDILGKIAVSIVKALEYLHSKLSV 125 (283)
T ss_pred hcccH-----------HHHHHHhcc-------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 55444 333321110 113478888999999999999999997 99
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc----CCCCCcchhhhhHHHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSlGviL~e 703 (902)
+||||||+|||++.++. +||+|||++....... ......|+..|+|||++.+ ..++.++|+|||||++|+
T Consensus 126 ~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~ 199 (283)
T cd06617 126 IHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDSV----AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIE 199 (283)
T ss_pred ecCCCCHHHEEECCCCC--EEEeeccccccccccc----ccccccCCccccChhhcCCcccccccCccccchhhHHHHHH
Confidence 99999999999988765 9999999998664321 1122457889999998865 446889999999999999
Q ss_pred HHhCCCCCCCCc---hhhHHHHHhhcccccc-ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 704 CITGGKHPYGES---FERDANIVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 704 lltG~~~Pf~~~---~~~~~~~~~~~~~~~~-~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
|++| ..||... .+.............+ ...++++.++|.+||..+|.+||++.++++||||....
T Consensus 200 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 200 LATG-RFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred HHhC-CCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9997 6777642 2222233322222222 23567899999999999999999999999999996644
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=319.96 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=189.6
Q ss_pred eEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 474 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
.|.+.+.||+|+||+||++. ..+++.||+|++...... ...+|+. ++..++||||+++++++.+.+..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e- 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELE-ILYKCDSPYIIGFYGAFFVENRISICTE- 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHH-HHHhCCCCCeeeEEEEEEECCEEEEEEe-
Confidence 35667899999999999984 467899999998654221 2334544 6688899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|..+. .+++..+..++.|++.||+|||+.+|+
T Consensus 80 ---------~~~~~~l~~~~---------------------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~ 117 (279)
T cd06619 80 ---------FMDGGSLDVYR---------------------------------KIPEHVLGRIAVAVVKGLTYLWSLKIL 117 (279)
T ss_pred ---------cCCCCChHHhh---------------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 55556553321 235566788999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|+||||+|||++.++. ++|+|||++...... ......||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 118 H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g- 189 (279)
T cd06619 118 HRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG- 189 (279)
T ss_pred eCCCCHHHEEECCCCC--EEEeeCCcceecccc-----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhC-
Confidence 9999999999988876 999999999866432 12334689999999999988899999999999999999997
Q ss_pred CCCCCCchhh--------HHHHHh-hccc-cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 709 KHPYGESFER--------DANIVK-DRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 709 ~~Pf~~~~~~--------~~~~~~-~~~~-~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
..||...... ...... .... ......++++.++|.+||+.||.+||+++|+++||||...+
T Consensus 190 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 190 RFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 6777542211 011111 1111 11223567899999999999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=329.32 Aligned_cols=250 Identities=22% Similarity=0.301 Sum_probs=185.8
Q ss_pred eeeeccc--CceEEEEEE-eeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 478 NKEIAKG--SNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 478 ~~~LG~G--sfGtVy~a~-~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
.++||+| +||+||++. ..+|+.||||++..... ...++++..+++.++|||||++++++.+++..|+|||
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e--- 79 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS--- 79 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe---
Confidence 4679999 789999974 46799999999865321 1234444457788899999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.+++.... ...+++..+++++.|++.||+|||+++|+||
T Consensus 80 -------~~~~~~l~~~~~~~~---------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~ 125 (327)
T cd08227 80 -------FMAYGSAKDLICTHF---------------------------MDGMSELAIAYILQGVLKALDYIHHMGYVHR 125 (327)
T ss_pred -------ccCCCcHHHHHHhhc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence 666777776653211 1346778889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccc----cccccCCCCccccCchhhcc--CCCCCcchhhhhHHHHHHH
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGviL~el 704 (902)
||||+|||++.++. ++++|||.+.......... .......++..|+|||++.+ ..++.++|||||||++|||
T Consensus 126 dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el 203 (327)
T cd08227 126 SVKASHILISVDGK--VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203 (327)
T ss_pred CCChhhEEEecCCc--EEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHH
Confidence 99999999988876 8899998755433211100 01122346788999999976 4588999999999999999
Q ss_pred HhCCCCCCCCchhhHH--HHHhhcc---------------------------------------------ccccccCChH
Q 002601 705 ITGGKHPYGESFERDA--NIVKDRK---------------------------------------------DLFLVEHIPE 737 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~~--~~~~~~~---------------------------------------------~~~~~~~~~e 737 (902)
++| ..||........ ....... .......+++
T Consensus 204 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (327)
T cd08227 204 ANG-HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282 (327)
T ss_pred HHC-CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHH
Confidence 997 778764322111 0000000 0011123568
Q ss_pred HHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 738 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 738 ~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+.++|.+||+.||++|||++|+++||||..
T Consensus 283 ~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 283 FHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred HHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 899999999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=310.26 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=195.8
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||+|++|.||++.. .+|+.||+|.+.... .....+|+. +++.++||||+++++++.+++..|+|||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e- 79 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEAR-VLAKLDSSYIIRYYESFLDKGKLNIVME- 79 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHH-HHHhcCCCCeehheeeeccCCEEEEEEE-
Confidence 56778999999999999854 468999999985421 223345554 6688899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++++|.++++... ...+++..+..++.|++.||+|||+.+|+
T Consensus 80 ---------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~i~~~l~~al~~lH~~~i~ 123 (256)
T cd08529 80 ---------YAENGDLHKLLKMQR---------------------------GRPLPEDQVWRFFIQILLGLAHLHSKKIL 123 (256)
T ss_pred ---------eCCCCcHHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 666777777664321 13466778899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|+||||+||+++.++. ++|+|||+++....... ......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 124 h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g- 197 (256)
T cd08529 124 HRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTN---FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG- 197 (256)
T ss_pred cCCCCcceEEEeCCCC--EEEcccccceeccCccc---hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC-
Confidence 9999999999988776 89999999987654321 11334588999999999998899999999999999999997
Q ss_pred CCCCCCchhhHH--HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 709 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 709 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||........ .+........+....+++.++|.+||+.+|++||++.++++|||.
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 198 KHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 778865433221 222222223333566789999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=327.57 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=209.4
Q ss_pred ceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
+.|..-++||+|+||.|+-.. ..+|+.+|.|++.+.. ...++.|-+ ++..++.+.||.+--.|+..+.+++|
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~-iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQ-ILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHH-HHHHhccCcEEEEeeeecCCCceEEE
Confidence 446677899999999999754 4579999999885432 223455544 67888999999998889999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
+. -|.+|+|.-+|... ...++++..++.++.+|+.||+|||+.
T Consensus 264 Lt----------lMNGGDLkfHiyn~---------------------------g~~gF~e~ra~FYAAEi~cGLehlH~~ 306 (591)
T KOG0986|consen 264 LT----------LMNGGDLKFHIYNH---------------------------GNPGFDEQRARFYAAEIICGLEHLHRR 306 (591)
T ss_pred EE----------eecCCceeEEeecc---------------------------CCCCCchHHHHHHHHHHHhhHHHHHhc
Confidence 99 78888887665321 124789999999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+||+|||||+|||||+.|+ ++|+|.|||..+.... .....+||.+|||||++.++.|+...|+|||||+||||+
T Consensus 307 ~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~----~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi 380 (591)
T KOG0986|consen 307 RIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGK----PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMI 380 (591)
T ss_pred ceeeccCChhheeeccCCC--eEeeccceEEecCCCC----ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHH
Confidence 9999999999999999988 8899999999887542 223448999999999999999999999999999999999
Q ss_pred hCCCCCCCCchhh-----HHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCcchhh
Q 002601 706 TGGKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTRL 772 (902)
Q Consensus 706 tG~~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~~~~~ 772 (902)
.| ..||....+. ....+......++..++++++++.+.+|++||++|.. ++++.+||||.+-+.+.
T Consensus 381 ~G-~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 381 AG-HSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred cc-cCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 98 6788654332 2334445555677888999999999999999999974 66899999998866553
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=312.63 Aligned_cols=253 Identities=23% Similarity=0.336 Sum_probs=205.1
Q ss_pred cceEEEe-eeecccCceEEEEE-EeeCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEeccccc----Cccceeee
Q 002601 472 GKLVVFN-KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES----DQDFVYLS 545 (902)
Q Consensus 472 ~~~~~~~-~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~----d~~~~yLV 545 (902)
.+.|.+. ++||-|-.|.|... +..+|..+|+|+|... ..+.+|+......-.|||||.++++|. ...++.+|
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiV 137 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIV 137 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEee
Confidence 3444433 57999999999875 5678999999998754 667888876667778999999999865 46789999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| .|++|.|...+.++. ...+++.++..|++||+.|+.|||+.
T Consensus 138 mE----------~meGGeLfsriq~~g---------------------------~~afTErea~eI~~qI~~Av~~lH~~ 180 (400)
T KOG0604|consen 138 ME----------CMEGGELFSRIQDRG---------------------------DQAFTEREASEIMKQIGLAVRYLHSM 180 (400)
T ss_pred ee----------cccchHHHHHHHHcc---------------------------cccchHHHHHHHHHHHHHHHHHHHhc
Confidence 99 899999988875433 24578899999999999999999999
Q ss_pred cccccccccceeEeccC-CCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d-~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
+|.||||||+|+|.+.. .+..+||+|||+|+..... ....+.|-||.|+|||++...+|+..+|+||+||++|-|
T Consensus 181 nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~----~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIl 256 (400)
T KOG0604|consen 181 NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP----GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256 (400)
T ss_pred chhhccCChhheeeecCCCCcceEecccccccccCCC----ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHh
Confidence 99999999999999543 3456999999999976642 234567889999999999999999999999999999999
Q ss_pred HhCCCCCCCCchh-----hHHHHHhhcccccccc----CChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 705 ITGGKHPYGESFE-----RDANIVKDRKDLFLVE----HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 705 ltG~~~Pf~~~~~-----~~~~~~~~~~~~~~~~----~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
+.| .+||..... .....+......|+.+ .+++++|+|+.+|..+|++|.|+++++.|||....
T Consensus 257 LCG-yPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 257 LCG-YPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hcC-CCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 998 667654322 2234444455555543 35789999999999999999999999999998653
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=313.45 Aligned_cols=248 Identities=33% Similarity=0.516 Sum_probs=192.8
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------------hHHHHHHHHHHHhCCCCCeeEecccccCccc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------------DVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~ 541 (902)
|.+.+.||+|++|.||+|.. .+++.||+|.+..... +...+|+ .++..++||||+++++++.+.+.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREI-ALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHH-HHHHhcCCCCeeeEEEEEEeCCc
Confidence 34567899999999999854 5689999998854321 1122343 46788899999999999999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.++||| |.++++|.+++... ..+++..+..++.|++.||+|
T Consensus 81 ~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~l~~~l~~ 121 (267)
T cd06628 81 LNIFLE----------YVPGGSVAALLNNY-----------------------------GAFEETLVRNFVRQILKGLNY 121 (267)
T ss_pred cEEEEE----------ecCCCCHHHHHHhc-----------------------------cCccHHHHHHHHHHHHHHHHH
Confidence 999999 55666666665321 235667788999999999999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCccc---cccccCCCCccccCchhhccCCCCCcchhhhhH
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL---TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 698 (902)
||+.+++||||+|+||+++.++. ++|+|||+++......... .......|+..|+|||.+.+..++.++|+||||
T Consensus 122 lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG 199 (267)
T cd06628 122 LHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLG 199 (267)
T ss_pred HHhcCcccccCCHHHEEEcCCCC--EEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHH
Confidence 99999999999999999987765 8999999998776322111 111234588999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCchhhH--HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 699 CILFFCITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
|++|+|++| ..||.+..... ..+........+...+.++.++|++||+.||.+||++.++++||||
T Consensus 200 ~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 200 CLVVEMLTG-KHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHhhC-CCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 999999997 77886542221 1222222333445567899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=309.15 Aligned_cols=247 Identities=26% Similarity=0.447 Sum_probs=191.8
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccC-ccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d-~~~~yLV~E 547 (902)
|.+.+.||+|++|.||++.. .+++.||||++..... +...+|+ .+++.++|+|++++++.+.. +..+|++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEA-QLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHH-HHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 66789999999999999854 4578999999854321 1233343 46788899999999988764 456899999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++... ....+++.++..++.|++.||++||+.+|
T Consensus 81 ----------~~~~~~l~~~l~~~---------------------------~~~~l~~~~~~~~~~~l~~~l~~lH~~~i 123 (257)
T cd08223 81 ----------FCEGGDLYHKLKEQ---------------------------KGKLLPENQVVEWFVQIAMALQYLHEKHI 123 (257)
T ss_pred ----------ccCCCcHHHHHHHh---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 55566666665321 11346788899999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+||+++.++. ++|+|||++....... .......|++.|+|||++.+..++.++|||||||++++|++|
T Consensus 124 ~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08223 124 LHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQC---DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198 (257)
T ss_pred eccCCCchhEEEecCCc--EEEecccceEEecccC---CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC
Confidence 99999999999987765 9999999998764322 122344689999999999998899999999999999999998
Q ss_pred CCCCCCCch-hhHH-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 708 GKHPYGESF-ERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 708 ~~~Pf~~~~-~~~~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||.... .... .+........+...++++.+++.+||+.||..||++.++++||||
T Consensus 199 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 199 -KHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 56775432 2222 222222223345567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=333.55 Aligned_cols=276 Identities=23% Similarity=0.307 Sum_probs=193.8
Q ss_pred ceEEEeeeecccCceEEEEEEe------eCCcEEEEEEeccCCc----hHHHHHHHHHHHhC-CCCCeeEecccccCccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQDF 541 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~~ 541 (902)
+.|.+.+.||+|+||+||++.. .++..||||+++.... +...+|+. ++..+ +|||||+++++|.+.+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~-il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK-VLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHH-HHHHhcCCcceeeeeeeeccCCc
Confidence 3577889999999999999753 2467899999864321 23456776 44555 89999999999999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccch-------------------------hHHHHh-------------
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL-------------------------LNEVRI------------- 583 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~-------------------------l~~~~~------------- 583 (902)
.|+||| |+++|+|.+++......... +.+...
T Consensus 114 ~~lv~E----------~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 183 (375)
T cd05104 114 TLVITE----------YCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA 183 (375)
T ss_pred ceeeeh----------hccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence 999999 55566666666432210000 000000
Q ss_pred --------hhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCcc
Q 002601 584 --------RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655 (902)
Q Consensus 584 --------r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla 655 (902)
...................+++..+.+++.||+.||+|||+.+|+||||||+|||++.++. +||+|||++
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a 261 (375)
T cd05104 184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLA 261 (375)
T ss_pred ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccc
Confidence 0000000001111122346788999999999999999999999999999999999987654 899999999
Q ss_pred ccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhh--HHHHHhhc-cccccc
Q 002601 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER--DANIVKDR-KDLFLV 732 (902)
Q Consensus 656 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~--~~~~~~~~-~~~~~~ 732 (902)
+........ .......++..|+|||++.+..++.++|||||||++|||++++..||...... ....+... ....+.
T Consensus 262 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 262 RDIRNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE 340 (375)
T ss_pred eeccCcccc-cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCC
Confidence 876543211 11122335678999999999999999999999999999999668888654221 12222222 122233
Q ss_pred cCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 733 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 733 ~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
..+.++.++|.+||+.||++||++.|+++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 456789999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=320.81 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=188.8
Q ss_pred EEEeeeecccCceEEEEEEee---CCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCc--ccee
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVY 543 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~---~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~--~~~y 543 (902)
|.+.+.||+|+||.||++... +++.||+|.+.... .....+|+. ++..++||||+++++++.+. +..|
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIA-LLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHH-HHHhcCCCCccceEEEEeCCCCceEE
Confidence 556788999999999998553 58999999987622 234456664 67889999999999999988 8899
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+|||+|.+++.+++.. ... .....+++..+..++.||+.||+|||
T Consensus 81 lv~e~~~~~l~~~~~~-----------~~~------------------------~~~~~~~~~~~~~i~~qi~~~l~~lH 125 (316)
T cd07842 81 LLFDYAEHDLWQIIKF-----------HRQ------------------------AKRVSIPPSMVKSLLWQILNGVHYLH 125 (316)
T ss_pred EEEeCCCcCHHHHHHh-----------hcc------------------------CCCcCcCHHHHHHHHHHHHHHHHHHH
Confidence 9999887665554310 000 00124677888999999999999999
Q ss_pred cccccccccccceeEecc----CCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhH
Q 002601 624 EIGLIHRDLKPQNVLISK----DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLG 698 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~----d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlG 698 (902)
+.+|+||||||+|||++. ++ .+||+|||++.................++..|+|||++.+. .++.++||||||
T Consensus 126 ~~~i~h~dlkp~Nil~~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 203 (316)
T cd07842 126 SNWVLHRDLKPANILVMGEGPERG--VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG 203 (316)
T ss_pred hCCEeeCCCCHHHEEEcCCCCccc--eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHH
Confidence 999999999999999987 54 49999999998765432212222344678999999988764 578999999999
Q ss_pred HHHHHHHhCCCCCCCCchhhH-----------HHHHh------------------------h-cccccc-----------
Q 002601 699 CILFFCITGGKHPYGESFERD-----------ANIVK------------------------D-RKDLFL----------- 731 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~-----------~~~~~------------------------~-~~~~~~----------- 731 (902)
|++|+|++| .+||....... ..++. . ....+.
T Consensus 204 ~~l~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (316)
T cd07842 204 CIFAELLTL-EPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKH 282 (316)
T ss_pred HHHHHHHhc-CCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhc
Confidence 999999998 67775432111 00000 0 000000
Q ss_pred ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 732 VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 732 ~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
...++++.+++.+||+.||++|||+.|+++||||
T Consensus 283 ~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 283 KKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred cCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=325.97 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=185.9
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
..+.+.+.||+|+||+||+|.++. .||||++.-.. .-++|+.+...++.-+|.||+-+.|+|..... .||..+
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqw 468 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQW 468 (678)
T ss_pred HHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehh
Confidence 344567889999999999976654 59999996543 22455555557788999999999999998877 999998
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|++ .+|+.+||..+ ..|...+.+.|++||++|+.|||.++||
T Consensus 469 CeG----------sSLY~hlHv~e----------------------------tkfdm~~~idIAqQiaqGM~YLHAK~II 510 (678)
T KOG0193|consen 469 CEG----------SSLYTHLHVQE----------------------------TKFDMNTTIDIAQQIAQGMDYLHAKNII 510 (678)
T ss_pred ccC----------chhhhhccchh----------------------------hhhhHHHHHHHHHHHHHhhhhhhhhhhh
Confidence 875 35666666433 2356667899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc---CCCCCcchhhhhHHHHHHHH
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGviL~ell 705 (902)
|||||..||+|.+++. |||+||||+..-.-. ....+.....|...|||||+++. .+|++.+|||||||++|||+
T Consensus 511 HrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w-~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELl 587 (678)
T KOG0193|consen 511 HRDLKSNNIFLHEDLK--VKIGDFGLATVKTRW-SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELL 587 (678)
T ss_pred hhhccccceEEccCCc--EEEecccceeeeeee-ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHH
Confidence 9999999999988765 999999998643321 22233344458889999999874 36899999999999999999
Q ss_pred hCCCCCCCCchhhHHHHHhhcc------ccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 706 TGGKHPYGESFERDANIVKDRK------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 706 tG~~~Pf~~~~~~~~~~~~~~~------~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
|| ..||......+.-.+.++. .........++++|+..||..++++||...++|.
T Consensus 588 tg-~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 588 TG-ELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred hC-cCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 98 8899843332221111111 1112234459999999999999999999998874
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=312.83 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=204.6
Q ss_pred eeecccCceEEEEE-EeeCCcEEEEEEeccCC---chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChh
Q 002601 479 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (902)
Q Consensus 479 ~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~ 554 (902)
+.||+|+||.|--+ ...+|.++|||++.+.. ....++|+..+...-.|+||++|+.+|+|++.+|||||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfE------- 156 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFE------- 156 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEe-------
Confidence 57999999999764 67899999999997653 34679999988889999999999999999999999999
Q ss_pred hHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccccc
Q 002601 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (902)
Q Consensus 555 dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp 634 (902)
.|.+|+|-.+++. ...+.+.++.++.++|+.||.|||.+||.||||||
T Consensus 157 ---Km~GGplLshI~~-----------------------------~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKP 204 (463)
T KOG0607|consen 157 ---KMRGGPLLSHIQK-----------------------------RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKP 204 (463)
T ss_pred ---cccCchHHHHHHH-----------------------------hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCc
Confidence 9999999888753 34578889999999999999999999999999999
Q ss_pred ceeEeccCCCce-EEEccCCccccccCCCcc----ccccccCCCCccccCchhhc-----cCCCCCcchhhhhHHHHHHH
Q 002601 635 QNVLISKDKSFC-AKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 635 ~NILL~~d~~~~-vkL~DFGla~~~~~~~~~----~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGviL~el 704 (902)
+|||-...+.++ +||+||.|.......... .....+.+|+..|||||+.. ...|+.++|.||||||+|-|
T Consensus 205 ENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYIm 284 (463)
T KOG0607|consen 205 ENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIM 284 (463)
T ss_pred cceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHH
Confidence 999987655443 899999987654422211 22335678999999999864 23578999999999999999
Q ss_pred HhCCCCCCCCch----------------hhHHHHHhhcccccccc----CChHHHHHHHcccCCCCCCCcCHHHHHcCCC
Q 002601 705 ITGGKHPYGESF----------------ERDANIVKDRKDLFLVE----HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764 (902)
Q Consensus 705 ltG~~~Pf~~~~----------------~~~~~~~~~~~~~~~~~----~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPf 764 (902)
++| .+||.+.- ......++..+..||.. .+.+++|+|..+|..|+.+|.++.++++|||
T Consensus 285 LsG-YpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 285 LSG-YPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred HhC-CCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 998 77885421 11233455555566643 4679999999999999999999999999999
Q ss_pred CCCcc
Q 002601 765 FWTAD 769 (902)
Q Consensus 765 F~~~~ 769 (902)
+....
T Consensus 364 ~~~~~ 368 (463)
T KOG0607|consen 364 VQRCA 368 (463)
T ss_pred ccccc
Confidence 96543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.84 Aligned_cols=264 Identities=24% Similarity=0.335 Sum_probs=189.0
Q ss_pred ceEEEeeeecccCceEEEEEEee-----------------CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeE
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-----------------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVR 531 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-----------------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~ 531 (902)
..|.+.++||+|+||.||++... .+..||||.+...... ...+|+. ++..++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK-ILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHH-HHhhcCCCCeeE
Confidence 45678899999999999998542 2347999998754322 3445654 678889999999
Q ss_pred ecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHH
Q 002601 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611 (902)
Q Consensus 532 l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I 611 (902)
+++++.+.+..++||| |+++|+|.+++........... .............+++..+.++
T Consensus 84 ~~~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~i 143 (304)
T cd05096 84 LLGVCVDEDPLCMITE----------YMENGDLNQFLSSHHLDDKEEN----------GNDAVPPAHCLPAISYSSLLHV 143 (304)
T ss_pred EEEEEecCCceEEEEe----------cCCCCcHHHHHHhccccccccc----------cccccccccccccccHHHHHHH
Confidence 9999999999999999 5556666666643221100000 0000000011234677888999
Q ss_pred HHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCc
Q 002601 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691 (902)
Q Consensus 612 ~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~k 691 (902)
+.||+.||+|||+.+|+||||||+|||++.++. +||+|||+++.+..... ........++..|+|||++..+.++.+
T Consensus 144 ~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~DfG~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 220 (304)
T cd05096 144 ALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILMGKFTTA 220 (304)
T ss_pred HHHHHHHHHHHHHCCccccCcchhheEEcCCcc--EEECCCccceecccCce-eEecCcCCCCccccCHHHHhcCCCCch
Confidence 999999999999999999999999999988765 99999999986643221 111223346788999999998899999
Q ss_pred chhhhhHHHHHHHHhC-CCCCCCCchhhH-HHHH----hhc----cccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 692 IDLFSLGCILFFCITG-GKHPYGESFERD-ANIV----KDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 692 sDVwSlGviL~elltG-~~~Pf~~~~~~~-~~~~----~~~----~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
+|||||||++|||+++ +..||....... .... ... ....+...++.+.+++.+||+.||++|||++++.
T Consensus 221 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 221 SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 9999999999999975 456776532221 1111 000 1112334567899999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=320.53 Aligned_cols=247 Identities=24% Similarity=0.345 Sum_probs=190.9
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
.|.+.+.||+|+||.||++.. .+|..||+|.+..... ....+|+. ++..++||||+++++++.+++..|+|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e- 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELK-VLHECNSPYIVGFYGAFYSDGEISICME- 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEeeCCEEEEEee-
Confidence 467788999999999999854 4688999998864322 23445655 5677899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc-ccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 627 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~-~~I 627 (902)
|+++|+|.+++... ..+++..+..++.|++.||+|||+ .++
T Consensus 80 ---------y~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~i 121 (308)
T cd06615 80 ---------HMDGGSLDQVLKKA-----------------------------GRIPENILGKISIAVLRGLTYLREKHKI 121 (308)
T ss_pred ---------ccCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhhCCE
Confidence 66677777766321 346777889999999999999997 589
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+|||++.++. +||+|||++...... ......|+..|+|||.+.+..++.++|+|||||++|+|++|
T Consensus 122 ~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g 194 (308)
T cd06615 122 MHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIG 194 (308)
T ss_pred EECCCChHHEEEecCCc--EEEccCCCccccccc-----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhC
Confidence 99999999999987765 899999998765432 12344689999999999888899999999999999999998
Q ss_pred CCCCCCCchhhH-HHHHhhc-------------------------------------ccccc-ccCChHHHHHHHcccCC
Q 002601 708 GKHPYGESFERD-ANIVKDR-------------------------------------KDLFL-VEHIPEAVDLFTRLLDP 748 (902)
Q Consensus 708 ~~~Pf~~~~~~~-~~~~~~~-------------------------------------~~~~~-~~~~~e~~dLI~~~L~~ 748 (902)
..||....... ....... ....+ ...++++.++|.+||..
T Consensus 195 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 273 (308)
T cd06615 195 -RYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKK 273 (308)
T ss_pred -CCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccC
Confidence 55664322111 1111000 00000 12456899999999999
Q ss_pred CCCCCcCHHHHHcCCCCCCc
Q 002601 749 NPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 749 dP~~Rpt~~elL~HPfF~~~ 768 (902)
||++||++.++++||||.++
T Consensus 274 ~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 274 NPKERADLKELTKHPFIKRA 293 (308)
T ss_pred ChhhCcCHHHHhcChhhhhc
Confidence 99999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=313.81 Aligned_cols=246 Identities=21% Similarity=0.289 Sum_probs=188.8
Q ss_pred ceEEEeeeecccCceEEEEEEe----eCCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~----~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
+.|.+.+.||+|+||.||+|.. ..+..||+|.+...... ...+|+. .+..++||||+++++++.+++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL-TLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHH-HHhcCCCCCcCeEEEEEecCCCcEE
Confidence 4577889999999999999854 24678999998754322 2344554 5677899999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||| |+++|+|.+++... ...+++..++.++.||+.||+|||+
T Consensus 84 v~e----------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~i~~al~~lH~ 125 (266)
T cd05064 84 VTE----------YMSNGALDSFLRKH----------------------------EGQLVAGQLMGMLPGLASGMKYLSE 125 (266)
T ss_pred EEE----------eCCCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 66677777666421 1236778889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
.+++||||||+|||++.++. ++++|||.+........ .......++..|+|||++.+..++.++|||||||++||+
T Consensus 126 ~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 201 (266)
T cd05064 126 MGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAI--YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEV 201 (266)
T ss_pred CCEeeccccHhhEEEcCCCc--EEECCCcccccccccch--hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHH
Confidence 99999999999999987765 89999998765432211 111223456789999999999999999999999999998
Q ss_pred HhCCCCCCCCchhh-HHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 705 ITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 705 ltG~~~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
++.+..||...... ....+... ....+...+..+.+++.+||+.+|.+||+++++++
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 202 MSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred hcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 87457788654332 22222222 22334456678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=309.63 Aligned_cols=247 Identities=27% Similarity=0.430 Sum_probs=193.2
Q ss_pred eEEEeeeecccCceEEEEEEeeC-CcEEEEEEeccCCc-hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~~-g~~VAVKrl~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
.|.+.+.||+|+||.||++...+ ++.||+|.+..... +...+|+. +++.++||||+++++++.+++..|+++|
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~l~~e---- 78 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEIS-ILKQCDSPYIVKYYGSYFKNTDLWIVME---- 78 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHH-HHHhCCCCcEeeeeeeeecCCcEEEEEe----
Confidence 45667889999999999986654 89999999865432 33444554 6678899999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|.++++|.+++... ...+++..+..++.|++.||.|||+.+|+|||
T Consensus 79 ------~~~~~~L~~~l~~~----------------------------~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~d 124 (256)
T cd06612 79 ------YCGAGSVSDIMKIT----------------------------NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRD 124 (256)
T ss_pred ------cCCCCcHHHHHHhC----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 55566666655321 13467788899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|+|+||+++.++. ++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|+|++| .+|
T Consensus 125 l~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g-~~p 198 (256)
T cd06612 125 IKAGNILLNEEGQ--AKLADFGVSGQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG-KPP 198 (256)
T ss_pred CCcceEEECCCCc--EEEcccccchhcccCcc---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC-CCC
Confidence 9999999988776 89999999987654321 12234478899999999988899999999999999999997 677
Q ss_pred CCCchhhHHHHH-hh-cc--ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 712 YGESFERDANIV-KD-RK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 712 f~~~~~~~~~~~-~~-~~--~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
|........... .. .. ...+.....++.++|.+||+.||.+||++.|++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 199 YSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 765433222111 11 11 11122345689999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.47 Aligned_cols=248 Identities=31% Similarity=0.399 Sum_probs=186.7
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc--------hHHHHHHHHHHHhCCCCCeeEecccccC--cccee
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVY 543 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d--~~~~y 543 (902)
|...+.||+|+||.||++.. .+|+.||+|++..... ....+|+. +++.++||||+++++++.+ .+..+
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQ-LLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHH-HHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 55678899999999999854 5689999998854311 12334554 6788899999999998765 46789
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+++| |.++++|.+++... ..+++...+.++.|++.||+|||
T Consensus 83 l~~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~LH 123 (266)
T cd06651 83 IFME----------YMPGGSVKDQLKAY-----------------------------GALTESVTRKYTRQILEGMSYLH 123 (266)
T ss_pred EEEe----------CCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 55566666665321 23566677889999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
+.+|+||||||+||+++.++. +||+|||+++................++..|+|||.+.+..++.++|||||||++||
T Consensus 124 ~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~e 201 (266)
T cd06651 124 SNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVE 201 (266)
T ss_pred hCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHH
Confidence 999999999999999987765 999999999866432111111223458899999999998889999999999999999
Q ss_pred HHhCCCCCCCCchhhHH--HHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 704 CITGGKHPYGESFERDA--NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~~--~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
|++| .+||........ .... ......+....+.+.+++ +||..+|++||+++|+++||||.
T Consensus 202 l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 202 MLTE-KPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHC-CCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 9997 778875432211 1111 112223344567788888 67778999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.57 Aligned_cols=239 Identities=26% Similarity=0.393 Sum_probs=195.6
Q ss_pred eeecccCceEEEEE-EeeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||.|+||.||+| ...+...||||++.-.. -...++|+. .+..++|||+|.+.|+|-.+...|||||||-+
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVr-FL~~l~HPntieYkgCyLre~TaWLVMEYClG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVR-FLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHH-HHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence 56999999999998 45678899999985321 134677876 67899999999999999999999999999988
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
+-.|++.+. ..++-+.++..|+.+.+.||+|||+++.||||
T Consensus 111 SAsDlleVh---------------------------------------kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRD 151 (948)
T KOG0577|consen 111 SASDLLEVH---------------------------------------KKPLQEVEIAAITHGALQGLAYLHSHNRIHRD 151 (948)
T ss_pred cHHHHHHHH---------------------------------------hccchHHHHHHHHHHHHHHHHHHHHhhHHhhh
Confidence 777666332 23455667889999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc---cCCCCCcchhhhhHHHHHHHHhCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGviL~elltG~ 708 (902)
||..||||++.|. |||+|||.|....+ ..+++|||.|||||++. .+.|+-++||||||++..|+...
T Consensus 152 iKAGNILLse~g~--VKLaDFGSAsi~~P-------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER- 221 (948)
T KOG0577|consen 152 IKAGNILLSEPGL--VKLADFGSASIMAP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER- 221 (948)
T ss_pred ccccceEecCCCe--eeeccccchhhcCc-------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhc-
Confidence 9999999988876 99999998876543 36788999999999986 47899999999999999999986
Q ss_pred CCCCCCch--hhHHHHHhhccccc-cccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 709 KHPYGESF--ERDANIVKDRKDLF-LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 709 ~~Pf~~~~--~~~~~~~~~~~~~~-~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+||+-... .....|..+..+.. ..+.+..++.+|..||++-|..|||.+++++|+|...
T Consensus 222 kPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 222 KPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred CCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 66655432 23345555544333 3456678999999999999999999999999999853
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.55 Aligned_cols=248 Identities=25% Similarity=0.368 Sum_probs=192.3
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc-hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.|.+.++||+|+||+||+|...++..||+|.+..... ...+.++..+++.++|+||+++++++.+.+..|++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e---- 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE---- 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe----
Confidence 45778899999999999999877888999999865332 2233334457788999999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+++|||
T Consensus 82 ------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~d 128 (261)
T cd05072 82 ------YMAKGSLLDFLKSDE---------------------------GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128 (261)
T ss_pred ------cCCCCcHHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 667777777764321 12356677889999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+||+++.++. ++|+|||++........ .......++..|+|||++....++.++|||||||++|+|++++..|
T Consensus 129 l~p~nili~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p 204 (261)
T cd05072 129 LRAANVLVSESLM--CKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204 (261)
T ss_pred cchhhEEecCCCc--EEECCCccceecCCCce--eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCC
Confidence 9999999987765 89999999987653221 1112233567899999998888999999999999999999955888
Q ss_pred CCCchhhH-HHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 712 YGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 712 f~~~~~~~-~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
|....... ...+. ..........+.++.+++.+||..+|++||+++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 205 YPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 86543222 22222 1122223345678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.15 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=194.6
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
.|.+.+.||.|+||+||++.. .++..||+|++..... ....+|+. .++.++|+||+++++.+.+.+..|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e- 79 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQ-AMSQCNHPNVVKYYTSFVVGDELWLVMP- 79 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHH-HHHhcCCCCEEEEEEEEeeCCEEEEEEe-
Confidence 567889999999999999864 4688999999864331 23345554 6688899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
++++++|.+++.... ....+++..+..++.|++.||+|||+.||+
T Consensus 80 ---------~~~~~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~ql~~al~~lh~~~i~ 124 (267)
T cd06610 80 ---------YLSGGSLLDIMKSSY--------------------------PRGGLDEAIIATVLKEVLKGLEYLHSNGQI 124 (267)
T ss_pred ---------ccCCCcHHHHHHHhc--------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 555666666553211 113467788899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccc-cccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHh
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ellt 706 (902)
||||||+||++++++. ++|+|||++..+....... .......|+..|+|||++... .++.++|+|||||++|+|++
T Consensus 125 h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~ 202 (267)
T cd06610 125 HRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202 (267)
T ss_pred cCCCCHHhEEEcCCCC--EEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHh
Confidence 9999999999988765 8999999998776432221 122334689999999998877 78999999999999999999
Q ss_pred CCCCCCCCchhhH--HHHHhhcccccc-----ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 707 GGKHPYGESFERD--ANIVKDRKDLFL-----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 707 G~~~Pf~~~~~~~--~~~~~~~~~~~~-----~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
| ..||....... ............ ...++++.+++.+||+.||++||+++++++||||
T Consensus 203 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 203 G-AAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred C-CCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 7 77876543211 122222111111 2446789999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=308.53 Aligned_cols=245 Identities=23% Similarity=0.361 Sum_probs=190.8
Q ss_pred eEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCC--chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
.|.+.+.||+|+||.||++...++..+|+|.+.... .....+|+. +++.++||||+++++++.+.+..++|||
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~iv~e---- 79 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAK-VMMKLSHPKLVQLYGVCTQQKPLYIVTE---- 79 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHH-HHHHCCCCCceeEEEEEccCCCEEEEEE----
Confidence 466778999999999999988788899999886533 234455554 6788999999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|.++|+|.++++... ..+++..+..++.|++.||+|||+++|+|||
T Consensus 80 ------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 125 (256)
T cd05114 80 ------FMENGCLLNYLRQRQ----------------------------GKLSKDMLLSMCQDVCEGMEYLERNSFIHRD 125 (256)
T ss_pred ------cCCCCcHHHHHHhCc----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 666677766654211 1356778899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+||+++.++. +||+|||+++....... .......++..|+|||++....++.++|||||||++|||++++.+|
T Consensus 126 l~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p 201 (256)
T cd05114 126 LAARNCLVSSTGV--VKVSDFGMTRYVLDDEY--TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201 (256)
T ss_pred cCcceEEEcCCCe--EEECCCCCccccCCCce--eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCC
Confidence 9999999977654 89999999886543211 1111223566899999998888999999999999999999955888
Q ss_pred CCCchhh-HH-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 712 YGESFER-DA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 712 f~~~~~~-~~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
|...... .. .+........+...++++.+++.+||+.||.+||+++++++
T Consensus 202 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 202 FEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8754322 22 22222222234445678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=308.30 Aligned_cols=247 Identities=26% Similarity=0.444 Sum_probs=194.5
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||+|+||+||++. ..+|+.||+|++.... .....+|+. .++.++||||+++++++.+.+..|+|+|
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e- 79 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVA-VLSNMKHPNIVQYQESFEENGNLYIVMD- 79 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHH-HHHhCCCCCeeeeEeeecCCCeEEEEEe-
Confidence 5677899999999999974 4568999999985321 123445554 6788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|.+++.... ...+++.++++++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~l~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (256)
T cd08218 80 ---------YCEGGDLYKKINAQR---------------------------GVLFPEDQILDWFVQICLALKHVHDRKIL 123 (256)
T ss_pred ---------cCCCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 556666666553211 12356778899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|+||+|+|||++.++. ++|+|||++........ ......|++.|+|||++.+...+.++|+|||||++++|++|
T Consensus 124 h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g- 197 (256)
T cd08218 124 HRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL- 197 (256)
T ss_pred cCCCCHHHEEEcCCCC--EEEeeccceeecCcchh---hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcC-
Confidence 9999999999987765 89999999986653211 11234588899999999988899999999999999999998
Q ss_pred CCCCCCchhh-H-HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 709 KHPYGESFER-D-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 709 ~~Pf~~~~~~-~-~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||...... . ..+........+...+.++.++|.+||+.+|.+||++.++++||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 198 KHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 6676543222 2 2233333333455667899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.82 Aligned_cols=247 Identities=30% Similarity=0.454 Sum_probs=197.6
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+.+.||+|+||.||++.. .+++.||+|.+.+.. .+...+|+. +++.+.||||+++++++.+++..|+||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKR-ILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHH-HHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 467789999999999999854 468999999986432 122344554 678889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++.. ...+++..+..++.||+.||+|||+.+
T Consensus 81 e----------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~qil~~l~~lH~~~ 121 (290)
T cd05580 81 E----------YVPGGELFSHLRK-----------------------------SGRFPEPVARFYAAQVVLALEYLHSLD 121 (290)
T ss_pred e----------cCCCCCHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 5555666655532 134677788999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
|+||||+|+|||++.++. +||+|||+++..... .....|++.|+|||.+.+...+.++||||||+++|+|++
T Consensus 122 i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 193 (290)
T cd05580 122 IVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLA 193 (290)
T ss_pred EecCCCCHHHEEECCCCC--EEEeeCCCccccCCC------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHh
Confidence 999999999999988765 899999999876543 234468999999999988888999999999999999999
Q ss_pred CCCCCCCCchhh-HHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcc
Q 002601 707 GGKHPYGESFER-DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 769 (902)
Q Consensus 707 G~~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~ 769 (902)
| ..||...... ....+.......+...++.++++|.+||+.||.+|+ +++|+++||||...+
T Consensus 194 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 194 G-YPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred C-CCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 7 7777654322 222222333344555678999999999999999999 999999999996654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=320.70 Aligned_cols=238 Identities=26% Similarity=0.366 Sum_probs=178.7
Q ss_pred EeeeecccCceEEEEEEeeCCcEEEEEEeccCCchHHHHH--HHHHHHhCCCCCeeEecccccCcc----ceeeeecccc
Q 002601 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKE--IQNLIASDQHPNIVRWYGVESDQD----FVYLSLERCT 550 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~~~~~E--i~~ll~~l~HpNIV~l~g~~~d~~----~~yLV~E~c~ 550 (902)
+.+.||+|.||.||+|.+ +++.||||++...+.+.+..| |-.+ -.++|+||++++++....+ ..+||+|
T Consensus 214 l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~kqs~~~Ek~Iy~l-p~m~h~nIl~Fi~~ekr~t~~~~eywLVt~--- 288 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEKQSFQNEKNIYSL-PGMKHENILQFIGAEKRGTADRMEYWLVTE--- 288 (534)
T ss_pred hHHHhhcCccceeehhhc-cCceeEEEecCHHHHHHHHhHHHHHhc-cCccchhHHHhhchhccCCccccceeEEee---
Confidence 457799999999998665 559999999976554444333 3322 3679999999999977665 7899999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc-----
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI----- 625 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~----- 625 (902)
|.++|+|.++|.. +.++|....+|+..+++||+|||+.
T Consensus 289 -------fh~kGsL~dyL~~------------------------------ntisw~~~cria~SmarGLa~LHee~p~~d 331 (534)
T KOG3653|consen 289 -------FHPKGSLCDYLKA------------------------------NTISWNSLCRIAESMARGLAHLHEELPRGD 331 (534)
T ss_pred -------eccCCcHHHHHHh------------------------------ccccHHHHHHHHHHHHHHHHHhcccCCcCC
Confidence 9999999999843 4467888999999999999999974
Q ss_pred ----cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCC------CCcchhh
Q 002601 626 ----GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLF 695 (902)
Q Consensus 626 ----~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~------s~ksDVw 695 (902)
.|+|||||++||||..|+. +.|+|||||..+....... .....+||.+|||||++.+..- -.+.|||
T Consensus 332 ~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl~~~p~~~~~-d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvY 408 (534)
T KOG3653|consen 332 HHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLALRLEPGKPQG-DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVY 408 (534)
T ss_pred CCCCccccccccccceEEccCCc--EEeeccceeEEecCCCCCc-chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHH
Confidence 5999999999999988866 7799999999988654433 2344789999999999976432 2579999
Q ss_pred hhHHHHHHHHhCCC-------CCCCCchh----------hHHH-HHh-hcccccccc-----CChHHHHHHHcccCCCCC
Q 002601 696 SLGCILFFCITGGK-------HPYGESFE----------RDAN-IVK-DRKDLFLVE-----HIPEAVDLFTRLLDPNPD 751 (902)
Q Consensus 696 SlGviL~elltG~~-------~Pf~~~~~----------~~~~-~~~-~~~~~~~~~-----~~~e~~dLI~~~L~~dP~ 751 (902)
|+|.|||||++.-. ++|.-.++ +... .+. ...+.++.. ....+++.+..||+.||+
T Consensus 409 amgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDae 488 (534)
T KOG3653|consen 409 AMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAE 488 (534)
T ss_pred HHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchh
Confidence 99999999998522 22222222 1111 111 122222221 234678999999999999
Q ss_pred CCcCHHHH
Q 002601 752 LRPKAQNV 759 (902)
Q Consensus 752 ~Rpt~~el 759 (902)
.|.|+.-+
T Consensus 489 ARLTA~Cv 496 (534)
T KOG3653|consen 489 ARLTAGCV 496 (534)
T ss_pred hhhhhHHH
Confidence 99998754
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.86 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=196.2
Q ss_pred ccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
..+.|...+.||+|+||.||++. ..+++.||+|.+..... +...+|+. ++..+.||||+++++.+.+++..|+||
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~-~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHH-HHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 34567788999999999999985 45789999999865432 23344554 667889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++.. ..+++.++..++.|++.||+|||+.+
T Consensus 97 e----------~~~~~~L~~~~~~------------------------------~~~~~~~~~~i~~ql~~aL~~LH~~g 136 (296)
T cd06654 97 E----------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALEFLHSNQ 136 (296)
T ss_pred c----------ccCCCCHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 6777777776532 12456677899999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
|+||||||+|||++.++. +||+|||++........ ......|++.|+|||.+.+..++.++|||||||++|+|++
T Consensus 137 i~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~ 211 (296)
T cd06654 137 VIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211 (296)
T ss_pred cccCCCCHHHEEEcCCCC--EEECccccchhcccccc---ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHh
Confidence 999999999999987765 89999999886543211 1123468999999999998888999999999999999999
Q ss_pred CCCCCCCCchhhHH--HHHhhcc--ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 707 GGKHPYGESFERDA--NIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 707 G~~~Pf~~~~~~~~--~~~~~~~--~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
| .+||........ ....... ...+....+.+.++|.+||..||++||++.++++||||...
T Consensus 212 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 212 G-EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred C-CCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 8 667755432211 1111111 11233456789999999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.37 Aligned_cols=233 Identities=19% Similarity=0.260 Sum_probs=183.3
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccC----ccceeeeecc
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSLER 548 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d----~~~~yLV~E~ 548 (902)
..||+|++|.||+|. .+|+.||||++..... +...+|+. ++..++|||||+++|++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E- 102 (283)
T PHA02988 26 VLIKENDQNSIYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIK-NLRRIDSNNILKIYGFIIDIVDDLPRLSLILE- 102 (283)
T ss_pred eEEeeCCceEEEEEE-ECCEEEEEEeccccccccHHHHHHHHHHHH-HHHhcCCCCEEEEeeeEEecccCCCceEEEEE-
Confidence 469999999999965 5899999999865421 12235554 6788999999999999876 457899999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc-cc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GL 627 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~-~I 627 (902)
|+++|+|.+++... ..+++....+++.|++.||+|||+. ++
T Consensus 103 ---------y~~~g~L~~~l~~~-----------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~ 144 (283)
T PHA02988 103 ---------YCTRGYLREVLDKE-----------------------------KDLSFKTKLDMAIDCCKGLYNLYKYTNK 144 (283)
T ss_pred ---------eCCCCcHHHHHhhC-----------------------------CCCChhHHHHHHHHHHHHHHHHHhcCCC
Confidence 66777787776422 2356667789999999999999984 99
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc--CCCCCcchhhhhHHHHHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ--GRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~--~~~s~ksDVwSlGviL~ell 705 (902)
+||||||+|||++.++. +||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||+
T Consensus 145 ~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~ 216 (283)
T PHA02988 145 PYKNLTSVSFLVTENYK--LKIICHGLEKILSSP------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216 (283)
T ss_pred CCCcCChhhEEECCCCc--EEEcccchHhhhccc------cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 99999999999988765 999999999865432 123458999999999976 67899999999999999999
Q ss_pred hCCCCCCCCchhhH-HHHH-hh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 706 TGGKHPYGESFERD-ANIV-KD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 706 tG~~~Pf~~~~~~~-~~~~-~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+| ..||....... ...+ .. .....+...++++.+++.+||+.||++|||++|+++
T Consensus 217 ~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 217 TG-KIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HC-CCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 97 77887653322 2222 12 222334457789999999999999999999999974
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=330.46 Aligned_cols=275 Identities=22% Similarity=0.301 Sum_probs=191.5
Q ss_pred ceEEEeeeecccCceEEEEEEe------eCCcEEEEEEeccCCc----hHHHHHHHHHHHhC-CCCCeeEecccccCccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQDF 541 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~~ 541 (902)
+.|.+.+.||+|+||.||++.. .++..||||++..... ....+|+. +++.+ +|+|||+++++|.+.+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELK-ILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHH-HHHhhccCCceeeEeeEecCCCC
Confidence 4577889999999999998742 2346899999975432 23445665 45555 89999999999999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHH-----------HHh---------------------------
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE-----------VRI--------------------------- 583 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~-----------~~~--------------------------- 583 (902)
.|+||| |+++|+|.+++............ ...
T Consensus 117 ~~lv~e----------y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (374)
T cd05106 117 VLVITE----------YCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP 186 (374)
T ss_pred eEEeHh----------hccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence 999999 55566666666432210000000 000
Q ss_pred ---hhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccC
Q 002601 584 ---RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660 (902)
Q Consensus 584 ---r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~ 660 (902)
...................+++..+++|+.||+.||+|||+++|+||||||+|||++.++. +||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~ 264 (374)
T cd05106 187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMN 264 (374)
T ss_pred ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccC
Confidence 0000000000001112245788899999999999999999999999999999999987654 99999999987653
Q ss_pred CCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhH--HHHHhhc-cccccccCChH
Q 002601 661 DMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDR-KDLFLVEHIPE 737 (902)
Q Consensus 661 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~--~~~~~~~-~~~~~~~~~~e 737 (902)
.... ....+..++..|||||++....++.++|||||||++|||++.|..||....... ....... ....+...+++
T Consensus 265 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 265 DSNY-VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred Ccce-eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence 3211 111223356789999999988999999999999999999984488886543221 2222222 22233345789
Q ss_pred HHHHHHcccCCCCCCCcCHHHHHc
Q 002601 738 AVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 738 ~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+.++|.+||+.||.+||++.++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.71 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=193.2
Q ss_pred cccccceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCchHHHHHHHHHHH-hCCCCCeeEecccccCc----cce
Q 002601 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIA-SDQHPNIVRWYGVESDQ----DFV 542 (902)
Q Consensus 468 ~~~i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~-~l~HpNIV~l~g~~~d~----~~~ 542 (902)
.+.+++++.+.+.||+|.||.||+ +.+-|..||||++...++..+++|-+.... .++|+||+.+++.-..+ .++
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwr-G~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWR-GRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred HHhhhheeEEEEEecCccccceee-ccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 477889999999999999999998 567889999999999888889998876554 47999999999874332 358
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|||.+ |.++|||+++|.. ..++...+++++..+|.||+||
T Consensus 285 wLvTd----------YHe~GSL~DyL~r------------------------------~tv~~~~ml~LalS~AsGLaHL 324 (513)
T KOG2052|consen 285 WLVTD----------YHEHGSLYDYLNR------------------------------NTVTTEGMLKLALSIASGLAHL 324 (513)
T ss_pred EEeee----------cccCCcHHHHHhh------------------------------ccCCHHHHHHHHHHHhhhHHHH
Confidence 99999 9999999999854 3456677899999999999999
Q ss_pred ccc--------cccccccccceeEeccCCCceEEEccCCccccccCCCc-cccccccCCCCccccCchhhccCCC-----
Q 002601 623 HEI--------GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQGRQ----- 688 (902)
Q Consensus 623 H~~--------~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~-~~~~~~~~~Gt~~Y~APE~l~~~~~----- 688 (902)
|-. .|.|||||+.|||+.+++. +.|+|+|||........ .....+..+||.+|||||++...-.
T Consensus 325 H~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fe 402 (513)
T KOG2052|consen 325 HMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFE 402 (513)
T ss_pred HHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhh
Confidence 954 5999999999999988876 66999999998876533 3345567789999999999976432
Q ss_pred -CCcchhhhhHHHHHHHHh----CC-----CCCCCCchhhHHH------HH--hhcccccccc-CC----hHHHHHHHcc
Q 002601 689 -TRAIDLFSLGCILFFCIT----GG-----KHPYGESFERDAN------IV--KDRKDLFLVE-HI----PEAVDLFTRL 745 (902)
Q Consensus 689 -s~ksDVwSlGviL~ellt----G~-----~~Pf~~~~~~~~~------~~--~~~~~~~~~~-~~----~e~~dLI~~~ 745 (902)
-..+||||||.|+||+.- || .+||.+..+.+.. .+ +...+..+.. .+ ..+..+++.|
T Consensus 403 syk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeC 482 (513)
T KOG2052|consen 403 SYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKEC 482 (513)
T ss_pred hhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHh
Confidence 257999999999999764 32 4677654333221 11 1112222222 12 2455789999
Q ss_pred cCCCCCCCcCHHHHH
Q 002601 746 LDPNPDLRPKAQNVL 760 (902)
Q Consensus 746 L~~dP~~Rpt~~elL 760 (902)
|..+|..|.|+-.+.
T Consensus 483 W~~Np~aRltALriK 497 (513)
T KOG2052|consen 483 WYANPAARLTALRIK 497 (513)
T ss_pred hcCCchhhhHHHHHH
Confidence 999999999876553
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.89 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=196.6
Q ss_pred cceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.+.|.+.+.||.|++|+||++. ..+|+.||+|.+..... +...+|+ .+++.++||||+++++++.+.+..|+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI-LVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHH-HHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 3568888999999999999984 46789999998854322 2334454 46688899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++.. ..+++.++..++.|++.||+|||+.++
T Consensus 97 ----------~~~~~~L~~~~~~------------------------------~~l~~~~~~~i~~~l~~al~~LH~~~i 136 (296)
T cd06655 97 ----------YLAGGSLTDVVTE------------------------------TCMDEAQIAAVCRECLQALEFLHANQV 136 (296)
T ss_pred ----------ecCCCcHHHHHHh------------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 6666777665421 235778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+||+++.++. +||+|||++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 137 ~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg 211 (296)
T cd06655 137 IHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (296)
T ss_pred ccCCCCHHHEEECCCCC--EEEccCccchhcccccc---cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999988775 99999999887654321 11234588999999999988899999999999999999998
Q ss_pred CCCCCCCchhh-HH-HHHhhcc--ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 708 GKHPYGESFER-DA-NIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 708 ~~~Pf~~~~~~-~~-~~~~~~~--~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
..||...... .. .+..... ...+...++++.++|.+||..||.+||++.+++.||||..
T Consensus 212 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 212 -EPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred -CCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 6677553322 11 1111111 1123456778999999999999999999999999999954
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=313.88 Aligned_cols=244 Identities=27% Similarity=0.384 Sum_probs=186.8
Q ss_pred eecccCceEEEEEEe-eCCcEEEEEEeccCCc-----h-HHHHHH--HHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 480 EIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----D-VALKEI--QNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~-~~~~Ei--~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
.||+|+||.||++.. .+|+.||||.+.+... . ...+|. ..++....||||+.+++++.+++..|+|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e--- 77 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILD--- 77 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEe---
Confidence 389999999999854 5689999998864321 1 122222 223444589999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+|+||
T Consensus 78 -------~~~~~~L~~~i~~-----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~ 121 (279)
T cd05633 78 -------LMNGGDLHYHLSQ-----------------------------HGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121 (279)
T ss_pred -------cCCCCCHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCC
Confidence 6667777666532 1346788889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHhCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~elltG~~ 709 (902)
||||+|||++.++. ++|+|||++....... .....||..|+|||.+.. ..++.++||||+||++|+|++| .
T Consensus 122 dikp~Nil~~~~~~--~~l~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~ 193 (279)
T cd05633 122 DLKPANILLDEHGH--VRISDLGLACDFSKKK-----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG-H 193 (279)
T ss_pred CCCHHHEEECCCCC--EEEccCCcceeccccC-----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhC-C
Confidence 99999999987765 8999999987654321 123458999999999864 5578999999999999999998 6
Q ss_pred CCCCCchhhHH----HHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcch
Q 002601 710 HPYGESFERDA----NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 770 (902)
Q Consensus 710 ~Pf~~~~~~~~----~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~~ 770 (902)
.||........ ..........+...++++.++|.+||+.||.+|| +++++++||||...+.
T Consensus 194 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 194 SPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred CCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 67754321111 1111112233445678999999999999999999 6999999999977553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=312.86 Aligned_cols=264 Identities=21% Similarity=0.319 Sum_probs=196.9
Q ss_pred cceEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~ 541 (902)
.+.|.+.+.||+|+||.||+|... .+..||||.+...... ...+|+ ..++.++||||+++++++.+.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA-SVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHH-HHHHhCCCCCeeeEEEEEcCCCC
Confidence 356778899999999999997432 3568999988644321 223343 46788899999999999999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.|+||| |+++|+|.+++......... .-.....+...+.+++.|++.||+|
T Consensus 84 ~~lv~e----------~~~~g~L~~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~~l~~ 134 (288)
T cd05061 84 TLVVME----------LMAHGDLKSYLRSLRPEAEN-------------------NPGRPPPTLQEMIQMAAEIADGMAY 134 (288)
T ss_pred cEEEEe----------CCCCCCHHHHHHHhcccccc-------------------CCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 66677777777532211000 0001234566788999999999999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHH
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL 701 (902)
||+++|+||||||+|||++.++. ++|+|||+++....... ........++..|+|||.+.+..++.++|||||||++
T Consensus 135 lH~~~i~H~dikp~nili~~~~~--~~L~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 135 LNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred HHhCCCcCCCCChheEEEcCCCc--EEECcCCcccccccccc-ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 99999999999999999987765 89999999986543211 1112223457789999999988899999999999999
Q ss_pred HHHHhCCCCCCCCchhhHH-H-HHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc------CCCCCCc
Q 002601 702 FFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN------HPFFWTA 768 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~------HPfF~~~ 768 (902)
|||++++.+||........ . +........+...++++.+++.+||+.||.+||++.++++ ||||.+.
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 9999976888875433222 2 2222222334455688999999999999999999999986 9998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.18 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=194.6
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|...+.||+|+||.||++. ..+++.||||++..... ....+|+ .+++.++||||+++++.+.+++..++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~~lv~e- 79 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNEC-QVLKLLSHPNIIEYYENFLEDKALMIVME- 79 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHH-HHHhhCCCCchhheeeeEecCCEEEEEEe-
Confidence 5677899999999999974 45789999999864321 1233444 46788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|.+++.... ...+++..+.+++.|++.||+|||+++|+
T Consensus 80 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 123 (256)
T cd08220 80 ---------YAPGGTLAEYIQKRC---------------------------NSLLDEDTILHFFVQILLALHHVHTKLIL 123 (256)
T ss_pred ---------cCCCCCHHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 666777777664321 12367788899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|+||||+||+++.++. .+||+|||++....... ......|+..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 124 h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~- 197 (256)
T cd08220 124 HRDLKTQNILLDKHKM-VVKIGDFGISKILSSKS----KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL- 197 (256)
T ss_pred cCCCCHHHEEEcCCCC-EEEEccCCCceecCCCc----cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC-
Confidence 9999999999976553 58999999998765431 12234588999999999988889999999999999999998
Q ss_pred CCCCCCchhh-HH-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 709 KHPYGESFER-DA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 709 ~~Pf~~~~~~-~~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||...... .. .+........+...++++.+++.+||+.||.+|||+.|++.||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 198 KRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 6677553222 22 222222233344567899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=312.25 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=186.1
Q ss_pred cceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.+.|...+.||+|+||.||++. ..+|+.||+|++..... ....+|+. +++.++|+||+++++++.+++..|+||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREAS-LLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHH-HHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3567888999999999999985 45689999999864321 23455664 667889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
|++.+++.+++.. . ...+++..+..++.|++.||+|||+.+
T Consensus 83 e~~~~~l~~~~~~-----------~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ 123 (291)
T cd07870 83 EYMHTDLAQYMIQ-----------H----------------------------PGGLHPYNVRLFMFQLLRGLAYIHGQH 123 (291)
T ss_pred ecccCCHHHHHHh-----------C----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9766555443311 0 123456667889999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ell 705 (902)
|+||||||+|||++.++. +||+|||+++....... ......+++.|+|||++.+. .++.++|||||||++|+|+
T Consensus 124 i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 198 (291)
T cd07870 124 ILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQ---TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198 (291)
T ss_pred cccCCCChHHEEEcCCCc--EEEeccccccccCCCCC---CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999988776 99999999876432211 11233578999999998754 4788999999999999999
Q ss_pred hCCCCCCCCchhhHH---HHHh--------------hc----cccc-------------cccCChHHHHHHHcccCCCCC
Q 002601 706 TGGKHPYGESFERDA---NIVK--------------DR----KDLF-------------LVEHIPEAVDLFTRLLDPNPD 751 (902)
Q Consensus 706 tG~~~Pf~~~~~~~~---~~~~--------------~~----~~~~-------------~~~~~~e~~dLI~~~L~~dP~ 751 (902)
+| .+||........ .+.. .. .... .....+++.+++.+|++.||.
T Consensus 199 ~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~ 277 (291)
T cd07870 199 QG-QPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPK 277 (291)
T ss_pred hC-CCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcc
Confidence 98 667764322111 1000 00 0000 001245788999999999999
Q ss_pred CCcCHHHHHcCCCC
Q 002601 752 LRPKAQNVLNHPFF 765 (902)
Q Consensus 752 ~Rpt~~elL~HPfF 765 (902)
+|||+.|++.||||
T Consensus 278 ~R~t~~~~l~h~~~ 291 (291)
T cd07870 278 DRISAQDALLHPYF 291 (291)
T ss_pred cCcCHHHHhcCCCC
Confidence 99999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=306.19 Aligned_cols=244 Identities=32% Similarity=0.465 Sum_probs=192.2
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC--------chHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~--------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
|...+.||+|++|+||+|... ++..||+|.+.... .....+|+. +++.++|+||+++++++.+++..|++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIA-LLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHH-HHHhcCCCCchheeeeEecCCeEEEE
Confidence 345678999999999998665 78999999885432 122344554 67888999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
+| |+++++|.+++... ..+++..+..++.|++.||+|||+.
T Consensus 81 ~e----------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (258)
T cd06632 81 LE----------LVPGGSLAKLLKKY-----------------------------GSFPEPVIRLYTRQILLGLEYLHDR 121 (258)
T ss_pred EE----------ecCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 66666766665321 2356677889999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-CCCcchhhhhHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFC 704 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~el 704 (902)
+|+|+||+|+||+++.++. +||+|||++....... ......|+..|+|||.+.... ++.++|+|||||++|+|
T Consensus 122 ~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l 195 (258)
T cd06632 122 NTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFS----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195 (258)
T ss_pred CcccCCCCHHHEEECCCCC--EEEccCccceeccccc----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHH
Confidence 9999999999999988765 9999999988765332 123445889999999987766 89999999999999999
Q ss_pred HhCCCCCCCCchhhHH--HHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 705 ITGGKHPYGESFERDA--NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~~--~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
++| .+||.+...... .+.. ......+....+++.+++.+||+.+|.+||++.+++.|||+
T Consensus 196 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 196 ATG-KPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhC-CCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 997 778876543222 1111 11223344567889999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=311.29 Aligned_cols=259 Identities=19% Similarity=0.283 Sum_probs=194.5
Q ss_pred ccceEEEeeeecccCceEEEEEEe------eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCcc
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~ 540 (902)
..+.|.+.+.||+|+||+||++.. .++..||||++..... ....+|+. +++.++||||+++++++.+++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCeeeEEEEEcCCC
Confidence 345678889999999999998743 2357899999864322 12345554 667889999999999999999
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
..++||| |+++|+|.+++......... .+....+++..+..++.|++.||+
T Consensus 83 ~~~lv~e----------~~~~~~L~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~~l~ 133 (277)
T cd05062 83 PTLVIME----------LMTRGDLKSYLRSLRPEMEN-------------------NPVQAPPSLKKMIQMAGEIADGMA 133 (277)
T ss_pred CeEEEEe----------cCCCCCHHHHHHHcCccccc-------------------cccccCCCHHHHHHHHHHHHHHHH
Confidence 9999999 66677777776432211000 011234567788999999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvi 700 (902)
|||+.+++||||||+|||++.++. ++|+|||+++....... ........+++.|+|||++.+..++.++|||||||+
T Consensus 134 ~lH~~~~vH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 210 (277)
T cd05062 134 YLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 210 (277)
T ss_pred HHHHCCcccCCcchheEEEcCCCC--EEECCCCCccccCCcce-eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHH
Confidence 999999999999999999987765 89999999886543221 111123346788999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCchhhHH-H-HHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 701 LFFCITGGKHPYGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~~~~-~-~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
+|||++++.+||........ . +........+...++++.+++.+||+.||++||++.|++++
T Consensus 211 l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 211 LWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999976888875433222 2 22222223344567789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=310.91 Aligned_cols=246 Identities=23% Similarity=0.359 Sum_probs=188.2
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
+.|.+.+.||+|+||.||++.. .+|+.||+|++..... ....+|+. ++..++||||+++++++.+++..|+|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~-~l~~~~h~~ii~~~~~~~~~~~~~iv~e- 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIF-MVKECKHCNIVAYFGSYLSREKLWICME- 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHH-HHHhcCCCCeeeeeEEEEeCCEEEEEEe-
Confidence 4567788999999999999854 5789999999864321 22344554 6788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|.++++.. ..+++..+..++.|++.||+|||+.+|+
T Consensus 87 ---------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (267)
T cd06646 87 ---------YCGGGSLQDIYHVT-----------------------------GPLSELQIAYVCRETLQGLAYLHSKGKM 128 (267)
T ss_pred ---------CCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 66667776665321 2356778899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc---cCCCCCcchhhhhHHHHHHHH
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGviL~ell 705 (902)
||||||+||+++.++. ++|+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||+
T Consensus 129 H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 129 HRDIKGANILLTDNGD--VKLADFGVAAKITATI---AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred ccCCCHHHEEECCCCC--EEECcCccceeecccc---cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999987765 9999999998764321 1123345889999999885 344788999999999999999
Q ss_pred hCCCCCCCCchhhH-H-HHHhhc-c---ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCC
Q 002601 706 TGGKHPYGESFERD-A-NIVKDR-K---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764 (902)
Q Consensus 706 tG~~~Pf~~~~~~~-~-~~~~~~-~---~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPf 764 (902)
+| .+||....... . .+.... . .......+.++.++|.+||+.||++||+++++++|+|
T Consensus 204 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 204 EL-QPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred hC-CCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 98 55654322111 1 111110 0 0111234678999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=316.82 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=195.5
Q ss_pred eEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCch------HHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~~------~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|...+.||+|++|+||++... +++.||+|.+...... ....|+ .++..++||||+++++++.+.+..|+||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQ-EILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHH-HHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4677889999999999998554 5899999998654322 233444 4678889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |..+|+|.+++.... ...+++..+..++.|++.||+|||+.+
T Consensus 81 e----------~~~~~~L~~~~~~~~---------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~ 123 (316)
T cd05574 81 D----------YCPGGELFRLLQRQP---------------------------GKCLSEEVARFYAAEVLLALEYLHLLG 123 (316)
T ss_pred E----------ecCCCCHHHHHHhCC---------------------------CCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 555666666553211 134677788899999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccc--------------------------cccccCCCCccccCc
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL--------------------------TQNATGYGSSGWQAP 680 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~--------------------------~~~~~~~Gt~~Y~AP 680 (902)
++|+||||+||+++.++. ++|+|||++.......... .......||..|+||
T Consensus 124 i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aP 201 (316)
T cd05574 124 IVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP 201 (316)
T ss_pred eeccCCChHHeEEcCCCC--EEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCH
Confidence 999999999999988776 8999999987654221100 011234688999999
Q ss_pred hhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhh-HHHHHhhcccccccc--CChHHHHHHHcccCCCCCCCcC--
Q 002601 681 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-DANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRPK-- 755 (902)
Q Consensus 681 E~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~-~~~~~~~~~~~~~~~--~~~e~~dLI~~~L~~dP~~Rpt-- 755 (902)
|++.+..++.++|||||||++|+|++| ..||...... ....+......++.. .++++.++|.+||+.||++||+
T Consensus 202 E~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 280 (316)
T cd05574 202 EVISGDGHGSAVDWWTLGILLYEMLYG-TTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSK 280 (316)
T ss_pred HHHcCCCCCchHHHHHHHHHHHHHhhC-CCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCch
Confidence 999988899999999999999999997 6777644322 221111222122222 4788999999999999999999
Q ss_pred --HHHHHcCCCCCCcc
Q 002601 756 --AQNVLNHPFFWTAD 769 (902)
Q Consensus 756 --~~elL~HPfF~~~~ 769 (902)
++|++.||||.+..
T Consensus 281 ~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 281 RGAAEIKQHPFFRGVN 296 (316)
T ss_pred hhHHHHHcCchhhcCC
Confidence 99999999997654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=320.44 Aligned_cols=253 Identities=26% Similarity=0.399 Sum_probs=188.5
Q ss_pred ccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCc-----c
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ-----D 540 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~-----~ 540 (902)
+++.|.+.+.||+|+||+||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK-ILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHH-HHHhCCCCCcCchhheeecccccccc
Confidence 45678899999999999999984 45789999999864221 22344554 67888999999999886544 3
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
..|+|+|++..+|.++ + ....+++..+..++.|++.||+
T Consensus 82 ~~~lv~e~~~~~l~~~-----------~------------------------------~~~~l~~~~~~~i~~ql~~aL~ 120 (336)
T cd07849 82 DVYIVQELMETDLYKL-----------I------------------------------KTQHLSNDHIQYFLYQILRGLK 120 (336)
T ss_pred eEEEEehhcccCHHHH-----------H------------------------------hcCCCCHHHHHHHHHHHHHHHH
Confidence 5799999665443332 2 1234677788999999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGC 699 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGv 699 (902)
|||+.+|+||||||+|||++.++. +||+|||++.................||..|+|||++.+ ..++.++|||||||
T Consensus 121 ~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv 198 (336)
T cd07849 121 YIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGC 198 (336)
T ss_pred HHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHH
Confidence 999999999999999999988766 899999999876543222222233468999999998755 46889999999999
Q ss_pred HHHHHHhCCCCCCCCchh-hHHH----------------HHhhc----------cc-----cccccCChHHHHHHHcccC
Q 002601 700 ILFFCITGGKHPYGESFE-RDAN----------------IVKDR----------KD-----LFLVEHIPEAVDLFTRLLD 747 (902)
Q Consensus 700 iL~elltG~~~Pf~~~~~-~~~~----------------~~~~~----------~~-----~~~~~~~~e~~dLI~~~L~ 747 (902)
++|+|++| .+||..... .... +.... .. ......++++.++|.+||+
T Consensus 199 il~el~~G-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 277 (336)
T cd07849 199 ILAEMLSN-RPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLT 277 (336)
T ss_pred HHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcC
Confidence 99999998 677754311 1000 00000 00 0012346789999999999
Q ss_pred CCCCCCcCHHHHHcCCCCCCc
Q 002601 748 PNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 748 ~dP~~Rpt~~elL~HPfF~~~ 768 (902)
.||++|||+.|+++||||...
T Consensus 278 ~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 278 FNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred CChhhCcCHHHHhcCcccccc
Confidence 999999999999999999653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.18 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=202.3
Q ss_pred EeeeecccCceEEEEE-EeeCCcEEEEEEeccC-CchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChh
Q 002601 477 FNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~-~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~ 554 (902)
+.++||+|+||.||+| +...|..||+|...-. +-+...+|+. +++....|++|++||.+..+..+|||||||..
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEIS-IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA--- 112 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEIS-IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA--- 112 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHH-HHHHcCCchhhhhhhhhccCCceEeehhhcCC---
Confidence 4467999999999998 6678999999987543 3455677876 55777899999999999999999999998873
Q ss_pred hHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccccc
Q 002601 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (902)
Q Consensus 555 dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp 634 (902)
|+..+.++ .+..++.+.++..+++..+.||+|||...-||||||.
T Consensus 113 -------GSiSDI~R----------------------------~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKA 157 (502)
T KOG0574|consen 113 -------GSISDIMR----------------------------ARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKA 157 (502)
T ss_pred -------CcHHHHHH----------------------------HhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhccc
Confidence 44444432 1234577888999999999999999999999999999
Q ss_pred ceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCC
Q 002601 635 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714 (902)
Q Consensus 635 ~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~ 714 (902)
.||||+.+|. +||+|||.|-.+.+. ....++..|||.|||||++..-.|+.++||||||+...||..| ++||.+
T Consensus 158 GNILLNT~G~--AKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG-~PPYsD 231 (502)
T KOG0574|consen 158 GNILLNTDGI--AKLADFGVAGQLTDT---MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG-RPPYSD 231 (502)
T ss_pred ccEEEcccch--hhhhhccccchhhhh---HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC-CCCccc
Confidence 9999999987 999999999887653 3445678899999999999999999999999999999999997 889987
Q ss_pred chhhHHHHHhhcc--cc--ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 715 SFERDANIVKDRK--DL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 715 ~~~~~~~~~~~~~--~~--~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
-..-..-.+.... +. .+...+.++-|+|++||.+.|++|-|+.++++|||.+++.
T Consensus 232 IHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 232 IHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 5432221121111 11 2344567899999999999999999999999999998754
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=319.42 Aligned_cols=248 Identities=26% Similarity=0.369 Sum_probs=195.4
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
+...+.++||+|-||.|.+.....+..||||.++.... ....+|++ .+.+++|||||+|+|+|..++.+++++|
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIk-iLsqLkhPNIveLvGVC~~DePicmI~E- 615 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIK-ILSRLKHPNIVELLGVCVQDDPLCMITE- 615 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHH-HHhccCCCCeeEEEeeeecCCchHHHHH-
Confidence 44678899999999999998888889999999976543 34566776 5577799999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
||++|+|.+++...+... +......+|+.||+.|++||.+.++|
T Consensus 616 ---------YmEnGDLnqFl~aheapt---------------------------~~t~~~vsi~tqiasgmaYLes~nfV 659 (807)
T KOG1094|consen 616 ---------YMENGDLNQFLSAHELPT---------------------------AETAPGVSICTQIASGMAYLESLNFV 659 (807)
T ss_pred ---------HHhcCcHHHHHHhccCcc---------------------------cccchhHHHHHHHHHHHHHHHhhchh
Confidence 999999999986543211 12234477999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh-C
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT-G 707 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt-G 707 (902)
||||.+.|||+ ++++++||+|||+++.+-.......+ ...+-..+|||+|.+..++++.++|||+||+++||+++ .
T Consensus 660 Hrd~a~rNcLv--~~e~~iKiadfgmsR~lysg~yy~vq-gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C 736 (807)
T KOG1094|consen 660 HRDLATRNCLV--DGEFTIKIADFGMSRNLYSGDYYRVQ-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLC 736 (807)
T ss_pred hccccccceee--cCcccEEecCcccccccccCCceeee-cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHH
Confidence 99999999999 55567999999999976654332222 22345678999999999999999999999999999876 3
Q ss_pred CCCCCCCchhhHHH-----HHhhc----cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 708 GKHPYGESFERDAN-----IVKDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 708 ~~~Pf~~~~~~~~~-----~~~~~----~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+..||++...++.. ....+ ....|.-++.++.+++.+||..|.++||+.+++-.
T Consensus 737 ~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 737 REQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred hhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 46788875443321 11111 11223345678899999999999999999999843
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=314.25 Aligned_cols=250 Identities=28% Similarity=0.380 Sum_probs=188.3
Q ss_pred EeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 477 FNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
..+.||+|+||.||++. ..+|+.||+|.+..... ....+|+..+.+...||||+++++++.+++..+++||++..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 34679999999999974 45689999999865321 23455665554444699999999999999999999998876
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc-ccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHR 630 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~-~IvHr 630 (902)
++.++.. .+.. .....+++..+.+++.|++.||+|||+. +|+||
T Consensus 88 ~l~~l~~--------~~~~---------------------------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~ 132 (288)
T cd06616 88 SLDKFYK--------YVYE---------------------------VLKSVIPEEILGKIAVATVKALNYLKEELKIIHR 132 (288)
T ss_pred CHHHHHH--------HHHH---------------------------hhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeecc
Confidence 6554421 1100 1123467888899999999999999975 99999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC---CCCCcchhhhhHHHHHHHHhC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSlGviL~elltG 707 (902)
||||+||+++.++. +||+|||+++.+.... ......|+..|+|||++... .++.++|||||||++|+|++|
T Consensus 133 dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 206 (288)
T cd06616 133 DVKPSNILLDRNGN--IKLCDFGISGQLVDSI----AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206 (288)
T ss_pred CCCHHHEEEccCCc--EEEeecchhHHhccCC----ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhC
Confidence 99999999987765 8999999998665321 11233588999999999876 688999999999999999997
Q ss_pred CCCCCCCchhhHH---HHHhhcccc----ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 708 GKHPYGESFERDA---NIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 708 ~~~Pf~~~~~~~~---~~~~~~~~~----~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
.+||........ ......... .....++++.+||.+||+.||++||+++++++||||...
T Consensus 207 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 207 -KFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred -CCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 778865432111 111111111 112356789999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=315.47 Aligned_cols=250 Identities=27% Similarity=0.418 Sum_probs=196.1
Q ss_pred cceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.+.|...+.||+|+||.||++.. .+|+.||+|.+..... +...+|+ .+++.++||||+++++++.+.+..|+|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI-LVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHH-HHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 36677889999999999999854 5799999999864332 2234454 46788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|.+++.. ..+++.++..++.|++.||.|||+.+|
T Consensus 97 ----------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~l~~~L~~LH~~~i 136 (297)
T cd06656 97 ----------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALDFLHSNQV 136 (297)
T ss_pred ----------ccCCCCHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 7777777766531 235667789999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+|||++.++. ++|+|||++........ ......|++.|+|||.+.+..++.++|+|||||++|++++|
T Consensus 137 ~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg 211 (297)
T cd06656 137 IHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (297)
T ss_pred ccCCCCHHHEEECCCCC--EEECcCccceEccCCcc---CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999988776 89999999876543321 11234588999999999988899999999999999999998
Q ss_pred CCCCCCCchhhHH--HHHhhc--cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 708 GKHPYGESFERDA--NIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 708 ~~~Pf~~~~~~~~--~~~~~~--~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
.+||........ .+.... ....+...++.+.+++.+||+.||++||+++++++||||...
T Consensus 212 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 212 -EPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred -CCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 677754322111 111111 111233456789999999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.33 Aligned_cols=245 Identities=24% Similarity=0.397 Sum_probs=186.1
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
.|.+.+.||+|+||.||++.. .+++.||+|.+...... ...+|+ .+++.++||||+++++++.+.+..|+|||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~-~~~~~l~h~~ii~~~~~~~~~~~~~lv~e-- 86 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI-IMMKDCKHSNIVAYFGSYLRRDKLWICME-- 86 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHH-HHHHhCCCCCeeeEEEEEEeCCEEEEEEe--
Confidence 455567899999999999854 56899999998654322 233444 46788899999999999999999999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|.++|+|.+++.. ...+++.+++.++.|++.||+|||+.||+|
T Consensus 87 --------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 129 (267)
T cd06645 87 --------FCGGGSLQDIYHV-----------------------------TGPLSESQIAYVSRETLQGLYYLHSKGKMH 129 (267)
T ss_pred --------ccCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 5555666555421 124677888999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc---cCCCCCcchhhhhHHHHHHHHh
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGviL~ellt 706 (902)
+||||+||+++.++. ++|+|||++....... .......|+..|+|||++. ...++.++|+|||||++|+|++
T Consensus 130 ~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~ 204 (267)
T cd06645 130 RDIKGANILLTDNGH--VKLADFGVSAQITATI---AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE 204 (267)
T ss_pred CCCCHHHEEECCCCC--EEECcceeeeEccCcc---cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc
Confidence 999999999987765 8999999987664321 1223346899999999974 4457899999999999999999
Q ss_pred CCCCCCCCchh-hHH-HHHhhcc-cc---ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCC
Q 002601 707 GGKHPYGESFE-RDA-NIVKDRK-DL---FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764 (902)
Q Consensus 707 G~~~Pf~~~~~-~~~-~~~~~~~-~~---~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPf 764 (902)
| .+||..... ... ....... .. .....+..+.++|.+||+.||++||+++++++|||
T Consensus 205 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 205 L-QPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred C-CCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 8 556543222 111 1111110 00 11234568999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.57 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=191.2
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCC--chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
+.|.+.+.||+|+||+||++...++..||||.+.... .+...+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e--- 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMKLSHEKLVQLYGVCTKQRPIYIVTE--- 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHH-HHhcCCCCCeeeEEEEEccCCCcEEEEE---
Confidence 3467888999999999999877667789999886543 233455554 6788899999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|.++|+|.+++... ...+++.+++.++.||+.||+|||+.+|+|+
T Consensus 80 -------~~~~~~l~~~i~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 124 (256)
T cd05113 80 -------YMSNGCLLNYLREH----------------------------GKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124 (256)
T ss_pred -------cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 55566666655321 1235777889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+||+++.++. +||+|||+++....... .......++..|+|||++....++.++|||||||++|+|++.+..
T Consensus 125 dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 200 (256)
T cd05113 125 DLAARNCLVDDQGC--VKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200 (256)
T ss_pred ccCcceEEEcCCCC--EEECCCccceecCCCce--eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCC
Confidence 99999999987765 99999999886643211 111122356789999999888899999999999999999995588
Q ss_pred CCCCchhhH--HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 711 PYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 711 Pf~~~~~~~--~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
||....... ..+........+...++++.+++.+||+.||.+||++.+++.+
T Consensus 201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 201 PYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 887543322 2232222222334456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.69 Aligned_cols=245 Identities=28% Similarity=0.446 Sum_probs=186.0
Q ss_pred EEeeeecccCceEEEEEEee-----CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 476 VFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~-----~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.+.+.||.|+||.||+|... .+..||||.+..... +...+|+. .+..++||||++++|++.+.+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQ-ILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHH-HHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccc-ccccccccccccccccccccccccccc
Confidence 45688999999999998766 367899999965332 23445554 567779999999999999888899999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.++|.... ...+++.++.+|+.||++||+|||+++
T Consensus 81 e----------~~~~g~L~~~L~~~~---------------------------~~~~~~~~~~~i~~~i~~~l~~Lh~~~ 123 (259)
T PF07714_consen 81 E----------YCPGGSLDDYLKSKN---------------------------KEPLSEQQRLSIAIQIAEALSYLHSNN 123 (259)
T ss_dssp E------------TTEBHHHHHHHTC---------------------------TTTSBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred c----------ccccccccccccccc---------------------------ccccccccccccccccccccccccccc
Confidence 9 666777777775431 134677788999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
|+|+||+++|||++.++ .+||+|||++........ ........+...|+|||.+....++.++||||||+++||+++
T Consensus 124 iiH~~l~~~nill~~~~--~~Kl~~f~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 124 IIHGNLSPSNILLDSNG--QVKLSDFGLSRPISEKSK-YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp EEEST-SGGGEEEETTT--EEEEESTTTGEETTTSSS-EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccc--cccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999998776 499999999987732211 122233346788999999999899999999999999999999
Q ss_pred CCCCCCCCchhhH--HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 707 GGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 707 G~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
++..||.+..... ..+........+...+..+.++|.+||..||++||+++++++
T Consensus 201 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 201 LGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 7678887653332 233333333445556788999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=307.55 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=192.4
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC---------chHHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~---------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
|...+.||+|++|.||++. ..+|+.||+|.+.... .....+|+. +++.++|+||+++++++.+.+..++
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIR-LMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHH-HHHHcCCCceehhhceeccCCeEEE
Confidence 3456789999999999974 4678999999986432 122344554 6688999999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
|+| |+++|+|.+++.. ...+++..+..++.|++.||+|||+
T Consensus 81 v~e----------~~~~~~L~~~l~~-----------------------------~~~~~~~~~~~~~~ql~~al~~LH~ 121 (268)
T cd06630 81 FVE----------WMAGGSVSHLLSK-----------------------------YGAFKEAVIINYTEQLLRGLSYLHE 121 (268)
T ss_pred EEe----------ccCCCcHHHHHHH-----------------------------hCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 6666777666532 1245677889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccc-cccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
+|++|+||||+||+++.++. .+||+|||++.......... .......|+..|+|||.+.+..++.++||||+||++|+
T Consensus 122 ~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 200 (268)
T cd06630 122 NQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIE 200 (268)
T ss_pred CCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHH
Confidence 99999999999999976653 48999999998775431111 11123458899999999988889999999999999999
Q ss_pred HHhCCCCCCCCchh-hHHHHH-h----hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 704 CITGGKHPYGESFE-RDANIV-K----DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 704 lltG~~~Pf~~~~~-~~~~~~-~----~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
|++| ..||..... ...... . ......+...++++.+++.+||+.+|.+||++.++++||||.
T Consensus 201 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 201 MATA-KPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHhC-CCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 9998 667753221 111111 1 112233344668999999999999999999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.99 Aligned_cols=245 Identities=30% Similarity=0.436 Sum_probs=187.2
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChh
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~ 554 (902)
..||+|+||.||++.. .++..||+|.+...... ...+|+ .+++.++|+||+++++++.+++..++|+|
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e------- 85 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEI-ALHSYLKHRNIVQYLGSDSENGFFKIFME------- 85 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHH-HHHHhcCCCCeeeeeeeeccCCEEEEEEe-------
Confidence 5799999999999864 46789999988654322 234454 46788999999999999999999999999
Q ss_pred hHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccccc
Q 002601 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (902)
Q Consensus 555 dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp 634 (902)
|+++|+|.+++..... ....++..+..++.||+.||+|||+.+|+||||||
T Consensus 86 ---~~~~~~L~~~l~~~~~--------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p 136 (268)
T cd06624 86 ---QVPGGSLSALLRSKWG--------------------------PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKG 136 (268)
T ss_pred ---cCCCCCHHHHHHHhcc--------------------------cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence 6667777776643211 01125667788999999999999999999999999
Q ss_pred ceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC--CCCcchhhhhHHHHHHHHhCCCCCC
Q 002601 635 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCILFFCITGGKHPY 712 (902)
Q Consensus 635 ~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGviL~elltG~~~Pf 712 (902)
+||+++.+.. .++|+|||++........ ......|++.|+|||++.... ++.++|||||||++|+|++| .+||
T Consensus 137 ~nil~~~~~~-~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g-~~p~ 211 (268)
T cd06624 137 DNVLVNTYSG-VVKISDFGTSKRLAGINP---CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG-KPPF 211 (268)
T ss_pred HHEEEcCCCC-eEEEecchhheecccCCC---ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC-CCCC
Confidence 9999976332 489999999876643211 112234789999999986643 78999999999999999997 6787
Q ss_pred CCchhhHHHH----HhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 713 GESFERDANI----VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 713 ~~~~~~~~~~----~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
.+........ ........+....+++++++.+||+.+|.+||++.|++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 212 IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred ccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 6532221111 1112223445567899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=336.36 Aligned_cols=249 Identities=25% Similarity=0.375 Sum_probs=203.2
Q ss_pred ceEEEeeeecccCceEEEEEEeeC----CcEEEEEEeccCCchHH----HHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~----g~~VAVKrl~~~~~~~~----~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
..+.+.++||.|.||.|+++++.. ...||||.|+....+.. +.|. .+|....||||++|-|+......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EA-sIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEA-SIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhh-hhcccCCCCcEEEEEEEEecCceeEE
Confidence 456788999999999999987653 46899999987654433 3343 47788999999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
|.| ||+||+|+.+|..+++ .+..-++.-++++|+.|+.||-+
T Consensus 708 iTE----------yMENGsLDsFLR~~DG----------------------------qftviQLVgMLrGIAsGMkYLsd 749 (996)
T KOG0196|consen 708 ITE----------YMENGSLDSFLRQNDG----------------------------QFTVIQLVGMLRGIASGMKYLSD 749 (996)
T ss_pred Ehh----------hhhCCcHHHHHhhcCC----------------------------ceEeehHHHHHHHHHHHhHHHhh
Confidence 999 9999999999976654 35556778899999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
.++|||||.++|||++ .++++|++||||++.+.++......+....-..+|.|||.+..++++.++||||+|++|||+
T Consensus 750 m~YVHRDLAARNILVN--snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEV 827 (996)
T KOG0196|consen 750 MNYVHRDLAARNILVN--SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 827 (996)
T ss_pred cCchhhhhhhhheeec--cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEe
Confidence 9999999999999995 55889999999999887654322222222234679999999999999999999999999999
Q ss_pred HhCCCCCCCCchh-hHHHHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 705 ITGGKHPYGESFE-RDANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 705 ltG~~~Pf~~~~~-~~~~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
++-|..||.+... ...+.+ +.-..+.|.+++..+.+|+..||++|-.+||...|++.+
T Consensus 828 mSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 828 MSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred cccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 9877778776533 333434 444445567788889999999999999999999998764
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=309.00 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=187.6
Q ss_pred eEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|.+.+.||+|+||.||++... +|+.||+|++..... ....+|+. +++.++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR-MLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHH-HHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4677789999999999998654 689999999854321 22345554 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|++ ++.+...+. ....+++..++.++.|++.||+|||+.+|
T Consensus 81 ~~~----------~~~l~~~~~-----------------------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~i 121 (286)
T cd07847 81 YCD----------HTVLNELEK-----------------------------NPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121 (286)
T ss_pred ccC----------ccHHHHHHh-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 554 444433321 11236778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHh
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ellt 706 (902)
+||||||+||+++.++. ++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|+|++
T Consensus 122 ~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~ 196 (286)
T cd07847 122 IHRDVKPENILITKQGQ--IKLCDFGFARILTGPGD---DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196 (286)
T ss_pred eecCCChhhEEEcCCCc--EEECccccceecCCCcc---cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh
Confidence 99999999999988775 99999999987654321 1123347889999999876 457899999999999999999
Q ss_pred CCCCCCCCchhhH--HHHHhhcc--------------------c----------cccccCChHHHHHHHcccCCCCCCCc
Q 002601 707 GGKHPYGESFERD--ANIVKDRK--------------------D----------LFLVEHIPEAVDLFTRLLDPNPDLRP 754 (902)
Q Consensus 707 G~~~Pf~~~~~~~--~~~~~~~~--------------------~----------~~~~~~~~e~~dLI~~~L~~dP~~Rp 754 (902)
| .+||.+..... ..+..... . ......++++.++|.+||+.||++||
T Consensus 197 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd07847 197 G-QPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275 (286)
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC
Confidence 8 67876432211 11110000 0 00123456789999999999999999
Q ss_pred CHHHHHcCCCC
Q 002601 755 KAQNVLNHPFF 765 (902)
Q Consensus 755 t~~elL~HPfF 765 (902)
++.|++.||||
T Consensus 276 ~~~eil~~~~f 286 (286)
T cd07847 276 SCEELLEHPYF 286 (286)
T ss_pred CHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=312.99 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=184.6
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCcc------
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD------ 540 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~------ 540 (902)
+.|...+.||+|+||.||++.. .+|+.||||++.... .....+|+. +++.++||||+++++++.+.+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHH-HHHhCCCCCccceEEEEecccccccCC
Confidence 4577889999999999999854 468999999885432 113345665 678889999999999876544
Q ss_pred --ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 541 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 541 --~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
..++|||||.++|.+++ .. ....+++.+++.++.||+.|
T Consensus 91 ~~~~~lv~e~~~~~l~~~l-----------~~----------------------------~~~~~~~~~~~~i~~qi~~a 131 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLL-----------SN----------------------------KNVKFTLSEIKKVMKMLLNG 131 (310)
T ss_pred CceEEEEEcCCCcCHHHHH-----------Hh----------------------------cccCCCHHHHHHHHHHHHHH
Confidence 45999998776554443 11 01236778889999999999
Q ss_pred ccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccc-cccccCCCCccccCchhhccCC-CCCcchhhh
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGR-QTRAIDLFS 696 (902)
Q Consensus 619 L~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwS 696 (902)
|+|||+++|+|+||||+||+++.++. +||+|||++.......... .......++..|+|||.+.+.. ++.++||||
T Consensus 132 l~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 209 (310)
T cd07865 132 LYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWG 209 (310)
T ss_pred HHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHH
Confidence 99999999999999999999987765 9999999998765322111 1112345788999999887654 688999999
Q ss_pred hHHHHHHHHhCCCCCCCCchhh-HHHHHhhccc-------------------cc-------------cccCChHHHHHHH
Q 002601 697 LGCILFFCITGGKHPYGESFER-DANIVKDRKD-------------------LF-------------LVEHIPEAVDLFT 743 (902)
Q Consensus 697 lGviL~elltG~~~Pf~~~~~~-~~~~~~~~~~-------------------~~-------------~~~~~~e~~dLI~ 743 (902)
|||++|||++| .+||...... ....+..... .. .....+.+.++|.
T Consensus 210 lG~~l~el~t~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~ 288 (310)
T cd07865 210 AGCIMAEMWTR-SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLID 288 (310)
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHH
Confidence 99999999997 6677543221 1111000000 00 0112457789999
Q ss_pred cccCCCCCCCcCHHHHHcCCCC
Q 002601 744 RLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 744 ~~L~~dP~~Rpt~~elL~HPfF 765 (902)
+||..||.+|||++|+++||||
T Consensus 289 ~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 289 KLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred HHhcCChhhccCHHHHhcCCCC
Confidence 9999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=309.63 Aligned_cols=253 Identities=26% Similarity=0.375 Sum_probs=189.3
Q ss_pred ccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc--hHHHHHHHHHHHhC-CCCCeeEeccccc-----Cccc
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHPNIVRWYGVES-----DQDF 541 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l-~HpNIV~l~g~~~-----d~~~ 541 (902)
..+.|.+.+.||+|+||+||++.. .+|+.+|+|++..... .....|+. ++..+ +||||+++++++. +++.
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYN-ILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHH-HHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 446677889999999999999744 5688999998865332 23445655 44555 7999999999873 4567
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.|+||| |+++|+|.++++.... ....+++..+..++.|++.||.|
T Consensus 95 ~~lv~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~ 139 (286)
T cd06638 95 LWLVLE----------LCNGGSVTDLVKGFLK-------------------------RGERMEEPIIAYILHEALMGLQH 139 (286)
T ss_pred EEEEEe----------ecCCCCHHHHHHHhhc-------------------------cCccccHHHHHHHHHHHHHHHHH
Confidence 899999 6667777666542111 11346778889999999999999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-----CCCCCcchhhh
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFS 696 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwS 696 (902)
||+.+|+||||||+||+++.++. +||+|||+++...... .......|++.|+|||++.. ..++.++||||
T Consensus 140 lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 214 (286)
T cd06638 140 LHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTR---LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214 (286)
T ss_pred HHhCCccccCCCHHhEEECCCCC--EEEccCCceeecccCC---CccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence 99999999999999999988876 8999999988764321 11233458999999998853 34788999999
Q ss_pred hHHHHHHHHhCCCCCCCCchh-hHH-HHHhhcccc--ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 697 LGCILFFCITGGKHPYGESFE-RDA-NIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 697 lGviL~elltG~~~Pf~~~~~-~~~-~~~~~~~~~--~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
|||++|||++| ..||..... ... ......... .+.....++.++|.+||+.||++||++.|+++|+||
T Consensus 215 lGvi~~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 215 LGITAIELGDG-DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHhcC-CCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 99999999998 667654322 111 111111111 122245689999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.01 Aligned_cols=237 Identities=22% Similarity=0.374 Sum_probs=184.6
Q ss_pred ecccCceEEEEEE-eeCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChhhHHHH
Q 002601 481 IAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYV 559 (902)
Q Consensus 481 LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~dliy~ 559 (902)
||+|+||.||++. ..+|+.+|+|.+..........+...+ ..+||||+++++++.+.+..|+||| |+
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~--~~~h~~iv~~~~~~~~~~~~~iv~e----------~~ 91 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQL--MKDNPNFIKLYYSVTTLKGHVLIMD----------YI 91 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHH--hhcCCCEEEEEEEEecCCeeEEEEE----------cC
Confidence 6999999999975 456889999998654322211122211 2379999999999999999999999 66
Q ss_pred hcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEe
Q 002601 560 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639 (902)
Q Consensus 560 ~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL 639 (902)
++|+|.+++... ..+++.++..++.||++||+|||+.+++||||||+||++
T Consensus 92 ~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~ 142 (267)
T PHA03390 92 KDGDLFDLLKKE-----------------------------GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY 142 (267)
T ss_pred CCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 677777766321 246788899999999999999999999999999999999
Q ss_pred ccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhH
Q 002601 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD 719 (902)
Q Consensus 640 ~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~ 719 (902)
+.++. .++|+|||+++..... ....|+..|+|||++.+..++.++|||||||++|+|++| ..||.......
T Consensus 143 ~~~~~-~~~l~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g-~~p~~~~~~~~ 213 (267)
T PHA03390 143 DRAKD-RIYLCDYGLCKIIGTP-------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTG-KHPFKEDEDEE 213 (267)
T ss_pred eCCCC-eEEEecCccceecCCC-------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHC-CCCCCCCCcch
Confidence 88762 4899999998765432 223588999999999988899999999999999999998 67876433221
Q ss_pred H--H-H--HhhccccccccCChHHHHHHHcccCCCCCCCcC-HHHHHcCCCCCC
Q 002601 720 A--N-I--VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-AQNVLNHPFFWT 767 (902)
Q Consensus 720 ~--~-~--~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-~~elL~HPfF~~ 767 (902)
. . . ........+...++.+.++|.+||+.||.+||+ ++++++||||.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 1 1 1 111122233456789999999999999999996 699999999953
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=306.98 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=192.2
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
..+.+.+.||+|+||.||++.. ..++.||+|++..... ....+|+. ++..++||||+++++++.+++..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTREPPFYIITE-- 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHH-HHHhCCCCChhheEEEEcCCCCcEEEEE--
Confidence 3467788999999999999854 4588999999875432 23455655 6677899999999999999999999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+++|+|.+++.... ...+++..++.++.|++.||+|||+.+++|
T Consensus 83 --------~~~~~~L~~~~~~~~---------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H 127 (263)
T cd05052 83 --------FMTYGNLLDYLRECN---------------------------RQEVNAVVLLYMATQISSAMEYLEKKNFIH 127 (263)
T ss_pred --------eCCCCcHHHHHHhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence 667777777664321 123577788999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
|||||+|||+++++. +||+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++++.
T Consensus 128 ~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~ 203 (263)
T cd05052 128 RDLAARNCLVGENHL--VKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 203 (263)
T ss_pred cccCcceEEEcCCCc--EEeCCCcccccccccee--eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCC
Confidence 999999999987765 99999999987654321 11112234678999999998899999999999999999999557
Q ss_pred CCCCCch-hhHHHHHhh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 710 HPYGESF-ERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 710 ~Pf~~~~-~~~~~~~~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
.||.... +.....+.. .....+...++++.++|.+||+.||++||++.++++
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 204 SPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 7876532 222222222 223344556789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=310.59 Aligned_cols=249 Identities=28% Similarity=0.405 Sum_probs=196.0
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
.|.+.+.||.|++|.||++.. .+|..||+|++..... ....+|+. +++.++|+||+++++++.++...|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e- 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQ-FLSQCRSPYITKYYGSFLKGSKLWIIME- 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHH-HHHHcCCCCeeeeeEEEEECCeEEEEEE-
Confidence 345667899999999999854 4689999999865431 22344554 6788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+.+++
T Consensus 80 ---------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~i~ 120 (274)
T cd06609 80 ---------YCGGGSCLDLLKP------------------------------GKLDETYIAFILREVLLGLEYLHEEGKI 120 (274)
T ss_pred ---------eeCCCcHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 6666777665532 1457788899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
||||+|+||+++.++. ++|+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 121 h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg- 194 (274)
T cd06609 121 HRDIKAANILLSEEGD--VKLADFGVSGQLTSTM---SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG- 194 (274)
T ss_pred cCCCCHHHEEECCCCC--EEEcccccceeecccc---cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999988776 8999999998776432 122334588899999999988899999999999999999997
Q ss_pred CCCCCCchhhHH--HHHhhcccccccc-CChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 709 KHPYGESFERDA--NIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 709 ~~Pf~~~~~~~~--~~~~~~~~~~~~~-~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
.+||........ .+........... .++++.+++.+||..||++||+++++++||||....
T Consensus 195 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 195 EPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred CCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 778865432221 1222222222223 567899999999999999999999999999996543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=310.90 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=192.0
Q ss_pred ccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCc-----cce
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFV 542 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~-----~~~ 542 (902)
..+.|.+.+.||+|+||.||++.. .+|+.+|+|++..... ....+|+..+....+||||+++++++... +..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 346688889999999999999855 5689999999865432 23445665443334899999999987643 468
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+||| |+++|+|.++++.... ....+++..++.++.|++.||+||
T Consensus 100 ~lv~e----------y~~~~sL~~~~~~~~~-------------------------~~~~~~~~~~~~~~~qi~~al~~l 144 (291)
T cd06639 100 WLVLE----------LCNGGSVTELVKGLLI-------------------------CGQRLDEAMISYILYGALLGLQHL 144 (291)
T ss_pred EEEEE----------ECCCCcHHHHHHHhhh-------------------------cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 6667777776642111 123467788899999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-----CCCcchhhhh
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-----QTRAIDLFSL 697 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-----~s~ksDVwSl 697 (902)
|+.+|+||||||+||+++.++. +||+|||++........ ......|+..|+|||++.... ++.++|||||
T Consensus 145 H~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 219 (291)
T cd06639 145 HNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRL---RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSL 219 (291)
T ss_pred HhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcccccc---cccCccCCccccChhhhcCCCCcccccCCccchHHH
Confidence 9999999999999999988776 89999999887653211 112345889999999986433 5899999999
Q ss_pred HHHHHHHHhCCCCCCCCchhhH--HHHHhhccc--cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 698 GCILFFCITGGKHPYGESFERD--ANIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 698 GviL~elltG~~~Pf~~~~~~~--~~~~~~~~~--~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
||++|||++| .+||....... ..+...... ..+.....++.++|.+||+.||++||++.|+++||||.
T Consensus 220 Gvi~~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 220 GITAIELGDG-DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHhhC-CCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 9999999998 77776543211 122111111 11334557899999999999999999999999999983
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=316.45 Aligned_cols=255 Identities=26% Similarity=0.374 Sum_probs=196.3
Q ss_pred EeeeecccCceEEEEEEe-eCCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 477 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
..+.||+|+||.||++.. .+|+.||+|.+...... ...+|+. +++.++||||+++++++.+++..|+|||
T Consensus 8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e---- 82 (277)
T cd06642 8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDSPYITRYYGSYLKGTKLWIIME---- 82 (277)
T ss_pred HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHH-HHHcCCCCccHhhhcccccCCceEEEEE----
Confidence 346799999999999854 56889999998643321 2344554 6688899999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+++++|+|
T Consensus 83 ------~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~d 126 (277)
T cd06642 83 ------YLGGGSALDLLKP------------------------------GPLEETYIATILREILKGLDYLHSERKIHRD 126 (277)
T ss_pred ------ccCCCcHHHHhhc------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccC
Confidence 6666676665521 2356677889999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|+|+||+++.++. ++|+|||++..+..... ......|+..|+|||++.+..++.++|||||||++|||++| ..|
T Consensus 127 l~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg-~~p 200 (277)
T cd06642 127 IKAANVLLSEQGD--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG-EPP 200 (277)
T ss_pred CChheEEEeCCCC--EEEccccccccccCcch---hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhC-CCC
Confidence 9999999988776 89999999976653211 11234578899999999988899999999999999999997 667
Q ss_pred CCCchhhHH-H-HHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcchhhhhhhhc
Q 002601 712 YGESFERDA-N-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDV 778 (902)
Q Consensus 712 f~~~~~~~~-~-~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~~~~~l~~~ 778 (902)
+.+...... . +............+.++.++|.+||+.+|.+||++.++++||||.....+..++.++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~ 269 (277)
T cd06642 201 NSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTEL 269 (277)
T ss_pred CcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhhHHHHHHH
Confidence 764332221 1 111112222234567899999999999999999999999999997666655555443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=351.02 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=212.7
Q ss_pred ccccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEecc-----CCchHHHHHHHHHHHhCCCCCeeEecccccCccce
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVK-----THHDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~-----~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~ 542 (902)
+.-.++|.+.++||+|+||.|.+. ...+++.+|+|++.+ ..+...|+|+..+|...+.+-||+|+-.|+|++++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 344566778899999999999886 446789999999976 34456789999899988899999999999999999
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+||| ||++|+|-.+|... ..+|++.++.++..|+.||.-|
T Consensus 151 YlVMd----------Y~pGGDlltLlSk~-----------------------------~~~pE~~ArFY~aEiVlAldsl 191 (1317)
T KOG0612|consen 151 YLVMD----------YMPGGDLLTLLSKF-----------------------------DRLPEDWARFYTAEIVLALDSL 191 (1317)
T ss_pred EEEEe----------cccCchHHHHHhhc-----------------------------CCChHHHHHHHHHHHHHHHHHH
Confidence 99999 99999998887432 2478888999999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-----CCCCCcchhhhh
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSL 697 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSl 697 (902)
|+.|+|||||||+||||+..|+ +||+|||.|-.+..+. .-+..+.+|||.|++||++.. +.|+..+|+||+
T Consensus 192 H~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSl 267 (1317)
T KOG0612|consen 192 HSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADG--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSL 267 (1317)
T ss_pred HhccceeccCCcceeEecccCc--EeeccchhHHhcCCCC--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhh
Confidence 9999999999999999999988 9999999998887543 234466789999999999963 568999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhhHH-HHHhhc-ccccc--ccCChHHHHHHHcccCCCCCCCcC---HHHHHcCCCCCCcch
Q 002601 698 GCILFFCITGGKHPYGESFERDA-NIVKDR-KDLFL--VEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTADT 770 (902)
Q Consensus 698 GviL~elltG~~~Pf~~~~~~~~-~~~~~~-~~~~~--~~~~~e~~dLI~~~L~~dP~~Rpt---~~elL~HPfF~~~~~ 770 (902)
||++|||+.|..|+|.++.-... +|+... .-.|| ...++++++||.+++. +|+.|.+ ++++..||||.+.++
T Consensus 268 GV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 268 GVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 99999999996666666544333 444332 22344 4578899999999876 6888887 999999999966544
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.45 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=186.4
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccC------cccee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESD------QDFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d------~~~~y 543 (902)
..|.+.+.||+|+||+||++.. .+++.||+|++..... .....|+..+....+|+||+++++++.. .+..|
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 4566678899999999999854 5688999999865432 2344555544444489999999999853 46789
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
++|| |+++|+|.+++... +...+++..+..++.||+.||+|||
T Consensus 96 iv~e----------~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~al~~LH 138 (282)
T cd06636 96 LVME----------FCGAGSVTDLVKNT---------------------------KGNALKEDWIAYICREILRGLAHLH 138 (282)
T ss_pred EEEE----------eCCCCcHHHHHHHc---------------------------cCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 55555665554321 1123566778899999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc-----cCCCCCcchhhhhH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLG 698 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlG 698 (902)
+.+|+||||||+||+++.++. ++|+|||++....... .......|+..|+|||++. ...++.++||||||
T Consensus 139 ~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG 213 (282)
T cd06636 139 AHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTV---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLG 213 (282)
T ss_pred HCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhccc---cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHH
Confidence 999999999999999988776 8999999987654321 1223456899999999986 34578899999999
Q ss_pred HHHHHHHhCCCCCCCCchhhH-HH-HHhhcc-ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 699 CILFFCITGGKHPYGESFERD-AN-IVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~-~~-~~~~~~-~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
|++|||++| .+||....... .. +..... .......++++.++|.+||+.||.+||++.|+++||||
T Consensus 214 ~~l~el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 214 ITAIEMAEG-APPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHhC-CCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 999999998 66775432211 11 111111 11122456799999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=310.11 Aligned_cols=246 Identities=28% Similarity=0.462 Sum_probs=188.4
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||+|+||.||+|.. .+|+.||||++.... .....+|+. +++.++||||+++++++.+.+..|+|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK-ALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHH-HHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 56778999999999999865 468999999986543 123445554 66788999999999999999999999994
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
+ +++|.+++... ...+++.+++.++.||+.||+|||+.+|+
T Consensus 81 ----------~-~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 121 (286)
T cd07832 81 ----------M-PSDLSEVLRDE----------------------------ERPLPEAQVKSYMRMLLKGVAYMHANGIM 121 (286)
T ss_pred ----------c-CCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 4 55555544321 13467788899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-CCCcchhhhhHHHHHHHHhC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~elltG 707 (902)
|+||||+||+++.++. ++|+|||++........ .......|+..|+|||++.... ++.++||||+||++|||++|
T Consensus 122 H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg 197 (286)
T cd07832 122 HRDLKPANLLISADGV--LKIADFGLARLFSEEEP--RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197 (286)
T ss_pred cCCcCHHHEEEcCCCc--EEEeeeeecccccCCCC--CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC
Confidence 9999999999988765 89999999987654321 1123346899999999986544 68999999999999999998
Q ss_pred CCCCCCCchhhH-H-HHHhhc------------------c-----------ccccccCChHHHHHHHcccCCCCCCCcCH
Q 002601 708 GKHPYGESFERD-A-NIVKDR------------------K-----------DLFLVEHIPEAVDLFTRLLDPNPDLRPKA 756 (902)
Q Consensus 708 ~~~Pf~~~~~~~-~-~~~~~~------------------~-----------~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~ 756 (902)
.+||....... . .+.... . .....+...++.++|.+||+.||.+||++
T Consensus 198 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 198 -SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred -CcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 77775432211 0 111000 0 00012345788999999999999999999
Q ss_pred HHHHcCCCC
Q 002601 757 QNVLNHPFF 765 (902)
Q Consensus 757 ~elL~HPfF 765 (902)
+++++||||
T Consensus 277 ~~~l~h~~~ 285 (286)
T cd07832 277 AEALRHPYF 285 (286)
T ss_pred HHHhhCcCc
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=312.38 Aligned_cols=251 Identities=26% Similarity=0.378 Sum_probs=191.3
Q ss_pred cceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.+.|.+.+.||+|+||.||++.. .+++.||+|.+...... ...+|+. +++.++||||+++++++..++..|+|||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIE-ILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHH-HHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 35567778999999999999855 45899999998654432 2334544 6688999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++|+|..++... ...+++..+..++.|++.||+|||+.+|
T Consensus 90 ----------~~~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i 131 (292)
T cd06644 90 ----------FCPGGAVDAIMLEL----------------------------DRGLTEPQIQVICRQMLEALQYLHSMKI 131 (292)
T ss_pred ----------cCCCCcHHHHHHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 55566665544321 1246778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc-----cCCCCCcchhhhhHHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGviL~ 702 (902)
+||||||+||+++.++. +||+|||++....... .......+++.|+|||++. ...++.++|||||||++|
T Consensus 132 ~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 132 IHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTL---QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred eecCCCcceEEEcCCCC--EEEccCccceeccccc---cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 99999999999987766 8999999987643321 1122345788999999985 344688999999999999
Q ss_pred HHHhCCCCCCCCchhh-HH-HHHhhccc--cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 703 FCITGGKHPYGESFER-DA-NIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 703 elltG~~~Pf~~~~~~-~~-~~~~~~~~--~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
||++| .+||...... .. .+...... ..+...+.++.++|.+||+.||++||+++++++||||..
T Consensus 207 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 207 EMAQI-EPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHhcC-CCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 99998 6677543221 11 12111111 122345678999999999999999999999999999964
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=343.27 Aligned_cols=260 Identities=19% Similarity=0.281 Sum_probs=186.7
Q ss_pred cccceEEEeeeecccCceEEEEEEeeC--CcEEEEE------------------EeccCC--chHHHHHHHHHHHhCCCC
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE--GRSVAVK------------------RLVKTH--HDVALKEIQNLIASDQHP 527 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~~~~--g~~VAVK------------------rl~~~~--~~~~~~Ei~~ll~~l~Hp 527 (902)
.+.+.|.+.+.||+|+||+||++.... +..+++| .+.... .....+|+. ++..++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~-il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEIL-ALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHH-HHHhCCCC
Confidence 345678899999999999999874322 2222222 111111 112345554 67889999
Q ss_pred CeeEecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHH
Q 002601 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607 (902)
Q Consensus 528 NIV~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~ 607 (902)
|||++++++.+.+..|+|+|++..+|.++++. +.+. |. .......
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~--~~~~--------------------------------~~-~~~~~~~ 268 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDFDLYSFMYD--EAFD--------------------------------WK-DRPLLKQ 268 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccccCHHHHHhh--cccc--------------------------------cc-ccccHHH
Confidence 99999999999999999999887776665421 1110 11 1122345
Q ss_pred HHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC
Q 002601 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR 687 (902)
Q Consensus 608 ~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~ 687 (902)
++.|+.||+.||+|||+++|+||||||+||||+.++. +||+|||+++.+..... ......+||..|+|||++.+..
T Consensus 269 ~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 344 (501)
T PHA03210 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK--IVLGDFGTAMPFEKERE--AFDYGWVGTVATNSPEILAGDG 344 (501)
T ss_pred HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEeCCCceecCcccc--cccccccCCcCCCCchhhcCCC
Confidence 6789999999999999999999999999999988876 99999999987654321 1123456999999999999999
Q ss_pred CCCcchhhhhHHHHHHHHhCCCCCCCCchh----hHHHHHhhc---cccc----------------------------cc
Q 002601 688 QTRAIDLFSLGCILFFCITGGKHPYGESFE----RDANIVKDR---KDLF----------------------------LV 732 (902)
Q Consensus 688 ~s~ksDVwSlGviL~elltG~~~Pf~~~~~----~~~~~~~~~---~~~~----------------------------~~ 732 (902)
++.++|||||||++|||++|+.+|+..... ....++... ...+ ..
T Consensus 345 ~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 424 (501)
T PHA03210 345 YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL 424 (501)
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhc
Confidence 999999999999999999987777754311 111111100 0000 01
Q ss_pred cCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 733 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 733 ~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
....++.++|.+||+.||.+|||+.|+|.||||....
T Consensus 425 ~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 425 GLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred CCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 2345678889999999999999999999999996543
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.23 Aligned_cols=262 Identities=23% Similarity=0.337 Sum_probs=193.4
Q ss_pred eEEEeeeecccCceEEEEEEeeC------CcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~~------g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
.|.+.+.||+|+||.||++.... +..||+|.+...... ...+|+. .+..++||||+++++++.+.+..|
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE-LMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHH-HHHhcCCcccceEEEEEcCCCceE
Confidence 46677899999999999985433 268999998654322 2344554 668889999999999999999999
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
++|| |+++|+|.+++........... ..........+++..++.++.|++.||+|||
T Consensus 85 ~~~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 85 MLFE----------YLAHGDLHEFLVRNSPHSDVGA-------------ESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred EEEe----------cCCCCcHHHHHHhcCCCccccc-------------ccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 5566677666643221110000 0000012245788889999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
+.+|+||||||+||+++.++. ++|+|||+++....... ........+++.|+|||.+.+..++.++|||||||++||
T Consensus 142 ~~~i~H~dlkp~Nil~~~~~~--~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEGLT--VKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred hCCeeccccccceEEEcCCCc--EEECCCcceeecccccc-ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 999999999999999988765 89999999986543211 112233456889999999998899999999999999999
Q ss_pred HHhCCCCCCCCc-hhhHHHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 704 CITGGKHPYGES-FERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 704 lltG~~~Pf~~~-~~~~~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
|++.+..||... .......+. ......+...++++.+|+.+||+.||.+||+++|+++|
T Consensus 219 l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 219 IFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 998336676543 333333332 22233445677899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=310.10 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=185.4
Q ss_pred ceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+.|.+.+.||+|++|+||++... +++.||||.+.... .....+|+. +++.++||||+++++++.+++..|+|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREAS-LLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHH-HHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 45778899999999999998554 68999999985432 123445655 6688899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+.++|.+++ ... ...+++..++.++.|++.||.|||+.+|
T Consensus 84 ~~~~~L~~~~-----------~~~----------------------------~~~~~~~~~~~~~~ql~~al~~lH~~~i 124 (291)
T cd07844 84 YLDTDLKQYM-----------DDC----------------------------GGGLSMHNVRLFLFQLLRGLAYCHQRRV 124 (291)
T ss_pred cCCCCHHHHH-----------HhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 6655444433 211 1235677889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHh
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ellt 706 (902)
+||||||+||+++.++. +||+|||+++....... ......++..|+|||++.+ ..++.++||||+||++|+|++
T Consensus 125 ~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~ 199 (291)
T cd07844 125 LHRDLKPQNLLISERGE--LKLADFGLARAKSVPSK---TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199 (291)
T ss_pred ecccCCHHHEEEcCCCC--EEECccccccccCCCCc---cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh
Confidence 99999999999988776 99999999875432111 1122346888999999875 457899999999999999999
Q ss_pred CCCCCCCCchhh--HHH-HHhh---c---------------c--------c---cccccCC--hHHHHHHHcccCCCCCC
Q 002601 707 GGKHPYGESFER--DAN-IVKD---R---------------K--------D---LFLVEHI--PEAVDLFTRLLDPNPDL 752 (902)
Q Consensus 707 G~~~Pf~~~~~~--~~~-~~~~---~---------------~--------~---~~~~~~~--~e~~dLI~~~L~~dP~~ 752 (902)
| .+||...... ... +... . . . ....... +++.+++.+||+.||++
T Consensus 200 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 278 (291)
T cd07844 200 G-RPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKK 278 (291)
T ss_pred C-CCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccc
Confidence 8 6777543211 100 0000 0 0 0 0001122 67889999999999999
Q ss_pred CcCHHHHHcCCCC
Q 002601 753 RPKAQNVLNHPFF 765 (902)
Q Consensus 753 Rpt~~elL~HPfF 765 (902)
||++.|++.||||
T Consensus 279 Rps~~e~l~~~~f 291 (291)
T cd07844 279 RISAAEAMKHPYF 291 (291)
T ss_pred ccCHHHHhcCCCC
Confidence 9999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=308.03 Aligned_cols=239 Identities=22% Similarity=0.307 Sum_probs=180.5
Q ss_pred eeecccCceEEEEEEee-------------CCcEEEEEEeccCCch--HHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 479 KEIAKGSNGTVVLEGNY-------------EGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~-------------~g~~VAVKrl~~~~~~--~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
+.||+|+||.||++... ....||+|.+...... ..+.|+..++..++||||+++++++.++...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 35899999999998532 2346899987654322 34455556788899999999999999999999
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+||| |+++|+|..+++.. ...+++..+.+++.||+.||+|||
T Consensus 81 lv~e----------~~~~~~l~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~lH 122 (262)
T cd05077 81 MVEE----------FVEFGPLDLFMHRK----------------------------SDVLTTPWKFKVAKQLASALSYLE 122 (262)
T ss_pred EEEe----------cccCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHhh
Confidence 9999 55566665554321 123567778999999999999999
Q ss_pred cccccccccccceeEeccCCC-----ceEEEccCCccccccCCCccccccccCCCCccccCchhhc-cCCCCCcchhhhh
Q 002601 624 EIGLIHRDLKPQNVLISKDKS-----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSL 697 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~-----~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-~~~~s~ksDVwSl 697 (902)
+.+|+||||||+|||++.++. ..++++|||++...... ....|+..|+|||++. ...++.++|||||
T Consensus 123 ~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 195 (262)
T cd05077 123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR-------QECVERIPWIAPECVEDSKNLSIAADKWSF 195 (262)
T ss_pred hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc-------ccccccccccChhhhcCCCCCCchhHHHHH
Confidence 999999999999999976542 23899999998755321 2335788999999987 4568999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 698 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 698 GviL~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
||++|||++++..|+.......................+++.++|.+||+.||.+||++.+++++
T Consensus 196 G~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 196 GTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 99999999766888875433222222122212223345789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=309.36 Aligned_cols=245 Identities=27% Similarity=0.404 Sum_probs=188.5
Q ss_pred eecccCceEEEEEEe-eCCcEEEEEEeccCCc-----h-HHHHHH--HHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 480 EIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----D-VALKEI--QNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~-~~~~Ei--~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
.||+|+||+||++.. .+|+.||+|.+.+... + ....|. ..++....||||+++++++.+.+..|+|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e--- 77 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD--- 77 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEe---
Confidence 389999999999854 5689999998865321 1 122222 223445689999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|..++.. ...+++..+..++.|++.||+|||+.+|+||
T Consensus 78 -------~~~g~~L~~~l~~-----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~ 121 (278)
T cd05606 78 -------LMNGGDLHYHLSQ-----------------------------HGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121 (278)
T ss_pred -------cCCCCcHHHHHHh-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence 6666777655421 1346788899999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG~~ 709 (902)
||||+||+++.++. ++|+|||++...... ......|+..|+|||++..+ .++.++||||+||++|||++| .
T Consensus 122 di~p~nili~~~~~--~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g-~ 193 (278)
T cd05606 122 DLKPANILLDEHGH--VRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG-H 193 (278)
T ss_pred CCCHHHEEECCCCC--EEEccCcCccccCcc-----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhC-C
Confidence 99999999987765 899999998765432 12344689999999998754 589999999999999999997 6
Q ss_pred CCCCCchh----hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcchh
Q 002601 710 HPYGESFE----RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 771 (902)
Q Consensus 710 ~Pf~~~~~----~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~~~ 771 (902)
.||..... .............+...++++.+++.+||..+|.+|| ++.++++||||...+..
T Consensus 194 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 194 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred CCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 67765421 1111122222233445678999999999999999999 99999999999765543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=305.49 Aligned_cols=248 Identities=29% Similarity=0.396 Sum_probs=187.1
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC----c----hHHHHHHHHHHHhCCCCCeeEecccccC--ccce
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----H----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFV 542 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~----~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d--~~~~ 542 (902)
.|...+.||+|+||.||.+.. .+|+.||||.+.... . ....+|+. ++..+.||||+++++++.+ ...+
T Consensus 3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQ-LLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHH-HHHhcCCCCeeeEEeEeccCCCceE
Confidence 466788999999999999854 568999999875321 1 12334554 6788899999999998776 3568
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
+++|| |+++|+|.+++... ..+++..+++++.|++.||+||
T Consensus 82 ~~v~e----------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~l 122 (265)
T cd06652 82 SIFME----------HMPGGSIKDQLKSY-----------------------------GALTENVTRKYTRQILEGVSYL 122 (265)
T ss_pred EEEEE----------ecCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 89999 66667776655321 2245667789999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
|+.+|+|+||||+||+++.++. ++|+|||+++................|+..|+|||++.+..++.++|||||||++|
T Consensus 123 H~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 200 (265)
T cd06652 123 HSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVV 200 (265)
T ss_pred HhCCEecCCCCHHHEEecCCCC--EEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHH
Confidence 9999999999999999987765 89999999986543211111223345889999999998888999999999999999
Q ss_pred HHHhCCCCCCCCchhhH--HHHHhh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 703 FCITGGKHPYGESFERD--ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~--~~~~~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
||++| ..||....... ...... .....+......+.++|.+|+. +|++||+++++++|||+
T Consensus 201 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 201 EMLTE-KPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred HHhhC-CCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 99997 66776532111 111111 1222334455678999999995 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=303.44 Aligned_cols=248 Identities=27% Similarity=0.457 Sum_probs=192.9
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccC-----CchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||+|+||.||++.. .+|..||+|.+... ..+...+|+. +++.++|+||+++++.+.+.+..|+|+|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~~~h~~i~~~~~~~~~~~~~~lv~e- 79 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVI-LLAKMKHPNIVTFFASFQENGRLFIVME- 79 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHH-HHHhCCCCChhhhhheeccCCeEEEEEe-
Confidence 56778999999999999854 46899999998543 1223445554 6788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++++|.+++.... ...+++..+..++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (257)
T cd08225 80 ---------YCDGGDLMKRINRQR---------------------------GVLFSEDQILSWFVQISLGLKHIHDRKIL 123 (257)
T ss_pred ---------cCCCCcHHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 556666666653211 12356778899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|+||||+||++++++. .+||+|||.+........ ......|++.|+|||++....++.++|+|||||++|||++|
T Consensus 124 H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g- 198 (257)
T cd08225 124 HRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSME---LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL- 198 (257)
T ss_pred cccCCHHHEEEcCCCC-eEEecccccchhccCCcc---cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999987654 479999999987654321 11234588999999999888899999999999999999998
Q ss_pred CCCCCCchhhH-H-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 709 KHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 709 ~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||....... . .+............+.+++++|.+||+.+|++|||+.++++||||
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 199 KHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 66776432221 1 222222222233456789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=311.09 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=197.1
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
|...+.||.|+||.||++.. .++..||+|++...... ...+|+. +++.+.||||+++++++.+++..|+|||
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 82 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEIT-VLSQCDSPYVTKYYGSYLKGTKLWIIME-- 82 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEEECCEEEEEEe--
Confidence 44457799999999999854 46899999998654322 2334444 6678899999999999999999999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+++|+|.+++.. ..+++.++..++.|++.||+|||+.+++|
T Consensus 83 --------~~~~~~L~~~i~~------------------------------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH 124 (277)
T cd06640 83 --------YLGGGSALDLLRA------------------------------GPFDEFQIATMLKEILKGLDYLHSEKKIH 124 (277)
T ss_pred --------cCCCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 6667777666531 23456677889999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
+||+|+||+++.++. ++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|||++| .
T Consensus 125 ~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg-~ 198 (277)
T cd06640 125 RDIKAANVLLSEQGD--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG-E 198 (277)
T ss_pred cCCChhhEEEcCCCC--EEEcccccceeccCCcc---ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHC-C
Confidence 999999999988776 89999999977654221 11233578899999999888899999999999999999998 6
Q ss_pred CCCCCchhhHH-HHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcchhhhhhhhc
Q 002601 710 HPYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDV 778 (902)
Q Consensus 710 ~Pf~~~~~~~~-~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~~~~~l~~~ 778 (902)
.||........ ..+ ...........+.++.++|.+||+.+|++||++.++++||||.....+...+.++
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~ 269 (277)
T cd06640 199 PPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTEL 269 (277)
T ss_pred CCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchhhhHHHHH
Confidence 77765432221 111 1112222334557899999999999999999999999999997655554444433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=305.50 Aligned_cols=242 Identities=30% Similarity=0.440 Sum_probs=192.9
Q ss_pred ecccCceEEEEEEee-CCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 481 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 481 LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
||.|++|+||++... +++.||+|++.+... ....+|+ .+++.++||||+++++++.+++..|+++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e------ 73 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKLYRTFKDKKYIYMLME------ 73 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHH-HHHHhCCCCCEeeeeeeEEcCCccEEEEe------
Confidence 699999999998654 489999999865321 2234454 46788899999999999999999999999
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+++|+||+
T Consensus 74 ----~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~ 120 (262)
T cd05572 74 ----YCLGGELWTILRDR-----------------------------GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120 (262)
T ss_pred ----cCCCCcHHHHHhhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence 77788888777432 225677788999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
|+||+++.++. ++|+|||+++...... ......|+..|+|||.+....++.++|+|||||++|+|++| .+||.
T Consensus 121 ~~nilv~~~~~--~~l~df~~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~ 193 (262)
T cd05572 121 PENLLLDSNGY--VKLVDFGFAKKLKSGQ----KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG-RPPFG 193 (262)
T ss_pred HHHEEEcCCCC--EEEeeCCcccccCccc----ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC-CCCcC
Confidence 99999988775 8999999998765431 12334688999999999888899999999999999999997 77876
Q ss_pred Cchh---hHH-HHHh-hccccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCcc
Q 002601 714 ESFE---RDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTAD 769 (902)
Q Consensus 714 ~~~~---~~~-~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~~ 769 (902)
.... ... .+.. .....++...++++.++|.+||+.||.+||+ ++|+++||||.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 194 EDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred CCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 5431 111 1221 2233344455789999999999999999999 99999999996543
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=312.74 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=192.8
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
|.+.+.||+|+||+||++... +|+.||+|.+..... ....+|+. ++..++||||+++++++...+..|+|||
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e-- 79 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELD-ILHKAVSPYIVDFYGAFFIEGAVYMCME-- 79 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHH-HHHhcCCCcHHhhhhheecCCeEEEEEe--
Confidence 456688999999999998554 789999998864322 23445554 5677899999999999999999999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc-cccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLI 628 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~-~~Iv 628 (902)
|+++|+|.+++..... ...+++..+..++.|++.||+|||+ .+|+
T Consensus 80 --------~~~~~~l~~~~~~~~~--------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~ 125 (286)
T cd06622 80 --------YMDAGSLDKLYAGGVA--------------------------TEGIPEDVLRRITYAVVKGLKFLKEEHNII 125 (286)
T ss_pred --------ecCCCCHHHHHHhccc--------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEe
Confidence 5556666555532100 1246788889999999999999996 5999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC------CCCcchhhhhHHHHH
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR------QTRAIDLFSLGCILF 702 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~------~s~ksDVwSlGviL~ 702 (902)
||||||+||+++.++. +||+|||++...... ......|+..|+|||++.+.. ++.++|+|||||++|
T Consensus 126 H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 198 (286)
T cd06622 126 HRDVKPTNVLVNGNGQ--VKLCDFGVSGNLVAS-----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSIL 198 (286)
T ss_pred eCCCCHHHEEECCCCC--EEEeecCCcccccCC-----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHH
Confidence 9999999999988765 899999998765432 123345888999999986543 478999999999999
Q ss_pred HHHhCCCCCCCCchh-hHH----HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 703 FCITGGKHPYGESFE-RDA----NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 703 elltG~~~Pf~~~~~-~~~----~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
+|++| ..||..... ... .+........+...++++.++|.+||+.+|.+||++++++.||||....
T Consensus 199 ~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 199 EMALG-RYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHhC-CCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99998 668754322 111 1222223334455778999999999999999999999999999996544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=310.32 Aligned_cols=259 Identities=25% Similarity=0.370 Sum_probs=193.0
Q ss_pred eEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
.|.+.+.||+|+||.||++... +++.||||.+...... ...+|+ .+++.++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREA-ELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHH-HHHHhcCCCCchheeeEEecCCCeE
Confidence 3566788999999999998653 3578999998754332 334455 4678899999999999999999999
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+||| |+++|+|.+++.........+. ...-....+++.++..++.|++.||+|||
T Consensus 85 lv~e----------~~~~~~L~~~i~~~~~~~~~~~---------------~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 139 (280)
T cd05049 85 MVFE----------YMEHGDLNKFLRSHGPDAAFLK---------------SPDSPMGELTLSQLLQIAVQIASGMVYLA 139 (280)
T ss_pred EEEe----------cCCCCCHHHHHHhcCCchhhhc---------------ccccccccccHHHHHHHHHHHHHHHHHHh
Confidence 9999 6667777777654322110000 00012244678889999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
+++|+||||||+||+++.++. +||+|||+++........ .......+++.|+|||++.+..++.++|||||||++||
T Consensus 140 ~~~i~h~dlkp~nili~~~~~--~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05049 140 SQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216 (280)
T ss_pred hCCeeccccccceEEEcCCCe--EEECCcccceecccCcce-ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHH
Confidence 999999999999999988765 999999999765432111 11123346788999999999999999999999999999
Q ss_pred HHhCCCCCCCCc-hhhHHHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 704 CITGGKHPYGES-FERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 704 lltG~~~Pf~~~-~~~~~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
|++.+..||... .......+. ......+...+.++.+++.+||+.||.+||++.|+++
T Consensus 217 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 217 IFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999447777543 222222222 2222334456789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=346.21 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=203.1
Q ss_pred ceEEEeeeecccCceEEEEEEeeC--Cc----EEEEEEeccCCchH---HHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYE--GR----SVAVKRLVKTHHDV---ALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~--g~----~VAVKrl~~~~~~~---~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
+.+.+.+.||+|.||.||.|...+ |. .||||.+.+....+ .+-.+..+|+..+|||||+++|+|-+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345678899999999999985443 43 49999997654332 2333345789999999999999999999999
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
|++| ||++|+|..+|....... .....+....++.++.|||+|+.||+
T Consensus 772 i~le----------yM~gGDL~sflr~~r~~~----------------------~~~~~L~~~dLl~~a~dvA~G~~YLe 819 (1025)
T KOG1095|consen 772 ILLE----------YMEGGDLLSFLRESRPAP----------------------FQPSNLSMRDLLAFALDVAKGMNYLE 819 (1025)
T ss_pred EEeh----------hcccCcHHHHHHhccccc----------------------CCCCCCCHHHHHHHHHHHhhhhHHHH
Confidence 9999 999999999996543211 22456788899999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
++++|||||..+|+||+.. ..+||+|||+|+.+..... ........-...|||||.+..+.++.|+|||||||++||
T Consensus 820 ~~~fvHRDLAaRNCLL~~~--r~VKIaDFGlArDiy~~~y-yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWE 896 (1025)
T KOG1095|consen 820 SKHFVHRDLAARNCLLDER--RVVKIADFGLARDIYDKDY-YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWE 896 (1025)
T ss_pred hCCCcCcchhhhheeeccc--CcEEEcccchhHhhhhchh-eeccCccccceecCCHHHHhhcccccccchhhhHHHHHH
Confidence 9999999999999999777 4599999999995543321 111111223568999999999999999999999999999
Q ss_pred HHhCCCCCCCCchhhHH--HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 704 CITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
++|.|..||.+....+. ..+....-..|..++..+.+++.+||+.+|++||+...+++
T Consensus 897 ifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 897 IFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHhCCCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999998654443 23444444556667778889999999999999999999987
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=309.69 Aligned_cols=245 Identities=28% Similarity=0.443 Sum_probs=191.4
Q ss_pred ecccCceEEEEEE-eeCCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 481 IAKGSNGTVVLEG-NYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 481 LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
||+|+||+||++. ..+|+.||+|.+.+.. ......|+ .++..++||||+++++++.+.+..|+|||
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e------ 73 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEK-KILEKVSSRFIVSLAYAFETKDDLCLVMT------ 73 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHH-HHHHhCCCCCEeeeeeEEecCCeEEEEEe------
Confidence 6999999999984 4568999999986432 11223454 46788899999999999999999999999
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+++||||+
T Consensus 74 ----~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~ 122 (277)
T cd05577 74 ----LMNGGDLKYHIYNVG---------------------------EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122 (277)
T ss_pred ----cCCCCcHHHHHHHcC---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 666777776664221 1246778889999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
|+||+++.++. ++|+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++| ..||.
T Consensus 123 p~Nil~~~~~~--~~l~dfg~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~ 195 (277)
T cd05577 123 PENVLLDDHGN--VRISDLGLAVELKGG----KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAG-RSPFR 195 (277)
T ss_pred HHHEEECCCCC--EEEccCcchhhhccC----CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhC-CCCCC
Confidence 99999988775 899999998765432 112234578899999999888899999999999999999997 77876
Q ss_pred Cchhh-----HHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcch
Q 002601 714 ESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 770 (902)
Q Consensus 714 ~~~~~-----~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~~ 770 (902)
..... ............+...++++.++|.+||+.||.+|| ++.+++.||||...+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 196 QRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred CCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 53221 111111122233445678999999999999999999 8899999999976554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=348.82 Aligned_cols=256 Identities=23% Similarity=0.335 Sum_probs=193.7
Q ss_pred cccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccC--ccc
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD--QDF 541 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d--~~~ 541 (902)
..-..|.+.+.||+|+||+||++.. .++..||+|.+.... ......|+. ++..++|||||++++++.+ .+.
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~-IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN-VMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHH-HHHHcCCCCcCeEEEEEEecCCCE
Confidence 3445688899999999999999844 567899999886432 123445654 6788999999999998754 457
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
+||||| |+++|+|.++|..... ....+++..++.|+.||+.||+|
T Consensus 89 lyIVME----------Y~~gGSL~~lL~k~~~-------------------------~~g~L~E~~Il~Ia~QIL~ALaY 133 (1021)
T PTZ00266 89 LYILME----------FCDAGDLSRNIQKCYK-------------------------MFGKIEEHAIVDITRQLLHALAY 133 (1021)
T ss_pred EEEEEe----------CCCCCcHHHHHHHHhh-------------------------ccCCCCHHHHHHHHHHHHHHHHH
Confidence 899999 5556677666642110 11357888999999999999999
Q ss_pred cccc-------cccccccccceeEeccC---------------CCceEEEccCCccccccCCCccccccccCCCCccccC
Q 002601 622 LHEI-------GLIHRDLKPQNVLISKD---------------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQA 679 (902)
Q Consensus 622 LH~~-------~IvHrDLKp~NILL~~d---------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~A 679 (902)
||+. +|+||||||+||||+.+ +...+||+|||++..+.... ......||+.|+|
T Consensus 134 LHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s----~~~s~vGTp~YmA 209 (1021)
T PTZ00266 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES----MAHSCVGTPYYWS 209 (1021)
T ss_pred HHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc----cccccCCCccccC
Confidence 9984 49999999999999642 23458999999998664321 1234469999999
Q ss_pred chhhcc--CCCCCcchhhhhHHHHHHHHhCCCCCCCCch--hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC
Q 002601 680 PEQLLQ--GRQTRAIDLFSLGCILFFCITGGKHPYGESF--ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 755 (902)
Q Consensus 680 PE~l~~--~~~s~ksDVwSlGviL~elltG~~~Pf~~~~--~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt 755 (902)
||++.+ ..++.++||||||||||||++| .+||.... ......+...........++++.+||.+||+.+|.+||+
T Consensus 210 PEvL~ge~~~~s~KSDVWSLG~ILYELLTG-k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPS 288 (1021)
T PTZ00266 210 PELLLHETKSYDDKSDMWALGCIIYELCSG-KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPS 288 (1021)
T ss_pred HHHHhccCCCCCchhHHHHHHHHHHHHHHC-CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcC
Confidence 999864 4578999999999999999997 77876432 222222322222222345789999999999999999999
Q ss_pred HHHHHcCCCCC
Q 002601 756 AQNVLNHPFFW 766 (902)
Q Consensus 756 ~~elL~HPfF~ 766 (902)
+.|+|.|||+.
T Consensus 289 a~QlL~h~~ik 299 (1021)
T PTZ00266 289 ALQCLGYQIIK 299 (1021)
T ss_pred HHHHhccHHHh
Confidence 99999999995
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=308.45 Aligned_cols=243 Identities=28% Similarity=0.432 Sum_probs=182.7
Q ss_pred EEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCc--cceeeeecc
Q 002601 476 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLER 548 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~--~~~yLV~E~ 548 (902)
.+.+.||+|+||.||++.. .+++.||+|++.+... ...++|+..+.....|+||+++++++.+. +..++||||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 4568899999999999854 5689999999865321 23456766554455699999999999887 889999996
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
+.+++.+ .+... ...+++.++..++.|++.||+|||+.+|+
T Consensus 82 ~~~~l~~-----------~l~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~ 122 (282)
T cd07831 82 MDMNLYE-----------LIKGR----------------------------KRPLPEKRVKSYMYQLLKSLDHMHRNGIF 122 (282)
T ss_pred CCccHHH-----------HHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 6544433 33211 12467788899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHhC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~elltG 707 (902)
||||||+||+++. +. +||+|||+++....... .....++..|+|||++.. ..++.++|||||||++|||++|
T Consensus 123 H~dl~p~ni~l~~-~~--~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~ 195 (282)
T cd07831 123 HRDIKPENILIKD-DI--LKLADFGSCRGIYSKPP----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSL 195 (282)
T ss_pred ecccCHHHEEEcC-CC--eEEEecccccccccCCC----cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcC
Confidence 9999999999987 54 99999999987653321 122357889999998654 4578999999999999999997
Q ss_pred CCCCCCCchhhH--HHHHhh-----------------ccccc-----------cccCChHHHHHHHcccCCCCCCCcCHH
Q 002601 708 GKHPYGESFERD--ANIVKD-----------------RKDLF-----------LVEHIPEAVDLFTRLLDPNPDLRPKAQ 757 (902)
Q Consensus 708 ~~~Pf~~~~~~~--~~~~~~-----------------~~~~~-----------~~~~~~e~~dLI~~~L~~dP~~Rpt~~ 757 (902)
.+||....... ..+... ....+ ....+.++.++|.+||++||++||+++
T Consensus 196 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 274 (282)
T cd07831 196 -FPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAK 274 (282)
T ss_pred -CcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHH
Confidence 77886432211 011000 00000 123467899999999999999999999
Q ss_pred HHHcCCCC
Q 002601 758 NVLNHPFF 765 (902)
Q Consensus 758 elL~HPfF 765 (902)
++++||||
T Consensus 275 ~~l~~~~~ 282 (282)
T cd07831 275 QALRHPYF 282 (282)
T ss_pred HHhhCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=320.24 Aligned_cols=246 Identities=27% Similarity=0.417 Sum_probs=186.8
Q ss_pred ccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCc-----
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~----- 539 (902)
+.+.|...+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. ++..++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV-LMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHH-HHHhcCCCCCcceeeeeccCCCccc
Confidence 456788889999999999999854 579999999986432 123445664 67889999999999987643
Q ss_pred -cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 540 -~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
...|+|||+|.++|.+++. ..++...+..++.|++.|
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~------------------------------------------~~l~~~~~~~~~~ql~~a 130 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQ------------------------------------------MDLDHERMSYLLYQMLCG 130 (353)
T ss_pred cCcEEEEEeccCCCHHHHHh------------------------------------------hcCCHHHHHHHHHHHHHH
Confidence 3579999987766554431 114556678899999999
Q ss_pred ccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhH
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 619 L~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 698 (902)
|+|||+.||+||||||+||+++.++. +||+|||+++...... ......|+..|+|||++.+..++.++||||||
T Consensus 131 L~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 204 (353)
T cd07850 131 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSF----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204 (353)
T ss_pred HHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCCCC----CCCCCcccccccCHHHHhCCCCCCchhhHhHH
Confidence 99999999999999999999988876 8999999998765321 12234578999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchh-hHH-HHHh----------------------hcc-------------ccc-------cccC
Q 002601 699 CILFFCITGGKHPYGESFE-RDA-NIVK----------------------DRK-------------DLF-------LVEH 734 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~-~~~-~~~~----------------------~~~-------------~~~-------~~~~ 734 (902)
|++|+|++| ..||..... ... .+.. ... ..+ ....
T Consensus 205 ~~l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (353)
T cd07850 205 CIMGEMIRG-TVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLK 283 (353)
T ss_pred HHHHHHHHC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccc
Confidence 999999998 667753211 000 0000 000 000 0112
Q ss_pred ChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 735 IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 735 ~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
++++.++|.+||+.||.+|||+.|++.||||.
T Consensus 284 ~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 284 ASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred hhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 44688999999999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=307.88 Aligned_cols=257 Identities=22% Similarity=0.297 Sum_probs=194.2
Q ss_pred cceEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~ 541 (902)
++.|.+.+.||+|++|.||++... .+..||+|.+..... ....+|+. +++.++|+||+++++++.+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL-IMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHH-HHHhCCCCCEeeEEEEEccCCC
Confidence 345778899999999999998654 467899998764322 22445554 6688999999999999999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.++||| |+++|+|.++++...... -....+++..+++++.||+.||+|
T Consensus 84 ~~lv~e----------~~~g~~L~~~i~~~~~~~----------------------~~~~~~~~~~~~~~~~qi~~~l~~ 131 (277)
T cd05036 84 RFILLE----------LMAGGDLKSFLRENRPRP----------------------ERPSSLTMKDLLFCARDVAKGCKY 131 (277)
T ss_pred cEEEEe----------cCCCCCHHHHHHHhCCCC----------------------CCCCCCCHHHHHHHHHHHHHHHHH
Confidence 999999 666677777664332100 011246788899999999999999
Q ss_pred cccccccccccccceeEeccCC-CceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHH
Q 002601 622 LHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvi 700 (902)
||+.+++||||||+|||++.++ ...+||+|||+++....... ........++..|+|||++.+..++.++|||||||+
T Consensus 132 LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 210 (277)
T cd05036 132 LEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY-YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVL 210 (277)
T ss_pred HHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccc-eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHH
Confidence 9999999999999999997654 23589999999987643211 111122234568999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCchh-hHHHHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 701 LFFCITGGKHPYGESFE-RDANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~-~~~~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
+|||++++..||..... .....+ .......+...++++.+++.+||+.+|++||++.++++|
T Consensus 211 l~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 211 LWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99999866888875432 222222 222333445667899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.12 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=190.2
Q ss_pred EEeeeecccCceEEEEEEee-CCcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 476 VFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
.+.+.||+|+||.||++... ++..+|+|.+...... ...+|+. ++..++||||+++++++.+++..|+|+|
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~ii~~~~~~~~~~~~~~v~e---- 82 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEID-ILASCDHPNIVKLLDAFYYENNLWILIE---- 82 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHH-HHHHCCCCCeeeEEEEEeeCCEEEEEEE----
Confidence 34577999999999998554 5788999998654322 2344554 6678899999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|.++|+|..+++.. ...+++..+..++.|++.||+|||+.+|+|||
T Consensus 83 ------~~~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~d 128 (282)
T cd06643 83 ------FCAGGAVDAVMLEL----------------------------ERPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128 (282)
T ss_pred ------ecCCCcHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 55566665554321 13467788899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc-----cCCCCCcchhhhhHHHHHHHHh
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGviL~ellt 706 (902)
|||+|||++.++. +||+|||++....... .......|+..|+|||++. ...++.++|||||||++|||++
T Consensus 129 lkp~nili~~~~~--~kl~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~ 203 (282)
T cd06643 129 LKAGNILFTLDGD--IKLADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ 203 (282)
T ss_pred CCcccEEEccCCC--EEEccccccccccccc---cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc
Confidence 9999999988776 9999999987654321 1223346899999999984 3456789999999999999999
Q ss_pred CCCCCCCCchhhH--HHHHhhcc--ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 707 GGKHPYGESFERD--ANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 707 G~~~Pf~~~~~~~--~~~~~~~~--~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
| .+||....... ..+..... ...+...+.++.++|.+||+.||.+||++.++++||||...
T Consensus 204 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 204 I-EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred C-CCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 8 66776532221 22222211 12233456789999999999999999999999999999643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=308.08 Aligned_cols=247 Identities=28% Similarity=0.427 Sum_probs=191.2
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
|.+.+.||+|++|.||++... +++.||+|++..... ....+|+. +++.+.||||+++++++.+++..++++|+|
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD-ILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHH-HHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 445678999999999998654 689999999865432 23455554 567788999999999999999999999954
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc-cccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLI 628 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~-~~Iv 628 (902)
++++|.+++... ...+++..+.+++.|++.||+|||+ .+++
T Consensus 82 ----------~~~~L~~~~~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~ 123 (265)
T cd06605 82 ----------DGGSLDKILKEV----------------------------QGRIPERILGKIAVAVLKGLTYLHEKHKII 123 (265)
T ss_pred ----------CCCcHHHHHHHc----------------------------cCCCCHHHHHHHHHHHHHHHHHHcCCCCee
Confidence 455555554321 0346677888999999999999999 9999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|+||||+||+++.++. ++|+|||.+........ ....|+..|+|||.+.+..++.++|||||||++|+|++|
T Consensus 124 H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~-----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g- 195 (265)
T cd06605 124 HRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLA-----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG- 195 (265)
T ss_pred cCCCCHHHEEECCCCC--EEEeecccchhhHHHHh-----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999988765 89999999876643211 125688999999999988999999999999999999997
Q ss_pred CCCCCCch---h---hH-HHHHhhcccccccc-CChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 709 KHPYGESF---E---RD-ANIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 709 ~~Pf~~~~---~---~~-~~~~~~~~~~~~~~-~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
..||.... . .. ..+........+.. .++++.++|.+||..||++||++.+++.||||...
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 196 RFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 56665431 1 11 11222222222222 67789999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=327.46 Aligned_cols=249 Identities=27% Similarity=0.347 Sum_probs=194.4
Q ss_pred eeeecccCceEEEEEEeeC-CcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 478 NKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~~-g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
...||.|+||.||+|...+ +...|-|++.....+ ...-||. +++...||+||+|++.|..++.++|..|+|.++-
T Consensus 37 iGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIe-ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGA 115 (1187)
T KOG0579|consen 37 IGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIE-ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGA 115 (1187)
T ss_pred HhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhh-hhhcCCChHHHHHHHHHhccCceEEEEeecCCch
Confidence 3569999999999986554 455567776543322 3444665 5677889999999999999999999999888654
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
-|-|-+. -.+++.+.++.-+++|++.||.|||+++|||||||
T Consensus 116 VDaimlE--------------------------------------L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLK 157 (1187)
T KOG0579|consen 116 VDAIMLE--------------------------------------LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLK 157 (1187)
T ss_pred HhHHHHH--------------------------------------hccccchHHHHHHHHHHHHHHHHHhhcchhhhhcc
Confidence 4333111 12567889999999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc-----cCCCCCcchhhhhHHHHHHHHhCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~-----~~~~s~ksDVwSlGviL~elltG~ 708 (902)
..|||++-||. ++|+|||.+..... ......++.|||.|||||++. ..+|+.++||||||+.|.||..+
T Consensus 158 AGNiL~TldGd--irLADFGVSAKn~~---t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqi- 231 (1187)
T KOG0579|consen 158 AGNILLTLDGD--IRLADFGVSAKNKS---TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQI- 231 (1187)
T ss_pred ccceEEEecCc--Eeeecccccccchh---HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhcc-
Confidence 99999999998 89999998876543 233446788999999999875 46799999999999999999997
Q ss_pred CCCCCCchh-hH-HHHHhhc--cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcchh
Q 002601 709 KHPYGESFE-RD-ANIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 771 (902)
Q Consensus 709 ~~Pf~~~~~-~~-~~~~~~~--~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~~ 771 (902)
.||..+... +. ..+.+.. ....|...+..+.|++.+||.+||..||+++++++||||.+.+..
T Consensus 232 EPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 232 EPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred CCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 778776432 22 1222222 123355667799999999999999999999999999999865543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.48 Aligned_cols=247 Identities=24% Similarity=0.332 Sum_probs=191.3
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
+.|.+.+.||+|++|.||++...+++.||||.+..... ....+|+. +++.++||||+++++++.+.+..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e--- 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQ-IMKKLRHPKLIQLYAVCTLEEPIYIVTE--- 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHH-HHHHCCCCCccceeEEEecCCCeeeeee---
Confidence 45778899999999999998777788999999865432 33445554 6788899999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|.++|+|.+++.... ...+++..+..++.|++.||.|||+.+|+||
T Consensus 82 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 127 (261)
T cd05068 82 -------LMKYGSLLEYLQGGA---------------------------GRALKLPQLIDMAAQVASGMAYLEAQNYIHR 127 (261)
T ss_pred -------cccCCcHHHHHhccC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 555566666553211 1235777889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+||+++.++. +||+|||+++....... .......++..|+|||++....++.++|||||||++|||++++.+
T Consensus 128 dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 203 (261)
T cd05068 128 DLAARNVLVGENNI--CKVADFGLARVIKEDIY--EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM 203 (261)
T ss_pred cCCcceEEEcCCCC--EEECCcceEEEccCCcc--cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCC
Confidence 99999999988876 89999999987753211 111111234579999999988899999999999999999996688
Q ss_pred CCCCchhh-HHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 711 PYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 711 Pf~~~~~~-~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||...... ....+... ....+...++.+.+++.+||+.+|.+||++.++++
T Consensus 204 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 204 PYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 88764332 22222222 22234456788999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=308.51 Aligned_cols=264 Identities=23% Similarity=0.340 Sum_probs=193.9
Q ss_pred eEEEeeeecccCceEEEEEEe-----eCCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-----~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
.+.+.+.||+|+||+||+|.. ..++.||+|.+...... ...+|+. +++.++||||+++++++.+++..|+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEAS-LMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHH-HHhhCCCCCeeeEEEEEecCCceEE
Confidence 456778999999999999853 35689999998753322 2334554 6788999999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||| |+++|+|.+++.......... ............+++.++..++.|++.||+|||+
T Consensus 85 v~e----------~~~~~~L~~~l~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~ 142 (283)
T cd05090 85 LFE----------YLNQGDLHEFLIMRSPHSDVG------------CSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS 142 (283)
T ss_pred EEE----------cCCCCcHHHHHHhcCCCCccc------------cccccccccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 999 555666666654322110000 0000000112346788899999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
++|+||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||
T Consensus 143 ~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 219 (283)
T cd05090 143 HFFVHKDLAARNILIGEQLH--VKISDLGLSREIYSADYY-RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219 (283)
T ss_pred cCeehhccccceEEEcCCCc--EEeccccccccccCCcce-ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999987765 899999999876433211 112333467789999999888899999999999999999
Q ss_pred HhCCCCCCCCch-hhHHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCC
Q 002601 705 ITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 763 (902)
Q Consensus 705 ltG~~~Pf~~~~-~~~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HP 763 (902)
++++.+||.... ......+... ....+...++++.+++.+||+.||++||++.+++++-
T Consensus 220 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 220 FSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 995577875532 2223333222 2223445678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.74 Aligned_cols=262 Identities=20% Similarity=0.324 Sum_probs=190.5
Q ss_pred EEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
|.+.+.||+|+||+||++... .++.||||++...... ..+.++..++..++||||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 345578999999999998653 3578999998754322 2233344577889999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
+||+. +++|.+++......... ..... ..-....+++..+.+++.|++.||+|||++
T Consensus 87 ~e~~~----------~~~l~~~l~~~~~~~~~------------~~~~~-~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~ 143 (283)
T cd05091 87 FSYCS----------HSDLHEFLVMRSPHSDV------------GSTDD-DKTVKSTLEPADFVHIVTQIAAGMEFLSSH 143 (283)
T ss_pred EEcCC----------CCcHHHHHHhcCCCccc------------ccccc-ccccccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 99554 44555444321110000 00000 000123477888999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+|+||||||+|||++.++. +||+|||+++....... ........+++.|+|||++....++.++|||||||++|||+
T Consensus 144 gi~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 220 (283)
T cd05091 144 HVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220 (283)
T ss_pred CccccccchhheEecCCCc--eEecccccccccccchh-eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 9999999999999987765 89999999887643211 11122334678999999998888999999999999999999
Q ss_pred hCCCCCCCCchhh-HHHHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 706 TGGKHPYGESFER-DANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 706 tG~~~Pf~~~~~~-~~~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
+++.+||...... ....+ .......+...++++.+++.+||+.+|.+||++++++..
T Consensus 221 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 221 SYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 9668888654332 22222 222233455677889999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=310.34 Aligned_cols=258 Identities=25% Similarity=0.385 Sum_probs=193.3
Q ss_pred ceEEEeeeecccCceEEEEEEe------eCCcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
..|.+.+.||+|+||+||++.. .++..||+|.+...... ...+|+. ++..++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAE-LLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEecCCccE
Confidence 4577889999999999999853 23567999998654322 3445554 678889999999999999999999
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+||| |+++|+|.+++........... ..-+...+++.+++.++.|++.||+|||
T Consensus 84 lv~e----------~~~~~~L~~~i~~~~~~~~~~~----------------~~~~~~~l~~~~~~~~~~ql~~aL~~lH 137 (288)
T cd05093 84 MVFE----------YMKHGDLNKFLRAHGPDAVLMA----------------EGNRPAELTQSQMLHIAQQIAAGMVYLA 137 (288)
T ss_pred EEEE----------cCCCCCHHHHHHHcCCcccccc----------------ccCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 6666777766643221110000 0011234788999999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
++||+||||||+|||++.++. +||+|||+++....... ........++..|+|||++.+..++.++|||||||++|+
T Consensus 138 ~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 214 (288)
T cd05093 138 SQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214 (288)
T ss_pred hCCeeecccCcceEEEccCCc--EEeccCCccccccCCce-eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999987765 89999999986643211 111223346788999999998889999999999999999
Q ss_pred HHhCCCCCCCCchhhH--HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 704 CITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
|++++.+||....... ..+........+...++++.+++.+||+.||.+|||+.+++
T Consensus 215 l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 215 IFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 9996588886543322 12222222223345678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=308.52 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=193.9
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
|...+.||+|+||.||++.. .+++.||||++...... ...+|+ ..+..++||||+++++++.+++..|+|||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e-- 82 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEI-TVLSQCDSPYVTKYYGSYLKDTKLWIIME-- 82 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHH-HHHHhcCCCCEeEEEEEEEeCCeEEEEEE--
Confidence 45667899999999999854 57899999987643321 233344 46788999999999999999999999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+++|+|.+++.. ..+++..+..++.|++.|++|||+.+++|
T Consensus 83 --------~~~~~~l~~~i~~------------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 124 (277)
T cd06641 83 --------YLGGGSALDLLEP------------------------------GPLDETQIATILREILKGLDYLHSEKKIH 124 (277)
T ss_pred --------eCCCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHccCCeec
Confidence 5555666555421 23566778999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
+||||+||+++.++. ++|+|||++........ ......|+..|+|||.+.....+.++|+|||||++|+|++| .
T Consensus 125 ~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~ 198 (277)
T cd06641 125 RDIKAANVLLSEHGE--VKLADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-E 198 (277)
T ss_pred CCCCHHhEEECCCCC--EEEeecccceecccchh---hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcC-C
Confidence 999999999987765 89999999876653211 11234578899999999888889999999999999999997 7
Q ss_pred CCCCCchhhHH-HHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcchh
Q 002601 710 HPYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 771 (902)
Q Consensus 710 ~Pf~~~~~~~~-~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~~ 771 (902)
.||........ ..+ ...........+.++.++|.+||+.+|.+||++.++++||||.....+
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 199 PPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred CCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence 78765432221 111 122222334556789999999999999999999999999999664443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=304.56 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=190.7
Q ss_pred eEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCC--chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
.+.+.+.||+|+||.||++...++..+|||++.+.. .+...+|+. +++.++||||+++++++.+.+..|+|||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e---- 79 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAK-VMMKLSHPNLVQLYGVCTKQRPIFIVTE---- 79 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHH-HHHhCCCCCEEEEEEEEcCCCceEEEEe----
Confidence 356778899999999999877677789999986543 234455655 6678899999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+|+|||
T Consensus 80 ------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 125 (256)
T cd05059 80 ------YMANGCLLNYLRERK----------------------------GKLGTEWLLDMCSDVCEAMEYLESNGFIHRD 125 (256)
T ss_pred ------cCCCCCHHHHHHhcc----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 666777776664221 1356778899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+||+++.++. +||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++++.+|
T Consensus 126 l~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p 201 (256)
T cd05059 126 LAARNCLVGEDNV--VKVSDFGLARYVLDDQY--TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201 (256)
T ss_pred ccHhhEEECCCCc--EEECCcccceecccccc--cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCC
Confidence 9999999988776 99999999886543211 1111112345799999999889999999999999999999966888
Q ss_pred CCCchhhH-H-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 712 YGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 712 f~~~~~~~-~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
|....... . .+........+...++++.+++.+||..+|++||++.++++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 202 YERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 86543222 1 221111222334467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.23 Aligned_cols=245 Identities=28% Similarity=0.364 Sum_probs=196.7
Q ss_pred ccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
..+.|.+...+|.|+|+.|-+. ...+++..|||++.+. ..+..+|+..++...+||||+++++++.+..+.|+|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e-- 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME-- 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceecCCceeeeeeh--
Confidence 4567788888999999999775 5667899999999775 33445666667778899999999999999999999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
.+.+|-+.+.+. |+ . ....++..|+++|+.|+.|||++||+|
T Consensus 397 --------~l~g~ell~ri~----------------------------~~-~-~~~~e~~~w~~~lv~Av~~LH~~gvvh 438 (612)
T KOG0603|consen 397 --------LLDGGELLRRIR----------------------------SK-P-EFCSEASQWAAELVSAVDYLHEQGVVH 438 (612)
T ss_pred --------hccccHHHHHHH----------------------------hc-c-hhHHHHHHHHHHHHHHHHHHHhcCeee
Confidence 554554433331 11 1 122567789999999999999999999
Q ss_pred cccccceeEe-ccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 630 RDLKPQNVLI-SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 630 rDLKp~NILL-~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|||||+|||+ +.+++ ++|+|||.++..... ..+.+-|..|.|||++....|++++|+||||++||+|++|
T Consensus 439 RDLkp~NIL~~~~~g~--lrltyFG~a~~~~~~------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G- 509 (612)
T KOG0603|consen 439 RDLKPGNILLDGSAGH--LRLTYFGFWSELERS------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTG- 509 (612)
T ss_pred cCCChhheeecCCCCc--EEEEEechhhhCchh------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhC-
Confidence 9999999999 46766 899999999987653 3455678999999999999999999999999999999998
Q ss_pred CCCCCCchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 709 KHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 709 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||........-...-....+....+++++|||.+||+.||.+|+++.+++.||||
T Consensus 510 ~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 510 RTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CCccccCCchHHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 667765433311111122333446788999999999999999999999999999999
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=307.31 Aligned_cols=246 Identities=28% Similarity=0.447 Sum_probs=185.6
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|...+.||.|++|.||++.. .+|+.||||++..... ....+|+. +++.++||||+++++++.+++..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHH-HHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 45678899999999999854 4689999998864321 23455654 67888999999999999999999999996
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
+.++|. +++.... ...+++..+..++.|++.||+|||+.+++
T Consensus 81 ~~~~l~-----------~~~~~~~---------------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~i~ 122 (284)
T cd07860 81 LHQDLK-----------KFMDASP---------------------------LSGIPLPLIKSYLFQLLQGLAFCHSHRVL 122 (284)
T ss_pred cccCHH-----------HHHHhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 554443 3332111 13467778899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-CCCcchhhhhHHHHHHHHhC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~elltG 707 (902)
||||+|+||+++.++. +||+|||++........ ......++..|+|||++.+.. ++.++|||||||++|+|+||
T Consensus 123 H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 123 HRDLKPQNLLINTEGA--IKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred cCCCCHHHEEECCCCC--EEEeeccchhhcccCcc---ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9999999999988876 89999999876543211 112334788999999887654 58899999999999999998
Q ss_pred CCCCCCCchhhH--HHHHhhcc-----------------c-----------cccccCChHHHHHHHcccCCCCCCCcCHH
Q 002601 708 GKHPYGESFERD--ANIVKDRK-----------------D-----------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 757 (902)
Q Consensus 708 ~~~Pf~~~~~~~--~~~~~~~~-----------------~-----------~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~ 757 (902)
..||....+.. ..+..... . ......+++++++|.+||+.||.+|||++
T Consensus 198 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 276 (284)
T cd07860 198 -RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAK 276 (284)
T ss_pred -CCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHH
Confidence 66775432211 11111000 0 00123457889999999999999999999
Q ss_pred HHHcCCCC
Q 002601 758 NVLNHPFF 765 (902)
Q Consensus 758 elL~HPfF 765 (902)
++++||||
T Consensus 277 ~~l~~~~f 284 (284)
T cd07860 277 AALAHPFF 284 (284)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=312.11 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=188.6
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCc--cceee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~--~~~yL 544 (902)
+.|...+.||+|+||.||++.. .+|+.||+|++..... ....+|+. ++..++|+||+++++++.+. +..|+
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREIT-LLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHH-HHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4577889999999999999855 4689999999864321 12345665 66889999999999998654 56899
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
|||+|.++|.+++... ...+++.++..++.||+.||+|||+
T Consensus 86 v~e~~~~~l~~~l~~~---------------------------------------~~~l~~~~~~~~~~qi~~~l~~lH~ 126 (309)
T cd07845 86 VMEYCEQDLASLLDNM---------------------------------------PTPFSESQVKCLMLQLLRGLQYLHE 126 (309)
T ss_pred EEecCCCCHHHHHHhc---------------------------------------ccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9998876665554210 1235777889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~e 703 (902)
.+++||||||+||+++.++. +||+|||++........ ......++..|+|||++.+ ..++.++|||||||++||
T Consensus 127 ~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 127 NFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAK---PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred CCeecCCCCHHHEEECCCCC--EEECccceeeecCCccC---CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHH
Confidence 99999999999999988775 89999999987654321 1122235788999999875 457899999999999999
Q ss_pred HHhCCCCCCCCchhhH-H-HHHhhc------------------cccc-----------cccCChHHHHHHHcccCCCCCC
Q 002601 704 CITGGKHPYGESFERD-A-NIVKDR------------------KDLF-----------LVEHIPEAVDLFTRLLDPNPDL 752 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~-~-~~~~~~------------------~~~~-----------~~~~~~e~~dLI~~~L~~dP~~ 752 (902)
|++| .+||....... . .+.... .... ....++++.++|.+||+.||++
T Consensus 202 l~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 280 (309)
T cd07845 202 LLAH-KPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280 (309)
T ss_pred HHhC-CCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhh
Confidence 9997 67775432221 1 111100 0000 0124678899999999999999
Q ss_pred CcCHHHHHcCCCCCCc
Q 002601 753 RPKAQNVLNHPFFWTA 768 (902)
Q Consensus 753 Rpt~~elL~HPfF~~~ 768 (902)
|||+++++.||||...
T Consensus 281 R~t~~~il~h~~f~~~ 296 (309)
T cd07845 281 RATAEEALESSYFKEK 296 (309)
T ss_pred CcCHHHHhcChhhccC
Confidence 9999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=304.53 Aligned_cols=244 Identities=27% Similarity=0.461 Sum_probs=195.4
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|.+.+.||.|+||.||++... +++.||+|.+.+.. .....+|+. .++.++||||+++++++.+++..|+|+|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERR-ILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHH-HHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 567899999999999998654 68999999986432 123344554 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+.+++|.+++... ..+++..+..++.|+++||+|||+.++
T Consensus 81 ----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~i~~~l~~lh~~~i 121 (258)
T cd05578 81 ----------LLLGGDLRYHLSQK-----------------------------VKFSEEQVKFWICEIVLALEYLHSKGI 121 (258)
T ss_pred ----------CCCCCCHHHHHHhc-----------------------------CCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 55666776665321 246677889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+|+||+|+||+++.++. ++|+|||++....... ......|+..|+|||.+....++.++|+|||||++|+|++|
T Consensus 122 ~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g 195 (258)
T cd05578 122 IHRDIKPDNILLDEQGH--VHITDFNIATKVTPDT----LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195 (258)
T ss_pred eccCCCHHHeEEcCCCC--EEEeecccccccCCCc----cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhC
Confidence 99999999999988876 8999999988765432 22334588899999999888899999999999999999998
Q ss_pred CCCCCCCchh----hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH--HHHHcCCCC
Q 002601 708 GKHPYGESFE----RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA--QNVLNHPFF 765 (902)
Q Consensus 708 ~~~Pf~~~~~----~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~--~elL~HPfF 765 (902)
..||..... .............+...++++.++|.+||+.||.+||++ +|+++||||
T Consensus 196 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 196 -KRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -CCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 667765432 111222212334455567899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=308.89 Aligned_cols=246 Identities=26% Similarity=0.413 Sum_probs=186.5
Q ss_pred eEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|...+.||+|+||.||++... +++.||+|++.+... +...+|+. +++.++||||+++++++.+++..|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR-MLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHH-HHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4667789999999999998654 589999999854321 23345554 6788999999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+. ++.+..+.. ....+++.+++.++.||+.||+|||+.+|
T Consensus 81 ~~~----------~~~l~~~~~-----------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 121 (286)
T cd07846 81 FVD----------HTVLDDLEK-----------------------------YPNGLDESRVRKYLFQILRGIEFCHSHNI 121 (286)
T ss_pred cCC----------ccHHHHHHh-----------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 554 444443321 11236778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHh
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ellt 706 (902)
+|+||+|+||++++++. ++|+|||++........ ......++..|+|||++.+. .++.++|||||||++|||++
T Consensus 122 ~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~ 196 (286)
T cd07846 122 IHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196 (286)
T ss_pred cccCCCHHHEEECCCCc--EEEEeeeeeeeccCCcc---ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc
Confidence 99999999999988775 89999999987654321 11234578899999998753 46889999999999999999
Q ss_pred CCCCCCCCchhhH--HHHHhh--------------------ccc----------cccccCChHHHHHHHcccCCCCCCCc
Q 002601 707 GGKHPYGESFERD--ANIVKD--------------------RKD----------LFLVEHIPEAVDLFTRLLDPNPDLRP 754 (902)
Q Consensus 707 G~~~Pf~~~~~~~--~~~~~~--------------------~~~----------~~~~~~~~e~~dLI~~~L~~dP~~Rp 754 (902)
| .+||....... ..+... ... ......++++.+++.+||+.+|++||
T Consensus 197 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 275 (286)
T cd07846 197 G-EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP 275 (286)
T ss_pred C-CCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch
Confidence 8 66775322110 011100 000 00123456899999999999999999
Q ss_pred CHHHHHcCCCC
Q 002601 755 KAQNVLNHPFF 765 (902)
Q Consensus 755 t~~elL~HPfF 765 (902)
++.++++||||
T Consensus 276 ~~~~il~~~~~ 286 (286)
T cd07846 276 SSSQLLHHEFF 286 (286)
T ss_pred hHHHHhcCCCC
Confidence 99999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=309.08 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=192.8
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
|.+.+.||.|+||+||++.. .++..||+|++...... ...+|+ .+++.++||||+++++++.+++..|+|||
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e--- 82 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEI-DILSECKHPNIVGLYEAYFYENKLWILIE--- 82 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHH-HHHHhCCCCceeEEEEEEecCCeEEEEee---
Confidence 55667899999999999865 46899999998654322 234555 46788899999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.+++... ...+++..+..++.|++.||+|||+.+|+|+
T Consensus 83 -------~~~~~~L~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~ 127 (280)
T cd06611 83 -------FCDGGALDSIMLEL----------------------------ERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127 (280)
T ss_pred -------ccCCCcHHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 66677776665321 1346788899999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-----CCCCCcchhhhhHHHHHHHH
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwSlGviL~ell 705 (902)
||||+||+++.++. ++|+|||++....... .......|++.|+|||++.. ..++.++|+|||||++|||+
T Consensus 128 dl~p~nili~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~ 202 (280)
T cd06611 128 DLKAGNILLTLDGD--VKLADFGVSAKNKSTL---QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA 202 (280)
T ss_pred CCChhhEEECCCCC--EEEccCccchhhcccc---cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH
Confidence 99999999988766 8999999987654321 11233458999999999853 34678999999999999999
Q ss_pred hCCCCCCCCchh-hHH-HHHhhccc--cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 706 TGGKHPYGESFE-RDA-NIVKDRKD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 706 tG~~~Pf~~~~~-~~~-~~~~~~~~--~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
+| .+||..... ... .+...... ..+...+.++.++|.+||+.||.+||++.++++||||.+.
T Consensus 203 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 203 QM-EPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred hC-CCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 98 677765422 111 22211111 1233456799999999999999999999999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=304.34 Aligned_cols=239 Identities=26% Similarity=0.356 Sum_probs=182.9
Q ss_pred eecccCceEEEEEEe---eCCcEEEEEEeccCCch-----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 480 EIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~---~~g~~VAVKrl~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+||+|+||.||++.. .++..||||++...... ...+|+ .+++.+.||||+++++++.+ +..++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~-~~~~lv~e---- 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREA-NVMQQLDNPYIVRMIGICEA-ESWMLVME---- 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHH-HHHHhCCCCCcceEEEEEcC-CCcEEEEe----
Confidence 589999999999743 46789999998644321 233444 46788999999999998864 56789999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|.++|+|.+++... ..+++..+..++.|++.||+|||+++|+|||
T Consensus 76 ------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~qi~~al~~lH~~~i~H~d 120 (257)
T cd05116 76 ------LAELGPLNKFLQKN-----------------------------KHVTEKNITELVHQVSMGMKYLEETNFVHRD 120 (257)
T ss_pred ------cCCCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecc
Confidence 66667776665321 2356778899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+||+++.++. +||+|||+++................++..|+|||.+....++.++|||||||++|||++.+.+|
T Consensus 121 lkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p 198 (257)
T cd05116 121 LAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198 (257)
T ss_pred cchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCC
Confidence 9999999987754 99999999987654322222222334567899999998888999999999999999999844788
Q ss_pred CCCchhh-HHHHHhh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 712 YGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 712 f~~~~~~-~~~~~~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
|...... ....+.. .....+...++++.++|.+||+.||.+||++++|..
T Consensus 199 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 199 YKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 8754322 2222322 223345567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=320.55 Aligned_cols=276 Identities=21% Similarity=0.312 Sum_probs=193.0
Q ss_pred ceEEEeeeecccCceEEEEEEe------eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccC-ccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 541 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d-~~~ 541 (902)
+.|.+.+.||+|+||.||+|.. .+++.||+|++..... ....+|+..+.+..+|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 4577889999999999999742 2357999999864322 2345676644444489999999998764 567
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHH---------------------------------Hhhhccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV---------------------------------RIRLLPV 588 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~---------------------------------~~r~~~~ 588 (902)
++++|| |+++|+|.+++............. ......
T Consensus 87 ~~~v~e----------y~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 155 (337)
T cd05054 87 LMVIVE----------YCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSD- 155 (337)
T ss_pred EEEEEe----------cCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhh-
Confidence 899999 555666666554321100000000 000000
Q ss_pred cccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCcccccc
Q 002601 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN 668 (902)
Q Consensus 589 ~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~ 668 (902)
.+............+++..+.+++.||+.||+|||+.+|+||||||+|||++.++. ++|+|||+++.+...... ...
T Consensus 156 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~-~~~ 232 (337)
T cd05054 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDY-VRK 232 (337)
T ss_pred cccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc--EEEeccccchhcccCcch-hhc
Confidence 00111112233457899999999999999999999999999999999999987765 999999999876533221 122
Q ss_pred ccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchh--hHHHHHhh-ccccccccCChHHHHHHHcc
Q 002601 669 ATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDANIVKD-RKDLFLVEHIPEAVDLFTRL 745 (902)
Q Consensus 669 ~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~--~~~~~~~~-~~~~~~~~~~~e~~dLI~~~ 745 (902)
....++..|+|||++.+..++.++|||||||++|||++.+..||..... .....+.. .....+....+++.+++.+|
T Consensus 233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 312 (337)
T cd05054 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDC 312 (337)
T ss_pred cCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHH
Confidence 2344677899999999999999999999999999999844788865321 11122222 12223345678999999999
Q ss_pred cCCCCCCCcCHHHHHcC
Q 002601 746 LDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 746 L~~dP~~Rpt~~elL~H 762 (902)
|+.+|++||++.|+++|
T Consensus 313 l~~~p~~RPs~~ell~~ 329 (337)
T cd05054 313 WHNNPEDRPTFSELVEI 329 (337)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=301.70 Aligned_cols=248 Identities=30% Similarity=0.519 Sum_probs=191.5
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|...+.||+|+||.||++.. .+++.||+|.+..... .....|+ ..++.++|+||+++++++.+.+..++|+|
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~~~~l~~~~i~~~~~~~~~~~~~~lv~e- 79 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEM-KVLELLKHPNLVKYYGVEVHREKVYIFME- 79 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHH-HHHHhCCCCChhheeeeEecCCEEEEEEe-
Confidence 56678999999999999854 4789999999865433 1234444 46788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+|+
T Consensus 80 ---------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~i~~~i~~~l~~lh~~~i~ 121 (264)
T cd06626 80 ---------YCSGGTLEELLEHG-----------------------------RILDEHVIRVYTLQLLEGLAYLHSHGIV 121 (264)
T ss_pred ---------cCCCCcHHHHHhhc-----------------------------CCCChHHHHHHHHHHHHHHHHHHHCCcc
Confidence 55666666655321 1245667789999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccc-cccCCCCccccCchhhccCC---CCCcchhhhhHHHHHHH
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ-NATGYGSSGWQAPEQLLQGR---QTRAIDLFSLGCILFFC 704 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSlGviL~el 704 (902)
|+||+|+||+++.++. +||+|||++............ .....++..|+|||++.... .+.++|||||||++|++
T Consensus 122 H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l 199 (264)
T cd06626 122 HRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEM 199 (264)
T ss_pred cCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHH
Confidence 9999999999988766 899999999877543222111 22345788999999998766 78999999999999999
Q ss_pred HhCCCCCCCCchhh--HH-HHHhhcccccccc--CChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 705 ITGGKHPYGESFER--DA-NIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 705 ltG~~~Pf~~~~~~--~~-~~~~~~~~~~~~~--~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
++| ..||...... .. .+........+.. .++++.++|.+||+.+|.+||++.+++.|||+
T Consensus 200 ~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 200 ATG-KRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HhC-CCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 997 6787643211 11 1121112222333 36789999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.55 Aligned_cols=247 Identities=27% Similarity=0.418 Sum_probs=194.8
Q ss_pred EEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||.|+||.||.+ ...+++.||+|++.... .....+|+. +++.++|+||+++++++.+.+..+++||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~~~e- 79 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIV-ILSLLQHPNIIAYYNHFMDDNTLLIEME- 79 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHH-HHHhCCCCCeeEEEeEEecCCeEEEEEE-
Confidence 567789999999999886 45668999999875432 123455654 6788899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|.+++.... ...+++.++..++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~ 123 (256)
T cd08221 80 ---------YANGGTLYDKIVRQK---------------------------GQLFEEEMVLWYLFQIVSAVSYIHKAGIL 123 (256)
T ss_pred ---------ecCCCcHHHHHHhcc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 556677776664221 12357778899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|+||+|+||+++.++. +||+|||++........ ......|++.|+|||++.+..++.++|||||||++|||++|
T Consensus 124 h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~---~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g- 197 (256)
T cd08221 124 HRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYS---MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL- 197 (256)
T ss_pred ccCCChHhEEEeCCCC--EEECcCcceEEcccccc---cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHC-
Confidence 9999999999988775 99999999987654321 22344689999999999888889999999999999999998
Q ss_pred CCCCCCchh-hHH-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 709 KHPYGESFE-RDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 709 ~~Pf~~~~~-~~~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||..... ... .+........+...+.++.++|.+||..+|.+||++.++++|||+
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 198 KRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 567655322 222 222222222334457899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.70 Aligned_cols=253 Identities=26% Similarity=0.338 Sum_probs=191.5
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+.+.||+|+||.||++.. .+++.||+|.+..... ....+|+ .++..++||||+++++.+.+++..|+||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVER-DILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHH-HHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 356778999999999999854 5688999999865421 1223444 4678889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++... ..+++..+..++.|++.||+|||+.+
T Consensus 81 e----------~~~g~~L~~~l~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~ 121 (305)
T cd05609 81 E----------YVEGGDCATLLKNI-----------------------------GALPVDMARMYFAETVLALEYLHNYG 121 (305)
T ss_pred e----------cCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 66677777766321 23577788899999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCcc------------ccccccCCCCccccCchhhccCCCCCcchh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------------LTQNATGYGSSGWQAPEQLLQGRQTRAIDL 694 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~------------~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDV 694 (902)
|+||||||+||+++.++. +||+|||+++........ ........|+..|+|||.+....++.++|+
T Consensus 122 i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 199 (305)
T cd05609 122 IVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW 199 (305)
T ss_pred ccccCCchHHEEECCCCC--EEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhH
Confidence 999999999999988776 899999998742111000 001112357889999999988889999999
Q ss_pred hhhHHHHHHHHhCCCCCCCCc-hhhHHHHHhhcccccc---ccCChHHHHHHHcccCCCCCCCcC---HHHHHcCCCCCC
Q 002601 695 FSLGCILFFCITGGKHPYGES-FERDANIVKDRKDLFL---VEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWT 767 (902)
Q Consensus 695 wSlGviL~elltG~~~Pf~~~-~~~~~~~~~~~~~~~~---~~~~~e~~dLI~~~L~~dP~~Rpt---~~elL~HPfF~~ 767 (902)
|||||++|||++| ..||... ...............+ ...++++.++|.+||+.||++||+ +.++++||||..
T Consensus 200 ~slG~vl~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 200 WAMGIILYEFLVG-CVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 9999999999998 5566543 2222222221111111 235678999999999999999998 789999999965
Q ss_pred cc
Q 002601 768 AD 769 (902)
Q Consensus 768 ~~ 769 (902)
.+
T Consensus 279 ~~ 280 (305)
T cd05609 279 LD 280 (305)
T ss_pred CC
Confidence 44
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=302.24 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=184.9
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
+.||+|+||+||++.. .+|+.||+|.+..... ....+|+. +++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e------ 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEAR-ILKQYSHPNIVRLIGVCTQKQPIYIVME------ 73 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEcCCCCeEEEEe------
Confidence 3599999999999855 4789999998764322 23445554 6788899999999999999999999999
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
|.++|+|.+++.... ..+++..++.++.|++.||+|||+.+|+|||||
T Consensus 74 ----~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~ 121 (252)
T cd05084 74 ----LVQGGDFLTFLRTEG----------------------------PRLKVKELIQMVENAAAGMEYLESKHCIHRDLA 121 (252)
T ss_pred ----eccCCcHHHHHHhCC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence 666777776663211 235677889999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
|+|||++.++. +||+|||++........ ........++..|+|||.+..+.++.++|||||||++|||++++.+||.
T Consensus 122 p~nil~~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 122 ARNCLVTEKNV--LKISDFGMSREEEDGVY-ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred hheEEEcCCCc--EEECccccCcccccccc-cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 99999987765 89999999876543211 1111111234579999999988899999999999999999986688886
Q ss_pred CchhhH-HH-HHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 714 ESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 714 ~~~~~~-~~-~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
...... .. +........+...+.++.+++.+||+.||++||++.++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 199 NLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 543222 22 2222223344456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=324.15 Aligned_cols=276 Identities=23% Similarity=0.360 Sum_probs=191.4
Q ss_pred cceEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCc----hHHHHHHHHHHHhC-CCCCeeEecccccCcc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQD 540 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~ 540 (902)
.+.|.+.+.||+|+||+||++... .+..||||++..... +...+|+. ++..+ .|||||+++++|.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~-~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELK-IMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHH-HHHhcCCCCCeeeEEEEEccCC
Confidence 355778899999999999997542 235799999965332 23456766 45666 5999999999999999
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchh-HHH------------------Hhhh----------------
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLL-NEV------------------RIRL---------------- 585 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l-~~~------------------~~r~---------------- 585 (902)
..||||| |+++|+|.++++......... ... +...
T Consensus 115 ~~~lv~E----------y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (400)
T cd05105 115 PIYIITE----------YCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD 184 (400)
T ss_pred ceEEEEE----------ecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence 9999999 455566666554322100000 000 0000
Q ss_pred -------------------------cccc---ccchhHHHH----hhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 586 -------------------------LPVM---ENTKDIELW----KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 586 -------------------------~~~~---e~~~~~~~~----~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
.+.. .+......+ ....+++..+.+++.||+.||+|||+.+|+|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik 264 (400)
T cd05105 185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264 (400)
T ss_pred ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 0000 000000000 12457889999999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
|+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++.+..||.
T Consensus 265 p~Nill~~~~~--~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~ 341 (400)
T cd05105 265 ARNVLLAQGKI--VKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYP 341 (400)
T ss_pred hHhEEEeCCCE--EEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCc
Confidence 99999987654 999999999876533211 122234577889999999988899999999999999999985577776
Q ss_pred Cchhh--HHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 714 ESFER--DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 714 ~~~~~--~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
..... ....+... ....+...++++.+++.+||+.||++||++.++.+
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 342 GMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 53221 11222221 22233456778999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.33 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=189.7
Q ss_pred EEeeeecccCceEEEEEEeeC----CcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccc-----
Q 002601 476 VFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDF----- 541 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~~----g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~----- 541 (902)
.+.+.||+|+||.||+|.... +..||||++..... ....+|+. .++.++||||+++++++.+.+.
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAA-CMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHH-HHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999986542 47899999864321 23445554 6678999999999998766544
Q ss_pred -eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 542 -VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 542 -~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
.++++| |+++|+|..++....... ....+++..+..++.|++.||+
T Consensus 81 ~~~~v~e----------~~~~~~l~~~l~~~~~~~-----------------------~~~~~~~~~~~~~~~~i~~aL~ 127 (273)
T cd05035 81 KPMVILP----------FMKHGDLHSFLLYSRLGG-----------------------LPEKLPLQTLLKFMVDIALGME 127 (273)
T ss_pred ccEEEEe----------ccCCCCHHHHHHHhhccC-----------------------CcccCCHHHHHHHHHHHHHHHH
Confidence 799999 777888877764332110 1134677888999999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvi 700 (902)
|||+.+|+||||||+||++++++. +||+|||+++......... ......++..|+|||++....++.++|||||||+
T Consensus 128 ~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~i 204 (273)
T cd05035 128 YLSNRNFIHRDLAARNCMLREDMT--VCVADFGLSKKIYSGDYYR-QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 204 (273)
T ss_pred HHHhCCeeccccchheEEECCCCe--EEECCccceeecccccccc-ccccccCCccccCHhhcccCCCCcccchHHHHHH
Confidence 999999999999999999987765 8999999998765432211 1122235678999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCchhhH-H-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 701 LFFCITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
+|||++++.+||.+..... . .+........+...++++.+++.+||+.||.+||++.|++++
T Consensus 205 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 205 MWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999996688886543222 1 222222333445667899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.33 Aligned_cols=250 Identities=26% Similarity=0.363 Sum_probs=192.7
Q ss_pred eeecccCceEEEEEEeeC----CcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 479 KEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~----g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
+.||+|+||.||++.... +..||||.+...... ...+|+. ++..++|+||+++++++.+....++|||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~lv~e--- 76 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEAR-VMKKLGHPNVVRLLGVCTEEEPLYLVLE--- 76 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHH-HHhhcCCCChheeeeeecCCCceEEEEE---
Confidence 369999999999986654 889999998765432 3344544 6677889999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.+++....... .......+++..+.+++.|++.||+|||+++|+||
T Consensus 77 -------~~~~~~L~~~l~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 129 (262)
T cd00192 77 -------YMEGGDLLDYLRKSRPVF--------------------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHR 129 (262)
T ss_pred -------eccCCcHHHHHhhccccc--------------------cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 556666666654321100 00012457888999999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+||+++.++. +||+|||.+........ ........++..|+|||.+....++.++|||||||++|+|++++..
T Consensus 130 di~p~nili~~~~~--~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 130 DLAARNCLVGEDLV--VKISDFGLSRDVYDDDY-YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred ccCcceEEECCCCc--EEEcccccccccccccc-cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 99999999988765 89999999987764322 1222344578899999999888899999999999999999997788
Q ss_pred CCCCchhhH-HHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 711 PYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 711 Pf~~~~~~~-~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
||....... ...+. ......+...++++.+++.+||..||.+||++.++++|
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 207 PYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 987653322 22222 22223345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=314.61 Aligned_cols=248 Identities=23% Similarity=0.297 Sum_probs=188.6
Q ss_pred ceEEEeeeecccCceEEEEEEee-CCc----EEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~g~----~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
..|...+.||+|+||+||+|... +|. .||||++...... ..+.++..+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 34677789999999999998643 343 4899998643321 2233333577889999999999998875 5678
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
++| |+++|+|.+++.... ..+++..+..++.||+.||+|||+
T Consensus 86 v~e----------~~~~g~l~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~L~~LH~ 127 (316)
T cd05108 86 ITQ----------LMPFGCLLDYVREHK----------------------------DNIGSQYLLNWCVQIAKGMNYLEE 127 (316)
T ss_pred eee----------cCCCCCHHHHHHhcc----------------------------ccCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 777888887765321 235667788999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
.+|+||||||+|||++.++. +||+|||+++.......... .....++..|+|||++.+..++.++|||||||++|||
T Consensus 128 ~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el 204 (316)
T cd05108 128 RRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEYH-AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 204 (316)
T ss_pred cCeeccccchhheEecCCCc--EEEccccccccccCCCccee-ccCCccceeecChHHhccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999987765 89999999987654322111 1222346789999999999999999999999999999
Q ss_pred HhCCCCCCCCchhhH-HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 705 ITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
++.+..||....... ..+.... ....+.....++.+++.+||..||.+||++.+++.+
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 205 MTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 984578887643322 2222222 222334456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=309.46 Aligned_cols=238 Identities=22% Similarity=0.272 Sum_probs=180.5
Q ss_pred eecccCceEEEEEEeeC-------------------------CcEEEEEEeccCCch--HHHHHHHHHHHhCCCCCeeEe
Q 002601 480 EIAKGSNGTVVLEGNYE-------------------------GRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRW 532 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~~~-------------------------g~~VAVKrl~~~~~~--~~~~Ei~~ll~~l~HpNIV~l 532 (902)
.||+|+||.||+|.... ...||||++...... ..+.|+..+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999875321 246899988654322 234455567889999999999
Q ss_pred cccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHH
Q 002601 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVT 612 (902)
Q Consensus 533 ~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~ 612 (902)
+++|.+++..++||| |+++|+|..++... ...+++..+..++
T Consensus 82 ~~~~~~~~~~~lv~e----------y~~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~ 123 (274)
T cd05076 82 HGVCVRGSENIMVEE----------FVEHGPLDVCLRKE----------------------------KGRVPVAWKITVA 123 (274)
T ss_pred EEEEEeCCceEEEEe----------cCCCCcHHHHHHhc----------------------------CCCCCHHHHHHHH
Confidence 999999999999999 66677776665321 1235677789999
Q ss_pred HhhhccccccccccccccccccceeEeccCCC-----ceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-C
Q 002601 613 RDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS-----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-G 686 (902)
Q Consensus 613 ~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~-----~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~ 686 (902)
.||++||+|||+.+|+||||||+|||++.++. ..+|++|||++...... ....++..|+|||.+.+ .
T Consensus 124 ~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~~ 196 (274)
T cd05076 124 QQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGGN 196 (274)
T ss_pred HHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc-------cccccCCcccCchhhcCCC
Confidence 99999999999999999999999999976432 24799999988654321 12347888999998875 4
Q ss_pred CCCCcchhhhhHHHHHHHHhCCCCCCCCchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 687 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 687 ~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
.++.++|||||||++||+++++.+||..................+....+++.++|.+||+.+|++||++.+++++
T Consensus 197 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 197 SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 5799999999999999997656888865433222111122223334456789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=309.09 Aligned_cols=252 Identities=26% Similarity=0.399 Sum_probs=184.9
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccc-----e
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF-----V 542 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~-----~ 542 (902)
.|...+.||+|+||.||++.. .+|+.||||++.... .....+|+..+....+||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 366778999999999999864 468999999875432 13456677644343467999999999877665 8
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+|||||.++|.+++ ..... .....+++..++.++.||+.||+||
T Consensus 82 ~lv~e~~~~~l~~~~-----------~~~~~------------------------~~~~~~~~~~~~~~~~qi~~~L~~L 126 (295)
T cd07837 82 YLVFEYLDSDLKKFM-----------DSNGR------------------------GPGRPLPAKTIKSFMYQLLKGVAHC 126 (295)
T ss_pred EEEeeccCcCHHHHH-----------HHhcc------------------------cCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 999997766555544 21110 0113467888899999999999999
Q ss_pred ccccccccccccceeEecc-CCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHH
Q 002601 623 HEIGLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCI 700 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~-d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvi 700 (902)
|+.+|+||||||+||+++. ++ .+||+|||+++....... ......+++.|+|||++.+ ..++.++|||||||+
T Consensus 127 H~~~i~H~dl~~~nil~~~~~~--~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 201 (295)
T cd07837 127 HKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAFSIPVK---SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCI 201 (295)
T ss_pred HHCCeeecCCChHHEEEecCCC--eEEEeecccceecCCCcc---ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHH
Confidence 9999999999999999987 44 499999999886543211 1122346889999998865 457899999999999
Q ss_pred HHHHHhCCCCCCCCchh--hHHHHHhhc-----------------------c----ccccccCChHHHHHHHcccCCCCC
Q 002601 701 LFFCITGGKHPYGESFE--RDANIVKDR-----------------------K----DLFLVEHIPEAVDLFTRLLDPNPD 751 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~--~~~~~~~~~-----------------------~----~~~~~~~~~e~~dLI~~~L~~dP~ 751 (902)
+|+|++| .+||..... ....+.... . .......++++.++|.+||+.||.
T Consensus 202 l~~l~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 202 FAEMSRK-QPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHHcC-CCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 9999998 667654221 111111100 0 000123567899999999999999
Q ss_pred CCcCHHHHHcCCCCC
Q 002601 752 LRPKAQNVLNHPFFW 766 (902)
Q Consensus 752 ~Rpt~~elL~HPfF~ 766 (902)
+||++.|++.||||.
T Consensus 281 ~R~~~~eil~~~~~~ 295 (295)
T cd07837 281 KRISAKAALTHPYFD 295 (295)
T ss_pred hcCCHHHHhcCCCcC
Confidence 999999999999983
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=303.55 Aligned_cols=248 Identities=26% Similarity=0.396 Sum_probs=191.2
Q ss_pred ceEEEeeeecccCceEEEEEEee----CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~----~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
+.|.+.+.||+|+||+||+|... +...||||++...... ...+|+. ++..++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEAS-IMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHH-HHHhCCCCCcceEeEEEecCCceEE
Confidence 34678899999999999998653 2468999998654322 2344554 6688899999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||| |+++|+|.+++.... ..+++..+.+++.|++.||+|||+
T Consensus 83 v~e----------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~l~~Lh~ 124 (266)
T cd05033 83 ITE----------YMENGSLDKFLREND----------------------------GKFTVGQLVGMLRGIASGMKYLSE 124 (266)
T ss_pred EEE----------cCCCCCHHHHHHhcc----------------------------CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 666677776664211 235777889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
.+|+||||||+|||++.++. ++|+|||+++.......... .....++..|+|||.+.+..++.++|||||||++|+|
T Consensus 125 ~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l 201 (266)
T cd05033 125 MNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEATYT-TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 201 (266)
T ss_pred CCcccCCCCcceEEEcCCCC--EEECccchhhccccccccee-ccCCCCCccccChhhhccCCCccccchHHHHHHHHHH
Confidence 99999999999999987765 89999999988752211111 1223356789999999988899999999999999999
Q ss_pred HhCCCCCCCCchhh-HHHHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 705 ITGGKHPYGESFER-DANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 705 ltG~~~Pf~~~~~~-~~~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
++.+..||.+.... ....+ .......+...++++.+++.+||+.+|++||++++++++
T Consensus 202 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 202 MSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 98447787654322 22222 222223345567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.54 Aligned_cols=247 Identities=31% Similarity=0.485 Sum_probs=189.0
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-------------hHHHHHHHHHHHhCCCCCeeEecccccCcc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-------------DVALKEIQNLIASDQHPNIVRWYGVESDQD 540 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-------------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~ 540 (902)
|...+.||+|+||.||++.. .+|+.||||.+..... +...+|+ .++..++||||+++++++.+.+
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEI-ETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHH-HHHHhcCCCCcceEEEEeccCC
Confidence 55678899999999999854 5689999998753110 1123444 4678889999999999999999
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
..++||| |+++|+|.+++... ..+++..+..++.||+.||.
T Consensus 82 ~~~lv~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~ 122 (272)
T cd06629 82 YLSIFLE----------YVPGGSIGSCLRTY-----------------------------GRFEEQLVRFFTEQVLEGLA 122 (272)
T ss_pred ceEEEEe----------cCCCCcHHHHHhhc-----------------------------cCCCHHHHHHHHHHHHHHHH
Confidence 9999999 66677777766321 23567778899999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC--CCCcchhhhhH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLG 698 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlG 698 (902)
|||+.+++||||+|+||+++.++. ++|+|||+++....... ........|+..|+|||.+.... ++.++|+||||
T Consensus 123 ~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG 199 (272)
T cd06629 123 YLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYD-NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLG 199 (272)
T ss_pred HHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccccccc-ccccccccCCccccCHHHhccccCCCCccchhHHHH
Confidence 999999999999999999987765 99999999976543211 11123345889999999987654 78999999999
Q ss_pred HHHHHHHhCCCCCCCCchhhH--HHHHhh-cccccc----ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 699 CILFFCITGGKHPYGESFERD--ANIVKD-RKDLFL----VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~--~~~~~~-~~~~~~----~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
|++|++++| ..||....... ...... .....+ ...+.++.++|.+||.+||.+||++.++++||||
T Consensus 200 ~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 200 CVVLEMFAG-RRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHhC-CCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 999999997 66775432211 111111 111111 2346789999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.11 Aligned_cols=246 Identities=24% Similarity=0.382 Sum_probs=189.7
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
..|.+.++||+|+||+||++...++..||||++..... ....+|+. ++..++||||+++++++.+ +..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~-~~~~lv~e--- 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYAVVSE-EPIYIVTE--- 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHH-HHHhCCCCCcceEEEEECC-CCcEEEEE---
Confidence 45788899999999999998776667899999975332 33455655 6678899999999998754 56899999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~ 126 (262)
T cd05071 81 -------YMSKGSLLDFLKGEM---------------------------GKYLRLPQLVDMAAQIASGMAYVERMNYVHR 126 (262)
T ss_pred -------cCCCCcHHHHHhhcc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 666777766664211 1235677889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+||+++.++. ++|+|||+++....... .......++..|+|||++....++.++|||||||++|||++|+.+
T Consensus 127 dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~ 202 (262)
T cd05071 127 DLRAANILVGENLV--CKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 202 (262)
T ss_pred ccCcccEEEcCCCc--EEeccCCceeecccccc--ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999988765 89999999986653221 111223467789999999888899999999999999999997788
Q ss_pred CCCCchhhH-HHHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 711 PYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 711 Pf~~~~~~~-~~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||....... .... ...........++.+.++|.+|++.||.+||+++++++
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 203 PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 987653322 1211 11122233456778999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=309.53 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=188.7
Q ss_pred cceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
.+.|...+.||+|+||+||++.. .+|+.||+|.+..... ....+|+. ++..++||||++++++|.+++..|+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHH-HHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 34577778999999999999865 4689999998853321 12445554 6788899999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
|+|||.+++.+++ .. ....+++..+..++.|++.||.|||+
T Consensus 93 v~e~~~g~l~~~~-----------~~----------------------------~~~~l~~~~~~~~~~ql~~~L~~LH~ 133 (307)
T cd06607 93 VMEYCLGSASDIL-----------EV----------------------------HKKPLQEVEIAAICHGALQGLAYLHS 133 (307)
T ss_pred EHHhhCCCHHHHH-----------HH----------------------------cccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9997665544433 11 11235677889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc---cCCCCCcchhhhhHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGviL 701 (902)
.+|+||||+|+||+++.++. ++|+|||++...... ....|+..|+|||++. ...++.++|||||||++
T Consensus 134 ~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il 204 (307)
T cd06607 134 HERIHRDIKAGNILLTEPGT--VKLADFGSASLVSPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204 (307)
T ss_pred CCceecCCCcccEEECCCCC--EEEeecCcceecCCC-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHH
Confidence 99999999999999988776 999999998765422 2345788999999874 35678999999999999
Q ss_pred HHHHhCCCCCCCCchhhH-H-HHHhhccc-cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 702 FFCITGGKHPYGESFERD-A-NIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~-~-~~~~~~~~-~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
|||++| .+||....... . .+...... ......+.++.++|.+||+.||.+||++.+++.||||..
T Consensus 205 ~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 205 IELAER-KPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred HHHHcC-CCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 999998 66665432211 1 11111111 112335678999999999999999999999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.98 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=190.4
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
+.|.+.+.||.|+||.||++.. .+++.+|+|.+..... ....+|+. +++.++||||+++++++.+++..|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~l~~e- 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEIS-MLKECRHPNIVAYFGSYLRRDKLWIVME- 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHH-HHHhCCCCChhceEEEEEeCCEEEEEEe-
Confidence 4577889999999999999855 4678999999865432 23444544 6788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|.++++|.+++... ...+++.++..++.|++.||+|||+.+|+
T Consensus 81 ---------~~~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~ 123 (262)
T cd06613 81 ---------YCGGGSLQDIYQVT----------------------------RGPLSELQIAYVCRETLKGLAYLHETGKI 123 (262)
T ss_pred ---------CCCCCcHHHHHHhh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence 55555665554321 13467778899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC---CCCCcchhhhhHHHHHHHH
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---RQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~~s~ksDVwSlGviL~ell 705 (902)
|+||||+||+++.++. +||+|||++....... .......|+..|+|||.+... .++.++|+|||||++|+|+
T Consensus 124 h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 124 HRDIKGANILLTEDGD--VKLADFGVSAQLTATI---AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred ecCCChhhEEECCCCC--EEECccccchhhhhhh---hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence 9999999999988776 8999999988765321 112234588899999998776 7889999999999999999
Q ss_pred hCCCCCCCCchhh-HHHHHhhc--c---ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCC
Q 002601 706 TGGKHPYGESFER-DANIVKDR--K---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764 (902)
Q Consensus 706 tG~~~Pf~~~~~~-~~~~~~~~--~---~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPf 764 (902)
+| .+||.+.... ........ . .......+.++.+++.+||..||..||++++++.|||
T Consensus 199 tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 199 EL-QPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hC-CCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 98 6677553221 11111111 0 0112233568999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.08 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=191.2
Q ss_pred cceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
.+.|.+.++||+|+||.||++...+++.||+|++..... ....+|+ .+++.++|+||+++++++. .+..|++||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~-~~~~~~v~e-- 80 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEA-NLMKQLQHPRLVRLYAVVT-QEPIYIITE-- 80 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHH-HHHHhcCCcCeeeEEEEEc-cCCcEEEEE--
Confidence 355778899999999999999888899999999875432 3345555 4778899999999999874 457899999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+++|+|.+++.... ...+++.++..++.|++.||+|||+.+++|
T Consensus 81 --------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~i~H 125 (260)
T cd05067 81 --------YMENGSLVDFLKTPE---------------------------GIKLTINKLIDMAAQIAEGMAFIERKNYIH 125 (260)
T ss_pred --------cCCCCCHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence 666677766654221 123567788999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
|||||+||+++.++. ++|+|||++........ .......++..|+|||++....++.++|||||||++||+++++.
T Consensus 126 ~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~ 201 (260)
T cd05067 126 RDLRAANILVSETLC--CKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201 (260)
T ss_pred ccccHHhEEEcCCCC--EEEccCcceeecCCCCc--ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCC
Confidence 999999999988765 89999999977653211 11122335678999999998889999999999999999999558
Q ss_pred CCCCCchhhH-HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 710 HPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 710 ~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+||....... ...+... ....+...+.++.++|.+||..+|++||++++++.
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 202 IPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8986543322 2222221 22233445678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=327.55 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=197.6
Q ss_pred ccccccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEe------ccCCchHHHHHHHHHHHhCCCCCeeEecccccCc
Q 002601 467 DGRRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRL------VKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (902)
Q Consensus 467 ~~~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl------~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~ 539 (902)
+...-++..++..+||+|+|-+||+| +..+|.+||=--+ +....-+.+.++..|++.++|||||++|.+|.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 33455677788999999999999998 5566877764222 2222225566666799999999999999999876
Q ss_pred cc--eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhc
Q 002601 540 DF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (902)
Q Consensus 540 ~~--~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~ 617 (902)
.. +-+|+| -+..|+|..++.. .+....+.+..|++||++
T Consensus 114 ~n~~in~iTE----------L~TSGtLr~Y~kk-----------------------------~~~vn~kaik~W~RQILk 154 (632)
T KOG0584|consen 114 DNKTINFITE----------LFTSGTLREYRKK-----------------------------HRRVNIKAIKSWCRQILK 154 (632)
T ss_pred CCceeeeeee----------cccCCcHHHHHHH-----------------------------hccCCHHHHHHHHHHHHH
Confidence 55 778889 6677888777632 234566788999999999
Q ss_pred cccccccc--cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhh
Q 002601 618 GLSHLHEI--GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 695 (902)
Q Consensus 618 gL~yLH~~--~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVw 695 (902)
||.|||++ .|||||||-+||+|+.+- ..+||+|+|||...... ......|||.|||||+.. ..|++.+|||
T Consensus 155 GL~yLHs~~PPIIHRDLKCDNIFinG~~-G~VKIGDLGLAtl~r~s-----~aksvIGTPEFMAPEmYE-E~YnE~VDVY 227 (632)
T KOG0584|consen 155 GLVYLHSQDPPIIHRDLKCDNIFVNGNL-GEVKIGDLGLATLLRKS-----HAKSVIGTPEFMAPEMYE-ENYNELVDVY 227 (632)
T ss_pred HhhhhhcCCCCccccccccceEEEcCCc-CceeecchhHHHHhhcc-----ccceeccCccccChHHHh-hhcchhhhhh
Confidence 99999988 699999999999996432 35999999999987643 223467999999999987 7899999999
Q ss_pred hhHHHHHHHHhCCCCCCCCchh--hHHHH-Hhhcccc-ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 696 SLGCILFFCITGGKHPYGESFE--RDANI-VKDRKDL-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 696 SlGviL~elltG~~~Pf~~~~~--~~~~~-~~~~~~~-~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
|||+.|+||+|+ ..||.+... ...+. ..+.++. +..-..|+++++|.+||.. .+.|+|+.|+|+||||...
T Consensus 228 aFGMCmLEMvT~-eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 228 AFGMCMLEMVTS-EYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred hhhHHHHHHHhc-cCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999997 789987532 23333 3333222 2222368999999999999 9999999999999999764
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.35 Aligned_cols=251 Identities=28% Similarity=0.398 Sum_probs=189.9
Q ss_pred ceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+.|.+.+.||+|+||+||++... +|+.||||++.+... ....+|+..+.....||||+++++++.+....|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 44667889999999999998665 489999999875432 2234565555555569999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc-cc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IG 626 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~-~~ 626 (902)
++..++.+++.. ....+++..+.+++.|++.||+|||+ .+
T Consensus 95 ~~~~~l~~l~~~---------------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~ 135 (296)
T cd06618 95 LMSTCLDKLLKR---------------------------------------IQGPIPEDILGKMTVAIVKALHYLKEKHG 135 (296)
T ss_pred ccCcCHHHHHHH---------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 765544443311 11246777788999999999999997 59
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC----CCCcchhhhhHHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR----QTRAIDLFSLGCILF 702 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~----~s~ksDVwSlGviL~ 702 (902)
|+||||+|+||+++.++. +||+|||++..+..... .....++..|+|||.+.... ++.++|||||||++|
T Consensus 136 i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 209 (296)
T cd06618 136 VIHRDVKPSNILLDASGN--VKLCDFGISGRLVDSKA----KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLV 209 (296)
T ss_pred EecCCCcHHHEEEcCCCC--EEECccccchhccCCCc----ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHH
Confidence 999999999999987765 99999999876643211 12234788999999987553 788999999999999
Q ss_pred HHHhCCCCCCCCchhh---HHHHHhhcccccc--ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 703 FCITGGKHPYGESFER---DANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 703 elltG~~~Pf~~~~~~---~~~~~~~~~~~~~--~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
+|++| +.||...... ...+........+ ...++++.+++.+||+.||.+||++++++.||||....
T Consensus 210 el~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 210 ELATG-QFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred HHHhC-CCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 99997 7787653221 1122222211111 12567899999999999999999999999999997544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.35 Aligned_cols=241 Identities=30% Similarity=0.491 Sum_probs=187.9
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.||+|+||.||+|.. .+|+.||||++.+... .....|...+.....|+||+++++++.+++..|+|+|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e---- 77 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVME---- 77 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEe----
Confidence 4689999999999854 4689999999865421 1123344445556789999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+|||
T Consensus 78 ------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~d 122 (260)
T cd05611 78 ------YLNGGDCASLIKTL-----------------------------GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122 (260)
T ss_pred ------ccCCCCHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 66777777765321 2467788899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|+|+||+++.++. ++|+|||+++.... .....|+..|+|||.+.+..++.++|||||||++|+|++| ..|
T Consensus 123 l~p~nil~~~~~~--~~l~dfg~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g-~~p 192 (260)
T cd05611 123 IKPENLLIDQTGH--LKLTDFGLSRNGLE-------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG-YPP 192 (260)
T ss_pred CCHHHeEECCCCc--EEEeecccceeccc-------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHC-CCC
Confidence 9999999988765 89999999875432 1234588999999999888889999999999999999997 678
Q ss_pred CCCchhhH-HHHHhhcc----ccccccCChHHHHHHHcccCCCCCCCcC---HHHHHcCCCCCCc
Q 002601 712 YGESFERD-ANIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTA 768 (902)
Q Consensus 712 f~~~~~~~-~~~~~~~~----~~~~~~~~~e~~dLI~~~L~~dP~~Rpt---~~elL~HPfF~~~ 768 (902)
|....... ........ .......++++.++|.+||+.||++||+ ++|++.||||.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred CCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 76543222 11111111 1112245789999999999999999995 5799999999653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=301.88 Aligned_cols=245 Identities=23% Similarity=0.381 Sum_probs=188.8
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
+.|.+.+.||+|+||.||++...++..||+|.+..... +...+|+. +++.++|+||+++++++.+ +..|++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~-~~~~lv~e--- 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQ-IMKKLRHDKLVQLYAVVSE-EPIYIVTE--- 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHH-HHHhcCCCceEEEEeEECC-CCcEEEEE---
Confidence 34667789999999999999877888999999865322 33445554 6788999999999998754 56899999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.++++... ...+++..++.++.|++.||+|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 126 (260)
T cd05070 81 -------YMSKGSLLDFLKDGE---------------------------GRALKLPNLVDMAAQVAAGMAYIERMNYIHR 126 (260)
T ss_pred -------ecCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 666777777664321 1235778889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+||+++.++. ++|+|||++......... ......++..|+|||++....++.++|+|||||++|+|++++.+
T Consensus 127 di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 202 (260)
T cd05070 127 DLRSANILVGDGLV--CKIADFGLARLIEDNEYT--ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred CCccceEEEeCCce--EEeCCceeeeeccCcccc--cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCC
Confidence 99999999987754 899999999876432211 11222356789999999888899999999999999999996688
Q ss_pred CCCCchhhH-HH-HHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 711 PYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 711 Pf~~~~~~~-~~-~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
||....... .. +........+...+.++.+++.+||+.||.+|||+.++.
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 203 PYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 886543222 22 222222233445678899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=304.57 Aligned_cols=245 Identities=23% Similarity=0.322 Sum_probs=193.0
Q ss_pred eEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
.|.+.+.||.|+||+||++...+++.||+|.+..... ....+|+. ++..++||||+++++++.+.+..++|||
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e--- 82 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQ-ALKRLRHKHLISLFAVCSVGEPVYIITE--- 82 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHH-HHhcCCCcchhheeeeEecCCCeEEEEe---
Confidence 4566788999999999999877799999999875543 23444554 6788899999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.+++.... ...+++..+..++.||+.||+|||+.+|+||
T Consensus 83 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~ 128 (261)
T cd05148 83 -------LMEKGSLLAFLRSPE---------------------------GQVLPVASLIDMACQVAEGMAYLEEQNSIHR 128 (261)
T ss_pred -------ecccCCHHHHHhcCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 666677776664321 1235677889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+||+++.++. +||+|||++......... .....++..|+|||++....++.++|||||||++|+|++++.+
T Consensus 129 dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~ 203 (261)
T cd05148 129 DLAARNILVGEDLV--CKVADFGLARLIKEDVYL---SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQV 203 (261)
T ss_pred ccCcceEEEcCCce--EEEccccchhhcCCcccc---ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999987765 999999999876543211 1133467789999999888899999999999999999996688
Q ss_pred CCCCchhh-HHH-HHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 711 PYGESFER-DAN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 711 Pf~~~~~~-~~~-~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||...... ... +........+...++++.++|.+||+.||.+|||+.++++
T Consensus 204 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 204 PYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 88654322 222 2222222334566789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=303.90 Aligned_cols=249 Identities=31% Similarity=0.443 Sum_probs=196.0
Q ss_pred eEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC------chHHHHHHHHHHHhCC-CCCeeEecccccCccceeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~d~~~~yLV 545 (902)
.|.+.+.||+|+||.||++... +|..||+|++.+.. .....+|. .++..+. ||||+++++++.+++..++|
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~-~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK-EVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHH-HHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4677889999999999998654 78999999986521 12233444 4566777 99999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| ++++|+|.+++.. ...+++..+..++.|++.||+|||+.
T Consensus 81 ~e----------~~~~~~L~~~l~~-----------------------------~~~l~~~~~~~i~~ql~~~l~~Lh~~ 121 (280)
T cd05581 81 LE----------YAPNGELLQYIRK-----------------------------YGSLDEKCTRFYAAEILLALEYLHSK 121 (280)
T ss_pred Ec----------CCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 5555666555532 12467888999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCcc-----------------ccccccCCCCccccCchhhccCCC
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-----------------LTQNATGYGSSGWQAPEQLLQGRQ 688 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~-----------------~~~~~~~~Gt~~Y~APE~l~~~~~ 688 (902)
+++|+||+|+||+++.++. ++|+|||++......... ........|+..|+|||++....+
T Consensus 122 ~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 199 (280)
T cd05581 122 GIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199 (280)
T ss_pred CeeecCCCHHHeEECCCCC--EEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence 9999999999999988876 899999999876543211 112233457899999999988889
Q ss_pred CCcchhhhhHHHHHHHHhCCCCCCCCchhhH-HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH----HHHHcCC
Q 002601 689 TRAIDLFSLGCILFFCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA----QNVLNHP 763 (902)
Q Consensus 689 s~ksDVwSlGviL~elltG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~----~elL~HP 763 (902)
+.++|+|||||+++++++| ..||....... ...........+...++++.++|.+||+.||.+||++ +++++||
T Consensus 200 ~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 200 GKSSDLWALGCIIYQMLTG-KPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred ChhhhHHHHHHHHHHHHhC-CCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 9999999999999999997 77887543221 2222233334555667899999999999999999999 9999999
Q ss_pred CC
Q 002601 764 FF 765 (902)
Q Consensus 764 fF 765 (902)
||
T Consensus 279 ~~ 280 (280)
T cd05581 279 FF 280 (280)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=298.38 Aligned_cols=249 Identities=24% Similarity=0.411 Sum_probs=193.4
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccC--ccceeeee
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSL 546 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d--~~~~yLV~ 546 (902)
|.+.+.||.|+||.||++. ..+|..||+|++..... +....|+ .+++.++||||+++++++.+ +...|++|
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEV-NILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHH-HHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5567889999999999984 45789999999864321 1223344 46788999999999997753 45689999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc---
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--- 623 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH--- 623 (902)
| |+++|+|.+++..... ....+++..++.++.||+.||+|||
T Consensus 81 e----------~~~~~~L~~~l~~~~~-------------------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 125 (265)
T cd08217 81 E----------YCEGGDLAQLIQKCKK-------------------------ERKYIEEEFIWRILTQLLLALYECHNRS 125 (265)
T ss_pred h----------hccCCCHHHHHHHHhh-------------------------cccCCCHHHHHHHHHHHHHHHHHHhcCc
Confidence 9 6677777777643211 1245678889999999999999999
Q ss_pred --cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHH
Q 002601 624 --EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 624 --~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL 701 (902)
+.+|+|+||||+||+++.++. +||+|||++........ ......|++.|+|||++....++.++|+|||||++
T Consensus 126 ~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il 200 (265)
T cd08217 126 DPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSS---FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLI 200 (265)
T ss_pred cccCcceecCCCHHHEEEecCCC--EEEecccccccccCCcc---cccccccCCCccChhhhcCCCCCchhHHHHHHHHH
Confidence 889999999999999988765 99999999987764321 12234589999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCchhhH-HHHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 702 FFCITGGKHPYGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~-~~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
|+|++| ..||....... ...+ .......+...++++.+++.+||+.+|.+||++.++++|||+
T Consensus 201 ~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 201 YELCAL-SPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHC-CCcccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999997 67876543222 2222 222223445567899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.89 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=188.1
Q ss_pred EEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCch-----------------HHHHHHHHHHHhCCCCCeeEeccccc
Q 002601 476 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD-----------------VALKEIQNLIASDQHPNIVRWYGVES 537 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~-----------------~~~~Ei~~ll~~l~HpNIV~l~g~~~ 537 (902)
.+.+.||.|+||+||++.. .+|+.||||.+...... ...+|+. ++..++||||+++++++.
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~ 90 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK-IMNEIKHENIMGLVDVYV 90 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHH-HHHhCCCcceeeeeEEEe
Confidence 4567899999999999854 47899999988643211 2345654 668889999999999999
Q ss_pred CccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhc
Q 002601 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (902)
Q Consensus 538 d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~ 617 (902)
+++..++|||++.++|.++ +.. ...+++..+..++.|++.
T Consensus 91 ~~~~~~lv~e~~~~~l~~~-----------l~~-----------------------------~~~~~~~~~~~~~~ql~~ 130 (335)
T PTZ00024 91 EGDFINLVMDIMASDLKKV-----------VDR-----------------------------KIRLTESQVKCILLQILN 130 (335)
T ss_pred cCCcEEEEEeccccCHHHH-----------HHh-----------------------------cCCCCHHHHHHHHHHHHH
Confidence 9999999999665544433 311 123567788999999999
Q ss_pred cccccccccccccccccceeEeccCCCceEEEccCCccccccCCCc-----------cccccccCCCCccccCchhhccC
Q 002601 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-----------CLTQNATGYGSSGWQAPEQLLQG 686 (902)
Q Consensus 618 gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~-----------~~~~~~~~~Gt~~Y~APE~l~~~ 686 (902)
||+|||+.+|+||||||+||+++.++. ++|+|||++........ .........++..|+|||.+.+.
T Consensus 131 aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 208 (335)
T PTZ00024 131 GLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208 (335)
T ss_pred HHHHHHhCCeecccccHHHeEECCCCC--EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccC
Confidence 999999999999999999999988775 89999999986652110 01111223468889999998764
Q ss_pred -CCCCcchhhhhHHHHHHHHhCCCCCCCCchhhH--HHHHhhcc----c-----------------------cccccCCh
Q 002601 687 -RQTRAIDLFSLGCILFFCITGGKHPYGESFERD--ANIVKDRK----D-----------------------LFLVEHIP 736 (902)
Q Consensus 687 -~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~--~~~~~~~~----~-----------------------~~~~~~~~ 736 (902)
.++.++|||||||++|+|++| .+||....... ..+..... . ......++
T Consensus 209 ~~~~~~~Dv~slG~~l~el~tg-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (335)
T PTZ00024 209 EKYHFAVDMWSVGCIFAELLTG-KPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASD 287 (335)
T ss_pred CCCCcHHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCCh
Confidence 468999999999999999997 77776443211 11111000 0 00112356
Q ss_pred HHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcchh
Q 002601 737 EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 771 (902)
Q Consensus 737 e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~~ 771 (902)
++.++|.+||+.||++||+++|++.||||+.....
T Consensus 288 ~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 288 DAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 78999999999999999999999999999876554
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=300.56 Aligned_cols=242 Identities=28% Similarity=0.390 Sum_probs=186.8
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCchH-HHHHHHHHHHhCCCCCeeEecccc-cCccceeeeecccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVE-SDQDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~~-~~~Ei~~ll~~l~HpNIV~l~g~~-~d~~~~yLV~E~c~ 550 (902)
+.|.+.+.||+|+||.||++. ..|..||+|.+....... ..+|+ .+++.++|+||+++++++ .+++..|++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~-~~~~~~~~k~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e--- 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQAFLAEA-SVMTQLRHSNLVQLLGVIVEEKGGLYIVTE--- 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEE-EcCCcEEEEEeCCCchHHHHHHHH-HHHHhCCCCCeeeEEEEEEcCCCceEEEEE---
Confidence 346778999999999999975 458889999987544333 34454 467889999999999975 45667899999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.+++.... ...+++..+.+++.|++.||+|||++||+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 126 (256)
T cd05082 81 -------YMAKGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126 (256)
T ss_pred -------CCCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence 666677766654221 1235677889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+||+++.++. +||+|||+++...... ....++..|+|||++....++.++|||||||++|+|++.+..
T Consensus 127 dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~ 198 (256)
T cd05082 127 DLAARNVLVSEDNV--AKVSDFGLTKEASSTQ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred ccchheEEEcCCCc--EEecCCccceeccccC------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999988775 8999999988654321 122346789999999988899999999999999999985578
Q ss_pred CCCCchhh-HHHHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 711 PYGESFER-DANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 711 Pf~~~~~~-~~~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||...... ....+ .......+...++++.+++.+||+.+|++|||+.++++
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 199 PYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 88654322 22222 22222334456789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=308.39 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=188.1
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCch--------HHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHD--------VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~--------~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
|.+.+.||+|+||.||++.. .+|+.||||++...... ....|+. ++..++|+||+++++++.+++..|+|
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIK-LLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHH-HHhhcCCCCChhhhheeecCCEEEEE
Confidence 55678899999999999864 46899999998654221 2234554 66888999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+ .|+|.+++.... ..+++..+.+++.||++||+|||++
T Consensus 81 ~e----------~~-~~~L~~~i~~~~----------------------------~~~~~~~~~~~~~qi~~al~~lH~~ 121 (298)
T cd07841 81 FE----------FM-ETDLEKVIKDKS----------------------------IVLTPADIKSYMLMTLRGLEYLHSN 121 (298)
T ss_pred Ec----------cc-CCCHHHHHhccC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 55 555555543211 1367788899999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~el 704 (902)
+|+|+||||+||+++.++. ++|+|||+++....... ......+++.|+|||.+.+ ..++.++|||||||++|||
T Consensus 122 ~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~ 196 (298)
T cd07841 122 WILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNR---KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAEL 196 (298)
T ss_pred CeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCc---cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999988776 89999999987654321 1122346788999998865 4578999999999999999
Q ss_pred HhCCCCCCCCchhhH--HHHHhhcc---------------------------ccccccCChHHHHHHHcccCCCCCCCcC
Q 002601 705 ITGGKHPYGESFERD--ANIVKDRK---------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPK 755 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~--~~~~~~~~---------------------------~~~~~~~~~e~~dLI~~~L~~dP~~Rpt 755 (902)
++| .+||....... ..+..... .......+.++.++|.+||+.||++||+
T Consensus 197 ~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 275 (298)
T cd07841 197 LLR-VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT 275 (298)
T ss_pred HcC-CccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC
Confidence 998 66665432111 11110000 0001223568899999999999999999
Q ss_pred HHHHHcCCCCCCcc
Q 002601 756 AQNVLNHPFFWTAD 769 (902)
Q Consensus 756 ~~elL~HPfF~~~~ 769 (902)
+.|+++||||.+..
T Consensus 276 ~~e~l~~~~~~~~~ 289 (298)
T cd07841 276 ARQALEHPYFSNDP 289 (298)
T ss_pred HHHHhhCccccCCC
Confidence 99999999997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.65 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=188.8
Q ss_pred cceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc--hHHHHHHHHHHHhC-CCCCeeEecccccCcc------c
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--DVALKEIQNLIASD-QHPNIVRWYGVESDQD------F 541 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~------~ 541 (902)
.+.|.+.+.||+|++|+||++.. .+++.||+|++..... +...+|+. ++..+ .|+||+++++++.+.. .
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~-~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYN-ILRKYSNHPNIATFYGAFIKKNPPGNDDQ 83 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHH-HHHHhcCCCChheEEEEEEecCCCCcceE
Confidence 45678889999999999999865 4678999999865432 33445655 44555 7999999999986544 4
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.|+||| |+++++|.+++..... +...+++..+..++.|++.||+|
T Consensus 84 ~~lv~e----------~~~~~~L~~~~~~~~~-------------------------~~~~~~~~~~~~~~~ql~~al~~ 128 (275)
T cd06608 84 LWLVME----------LCGGGSVTDLVKGLRK-------------------------KGKRLKEEWIAYILRETLRGLAY 128 (275)
T ss_pred EEEEEE----------cCCCCcHHHHHHHHhh-------------------------cCCCCCHHHHHHHHHHHHHHHHH
Confidence 899999 5556666665532110 12346778889999999999999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-----CCCCCcchhhh
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----GRQTRAIDLFS 696 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-----~~~s~ksDVwS 696 (902)
||+.+++|+||+|+||+++.++. ++|+|||++....... .......|+..|+|||++.. ..++.++||||
T Consensus 129 lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 203 (275)
T cd06608 129 LHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTL---GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWS 203 (275)
T ss_pred HhcCCcccCCCCHHHEEEccCCe--EEECCCccceecccch---hhhcCccccccccCHhHhcccccccCCccccccHHH
Confidence 99999999999999999988765 8999999987654321 12233458999999998754 34678999999
Q ss_pred hHHHHHHHHhCCCCCCCCchhh--HHHHHhhcccc--ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 697 LGCILFFCITGGKHPYGESFER--DANIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 697 lGviL~elltG~~~Pf~~~~~~--~~~~~~~~~~~--~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
|||++|+|++| .+||...... ...+....... .....++++.++|.+||..||++|||+.++++|||+
T Consensus 204 lG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 204 LGITAIELADG-KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hHHHHHHHHhC-CCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 99999999997 7787643221 11222211111 112245789999999999999999999999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=310.01 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=192.4
Q ss_pred ceEEEeeeecccCceEEEEEEee--------CCcEEEEEEeccCCch----HHHHHHHHHHHhC-CCCCeeEecccccCc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQ 539 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~--------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~ 539 (902)
+.|.+.+.||+|+||.||++... ++..||+|.+...... ...+|+. ++..+ +||||+++++++.+.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~-~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEME-MMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHH-HHHHhcCCCCEeeEEEEEecC
Confidence 45788999999999999987532 2357999998754222 3445555 44555 899999999999999
Q ss_pred cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccc
Q 002601 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (902)
Q Consensus 540 ~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL 619 (902)
+..|+||| |+++|+|.+++......... ............+++.++++++.|++.||
T Consensus 97 ~~~~lv~e----------~~~~~~L~~~i~~~~~~~~~-------------~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 153 (307)
T cd05098 97 GPLYVIVE----------YASKGNLREYLRARRPPGME-------------YCYNPTQVPEEQLSFKDLVSCAYQVARGM 153 (307)
T ss_pred CceEEEEe----------cCCCCcHHHHHHhcCCcccc-------------cccccccCccccCCHHHHHHHHHHHHHHH
Confidence 99999999 55667777776543211000 00000001123477888999999999999
Q ss_pred cccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHH
Q 002601 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (902)
Q Consensus 620 ~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGv 699 (902)
+|||+.|++||||||+|||++.++. +||+|||+++....... ........++..|+|||++.+..++.++|||||||
T Consensus 154 ~~lH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 230 (307)
T cd05098 154 EYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDY-YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 230 (307)
T ss_pred HHHHHCCcccccccHHheEEcCCCc--EEECCCcccccccccch-hhccccCCCccceeChHHhccCCCCcHHHHHHHHH
Confidence 9999999999999999999988765 89999999876643211 11112223457899999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCchhhH-HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 700 ILFFCITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 700 iL~elltG~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
++|||++++.+||....... ...+... ....+...++++.++|.+||+.+|.+||++.+++++
T Consensus 231 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 231 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 99999996688887644322 2222222 223344567899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=319.52 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=192.2
Q ss_pred cceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
++.|...+.||+|+...||++...+.+.+|+|+...... +-...|+.-+-+.-.|.+||+|++|...++.+||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 556777789999999999998777788899987643321 234567765545557999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
|+-+++|...+.-..+. .+.-.++.+..|++.|+.++|++|
T Consensus 440 E~Gd~DL~kiL~k~~~~---------------------------------------~~~~~lk~ywkqML~aV~~IH~~g 480 (677)
T KOG0596|consen 440 ECGDIDLNKILKKKKSI---------------------------------------DPDWFLKFYWKQMLLAVKTIHQHG 480 (677)
T ss_pred ecccccHHHHHHhccCC---------------------------------------CchHHHHHHHHHHHHHHHHHHHhc
Confidence 97777766555211111 111245788999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-----------CCCcchhh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-----------QTRAIDLF 695 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-----------~s~ksDVw 695 (902)
|||.||||.|.|+-.. .+||+|||+|..+..+... ....+.+||+.||+||.+.... .++++|||
T Consensus 481 IVHSDLKPANFLlVkG---~LKLIDFGIA~aI~~DTTs-I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvW 556 (677)
T KOG0596|consen 481 IVHSDLKPANFLLVKG---RLKLIDFGIANAIQPDTTS-IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVW 556 (677)
T ss_pred eeecCCCcccEEEEee---eEEeeeechhcccCccccc-eeeccccCcccccCHHHHhhccccccCCCcceeecCccchh
Confidence 9999999999999643 3999999999988765433 3345678999999999986532 45899999
Q ss_pred hhHHHHHHHHhCCCCCCCCchhhHH---HHHhhcc-ccccccCC-hHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 696 SLGCILFFCITGGKHPYGESFERDA---NIVKDRK-DLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 696 SlGviL~elltG~~~Pf~~~~~~~~---~~~~~~~-~~~~~~~~-~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
|||||||+|+.| ++||+.-..... .+..... -.|+.--. .++.++++.||..||.+||++.|+|+|||...
T Consensus 557 SLGCILYqMvYg-ktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 557 SLGCILYQMVYG-KTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred hhhhHHHHHHhc-CCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 999999999997 889987543322 2222211 12332222 25999999999999999999999999999865
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=299.03 Aligned_cols=248 Identities=29% Similarity=0.450 Sum_probs=195.3
Q ss_pred eEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
.|.+.+.||+|++|.||++... +|+.||||++..... ....+|+. .+..++|+||+++++++.+.+..++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e- 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK-TLRSCESPYVVKCYGAFYKEGEISIVLE- 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHH-HHHhcCCCCeeeEEEEEccCCeEEEEEE-
Confidence 3567789999999999998655 599999999876532 23444554 5577889999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc-ccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 627 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~-~~I 627 (902)
|+++++|.+++... ..+++..+..++.|+++||+|||+ .++
T Consensus 80 ---------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~~l~~~l~~lh~~~~~ 121 (264)
T cd06623 80 ---------YMDGGSLADLLKKV-----------------------------GKIPEPVLAYIARQILKGLDYLHTKRHI 121 (264)
T ss_pred ---------ecCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHhccCCC
Confidence 55666666665321 346777889999999999999999 999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||+|+||+++.++. ++|+|||++......... .....++..|+|||.+....++.++|+||||+++|+|++|
T Consensus 122 ~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg 196 (264)
T cd06623 122 IHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQ---CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196 (264)
T ss_pred ccCCCCHHHEEECCCCC--EEEccCccceecccCCCc---ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999987765 899999999876543221 1234578899999999988899999999999999999997
Q ss_pred CCCCCCCch--h---hHHHHHhhcccccccc-CChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 708 GKHPYGESF--E---RDANIVKDRKDLFLVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 708 ~~~Pf~~~~--~---~~~~~~~~~~~~~~~~-~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
..||.... . ....+........... .+..+.++|.+||..+|++||++.++++||||..
T Consensus 197 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 197 -KFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred -CCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 67876543 1 1112222222223333 5678999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.93 Aligned_cols=240 Identities=24% Similarity=0.346 Sum_probs=182.7
Q ss_pred eecccCceEEEEEEee---CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 480 EIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~~---~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
.||+|+||.||++... .+..||||++...... ...+|+. +++.++||||+++++++.. +..++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~-~l~~l~h~~ii~~~~~~~~-~~~~lv~e----- 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAE-IMHQLDNPYIVRMIGVCEA-EALMLVME----- 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHH-HHHhcCCCCeEEEEEEEcC-CCeEEEEE-----
Confidence 3899999999987543 4567999998654322 2344544 6788999999999998864 57899999
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDL 632 (902)
|+++|+|.+++... ...+++..+++++.|++.||+|||+++++||||
T Consensus 75 -----~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 121 (257)
T cd05115 75 -----MASGGPLNKFLSGK----------------------------KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDL 121 (257)
T ss_pred -----eCCCCCHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeeccc
Confidence 66677777665421 124677888999999999999999999999999
Q ss_pred ccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCC
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf 712 (902)
||+|||++.++. +||+|||++.................++..|+|||++....++.++|||||||++||+++.+..||
T Consensus 122 kp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 199 (257)
T cd05115 122 AARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199 (257)
T ss_pred chheEEEcCCCc--EEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 999999987765 999999999866543222221222234678999999988889999999999999999997447788
Q ss_pred CCchhhH-HHHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 713 GESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 713 ~~~~~~~-~~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
....... ...+ .......+...++++.++|.+||+.||++||++.++.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 200 KKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6543322 2222 22233344556789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=312.86 Aligned_cols=252 Identities=29% Similarity=0.429 Sum_probs=185.8
Q ss_pred cceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCc--------
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQ-------- 539 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~-------- 539 (902)
+..|.+.+.||.|+||+||++.. .+|+.||+|.+..... ....+|+. +++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~-~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHH-HHHhcCCCcchhhHhhhccccccccccc
Confidence 46788899999999999999854 5689999999855432 23455655 66888999999999876553
Q ss_pred ------cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHH
Q 002601 540 ------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (902)
Q Consensus 540 ------~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~ 613 (902)
...|+||||+.++|.+++ . ...+++..++.++.
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~-----------~------------------------------~~~l~~~~~~~~~~ 121 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVL-----------E------------------------------QGPLSEEHARLFMY 121 (342)
T ss_pred ccccccceEEEEeecccccHHHHH-----------H------------------------------cCCCCHHHHHHHHH
Confidence 357999996655443322 1 12356778899999
Q ss_pred hhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcc
Q 002601 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAI 692 (902)
Q Consensus 614 qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ks 692 (902)
||+.||+|||+.||+||||||+||+++.++. .+||+|||+++.+..............|+..|+|||.+.. ..++.++
T Consensus 122 qi~~aL~~LH~~givH~dikp~Nili~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 200 (342)
T cd07854 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDL-VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200 (342)
T ss_pred HHHHHHHHHHhCCcccCCCCHHHEEEcCCCc-eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchh
Confidence 9999999999999999999999999975543 4899999999876432221111223357889999998754 4578899
Q ss_pred hhhhhHHHHHHHHhCCCCCCCCchhhH--HHHHhh-----------------------c-c-----ccccccCChHHHHH
Q 002601 693 DLFSLGCILFFCITGGKHPYGESFERD--ANIVKD-----------------------R-K-----DLFLVEHIPEAVDL 741 (902)
Q Consensus 693 DVwSlGviL~elltG~~~Pf~~~~~~~--~~~~~~-----------------------~-~-----~~~~~~~~~e~~dL 741 (902)
|||||||++|+|++| ..||....... ...... . . .......+.++.++
T Consensus 201 DiwSlGvil~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (342)
T cd07854 201 DMWAAGCIFAEMLTG-KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDF 279 (342)
T ss_pred hHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHH
Confidence 999999999999998 56765332111 011000 0 0 00112356789999
Q ss_pred HHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 742 FTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 742 I~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
|.+||+.||.+||+++++++||||..
T Consensus 280 i~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 280 LEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HHHHhCCCchhccCHHHHhCCCcccc
Confidence 99999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.25 Aligned_cols=244 Identities=31% Similarity=0.483 Sum_probs=189.2
Q ss_pred ecccCceEEEEEEee-CCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 481 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 481 LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
||+|+||.||++... +|+.||+|++..... ....+|+ .++..++||||+++++.+.+++..|+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~lv~e------ 73 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTER-DILSQAQSPYVVKLYYSFQGKKNLYLVME------ 73 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHH-HHHHhCCCcchhHHHHheecCcEEEEEEe------
Confidence 689999999998665 499999999865432 1233444 46688899999999999999999999999
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+++|+||+
T Consensus 74 ----~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~ 120 (265)
T cd05579 74 ----YLPGGDLASLLENV-----------------------------GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120 (265)
T ss_pred ----cCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCC
Confidence 66666776665321 246777889999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCcc-----ccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSC-----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~-----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|+||+++.++. ++|+|||++......... ........++..|+|||.+.....+.++|||||||++|++++|
T Consensus 121 ~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g- 197 (265)
T cd05579 121 PDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG- 197 (265)
T ss_pred HHHeEEcCCCC--EEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhC-
Confidence 99999988876 899999998765432110 0112234578899999999888899999999999999999997
Q ss_pred CCCCCCchhhH-HHHHhhccccccccC--ChHHHHHHHcccCCCCCCCcCH---HHHHcCCCCCC
Q 002601 709 KHPYGESFERD-ANIVKDRKDLFLVEH--IPEAVDLFTRLLDPNPDLRPKA---QNVLNHPFFWT 767 (902)
Q Consensus 709 ~~Pf~~~~~~~-~~~~~~~~~~~~~~~--~~e~~dLI~~~L~~dP~~Rpt~---~elL~HPfF~~ 767 (902)
..||....... ...........+... ++++.+++.+||+.+|.+|||+ .++++||||.+
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 198 IPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 67776543322 222222222223333 7899999999999999999999 99999999964
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=301.65 Aligned_cols=256 Identities=20% Similarity=0.313 Sum_probs=193.1
Q ss_pred ceEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccce
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~ 542 (902)
+.|.+.+.||+|+||.||++... .+..||+|.+...... ...+|+. ++..++||||+++++++.+....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHH-HHHhCCCCceeEEEEEEcCCCCc
Confidence 45677899999999999997543 3478999998654321 2334444 66788999999999999999999
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+||| |+++|+|.+++......... .-....+++..+..++.|++.||+||
T Consensus 85 ~~v~e----------~~~~~~L~~~l~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~i~~~l~~l 135 (277)
T cd05032 85 LVVME----------LMAKGDLKSYLRSRRPEAEN-------------------NPGLGPPTLQKFIQMAAEIADGMAYL 135 (277)
T ss_pred EEEEe----------cCCCCCHHHHHHhcccchhh-------------------ccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 55566666666432211000 01123467788899999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
|+.+|+||||||+|||++.++. +||+|||+++....... ........++..|+|||.+....++.++|||||||++|
T Consensus 136 H~~~i~H~di~p~nill~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 212 (277)
T cd05032 136 AAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDY-YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLW 212 (277)
T ss_pred HhCCccccccChheEEEcCCCC--EEECCcccchhhccCcc-cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHH
Confidence 9999999999999999988876 89999999986653221 12223445788999999998888999999999999999
Q ss_pred HHHhCCCCCCCCchhhH-HHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 703 FCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
|+++++.+||....... ..... ......+...+.++.++|.+||+.+|++|||+.+++.
T Consensus 213 el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 213 EMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HhhccCCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99995588886543222 22222 2223345556789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=306.52 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=186.8
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|.+.+.||+|++|+||++.. .+|+.||+|++..... ....+|+. +++.++||||+++++++.+.+..|+|||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREIS-LLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHH-HHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 467788999999999999854 4789999998854321 23445554 6688899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+..+|.+ ++.... ...+++..+..++.||+.||+|||+++|
T Consensus 82 ~~~~~l~~-----------~~~~~~---------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~i 123 (294)
T PLN00009 82 YLDLDLKK-----------HMDSSP---------------------------DFAKNPRLIKTYLYQILRGIAYCHSHRV 123 (294)
T ss_pred cccccHHH-----------HHHhCC---------------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 66544433 321110 1123566778899999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHh
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ellt 706 (902)
+||||||+||+++.++. .+||+|||++........ ......|++.|+|||++.+. .++.++|||||||++|+|+|
T Consensus 124 ~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t 199 (294)
T PLN00009 124 LHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVR---TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199 (294)
T ss_pred eCCCCCcceEEEECCCC-EEEEcccccccccCCCcc---ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999986543 489999999976543211 11233578899999998764 57899999999999999999
Q ss_pred CCCCCCCCchhhH--HHHHhhcc--------------------c--------cccccCChHHHHHHHcccCCCCCCCcCH
Q 002601 707 GGKHPYGESFERD--ANIVKDRK--------------------D--------LFLVEHIPEAVDLFTRLLDPNPDLRPKA 756 (902)
Q Consensus 707 G~~~Pf~~~~~~~--~~~~~~~~--------------------~--------~~~~~~~~e~~dLI~~~L~~dP~~Rpt~ 756 (902)
| .+||....+.. ..+..... . ......++++.++|.+||+.||++||++
T Consensus 200 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 278 (294)
T PLN00009 200 Q-KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA 278 (294)
T ss_pred C-CCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH
Confidence 7 77876432211 11111000 0 0112356789999999999999999999
Q ss_pred HHHHcCCCCCCc
Q 002601 757 QNVLNHPFFWTA 768 (902)
Q Consensus 757 ~elL~HPfF~~~ 768 (902)
.++++||||.+.
T Consensus 279 ~~~l~~~~~~~~ 290 (294)
T PLN00009 279 RAALEHEYFKDL 290 (294)
T ss_pred HHHhcCchHhHH
Confidence 999999999653
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=307.64 Aligned_cols=246 Identities=25% Similarity=0.382 Sum_probs=190.8
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
.|.+.+.||+|+||+||++.. .+|+.||+|++..... ....+|+. ++..++||||+++++++.+.+..|+|||
T Consensus 6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e- 83 (284)
T cd06620 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ-IMHECRSPYIVSFYGAFLNENNICMCME- 83 (284)
T ss_pred HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHH-HHHHcCCCCcceEeeeEecCCEEEEEEe-
Confidence 345567899999999999854 4689999998764322 23445554 5677899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc-ccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGL 627 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~-~~I 627 (902)
|+++|+|.+++.. ...+++..+..++.+++.||.|||+ .+|
T Consensus 84 ---------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i 125 (284)
T cd06620 84 ---------FMDCGSLDRIYKK-----------------------------GGPIPVEILGKIAVAVVEGLTYLYNVHRI 125 (284)
T ss_pred ---------cCCCCCHHHHHHh-----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHhcCe
Confidence 6667777665532 1246777889999999999999997 589
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+||+++.++. ++|+|||++....... .....|+..|+|||++.+..++.++|+|||||++|++++|
T Consensus 126 ~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg 198 (284)
T cd06620 126 MHRDIKPSNILVNSRGQ--IKLCDFGVSGELINSI-----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALG 198 (284)
T ss_pred eccCCCHHHEEECCCCc--EEEccCCcccchhhhc-----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhC
Confidence 99999999999987765 8999999987553221 1234689999999999888899999999999999999997
Q ss_pred CCCCCCCchhh-------------HHHHHhhccccccc-cCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 708 GKHPYGESFER-------------DANIVKDRKDLFLV-EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 708 ~~~Pf~~~~~~-------------~~~~~~~~~~~~~~-~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
..||...... ...+........+. ..+.++.+++.+||+.||.+||++.|+++||||..
T Consensus 199 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 199 -KFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred -CCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 6777643321 01111111111122 25678999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=306.78 Aligned_cols=239 Identities=23% Similarity=0.320 Sum_probs=183.4
Q ss_pred eeecccCceEEEEEEee--------CCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 479 KEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~--------~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
+.||+|+||+||++... ....||+|.+..... ...+.++..++..+.||||+++++++.+++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e- 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE- 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe-
Confidence 35999999999997542 234589998765432 2334455567788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|.+++.... ..+++..+++++.||+.||+|||+.+|+
T Consensus 80 ---------~~~~g~L~~~l~~~~----------------------------~~~~~~~~~~~~~qi~~~l~~lH~~~ii 122 (258)
T cd05078 80 ---------YVKFGSLDTYLKKNK----------------------------NLINISWKLEVAKQLAWALHFLEDKGLT 122 (258)
T ss_pred ---------cCCCCcHHHHHhcCC----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 666677776664321 1356677789999999999999999999
Q ss_pred ccccccceeEeccCCCc------eEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHH
Q 002601 629 HRDLKPQNVLISKDKSF------CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCIL 701 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~------~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL 701 (902)
||||||+|||++.++.. .++++|||++...... ....++..|+|||++.+. .++.++|||||||++
T Consensus 123 H~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 195 (258)
T cd05078 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK-------EILLERIPWVPPECIENPQNLSLAADKWSFGTTL 195 (258)
T ss_pred cCCCccceEEEecccccccCCCceEEecccccccccCCc-------hhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence 99999999999876542 3789999988654321 234578899999999864 579999999999999
Q ss_pred HHHHhCCCCCCCCchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 702 FFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
|||++|+.+|+..................+....+++.++|.+||+.||++|||++++++.
T Consensus 196 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 196 WEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 9999997778765433322222222233444556789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.27 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=184.3
Q ss_pred EeeeecccCceEEEEEEeeC-Cc--EEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCc------cce
Q 002601 477 FNKEIAKGSNGTVVLEGNYE-GR--SVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ------DFV 542 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~~~-g~--~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~------~~~ 542 (902)
+++.||+|+||.||++.... +. .||||.+.... .....+|.. .+..++||||+++++++... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAV-CMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 46789999999999986544 32 69999876432 122344544 66788999999999976432 246
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
+++|| |+++|+|.+++...... .+...+++..+..++.|++.||+||
T Consensus 82 ~~v~e----------~~~~~~l~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~i~~~l~~l 128 (272)
T cd05075 82 VVILP----------FMKHGDLHSFLLYSRLG-----------------------DCPQYLPTQMLVKFMTDIASGMEYL 128 (272)
T ss_pred EEEEE----------eCCCCcHHHHHHHhccc-----------------------CCcccCCHHHHHHHHHHHHHHHHHH
Confidence 89999 66777777665321110 0123467888999999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
|+++|+||||||+|||++.++. +||+|||+++........ .......+++.|+|||++....++.++|||||||++|
T Consensus 129 H~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~ 205 (272)
T cd05075 129 SSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIYNGDYY-RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW 205 (272)
T ss_pred HHCCeeccccchhheEEcCCCC--EEECCCCcccccCcccce-ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHH
Confidence 9999999999999999987765 899999999876532211 1112234677899999999888999999999999999
Q ss_pred HHHhCCCCCCCCchhhH-HHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 703 FCITGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
||++++..||....... ...+. ......+...+..+.++|.+||+.||++|||+.+++++
T Consensus 206 el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 206 EIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 99996688886543222 22222 22223344566789999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=298.09 Aligned_cols=247 Identities=26% Similarity=0.386 Sum_probs=192.9
Q ss_pred cceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
.+.|.+.+.||+|+||+||++...+++.||||.+..... ....+|+. +++.++|+||+++++++.+....++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e-- 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-IMKKLRHDKLVQLYAVCSEEEPIYIVTE-- 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHH-HHhhCCCCCEeeeeeeeecCCceEEEEe--
Confidence 356788899999999999999877788999999875432 33445554 6788999999999999999899999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+++|+|
T Consensus 82 --------~~~~~~L~~~i~~~~---------------------------~~~~~~~~~~~~~~~i~~al~~lh~~~i~h 126 (261)
T cd05034 82 --------YMSKGSLLDFLKSGE---------------------------GKKLRLPQLVDMAAQIAEGMAYLESRNYIH 126 (261)
T ss_pred --------ccCCCCHHHHHhccc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 666777777664321 123577788999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
+||||+||+++.++. +||+|||++........ .......++..|+|||.+.+..++.++|||||||++|++++++.
T Consensus 127 ~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~ 202 (261)
T cd05034 127 RDLAARNILVGENLV--CKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202 (261)
T ss_pred CCcchheEEEcCCCC--EEECccccceeccchhh--hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCC
Confidence 999999999988866 89999999987653211 11112234678999999998889999999999999999999668
Q ss_pred CCCCCchhhH-H-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 710 HPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 710 ~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
.||....... . .+........+...++++.+++.+||+.+|.+||+++++.
T Consensus 203 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 255 (261)
T cd05034 203 VPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255 (261)
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 8886543222 1 2222212233445577899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=306.28 Aligned_cols=263 Identities=23% Similarity=0.348 Sum_probs=193.1
Q ss_pred ceEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCch----HHHHHHHHHHHhC-CCCCeeEecccccCccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQDF 541 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~~ 541 (902)
..|.+.+.||+|+||.||++... ....||+|++...... ...+|+. ++..+ +|+||+++++++.+++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHH-HHHhhcCCCCeeeEEEEEcCCCC
Confidence 34677889999999999998543 3468999998754322 2445665 44555 89999999999999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.+++|| |.++|+|..+++.......... .....-....+++..+++++.|++.||+|
T Consensus 91 ~~li~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 147 (293)
T cd05053 91 LYVVVE----------YAAHGNLRDFLRARRPPGEYAS-------------PDDPRPPEETLTQKDLVSFAYQVARGMEF 147 (293)
T ss_pred eEEEEE----------eCCCCcHHHHHHhcCCCccccc-------------cccccccccccCHHHHHHHHHHHHHHHHH
Confidence 999999 6666777766654321110000 00000112457888999999999999999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHH
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL 701 (902)
||+.+|+||||||+|||++.++. +||+|||+++.+..... ........++..|+|||++.+..++.++|||||||++
T Consensus 148 LH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 224 (293)
T cd05053 148 LASKKCIHRDLAARNVLVTEDHV--MKIADFGLARDIHHIDY-YRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLL 224 (293)
T ss_pred HHHCCccccccceeeEEEcCCCe--EEeCccccccccccccc-eeccCCCCCCccccCHHHhccCCcCcccceeehhhHH
Confidence 99999999999999999987765 89999999987654221 1111223356789999999888899999999999999
Q ss_pred HHHHhCCCCCCCCchh-hHHHHHhh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 702 FFCITGGKHPYGESFE-RDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~-~~~~~~~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
||+++.+..||..... .....+.. .....+...++++.+++.+||..||++|||+.+++++
T Consensus 225 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 225 WEIFTLGGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9999855778765432 22222222 2223344567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=304.95 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=188.5
Q ss_pred eEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.|.+.+.||+|+||.||++... +++.||||++.... .....+|+. +++.+.|+||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVK-VLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHH-HHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 4678899999999999998554 58899999886432 123445554 6688899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
||++++.+. .. .+...+++.++..++.||+.||+|||+.+|
T Consensus 81 ~~~~~~l~~----------~~-----------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 121 (288)
T cd07833 81 YVERTLLEL----------LE-----------------------------ASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121 (288)
T ss_pred cCCCCHHHH----------HH-----------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 665443322 11 112336777889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHh
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ellt 706 (902)
+||||+|+||+++.++. +||+|||++........ .......++..|+|||++... .++.++|||||||++|+|++
T Consensus 122 ~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 197 (288)
T cd07833 122 IHRDIKPENILVSESGV--LKLCDFGFARALRARPA--SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD 197 (288)
T ss_pred ecCCCCHHHeEECCCCC--EEEEeeecccccCCCcc--ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence 99999999999987765 99999999987664321 112234578899999999888 78999999999999999999
Q ss_pred CCCCCCCCchhhHH--HHHh--------------------h-----------ccccccccCChHHHHHHHcccCCCCCCC
Q 002601 707 GGKHPYGESFERDA--NIVK--------------------D-----------RKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (902)
Q Consensus 707 G~~~Pf~~~~~~~~--~~~~--------------------~-----------~~~~~~~~~~~e~~dLI~~~L~~dP~~R 753 (902)
| .+||........ .+.. . ....++...++++.++|++||..+|++|
T Consensus 198 g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 276 (288)
T cd07833 198 G-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKER 276 (288)
T ss_pred C-CCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhc
Confidence 8 667754322110 0000 0 0001122236789999999999999999
Q ss_pred cCHHHHHcCCCC
Q 002601 754 PKAQNVLNHPFF 765 (902)
Q Consensus 754 pt~~elL~HPfF 765 (902)
|+++++++||||
T Consensus 277 ps~~~il~~~~f 288 (288)
T cd07833 277 LTCDELLQHPYF 288 (288)
T ss_pred ccHHHHhcCCCC
Confidence 999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.41 Aligned_cols=261 Identities=24% Similarity=0.366 Sum_probs=193.3
Q ss_pred ceEEEeeeecccCceEEEEEEe------eCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
+++.+.++||+|+||+||++.. .++..||+|.+..... ....+|+. ++..++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE-LLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHH-HHhcCCCCCCceEEEEEecCCceE
Confidence 3466788999999999999743 2467899998865432 23444554 678889999999999999999999
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
++|| |+++|+|.++++.......... ....-....+++..++.++.|++.||+|||
T Consensus 84 lv~e----------~~~~~~L~~~i~~~~~~~~~~~--------------~~~~~~~~~l~~~~~~~~~~qi~~al~~LH 139 (280)
T cd05092 84 MVFE----------YMRHGDLNRFLRSHGPDAKILA--------------GGEDVAPGQLTLGQMLAIASQIASGMVYLA 139 (280)
T ss_pred EEEe----------cCCCCCHHHHHHhcCcchhhhc--------------ccccCCccccCHHHHHHHHHHHHHHHHHHH
Confidence 9999 6666677666653322110000 000011234788899999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
+.+|+||||||+|||+++++. +||+|||+++....... ........+++.|+|||++.+..++.++|||||||++||
T Consensus 140 ~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05092 140 SLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWE 216 (280)
T ss_pred HCCeecccccHhhEEEcCCCC--EEECCCCceeEcCCCce-eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHH
Confidence 999999999999999987765 89999999976543211 111122335788999999999899999999999999999
Q ss_pred HHhCCCCCCCCchhhH-H-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 704 CITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
|++++.+||.+..... . .+........+...++++.++|.+||+.||.+||++.++++
T Consensus 217 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 217 IFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCCCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9996688886543222 2 22222233334556789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=301.22 Aligned_cols=259 Identities=26% Similarity=0.376 Sum_probs=195.6
Q ss_pred EEEeeeecccCceEEEEEEeeC-----CcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccC-cccee
Q 002601 475 VVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-QDFVY 543 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~~-----g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d-~~~~y 543 (902)
|...+.||+|.||.||+|...+ .+.+|+|+++.+. ...+.+|+. +++.++|||||.|..++-. +..++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREia-L~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIA-LLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHH-HHHHhcCCcchhHHHHHhccCceEE
Confidence 5566789999999999983322 2479999997652 346889986 7789999999999999877 78899
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
|++||.+.+|...|.....+ +.+.+|...+..|+.||+.|+.|||
T Consensus 105 l~fdYAEhDL~~II~fHr~~-----------------------------------~~~~lp~~mvKsilwQil~Gv~YLH 149 (438)
T KOG0666|consen 105 LLFDYAEHDLWHIIKFHRAS-----------------------------------KAKQLPRSMVKSILWQILDGVHYLH 149 (438)
T ss_pred EEehhhhhhHHHHHHHhccc-----------------------------------hhccCCHHHHHHHHHHHHhhhHHHh
Confidence 99998888877777443221 1235778888999999999999999
Q ss_pred cccccccccccceeEeccCCC--ceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCI 700 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~--~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGvi 700 (902)
++=|+||||||.|||+..+|. .++||+|||+++.+.+...........+-|..|.|||.+.+. .||.++||||.|||
T Consensus 150 ~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCI 229 (438)
T KOG0666|consen 150 SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCI 229 (438)
T ss_pred hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHH
Confidence 999999999999999976632 459999999999987654444344455679999999999876 48999999999999
Q ss_pred HHHHHhCCCCCCCCc-------------hhhHHHHHh---------------------hcccccc------------ccC
Q 002601 701 LFFCITGGKHPYGES-------------FERDANIVK---------------------DRKDLFL------------VEH 734 (902)
Q Consensus 701 L~elltG~~~Pf~~~-------------~~~~~~~~~---------------------~~~~~~~------------~~~ 734 (902)
+.||+|-...+++.. ..+...++. ....... ...
T Consensus 230 faElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k 309 (438)
T KOG0666|consen 230 FAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVK 309 (438)
T ss_pred HHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCC
Confidence 999999633332210 111111110 0000000 012
Q ss_pred ChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 735 IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 735 ~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
++.+.+|+.+||+.||.+|.|++++|+|+||...+
T Consensus 310 ~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 310 DPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred CchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 34588999999999999999999999999997653
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=298.79 Aligned_cols=246 Identities=24% Similarity=0.377 Sum_probs=188.0
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
+.+.+.+.||+|++|+||++....+..||+|++..... +...+|+. +++.++||||+++++++.+ +..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~-~~~~~v~e--- 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQ-IMKKLRHDKLVPLYAVVSE-EPIYIVTE--- 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHH-HHHhCCCCCeeeEEEEEcC-CCcEEEEE---
Confidence 44677889999999999998777777899998865332 23445554 6788999999999998754 56899999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.++++... ...+++..+..++.|++.||+|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 126 (260)
T cd05069 81 -------FMGKGSLLDFLKEGD---------------------------GKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126 (260)
T ss_pred -------cCCCCCHHHHHhhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence 666677766664321 1235677789999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+||++++++. ++|+|||++........ .......++..|+|||.+....++.++|||||||++|||++++.+
T Consensus 127 dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~ 202 (260)
T cd05069 127 DLRAANILVGDNLV--CKIADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 202 (260)
T ss_pred ccCcceEEEcCCCe--EEECCCccceEccCCcc--cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCC
Confidence 99999999987765 89999999976643211 111222357789999999888899999999999999999996688
Q ss_pred CCCCchhhH-HHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 711 PYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 711 Pf~~~~~~~-~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||.+..... ...+. ......+...+..+.+++.+||.+||.+||+++++++
T Consensus 203 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 203 PYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 887643322 22222 2122234456778999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=307.07 Aligned_cols=246 Identities=28% Similarity=0.423 Sum_probs=185.5
Q ss_pred eEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCc--cceeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLS 545 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~--~~~yLV 545 (902)
.|.+.+.||+|+||.||+|... +++.||+|.+..... ....+|+. ++..++||||+++++++.+. +..|+|
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN-ILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHH-HHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 4566788999999999998654 588999999864321 12345665 56788899999999998777 889999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
||||..+|.+++ ... ...+++..++.++.||+.||+|||+.
T Consensus 85 ~e~~~~~L~~~~-----------~~~----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~ 125 (293)
T cd07843 85 MEYVEHDLKSLM-----------ETM----------------------------KQPFLQSEVKCLMLQLLSGVAHLHDN 125 (293)
T ss_pred ehhcCcCHHHHH-----------Hhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 996655444433 211 12367788899999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-CCCcchhhhhHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFC 704 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~el 704 (902)
+|+|+||||+||+++.++. +||+|||++........ ......+++.|+|||.+.+.. ++.++|+|||||++|+|
T Consensus 126 ~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 200 (293)
T cd07843 126 WILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPLK---PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200 (293)
T ss_pred CeeeccCCHHHEEECCCCc--EEEeecCceeeccCCcc---ccccccccccccCchhhcCCccccchhhHHHHHHHHHHH
Confidence 9999999999999987765 89999999987654311 112334788999999987654 68999999999999999
Q ss_pred HhCCCCCCCCchhhH-H-HHHhh------------------------------cccccccc-CChHHHHHHHcccCCCCC
Q 002601 705 ITGGKHPYGESFERD-A-NIVKD------------------------------RKDLFLVE-HIPEAVDLFTRLLDPNPD 751 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~-~-~~~~~------------------------------~~~~~~~~-~~~e~~dLI~~~L~~dP~ 751 (902)
++| .+||....... . .+... ....++.. .++.+.++|++||+.||+
T Consensus 201 ~~g-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 201 LTK-KPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HhC-CCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCcc
Confidence 998 66775432111 0 00000 00011111 367789999999999999
Q ss_pred CCcCHHHHHcCCCC
Q 002601 752 LRPKAQNVLNHPFF 765 (902)
Q Consensus 752 ~Rpt~~elL~HPfF 765 (902)
+|||+.|++.||||
T Consensus 280 ~R~t~~ell~~~~f 293 (293)
T cd07843 280 KRISAEDALKHPYF 293 (293)
T ss_pred ccCCHHHHhcCCCC
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.40 Aligned_cols=244 Identities=24% Similarity=0.382 Sum_probs=190.1
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
|.+.+.||+|+||.||++. ..+++.||+|.+..... +...+|+. +++.++|+||+++++++.+++..|++||
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-- 78 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV-LLAKMKHPNIVAFKESFEADGHLYIVME-- 78 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHH-HHHhCCCCCcceEEEEEEECCEEEEEEe--
Confidence 5677899999999999984 45789999998854321 23344544 6788999999999999999999999999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+++|+|.+++... +...+++..+..++.|++.||.|||+++|+|
T Consensus 79 --------~~~~~~l~~~~~~~---------------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H 123 (255)
T cd08219 79 --------YCDGGDLMQKIKLQ---------------------------RGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123 (255)
T ss_pred --------eCCCCcHHHHHHhc---------------------------cCCCCCHHHHHHHHHHHHHHHHHHhhCCccc
Confidence 66667776655321 1123577788999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
+||||+||+++.++. ++|+|||++........ ......|++.|+|||++.+..++.++|+|||||++|+|++| .
T Consensus 124 ~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g-~ 197 (255)
T cd08219 124 RDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGA---YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL-K 197 (255)
T ss_pred CCCCcceEEECCCCc--EEEcccCcceeeccccc---ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc-c
Confidence 999999999988776 89999999876643211 11234588999999999988899999999999999999998 6
Q ss_pred CCCCCchhh-HH-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 710 HPYGESFER-DA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 710 ~Pf~~~~~~-~~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
.||...... .. .+........+...+.++.++|.+||+.||++||++.+++.-
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 198 HPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 677654322 22 222222223344567789999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=303.14 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=190.0
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccC--ccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d--~~~~yLV~ 546 (902)
.|...+.||.|++|.||++.. .+++.||+|++..... ....+|++ +++.++||||+++++++.+ .+.+|+||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELE-INKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHH-HHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 356778999999999999865 4689999999875432 23556665 6688899999999998754 44789999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++..... ....+++..+..++.||+.||+|||+.+
T Consensus 81 e----------~~~~~~L~~~l~~~~~-------------------------~~~~l~~~~~~~i~~~i~~~L~~lH~~~ 125 (287)
T cd06621 81 E----------YCEGGSLDSIYKKVKK-------------------------RGGRIGEKVLGKIAESVLKGLSYLHSRK 125 (287)
T ss_pred E----------ecCCCCHHHHHHHHHh-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 5566666665532111 1234677788999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
++|+||+|+||+++.++. ++|+|||++....... .....++..|+|||.+.+..++.++|||||||++|+|++
T Consensus 126 i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~-----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 198 (287)
T cd06621 126 IIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNSL-----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQ 198 (287)
T ss_pred cccCCCCHHHEEEecCCe--EEEeeccccccccccc-----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999987765 9999999987654321 123347889999999998899999999999999999999
Q ss_pred CCCCCCCCchh------hHHHHHhh-cccccc------ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 707 GGKHPYGESFE------RDANIVKD-RKDLFL------VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 707 G~~~Pf~~~~~------~~~~~~~~-~~~~~~------~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
| ..||..... .....+.. ...... ...++++.++|.+||+.+|.+|||+.|+++||||.+.
T Consensus 199 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 199 N-RFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred C-CCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 7 667765411 11111111 111111 1224678999999999999999999999999999543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.71 Aligned_cols=243 Identities=26% Similarity=0.465 Sum_probs=189.4
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC---chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChh
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~ 554 (902)
..||+|+||.||++.. .+++.||+|++.... .+...+|+. .+..+.||||+++++++..++..|+|+|
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~iv~e------- 98 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVV-IMRDYQHQNVVEMYKSYLVGEELWVLME------- 98 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHH-HHHhCCCCchhhhhhheeeCCeEEEEEe-------
Confidence 4699999999999854 578999999985432 223455554 5677899999999999999999999999
Q ss_pred hHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccccc
Q 002601 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (902)
Q Consensus 555 dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp 634 (902)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+.+|+||||||
T Consensus 99 ---~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p 145 (297)
T cd06659 99 ---FLQGGALTDIVSQ------------------------------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145 (297)
T ss_pred ---cCCCCCHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 5566666654421 2356778899999999999999999999999999
Q ss_pred ceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCC
Q 002601 635 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714 (902)
Q Consensus 635 ~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~ 714 (902)
+||+++.++. +||+|||++........ ......|+..|+|||++.+..++.++|||||||++|||++| ..||..
T Consensus 146 ~Nill~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g-~~p~~~ 219 (297)
T cd06659 146 DSILLTLDGR--VKLSDFGFCAQISKDVP---KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG-EPPYFS 219 (297)
T ss_pred HHeEEccCCc--EEEeechhHhhcccccc---cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Confidence 9999988775 99999999876543221 12334689999999999988899999999999999999998 566653
Q ss_pred ch-hhHHHHHhhccc---cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 715 SF-ERDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 715 ~~-~~~~~~~~~~~~---~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
.. ......+..... ......++++.++|.+||+.+|.+||+++++++||||..+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 220 DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred CCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 32 222222221111 1122456789999999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=305.38 Aligned_cols=262 Identities=24% Similarity=0.366 Sum_probs=192.2
Q ss_pred ceEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
+.|.+.+.||+|+||.||++... ++..||+|++..... ....+|+. .++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE-LLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHH-HHhcCCCCCcceEEEEEccCCceE
Confidence 34677899999999999997532 456799999865432 23445554 678899999999999999999999
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+||| |+++|+|.+++.........+. +. ...-....+++..++.++.||+.||+|||
T Consensus 84 lv~e----------~~~~~~L~~~i~~~~~~~~~~~----------~~---~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 84 MVFE----------YMKHGDLNKFLRAHGPDAMILV----------DG---QPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred EEEe----------cCCCCcHHHHHHhcCccccccc----------cc---ccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 6666777766643221100000 00 00011134688889999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
+++|+||||||+|||++.++. ++|+|||+++....... ........|+..|+|||++.+..++.++|||||||++||
T Consensus 141 ~~~i~H~dlkp~Nil~~~~~~--~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 141 SQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred hCCeeecccCcceEEEccCCc--EEECCCCcccccCCCce-eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999987765 99999999976543211 111223456888999999999899999999999999999
Q ss_pred HHhCCCCCCCCchhhH-HHHHhh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 704 CITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
|++++..||....... ...+.. .....+...+.++.+++.+||+.||++||++.++++
T Consensus 218 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 9995588876543322 222222 222223345678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.30 Aligned_cols=243 Identities=25% Similarity=0.419 Sum_probs=188.3
Q ss_pred eeeecccCceEEEEEEe-eCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 478 NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
...||+|+||.||++.. .++..||||++..... +...+|+. .+..++||||+++++.+.+.+..|+|||
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~-~l~~l~h~~ii~~~~~~~~~~~~~lv~e------ 99 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVV-IMRDYHHENVVDMYNSYLVGDELWVVME------ 99 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHH-HHHhCCCCcHHHHHHheecCCeEEEEEe------
Confidence 35699999999999854 4689999999854322 23445655 6678899999999999999999999999
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
|+++|+|.+++.. ..+++.++..++.||+.||+|||+++|+|||||
T Consensus 100 ----~~~~~~L~~~~~~------------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk 145 (292)
T cd06658 100 ----FLEGGALTDIVTH------------------------------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145 (292)
T ss_pred ----CCCCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 5556666555421 124667789999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
|+||+++.++. ++|+|||++........ ......|+..|+|||.+.+..++.++|||||||++|||++| ..||.
T Consensus 146 p~Nill~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g-~~p~~ 219 (292)
T cd06658 146 SDSILLTSDGR--IKLSDFGFCAQVSKEVP---KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG-EPPYF 219 (292)
T ss_pred HHHEEEcCCCC--EEEccCcchhhcccccc---cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCCC
Confidence 99999987765 89999999876543221 12334589999999999888899999999999999999998 56765
Q ss_pred Cch-hhHHHHHhhc-cc--cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 714 ESF-ERDANIVKDR-KD--LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 714 ~~~-~~~~~~~~~~-~~--~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
... ......+... .. ......++++.+++.+||..||.+|||++++++||||..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 220 NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred CCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 432 2222222111 11 112235678999999999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=275.69 Aligned_cols=245 Identities=27% Similarity=0.449 Sum_probs=192.7
Q ss_pred eeeecccCceEEEEEEee-CCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 478 NKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
.++||+|.||+|++|... ++..||+|+.+-.. ...+++|+- +++.++|.|||+++++...++.+.+|+|+|+.
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreic-llkelkhknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHH-HHHHhhhcceeehhhhhccCceeEEeHHHhhH
Confidence 367999999999998654 57889999985433 246889984 78999999999999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
.|..|..--||.+ +.+.++.++.|+++||.++|++++.|||
T Consensus 86 dlkkyfdslng~~---------------------------------------d~~~~rsfmlqllrgl~fchshnvlhrd 126 (292)
T KOG0662|consen 86 DLKKYFDSLNGDL---------------------------------------DPEIVRSFMLQLLRGLGFCHSHNVLHRD 126 (292)
T ss_pred HHHHHHHhcCCcC---------------------------------------CHHHHHHHHHHHHhhhhhhhhhhhhhcc
Confidence 8888765445543 4455688999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-CCCcchhhhhHHHHHHHHhCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~-~s~ksDVwSlGviL~elltG~~~ 710 (902)
|||+|.||+.+|. +|++|||+++-+.-...+.. ..+-|..|.+|.++.+.+ |+...|+||-|||+.|+...|.+
T Consensus 127 lkpqnllin~nge--lkladfglarafgipvrcys---aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp 201 (292)
T KOG0662|consen 127 LKPQNLLINRNGE--LKLADFGLARAFGIPVRCYS---AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201 (292)
T ss_pred CCcceEEeccCCc--EEecccchhhhcCCceEeee---ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence 9999999999887 89999999998765433332 234589999999998765 79999999999999999987777
Q ss_pred CCCCc-hhhHH-HHHhhc----c---------------ccccc---------cCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 711 PYGES-FERDA-NIVKDR----K---------------DLFLV---------EHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 711 Pf~~~-~~~~~-~~~~~~----~---------------~~~~~---------~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
-|... ...+. .+.... + +.++. .....-+|+++++|.-+|.+|.++++++
T Consensus 202 lfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 202 LFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred CCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 77553 22222 221100 0 00110 1112457999999999999999999999
Q ss_pred cCCCCCC
Q 002601 761 NHPFFWT 767 (902)
Q Consensus 761 ~HPfF~~ 767 (902)
+||||.+
T Consensus 282 qhpyf~d 288 (292)
T KOG0662|consen 282 QHPYFSD 288 (292)
T ss_pred cCccccc
Confidence 9999964
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.46 Aligned_cols=253 Identities=23% Similarity=0.404 Sum_probs=188.6
Q ss_pred ccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEeccccc----Ccc
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVES----DQD 540 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~----d~~ 540 (902)
++..|.+.+.||+|+||.||++. ..+|+.||+|++.... .....+|+. ++..++||||+++++++. +..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK-ILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHH-HHHhcCCCCccCHHHhccccCCCCc
Confidence 34667788999999999999985 4569999999986532 123455664 678889999999999875 345
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
..|+||||+.++ |.+++.. ...+++..+..++.||+.||+
T Consensus 82 ~~~lv~e~~~~~-----------l~~~~~~-----------------------------~~~~~~~~~~~i~~qi~~aL~ 121 (334)
T cd07855 82 DVYVVMDLMESD-----------LHHIIHS-----------------------------DQPLTEEHIRYFLYQLLRGLK 121 (334)
T ss_pred eEEEEEehhhhh-----------HHHHhcc-----------------------------CCCCCHHHHHHHHHHHHHHHH
Confidence 689999955443 4333321 123677888999999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccc-cccccCCCCccccCchhhcc-CCCCCcchhhhhH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 698 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlG 698 (902)
|||+.+|+||||||+||+++.++. +||+|||+++......... .......|+..|+|||.+.. ..++.++||||||
T Consensus 122 ~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 199 (334)
T cd07855 122 YIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVG 199 (334)
T ss_pred HHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHH
Confidence 999999999999999999988876 8999999997764322111 11123468899999999865 4578999999999
Q ss_pred HHHHHHHhCCCCCCCCchhh-HHHH------------------------Hhhc--ccc-----ccccCChHHHHHHHccc
Q 002601 699 CILFFCITGGKHPYGESFER-DANI------------------------VKDR--KDL-----FLVEHIPEAVDLFTRLL 746 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~-~~~~------------------------~~~~--~~~-----~~~~~~~e~~dLI~~~L 746 (902)
|++|||++| .+||...... .... .... ... .....++++.++|.+||
T Consensus 200 ~~l~el~~g-~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 278 (334)
T cd07855 200 CIFAEMLGR-RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQML 278 (334)
T ss_pred HHHHHHHcC-CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHc
Confidence 999999997 7787543211 0000 0000 000 11234678999999999
Q ss_pred CCCCCCCcCHHHHHcCCCCCC
Q 002601 747 DPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 747 ~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+.||.+||++++++.||||..
T Consensus 279 ~~~P~~Rpt~~~~l~~~~~~~ 299 (334)
T cd07855 279 QFDPEERITVEQALQHPFLAQ 299 (334)
T ss_pred cCChhhCcCHHHHHhChhhhh
Confidence 999999999999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=304.20 Aligned_cols=244 Identities=25% Similarity=0.330 Sum_probs=183.0
Q ss_pred eEEEeeeecccCceEEEEEE-----eeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccC--ccce
Q 002601 474 LVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD--QDFV 542 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~-----~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d--~~~~ 542 (902)
.+.+.+.||+|+||+||++. ..+++.||+|.+..... ....+|+. +++.++||||+++++++.+ ....
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEIN-ILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHH-HHHhCCCCCEeeEEEEEecCCCceE
Confidence 34778899999999998743 24678999999865422 23345554 6788999999999998765 3468
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+||| |+++|+|.+++.. ..+++.++..++.|++.||+||
T Consensus 84 ~lv~e----------~~~~~~l~~~~~~------------------------------~~l~~~~~~~i~~~l~~~l~~l 123 (283)
T cd05080 84 QLIME----------YVPLGSLRDYLPK------------------------------HKLNLAQLLLFAQQICEGMAYL 123 (283)
T ss_pred EEEec----------CCCCCCHHHHHHH------------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 6666777666531 2367788899999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
|+++|+||||||+|||++.++. ++|+|||+++................++..|+|||++....++.++|||||||++|
T Consensus 124 H~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~ 201 (283)
T cd05080 124 HSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201 (283)
T ss_pred HHCCeeccccChheEEEcCCCc--EEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHH
Confidence 9999999999999999988765 89999999987654322111112234567799999998888999999999999999
Q ss_pred HHHhCCCCCCCCchhhHHH----------------HHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 703 FCITGGKHPYGESFERDAN----------------IVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~~~----------------~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||++| ..|+......... ... ......+...+.++.+++.+||+.||++||++++++.
T Consensus 202 el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 202 ELLTH-CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HHHhC-CCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99998 5566542211100 000 0111123345679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=299.65 Aligned_cols=249 Identities=21% Similarity=0.354 Sum_probs=188.1
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC---c---hHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---H---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~---~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
..|.+.+.||+|+||.||++.. .+|+.||||.+.... . ....+|+. +++.++||||+++++++.+.+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEID-LLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHH-HHHhCCCcceeeeeeeEEECCeEEEE
Confidence 3567889999999999999854 578999999875321 1 12344554 67889999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
+| |+++|+|.+++..... +...+++..+..++.|++.||+|||++
T Consensus 81 ~e----------~~~~~~L~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~ 125 (267)
T cd08228 81 LE----------LADAGDLSQMIKYFKK-------------------------QKRLIPERTVWKYFVQLCSAVEHMHSR 125 (267)
T ss_pred EE----------ecCCCcHHHHHHHhhh-------------------------ccCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 99 5566666665532110 123467788899999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+|+|+||||+||+++.++. ++|+|||++........ ......|++.|+|||.+.+..++.++|+|||||++|||+
T Consensus 126 ~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~ 200 (267)
T cd08228 126 RVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred CeeCCCCCHHHEEEcCCCC--EEECccccceeccchhH---HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence 9999999999999988776 89999999887653221 112345889999999998888999999999999999999
Q ss_pred hCCCCCCCCchh--hHHHHHhh-ccc-cccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 706 TGGKHPYGESFE--RDANIVKD-RKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 706 tG~~~Pf~~~~~--~~~~~~~~-~~~-~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
+|+.+++..... .....+.. ... ......+.++.++|.+||+.+|++||++.++++.
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 201 ALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred cCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 985443333221 11122211 111 1122355689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=303.21 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=184.0
Q ss_pred eEEEeeeecccCceEEEEEEee-CCc----EEEEEEeccCCchHHHHHHH---HHHHhCCCCCeeEecccccCccceeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g~----~VAVKrl~~~~~~~~~~Ei~---~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
.|...+.||+|+||+||++... +|+ .||+|.+........+.++. ..++.+.||||+++++++.+ ...+++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 4556788999999999998643 454 47788775433222223322 24577899999999998764 457889
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
+| |+++|+|.+++.... ..+++..+..++.||+.||+|||+.
T Consensus 87 ~e----------~~~~gsL~~~l~~~~----------------------------~~~~~~~~~~i~~qi~~~l~~lH~~ 128 (279)
T cd05111 87 TQ----------LSPLGSLLDHVRQHR----------------------------DSLDPQRLLNWCVQIAKGMYYLEEH 128 (279)
T ss_pred EE----------eCCCCcHHHHHHhcc----------------------------cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 777888888775321 2367788899999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+++||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++|||||||++||++
T Consensus 129 ~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~ 205 (279)
T cd05111 129 RMVHRNLAARNILLKSDSI--VQIADFGVADLLYPDDKK-YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205 (279)
T ss_pred CEeccccCcceEEEcCCCc--EEEcCCccceeccCCCcc-cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 9999999999999987765 899999999876432211 1112334678899999999889999999999999999999
Q ss_pred hCCCCCCCCchhh-HHHHHhhcc-ccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 706 TGGKHPYGESFER-DANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 706 tG~~~Pf~~~~~~-~~~~~~~~~-~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+.+..||.+.... ...++.... ...+.....++.+++.+|+..||.+||++.|+++
T Consensus 206 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 206 SYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred cCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 8447788654332 233333222 1222334568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=317.69 Aligned_cols=248 Identities=25% Similarity=0.431 Sum_probs=199.5
Q ss_pred EeeeecccCceEEEEE-EeeCCcEEEEEEeccC----CchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 477 FNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
-.++||.|-||+||-| +..+|+.||||++.+. ..+..++.+..+++.+.||.||.|-..|+..+.+++|||-+.+
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 3578999999999976 5678999999998653 2334444444578999999999999999999999999996665
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
++.+.| |.. ..+.+++.....+..||+.||.|||.++|+|+|
T Consensus 648 DMLEMI----------LSs----------------------------EkgRL~er~TkFlvtQIL~ALr~LH~knIvHCD 689 (888)
T KOG4236|consen 648 DMLEMI----------LSS----------------------------EKGRLPERITKFLVTQILVALRYLHFKNIVHCD 689 (888)
T ss_pred hHHHHH----------HHh----------------------------hcccchHHHHHHHHHHHHHHHHHhhhcceeecc
Confidence 555444 211 123456666788899999999999999999999
Q ss_pred cccceeEeccCCCc-eEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 632 LKPQNVLISKDKSF-CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 632 LKp~NILL~~d~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
|||+||||.....+ ++||||||+|+.+.+. ....+.+|||.|.|||++..+.|...-|+||.|||+|--++| ..
T Consensus 690 LKPENVLLas~~~FPQvKlCDFGfARiIgEk----sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSG-TF 764 (888)
T KOG4236|consen 690 LKPENVLLASASPFPQVKLCDFGFARIIGEK----SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSG-TF 764 (888)
T ss_pred CCchheeeccCCCCCceeeccccceeecchh----hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecc-cc
Confidence 99999999765433 6999999999998753 334567899999999999999999999999999999999997 88
Q ss_pred CCCCchhhHHHHHhhccccc----cccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 711 PYGESFERDANIVKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 711 Pf~~~~~~~~~~~~~~~~~~----~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
||.+..+...+ +++..-.+ ..+.++++.|||..+|+..-.+|.+..+.+.|||+++.
T Consensus 765 PFNEdEdIndQ-IQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 765 PFNEDEDINDQ-IQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred cCCCccchhHH-hhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 99876443333 33332233 34567899999999999999999999999999998653
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=301.51 Aligned_cols=247 Identities=29% Similarity=0.443 Sum_probs=187.4
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
|...+.||.|++|+||+|.. .+|+.||||++.... .....+|+. +++.++||||+++++++.+.+..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS-LMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHH-HHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 56778999999999999865 468999999986432 234456655 667889999999999999999999999977
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
.++|.+++ .... ....+++..+..++.|++.||+|||+.+|+|
T Consensus 81 ~~~l~~~~-----------~~~~--------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h 123 (284)
T cd07836 81 DKDLKKYM-----------DTHG--------------------------VRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123 (284)
T ss_pred CccHHHHH-----------HhcC--------------------------CCCCcCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 65544433 2111 1124678888999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG~ 708 (902)
|||||+||+++.++. ++|+|||++........ ......++..|++||++.+. .++.++|||||||++|+|++|
T Consensus 124 ~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g- 197 (284)
T cd07836 124 RDLKPQNLLINKRGE--LKLADFGLARAFGIPVN---TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG- 197 (284)
T ss_pred CCCCHHHEEECCCCc--EEEeecchhhhhcCCcc---ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC-
Confidence 999999999987766 89999999976543211 11234578899999998664 468999999999999999998
Q ss_pred CCCCCCchhhH--HHHHhh--------------c---cc-----------cccccCChHHHHHHHcccCCCCCCCcCHHH
Q 002601 709 KHPYGESFERD--ANIVKD--------------R---KD-----------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 758 (902)
Q Consensus 709 ~~Pf~~~~~~~--~~~~~~--------------~---~~-----------~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~e 758 (902)
.+||....... ..+... . .. ......+++++++|.+||+.||.+||++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 198 RPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 67776432211 011000 0 00 001134568899999999999999999999
Q ss_pred HHcCCCC
Q 002601 759 VLNHPFF 765 (902)
Q Consensus 759 lL~HPfF 765 (902)
+++||||
T Consensus 278 ~l~~~~f 284 (284)
T cd07836 278 ALQHPWF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=324.26 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=190.6
Q ss_pred cccceEEEeeeecccCceEEEEEEeeCC----cE-EEEEEeccCC--ch----HHHHHHHHHHHhCCCCCeeEecccccC
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEGNYEG----RS-VAVKRLVKTH--HD----VALKEIQNLIASDQHPNIVRWYGVESD 538 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~~~~g----~~-VAVKrl~~~~--~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d 538 (902)
-...++.+.++||+|+||.||+|.+..+ .. ||||..+... .. ...+|. ++|+.++|||||++||++.+
T Consensus 154 l~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EA-rvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 154 LSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEA-RVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHH-HHHHhCCCCCEEEEEEEEcC
Confidence 3345567779999999999999865432 23 8999887421 11 234444 47788999999999999999
Q ss_pred ccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 539 ~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
+..+||||| ++.+|+|.++|.... ..++..+..+++.+.|+|
T Consensus 233 ~~Pl~ivmE----------l~~gGsL~~~L~k~~----------------------------~~v~~~ek~~~~~~AA~G 274 (474)
T KOG0194|consen 233 EEPLMLVME----------LCNGGSLDDYLKKNK----------------------------KSLPTLEKLRFCYDAARG 274 (474)
T ss_pred CCccEEEEE----------ecCCCcHHHHHHhCC----------------------------CCCCHHHHHHHHHHHHhH
Confidence 999999999 556778888775332 136777889999999999
Q ss_pred ccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhH
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 619 L~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 698 (902)
|+|||++++|||||.++|+|++.++. +||+|||+++....-. .......-...|+|||.+..+.++.++||||||
T Consensus 275 l~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~~---~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfG 349 (474)
T KOG0194|consen 275 LEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQYV---MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFG 349 (474)
T ss_pred HHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCccee---eccccccCcceecChhhhccCccccccchhhee
Confidence 99999999999999999999987764 8999999987654111 111011235789999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCchhhHH--HHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 699 CILFFCITGGKHPYGESFERDA--NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~~--~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
|++||+++-+..||.+....+. .+.... ....+...+.++..++.+|+..||+.||+|.++.
T Consensus 350 V~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 350 VLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred eeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence 9999999966779887544433 332333 3334445667888999999999999999999985
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=301.51 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=188.1
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCc----EEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~----~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
+.|.+.+.||+|+||+||+|.. .+|. .||||++...... ...+|+ ..+..+.||||+++++++.+. ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEA-YVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHH-HHHHhcCCCCCceEEEEEcCC-CcE
Confidence 4577789999999999999853 3454 4899998654322 223444 356788999999999998764 578
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+++| |+++|+|.++++.. ...+++..++.++.||+.||+|||
T Consensus 85 l~~~----------~~~~g~l~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH 126 (279)
T cd05109 85 LVTQ----------LMPYGCLLDYVREN----------------------------KDRIGSQDLLNWCVQIAKGMSYLE 126 (279)
T ss_pred EEEE----------cCCCCCHHHHHhhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 8999 77788887776432 123677888999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
+.+|+||||||+|||++.++. +||+|||+++......... ......++..|+|||.+.+..++.++|||||||++||
T Consensus 127 ~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~e 203 (279)
T cd05109 127 EVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEY-HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWE 203 (279)
T ss_pred HCCeeccccccceEEEcCCCc--EEECCCCceeeccccccee-ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHH
Confidence 999999999999999987765 8999999998775322111 1112235678999999998889999999999999999
Q ss_pred HHhCCCCCCCCchhhH-HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 704 CITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
|++.+.+||....... ...+... ....+...++++.++|.+||+.||+.||++.+++.
T Consensus 204 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 204 LMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9995588887543322 2222222 22234456789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=298.54 Aligned_cols=243 Identities=21% Similarity=0.338 Sum_probs=180.9
Q ss_pred eeecccCceEEEEEEee----CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEeccccc-Cccceeeeeccc
Q 002601 479 KEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVES-DQDFVYLSLERC 549 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~----~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~-d~~~~yLV~E~c 549 (902)
+.||+|+||+||++... .+..||+|++..... ....+|+. +++.++||||+++++++. .++..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~lv~e-- 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGI-IMKDFSHPNVLSLLGICLPSEGSPLVVLP-- 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHH-HHccCCCCCcceEEEEeecCCCCcEEEEe--
Confidence 35899999999998643 246799999854322 12334544 678899999999999765 4566899999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+.+|+|.+++.... ...++..+..++.|++.||+|||+.+|+|
T Consensus 78 --------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 121 (262)
T cd05058 78 --------YMKHGDLRNFIRSET----------------------------HNPTVKDLIGFGLQVAKGMEYLASKKFVH 121 (262)
T ss_pred --------cCCCCCHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 667778777764321 11344566889999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCcc-ccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|||||+|||++.++. +||+|||+++........ ........++..|+|||.+....++.++|||||||++|||++|+
T Consensus 122 ~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 122 RDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred cccCcceEEEcCCCc--EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCC
Confidence 999999999987765 899999999865432111 11112234677899999998888999999999999999999987
Q ss_pred CCCCCCchhhHH--HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 709 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 709 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
.+||........ ..........+...++.+.+++.+||+.+|++||++.++++.
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 200 APPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 888865432221 222222222333456789999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=307.19 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=190.2
Q ss_pred cceEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCch----HHHHHHHHHHHhC-CCCCeeEecccccCcc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQD 540 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~ 540 (902)
.+.|.+.+.||+|+||.||++... .+..||||++...... ...+|+. +++.+ +||||+++++++.+.+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK-IMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHH-HHHhccCCCCcceEEEEEecCC
Confidence 356788899999999999997532 3568999998754322 2345555 55666 8999999999999999
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
..|+||| |+++|+|.++++.... ..+++.++..++.|++.||+
T Consensus 113 ~~~lv~e----------~~~~~~L~~~i~~~~~---------------------------~~l~~~~~~~i~~~i~~~l~ 155 (302)
T cd05055 113 PILVITE----------YCCYGDLLNFLRRKRE---------------------------SFLTLEDLLSFSYQVAKGMA 155 (302)
T ss_pred ceEEEEE----------cCCCCcHHHHHHhCCC---------------------------CCCCHHHHHHHHHHHHHHHH
Confidence 9999999 6677777777643211 22677888999999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvi 700 (902)
|||+++|+|+||||+|||++.++. ++|+|||+++........ .......++..|+|||++....++.++|||||||+
T Consensus 156 ~lH~~~ivH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvi 232 (302)
T cd05055 156 FLASKNCIHRDLAARNVLLTHGKI--VKICDFGLARDIMNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIL 232 (302)
T ss_pred HHHHCCeehhhhccceEEEcCCCe--EEECCCcccccccCCCce-eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHH
Confidence 999999999999999999976654 899999999866543211 11122346788999999998899999999999999
Q ss_pred HHHHHhCCCCCCCCchhhH--HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 701 LFFCITGGKHPYGESFERD--ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~~~--~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+|||++++.+||....... ....... ....+...++++.+++.+||+.+|++||++.|+++
T Consensus 233 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 233 LWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999995577876533221 1222211 11223345679999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=291.61 Aligned_cols=244 Identities=30% Similarity=0.493 Sum_probs=190.9
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
|...+.||+|++|.||++... +|+.||+|++..... ....+|+. +++.++|+||+++++++.+.+..++++|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~l~~e--- 77 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQ-ILKKCKHPNIVKYYGSYLKKDELWIVME--- 77 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHH-HHHhCCCCCEeEEEEEEecCCeEEEEEe---
Confidence 456688999999999998654 689999999866542 23445554 6788899999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++++|.+++... ...+++..+..++.|++.||+|||+.+++|+
T Consensus 78 -------~~~~~~L~~~~~~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~ 122 (253)
T cd05122 78 -------FCSGGSLKDLLKST----------------------------NQTLTESQIAYVCKELLKGLEYLHSNGIIHR 122 (253)
T ss_pred -------cCCCCcHHHHHhhc----------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCEecC
Confidence 55555665554321 0346778889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||+|+||+++.++. ++|+|||.+........ .....|+..|+|||.+.....+.++|||||||++|+|++| ..
T Consensus 123 dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g-~~ 195 (253)
T cd05122 123 DIKAANILLTSDGE--VKLIDFGLSAQLSDTKA----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG-KP 195 (253)
T ss_pred CCCHHHEEEccCCe--EEEeecccccccccccc----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhC-CC
Confidence 99999999987765 99999999987664321 2344588999999999888899999999999999999998 66
Q ss_pred CCCCc-hhh-HHHHHhhcccccccc--CChHHHHHHHcccCCCCCCCcCHHHHHcCCC
Q 002601 711 PYGES-FER-DANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764 (902)
Q Consensus 711 Pf~~~-~~~-~~~~~~~~~~~~~~~--~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPf 764 (902)
||... ... ............+.. .+.++.++|.+||+.||++|||+.++++|||
T Consensus 196 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 196 PYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 77654 211 111111111112222 2678999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=299.03 Aligned_cols=236 Identities=23% Similarity=0.319 Sum_probs=180.7
Q ss_pred eeecccCceEEEEEEeeC-C----------cEEEEEEeccCCc-hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 479 KEIAKGSNGTVVLEGNYE-G----------RSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~-g----------~~VAVKrl~~~~~-~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
+.||+|+||.||++...+ + ..||+|.+..... ...+.++..+++.++||||+++++++.. +..++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 358999999999986654 3 3588888765433 3344444457788999999999999888 7789999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++.... ..+++..+..++.||+.||+|||+.+
T Consensus 80 e----------~~~~~~L~~~l~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~LH~~~ 121 (259)
T cd05037 80 E----------YVKFGPLDVFLHREK----------------------------NNVSLHWKLDVAKQLASALHYLEDKK 121 (259)
T ss_pred E----------cCCCCcHHHHHHhhc----------------------------cCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 9 667777777764321 14677788999999999999999999
Q ss_pred ccccccccceeEeccCCCc-----eEEEccCCccccccCCCccccccccCCCCccccCchhhccC--CCCCcchhhhhHH
Q 002601 627 LIHRDLKPQNVLISKDKSF-----CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGC 699 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~-----~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGv 699 (902)
|+||||||+|||++.++.- .+||+|||++..... .....++..|+|||++... .++.++|||||||
T Consensus 122 i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~ 194 (259)
T cd05037 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-------REERVERIPWIAPECIRNGQASLTIAADKWSFGT 194 (259)
T ss_pred eecccCccceEEEecCccccCCceeEEeCCCCccccccc-------ccccccCCCccChhhhcCCCCCcchhhHHHHHHH
Confidence 9999999999999876621 489999999886543 1223467789999999876 7899999999999
Q ss_pred HHHHHHhCCCCCCCCchhhH-HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 700 ILFFCITGGKHPYGESFERD-ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 700 iL~elltG~~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
++|+|++|+..||....... ..... .....+.....++.++|.+||..+|.+||++.++++
T Consensus 195 ~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 195 TLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999997788886643221 11111 111222233478999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=295.35 Aligned_cols=239 Identities=27% Similarity=0.399 Sum_probs=185.4
Q ss_pred eecccCceEEEEEEeeCCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChhh
Q 002601 480 EIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~d 555 (902)
.||+|+||.||++...+++.||+|++...... ...+|+. +++.++||||+++++++.+.+..++|||
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e-------- 72 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEAR-ILKQYDHPNIVKLIGVCTQRQPIYIVME-------- 72 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHH-HHHhCCCCCcCeEEEEEecCCccEEEEE--------
Confidence 68999999999998778899999998654322 2344554 6678899999999999999999999999
Q ss_pred HHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccc
Q 002601 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 635 (902)
Q Consensus 556 liy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~ 635 (902)
|.++|+|.+++.... ..+++..+..++.|++.||.|||+.+++||||||+
T Consensus 73 --~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~ 122 (250)
T cd05085 73 --LVPGGDFLSFLRKKK----------------------------DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAAR 122 (250)
T ss_pred --CCCCCcHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChh
Confidence 556667766653211 23567778999999999999999999999999999
Q ss_pred eeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCc
Q 002601 636 NVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 715 (902)
Q Consensus 636 NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~ 715 (902)
||+++.++. +||+|||++........ .......++..|+|||++....++.++|||||||++|++++.+..||...
T Consensus 123 nili~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 123 NCLVGENNV--LKISDFGMSRQEDDGIY--SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred eEEEcCCCe--EEECCCccceecccccc--ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999987765 89999999876443211 11122234678999999998889999999999999999999557788654
Q ss_pred hhhHH--HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 716 FERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 716 ~~~~~--~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
..... .+........+...++++.+++.+||+.+|++||++.++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 199 TNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 33221 22222222334456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=314.60 Aligned_cols=277 Identities=22% Similarity=0.308 Sum_probs=190.4
Q ss_pred ceEEEeeeecccCceEEEEEE------eeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccC-ccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG------NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 541 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~------~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d-~~~ 541 (902)
+.|.+.+.||+|+||+||+|. ..+++.||||++..... ....+|+..+....+||||+++++++.+ +..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 457788999999999999984 24578999999865322 2355677655444489999999998765 456
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccch-----------------hHHHH-hhh------------------
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL-----------------LNEVR-IRL------------------ 585 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~-----------------l~~~~-~r~------------------ 585 (902)
.+++||||. +|+|.++++........ ..+.. .+.
T Consensus 87 ~~lv~ey~~----------~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (343)
T cd05103 87 LMVIVEFCK----------FGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK 156 (343)
T ss_pred eEEEEeccC----------CCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence 899999555 44444444322110000 00000 000
Q ss_pred --ccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCc
Q 002601 586 --LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663 (902)
Q Consensus 586 --~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~ 663 (902)
............+....+++..+.+++.||+.||+|||+++|+||||||+|||++.++. +||+|||++........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~ 234 (343)
T cd05103 157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPD 234 (343)
T ss_pred ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcc
Confidence 00000000111122345788999999999999999999999999999999999987765 89999999987643221
Q ss_pred cccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchh--hHHHHH-hhccccccccCChHHHH
Q 002601 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDANIV-KDRKDLFLVEHIPEAVD 740 (902)
Q Consensus 664 ~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~--~~~~~~-~~~~~~~~~~~~~e~~d 740 (902)
. .......++..|+|||++....++.++|||||||++|+|++++..||..... .....+ .......+...++++.+
T Consensus 235 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (343)
T cd05103 235 Y-VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 313 (343)
T ss_pred h-hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHH
Confidence 1 1112234567899999998888999999999999999999856788865321 111112 12222233345678999
Q ss_pred HHHcccCCCCCCCcCHHHHHcC
Q 002601 741 LFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 741 LI~~~L~~dP~~Rpt~~elL~H 762 (902)
++.+||+.||.+||++.++++|
T Consensus 314 ~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 314 TMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=301.94 Aligned_cols=245 Identities=25% Similarity=0.420 Sum_probs=184.7
Q ss_pred EEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 476 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
...+.||.|++|+||++.. .+|+.||||++.... .....+|+. .++.++||||+++++++.+.+..|++|||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS-LLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHH-HHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 3457899999999999854 579999999986432 123455665 678889999999999999999999999965
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
.. +|.+++.... ...+++..+..++.|+++||+|||+.+++|
T Consensus 81 ~~-----------~l~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H 122 (283)
T cd07835 81 DL-----------DLKKYMDSSP---------------------------LTGLDPPLIKSYLYQLLQGIAYCHSHRVLH 122 (283)
T ss_pred Cc-----------CHHHHHhhCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 44 4444432111 024677888999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG~ 708 (902)
|||+|+||+++.++. ++|+|||++........ ......++..|+|||++.+. .++.++|||||||++|+|++|
T Consensus 123 ~dl~p~nil~~~~~~--~~l~df~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g- 196 (283)
T cd07835 123 RDLKPQNLLIDREGA--LKLADFGLARAFGVPVR---TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR- 196 (283)
T ss_pred CCCCHHHEEEcCCCc--EEEeecccccccCCCcc---ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhC-
Confidence 999999999988765 89999999976543211 11223468899999988664 468999999999999999998
Q ss_pred CCCCCCchhh--HHHHHhhc----------------------------cccccccCChHHHHHHHcccCCCCCCCcCHHH
Q 002601 709 KHPYGESFER--DANIVKDR----------------------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 758 (902)
Q Consensus 709 ~~Pf~~~~~~--~~~~~~~~----------------------------~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~e 758 (902)
.+||...... ...+.... ........++++.++|.+||+.||.+||+++|
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ 276 (283)
T cd07835 197 RPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276 (283)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 6677543221 11111100 00011234578999999999999999999999
Q ss_pred HHcCCCC
Q 002601 759 VLNHPFF 765 (902)
Q Consensus 759 lL~HPfF 765 (902)
++.||||
T Consensus 277 il~~~~~ 283 (283)
T cd07835 277 ALQHPYF 283 (283)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=303.28 Aligned_cols=250 Identities=25% Similarity=0.395 Sum_probs=192.2
Q ss_pred EEEeeeecccCceEEEEEEe----eCCcEEEEEEeccCC-------chHHHHHHHHHHHhC-CCCCeeEecccccCccce
Q 002601 475 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-------HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~----~~g~~VAVKrl~~~~-------~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~~~ 542 (902)
|.+.+.||+|+||.||++.. .+|+.||+|++.... .+...+|+. ++..+ +|+||+++++++..+...
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQ-VLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHH-HHHhcccCCChhceeeEeecCCeE
Confidence 45678999999999999754 478999999986432 122344555 44555 699999999999999999
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+||| |+++|+|.+++... ..+++..+..++.|++.||+||
T Consensus 81 ~lv~e----------~~~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~al~~l 121 (290)
T cd05613 81 HLILD----------YINGGELFTHLSQR-----------------------------ERFKEQEVQIYSGEIVLALEHL 121 (290)
T ss_pred EEEEe----------cCCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 66677777766321 2356778888999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC--CCCCcchhhhhHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCI 700 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGvi 700 (902)
|+.+++||||||+|||++.++. +||+|||++........ .......|+..|+|||.+... .++.++|||||||+
T Consensus 122 H~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~ 197 (290)
T cd05613 122 HKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEV--ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197 (290)
T ss_pred HhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccccc--cccccccCCcccCChhhccCCCCCCCccccHHHHHHH
Confidence 9999999999999999988765 89999999987643211 112234589999999998753 46789999999999
Q ss_pred HHHHHhCCCCCCCCch-----hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCc-----CHHHHHcCCCCCCcc
Q 002601 701 LFFCITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 769 (902)
Q Consensus 701 L~elltG~~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rp-----t~~elL~HPfF~~~~ 769 (902)
+|+|++| ..||.... ......+......++....+.+.+++.+||+.||++|| ++++++.||||....
T Consensus 198 l~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 198 MYELLTG-ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHhcC-CCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999997 67775321 11122222223334555678899999999999999997 899999999996543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=296.25 Aligned_cols=240 Identities=27% Similarity=0.393 Sum_probs=182.9
Q ss_pred eeecccCceEEEEEEee----CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 479 KEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~----~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
++||+|+||.||+|... .+..||+|.+..... ....+|+. +++.+.|||||++++++. .+..++|||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~-~~~~~~v~e--- 75 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREAS-VMAQLDHPCIVRLIGVCK-GEPLMLVME--- 75 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHH-HHHhcCCCCeeeEEEEEc-CCceEEEEE---
Confidence 36999999999997432 237899999875443 23344554 667889999999999876 456899999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.+++... ..+++..+..++.|++.||+|||..+++||
T Consensus 76 -------~~~~~~L~~~l~~~-----------------------------~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~ 119 (257)
T cd05060 76 -------LAPLGPLLKYLKKR-----------------------------REIPVSDLKELAHQVAMGMAYLESKHFVHR 119 (257)
T ss_pred -------eCCCCcHHHHHHhC-----------------------------CCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence 66667776666421 135677889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+|||++.++. +||+|||+++................++..|+|||.+....++.++|||||||++|+|++++.+
T Consensus 120 di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~ 197 (257)
T cd05060 120 DLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK 197 (257)
T ss_pred CcccceEEEcCCCc--EEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCC
Confidence 99999999988776 8999999998775433222222222345689999999988999999999999999999985588
Q ss_pred CCCCchhhHH-HHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 711 PYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 711 Pf~~~~~~~~-~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||........ ..+ .......+...++.+.++|.+||..+|.+||++.++++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 198 PYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9876433222 222 22222344456788999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=294.88 Aligned_cols=246 Identities=23% Similarity=0.393 Sum_probs=190.4
Q ss_pred eEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCC--chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
.+.+.+.||+|+||.||++...+++.+|||++.... .....+|+. ++..++||||+++++++.+....++|||
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e---- 79 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQ-VMMKLSHPKLVQLYGVCTERSPICLVFE---- 79 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHH-HHHhCCCCCeeeEEEEEccCCceEEEEE----
Confidence 466778999999999999877778899999986543 234455654 6788899999999999999999999999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+.+|+|.+++.... ..+++..+..++.|++.||+|||+.+++|||
T Consensus 80 ------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~d 125 (256)
T cd05112 80 ------FMEHGCLSDYLRAQR----------------------------GKFSQETLLGMCLDVCEGMAYLESSNVIHRD 125 (256)
T ss_pred ------cCCCCcHHHHHHhCc----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 556666666653211 2356777889999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+||+++.++. ++|+|||+++....... .......++.+|+|||++.+..++.++|||||||++|||++++.+|
T Consensus 126 l~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 201 (256)
T cd05112 126 LAARNCLVGENQV--VKVSDFGMTRFVLDDQY--TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP 201 (256)
T ss_pred cccceEEEcCCCe--EEECCCcceeecccCcc--cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999987665 89999999886643211 1112223567899999999888999999999999999999955888
Q ss_pred CCCchhhH-HHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 712 YGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 712 f~~~~~~~-~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
|....... ...+. ......+...++++.+++.+||+.+|++||++.+++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 202 YENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 87543222 22221 11222233456889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=310.21 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=188.0
Q ss_pred ccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCc-----
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~----- 539 (902)
+.+.|...+.||+|+||+||++. ..+|+.||||.+.... .....+|+. ++..++|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIK-LLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHH-HHHhcCCCCccchHHheeccccccc
Confidence 34567888999999999999985 4568999999986431 123445654 66788999999999987654
Q ss_pred cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccc
Q 002601 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (902)
Q Consensus 540 ~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL 619 (902)
...|+|+||+.++|.+++ . ....+++..+..++.|++.||
T Consensus 82 ~~~~lv~e~~~~~L~~~~-----------~-----------------------------~~~~l~~~~~~~i~~qi~~aL 121 (337)
T cd07858 82 NDVYIVYELMDTDLHQII-----------R-----------------------------SSQTLSDDHCQYFLYQLLRGL 121 (337)
T ss_pred CcEEEEEeCCCCCHHHHH-----------h-----------------------------cCCCCCHHHHHHHHHHHHHHH
Confidence 358999997765554433 1 112367778899999999999
Q ss_pred cccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhH
Q 002601 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 698 (902)
Q Consensus 620 ~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlG 698 (902)
+|||+.+++||||||+||+++.++. +||+|||+++...... .......|+..|+|||.+.. ..++.++||||||
T Consensus 122 ~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 196 (337)
T cd07858 122 KYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKG---DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVG 196 (337)
T ss_pred HHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCCc---ccccccccccCccChHHHhcCCCCCCcccHHHHH
Confidence 9999999999999999999988765 9999999998764321 11233457889999998865 4688999999999
Q ss_pred HHHHHHHhCCCCCCCCchhh-HHH-H-----------------------Hhhc-------cccccccCChHHHHHHHccc
Q 002601 699 CILFFCITGGKHPYGESFER-DAN-I-----------------------VKDR-------KDLFLVEHIPEAVDLFTRLL 746 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~-~~~-~-----------------------~~~~-------~~~~~~~~~~e~~dLI~~~L 746 (902)
|++|+|++| .+||...... ... + +... ........++++.++|.+||
T Consensus 197 ~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 275 (337)
T cd07858 197 CIFAELLGR-KPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKML 275 (337)
T ss_pred HHHHHHHcC-CCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHh
Confidence 999999997 6777542110 000 0 0000 00012245678999999999
Q ss_pred CCCCCCCcCHHHHHcCCCCCC
Q 002601 747 DPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 747 ~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+.||++|||++++++||||..
T Consensus 276 ~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 276 VFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred cCChhhccCHHHHHcCcchhh
Confidence 999999999999999999954
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=299.95 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=178.1
Q ss_pred eecccCceEEEEEEeeC---CcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 480 EIAKGSNGTVVLEGNYE---GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~~~---g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
+||+|+||+||++...+ ...||+|.+...... ...+|+. .++.++||||+++++++.+.+..|+|||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~~~~l~h~nii~~~~~~~~~~~~~lv~e----- 75 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQ-PYRELNHPNVLQCLGQCIESIPYLLVLE----- 75 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHH-HHHhCCCCCcceEEEEECCCCceEEEEE-----
Confidence 59999999999986544 357889987544322 2344544 5678899999999999999999999999
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDL 632 (902)
|+++|+|.+++...... .....++..++.++.||+.||+|||+++|+||||
T Consensus 76 -----~~~~g~L~~~l~~~~~~------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 126 (269)
T cd05042 76 -----FCPLGDLKNYLRSNRGM------------------------VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDL 126 (269)
T ss_pred -----eCCCCcHHHHHHhcccc------------------------ccccccHHHHHHHHHHHHHHHHHHHhcCEecccc
Confidence 66677777776543211 0122356677899999999999999999999999
Q ss_pred ccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-------CCCCCcchhhhhHHHHHHHH
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-------GRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSlGviL~ell 705 (902)
||+|||++.++. +||+|||++......... .......++..|+|||++.. ..++.++|||||||++|||+
T Consensus 127 kp~Nill~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05042 127 ALRNCQLTADLS--VKIGDYGLALEQYPEDYY-ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203 (269)
T ss_pred cHhheEecCCCc--EEEeccccccccccchhe-eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHH
Confidence 999999988765 899999998754332111 11123346778999998753 34678999999999999999
Q ss_pred hCCCCCCCCchhhH--HHHHhhcc-----ccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 706 TGGKHPYGESFERD--ANIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 706 tG~~~Pf~~~~~~~--~~~~~~~~-----~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+++.+||....... ...+.... .......++++.+++..|+ .||++||++++|++
T Consensus 204 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred hCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 97788887653322 12222111 1122345677888999998 59999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=306.30 Aligned_cols=262 Identities=24% Similarity=0.343 Sum_probs=191.1
Q ss_pred ceEEEeeeecccCceEEEEEEe--------eCCcEEEEEEeccCCch----HHHHHHHHHHHhC-CCCCeeEecccccCc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN--------YEGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQ 539 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~--------~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~ 539 (902)
..|.+.+.||+|+||.||++.. ..+..||+|++...... ...+|+. ++..+ +||||+++++++.++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEME-LMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHH-HHHhccCCCCeeeEEEEEccC
Confidence 4567889999999999999743 23567999998754322 2345655 44555 799999999999999
Q ss_pred cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccc
Q 002601 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (902)
Q Consensus 540 ~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL 619 (902)
+..|++|| |+++|+|.+++......... .......-....+++.++.+++.||+.||
T Consensus 91 ~~~~lv~e----------~~~~g~L~~~i~~~~~~~~~-------------~~~~~~~~~~~~l~~~~~~~~~~qi~~aL 147 (314)
T cd05099 91 GPLYVIVE----------YAAKGNLREFLRARRPPGPD-------------YTFDITKVPEEQLSFKDLVSCAYQVARGM 147 (314)
T ss_pred CceEEEEe----------cCCCCcHHHHHHhcCCCccc-------------ccccccCCcccccCHHHHHHHHHHHHHHH
Confidence 99999999 66777777776543211000 00000001123477888999999999999
Q ss_pred cccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHH
Q 002601 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (902)
Q Consensus 620 ~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGv 699 (902)
+|||++||+||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++|||||||
T Consensus 148 ~~lH~~gi~H~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 224 (314)
T cd05099 148 EYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYY-KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI 224 (314)
T ss_pred HHHHHCCeeeccccceeEEEcCCCc--EEEccccccccccccccc-cccccCCCCccccCHHHHccCCcCccchhhHHHH
Confidence 9999999999999999999988765 899999999876532111 1112223456899999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCchhh-HHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 700 ILFFCITGGKHPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 700 iL~elltG~~~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
++|+|++++..||...... ....+... ....+...+.++.+++.+||+.||++||++.++++
T Consensus 225 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 225 LMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 9999999667888654322 22222222 12234455678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.40 Aligned_cols=247 Identities=34% Similarity=0.513 Sum_probs=193.6
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCc--cceeeee
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSL 546 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~--~~~yLV~ 546 (902)
|...+.||+|++|.||++... +|+.|++|++.... .+...+|+ ..++.++||||+++++.+.+. +..++++
T Consensus 2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREI-RILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHH-HHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 456688999999999998655 68999999986554 22334444 467889999999999999988 8999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| ++++++|.+++... ..+++..+..++.|++.||+|||+.+
T Consensus 81 e----------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~ 121 (260)
T cd06606 81 E----------YVSGGSLSSLLKKF-----------------------------GKLPEPVIRKYTRQILEGLAYLHSNG 121 (260)
T ss_pred E----------ecCCCcHHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 55556666555321 14677788999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
++|+||+|+||+++.++. ++|+|||.+......... .......++..|+|||.+.....+.++|||||||++|+|++
T Consensus 122 ~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 198 (260)
T cd06606 122 IVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETG-EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT 198 (260)
T ss_pred ccccCCCHHHEEEcCCCC--EEEcccccEEeccccccc-ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999988765 899999999877653221 11234458899999999988889999999999999999999
Q ss_pred CCCCCCCCchhhHH--HHHh--hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 707 GGKHPYGESFERDA--NIVK--DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 707 G~~~Pf~~~~~~~~--~~~~--~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
| ..||........ .... ......+...++++.++|.+||+.||.+||++.++++||||
T Consensus 199 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 199 G-KPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred C-CCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 7 667765431111 1111 11222344557899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=319.22 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=202.2
Q ss_pred cceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCch-----HHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 472 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~~-----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
...|.+.+.||+|.|++|.++ +..+|..||+|.+.+...+ ...+|+. +|..++|||||+++.+......+|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~-imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVD-IMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHH-HHHhcCCcceeeeeeeeeecceeEEE
Confidence 345778899999999999998 5567999999999876532 3467776 66899999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |..+|.+++++..... ..+..+..++.|+++|++|||++
T Consensus 134 ~e----------ya~~ge~~~yl~~~gr-----------------------------~~e~~ar~~F~q~vsaveYcH~k 174 (596)
T KOG0586|consen 134 ME----------YASGGELFDYLVKHGR-----------------------------MKEKEARAKFRQIVSAVEYCHSK 174 (596)
T ss_pred EE----------eccCchhHHHHHhccc-----------------------------chhhhhhhhhHHHHHHHHHHhhc
Confidence 99 6666777777653322 22345678999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCC-CCcchhhhhHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 704 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlGviL~el 704 (902)
+|+|||||++||||+.+.+ +||+|||++..+... ....+.||++.|.|||+..+..| ++.+|+||+|+++|-|
T Consensus 175 ~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~L 248 (596)
T KOG0586|consen 175 NIVHRDLKAENILLDENMN--IKIADFGFSTFFDYG----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYAL 248 (596)
T ss_pred ceeccccchhhcccccccc--eeeeccccceeeccc----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheee
Confidence 9999999999999977765 999999999988743 34467899999999999998887 6899999999999999
Q ss_pred HhCCCCCCCCchhhHH-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 705 ITGGKHPYGESFERDA-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+.| ..||++..-... ..+...+...+.-++.++.++|+++|.++|.+|++++++++|+|...
T Consensus 249 V~G-sLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~ 311 (596)
T KOG0586|consen 249 VEG-SLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND 311 (596)
T ss_pred eec-ccccCCcccccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence 997 889886432211 11222222334456779999999999999999999999999999744
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=298.72 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=187.4
Q ss_pred ceEEEeeeecccCceEEEEEEee----CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~----~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
.+|++.+.||+|+||.||++... .+..||+|.+..... ....+|+. ++..++||||+++++++.+++..|+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEAS-IMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEecCCccEE
Confidence 35677899999999999998653 234799999865432 23344554 6678899999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||| |+++|+|.+++.... ..+++.++..++.|++.||+|||+
T Consensus 83 v~e----------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~i~~~i~~~l~~lH~ 124 (267)
T cd05066 83 VTE----------YMENGSLDAFLRKHD----------------------------GQFTVIQLVGMLRGIASGMKYLSD 124 (267)
T ss_pred EEE----------cCCCCCHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 999 666677766664221 235677889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
.+++||||||+|||++.++. ++|+|||++.................++..|+|||++.+..++.++|+|||||++||+
T Consensus 125 ~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el 202 (267)
T cd05066 125 MGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202 (267)
T ss_pred CCEeehhhchhcEEECCCCe--EEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHH
Confidence 99999999999999987765 9999999998765432221111222345689999999988899999999999999999
Q ss_pred HhCCCCCCCCchhh-HHHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 705 ITGGKHPYGESFER-DANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 705 ltG~~~Pf~~~~~~-~~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
++.+..||.+.... ....+. ......+...++++.+++.+||+.+|.+||++.++++
T Consensus 203 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 203 MSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred hcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 87347787654322 222222 2122223345678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=305.96 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=193.6
Q ss_pred cceEEEeeeecccCceEEEEEEe--------eCCcEEEEEEeccCCc----hHHHHHHHHHHHhC-CCCCeeEecccccC
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN--------YEGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESD 538 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~--------~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~d 538 (902)
.+.|.+.+.||+|+||.||++.. .++..||+|.+..... ....+|+. ++..+ +||||+++++++.+
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME-MMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHH-HHHhhccCCCchheeEEEec
Confidence 45577889999999999998753 2346899999865322 23445555 55666 89999999999999
Q ss_pred ccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 539 ~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
.+..|++|| |+++|+|.+++........... ..........+++..+..++.||+.|
T Consensus 93 ~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~qi~~a 149 (304)
T cd05101 93 DGPLYVIVE----------YASKGNLREYLRARRPPGMEYS-------------YDIARVPDEQMTFKDLVSCTYQVARG 149 (304)
T ss_pred CCceEEEEe----------cCCCCcHHHHHHhcCCcccccc-------------cccccCCcccccHHHHHHHHHHHHHH
Confidence 999999999 6666777777654322110000 00000112357788899999999999
Q ss_pred ccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhH
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 619 L~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 698 (902)
|+|||++||+||||||+|||++.++. +||+|||+++........ .......++..|+|||++.+..++.++||||||
T Consensus 150 l~~LH~~givH~dlkp~Nili~~~~~--~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 226 (304)
T cd05101 150 MEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226 (304)
T ss_pred HHHHHHCCeeecccccceEEEcCCCc--EEECCCccceeccccccc-ccccCCCCCceeeCchhhccCCCCchhhHHHHH
Confidence 99999999999999999999987765 899999999876542211 112233467789999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCCch-hhHHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 699 CILFFCITGGKHPYGESF-ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~-~~~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
|++|+|++++..||.... ......+... ....+...+.++.++|.+||+.+|.+||++.|+++.
T Consensus 227 ~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 227 VLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 999999996677776542 2222222222 222344567899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=293.73 Aligned_cols=249 Identities=28% Similarity=0.464 Sum_probs=195.4
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||+|+||.||++... +++.||+|++..... ....+|+. .++.++|||++++++.+.+++..++|+|
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~~~~~~~~~~~~~lv~e- 79 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVK-ILKKLNHPNIIKYYESFEEKGKLCIVME- 79 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHH-HHHhcCCCChhheEEEEecCCEEEEEEE-
Confidence 556788999999999998544 689999999865422 23344544 6688899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
+.++++|.+++.... .+...+++..+..++.+++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~l~~~~-------------------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 125 (258)
T cd08215 80 ---------YADGGDLSQKIKKQK-------------------------KEGKPFPEEQILDWFVQLCLALKYLHSRKIL 125 (258)
T ss_pred ---------ecCCCcHHHHHHHhh-------------------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 555666666554321 1124578888999999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|+||+|+||+++.++. ++|+|||++....... .......|++.|+|||.+....++.++|+||+|+++++|++|
T Consensus 126 H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g- 199 (258)
T cd08215 126 HRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTV---DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL- 199 (258)
T ss_pred cccCChHHeEEcCCCc--EEECCccceeecccCc---ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcC-
Confidence 9999999999987765 8999999998765432 122334688999999999888899999999999999999997
Q ss_pred CCCCCCchhhH-H-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 709 KHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 709 ~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||....... . ..........+...+.++.+++.+||..+|.+||++.++++||||
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 200 KHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 67876543222 1 222222223344566799999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.36 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=189.5
Q ss_pred cceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
.+.+.+.+.||+|+||.||++...++..||+|.+..... ....+|+. +++.++|+||+++++++.+ ...|++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~-~~~~~v~e-- 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEAN-VMKTLQHDKLVKLHAVVTK-EPIYIITE-- 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHH-HHHhcCCCCcceEEEEEcC-CCeEEEEE--
Confidence 466788999999999999999877778899998865432 23445554 6788999999999999887 77899999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+.+++|
T Consensus 81 --------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H 125 (260)
T cd05073 81 --------FMAKGSLLDFLKSDE---------------------------GSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125 (260)
T ss_pred --------eCCCCcHHHHHHhCC---------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 666677766664321 122456678899999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
|||||+||+++.++. +||+|||++........ .......++..|+|||++....++.++|+|||||++|++++++.
T Consensus 126 ~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~ 201 (260)
T cd05073 126 RDLRAANILVSASLV--CKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201 (260)
T ss_pred cccCcceEEEcCCCc--EEECCCcceeeccCCCc--ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCC
Confidence 999999999987765 99999999976643211 11122235678999999988889999999999999999999668
Q ss_pred CCCCCchhh-HHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 710 HPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 710 ~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
+||...... ....+... ........+.++.+++.+||+.+|++||++.+++
T Consensus 202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~ 254 (260)
T cd05073 202 IPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQ 254 (260)
T ss_pred CCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 888754322 22222222 2122345667899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=294.99 Aligned_cols=242 Identities=29% Similarity=0.421 Sum_probs=189.8
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
+.|.+.+.||.|+||.||++.. .|+.||||.+..... ....+|+. ++..++|+||+++++++.+.+..++|||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e--- 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQAFLAEAS-VMTTLRHPNLVQLLGVVLQGNPLYIVTE--- 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchhHHHHHHHHHH-HHHhcCCcceeeeEEEEcCCCCeEEEEE---
Confidence 4566788999999999998754 589999999976543 23455554 6788899999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+.+|+||
T Consensus 81 -------~~~~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~ 126 (256)
T cd05039 81 -------YMAKGSLVDYLRSRG---------------------------RAVITLAQQLGFALDVCEGMEYLEEKNFVHR 126 (256)
T ss_pred -------ecCCCcHHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccch
Confidence 556666666653221 1246778889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+||+++.++. +||+|||+++....... ...++..|+|||++....++.++|||||||++||+++.+..
T Consensus 127 di~p~Nili~~~~~--~~l~d~g~~~~~~~~~~------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~ 198 (256)
T cd05039 127 DLAARNVLVSEDLV--AKVSDFGLAKEASQGQD------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 198 (256)
T ss_pred hcccceEEEeCCCC--EEEcccccccccccccc------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCC
Confidence 99999999987765 89999999987643211 22346679999999888899999999999999999984477
Q ss_pred CCCCchhhHH-HHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 711 PYGESFERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 711 Pf~~~~~~~~-~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||........ ..+. ......+...++++.++|.+||..+|++||++.++++
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 199 PYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 8866533322 2222 1122234456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=310.57 Aligned_cols=248 Identities=24% Similarity=0.310 Sum_probs=181.8
Q ss_pred eeccc--CceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 480 EIAKG--SNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 480 ~LG~G--sfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
.||+| +||+||++.. .+|+.||||++..... ...++++..+++.++||||+++++++.+++..++|+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e----- 79 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP----- 79 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe-----
Confidence 46666 9999999854 5799999999864321 1233444456778999999999999999999999999
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDL 632 (902)
|+..|++.+++... ....+++..+..++.|++.||+|||+.+|+||||
T Consensus 80 -----~~~~~~l~~~l~~~---------------------------~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDl 127 (328)
T cd08226 80 -----FMAYGSANSLLKTY---------------------------FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNI 127 (328)
T ss_pred -----cccCCCHHHHHHhh---------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 66667776665321 1134677888999999999999999999999999
Q ss_pred ccceeEeccCCCceEEEccCCccccccCCCccc----cccccCCCCccccCchhhccC--CCCCcchhhhhHHHHHHHHh
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL----TQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~----~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGviL~ellt 706 (902)
||+|||++.++. ++++|||.+.......... .......++..|+|||++.+. .++.++|||||||++|||++
T Consensus 128 kp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~ 205 (328)
T cd08226 128 KASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT 205 (328)
T ss_pred CHHHEEEeCCCc--EEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHh
Confidence 999999987765 8999998654332211100 001112356679999999764 47899999999999999999
Q ss_pred CCCCCCCCchhhHH--HHHhhc----------------------------------------------cccccccCChHH
Q 002601 707 GGKHPYGESFERDA--NIVKDR----------------------------------------------KDLFLVEHIPEA 738 (902)
Q Consensus 707 G~~~Pf~~~~~~~~--~~~~~~----------------------------------------------~~~~~~~~~~e~ 738 (902)
| .+||........ ...... ........++++
T Consensus 206 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (328)
T cd08226 206 G-RVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF 284 (328)
T ss_pred C-CCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHH
Confidence 7 778865432111 111000 000011234678
Q ss_pred HHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 739 VDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 739 ~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
.+||++||+.||++|||+.|+++||||..
T Consensus 285 ~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 285 QNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 99999999999999999999999999954
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.52 Aligned_cols=248 Identities=29% Similarity=0.402 Sum_probs=189.0
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----c---hHHHHHHHHHHHhCCCCCeeEecccccCc--cce
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----H---DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFV 542 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~--~~~ 542 (902)
.|.+.+.||+|+||.||++.. .+|+.||+|++.... . ....+|+. +++.++||||+++++++.+. +..
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQ-LLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHH-HHHHcCCCCcceEEEEEEcCCCCEE
Confidence 467789999999999999854 568999999874321 1 12334544 67888999999999988654 468
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
++++| |.++|+|.+++.. ...+++..+.+++.|++.||+||
T Consensus 82 ~~v~e----------~~~~~~L~~~~~~-----------------------------~~~l~~~~~~~~~~~i~~al~~L 122 (264)
T cd06653 82 SIFVE----------YMPGGSIKDQLKA-----------------------------YGALTENVTRRYTRQILQGVSYL 122 (264)
T ss_pred EEEEE----------eCCCCcHHHHHHH-----------------------------cCCCCHHHHHHHHHHHHHHHHHH
Confidence 89999 5556666555431 12356677889999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
|+.+|+|+||||+||+++.++. ++|+|||+++................|+..|+|||++.+..++.++|+|||||++|
T Consensus 123 H~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 200 (264)
T cd06653 123 HSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVV 200 (264)
T ss_pred HhCCEecCCCCHHHEEEcCCCC--EEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHH
Confidence 9999999999999999987765 89999999987643211111112345889999999998888899999999999999
Q ss_pred HHHhCCCCCCCCchhhHH--HHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 703 FCITGGKHPYGESFERDA--NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~~--~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
+|++| .+||.+...... .+.. ......+...++++.++|.+||+ +|..||++.+++.|||.
T Consensus 201 ~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 201 EMLTE-KPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHhC-CCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 99997 778876432221 1111 12233455677899999999999 57999999999999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=304.78 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=194.2
Q ss_pred ceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
+.|.+.+.||+|+||+||++. ..+++.||+|.+..... +...+|+. ++..++||||+++++++.+.+..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e- 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEIL-VMRENKHPNIVNYLDSYLVGDELWVVME- 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHH-HHhhcCCCCeeehhheeeeCCcEEEEEe-
Confidence 456778899999999999985 45788999999854322 23445554 6678899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|.+++.. ..+++..+..++.|++.||+|||+++++
T Consensus 97 ---------~~~~~~L~~~~~~------------------------------~~l~~~~~~~i~~~l~~al~~LH~~gi~ 137 (293)
T cd06647 97 ---------YLAGGSLTDVVTE------------------------------TCMDEGQIAAVCRECLQALEFLHSNQVI 137 (293)
T ss_pred ---------cCCCCcHHHHHhh------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 6667777666532 2345667889999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
||||||+||+++.++. ++|+|||++........ ......|++.|+|||.+....++.++|+|||||++|++++|
T Consensus 138 H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g- 211 (293)
T cd06647 138 HRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG- 211 (293)
T ss_pred eccCCHHHEEEcCCCC--EEEccCcceeccccccc---ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999988765 89999999876553221 11234588999999999888899999999999999999997
Q ss_pred CCCCCCchhhHH--HHHhhcccc--ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 709 KHPYGESFERDA--NIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 709 ~~Pf~~~~~~~~--~~~~~~~~~--~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
..||........ .+....... .+...++++.++|.+||+.+|.+||++.+++.||||....
T Consensus 212 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 212 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 778865432111 111111111 1223456799999999999999999999999999996543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=300.99 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=189.0
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc----hHHHHHHHHHHHhCC---CCCeeEecccccCccceeeee
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQ---HPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~---HpNIV~l~g~~~d~~~~yLV~ 546 (902)
|...+.||+|+||.||++.. .+|+.||||++..... ....+|+. +++.+. |||++++++++.++...|+||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVA-LLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHH-HHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 44567899999999999864 5789999999864322 23445554 445554 999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++.. ..+++..+..++.|++.||+|||+.+
T Consensus 82 e----------~~~~~~L~~~~~~------------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~ 121 (277)
T cd06917 82 E----------YAEGGSVRTLMKA------------------------------GPIAEKYISVIIREVLVALKYIHKVG 121 (277)
T ss_pred e----------cCCCCcHHHHHHc------------------------------cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 5566666655421 23567788999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ell 705 (902)
|+|+||+|+||+++.++. ++|+|||++....... .......|+..|+|||.+..+ .++.++|+|||||++|+|+
T Consensus 122 i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll 196 (277)
T cd06917 122 VIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNS---SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196 (277)
T ss_pred cccCCcCHHHEEEcCCCC--EEEccCCceeecCCCc---cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHH
Confidence 999999999999988765 8999999998765432 112334589999999998754 4689999999999999999
Q ss_pred hCCCCCCCCchhhHH-HHHhh-ccccccc-cCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 706 TGGKHPYGESFERDA-NIVKD-RKDLFLV-EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 706 tG~~~Pf~~~~~~~~-~~~~~-~~~~~~~-~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+| .+||........ ..... ....... ..+.++.+++.+||+.||.+||++.++++||||..
T Consensus 197 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~ 260 (277)
T cd06917 197 TG-NPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKA 260 (277)
T ss_pred hC-CCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhc
Confidence 97 778865432221 11111 1111222 25678999999999999999999999999999954
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=316.45 Aligned_cols=276 Identities=22% Similarity=0.345 Sum_probs=191.2
Q ss_pred ceEEEeeeecccCceEEEEEEe------eCCcEEEEEEeccCCch----HHHHHHHHHHHhCC-CCCeeEecccccCccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQ-HPNIVRWYGVESDQDF 541 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~-HpNIV~l~g~~~d~~~ 541 (902)
+.+.+.+.||+|+||.||++.. ..++.||||++...... ...+|+. ++..+. |||||+++++|.+.+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~-~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELK-IMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHH-HHHhcCCCCCeEEEEEEEccCCC
Confidence 4567788999999999999853 23578999999754322 3445665 456665 9999999999999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccc------------hhHHHHh--------------------------
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSN------------LLNEVRI-------------------------- 583 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~------------~l~~~~~-------------------------- 583 (902)
.++||||| ++|+|.++++....... .......
T Consensus 116 ~~iv~E~~----------~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (401)
T cd05107 116 IYIITEYC----------RYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDE 185 (401)
T ss_pred cEEEEecc----------CCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcc
Confidence 99999954 45555555543211000 0000000
Q ss_pred ------------------------------hhccccc-cchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccc
Q 002601 584 ------------------------------RLLPVME-NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (902)
Q Consensus 584 ------------------------------r~~~~~e-~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDL 632 (902)
...+..+ .......-....+++..+++|+.||+.||+|||+.+|+||||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdl 265 (401)
T cd05107 186 SADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDL 265 (401)
T ss_pred ccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccC
Confidence 0000000 000001112245678889999999999999999999999999
Q ss_pred ccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCC
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf 712 (902)
||+|||++.++ .+||+|||+++........ .......++..|+|||.+....++.++|||||||++|||++++..||
T Consensus 266 kp~NiLl~~~~--~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~ 342 (401)
T cd05107 266 AARNVLICEGK--LVKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342 (401)
T ss_pred CcceEEEeCCC--EEEEEecCcceeccccccc-ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence 99999998765 4999999999865432211 11223357889999999998889999999999999999999557788
Q ss_pred CCchhhH--HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 713 GESFERD--ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 713 ~~~~~~~--~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
....... ...+... ....+...+.++.+++.+||+.+|.+||+++++++.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6532221 2222222 222344567899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=308.66 Aligned_cols=249 Identities=28% Similarity=0.412 Sum_probs=188.9
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCcc-----cee
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD-----FVY 543 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~-----~~y 543 (902)
|.+.+.||.|++|.||++... +|..||||++.... .....+|+. .++.++||||+++++++.+.+ ..|
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIK-LLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHH-HHHhcCCcchhhhhhhhcccCcccccceE
Confidence 567789999999999998654 58999999986532 123445554 667889999999999988875 789
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
++||++.++ |.+.+.. ...+++..++.++.||+.||+|||
T Consensus 81 lv~e~~~~~-----------l~~~l~~-----------------------------~~~l~~~~~~~i~~~l~~~l~~LH 120 (330)
T cd07834 81 IVTELMETD-----------LHKVIKS-----------------------------PQPLTDDHIQYFLYQILRGLKYLH 120 (330)
T ss_pred EEecchhhh-----------HHHHHhC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999965543 3333321 124677888999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 702 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ 702 (902)
+.||+||||||+|||++.++. ++|+|||++.................++..|+|||++.+. .++.++|+|||||++|
T Consensus 121 ~~gi~H~dlkp~nili~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~ 198 (330)
T cd07834 121 SANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFA 198 (330)
T ss_pred hCCeecCCCCHHHEEEcCCCC--EEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHH
Confidence 999999999999999988765 9999999998776432111122334578899999999887 7899999999999999
Q ss_pred HHHhCCCCCCCCchhhH-HH-HHhhc-----------------------c-------ccccccCChHHHHHHHcccCCCC
Q 002601 703 FCITGGKHPYGESFERD-AN-IVKDR-----------------------K-------DLFLVEHIPEAVDLFTRLLDPNP 750 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-~~-~~~~~-----------------------~-------~~~~~~~~~e~~dLI~~~L~~dP 750 (902)
+|++| .+||....... .. +.... . .......++++.++|.+||+.||
T Consensus 199 ~l~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 277 (330)
T cd07834 199 ELLTR-KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDP 277 (330)
T ss_pred HHHcC-CCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCCh
Confidence 99997 77775432211 11 00000 0 00112346789999999999999
Q ss_pred CCCcCHHHHHcCCCCCC
Q 002601 751 DLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 751 ~~Rpt~~elL~HPfF~~ 767 (902)
.+||++++++.||||..
T Consensus 278 ~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 278 KKRITADEALAHPYLAQ 294 (330)
T ss_pred hhCCCHHHHHhCccHHh
Confidence 99999999999999954
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.39 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=186.9
Q ss_pred eEEEeeeecccCceEEEEEEee-CC---cEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EG---RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g---~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
.|...+.||+|+||.||++... ++ ..||||.+..... ....+|+ .++..++||||+++++++.+.+..|+|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEA-SIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHH-HHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 4567789999999999998654 33 3799999865422 2234454 467888999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+++|+|.+++.... ..+++.++..++.|++.||+|||+.
T Consensus 85 ~e----------~~~~~~L~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~al~~lH~~ 126 (268)
T cd05063 85 TE----------YMENGALDKYLRDHD----------------------------GEFSSYQLVGMLRGIAAGMKYLSDM 126 (268)
T ss_pred EE----------cCCCCCHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 666777776664221 2356778899999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+|+||||||+||+++.++. +||+|||++..................+..|+|||++....++.++|||||||++|||+
T Consensus 127 ~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell 204 (268)
T cd05063 127 NYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204 (268)
T ss_pred CeeccccchhhEEEcCCCc--EEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHH
Confidence 9999999999999987765 99999999987653221111111122355799999998888999999999999999999
Q ss_pred hCCCCCCCCchh-hHHHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 706 TGGKHPYGESFE-RDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 706 tG~~~Pf~~~~~-~~~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+.+..||..... .....+. ..........+.++.+++.+||+.+|..||++.++++
T Consensus 205 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 205 SFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred hCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 844777754322 2222222 2222233456788999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=301.44 Aligned_cols=245 Identities=27% Similarity=0.471 Sum_probs=190.3
Q ss_pred EeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 477 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
.-+.||+|++|.||++.. .+++.||+|++..... +...+|+. ++..+.||||+++++++...+..++++|
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~-~l~~~~h~~vv~~~~~~~~~~~~~~v~e----- 96 (285)
T cd06648 23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVV-IMRDYQHPNIVEMYSSYLVGDELWVVME----- 96 (285)
T ss_pred cceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHH-HHHHcCCCChheEEEEEEcCCeEEEEEe-----
Confidence 346899999999999854 5789999998854321 23455554 6788899999999999999999999999
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDL 632 (902)
|+++++|.+++.. ..+++..+..++.|++.||+|||+++|+||||
T Consensus 97 -----~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 141 (285)
T cd06648 97 -----FLEGGALTDIVTH------------------------------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDI 141 (285)
T ss_pred -----ccCCCCHHHHHHh------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 6666777665532 23566778899999999999999999999999
Q ss_pred ccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCC
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf 712 (902)
+|+||+++.++. ++|+|||++........ ......|++.|+|||.+.+..++.++|||||||++|+|++| ..||
T Consensus 142 ~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g-~~p~ 215 (285)
T cd06648 142 KSDSILLTSDGR--VKLSDFGFCAQVSKEVP---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG-EPPY 215 (285)
T ss_pred ChhhEEEcCCCc--EEEcccccchhhccCCc---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhC-CCCC
Confidence 999999987765 89999998876543211 12234589999999999888899999999999999999998 5566
Q ss_pred CCch-hhHHHHHhhccc-c--ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 713 GESF-ERDANIVKDRKD-L--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 713 ~~~~-~~~~~~~~~~~~-~--~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
.... ............ . .....++++.++|.+||+.+|++||++.++++||||..+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 216 FNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred cCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence 4432 222222222111 1 122256789999999999999999999999999999654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=309.57 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=190.0
Q ss_pred cccceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccc--
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDF-- 541 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~-- 541 (902)
.+++.|...+.||+|++|+||++.. .+++.||||++.... .....+|+. +++.+.||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELR-LLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHH-HHHhccCCCHHHHHHHhhcccccc
Confidence 3466788889999999999999855 468899999986431 123455665 5677899999999998876654
Q ss_pred ----eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhc
Q 002601 542 ----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (902)
Q Consensus 542 ----~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~ 617 (902)
.|+|+|++..+|.+++ . ...+++..+..++.|+++
T Consensus 91 ~~~~~~lv~e~~~~~L~~~~-----------~------------------------------~~~l~~~~~~~~~~ql~~ 129 (343)
T cd07851 91 DFQDVYLVTHLMGADLNNIV-----------K------------------------------CQKLSDDHIQFLVYQILR 129 (343)
T ss_pred ccccEEEEEecCCCCHHHHH-----------h------------------------------cCCCCHHHHHHHHHHHHH
Confidence 8999997765554443 1 123677788999999999
Q ss_pred cccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhh
Q 002601 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFS 696 (902)
Q Consensus 618 gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwS 696 (902)
||+|||+.||+||||||+||+++.++. ++|+|||++...... .....++..|+|||.+.+. .++.++||||
T Consensus 130 aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 201 (343)
T cd07851 130 GLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 201 (343)
T ss_pred HHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccccccc------ccCCcccccccCHHHHhCCCCCCchHhHHH
Confidence 999999999999999999999988766 899999999866432 1233578899999998653 6789999999
Q ss_pred hHHHHHHHHhCCCCCCCCchhh-HH-HHHhhc---------------------------cc---cccccCChHHHHHHHc
Q 002601 697 LGCILFFCITGGKHPYGESFER-DA-NIVKDR---------------------------KD---LFLVEHIPEAVDLFTR 744 (902)
Q Consensus 697 lGviL~elltG~~~Pf~~~~~~-~~-~~~~~~---------------------------~~---~~~~~~~~e~~dLI~~ 744 (902)
|||++|+|++| ..||...... .. .+.... .. ......++++.++|.+
T Consensus 202 lGv~l~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~ 280 (343)
T cd07851 202 VGCIMAELLTG-KTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEK 280 (343)
T ss_pred HHHHHHHHHhC-CCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHH
Confidence 99999999998 6677543211 11 111000 00 0012346789999999
Q ss_pred ccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 745 LLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 745 ~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
||+.||.+|||+.++++||||....
T Consensus 281 ~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 281 MLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred hCCCChhhCCCHHHHhcCCCccccC
Confidence 9999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=303.93 Aligned_cols=259 Identities=23% Similarity=0.312 Sum_probs=187.5
Q ss_pred eEEEeeeecccCceEEEEEEee-CC--cEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EG--RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g--~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+.+.||+|+||.||++... +| ..+|+|.++.... ....+|+..+.+..+||||+++++++.+.+..|+|+
T Consensus 3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 82 (297)
T cd05089 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI 82 (297)
T ss_pred cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence 4677889999999999998554 33 3578988864221 234456654434448999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHH-hhCCCCHHHHHHHHHhhhccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW-KANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~-~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
| |+++|+|.++++......... .....+ ....+++..++.++.|++.||+|||++
T Consensus 83 e----------~~~~~~L~~~l~~~~~~~~~~--------------~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~ 138 (297)
T cd05089 83 E----------YAPYGNLLDFLRKSRVLETDP--------------AFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK 138 (297)
T ss_pred E----------ecCCCcHHHHHHhcccccccc--------------ccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9 667777777775432110000 000001 123578889999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+|+||||||+|||++.++. +||+|||++...... ........+..|+|||++....++.++|||||||++|||+
T Consensus 139 ~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~ 212 (297)
T cd05089 139 QFIHRDLAARNVLVGENLA--SKIADFGLSRGEEVY----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212 (297)
T ss_pred CcccCcCCcceEEECCCCe--EEECCcCCCccccce----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999987765 899999998643211 1111122356799999998888999999999999999999
Q ss_pred hCCCCCCCCchhhH-HHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 706 TGGKHPYGESFERD-ANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 706 tG~~~Pf~~~~~~~-~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
+.+..||....... ..... ......+...++++.+++.+||+.+|.+||+++++++.
T Consensus 213 t~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 213 SLGGTPYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred cCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 84477886543322 22222 11222334567899999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=300.03 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=183.7
Q ss_pred ceEEEeeeecccCceEEEEEEe-----eCCcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEeccccc--Cccce
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-----YEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVES--DQDFV 542 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-----~~g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~--d~~~~ 542 (902)
+.+.+.+.||+|+||+||++.. .+++.||||++...... ...+|+. ++..++||||+++++++. +....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIE-ILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHH-HHHhCCCCCeeEEEEEEccCCCCce
Confidence 3466778999999999999753 35889999998654322 3345554 668899999999999764 34568
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
++||| |+++|+|.+++.... ..+++..+..++.|++.||+||
T Consensus 83 ~lv~e----------~~~~~~L~~~l~~~~----------------------------~~l~~~~~~~~~~~l~~aL~~L 124 (284)
T cd05081 83 RLVME----------YLPYGSLRDYLQKHR----------------------------ERLDHRKLLLYASQICKGMEYL 124 (284)
T ss_pred EEEEE----------ecCCCCHHHHHHhcC----------------------------cCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 777888877764211 2357778899999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
|++||+||||||+||+++.++. +||+|||+++................++..|+|||++.+..++.++|||||||++|
T Consensus 125 H~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 202 (284)
T cd05081 125 GSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202 (284)
T ss_pred HHCCceeccCCHhhEEECCCCe--EEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHH
Confidence 9999999999999999987765 89999999987754322211112223455699999998888999999999999999
Q ss_pred HHHhCCCCCCCCchhhH-----------------HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 703 FCITGGKHPYGESFERD-----------------ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-----------------~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||++|.. ++....... ...+... ....+...++++.++|.+||..+|++|||+.++++
T Consensus 203 el~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 203 ELFTYSD-KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhhcCC-cCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999744 332211100 0111111 11122345678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.78 Aligned_cols=245 Identities=31% Similarity=0.516 Sum_probs=193.8
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||+|++|.||++.. .+++.||||.+..... +...+|+ .++..++|||++++++++.+.+..+++||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e- 79 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEI-DLLKNLKHPNIVKYIGSIETSDSLYIILE- 79 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHH-HHHHhCCCCCccEEEEEEEeCCEEEEEEe-
Confidence 55678999999999999854 4688999999865532 1233444 46678899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++++|.+++... ..+++..+..++.|++.||.|||+.||+
T Consensus 80 ---------~~~~~~L~~~~~~~-----------------------------~~l~~~~~~~~~~~i~~~l~~lH~~~i~ 121 (254)
T cd06627 80 ---------YAENGSLRQIIKKF-----------------------------GPFPESLVAVYVYQVLQGLAYLHEQGVI 121 (254)
T ss_pred ---------cCCCCcHHHHHHhc-----------------------------cCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 55566666554321 3467788899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
||||||+||+++.++. ++|+|||++......... .....|+..|+|||.+....++.++||||+|+++|+|++|
T Consensus 122 H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g- 195 (254)
T cd06627 122 HRDIKAANILTTKDGV--VKLADFGVATKLNDVSKD---DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG- 195 (254)
T ss_pred cCCCCHHHEEECCCCC--EEEeccccceecCCCccc---ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC-
Confidence 9999999999988765 899999999877643221 2334588999999999888889999999999999999998
Q ss_pred CCCCCCchhh--HHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 709 KHPYGESFER--DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 709 ~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||...... ............+...++++.+++.+||+.+|++||++.+++.||||
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 196 NPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 6677543221 12222233333445567899999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=335.55 Aligned_cols=156 Identities=32% Similarity=0.542 Sum_probs=127.1
Q ss_pred HHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCcccccc---CC------------Cccccccc
Q 002601 605 SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ---GD------------MSCLTQNA 669 (902)
Q Consensus 605 ~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~---~~------------~~~~~~~~ 669 (902)
...+++++++|+.||+|+|+.|||||||||.||+|+++++ +||+|||+|+... .. ........
T Consensus 696 ~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T 773 (1351)
T KOG1035|consen 696 RDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT 773 (1351)
T ss_pred hHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence 6788999999999999999999999999999999998877 9999999998732 00 00111223
Q ss_pred cCCCCccccCchhhccCC---CCCcchhhhhHHHHHHHHhCCCCCCCCchhhHHHHHhhccccccc------cCChHHHH
Q 002601 670 TGYGSSGWQAPEQLLQGR---QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLV------EHIPEAVD 740 (902)
Q Consensus 670 ~~~Gt~~Y~APE~l~~~~---~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~------~~~~e~~d 740 (902)
..+||.-|+|||++.+.. |+.|+||||||+|++||+. ||+...++...+..-+....+. ...++...
T Consensus 774 s~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y----PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 774 SQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY----PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEAS 849 (1351)
T ss_pred cccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc----cCCchHHHHHHHHhcccCCCCCCcccccccchHHHH
Confidence 457999999999998654 9999999999999999986 7999888876544433333332 23467788
Q ss_pred HHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 741 LFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 741 LI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
+|++|++.||.+||||.|+|++.||-
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhhccCCC
Confidence 99999999999999999999999985
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=304.98 Aligned_cols=260 Identities=24% Similarity=0.330 Sum_probs=187.0
Q ss_pred eEEEeeeecccCceEEEEEEee-CCc--EEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EGR--SVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g~--~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+.+.||+|+||.||+|... +|. .+|+|++..... ....+|+..+....+||||+++++++.+++..|+||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 4677889999999999998653 454 468887764322 133456654434448999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.++++.......... ..........+++.+++.++.||+.||+|||++|
T Consensus 88 e----------~~~~~~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 144 (303)
T cd05088 88 E----------YAPHGNLLDFLRKSRVLETDPA-------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ 144 (303)
T ss_pred E----------eCCCCcHHHHHHhccccccccc-------------ccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9 6667777777654321100000 0000001234788899999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
|+||||||+|||++.++. +||+|||+++..... .......++..|+|||++....++.++|||||||++|||+|
T Consensus 145 i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 218 (303)
T cd05088 145 FIHRDLAARNILVGENYV--AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218 (303)
T ss_pred ccccccchheEEecCCCc--EEeCccccCcccchh----hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHh
Confidence 999999999999987765 899999998643211 11122234678999999988889999999999999999998
Q ss_pred CCCCCCCCchhhH-HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 707 GGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 707 G~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
++.+||....... ....... ....+...++++.++|.+||+.+|.+||++++++.+
T Consensus 219 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 219 LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cCCCCcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4477775432222 2222221 122334467899999999999999999999999866
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=301.86 Aligned_cols=257 Identities=23% Similarity=0.317 Sum_probs=188.8
Q ss_pred ceEEEeeeecccCceEEEEEEee-----------------CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeE
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-----------------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVR 531 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-----------------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~ 531 (902)
+.|.+.+.||+|+||.||++... .+..||+|++...... ...+|+. ++..++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK-ILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHH-HHHhcCCCCEeE
Confidence 34667789999999999987543 2356899998754322 2334554 668889999999
Q ss_pred ecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHH
Q 002601 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611 (902)
Q Consensus 532 l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I 611 (902)
+++++.+++..+++|| +.++|+|.+++.......... ......+++..++.+
T Consensus 84 ~~~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~~------------------~~~~~~~~~~~~~~~ 135 (296)
T cd05051 84 LLGVCTVDPPLCMIME----------YMENGDLNQFLQKHVAETSGL------------------ACNSKSLSFSTLLYM 135 (296)
T ss_pred EEEEEecCCCcEEEEe----------cCCCCCHHHHHHhcccccccc------------------cccCCCCCHHHHHHH
Confidence 9999999999999999 555666666664322110000 012245788899999
Q ss_pred HHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCc
Q 002601 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691 (902)
Q Consensus 612 ~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~k 691 (902)
+.|++.||+|||+.+|+||||||+||+++.++. ++|+|||+++....... ........++..|+|||++....++.+
T Consensus 136 ~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~ 212 (296)
T cd05051 136 ATQIASGMRYLESLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSSDY-YRVQGRAPLPIRWMAWESVLLGKFTTK 212 (296)
T ss_pred HHHHHHHHHHHHHcCccccccchhceeecCCCc--eEEccccceeecccCcc-eeecCcCCCCceecCHHHhhcCCCCcc
Confidence 999999999999999999999999999988765 89999999986543221 111223446788999999988889999
Q ss_pred chhhhhHHHHHHHHhC-CCCCCCCchhhHH--HHHhh-----c--cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 692 IDLFSLGCILFFCITG-GKHPYGESFERDA--NIVKD-----R--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 692 sDVwSlGviL~elltG-~~~Pf~~~~~~~~--~~~~~-----~--~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+|||||||++|||+++ +..||........ ..... . ....+...++++.+++.+||+.||.+||++.|+++
T Consensus 213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 9999999999999984 4677765322211 11111 0 01122334578999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=301.02 Aligned_cols=250 Identities=25% Similarity=0.338 Sum_probs=186.6
Q ss_pred ccceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCcc----
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 540 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~---- 540 (902)
..+.|.+.+.||+|+||+||++... +|+.||||++..... ....+|+. +++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~-~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIK-ILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHH-HHHhCCCCCeeeeeheecCcchhhh
Confidence 3456777899999999999998654 689999999864321 23345554 668889999999999987655
Q ss_pred ------ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHh
Q 002601 541 ------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614 (902)
Q Consensus 541 ------~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~q 614 (902)
..|+|+||+++++.+++ .. ....+++..+..++.|
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l-----------~~----------------------------~~~~~~~~~~~~i~~q 124 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLL-----------ES----------------------------GLVHFSEDHIKSFMKQ 124 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHH-----------hc----------------------------CCCCCCHHHHHHHHHH
Confidence 78999997765443332 11 1124677888999999
Q ss_pred hhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcch
Q 002601 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAID 693 (902)
Q Consensus 615 Ia~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksD 693 (902)
|+.||+|||+.+|+||||||+||+++.++. +||+|||++........ .......++..|+|||.+.+. .++.++|
T Consensus 125 i~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~D 200 (302)
T cd07864 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLARLYNSEES--RPYTNKVITLWYRPPELLLGEERYGPAID 200 (302)
T ss_pred HHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccccccccCCcc--cccccceeccCccChHHhcCCCCCCchhH
Confidence 999999999999999999999999987765 99999999987654321 111122467889999988654 4689999
Q ss_pred hhhhHHHHHHHHhCCCCCCCCchhhH-H-HHHhh---ccc--------------------------cccccCChHHHHHH
Q 002601 694 LFSLGCILFFCITGGKHPYGESFERD-A-NIVKD---RKD--------------------------LFLVEHIPEAVDLF 742 (902)
Q Consensus 694 VwSlGviL~elltG~~~Pf~~~~~~~-~-~~~~~---~~~--------------------------~~~~~~~~e~~dLI 742 (902)
||||||++|+|++| ++||....... . .+... ... ......++.+.++|
T Consensus 201 i~slG~~~~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 279 (302)
T cd07864 201 VWSCGCILGELFTK-KPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLL 279 (302)
T ss_pred HHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHH
Confidence 99999999999997 77886432211 1 11110 000 00112467899999
Q ss_pred HcccCCCCCCCcCHHHHHcCCCC
Q 002601 743 TRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 743 ~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
.+||+.||.+||++.+++.||||
T Consensus 280 ~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 280 DHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HHHccCChhhCCCHHHHhcCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=303.96 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=185.4
Q ss_pred cceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCc------
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ------ 539 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~------ 539 (902)
.+.|.+.+.||+|+||.||++.. .+|+.||||++.... .....+|+. ++..++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK-ILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHH-HHHhcCCCCccchhhheecccccccc
Confidence 46788889999999999999854 468999999885322 123456665 67888999999999987543
Q ss_pred --cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhc
Q 002601 540 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (902)
Q Consensus 540 --~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~ 617 (902)
..+|+|+||+..++.+.+ .. ....+++..+..++.|+++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~-----------~~----------------------------~~~~~~~~~~~~i~~~l~~ 126 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLL-----------EN----------------------------PSVKLTESQIKCYMLQLLE 126 (311)
T ss_pred cCceEEEEEecCCcCHHHHH-----------hc----------------------------cccCCCHHHHHHHHHHHHH
Confidence 356999997665443332 11 1123677888999999999
Q ss_pred cccccccccccccccccceeEeccCCCceEEEccCCccccccCCCcccc--------ccccCCCCccccCchhhccC-CC
Q 002601 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT--------QNATGYGSSGWQAPEQLLQG-RQ 688 (902)
Q Consensus 618 gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~--------~~~~~~Gt~~Y~APE~l~~~-~~ 688 (902)
||+|||+.||+||||||+||++++++. ++|+|||+++.......... ......|++.|+|||.+.+. .+
T Consensus 127 al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 204 (311)
T cd07866 127 GINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRY 204 (311)
T ss_pred HHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCcc
Confidence 999999999999999999999988776 89999999986653321111 11223578889999988654 57
Q ss_pred CCcchhhhhHHHHHHHHhCCCCCCCCchhhH-H-HHHhhcc----------------------c-------cccccCChH
Q 002601 689 TRAIDLFSLGCILFFCITGGKHPYGESFERD-A-NIVKDRK----------------------D-------LFLVEHIPE 737 (902)
Q Consensus 689 s~ksDVwSlGviL~elltG~~~Pf~~~~~~~-~-~~~~~~~----------------------~-------~~~~~~~~e 737 (902)
+.++|||||||++|||++| .+||....... . .+..... . .......++
T Consensus 205 ~~~~Dv~slG~il~el~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (311)
T cd07866 205 TTAVDIWGIGCVFAEMFTR-RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283 (311)
T ss_pred CchhHhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChh
Confidence 8999999999999999997 77776432211 1 1100000 0 001123467
Q ss_pred HHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 738 AVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 738 ~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
+.++|.+||+.||.+|||+.|++.||||
T Consensus 284 ~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 284 GLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 8899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=304.67 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=188.8
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|...+.||+|+||.||++.. .+|..||+|++..... ....+|+. .++.++|||++++++++.+++..|+||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK-FLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHH-HHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 355667899999999999854 4689999999864321 12345554 668889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
|||.+++.+++.. ....+++.++..++.|++.||.|||+.+
T Consensus 105 e~~~g~l~~~~~~---------------------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 145 (317)
T cd06635 105 EYCLGSASDLLEV---------------------------------------HKKPLQEVEIAAITHGALQGLAYLHSHN 145 (317)
T ss_pred eCCCCCHHHHHHH---------------------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9776655444311 1123567788999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc---cCCCCCcchhhhhHHHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGviL~e 703 (902)
|+||||+|+||+++.++. ++|+|||++..... .....|+..|+|||++. .+.++.++|||||||++||
T Consensus 146 i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~e 216 (317)
T cd06635 146 MIHRDIKAGNILLTEPGQ--VKLADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 216 (317)
T ss_pred cccCCCCcccEEECCCCC--EEEecCCCccccCC-------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHH
Confidence 999999999999987765 89999999875432 12345889999999974 4568899999999999999
Q ss_pred HHhCCCCCCCCc-hhhH-HHHHhhcccc-ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcch
Q 002601 704 CITGGKHPYGES-FERD-ANIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 770 (902)
Q Consensus 704 lltG~~~Pf~~~-~~~~-~~~~~~~~~~-~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~ 770 (902)
|++| .+||... .... ..+....... .....++.+.++|.+||+.+|.+||++.++++|+|+.....
T Consensus 217 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 217 LAER-KPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHhC-CCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 9998 5555433 2221 2222222211 22345678999999999999999999999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=308.60 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=181.0
Q ss_pred eeeecccCceEEEEEEeeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
++.+|.|+++.||+ +..+|+.||||++.... .....+|+. .++.++||||+++++++.+.+..|++||
T Consensus 7 ~~~~~~~~~v~~~~-~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~~i~~~~~~~~~~~~~~~~~e----- 79 (314)
T cd08216 7 GKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKLLQQEII-TSRQLQHPNILPYVTSFIVDSELYVVSP----- 79 (314)
T ss_pred hHhhcCCceEEEEE-ecCCCCEEEEEEEeccccchhHHHHHHHHHH-HHHhcCCcchhhhhheeecCCeEEEEEe-----
Confidence 34456666666665 34479999999986531 123445554 6678899999999999999999999999
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDL 632 (902)
|+++|++.+++.... ...+++..+..++.|++.||+|||+++|+||||
T Consensus 80 -----~~~~~~l~~~l~~~~---------------------------~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dl 127 (314)
T cd08216 80 -----LMAYGSCEDLLKTHF---------------------------PEGLPELAIAFILKDVLNALDYIHSKGFIHRSV 127 (314)
T ss_pred -----ccCCCCHHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 556666666654221 123677788999999999999999999999999
Q ss_pred ccceeEeccCCCceEEEccCCccccccCCCcc----ccccccCCCCccccCchhhccC--CCCCcchhhhhHHHHHHHHh
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGviL~ellt 706 (902)
||+||+++.++. +||+|||.+......... ........++..|+|||++... .++.++|||||||++|||++
T Consensus 128 k~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~ 205 (314)
T cd08216 128 KASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN 205 (314)
T ss_pred CcceEEEecCCc--eEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh
Confidence 999999988776 899999998765432110 1111233477889999998763 57899999999999999999
Q ss_pred CCCCCCCCchhhHH--HHHhhc---------------------------------cccccccCChHHHHHHHcccCCCCC
Q 002601 707 GGKHPYGESFERDA--NIVKDR---------------------------------KDLFLVEHIPEAVDLFTRLLDPNPD 751 (902)
Q Consensus 707 G~~~Pf~~~~~~~~--~~~~~~---------------------------------~~~~~~~~~~e~~dLI~~~L~~dP~ 751 (902)
| ..||........ ...... ........++++.+++.+||+.||+
T Consensus 206 g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 284 (314)
T cd08216 206 G-HVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPE 284 (314)
T ss_pred C-CCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCC
Confidence 7 778865322111 101000 0000011235788999999999999
Q ss_pred CCcCHHHHHcCCCCCC
Q 002601 752 LRPKAQNVLNHPFFWT 767 (902)
Q Consensus 752 ~Rpt~~elL~HPfF~~ 767 (902)
+|||++++++||||..
T Consensus 285 ~Rpt~~~ll~~p~~~~ 300 (314)
T cd08216 285 SRPSASQLLNHSFFKQ 300 (314)
T ss_pred cCcCHHHHhcCchHhh
Confidence 9999999999999953
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=304.84 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=204.4
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc----h--HHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----D--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~----~--~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
..|.|..+||+|+||.|.+|.. .+...+|||+|++.-. + -..-|-..+--.-+-|.+++++.+++.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4578889999999999999844 4567899999976421 1 1122333222234578999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+.+|+|.-++.+- +.+.++.+..++..||-||-+||++
T Consensus 429 ME----------yvnGGDLMyhiQQ~-----------------------------GkFKEp~AvFYAaEiaigLFFLh~k 469 (683)
T KOG0696|consen 429 ME----------YVNGGDLMYHIQQV-----------------------------GKFKEPVAVFYAAEIAIGLFFLHSK 469 (683)
T ss_pred EE----------EecCchhhhHHHHh-----------------------------cccCCchhhhhhHHHHHHhhhhhcC
Confidence 99 66677776655432 3456677889999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
|||+||||..||||+.+|+ +||+|||+++.--- ....+.+.||||.|+|||++..++|+.++|+||+||+||||+
T Consensus 470 gIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~---~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEml 544 (683)
T KOG0696|consen 470 GIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIF---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 544 (683)
T ss_pred CeeeeeccccceEeccCCc--eEeeeccccccccc---CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHH
Confidence 9999999999999998887 99999999985432 234457889999999999999999999999999999999999
Q ss_pred hCCCCCCCCch-hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH-----HHHHcCCCCCCcch
Q 002601 706 TGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFFWTADT 770 (902)
Q Consensus 706 tG~~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~-----~elL~HPfF~~~~~ 770 (902)
.| .+||+... +.....+......++...+.|+.++.+.+|.+.|.+|..+ .++..||||...++
T Consensus 545 aG-QpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 545 AG-QPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred cC-CCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 98 67776544 4445666667778899999999999999999999999754 57999999966544
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.47 Aligned_cols=255 Identities=21% Similarity=0.282 Sum_probs=190.9
Q ss_pred cceEEEeeeecccCceEEEEEEeeC-----CcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccC-ccc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 541 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~~-----g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d-~~~ 541 (902)
++.|.+.+.||+|+||.||++.... +..||+|++..... ....+|+. .++.++||||+++++++.+ +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~-~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC-LLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHH-HHHhCCCCCCCeEEEEEecCCCC
Confidence 3567788999999999999987655 78899999865422 22344554 6678899999999998765 577
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.++++| |.++|+|.+++........ -....+++.++..++.|++.||+|
T Consensus 84 ~~~~~~----------~~~~~~L~~~l~~~~~~~~---------------------~~~~~l~~~~~~~i~~~i~~~l~~ 132 (280)
T cd05043 84 PFVLYP----------YMNWGNLKLFLQQCRLGEA---------------------NNPQALSTQQLVHMAIQIACGMSY 132 (280)
T ss_pred CEEEEE----------cCCCCcHHHHHHhcccccc---------------------ccccCCCHHHHHHHHHHHHHHHHH
Confidence 899999 5566777766643211000 011347788899999999999999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHH
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL 701 (902)
||+.+++||||||+||+++.++. +||+|||+++.+....... ......++..|+|||++.+..++.++|||||||++
T Consensus 133 LH~~~i~H~di~p~nil~~~~~~--~kl~d~g~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l 209 (280)
T cd05043 133 LHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYHC-LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209 (280)
T ss_pred HHHCCEeecccCHhhEEEcCCCc--EEECCCCCcccccCCceEE-eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHH
Confidence 99999999999999999987755 9999999998664322111 11223467789999999888899999999999999
Q ss_pred HHHHhCCCCCCCCchhhH-HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 702 FFCITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||+++.+.+||....... ...+... ........++++.+++.+||..||++||++.++++
T Consensus 210 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 210 WELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999995588887643322 2222222 11223345678999999999999999999999973
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.52 Aligned_cols=245 Identities=25% Similarity=0.424 Sum_probs=184.2
Q ss_pred cceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCcc-----
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD----- 540 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~----- 540 (902)
.+.|...+.||+|+||+||+|.. .+|+.||||++.+.. .....+|+. +++.++||||+++++++.+..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELT-LLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHH-HHHhcCCCCccchhheecccccCCCC
Confidence 45677889999999999999864 578999999986532 123455665 667889999999999886543
Q ss_pred -ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccc
Q 002601 541 -FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (902)
Q Consensus 541 -~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL 619 (902)
..|+|+|++..+|.++ + ...+++..+..++.|++.||
T Consensus 93 ~~~~lv~e~~~~~l~~~-----------~-------------------------------~~~~~~~~~~~~~~qi~~aL 130 (342)
T cd07879 93 QDFYLVMPYMQTDLQKI-----------M-------------------------------GHPLSEDKVQYLVYQMLCGL 130 (342)
T ss_pred ceEEEEecccccCHHHH-----------H-------------------------------cCCCCHHHHHHHHHHHHHHH
Confidence 4689999654332221 1 12366778899999999999
Q ss_pred cccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhH
Q 002601 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 698 (902)
Q Consensus 620 ~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlG 698 (902)
+|||+.+|+||||||+|||++.++. +||+|||+++..... .....|+..|+|||++.+ ..++.++||||||
T Consensus 131 ~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 202 (342)
T cd07879 131 KYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHADAE------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVG 202 (342)
T ss_pred HHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCCCC------CCCceeeecccChhhhcCccccCchHHHHHHH
Confidence 9999999999999999999988765 999999998765321 123357889999999876 4588999999999
Q ss_pred HHHHHHHhCCCCCCCCchh-hHH-HHHhhc----------------------cccc--------cccCChHHHHHHHccc
Q 002601 699 CILFFCITGGKHPYGESFE-RDA-NIVKDR----------------------KDLF--------LVEHIPEAVDLFTRLL 746 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~-~~~-~~~~~~----------------------~~~~--------~~~~~~e~~dLI~~~L 746 (902)
|++|||++| +.||..... ... .+.... .... ....++++.++|.+||
T Consensus 203 vil~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 281 (342)
T cd07879 203 CIMAEMLTG-KTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML 281 (342)
T ss_pred HHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHc
Confidence 999999997 667764321 111 111000 0000 1124567899999999
Q ss_pred CCCCCCCcCHHHHHcCCCCCCc
Q 002601 747 DPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 747 ~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
+.||++||++++++.||||...
T Consensus 282 ~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 282 ELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred CCChhhCcCHHHHhcCcchhhc
Confidence 9999999999999999999654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=303.23 Aligned_cols=245 Identities=26% Similarity=0.392 Sum_probs=186.7
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|...++||+|+||+||++.. .+|+.||+|++..... ....+|+. +++.++|||++++++++.+.+..|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK-FLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHH-HHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 44557799999999999854 5689999999864321 12344554 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
||.+++.+++.. ....+++.++..++.||+.||+|||+.||
T Consensus 102 ~~~~~l~~~l~~---------------------------------------~~~~l~~~~~~~~~~qi~~al~~LH~~gi 142 (313)
T cd06633 102 YCLGSASDLLEV---------------------------------------HKKPLQEVEIAAITHGALQGLAYLHSHNM 142 (313)
T ss_pred cCCCCHHHHHHh---------------------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 876655444311 11235677888999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc---cCCCCCcchhhhhHHHHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGviL~el 704 (902)
+||||||+||+++.++. +||+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|
T Consensus 143 ~H~dl~p~nili~~~~~--~kL~dfg~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el 213 (313)
T cd06633 143 IHRDIKAGNILLTEPGQ--VKLADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213 (313)
T ss_pred ecCCCChhhEEECCCCC--EEEeecCCCcccCC-------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHH
Confidence 99999999999988776 89999998864322 22446889999999984 35678899999999999999
Q ss_pred HhCCCCCCCCch-hhH-HHHHhhccc-cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 705 ITGGKHPYGESF-ERD-ANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 705 ltG~~~Pf~~~~-~~~-~~~~~~~~~-~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
++| .+||.... ... ..+...... ......+..+++++.+||+.+|.+||++.+++.||||....
T Consensus 214 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 214 AER-KPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HhC-CCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 998 55654432 221 222221111 11223456799999999999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=301.94 Aligned_cols=247 Identities=26% Similarity=0.359 Sum_probs=185.4
Q ss_pred eEEEeeeecccCceEEEEEE-----eeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCc--cce
Q 002601 474 LVVFNKEIAKGSNGTVVLEG-----NYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQ--DFV 542 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~-----~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~--~~~ 542 (902)
.|+..+.||+|+||.||++. ..+++.||+|.+..... ....+|+. +++.++||||+++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE-ILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHH-HHHhCCCCCeeeeeeEEecCCCCce
Confidence 35667889999999999875 34688999999864432 23344554 67889999999999988775 678
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
++||| |.++|+|.+++.... ..+++..+..++.|++.||+||
T Consensus 84 ~lv~e----------~~~g~~L~~~l~~~~----------------------------~~~~~~~~~~i~~~i~~aL~~l 125 (284)
T cd05079 84 KLIME----------FLPSGSLKEYLPRNK----------------------------NKINLKQQLKYAVQICKGMDYL 125 (284)
T ss_pred EEEEE----------ccCCCCHHHHHHhcc----------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 99999 667777777663211 2357778899999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
|+.||+||||||+||+++.++. ++|+|||+++.+..............|+..|+|||++.+..++.++|||||||++|
T Consensus 126 H~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 126 GSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred HHCCeeecccchheEEEcCCCC--EEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 9999999999999999988776 89999999987654322212222345677899999998888999999999999999
Q ss_pred HHHhCCCCCCCCch----------------hhHHHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 703 FCITGGKHPYGESF----------------ERDANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 703 elltG~~~Pf~~~~----------------~~~~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
||+++.. |..... ......+. ......+...++++.+++.+||+.||.+||++++++++
T Consensus 204 ellt~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 204 ELLTYCD-SESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhcCCC-CCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999743 322111 00111111 11112234466899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.22 Aligned_cols=241 Identities=25% Similarity=0.379 Sum_probs=185.1
Q ss_pred ceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCchH-HHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~~-~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
+.|.+.+.||+|+||.||++. .+++.||+|.+....... ..+|+ .++..++||||+++++++.++ ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~~~~~~~~~e~-~~l~~~~~~~i~~~~~~~~~~-~~~~v~e---- 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTAQAFLEET-AVMTKLHHKNLVRLLGVILHN-GLYIVME---- 78 (254)
T ss_pred HHceeeeeeccCCCCceEecc-cCCCceEEEeecCcchHHHHHHHH-HHHHhCCCCCcCeEEEEEcCC-CcEEEEE----
Confidence 457788999999999999854 678899999986543333 34454 467889999999999998765 4799999
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
|+++|+|.+++.... ...+++..+..++.|++.||+|||+.|++|||
T Consensus 79 ------~~~~~~L~~~l~~~~---------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~d 125 (254)
T cd05083 79 ------LMSKGNLVNFLRTRG---------------------------RALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125 (254)
T ss_pred ------CCCCCCHHHHHHhcC---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 555666666654221 12356778899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+||+++.++. +||+|||++....... .....+..|+|||.+.+..++.++|+|||||++|||++++.+|
T Consensus 126 l~p~nili~~~~~--~kl~Dfg~~~~~~~~~------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 197 (254)
T cd05083 126 LAARNILVSEDGV--AKVSDFGLARVGSMGV------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197 (254)
T ss_pred cCcceEEEcCCCc--EEECCCccceeccccC------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999987765 9999999987643211 1122456799999998888999999999999999999855888
Q ss_pred CCCchhhH-HHHH-hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 712 YGESFERD-ANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 712 f~~~~~~~-~~~~-~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
|....... .... .......+...++++.+++.+||+.+|..||++++++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 198 YPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 86543222 1222 22122223445678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.89 Aligned_cols=245 Identities=31% Similarity=0.460 Sum_probs=183.6
Q ss_pred EEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc-----hHHHHHHHHH--HHhCCCCCeeEecccccCccc-----e
Q 002601 476 VFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH-----DVALKEIQNL--IASDQHPNIVRWYGVESDQDF-----V 542 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~-----~~~~~Ei~~l--l~~l~HpNIV~l~g~~~d~~~-----~ 542 (902)
.+.+.||+|+||.||++... +|+.||||++..... ....+|+..+ +..++||||+++++++.+.+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45688999999999998665 589999999864321 1233454422 344579999999999988776 9
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
+++||++.++|.++ +.... ...+++..++.++.|++.||+||
T Consensus 82 ~l~~e~~~~~l~~~-----------l~~~~---------------------------~~~l~~~~~~~~~~~i~~al~~L 123 (287)
T cd07838 82 TLVFEHVDQDLATY-----------LSKCP---------------------------KPGLPPETIKDLMRQLLRGVDFL 123 (287)
T ss_pred EEEehhcccCHHHH-----------HHHcc---------------------------CCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999665444433 32110 12367788899999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
|+.+++|+||+|+||+++.++. +||+|||++....... ......++..|+|||++.+..++.++|+|||||++|
T Consensus 124 H~~~i~h~~l~~~nili~~~~~--~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~ 197 (287)
T cd07838 124 HSHRIVHRDLKPQNILVTSDGQ--VKIADFGLARIYSFEM----ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197 (287)
T ss_pred HHCCeeeccCChhhEEEccCCC--EEEeccCcceeccCCc----ccccccccccccChHHhccCCCCCcchhhhHHHHHH
Confidence 9999999999999999988765 9999999998765331 112334788999999999888999999999999999
Q ss_pred HHHhCCCCCCCCchhhH--HHHHhhcc--------------------------ccccccCChHHHHHHHcccCCCCCCCc
Q 002601 703 FCITGGKHPYGESFERD--ANIVKDRK--------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRP 754 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~--~~~~~~~~--------------------------~~~~~~~~~e~~dLI~~~L~~dP~~Rp 754 (902)
+|++| .+||....... ..+..... ........+++.++|.+||+.||.+||
T Consensus 198 ~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 198 ELFRR-RPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred HHHhC-CCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 99997 77776432211 11111000 000112346788999999999999999
Q ss_pred CHHHHHcCCCC
Q 002601 755 KAQNVLNHPFF 765 (902)
Q Consensus 755 t~~elL~HPfF 765 (902)
++.+++.||||
T Consensus 277 ~~~~il~~~~~ 287 (287)
T cd07838 277 SAFEALQHPYF 287 (287)
T ss_pred CHHHHhcCcCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=305.60 Aligned_cols=247 Identities=25% Similarity=0.384 Sum_probs=187.8
Q ss_pred ccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCcc----
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 540 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~---- 540 (902)
+++.|...+.||+|+||+||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHH-HHHhcCCCCccceeeeecCCccccc
Confidence 45668888999999999999985 45789999999854321 22445554 678899999999999887654
Q ss_pred --ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 541 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 541 --~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
..++|||++..+|.+++ . ...+++..++.++.||+.|
T Consensus 92 ~~~~~lv~e~~~~~l~~~~-----------~------------------------------~~~l~~~~~~~i~~qi~~a 130 (343)
T cd07880 92 FHDFYLVMPFMGTDLGKLM-----------K------------------------------HEKLSEDRIQFLVYQMLKG 130 (343)
T ss_pred cceEEEEEecCCCCHHHHH-----------h------------------------------cCCCCHHHHHHHHHHHHHH
Confidence 35899997655444332 1 1235777889999999999
Q ss_pred ccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhh
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 697 (902)
Q Consensus 619 L~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSl 697 (902)
|+|||+.||+||||||+||+++.++. ++|+|||++...... .....+++.|+|||++.+ ..++.++|+|||
T Consensus 131 l~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 202 (343)
T cd07880 131 LKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQTDSE------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSV 202 (343)
T ss_pred HHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccccccccC------ccccccCCcccCHHHHhCCCCCCcHHHHHHH
Confidence 99999999999999999999987765 899999999865432 123357889999999876 457899999999
Q ss_pred HHHHHHHHhCCCCCCCCchhh--HHHHHhhc------------------------------cccccccCChHHHHHHHcc
Q 002601 698 GCILFFCITGGKHPYGESFER--DANIVKDR------------------------------KDLFLVEHIPEAVDLFTRL 745 (902)
Q Consensus 698 GviL~elltG~~~Pf~~~~~~--~~~~~~~~------------------------------~~~~~~~~~~e~~dLI~~~ 745 (902)
||++|++++| .+||...... ...+.... ........++++.++|.+|
T Consensus 203 G~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 281 (343)
T cd07880 203 GCIMAEMLTG-KPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKM 281 (343)
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHH
Confidence 9999999997 6777643211 11111000 0001124567899999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCc
Q 002601 746 LDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 746 L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
|+.||.+|||+.+++.||||...
T Consensus 282 l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 282 LVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cCCChhhCCCHHHHhcCccHhhh
Confidence 99999999999999999999654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=299.09 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=197.8
Q ss_pred ccceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC--chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
..+.|...+.||+|++|.||++... ++..||+|++.... .....+|+. ++..++|+||+++++++.+.+..|+++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEIL-IMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHH-HHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4455677788999999999998654 68999999997654 234455655 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.||
T Consensus 96 ----------~~~~~~L~~~l~~~~----------------------------~~l~~~~~~~i~~~i~~~L~~lH~~gi 137 (286)
T cd06614 96 ----------YMDGGSLTDIITQNF----------------------------VRMNEPQIAYVCREVLQGLEYLHSQNV 137 (286)
T ss_pred ----------ccCCCcHHHHHHHhc----------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 555666666654211 246777889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+|+||+|+||+++.++. ++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 138 ~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g 212 (286)
T cd06614 138 IHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKS---KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212 (286)
T ss_pred eeCCCChhhEEEcCCCC--EEECccchhhhhccchh---hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhC
Confidence 99999999999988776 89999999876553211 12334578899999999888899999999999999999998
Q ss_pred CCCCCCCchhhH--HHHHhhcccc--ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 708 GKHPYGESFERD--ANIVKDRKDL--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 708 ~~~Pf~~~~~~~--~~~~~~~~~~--~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
..||....... ..+....... .....+.++.++|.+||+.+|.+||++.++++||||...
T Consensus 213 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 213 -EPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred -CCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 67776543221 1111111111 112256789999999999999999999999999999663
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=345.42 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=200.6
Q ss_pred ccccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-h---HHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-D---VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
+.+.-++.-+..||.|.||.||-|. ..+|...|||-+.-... . ....|+..++..++|||+|++||+..+.+.+|
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3444445556789999999999984 56789999997643221 1 22445556889999999999999999999999
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
|.||||. +|+|.+.+.-. +-.++.....+..|++.|++|||
T Consensus 1311 IFMEyC~----------~GsLa~ll~~g-----------------------------ri~dE~vt~vyt~qll~gla~LH 1351 (1509)
T KOG4645|consen 1311 IFMEYCE----------GGSLASLLEHG-----------------------------RIEDEMVTRVYTKQLLEGLAYLH 1351 (1509)
T ss_pred HHHHHhc----------cCcHHHHHHhc-----------------------------chhhhhHHHHHHHHHHHHHHHHH
Confidence 9999665 45555544211 11233445678999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCC-ccccccccCCCCccccCchhhccCC---CCCcchhhhhHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM-SCLTQNATGYGSSGWQAPEQLLQGR---QTRAIDLFSLGC 699 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~-~~~~~~~~~~Gt~~Y~APE~l~~~~---~s~ksDVwSlGv 699 (902)
++|||||||||.||+|+.+|- +|++|||.|..+.... +.........||+.|||||++.+.. ...++||||+||
T Consensus 1352 ~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGC 1429 (1509)
T KOG4645|consen 1352 EHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGC 1429 (1509)
T ss_pred hcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccc
Confidence 999999999999999988874 9999999999887653 1222234567999999999998654 568999999999
Q ss_pred HHHHHHhCCCCCCCCc---hhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 700 ILFFCITGGKHPYGES---FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 700 iL~elltG~~~Pf~~~---~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
|+.||+|| +.||.+- .+-......+..+..|...+++.+|+|.+||+.||++|.++.|+++|-|-..
T Consensus 1430 VVlEM~tG-krPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1430 VVLEMATG-KRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred eEEEeecC-CCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 99999998 6687653 2233445556677778889999999999999999999999999999998543
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=300.00 Aligned_cols=268 Identities=25% Similarity=0.359 Sum_probs=190.3
Q ss_pred EEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
|.+.+.||+|+||+||+|... ....||+|.+...... ...+|+. +++.++||||+++++.+.+++..|+
T Consensus 2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN-LLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHH-HHhhCCCCCEeeEEEEEecCCCcEE
Confidence 456688999999999997542 2367999988654322 3445655 6688999999999999999999999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
++| |+.+|+|.+++........... -............-....+++..++.++.|++.||+|||+
T Consensus 81 v~e----------~~~~~~L~~~l~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 145 (290)
T cd05045 81 IVE----------YAKYGSLRSFLRESRKVGPSYL-----GSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE 145 (290)
T ss_pred EEE----------ecCCCCHHHHHHhcCCcccccc-----ccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH
Confidence 999 5555666665542211000000 0000000000000112457888999999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
.+|+||||||+|||++.++. +||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||
T Consensus 146 ~~ivH~dikp~nill~~~~~--~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el 222 (290)
T cd05045 146 MKLVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 222 (290)
T ss_pred CCeehhhhhhheEEEcCCCc--EEeccccccccccCccchh-cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHH
Confidence 99999999999999987765 9999999998664332211 12233467789999999888899999999999999999
Q ss_pred HhCCCCCCCCchhhH-HHHHhh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 705 ITGGKHPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~-~~~~~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
++++..||....... ...... .....+...+.++.+++.+||+.||.+||++.++++
T Consensus 223 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 223 VTLGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HhcCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 995578886543322 222222 122234456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=296.66 Aligned_cols=245 Identities=29% Similarity=0.440 Sum_probs=184.4
Q ss_pred EEeeeecccCceEEEEEEee-CCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCc--cceeeeec
Q 002601 476 VFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLE 547 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~--~~~yLV~E 547 (902)
.+.+.||+|++|.||++... +|+.||||++.... .....+|+. ++..++|||++++++++.+. +..++|+|
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIK-LLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHH-HHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 45688999999999998654 58999999997642 123445654 66788999999999999888 89999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|++.+| .+++... ...+++..++.++.||+.||+|||+.++
T Consensus 81 ~~~~~l-----------~~~~~~~----------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~~ 121 (287)
T cd07840 81 YMDHDL-----------TGLLDSP----------------------------EVKFTESQIKCYMKQLLEGLQYLHSNGI 121 (287)
T ss_pred cccccH-----------HHHHhcc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 655443 3333211 1246777889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHh
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ellt 706 (902)
+|+||||+||++++++. +||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++
T Consensus 122 ~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t 197 (287)
T cd07840 122 LHRDIKGSNILINNDGV--LKLADFGLARPYTKRNS--ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197 (287)
T ss_pred eeccCcHHHeEEcCCCC--EEEccccceeeccCCCc--ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHh
Confidence 99999999999988765 89999999987654321 11122346888999998765 457899999999999999999
Q ss_pred CCCCCCCCchhhH-H-HHHhhcc-----------------------------cccccc-CChHHHHHHHcccCCCCCCCc
Q 002601 707 GGKHPYGESFERD-A-NIVKDRK-----------------------------DLFLVE-HIPEAVDLFTRLLDPNPDLRP 754 (902)
Q Consensus 707 G~~~Pf~~~~~~~-~-~~~~~~~-----------------------------~~~~~~-~~~e~~dLI~~~L~~dP~~Rp 754 (902)
| .+||....... . .+..... ...... .++++.++|.+||+.+|.+||
T Consensus 198 ~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (287)
T cd07840 198 G-KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI 276 (287)
T ss_pred C-CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc
Confidence 8 67776433211 1 1110000 000111 267889999999999999999
Q ss_pred CHHHHHcCCCC
Q 002601 755 KAQNVLNHPFF 765 (902)
Q Consensus 755 t~~elL~HPfF 765 (902)
+++++++||||
T Consensus 277 ~~~~~l~~~~~ 287 (287)
T cd07840 277 SADQALQHEYF 287 (287)
T ss_pred CHHHHhhCcCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.98 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=192.0
Q ss_pred ceEEEeeeecccCceEEEEEEee--------CCcEEEEEEeccCCc----hHHHHHHHHHHHhC-CCCCeeEecccccCc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH----DVALKEIQNLIASD-QHPNIVRWYGVESDQ 539 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~--------~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~ 539 (902)
..|.+.+.||+|+||.||++... .+..||+|.+..... ....+|+. ++..+ +||||++++++|.++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEME-MMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHH-HHHhhcCCCCeeeeeEEEccC
Confidence 45778899999999999998532 234799998864322 23455665 45555 899999999999999
Q ss_pred cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccc
Q 002601 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (902)
Q Consensus 540 ~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL 619 (902)
+..|++|| |+++|+|.+++......... ............+++.+++.++.|++.||
T Consensus 91 ~~~~lv~e----------~~~~g~L~~~l~~~~~~~~~-------------~~~~~~~~~~~~l~~~~~~~~~~qi~~al 147 (334)
T cd05100 91 GPLYVLVE----------YASKGNLREYLRARRPPGMD-------------YSFDTCKLPEEQLTFKDLVSCAYQVARGM 147 (334)
T ss_pred CceEEEEe----------cCCCCcHHHHHHhcCCcccc-------------cccccccCccccCCHHHHHHHHHHHHHHH
Confidence 99999999 66667777766532211000 00000001123467788899999999999
Q ss_pred cccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHH
Q 002601 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (902)
Q Consensus 620 ~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGv 699 (902)
+|||++||+||||||+|||++.++. +||+|||+++....... ........++..|+|||++.+..++.++|||||||
T Consensus 148 ~~LH~~givH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 224 (334)
T cd05100 148 EYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDY-YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 224 (334)
T ss_pred HHHHHCCeeccccccceEEEcCCCc--EEECCcccceecccccc-cccccCCCcCceEcCHHHhccCCcCchhhhHHHHH
Confidence 9999999999999999999987765 89999999986643211 11122233467899999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCch-hhHHHHHhh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 700 ILFFCITGGKHPYGESF-ERDANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 700 iL~elltG~~~Pf~~~~-~~~~~~~~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
++|||++++.+||.... +.....+.. .....+...+.++.+++.+||+.+|.+||++.|++++
T Consensus 225 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 225 LLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 99999996677886543 222222222 2223344567799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=292.50 Aligned_cols=247 Identities=25% Similarity=0.393 Sum_probs=189.4
Q ss_pred ceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC------chHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
+.|.+.+.||+|+||.||++... +|+.||+|.+.... .....+|+. +++.++|+||+++++++.+.+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~-~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID-LLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHH-HHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 35778899999999999998655 79999999875321 123445554 66888999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+++|+|.+++..... ....+++.++..++.|++.||+|||+.
T Consensus 81 ~e----------~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~ 125 (267)
T cd08224 81 LE----------LADAGDLSRMIKHFKK-------------------------QKRLIPERTIWKYFVQLCSALEHMHSK 125 (267)
T ss_pred Ee----------cCCCCCHHHHHHHhcc-------------------------cCCCcCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 6666777666532111 113467788899999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
||+||||||+||+++.++. ++|+|||++........ ......|+..|+|||.+.+..++.++|||||||++|+|+
T Consensus 126 ~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 126 RIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred CEecCCcChhhEEECCCCc--EEEeccceeeeccCCCc---ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 9999999999999988776 89999999876543211 112345888999999999888999999999999999999
Q ss_pred hCCCCCCCCchhhH---H-HHHhhccccccc-cCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 706 TGGKHPYGESFERD---A-NIVKDRKDLFLV-EHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 706 tG~~~Pf~~~~~~~---~-~~~~~~~~~~~~-~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+| ..||....... . .+........+. ..+.++.++|.+||..+|.+||++.++++
T Consensus 201 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 201 AL-QSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HC-CCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 98 56664332111 1 111111122222 45668999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=334.97 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=188.9
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+.+.||+|+||+||+|.. .+|+.||||++..... ....+|+ .+++.++||||+++++++.+++..|+||
T Consensus 3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi-~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREA-KIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHH-HHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 567889999999999999854 4689999999864321 2234555 4678899999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|+|.+++........ +. .-.....+...+++++.||++||+|||+.|
T Consensus 82 E----------Y~eGGSL~~lL~s~~~~~~-l~-----------------e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G 133 (932)
T PRK13184 82 P----------YIEGYTLKSLLKSVWQKES-LS-----------------KELAEKTSVGAFLSIFHKICATIEYVHSKG 133 (932)
T ss_pred E----------cCCCCCHHHHHHHhhhccc-cc-----------------hhhhcccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9 6667777776643211000 00 001233566778999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCc---------------cccccccCCCCccccCchhhccCCCCCc
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS---------------CLTQNATGYGSSGWQAPEQLLQGRQTRA 691 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~---------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~k 691 (902)
|+||||||+|||++.++. +||+|||+++....... ........+||+.|+|||++.+..++.+
T Consensus 134 IIHRDLKPeNILLd~dg~--vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k 211 (932)
T PRK13184 134 VLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES 211 (932)
T ss_pred ccccCCchheEEEcCCCC--EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH
Confidence 999999999999988876 89999999987621110 0111123469999999999999999999
Q ss_pred chhhhhHHHHHHHHhCCCCCCCCchhhHHHH---Hhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 692 IDLFSLGCILFFCITGGKHPYGESFERDANI---VKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 692 sDVwSlGviL~elltG~~~Pf~~~~~~~~~~---~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
+|||||||++|||+|| ..||.......... .... ........++.+.+++.+||+.||++|++..+.+.+
T Consensus 212 SDIWSLGVILyELLTG-~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 212 TDIYALGVILYQMLTL-SFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hHHHHHHHHHHHHHHC-CCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999998 67876532221111 1000 101123456789999999999999999876655433
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=293.10 Aligned_cols=242 Identities=24% Similarity=0.304 Sum_probs=184.6
Q ss_pred eeecccCceEEEEEEeeC--C--cEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 479 KEIAKGSNGTVVLEGNYE--G--RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~--g--~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
+.||+|++|+||++...+ + ..||||.+..... ....+|+. .++.++||||+++++++.+ ...++|||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~-~~~~~v~e--- 75 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAA-IMHSLDHENLIRLYGVVLT-HPLMMVTE--- 75 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHH-HHhhcCCCCccceeEEEcC-CeEEEEEE---
Confidence 358999999999986543 3 3699999876543 12344554 6788899999999999988 88999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+.+++||
T Consensus 76 -------~~~~~~L~~~l~~~~~---------------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~ 121 (257)
T cd05040 76 -------LAPLGSLLDRLRKDAL---------------------------GHFLISTLCDYAVQIANGMRYLESKRFIHR 121 (257)
T ss_pred -------ecCCCcHHHHHHhccc---------------------------ccCcHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 5566777666543210 235778889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||||+||+++.++. +||+|||+++.+..............++..|+|||++....++.++|||||||++|||++.+..
T Consensus 122 di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 199 (257)
T cd05040 122 DLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199 (257)
T ss_pred ccCcccEEEecCCE--EEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999988765 9999999998775432222222234578899999999988999999999999999999994477
Q ss_pred CCCCchhh-HHHHHhh--ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 711 PYGESFER-DANIVKD--RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 711 Pf~~~~~~-~~~~~~~--~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||...... ....+.. .....+...+.++.+++.+||+.+|++||++.++++
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 200 PWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 88543222 2221111 111223345678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.46 Aligned_cols=241 Identities=27% Similarity=0.384 Sum_probs=186.2
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChh
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~ 554 (902)
+.||+|+||.||++...+++.||+|++...... ...+|+ .+++.+.|+||+++++++.+.+..++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~e------- 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEA-EILKQYDHPNIVKLIGVCVQKQPIYIVME------- 72 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCeEEEEEEEecCCCeEEEEE-------
Confidence 368999999999997766999999988654322 233444 46788999999999999999999999999
Q ss_pred hHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccccc
Q 002601 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (902)
Q Consensus 555 dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp 634 (902)
|+.+++|.+++.... ..+++..+..++.+++.||+|||+++++||||||
T Consensus 73 ---~~~~~~l~~~l~~~~----------------------------~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p 121 (251)
T cd05041 73 ---LVPGGSLLTFLRKKK----------------------------NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAA 121 (251)
T ss_pred ---cCCCCcHHHHHHhcC----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCc
Confidence 666667766653221 2346677789999999999999999999999999
Q ss_pred ceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCC
Q 002601 635 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714 (902)
Q Consensus 635 ~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~ 714 (902)
+|||++.++. +||+|||++......... .......++..|+|||.+.+..++.++|+|||||++|||++++..||..
T Consensus 122 ~nili~~~~~--~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 122 RNCLVGENNV--LKISDFGMSREEEGGIYT-VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred ceEEEcCCCc--EEEeeccccccccCCcce-eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 9999987765 999999999865432111 1111223466799999998888999999999999999999976888865
Q ss_pred chhhH-HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 715 SFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 715 ~~~~~-~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
..... ...+... ....+...+.++.+++.+||+.+|.+||++.|+++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 199 MSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 43322 2222221 22234456679999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=294.42 Aligned_cols=247 Identities=25% Similarity=0.363 Sum_probs=185.8
Q ss_pred eEEEeeeecccCceEEEEEEee-CC---cEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-EG---RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-~g---~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
.+.+.+.||+|+||.||+|... +| ..||||++...... ....|+ .+++.+.||||+++++++.+++..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEA-SIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHH-HHHHhCCCcCcceEEEEECCCCceEEE
Confidence 4677899999999999998654 33 36999998754322 233444 466788999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+++|+|.+++... ...+++.+++.++.|++.||+|||+.
T Consensus 84 ~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~i~~~l~~al~~lH~~ 125 (269)
T cd05065 84 TE----------FMENGALDSFLRQN----------------------------DGQFTVIQLVGMLRGIAAGMKYLSEM 125 (269)
T ss_pred Ee----------cCCCCcHHHHHhhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99 66667776665422 12356778899999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccC--CCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~--~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
|++||||||+||+++.++. +||+|||++................ .++..|+|||++....++.++|||||||++||
T Consensus 126 g~~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e 203 (269)
T cd05065 126 NYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 203 (269)
T ss_pred CEeecccChheEEEcCCCc--EEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHH
Confidence 9999999999999976654 9999999987665332211111111 12457999999998899999999999999999
Q ss_pred HHhCCCCCCCCchhh-HHHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 704 CITGGKHPYGESFER-DANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 704 lltG~~~Pf~~~~~~-~~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+++.+.+||...... ....+. ......+...++++.+++.+||+.+|.+||++.+++.
T Consensus 204 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 204 VMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 997447777654322 222222 1122233456778999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=290.68 Aligned_cols=243 Identities=26% Similarity=0.405 Sum_probs=188.8
Q ss_pred EeeeecccCceEEEEEEeeC-----CcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 477 FNKEIAKGSNGTVVLEGNYE-----GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~~~-----g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+.+.||.|+||.||++.... +..||+|++..... ....+|+. ++..++|+||+++++++.+.+..|++||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREAR-IMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHH-HHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 55789999999999986543 48899999975542 23344554 5677799999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|.++|+|.+++..... ..+++.++..++.|++.||+|||+.++
T Consensus 82 ----------~~~~~~l~~~~~~~~~---------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~~ 124 (258)
T smart00219 82 ----------YMEGGDLLDYLRKNRP---------------------------KELSLSDLLSFALQIARGMEYLESKNF 124 (258)
T ss_pred ----------ccCCCCHHHHHHhhhh---------------------------ccCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 5566777666543211 116778889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+||||||+||+++.++. ++|+|||+++.......... ....+++.|+|||.+....++.++||||+||++|+|+++
T Consensus 125 ~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~--~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~ 200 (258)
T smart00219 125 IHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDYYKK--KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200 (258)
T ss_pred eecccccceEEEccCCe--EEEcccCCceeccccccccc--ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence 99999999999988765 99999999987764322111 122367899999999888899999999999999999997
Q ss_pred CCCCCCCchhhH-H-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 708 GKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 708 ~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+.+||....... . .+........+...+.++.+++.+||..||++|||+.++++
T Consensus 201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 201 GESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 688887533222 2 22222223334456789999999999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=295.74 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=186.4
Q ss_pred eecccCceEEEEEEeeC-------CcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 480 EIAKGSNGTVVLEGNYE-------GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~~~-------g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
.||+|+||.||++...+ ++.||||.+.+.. .....+|+. +++.++||||+++++++.+.+..++|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~v~e- 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAH-LMSNFNHPNIVKLLGVCLLNEPQYIIME- 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHH-HHHhcCCCCeeeEeeeecCCCCeEEEEe-
Confidence 58999999999975432 3689999876532 123344444 6788999999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++|+|.+++....... .....+++.+++.++.|++.||+|||+.+++
T Consensus 80 ---------~~~~~~L~~~l~~~~~~~----------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 128 (269)
T cd05044 80 ---------LMEGGDLLSYLRDARVER----------------------FGPPLLTLKELLDICLDVAKGCVYLEQMHFI 128 (269)
T ss_pred ---------ccCCCcHHHHHHHhhhcc----------------------cCCccccHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 777888888775432110 0123467788899999999999999999999
Q ss_pred ccccccceeEeccCC---CceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 629 HRDLKPQNVLISKDK---SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 629 HrDLKp~NILL~~d~---~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
|+||||+||+++.++ ...++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|||+
T Consensus 129 H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 207 (269)
T cd05044 129 HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY-YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207 (269)
T ss_pred cCCCChheEEEecCCCCCCcceEECCcccccccccccc-cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH
Confidence 999999999998765 22589999999986643211 11122334678899999999999999999999999999999
Q ss_pred hCCCCCCCCchhhHH-HHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 706 TGGKHPYGESFERDA-NIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 706 tG~~~Pf~~~~~~~~-~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+.+..||........ ..+. ......+...++++.++|.+||..+|.+||++.++++
T Consensus 208 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 208 TLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 844778865432221 1111 1222233455678999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=294.47 Aligned_cols=248 Identities=24% Similarity=0.372 Sum_probs=188.5
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccC--------CchHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~--------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
|.+.+.||+|+||+||++... .+..+++|.++.. .......|.. ++..++||||+++++++.+.+..++|
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ-LLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHH-HHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 567789999999999997543 3455666665421 1112344554 67889999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+++++|.+.+.... .....+++..++.++.|++.||+|||+.
T Consensus 81 ~e----------~~~~~~l~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (260)
T cd08222 81 TE----------YCEGRDLDCKLEELK-------------------------HTGKTLSENQVCEWFIQLLLGVHYMHQR 125 (260)
T ss_pred EE----------eCCCCCHHHHHHHHh-------------------------hcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence 99 666677766654211 1124578888999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
+++|+||||+||+++. +. ++|+|||+++....... ......|++.|+|||.+....++.++|+||||+++|+|+
T Consensus 126 ~i~h~~l~~~nili~~-~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~ 199 (260)
T cd08222 126 RILHRDLKAKNIFLKN-NL--LKIGDFGVSRLLMGSCD---LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC 199 (260)
T ss_pred CccccCCChhheEeec-CC--EeecccCceeecCCCcc---cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999964 33 89999999887653321 122345788999999998888899999999999999999
Q ss_pred hCCCCCCCCchhhH--HHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 706 TGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 706 tG~~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
+| ..||....... ..+........+...++++.++|.+||+.||++||++.++++||||
T Consensus 200 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 200 CL-AHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred hC-CCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 98 56775432211 1222222223344567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=298.55 Aligned_cols=266 Identities=22% Similarity=0.297 Sum_probs=189.5
Q ss_pred eEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
.|...+.||+|+||.||++... ++..||+|++...... ...+|+. +++.+.||||+++++++.+++..+
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~-~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHH-HHHhcCCCchheEEEEEcCCCccE
Confidence 4667788999999999998542 4689999998754322 2334544 678889999999999999999999
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccc-hhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSN-LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~-~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
++|| |+++|+|.+++........ ..... .............+++..++.++.|++.||+||
T Consensus 85 lv~e----------~~~~~~L~~~l~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~l 146 (288)
T cd05050 85 LLFE----------YMAYGDLNEFLRHRSPRAQCSLSHS--------TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL 146 (288)
T ss_pred EEEe----------cCCCCCHHHHHHHcCcccccccccc--------ccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 9999 5555666666543211000 00000 000000001224578889999999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
|+.+++||||||+||+++.++. ++|+|||++......... .......++..|+|||.+.+..++.++|||||||++|
T Consensus 147 H~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 223 (288)
T cd05050 147 SERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 223 (288)
T ss_pred HhCCeecccccHhheEecCCCc--eEECccccceecccCccc-cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHH
Confidence 9999999999999999988765 899999998765432211 1112223467799999999889999999999999999
Q ss_pred HHHhCCCCCCCCc-hhhHHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 703 FCITGGKHPYGES-FERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 703 elltG~~~Pf~~~-~~~~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||++.+..||... .+.....+... ....+...++++.++|.+||+.||.+||++.|+++
T Consensus 224 el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 224 EIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 9998546676443 33222222222 11223456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=295.39 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=178.0
Q ss_pred eecccCceEEEEEEee---CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 480 EIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~~---~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
.||+|+||.||++... ++..+|+|++..... ....+|+ .+++.++||||+++++++.+....++|||
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e----- 75 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEA-QPYRSLQHSNLLQCLGQCTEVTPYLLVME----- 75 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHH-HHHHhCCCCCEeeEEEEEcCCCCcEEEEE-----
Confidence 5899999999998543 346799998865432 1234454 47788999999999999999999999999
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDL 632 (902)
|+++|+|.++++..... .....++..++.++.|++.||+|||+.+++||||
T Consensus 76 -----~~~~g~L~~~l~~~~~~------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl 126 (269)
T cd05087 76 -----FCPLGDLKGYLRSCRKA------------------------ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDL 126 (269)
T ss_pred -----CCCCCcHHHHHHHhhhc------------------------ccccccHHHHHHHHHHHHHHHHHHHHCCEecccc
Confidence 66777887777543210 1122455677889999999999999999999999
Q ss_pred ccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-------CCCCcchhhhhHHHHHHHH
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-------RQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-------~~s~ksDVwSlGviL~ell 705 (902)
||+||+++.++. +||+|||+++....... ........|+..|+|||++... .++.++|||||||++|||+
T Consensus 127 kp~nil~~~~~~--~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05087 127 ALRNCLLTADLT--VKIGDYGLSHNKYKEDY-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203 (269)
T ss_pred CcceEEEcCCCc--EEECCccccccccCcce-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHH
Confidence 999999987765 99999999875433211 1112234578899999998642 3578999999999999999
Q ss_pred hCCCCCCCCchhhHH--HHHhhcc-----ccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 706 TGGKHPYGESFERDA--NIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 706 tG~~~Pf~~~~~~~~--~~~~~~~-----~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+.|..||........ ....... .......++++.+++.+|+ .+|++|||++||+.
T Consensus 204 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 204 ELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred hCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 734778865433221 1111111 1111234568899999998 68999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=289.55 Aligned_cols=247 Identities=26% Similarity=0.417 Sum_probs=195.2
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
|.+.+.||+|+||.||++. ..+|+.+|+|++..... ....+|+. +++.++|+||+++++++.+++..|+|+|
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e- 79 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR-ILASVNHPNIISYKEAFLDGNKLCIVME- 79 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHH-HHHhCCCCCchhhhhhhccCCEEEEEeh-
Confidence 5667889999999999974 45788999999865321 12334543 6688899999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
|+++++|.+++..... ....+++..+..++.|++.||+|||+.|++
T Consensus 80 ---------~~~~~~L~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~l~~al~~lh~~~i~ 125 (256)
T cd08530 80 ---------YAPFGDLSKAISKRKK-------------------------KRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125 (256)
T ss_pred ---------hcCCCCHHHHHHHHHh-------------------------hcCCCCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 7777777777643211 123467788899999999999999999999
Q ss_pred ccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
|+||+|+||+++.++. +||+|||++...... ......|+..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 126 h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g- 197 (256)
T cd08530 126 HRDLKSANILLVANDL--VKIGDLGISKVLKKN-----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF- 197 (256)
T ss_pred cCCCCcceEEEecCCc--EEEeeccchhhhccC-----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhC-
Confidence 9999999999988765 899999999877543 12234578999999999988899999999999999999997
Q ss_pred CCCCCCchhhHH--HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 709 KHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 709 ~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
..||........ .+........+...+.++.+++.+||+.+|.+||++.++++||+.
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 198 APPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 778865433221 222222222333456789999999999999999999999999973
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=286.16 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=193.1
Q ss_pred ccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccC---CchHHHHHHHHHHHhCCCCCeeEecccccCc-----cc
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT---HHDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DF 541 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~---~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~-----~~ 541 (902)
.+++|.+.+.||+|+|.-||++ +..+++.+|+|++.-. ..+.+.+|+. ..++.+|||++++++++..+ .+
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid-~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREID-NHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHH-HHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3578999999999999999997 6788999999998533 2345677776 66889999999999987543 34
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.||++. |...|+|.+.+.... -+...+++.++++|+.+|++||++
T Consensus 98 ~yll~P----------yy~~Gsl~d~i~~~k-------------------------~kg~~~sE~~iL~if~gic~gL~~ 142 (302)
T KOG2345|consen 98 AYLLLP----------YYKRGSLLDEIERLK-------------------------IKGNFVSEAQILWIFLGICRGLEA 142 (302)
T ss_pred EEEEee----------hhccccHHHHHHHHh-------------------------hcCCccCHHHHHHHHHHHHHHHHH
Confidence 899999 888898888774322 233457899999999999999999
Q ss_pred ccccc--ccccccccceeEeccCCCceEEEccCCccccccCCCccccc------cccCCCCccccCchhhccC---CCCC
Q 002601 622 LHEIG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ------NATGYGSSGWQAPEQLLQG---RQTR 690 (902)
Q Consensus 622 LH~~~--IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~------~~~~~Gt~~Y~APE~l~~~---~~s~ 690 (902)
||+.. ++||||||.|||++.++. ++|.|||.+....-......+ -.....|..|.|||.+.-. ..++
T Consensus 143 lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~e 220 (302)
T KOG2345|consen 143 LHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITE 220 (302)
T ss_pred HhccCCcccccCCCcceeEecCCCc--eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccccc
Confidence 99997 999999999999988765 899999998765421111110 0112358899999988644 4589
Q ss_pred cchhhhhHHHHHHHHhCCCCCCCCchhhHHH---HHhhcccccc--ccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 691 AIDLFSLGCILFFCITGGKHPYGESFERDAN---IVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 691 ksDVwSlGviL~elltG~~~Pf~~~~~~~~~---~~~~~~~~~~--~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
++|||||||++|.|+.| ..||....+.-.. .+......+| ..+++.+.++|+.||++||.+||++.+++.+
T Consensus 221 rtDIWSLGCtLYa~mf~-~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 221 RTDIWSLGCTLYAMMFG-ESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccchhhhhHHHHHHHHc-CCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 99999999999999998 7788654332110 1111111222 2367789999999999999999999999865
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=325.78 Aligned_cols=245 Identities=27% Similarity=0.401 Sum_probs=184.5
Q ss_pred eEEEeeeecccCceEEEEEEeeCC-cEEEEEEeccCCc---hHHHHHHHHHHHhCCCCCeeEecccc-c---C---ccce
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVE-S---D---QDFV 542 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~~g-~~VAVKrl~~~~~---~~~~~Ei~~ll~~l~HpNIV~l~g~~-~---d---~~~~ 542 (902)
.+.+.+.|.+|+|+.||+|....+ ..||+||+...+. ....+|+..|-..-.|+|||.|++.. . . .-++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 467789999999999999977666 9999999865532 23456776444444599999999932 1 1 2357
Q ss_pred eeeecccc-CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 543 YLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 543 yLV~E~c~-~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
+|.||||. ++|.|++ ..+ ...+|++.++++|+.|+++|+++
T Consensus 118 llLmEyC~gg~Lvd~m-----------n~R---------------------------lq~~lte~eVLkIf~dv~~AVa~ 159 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFM-----------NTR---------------------------LQTRLTEDEVLKIFYDVCEAVAA 159 (738)
T ss_pred EeehhhccCCcHHHHH-----------HHH---------------------------HhccCChHHHHHHHHHHHHHHHH
Confidence 99999887 3566554 221 12458899999999999999999
Q ss_pred ccccc--ccccccccceeEeccCCCceEEEccCCccccccCCCcc------ccccccCCCCccccCchhhc---cCCCCC
Q 002601 622 LHEIG--LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC------LTQNATGYGSSGWQAPEQLL---QGRQTR 690 (902)
Q Consensus 622 LH~~~--IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~------~~~~~~~~Gt~~Y~APE~l~---~~~~s~ 690 (902)
||... |||||||-+||||+.+|+ .||||||.|......... ........-|+.|+|||++. +...++
T Consensus 160 mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~e 237 (738)
T KOG1989|consen 160 MHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGE 237 (738)
T ss_pred HhcCCCccchhhhhhhheEEcCCCC--EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcc
Confidence 99886 999999999999999987 899999988643322110 00111223589999999875 567899
Q ss_pred cchhhhhHHHHHHHHhCCCCCCCCchhhHHHHHhhcccccc--ccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 691 AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 691 ksDVwSlGviL~elltG~~~Pf~~~~~~~~~~~~~~~~~~~--~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
|+|||||||+||-|+.. .+||++.-. ..|+.... .+| ...+..+.+||+.||++||.+||++-+++.+
T Consensus 238 KsDIWALGclLYkLCy~-t~PFe~sg~--laIlng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 238 KSDIWALGCLLYKLCYF-TTPFEESGK--LAILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred hhHHHHHHHHHHHHHHh-CCCcCcCcc--eeEEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 99999999999999996 889987522 12222222 233 3567899999999999999999999998865
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=302.16 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=184.1
Q ss_pred EEEeeeecccCceEEEEEEee-C--CcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccC----ccce
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-E--GRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD----QDFV 542 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~--g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d----~~~~ 542 (902)
|.+.+.||+|+||.||++... . +..||||++.... .....+|+..+.....||||+++++++.. ....
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 567789999999999998543 3 7899999986421 22345676644444479999999986432 2457
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+++|++.++|.+++ . ....+++..++.++.||+.||+||
T Consensus 82 ~~~~e~~~~~L~~~l-----------~-----------------------------~~~~~~~~~~~~~~~qi~~aL~~L 121 (332)
T cd07857 82 YLYEELMEADLHQII-----------R-----------------------------SGQPLTDAHFQSFIYQILCGLKYI 121 (332)
T ss_pred EEEEecccCCHHHHH-----------h-----------------------------cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 899997665554433 1 123467778899999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCcc-ccccccCCCCccccCchhhcc-CCCCCcchhhhhHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCI 700 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGvi 700 (902)
|+.||+||||||+|||++.++. +||+|||+++.+...... ........||..|+|||++.+ ..++.++||||+||+
T Consensus 122 H~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~ 199 (332)
T cd07857 122 HSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCI 199 (332)
T ss_pred HhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHH
Confidence 9999999999999999988776 899999999876543211 111233468999999998765 468999999999999
Q ss_pred HHHHHhCCCCCCCCchhhH-H-HHH-----------------------hhc----cc---cccccCChHHHHHHHcccCC
Q 002601 701 LFFCITGGKHPYGESFERD-A-NIV-----------------------KDR----KD---LFLVEHIPEAVDLFTRLLDP 748 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~~~-~-~~~-----------------------~~~----~~---~~~~~~~~e~~dLI~~~L~~ 748 (902)
+|+|++| .+||....... . .++ ... .. ......+.++.+++.+||+.
T Consensus 200 l~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 278 (332)
T cd07857 200 LAELLGR-KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAF 278 (332)
T ss_pred HHHHHhC-CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccC
Confidence 9999987 77876432110 0 000 000 00 01112356899999999999
Q ss_pred CCCCCcCHHHHHcCCCCCCcc
Q 002601 749 NPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 749 dP~~Rpt~~elL~HPfF~~~~ 769 (902)
||.+|||+.+++.||||..+.
T Consensus 279 ~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 279 DPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred CcccCCCHHHHhcChhhhhhc
Confidence 999999999999999996543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=297.43 Aligned_cols=251 Identities=27% Similarity=0.395 Sum_probs=190.2
Q ss_pred EEEeeeecccCceEEEEEEe----eCCcEEEEEEeccCCc-------hHHHHHHHHHHHhC-CCCCeeEecccccCccce
Q 002601 475 VVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTHH-------DVALKEIQNLIASD-QHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~----~~g~~VAVKrl~~~~~-------~~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~~~ 542 (902)
|.+.+.||+|++|.||++.. .+++.||||++.+... ....+|+. ++..+ +||||+++++.+.+++..
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~-~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQ-VLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHH-HHHhccCCcchhhhheeeecCCEE
Confidence 55678999999999998753 3578999999864321 22345555 44555 799999999999999999
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+||| |+++|+|.+++.. ...+++..+..++.|+++||+||
T Consensus 81 ~lv~e----------~~~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~ql~~~l~~l 121 (288)
T cd05583 81 HLILD----------YVNGGELFTHLYQ-----------------------------REHFTESEVRVYIAEIVLALDHL 121 (288)
T ss_pred EEEEe----------cCCCCcHHHHHhh-----------------------------cCCcCHHHHHHHHHHHHHHHHHH
Confidence 99999 6667777666532 12356777889999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC--CCCcchhhhhHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR--QTRAIDLFSLGCI 700 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~--~s~ksDVwSlGvi 700 (902)
|+.+++||||||+||+++.++. ++|+|||+++....... .......|+..|+|||.+.+.. .+.++||||||++
T Consensus 122 H~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~i 197 (288)
T cd05583 122 HQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEEE--ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVL 197 (288)
T ss_pred HHCCeeccCCCHHHeEECCCCC--EEEEECccccccccccc--cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHH
Confidence 9999999999999999987765 89999999887653321 1122345889999999987655 6889999999999
Q ss_pred HHHHHhCCCCCCCCch-----hhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC---HHHHHcCCCCCCcch
Q 002601 701 LFFCITGGKHPYGESF-----ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK---AQNVLNHPFFWTADT 770 (902)
Q Consensus 701 L~elltG~~~Pf~~~~-----~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt---~~elL~HPfF~~~~~ 770 (902)
+|||++| ..||.... ..............+....+++.++|.+||+.||++||| +.++++||||.+.++
T Consensus 198 l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~ 274 (288)
T cd05583 198 TFELLTG-ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW 274 (288)
T ss_pred HHHHHhC-CCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence 9999997 67775321 111111112222334456789999999999999999998 567799999976543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.33 Aligned_cols=245 Identities=22% Similarity=0.368 Sum_probs=186.4
Q ss_pred EEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|.+.+.||+|+||.||++. ..+|+.||||.+..... ....+|+. ++..+.||||+++++++.+++..+++||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEID-LLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHH-HHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4566789999999999986 45799999998754221 12334554 6678899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|.++|+|.+++..... ....+++..+..++.||+.||+|||+.+|
T Consensus 83 ----------~~~~~~L~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 127 (267)
T cd08229 83 ----------LADAGDLSRMIKHFKK-------------------------QKRLIPEKTVWKYFVQLCSALEHMHSRRV 127 (267)
T ss_pred ----------ecCCCCHHHHHHHhhc-------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 5666677666532111 12346788889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
+|+||||+||+++.++. ++|+|||++........ ......|+..|+|||++.+..++.++|+|||||++|+|++|
T Consensus 128 ~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 202 (267)
T cd08229 128 MHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTT---AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 202 (267)
T ss_pred ecCCCCHHHEEEcCCCC--EEECcchhhhccccCCc---ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhC
Confidence 99999999999987765 99999999876643221 11234588999999999888899999999999999999998
Q ss_pred CCCCCCCchhhHH---HHH-hhccc-cccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 708 GKHPYGESFERDA---NIV-KDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 708 ~~~Pf~~~~~~~~---~~~-~~~~~-~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
..||........ ..+ ..... ......++++.+++.+||+.||.+|||+.++++
T Consensus 203 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 203 -QSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -CCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 556643222111 111 11111 112335678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=306.48 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=185.0
Q ss_pred cccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCc----
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ---- 539 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~---- 539 (902)
.+.+.|...+.||+|+||.||++. ..+|+.||||++..... ....+|+. ++..++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~-~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHH-HHHHcCCCcccceeeeeeeccccc
Confidence 345778888999999999999985 45789999999865321 23445554 67889999999999987543
Q ss_pred --cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhc
Q 002601 540 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (902)
Q Consensus 540 --~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~ 617 (902)
...|++++++.++|. +++. ...+++..+..++.|+++
T Consensus 93 ~~~~~~lv~~~~~~~L~-----------~~~~------------------------------~~~l~~~~~~~i~~qi~~ 131 (345)
T cd07877 93 EFNDVYLVTHLMGADLN-----------NIVK------------------------------CQKLTDDHVQFLIYQILR 131 (345)
T ss_pred ccccEEEEehhcccCHH-----------HHHh------------------------------cCCCCHHHHHHHHHHHHH
Confidence 347888885544433 3221 123567778999999999
Q ss_pred cccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhh
Q 002601 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFS 696 (902)
Q Consensus 618 gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwS 696 (902)
||+|||+.+|+||||||+||+++.++. +||+|||+++..... .....|+..|+|||.+.+ ..++.++||||
T Consensus 132 aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 203 (345)
T cd07877 132 GLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDDE------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS 203 (345)
T ss_pred HHHHHHHCCeeecCCChHHEEEcCCCC--EEEeccccccccccc------ccccccCCCccCHHHHhCccCCCchhhHHH
Confidence 999999999999999999999988876 899999998765422 123357889999999866 46789999999
Q ss_pred hHHHHHHHHhCCCCCCCCchhh-H-HHHHhhc-----------------------c-------ccccccCChHHHHHHHc
Q 002601 697 LGCILFFCITGGKHPYGESFER-D-ANIVKDR-----------------------K-------DLFLVEHIPEAVDLFTR 744 (902)
Q Consensus 697 lGviL~elltG~~~Pf~~~~~~-~-~~~~~~~-----------------------~-------~~~~~~~~~e~~dLI~~ 744 (902)
|||++|+|++| .+||...... . ..+.... . .......++++.++|.+
T Consensus 204 lG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 282 (345)
T cd07877 204 VGCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 282 (345)
T ss_pred HHHHHHHHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHH
Confidence 99999999998 6677532211 1 0110000 0 00011246789999999
Q ss_pred ccCCCCCCCcCHHHHHcCCCCCC
Q 002601 745 LLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 745 ~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
||+.||.+||++.+++.||||..
T Consensus 283 ~L~~dp~~R~t~~e~l~h~~f~~ 305 (345)
T cd07877 283 MLVLDSDKRITAAQALAHAYFAQ 305 (345)
T ss_pred HcCCChhhcCCHHHHhcChhhhh
Confidence 99999999999999999999964
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.62 Aligned_cols=243 Identities=28% Similarity=0.480 Sum_probs=185.2
Q ss_pred EeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 477 FNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
..+.||+|++|.||++.. .+|+.+|+|++..... ....+|+. .++.++|+||+++++++.+++..++|+||+.
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK-LLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHH-HHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 457899999999999854 4789999999865432 23445554 5678889999999999999999999999776
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
+++.+++ ..+ ...+++..+..++.|++.||+|||+.+|+|+
T Consensus 82 ~~l~~~l-----------~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~ 122 (283)
T cd05118 82 TDLYKLI-----------KDR----------------------------QRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122 (283)
T ss_pred CCHHHHH-----------Hhh----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 5554433 111 1245777889999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG~~ 709 (902)
||||+||+++.++. ++|+|||.+........ ......++..|+|||.+.+. .++.++|+|||||++|+|++| .
T Consensus 123 dl~p~nili~~~~~--~~l~df~~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg-~ 196 (283)
T cd05118 123 DLKPENLLINTEGV--LKLADFGLARSFGSPVR---PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-R 196 (283)
T ss_pred CcCHHHEEECCCCc--EEEeeeeeeEecCCCcc---cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhC-C
Confidence 99999999987765 99999999987754321 11223478889999998876 689999999999999999998 6
Q ss_pred CCCCCchhh-H-HHHHhhcc-----------------------------ccccccCChHHHHHHHcccCCCCCCCcCHHH
Q 002601 710 HPYGESFER-D-ANIVKDRK-----------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 758 (902)
Q Consensus 710 ~Pf~~~~~~-~-~~~~~~~~-----------------------------~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~e 758 (902)
+||...... . ..+..... .......+.++.++|.+||++||.+||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 197 PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence 777543211 1 01100000 0001124568999999999999999999999
Q ss_pred HHcCCCC
Q 002601 759 VLNHPFF 765 (902)
Q Consensus 759 lL~HPfF 765 (902)
+++||||
T Consensus 277 ll~~~~~ 283 (283)
T cd05118 277 ALAHPYF 283 (283)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=294.89 Aligned_cols=244 Identities=28% Similarity=0.490 Sum_probs=183.2
Q ss_pred EEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc----hHHHHHHHHHHHhCC-CCCeeEecccccCccceeeeeccc
Q 002601 476 VFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~-HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
.+.+.||+|++|+||+|... +++.||||++..... ....+|+.. +..++ ||||+++++++.+++..|+|||+|
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~-l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKS-LRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHH-HHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 46688999999999998664 588999999865422 233456654 45666 999999999999999999999966
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
.++| .+.+.... ...+++..+..++.|++.||.|||+++++|
T Consensus 81 ~~~l-----------~~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H 122 (283)
T cd07830 81 EGNL-----------YQLMKDRK---------------------------GKPFSESVIRSIIYQILQGLAHIHKHGFFH 122 (283)
T ss_pred CCCH-----------HHHHHhcc---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 4444 33332211 124677888999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHhCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~elltG~ 708 (902)
+||+|+||+++.++. ++|+|||++....... ......|+..|+|||++.. ..++.++|+|||||+++||++|
T Consensus 123 ~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g- 195 (283)
T cd07830 123 RDLKPENLLVSGPEV--VKIADFGLAREIRSRP----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL- 195 (283)
T ss_pred CCCChhhEEEcCCCC--EEEeecccceeccCCC----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC-
Confidence 999999999987765 8999999998665321 1123457889999998854 4578999999999999999998
Q ss_pred CCCCCCchhh-HH-HHHhh------------------c-----------cccccccCChHHHHHHHcccCCCCCCCcCHH
Q 002601 709 KHPYGESFER-DA-NIVKD------------------R-----------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ 757 (902)
Q Consensus 709 ~~Pf~~~~~~-~~-~~~~~------------------~-----------~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~ 757 (902)
.+||...... .. .+... . .........+++.++|++||+.||.+||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ 275 (283)
T cd07830 196 RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTAS 275 (283)
T ss_pred CCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHH
Confidence 6677433211 10 00000 0 0000112256899999999999999999999
Q ss_pred HHHcCCCC
Q 002601 758 NVLNHPFF 765 (902)
Q Consensus 758 elL~HPfF 765 (902)
|++.||||
T Consensus 276 ei~~~~~~ 283 (283)
T cd07830 276 QALQHPYF 283 (283)
T ss_pred HHhhCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=292.03 Aligned_cols=228 Identities=25% Similarity=0.273 Sum_probs=178.4
Q ss_pred cCceEEEEE-EeeCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChhhHHHHhcC
Q 002601 484 GSNGTVVLE-GNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSG 562 (902)
Q Consensus 484 GsfGtVy~a-~~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~G 562 (902)
|.+|.||++ ...+|+.||+|++.... ...+|.. .+....||||+++++++.+.+..++||| |+++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~lv~e----------~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERL-TIIPHCVPNMVCLHKYIVSEDSVFLVLQ----------HAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHH-HHHhcCCCceeehhhheecCCeEEEEEe----------cCCCC
Confidence 899999997 45678999999997643 2223333 3344569999999999999999999999 66677
Q ss_pred ChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEeccC
Q 002601 563 SFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642 (902)
Q Consensus 563 sL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d 642 (902)
+|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+||+++.+
T Consensus 71 ~L~~~l~~-----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~ 121 (237)
T cd05576 71 KLWSHISK-----------------------------FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDR 121 (237)
T ss_pred CHHHHHHH-----------------------------hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCC
Confidence 77666532 1236778889999999999999999999999999999999888
Q ss_pred CCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhHHHH
Q 002601 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANI 722 (902)
Q Consensus 643 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~~~~ 722 (902)
+. ++++|||++...... .....++..|+|||.+....++.++|+||+||++|||++| ..|+.......
T Consensus 122 ~~--~~l~df~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g-~~~~~~~~~~~--- 189 (237)
T cd05576 122 GH--IQLTYFSRWSEVEDS------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGI--- 189 (237)
T ss_pred CC--EEEecccchhccccc------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHC-cchhhcCchhc---
Confidence 76 899999988765432 1223467789999999888899999999999999999998 55554321110
Q ss_pred HhhccccccccCChHHHHHHHcccCCCCCCCcCH-----HHHHcCCCC
Q 002601 723 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA-----QNVLNHPFF 765 (902)
Q Consensus 723 ~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~-----~elL~HPfF 765 (902)
........+...+++++++|.+||+.||.+||++ +++++||||
T Consensus 190 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 190 NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0011112334567889999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=285.94 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=191.5
Q ss_pred eeeecccCceEEEEEEe-eCCcEEEEEEeccCCchH----HHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 478 NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~~~----~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
...||.|+.|+|+++.. .+|..+|||.+.+..... .+..+..++.+-..|.||+.+|||..+..++++||.+..+
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C 176 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTC 176 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHH
Confidence 35699999999999854 568999999997664333 3344444555556799999999999999999999965543
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc-cccccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRD 631 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~-~IvHrD 631 (902)
.+.++. .-..++|+..+-++...++.||.||.++ +|+|||
T Consensus 177 ~ekLlk---------------------------------------rik~piPE~ilGk~tva~v~AL~YLKeKH~viHRD 217 (391)
T KOG0983|consen 177 AEKLLK---------------------------------------RIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 217 (391)
T ss_pred HHHHHH---------------------------------------HhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecc
Confidence 333321 1224577778888999999999999865 899999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc---CCCCCcchhhhhHHHHHHHHhCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGviL~elltG~ 708 (902)
+||+|||+++.|+ +|+||||++-++.+... .....|.+.|||||.+.. ..|+.++||||||+.++||.||
T Consensus 218 vKPSNILlDe~Gn--iKlCDFGIsGrlvdSkA----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg- 290 (391)
T KOG0983|consen 218 VKPSNILLDERGN--IKLCDFGISGRLVDSKA----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATG- 290 (391)
T ss_pred cCccceEEccCCC--EEeecccccceeecccc----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcc-
Confidence 9999999998887 99999999988765422 233458999999999864 3689999999999999999998
Q ss_pred CCCCCCc---hhhHHHHHhhcccccc--ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcc
Q 002601 709 KHPYGES---FERDANIVKDRKDLFL--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 709 ~~Pf~~~---~~~~~~~~~~~~~~~~--~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
..||... ++....++....+..+ ..+++++++++..||++|+.+||...++|+|||+...+
T Consensus 291 ~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 291 QYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred cCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 6688653 3333444443332222 23789999999999999999999999999999986544
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=306.40 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=187.0
Q ss_pred cccceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCC-----chHHHHHHHHHHHhC-CCCCeeEecccccCc--c
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASD-QHPNIVRWYGVESDQ--D 540 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~--~ 540 (902)
.+.+.|.+.+.||+|+||.||++... +|+.||||++.+.. .....+|+. ++..+ +||||+++++++... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~-~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIM-FLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHH-HHHHhcCCCCccceeeeeccCCCc
Confidence 44566777889999999999998654 68899999885421 123455665 56777 999999999987643 4
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
..|+|||+|.++|.+++ .. ..+++..+..++.||+.||+
T Consensus 83 ~~~lv~e~~~~~L~~~~-----------~~------------------------------~~~~~~~~~~i~~qi~~~L~ 121 (337)
T cd07852 83 DIYLVFEYMETDLHAVI-----------RA------------------------------NILEDVHKRYIMYQLLKALK 121 (337)
T ss_pred eEEEEecccccCHHHHH-----------hc------------------------------CCCCHHHHHHHHHHHHHHHH
Confidence 68999997765554433 11 12445566789999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccc--cccccCCCCccccCchhhcc-CCCCCcchhhhh
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL--TQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSL 697 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~--~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSl 697 (902)
|||+.||+||||||+||+++.++. +||+|||++.......... .......||..|+|||++.+ ..++.++|||||
T Consensus 122 ~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~sl 199 (337)
T cd07852 122 YIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSV 199 (337)
T ss_pred HHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHH
Confidence 999999999999999999988875 8999999998765432110 11223458999999998765 457899999999
Q ss_pred HHHHHHHHhCCCCCCCCchhhH-H-HH-----------------------Hhh---cc----ccccccCChHHHHHHHcc
Q 002601 698 GCILFFCITGGKHPYGESFERD-A-NI-----------------------VKD---RK----DLFLVEHIPEAVDLFTRL 745 (902)
Q Consensus 698 GviL~elltG~~~Pf~~~~~~~-~-~~-----------------------~~~---~~----~~~~~~~~~e~~dLI~~~ 745 (902)
||++|+|++| .+||....... . .+ ... .. .......+.++.++|.+|
T Consensus 200 G~~l~el~tg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (337)
T cd07852 200 GCILGEMLLG-KPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKL 278 (337)
T ss_pred HHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHh
Confidence 9999999998 66775422111 0 00 000 00 001122467899999999
Q ss_pred cCCCCCCCcCHHHHHcCCCCCCc
Q 002601 746 LDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 746 L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
|+.||.+||++.++++||||...
T Consensus 279 l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 279 LVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred ccCCcccccCHHHHhhChhhhhh
Confidence 99999999999999999999553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=298.41 Aligned_cols=257 Identities=24% Similarity=0.324 Sum_probs=188.0
Q ss_pred ceEEEeeeecccCceEEEEEEee-----------------CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeE
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-----------------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVR 531 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-----------------~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~ 531 (902)
+.|.+.+.||+|+||+||++... ++..||||++..... ....+|+. ++..++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK-IMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHH-HHHhCCCCCcce
Confidence 35778899999999999986322 245799999865322 23345654 678889999999
Q ss_pred ecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHH
Q 002601 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611 (902)
Q Consensus 532 l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I 611 (902)
+++++.+.+..++||| |+++|+|.+++........ ...+....+++.++..+
T Consensus 84 ~~~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~------------------~~~~~~~~~~~~~~~~~ 135 (296)
T cd05095 84 LLAVCITSDPLCMITE----------YMENGDLNQFLSRHEPQEA------------------AEKADVVTISYSTLIFM 135 (296)
T ss_pred EEEEEecCCccEEEEE----------eCCCCcHHHHHHhcCcccc------------------cccccccccCHHHHHHH
Confidence 9999999999999999 5566677666653321100 00122344678889999
Q ss_pred HHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCc
Q 002601 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691 (902)
Q Consensus 612 ~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~k 691 (902)
+.|++.||+|||+.+|+||||||+|||++.++. ++|+|||+++.+...... .......++..|+|||+...+.++.+
T Consensus 136 ~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~ 212 (296)
T cd05095 136 ATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTA 212 (296)
T ss_pred HHHHHHHHHHHHHCCeecccCChheEEEcCCCC--EEeccCcccccccCCcce-eccCcCcCccccCCHHHHhcCCccch
Confidence 999999999999999999999999999987765 899999999866432211 11122234678999999888889999
Q ss_pred chhhhhHHHHHHHHhC-CCCCCCCchhhH-HHHH----hh----ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 692 IDLFSLGCILFFCITG-GKHPYGESFERD-ANIV----KD----RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 692 sDVwSlGviL~elltG-~~~Pf~~~~~~~-~~~~----~~----~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+|||||||++|||+++ +..||....... .... .. .....+...++.+.+++.+||+.||.+||++.++++
T Consensus 213 ~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999984 467775432211 1100 00 011122345678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=292.83 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=176.6
Q ss_pred eecccCceEEEEEEeeCC---cEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 480 EIAKGSNGTVVLEGNYEG---RSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~~~g---~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
+||+|+||+||++...++ ..+++|.+..... ....+|+ .++..++||||+++++.|.+....|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~-~~~~~l~h~~iv~~~~~~~~~~~~~lv~e----- 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQG-DPYRILQHPNILQCLGQCVEAIPYLLVFE----- 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHH-HHHhccCCcchhheEEEecCCCccEEEEe-----
Confidence 599999999999865544 3466776654322 2334444 46678899999999999999999999999
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDL 632 (902)
|+++|+|.++++.... .....+...+..++.||++||+|||+.+|+||||
T Consensus 76 -----~~~~~~L~~~l~~~~~-------------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~di 125 (268)
T cd05086 76 -----YCELGDLKSYLSQEQW-------------------------HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDL 125 (268)
T ss_pred -----cCCCCcHHHHHHhhhc-------------------------ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 6667777777753211 1123455677899999999999999999999999
Q ss_pred ccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-------CCCCCcchhhhhHHHHHHHH
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-------GRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-------~~~s~ksDVwSlGviL~ell 705 (902)
||+|||++.++. +||+|||++....... ........+|+..|+|||++.. ..++.++|||||||++|||+
T Consensus 126 kp~nil~~~~~~--~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 202 (268)
T cd05086 126 ALRNCFLTSDLT--VKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202 (268)
T ss_pred ccceEEEcCCcc--EEecccccccccCcch-hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHH
Confidence 999999987765 9999999986432211 1112234568899999998753 23578999999999999999
Q ss_pred hCCCCCCCCchhhH--HHHHhhcc-----ccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 706 TGGKHPYGESFERD--ANIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 706 tG~~~Pf~~~~~~~--~~~~~~~~-----~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
+++.+||....... ..+..... ........+.+.+++..|+ .+|.+||+++++++
T Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 203 ENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred hCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 98788886543321 12222211 1122335678899999999 67999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=292.76 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=190.0
Q ss_pred eEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
.|...+.||+|+||+||++... +.+.||+|.+...... ...+|+. +++.++|+||+++++++.+.+..|
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELD-MFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHH-HHHhcCCcceeeeEEEECCCCcce
Confidence 3556688999999999998643 3578999988654332 3445554 678889999999999999999999
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+||| |.+.|+|.+++........ .-+...+++..+..++.|++.||+|||
T Consensus 85 lv~e----------~~~~~~L~~~i~~~~~~~~--------------------~~~~~~l~~~~~~~~~~~l~~~l~~LH 134 (275)
T cd05046 85 MILE----------YTDLGDLKQFLRATKSKDE--------------------KLKPPPLSTKQKVALCTQIALGMDHLS 134 (275)
T ss_pred EEEE----------ecCCCcHHHHHHhcccccc--------------------cccccCCCHHHHHHHHHHHHHHHHHhh
Confidence 9999 5556666666643221000 001124678889999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
+.+|+||||||+|||++.++. ++++|||+++...... ........++..|+|||.+.+...+.++|||||||++|+
T Consensus 135 ~~~i~H~dlkp~Nili~~~~~--~~l~~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 210 (275)
T cd05046 135 NARFVHRDLAARNCLVSSQRE--VKVSLLSLSKDVYNSE--YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWE 210 (275)
T ss_pred hcCcccCcCccceEEEeCCCc--EEEcccccccccCccc--ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHH
Confidence 999999999999999988876 8999999987543221 111223346778999999988888999999999999999
Q ss_pred HHhCCCCCCCCchhhH-HHHHhhcc--ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 704 CITGGKHPYGESFERD-ANIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~-~~~~~~~~--~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
|++++..||....... ........ ...+...++.+.+++.+||+.||.+||++.+++.+
T Consensus 211 l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 211 VFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 9997688886533222 22222111 11233456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=294.45 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=181.4
Q ss_pred eecccCceEEEEEEee-CCc--EEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 480 EIAKGSNGTVVLEGNY-EGR--SVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~~-~g~--~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
.||+|+||.||++... +|. .+|+|.+..... ....+|+..+.+...||||+++++++...+..|+|||
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e----- 76 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE----- 76 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE-----
Confidence 5899999999998654 343 578898864322 2344566544333389999999999999999999999
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDL 632 (902)
|+++|+|.+++........... . ....-....+++.++..++.|++.||+|||+.+++||||
T Consensus 77 -----~~~~~~L~~~i~~~~~~~~~~~---------~----~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~di 138 (270)
T cd05047 77 -----YAPHGNLLDFLRKSRVLETDPA---------F----AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDL 138 (270)
T ss_pred -----eCCCCcHHHHHHhccccccccc---------c----ccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 6667777777654321100000 0 000001234778899999999999999999999999999
Q ss_pred ccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCC
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf 712 (902)
||+|||++.++. +||+|||++...... ........+..|+|||++....++.++|||||||++|||++++..||
T Consensus 139 kp~nili~~~~~--~kl~dfgl~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf 212 (270)
T cd05047 139 AARNILVGENYV--AKIADFGLSRGQEVY----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212 (270)
T ss_pred ccceEEEcCCCe--EEECCCCCccccchh----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999999987764 999999998643211 11122234667999999988889999999999999999998447787
Q ss_pred CCchh-hHHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 713 GESFE-RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 713 ~~~~~-~~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
..... .....+... ....+...+.++.+++.+||+.||.+||++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 213 CGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 54322 222222221 22233445678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=288.62 Aligned_cols=239 Identities=32% Similarity=0.460 Sum_probs=188.7
Q ss_pred ecccCceEEEEEEee-CCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 481 IAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 481 LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
||+|+||.||++... +++.||+|++.+... .....|+ .+++.++||||+++++.+.+++..|+|||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~---- 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTER-NILSRINHPFIVKLHYAFQTEEKLYLVLEYA---- 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHH-HHHHHcCCCcHHHHHHHeecCCeeEEEEecC----
Confidence 699999999998544 589999999865432 1334455 4678889999999999999999999999954
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLK 633 (902)
++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+
T Consensus 76 ------~~~~L~~~l~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~ 120 (250)
T cd05123 76 ------PGGELFSHLSKE-----------------------------GRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120 (250)
T ss_pred ------CCCcHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 455555554221 236777889999999999999999999999999
Q ss_pred cceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 634 p~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
|+||+++.++. ++|+|||++....... .......|+..|+|||...+...+.++|+|||||++|++++| ..||.
T Consensus 121 p~ni~~~~~~~--~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g-~~p~~ 194 (250)
T cd05123 121 PENILLDADGH--IKLTDFGLAKELSSEG---SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG-KPPFY 194 (250)
T ss_pred cceEEEcCCCc--EEEeecCcceecccCC---CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHC-CCCCC
Confidence 99999988765 8999999998765431 112334578899999999888889999999999999999997 67776
Q ss_pred Cchh-hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCH---HHHHcCCCC
Q 002601 714 ESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA---QNVLNHPFF 765 (902)
Q Consensus 714 ~~~~-~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~---~elL~HPfF 765 (902)
.... .....+.......+...+.++.++|++||..||..||++ +++++||||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 195 AEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 5432 222222223333445557899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=292.55 Aligned_cols=244 Identities=30% Similarity=0.494 Sum_probs=185.6
Q ss_pred EEeeeecccCceEEEEEEee-CCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 476 VFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
.+.+.||+|++|.||++... +++.||+|++.... ......|+. .++.++|+||+++++++.+.+..++|+|++
T Consensus 2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~-~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREIS-LLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHH-HHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 34577999999999998654 58999999987542 123445554 567889999999999999999999999977
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
.++|.+++ ... ...+++..+.+++.|++.||+|||+.+|+|
T Consensus 81 ~~~l~~~i-----------~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H 121 (282)
T cd07829 81 DMDLKKYL-----------DKR----------------------------PGPLSPNLIKSIMYQLLRGLAYCHSHRILH 121 (282)
T ss_pred CcCHHHHH-----------Hhh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 65555544 211 023677788999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG~ 708 (902)
|||+|+||+++.++. ++|+|||+++....... ......++..|+|||.+... .++.++|||||||++||+++|
T Consensus 122 ~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~- 195 (282)
T cd07829 122 RDLKPQNILINRDGV--LKLADFGLARAFGIPLR---TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG- 195 (282)
T ss_pred CCCChheEEEcCCCC--EEEecCCcccccCCCcc---ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhC-
Confidence 999999999987765 89999999987653221 11223457789999998776 789999999999999999998
Q ss_pred CCCCCCchhhH--HHHHhh--------------c---cc-----------cccccCChHHHHHHHcccCCCCCCCcCHHH
Q 002601 709 KHPYGESFERD--ANIVKD--------------R---KD-----------LFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 758 (902)
Q Consensus 709 ~~Pf~~~~~~~--~~~~~~--------------~---~~-----------~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~e 758 (902)
.+||....... ..+... . .. ......+.++.++|.+||+.||++||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 275 (282)
T cd07829 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275 (282)
T ss_pred CCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHH
Confidence 77776532111 011000 0 00 001123568999999999999999999999
Q ss_pred HHcCCCC
Q 002601 759 VLNHPFF 765 (902)
Q Consensus 759 lL~HPfF 765 (902)
+++||||
T Consensus 276 ~l~~p~~ 282 (282)
T cd07829 276 ALKHPYF 282 (282)
T ss_pred HhhCcCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=300.17 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=186.0
Q ss_pred ccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccC-cccee
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-QDFVY 543 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d-~~~~y 543 (902)
+++.|.+.+.||+|+||.||++. ..+|+.||||++.+.. .....+|+. ++..++||||+++++++.+ .+..|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~-~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK-LLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHH-HHHhcCCCCeeeEeeeEecCCCcEE
Confidence 56778889999999999999984 5579999999885421 123445655 6788899999999998865 56789
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+++|++.++|.+ .+. ...+++..+..++.|++.||+|||
T Consensus 87 lv~e~~~~~L~~-----------~~~------------------------------~~~~~~~~~~~~~~ql~~aL~~LH 125 (328)
T cd07856 87 FVTELLGTDLHR-----------LLT------------------------------SRPLEKQFIQYFLYQILRGLKYVH 125 (328)
T ss_pred EEeehhccCHHH-----------HHh------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999966544433 221 123556667889999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 702 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ 702 (902)
+.+|+||||+|+|||++.++. ++|+|||++...... .....++..|+|||++.+ ..++.++|||||||++|
T Consensus 126 ~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~ 197 (328)
T cd07856 126 SAGVVHRDLKPSNILINENCD--LKICDFGLARIQDPQ------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFA 197 (328)
T ss_pred hCCcccCCCCHHHEeECCCCC--EEeCccccccccCCC------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHH
Confidence 999999999999999987765 899999998754321 123357889999998766 56899999999999999
Q ss_pred HHHhCCCCCCCCchhhH-H----HH--------------------Hhhcc--cc-----ccccCChHHHHHHHcccCCCC
Q 002601 703 FCITGGKHPYGESFERD-A----NI--------------------VKDRK--DL-----FLVEHIPEAVDLFTRLLDPNP 750 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-~----~~--------------------~~~~~--~~-----~~~~~~~e~~dLI~~~L~~dP 750 (902)
+|++| .+||....... . .. ..... .. .....++++.++|.+||+.+|
T Consensus 198 el~tg-~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 276 (328)
T cd07856 198 EMLEG-KPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDP 276 (328)
T ss_pred HHHhC-CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCCh
Confidence 99998 67775432110 0 00 00000 00 012345789999999999999
Q ss_pred CCCcCHHHHHcCCCCCC
Q 002601 751 DLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 751 ~~Rpt~~elL~HPfF~~ 767 (902)
++||++++++.||||..
T Consensus 277 ~~R~t~~ell~~~~~~~ 293 (328)
T cd07856 277 QKRISAAEALAHPYLAP 293 (328)
T ss_pred hhCCCHHHHhcCCcccc
Confidence 99999999999999954
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=297.63 Aligned_cols=258 Identities=24% Similarity=0.319 Sum_probs=187.2
Q ss_pred ceEEEeeeecccCceEEEEEEeeC---------------CcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEec
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYE---------------GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWY 533 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~---------------g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~ 533 (902)
++|.+.+.||+|+||.||++.... ...||||.+..... ....+|+. ++..++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~-~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK-IMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHH-HHHhCCCCCcCeEE
Confidence 356778899999999999864321 23589999865322 22345555 67889999999999
Q ss_pred ccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHH
Q 002601 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTR 613 (902)
Q Consensus 534 g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~ 613 (902)
+++...+..++||| |+++|+|.+++......... . .......+++..++.++.
T Consensus 84 ~~~~~~~~~~lv~e----------~~~~~~L~~~l~~~~~~~~~-~----------------~~~~~~~~~~~~~~~i~~ 136 (295)
T cd05097 84 GVCVSDDPLCMITE----------YMENGDLNQFLSQREIESTF-T----------------HANNIPSVSIANLLYMAV 136 (295)
T ss_pred EEEcCCCccEEEEe----------cCCCCcHHHHHHhccccccc-c----------------ccccCCcccHHHHHHHHH
Confidence 99999999999999 66677777776432211000 0 001122357788899999
Q ss_pred hhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcch
Q 002601 614 DIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAID 693 (902)
Q Consensus 614 qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksD 693 (902)
|++.||+|||+.+++||||||+||+++.++. +||+|||++........ ........++..|+|||++..+.++.++|
T Consensus 137 ~i~~al~~lH~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 213 (295)
T cd05097 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFTTASD 213 (295)
T ss_pred HHHHHHHHHHhcCeeccccChhhEEEcCCCc--EEecccccccccccCcc-eeccCcCcCceeecChhhhccCCcCchhh
Confidence 9999999999999999999999999987765 99999999986543211 11122234577899999999889999999
Q ss_pred hhhhHHHHHHHHhC-CCCCCCCchhhH-H-HHHh---h----ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 694 LFSLGCILFFCITG-GKHPYGESFERD-A-NIVK---D----RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 694 VwSlGviL~elltG-~~~Pf~~~~~~~-~-~~~~---~----~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||||||++|+|+++ +..||....... . .... . .....+...++.+.+++.+||+.||++||++.++++
T Consensus 214 vwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 214 VWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99999999999984 356776532211 1 1111 0 011112335678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=290.62 Aligned_cols=246 Identities=23% Similarity=0.337 Sum_probs=186.0
Q ss_pred ceEEEeeeecccCceEEEEEEeeC----CcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~----g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
+.+.+.+.||+|+||.||+|...+ ...||||........ ...+|+ .+++.+.||||+++++++.+ +..|+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~-~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEA-YIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHH-HHHHhCCCCchhceeEEEcC-CCcEE
Confidence 346778999999999999986543 347999988654321 233444 46788899999999999876 45789
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||| |.+.|+|.+++... ...+++..++.++.|++.||+|||+
T Consensus 84 v~e----------~~~~~~L~~~l~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~ 125 (270)
T cd05056 84 VME----------LAPLGELRSYLQVN----------------------------KYSLDLASLILYSYQLSTALAYLES 125 (270)
T ss_pred EEE----------cCCCCcHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999 55667776665321 1235777889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
.+++||||||+|||++.++. +||+|||+++......... .....++..|+|||.+....++.++|||||||++||+
T Consensus 126 ~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 201 (270)
T cd05056 126 KRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESYYK--ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 201 (270)
T ss_pred CCeeccccChheEEEecCCC--eEEccCceeeeccccccee--cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999987765 8999999998765432111 1122345689999999888899999999999999999
Q ss_pred HhCCCCCCCCchhhH-H-HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 705 ITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~-~-~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
++.+.+||....... . .+........+...++++.++|.+|+..+|.+|||+.+++.+
T Consensus 202 ~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 202 LMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 974477886543322 1 222222223445667899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-32 Score=299.95 Aligned_cols=243 Identities=25% Similarity=0.362 Sum_probs=185.2
Q ss_pred EEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC--c----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--H----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~--~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
|...+.||+|+||+||++.. .++..||+|.+.... . ....+|+. +++.++|+|++++++++.+.+..|+|||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHH-HHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 44457799999999999864 468899999885321 1 12345554 6788899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
||.+++.+++... ...+++..+..++.|++.||.|||+.++
T Consensus 96 ~~~~~l~~~~~~~---------------------------------------~~~l~~~~~~~~~~~l~~~l~~LH~~~i 136 (308)
T cd06634 96 YCLGSASDLLEVH---------------------------------------KKPLQEVEIAAVTHGALQGLAYLHSHNM 136 (308)
T ss_pred ccCCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 7766655443211 1235667788999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc---cCCCCCcchhhhhHHHHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGviL~el 704 (902)
+||||||+|||++.++. ++|+|||++...... ....|+..|+|||++. ...++.++|||||||++|+|
T Consensus 137 ~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 137 IHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred ccCCCCHHhEEECCCCc--EEECCcccceeecCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHH
Confidence 99999999999987765 999999998765432 2345789999999975 34678899999999999999
Q ss_pred HhCCCCCCCCchh-h-HHHHHhhcccc-ccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 705 ITGGKHPYGESFE-R-DANIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 705 ltG~~~Pf~~~~~-~-~~~~~~~~~~~-~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
++| ..||..... . ...+....... .....+..+.++|.+||+.+|.+||+++++++|||+..
T Consensus 208 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 208 AER-KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HcC-CCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 998 556544322 1 12222222111 12245678999999999999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=297.06 Aligned_cols=243 Identities=26% Similarity=0.459 Sum_probs=188.1
Q ss_pred eeecccCceEEEEEEe-eCCcEEEEEEeccCC---chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChh
Q 002601 479 KEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~ 554 (902)
..||+|+||.||++.. .+|..||||++.... .....+|+. +++.++|+||+++++++.+.+..|+|||
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e------- 97 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVV-IMRDYQHENVVEMYNSYLVGDELWVVME------- 97 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHH-HHHhcCCcchhheeeEEEeCCEEEEEEe-------
Confidence 4699999999999855 578999999875322 123455665 6688999999999999999999999999
Q ss_pred hHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccccc
Q 002601 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (902)
Q Consensus 555 dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp 634 (902)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.|++||||||
T Consensus 98 ---~~~~~~L~~~~~~------------------------------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p 144 (292)
T cd06657 98 ---FLEGGALTDIVTH------------------------------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKS 144 (292)
T ss_pred ---cCCCCcHHHHHhc------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 5555666554321 2346677889999999999999999999999999
Q ss_pred ceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCC
Q 002601 635 QNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE 714 (902)
Q Consensus 635 ~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~ 714 (902)
+||+++.++. ++|+|||++....... .......|+..|+|||.+....++.++|+||+||++|+|++| .+||..
T Consensus 145 ~Nilv~~~~~--~~l~dfg~~~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg-~~p~~~ 218 (292)
T cd06657 145 DSILLTHDGR--VKLSDFGFCAQVSKEV---PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG-EPPYFN 218 (292)
T ss_pred HHEEECCCCC--EEEcccccceeccccc---ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Confidence 9999988775 8999999987654321 112334588999999999888889999999999999999997 667754
Q ss_pred ch-hhHHHHHhhccc---cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 715 SF-ERDANIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 715 ~~-~~~~~~~~~~~~---~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
.. ............ ......++++.+++.+||+.||.+||++.++++||||...
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~ 276 (292)
T cd06657 219 EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276 (292)
T ss_pred CCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhcc
Confidence 32 222222221111 1123356789999999999999999999999999999543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=293.51 Aligned_cols=246 Identities=27% Similarity=0.377 Sum_probs=184.6
Q ss_pred eEEEeeeecccCceEEEEEEee-----CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccC--ccce
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY-----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD--QDFV 542 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~-----~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d--~~~~ 542 (902)
.+.+.+.||+|+||.||++... +++.||||++...... ...+|+. +++.+.||||+++++++.+ ....
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~-~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIE-ILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHH-HHHhCCCCChheEEeeeecCCCCce
Confidence 4556688999999999998643 4789999999765432 3445554 6688899999999999877 6689
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
+++|| |.++|+|.+++.... ..+++..+..++.|++.||+||
T Consensus 84 ~lv~e----------~~~~~~l~~~l~~~~----------------------------~~~~~~~~~~~~~~l~~aL~~l 125 (284)
T cd05038 84 RLIME----------YLPSGSLRDYLQRHR----------------------------DQINLKRLLLFSSQICKGMDYL 125 (284)
T ss_pred EEEEe----------cCCCCCHHHHHHhCc----------------------------cccCHHHHHHHHHHHHHHHHHH
Confidence 99999 555667766654221 1357778899999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
|+.+|+||||||+||+++.++. ++|+|||++.................++..|+|||.+....++.++|||||||++|
T Consensus 126 H~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~ 203 (284)
T cd05038 126 GSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLY 203 (284)
T ss_pred HhCCeecCCCCHHhEEEcCCCC--EEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhh
Confidence 9999999999999999987765 89999999987764322222222233566799999998888999999999999999
Q ss_pred HHHhCCCCCCCCchhhH----------------HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHHc
Q 002601 703 FCITGGKHPYGESFERD----------------ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~----------------~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~ 761 (902)
||++|. .|+....... ...+... ....+...+.++.+++.+||+.+|.+||++.|+++
T Consensus 204 el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 204 ELFTYG-DPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred eeeccC-CCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 999984 4544321111 1111111 11122344578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-33 Score=289.80 Aligned_cols=247 Identities=28% Similarity=0.403 Sum_probs=195.9
Q ss_pred eeecccCceEEEEE-EeeCCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCCh
Q 002601 479 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSL 553 (902)
Q Consensus 479 ~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL 553 (902)
..||.|+||+|++- +...|+.+|||++..... .+.+.|....+++-+.||||++||.+..++..||+||+++.+|
T Consensus 70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~Sl 149 (361)
T KOG1006|consen 70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISL 149 (361)
T ss_pred HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhH
Confidence 45999999999985 667899999999975432 3456777778888999999999999999999999999998887
Q ss_pred hhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc-ccccccc
Q 002601 554 NDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDL 632 (902)
Q Consensus 554 ~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~-~IvHrDL 632 (902)
..+ |+ +.+ .-+...+|+..+-.|...++.||.||-+. +|||||+
T Consensus 150 Dkl-Yk-------~vy---------------------------~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDv 194 (361)
T KOG1006|consen 150 DKL-YK-------RVY---------------------------SVQKSRIPENILGHITVATVDALDYLKEELKIIHRDV 194 (361)
T ss_pred HHH-HH-------HHH---------------------------HHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccC
Confidence 654 32 111 12334578888889999999999999865 8999999
Q ss_pred ccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC--CCCCcchhhhhHHHHHHHHhCCCC
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~--~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||+||||+..|. +||||||++-.+.+.. ......|...|||||.+... .|+.++||||||++|||+.|| ..
T Consensus 195 KPSNILldr~G~--vKLCDFGIcGqLv~Si----AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG-~f 267 (361)
T KOG1006|consen 195 KPSNILLDRHGD--VKLCDFGICGQLVDSI----AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG-NF 267 (361)
T ss_pred ChhheEEecCCC--EeeecccchHhHHHHH----HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC-CC
Confidence 999999988776 9999999998876532 12334588999999998643 489999999999999999998 88
Q ss_pred CCCCchhh---HHHHHhhcccc--cc---ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 711 PYGESFER---DANIVKDRKDL--FL---VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 711 Pf~~~~~~---~~~~~~~~~~~--~~---~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
||...... ...++....+. +. .+.+..++.+|..||.+|-..||...+++++||+..
T Consensus 268 Pyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 268 PYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred CcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 98875432 22333322211 11 236778999999999999999999999999999854
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=296.13 Aligned_cols=249 Identities=18% Similarity=0.227 Sum_probs=174.7
Q ss_pred cccceEEEeeeecccCceEEEEEEeeC----CcEEEEEEeccCCchH-----H------HHHHH--HHHHhCCCCCeeEe
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHDV-----A------LKEIQ--NLIASDQHPNIVRW 532 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~~~~----g~~VAVKrl~~~~~~~-----~------~~Ei~--~ll~~l~HpNIV~l 532 (902)
..++.|.+.+.||+|+||+||++...+ +..+|+|+........ . ..++. ..+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 345678999999999999999986544 4566777543221110 0 01111 12345789999999
Q ss_pred cccccCcc----ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHH
Q 002601 533 YGVESDQD----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608 (902)
Q Consensus 533 ~g~~~d~~----~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~ 608 (902)
++++.... ..++++|++..++.+++ . .....++..+
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~-----------------------------~~~~~~~~~~ 128 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVENTKEIF-----------K-----------------------------RIKCKNKKLI 128 (294)
T ss_pred EEeeeEecCCceEEEEEEehhccCHHHHH-----------H-----------------------------hhccCCHHHH
Confidence 98765443 34777785544433322 0 0112356677
Q ss_pred HHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCcc----ccccccCCCCccccCchhhc
Q 002601 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLL 684 (902)
Q Consensus 609 ~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~----~~~~~~~~Gt~~Y~APE~l~ 684 (902)
..|+.|++.||+|||+.+|+||||||+|||++.++. ++|+|||+|+.+...... ........||+.|+|||+..
T Consensus 129 ~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~ 206 (294)
T PHA02882 129 KNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN 206 (294)
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhC
Confidence 899999999999999999999999999999987765 899999999876432111 11122346999999999999
Q ss_pred cCCCCCcchhhhhHHHHHHHHhCCCCCCCCchh--hHH-----HHHhh--ccccccccCChHHHHHHHcccCCCCCCCcC
Q 002601 685 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDA-----NIVKD--RKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 755 (902)
Q Consensus 685 ~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~--~~~-----~~~~~--~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt 755 (902)
+..++.++|||||||++|||++| .+||..... ... ..... .........++++.+++..|+..+|++||+
T Consensus 207 ~~~~~~~~DiwSlG~~l~el~~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~ 285 (294)
T PHA02882 207 GACVTRRGDLESLGYCMLKWAGI-KLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPD 285 (294)
T ss_pred CCCCCcHHHHHHHHHHHHHHHhC-CCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997 888865421 111 11111 011123345678999999999999999999
Q ss_pred HHHHHc
Q 002601 756 AQNVLN 761 (902)
Q Consensus 756 ~~elL~ 761 (902)
++++++
T Consensus 286 ~~~l~~ 291 (294)
T PHA02882 286 YDALIK 291 (294)
T ss_pred HHHHHH
Confidence 999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=318.28 Aligned_cols=274 Identities=18% Similarity=0.191 Sum_probs=172.2
Q ss_pred cceEEEeeeecccCceEEEEEEee-C----CcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEeccc------ccCcc
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNY-E----GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV------ESDQD 540 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~-~----g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~------~~d~~ 540 (902)
.+.|.+.+.||+|+||+||+|... + +..||||++..........+. .+....+.+++.+... +.+++
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 456889999999999999998654 4 689999998654322211111 1222233333333222 24567
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
..++||| |+.+|+|.+++........... . .... ....-.........+..++.||+.||+
T Consensus 209 ~~~LV~e----------y~~~gsL~~~l~~~~~~~~v~~-~-------l~~~-~~~l~~~~~r~~~~i~~i~~qll~aL~ 269 (566)
T PLN03225 209 EYWLVWR----------YEGESTLADLMQSKEFPYNVEP-Y-------LLGK-VQDLPKGLERENKIIQTIMRQILFALD 269 (566)
T ss_pred ceEEEEE----------ecCCCcHHHHHHhcCCchhHHH-H-------hccc-hhhccccchhhHHHHHHHHHHHHHHHH
Confidence 8999999 5556666665543221000000 0 0000 000000011123456789999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCC-------------
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR------------- 687 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~------------- 687 (902)
|||+++|+||||||+|||++.+. ..+||+|||+|+.+..... ......+||+.|||||.+....
T Consensus 270 yLH~~gIiHRDLKP~NILl~~~~-~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~ 346 (566)
T PLN03225 270 GLHSTGIVHRDVKPQNIIFSEGS-GSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATA 346 (566)
T ss_pred HHHHCCEEeCcCCHHHEEEeCCC-CcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCcccccccc
Confidence 99999999999999999997542 2499999999986653322 1224457899999999764322
Q ss_pred ---------CCCcchhhhhHHHHHHHHhCCCCCCCCchhhHHHHHhhcc-----------cccc----------ccCChH
Q 002601 688 ---------QTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK-----------DLFL----------VEHIPE 737 (902)
Q Consensus 688 ---------~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~~~~~~~~~-----------~~~~----------~~~~~e 737 (902)
++.++|||||||++|||+++ ..++..........+.... .... .....+
T Consensus 347 ~sp~l~~~~~~~k~DVwSlGviL~el~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 425 (566)
T PLN03225 347 LSPVLWQLNLPDRFDIYSAGLIFLQMAFP-NLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGA 425 (566)
T ss_pred ccchhccccCCCCcccHHHHHHHHHHHhC-cCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchH
Confidence 34567999999999999996 4454433221111111100 0000 011224
Q ss_pred HHHHHHcccCCCCCCCcCHHHHHcCCCCCCcch
Q 002601 738 AVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 770 (902)
Q Consensus 738 ~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~ 770 (902)
..+||.+||+.||.+|||+.|+|+||||.....
T Consensus 426 ~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 426 GWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred HHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 568999999999999999999999999976544
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=290.90 Aligned_cols=245 Identities=24% Similarity=0.299 Sum_probs=187.0
Q ss_pred ceEEEeeeecccCceEEEEEEee-CCc----EEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCcccee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-EGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~g~----~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~y 543 (902)
..|.+.+.||+|+||+||++... +|. .||+|++...... ...+|+. .++.++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY-VMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHH-HHHhCCCCCcceEEEEEec-CceE
Confidence 45677899999999999998643 333 6899988655322 2344554 6688899999999999887 7889
Q ss_pred eeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+||| |+++|+|.+++... ...+++..+..++.||+.||+|||
T Consensus 85 ~v~e----------~~~~g~L~~~l~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~LH 126 (279)
T cd05057 85 LITQ----------LMPLGCLLDYVRNH----------------------------KDNIGSQYLLNWCVQIAKGMSYLE 126 (279)
T ss_pred EEEe----------cCCCCcHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 9999 66677777766422 123677788999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~e 703 (902)
+.+|+||||||+|||++.++. +||+|||+++.......... .....++..|+|||.+....++.++|+|||||++||
T Consensus 127 ~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~e 203 (279)
T cd05057 127 EKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYH-AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWE 203 (279)
T ss_pred hCCEEecccCcceEEEcCCCe--EEECCCcccccccCccccee-cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHH
Confidence 999999999999999987765 89999999987654322111 112224668999999988889999999999999999
Q ss_pred HHhCCCCCCCCchhh-HHHHHh-hccccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 704 CITGGKHPYGESFER-DANIVK-DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 704 lltG~~~Pf~~~~~~-~~~~~~-~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
+++.+..||...... ....+. ......+.....++.+++.+||..||..||++.+++
T Consensus 204 l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 204 LMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred HhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 999447788664332 222222 222233444567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=286.87 Aligned_cols=254 Identities=26% Similarity=0.426 Sum_probs=189.5
Q ss_pred eeecccCceEEEEEE-eeCCcEEEEEEec-----cCCchHHHHHHHHHHHhCCCCCeeEecccccC--------ccceee
Q 002601 479 KEIAKGSNGTVVLEG-NYEGRSVAVKRLV-----KTHHDVALKEIQNLIASDQHPNIVRWYGVESD--------QDFVYL 544 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~-~~~g~~VAVKrl~-----~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d--------~~~~yL 544 (902)
.+||+|.||.|++|. ..+|+.||+|+.. ......+++|+. ++..++|+|++.++..|.. ...+|+
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreik-iL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHH-HHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 469999999999984 4568889998752 223456888987 6788999999999998753 345899
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
|+.+|+.+|.-++ .. ....+...++.+++.++..||.|+|.
T Consensus 102 Vf~~cehDLaGlL-----------sn----------------------------~~vr~sls~Ikk~Mk~Lm~GL~~iHr 142 (376)
T KOG0669|consen 102 VFDFCEHDLAGLL-----------SN----------------------------RKVRFSLSEIKKVMKGLMNGLYYIHR 142 (376)
T ss_pred eHHHhhhhHHHHh-----------cC----------------------------ccccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999987665443 00 01236677889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccc-cccccCCCCccccCchhhccC-CCCCcchhhhhHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILF 702 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ 702 (902)
..|+|||+||.|+||+.+|. +||+|||+++.+....... ..-...+-|..|.+||.+.+. .|+.+.|||.-|||+.
T Consensus 143 ~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCima 220 (376)
T KOG0669|consen 143 NKILHRDMKAANVLITKDGI--LKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMA 220 (376)
T ss_pred hhHHhhcccHhhEEEcCCce--EEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHH
Confidence 99999999999999988876 8999999998765332221 222234469999999998875 5899999999999999
Q ss_pred HHHhCCCCCCCCch-hhHHHHHhhc------------------------------ccc-----ccccCChHHHHHHHccc
Q 002601 703 FCITGGKHPYGESF-ERDANIVKDR------------------------------KDL-----FLVEHIPEAVDLFTRLL 746 (902)
Q Consensus 703 elltG~~~Pf~~~~-~~~~~~~~~~------------------------------~~~-----~~~~~~~e~~dLI~~~L 746 (902)
||.|+ .|-+..+. ..+...+... ... -+--..+++.||+.+||
T Consensus 221 eMwtr-spimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll 299 (376)
T KOG0669|consen 221 EMWTR-SPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLL 299 (376)
T ss_pred HHHcc-CccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHh
Confidence 99997 44444332 2221111100 000 00011358999999999
Q ss_pred CCCCCCCcCHHHHHcCCCCCCcchhhhhh
Q 002601 747 DPNPDLRPKAQNVLNHPFFWTADTRLSFL 775 (902)
Q Consensus 747 ~~dP~~Rpt~~elL~HPfF~~~~~~~~~l 775 (902)
..||.+|++++++++|.|||......+-+
T Consensus 300 ~~DP~kR~~ad~alnh~~F~kdp~pqanl 328 (376)
T KOG0669|consen 300 KLDPTKRIDADQALNHDFFWKDPMPQANL 328 (376)
T ss_pred ccCcccCcchHhhhchhhhhcCCcchhhH
Confidence 99999999999999999999876654433
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=295.86 Aligned_cols=246 Identities=25% Similarity=0.303 Sum_probs=185.0
Q ss_pred eEEEeeeecccCceEEEEEEe-eCCc----EEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGR----SVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~----~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
.|...+.||+|+||.||++.. .+|. .||+|++...... ...+|+ .++..+.||||++++++|.+. ..++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~-~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEA-LIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHH-HHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 345667899999999999854 3444 5799988654322 233444 467888999999999998764 4678
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
++| |+++|+|.+++... ...+++..+..++.|++.||+|||+
T Consensus 86 v~e----------~~~~g~l~~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~LH~ 127 (303)
T cd05110 86 VTQ----------LMPHGCLLDYVHEH----------------------------KDNIGSQLLLNWCVQIAKGMMYLEE 127 (303)
T ss_pred eeh----------hcCCCCHHHHHHhc----------------------------ccCCCHHHHHHHHHHHHHHHHHHhh
Confidence 999 77778877766421 1235677889999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
++|+||||||+|||++.++. +||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||
T Consensus 128 ~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el 204 (303)
T cd05110 128 RRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEY-NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWEL 204 (303)
T ss_pred cCeeccccccceeeecCCCc--eEEccccccccccCccccc-ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 99999999999999987765 8999999998765432211 11223457789999999988899999999999999999
Q ss_pred HhCCCCCCCCchhh-HHHHHhhcc-ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 705 ITGGKHPYGESFER-DANIVKDRK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 705 ltG~~~Pf~~~~~~-~~~~~~~~~-~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
++.+..||...... ....+.... ...+......+.+++.+||..+|++||+++++++.
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 205 MTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98446787654322 223332221 22233456789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=287.82 Aligned_cols=246 Identities=22% Similarity=0.361 Sum_probs=186.7
Q ss_pred EEEeeeecccCceEEEEEEeeC--CcEEEEEEeccCC----------c---hHHHHHHHHHHHhCCCCCeeEecccccCc
Q 002601 475 VVFNKEIAKGSNGTVVLEGNYE--GRSVAVKRLVKTH----------H---DVALKEIQNLIASDQHPNIVRWYGVESDQ 539 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~~--g~~VAVKrl~~~~----------~---~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~ 539 (902)
|.+.+.||+|+||.||++.... ++.||||.+.... . ....+|+..+.+.++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4456789999999999986544 7899999875321 1 12345555555568999999999999999
Q ss_pred cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccc
Q 002601 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (902)
Q Consensus 540 ~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL 619 (902)
+..+++|| |+++++|.+.+.... -....+++..+++++.|++.||
T Consensus 82 ~~~~lv~e----------~~~~~~l~~~l~~~~-------------------------~~~~~~~~~~~~~~~~~l~~~l 126 (269)
T cd08528 82 DRLYIVMD----------LIEGAPLGEHFNSLK-------------------------EKKQRFTEERIWNIFVQMVLAL 126 (269)
T ss_pred CeEEEEEe----------cCCCCcHHHHHHHHH-------------------------hccCCCCHHHHHHHHHHHHHHH
Confidence 99999999 666666666553211 0123467788899999999999
Q ss_pred ccccc-ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhH
Q 002601 620 SHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 620 ~yLH~-~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlG 698 (902)
.|||+ .+++|+||||+||+++.++. +||+|||++....... ......|+..|+|||.+.+..++.++||||||
T Consensus 127 ~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG 200 (269)
T cd08528 127 RYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQKQPES----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFG 200 (269)
T ss_pred HHhccCCceeecCCCHHHEEECCCCc--EEEecccceeeccccc----ccccccCcccCcChhhhcCCCCchHHHHHHHH
Confidence 99996 68999999999999988765 8999999998765432 12334588999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCchhhH-HH-HHhhcccccc-ccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 699 CILFFCITGGKHPYGESFERD-AN-IVKDRKDLFL-VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~-~~-~~~~~~~~~~-~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
|++|+|++| .+||....... .. +......... ...++++.++|.+||+.||++||++.|+..+
T Consensus 201 ~ll~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 201 CILYQMCTL-QPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHhC-CCcccccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999998 67776543221 11 1222111111 2456899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=289.69 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=185.0
Q ss_pred EEeeeecccCceEEEEEEee----CCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCcc------
Q 002601 476 VFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQD------ 540 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~----~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~------ 540 (902)
.+.+.||+|+||+||++... +++.||||++.... .+...+|+. +++.++||||+++++++...+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAA-CMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHH-HHhcCCCCCcceEEEEEccCCCCCccc
Confidence 35678999999999998543 46899999986532 123445654 678899999999999875432
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
..++++| |+.+|+|..++....... +...+++..+++++.||+.||+
T Consensus 81 ~~~~~~~----------~~~~~~l~~~~~~~~~~~-----------------------~~~~l~~~~~~~~~~~i~~~l~ 127 (273)
T cd05074 81 IPMVILP----------FMKHGDLHTFLLMSRIGE-----------------------EPFTLPLQTLVRFMIDIASGME 127 (273)
T ss_pred ceEEEEe----------cCCCCcHHHHHHHhcccC-----------------------CCCCCCHHHHHHHHHHHHHHHH
Confidence 2367888 666777766654221100 0123577788999999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvi 700 (902)
|||+.+|+||||||+||+++.++. +||+|||+++....... ........+++.|++||.+....++.++|||||||+
T Consensus 128 ~lH~~~i~H~dikp~nili~~~~~--~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~i 204 (273)
T cd05074 128 YLSSKNFIHRDLAARNCMLNENMT--VCVADFGLSKKIYSGDY-YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVT 204 (273)
T ss_pred HHHhCCEeecccchhhEEEcCCCC--EEECcccccccccCCcc-eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHH
Confidence 999999999999999999987765 89999999987643221 111122345678999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCchhhH-HH-HHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 701 LFFCITGGKHPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~~~-~~-~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
+|+|++++.+||....... .. +........+...++++.+++.+||+.+|..||++.+++.+
T Consensus 205 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 205 MWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999996688887543322 11 22222222334566899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=320.93 Aligned_cols=142 Identities=32% Similarity=0.465 Sum_probs=115.9
Q ss_pred ceEEEeeeecccCceEEEEEEee-CCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
+.|.+.+.||+|+||+||++... +++.||||++..... ....+|+ .++..++||||+++++++.+.+..|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~-~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAER-DALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHH-HHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 45778899999999999998554 689999999865321 2233343 466888999999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
|| |+.+|+|.+++... ..+++..+++|+.||+.||+|||++
T Consensus 83 mE----------y~~g~~L~~li~~~-----------------------------~~l~~~~~~~i~~qil~aL~yLH~~ 123 (669)
T cd05610 83 ME----------YLIGGDVKSLLHIY-----------------------------GYFDEEMAVKYISEVALALDYLHRH 123 (669)
T ss_pred Ee----------CCCCCCHHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99 56666776665321 2356677899999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccc
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~ 656 (902)
+|+||||||+||||+.++. +||+|||+++
T Consensus 124 gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 124 GIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred CEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 9999999999999987765 8999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=305.58 Aligned_cols=248 Identities=22% Similarity=0.297 Sum_probs=195.7
Q ss_pred EEEeeeecccCceEEEEEEee--CCc--EEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY--EGR--SVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~--~g~--~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
+.+.++||+|+||.|++|.+. +|+ .||||.+.... .+.+++|.. .|.+++|||+|||||+.-+ ....||+
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas-~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREAS-HMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHH-HHHhccCcceeEEeeeecc-chhhHHh
Confidence 345678999999999998554 354 58999996543 245667765 6688999999999999888 7889999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
|+ .+.|+|.+.|+.... ..|....+..++.|||.|++||.+++
T Consensus 190 EL----------aplGSLldrLrka~~---------------------------~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 190 EL----------APLGSLLDRLRKAKK---------------------------AILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred hh----------cccchHHHHHhhccc---------------------------cceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 94 456788777765211 23455667889999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHh
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ellt 706 (902)
+|||||..+|+||-.... +||+||||.+-+......+.......-...|+|||.+....++.++|||+|||+||||+|
T Consensus 233 lvHRDLAARNlllasprt--VKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 233 LVHRDLAARNLLLASPRT--VKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT 310 (1039)
T ss_pred hhhhhhhhhhheecccce--eeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence 999999999999976543 999999999998876555433333334567999999999999999999999999999999
Q ss_pred CCCCCCCCchhhHH-HHHhh-ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCC
Q 002601 707 GGKHPYGESFERDA-NIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 763 (902)
Q Consensus 707 G~~~Pf~~~~~~~~-~~~~~-~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HP 763 (902)
+|..||-+....+. ..++. ....-+..+++++.+++.+||..+|..|||...+.+.-
T Consensus 311 yGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 311 YGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 99999987644332 33332 22334556778999999999999999999999886543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=301.51 Aligned_cols=245 Identities=27% Similarity=0.381 Sum_probs=197.9
Q ss_pred eeecccCceEEEEEEeeCCc-EEEEEEeccCCc------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccC
Q 002601 479 KEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~-~VAVKrl~~~~~------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~ 551 (902)
..||-|+||.|=+......+ .+|+|++++.+. +..+.|-. +|...+.|.||++|-.|.|+.++|+.||-|-
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~-Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl- 503 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERN-IMMECRSDFIVRLYRTFRDSKYVYMLMEACL- 503 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHH-HHHhcCchHHHHHHHHhccchhhhhhHHhhc-
Confidence 46999999999875444333 489999877542 23344444 4556679999999999999999999999664
Q ss_pred ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccc
Q 002601 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631 (902)
Q Consensus 552 sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrD 631 (902)
+|.+-..|. +++.++....+.++..+++|++|||++|||+||
T Consensus 504 ---------GGElWTiLr-----------------------------dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRD 545 (732)
T KOG0614|consen 504 ---------GGELWTILR-----------------------------DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRD 545 (732)
T ss_pred ---------Cchhhhhhh-----------------------------hcCCcccchhhhhHHHHHHHHHHHHhcCceecc
Confidence 455544443 335577778899999999999999999999999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~P 711 (902)
|||+|.+|+.+|- +||.|||+|+.+..+ ..+.++||||.|+|||++.+...+.++|.||||+++|||++| .+|
T Consensus 546 LKPENllLd~~Gy--~KLVDFGFAKki~~g----~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G-~pP 618 (732)
T KOG0614|consen 546 LKPENLLLDNRGY--LKLVDFGFAKKIGSG----RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTG-SPP 618 (732)
T ss_pred CChhheeeccCCc--eEEeehhhHHHhccC----CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcC-CCC
Confidence 9999999998887 899999999998754 456789999999999999999999999999999999999998 889
Q ss_pred CCCchhhH-H-HHHhhc-cccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCcch
Q 002601 712 YGESFERD-A-NIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 770 (902)
Q Consensus 712 f~~~~~~~-~-~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~~~ 770 (902)
|....+-. . .|++.. .-.+|......+.+||+++...+|.+|.. +.++.+|-||.+.++
T Consensus 619 Fs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 619 FSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred CCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 98754432 2 233332 23456667789999999999999999975 889999999966554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=303.24 Aligned_cols=276 Identities=20% Similarity=0.302 Sum_probs=182.5
Q ss_pred ccceEEEeeeecccCceEEEEEEe-----------------eCCcEEEEEEeccCCch-----------------HHHHH
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGN-----------------YEGRSVAVKRLVKTHHD-----------------VALKE 516 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~-----------------~~g~~VAVKrl~~~~~~-----------------~~~~E 516 (902)
..+.|.+.++||+|+||+||+|.. ..++.||||++...... ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356688899999999999998742 34678999998543211 11123
Q ss_pred HHHHHHhCCCCCe-----eEecccccC--------ccceeeeeccccCChhhHHHHhcCChhHHhhhhhccc-chhHHHH
Q 002601 517 IQNLIASDQHPNI-----VRWYGVESD--------QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDS-NLLNEVR 582 (902)
Q Consensus 517 i~~ll~~l~HpNI-----V~l~g~~~d--------~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~-~~l~~~~ 582 (902)
+. ++..++|.|+ ++++++|.. ++..||||| |+++|+|.++++...... ..+.+..
T Consensus 223 ~~-~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~E----------y~~~gsL~~~L~~~~~~~~~~L~e~l 291 (507)
T PLN03224 223 AY-MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWK----------FESDATLGDALDGKLGPFPGCLEEFM 291 (507)
T ss_pred HH-HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEE----------cCCCCcHHHHHhhccCCCcchHHHHH
Confidence 32 3445555544 677787653 356899999 777777777776432211 0111000
Q ss_pred hhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCC
Q 002601 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM 662 (902)
Q Consensus 583 ~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~ 662 (902)
. .............+++..++.++.|++.||+|||+.+|+||||||+|||++.++. +||+|||+++......
T Consensus 292 ~------~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~--~kL~DFGla~~~~~~~ 363 (507)
T PLN03224 292 M------AGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ--VKIIDFGAAVDMCTGI 363 (507)
T ss_pred h------cCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc--EEEEeCcCccccccCC
Confidence 0 0000001112234677889999999999999999999999999999999988765 8999999997654321
Q ss_pred ccccccccCCCCccccCchhhccCCC----------------------CCcchhhhhHHHHHHHHhCCCCCCCCchh--h
Q 002601 663 SCLTQNATGYGSSGWQAPEQLLQGRQ----------------------TRAIDLFSLGCILFFCITGGKHPYGESFE--R 718 (902)
Q Consensus 663 ~~~~~~~~~~Gt~~Y~APE~l~~~~~----------------------s~ksDVwSlGviL~elltG~~~Pf~~~~~--~ 718 (902)
. .......+|+.|+|||.+..... ..+.||||+||++|+|++|...|+..... .
T Consensus 364 ~--~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~ 441 (507)
T PLN03224 364 N--FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT 441 (507)
T ss_pred c--cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh
Confidence 1 11122345899999998864321 13479999999999999986667653211 0
Q ss_pred HH-------H---HHhhccccc--cccCChHHHHHHHcccCCCC---CCCcCHHHHHcCCCCCC
Q 002601 719 DA-------N---IVKDRKDLF--LVEHIPEAVDLFTRLLDPNP---DLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 719 ~~-------~---~~~~~~~~~--~~~~~~e~~dLI~~~L~~dP---~~Rpt~~elL~HPfF~~ 767 (902)
.. . ........+ ....++++.||+.+||..+| .+|+|++|+|+||||..
T Consensus 442 ~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 442 ELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 00 0 011111111 23356789999999999876 68999999999999953
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=303.68 Aligned_cols=241 Identities=24% Similarity=0.307 Sum_probs=191.6
Q ss_pred eeeecccCceEEEEEEeeC-C----cEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 478 NKEIAKGSNGTVVLEGNYE-G----RSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~~-g----~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
.++||.|+||+||++.+.. | -+||+|++...... ..+-|..-.|.++.|||++||+|+|.... +.||++
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq-- 777 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ-- 777 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH--
Confidence 4789999999999986543 3 57999998654332 23333344679999999999999998876 889999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
+||.|.|.++++... ..+..+.++.|+.|||+||.|||++.++|
T Consensus 778 --------~mP~G~LlDyvr~hr----------------------------~~igsq~lLnw~~QIAkgM~YLe~qrlVH 821 (1177)
T KOG1025|consen 778 --------LMPLGCLLDYVREHR----------------------------DNIGSQDLLNWCYQIAKGMKYLEEQRLVH 821 (1177)
T ss_pred --------hcccchHHHHHHHhh----------------------------ccccHHHHHHHHHHHHHHHHHHHhcchhh
Confidence 888899888876432 23556678999999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~ 709 (902)
|||-.+|||+.+-.. +||.|||+++.+..+........ ..-.+.|||-|.+....++.++|||||||.+||++|-|.
T Consensus 822 rdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey~~~~-gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa 898 (1177)
T KOG1025|consen 822 RDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEYSAPG-GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGA 898 (1177)
T ss_pred hhhhhhheeecCCCe--EEEEecchhhccCcccccccccc-cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCC
Confidence 999999999987765 99999999999887654433222 223567999999999999999999999999999999888
Q ss_pred CCCCCchhh-HHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 710 HPYGESFER-DANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 710 ~Pf~~~~~~-~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
.||.....+ ..+.++.. ....+...+-++.-++.+||..|+..||+++++.
T Consensus 899 ~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 899 KPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred CccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 888765433 34444433 3344555667899999999999999999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=299.39 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=197.3
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
..|+..+.||-|+||.|-++.. .+...+|+|.|.+.+. ....+.+..+++....+-||+||-.|+|++++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 3466778999999999999854 4567899999876431 112334445778889999999999999999999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
| |+++|++..+|.. .+-|++..++.++..++.|+++.|..|
T Consensus 709 d----------YIPGGDmMSLLIr-----------------------------mgIFeE~LARFYIAEltcAiesVHkmG 749 (1034)
T KOG0608|consen 709 D----------YIPGGDMMSLLIR-----------------------------MGIFEEDLARFYIAELTCAIESVHKMG 749 (1034)
T ss_pred e----------ccCCccHHHHHHH-----------------------------hccCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 9 9999999888753 234677788999999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccC--C------Cc------------------cc-------------cc
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG--D------MS------------------CL-------------TQ 667 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~--~------~~------------------~~-------------~~ 667 (902)
+|||||||+||||+.||+ +||+|||||.-+.- + .+ +. ..
T Consensus 750 FIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ 827 (1034)
T KOG0608|consen 750 FIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRIL 827 (1034)
T ss_pred ceecccCccceEEccCCc--eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhh
Confidence 999999999999999998 99999999975421 0 00 00 00
Q ss_pred cccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchh--hHHHHHhhc---cccccccCChHHHHHH
Q 002601 668 NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDANIVKDR---KDLFLVEHIPEAVDLF 742 (902)
Q Consensus 668 ~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~--~~~~~~~~~---~~~~~~~~~~e~~dLI 742 (902)
....+||+.|+|||++....++..+|+||.|||||||+.| .+||..... .+..++.+. ...+..+.++|+.++|
T Consensus 828 ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g-~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li 906 (1034)
T KOG0608|consen 828 AHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG-QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLI 906 (1034)
T ss_pred hhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC-CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHH
Confidence 1234699999999999999999999999999999999998 778865432 223333333 2233456789999999
Q ss_pred HcccCCCCCCCc---CHHHHHcCCCCCCcc
Q 002601 743 TRLLDPNPDLRP---KAQNVLNHPFFWTAD 769 (902)
Q Consensus 743 ~~~L~~dP~~Rp---t~~elL~HPfF~~~~ 769 (902)
.+++. +++.|. .+++|..||||...+
T Consensus 907 ~kLc~-sad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 907 QKLCC-SADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred HHHhc-ChhhhhcccchhhhhcCccccccc
Confidence 98654 577776 467899999997654
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=294.56 Aligned_cols=244 Identities=24% Similarity=0.350 Sum_probs=197.2
Q ss_pred eEEEeeeecccCceEEEEEEeeC-CcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~~-g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
.+....+||-|-||.||.+.+.. .-.||||.|+.... +.+++|.. +|+.++|||+|+|+|+|..+..+|||.|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAA-vMKeikHpNLVqLLGVCT~EpPFYIiTE--- 343 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTHEPPFYIITE--- 343 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHH-HHHhhcCccHHHHhhhhccCCCeEEEEe---
Confidence 34567899999999999876543 57899999986532 34555554 7789999999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
||.+|+|-++|..-+. .-++.-.++.++.||..|++||..+++|||
T Consensus 344 -------fM~yGNLLdYLRecnr---------------------------~ev~avvLlyMAtQIsSaMeYLEkknFIHR 389 (1157)
T KOG4278|consen 344 -------FMCYGNLLDYLRECNR---------------------------SEVPAVVLLYMATQISSAMEYLEKKNFIHR 389 (1157)
T ss_pred -------cccCccHHHHHHHhch---------------------------hhcchhHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 9999999998864322 224555678999999999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
||..+|+|+.++. .+|++||||++.+.++.. +......-...|.|||.+....++.|+|||+|||+|||+.|-|..
T Consensus 390 DLAARNCLVgEnh--iVKvADFGLsRlMtgDTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMs 465 (1157)
T KOG4278|consen 390 DLAARNCLVGENH--IVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMS 465 (1157)
T ss_pred hhhhhhccccccc--eEEeeccchhhhhcCCce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCC
Confidence 9999999997664 499999999999887532 222222235679999999999999999999999999999998888
Q ss_pred CCCCch-hhHHHHHhhccc-cccccCChHHHHHHHcccCCCCCCCcCHHHH
Q 002601 711 PYGESF-ERDANIVKDRKD-LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 759 (902)
Q Consensus 711 Pf~~~~-~~~~~~~~~~~~-~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~el 759 (902)
||.... ......++.... ..+..+++.+.+|++.||+..|..||+..|+
T Consensus 466 PYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 466 PYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 987643 333444444432 3466788899999999999999999999987
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=295.24 Aligned_cols=242 Identities=24% Similarity=0.383 Sum_probs=189.0
Q ss_pred eEEEeeeecccCceEEEEEEee---CC--cEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY---EG--RSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~---~g--~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
++..++.||+|-||.||+|... .| -.||||..+... .+.++.|. .+++..+|||||+|+|+|.+. ..||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa-~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEA-SIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHH-HHHHhCCCcchhheeeeeecc-ceeE
Confidence 3456678999999999997432 23 368999887632 23344554 477899999999999999874 7899
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
|||+| +-|.|..+|..+. ..++...+..++.||+.||+|||+
T Consensus 468 vmEL~----------~~GELr~yLq~nk----------------------------~sL~l~tL~ly~~Qi~talaYLeS 509 (974)
T KOG4257|consen 468 VMELA----------PLGELREYLQQNK----------------------------DSLPLRTLTLYCYQICTALAYLES 509 (974)
T ss_pred EEecc----------cchhHHHHHHhcc----------------------------ccchHHHHHHHHHHHHHHHHHHHh
Confidence 99955 4566766664322 235666778999999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHH
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
.++|||||..+|||+... -|+||+||||++.+..+... .. ....-...|||||.+.-++++.++|||-|||.+||+
T Consensus 510 krfVHRDIAaRNiLVsSp--~CVKLaDFGLSR~~ed~~yY-ka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEI 585 (974)
T KOG4257|consen 510 KRFVHRDIAARNILVSSP--QCVKLADFGLSRYLEDDAYY-KA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEI 585 (974)
T ss_pred hchhhhhhhhhheeecCc--ceeeecccchhhhccccchh-hc-cccccceeecCccccchhcccchhhHHHHHHHHHHH
Confidence 999999999999999655 47999999999988765332 22 233346679999999999999999999999999999
Q ss_pred HhCCCCCCCCchhh--HHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHH
Q 002601 705 ITGGKHPYGESFER--DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 759 (902)
Q Consensus 705 ltG~~~Pf~~~~~~--~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~el 759 (902)
++-|..||..-... ...+..+...+.|..++|.+..|+.+||..||.+||...|+
T Consensus 586 l~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 586 LSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred HHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 98777787653322 22444555666788899999999999999999999998765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=287.02 Aligned_cols=254 Identities=22% Similarity=0.303 Sum_probs=187.2
Q ss_pred cccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccC--CchHHHHHHHHHHHhCCCC-----CeeEecccccCccc
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT--HHDVALKEIQNLIASDQHP-----NIVRWYGVESDQDF 541 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~--~~~~~~~Ei~~ll~~l~Hp-----NIV~l~g~~~d~~~ 541 (902)
.++..|.+...+|+|.||.|... ....+..||||+++.- ..+.+.-|+..+.....+. -+|.+.+++.-.++
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 34667788889999999999875 3344789999998643 2345666776554443332 37888899999999
Q ss_pred eeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccc
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 ~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.+||+|.++.++.|++ ..+ +..++|...++.++.|+++++++
T Consensus 166 iCivfellG~S~~dFl-----------k~N---------------------------~y~~fpi~~ir~m~~QL~~sv~f 207 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFL-----------KEN---------------------------NYIPFPIDHIRHMGYQLLESVAF 207 (415)
T ss_pred eEEEEeccChhHHHHh-----------ccC---------------------------CccccchHHHHHHHHHHHHHHHH
Confidence 9999997766655543 211 12457889999999999999999
Q ss_pred cccccccccccccceeEeccCC------------------CceEEEccCCccccccCCCccccccccCCCCccccCchhh
Q 002601 622 LHEIGLIHRDLKPQNVLISKDK------------------SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL 683 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~------------------~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l 683 (902)
||+.+++|-||||+|||+.... +..++++|||.|+...... .+.+.|..|.|||++
T Consensus 208 Lh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEVi 281 (415)
T KOG0671|consen 208 LHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVI 281 (415)
T ss_pred HHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchhe
Confidence 9999999999999999994311 2358999999998655432 445679999999999
Q ss_pred ccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhHHHH------------Hhhc---------ccc-------------
Q 002601 684 LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANI------------VKDR---------KDL------------- 729 (902)
Q Consensus 684 ~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~~~~------------~~~~---------~~~------------- 729 (902)
.+-.++.++||||+||||.|+.||...++.....+...+ +... ...
T Consensus 282 LgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v 361 (415)
T KOG0671|consen 282 LGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYV 361 (415)
T ss_pred eccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhh
Confidence 999999999999999999999999655443321111000 0000 000
Q ss_pred ---------cccc---CChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 730 ---------FLVE---HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 730 ---------~~~~---~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
+... ...++.||+++||..||.+|+|+.|+|.||||..
T Consensus 362 ~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 362 FEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred hcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhc
Confidence 0000 0125779999999999999999999999999954
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=300.33 Aligned_cols=250 Identities=28% Similarity=0.404 Sum_probs=196.9
Q ss_pred ceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEeccccc-----Cccceee
Q 002601 473 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVES-----DQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~-----d~~~~yL 544 (902)
+.+.+.++||.|.+|.||++ +..+|+.+|||++..... +....|...++..-.|||++.+||++. .++.+||
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWL 98 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWL 98 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEE
Confidence 34678899999999999997 677899999999865443 333334444556678999999999875 3578999
Q ss_pred eeccccC-ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 545 SLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 545 V~E~c~~-sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
|||||.+ +..|++ ..- +.+.+.|..+..|++.+++||.|||
T Consensus 99 VMEfC~gGSVTDLV-----------Kn~---------------------------~g~rl~E~~IaYI~re~lrgl~HLH 140 (953)
T KOG0587|consen 99 VMEFCGGGSVTDLV-----------KNT---------------------------KGNRLKEEWIAYILREILRGLAHLH 140 (953)
T ss_pred EeeccCCccHHHHH-----------hhh---------------------------cccchhhHHHHHHHHHHHHHHHHHh
Confidence 9998874 455554 110 1234567788999999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-----CCCCcchhhhhH
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-----RQTRAIDLFSLG 698 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-----~~s~ksDVwSlG 698 (902)
.+.++|||+|-.||||+.++. +||+|||++..+.. ......+..|||.|||||++... .|+..+|+||||
T Consensus 141 ~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQlds---T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLG 215 (953)
T KOG0587|consen 141 NNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDS---TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLG 215 (953)
T ss_pred hcceeeecccCceEEEeccCc--EEEeeeeeeeeeec---ccccccCcCCCcccccceeeecccCCCCCcccccchhhcc
Confidence 999999999999999999887 99999999988874 34566788999999999998653 367899999999
Q ss_pred HHHHHHHhCCCCCCCCchhhHHHHHhhccc----cccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 699 CILFFCITGGKHPYGESFERDANIVKDRKD----LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 699 viL~elltG~~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
++..||.-| .+|+-+.....+-+...+.+ ..+...+.++.|+|..||.+|-++||++.++++|||..
T Consensus 216 ITaIEladG-~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 216 ITAIEMAEG-APPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred ceeehhcCC-CCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 999999997 78887654433322222211 11334567899999999999999999999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=272.65 Aligned_cols=254 Identities=22% Similarity=0.307 Sum_probs=202.6
Q ss_pred ceEEEeeeecccCceEEEEEEe-eCCcEEEEEEeccCC-----chHHH-HHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVAL-KEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~~~~-----~~~~~-~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
+.|.+-.+||+|+|..|.++.+ .+.+.+|+|++++.- .-.+. .|....-+..+||.+|-|+.+|+.+..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 4567788999999999998754 567899999987531 11222 2332334567899999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
.| |+++|+|.-++. +.+.+|++.++.+...|+.||.|||+.
T Consensus 330 ie----------yv~ggdlmfhmq-----------------------------rqrklpeeharfys~ei~lal~flh~r 370 (593)
T KOG0695|consen 330 IE----------YVNGGDLMFHMQ-----------------------------RQRKLPEEHARFYSAEICLALNFLHER 370 (593)
T ss_pred EE----------EecCcceeeehh-----------------------------hhhcCcHHHhhhhhHHHHHHHHHHhhc
Confidence 99 888888865543 235688999999999999999999999
Q ss_pred cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHH
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ell 705 (902)
|||.||||..|+||+..|+ +||+|+|+++.--.. ...+.+.||||.|+|||++.+..|...+|+|+|||+++||+
T Consensus 371 giiyrdlkldnvlldaegh--ikltdygmcke~l~~---gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemm 445 (593)
T KOG0695|consen 371 GIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGP---GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 445 (593)
T ss_pred CeeeeeccccceEEccCCc--eeecccchhhcCCCC---CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHH
Confidence 9999999999999998887 999999999864432 23457889999999999999999999999999999999999
Q ss_pred hCCCCCCCC---------chhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC------HHHHHcCCCCCCcch
Q 002601 706 TGGKHPYGE---------SFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK------AQNVLNHPFFWTADT 770 (902)
Q Consensus 706 tG~~~Pf~~---------~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt------~~elL~HPfF~~~~~ 770 (902)
.| +.||+- ..+...+++.......+...+-.+..+++..|.+||.+|.. ..++..|+||...++
T Consensus 446 ag-rspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idw 524 (593)
T KOG0695|consen 446 AG-RSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDW 524 (593)
T ss_pred cC-CCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCH
Confidence 98 667752 11122344444444556666778889999999999999964 678999999976554
Q ss_pred h
Q 002601 771 R 771 (902)
Q Consensus 771 ~ 771 (902)
.
T Consensus 525 d 525 (593)
T KOG0695|consen 525 D 525 (593)
T ss_pred H
Confidence 3
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-30 Score=306.91 Aligned_cols=261 Identities=26% Similarity=0.352 Sum_probs=196.4
Q ss_pred EEEeeeecccCceEEEEEEee--------CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccce
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY--------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~--------~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~ 542 (902)
..+.+.||+|.||.|++|... ....||||.++.... .....|+..+.....|+|||.++|+|..++.+
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 355669999999999997432 146799999976543 34566777777778899999999999999999
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
++|+| |..+|+|.++|......... ... + ........++...++.++.|||.|++||
T Consensus 378 ~~v~E----------y~~~G~L~~~Lr~~r~~~~~---------~~~--~--~~~~~~~~L~~~dLlsfa~QIa~GMe~L 434 (609)
T KOG0200|consen 378 YVIVE----------YAEHGDLLEFLRKKRVTESI---------DGS--G--VFPNERDALTTKDLLSFAYQIANGMEYL 434 (609)
T ss_pred EEEEE----------eccCCcHHHHHHhccccccc---------ccc--C--CCccccCCcCHHHHHHHHHHHHHHHHHH
Confidence 99999 66677887777654400000 000 0 0000002478889999999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
++.+++||||..+|||++++. .+||+|||+|+................-...|||||.+....++.++|||||||+||
T Consensus 435 ~~~~~vHRDLAaRNVLi~~~~--~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~ 512 (609)
T KOG0200|consen 435 ASVPCVHRDLAARNVLITKNK--VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLW 512 (609)
T ss_pred hhCCccchhhhhhhEEecCCC--EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHH
Confidence 999999999999999998774 499999999997654332221111100234599999999999999999999999999
Q ss_pred HHHhCCCCCCCCch--hhHHHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 703 FCITGGKHPYGESF--ERDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 703 elltG~~~Pf~~~~--~~~~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
|++|.|..||.+.. +.....++.. ....|..+.+++.++++.||+.+|++||+..++.
T Consensus 513 EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 513 EIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred HHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 99999999998722 2223333333 3355666789999999999999999999999886
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-30 Score=299.43 Aligned_cols=195 Identities=33% Similarity=0.565 Sum_probs=164.3
Q ss_pred EeeeecccCceEEEEEE-eeCCcEEEEEEeccC----CchHHHHHHHHHHHhCCCCCeeEecccccCcc------ceeee
Q 002601 477 FNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKT----HHDVALKEIQNLIASDQHPNIVRWYGVESDQD------FVYLS 545 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~------~~yLV 545 (902)
..+.||+|+||.||++. ..+|+.||||.+++. ..+..-+|++ ++++++|+|||+++++..+.. ...+|
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~Eie-ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIE-ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHH-HHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 34679999999999986 678999999998763 3456778886 668899999999999977654 56899
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
||||. +|+|...|..- -+..|+|+.+++.++.+++.||.|||++
T Consensus 96 mEyC~----------gGsL~~~L~~P--------------------------EN~~GLpE~e~l~lL~d~~~al~~LrEn 139 (732)
T KOG4250|consen 96 MEYCS----------GGSLRKVLNSP--------------------------ENAYGLPESEFLDLLSDLVSALRHLREN 139 (732)
T ss_pred EeecC----------CCcHHHHhcCc--------------------------ccccCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 99654 67887777432 2357899999999999999999999999
Q ss_pred cccccccccceeEe--ccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHH
Q 002601 626 GLIHRDLKPQNVLI--SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 702 (902)
Q Consensus 626 ~IvHrDLKp~NILL--~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~ 702 (902)
||+||||||.||++ ..+|...-||+|||.|+.+.++. ...+.+||..|.+||.... +.|+..+|.|||||++|
T Consensus 140 ~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s----~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY 215 (732)
T KOG4250|consen 140 GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS----LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLY 215 (732)
T ss_pred CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC----eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHH
Confidence 99999999999998 45566678999999999988653 4467789999999999984 88999999999999999
Q ss_pred HHHhCCCCCCC
Q 002601 703 FCITGGKHPYG 713 (902)
Q Consensus 703 elltG~~~Pf~ 713 (902)
+++|| ..||-
T Consensus 216 ~caTG-~lPF~ 225 (732)
T KOG4250|consen 216 ECATG-ELPFI 225 (732)
T ss_pred HHhcc-CCCCC
Confidence 99998 66664
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=262.92 Aligned_cols=234 Identities=36% Similarity=0.556 Sum_probs=183.4
Q ss_pred CceEEEEEEee-CCcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChhhHHHH
Q 002601 485 SNGTVVLEGNY-EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYV 559 (902)
Q Consensus 485 sfGtVy~a~~~-~g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~dliy~ 559 (902)
+||.||++... +|+.||+|++..... +...+|+. .++.++|+||+++++++.+....++++| ++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~l~~e----------~~ 69 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREIS-ILKKLKHPNIVRLYDVFEDEDKLYLVME----------YC 69 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHH-HHHhCCCCcHHHHHhheeeCCEEEEEEe----------CC
Confidence 58999998665 489999999865432 33445554 6677899999999999999999999999 55
Q ss_pred hcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEe
Q 002601 560 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639 (902)
Q Consensus 560 ~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL 639 (902)
++|+|.+++... ..+++..+..++.++++++.|||+.+|+|+||+|+||++
T Consensus 70 ~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~ 120 (244)
T smart00220 70 DGGDLFDLLKKR-----------------------------GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL 120 (244)
T ss_pred CCCCHHHHHHhc-----------------------------cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE
Confidence 555666554321 115667789999999999999999999999999999999
Q ss_pred ccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCC--chh
Q 002601 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGE--SFE 717 (902)
Q Consensus 640 ~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~--~~~ 717 (902)
+.++. ++|+|||.+....... ......++..|++||.+....++.++||||||++++++++| ..||.. ...
T Consensus 121 ~~~~~--~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~-~~p~~~~~~~~ 193 (244)
T smart00220 121 DEDGH--VKLADFGLARQLDPGG----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTG-KPPFPGDDQLL 193 (244)
T ss_pred CCCCc--EEEccccceeeecccc----ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcHH
Confidence 88765 8999999998776432 22344578899999999888889999999999999999997 667765 222
Q ss_pred hHHHHHhhcccccccc---CChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 718 RDANIVKDRKDLFLVE---HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 718 ~~~~~~~~~~~~~~~~---~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
................ ...++.+++.+||..+|.+||++.++++||||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 194 ELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 2223333222222222 56789999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=282.40 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=194.0
Q ss_pred ccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEec--cCC--------chHHHHHHHHHHHhCCCCCeeEeccccc-C
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLV--KTH--------HDVALKEIQNLIASDQHPNIVRWYGVES-D 538 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~--~~~--------~~~~~~Ei~~ll~~l~HpNIV~l~g~~~-d 538 (902)
+.++|-+-..||+|+|..||+| ++...+.||||+-. +.. ...+.+|.. +.+.+.||.||++|+|+. |
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyr-IHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYR-IHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHh-hhhccCcceeeeeeeeeeec
Confidence 3344444456999999999998 67788999999752 211 123445553 678899999999999986 6
Q ss_pred ccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 539 ~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
.+.++-|+|||+++-.|+. |. ..+-+++++++.|+.||+.|
T Consensus 540 tdsFCTVLEYceGNDLDFY----------LK-----------------------------QhklmSEKEARSIiMQiVnA 580 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFY----------LK-----------------------------QHKLMSEKEARSIIMQIVNA 580 (775)
T ss_pred cccceeeeeecCCCchhHH----------HH-----------------------------hhhhhhHHHHHHHHHHHHHH
Confidence 6778999998887644442 21 11235677889999999999
Q ss_pred ccccccc--cccccccccceeEeccCCC-ceEEEccCCccccccCCCcc----ccccccCCCCccccCchhhccC----C
Q 002601 619 LSHLHEI--GLIHRDLKPQNVLISKDKS-FCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQG----R 687 (902)
Q Consensus 619 L~yLH~~--~IvHrDLKp~NILL~~d~~-~~vkL~DFGla~~~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~~----~ 687 (902)
|.||.+. .|||-||||.||||-.... ..+||+||||++.+.++... ...+....||..|++||.+.-+ +
T Consensus 581 L~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPK 660 (775)
T KOG1151|consen 581 LKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPK 660 (775)
T ss_pred HHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCc
Confidence 9999976 6999999999999954322 23999999999998765322 1223445699999999987543 4
Q ss_pred CCCcchhhhhHHHHHHHHhCCCCCCCCchhhHH-----HHHhhccccccc--cCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 688 QTRAIDLFSLGCILFFCITGGKHPYGESFERDA-----NIVKDRKDLFLV--EHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 688 ~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~~-----~~~~~~~~~~~~--~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
.+.++||||+|||+|.|+.| +-||+.+...+. .+++.....|+. -.+++++++|++||+..-+.|..+.++.
T Consensus 661 IsnKVDVWSvGVIFyQClYG-rKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 661 ISNKVDVWSVGVIFYQCLYG-RKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred cccceeeEeeehhhhhhhcc-CCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 68999999999999999998 668987654332 234444444443 3578999999999999999999999999
Q ss_pred cCCCCCC
Q 002601 761 NHPFFWT 767 (902)
Q Consensus 761 ~HPfF~~ 767 (902)
.||||..
T Consensus 740 ~dpyllP 746 (775)
T KOG1151|consen 740 CDPYLLP 746 (775)
T ss_pred cCccccc
Confidence 9999954
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-30 Score=280.46 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=188.2
Q ss_pred ccccceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC--chHHHHHHHHHHHhCC------CCCeeEecccccCc
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ------HPNIVRWYGVESDQ 539 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~------HpNIV~l~g~~~d~ 539 (902)
+.+...|.+....|+|-|++|+.|. ...|.+||||++.+.. +...++|++. +..++ --|+++|+..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~Elei-LkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEI-LKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHH-HHHhhccCchhhhHHHHHHHHhhhc
Confidence 3344567778889999999999984 4458899999997653 2345677764 44443 34799999999999
Q ss_pred cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccc
Q 002601 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (902)
Q Consensus 540 ~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL 619 (902)
+++|||+|.+.-+|.+.+.--+ +..++....++.++.|+..||
T Consensus 507 nHLClVFE~LslNLRevLKKyG-------------------------------------~nvGL~ikaVRsYaqQLflAL 549 (752)
T KOG0670|consen 507 NHLCLVFEPLSLNLREVLKKYG-------------------------------------RNVGLHIKAVRSYAQQLFLAL 549 (752)
T ss_pred ceeEEEehhhhchHHHHHHHhC-------------------------------------cccceeehHHHHHHHHHHHHH
Confidence 9999999988877777653211 123566677899999999999
Q ss_pred cccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHH
Q 002601 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (902)
Q Consensus 620 ~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGv 699 (902)
..|-..||+|.||||.|||+++..+ .+||||||.|.......- ....-+..|.|||++.+.+|+...|+||.||
T Consensus 550 klLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~enei-----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 550 KLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASENEI-----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGC 623 (752)
T ss_pred HHHHhcCeeecccCccceEeccCcc-eeeeccCccccccccccc-----cHHHHHHhccCcceeecCcccCCccceeece
Confidence 9999999999999999999998765 699999999877654311 1111345699999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCchhhHHHHHhhcccc--------------------------------------------------
Q 002601 700 ILFFCITGGKHPYGESFERDANIVKDRKDL-------------------------------------------------- 729 (902)
Q Consensus 700 iL~elltG~~~Pf~~~~~~~~~~~~~~~~~-------------------------------------------------- 729 (902)
.||||.||.-.+-+.....+.......+..
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s 703 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGS 703 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHH
Confidence 999999984433332222111000000000
Q ss_pred -------ccc---cCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 730 -------FLV---EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 730 -------~~~---~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
.+. .....+++|+.+||..||++|.|+.++|+||||.
T Consensus 704 ~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 704 ELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCccc
Confidence 000 0113578999999999999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=261.90 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=189.4
Q ss_pred eEEEeeeecccCceEEEEEEee------CCcEEEEEEeccCCch----HHHHHHHHHHHhCCCCCeeEecccccCc-cce
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQ-DFV 542 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l~HpNIV~l~g~~~d~-~~~ 542 (902)
++.....+-+|.||.||+|-+. +.+.|-||.++....+ ..+.|- .++....|||+....|++.++ +.-
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es-~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQES-MLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHH-HHHhcCcCCCccceeEEEeeccCcc
Confidence 3666778999999999998333 3466777776543322 123333 456677899999999998754 556
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
++++. ++.-|+|..+|..-.... ....+.+...++..++.|++.|++||
T Consensus 364 ~V~y~----------~~~~gNLK~FL~~Cr~~~---------------------~~~aqtvtt~qlV~masQla~am~hl 412 (563)
T KOG1024|consen 364 FVLYP----------ATGVGNLKSFLQICRGDD---------------------PSYAQTVTTIQLVLMASQLAMAMEHL 412 (563)
T ss_pred eEEEe----------ccCcchHHHHHHHhccCC---------------------CccccchhHHHHHHHHHHHHHHHHHH
Confidence 77777 666788888775221110 01223455667889999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCC-CccccccccCCCCccccCchhhccCCCCCcchhhhhHHHH
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD-MSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~-~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL 701 (902)
|.++|||.||..+|++|++ .+++||+|=.+++.+-.. ..+.. ........||+||.+.+..|+.++|||||||+|
T Consensus 413 h~~~ViHkDiAaRNCvIdd--~LqVkltDsaLSRDLFP~DYhcLG--DnEnRPvkWMslEal~n~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 413 HNHGVIHKDIAARNCVIDD--QLQVKLTDSALSRDLFPGDYHCLG--DNENRPVKWMSLEALQNSHYSSASDVWSFGVLL 488 (563)
T ss_pred HhcCcccchhhhhcceehh--heeEEeccchhccccCcccccccC--CCCCCcccccCHHHHhhhhhcchhhhHHHHHHH
Confidence 9999999999999999954 488999999999976542 22222 222346789999999999999999999999999
Q ss_pred HHHHhCCCCCCCCchhhH-HHHHhhc-cccccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 702 FFCITGGKHPYGESFERD-ANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~-~~~~~~~-~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
|||+|-|+.||.+-.+.+ ...+++. .-..|.++++|+..++..||..+|++||+.+|+.
T Consensus 489 WELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 489 WELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred HHHHhcCCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 999999999998764433 3444443 4456778899999999999999999999999986
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=250.48 Aligned_cols=247 Identities=22% Similarity=0.327 Sum_probs=187.7
Q ss_pred ceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCc--cceeeeeccc
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQ--DFVYLSLERC 549 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~--~~~yLV~E~c 549 (902)
+.|.+.+++|+|.++.|+.|. ..+...++||+++.-......+|+..+.....||||++|+++..|. ...-|++|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE-- 115 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE-- 115 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh--
Confidence 345566789999999999873 4567889999998877778889998766666799999999998764 44678899
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+.|-++.... ..++...++.++.+++.||.|||+.||+|
T Consensus 116 --------~v~n~Dfk~ly--------------------------------~tl~d~dIryY~~elLkALdyCHS~GImH 155 (338)
T KOG0668|consen 116 --------YVNNTDFKQLY--------------------------------PTLTDYDIRYYIYELLKALDYCHSMGIMH 155 (338)
T ss_pred --------hhccccHHHHh--------------------------------hhhchhhHHHHHHHHHHHHhHHHhcCccc
Confidence 66555544332 12445567899999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHhCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~elltG~ 708 (902)
||+||.|++|+.... .++|+|+|||......... +..+.+.-|--||.+.. ..|+..-|+|||||++..|+...
T Consensus 156 RDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eY----nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrk 230 (338)
T KOG0668|consen 156 RDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 230 (338)
T ss_pred ccCCcceeeechhhc-eeeeeecchHhhcCCCcee----eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhcc
Confidence 999999999986543 5899999999988765433 23345667889998876 45799999999999999999986
Q ss_pred CCCCCCch--hhHHHHH---------------------------hhccc----cc-----cccCChHHHHHHHcccCCCC
Q 002601 709 KHPYGESF--ERDANIV---------------------------KDRKD----LF-----LVEHIPEAVDLFTRLLDPNP 750 (902)
Q Consensus 709 ~~Pf~~~~--~~~~~~~---------------------------~~~~~----~~-----~~~~~~e~~dLI~~~L~~dP 750 (902)
.++|.+.. ++...+. ..... .| ..-.++|+.|++.++|..|.
T Consensus 231 epFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH 310 (338)
T KOG0668|consen 231 EPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH 310 (338)
T ss_pred CcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc
Confidence 66665422 1111110 00000 00 01124899999999999999
Q ss_pred CCCcCHHHHHcCCCCC
Q 002601 751 DLRPKAQNVLNHPFFW 766 (902)
Q Consensus 751 ~~Rpt~~elL~HPfF~ 766 (902)
.+|+|+.|++.||||.
T Consensus 311 qeRlTakEam~HpyF~ 326 (338)
T KOG0668|consen 311 QERLTAKEAMAHPYFA 326 (338)
T ss_pred ccccchHHHhcCchHH
Confidence 9999999999999994
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=261.57 Aligned_cols=131 Identities=27% Similarity=0.357 Sum_probs=106.6
Q ss_pred ceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC--chHHHHHHHHHHHhCC----C---CCeeEecccccC----
Q 002601 473 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQ----H---PNIVRWYGVESD---- 538 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~----H---pNIV~l~g~~~d---- 538 (902)
.+|.+.++||=|.|.|||++ +..+.+.||+|+.+... .+.+..||..+.+... | ..||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 56778899999999999998 56678899999987643 3567888875544332 3 379999999864
Q ss_pred ccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcc
Q 002601 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 539 ~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
+.+++||+|++..+|..+|.. ...+++|...+++|++||+.|
T Consensus 158 G~HVCMVfEvLGdnLLklI~~--------------------------------------s~YrGlpl~~VK~I~~qvL~G 199 (590)
T KOG1290|consen 158 GQHVCMVFEVLGDNLLKLIKY--------------------------------------SNYRGLPLSCVKEICRQVLTG 199 (590)
T ss_pred CcEEEEEehhhhhHHHHHHHH--------------------------------------hCCCCCcHHHHHHHHHHHHHH
Confidence 568999999988887777621 334789999999999999999
Q ss_pred ccccccc-cccccccccceeEecc
Q 002601 619 LSHLHEI-GLIHRDLKPQNVLISK 641 (902)
Q Consensus 619 L~yLH~~-~IvHrDLKp~NILL~~ 641 (902)
|.|||.. ||||-||||+||||..
T Consensus 200 LdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 200 LDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred HHHHHHhcCccccCCCcceeeeec
Confidence 9999965 9999999999999953
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=258.07 Aligned_cols=244 Identities=30% Similarity=0.444 Sum_probs=180.0
Q ss_pred ceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccC-----CchHHHHHHHHHHHhCCCCCeeEecccccCc------c
Q 002601 473 KLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQ------D 540 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~------~ 540 (902)
.+|.--+.+|.|.- .|.-| +.-.++.||+|++... +...+.+|.. ++..++|+||++++.++.-. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~-l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELK-LMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhh-hhhhhcccceeeeeeccCccccHHHHH
Confidence 34444566888887 45444 4456899999987543 3456788886 67889999999999998654 3
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
.+|+|||++..+|.+.+.++ ++-..+..|..|++.|++
T Consensus 95 e~y~v~e~m~~nl~~vi~~e------------------------------------------lDH~tis~i~yq~~~~ik 132 (369)
T KOG0665|consen 95 EVYLVMELMDANLCQVILME------------------------------------------LDHETISYILYQMLCGIK 132 (369)
T ss_pred hHHHHHHhhhhHHHHHHHHh------------------------------------------cchHHHHHHHHHHHHHHH
Confidence 57999998887777666321 223456889999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHH
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGvi 700 (902)
|||+.||+||||||+||++..+.. +||.|||+|+..... -....-+.|..|.|||++.+..+...+||||+||+
T Consensus 133 ~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci 206 (369)
T KOG0665|consen 133 HLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDTD----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 206 (369)
T ss_pred HHHhcceeecccCcccceecchhh--eeeccchhhcccCcc----cccCchhheeeccCchheeccCCcccchhhhhhhH
Confidence 999999999999999999977754 999999999875532 12223357888999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCchhhHH-----------------------HHHhhc--------cccccc-----------cCChHH
Q 002601 701 LFFCITGGKHPYGESFERDA-----------------------NIVKDR--------KDLFLV-----------EHIPEA 738 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~~~~-----------------------~~~~~~--------~~~~~~-----------~~~~e~ 738 (902)
+.||++|.-.+-+...-.+. ..+... ...++. .....+
T Consensus 207 ~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~a 286 (369)
T KOG0665|consen 207 MGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLA 286 (369)
T ss_pred HHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHH
Confidence 99999984433332211110 000000 000110 112368
Q ss_pred HHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 739 VDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 739 ~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
+|++.+||..||++|.+++++|+||||.
T Consensus 287 rdll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 287 RDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHHhhccChhhcccHHHHhcCCeee
Confidence 8999999999999999999999999995
|
|
| >PF06479 Ribonuc_2-5A: Ribonuclease 2-5A; InterPro: IPR010513 The proteins listed below share a common architecture with a protein kinase homology domain (see PDOC00100 from PROSITEDOC) followed by an ~135-residue globular kinase-extension nuclease (KEN) domain made of eight helices []: - Mammalian 2-5A-dependent RNase or RNase L (EC 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-29 Score=240.59 Aligned_cols=129 Identities=53% Similarity=0.986 Sum_probs=114.6
Q ss_pred hhhhhhhhcccchhhccccchHHHHHHHHHHHHhhhcccchHHHhHHHHHhhhhcccCCcchHHHHHHHhccccCcccCC
Q 002601 770 TRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFREL 849 (902)
Q Consensus 770 ~~~~~l~~~s~~~e~~~~~~~~~ll~~le~~~~~~~~~~w~~~~~~~l~~~~~~~R~y~~~~vrdLLr~irnk~~h~~el 849 (902)
+++.|++++||++|.+.++..+.++..||..+..+.+++|++++|+.++++|+++|+|++++|+||||+||||+|||+|+
T Consensus 1 krl~Fl~dvSDr~E~~~~~~~s~~l~~Le~~~~~v~~~~W~~~ld~~l~~~l~~~R~Y~~~sv~DLLR~IRNk~~Hy~el 80 (129)
T PF06479_consen 1 KRLSFLQDVSDRIEKESRDPPSPLLQELESNAEDVLGGDWDKKLDPELLDDLGKYRKYDGDSVRDLLRAIRNKKHHYQEL 80 (129)
T ss_dssp HHHHHHHHHHHHCSSS-TTTTSHHHHHHHHCCCCCTTS-CGGCSBHHHHHCCTTTSS--TT-HHHHHHHHHHHHHTCCCS
T ss_pred ChhHHHHHhhhHhhhcccccchHHHHHHHhcCCCCCCccHhHHhCHHHHHHHHhccCCCccCHHHHHHHHHcchHhHHHC
Confidence 47899999999999999998899999999877777889999999999999999999999999999999999999999999
Q ss_pred CHHHHHHhCCCCCcccccccccCCchHHHHHHHHHHhhccchhhhccccC
Q 002601 850 PQDIQELLGSHPEGFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKYVTN 899 (902)
Q Consensus 850 ~~~~~~~~G~~p~~f~~yf~~~fP~ll~~~y~~~~~~~~~e~~~~~y~~~ 899 (902)
|+++|+.+|++|+||..||++|||+||||||.++. +|++|+.|++||.+
T Consensus 81 ~~~~k~~lg~~p~gf~~YF~~rFP~Ll~~~Y~~~~-~~~~e~~F~~y~~~ 129 (129)
T PF06479_consen 81 PEEVKEILGSLPDGFLNYFTSRFPNLLIHVYNFVR-NCKNEPHFKKYFNP 129 (129)
T ss_dssp -HHHHHHC-STTHHHHHHHHTT-TTHHHHHHHHHH-HCTTSCCCHHHH--
T ss_pred CHHHHHHhCCCchHHHHHHHHHCcHHHHHHHHHHH-hcCccHHHHhhccC
Confidence 99999999999999999999999999999999999 99999999999974
|
1.26.-), an interferon- induced enzyme implicated in both the molecular mechanisms of interferon action and the fundamental control of RNA stability. 2-5A-dependent RNase is a unique enzyme in that it requires 2-5A, unusual oligoadenylates with 2',5'-phosphodiester linkages. RNase L is catalytically active only after binding to an unusual activator molecule containing a 5'-phosphorylated 2', 5'-linked oligoadenylate (2-5A), in the N-terminal half. RNase L consists of three domains, namely the N-terminal ankyrin repeat domain (see PDOC50088 from PROSITEDOC), the protein kinase homology domain, and the C-terminal KEN domain [, , ]. - Eukaryotic Ire1/Ern1, an ancient transmembrane sensor of endoplasmic reticulum (ER) stress with dual protein kinase and ribonuclease activities. In response to ER stress Ire1/Ern1 catalyzes the splicing of target mRNAs in a spliceosome-independent manner. Ire1/Ern1 is a type 1 transmembrane receptor consisting of an N-terminal ER luminal domain, a transmembrane segment and a cytoplasmic region. The cytoplasmic region encompasses a protein kinase domain followed by a C-terminal KEN domain [, ]. The dimerisation of the kinase domain activates the ribonuclease function of the KEN domain [].; GO: 0016891 endoribonuclease activity, producing 5'-phosphomonoesters, 0006397 mRNA processing; PDB: 3SDJ_D 3FBV_L 3LJ2_A 3SDM_A 3LJ0_A 2RIO_A 3LJ1_A 3P23_A. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=258.56 Aligned_cols=242 Identities=24% Similarity=0.381 Sum_probs=177.3
Q ss_pred eeecccCceEEEEE-EeeCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCc-----cceeeeec
Q 002601 479 KEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQ-----DFVYLSLE 547 (902)
Q Consensus 479 ~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~-----~~~yLV~E 547 (902)
+.||-|+||.||-. +-.+|+.||.|++.... ....++|+. ++...+|.|++..++..+-. .++|++.|
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~k-mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIK-MLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHH-HHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 56999999999965 45679999999986432 245688886 77889999999998876543 24688888
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
++..+|+..| -....++.+.+.-+..||++||.|||+.+|
T Consensus 138 LmQSDLHKII----------------------------------------VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~I 177 (449)
T KOG0664|consen 138 LMQSDLHKII----------------------------------------VSPQALTPDHVKVFVYQILRGLKYLHTANI 177 (449)
T ss_pred HHHhhhhhee----------------------------------------ccCCCCCcchhhhhHHHHHhhhHHHhhcch
Confidence 6655554443 122445666778899999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHh
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~ellt 706 (902)
+||||||.|.|++.+ +.+||||||+++....+.. ......+-|..|.|||++.+. .|+.++||||.|||+.|++-
T Consensus 178 LHRDIKPGNLLVNSN--CvLKICDFGLARvee~d~~--~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 178 LHRDIKPGNLLVNSN--CILKICDFGLARTWDQRDR--LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred hhccCCCccEEeccC--ceEEecccccccccchhhh--hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh
Confidence 999999999999554 7799999999997654321 111223457889999999875 58999999999999999986
Q ss_pred CCCCCCCCchh-hHH------------------------HHHhhccc--cc--------cccCChHHHHHHHcccCCCCC
Q 002601 707 GGKHPYGESFE-RDA------------------------NIVKDRKD--LF--------LVEHIPEAVDLFTRLLDPNPD 751 (902)
Q Consensus 707 G~~~Pf~~~~~-~~~------------------------~~~~~~~~--~~--------~~~~~~e~~dLI~~~L~~dP~ 751 (902)
. +.-|..... .+. .++..... .+ +.....++.+++.++|..||.
T Consensus 254 R-rILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~d 332 (449)
T KOG0664|consen 254 R-KILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPD 332 (449)
T ss_pred h-hhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCc
Confidence 4 555543211 111 11111100 00 111224788999999999999
Q ss_pred CCcCHHHHHcCCCCC
Q 002601 752 LRPKAQNVLNHPFFW 766 (902)
Q Consensus 752 ~Rpt~~elL~HPfF~ 766 (902)
+|.+.++.+.|++..
T Consensus 333 kris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 333 KRISVEEALQHRYLE 347 (449)
T ss_pred ccccHhhhccccccc
Confidence 999999999999863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=243.34 Aligned_cols=195 Identities=28% Similarity=0.397 Sum_probs=157.8
Q ss_pred eeeecccCceEEEEE-EeeCCcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 478 NKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
...||+|++|.|-+- +.++|+..|||++..+- ....++|+...++....|.+|.+||...+....+|+||.+..+
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tS 130 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTS 130 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhh
Confidence 467999999988553 67889999999986432 2345677777778889999999999999999999999988777
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc-cccccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRD 631 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~-~IvHrD 631 (902)
|..+. - + -+-+...+|+..+-+|+..+++||.|||++ .++|||
T Consensus 131 ldkfy-~------~-----------------------------v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRD 174 (282)
T KOG0984|consen 131 LDKFY-R------K-----------------------------VLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRD 174 (282)
T ss_pred HHHHH-H------H-----------------------------HHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhcc
Confidence 66542 0 0 012335578889999999999999999987 899999
Q ss_pred cccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhcc----CCCCCcchhhhhHHHHHHHHhC
Q 002601 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ----GRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 632 LKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~----~~~s~ksDVwSlGviL~elltG 707 (902)
+||+||||+.+|. +|+||||++-.+.+.... ....|...|||||.+.. ..|+.++||||||+.+.||.++
T Consensus 175 vKPsNiLIn~~Gq--VKiCDFGIsG~L~dSiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~l 248 (282)
T KOG0984|consen 175 VKPSNILINYDGQ--VKICDFGISGYLVDSIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAIL 248 (282)
T ss_pred CCcceEEEccCCc--EEEcccccceeehhhhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhc
Confidence 9999999999987 999999999887653211 11348889999998764 3689999999999999999998
Q ss_pred CCCCCCCc
Q 002601 708 GKHPYGES 715 (902)
Q Consensus 708 ~~~Pf~~~ 715 (902)
+.||...
T Consensus 249 -r~PY~~w 255 (282)
T KOG0984|consen 249 -RFPYESW 255 (282)
T ss_pred -ccccccc
Confidence 7788654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=258.93 Aligned_cols=260 Identities=29% Similarity=0.426 Sum_probs=189.4
Q ss_pred cccccceEEEeeeecccCceEEEEEEee----CCcEEEEEEeccCC-chHHHHHHHHHHHhCCCCCeeEecccccCccce
Q 002601 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTH-HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 468 ~~~i~~~~~~~~~LG~GsfGtVy~a~~~----~g~~VAVKrl~~~~-~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~ 542 (902)
...+.+.|...++||+|+|++||++... ..+.||+|.+.... ......|++.+-....|.||+++.+++..++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 3556667778899999999999998543 46889999986654 345677887666777899999999999999999
Q ss_pred eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccc
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
.+|+| |++.-...+++. .++..+++.+++.++.||+++
T Consensus 111 ~ivlp----------~~~H~~f~~l~~--------------------------------~l~~~~i~~Yl~~ll~Al~~~ 148 (418)
T KOG1167|consen 111 AIVLP----------YFEHDRFRDLYR--------------------------------SLSLAEIRWYLRNLLKALAHL 148 (418)
T ss_pred EEEec----------ccCccCHHHHHh--------------------------------cCCHHHHHHHHHHHHHHhhhh
Confidence 99999 555555555442 245667889999999999999
Q ss_pred ccccccccccccceeEeccCCCceEEEccCCccccccCCC------c--------------------------c------
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM------S--------------------------C------ 664 (902)
Q Consensus 623 H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~------~--------------------------~------ 664 (902)
|.+|||||||||+|+|.+.... .-.|.|||||....... . .
T Consensus 149 h~~GIvHRDiKpsNFL~n~~t~-rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~ 227 (418)
T KOG1167|consen 149 HKNGIVHRDIKPSNFLYNRRTQ-RGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCN 227 (418)
T ss_pred hccCccccCCCccccccccccC-CceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccC
Confidence 9999999999999999976433 35699999997321100 0 0
Q ss_pred ---ccccccCCCCccccCchhhcc-CCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhH-----HH------H-----Hh
Q 002601 665 ---LTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-----AN------I-----VK 724 (902)
Q Consensus 665 ---~~~~~~~~Gt~~Y~APE~l~~-~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~-----~~------~-----~~ 724 (902)
........||+||.|||++.. ...+.++||||.|||+..++++..|+|....+.. .. + ..
T Consensus 228 ~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~ 307 (418)
T KOG1167|consen 228 DGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALP 307 (418)
T ss_pred CCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcC
Confidence 000112359999999999875 4578999999999999999998444443221110 00 0 00
Q ss_pred hc----------------------------cccc-------ccc-CChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 725 DR----------------------------KDLF-------LVE-HIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 725 ~~----------------------------~~~~-------~~~-~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
+. +... ..+ .+..+.|++.+||..||.+|.|++++|+||||...
T Consensus 308 g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 308 GRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred CceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 00 0000 001 12368899999999999999999999999999754
Q ss_pred ch
Q 002601 769 DT 770 (902)
Q Consensus 769 ~~ 770 (902)
+.
T Consensus 388 ~~ 389 (418)
T KOG1167|consen 388 DR 389 (418)
T ss_pred hh
Confidence 43
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=292.95 Aligned_cols=205 Identities=19% Similarity=0.244 Sum_probs=144.6
Q ss_pred CCC-CCeeEecccc-------cCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhH
Q 002601 524 DQH-PNIVRWYGVE-------SDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595 (902)
Q Consensus 524 l~H-pNIV~l~g~~-------~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~ 595 (902)
+.| +||++++++| .+.+.++.++|+++.+|.+++ ...
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l-----------~~~------------------------ 73 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWL-----------DNP------------------------ 73 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHH-----------hcc------------------------
Confidence 345 5788888877 334567888886655555443 211
Q ss_pred HHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEeccCC-----------------CceEEEccCCccccc
Q 002601 596 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK-----------------SFCAKLSDMGISKRL 658 (902)
Q Consensus 596 ~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~-----------------~~~vkL~DFGla~~~ 658 (902)
...+++.+++.|++||++||+|||++||+||||||+||||+..+ ...+|++|||+++..
T Consensus 74 ----~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~ 149 (793)
T PLN00181 74 ----DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRRE 149 (793)
T ss_pred ----cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccc
Confidence 12367778899999999999999999999999999999996422 234778888887653
Q ss_pred cCCCc-------------cccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhHHHHHhh
Q 002601 659 QGDMS-------------CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKD 725 (902)
Q Consensus 659 ~~~~~-------------~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~~~~~~~ 725 (902)
..... ........+||+.|||||++.+..++.++|||||||+||||++| .+|+.........+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~-~~~~~~~~~~~~~~~~~ 228 (793)
T PLN00181 150 EILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP-VSSREEKSRTMSSLRHR 228 (793)
T ss_pred ccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC-CCchhhHHHHHHHHHHh
Confidence 21000 00011124689999999999999999999999999999999996 66665432221111111
Q ss_pred ccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 726 RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 726 ~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
..........++..+++.+||++||.+||++.|+++||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 229 VLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 1111112235677899999999999999999999999999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=225.08 Aligned_cols=208 Identities=38% Similarity=0.661 Sum_probs=170.6
Q ss_pred ecccCceEEEEEEeeC-CcEEEEEEeccCCc----hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChhh
Q 002601 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLND 555 (902)
Q Consensus 481 LG~GsfGtVy~a~~~~-g~~VAVKrl~~~~~----~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~d 555 (902)
||+|++|.||++...+ |+.++||++..... ....+|+. .+..+.|++|+++++++......++++|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~----- 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIE-ILKKLNHPNIVKLYGVFEDENHLYLVMEYCE----- 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHH-HHHhcCCCCeeeEeeeeecCCeEEEEEecCC-----
Confidence 6899999999986654 89999999976644 34556665 6688899999999999999999999999554
Q ss_pred HHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccc
Q 002601 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ 635 (902)
Q Consensus 556 liy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~ 635 (902)
+++|.+++.... ..++...+..++.+++++|++||+.+++|+||+|.
T Consensus 75 -----~~~l~~~~~~~~----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ 121 (215)
T cd00180 75 -----GGSLKDLLKENE----------------------------GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121 (215)
T ss_pred -----CCcHHHHHHhcc----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHh
Confidence 455555442210 23567788999999999999999999999999999
Q ss_pred eeEecc-CCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC-CCCCcchhhhhHHHHHHHHhCCCCCCC
Q 002601 636 NVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITGGKHPYG 713 (902)
Q Consensus 636 NILL~~-d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~-~~s~ksDVwSlGviL~elltG~~~Pf~ 713 (902)
||+++. ++. ++|+|||.+........ ......+...|++||.+... ..+.+.|+|++|++++++
T Consensus 122 ni~~~~~~~~--~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------- 187 (215)
T cd00180 122 NILLDSDNGK--VKLADFGLSKLLTSDKS---LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------- 187 (215)
T ss_pred hEEEeCCCCc--EEEecCCceEEccCCcc---hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------
Confidence 999987 554 89999999987654321 12233478889999999887 788999999999999998
Q ss_pred CchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCC
Q 002601 714 ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 763 (902)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HP 763 (902)
+.+.+++.+|++.||.+||++.++++|+
T Consensus 188 ----------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ----------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ----------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6789999999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=261.75 Aligned_cols=252 Identities=24% Similarity=0.362 Sum_probs=192.7
Q ss_pred cceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCch---HHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 472 GKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~~---~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.+.|.+..++|.|+||.||+| ...+++..|||+++-.-.+ ...+|+. +++..+|||||.++|.+-..+.++++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~-~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIG-MLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcccccccccee-eeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 456778889999999999998 5567999999998643222 2344554 5677899999999999999999999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
||++ |+|++..| -..++.+.++...++..++||+|||+.|-
T Consensus 93 ycgg----------gslQdiy~-----------------------------~TgplselqiayvcRetl~gl~ylhs~gk 133 (829)
T KOG0576|consen 93 YCGG----------GSLQDIYH-----------------------------VTGPLSELQIAYVCRETLQGLKYLHSQGK 133 (829)
T ss_pred ecCC----------Ccccceee-----------------------------ecccchhHHHHHHHhhhhccchhhhcCCc
Confidence 8875 33333222 12345566778899999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhc---cCCCCCcchhhhhHHHHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~---~~~~s~ksDVwSlGviL~el 704 (902)
+|||||-.|||++..|. +|++|||.+..+.. .......+.||+.|||||+.. .+.|...+|||++|+...|+
T Consensus 134 ~hRdiKGanilltd~gD--vklaDfgvsaqita---ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 134 IHRDIKGANILLTDEGD--VKLADFGVSAQITA---TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred ccccccccceeecccCc--eeecccCchhhhhh---hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 99999999999999988 99999999877653 234456678999999999763 56789999999999999998
Q ss_pred HhCCCCCCCCchhhHHHHHhhcc-----ccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 705 ITGGKHPYGESFERDANIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~~~~~~~~~-----~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
-....+-|+-...+...++.... ........+-+-++++.+|.++|++||+++.+|.|||....
T Consensus 209 ~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 209 GELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred hhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 77533334333322222222111 11122345678899999999999999999999999998654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=250.96 Aligned_cols=192 Identities=25% Similarity=0.397 Sum_probs=152.8
Q ss_pred EEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCCc--h---------HHHHHHHHHHHhCC---CCCeeEecccccCc
Q 002601 475 VVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTHH--D---------VALKEIQNLIASDQ---HPNIVRWYGVESDQ 539 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~~--~---------~~~~Ei~~ll~~l~---HpNIV~l~g~~~d~ 539 (902)
|...+.+|+|+||.|++| +..+..+|+||.+.+... + ..-.||+ +|..++ |+||++++.+|+++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIq-Ila~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQ-ILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHH-HHHHhhhcCccchhhhhheeecC
Confidence 667789999999999998 455678999999876531 1 1234776 456665 99999999999999
Q ss_pred cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccc
Q 002601 540 DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (902)
Q Consensus 540 ~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL 619 (902)
++.||+||.-..+ =+|++++..+ ..+++.++..|++||+.|+
T Consensus 642 d~yyl~te~hg~g---------IDLFd~IE~k-----------------------------p~m~E~eAk~IFkQV~agi 683 (772)
T KOG1152|consen 642 DYYYLETEVHGEG---------IDLFDFIEFK-----------------------------PRMDEPEAKLIFKQVVAGI 683 (772)
T ss_pred CeeEEEecCCCCC---------cchhhhhhcc-----------------------------CccchHHHHHHHHHHHhcc
Confidence 9999999954322 1333443211 2367788899999999999
Q ss_pred cccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCC-CCcchhhhhH
Q 002601 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLG 698 (902)
Q Consensus 620 ~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~-s~ksDVwSlG 698 (902)
+|||+.||||||||-+||.++.+ .++||+|||.|....++ .-.+++||.+|.|||++.+.+| +..-|||++|
T Consensus 684 ~hlh~~~ivhrdikdenvivd~~--g~~klidfgsaa~~ksg-----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalg 756 (772)
T KOG1152|consen 684 KHLHDQGIVHRDIKDENVIVDSN--GFVKLIDFGSAAYTKSG-----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALG 756 (772)
T ss_pred ccccccCceecccccccEEEecC--CeEEEeeccchhhhcCC-----CcceeeeeccccchhhhCCCccCCCcchhhhhh
Confidence 99999999999999999999555 46999999998876543 3356789999999999999887 6889999999
Q ss_pred HHHHHHHhCCCCCCC
Q 002601 699 CILFFCITGGKHPYG 713 (902)
Q Consensus 699 viL~elltG~~~Pf~ 713 (902)
++||-++.. ..||.
T Consensus 757 illytivyk-enpyy 770 (772)
T KOG1152|consen 757 ILLYTIVYK-ENPYY 770 (772)
T ss_pred heeeEEEec-cCCCc
Confidence 999998875 56654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=224.57 Aligned_cols=246 Identities=22% Similarity=0.345 Sum_probs=181.0
Q ss_pred cceEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCC--chHHHHHHHHHHHhCCCCCeeEeccc-ccCccceeeeec
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGV-ESDQDFVYLSLE 547 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~HpNIV~l~g~-~~d~~~~yLV~E 547 (902)
.+.|.+.+.||+|.||.+.++. ..+...+++|.+.+.. .....+|+.--.....|.||+.-|.+ |+..+...+++|
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 3556778899999999999984 4567889999886643 23456776644455679999988865 777888889999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|.|.|+|.+-+.. .++.+....+++.|++.|++|+|++++
T Consensus 103 ----------~aP~gdL~snv~~------------------------------~GigE~~~K~v~~ql~SAi~fMHsknl 142 (378)
T KOG1345|consen 103 ----------FAPRGDLRSNVEA------------------------------AGIGEANTKKVFAQLLSAIEFMHSKNL 142 (378)
T ss_pred ----------cCccchhhhhcCc------------------------------ccccHHHHHHHHHHHHHHHHHhhccch
Confidence 7778888665432 345566678999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccC---C--CCCcchhhhhHHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG---R--QTRAIDLFSLGCILF 702 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~---~--~s~ksDVwSlGviL~ 702 (902)
||||||.+||||-...-.++||||||+++..+..... ..-+..|.+||.+... . ..+.+|+|.||+++|
T Consensus 143 VHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f 216 (378)
T KOG1345|consen 143 VHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFF 216 (378)
T ss_pred hhcccccceEEEecCCccEEEeeecccccccCceehh------hhhhcccCCcHHHhhccccceEecccccchheeeeee
Confidence 9999999999996555558999999998876532111 1135679999987542 2 368899999999999
Q ss_pred HHHhCCCCCCCCchh---hHHHHHhhcc------ccccccCChHHHHHHHcccCCCCCCC---cCHHHHHcCCC
Q 002601 703 FCITGGKHPYGESFE---RDANIVKDRK------DLFLVEHIPEAVDLFTRLLDPNPDLR---PKAQNVLNHPF 764 (902)
Q Consensus 703 elltG~~~Pf~~~~~---~~~~~~~~~~------~~~~~~~~~e~~dLI~~~L~~dP~~R---pt~~elL~HPf 764 (902)
.|+|| .+||..... +..+.++... +.....+++.+..+.++-|.++|++| -++....+.-|
T Consensus 217 ~cltG-~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 217 YCLTG-KFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred eeecC-CCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 99998 889874321 1122222221 12234467899999999999999999 45555444444
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-24 Score=213.51 Aligned_cols=147 Identities=21% Similarity=0.194 Sum_probs=114.6
Q ss_pred CCCCHHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCc
Q 002601 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680 (902)
Q Consensus 601 ~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~AP 680 (902)
.++++.+++.|+.||+.||+|||+.+ ||+|||++.++. +|+ ||+++..... ...||+.||||
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~--------~~~g~~~y~aP 73 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE--------QSRVDPYFMAP 73 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc--------cCCCcccccCh
Confidence 35789999999999999999999998 999999987765 777 9998865432 12589999999
Q ss_pred hhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchh--hHH-HHHhhcccc------ccccCCh--HHHHHHHcccCCC
Q 002601 681 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE--RDA-NIVKDRKDL------FLVEHIP--EAVDLFTRLLDPN 749 (902)
Q Consensus 681 E~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~--~~~-~~~~~~~~~------~~~~~~~--e~~dLI~~~L~~d 749 (902)
|++.+..++.++|||||||++|||++| .+||..... ... ......... ......+ ++.++|.+||..|
T Consensus 74 E~~~~~~~~~~~DiwSlG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~ 152 (176)
T smart00750 74 EVIQGQSYTEKADIYSLGITLYEALDY-ELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRL 152 (176)
T ss_pred HHhcCCCCcchhhHHHHHHHHHHHHhC-CCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcc
Confidence 999999999999999999999999998 667754322 111 111111111 0111122 6899999999999
Q ss_pred CCCCcCHHHHHcCCCCC
Q 002601 750 PDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 750 P~~Rpt~~elL~HPfF~ 766 (902)
|.+||++.|+++|+|+.
T Consensus 153 p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 153 PQRREAANHYLAHCRAL 169 (176)
T ss_pred cccccCHHHHHHHHHHH
Confidence 99999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=211.55 Aligned_cols=194 Identities=35% Similarity=0.561 Sum_probs=153.9
Q ss_pred EEeeeecccCceEEEEEEeeC-CcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecccc
Q 002601 476 VFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~~-g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
.+.+.||.|++|+||++.... ++.+|+|.+.... .....+|+. .+..++|+|++++++++...+..++++|
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~-~~~~~~~~~i~~~~~~~~~~~~~~~v~e--- 77 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIR-ILKKLKHPNIVKLYGVFEDPEPLYLVME--- 77 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHH-HHHhCCCCChhhheeeeecCCceEEEEe---
Confidence 356789999999999986654 8999999987643 223445555 5677799999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCC-CCHHHHHHHHHhhhccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANG-HPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~-l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
++++++|.+++... .. +++..+..++.+++.++.+||+.+++|
T Consensus 78 -------~~~~~~L~~~~~~~-----------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 121 (225)
T smart00221 78 -------YCEGGDLFDYLRKK-----------------------------GGKLSEEEARFYLRQILEALEYLHSLGIVH 121 (225)
T ss_pred -------ccCCCCHHHHHHhc-----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 44555665554321 11 466778899999999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhh-ccCCCCCcchhhhhHHHHHHHHhCC
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-LQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l-~~~~~s~ksDVwSlGviL~elltG~ 708 (902)
+||+|.||+++.++. ++|+|||++........ .......++..|++||.+ ....++.++|+|+||+++++|++|
T Consensus 122 ~di~~~ni~v~~~~~--~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g- 196 (225)
T smart00221 122 RDLKPENILLGMDGL--VKLADFGLARFIHRDLA--ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG- 196 (225)
T ss_pred CCCCHHHEEEcCCCC--EEEeeCceeeEecCccc--ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC-
Confidence 999999999987754 89999999987764320 122334578889999998 666778899999999999999997
Q ss_pred CCCCCC
Q 002601 709 KHPYGE 714 (902)
Q Consensus 709 ~~Pf~~ 714 (902)
+.||..
T Consensus 197 ~~pf~~ 202 (225)
T smart00221 197 PEPFSG 202 (225)
T ss_pred CCCccc
Confidence 778855
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-22 Score=228.80 Aligned_cols=238 Identities=26% Similarity=0.381 Sum_probs=188.5
Q ss_pred eecccCceEEEEE----EeeCCcEEEEEEeccCCch----HHHHHHHHHHHhC-CCCCeeEecccccCccceeeeecccc
Q 002601 480 EIAKGSNGTVVLE----GNYEGRSVAVKRLVKTHHD----VALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 480 ~LG~GsfGtVy~a----~~~~g~~VAVKrl~~~~~~----~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~~~yLV~E~c~ 550 (902)
.+|+|+||.|.+. +...|..+|+|.+++.... ...+-+..++... +||.+|+++-.++.+..++++++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld--- 77 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD--- 77 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh---
Confidence 3799999999863 4556788999988654321 1222222344444 49999999999999999999999
Q ss_pred CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccc
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHr 630 (902)
+..+|.+...+... ..+.+.....+...++-|++++|+.+|+||
T Consensus 78 -------~~rgg~lft~l~~~-----------------------------~~f~~~~~~~~~aelaLald~lh~l~iiyr 121 (612)
T KOG0603|consen 78 -------FLRGGDLFTRLSKE-----------------------------VMFDELDVAFYLAELALALDHLHKLGIAYR 121 (612)
T ss_pred -------hcccchhhhccccC-----------------------------CchHHHHHHHHHHHHHHHHhhcchhHHHHh
Confidence 88888887766432 223445567788899999999999999999
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~ 710 (902)
|+|++||+++.+|+ +++.|||+++..... ...|||..|||||++. ....++|.||||++++||+|| ..
T Consensus 122 d~k~enilld~~Gh--i~~tdfglske~v~~-------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg-~~ 189 (612)
T KOG0603|consen 122 DYKLENVLLLLEGH--IKLTDFGLSKEAVKE-------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTG-TL 189 (612)
T ss_pred cccccceeecccCc--cccCCchhhhHhHhh-------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhC-CC
Confidence 99999999999987 899999999977643 1228999999999997 678899999999999999998 77
Q ss_pred CCCCchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcC-----HHHHHcCCCCCCcchh
Q 002601 711 PYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTR 771 (902)
Q Consensus 711 Pf~~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt-----~~elL~HPfF~~~~~~ 771 (902)
||.. .....+...+...+.+.+.++++++..++..+|..|.. +.|+++|+||+..++.
T Consensus 190 pf~~---~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 190 PFGG---DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred CCch---HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 7776 33344444455678888999999999999999999975 4689999999876543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-20 Score=196.29 Aligned_cols=251 Identities=32% Similarity=0.485 Sum_probs=183.8
Q ss_pred EEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc------hHHHHHHHHHHHhCCCC-CeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHP-NIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~------~~~~~Ei~~ll~~l~Hp-NIV~l~g~~~d~~~~yLV~E 547 (902)
|...+.||.|+||.||++... ..+|+|.+..... ....+|.. +++.+.|+ +|++++.++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQ-ILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHH-HHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 456688999999999997655 8899999865422 23445554 66777877 79999999977777899999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
+..++++.+.+..... + ..++......++.|++.+++|+|+.++
T Consensus 79 ----------~~~~~~l~~~~~~~~~------------------------~--~~~~~~~~~~~~~~~~~~l~~~H~~~~ 122 (384)
T COG0515 79 ----------YVDGGSLEDLLKKIGR------------------------K--GPLSESEALFILAQILSALEYLHSKGI 122 (384)
T ss_pred ----------cCCCCcHHHHHHhccc------------------------c--cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4555555533321100 0 245677889999999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccCCCcccc---ccccCCCCccccCchhhcc---CCCCCcchhhhhHHHH
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT---QNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCIL 701 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~---~~~~~~Gt~~Y~APE~l~~---~~~s~ksDVwSlGviL 701 (902)
+|||+||+||+++..+. .++++|||+++.......... ......||..|+|||.+.. ..+....|+||+|+++
T Consensus 123 ~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~ 201 (384)
T COG0515 123 IHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL 201 (384)
T ss_pred eccCCCHHHeeecCCCC-eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence 99999999999987652 489999999986654322211 2356679999999999987 5789999999999999
Q ss_pred HHHHhCCCCCCCCchh-----hHHHHHhhcccc-ccccCC--------hHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 702 FFCITGGKHPYGESFE-----RDANIVKDRKDL-FLVEHI--------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~-----~~~~~~~~~~~~-~~~~~~--------~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
+++++| ..||..... .....+...... ...... ..+.+++.+++..+|..|.++.+...++|..
T Consensus 202 ~~~~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~ 279 (384)
T COG0515 202 YELLTG-LPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279 (384)
T ss_pred HHHHhC-CCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence 999998 556655432 222222222211 111111 4688999999999999999999999886653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-20 Score=210.89 Aligned_cols=166 Identities=19% Similarity=0.140 Sum_probs=120.1
Q ss_pred ccccceEEEeeeecccCceEEEEEEee--CCcEEEEEEeccCC--------chHHHHHHHHHHHhCCCCCeeE-eccccc
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNIVR-WYGVES 537 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a~~~--~g~~VAVKrl~~~~--------~~~~~~Ei~~ll~~l~HpNIV~-l~g~~~ 537 (902)
+.+...|.+.+.||+|+||+||+|... +|+.||||++.... .....+|+. ++..++|+||+. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~-iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIR-ALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHH-HHHhccCCCCCcEEEEc--
Confidence 345667889999999999999998553 57888999875321 122345554 678899999984 5542
Q ss_pred CccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhc
Q 002601 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (902)
Q Consensus 538 d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~ 617 (902)
+..||||||| ++++|... ... . ...++.|+++
T Consensus 91 --~~~~LVmE~~----------~G~~L~~~-~~~--------------------------------~---~~~~~~~i~~ 122 (365)
T PRK09188 91 --GKDGLVRGWT----------EGVPLHLA-RPH--------------------------------G---DPAWFRSAHR 122 (365)
T ss_pred --CCcEEEEEcc----------CCCCHHHh-Ccc--------------------------------c---hHHHHHHHHH
Confidence 4579999954 45555311 000 0 1357889999
Q ss_pred ccccccccccccccc-ccceeEeccCCCceEEEccCCccccccCCCcccc-----ccccCCCCccccCchhhccCC
Q 002601 618 GLSHLHEIGLIHRDL-KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT-----QNATGYGSSGWQAPEQLLQGR 687 (902)
Q Consensus 618 gL~yLH~~~IvHrDL-Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~-----~~~~~~Gt~~Y~APE~l~~~~ 687 (902)
||+|||+.||+|||| ||+|||++.++. +||+|||+|+.+........ ...+.++++.|+|||.+....
T Consensus 123 aL~~lH~~gIiHrDL~KP~NILv~~~~~--ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~ 196 (365)
T PRK09188 123 ALRDLHRAGITHNDLAKPQNWLMGPDGE--AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRE 196 (365)
T ss_pred HHHHHHHCCCeeCCCCCcceEEEcCCCC--EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhh
Confidence 999999999999999 999999977765 89999999997764322111 113456899999999987543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-21 Score=232.35 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=174.9
Q ss_pred EEeeeecccCceEEEEEEe-eCCcEEEEEEec----cCCchHH----HHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 476 VFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLV----KTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrl~----~~~~~~~----~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.....+|.|++|.|+.+.. ...+..+.|... ....+.. ..++..+-..+.|||++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999997665432 233334444332 2221111 112223445689999999888888877777779
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
|||+.+|..+ +... ..+...++..+++|++.||.|||+.|
T Consensus 401 E~~~~Dlf~~-----------~~~~-----------------------------~~~~~~e~~c~fKqL~~Gv~y~h~~G 440 (601)
T KOG0590|consen 401 EYCPYDLFSL-----------VMSN-----------------------------GKLTPLEADCFFKQLLRGVKYLHSMG 440 (601)
T ss_pred hcccHHHHHH-----------Hhcc-----------------------------cccchhhhhHHHHHHHHHHHHHHhcC
Confidence 9777543333 2111 12344566789999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCcc-ccccccCCCCccccCchhhccCCCC-CcchhhhhHHHHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQNATGYGSSGWQAPEQLLQGRQT-RAIDLFSLGCILFFC 704 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~s-~ksDVwSlGviL~el 704 (902)
|.|||||++|++++.+|. +||+|||.+....-.... .......+|+..|+|||++.+..|. ..+||||.|+++..|
T Consensus 441 iahrdlK~enll~~~~g~--lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m 518 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGI--LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICM 518 (601)
T ss_pred ceeccCccccEEEecCCc--eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEE
Confidence 999999999999998875 999999998766533221 1334566799999999999999885 679999999999999
Q ss_pred HhCCCCCCCCchhhHHH---HH-------hhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCc
Q 002601 705 ITGGKHPYGESFERDAN---IV-------KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~~~---~~-------~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
++| +.||......+.. .. ...........+.+.+.+|.+||++||.+|.|++++++.+||...
T Consensus 519 ~~~-~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 519 ILG-RFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred ecC-CCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 998 7788643222111 00 001111122334578899999999999999999999999999653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.5e-20 Score=193.66 Aligned_cols=206 Identities=21% Similarity=0.317 Sum_probs=167.6
Q ss_pred ccccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEecc-CCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVK-THHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~-~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.++|-.|.++++||+|+||..+.+ .+.++..||||.-.. ....+...|....-.....+.|-..|-+-.++.+-.||+
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 356777899999999999999987 678999999997533 233455556554333346788988888888888899999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
|++.-+|+|++. |..+.|+.+++..|+.|++.-++|+|++.
T Consensus 104 dLLGPSLEDLFD---------------------------------------~CgR~FSvKTV~miA~Qmi~rie~vH~k~ 144 (449)
T KOG1165|consen 104 DLLGPSLEDLFD---------------------------------------LCGRRFSVKTVAMIAKQMITRIEYVHEKD 144 (449)
T ss_pred hhhCcCHHHHHH---------------------------------------HhcCcccHHhHHHHHHHHHHHHHHHHhcc
Confidence 999999988762 66778899999999999999999999999
Q ss_pred ccccccccceeEeccCCC---ceEEEccCCccccccCCCcc----ccccccCCCCccccCchhhccCCCCCcchhhhhHH
Q 002601 627 LIHRDLKPQNVLISKDKS---FCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~---~~vkL~DFGla~~~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGv 699 (902)
+|.|||||+|.||...++ -.+.|+|||+|+.+-+.... ........||.+||+-.-..+...+.+-|+-|||-
T Consensus 145 LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGH 224 (449)
T KOG1165|consen 145 LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGH 224 (449)
T ss_pred eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhh
Confidence 999999999999965332 24889999999988654322 22334456999999999988999999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 002601 700 ILFFCITGGKHPYGE 714 (902)
Q Consensus 700 iL~elltG~~~Pf~~ 714 (902)
++.+.|-| ..||..
T Consensus 225 vFmYFLRG-sLPWQG 238 (449)
T KOG1165|consen 225 VFMYFLRG-SLPWQG 238 (449)
T ss_pred hhhhhccC-CCcccc
Confidence 99999987 889875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.9e-19 Score=195.41 Aligned_cols=248 Identities=23% Similarity=0.257 Sum_probs=170.4
Q ss_pred eEEEeeeecccCceEEEEEEeeCC--cEEEEEEeccCCc---hHHHHHHHHHHHhC---CCCCeeEecccc-cCccceee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGNYEG--RSVAVKRLVKTHH---DVALKEIQNLIASD---QHPNIVRWYGVE-SDQDFVYL 544 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~~~g--~~VAVKrl~~~~~---~~~~~Ei~~ll~~l---~HpNIV~l~g~~-~d~~~~yL 544 (902)
.|.+.+.||+|+||.||++..... ..+|+|....... .....|...+.... .-+++.++++.. ..+.+.|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 688899999999999999865543 5789998754321 13444544332222 125788888877 57888999
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||+++..+|.++.... ..+.++..++.+|+.|++.+|++||+
T Consensus 99 VM~l~G~sL~dl~~~~--------------------------------------~~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRN--------------------------------------PPGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred EEeccCccHHHHHHhC--------------------------------------CCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 9999999988864211 01346777889999999999999999
Q ss_pred ccccccccccceeEeccCC-C--ceEEEccCCccc--cccCCCcc----ccc-cccCCCCccccCchhhccCCCCCcchh
Q 002601 625 IGLIHRDLKPQNVLISKDK-S--FCAKLSDMGISK--RLQGDMSC----LTQ-NATGYGSSGWQAPEQLLQGRQTRAIDL 694 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~-~--~~vkL~DFGla~--~~~~~~~~----~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDV 694 (902)
.|++||||||+|+++.... . ..+.|.|||+++ ........ ... .....||..|+++....+...+.+.|+
T Consensus 141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl 220 (322)
T KOG1164|consen 141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL 220 (322)
T ss_pred cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence 9999999999999997653 1 358999999999 43322211 111 223459999999999999999999999
Q ss_pred hhhHHHHHHHHhCCCCCCCCchhh--HHHHHhhcccc----ccccCChHHHHHHHcccCCCCCCCcCHHHHH
Q 002601 695 FSLGCILFFCITGGKHPYGESFER--DANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 695 wSlGviL~elltG~~~Pf~~~~~~--~~~~~~~~~~~----~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL 760 (902)
||++.++.|++.| ..||...... ........... .......++.++...+-..+...+|....+.
T Consensus 221 es~~Y~l~el~~g-~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 221 ESLFYMLLELLKG-SLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred hhHHHHHHHHhcC-CCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 9999999999997 5888543211 11111111100 1112234555555555556666666665544
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.7e-20 Score=196.70 Aligned_cols=203 Identities=22% Similarity=0.302 Sum_probs=141.3
Q ss_pred CCCCCeeEecccccCc---------------------------cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccc
Q 002601 524 DQHPNIVRWYGVESDQ---------------------------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSN 576 (902)
Q Consensus 524 l~HpNIV~l~g~~~d~---------------------------~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~ 576 (902)
.+|||||++.++|.|+ ..+|+||....++|.+|+...
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~---------------- 336 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR---------------- 336 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC----------------
Confidence 4699999999876542 357899998888888776221
Q ss_pred hhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccceeEe--ccCCCceEEEccCCc
Q 002601 577 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI--SKDKSFCAKLSDMGI 654 (902)
Q Consensus 577 ~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL--~~d~~~~vkL~DFGl 654 (902)
..+.....-++.|+++|+.|||.+||.|||||++|||| ++|+-..+.|+|||.
T Consensus 337 -------------------------~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGC 391 (598)
T KOG4158|consen 337 -------------------------HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGC 391 (598)
T ss_pred -------------------------CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccce
Confidence 12223346789999999999999999999999999998 455555688999997
Q ss_pred cccccCC---CccccccccCCCCccccCchhhccCCC------CCcchhhhhHHHHHHHHhCCCCCCCCchhhH---HHH
Q 002601 655 SKRLQGD---MSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFSLGCILFFCITGGKHPYGESFERD---ANI 722 (902)
Q Consensus 655 a~~~~~~---~~~~~~~~~~~Gt~~Y~APE~l~~~~~------s~ksDVwSlGviL~elltG~~~Pf~~~~~~~---~~~ 722 (902)
+---... ...........|...-||||+....+- -.|+|.|+.|.+.||++.. ..||...-+.. ...
T Consensus 392 cLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~-~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 392 CLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGR-SNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhcc-CCcccccchheechhhh
Confidence 6432211 011111223347778999999865331 3689999999999999976 55665422211 122
Q ss_pred HhhccccccccCChHHHHHHHcccCCCCCCCcCHH---HHHcCCCCCCcc
Q 002601 723 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ---NVLNHPFFWTAD 769 (902)
Q Consensus 723 ~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~---elL~HPfF~~~~ 769 (902)
.+.+.+..+...++.+++++..+|+.||++|++.. .++ |=++|...
T Consensus 471 qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl-~LsLw~~~ 519 (598)
T KOG4158|consen 471 QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL-NLSLWRMG 519 (598)
T ss_pred hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHH-HHHHhcCc
Confidence 23334455667789999999999999999998854 344 44555433
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-19 Score=185.42 Aligned_cols=205 Identities=22% Similarity=0.297 Sum_probs=158.2
Q ss_pred cccceEEEeeeecccCceEEEEE-EeeCCcEEEEEEeccCC-chHHHHHHHHHHHhCC-CCCeeEecccccCccceeeee
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLE-GNYEGRSVAVKRLVKTH-HDVALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a-~~~~g~~VAVKrl~~~~-~~~~~~Ei~~ll~~l~-HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.++..|.+.++||.||||.+|+| ...+|.+||||.-.+.. +.+...|-. +-..++ -..|..++.|..++++-.+||
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEsk-vY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESK-VYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHH-HHHHhccCCCCchhhhhccccccceeee
Confidence 34567889999999999999998 67789999999865432 233444443 223333 356667777888899999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
|++..+|+++.-+ ..+.++.++++.++-|++.-++|+|.++
T Consensus 91 dLLGPsLEdLfnf---------------------------------------C~R~ftmkTvLMLaDQml~RiEyvH~r~ 131 (341)
T KOG1163|consen 91 DLLGPSLEDLFNF---------------------------------------CSRRFTMKTVLMLADQMLSRIEYVHLRN 131 (341)
T ss_pred eccCccHHHHHHH---------------------------------------HhhhhhHHhHHHHHHHHHHHHHHHHhhc
Confidence 9999999888632 2234667788999999999999999999
Q ss_pred ccccccccceeEeccCCCc-eEEEccCCccccccCCCcc----ccccccCCCCccccCchhhccCCCCCcchhhhhHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSF-CAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~-~vkL~DFGla~~~~~~~~~----~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL 701 (902)
+|||||||+|.|..-+.++ .+.++|||+|+.+-+..+. ........||..|.+-....+-..+..-|+-|+|.+|
T Consensus 132 fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 132 FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVL 211 (341)
T ss_pred cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhccee
Confidence 9999999999998644332 3789999999988653221 1222344699999998888777789999999999998
Q ss_pred HHHHhCCCCCCCCc
Q 002601 702 FFCITGGKHPYGES 715 (902)
Q Consensus 702 ~elltG~~~Pf~~~ 715 (902)
.+..-| ..||.+.
T Consensus 212 mYfnrG-~LPWQgl 224 (341)
T KOG1163|consen 212 MYFNRG-SLPWQGL 224 (341)
T ss_pred eeeecC-CCccccc
Confidence 888876 8899764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.2e-20 Score=218.75 Aligned_cols=243 Identities=23% Similarity=0.254 Sum_probs=171.2
Q ss_pred EEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc-------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~-------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+...+.||.+.|=+|.++...+|. |.||++.+... .+.++|++ ....+|||.+.+.-+...+.-.|||-+
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 456688999999999998888887 99999977542 23445554 567899999999988888888899989
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|...+|.|.+ |..-+| ..-+.+-|+.|++.||.-+|..||
T Consensus 102 yvkhnLyDRl-----STRPFL-----------------------------------~~iEKkWiaFQLL~al~qcH~~gV 141 (1431)
T KOG1240|consen 102 YVKHNLYDRL-----STRPFL-----------------------------------VLIEKKWIAFQLLKALSQCHKLGV 141 (1431)
T ss_pred HHhhhhhhhh-----ccchHH-----------------------------------HHHHHHHHHHHHHHHHHHHHHcCc
Confidence 6665555443 111111 223446799999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccc--cCCC--ccccccccCCCCccccCchhhccC----------C-CCCcc
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRL--QGDM--SCLTQNATGYGSSGWQAPEQLLQG----------R-QTRAI 692 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~--~~~~--~~~~~~~~~~Gt~~Y~APE~l~~~----------~-~s~ks 692 (902)
+|+|||.+||||+.-+- +.|+||..-+.. ..+. +....-.+...-..|+|||.+... . .+++.
T Consensus 142 cHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paM 219 (1431)
T KOG1240|consen 142 CHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAM 219 (1431)
T ss_pred cccccccceEEEeeech--hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhh
Confidence 99999999999998765 679999865432 1111 111111222334569999987541 1 46889
Q ss_pred hhhhhHHHHHHHHhCCCCCCCCchhhHHHHHhhcccccccc--CChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 693 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE--HIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 693 DVwSlGviL~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
||||+||++.|+++-|.++|.-+.--..............+ ....++.+|..|++.||++|.++++.|+.
T Consensus 220 DIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 220 DIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 99999999999999889998643211110000000000001 12368999999999999999999999976
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-18 Score=179.15 Aligned_cols=234 Identities=19% Similarity=0.263 Sum_probs=173.2
Q ss_pred EeeeecccCceEEEEEEeeCCcEEEEEEeccCC----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
+..+|.+...|..|++. ..|..+++|++.-.+ ....++|+--.++...||||+..+|.|....++.++..
T Consensus 194 l~tkl~e~hsgelwrgr-wqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq----- 267 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGR-WQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ----- 267 (448)
T ss_pred hhhhhccCCCccccccc-ccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee-----
Confidence 34567888889999854 556667778775332 12345554445677899999999999999999999999
Q ss_pred hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc--cccc
Q 002601 553 LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHR 630 (902)
Q Consensus 553 L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~--IvHr 630 (902)
|||.|+|+..||.... ...+..++.+++.+|++|++|||+.. |.--
T Consensus 268 -----~mp~gslynvlhe~t~---------------------------vvvd~sqav~faldiargmaflhslep~ipr~ 315 (448)
T KOG0195|consen 268 -----YMPFGSLYNVLHEQTS---------------------------VVVDHSQAVRFALDIARGMAFLHSLEPMIPRF 315 (448)
T ss_pred -----eccchHHHHHHhcCcc---------------------------EEEecchHHHHHHHHHhhHHHHhhcchhhhhh
Confidence 9999999999986432 11344678999999999999999873 4445
Q ss_pred ccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCC---CCcchhhhhHHHHHHHHhC
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~---s~ksDVwSlGviL~elltG 707 (902)
-|.+..++|+++-..++-.+|--++.. .....-.|.||+||.+...+- -.++|+|||.+++||+.|.
T Consensus 316 ~lns~hvmidedltarismad~kfsfq----------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tr 385 (448)
T KOG0195|consen 316 YLNSKHVMIDEDLTARISMADTKFSFQ----------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTR 385 (448)
T ss_pred hcccceEEecchhhhheecccceeeee----------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcc
Confidence 688999999877553333344332221 222335789999999987664 3689999999999999995
Q ss_pred CCCCCCCchhhHH---HHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHH
Q 002601 708 GKHPYGESFERDA---NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 759 (902)
Q Consensus 708 ~~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~el 759 (902)
..||.+...-+. ..++......+...++....|+.-|+..||.+||....+
T Consensus 386 -evpfadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 386 -EVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred -ccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 889987544332 223444455677788899999999999999999987665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6e-18 Score=201.65 Aligned_cols=154 Identities=32% Similarity=0.439 Sum_probs=122.5
Q ss_pred hccccccccccccccccccceeEeccCCCceEEEccCCccccccCCC------------ccccccccCCCCccccCchhh
Q 002601 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM------------SCLTQNATGYGSSGWQAPEQL 683 (902)
Q Consensus 616 a~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~------------~~~~~~~~~~Gt~~Y~APE~l 683 (902)
+.+++|||+-||+|||+||+|.||+.=|+ +|++|||+++...-.. ...-.....|||+.|+|||++
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi 230 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI 230 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence 78899999999999999999999998887 9999999987542110 011122445899999999999
Q ss_pred ccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhHHHHHhhcccccc---ccCChHHHHHHHcccCCCCCCCc---CHH
Q 002601 684 LQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL---VEHIPEAVDLFTRLLDPNPDLRP---KAQ 757 (902)
Q Consensus 684 ~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~e~~dLI~~~L~~dP~~Rp---t~~ 757 (902)
..+.|+..+|+|++|+|+||.+-|..++|++..+.....+......++ ....+|++++|.++|+.+|..|. .+-
T Consensus 231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhh
Confidence 999999999999999999999999777777766666544433333333 34568999999999999999994 567
Q ss_pred HHHcCCCCCCcchh
Q 002601 758 NVLNHPFFWTADTR 771 (902)
Q Consensus 758 elL~HPfF~~~~~~ 771 (902)
++.+|+||..-++.
T Consensus 311 evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 311 EVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhccceeecccc
Confidence 89999999665543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.1e-18 Score=173.21 Aligned_cols=136 Identities=17% Similarity=0.111 Sum_probs=94.2
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCCc---h--------------------------HHHHHHHHHHHhCCCCCe
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---D--------------------------VALKEIQNLIASDQHPNI 529 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~---~--------------------------~~~~Ei~~ll~~l~HpNI 529 (902)
..||+|+||.||+|...+|+.||||+++.... . ...+|.. .+..+.|+++
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~v 81 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMR-NLKRLVTAGI 81 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHH-HHHHHHHCCC
Confidence 56999999999999777899999999864321 0 1122544 4455555554
Q ss_pred eEecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHH
Q 002601 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609 (902)
Q Consensus 530 V~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~ 609 (902)
.....+.. ...+||||||+++ ++.... .+..+++...+.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~----------~l~~~~-----------------------------~~~~~~~~~~~~ 120 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDD----------GWAAPR-----------------------------LKDAPLSESKAR 120 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCC----------CCcchh-----------------------------hhcCCCCHHHHH
Confidence 32222211 2238999966543 222111 011346677889
Q ss_pred HHHHhhhcccccc-ccccccccccccceeEeccCCCceEEEccCCcccccc
Q 002601 610 KVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (902)
Q Consensus 610 ~I~~qIa~gL~yL-H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~ 659 (902)
+++.|++.+|++| |+.||+||||||+|||++. +. ++|+|||+|....
T Consensus 121 ~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~--v~LiDFG~a~~~~ 168 (190)
T cd05147 121 ELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GK--LYIIDVSQSVEHD 168 (190)
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-Cc--EEEEEccccccCC
Confidence 9999999999999 6999999999999999973 43 8999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=3e-17 Score=169.23 Aligned_cols=137 Identities=18% Similarity=0.137 Sum_probs=97.4
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCCch-----------------------------HHHHHHHHHHHhCCCCCe
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-----------------------------VALKEIQNLIASDQHPNI 529 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~-----------------------------~~~~Ei~~ll~~l~HpNI 529 (902)
+.||+|++|.||+|...+|+.||||++...... ...+|.. .+..+.|++|
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i 81 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFR-NLKRLYEAGV 81 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHH-HHHHHHhCCC
Confidence 579999999999997778999999998653210 0123443 4566778876
Q ss_pred eEecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHH
Q 002601 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609 (902)
Q Consensus 530 V~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~ 609 (902)
.....+... ..|||||||++. ++.... .....++.....
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~----------~~~~~~-----------------------------l~~~~~~~~~~~ 120 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDD----------GSPAPR-----------------------------LKDVPLEEEEAE 120 (190)
T ss_pred CCceEEEec--CCEEEEEEecCC----------Cchhhh-----------------------------hhhccCCHHHHH
Confidence 443333222 248999966543 211110 011234566778
Q ss_pred HHHHhhhcccccccc-ccccccccccceeEeccCCCceEEEccCCccccccC
Q 002601 610 KVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660 (902)
Q Consensus 610 ~I~~qIa~gL~yLH~-~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~ 660 (902)
+++.|++.+|.+||+ .||+||||||+|||++ ++. ++|+|||++.....
T Consensus 121 ~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~--~~liDFG~a~~~~~ 169 (190)
T cd05145 121 ELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK--PYIIDVSQAVELDH 169 (190)
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC--EEEEEcccceecCC
Confidence 999999999999999 9999999999999998 554 89999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-17 Score=174.49 Aligned_cols=170 Identities=12% Similarity=0.059 Sum_probs=121.5
Q ss_pred cccceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc--hH----------HHHHHHHHHHhCCCCCeeEeccccc
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DV----------ALKEIQNLIASDQHPNIVRWYGVES 537 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~--~~----------~~~Ei~~ll~~l~HpNIV~l~g~~~ 537 (902)
-+...|...+.||.|+||.||++.. ++..+|||.+..... +. ..+|.. .+.++.|++|.....++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~-~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIV-QTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHH-HHHHHHHCCCCcceEeee
Confidence 3456788999999999999999755 677899999964321 11 124433 457779999999888755
Q ss_pred Cc--------cceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHH
Q 002601 538 DQ--------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609 (902)
Q Consensus 538 d~--------~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~ 609 (902)
+. +..+|+||||++ .+|.+... ++ .
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G----------~tL~~~~~---------------------------------~~----~ 138 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEG----------VELNDMPE---------------------------------IS----E 138 (232)
T ss_pred ecccccccccCCeEEEEEEECC----------ccHHHhhh---------------------------------cc----H
Confidence 33 358999996653 34433210 01 1
Q ss_pred HHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCC
Q 002601 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT 689 (902)
Q Consensus 610 ~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s 689 (902)
....+++.+|..||+.|++|||+||+||+++++| ++|+|||.......+... ..+.....+.
T Consensus 139 ~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a~---------------d~~vler~y~ 200 (232)
T PRK10359 139 DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKAK---------------DRIDLERHYG 200 (232)
T ss_pred HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhhH---------------HHHHHHhHhc
Confidence 2456889999999999999999999999998776 789999988755322110 1134455677
Q ss_pred CcchhhhhHHHHHHHHh
Q 002601 690 RAIDLFSLGCILFFCIT 706 (902)
Q Consensus 690 ~ksDVwSlGviL~ellt 706 (902)
.++|+||||+.+.....
T Consensus 201 ~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 201 IKNEIKDLGYYLLIYKK 217 (232)
T ss_pred ccccccceeEeehHHHH
Confidence 89999999998776543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=172.88 Aligned_cols=235 Identities=26% Similarity=0.266 Sum_probs=139.6
Q ss_pred eEEEeeeecccCceEEEEEE-eeCCcEEEEEEeccCCc-----hHHHHHHHHHHHhCC----------CC------CeeE
Q 002601 474 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQ----------HP------NIVR 531 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrl~~~~~-----~~~~~Ei~~ll~~l~----------Hp------NIV~ 531 (902)
.++.++.||.|+++.||.+. ..+|+.+|||++.-... -..++|......... |- -+++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45677899999999999974 45689999998743321 112222221111111 11 1223
Q ss_pred eccc---ccCc---c-----ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhh
Q 002601 532 WYGV---ESDQ---D-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 600 (902)
Q Consensus 532 l~g~---~~d~---~-----~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~ 600 (902)
+-+- ..-. + ..+++|+...++|.+++- .|....... .
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~--------~l~~~~~~~-~----------------------- 140 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVE--------ALFSRAQTH-S----------------------- 140 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHH--------HHHHHTTTS-H-----------------------
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHH--------HHhhccccc-c-----------------------
Confidence 3221 1111 1 346788877777776652 121111100 0
Q ss_pred CCCCHHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCc
Q 002601 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680 (902)
Q Consensus 601 ~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~AP 680 (902)
.+.....+.+..|+++.+++||..|++|+||||+|++++++|. +.|+||+........... ...+..|.+|
T Consensus 141 -~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~--v~Lg~F~~~~r~g~~~~~------~~~~~~~~PP 211 (288)
T PF14531_consen 141 -PLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGG--VFLGDFSSLVRAGTRYRC------SEFPVAFTPP 211 (288)
T ss_dssp -HHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE--GGGEEETTEEEEG------GGS-TTTS-H
T ss_pred -hhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCC--EEEcChHHHeecCceeec------cCCCcccCCh
Confidence 0011233667799999999999999999999999999999987 899999977765432111 2245779999
Q ss_pred hhhccC--------CCCCcchhhhhHHHHHHHHhCCCCCCCCchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCC
Q 002601 681 EQLLQG--------RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDL 752 (902)
Q Consensus 681 E~l~~~--------~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~ 752 (902)
|..... .++.+.|.|+||+++|.|.++ ..||+.......... ...... +.++.+++||..+|+.||.+
T Consensus 212 e~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~-~lPf~~~~~~~~~~~--~f~~C~-~~Pe~v~~LI~~lL~~~~~~ 287 (288)
T PF14531_consen 212 ELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG-RLPFGLSSPEADPEW--DFSRCR-DMPEPVQFLIRGLLQRNPED 287 (288)
T ss_dssp HHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS-S-STCCCGGGSTSGG--GGTTSS----HHHHHHHHHHT-SSGGG
T ss_pred hhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc-cCCCCCCCccccccc--cchhcC-CcCHHHHHHHHHHccCCccc
Confidence 977542 468899999999999999998 788885432211100 111223 66778999999999999998
Q ss_pred C
Q 002601 753 R 753 (902)
Q Consensus 753 R 753 (902)
|
T Consensus 288 R 288 (288)
T PF14531_consen 288 R 288 (288)
T ss_dssp S
T ss_pred C
Confidence 7
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-16 Score=165.59 Aligned_cols=183 Identities=19% Similarity=0.176 Sum_probs=127.5
Q ss_pred eeeecccCceEEEEEEeeCCcEEEEEEeccCCc--h-----HHHHHHHHHHHhC-CCCCeeEecccccCccceeeeeccc
Q 002601 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--D-----VALKEIQNLIASD-QHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~--~-----~~~~Ei~~ll~~l-~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
...|++|+||+||++.. .+..++.+.+..... . .+.+|+..+ +.+ .|++|.+++++ +..|++||
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL-~~L~~~~~vP~ll~~----~~~~lvme-- 78 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALAL-RQLDGLPRTPRLLHW----DGRHLDRS-- 78 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHH-HhcCCCCCCCEEEEE----cCEEEEEe--
Confidence 46799999999998765 778888777754321 1 245677644 555 56889898886 34699999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+.+++|.+.+.. ....++.|++++|+++|++||+|
T Consensus 79 --------yI~G~~L~~~~~~------------------------------------~~~~~~~qi~~~L~~lH~~GIvH 114 (218)
T PRK12274 79 --------YLAGAAMYQRPPR------------------------------------GDLAYFRAARRLLQQLHRCGVAH 114 (218)
T ss_pred --------eecCccHHhhhhh------------------------------------hhHHHHHHHHHHHHHHHHCcCcc
Confidence 4445555332110 01346788999999999999999
Q ss_pred ccc-ccceeEeccCCCceEEEccCCccccccCCCcc---ccc-------cccCCCCccccCchhhccC-CCC-Ccchhhh
Q 002601 630 RDL-KPQNVLISKDKSFCAKLSDMGISKRLQGDMSC---LTQ-------NATGYGSSGWQAPEQLLQG-RQT-RAIDLFS 696 (902)
Q Consensus 630 rDL-Kp~NILL~~d~~~~vkL~DFGla~~~~~~~~~---~~~-------~~~~~Gt~~Y~APE~l~~~-~~s-~ksDVwS 696 (902)
||| ||+|||++.++. ++|+|||+|......... ... ..-..+++.|++|+...-. ..+ ...++++
T Consensus 115 rDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~ 192 (218)
T PRK12274 115 NDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFA 192 (218)
T ss_pred CCCCCcceEEEcCCCC--EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHH
Confidence 999 799999988776 899999999865432210 000 0011268889999854322 223 6778999
Q ss_pred hHHHHHHHHhCCCCCCCC
Q 002601 697 LGCILFFCITGGKHPYGE 714 (902)
Q Consensus 697 lGviL~elltG~~~Pf~~ 714 (902)
.|+-+|.++|++-+-|++
T Consensus 193 ~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 193 TGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hcchHHHHHhccCCcccc
Confidence 999999999986655554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.8e-17 Score=185.10 Aligned_cols=242 Identities=24% Similarity=0.409 Sum_probs=160.3
Q ss_pred eeecccCceEEEEEEeeC----CcEEEEEEeccCC---chHHHHHHHHHHHhCCCCCeeEec--c----cc-----cCcc
Q 002601 479 KEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWY--G----VE-----SDQD 540 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~----g~~VAVKrl~~~~---~~~~~~Ei~~ll~~l~HpNIV~l~--g----~~-----~d~~ 540 (902)
+..+..++|.+..+.... ...++.|+....+ ....++++..+.....|++.+..= - .. ....
T Consensus 250 k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~ 329 (516)
T KOG1033|consen 250 KSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKV 329 (516)
T ss_pred ccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccccccc
Confidence 345555666555432222 2334444443222 123455655555555566554332 0 11 1133
Q ss_pred ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccc
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
++||.|++|. .++|.+||..+... ...++..++.++.|++.|++
T Consensus 330 ~lyI~Mn~c~----------~~tledWl~rr~~~--------------------------e~~s~s~~~~~~~q~~~~~~ 373 (516)
T KOG1033|consen 330 YLYIQMNLCE----------KETLEDWLRRRRTG--------------------------EERSLSLMLDIFKQIAPAVE 373 (516)
T ss_pred chhhhhhhhh----------hhhHHHHhhCCCcc--------------------------cccchhHHHHHHHhhccchh
Confidence 5789999665 34555555432221 12345567899999999999
Q ss_pred ccccccccccccccceeEeccCCCceEEEccCCccccccCCC---ccccccccCCCCccccCchhhccCCCCCcchhhhh
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (902)
Q Consensus 621 yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~---~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSl 697 (902)
| ++.+|||+||.||+...+.. +||.|||+........ ..........||..||+||.+.+..|+.++|||||
T Consensus 374 y---k~~ihrdlkp~nif~~~d~q--~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaL 448 (516)
T KOG1033|consen 374 Y---KGLIHRDLKPSNIFFSDDDQ--LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYAL 448 (516)
T ss_pred h---ccchhhhccccccccccchh--hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhH
Confidence 9 99999999999999977764 8999999988766543 11223345579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCchhhHHHHHhhccccccc---cCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 698 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLV---EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 698 GviL~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
|+||+|++. +|....++....-..+...++. ..-|+-.+|+.+|+.+.|..||++.+.-.|+|.
T Consensus 449 Glil~EL~~----~f~T~~er~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 449 GLILAELLI----QFSTQFERIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred HHHHHHHHH----HhccHHHHHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 999999998 4555445444333333333332 223567789999999999999988888888764
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=5e-16 Score=189.18 Aligned_cols=198 Identities=22% Similarity=0.256 Sum_probs=148.3
Q ss_pred cccceEEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCch--HHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~--~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
.-+..|.+.+.||+|+||+||+|...+|+.||+|.=+....- ..-.++...++..--+-|+.+...+.-.+.-+||+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e 774 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE 774 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence 345678888999999999999998888999999986654321 112222222221123456666666666777899999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|.+.|+|.++++.. +..++..+..+..|+++-+++||..+|
T Consensus 775 ----------y~~~Gtlld~~N~~-----------------------------~~m~e~lv~~~~~qml~ive~lH~~~I 815 (974)
T KOG1166|consen 775 ----------YSPYGTLLDLINTN-----------------------------KVMDEYLVMFFSCQMLRIVEHLHAMGI 815 (974)
T ss_pred ----------ccccccHHHhhccC-----------------------------CCCCchhhhHHHHHHHHHHHHHHhcce
Confidence 77778887776521 234566678999999999999999999
Q ss_pred cccccccceeEecc-----CCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHH
Q 002601 628 IHRDLKPQNVLISK-----DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 628 vHrDLKp~NILL~~-----d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~ 702 (902)
||+||||+|.||.. .+...++|+|||.+..+.--... ..-...++|-++-.+|+..+.+++..+|.|.|+.+++
T Consensus 816 IHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h 894 (974)
T KOG1166|consen 816 IHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVH 894 (974)
T ss_pred ecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCC-cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHH
Confidence 99999999999942 23445999999998765421111 1223456788999999999999999999999999999
Q ss_pred HHHhC
Q 002601 703 FCITG 707 (902)
Q Consensus 703 elltG 707 (902)
-||.|
T Consensus 895 ~mLFG 899 (974)
T KOG1166|consen 895 VMLFG 899 (974)
T ss_pred HHHHH
Confidence 99998
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.1e-16 Score=161.28 Aligned_cols=134 Identities=16% Similarity=0.187 Sum_probs=94.2
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccC---CchHHHHHHHHHHHhC-----CCCCeeEecccccCcc---cee-eee
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKT---HHDVALKEIQNLIASD-----QHPNIVRWYGVESDQD---FVY-LSL 546 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~---~~~~~~~Ei~~ll~~l-----~HpNIV~l~g~~~d~~---~~y-LV~ 546 (902)
+.||+|+||.||. +..++.. +||++... ..+...+|+.. +..+ .||||++++|++.++. .++ +|+
T Consensus 8 ~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~-l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 8 SPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKY-YAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred ceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHH-HHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 5799999999996 5555554 69987643 23456777764 4445 6899999999988763 434 789
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccc-cccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL-SHLHEI 625 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL-~yLH~~ 625 (902)
||+. .+.|+|.+++... .+++. ..++.|++.++ +|||++
T Consensus 85 e~~G--------~~~~tL~~~l~~~------------------------------~~~e~--~~~~~~~L~~l~~yLh~~ 124 (210)
T PRK10345 85 DFDG--------KPSITLTEFAEQC------------------------------RYEED--VAQLRQLLKKLKRYLLDN 124 (210)
T ss_pred cCCC--------CcchhHHHHHHcc------------------------------cccHh--HHHHHHHHHHHHHHHHHC
Confidence 9643 2345665555211 12222 35678888888 999999
Q ss_pred cccccccccceeEeccC--CCceEEEccCCcc
Q 002601 626 GLIHRDLKPQNVLISKD--KSFCAKLSDMGIS 655 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d--~~~~vkL~DFGla 655 (902)
+|+||||||+|||++.. +...++|+||+-+
T Consensus 125 ~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 125 RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99999999999999743 3346999995433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.6e-15 Score=170.23 Aligned_cols=197 Identities=25% Similarity=0.351 Sum_probs=139.9
Q ss_pred HhCCCCCeeEecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhC
Q 002601 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKAN 601 (902)
Q Consensus 522 ~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~ 601 (902)
+.+.|.|+.+++|.+.++...++|.+||. +|+|.+.+.... .
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~~~~i~~~c~----------rGsl~D~i~~~~----------------------------~ 43 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPEMIVIWEYCS----------RGSLLDILSNED----------------------------I 43 (484)
T ss_pred cccchhhhhhheeeEecCCceEEEEeeec----------CccHHhHHhccc----------------------------c
Confidence 45789999999999999999999999776 344444442211 2
Q ss_pred CCCHHHHHHHHHhhhccccccccccc-cccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCc
Q 002601 602 GHPSAQLLKVTRDIVSGLSHLHEIGL-IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680 (902)
Q Consensus 602 ~l~~~~~~~I~~qIa~gL~yLH~~~I-vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~AP 680 (902)
.+++.....++++|+.||+|||...| .|+.|++.|++++ ..+.+||+|||+......... ........-..-|.||
T Consensus 44 ~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd--~~w~lklt~~Gl~~~~~~~~~-~~~~~~~~~~~lw~aP 120 (484)
T KOG1023|consen 44 KLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLVD--SRWVLKLTDFGLNSLLEETAE-PEAHHPIRKALLWTAP 120 (484)
T ss_pred CccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccceee--eeEEEEechhhhccccccccc-ccccchhHHHHhccCH
Confidence 24455567899999999999998866 9999999999994 557899999999876643100 0000111123459999
Q ss_pred hhhccCC-------CCCcchhhhhHHHHHHHHhCCCCCCCCchh-----hHHHHHhh-cccccc-----c-cCChHHHHH
Q 002601 681 EQLLQGR-------QTRAIDLFSLGCILFFCITGGKHPYGESFE-----RDANIVKD-RKDLFL-----V-EHIPEAVDL 741 (902)
Q Consensus 681 E~l~~~~-------~s~ksDVwSlGviL~elltG~~~Pf~~~~~-----~~~~~~~~-~~~~~~-----~-~~~~e~~dL 741 (902)
|.+.... .+.+.|+||||++++|+++. ..||..... +....++. ....+. . +..++...+
T Consensus 121 ellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r-~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l 199 (484)
T KOG1023|consen 121 ELLRGALSQSLESALTQKGDIYSFGIIMYEILFR-SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLL 199 (484)
T ss_pred HHhcccccccccccccccCCeehHHHHHHHHHhc-cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHH
Confidence 9987641 46789999999999999995 778875221 11222222 211111 1 344578899
Q ss_pred HHcccCCCCCCCcCHHHHH
Q 002601 742 FTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 742 I~~~L~~dP~~Rpt~~elL 760 (902)
+.+||..+|..||+++++-
T Consensus 200 ~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 200 VARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred HHHhcccChhhCccHHHHH
Confidence 9999999999999999875
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.2e-15 Score=156.06 Aligned_cols=141 Identities=21% Similarity=0.178 Sum_probs=96.2
Q ss_pred cceEEEeeeecccCceEEEEEE--eeCCcEEEEEEeccCCc---------------------------hHHHHHHHHHHH
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEG--NYEGRSVAVKRLVKTHH---------------------------DVALKEIQNLIA 522 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~--~~~g~~VAVKrl~~~~~---------------------------~~~~~Ei~~ll~ 522 (902)
|..|.+.+.||+|+||.||+|. ..+|+.||||++..... ....+|...+ .
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L-~ 105 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL-Q 105 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH-H
Confidence 3446677899999999999997 67899999999864321 0123455433 4
Q ss_pred hCCC--CCeeEecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhh
Q 002601 523 SDQH--PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 600 (902)
Q Consensus 523 ~l~H--pNIV~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~ 600 (902)
.+.| ..+.+.+++ ...++|||++.+ +++...... .
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g----------~~L~~~~~~-----------------------------~ 142 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGG----------DGLPAPRLK-----------------------------D 142 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecC----------Ccccccccc-----------------------------c
Confidence 4443 223344432 235899996654 333222100 0
Q ss_pred CCCCHHHHHHHHHhhhcccccccccc-ccccccccceeEeccCCCceEEEccCCcccccc
Q 002601 601 NGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (902)
Q Consensus 601 ~~l~~~~~~~I~~qIa~gL~yLH~~~-IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~ 659 (902)
.......+..++.||+.+|++||+.| |+||||||+||+++ ++. ++|+|||.+....
T Consensus 143 ~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~--i~LiDFg~a~~~~ 199 (237)
T smart00090 143 VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGK--VVIIDVSQSVELD 199 (237)
T ss_pred CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCC--EEEEEChhhhccC
Confidence 11233455789999999999999999 99999999999998 544 8999999987544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.5e-15 Score=179.52 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=182.2
Q ss_pred EeeeecccCceEEEEEEe--eCCcEEEEEEeccCC--chH---HHHHHHHHHHhCC-CCCeeEecccccCccceeeeecc
Q 002601 477 FNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTH--HDV---ALKEIQNLIASDQ-HPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~--~~g~~VAVKrl~~~~--~~~---~~~Ei~~ll~~l~-HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
+.+.||+|+|+.|-.+.. .....+|+|.+.... ... .-.|.. +..... |+|++++++...+.+..++.+|
T Consensus 24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~-~~~~~s~h~n~~~~~~~~~~~~~~~~~~~- 101 (601)
T KOG0590|consen 24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETD-IQKKLSKHSNTVHMIEPSSSPRSYLLSLS- 101 (601)
T ss_pred ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCcccc-ccccccccccccccCCccCCCcccccccC-
Confidence 445699999999977644 345667888765432 111 112332 334444 9999999999999999999999
Q ss_pred ccCChhhHHHHhcCChhHHh-hhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc-ccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIG 626 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L-~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH-~~~ 626 (902)
+..+|++...+ +.. ..+.+......++.|+..++.|+| ..+
T Consensus 102 ---------~s~g~~~f~~i~~~~----------------------------~~~~~~~~~~~~~~ql~s~l~~~H~~~~ 144 (601)
T KOG0590|consen 102 ---------YSDGGSLFSKISHPD----------------------------STGTSSSSASRYLPQLNSGLSYLHPENG 144 (601)
T ss_pred ---------cccccccccccccCC----------------------------ccCCCCcchhhhhhhhccCccccCcccc
Confidence 55556655544 211 013445566789999999999999 999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCC-CccccCchhhccC-CCCCcchhhhhHHHHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG-SSGWQAPEQLLQG-RQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~G-t~~Y~APE~l~~~-~~s~ksDVwSlGviL~el 704 (902)
+.|||+||+|.+++..+. .++++|||+|..+.............+| ++.|+|||...+. ......|+||.|+++.-+
T Consensus 145 ~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~ 223 (601)
T KOG0590|consen 145 VTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAM 223 (601)
T ss_pred cccCCCCCccchhccCCC-cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccccccccccc
Confidence 999999999999988772 4899999999887652222333455678 9999999998875 457899999999999999
Q ss_pred HhCCCCCCCCchhhHHH---HHhhc---cccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCC
Q 002601 705 ITGGKHPYGESFERDAN---IVKDR---KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~~~---~~~~~---~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~ 767 (902)
++| ..|+......... ..... ...........+.+++.+++..+|..|.+.+++..+||+..
T Consensus 224 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 224 LTG-ELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccC-CCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 998 6676644322211 11111 12233445678999999999999999999999999999976
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.8e-14 Score=146.85 Aligned_cols=133 Identities=17% Similarity=0.130 Sum_probs=94.2
Q ss_pred EEEeeeecccCceEEEEEEeeCCcEEEEEEeccCCc-------------------------hHHHHHHHHHHHhCCCCC-
Q 002601 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-------------------------DVALKEIQNLIASDQHPN- 528 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~-------------------------~~~~~Ei~~ll~~l~HpN- 528 (902)
+.+.+.||+|+||.||++...+|+.||||++..... ....+|+. ++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA-ALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH-HHHHHHHcCC
Confidence 455688999999999998777899999998654220 01233444 345555663
Q ss_pred -eeEecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHH
Q 002601 529 -IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607 (902)
Q Consensus 529 -IV~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~ 607 (902)
+...++ ....++|||++ ++++|...... ..
T Consensus 96 ~v~~~~~----~~~~~lv~e~~----------~g~~L~~~~~~-----------------------------------~~ 126 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYI----------DGVELYRVRVL-----------------------------------ED 126 (198)
T ss_pred CCCceee----cCCceEEEEEe----------CCcchhhcccc-----------------------------------cc
Confidence 334433 23458999944 44554332110 12
Q ss_pred HHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCcccccc
Q 002601 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (902)
Q Consensus 608 ~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~ 659 (902)
...++.+++.++.++|+.||+||||||+||++++++. ++|+|||++....
T Consensus 127 ~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~--~~liDfg~~~~~~ 176 (198)
T cd05144 127 PEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK--IYIIDWPQMVSTD 176 (198)
T ss_pred HHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc--EEEEECCccccCC
Confidence 3568889999999999999999999999999987765 8999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.7e-14 Score=147.02 Aligned_cols=131 Identities=20% Similarity=0.324 Sum_probs=98.7
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCCc-----------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~-----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+.||+|++|.||++.. .|..|+||+...... ....+|+. ++..+.|++|.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREAR-IMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHH-HHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 4689999999999765 778899998653211 12334544 5567788888877777777778899999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|+++++|.+.+... .. ....++.+++.+|++||+.++
T Consensus 80 ----------~~~G~~L~~~~~~~--------------------------------~~-~~~~i~~~i~~~l~~lH~~~i 116 (211)
T PRK14879 80 ----------YIEGEPLKDLINSN--------------------------------GM-EELELSREIGRLVGKLHSAGI 116 (211)
T ss_pred ----------EeCCcCHHHHHHhc--------------------------------cH-HHHHHHHHHHHHHHHHHhCCc
Confidence 55556665554211 01 457899999999999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCcccc
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~ 657 (902)
+|+|++|.|||++ ++. ++|+|||++..
T Consensus 117 ~H~Dl~p~Nil~~-~~~--~~liDf~~a~~ 143 (211)
T PRK14879 117 IHGDLTTSNMILS-GGK--IYLIDFGLAEF 143 (211)
T ss_pred ccCCCCcccEEEE-CCC--EEEEECCcccC
Confidence 9999999999998 444 88999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.5e-14 Score=145.24 Aligned_cols=127 Identities=22% Similarity=0.375 Sum_probs=92.8
Q ss_pred ecccCceEEEEEEeeCCcEEEEEEeccCC---c--------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccc
Q 002601 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTH---H--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 481 LG~GsfGtVy~a~~~~g~~VAVKrl~~~~---~--------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c 549 (902)
||+|+||+||++. .+|+.|+||+..... . ....+|+. ++..+.|+++.....++.+.+..++|||
T Consensus 2 ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~-~l~~l~~~~i~~p~~~~~~~~~~~lv~e-- 77 (199)
T TIGR03724 2 IAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEAR-LLSRARKAGVNTPVVYDVDPDNKTIVME-- 77 (199)
T ss_pred CCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHH-HHHHHHHCCCCCCEEEEEECCCCEEEEE--
Confidence 8999999999986 678899999865321 1 11234544 5566777765544444556667799999
Q ss_pred cCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccc
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvH 629 (902)
|+++++|.+.+.... ..++.+++.+|++||+.+++|
T Consensus 78 --------~~~g~~l~~~~~~~~------------------------------------~~~~~~i~~~l~~lH~~gi~H 113 (199)
T TIGR03724 78 --------YIEGKPLKDVIEEGN------------------------------------DELLREIGRLVGKLHKAGIVH 113 (199)
T ss_pred --------EECCccHHHHHhhcH------------------------------------HHHHHHHHHHHHHHHHCCeec
Confidence 555666655542110 168899999999999999999
Q ss_pred cccccceeEeccCCCceEEEccCCccccc
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vkL~DFGla~~~ 658 (902)
+|++|.||+++ ++. ++++|||++...
T Consensus 114 ~Dl~~~Nil~~-~~~--~~liDfg~a~~~ 139 (199)
T TIGR03724 114 GDLTTSNIIVR-DDK--LYLIDFGLGKYS 139 (199)
T ss_pred CCCCcceEEEE-CCc--EEEEECCCCcCC
Confidence 99999999998 544 889999988753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.8e-14 Score=166.22 Aligned_cols=131 Identities=21% Similarity=0.331 Sum_probs=98.0
Q ss_pred EEeeeecccCceEEEEEEeeCCcEEEEEEeccC--Cc---------hHHHHHHHHHHHhCCCCCeeEecccccCccceee
Q 002601 476 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT--HH---------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~--~~---------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yL 544 (902)
...+.||+|+||+||++.. .+..+++|+.... .. +...+|. .++..++|++|+..+.++.+.+..++
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~-~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~-~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEY-LGRDAVIKERVPKGYRHPELDERLRTERTRAEA-RLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred CccceeccCCcEEEEEEee-cCccceeEEEecccccchhHHHHHHHHHHHHHH-HHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 4467899999999999654 4445555543211 10 1223444 46788899999988878777778899
Q ss_pred eeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccc
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~ 624 (902)
||| |+++++|.+++. ....++.+++++|++||+
T Consensus 414 v~E----------~~~g~~L~~~l~-------------------------------------~~~~~~~~i~~~L~~lH~ 446 (535)
T PRK09605 414 VME----------YIGGKDLKDVLE-------------------------------------GNPELVRKVGEIVAKLHK 446 (535)
T ss_pred EEE----------ecCCCcHHHHHH-------------------------------------HHHHHHHHHHHHHHHHHh
Confidence 999 666777766552 125689999999999999
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccc
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~ 658 (902)
.+|+||||||+|||++ ++. ++|+|||+++..
T Consensus 447 ~giiHrDlkp~NILl~-~~~--~~liDFGla~~~ 477 (535)
T PRK09605 447 AGIVHGDLTTSNFIVR-DDR--LYLIDFGLGKYS 477 (535)
T ss_pred CCCccCCCChHHEEEE-CCc--EEEEeCcccccC
Confidence 9999999999999993 444 899999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-13 Score=141.20 Aligned_cols=51 Identities=22% Similarity=0.345 Sum_probs=44.9
Q ss_pred HHHHHHHHhhhcccccccc-ccccccccccceeEeccCCCceEEEccCCcccccc
Q 002601 606 AQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (902)
Q Consensus 606 ~~~~~I~~qIa~gL~yLH~-~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~ 659 (902)
..+..++.+++.++.++|. .+|+||||||+||+++ ++. ++|+|||.+....
T Consensus 114 ~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~--~~liDfg~a~~~~ 165 (187)
T cd05119 114 EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK--VYIIDVPQAVEID 165 (187)
T ss_pred ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc--EEEEECccccccc
Confidence 3457899999999999999 9999999999999998 554 8999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.4e-13 Score=155.04 Aligned_cols=248 Identities=25% Similarity=0.283 Sum_probs=179.5
Q ss_pred EEeeeecc--cCceEEEEEEe---eCCcEEEEEEeccC-----CchHHHHHHHHHHHhCCCCCeeEecccccCccceeee
Q 002601 476 VFNKEIAK--GSNGTVVLEGN---YEGRSVAVKRLVKT-----HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 476 ~~~~~LG~--GsfGtVy~a~~---~~g~~VAVKrl~~~-----~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV 545 (902)
...+.+|. |++|.||.+.. .++..+|+|+-+.. ......+|+......-.|+|.|+.+..+.+.+.+|+-
T Consensus 117 ~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiq 196 (524)
T KOG0601|consen 117 PISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQ 196 (524)
T ss_pred ccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceee
Confidence 34567899 99999998755 56889999973221 1123456666555666799999999999999999999
Q ss_pred eccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhc----cccc
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS----GLSH 621 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~----gL~y 621 (902)
+|+|..+|..+..... ..++...++.+..+..+ ||.+
T Consensus 197 tE~~~~sl~~~~~~~~---------------------------------------~~~p~~~l~~~~~~~~~~~~~al~~ 237 (524)
T KOG0601|consen 197 TELCGESLQSYCHTPC---------------------------------------NFLPDNLLWNSLRDWLSRDVTALSH 237 (524)
T ss_pred eccccchhHHhhhccc---------------------------------------ccCCchhhhhHHhhhhhcccccccc
Confidence 9999877666652111 22455566677777777 9999
Q ss_pred cccccccccccccceeEeccCCCceEEEccCCccccccCCCcc-ccc-cccCCCCccccCchhhccCCCCCcchhhhhHH
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSC-LTQ-NATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (902)
Q Consensus 622 LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~-~~~-~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGv 699 (902)
+|+.+|+|-|+||.||++..+. ...+++|||+...+....-. ... .....|...|++||.+. +.++...|+|++|.
T Consensus 238 ~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~e 315 (524)
T KOG0601|consen 238 LHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGE 315 (524)
T ss_pred cCCCcccccccchhheeccccc-ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhh
Confidence 9999999999999999998873 34899999999988754311 111 12225778899999874 46889999999999
Q ss_pred HHHHHHhCCCCCCCCchh---hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCC
Q 002601 700 ILFFCITGGKHPYGESFE---RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 700 iL~elltG~~~Pf~~~~~---~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~ 766 (902)
++.+..++-.+|-..... ...+.. ....+....+.+....+..|++.+|..|++++.+++|++..
T Consensus 316 v~l~~~l~~~~~~~g~~~~W~~~r~~~--ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~ 383 (524)
T KOG0601|consen 316 VILEAILGSHLPSVGKNSSWSQLRQGY--IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH 383 (524)
T ss_pred hhHhhHhhcccccCCCCCCcccccccc--CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence 999999885555433111 000100 11223333445666699999999999999999999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.3e-12 Score=136.62 Aligned_cols=132 Identities=17% Similarity=0.218 Sum_probs=88.6
Q ss_pred eeec-ccCceEEEEEEeeCCcEEEEEEeccCC----------------chHHHHHHHHHHHhCCCCCe--eEecccccCc
Q 002601 479 KEIA-KGSNGTVVLEGNYEGRSVAVKRLVKTH----------------HDVALKEIQNLIASDQHPNI--VRWYGVESDQ 539 (902)
Q Consensus 479 ~~LG-~GsfGtVy~a~~~~g~~VAVKrl~~~~----------------~~~~~~Ei~~ll~~l~HpNI--V~l~g~~~d~ 539 (902)
..|| .|+.|+||+... ++..++||++.... .....+|+. ++..+.|++| ++.+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~-ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFR-LLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHH-HHHHHHhCCCCCceeEeeeeee
Confidence 4577 788888887544 47789999874311 123455664 6677777774 6677664332
Q ss_pred -cce---eeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhh
Q 002601 540 -DFV---YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDI 615 (902)
Q Consensus 540 -~~~---yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qI 615 (902)
... ++|||++++. ++|.+++... .++. ..+.+|
T Consensus 115 ~~~~~~~~lV~e~l~G~---------~~L~~~l~~~------------------------------~l~~----~~~~~i 151 (239)
T PRK01723 115 HGLFYRADILIERIEGA---------RDLVALLQEA------------------------------PLSE----EQWQAI 151 (239)
T ss_pred cCcceeeeEEEEecCCC---------CCHHHHHhcC------------------------------CCCH----HHHHHH
Confidence 222 5999955531 3444433210 1121 235688
Q ss_pred hccccccccccccccccccceeEeccCCCceEEEccCCcccc
Q 002601 616 VSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (902)
Q Consensus 616 a~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~ 657 (902)
+.+|.+||+.||+||||||.|||++.++. ++|+|||.+..
T Consensus 152 ~~~l~~lH~~GI~HrDlkp~NILv~~~~~--v~LIDfg~~~~ 191 (239)
T PRK01723 152 GQLIARFHDAGVYHADLNAHNILLDPDGK--FWLIDFDRGEL 191 (239)
T ss_pred HHHHHHHHHCCCCCCCCCchhEEEcCCCC--EEEEECCCccc
Confidence 99999999999999999999999987765 89999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.5e-11 Score=118.98 Aligned_cols=129 Identities=18% Similarity=0.251 Sum_probs=96.2
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCCc-hHHHHHHHHHHHhCCC--CCeeEecccccCccceeeeeccccCChhh
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQH--PNIVRWYGVESDQDFVYLSLERCTCSLND 555 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~-~~~~~Ei~~ll~~l~H--pNIV~l~g~~~d~~~~yLV~E~c~~sL~d 555 (902)
+.||+|.++.||++...+ ..++||+...... ....+|+. .+..+.| .++.+++++....+..+++||++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~~~~~~~e~~-~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~------ 75 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREKGADREREVA-ILQLLARKGLPVPKVLASGESDGWSYLLMEWI------ 75 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCchhHHHHHHH-HHHHHHHcCCCCCeEEEEcCCCCccEEEEEec------
Confidence 679999999999976544 7899999866432 23445554 4455544 58889888888888899999954
Q ss_pred HHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc---ccccccc
Q 002601 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI---GLIHRDL 632 (902)
Q Consensus 556 liy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~---~IvHrDL 632 (902)
.++.+... +......++.+++++|++||.. +++|+|+
T Consensus 76 ----~g~~~~~~------------------------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl 115 (155)
T cd05120 76 ----EGETLDEV------------------------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDL 115 (155)
T ss_pred ----CCeecccC------------------------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCC
Confidence 33333221 1123356889999999999985 6999999
Q ss_pred ccceeEeccCCCceEEEccCCcccc
Q 002601 633 KPQNVLISKDKSFCAKLSDMGISKR 657 (902)
Q Consensus 633 Kp~NILL~~d~~~~vkL~DFGla~~ 657 (902)
+|.||++++++. ++++|||.+..
T Consensus 116 ~~~Nil~~~~~~--~~l~Df~~~~~ 138 (155)
T cd05120 116 HPGNILVDDGKI--LGIIDWEYAGY 138 (155)
T ss_pred CcceEEEECCcE--EEEEecccccC
Confidence 999999987554 89999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.13 E-value=9.3e-11 Score=136.10 Aligned_cols=138 Identities=24% Similarity=0.203 Sum_probs=86.5
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCCchHH-------------------------------------------HH
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-------------------------------------------LK 515 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~~~-------------------------------------------~~ 515 (902)
+.||.||+|.||+|.+.+|+.||||+......+.. .+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 56999999999999999999999999854321111 01
Q ss_pred HHHH---HHHhCCCCCeeEeccccc-CccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhcccccc
Q 002601 516 EIQN---LIASDQHPNIVRWYGVES-DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591 (902)
Q Consensus 516 Ei~~---ll~~l~HpNIV~l~g~~~-d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~ 591 (902)
|..+ +.....|.+-|..-.++. ..+..+|||||| +++++.+.......
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i----------~G~~L~~~~~~~~~------------------ 254 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWI----------DGIPLSDIAALDEA------------------ 254 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeE----------CCcccccHHHHHhc------------------
Confidence 1111 111223333333333332 234579999955 44555443321100
Q ss_pred chhHHHHhhCCCCHHHHHHHHHhhhc-cccccccccccccccccceeEeccCCCceEEEccCCcccccc
Q 002601 592 TKDIELWKANGHPSAQLLKVTRDIVS-GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (902)
Q Consensus 592 ~~~~~~~~~~~l~~~~~~~I~~qIa~-gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~ 659 (902)
+.+ ..+++.+++. .+..+|..|++|+|+||.||+++.++. ++++|||++..+.
T Consensus 255 ----------~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~--i~liDfG~~~~l~ 308 (437)
T TIGR01982 255 ----------GLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGK--IIALDFGIVGRLS 308 (437)
T ss_pred ----------CCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCc--EEEEeCCCeeECC
Confidence 011 1335555554 356789999999999999999988876 8999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6e-11 Score=126.87 Aligned_cols=203 Identities=21% Similarity=0.264 Sum_probs=137.0
Q ss_pred hCCCCCeeEecccccCcc-----ceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHH
Q 002601 523 SDQHPNIVRWYGVESDQD-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597 (902)
Q Consensus 523 ~l~HpNIV~l~g~~~d~~-----~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~ 597 (902)
.+.|.|||+++.|+.+.. ...++.| ||..|++.++|..-..
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFite----------ymssgs~~~fLkrt~~------------------------ 168 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITE----------YMSSGSLKQFLKRTKK------------------------ 168 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEe----------cccchhHHHHHHHHHH------------------------
Confidence 456999999999987654 3688889 9999999999864322
Q ss_pred HhhCCCCHHHHHHHHHhhhccccccccc--cccccccccceeEeccCCCceEEEccCCccccccCCCc--cccccccCCC
Q 002601 598 WKANGHPSAQLLKVTRDIVSGLSHLHEI--GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS--CLTQNATGYG 673 (902)
Q Consensus 598 ~~~~~l~~~~~~~I~~qIa~gL~yLH~~--~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~--~~~~~~~~~G 673 (902)
....+......+|+-||+.||.|||+. .|+|+++.-.-|++..+|- +|+.- +.-........ .........|
T Consensus 169 -~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngL--Ikig~-~ap~s~h~s~~~~~~~Ek~~~~~ 244 (458)
T KOG1266|consen 169 -NQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGL--IKIGS-VAPDSTHPSVNSTREAEKSVNTS 244 (458)
T ss_pred -hhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCce--EEecc-cCccccchhhhhhhHhhhhcccc
Confidence 223345566689999999999999987 6999999999999986663 44431 11100100000 0011122346
Q ss_pred CccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCc--hhhHHHHHhhccccccccCChHHHHHHHcccCCCCC
Q 002601 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES--FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751 (902)
Q Consensus 674 t~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~--~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~ 751 (902)
-++|.|||.=.....+-++|||+||....+|..+.-.|-... ...+.++.... ..-..+.-+++|.+|++..|.
T Consensus 245 ~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i----~~len~lqr~~i~kcl~~eP~ 320 (458)
T KOG1266|consen 245 LPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI----IGLENGLQRGSITKCLEGEPN 320 (458)
T ss_pred CCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe----eeccCccccCcCcccccCCCC
Confidence 789999998766677889999999999999988744332211 11111111000 000112345789999999999
Q ss_pred CCcCHHHHHcCCCCCC
Q 002601 752 LRPKAQNVLNHPFFWT 767 (902)
Q Consensus 752 ~Rpt~~elL~HPfF~~ 767 (902)
.||+|.+++.||....
T Consensus 321 ~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 321 GRPDARLLLFHPLLFE 336 (458)
T ss_pred CCcchhhhhcCceeee
Confidence 9999999999998644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-10 Score=140.67 Aligned_cols=253 Identities=25% Similarity=0.282 Sum_probs=173.0
Q ss_pred EEEeeeecccCceEEEEEEee-CCcEEEEEEeccC------CchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 475 VVFNKEIAKGSNGTVVLEGNY-EGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~-~g~~VAVKrl~~~------~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
+...+-+-.|+++.+..+... .|...+.|..... ..+....+- ...-...||-+++..-.+......+|+++
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s-~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKS-NILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCcc-CccccCCCCceecccCCCCCCCCcchhhH
Confidence 444557788999988765222 2333444433211 111111111 12222456777877766667788999999
Q ss_pred cccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I 627 (902)
|..+|+|...||... +...+-.+.....+..+++|||...+
T Consensus 885 ----------~~~~~~~~Skl~~~~-----------------------------~~saepaRs~i~~~vqs~e~L~s~~r 925 (1205)
T KOG0606|consen 885 ----------YLNGGDLPSKLHNSG-----------------------------CLSAEPARSPILERVQSLESLHSSLR 925 (1205)
T ss_pred ----------HhccCCchhhhhcCC-----------------------------CcccccccchhHHHHhhhhccccchh
Confidence 777888888876433 12223345667788899999999999
Q ss_pred cccccccceeEeccCCCceEEEccCCccccccC------C---------------C-------ccccccccCCCCccccC
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG------D---------------M-------SCLTQNATGYGSSGWQA 679 (902)
Q Consensus 628 vHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~------~---------------~-------~~~~~~~~~~Gt~~Y~A 679 (902)
.|||++|.|+|+..+++ .+++|||......- . . ..........||+.|.|
T Consensus 926 ~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~la 1003 (1205)
T KOG0606|consen 926 KHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLA 1003 (1205)
T ss_pred hcccccccchhhcccCC--cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccC
Confidence 99999999999998887 78999984332210 0 0 00011234469999999
Q ss_pred chhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchh-hHHHHHhhcc---ccccccCChHHHHHHHcccCCCCCCCcC
Q 002601 680 PEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE-RDANIVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPK 755 (902)
Q Consensus 680 PE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~-~~~~~~~~~~---~~~~~~~~~e~~dLI~~~L~~dP~~Rpt 755 (902)
||.+.+......+|+|+.|++++|.++| .+||..... +...-+.... ..-+...++++++++..++..+|.+|.+
T Consensus 1004 Pe~~lg~~hgs~ad~~~~g~~l~e~l~g-~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~ 1082 (1205)
T KOG0606|consen 1004 PEILLGRRHGSAADWWSSGVCLFEVLTG-IPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLG 1082 (1205)
T ss_pred CcccccccCCCcchhhhhhhhhhhhhcC-CCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccC
Confidence 9999999999999999999999999998 777765433 3322222221 2234456789999999999999999998
Q ss_pred HH---HHHcCCCCCCcch
Q 002601 756 AQ---NVLNHPFFWTADT 770 (902)
Q Consensus 756 ~~---elL~HPfF~~~~~ 770 (902)
+. ++-.||||...++
T Consensus 1083 a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1083 AKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred cccccccccCCccCCCCc
Confidence 87 8999999976543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-10 Score=133.11 Aligned_cols=243 Identities=23% Similarity=0.201 Sum_probs=169.0
Q ss_pred eEEEeeeecccCceEEEEEEe--eCCcEEEEEEeccCC-----chHHHHHHHHHHHhCCCCCeeEecccccCccceeeee
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN--YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~--~~g~~VAVKrl~~~~-----~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~ 546 (902)
.|.+...||.|.|+.|+.... .++..+|+|.+.+.- +...+.|+........|.++++++..|...+..|+-.
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~ 345 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL 345 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch
Confidence 345567899999999987643 457889999876532 2234566655555667999999999998888999999
Q ss_pred ccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccc
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~ 626 (902)
|||.+ +++..... -...+++...+++..|++.++.++|+..
T Consensus 346 e~~~~----------~s~~l~~~-----------------------------~~~~~d~~~~~~~~~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 346 EFCEG----------GSSSLRSV-----------------------------TSQMLDEDPRLRLTAQILTALNVIHSKL 386 (524)
T ss_pred hhhcC----------cchhhhhH-----------------------------HHHhcCcchhhhhHHHHHhccccccchh
Confidence 96653 33222110 0011344456889999999999999999
Q ss_pred ccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCcccc--CchhhccCCCCCcchhhhhHHHHHHH
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ--APEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 627 IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~--APE~l~~~~~s~ksDVwSlGviL~el 704 (902)
++|+|+||+||++..++ +..++.|||.+..+.-.. ....++-+++ +++......+..+.|++|||.-+.+.
T Consensus 387 ~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~~~------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~ 459 (524)
T KOG0601|consen 387 FVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAFSS------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEA 459 (524)
T ss_pred hhcccccccceeeccch-hhhhccccccccccceec------ccccccccccccchhhcccccccccccccccccccccc
Confidence 99999999999998765 447899999887533211 1112333444 55555566788999999999999999
Q ss_pred HhCCCCCCCCchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCC
Q 002601 705 ITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF 765 (902)
+++...+... .....+....... ......++..+.+.++.+|+..||.+.++..|.-|
T Consensus 460 ~~~~~ls~~~--~~~~~i~~~~~p~-~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 460 ITGSPLSESG--VQSLTIRSGDTPN-LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred ccCcccCccc--ccceeeecccccC-CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 9984444332 1111222222211 22223678889999999999999999999988754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.8e-10 Score=132.82 Aligned_cols=205 Identities=20% Similarity=0.315 Sum_probs=144.8
Q ss_pred HHhhhccccccccc-cccccccccceeEeccCCCceEEEccCCccccccCCCccccc------cccCCCCccccCchhhc
Q 002601 612 TRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ------NATGYGSSGWQAPEQLL 684 (902)
Q Consensus 612 ~~qIa~gL~yLH~~-~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~------~~~~~Gt~~Y~APE~l~ 684 (902)
+.+++.||.|+|.. ++||++|.|++|.++..+. +||+.|+.+....+....... .....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 44666999999976 8999999999999988877 899999998776653221111 11112455799999999
Q ss_pred cCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhhH-HH----HHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHH
Q 002601 685 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERD-AN----IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 759 (902)
Q Consensus 685 ~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~~-~~----~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~el 759 (902)
....+.++|+||+||++|.+..||+.-+....... .. ........+....++|+++-+.+++..++..||++.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l 262 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL 262 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence 98889999999999999998867665443321111 11 11111112235567899999999999999999999999
Q ss_pred HcCCCCCCcc-hhhhhhhhcccchhhccccchHHHHHHHHHHHHhhhcccchHHHhHHHHHhhh
Q 002601 760 LNHPFFWTAD-TRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIG 822 (902)
Q Consensus 760 L~HPfF~~~~-~~~~~l~~~s~~~e~~~~~~~~~ll~~le~~~~~~~~~~w~~~~~~~l~~~~~ 822 (902)
+.-|||.+.. ..++|+.++.. .+-.+++..++.|-.+......+-|..++-+.+.+.+.
T Consensus 263 ~~~~ff~D~~~~aLrfLD~l~~----kdn~qKs~Flk~Ls~~ip~fp~rv~~~kiLP~L~~el~ 322 (700)
T KOG2137|consen 263 LSIPFFSDPGLKALRFLDDLPQ----KDNSQKSSFLKGLSKLIPTFPARVLFQKILPTLVAELV 322 (700)
T ss_pred hcccccCCchhhhhhhcccccc----cCcHHHHHHHHHHHHhhccCCHHHHHHhhhhHHHHHhc
Confidence 9999997654 33455554432 34445566777765555555566688888888877764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.93 E-value=9.2e-10 Score=129.72 Aligned_cols=46 Identities=24% Similarity=0.343 Sum_probs=35.6
Q ss_pred HHHHHHhhhccccccccccccccccccceeEeccCC--CceEEEccCCccccccC
Q 002601 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK--SFCAKLSDMGISKRLQG 660 (902)
Q Consensus 608 ~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~--~~~vkL~DFGla~~~~~ 660 (902)
+..++.|++ ..|++|+|+||.||+++.++ ...+++.|||++..+..
T Consensus 269 v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345566665 47999999999999998776 12488999999887653
|
|
| >smart00580 PUG domain in protein kinases, N-glycanases and other nuclear proteins | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.7e-10 Score=93.80 Aligned_cols=53 Identities=51% Similarity=0.835 Sum_probs=49.6
Q ss_pred chHHHHHHHhccccCcccCC--CHHHHHHhCCCCCcccccccccCCchHHH-HHHH
Q 002601 830 DNVRDLLRVIRNKSNHFREL--PQDIQELLGSHPEGFYNYFSCRFPKLLIE-VYNV 882 (902)
Q Consensus 830 ~~vrdLLr~irnk~~h~~el--~~~~~~~~G~~p~~f~~yf~~~fP~ll~~-~y~~ 882 (902)
++++||||.|||+.+|++|+ ++.+|+.+|++|++|..||..+||+|+++ +|..
T Consensus 1 ~sv~dLLr~irNi~~hp~e~k~n~~~~~~l~~~pg~~~~l~~~gFp~l~~~~~y~l 56 (58)
T smart00580 1 ESVRDLLRALRNILHHPREEKGNPAIKERLGDVPGGFELYFTVGFPRLLISEVYTL 56 (58)
T ss_pred CcHHHHHHHHHHHhhCcchhhcCHHHHHHhcCCCcHHHHHHHcCCCcccccceeee
Confidence 36899999999999999999 99999999999999999999999999998 7653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-08 Score=119.13 Aligned_cols=164 Identities=21% Similarity=0.328 Sum_probs=114.0
Q ss_pred EeeCCcEEEEEEeccCCc--hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCChhhHHHHhcCChhHHhhh
Q 002601 493 GNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNA 570 (902)
Q Consensus 493 ~~~~g~~VAVKrl~~~~~--~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~ 570 (902)
...++.+|.|...+.... ....++....++.++||||++++..+..++.+|||+|.+.- |...+
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P------------l~~~l-- 98 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP------------LETVL-- 98 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc------------HHHHH--
Confidence 446788888888866554 12233333456889999999999999999999999996641 11111
Q ss_pred hhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc-cccccccccccceeEeccCCCceEEE
Q 002601 571 KEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKL 649 (902)
Q Consensus 571 ~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH-~~~IvHrDLKp~NILL~~d~~~~vkL 649 (902)
+.. ....+.-.+.||+.||.||| ..+++|++|.-+.|+++..|+ .||
T Consensus 99 ----------------------------k~l--~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkL 146 (690)
T KOG1243|consen 99 ----------------------------KEL--GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKL 146 (690)
T ss_pred ----------------------------HHh--HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEE
Confidence 111 12344567899999999998 568999999999999999988 899
Q ss_pred ccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhC
Q 002601 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 650 ~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG 707 (902)
++|-++....+... ......---.|..|+.+... +-..|.|-|||+++|++.|
T Consensus 147 ggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~~s--~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 147 GGLELVSKASGFNA---PAKSLYLIESFDDPEEIDPS--EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeeEEEeccccCCc---ccccchhhhcccChhhcCcc--ccchhhhhHHHHHHHHhCc
Confidence 99998866543211 00000111235566644322 2457999999999999987
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.6e-09 Score=104.62 Aligned_cols=124 Identities=18% Similarity=0.118 Sum_probs=82.2
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCC--chHHHHHHHHHHHhCCCCCe-eEecccccCccceeeeeccccCChhh
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNI-VRWYGVESDQDFVYLSLERCTCSLND 555 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~--~~~~~~Ei~~ll~~l~HpNI-V~l~g~~~d~~~~yLV~E~c~~sL~d 555 (902)
+.|+.|.++.||+... .|..|++|...... .....+|...+ ..+.+.++ .+++.+.. +..++|||
T Consensus 4 ~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~~~~~~~~E~~~l-~~l~~~~~~P~~~~~~~--~~~~lv~e-------- 71 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTELLINRENEAENS-KLAAEAGIGPKLYYFDP--ETGVLITE-------- 71 (170)
T ss_pred eecCCcccCceEEEEE-CCeEEEEEeCCCCcccccCHHHHHHHH-HHHHHhCCCCceEEEeC--CCCeEEEE--------
Confidence 5689999999998654 47889999875543 12234555433 33333333 34444432 34589999
Q ss_pred HHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccc-----ccc
Q 002601 556 LIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL-----IHR 630 (902)
Q Consensus 556 liy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~I-----vHr 630 (902)
+++++++.... . ....++.+++++|+.||..++ +|+
T Consensus 72 --~i~G~~l~~~~----~---------------------------------~~~~~~~~l~~~l~~LH~~~~~~~~~~Hg 112 (170)
T cd05151 72 --FIEGSELLTED----F---------------------------------SDPENLEKIAKLLKKLHSSPLPDLVPCHN 112 (170)
T ss_pred --ecCCCcccccc----c---------------------------------cCHHHHHHHHHHHHHHhCCCCCCceeecC
Confidence 55554442210 0 013456789999999999875 999
Q ss_pred ccccceeEeccCCCceEEEccCCccc
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISK 656 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vkL~DFGla~ 656 (902)
|++|.||+++ ++. ++++|||.+.
T Consensus 113 D~~~~Nil~~-~~~--~~liDf~~a~ 135 (170)
T cd05151 113 DLLPGNFLLD-DGR--LWLIDWEYAG 135 (170)
T ss_pred CCCcCcEEEE-CCe--EEEEeccccc
Confidence 9999999998 443 8899999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.6e-08 Score=103.09 Aligned_cols=52 Identities=21% Similarity=0.273 Sum_probs=43.5
Q ss_pred HHHHHHHHHhhhcccccc-ccccccccccccceeEeccCCCceEEEccCCcccccc
Q 002601 605 SAQLLKVTRDIVSGLSHL-HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (902)
Q Consensus 605 ~~~~~~I~~qIa~gL~yL-H~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~ 659 (902)
..+...+..+++.+|..| |..||+|+||++.|||+.. +. +.|+|||.+....
T Consensus 123 ~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~-~~--v~iIDF~qav~~~ 175 (197)
T cd05146 123 DEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD-GK--VWFIDVSQSVEPT 175 (197)
T ss_pred HHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC-Cc--EEEEECCCceeCC
Confidence 345567889999999998 8999999999999999964 44 8899999887554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=8.9e-09 Score=124.87 Aligned_cols=75 Identities=12% Similarity=0.037 Sum_probs=53.1
Q ss_pred cCCCccccCCCCCccccccccccccccCCcCccccch-hccC-CCccccccCCcccccCCCCCCC------CCCCcCCCC
Q 002601 244 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSS------QNSLLGPVD 315 (902)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~fsG~I~~-L~~l-~L~~LNlsnN~fsG~IP~~~~~------~~sf~GN~~ 315 (902)
.+|+|++.|.+|..++.+.+|+.|.|.+|+|+|.||. +..+ .|+.|||++|+|+|.||..+.. ..+|.||.+
T Consensus 448 ~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 448 NLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred ECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCcc
Confidence 4677777777777777777777777777777777764 6666 4777888888888888744322 234458888
Q ss_pred CCC
Q 002601 316 RNS 318 (902)
Q Consensus 316 lcg 318 (902)
+||
T Consensus 528 lc~ 530 (623)
T PLN03150 528 LCG 530 (623)
T ss_pred ccC
Confidence 887
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.58 E-value=4.2e-07 Score=103.31 Aligned_cols=223 Identities=19% Similarity=0.199 Sum_probs=148.6
Q ss_pred eEEEEE-EeeCCcEEEEEEeccCCch--HHHHHHHHHHHhCCCCCeeEecccccC----ccceeeeeccccC--ChhhHH
Q 002601 487 GTVVLE-GNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSLERCTC--SLNDLI 557 (902)
Q Consensus 487 GtVy~a-~~~~g~~VAVKrl~~~~~~--~~~~Ei~~ll~~l~HpNIV~l~g~~~d----~~~~yLV~E~c~~--sL~dli 557 (902)
.+.|++ ...+|..|..||+...... .....+.+..+.+.|+|||++..++.. +.-+++||+|.++ +|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 467887 6778999999999332211 122334456788999999999998873 4457999998886 466653
Q ss_pred HHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccccccee
Q 002601 558 YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637 (902)
Q Consensus 558 y~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NI 637 (902)
+. +-... .. ......-.....++..++.++.|++.||.++|+.|..-+-|.+.+|
T Consensus 370 F~-~~~~t----------~~--------------~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kI 424 (655)
T KOG3741|consen 370 FA-NPPFT----------KR--------------TNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKI 424 (655)
T ss_pred cc-CCccc----------cc--------------cccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHe
Confidence 22 11110 00 0000112234578889999999999999999999999999999999
Q ss_pred EeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCchh
Q 002601 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 717 (902)
Q Consensus 638 LL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~ 717 (902)
|++ |..+++|+..|....+..+. + |-+. --.+-|.=.||.++..|.||...-+.....
T Consensus 425 lv~--G~~RIriS~C~i~Dvl~~d~----------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~ 482 (655)
T KOG3741|consen 425 LVT--GKMRIRISGCGIMDVLQEDP----------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDST 482 (655)
T ss_pred Eee--CcceEEEecccceeeecCCC----------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccch
Confidence 995 44568898888776555431 0 0011 124568889999999999985544433222
Q ss_pred hHHHHHhhccccccccCChHHHHHHHcccCCCCCCCcCHHHHHcC
Q 002601 718 RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~H 762 (902)
.... ........+.+++++|.-+...++.. -++.+++.|
T Consensus 483 ~~s~-----~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 483 QSSH-----LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHH-----HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1111 11112235678889999988888886 678888766
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.7e-07 Score=100.44 Aligned_cols=150 Identities=25% Similarity=0.356 Sum_probs=105.8
Q ss_pred CCHHHHHHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchh
Q 002601 603 HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQ 682 (902)
Q Consensus 603 l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~ 682 (902)
+.|+.+++.++.++.+.+-||..|.+-+|+.++|+|+.+++. +.|.|-..-..... .......+|.+.|.+||.
T Consensus 114 ~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVdsDsfqi~~n----g~~~~cpVg~~eftPPEl 187 (637)
T COG4248 114 CAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDSDSFQINAN----GTLHLCPVGVSEFTPPEL 187 (637)
T ss_pred cccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcccceeeccC----CceEecccCccccCCHHH
Confidence 567889999999999999999999999999999999988876 66766432211111 122245578999999996
Q ss_pred hc-----cCCCCCcchhhhhHHHHHHHHhCCCCCCCCchhh-------HHHHHhh--------cc--cc----cc-ccCC
Q 002601 683 LL-----QGRQTRAIDLFSLGCILFFCITGGKHPYGESFER-------DANIVKD--------RK--DL----FL-VEHI 735 (902)
Q Consensus 683 l~-----~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~~~-------~~~~~~~--------~~--~~----~~-~~~~ 735 (902)
-. +..-+...|.|.|||++++++.||.+||..-... +..|-.. .. .. .+ .-..
T Consensus 188 Q~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lp 267 (637)
T COG4248 188 QTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLP 267 (637)
T ss_pred hccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcC
Confidence 54 2334678999999999999999999999763221 1111110 00 01 11 1134
Q ss_pred hHHHHHHHcccCCC--CCCCcCHHH
Q 002601 736 PEAVDLFTRLLDPN--PDLRPKAQN 758 (902)
Q Consensus 736 ~e~~dLI~~~L~~d--P~~Rpt~~e 758 (902)
+++..|..+|+... +.-||+++.
T Consensus 268 p~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 268 PDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred HHHHHHHHHHhcccCCCCCCCCHHH
Confidence 67888999998653 678999764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.41 E-value=5.2e-07 Score=94.09 Aligned_cols=73 Identities=12% Similarity=0.173 Sum_probs=48.9
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCC----chHHHHHHHHHHHhCCC--CCeeEecccccCc---cceeeeeccc
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQH--PNIVRWYGVESDQ---DFVYLSLERC 549 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~----~~~~~~Ei~~ll~~l~H--pNIV~l~g~~~d~---~~~yLV~E~c 549 (902)
+.||.|..+.||+....+|+.++||+..... .....+|.. .+..+.+ .++.+++.+..+. +..++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~-~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYR-VLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHH-HHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 4689999999999877667899999875432 223445554 3444443 3455666666554 3668999987
Q ss_pred cCC
Q 002601 550 TCS 552 (902)
Q Consensus 550 ~~s 552 (902)
++.
T Consensus 83 ~G~ 85 (223)
T cd05154 83 DGR 85 (223)
T ss_pred CCE
Confidence 753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=1.2e-06 Score=88.25 Aligned_cols=138 Identities=23% Similarity=0.305 Sum_probs=85.2
Q ss_pred eeecccCceEEEEEEeeCCcEEEEE-EeccCCc----------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeec
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVK-RLVKTHH----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVK-rl~~~~~----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E 547 (902)
..|-+|+-+.|++ +.+.|+...|| |+.+... ....+|.. ++.+..--.|.--.-++.|...-.|+||
T Consensus 13 ~likQGAEArv~~-~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear-~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 13 ELIKQGAEARVPR-GSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEAR-LLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred eeeeccceeeEee-eccCCceeEEeecccccccchHHHHHHHHHHHHHHHH-HHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4677999999987 55678887777 3433211 12234444 2332221122211223445555678999
Q ss_pred cccC--ChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccc
Q 002601 548 RCTC--SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 548 ~c~~--sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~ 625 (902)
+.++ ++.+++.... . ..........+++.|-+.+.-||..
T Consensus 91 ~~~g~~~vk~~i~~~~-----------~---------------------------~~~~d~~~~~~~~~iG~~igklH~n 132 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTM-----------E---------------------------DESEDEGLAELARRIGELIGKLHDN 132 (229)
T ss_pred eccchhHHHHHHHHHc-----------c---------------------------CcccchhHHHHHHHHHHHHHHhhhC
Confidence 7776 4555542110 0 0011122356788888889999999
Q ss_pred cccccccccceeEeccCCC-ceEEEccCCccc
Q 002601 626 GLIHRDLKPQNVLISKDKS-FCAKLSDMGISK 656 (902)
Q Consensus 626 ~IvHrDLKp~NILL~~d~~-~~vkL~DFGla~ 656 (902)
+|+|+||..+||+|.++++ ..+.++|||++.
T Consensus 133 diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 133 DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred CeecccccccceEEecCCCcCceEEEeecchh
Confidence 9999999999999987664 335899999875
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.30 E-value=3e-06 Score=92.25 Aligned_cols=54 Identities=13% Similarity=0.201 Sum_probs=45.6
Q ss_pred CHHHHHHHHHhhhccccccccccccccccccceeEecc-----CCCceEEEccCCcccc
Q 002601 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK-----DKSFCAKLSDMGISKR 657 (902)
Q Consensus 604 ~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~-----d~~~~vkL~DFGla~~ 657 (902)
+......++.+++..+.-||..||+|+||+++|||++. ++...+.++||+.++.
T Consensus 136 ~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 136 DPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 34456789999999999999999999999999999975 2345689999998753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.5e-06 Score=87.88 Aligned_cols=127 Identities=19% Similarity=0.297 Sum_probs=78.5
Q ss_pred eecccCceEEEEEEeeCCcEEEEEE-eccCCc----------hHHHHHHHHHHHhCCCCCeeEecccccCccceeeeecc
Q 002601 480 EIAKGSNGTVVLEGNYEGRSVAVKR-LVKTHH----------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 480 ~LG~GsfGtVy~a~~~~g~~VAVKr-l~~~~~----------~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~ 548 (902)
.+++|+-..+|.+.. -|..+.+|. +.+... ....+|.. ++..++--.|-.-+=+..|.+...|+|||
T Consensus 3 ~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Ear-il~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 3 LIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREAR-ILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred hhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHH-HHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 478999999998644 444566663 333211 12233443 33333222222222234566778899995
Q ss_pred ccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccc
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~Iv 628 (902)
.++ -.|.+.+... ...+++.+-.-+.-||..||+
T Consensus 81 I~G----------~~lkd~l~~~------------------------------------~~~~~r~vG~~vg~lH~~giv 114 (204)
T COG3642 81 IEG----------ELLKDALEEA------------------------------------RPDLLREVGRLVGKLHKAGIV 114 (204)
T ss_pred eCC----------hhHHHHHHhc------------------------------------chHHHHHHHHHHHHHHhcCee
Confidence 554 3444444221 023556666667789999999
Q ss_pred ccccccceeEeccCCCceEEEccCCcccc
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vkL~DFGla~~ 657 (902)
|+||.++||++..++ +.++||||+..
T Consensus 115 HGDLTtsNiIl~~~~---i~~IDfGLg~~ 140 (204)
T COG3642 115 HGDLTTSNIILSGGR---IYFIDFGLGEF 140 (204)
T ss_pred cCCCccceEEEeCCc---EEEEECCcccc
Confidence 999999999997654 77999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=7.5e-07 Score=103.41 Aligned_cols=242 Identities=17% Similarity=0.152 Sum_probs=161.1
Q ss_pred eeeecccCceEEEEEEeeCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCC-eeEecccccCccceeeeeccccCChhhH
Q 002601 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN-IVRWYGVESDQDFVYLSLERCTCSLNDL 556 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpN-IV~l~g~~~d~~~~yLV~E~c~~sL~dl 556 (902)
-..+++|+++.+++++-...+...++.+... . ..+=+.+|+...+||| .++.++-+..++..++++++|...-
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~--l-~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r--- 320 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--L-SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR--- 320 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc--h-hhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc---
Confidence 3458999999999875444455556655433 2 2222234789999999 8888888888899999999776430
Q ss_pred HHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccccccccccccccce
Q 002601 557 IYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 636 (902)
Q Consensus 557 iy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~N 636 (902)
+..... ... ...+...+...+.+.-++++++||+..=+||| |
T Consensus 321 ------s~~~~~--------~~s--------------------e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~ 362 (829)
T KOG0576|consen 321 ------SSALEM--------TVS--------------------EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----N 362 (829)
T ss_pred ------cccccC--------Chh--------------------hHhhhhhhhhhhhhhhcccccccccccccCcc----c
Confidence 000000 000 01122334567888899999999998889999 8
Q ss_pred eEeccCCCceEEEccCCccccccCCCccccccccCCCCccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCCCCch
Q 002601 637 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESF 716 (902)
Q Consensus 637 ILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf~~~~ 716 (902)
||..+.. .+..||+....+.... ...+..+|+.|+|||+.....+..+.|+|++|+-..++--| .+|-....
T Consensus 363 ~l~s~~~---~~~~~~~v~~~L~~~~----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~-~pPr~~P~ 434 (829)
T KOG0576|consen 363 ILGSEEE---VKLLDFAVPPQLTRTM----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG-LPPRSSPP 434 (829)
T ss_pred ccccccc---cccccccCCcccCccc----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC-CCCCCCCc
Confidence 8887643 6899999888776532 34566799999999999999999999999999866666665 44433311
Q ss_pred hhHHHHHhhccccc---c--ccCChHHHHHHHcccCCCCCCCcCHHHHHcCCCCCCcchhh
Q 002601 717 ERDANIVKDRKDLF---L--VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 772 (902)
Q Consensus 717 ~~~~~~~~~~~~~~---~--~~~~~e~~dLI~~~L~~dP~~Rpt~~elL~HPfF~~~~~~~ 772 (902)
.... .+......+ . .+...+-.++...|+..-|..|+...+++.|-+|..++.+.
T Consensus 435 ~~~~-~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~i 494 (829)
T KOG0576|consen 435 AVLP-MIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLRI 494 (829)
T ss_pred cccC-CCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCcccc
Confidence 1110 000000000 0 01111222577889999999999999999999997776553
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.2e-06 Score=104.24 Aligned_cols=67 Identities=12% Similarity=0.014 Sum_probs=58.4
Q ss_pred cCCCccccCCCCCccccccccccccccCCcCccccc-hhccC-CCccccccCCcccccCCCCCCCCCCC
Q 002601 244 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLPGSSQNSL 310 (902)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~fsG~I~-~L~~l-~L~~LNlsnN~fsG~IP~~~~~~~sf 310 (902)
.+++|++.|.+|..+..+.+|+.|.|.+|+|+|.|| .+..+ .|+.|||++|+|+|.||..+....++
T Consensus 424 ~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L 492 (623)
T PLN03150 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL 492 (623)
T ss_pred ECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCC
Confidence 578899999999999999999999999999999998 48888 69999999999999999655443333
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.04 E-value=9e-06 Score=83.84 Aligned_cols=48 Identities=23% Similarity=0.462 Sum_probs=35.4
Q ss_pred HHHHHhhhccccc-cccccccccccccceeEeccCCCceEEEccCCcccccc
Q 002601 609 LKVTRDIVSGLSH-LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (902)
Q Consensus 609 ~~I~~qIa~gL~y-LH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~ 659 (902)
..++.+++..+.. +|..||+|+||.+.|||++++ . +.|+|||.+....
T Consensus 109 ~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~--~~iIDf~qav~~~ 157 (188)
T PF01163_consen 109 KELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-K--VYIIDFGQAVDSS 157 (188)
T ss_dssp HHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-C--EEE--GTTEEETT
T ss_pred HHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-e--EEEEecCcceecC
Confidence 5567777775555 579999999999999999876 3 8899999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK11138 outer membrane biogenesis protein BamB; Provisional | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.0001 Score=84.84 Aligned_cols=110 Identities=16% Similarity=0.212 Sum_probs=77.0
Q ss_pred cceEEEecCceEEEEeccCceeeeeecCCCC--ccccc----c-cCCCCCCceEEEecCCCceEEEeccccCceEEeccC
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRP--IYSSY----Q-ASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSS 121 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (902)
|...+++-+|.|+.+|..+|+.+|++..+.. .++.. . .+..-+..-+|+-. .+..||--+..-|++.--. .
T Consensus 70 ~~vy~~~~~g~l~ald~~tG~~~W~~~~~~~~~~~~~~~~~~~~~~~~v~~~~v~v~~-~~g~l~ald~~tG~~~W~~-~ 147 (394)
T PRK11138 70 NKVYAADRAGLVKALDADTGKEIWSVDLSEKDGWFSKNKSALLSGGVTVAGGKVYIGS-EKGQVYALNAEDGEVAWQT-K 147 (394)
T ss_pred CEEEEECCCCeEEEEECCCCcEeeEEcCCCcccccccccccccccccEEECCEEEEEc-CCCEEEEEECCCCCCcccc-c
Confidence 4556677899999999999999999987651 11110 0 11111223455543 5677888888888864321 2
Q ss_pred HHHHHhhCcccccCCceeeeceeeeEEEEEcccccEEeee
Q 002601 122 AEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (902)
.+..+.-+|.+ .||.|+++....++.++|++||+++-.+
T Consensus 148 ~~~~~~ssP~v-~~~~v~v~~~~g~l~ald~~tG~~~W~~ 186 (394)
T PRK11138 148 VAGEALSRPVV-SDGLVLVHTSNGMLQALNESDGAVKWTV 186 (394)
T ss_pred CCCceecCCEE-ECCEEEEECCCCEEEEEEccCCCEeeee
Confidence 23345667888 5899999999999999999999999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=1.9e-05 Score=101.16 Aligned_cols=76 Identities=11% Similarity=0.107 Sum_probs=43.2
Q ss_pred cCCCccccCCCCCccccccccccccccCCcCccccch-hccC-CCccccccCCcccccCCCC----CCCCCCCcCCCCCC
Q 002601 244 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLP----GSSQNSLLGPVDRN 317 (902)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~fsG~I~~-L~~l-~L~~LNlsnN~fsG~IP~~----~~~~~sf~GN~~lc 317 (902)
.+|+|+++|.+|..+..+.+|+.+.+.+|+++|.+|. +..+ .|+.||+++|+|+|.||.. .+...++.||+.+|
T Consensus 529 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc 608 (968)
T PLN00113 529 DLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC 608 (968)
T ss_pred ECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCcccc
Confidence 3455555555555555555666666666666666653 4444 3666666666666666532 23345566777777
Q ss_pred CC
Q 002601 318 SP 319 (902)
Q Consensus 318 g~ 319 (902)
|+
T Consensus 609 ~~ 610 (968)
T PLN00113 609 GG 610 (968)
T ss_pred CC
Confidence 63
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=97.79 E-value=5.8e-05 Score=79.03 Aligned_cols=53 Identities=26% Similarity=0.456 Sum_probs=45.6
Q ss_pred HHHHHHHHhhhccccccccccccccccccceeEeccCC-CceEEEccCCccccc
Q 002601 606 AQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK-SFCAKLSDMGISKRL 658 (902)
Q Consensus 606 ~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~-~~~vkL~DFGla~~~ 658 (902)
.....++.+++..++-||+.||+|+|+++.|||++.++ ...+.++||+.++..
T Consensus 118 ~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 118 SQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 34578999999999999999999999999999998775 456889999977643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=5.9e-05 Score=80.69 Aligned_cols=133 Identities=18% Similarity=0.160 Sum_probs=82.6
Q ss_pred EEEeeeecccCceEEEEEEeeCCcEEEEEEeccC------------------C-------chHHHHHHHHHHHhCCC-CC
Q 002601 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT------------------H-------HDVALKEIQNLIASDQH-PN 528 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~------------------~-------~~~~~~Ei~~ll~~l~H-pN 528 (902)
..+++.||.|--+.||.+...+|..+|||.-+-. + ...+.+|++.|...-.+ -.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3467889999999999998889999999943210 0 12356677654333222 13
Q ss_pred eeEecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHH
Q 002601 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQL 608 (902)
Q Consensus 529 IV~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~ 608 (902)
+-+-++ .+...+|||+.++. .|... + ++....
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~----------eL~~~----------------r------------------~~~en~ 204 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGV----------ELYRL----------------R------------------LDVENP 204 (304)
T ss_pred CCCccc----cccceeeeehcccc----------eeecc----------------c------------------CcccCH
Confidence 444443 35668999965542 11110 0 001111
Q ss_pred HHHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCcccc
Q 002601 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (902)
Q Consensus 609 ~~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~ 657 (902)
..|+..|++-+..+-..||||+|+.+-||++++||. +.++||=.+..
T Consensus 205 ~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vIDwPQ~v~ 251 (304)
T COG0478 205 DEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVIDWPQAVP 251 (304)
T ss_pred HHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--EEEEeCccccc
Confidence 233334444444444789999999999999999987 78999965543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00028 Score=73.78 Aligned_cols=137 Identities=12% Similarity=0.099 Sum_probs=87.7
Q ss_pred ecccCceEEEEEEeeCCcEEEEEEecc---------CCchHHHHHHHHHHHh--CCCCCeeEecccccC----ccceeee
Q 002601 481 IAKGSNGTVVLEGNYEGRSVAVKRLVK---------THHDVALKEIQNLIAS--DQHPNIVRWYGVESD----QDFVYLS 545 (902)
Q Consensus 481 LG~GsfGtVy~a~~~~g~~VAVKrl~~---------~~~~~~~~Ei~~ll~~--l~HpNIV~l~g~~~d----~~~~yLV 545 (902)
-|+|+-+.|+. -..+|+.+=||+-.. .......+|+..+... ..=| +.+....... .-.-+||
T Consensus 26 ~~rgG~SgV~r-~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQC-VERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEE-EEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccceeeeeccCCceEEEEE
Confidence 35677778876 344566788887531 1224567787644332 2222 3333322111 1235899
Q ss_pred ecccc--CChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhccccccc
Q 002601 546 LERCT--CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 546 ~E~c~--~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+|-++ .+|.+++ .. |.....+......+..+++..++-||
T Consensus 104 Te~L~g~~~L~~~l-----------~~---------------------------~~~~~~~~~~k~~il~~va~~ia~LH 145 (216)
T PRK09902 104 TEDMAGFISIADWY-----------AQ---------------------------HAVSPYSDEVRQAMLKAVALAFKKMH 145 (216)
T ss_pred EEeCCCCccHHHHH-----------hc---------------------------CCcCCcchHHHHHHHHHHHHHHHHHH
Confidence 99666 2344332 11 11122344556789999999999999
Q ss_pred cccccccccccceeEeccCCCceEEEccCCcccc
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~ 657 (902)
+.|+.|+|+.+.|||++.++.+.++++||.-++.
T Consensus 146 ~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 146 SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 9999999999999999866767799999986654
|
|
| >PF13360 PQQ_2: PQQ-like domain; PDB: 3HXJ_B 1YIQ_A 1KV9_A 3Q54_A 2YH3_A 3PRW_A 3P1L_A 3Q7M_A 3Q7O_A 3Q7N_A | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00045 Score=72.92 Aligned_cols=153 Identities=24% Similarity=0.381 Sum_probs=102.7
Q ss_pred CceEEEEeccCceeeeeecCCCCcccccccCCCCCCceEEEecCCCceEEEeccccCceEEeccCHHHHHhhCcccccCC
Q 002601 57 DGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIRRMPYISKDG 136 (902)
Q Consensus 57 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (902)
+|+|+.+|..+|+.+|+...+.++ ..+...+..+.-++|.. ..+..||.-+..-|++.--. ++++-+...|.+ .+|
T Consensus 2 ~g~l~~~d~~tG~~~W~~~~~~~~-~~~~~~~~~~~~~v~~~-~~~~~l~~~d~~tG~~~W~~-~~~~~~~~~~~~-~~~ 77 (238)
T PF13360_consen 2 DGTLSALDPRTGKELWSYDLGPGI-GGPVATAVPDGGRVYVA-SGDGNLYALDAKTGKVLWRF-DLPGPISGAPVV-DGG 77 (238)
T ss_dssp TSEEEEEETTTTEEEEEEECSSSC-SSEEETEEEETTEEEEE-ETTSEEEEEETTTSEEEEEE-ECSSCGGSGEEE-ETT
T ss_pred CCEEEEEECCCCCEEEEEECCCCC-CCccceEEEeCCEEEEE-cCCCEEEEEECCCCCEEEEe-eccccccceeee-ccc
Confidence 799999999999999999876544 33333333344566666 68888999998889865333 335555555855 889
Q ss_pred ceeeeceeeeEEEEEcccccEEeeeccCCCCCCCCCCCCCCceeeccCCccccccccccccccccceeEEEeeeeeeecc
Q 002601 137 GVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQST 216 (902)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (902)
.|+++....++.++|++||+++...... .. +....... ..+.+. ...+.+..++..+-.+
T Consensus 78 ~v~v~~~~~~l~~~d~~tG~~~W~~~~~-~~--~~~~~~~~------------~~~~~~-----~~~~~~~~~~g~l~~~ 137 (238)
T PF13360_consen 78 RVYVGTSDGSLYALDAKTGKVLWSIYLT-SS--PPAGVRSS------------SSPAVD-----GDRLYVGTSSGKLVAL 137 (238)
T ss_dssp EEEEEETTSEEEEEETTTSCEEEEEEE--SS--CTCSTB--------------SEEEEE-----TTEEEEEETCSEEEEE
T ss_pred ccccccceeeeEecccCCcceeeeeccc-cc--cccccccc------------cCceEe-----cCEEEEEeccCcEEEE
Confidence 9999987779999999999999994111 10 11100000 001111 3456666668888889
Q ss_pred cCCCCcEEEEeeccchh
Q 002601 217 SQDSGEVLWNVAYADFK 233 (902)
Q Consensus 217 ~~~~~~~~~~~~~~~~~ 233 (902)
.+..|.++|.....+-.
T Consensus 138 d~~tG~~~w~~~~~~~~ 154 (238)
T PF13360_consen 138 DPKTGKLLWKYPVGEPR 154 (238)
T ss_dssp ETTTTEEEEEEESSTT-
T ss_pred ecCCCcEEEEeecCCCC
Confidence 99999999999885534
|
... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00023 Score=84.03 Aligned_cols=34 Identities=38% Similarity=0.592 Sum_probs=29.9
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccccccC
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~ 660 (902)
.|+.|.|.+|.||+++.+|. +.+.|||+...+..
T Consensus 284 dgffHaDpHpGNi~v~~~g~--i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGR--IVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCc--EEEEcCcceecCCH
Confidence 69999999999999998877 77999999876653
|
|
| >PRK11138 outer membrane biogenesis protein BamB; Provisional | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0012 Score=76.06 Aligned_cols=158 Identities=15% Similarity=0.194 Sum_probs=102.0
Q ss_pred cceEEEecCceEEEEeccCceeeeeecCCCCcccccccCCCCCCceEEEecCCCceEEEeccccCceE-EeccCHHHH--
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEY-- 125 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-- 125 (902)
|...|++-||++|.+|..||+++|++..+.+++++-... + -.+|+. ..+..||--+..-|++. +.....+.+
T Consensus 121 ~~v~v~~~~g~l~ald~~tG~~~W~~~~~~~~~ssP~v~---~-~~v~v~-~~~g~l~ald~~tG~~~W~~~~~~~~~~~ 195 (394)
T PRK11138 121 GKVYIGSEKGQVYALNAEDGEVAWQTKVAGEALSRPVVS---D-GLVLVH-TSNGMLQALNESDGAVKWTVNLDVPSLTL 195 (394)
T ss_pred CEEEEEcCCCEEEEEECCCCCCcccccCCCceecCCEEE---C-CEEEEE-CCCCEEEEEEccCCCEeeeecCCCCcccc
Confidence 445677889999999999999999999988876653332 1 245554 35678888888888865 343332222
Q ss_pred -HhhCcccccCCceeeeceeeeEEEEEcccccEEeeeccC-CCCCCCCCCCCCCceeeccCCccccccccccccccccce
Q 002601 126 -IRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLD-FSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQL 203 (902)
Q Consensus 126 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (902)
..-+|.+ .+|.+++|.....+.++|++||+++-.+... .... ... .+...+ . ..|.|. .-.
T Consensus 196 ~~~~sP~v-~~~~v~~~~~~g~v~a~d~~~G~~~W~~~~~~~~~~---~~~-~~~~~~--~-----~sP~v~-----~~~ 258 (394)
T PRK11138 196 RGESAPAT-AFGGAIVGGDNGRVSAVLMEQGQLIWQQRISQPTGA---TEI-DRLVDV--D-----TTPVVV-----GGV 258 (394)
T ss_pred cCCCCCEE-ECCEEEEEcCCCEEEEEEccCChhhheeccccCCCc---cch-hccccc--C-----CCcEEE-----CCE
Confidence 2357888 5778999999999999999999998776211 0000 000 000000 0 112211 124
Q ss_pred eEEEeeeeeeecccCCCCcEEEEee
Q 002601 204 VYIMRTDYVLQSTSQDSGEVLWNVA 228 (902)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (902)
|++.-.|=.|-.+.+.+|.++|...
T Consensus 259 vy~~~~~g~l~ald~~tG~~~W~~~ 283 (394)
T PRK11138 259 VYALAYNGNLVALDLRSGQIVWKRE 283 (394)
T ss_pred EEEEEcCCeEEEEECCCCCEEEeec
Confidence 6665555567777888999999854
|
|
| >TIGR03300 assembly_YfgL outer membrane assembly lipoprotein YfgL | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0014 Score=74.71 Aligned_cols=159 Identities=20% Similarity=0.230 Sum_probs=91.8
Q ss_pred cceEEEecCceEEEEeccCceeeeeecCCCCcccccccCCCCCCceEEEecCCCceEEEeccccCceE-EeccCHHHH--
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK-KLSSSAEEY-- 125 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-- 125 (902)
+...|++.||++|.+|..+|+++|++..+.+++++=.. +...+|+.+ .|..||.-+..-|+++ +.....+.+
T Consensus 106 ~~v~v~~~~g~l~ald~~tG~~~W~~~~~~~~~~~p~v----~~~~v~v~~-~~g~l~a~d~~tG~~~W~~~~~~~~~~~ 180 (377)
T TIGR03300 106 GLVFVGTEKGEVIALDAEDGKELWRAKLSSEVLSPPLV----ANGLVVVRT-NDGRLTALDAATGERLWTYSRVTPALTL 180 (377)
T ss_pred CEEEEEcCCCEEEEEECCCCcEeeeeccCceeecCCEE----ECCEEEEEC-CCCeEEEEEcCCCceeeEEccCCCceee
Confidence 34456667777777777777777777666555432111 122455543 4677888887777763 222211111
Q ss_pred -HhhCcccccCCceeeeceeeeEEEEEcccccEEeeeccCCCCCCCCCCCCCCceeeccCCcccccccccccccccccee
Q 002601 126 -IRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLV 204 (902)
Q Consensus 126 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (902)
...+|.+ .||.+++|+...+++++|++||+++-........ +....++...+ . ..|.+. ...|
T Consensus 181 ~~~~sp~~-~~~~v~~~~~~g~v~ald~~tG~~~W~~~~~~~~---g~~~~~~~~~~--~-----~~p~~~-----~~~v 244 (377)
T TIGR03300 181 RGSASPVI-ADGGVLVGFAGGKLVALDLQTGQPLWEQRVALPK---GRTELERLVDV--D-----GDPVVD-----GGQV 244 (377)
T ss_pred cCCCCCEE-ECCEEEEECCCCEEEEEEccCCCEeeeeccccCC---CCCchhhhhcc--C-----CccEEE-----CCEE
Confidence 1246776 5789999999899999999999998765211000 00000000000 0 011111 1256
Q ss_pred EEEeeeeeeecccCCCCcEEEEee
Q 002601 205 YIMRTDYVLQSTSQDSGEVLWNVA 228 (902)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~ 228 (902)
++...+-.+-.+.++.|..+|+..
T Consensus 245 y~~~~~g~l~a~d~~tG~~~W~~~ 268 (377)
T TIGR03300 245 YAVSYQGRVAALDLRSGRVLWKRD 268 (377)
T ss_pred EEEEcCCEEEEEECCCCcEEEeec
Confidence 666666667778888999999875
|
Members of this protein family are YfgL, a lipoprotein component of a complex that acts protein insertion into the bacterial outer membrane. Other members of this complex are NlpB, YfiO, and YaeT. This protein contains multiple copies of a repeat that, in other contexts, are associated with binding of the coenzyme PQQ. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00033 Score=87.04 Aligned_cols=153 Identities=22% Similarity=0.314 Sum_probs=103.9
Q ss_pred CCCCHHHHHHHHHhhhccccccccccccccccccc---eeEeccCCCceEEEc--cCCccccccCCCccccccccCCCCc
Q 002601 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQ---NVLISKDKSFCAKLS--DMGISKRLQGDMSCLTQNATGYGSS 675 (902)
Q Consensus 601 ~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp~---NILL~~d~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~Gt~ 675 (902)
..++....+.+..++..||+|+|+....|.-|..+ +--.+.++ ...++ ||+.++.+...... ....-+.
T Consensus 281 ~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~--~~~~sl~~~~ss~~l~d~~~~----~~~~~~~ 354 (1351)
T KOG1035|consen 281 GSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEG--VVAISLSDFDSSKPLPDNEKS----FSDLLAE 354 (1351)
T ss_pred cccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccc--eeecchhhhcccccCCCcccc----hhhcCcc
Confidence 45677888999999999999999997666665555 33333333 35555 88888776643221 2223456
Q ss_pred cccCchhhccCCCCC--cchhhhhHHHHHHHHhCCCCCCCCchhhHHHHHhhccccccccCChHHHHHHHcccCCCCCCC
Q 002601 676 GWQAPEQLLQGRQTR--AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753 (902)
Q Consensus 676 ~Y~APE~l~~~~~s~--ksDVwSlGviL~elltG~~~Pf~~~~~~~~~~~~~~~~~~~~~~~~e~~dLI~~~L~~dP~~R 753 (902)
.|.|+|......+.. ..|+|.+|.....+..|...+-.... .... .......+..+...+|+..++++|
T Consensus 355 ~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~--~~~~-------l~~~~~~~~~d~~~~~~~~~~~~R 425 (1351)
T KOG1035|consen 355 IRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV--PVSL-------LDVLSTSELLDALPKCLDEDSEER 425 (1351)
T ss_pred ccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc--hhhh-------hccccchhhhhhhhhhcchhhhhc
Confidence 688999887766554 47999999999999987443321110 0000 011111267889999999999999
Q ss_pred cCHHHHHcCCCCCCc
Q 002601 754 PKAQNVLNHPFFWTA 768 (902)
Q Consensus 754 pt~~elL~HPfF~~~ 768 (902)
+++.+++.|||....
T Consensus 426 l~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 426 LSALELLTHPFLRFP 440 (1351)
T ss_pred cchhhhhhchhcccc
Confidence 999999999997543
|
|
| >PF01011 PQQ: PQQ enzyme repeat family | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00049 Score=51.85 Aligned_cols=35 Identities=40% Similarity=0.634 Sum_probs=30.8
Q ss_pred ceEEEecCceEEEEeccCceeeeeecCCCCccccc
Q 002601 50 VALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSY 84 (902)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (902)
+..+++.||.||++|..||+.+|+|.++.+..+..
T Consensus 2 ~v~~~~~~g~l~AlD~~TG~~~W~~~~~~~~~~~p 36 (38)
T PF01011_consen 2 RVYVGTPDGYLYALDAKTGKVLWKFQTGPPVDSSP 36 (38)
T ss_dssp EEEEETTTSEEEEEETTTTSEEEEEESSSGGGSCB
T ss_pred EEEEeCCCCEEEEEECCCCCEEEeeeCCCCCccCc
Confidence 34677999999999999999999999999986654
|
; InterPro: IPR002372 Pyrrolo-quinoline quinone (PQQ) is a redox coenzyme, which serves as a cofactor for a number of enzymes (quinoproteins) and particularly for some bacterial dehydrogenases [, ]. A number of bacterial quinoproteins belong to this family. Enzymes in this group have repeats of a beta propeller.; PDB: 1H4I_C 1H4J_E 1W6S_A 2YH3_A 3PRW_A 3P1L_A 3Q7M_A 3Q7O_A 3Q7N_A 1G72_A .... |
| >PF13360 PQQ_2: PQQ-like domain; PDB: 3HXJ_B 1YIQ_A 1KV9_A 3Q54_A 2YH3_A 3PRW_A 3P1L_A 3Q7M_A 3Q7O_A 3Q7N_A | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0029 Score=66.73 Aligned_cols=107 Identities=22% Similarity=0.357 Sum_probs=77.6
Q ss_pred cceEEEecCceEEEEeccCceeeeeecCCCCcccccccCCCCCCceEEEecCCCceEEEeccccCceEEe-ccCHHH---
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKL-SSSAEE--- 124 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--- 124 (902)
+..++++-+|+||.+|..+|+.+|++..+.++... +..+...+|+-. .|..||.-+..-|++.-- ....++
T Consensus 37 ~~v~~~~~~~~l~~~d~~tG~~~W~~~~~~~~~~~----~~~~~~~v~v~~-~~~~l~~~d~~tG~~~W~~~~~~~~~~~ 111 (238)
T PF13360_consen 37 GRVYVASGDGNLYALDAKTGKVLWRFDLPGPISGA----PVVDGGRVYVGT-SDGSLYALDAKTGKVLWSIYLTSSPPAG 111 (238)
T ss_dssp TEEEEEETTSEEEEEETTTSEEEEEEECSSCGGSG----EEEETTEEEEEE-TTSEEEEEETTTSCEEEEEEE-SSCTCS
T ss_pred CEEEEEcCCCEEEEEECCCCCEEEEeeccccccce----eeeccccccccc-ceeeeEecccCCcceeeeeccccccccc
Confidence 44567789999999999999999999998887444 122333455555 344999988888988654 232211
Q ss_pred H-HhhCcccccCCceeeeceeeeEEEEEcccccEEeee
Q 002601 125 Y-IRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 125 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (902)
+ ...+|.+ .++.++++.....++++|++||+++-.+
T Consensus 112 ~~~~~~~~~-~~~~~~~~~~~g~l~~~d~~tG~~~w~~ 148 (238)
T PF13360_consen 112 VRSSSSPAV-DGDRLYVGTSSGKLVALDPKTGKLLWKY 148 (238)
T ss_dssp TB--SEEEE-ETTEEEEEETCSEEEEEETTTTEEEEEE
T ss_pred cccccCceE-ecCEEEEEeccCcEEEEecCCCcEEEEe
Confidence 1 2233334 4778999999999999999999999988
|
... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0015 Score=77.21 Aligned_cols=140 Identities=21% Similarity=0.174 Sum_probs=82.7
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCCch----------------------------------------HHHHHHH
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD----------------------------------------VALKEIQ 518 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~----------------------------------------~~~~Ei~ 518 (902)
+.||.-|.|.||+|.+.+|+.||||+-+..-.+ ...+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 579999999999999999999999986432100 0111222
Q ss_pred ---HHHHhCCCCC---eeEecccccC-ccceeeeeccccCC-hhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccc
Q 002601 519 ---NLIASDQHPN---IVRWYGVESD-QDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590 (902)
Q Consensus 519 ---~ll~~l~HpN---IV~l~g~~~d-~~~~yLV~E~c~~s-L~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e 590 (902)
.......|-+ =|..=.++++ .....|+||||++. +.|+-++.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~------------------------------ 296 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID------------------------------ 296 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH------------------------------
Confidence 1223344555 1222233333 34678999977752 44433221
Q ss_pred cchhHHHHhhCCCCHHHHHHHHHhhhcccc-ccccccccccccccceeEeccC--CCceEEEccCCccccccC
Q 002601 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLS-HLHEIGLIHRDLKPQNVLISKD--KSFCAKLSDMGISKRLQG 660 (902)
Q Consensus 591 ~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~-yLH~~~IvHrDLKp~NILL~~d--~~~~vkL~DFGla~~~~~ 660 (902)
..+++... |+..+.++.. -+-..|++|.|-+|.||+++++ +...+.+-|||+...+..
T Consensus 297 ---------~~gi~~~~---i~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 297 ---------KRGISPHD---ILNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---------HcCCCHHH---HHHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 12222221 2222222211 1123589999999999999853 456789999999887653
|
|
| >TIGR03300 assembly_YfgL outer membrane assembly lipoprotein YfgL | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0043 Score=70.83 Aligned_cols=106 Identities=17% Similarity=0.234 Sum_probs=80.8
Q ss_pred cceEEEecCceEEEEeccCceeeeeecCCCCcccccccCCCCCCceEEEecCCCceEEEeccccCceEEeccCHHHHHhh
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEEYIRR 128 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 128 (902)
|...+++-||+||.+|..+|+++|++..+.++.+ ++.-+.-.+|+.. .|..||.-+..-|++.--. ..+.-+.-
T Consensus 66 ~~v~v~~~~g~v~a~d~~tG~~~W~~~~~~~~~~----~p~v~~~~v~v~~-~~g~l~ald~~tG~~~W~~-~~~~~~~~ 139 (377)
T TIGR03300 66 GKVYAADADGTVVALDAETGKRLWRVDLDERLSG----GVGADGGLVFVGT-EKGEVIALDAEDGKELWRA-KLSSEVLS 139 (377)
T ss_pred CEEEEECCCCeEEEEEccCCcEeeeecCCCCccc----ceEEcCCEEEEEc-CCCEEEEEECCCCcEeeee-ccCceeec
Confidence 4457788899999999999999999999987633 2333344666654 4568888888788875432 23333455
Q ss_pred CcccccCCceeeeceeeeEEEEEcccccEEeee
Q 002601 129 MPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (902)
+|.+ .++.|+++.....+.++|++||+++-.+
T Consensus 140 ~p~v-~~~~v~v~~~~g~l~a~d~~tG~~~W~~ 171 (377)
T TIGR03300 140 PPLV-ANGLVVVRTNDGRLTALDAATGERLWTY 171 (377)
T ss_pred CCEE-ECCEEEEECCCCeEEEEEcCCCceeeEE
Confidence 6777 7889999998899999999999999988
|
Members of this protein family are YfgL, a lipoprotein component of a complex that acts protein insertion into the bacterial outer membrane. Other members of this complex are NlpB, YfiO, and YaeT. This protein contains multiple copies of a repeat that, in other contexts, are associated with binding of the coenzyme PQQ. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0018 Score=68.81 Aligned_cols=136 Identities=24% Similarity=0.219 Sum_probs=84.6
Q ss_pred eeeecccCceEEEEEEeeCCcEEEEEEeccCCc---------------------------hHHHHHHHHHHHhC-CCCCe
Q 002601 478 NKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---------------------------DVALKEIQNLIASD-QHPNI 529 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~---------------------------~~~~~Ei~~ll~~l-~HpNI 529 (902)
...|..|--..||+|...++..||||+...... .-..+|+.+|.+.- .+-.+
T Consensus 53 ~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 53 VGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred EeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 346888888999999888899999998753210 01244555443321 12222
Q ss_pred eEecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHH
Q 002601 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609 (902)
Q Consensus 530 V~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~ 609 (902)
-+-+++ ..-.||||+++.. |.-.-.| +..++...+..
T Consensus 133 P~Pi~~----~~nVLvMEfIg~~---------g~pAP~L------------------------------kDv~~e~~e~~ 169 (268)
T COG1718 133 PEPIAF----RNNVLVMEFIGDD---------GLPAPRL------------------------------KDVPLELEEAE 169 (268)
T ss_pred CCceee----cCCeEEEEeccCC---------CCCCCCc------------------------------ccCCcCchhHH
Confidence 233332 1236999955421 1111111 11222233556
Q ss_pred HHHHhhhcccccccc-ccccccccccceeEeccCCCceEEEccCCcccccc
Q 002601 610 KVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQ 659 (902)
Q Consensus 610 ~I~~qIa~gL~yLH~-~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~ 659 (902)
.+..++++.+.-|-. .++||+||..=|||+. ++. +.|+|||.|....
T Consensus 170 ~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~--p~iID~~QaV~~~ 217 (268)
T COG1718 170 GLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE--PYIIDVSQAVTID 217 (268)
T ss_pred HHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--EEEEECccccccC
Confidence 777788888877766 7999999999999998 444 7899999886554
|
|
| >cd00216 PQQ_DH Dehydrogenases with pyrrolo-quinoline quinone (PQQ) as cofactor, like ethanol, methanol, and membrane bound glucose dehydrogenases | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0075 Score=71.62 Aligned_cols=164 Identities=15% Similarity=0.194 Sum_probs=96.2
Q ss_pred cceEEEecCceEEEEeccCceeeeeecCCCCcccccc--cCCCCCCceEEEec--------CCCceEEEeccccCceEE-
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQ--ASFNSNASEFYLDV--------DEDWELYFHSKRFGKMKK- 117 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~- 117 (902)
|...+++.||.|+++|..||+.+|++..+.++--.|. .++.-..-.+|+-. ..+..||--+..-|++.=
T Consensus 111 ~~V~v~~~~g~v~AlD~~TG~~~W~~~~~~~~~~~~~i~ssP~v~~~~v~vg~~~~~~~~~~~~g~v~alD~~TG~~~W~ 190 (488)
T cd00216 111 RKVFFGTFDGRLVALDAETGKQVWKFGNNDQVPPGYTMTGAPTIVKKLVIIGSSGAEFFACGVRGALRAYDVETGKLLWR 190 (488)
T ss_pred CeEEEecCCCeEEEEECCCCCEeeeecCCCCcCcceEecCCCEEECCEEEEeccccccccCCCCcEEEEEECCCCceeeE
Confidence 7888999999999999999999999998876300110 11111112344432 345677877777777542
Q ss_pred eccCHHH-H------------------HhhCcccc-cCCceeeecee------------------eeEEEEEcccccEEe
Q 002601 118 LSSSAEE-Y------------------IRRMPYIS-KDGGVTLGAMK------------------TSVFLVDVKSGRVVD 159 (902)
Q Consensus 118 ~~~~~~~-~------------------~~~~~~~~-~~~~~~~~~~~------------------~~~~~~~~~~~~~~~ 159 (902)
.....++ . |--+|.+. .+|.|++|+-. .+++++|++||+++-
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~g~~vw~~pa~d~~~g~V~vg~~~g~~~~~~~~~~~~~~~~~~~l~Ald~~tG~~~W 270 (488)
T cd00216 191 FYTTEPDPNAFPTWGPDRQMWGPGGGTSWASPTYDPKTNLVYVGTGNGSPWNWGGRRTPGDNLYTDSIVALDADTGKVKW 270 (488)
T ss_pred eeccCCCcCCCCCCCCCcceecCCCCCccCCeeEeCCCCEEEEECCCCCCCccCCccCCCCCCceeeEEEEcCCCCCEEE
Confidence 1111110 0 11145554 46889999743 389999999999999
Q ss_pred eec---cCC-C---CCCCCCCCCCCceeeccCCccccccccccccccccceeEEEeeeeeeecccCCCCcEEEEeecc
Q 002601 160 NYV---LDF-S---ASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYA 230 (902)
Q Consensus 160 ~~~---~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (902)
.|. +|. + .+.|.. . +-. .--..++.+|++-=.+=.+--+.+..|+++|.....
T Consensus 271 ~~~~~~~~~~~~~~~s~p~~--------~---------~~~-~~~g~~~~~V~~g~~~G~l~ald~~tG~~~W~~~~~ 330 (488)
T cd00216 271 FYQTTPHDLWDYDGPNQPSL--------A---------DIK-PKDGKPVPAIVHAPKNGFFYVLDRTTGKLISARPEV 330 (488)
T ss_pred EeeCCCCCCcccccCCCCeE--------E---------ecc-ccCCCeeEEEEEECCCceEEEEECCCCcEeeEeEee
Confidence 982 222 1 111110 0 000 000122345555434444666778899999987654
|
The alignment model contains an 8-bladed beta-propeller. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0064 Score=64.69 Aligned_cols=70 Identities=11% Similarity=0.033 Sum_probs=44.6
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCCc-hHHHHHHHHHHHhCCCC--CeeEecccccCccceeeeeccccCC
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHP--NIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~-~~~~~Ei~~ll~~l~Hp--NIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
..||+|..+.||+. .|..+++|....... ....+|.+. +..+..- .+.+.+++..+.+...+|||++.+.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~~~~i~~E~~~-l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFDKETIKREFDA-SRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCCCHHHHHHHHHH-HHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 46899999999973 355677888755332 334555543 3333221 2345566666777788999998873
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0042 Score=64.80 Aligned_cols=72 Identities=14% Similarity=0.135 Sum_probs=42.3
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCC-chHHHHHHHHHHHhCC-C-CCeeEecccc---cCccceeeeeccccCC
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-HDVALKEIQNLIASDQ-H-PNIVRWYGVE---SDQDFVYLSLERCTCS 552 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~-~~~~~~Ei~~ll~~l~-H-pNIV~l~g~~---~d~~~~yLV~E~c~~s 552 (902)
+.|+.|..+.||+....+ ..+++|...... .....+|.. ++..+. | ..+.+++.++ ......+++|+++++.
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~~~~~~~~~e~~-~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPPDAAERLRREAA-VLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSHHHHHHHHHHHH-HHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCCCCHHHHHHHHH-HHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 568999999999977666 689999876541 123333433 222221 1 1344555433 2233468999988874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.0067 Score=63.88 Aligned_cols=43 Identities=28% Similarity=0.516 Sum_probs=35.6
Q ss_pred HHHhhhccccccccccccccccccceeEeccCCCceEEEccCCccc
Q 002601 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656 (902)
Q Consensus 611 I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~ 656 (902)
+...++.++.-||+.|+.|+|.+|.|++++.++ ++++||+..+
T Consensus 140 ~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k~ 182 (229)
T PF06176_consen 140 LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGKR 182 (229)
T ss_pred HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECcccc
Confidence 345566778899999999999999999998654 7899998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.61 E-value=0.0074 Score=64.49 Aligned_cols=71 Identities=13% Similarity=0.026 Sum_probs=41.8
Q ss_pred ecccCc-eEEEEEEeeCCcEEEEEEeccCCchHHHHHHHHHHHhCCCCCeeEecccccCccceeeeeccccCC
Q 002601 481 IAKGSN-GTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 481 LG~Gsf-GtVy~a~~~~g~~VAVKrl~~~~~~~~~~Ei~~ll~~l~HpNIV~l~g~~~d~~~~yLV~E~c~~s 552 (902)
|-.|.. ..||+... ++..+.||+..........+|...+...-.+--+.+++++..+.+.-++|||++++.
T Consensus 6 ~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG-KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC-CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 334444 67887654 346788888755422334455553322222333556677666666789999988763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.0079 Score=62.69 Aligned_cols=129 Identities=19% Similarity=0.271 Sum_probs=83.3
Q ss_pred eeecccCceEEEEEEeeCCcEEEEEEeccCC-------------------chHHHHHHHHHH-----HhCCCCCeeEecc
Q 002601 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-------------------HDVALKEIQNLI-----ASDQHPNIVRWYG 534 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~-------------------~~~~~~Ei~~ll-----~~l~HpNIV~l~g 534 (902)
..||+|+.-.||. ..+.....||+..... ..+..+|+.... ....+.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4599999999995 3455667888876554 345556665322 2345889999999
Q ss_pred cccCccceeeeeccccCChhhHHHHhcCC----hhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHH
Q 002601 535 VESDQDFVYLSLERCTCSLNDLIYVLSGS----FEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610 (902)
Q Consensus 535 ~~~d~~~~yLV~E~c~~sL~dliy~~~Gs----L~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~ 610 (902)
+.+.+.-.-+|+|.... ..|+ |.+++ +...++. .
T Consensus 85 ~veT~~G~Glv~e~I~d--------~dG~~s~TL~~~l------------------------------~~~~~~~-~--- 122 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRD--------ADGNISPTLEDYL------------------------------KEGGLTE-E--- 122 (199)
T ss_pred EEecCCceEEEEEEEEC--------CCCCcCccHHHHH------------------------------HcCCccH-H---
Confidence 99998888999996642 1222 22222 1122332 2
Q ss_pred HHHhhhccccccccccccccccccceeEeccCC--CceEEEcc
Q 002601 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK--SFCAKLSD 651 (902)
Q Consensus 611 I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~--~~~vkL~D 651 (902)
+...+-+-.+||-+++|+.+||+|.||++...+ ...+.|+|
T Consensus 123 ~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 123 LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 233333445677888999999999999996543 22466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd00216 PQQ_DH Dehydrogenases with pyrrolo-quinoline quinone (PQQ) as cofactor, like ethanol, methanol, and membrane bound glucose dehydrogenases | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.014 Score=69.34 Aligned_cols=129 Identities=14% Similarity=0.066 Sum_probs=82.8
Q ss_pred ceEEEecCceEEEEeccCceeeeeecCC-CCcccccccCCCCCCceEEEec-----------------CCCceEEEeccc
Q 002601 50 VALVAALDGTIHLVDTKLGKIRWSFGTG-RPIYSSYQASFNSNASEFYLDV-----------------DEDWELYFHSKR 111 (902)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~ 111 (902)
+.++++-+|.+|.+|..+|+++|++..+ .++ .. +...+|+.- +.+..|+--+..
T Consensus 303 ~V~~g~~~G~l~ald~~tG~~~W~~~~~~~~~-------~~-~~~~vyv~~~~~~~~~~~~~~~~~~~~~~G~l~AlD~~ 374 (488)
T cd00216 303 AIVHAPKNGFFYVLDRTTGKLISARPEVEQPM-------AY-DPGLVYLGAFHIPLGLPPQKKKRCKKPGKGGLAALDPK 374 (488)
T ss_pred EEEEECCCceEEEEECCCCcEeeEeEeecccc-------cc-CCceEEEccccccccCcccccCCCCCCCceEEEEEeCC
Confidence 5677889999999999999999999865 222 11 114566632 235677777777
Q ss_pred cCceEEeccCHHH---------HHhhCcccccCCceeeeceeeeEEEEEcccccEEeeeccCCCCCCCCC--CCCCCcee
Q 002601 112 FGKMKKLSSSAEE---------YIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGF--QSDENKHV 180 (902)
Q Consensus 112 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 180 (902)
-|+++==. .... ...-+|..-.+|.|+.|+....++++|++||+++-.+-......+++. ..+.+.-+
T Consensus 375 tG~~~W~~-~~~~~~~~~~~g~~~~~~~~~~~g~~v~~g~~dG~l~ald~~tG~~lW~~~~~~~~~a~P~~~~~~g~~yv 453 (488)
T cd00216 375 TGKVVWEK-REGTIRDSWNIGFPHWGGSLATAGNLVFAGAADGYFRAFDATTGKELWKFRTPSGIQATPMTYEVNGKQYV 453 (488)
T ss_pred CCcEeeEe-eCCccccccccCCcccCcceEecCCeEEEECCCCeEEEEECCCCceeeEEECCCCceEcCEEEEeCCEEEE
Confidence 78754211 1110 011234444789999999999999999999999999933333333333 33545555
Q ss_pred eccCCcc
Q 002601 181 VPVDGYE 187 (902)
Q Consensus 181 ~~~~~~~ 187 (902)
...++-.
T Consensus 454 ~~~~g~~ 460 (488)
T cd00216 454 GVMVGGG 460 (488)
T ss_pred EEEecCC
Confidence 5444433
|
The alignment model contains an 8-bladed beta-propeller. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.15 E-value=0.034 Score=61.65 Aligned_cols=74 Identities=18% Similarity=0.035 Sum_probs=46.4
Q ss_pred EeeeecccCceEEEEEEeeCCcEEEEEEeccC-CchHHHHHHHHHHHhCCC--CCeeEecccccC---ccceeeeecccc
Q 002601 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKT-HHDVALKEIQNLIASDQH--PNIVRWYGVESD---QDFVYLSLERCT 550 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~-~~~~~~~Ei~~ll~~l~H--pNIV~l~g~~~d---~~~~yLV~E~c~ 550 (902)
-.+.||.|..+.||.....+|+ +.||..+.. .......|...+...-.+ -.+.+.+++|.+ .+..+||||+++
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~ 96 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLR 96 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccC
Confidence 3467999999999986655564 566764432 233556666544332222 245566665543 466899999887
Q ss_pred C
Q 002601 551 C 551 (902)
Q Consensus 551 ~ 551 (902)
+
T Consensus 97 G 97 (297)
T PRK10593 97 G 97 (297)
T ss_pred C
Confidence 5
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.036 Score=58.68 Aligned_cols=31 Identities=26% Similarity=0.372 Sum_probs=25.5
Q ss_pred cccccccccccceeEecc-CCCceEEEccCCccc
Q 002601 624 EIGLIHRDLKPQNVLISK-DKSFCAKLSDMGISK 656 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~-d~~~~vkL~DFGla~ 656 (902)
...++|+|+.+.|||++. ++. +.++||..|.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~--~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNS--VKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCC--EEEEEcccCC
Confidence 347999999999999986 344 7899998664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.06 Score=68.11 Aligned_cols=74 Identities=14% Similarity=0.192 Sum_probs=48.4
Q ss_pred eeeecccCceEEEEEEeeCC---cEEEEEEeccC----CchHHHHHHHHHHHhC-CCCCe--eEecccccCc---cceee
Q 002601 478 NKEIAKGSNGTVVLEGNYEG---RSVAVKRLVKT----HHDVALKEIQNLIASD-QHPNI--VRWYGVESDQ---DFVYL 544 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~~g---~~VAVKrl~~~----~~~~~~~Ei~~ll~~l-~HpNI--V~l~g~~~d~---~~~yL 544 (902)
.+.++.|.+..+|+....++ ..+++|+.... ......+|...+ ..+ .|.++ .+.+++|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l-~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVL-RALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHH-HHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 36789999999998654443 36777775332 123455676544 444 35554 6778887764 45789
Q ss_pred eeccccCC
Q 002601 545 SLERCTCS 552 (902)
Q Consensus 545 V~E~c~~s 552 (902)
|||++++.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99998874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.84 E-value=0.043 Score=57.20 Aligned_cols=39 Identities=33% Similarity=0.573 Sum_probs=31.5
Q ss_pred HHHHhhhccccccccccccccccccceeEeccCCCceEEEccCCcc
Q 002601 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655 (902)
Q Consensus 610 ~I~~qIa~gL~yLH~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla 655 (902)
+=+.+|.+-|..+|..||+-+|+++.|.. +| ||+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~G----~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKLGIVPRDVKPRNYR---GG----KLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHCCeeeccCcccccc---CC----EEEecccC
Confidence 34566777788899999999999999976 33 59999964
|
|
| >TIGR03074 PQQ_membr_DH membrane-bound PQQ-dependent dehydrogenase, glucose/quinate/shikimate family | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.05 Score=67.55 Aligned_cols=112 Identities=19% Similarity=0.250 Sum_probs=78.6
Q ss_pred CcceEEEecCceEEEEeccCceeeeeecCCCCcccccccCC----------------------CCCCceEEEecCCCceE
Q 002601 48 PDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASF----------------------NSNASEFYLDVDEDWEL 105 (902)
Q Consensus 48 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~ 105 (902)
-|+..+++.+|.||++|..||+.+|+|..+.++-+.++... ....--+|+... |..|
T Consensus 194 gg~lYv~t~~~~V~ALDa~TGk~lW~~d~~~~~~~~~~~~~cRGvay~~~p~~~~~~~~~~~p~~~~~rV~~~T~-Dg~L 272 (764)
T TIGR03074 194 GDTLYLCTPHNKVIALDAATGKEKWKFDPKLKTEAGRQHQTCRGVSYYDAPAAAAGPAAPAAPADCARRIILPTS-DARL 272 (764)
T ss_pred CCEEEEECCCCeEEEEECCCCcEEEEEcCCCCcccccccccccceEEecCCcccccccccccccccCCEEEEecC-CCeE
Confidence 36778889999999999999999999999988633222100 111124555433 6778
Q ss_pred EEeccccCceEE-ec------cC--H-----HH-HHhhCcccccCCceeeece----------eeeEEEEEcccccEEee
Q 002601 106 YFHSKRFGKMKK-LS------SS--A-----EE-YIRRMPYISKDGGVTLGAM----------KTSVFLVDVKSGRVVDN 160 (902)
Q Consensus 106 ~~~~~~~~~~~~-~~------~~--~-----~~-~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~ 160 (902)
|--+..-|++.- +. |. + .. .+--+|.| .||.|++|+- ...+.+.|++||+++-.
T Consensus 273 iALDA~TGk~~W~fg~~G~vdl~~~~g~~~~g~~~~ts~P~V-~~g~VIvG~~v~d~~~~~~~~G~I~A~Da~TGkl~W~ 351 (764)
T TIGR03074 273 IALDADTGKLCEDFGNNGTVDLTAGMGTTPPGYYYPTSPPLV-AGTTVVIGGRVADNYSTDEPSGVIRAFDVNTGALVWA 351 (764)
T ss_pred EEEECCCCCEEEEecCCCceeeecccCcCCCcccccccCCEE-ECCEEEEEecccccccccCCCcEEEEEECCCCcEeeE
Confidence 888888888772 11 11 1 11 34567888 6888999963 45689999999999988
Q ss_pred e
Q 002601 161 Y 161 (902)
Q Consensus 161 ~ 161 (902)
+
T Consensus 352 ~ 352 (764)
T TIGR03074 352 W 352 (764)
T ss_pred E
Confidence 8
|
This protein family has a phylogenetic distribution very similar to that coenzyme PQQ biosynthesis enzymes, as shown by partial phylogenetic profiling. Members of this family have several predicted transmembrane helices in the N-terminal region, and include the quinoprotein glucose dehydrogenase (EC 1.1.5.2) of Escherichia coli and the quinate/shikimate dehydrogenase of Acinetobacter sp. ADP1 (EC 1.1.99.25). Sequences closely related except for the absense of the N-terminal hydrophobic region, scoring in the gray zone between the trusted and noise cutoffs, include PQQ-dependent glycerol (EC 1.1.99.22) and and other polyol (sugar alcohol) dehydrogenases. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.067 Score=61.66 Aligned_cols=71 Identities=24% Similarity=0.251 Sum_probs=45.8
Q ss_pred eeecccCceEEEEEEeeCC-cEEEEEEecc------C----CchHHHHHHHHHHHh--CCCCCeeEecccccCccceeee
Q 002601 479 KEIAKGSNGTVVLEGNYEG-RSVAVKRLVK------T----HHDVALKEIQNLIAS--DQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~g-~~VAVKrl~~------~----~~~~~~~Ei~~ll~~--l~HpNIV~l~g~~~d~~~~yLV 545 (902)
+.||.|.+..||+....+| +.|.||.-.. . ..+....|...+... ..-.++.+++++ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999877776 5899997321 1 112334444433322 223456677766 44567899
Q ss_pred eccccC
Q 002601 546 LERCTC 551 (902)
Q Consensus 546 ~E~c~~ 551 (902)
||+++.
T Consensus 110 ME~L~~ 115 (401)
T PRK09550 110 MEDLSD 115 (401)
T ss_pred EecCCC
Confidence 998875
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.60 E-value=0.036 Score=56.33 Aligned_cols=125 Identities=20% Similarity=0.285 Sum_probs=71.4
Q ss_pred EeeeecccCceEEEEEEeeCCcEEEEEEeccCCchH-HHHHHHHHHHhCCCCCee-EecccccCccceeeeeccccCChh
Q 002601 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIV-RWYGVESDQDFVYLSLERCTCSLN 554 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~~~g~~VAVKrl~~~~~~~-~~~Ei~~ll~~l~HpNIV-~l~g~~~d~~~~yLV~E~c~~sL~ 554 (902)
..+.||+|.+|.||++. +.|..+|+|+-....... ..+|.+ ++..+.-.++- ++|.|-. -.+.||
T Consensus 26 v~~~L~KG~~s~Vyl~~-~~~~~~a~Kvrr~ds~r~~l~kEak-iLeil~g~~~~p~vy~yg~----~~i~me------- 92 (201)
T COG2112 26 VEKELAKGTTSVVYLGE-WRGGEVALKVRRRDSPRRNLEKEAK-ILEILAGEGVTPEVYFYGE----DFIRME------- 92 (201)
T ss_pred hhhhhhcccccEEEEee-ccCceEEEEEecCCcchhhHHHHHH-HHHHhhhcCCCceEEEech----hhhhhh-------
Confidence 34679999999999855 456689999765544333 344443 44555444443 4444422 245599
Q ss_pred hHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHhhCCCCHHHHHHHHHhhhcccccccccccccccccc
Q 002601 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKP 634 (902)
Q Consensus 555 dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH~~~IvHrDLKp 634 (902)
|+.+-.|.+.-... + .+-...+++.---|-..||-|..|.-
T Consensus 93 ---~i~G~~L~~~~~~~--------------------------------~----rk~l~~vlE~a~~LD~~GI~H~El~~ 133 (201)
T COG2112 93 ---YIDGRPLGKLEIGG--------------------------------D----RKHLLRVLEKAYKLDRLGIEHGELSR 133 (201)
T ss_pred ---hhcCcchhhhhhcc--------------------------------c----HHHHHHHHHHHHHHHHhccchhhhcC
Confidence 44444443322110 1 11222333332234456888988864
Q ss_pred --ceeEeccCCCceEEEccCCccc
Q 002601 635 --QNVLISKDKSFCAKLSDMGISK 656 (902)
Q Consensus 635 --~NILL~~d~~~~vkL~DFGla~ 656 (902)
.||++.. +. +.|+||..|+
T Consensus 134 ~~k~vlv~~-~~--~~iIDFd~At 154 (201)
T COG2112 134 PWKNVLVND-RD--VYIIDFDSAT 154 (201)
T ss_pred CceeEEecC-Cc--EEEEEccchh
Confidence 4666644 33 7899999876
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.0078 Score=46.91 Aligned_cols=36 Identities=14% Similarity=0.102 Sum_probs=29.8
Q ss_pred cccccccccCCcCccccch-hccC-CCccccccCCcccc
Q 002601 262 GDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAG 298 (902)
Q Consensus 262 ~~l~~~~l~nN~fsG~I~~-L~~l-~L~~LNlsnN~fsG 298 (902)
++|+.+.+.+|+++ .||. +.++ .|+.||+++|+++-
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~ 38 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISD 38 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSB
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCC
Confidence 47899999999999 6877 9999 49999999999884
|
... |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.26 E-value=0.021 Score=69.13 Aligned_cols=176 Identities=17% Similarity=0.116 Sum_probs=121.4
Q ss_pred ceEEEecCceEEEEeccCceeeeeecCCCCcccccccCCC----------CCCceEEEecCCCceEEEeccccCceEEec
Q 002601 50 VALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFN----------SNASEFYLDVDEDWELYFHSKRFGKMKKLS 119 (902)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (902)
+-...+.++..|+||.+||+..|-|++..||++.+++... ...-=.|.++.++|..|+.+.+.+++.-+.
T Consensus 109 i~ysg~k~d~~~lvD~~tg~~~~tf~~~~~~~~~v~~grt~ytv~m~d~~~~~~~wn~t~~dy~a~~~~~~~~~~~~~~~ 188 (903)
T KOG1027|consen 109 ILYSGSKQDIWYLVDPKTGEIDYTFNTAEPIKQLVYLGRTNYTVTMYDKNVRGKTWNTTFGDYSAQYPSGVRGEKMSHFH 188 (903)
T ss_pred eEEecccccceEEecCCccceeEEEecCCcchhheecccceeEEecccCcccCceeeccccchhccCCCccCCceeEEEe
Confidence 4467788999999999999999999999999999988632 122367999999999999999999999998
Q ss_pred cCHHHHHhhCcccccCCceeeeceeeeEEEEEcccccEEeeeccCCCCCCCCCCCCCCceeeccCCcccccc-------c
Q 002601 120 SSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVE-------S 192 (902)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 192 (902)
..--+|+--.++-|. -.+-+|-+.+.+++++-+++--++.+.++. -++++.+.+....-..+.+ +
T Consensus 189 ~~~~g~i~t~D~~~g-~~~~~q~~~spvv~~~~~~~~gl~~~~~~~-------v~~~t~~~~~~~~~~v~~~~~~~~~~s 260 (903)
T KOG1027|consen 189 SLGNGYIVTVDSESG-EKLWLQDLLSPVVALYTLFNDGLHSYPFVT-------VARETYQINALESGTVLLNIAPTKDES 260 (903)
T ss_pred ecCCccEEeccCccc-ceeeccccCCceEEEEeeccCceeeeccee-------hhHHHHHHHHhhccccccccCCCcCcc
Confidence 776777655555432 246688888889999888888888874331 1222222221111111111 1
Q ss_pred cccccccccceeEEEeeeeeeecccCCCCcEEEEeeccchhh
Q 002601 193 GVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNVAYADFKA 234 (902)
Q Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (902)
.....-+.+.+..|++-|+.+.=|.- =++|-||+++..-.+
T Consensus 261 ~~~s~~~~~~~~~l~~~~~~~~l~~~-~~~v~~~v~~~~~~~ 301 (903)
T KOG1027|consen 261 PLESSLDFQLLPTLYVGDSSTGLYAS-FSLVHQNVPLVPRAA 301 (903)
T ss_pred ccccccccccceeeEecCceeeEEee-hhhcccCceeccCCC
Confidence 11222356677888888888776653 345588887766544
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.0095 Score=76.04 Aligned_cols=150 Identities=13% Similarity=0.020 Sum_probs=102.0
Q ss_pred HhCCCCCeeEeccccc--CccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHHh
Q 002601 522 ASDQHPNIVRWYGVES--DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWK 599 (902)
Q Consensus 522 ~~l~HpNIV~l~g~~~--d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~~ 599 (902)
+...|+++++.+.-.. +..+.|.+++ |...|.+.+.+...-+....
T Consensus 1284 ~~~~h~~~~~~p~rI~ps~s~ee~~r~~----------~~~~g~~f~iIikg~ee~~~---------------------- 1331 (2724)
T KOG1826|consen 1284 REAKHYLTEVDPLRIPPSESTEEYIRSL----------YVEFGKLFSIIIKGLEESPD---------------------- 1331 (2724)
T ss_pred hhhhceeeecccccCCCCCChHHHHHHH----------HHHHhHHHHHHHhccccCCc----------------------
Confidence 3457999988776543 3445678888 66778877776544332211
Q ss_pred hCCCCHHHHHHHHHhhhccccccccc-----cccccccccceeEeccCCCceEEEccCCccccccCCCccccccccCCCC
Q 002601 600 ANGHPSAQLLKVTRDIVSGLSHLHEI-----GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674 (902)
Q Consensus 600 ~~~l~~~~~~~I~~qIa~gL~yLH~~-----~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~~~~~~~~~~~~~~~Gt 674 (902)
++..-+.....+.+.+..-+|+. --+|++||+.|.+|..+ ..+|++++|+.+...... .......++
T Consensus 1332 ---ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtn--y~v~~gk~gLdKIknp~~---sf~Gl~l~s 1403 (2724)
T KOG1826|consen 1332 ---LDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTN--YNVKLGKGGLDKIKNPVL---SFFGLELCS 1403 (2724)
T ss_pred ---chhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecC--CcccccccccccccCchH---hhhhhhhCC
Confidence 11222233344446666666654 27899999999999544 459999999998433321 222345678
Q ss_pred ccccCchhhccCCCCCcchhhhhHHHHHHHHhCCCCCC
Q 002601 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712 (902)
Q Consensus 675 ~~Y~APE~l~~~~~s~ksDVwSlGviL~elltG~~~Pf 712 (902)
+-|++|++...-.++.++|+|..|+.+|+.-.| ..+|
T Consensus 1404 p~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~-n~~f 1440 (2724)
T KOG1826|consen 1404 PIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG-NAYF 1440 (2724)
T ss_pred HHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc-cHHH
Confidence 889999999888899999999999999987765 4444
|
|
| >smart00564 PQQ beta-propeller repeat | Back alignment and domain information |
|---|
Probab=95.08 E-value=0.028 Score=40.38 Aligned_cols=26 Identities=35% Similarity=0.709 Sum_probs=23.5
Q ss_pred ceEEEecCceEEEEeccCceeeeeec
Q 002601 50 VALVAALDGTIHLVDTKLGKIRWSFG 75 (902)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 75 (902)
...+++.||.||.+|..+|+++|++.
T Consensus 8 ~v~~~~~~g~l~a~d~~~G~~~W~~~ 33 (33)
T smart00564 8 TVYVGSTDGTLYALDAKTGEILWTYK 33 (33)
T ss_pred EEEEEcCCCEEEEEEcccCcEEEEcC
Confidence 55788999999999999999999974
|
Beta-propeller repeat occurring in enzymes with pyrrolo-quinoline quinone (PQQ) as cofactor, in Ire1p-like Ser/Thr kinases, and in prokaryotic dehydrogenases. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.027 Score=58.27 Aligned_cols=97 Identities=20% Similarity=0.125 Sum_probs=68.0
Q ss_pred HHHhCCC-CCeeEecccccCccceeeeeccccCChhhHHHHhcCChhHHhhhhhcccchhHHHHhhhccccccchhHHHH
Q 002601 520 LIASDQH-PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 598 (902)
Q Consensus 520 ll~~l~H-pNIV~l~g~~~d~~~~yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~r~~~~~e~~~~~~~~ 598 (902)
++..+.+ +++.+++|+|-+ ++|.|+. ..+++...-. .+ -
T Consensus 12 ll~~l~~~~~~pk~lG~CG~----~~v~E~~----------~~~~~~~~~~-------~l-------------------~ 51 (188)
T PF12260_consen 12 LLQLLQGSEPFPKLLGSCGR----FYVVEYV----------GAGSLYGIYR-------PL-------------------S 51 (188)
T ss_pred HHHHcCCCCCCCCeeeECCC----EEEEEee----------cCcccccccc-------cc-------------------c
Confidence 5566655 699999999965 5788944 3333321100 00 0
Q ss_pred hhCCCCHHHHHHHHHhhhccccccccc---cccccccccceeEeccCCCceEEEccCCccccc
Q 002601 599 KANGHPSAQLLKVTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658 (902)
Q Consensus 599 ~~~~l~~~~~~~I~~qIa~gL~yLH~~---~IvHrDLKp~NILL~~d~~~~vkL~DFGla~~~ 658 (902)
.-...+|..+.+|+.++++.+++|+.. .+.-.|++++|+-+++++. +|++|...+...
T Consensus 52 ~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~--lk~iDld~v~~~ 112 (188)
T PF12260_consen 52 QFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGR--LKLIDLDDVFVE 112 (188)
T ss_pred cccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCc--EEEEechhcchh
Confidence 001246778899999999999999973 5777999999999998876 999999866443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF14593 PH_3: PH domain; PDB: 1W1H_D 1W1D_A 1W1G_A 2VKI_A | Back alignment and domain information |
|---|
Probab=95.01 E-value=8.4e-05 Score=68.86 Aligned_cols=87 Identities=22% Similarity=0.330 Sum_probs=67.7
Q ss_pred cchHHHh-HHHHHhhh--hcccCCcchHHHHHHHhccccCcccCCCHHHHHHhCCCC---------CcccccccccCCc-
Q 002601 808 KWDEKME-TKFIENIG--RYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHP---------EGFYNYFSCRFPK- 874 (902)
Q Consensus 808 ~w~~~~~-~~l~~~~~--~~R~y~~~~vrdLLr~irnk~~h~~el~~~~~~~~G~~p---------~~f~~yf~~~fP~- 874 (902)
+|+..++ .+.+-.++ ..|+..+.+-|+|+.+-++ |+.+++++.+++.|++| .++..|+.+ +|+
T Consensus 2 ~w~~fl~~ge~Il~~g~v~K~kgl~~kkR~liLTd~P---rL~Yvdp~~~~~KGeI~~~~~l~v~~k~~~~F~I~-tp~R 77 (104)
T PF14593_consen 2 KWHRFLNPGELILKQGYVKKRKGLFAKKRQLILTDGP---RLFYVDPKKMVLKGEIPWSKELSVEVKSFKTFFIH-TPKR 77 (104)
T ss_dssp TTGGGTT-T--EEEEEEEEEEETTEEEEEEEEEETTT---EEEEEETTTTEEEEEE--STT-EEEECSSSEEEEE-ETTE
T ss_pred chHHhhcCCCeEEEEEEEEEeeceEEEEEEEEEccCC---EEEEEECCCCeECcEEecCCceEEEEccCCEEEEE-CCCc
Confidence 5777777 45555444 2356777788888887776 99999999999999999 889999999 999
Q ss_pred --hHHHHHHHHHHhhcc-chhhhcccc
Q 002601 875 --LLIEVYNVIFTYCKG-EEVFHKYVT 898 (902)
Q Consensus 875 --ll~~~y~~~~~~~~~-e~~~~~y~~ 898 (902)
+|.++.+.+..||+. |++.+.||+
T Consensus 78 tY~l~d~~~~A~~W~~~I~~~~~~~~~ 104 (104)
T PF14593_consen 78 TYYLEDPEGNAQQWVEAIEEVKKQYYK 104 (104)
T ss_dssp EEEEE-TTS-HHHHHHHHHHHHHHHH-
T ss_pred EEEEECCCCCHHHHHHHHHHHHHHhcC
Confidence 899999999999999 999999884
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.13 Score=54.84 Aligned_cols=31 Identities=26% Similarity=0.408 Sum_probs=24.4
Q ss_pred cccccccccccceeEeccCCCceEEEccCCccc
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656 (902)
Q Consensus 624 ~~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~ 656 (902)
...++|+|+.+.|||++.++ ..-|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~--i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGR--LSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCC--EEEEEeCcccC
Confidence 34699999999999997543 24699999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR03075 PQQ_enz_alc_DH PQQ-dependent dehydrogenase, methanol/ethanol family | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.11 Score=62.36 Aligned_cols=110 Identities=21% Similarity=0.232 Sum_probs=75.4
Q ss_pred cceEEEecCceEEEEeccCceeeeeecCCCCccccc-ccC--CCCC----CceEEEecCCCceEEEeccccCceEEeccC
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSY-QAS--FNSN----ASEFYLDVDEDWELYFHSKRFGKMKKLSSS 121 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (902)
+...|++.+|.||.+|..||+.+|++..+.|....- ... .+.. ..-+|+. ..|..||--+..-|++.-=. .
T Consensus 70 g~vyv~s~~g~v~AlDa~TGk~lW~~~~~~~~~~~~~~~~~~~~rg~av~~~~v~v~-t~dg~l~ALDa~TGk~~W~~-~ 147 (527)
T TIGR03075 70 GVMYVTTSYSRVYALDAKTGKELWKYDPKLPDDVIPVMCCDVVNRGVALYDGKVFFG-TLDARLVALDAKTGKVVWSK-K 147 (527)
T ss_pred CEEEEECCCCcEEEEECCCCceeeEecCCCCcccccccccccccccceEECCEEEEE-cCCCEEEEEECCCCCEEeec-c
Confidence 455777889999999999999999999876631110 000 0010 1234543 34667888888889885321 1
Q ss_pred HH-----HHHhhCcccccCCceeeece------eeeEEEEEcccccEEeee
Q 002601 122 AE-----EYIRRMPYISKDGGVTLGAM------KTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 122 ~~-----~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 161 (902)
.+ ..+.-+|.+ .+|.|++|+- +-.+.++|++||+++-.+
T Consensus 148 ~~~~~~~~~~tssP~v-~~g~Vivg~~~~~~~~~G~v~AlD~~TG~~lW~~ 197 (527)
T TIGR03075 148 NGDYKAGYTITAAPLV-VKGKVITGISGGEFGVRGYVTAYDAKTGKLVWRR 197 (527)
T ss_pred cccccccccccCCcEE-ECCEEEEeecccccCCCcEEEEEECCCCceeEec
Confidence 12 235567888 6789999864 568999999999999988
|
This protein family has a phylogenetic distribution very similar to that coenzyme PQQ biosynthesis enzymes, as shown by partial phylogenetic profiling. Genes in this family often are found adjacent to the PQQ biosynthesis genes themselves. An unusual, strained disulfide bond between adjacent Cys residues contributes to PQQ-binding, as does a Trp residue that is part of a PQQ enzyme repeat (see pfam01011). Characterized members include the dehydrogenase subunit of a membrane-anchored, three subunit alcohol (ethanol) dehydrogenase of Gluconobacter suboxydans, a homodimeric ethanol dehydrogenase in Pseudomonas aeruginosa, and the large subunit of an alpha2/beta2 heterotetrameric methanol dehydrogenase in Methylobacterium extorquens. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.67 E-value=0.16 Score=55.83 Aligned_cols=30 Identities=33% Similarity=0.421 Sum_probs=24.6
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccc
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~ 656 (902)
.+++|+|+.|.|||++.++. +.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~--~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDEL--SGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCce--EEEeehhhhc
Confidence 37999999999999987542 5799998664
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG1520 FOG: WD40-like repeat [Function unknown] | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.38 Score=54.94 Aligned_cols=156 Identities=21% Similarity=0.316 Sum_probs=100.8
Q ss_pred eEEEecCceEEEEeccCceeeeeecCCC-CcccccccCCCCCCceEEEecCCCceEEEeccccCceEEe-ccC--HHHHH
Q 002601 51 ALVAALDGTIHLVDTKLGKIRWSFGTGR-PIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKL-SSS--AEEYI 126 (902)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~ 126 (902)
.+|++.||.+|..|..+|...|+++.+. |.+.+ ...-...-.|... +|..||--++.-|+.+=- ..+ +..-+
T Consensus 114 i~~g~~~g~~y~ld~~~G~~~W~~~~~~~~~~~~---~~v~~~~~v~~~s-~~g~~~al~~~tG~~~W~~~~~~~~~~~~ 189 (370)
T COG1520 114 IYVGSWDGKLYALDASTGTLVWSRNVGGSPYYAS---PPVVGDGTVYVGT-DDGHLYALNADTGTLKWTYETPAPLSLSI 189 (370)
T ss_pred EEEecccceEEEEECCCCcEEEEEecCCCeEEec---CcEEcCcEEEEec-CCCeEEEEEccCCcEEEEEecCCcccccc
Confidence 5888999999999999999999999998 33322 2222223444444 677788777777776321 111 34555
Q ss_pred hhCcccccCCceeeece--eeeEEEEEcccccEEeeec--cCC--CCCCCCCCCCCCceeeccCCccccccccccccccc
Q 002601 127 RRMPYISKDGGVTLGAM--KTSVFLVDVKSGRVVDNYV--LDF--SASTPGFQSDENKHVVPVDGYEELVESGVGNLKRI 200 (902)
Q Consensus 127 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (902)
...|. ..+|.+++|.. ...+.++|+.+|..+.+.. .+. +++. +. +...+..+.-.+
T Consensus 190 ~~~~~-~~~~~vy~~~~~~~~~~~a~~~~~G~~~w~~~~~~~~~~~~~~-------~~---~~~~~~~v~v~~------- 251 (370)
T COG1520 190 YGSPA-IASGTVYVGSDGYDGILYALNAEDGTLKWSQKVSQTIGRTAIS-------TT---PAVDGGPVYVDG------- 251 (370)
T ss_pred ccCce-eecceEEEecCCCcceEEEEEccCCcEeeeeeeecccCccccc-------cc---ccccCceEEECC-------
Confidence 66666 69999999998 7789999999999999951 122 1110 00 111111111122
Q ss_pred cceeEEEeeeeeeecccCCCCcEEEEeecc
Q 002601 201 RQLVYIMRTDYVLQSTSQDSGEVLWNVAYA 230 (902)
Q Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (902)
-+++...+..+=-+-.+.|+.+|+....
T Consensus 252 --~~~~~~~~g~~~~l~~~~G~~~W~~~~~ 279 (370)
T COG1520 252 --GVYAGSYGGKLLCLDADTGELIWSFPAG 279 (370)
T ss_pred --cEEEEecCCeEEEEEcCCCceEEEEecc
Confidence 1255566665666778899999998875
|
|
| >KOG4547 consensus WD40 repeat-containing protein [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.3 Score=56.97 Aligned_cols=156 Identities=18% Similarity=0.284 Sum_probs=113.1
Q ss_pred CCCcceEEEecCceEEEEeccCceeeeeecCCCCcccccccCCCCCC----ceEEEecCCCceEEEeccccCceEEeccC
Q 002601 46 PEPDVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNA----SEFYLDVDEDWELYFHSKRFGKMKKLSSS 121 (902)
Q Consensus 46 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 121 (902)
-.++++..++.-|-|++-+...|.+-|+|++|.-- .+-|... .--++.|++|.-+..-+..-+.+++..+.
T Consensus 68 ~~t~~lvlgt~~g~v~~ys~~~g~it~~~st~~h~-----~~v~~~~~~~~~~ciyS~~ad~~v~~~~~~~~~~~~~~~~ 142 (541)
T KOG4547|consen 68 LDTSMLVLGTPQGSVLLYSVAGGEITAKLSTDKHY-----GNVNEILDAQRLGCIYSVGADLKVVYILEKEKVIIRIWKE 142 (541)
T ss_pred CCceEEEeecCCccEEEEEecCCeEEEEEecCCCC-----CcceeeecccccCceEecCCceeEEEEecccceeeeeecc
Confidence 35677788999999999999999999999988643 2333222 35678899999888888888888888766
Q ss_pred HHHHHhhCcccccCCceee-eceeeeEEEEEcccccEEeee-ccCCCCCCCCCCCCCCceeeccCCcccccccccccccc
Q 002601 122 AEEYIRRMPYISKDGGVTL-GAMKTSVFLVDVKSGRVVDNY-VLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKR 199 (902)
Q Consensus 122 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (902)
-.+.+ -+=|||.||.+-+ ||.++.+ .|-+|++||.+| +|-.-- .+
T Consensus 143 ~~~~~-~sl~is~D~~~l~~as~~ik~--~~~~~kevv~~ftgh~s~v------------------------------~t 189 (541)
T KOG4547|consen 143 QKPLV-SSLCISPDGKILLTASRQIKV--LDIETKEVVITFTGHGSPV------------------------------RT 189 (541)
T ss_pred CCCcc-ceEEEcCCCCEEEeccceEEE--EEccCceEEEEecCCCcce------------------------------EE
Confidence 55544 4669999966433 4666655 588999999999 443111 11
Q ss_pred ccceeEEEee--eeeeecccCCCCcEEEEeeccchhhhhhhh
Q 002601 200 IRQLVYIMRT--DYVLQSTSQDSGEVLWNVAYADFKAEFRCQ 239 (902)
Q Consensus 200 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (902)
.++...|--+ +|||.++...+|.-.|.+-.+.=+..+.|-
T Consensus 190 ~~f~~~~~g~~G~~vLssa~~~r~i~~w~v~~~~kkks~~~s 231 (541)
T KOG4547|consen 190 LSFTTLIDGIIGKYVLSSAAAERGITVWVVEKEDKKKSLSCS 231 (541)
T ss_pred EEEEEeccccccceeeeccccccceeEEEEEcccccchhhee
Confidence 1222223333 799999999999999999997666666663
|
|
| >COG1520 FOG: WD40-like repeat [Function unknown] | Back alignment and domain information |
|---|
Probab=94.28 E-value=0.35 Score=55.26 Aligned_cols=109 Identities=17% Similarity=0.227 Sum_probs=70.0
Q ss_pred cceEEEecCceEEEEeccCceeeeeecCCC-CcccccccCCCCCCceEEEecCCCceEEEeccccCceEEeccCHHH-HH
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGR-PIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLSSSAEE-YI 126 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 126 (902)
+...+++.||+|+++|..+|+++|+..... .-.-+..+... |--.|+-+.++ .+|.=+.+-|.++--. +.+. +.
T Consensus 69 g~v~~~~~~G~i~A~d~~~g~~~W~~~~~~~~~~~~~~~~~~-~G~i~~g~~~g--~~y~ld~~~G~~~W~~-~~~~~~~ 144 (370)
T COG1520 69 GTVYVGTRDGNIFALNPDTGLVKWSYPLLGAVAQLSGPILGS-DGKIYVGSWDG--KLYALDASTGTLVWSR-NVGGSPY 144 (370)
T ss_pred CeEEEecCCCcEEEEeCCCCcEEecccCcCcceeccCceEEe-CCeEEEecccc--eEEEEECCCCcEEEEE-ecCCCeE
Confidence 344556799999999999999999776653 00011111111 11122222222 5555555445554333 3333 55
Q ss_pred hhCcccccCCceeeeceeeeEEEEEcccccEEeee
Q 002601 127 RRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (902)
-..|.+-.||.|+.++-...+.+||+.||..+-.+
T Consensus 145 ~~~~~v~~~~~v~~~s~~g~~~al~~~tG~~~W~~ 179 (370)
T COG1520 145 YASPPVVGDGTVYVGTDDGHLYALNADTGTLKWTY 179 (370)
T ss_pred EecCcEEcCcEEEEecCCCeEEEEEccCCcEEEEE
Confidence 56777779999999997789999999999999998
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.03 E-value=0.21 Score=55.43 Aligned_cols=30 Identities=37% Similarity=0.499 Sum_probs=25.1
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccc
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~ 656 (902)
.+++|+|+++.||+++.++. ..|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~--~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSV--KGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCce--EEEeeccccc
Confidence 58999999999999987652 5799999663
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.52 Score=52.45 Aligned_cols=30 Identities=33% Similarity=0.443 Sum_probs=24.1
Q ss_pred ccccccccccceeEeccCCCceEEEccCCccc
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656 (902)
Q Consensus 625 ~~IvHrDLKp~NILL~~d~~~~vkL~DFGla~ 656 (902)
.+++|+|++|.|||++.+. ..-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~--~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR--LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc--eEEEEeccccc
Confidence 4899999999999997443 24699999764
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.46 E-value=0.13 Score=59.90 Aligned_cols=76 Identities=20% Similarity=0.161 Sum_probs=50.0
Q ss_pred CcchhhhhHHHHHHHHhCCCCCCCCc-hhhHHHHHh------------hccccccccCChHHHHHHHcccCCCCCCCcCH
Q 002601 690 RAIDLFSLGCILFFCITGGKHPYGES-FERDANIVK------------DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 756 (902)
Q Consensus 690 ~ksDVwSlGviL~elltG~~~Pf~~~-~~~~~~~~~------------~~~~~~~~~~~~e~~dLI~~~L~~dP~~Rpt~ 756 (902)
+|+||||+|.++.++.-|... +.+. ..+...++. .....+..+.....+++..+|+-..|..||..
T Consensus 110 pKsdVwsl~~i~~el~L~~~l-~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISL-EAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHH-HHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 499999999999999887322 1111 111111110 01112233344567789999999999999999
Q ss_pred HHHHcCCCCC
Q 002601 757 QNVLNHPFFW 766 (902)
Q Consensus 757 ~elL~HPfF~ 766 (902)
.++++|+-|.
T Consensus 189 ~~~~k~~i~~ 198 (725)
T KOG1093|consen 189 MELSKRCSFT 198 (725)
T ss_pred hHHhcCccHH
Confidence 9999999883
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 902 | ||||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-84 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-84 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-84 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-83 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-68 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-18 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-16 | ||
| 2jam_B | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-16 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-16 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-16 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-15 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-15 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-15 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-15 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-14 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-14 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-14 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-12 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-11 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-11 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-11 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-10 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-10 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 4e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 4e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 4e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 6e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 8e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 8e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-09 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 7e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-07 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-07 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 7e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-06 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 2e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 2e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 3e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-06 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 9e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 4e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 6e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-05 |
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 459 bits (1183), Expect = e-154
Identities = 166/454 (36%), Positives = 253/454 (55%), Gaps = 59/454 (12%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPN 528
+ + LVV K + GS+GTVV +G+++GR VAVKR++ D+AL EI+ L SD HPN
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPN 70
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++R+Y E+ F+Y++LE C +L DL+ E N +++ L E
Sbjct: 71 VIRYYCSETTDRFLYIALELCNLNLQDLV--------ESKNVSDENLKLQKEYNPI---- 118
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC-- 646
+ R I SG++HLH + +IHRDLKPQN+L+S F
Sbjct: 119 ---------------------SLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTAD 157
Query: 647 ---------AKLSDMGISKRLQGDMSCLTQN-ATGYGSSGWQAPEQLLQG-------RQT 689
+SD G+ K+L S N G+SGW+APE L + R T
Sbjct: 158 QQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLT 217
Query: 690 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVK------DRKDLFLVEHIPEAVDLFT 743
R+ID+FS+GC+ ++ ++ GKHP+G+ + R++NI++ + K L I EA DL +
Sbjct: 218 RSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLIS 277
Query: 744 RLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIA-L 802
+++D +P RP A VL HP FW +L FL VSDR+E+E+R+ S LL + +
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDF 337
Query: 803 VALNGKWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPE 862
V +G W K + F++N+ RYR+Y + DLLR +RNK +HF +LP+DI EL+G P+
Sbjct: 338 VIPSGDWTVKFDKTFMDNLERYRKYHSSKLMDLLRALRNKYHHFMDLPEDIAELMGPVPD 397
Query: 863 GFYNYFSCRFPKLLIEVYNVIFTYCKGEEVFHKY 896
GFY+YF+ RFP LLI VY ++ +++ ++
Sbjct: 398 GFYDYFTKRFPNLLIGVYMIVKENLSDDQILREF 431
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 459 bits (1182), Expect = e-154
Identities = 141/449 (31%), Positives = 225/449 (50%), Gaps = 53/449 (11%)
Query: 459 TDLIDDRVDGRRIGKL-VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEI 517
D D+ +GK+ + G+ GT+V G ++ R VAVKR++ A +E+
Sbjct: 9 QDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREV 68
Query: 518 QNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 577
Q L SD+HPN++R++ E D+ F Y+++E C +L + +
Sbjct: 69 QLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYV-------------------- 108
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
K H + + + + SGL+HLH + ++HRDLKP N+
Sbjct: 109 -------------------EQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149
Query: 638 LIS---KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRA 691
LIS A +SD G+ K+L ++ + G+ GW APE L + T
Sbjct: 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYT 209
Query: 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE----HIPEAVDLFTRLLD 747
+D+FS GC+ ++ I+ G HP+G+S +R ANI+ L + A +L +++
Sbjct: 210 VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIA 269
Query: 748 PNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNG 807
+P RP A++VL HPFFW+ + +L F +DVSDR+E E D +++ LE +
Sbjct: 270 MDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESL--DGPIVKQLERGGRAVVKM 327
Query: 808 KWDEKMETKFIENIGRYRRYKYDNVRDLLRVIRNKSNHFRELPQDIQELLGSHPEGFYNY 867
W E + ++ ++R YK +VRDLLR +RNK +H+RELP +++E LG+ P+ F Y
Sbjct: 328 DWRENITVPLQTDLRKFRTYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDDFVCY 387
Query: 868 FSCRFPKLLIEVYNVIFTYCKGEEVFHKY 896
F+ RFP LL Y C E +F Y
Sbjct: 388 FTSRFPHLLAHTYRA-MELCSHERLFQPY 415
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 6e-46
Identities = 72/295 (24%), Positives = 104/295 (35%), Gaps = 57/295 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ GS G V +GR AVKR + L E+ + QHP VR
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ +YL E C SL S E
Sbjct: 123 EQAWEEGGILYLQTELCGPSLQQHCEAWGASLPE-------------------------- 156
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
AQ+ RD + L+HLH GL+H D+KP N+ + KL D
Sbjct: 157 -------------AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG--RCKLGDF 201
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 711
G+ L + Q G + APE LLQG A D+FSLG + + P
Sbjct: 202 GLLVELGTAGAGEVQE----GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPH 256
Query: 712 YGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
GE +++ + + + E + +L+P+P LR A+ +L P
Sbjct: 257 GGEGWQQ---LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 46/295 (15%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-E 536
+ I G G V + +G++ +KR VK +++ A +E+ +A H NIV + G +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKR-VKYNNEKAEREV-KALAKLDHVNIVHYNGCWD 74
Query: 537 SDQDFVYLSLERCTCSLNDLIYVL-----SGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
S + + S +++ G+ E+ + +++ L++
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI--EKRRGEKLDK----------- 121
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
L++ I G+ ++H LI+RDLKP N+ + K K+ D
Sbjct: 122 --------------VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK--QVKIGD 165
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G+ L+ D T + +PEQ+ + +DL++LG IL +
Sbjct: 166 FGLVTSLKNDGKRTRSKGTLR----YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 712 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766
FE R + + L +LL P+ RP +L W
Sbjct: 222 ----FETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-38
Identities = 60/317 (18%), Positives = 111/317 (35%), Gaps = 74/317 (23%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
++I G G+V +G A+KR K AL+E+ QH ++VR+
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ ++ D + + E Y GS + ++ + + E ++
Sbjct: 77 FSAWAEDDHMLIQNE----------YCNGGSLADAISENYRIMSYFKEAELK-------- 118
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD---------- 642
+ + GL ++H + L+H D+KP N+ IS+
Sbjct: 119 -----------------DLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161
Query: 643 -------KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAID 693
K+ D+G R+ G S + A E +LQ D
Sbjct: 162 DEDDWASNKVMFKIGDLGHVTRISSPQVEE-------GDSRFLANE-VLQENYTHLPKAD 213
Query: 694 LFSLGCILFFCITGGKHPY--GESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
+F+L + C G + G+ + I + R E +L ++ P+P+
Sbjct: 214 IFALALTV-VCAAGAEPLPRNGDQW---HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPE 269
Query: 752 LRPKAQNVLNHPFFWTA 768
RP A ++ H +A
Sbjct: 270 RRPSAMALVKHSVLLSA 286
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 63/324 (19%), Positives = 119/324 (36%), Gaps = 43/324 (13%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYG 534
+ + +G G V + + + A+KR+ + ++A +++ +A +HP IVR++
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP------- 587
+ E L D S ++A ++ +
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 588 -------VME--NTKDIELWKANG-----HPSAQLLKVTRDIVSGLSHLHEIGLIHRDLK 633
M+ ++++ W L + I + LH GL+HRDLK
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLK 191
Query: 634 PQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ---------APEQLL 684
P N+ + D K+ D G+ + D T + +PEQ+
Sbjct: 192 PSNIFFTMDD--VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIH 249
Query: 685 QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---LVEHIPEAVDL 741
+ +D+FSLG ILF + + + ER I R F + P+ +
Sbjct: 250 GNNYSHKVDIFSLGLILFELL----YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM 305
Query: 742 FTRLLDPNPDLRPKAQNVLNHPFF 765
+L P+P RP+A +++ + F
Sbjct: 306 VQDMLSPSPTERPEATDIIENAIF 329
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 77/305 (25%), Positives = 118/305 (38%), Gaps = 20/305 (6%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 529
I +GS G V + N A+K + K + E++ + HPNI
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNI 90
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
R Y V D+ ++ L +E C L D + V + + + +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ + + R I S L +LH G+ HRD+KP+N L S +KSF K
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIK 210
Query: 649 LSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCI 705
L D G+SK + T G+ + APE L + D +S G +L +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 706 TGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVL 760
G P G + + V ++K F + P A DL + LL+ N D R A L
Sbjct: 271 M-GAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329
Query: 761 NHPFF 765
HP+
Sbjct: 330 QHPWI 334
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-37
Identities = 60/308 (19%), Positives = 112/308 (36%), Gaps = 66/308 (21%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIA-----SDQHPNIVRW 532
K+I G + V N + + A+K + D L +N IA I+R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
Y E ++Y+ +E LN + S + E +
Sbjct: 75 YDYEITDQYIYMVMECGNIDLNSWL-KKKKSIDP------------WERK---------- 111
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
++++ + +H+ G++H DLKP N LI KL D
Sbjct: 112 -----------------SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDF 151
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAIDLFSLGCIL 701
GI+ ++Q D + + ++ + G+ + PE + + + D++SLGCIL
Sbjct: 152 GIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
Query: 702 FFCITGGKHPYG---ESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 757
++ GK P+ + I+ ++ + + D+ L +P R
Sbjct: 211 YYMTY-GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 269
Query: 758 NVLNHPFF 765
+L HP+
Sbjct: 270 ELLAHPYV 277
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 54/295 (18%)
Query: 481 IAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYGVE 536
+ KG+ G V + +A+K + + + L +H NIV++ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKE-IPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 537 SDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
S+ F+ + +E+ SL+ L+ G ++ NE I
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKD------------NEQTIGFY--------- 127
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
T+ I+ GL +LH+ ++HRD+K NVLI+ S K+SD G S
Sbjct: 128 ----------------TKQILEGLKYLHDNQIVHRDIKGDNVLIN-TYSGVLKISDFGTS 170
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHPYG 713
KRL G C T G+ + APE + +G + +A D++SLGC + T GK P+
Sbjct: 171 KRLAGINPC---TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFY 226
Query: 714 ESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
E E A + + + E + EA + +P+PD R A ++L F
Sbjct: 227 ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 60/308 (19%), Positives = 114/308 (37%), Gaps = 66/308 (21%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-VALKEIQNLIA-----SDQHPNIVRW 532
K+I G + V N + + A+K + D L +N IA I+R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
Y E ++Y+ +E LN + S + E +
Sbjct: 94 YDYEITDQYIYMVMECGNIDLNSWL-KKKKSIDP------------WERK---------- 130
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
++++ + +H+ G++H DLKP N LI KL D
Sbjct: 131 -----------------SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM---LKLIDF 170
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-----------GRQTRAIDLFSLGCIL 701
GI+ ++Q D + + ++ + G+ + PE + + + D++SLGCIL
Sbjct: 171 GIANQMQPDTTSVVKD-SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 702 FFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 757
++ GK P+ + + + I+ ++ + + D+ L +P R
Sbjct: 230 YYMTY-GKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288
Query: 758 NVLNHPFF 765
+L HP+
Sbjct: 289 ELLAHPYV 296
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 60/293 (20%), Positives = 100/293 (34%), Gaps = 51/293 (17%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES 537
+ +GS G V + + G AVK+ V+ ++E+ A P IV YG
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKK-VRLE-VFRVEEL-VACAGLSSPRIVPLYGAVR 120
Query: 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597
+ +V + +E + GS + + + L E R
Sbjct: 121 EGPWVNIFME----------LLEGGSLGQLI----KQMGCLPEDRAL------------- 153
Query: 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
+ GL +LH ++H D+K NVL+S D S L D G +
Sbjct: 154 ------------YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRA-ALCDFGHALC 200
Query: 658 LQGDMSCLTQNATGY--GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGES 715
LQ D + Y G+ APE ++ +D++S C++ + G HP+ +
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQY 259
Query: 716 FERDA--NIVKDRKDLF-LVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
F I + + + P L P R A +
Sbjct: 260 FRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-36
Identities = 67/400 (16%), Positives = 134/400 (33%), Gaps = 98/400 (24%)
Query: 387 YHSKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSH 446
+H + +T K ++ + T + +K + V
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISV-------- 53
Query: 447 ITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLV 506
G + + ++IG G + V N + + A+K +
Sbjct: 54 ---KGRIYSI-----------LKQIGS----------GGSSKVFQVLNEKKQIYAIKYVN 89
Query: 507 KTHHD-VALKEIQNLIA-----SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVL 560
D L +N IA I+R Y E ++Y+ +E LN +
Sbjct: 90 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL-KK 148
Query: 561 SGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620
S + E + ++++ +
Sbjct: 149 KKSIDP------------WERK---------------------------SYWKNMLEAVH 169
Query: 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680
+H+ G++H DLKP N LI KL D GI+ ++Q D + + ++ + G+ + P
Sbjct: 170 TIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKD-SQVGAVNYMPP 225
Query: 681 EQLL-----------QGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDA---NIVKDR 726
E + + + + D++SLGCIL++ GK P+ + + + I+
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY-GKTPFQQIINQISKLHAIIDPN 284
Query: 727 KDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
++ + + D+ L +P R +L HP+
Sbjct: 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 62/302 (20%), Positives = 119/302 (39%), Gaps = 66/302 (21%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
++I +GS G +L + +GR +K + + + +E+ ++A+ +HPNIV++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREV-AVLANMKHPNIVQY 88
Query: 533 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ +Y+ ++ C L I Q L E
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI-------------NAQKGVLFQE----------- 124
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
Q+L I L H+H+ ++HRD+K QN+ ++KD + +L D
Sbjct: 125 --------------DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGD 168
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 710
GI++ L + G+ + +PE + + + D+++LGC+L+ T KH
Sbjct: 169 FGIARVLNSTVELAR---ACIGTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCT-LKH 223
Query: 711 PY-GESFER-DANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKAQNVLNHP 763
+ S + I+ + + L ++L NP RP ++L
Sbjct: 224 AFEAGSMKNLVLKIISGS-----FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKG 278
Query: 764 FF 765
F
Sbjct: 279 FI 280
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 58/298 (19%), Positives = 113/298 (37%), Gaps = 54/298 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVR 531
K+I +G V +G VA+K++ +KEI +L+ HPN+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEI-DLLKQLNHPNVIK 96
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+Y + + + + LE +G + ++ L+ E +
Sbjct: 97 YYASFIEDNELNIVLE----------LADAGDLSRMIKHFKKQKRLIPERTV-------- 138
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
K + S L H+H ++HRD+KP NV I+ KL D
Sbjct: 139 -----------------WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG--VVKLGD 179
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
+G+ + + + G+ + +PE++ + D++SLGC+L+ + P
Sbjct: 180 LGLGRFFSSKTTAAH---SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-LQSP 235
Query: 712 Y-GESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
+ G+ + I + +H E L ++P+P+ RP V +
Sbjct: 236 FYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-35
Identities = 69/326 (21%), Positives = 122/326 (37%), Gaps = 89/326 (27%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV--ALKEIQNLIASDQHPNIVRWYGV 535
+ +G+ G VV + R A+K++ T + L E+ L+AS H +VR+Y
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-MLLASLNHQYVVRYYAA 70
Query: 536 ESDQD-------------FVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
++ +++ +E C +L DLI+ + + +
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-------------- 116
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
+ ++ R I+ LS++H G+IHRDLKP N+ I +
Sbjct: 117 -------------------------EYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDE 151
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY-----------GSSGWQAPEQLLQ-GRQT 689
++ K+ D G++K + + L ++ G++ + A E L G
Sbjct: 152 SRN--VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209
Query: 690 RAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI----------PEAV 739
ID++SLG I F I F V K L V
Sbjct: 210 EKIDMYSLGIIFFEMIYP--------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEK 261
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFF 765
+ L+D +P+ RP A+ +LN +
Sbjct: 262 KIIRLLIDHDPNKRPGARTLLNSGWL 287
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 62/318 (19%), Positives = 118/318 (37%), Gaps = 76/318 (23%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 533
+ + +G G V + + + A+KR+ + ++ ++E++ +A +HP IVR++
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVK-ALAKLEHPGIVRYF 69
Query: 534 GVESDQD------------FVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
+++ ++Y+ ++ C +L D + + + E
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-------------NGRCTIEERE 116
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 640
L + I + LH GL+HRDLKP N+ +
Sbjct: 117 RS------------------------VCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT 152
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ---------APEQLLQGRQTRA 691
D K+ D G+ + D T + +PEQ+ +
Sbjct: 153 MDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK 210
Query: 692 IDLFSLGCILF-FCITGGKHPYGESFERDANIVKDRKDLF---LVEHIPEAVDLFTRLLD 747
+D+FSLG ILF +P+ ER + R F + P + +L
Sbjct: 211 VDIFSLGLILFELL-----YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLS 265
Query: 748 PNPDLRPKAQNVLNHPFF 765
P+P RP+A N++ + F
Sbjct: 266 PSPMERPEAINIIENAVF 283
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 50/322 (15%), Positives = 104/322 (32%), Gaps = 28/322 (8%)
Query: 464 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA 522
+ G R + +V + + + + E G S V T + +
Sbjct: 70 ESELGER-PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT------ERPPSNAI 122
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
++R + ++ + DL+ ++ E+D +L+
Sbjct: 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 182
Query: 583 IRLLPVMENTKDIELWKANGH-----PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
+ E+ ++ L++T ++ L+ LH GL+H L+P ++
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 242
Query: 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAI 692
++ + L+ R S ++ G+ A L G+ T A
Sbjct: 243 VLDQRGG--VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAF 298
Query: 693 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPD 751
D ++LG +++ P DA + ++IP+ V L L +
Sbjct: 299 DTWTLGLAIYWIWC-ADLP----NTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKE 353
Query: 752 LRPKAQNVLNHPFFWTADTRLS 773
R + P + T LS
Sbjct: 354 DRLLPLQAMETPEYEQLRTELS 375
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-34
Identities = 48/329 (14%), Positives = 88/329 (26%), Gaps = 46/329 (13%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA-----LKEIQNLIA 522
+ + + + + G V L + E A+K + L E A
Sbjct: 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAA 117
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+ D + V S QL+ + D + N +
Sbjct: 118 RLLGESPEEARDRRRLLLPS------------DAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 583 IRLLPVMENTKDIELWKANGH-----PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
+ ++ L +T ++ ++L GL+H P N+
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNL 225
Query: 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDL 694
I D L D+ ++ AP + L T A++
Sbjct: 226 FIMPDGR--LMLGDVSALWKVGTRGPAS-------SVPVTYAPREFLNASTATFTHALNA 276
Query: 695 FSLGCILFFCITGGKHPYGESFERDANIVK---------DRKDLFLVEHIPEAV-DLFTR 744
+ LG ++ P+G K D +P+ V L R
Sbjct: 277 WQLGLSIYRVWC-LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335
Query: 745 LLDPNPDLRPKAQNVLNHPFFWTADTRLS 773
L+ + R + P F +S
Sbjct: 336 FLNFDRRRRLLPLEAMETPEFLQLQNEIS 364
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 66/322 (20%), Positives = 115/322 (35%), Gaps = 66/322 (20%)
Query: 466 VDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD---VALKEIQNLI 521
+D + +F +++ +G V L EG ++G A+KR++ A +E
Sbjct: 26 IDNKH----YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMH- 80
Query: 522 ASDQHPNIVRWYGVESDQDF----VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 577
HPNI+R + +L L + G+ ++ + N
Sbjct: 81 RLFNHPNILRLVAYCLRERGAKHEAWLLLP----------FFKRGTLWNEIERLKDKGNF 130
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
L E +I L + I GL +H G HRDLKP N+
Sbjct: 131 LTEDQI-------------------------LWLLLGICRGLEAIHAKGYAHRDLKPTNI 165
Query: 638 LISKDKSFCAKLSDMGISK------RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691
L+ + L D+G L A + ++APE L +
Sbjct: 166 LLGDEGQP--VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCV 222
Query: 692 I----DLFSLGCILFFCITGGKHPYGESFERD---ANIVKDRKDLFLVEHI-PEAVDLFT 743
I D++SLGC+L+ + G+ PY F++ A V+++ + L
Sbjct: 223 IDERTDVWSLGCVLYAMMF-GEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLN 281
Query: 744 RLLDPNPDLRPKAQNVLNHPFF 765
++ +P RP +L+
Sbjct: 282 SMMTVDPHQRPHIPLLLSQLEA 303
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-32
Identities = 72/309 (23%), Positives = 126/309 (40%), Gaps = 60/309 (19%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 523
+ ++ K++ G+ G V+L A+K + + + L+E+ L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
D HPNI++ Y D+ YL +E L D I + F E A
Sbjct: 94 D-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAV----------- 140
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 641
+ + ++SG+++LH+ ++HRDLKP+N+L+ SK
Sbjct: 141 ----------------------------IIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
+K K+ D G+S + + G++ + APE +L+ + D++S+G IL
Sbjct: 173 EKDALIKIVDFGLSAVFENQKKMKER----LGTAYYIAPE-VLRKKYDEKCDVWSIGVIL 227
Query: 702 FFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 756
F + G P G++ + V+ K F A DL ++L + R A
Sbjct: 228 FILLA-GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISA 286
Query: 757 QNVLNHPFF 765
Q L HP+
Sbjct: 287 QQALEHPWI 295
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 79/343 (23%), Positives = 135/343 (39%), Gaps = 71/343 (20%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLI 521
+ + KGS G V+L + G+ AVK + K + L+E+Q L
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
D HPNI++ Y D+ + YL E T L D I + F E A+
Sbjct: 82 QLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAAR--------- 130
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI- 639
+ R ++SG++++H+ ++HRDLKP+N+L+
Sbjct: 131 ------------------------------IIRQVLSGITYMHKNKIVHRDLKPENLLLE 160
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
SK K ++ D G+S + + G++ + APE +L G D++S G
Sbjct: 161 SKSKDANIRIIDFGLSTHFEASKKMKDK----IGTAYYIAPE-VLHGTYDEKCDVWSTGV 215
Query: 700 ILFFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRP 754
IL+ ++ G P G + V+ K F + A DL ++L P +R
Sbjct: 216 ILYILLS-GCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI 274
Query: 755 KAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 797
A++ L+H W ++ + D S + +
Sbjct: 275 SARDALDHE--W--------IQTYTKEQISVDVPSLDNAILNI 307
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-32
Identities = 73/304 (24%), Positives = 119/304 (39%), Gaps = 79/304 (25%)
Query: 464 DRVDGR-RIGKLVVFNKEIAKGSNGTVVL--EGNYEGRSVAVKRLVKTHHDVALK----E 516
D V G+ + IA G G + L + N GR V +K LV + A E
Sbjct: 76 DIVAGQYEVKGC------IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAE 129
Query: 517 IQNLIASDQHPNIVRWY--GVESDQD---FVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 571
Q L A HP+IV+ + +D+ Y+ +E YV S
Sbjct: 130 RQFL-AEVVHPSIVQIFNFVEHTDRHGDPVGYIVME----------YVGGQS-------- 170
Query: 572 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631
L + + LPV A+ + +I+ LS+LH IGL++ D
Sbjct: 171 ------LKRSKGQKLPV-----------------AEAIAYLLEILPALSYLHSIGLVYND 207
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA 691
LKP+N+++++++ KL D+G R + YG+ G+QAPE ++ T A
Sbjct: 208 LKPENIMLTEEQ---LKLIDLGAVSR-------INSFGYLYGTPGFQAPEI-VRTGPTVA 256
Query: 692 IDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVD-LFTRLLDPNP 750
D++++G L + V + V ++ L R +DP+P
Sbjct: 257 TDIYTVGRTLAALTL-DLPTR------NGRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDP 309
Query: 751 DLRP 754
R
Sbjct: 310 RQRF 313
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-32
Identities = 50/328 (15%), Positives = 105/328 (32%), Gaps = 39/328 (11%)
Query: 464 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA 522
+ G R LV + + + + E G S V T + +
Sbjct: 65 ESELGERPRTLV-RGTVLGQEDPYAYLEATDQETGESFEVHVPYFT------ERPPSNAI 117
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
++R + ++ + DL+ ++ E+D +L+
Sbjct: 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFF 177
Query: 583 IRLLPVMENTKDIELWKANGHPSAQL-----LKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
+ E+ ++ L L++T ++ L+ LH GL+H L+P ++
Sbjct: 178 LYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 237
Query: 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----------QG 686
++ + L+ R + S G++ PE +
Sbjct: 238 VLDQRGG--VFLTGFEHLVRDGARVVS-------SVSRGFEPPELEARRATISYHRDRRT 288
Query: 687 RQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAV-DLFTRL 745
T + D ++LG ++++ P +DA + ++IP+ V L
Sbjct: 289 LMTFSFDAWALGLVIYWIWC-ADLP----ITKDAALGGSEWIFRSCKNIPQPVRALLEGF 343
Query: 746 LDPNPDLRPKAQNVLNHPFFWTADTRLS 773
L + R + P + T LS
Sbjct: 344 LRYPKEDRLLPLQAMETPEYEQLRTELS 371
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 65/308 (21%), Positives = 110/308 (35%), Gaps = 69/308 (22%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
I GS G +G+ + K L + E+ NL+ +HPNIVR+
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEV-NLLRELKHPNIVRY 70
Query: 533 YG--VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
Y ++ +Y+ +E C G + ++ L+E +
Sbjct: 71 YDRIIDRTNTTLYIVMEYCE----------GGDLASVITKGTKERQYLDEEFV------- 113
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL-----IHRDLKPQNVLISKDKSF 645
L+V + L H +HRDLKP NV + ++
Sbjct: 114 ------------------LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN- 154
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFC 704
KL D G+++ L D S T G+ + +PE + D++SLGC+L+
Sbjct: 155 -VKLGDFGLARILNHDTSFAK---TFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYEL 209
Query: 705 ITGGKHP-YGESFER-DANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKAQ 757
P S + I + + IP E ++ TR+L+ RP +
Sbjct: 210 CAL-MPPFTAFSQKELAGKIREGK-----FRRIPYRYSDELNEIITRMLNLKDYHRPSVE 263
Query: 758 NVLNHPFF 765
+L +P
Sbjct: 264 EILENPLI 271
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 78/342 (22%), Positives = 135/342 (39%), Gaps = 69/342 (20%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA 522
+ + KGS G V+ + + AVK L+E++ L
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
D HPNI++ + + D Y+ E T L D I + F E A+
Sbjct: 78 LD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAAR---------- 125
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-S 640
+ + + SG++++H+ ++HRDLKP+N+L+ S
Sbjct: 126 -----------------------------IIKQVFSGITYMHKHNIVHRDLKPENILLES 156
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700
K+K K+ D G+S Q + + + G++ + APE +L+G D++S G I
Sbjct: 157 KEKDCDIKIIDFGLSTCFQQN-TKMKDRI---GTAYYIAPE-VLRGTYDEKCDVWSAGVI 211
Query: 701 LFFCITGGKHP-YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPK 755
L+ ++ G P YG++ V+ K F + +A DL ++L +P LR
Sbjct: 212 LYILLS-GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
Query: 756 AQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 797
A L HP W + S+ + D S + +
Sbjct: 271 ATQCLEHP--W-------IQKYSSETPTISDLPSLESAMTNI 303
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-31
Identities = 74/352 (21%), Positives = 141/352 (40%), Gaps = 81/352 (23%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKT----------------HHDV 512
+IG+ +++ G+ G V+L + A+K + K+ H+
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 513 ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAK 571
EI L + D HPNI++ + V D+ + YL E L + I + F+E A
Sbjct: 93 IYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAAN 150
Query: 572 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631
+ + I+SG+ +LH+ ++HRD
Sbjct: 151 ---------------------------------------IMKQILSGICYLHKHNIVHRD 171
Query: 632 LKPQNVLI-SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR 690
+KP+N+L+ +K+ K+ D G+S D L G++ + APE +L+ +
Sbjct: 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRL---GTAYYIAPE-VLKKKYNE 226
Query: 691 AIDLFSLGCILFFCITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRL 745
D++S G I++ + G P G++ + V+ K F +I EA +L +
Sbjct: 227 KCDVWSCGVIMYILLC-GYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLM 285
Query: 746 LDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 797
L + + R A+ LN W ++ ++ + D+++ L +
Sbjct: 286 LTYDYNKRCTAEEALNSR--W--------IKKYANNINKSDQKTLCGALSNM 327
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-31
Identities = 71/302 (23%), Positives = 114/302 (37%), Gaps = 59/302 (19%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV 535
++I GS AVK + K+ D +EI+ L+ QHPNI+ V
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP-TEEIEILLRYGQHPNIITLKDV 84
Query: 536 ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
D +VY+ E L D I + F E+
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKI-LRQKFFSER--------------------------- 116
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFCAKLSDM 652
+A+ V I + +LH G++HRDLKP N+L ++ D
Sbjct: 117 ----EAS--------AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP- 711
G +K+L+ + L T ++ + APE L + A D++SLG +L+ +TG +
Sbjct: 165 GFAKQLRAENGLLM---TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG--YTP 219
Query: 712 -YGESFERDANI---VKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHP 763
+ I + K + A DL +++L +P R A VL HP
Sbjct: 220 FANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279
Query: 764 FF 765
+
Sbjct: 280 WI 281
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 75/315 (23%), Positives = 124/315 (39%), Gaps = 69/315 (21%)
Query: 466 VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK-EIQ 518
VD R + V + + KG + + A K L+K H + EI
Sbjct: 9 VDPRSRRRYVR-GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEIS 67
Query: 519 NLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNL 577
S H ++V ++G D DFV++ LE C SL +L + E
Sbjct: 68 IH-RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-KRRKALTEP---------- 115
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
E R R IV G +LH +IHRDLK N+
Sbjct: 116 --EAR---------------------------YYLRQIVLGCQYLHRNRVIHRDLKLGNL 146
Query: 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 696
+ ++ K+ D G++ +++ D G+ + APE +L + + +D++S
Sbjct: 147 FL--NEDLEVKIGDFGLATKVEYDGERKK---VLCGTPNYIAPE-VLSKKGHSFEVDVWS 200
Query: 697 LGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNP 750
+GCI++ + GK P FE + + + + + +HI P A L ++L +P
Sbjct: 201 IGCIMYTLLV-GKPP----FE-TSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 254
Query: 751 DLRPKAQNVLNHPFF 765
RP +LN FF
Sbjct: 255 TARPTINELLNDEFF 269
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-31
Identities = 70/314 (22%), Positives = 116/314 (36%), Gaps = 71/314 (22%)
Query: 473 KLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVR 531
L + +K + +GS ++ AVK + K KEI L + HPNIV+
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 532 WYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ V DQ +L +E L + I F E +
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERI-KKKKHFSETEASY------------------- 110
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKL 649
+ R +VS +SH+H++G++HRDLKP+N+L ++ + K+
Sbjct: 111 --------------------IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
D G ++ D L T + + APE L Q + DL+SLG IL+ ++G
Sbjct: 151 IDFGFARLKPPDNQPLK---TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG-- 205
Query: 710 HP--YGESFERDANIVKDRKDLFLVEHI----------------PEAVDLFTRLLDPNPD 751
+ ++ + I EA DL LL +P+
Sbjct: 206 QVPFQSHD---RSLTCTSAVEIM--KKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPN 260
Query: 752 LRPKAQNVLNHPFF 765
R K + + +
Sbjct: 261 KRLKMSGLRYNEWL 274
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 69/283 (24%), Positives = 113/283 (39%), Gaps = 67/283 (23%)
Query: 497 GRSVAVK-----RLVKTHHDVALK-EIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550
A K L+K H + EI S H ++V ++G D DFV++ LE C
Sbjct: 66 KEVFAGKIVPKSLLLKPHQREKMSMEISIH-RSLAHQHVVGFHGFFEDNDFVFVVLELCR 124
Query: 551 C-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
SL +L + E E R
Sbjct: 125 RRSLLELH-KRRKALTEP------------EAR--------------------------- 144
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 669
R IV G +LH +IHRDLK N+ + ++ K+ D G++ +++ D
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFL--NEDLEVKIGDFGLATKVEYDGERKK--- 199
Query: 670 TGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRK- 727
G+ + APE +L + + +D++S+GCI++ + GK P FE + + +
Sbjct: 200 VLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLV-GKPP----FE-TSCLKETYLR 252
Query: 728 ----DLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+ + +HI P A L ++L +P RP +LN FF
Sbjct: 253 IKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF 295
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 73/305 (23%), Positives = 136/305 (44%), Gaps = 52/305 (17%)
Query: 471 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIA---SDQH 526
I L +F +++ G+ G V L E G +K + K V +++I+ I S H
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
PNI++ + V D +Y+ +E C G E++ + + L+E +
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCE----------GGELLERIVSAQARGKALSEGYVA-- 127
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSF 645
++ + +++ L++ H ++H+DLKP+N+L
Sbjct: 128 -----------------------ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS 164
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
K+ D G+++ + D T A G++ + APE + + T D++S G +++F +
Sbjct: 165 PIKIIDFGLAELFKSD-EHSTNAA---GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLL 219
Query: 706 TGGKHP--YGESFERDANIVKDRKDLFLVE--HI-PEAVDLFTRLLDPNPDLRPKAQNVL 760
TG G S E ++ + VE + P+AVDL ++L +P+ RP A VL
Sbjct: 220 TG--CLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277
Query: 761 NHPFF 765
+H +F
Sbjct: 278 HHEWF 282
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 67/310 (21%), Positives = 117/310 (37%), Gaps = 64/310 (20%)
Query: 472 GKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALKEIQNLIASDQ 525
G+ + F+ EI +GS TV + E VA +L K+ +E + L Q
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-Q 83
Query: 526 HPNIVR----WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
HPNIVR W + + L E + SG+ + L + ++
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTE----------LMTSGTLKTYL----KRFKVMKIK 129
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLI 639
+R R I+ GL LH +IHRDLK N+ I
Sbjct: 130 VLR-------------------------SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
+ + K+ D+G++ + + G+ + APE + + + ++D+++ G
Sbjct: 165 T-GPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPE-MYEEKYDESVDVYAFGM 217
Query: 700 ILFFCITGGKHPYGESFERDA--NIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPK 755
+ T ++PY E V + + PE ++ + N D R
Sbjct: 218 CMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276
Query: 756 AQNVLNHPFF 765
+++LNH FF
Sbjct: 277 IKDLLNHAFF 286
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 75/310 (24%), Positives = 128/310 (41%), Gaps = 62/310 (20%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 523
+ + KGS G V+ + + AVK L+E++ L
Sbjct: 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
D HPNI++ + + D Y+ E T L D I + F E A+
Sbjct: 79 D-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAAR----------- 125
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 641
+ + + SG++++H+ ++HRDLKP+N+L+ SK
Sbjct: 126 ----------------------------IIKQVFSGITYMHKHNIVHRDLKPENILLESK 157
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
+K K+ D G+S Q + + + G++ + APE +L+G D++S G IL
Sbjct: 158 EKDCDIKIIDFGLSTCFQQN-TKMKDRI---GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
Query: 702 FFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPK 755
+ ++G P YG++ V+ K F + I +A DL ++L +P LR
Sbjct: 213 YILLSG--TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
Query: 756 AQNVLNHPFF 765
A L HP+
Sbjct: 271 ATQCLEHPWI 280
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 66/308 (21%), Positives = 120/308 (38%), Gaps = 62/308 (20%)
Query: 471 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIASDQ 525
I + I +GS G V + A K V+ +EI+ + + D
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRF-KQEIEIMKSLD- 64
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
HPNI+R Y D +YL +E CT L + + V F E A+
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAAR------------- 110
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDK 643
+ +D++S +++ H++ + HRDLKP+N L ++
Sbjct: 111 --------------------------IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSP 144
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
KL D G++ R + + G+ + +P+ +L+G D +S G +++
Sbjct: 145 DSPLKLIDFGLAARFKPG-KMMRTKV---GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYV 199
Query: 704 CITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 757
+ G +P + +++ F + ++ P+A L RLL +P R +
Sbjct: 200 LLCG--YPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL 257
Query: 758 NVLNHPFF 765
L H +F
Sbjct: 258 QALEHEWF 265
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 71/315 (22%), Positives = 120/315 (38%), Gaps = 72/315 (22%)
Query: 468 GRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK---EIQ 518
G +I V + KGS V + G VA+K + K ++ +I
Sbjct: 7 GEKIEDFKV-GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 519 NLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNL 577
+ +HP+I+ Y D ++VYL LE C +N + F E
Sbjct: 66 CQL---KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN---------- 112
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
E R I++G+ +LH G++HRDL N+
Sbjct: 113 --EAR---------------------------HFMHQIITGMLYLHSHGILHRDLTLSNL 143
Query: 638 LISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFS 696
L+ ++ K++D G++ +L+ T G+ + +PE + D++S
Sbjct: 144 LL--TRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISPE-IATRSAHGLESDVWS 197
Query: 697 LGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNP 750
LGC+ + + G+ P F+ + D + + EA DL +LL NP
Sbjct: 198 LGCMFYTLLI-GRPP----FD-TDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNP 251
Query: 751 DLRPKAQNVLNHPFF 765
R +VL+HPF
Sbjct: 252 ADRLSLSSVLDHPFM 266
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 68/288 (23%), Positives = 116/288 (40%), Gaps = 56/288 (19%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWY 533
+ + + +G+ G V + + + VA+K++ ++ + E++ L + HPNIV+ Y
Sbjct: 10 IEVEEVVGRGAFGVV-CKAKWRAKDVAIKQIESESERKAFIVELRQL-SRVNHPNIVKLY 67
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
G + V L +E Y GS L+ E
Sbjct: 68 GACLNP--VCLVME----------YAEGGSLYNVLHGAEPLPYY---------------- 99
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI---GLIHRDLKPQNVLISKDKSFCAKLS 650
+A + G+++LH + LIHRDLKP N+L+ + K+
Sbjct: 100 ----------TAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKIC 148
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G + +Q M+ GS+ W APE + D+FS G IL+ IT +
Sbjct: 149 DFGTACDIQTHMTNNK------GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRK 201
Query: 711 PYGE---SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 754
P+ E R V + L++++P+ + L TR +P RP
Sbjct: 202 PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRP 249
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 81/365 (22%), Positives = 137/365 (37%), Gaps = 60/365 (16%)
Query: 466 VDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQN 519
+ R + +E+ KG+ V G+ A +L H +E +
Sbjct: 4 ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63
Query: 520 LIASDQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLL 578
HPNIVR + S++ YL + T L + I V + E +
Sbjct: 64 CRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI-VAREYYSEADASH------- 114
Query: 579 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 638
+ I+ + H H++G++HR+LKP+N+L
Sbjct: 115 --------------------------------CIQQILEAVLHCHQMGVVHRNLKPENLL 142
Query: 639 -ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697
SK K KL+D G++ ++G+ G+ G+ +PE L + + +DL++
Sbjct: 143 LASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSPEVLRKDPYGKPVDLWAC 199
Query: 698 GCILFFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPD 751
G IL+ + G +P + E R +K F + PEA DL ++L NP
Sbjct: 200 GVILYILLVG--YPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPS 257
Query: 752 LRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDE 811
R A L HP+ T S + L+ + KL A+ + L N +
Sbjct: 258 KRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRK 317
Query: 812 KMETK 816
+ K
Sbjct: 318 QEIIK 322
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 64/290 (22%), Positives = 107/290 (36%), Gaps = 54/290 (18%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNI 529
+ ++I GS GTV + G VAVK L++ +E+ + +HPNI
Sbjct: 39 LNIKEKIGAGSFGTV-HRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIM-KRLRHPNI 96
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V + G + + + E Y+ GS L+ L
Sbjct: 97 VLFMGAVTQPPNLSIVTE----------YLSRGSLYRLLHKSGAREQL------------ 134
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLISKDKSFCA 647
+ L + D+ G+++LH ++HR+LK N+L+ DK +
Sbjct: 135 --------------DERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV--DKKYTV 178
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K+ D G+S+ A G+ W APE L D++S G IL+ T
Sbjct: 179 KVCDFGLSRLKASTFLSSKSAA---GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT- 234
Query: 708 GKHPYGE--SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 754
+ P+G + A + K L + ++ V + P RP
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRP 284
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 71/316 (22%), Positives = 120/316 (37%), Gaps = 63/316 (19%)
Query: 463 DDRVDGRR---IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALK-EI 517
D +DG + E+ +G+ V + + A+K L KT ++ EI
Sbjct: 40 DYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEI 99
Query: 518 QNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSN 576
L+ HPNI++ + + L LE T L D I V G + E+ A
Sbjct: 100 GVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRI-VEKGYYSERDAAD----- 152
Query: 577 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 636
+ I+ +++LHE G++HRDLKP+N
Sbjct: 153 ----------------------------------AVKQILEAVAYLHENGIVHRDLKPEN 178
Query: 637 VL-ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLF 695
+L + K++D G+SK ++ + G+ G+ APE L +D++
Sbjct: 179 LLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVC---GTPGYCAPEILRGCAYGPEVDMW 234
Query: 696 SLGCILFFCITGGKHP--YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLD 747
S+G I + + G Y E ++ I+ F+ + A DL +L+
Sbjct: 235 SVGIITYILLCG--FEPFYDERGDQFMFRRILNCEYY-FISPWWDEVSLNAKDLVRKLIV 291
Query: 748 PNPDLRPKAQNVLNHP 763
+P R L HP
Sbjct: 292 LDPKKRLTTFQALQHP 307
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-28
Identities = 65/304 (21%), Positives = 108/304 (35%), Gaps = 56/304 (18%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIA---SDQHPN 528
+ I KG V G+ AVK + ++ ++++ + +HP+
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
IV S +Y+ E + DL E + + + +E
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGA--DL-------CFE-IVKRADAGFVYSEAVAS---- 133
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCA 647
R I+ L + H+ +IHRD+KP VL SK+ S
Sbjct: 134 ---------------------HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPV 172
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
KL G++ +L G+ + APE + + + +D++ G ILF ++G
Sbjct: 173 KLGGFGVAIQLGESGLVAGGRV---GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 708 GKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLN 761
YG I+K + HI A DL R+L +P R LN
Sbjct: 230 --CLPFYGTKERLFEGIIKGKYK-MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286
Query: 762 HPFF 765
HP+
Sbjct: 287 HPWL 290
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 54/337 (16%), Positives = 108/337 (32%), Gaps = 89/337 (26%)
Query: 476 VFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIV 530
+ + + +G+ V + + G A+K DV ++E + L + H NIV
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIV 70
Query: 531 RWYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + +E + L +E + GS L + L E
Sbjct: 71 KLFAIEEETTTRHKVLIME----------FCPCGSLYTVLEEPSN-AYGLPESEFL---- 115
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFC 646
V RD+V G++HL E G++HR++KP N++ +D
Sbjct: 116 ---------------------IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---------AIDLFSL 697
KL+D G ++ L+ D + YG+ + P+ + + R +DL+S+
Sbjct: 155 YKLTDFGAARELEDDEQF----VSLYGTEEYLHPD-MYERAVLRKDHQKKYGATVDLWSI 209
Query: 698 GCILFFCITG------------------------GKHPYGESFERDANIVKDRKDLFLVE 733
G + TG + + + D+ +
Sbjct: 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSC 269
Query: 734 HIP-----EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+ + +L+ + +
Sbjct: 270 SLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-28
Identities = 85/378 (22%), Positives = 145/378 (38%), Gaps = 80/378 (21%)
Query: 434 NESKVG--------ETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGS 485
N VG ++ + F+ + D V + + + +K + G+
Sbjct: 88 NTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGA 147
Query: 486 NGTVVL-EGNYEGRSVAVKRLVK-----------THHDVALKEIQNLIASDQHPNIVRWY 533
G V L + VA++ + K EI+ L + HP I++
Sbjct: 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIK 206
Query: 534 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+D Y+ LE L D + V + +E K
Sbjct: 207 NFFDAED-YYIVLELMEGGELFDKV-VGNKRLKEA-TCK--------------------- 242
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFCAKLSD 651
++ + +LHE G+IHRDLKP+NVL+ S+++ K++D
Sbjct: 243 -----------------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITGG 708
G SK + G+ S + T G+ + APE L+ RA+D +SLG ILF C++G
Sbjct: 286 FGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG- 340
Query: 709 KHP--YGESFERD-ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLN 761
+P + + + K F+ E + +A+DL +LL +P R + L
Sbjct: 341 -YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399
Query: 762 HPFFWTADTRLSFLRDVS 779
HP+ D + F +S
Sbjct: 400 HPWLQDEDMKRKFQDLLS 417
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-28
Identities = 75/336 (22%), Positives = 116/336 (34%), Gaps = 79/336 (23%)
Query: 476 VFNKEIAKGSNGTVVLEGNYE-GRSVAVK----RLVKTHHDVALKEIQNLIASDQHPNIV 530
+ + G G V+ + + G VA+K L + + EIQ + HPN+V
Sbjct: 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIM-KKLNHPNVV 75
Query: 531 RWYGVESDQ------DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
V D L++E Y G + LN E L E IR
Sbjct: 76 SAREVPDGLQKLAPNDLPLLAME----------YCEGGDLRKYLNQFEN-CCGLKEGPIR 124
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDK 643
+ DI S L +LHE +IHRDLKP+N+++ +
Sbjct: 125 -------------------------TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILF 702
K+ D+G +K L C G+ + APE LL+ ++ T +D +S G + F
Sbjct: 160 RLIHKIIDLGYAKELDQGELC----TEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAF 214
Query: 703 FCITG-------------------GKHPYGESFERDANIVKDRKDLFLVEHIP-----EA 738
CITG + + ++ VK L H+ +
Sbjct: 215 ECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKL 274
Query: 739 VDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSF 774
+L + R N F D+ LS
Sbjct: 275 ERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 62/323 (19%), Positives = 112/323 (34%), Gaps = 81/323 (25%)
Query: 475 VVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIV 530
+ + +A+G V + GR A+KRL+ + ++E+ + HPNIV
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 531 RWYGV--------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
++ ++ Q L E C L + + K + L+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK------------KMESRGPLSC-- 135
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLIS 640
+LK+ + H+H +IHRDLK +N+L+S
Sbjct: 136 -----------------------DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS 172
Query: 641 KDKSFCAKLSDMGISKRLQG---------DMSCLTQNATGYGSSGWQAPEQL-LQGRQ-- 688
+ KL D G + + + + + T + ++ PE + L
Sbjct: 173 NQGTI--KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 689 TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIP-------EAVDL 741
D+++LGCIL+ +HP FE D ++ + IP L
Sbjct: 231 GEKQDIWALGCILYLLCF-RQHP----FE-DGAKLRIVNGKY---SIPPHDTQYTVFHSL 281
Query: 742 FTRLLDPNPDLRPKAQNVLNHPF 764
+L NP+ R V++
Sbjct: 282 IRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 9e-28
Identities = 43/338 (12%), Positives = 99/338 (29%), Gaps = 68/338 (20%)
Query: 477 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPN 528
+ + +G+ V + +K + ++ +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 529 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+++Y Q+ L E + +L + I K ++ + +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAI----------NLYKNTPEKVMPQGLVI--- 175
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS------- 640
++ + +H+ +IH D+KP N ++
Sbjct: 176 ----------------------SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213
Query: 641 --KDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSGWQAPEQLLQGRQTRAIDLF 695
D S L D+G S DM + +SG+Q E L ID F
Sbjct: 214 DEDDLSAGLALIDLGQSI----DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269
Query: 696 SLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK 755
+ ++ + G + ++ + + L ++ + F +L+
Sbjct: 270 GVAATVYCMLF-GTYMKVKNEGGECKPEGLFRRLPHLDMWN---EFFHVMLNIPDCHHLP 325
Query: 756 AQNVLNHPFF-W---TADTRLSFLRDVSDRVELEDRES 789
+ ++L ++ LR+ + LE + S
Sbjct: 326 SLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLECKRS 363
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 68/310 (21%), Positives = 115/310 (37%), Gaps = 61/310 (19%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIAS 523
+ +E+ KG+ V G A K +L +E +
Sbjct: 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC-RK 84
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
QHPNIVR + ++ F YL + T L + I V + E +
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASH----------- 132
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISK 641
+ I+ +++ H G++HR+LKP+N+L SK
Sbjct: 133 ----------------------------CIQQILESIAYCHSNGIVHRNLKPENLLLASK 164
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
K KL+D G++ + D A G+ G+ +PE L + ++ +D+++ G IL
Sbjct: 165 AKGAAVKLADFGLAIEVN-DSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
Query: 702 FFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPK 755
+ + G +P + E R +K + + PEA L +L NP R
Sbjct: 221 YILLVG--YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT 278
Query: 756 AQNVLNHPFF 765
A L P+
Sbjct: 279 ADQALKVPWI 288
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 68/301 (22%), Positives = 114/301 (37%), Gaps = 61/301 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNIVRW 532
+E+ KG+ V G A K +L +E + QHPNIVR
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARIC-RKLQHPNIVRL 70
Query: 533 YGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ ++ F YL + T L + I V + E +
Sbjct: 71 HDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASH-------------------- 109
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLS 650
+ I+ +++ H G++HR+LKP+N+L SK K KL+
Sbjct: 110 -------------------CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G++ + D A G+ G+ +PE L + ++ +D+++ G IL+ + G +
Sbjct: 151 DFGLAIEVN-DSEAWHGFA---GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG--Y 204
Query: 711 P--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
P + E R +K + + PEA L +L NP R A L P+
Sbjct: 205 PPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 264
Query: 765 F 765
Sbjct: 265 I 265
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 59/315 (18%), Positives = 116/315 (36%), Gaps = 79/315 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR--SVAVKRLVKTHHDVA----------LKEIQNLIA 522
+ + K+I KG G V +G VA+K L+ + +E+ + +
Sbjct: 21 IEYEKQIGKGGFGLV-HKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM-S 78
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNE 580
+ HPNIV+ YG+ ++ +V G + L +
Sbjct: 79 NLNHPNIVKLYGL-------------MHNPPR-MVMEFVPCGDL----------YHRLLD 114
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVL 638
+ + L++ DI G+ ++ ++HRDL+ N+
Sbjct: 115 KAHPI------------------KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF 156
Query: 639 IS---KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAI 692
+ ++ CAK++D G+S++ +S L G+ W APE + + T
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVHSVSGLL------GNFQWMAPE-TIGAEEESYTEKA 209
Query: 693 DLFSLGCILFFCITGGKHPYGE----SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLD 747
D +S IL+ +T G+ P+ E + I ++ + E P + ++
Sbjct: 210 DTYSFAMILYTILT-GEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWS 268
Query: 748 PNPDLRPKAQNVLNH 762
+P RP ++
Sbjct: 269 GDPKKRPHFSYIVKE 283
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 77/408 (18%), Positives = 134/408 (32%), Gaps = 77/408 (18%)
Query: 386 FYHSKQVKSKKQNEEHITK---TGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETD 442
+HS V +K E + +P + +R + R+ + + E+K
Sbjct: 5 HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64
Query: 443 GLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVA 501
+ + D + D + + I +G + V G A
Sbjct: 65 QPKGTENLYFQSM-GPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFA 123
Query: 502 VKRLVKT-----------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550
VK + T + +E L HP+I+ F++L +
Sbjct: 124 VKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 551 CS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLL 609
L D + + E+ +
Sbjct: 184 KGELFDYL-TEKVALSEK-ETR-------------------------------------- 203
Query: 610 KVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNA 669
+ R ++ +S LH ++HRDLKP+N+L+ + +LSD G S L+ L
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI--RLSDFGFSCHLEPG-EKLR--- 257
Query: 670 TGYGSSGWQAPEQLLQGRQTR------AIDLFSLGCILFFCITGGKHP--YGESFERDAN 721
G+ G+ APE L +DL++ G ILF + G P +
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG--SPPFWHRRQILMLR 315
Query: 722 IVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
++ + + F DL +RLL +P+ R A+ L HPFF
Sbjct: 316 MIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 59/299 (19%), Positives = 115/299 (38%), Gaps = 61/299 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEGNY--EGRSVAVKRLVKTHHDVA---LKEIQNLIASDQHPNI 529
++ + + KG G ++ + G + +K L++ + LKE++ ++ +HPN+
Sbjct: 12 LIHGEVLGKGCFGQA-IKVTHRETGEVMVMKELIRFDEETQRTFLKEVK-VMRCLEHPNV 69
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+++ GV + E Y+ G+ + K DS
Sbjct: 70 LKFIGVLYKDKRLNFITE----------YIKGGTLRGII--KSMDSQY------------ 105
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
P +Q + +DI SG+++LH + +IHRDL N L+ ++ +
Sbjct: 106 --------------PWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV--RENKNVVV 149
Query: 650 SDMGISKRLQGDMSCLTQNA-----------TGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
+D G+++ + + + T G+ W APE + +D+FS G
Sbjct: 150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFG 209
Query: 699 CILFFCITGGK-HPYGESFERD-ANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 754
+L I P D V+ D + + P + + R D +P+ RP
Sbjct: 210 IVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRP 268
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 62/315 (19%), Positives = 107/315 (33%), Gaps = 74/315 (23%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------------HDVALKEIQNLIAS 523
+ + +G + V + AVK + T + LKE+ L
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
HPNI++ F +L + L D + + E+ +
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEK-ETR----------- 127
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
K+ R ++ + LH++ ++HRDLKP+N+L+ D
Sbjct: 128 ---------------------------KIMRALLEVICALHKLNIVHRDLKPENILLDDD 160
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFS 696
+ KL+D G S +L L G+ + APE + + +D++S
Sbjct: 161 MNI--KLTDFGFSCQLDPG-EKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 697 LGCILFFCITGGKHP--YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNP 750
G I++ + G P + ++ F DL +R L P
Sbjct: 215 TGVIMYTLLAG--SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 751 DLRPKAQNVLNHPFF 765
R A+ L HPFF
Sbjct: 273 QKRYTAEEALAHPFF 287
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 79/331 (23%), Positives = 125/331 (37%), Gaps = 83/331 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 529
+ + KG G V L + +A+K L K H EIQ+ + +HPNI
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL---RHPNI 71
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R YG D VYL LE Y G + + Q + +E R
Sbjct: 72 LRLYGYFHDATRVYLILE----------YAPLG----TVYRELQKLSKFDEQRTA----- 112
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
++ + LS+ H +IHRD+KP+N+L+ + K+
Sbjct: 113 --------------------TYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKI 150
Query: 650 SDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
+D G S C G+ + PE + +DL+SLG + + +
Sbjct: 151 ADFGWSVHAPSSRRTDLC--------GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202
Query: 707 GGKHPYGESFERDANIVKDRK----DLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLN 761
GK P FE + ++ + + + A DL +RLL NP RP + VL
Sbjct: 203 -GKPP----FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
Query: 762 HPFFWTADTRLSFLRDVSDRVELEDRESDSK 792
HP+ + S +++ES SK
Sbjct: 258 HPW---------ITANSSKPSNCQNKESASK 279
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 52/296 (17%), Positives = 104/296 (35%), Gaps = 67/296 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL-----KEIQNLIASDQHPNI 529
+ F ++ + +G + +G ++G + VK L +E L HPN+
Sbjct: 12 LNFLTKLNENHSGEL-WKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRL-RIFSHPNV 69
Query: 530 VRWYGVESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+ G + +L ++ GS L
Sbjct: 70 LPVLGACQSPPAPHPTLITH----------WMPYGS---------------------LYN 98
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--EIGLIHRDLKPQNVLISKDKSF 645
V+ + + +Q +K D+ G++ LH E + L ++V+I D+
Sbjct: 99 VLHEGTNFVV------DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI--DEDM 150
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ----TRAIDLFSLGCIL 701
A++S D+ Q+ + W APE LQ + R+ D++S +L
Sbjct: 151 TARISM--------ADVKFSFQSPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLL 201
Query: 702 FFCITGGKHPYGE--SFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRP 754
+ +T + P+ + + E + + + I V L ++ +P RP
Sbjct: 202 WELVT-REVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRP 256
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 66/325 (20%), Positives = 121/325 (37%), Gaps = 93/325 (28%)
Query: 459 TDLIDDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYEG------RSVAVKRLVKTHHD 511
+ +I ++ R +I + G TV Y VA+K +
Sbjct: 2 SHMIGKIINERYKIVDK------LGGGGMSTV-----YLAEDTILNIKVAIKAI---FIP 47
Query: 512 VAL---------KEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLS 561
+E+ N + H NIV V+ + D YL +E +L++ I
Sbjct: 48 PREKEETLKRFEREVHN-SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI---- 102
Query: 562 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH-PSAQLLKVTRDIVSGLS 620
+++G + T I+ G+
Sbjct: 103 -------------------------------------ESHGPLSVDTAINFTNQILDGIK 125
Query: 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP 680
H H++ ++HRD+KPQN+LI +K+ K+ D GI+K L + LTQ G+ + +P
Sbjct: 126 HAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSE--TSLTQTNHVLGTVQYFSP 181
Query: 681 EQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GES--------FERDANIVKDRKDLFL 731
EQ D++S+G +L+ + G+ P+ GE+ + V +
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLV-GEPPFNGETAVSIAIKHIQDSVPNVTTD----V 236
Query: 732 VEHIPEAVD-LFTRLLDPNPDLRPK 755
+ IP+++ + R + + R K
Sbjct: 237 RKDIPQSLSNVILRATEKDKANRYK 261
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 75/329 (22%), Positives = 121/329 (36%), Gaps = 74/329 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 533
E+ G+ G V + G +AVK++ ++ + K I ++ S P IV+ +
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
G V++++E L + G E+
Sbjct: 91 GTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER-------------------------- 124
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDM 652
L K+T IV L +L E G+IHRD+KP N+L+ + KL D
Sbjct: 125 -------------ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDF 169
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI-----DLFSLGCILFFCITG 707
GIS RL D + G + + APE++ T+ D++SLG L T
Sbjct: 170 GISGRLVDDKAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT- 224
Query: 708 GKHPYGES---FERDANIVKD------RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 758
G+ PY FE ++++ F + L + RPK
Sbjct: 225 GQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF----SGDFQSFVKDCLTKDHRKRPKYNK 280
Query: 759 VLNHPFFWTADTR----LSFLRDVSDRVE 783
+L H F +T S+ +DV + E
Sbjct: 281 LLEHSFIKRYETLEVDVASWFKDVMAKTE 309
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 81/329 (24%), Positives = 133/329 (40%), Gaps = 76/329 (23%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK------------THHDVALKEIQNLIAS 523
+K + G+ G V L + VA+K + K +V EI+ L
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNV-ETEIEILKKL 72
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+ HP I++ +D Y+ LE L D + V + +E K
Sbjct: 73 N-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKV-VGNKRLKEA-TCK----------- 117
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SK 641
++ + +LHE G+IHRDLKP+NVL+ S+
Sbjct: 118 ---------------------------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLG 698
++ K++D G SK + G+ S + T G+ + APE L+ RA+D +SLG
Sbjct: 151 EEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 699 CILFFCITGGKHP--YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNP 750
ILF C++G +P + I + + F+ E + +A+DL +LL +P
Sbjct: 207 VILFICLSG--YPPFSEHRTQVSLKDQITSGKYN-FIPEVWAEVSEKALDLVKKLLVVDP 263
Query: 751 DLRPKAQNVLNHPFFWTADTRLSFLRDVS 779
R + L HP+ D + F +S
Sbjct: 264 KARFTTEEALRHPWLQDEDMKRKFQDLLS 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 65/299 (21%), Positives = 106/299 (35%), Gaps = 67/299 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-------LKEIQNLIASDQHP 527
+ + I G G V + G VAVK + +E + L A +HP
Sbjct: 9 LTLEEIIGIGGFGKV-YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAK-LFAMLKHP 66
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NI+ GV + + L +E + G L+ K
Sbjct: 67 NIIALRGVCLKEPNLCLVME----------FARGGPLNRVLSGKRI-------------- 102
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG---LIHRDLKPQNVLISKDKS 644
P L+ I G+++LH+ +IHRDLK N+LI +
Sbjct: 103 ----------------PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
Query: 645 F------CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698
K++D G+++ T + G+ W APE + ++ D++S G
Sbjct: 147 NGDLSNKILKITDFGLAREWHR-----TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYG 201
Query: 699 CILFFCITGGKHPYGE-SFERDANIVKDRKD-LFLVEHIPEAV-DLFTRLLDPNPDLRP 754
+L+ +T G+ P+ A V K L + PE L +P+P RP
Sbjct: 202 VLLWELLT-GEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRP 259
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-26
Identities = 67/324 (20%), Positives = 112/324 (34%), Gaps = 78/324 (24%)
Query: 478 NKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK---THHDVALKEIQNLIASDQHPNIVRWY 533
+ +G++ V + AVK + K +E++ L H N++
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 534 GVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
++D YL E+ S+ I F E +
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHI-HKRRHFNELEASV--------------------- 115
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLSD 651
V +D+ S L LH G+ HRDLKP+N+L ++ K+ D
Sbjct: 116 ------------------VVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157
Query: 652 MGISKRLQGDMSCLTQNA----TGYGSSGWQAPEQLLQGRQTR-----AIDLFSLGCILF 702
+ ++ + C + T GS+ + APE + + DL+SLG IL+
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
Query: 703 FCITG-----GKHPYGESFERDANIVKDRKDLFLVEHI----------------PEAVDL 741
++G G+ ++R + LF E I A DL
Sbjct: 218 ILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF--ESIQEGKYEFPDKDWAHISCAAKDL 275
Query: 742 FTRLLDPNPDLRPKAQNVLNHPFF 765
++LL + R A VL HP+
Sbjct: 276 ISKLLVRDAKQRLSAAQVLQHPWV 299
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 58/333 (17%), Positives = 110/333 (33%), Gaps = 89/333 (26%)
Query: 477 FNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVR 531
+ + +G+ V + + G A+K DV ++E + L + H NIV+
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVK 71
Query: 532 WYGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ +E + L +E + GS L + L E
Sbjct: 72 LFAIEEETTTRHKVLIME----------FCPCGSLYTVLEEPSN-AYGLPESEFL----- 115
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI--SKDKSFCA 647
V RD+V G++HL E G++HR++KP N++ +D
Sbjct: 116 --------------------IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---------AIDLFSLG 698
KL+D G ++ L+ D + YG+ + P+ + + R +DL+S+G
Sbjct: 156 KLTDFGAARELEDDEQF----VSLYGTEEYLHPD-MYERAVLRKDHQKKYGATVDLWSIG 210
Query: 699 CILFFCITG----------------------GKHPYGESFERDA--NIVKDRKDLFLVEH 734
+ TG GK S + A + D+ +
Sbjct: 211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCS 270
Query: 735 IP-----EAVDLFTRLLDPNPDLRPKAQNVLNH 762
+ + +L+ + +
Sbjct: 271 LSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 66/306 (21%), Positives = 115/306 (37%), Gaps = 78/306 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKT--------HHDVALKEIQNLIASDQHPNI 529
+ + KG G V L + +A+K L K+ H EIQ+ + +HPNI
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL---RHPNI 76
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R Y D+ +YL LE + G +L + Q +E R
Sbjct: 77 LRMYNYFHDRKRIYLMLE----------FAPRG----ELYKELQKHGRFDEQRSA----- 117
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
++ L + HE +IHRD+KP+N+L+ K+
Sbjct: 118 --------------------TFMEELADALHYCHERKVIHRDIKPENLLM--GYKGELKI 155
Query: 650 SDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCI 705
+D G S C G+ + PE +++G+ +DL+ G + + +
Sbjct: 156 ADFGWSVHAPSLRRRTMC--------GTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFL 206
Query: 706 TGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNV 759
G P F+ + + + DL + + DL ++LL +P R + V
Sbjct: 207 V-GMPP----FD-SPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGV 260
Query: 760 LNHPFF 765
+ HP+
Sbjct: 261 MEHPWV 266
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 65/304 (21%), Positives = 118/304 (38%), Gaps = 66/304 (21%)
Query: 478 NKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV- 535
+ + G NG V+ G+ A+K L + A +E+ + + P+IV V
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--KARQEVDHHWQASGGPHIVCILDVY 91
Query: 536 ---ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ + + +E L I +E+ E
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRI-------------QERGDQAFTE----------- 127
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAKLS 650
++ +A++++ DI + + LH + HRD+KP+N+L SK+K KL+
Sbjct: 128 -RE----------AAEIMR---DIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173
Query: 651 DMGISKRL-QGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
D G +K Q + T + + APE L + ++ D++SLG I++ + G
Sbjct: 174 DFGFAKETTQNALQ------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-- 225
Query: 710 HP--YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNV 759
P Y + + + +K R + F + +A L LL +P R
Sbjct: 226 FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
Query: 760 LNHP 763
+NHP
Sbjct: 286 MNHP 289
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 58/315 (18%), Positives = 114/315 (36%), Gaps = 56/315 (17%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQ 525
+ + + + +++ +G G V ++ K + D KEI ++ +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS-ILNIAR 59
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H NI+ + + + + E ++ E++N + LNE I
Sbjct: 60 HRNILHLHESFESMEELVMIFE----------FISGLDIFERINTSAFE---LNEREIV- 105
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ L LH + H D++P+N++ +S
Sbjct: 106 ------------------------SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS 141
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
K+ + G +++L+ + + + APE + A D++SLG +++ +
Sbjct: 142 TIKIIEFGQARQLKPG----DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197
Query: 706 TGGKHP-YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQN 758
+ G +P E+ + NI+ F E I EA+D RLL R A
Sbjct: 198 S-GINPFLAET-NQQIIENIMNAEYT-FDEEAFKEISIEAMDFVDRLLVKERKSRMTASE 254
Query: 759 VLNHPFFWTADTRLS 773
L HP+ R+S
Sbjct: 255 ALQHPWLKQKIERVS 269
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 64/333 (19%), Positives = 111/333 (33%), Gaps = 83/333 (24%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQH 526
R + + + + + KG G V G+++G +VAVK E+ N + +H
Sbjct: 4 RTVARDITLLECVGKGRYGEV-WRGSWQGENVAVKIFSSRDEKSWFRETELYNTVML-RH 61
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIR 584
NI+ + SD + S + LI Y GS + L D
Sbjct: 62 ENILGFIA--SDMTSRHSSTQLW------LITHYHEMGSLYDYLQLTTLD---------- 103
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQN 636
L++ I SGL+HLH + HRDLK +N
Sbjct: 104 -------------TV-------SCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143
Query: 637 VLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPE------QLLQGRQT 689
+L+ K+ ++D+G++ + L G+ + APE Q+
Sbjct: 144 ILVKKN--GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 690 RAIDLFSLG---------CILFFCITGGKHPYGE------SFERDANIVKDRK------- 727
+ +D+++ G + + K P+ + SFE +V +
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPN 261
Query: 728 DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760
F + L NP R A +
Sbjct: 262 RWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 69/353 (19%), Positives = 131/353 (37%), Gaps = 65/353 (18%)
Query: 476 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 534
V ++ + G NG V+ A+K L A +E++ + Q P+IVR
Sbjct: 65 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVD 122
Query: 535 V----ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V + + + + +E L I +++ E
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTE--------- 160
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAK 648
++ +++++K I + +LH I + HRD+KP+N+L SK + K
Sbjct: 161 ---RE----------ASEIMK---SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 204
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
L+D G +K S T + + APE L + ++ D++SLG I++ + G
Sbjct: 205 LTDFGFAKETTSHNSLTTP----CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG- 259
Query: 709 KHP--YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQN 758
+P Y + +K R + F + E L LL P R
Sbjct: 260 -YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 318
Query: 759 VLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALVALNGKWDE 811
+NHP W + + L++ + + ++ AL + +++
Sbjct: 319 FMNHP--WIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQ 369
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 64/315 (20%), Positives = 112/315 (35%), Gaps = 83/315 (26%)
Query: 464 DRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTHHDVA---- 513
+ +G + G + + + +G G V YE R VA+K + ++
Sbjct: 26 ESREGTQFGPYRL-RRLVGRGGMGDV-----YEAEDTVRERIVALKLM---SETLSSDPV 76
Query: 514 -----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL 568
+E + Q P++V + +Y+ + + +
Sbjct: 77 FRTRMQREART-AGRLQEPHVVPIHDFGEIDGQLYVDMR----------LI------NGV 119
Query: 569 NAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628
+ +L + L + + + R I S L H G
Sbjct: 120 DLAA----MLRR-QGPL------------------APPRAVAIVRQIGSALDAAHAAGAT 156
Query: 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ 688
HRD+KP+N+L+S D A L D GI+ LTQ G+ + APE+ +
Sbjct: 157 HRDVKPENILVSADDF--AYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHA 212
Query: 689 TRAIDLFSLGCILFFCITGGKHPY-GES-------FERDANIVKDRKDLFLVEHIPEAVD 740
T D+++L C+L+ C+T G PY G+ + + IP A D
Sbjct: 213 TYRADIYALTCVLYECLT-GSPPYQGDQLSVMGAHINQAIPRPST-----VRPGIPVAFD 266
Query: 741 -LFTRLLDPNPDLRP 754
+ R + NP+ R
Sbjct: 267 AVIARGMAKNPEDRY 281
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-25
Identities = 76/327 (23%), Positives = 135/327 (41%), Gaps = 65/327 (19%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQN----LIASDQHPNIVRWY 533
EI +G+ G+V + G+ +AVKR+ T + K++ ++ S P IV++Y
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
G + ++ +E + S + K
Sbjct: 88 GALFREGDCWICMELMSTSFDKFY-----------------------------------K 112
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDM 652
+ + P L K+T V L+HL E +IHRD+KP N+L+ + + KL D
Sbjct: 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDF 170
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAIDLFSLGCILFFCITG 707
GIS +L ++ T++A G + APE++ R+ D++SLG L+ T
Sbjct: 171 GISGQLVDSIAK-TRDA---GCRPYMAPERIDPSASRQGYDVRS-DVWSLGITLYELAT- 224
Query: 708 GKHPYGES---FERDANIVKDR----KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760
G+ PY + F++ +VK + E P ++ L + RPK + +L
Sbjct: 225 GRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
Query: 761 NHPFFWTADTR----LSFLRDVSDRVE 783
HPF + R ++ + D++
Sbjct: 285 KHPFILMYEERAVEVACYVCKILDQMP 311
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 69/327 (21%), Positives = 118/327 (36%), Gaps = 96/327 (29%)
Query: 461 LIDDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYEG------RSVAVKRLVKTHHDVA 513
+ R +G++ + G V + R VAVK L D+A
Sbjct: 5 TTPSHLSDRYELGEI------LGFGGMSEV-----HLARDLRDHRDVAVKVL---RADLA 50
Query: 514 L---------KEIQNLIASDQHPNIVRWYGVESDQD----FVYLSLERCT-CSLNDLIYV 559
+E QN A+ HP IV Y + Y+ +E +L D++
Sbjct: 51 RDPSFYLRFRREAQN-AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-- 107
Query: 560 LSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH-PSAQLLKVTRDIVSG 618
G + ++V D
Sbjct: 108 ---------------------------------------HTEGPMTPKRAIEVIADACQA 128
Query: 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ 678
L+ H+ G+IHRD+KP N++IS + K+ D GI++ + + +TQ A G++ +
Sbjct: 129 LNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 679 APEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GES--------FERDANIVKDRKDL 729
+PEQ D++SLGC+L+ +T G+ P+ G+S D
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLT-GEPPFTGDSPVSVAYQHVREDPIPPSA---- 241
Query: 730 FLVEHIPEAVD-LFTRLLDPNPDLRPK 755
E + +D + + L NP+ R +
Sbjct: 242 -RHEGLSADLDAVVLKALAKNPENRYQ 267
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 72/312 (23%), Positives = 125/312 (40%), Gaps = 67/312 (21%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWY 533
E+ +G+ G V + G+ +AVKR+ T + L ++ + + P V +Y
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
G + V++ +E SL+ +V + + E+
Sbjct: 73 GALFREGDVWICMELMDTSLDKF---------------------YKQVIDKGQTIPED-- 109
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
L K+ IV L HLH ++ +IHRD+KP NVLI+ K+ D
Sbjct: 110 -------------ILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDF 154
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-----TRAIDLFSLGCILFFCITG 707
GIS L D++ +A G + APE++ ++ D++SLG +
Sbjct: 155 GISGYLVDDVAKDI-DA---GCKPYMAPERINPELNQKGYSVKS-DIWSLGITMIELAI- 208
Query: 708 GKHPYGES---FERDANIVKD-----RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV 759
+ PY F++ +V++ D F E VD ++ L N RP +
Sbjct: 209 LRFPYDSWGTPFQQLKQVVEEPSPQLPADKF----SAEFVDFTSQCLKKNSKERPTYPEL 264
Query: 760 LNHPFFWTADTR 771
+ HPFF +++
Sbjct: 265 MQHPFFTLHESK 276
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 57/326 (17%), Positives = 115/326 (35%), Gaps = 85/326 (26%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYG 534
+ A+G G V VAVK E+ +L +H NI+++ G
Sbjct: 28 LLEVKARGRFGCVWK-AQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIG 85
Query: 535 VESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+++ + ++ LI + GS + L +N+++
Sbjct: 86 --AEKRGTSVDVDLW------LITAFHEKGSLSDFLK-----ANVVS------------- 119
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHE----------IGLIHRDLKPQNVLISKD 642
W +L + + GL++LHE + HRD+K +NVL+
Sbjct: 120 -----WN-------ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL--K 165
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL-----LQGRQTRAIDLFSL 697
+ A ++D G++ + + S + G+ + APE L Q ID++++
Sbjct: 166 NNLTACIADFGLALKFEAGKSAGDTHGQ-VGTRRYMAPEVLEGAINFQRDAFLRIDMYAM 224
Query: 698 GCILFFCITG----------GKHPYGESFERDANI-------VKDRKDLFLVEHIP--EA 738
G +L+ + P+ E + ++ V +K L ++
Sbjct: 225 GLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAG 284
Query: 739 VDLFTRLL----DPNPDLRPKAQNVL 760
+ + + D + + R A V
Sbjct: 285 MAMLCETIEECWDHDAEARLSAGCVG 310
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 52/336 (15%), Positives = 112/336 (33%), Gaps = 95/336 (28%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALK----------------------E 516
+ + +G ++L + + A+K+ K+ + +
Sbjct: 37 RTLNQGKFNKIIL-CEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 517 IQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSN 576
I I ++ + G+ ++ D VY+ E Y+ + + ++
Sbjct: 96 IITDI---KNEYCLTCEGIITNYDEVYIIYE----------YMEND----SILKFDEYFF 138
Query: 577 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQ 635
+L++ +P+ + + + +++ S++H E + HRD+KP
Sbjct: 139 VLDKNYTCFIPIQV-----------------IKCIIKSVLNSFSYIHNEKNICHRDVKPS 181
Query: 636 NVLISKDKSFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT--- 689
N+L+ DK+ KLSD G S+ + S G+ + PE +
Sbjct: 182 NILM--DKNGRVKLSDFGESEYMVDKKIKGSR--------GTYEFMPPE-FFSNESSYNG 230
Query: 690 RAIDLFSLGCILFFCITG-------------------GKHPYGESFERDANIVKDRKDLF 730
+D++SLG L+ Y + ++K
Sbjct: 231 AKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTC 290
Query: 731 LVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+ E +D L NP R +++ L H +
Sbjct: 291 SNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 73/360 (20%), Positives = 127/360 (35%), Gaps = 87/360 (24%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK----RLVKTHHDVALK---EIQNL 520
+ IGK ++ + +GS G V + E AVK + ++ + EIQ L
Sbjct: 2 KLIGKYLM-GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 521 IASDQHPNIVRWYGV---ESDQDFVYLSLERCTCSLNDLI-YVLSGSFEEQLNAKEQDSN 576
H N+++ V E Q +Y+ +E C C + +++ V F
Sbjct: 61 RRLR-HKNVIQLVDVLYNEEKQK-MYMVMEYCVCGMQEMLDSVPEKRFPV---------- 108
Query: 577 LLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQN 636
+ ++ GL +LH G++H+D+KP N
Sbjct: 109 --CQAH---------------------------GYFCQLIDGLEYLHSQGIVHKDIKPGN 139
Query: 637 VLISKDKSFCAKLSDMGIS----KRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQT 689
+L+ K+S +G++ D S GS +Q PE + G T
Sbjct: 140 LLL--TTGGTLKISALGVAEALHPFAADDTCRTSQ--------GSPAFQPPE-IANGLDT 188
Query: 690 ---RAIDLFSLGCILFFCITGGKHPYGESFERDANIVK-----DRKDLFLVEHI-PEAVD 740
+D++S G L+ T G +P FE NI K + + P D
Sbjct: 189 FSGFKVDIWSAGVTLYNITT-GLYP----FE-GDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 741 LFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 800
L +L+ P R + + H +F + + +DR ++ LE +
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSMTVVPYLEDL 302
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/332 (18%), Positives = 106/332 (31%), Gaps = 79/332 (23%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQH 526
R I + +V + I KG G V G + G VAVK EI +H
Sbjct: 38 RTIARTIVLQESIGKGRFGEV-WRGKWRGEEVAVKIFSSREERSWFREAEIYQT-VMLRH 95
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NI+ + ++ + + L + Y GS + LN
Sbjct: 96 ENILGFIAADNKDNGTWTQLWLVSD------YHEHGSLFDYLNRYTVT------------ 137
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQNVL 638
+ ++K+ SGL+HLH + HRDLK +N+L
Sbjct: 138 -----------VE-------GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179
Query: 639 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPE------QLLQGRQTRA 691
+ K+ ++D+G++ R + G+ + APE + +
Sbjct: 180 VKKN--GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 237
Query: 692 IDLFSLGCIL----FFCITGGKH-----PYGESFERDAN-------IVKDR------KDL 729
D++++G + C GG H PY + D + + + +
Sbjct: 238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW 297
Query: 730 FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761
E + + N R A +
Sbjct: 298 QSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 72/428 (16%), Positives = 129/428 (30%), Gaps = 70/428 (16%)
Query: 389 SKQVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHIT 448
+K +SK ++K+ R + + N +
Sbjct: 86 NKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYY- 144
Query: 449 GNGEKFLLTFTDLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVK 507
+ + D + D D ++E+ G+ G V G + A K ++
Sbjct: 145 ---PQPVEIKHDHVLDHYD---------IHEELGTGAFGVVHRVTERATGNNFAAKFVMT 192
Query: 508 TH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGS 563
H + KEIQ ++ +HP +V + D + + + E + L + +
Sbjct: 193 PHESDKETVRKEIQ-TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251
Query: 564 FEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623
E + R + GL H+H
Sbjct: 252 MSEDEAVE---------------------------------------YMRQVCKGLCHMH 272
Query: 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQL 683
E +H DLKP+N++ + +S KL D G++ L G++ + APE
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK----QSVKVTTGTAEFAAPEVA 328
Query: 684 LQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEA 738
D++S+G + + ++ G P GE+ + VK I +
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 387
Query: 739 VDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALE 798
D +LL +P+ R L HP W K
Sbjct: 388 KDFIRKLLLADPNTRMTIHQALEHP--WLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAW 445
Query: 799 GIALVALN 806
L L
Sbjct: 446 PEPLPPLG 453
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 72/332 (21%), Positives = 113/332 (34%), Gaps = 81/332 (24%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKE--IQNLIASDQH 526
R I K + K+I KG G V G + G VAVK T +E I + +H
Sbjct: 33 RTIAKQIQMVKQIGKGRYGEV-WMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLM-RH 90
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NI+ + + + L T Y +GS + L + D
Sbjct: 91 ENILGFIAADIKGTGSWTQLYLITD------YHENGSLYDYLKSTTLD------------ 132
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--------IGLIHRDLKPQNVL 638
K +LK+ VSGL HLH + HRDLK +N+L
Sbjct: 133 -----------AK-------SMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL 174
Query: 639 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQ-------TR 690
+ K+ ++D+G++ + D + + G+ + PE +L
Sbjct: 175 VKKN--GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYI 231
Query: 691 AIDLFSLG---------CILFFCITGGKHPYGE------SFERDANIVKDRK-------D 728
D++S G C+ + + PY + S+E IV +K
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNR 291
Query: 729 LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760
E + + L T NP R A V
Sbjct: 292 WSSDECLRQMGKLMTECWAHNPASRLTALRVK 323
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 73/347 (21%), Positives = 126/347 (36%), Gaps = 96/347 (27%)
Query: 462 IDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVK-----RLVKTHHDVALK 515
D ++ + + EI KGS G V L N A+K +L++
Sbjct: 3 SGSSGDCVQLNQYTL-KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRP 61
Query: 516 EIQNLIASDQ-----------------------HPNIVRWYGV--ESDQDFVYLSLERCT 550
+ + HPN+V+ V + ++D +Y+ E
Sbjct: 62 PPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFE--- 118
Query: 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610
V G PVM ++ Q
Sbjct: 119 -------LVNQG------------------------PVM----EVP--TLKPLSEDQARF 141
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNAT 670
+D++ G+ +LH +IHRD+KP N+L+ +D K++D G+S +G + L +
Sbjct: 142 YFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG--HIKIADFGVSNEFKGSDALL---SN 196
Query: 671 GYGSSGWQAPEQLLQGRQT----RAIDLFSLGCILFFCITGGKHPYGESFERDANIV--- 723
G+ + APE L + +A+D++++G L +C G+ P F D I+
Sbjct: 197 TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTL-YCFVFGQCP----FM-DERIMCLH 249
Query: 724 -KDRKDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
K + + DL TR+LD NP+ R + HP+
Sbjct: 250 SKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 70/308 (22%), Positives = 103/308 (33%), Gaps = 78/308 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALK---------EIQNLI---ASDQ 525
+ KG GTV VA+K + + E+ L A
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 526 HPNIVRWYGVESDQDFVYLSLER-CTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
HP ++R Q+ L LER L D I G E R
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGE------------GPSR- 142
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+V+ + H H G++HRD+K +N+LI +
Sbjct: 143 --------------------------CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176
Query: 644 SFCAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLG 698
CAKL D G L + G+ + PE + Q ++SLG
Sbjct: 177 -GCAKLIDFGSGALLHDEPYTDFD--------GTRVYSPPE-WISRHQYHALPATVWSLG 226
Query: 699 CILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQ 757
+L+ + G P FERD I+ +L H+ P+ L R L P P RP +
Sbjct: 227 ILLYDMVC-GDIP----FERDQEIL--EAELHFPAHVSPDCCALIRRCLAPKPSSRPSLE 279
Query: 758 NVLNHPFF 765
+L P+
Sbjct: 280 EILLDPWM 287
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 59/300 (19%), Positives = 108/300 (36%), Gaps = 61/300 (20%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK----RLVKTHHDVALKEIQNLIASDQHPNIVR 531
+E+ G+ G V GR K + V EI ++ HP ++
Sbjct: 55 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEIS-IMNQLHHPKLIN 112
Query: 532 WYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ D+ + L LE + L D I + ++E +
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRIA--------------AEDYKMSEAEVINY---- 154
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
R GL H+HE ++H D+KP+N++ K+ K+
Sbjct: 155 ---------------------MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 193
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G++ +L D ++ + APE + + D++++G + + ++ G
Sbjct: 194 DFGLATKLNPD----EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLS 248
Query: 711 P-YGESFERD--ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNVLNHP 763
P GE + + N+ + + F + + PEA D LL P R + L HP
Sbjct: 249 PFAGED-DLETLQNVKRCDWE-FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 61/306 (19%), Positives = 102/306 (33%), Gaps = 76/306 (24%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALK---------EIQNL-IASDQHP 527
+ G G+V VA+K + K + E+ L S
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 528 NIVRWYGVESDQDFVYLSLERCTCS--LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
++R D L LER L D I G+ +E R
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQE------------ELAR--- 152
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
++ + H H G++HRD+K +N+LI ++
Sbjct: 153 ------------------------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-G 187
Query: 646 CAKLSDMGISKRLQGDM---SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCI 700
KL D G L+ + G+ + PE ++ + R+ ++SLG +
Sbjct: 188 ELKLIDFGSGALLKDTVYTDFD--------GTRVYSPPE-WIRYHRYHGRSAAVWSLGIL 238
Query: 701 LFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNV 759
L+ + G P FE D I++ +F + + E L L P RP + +
Sbjct: 239 LYDMVC-GDIP----FEHDEEIIRG--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 291
Query: 760 LNHPFF 765
NHP+
Sbjct: 292 QNHPWM 297
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 74/309 (23%), Positives = 127/309 (41%), Gaps = 70/309 (22%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNI 529
F K + +GS TVVL R A+K L K H + ++ ++++ HP
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEK-RHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V+ Y D + +Y L Y +G + + + +E R
Sbjct: 93 VKLYFTFQDDEKLYFGLS----------YAKNGELLKYI----RKIGSFDETCTRFY--- 135
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+A+ IVS L +LH G+IHRDLKP+N+L+ ++ ++
Sbjct: 136 ---------------TAE-------IVSALEYLHGKGIIHRDLKPENILL--NEDMHIQI 171
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
+D G +K L + N + G++ + +PE L + ++ DL++LGCI++ + G
Sbjct: 172 TDFGTAKVLSPESKQARAN-SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG-- 228
Query: 710 HP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRP------KA 756
P + F+ I+K + E P+A DL +LL + R
Sbjct: 229 LPPFRAGNEYLIFQ---KIIKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 283
Query: 757 QNVLNHPFF 765
+ HPFF
Sbjct: 284 GPLKAHPFF 292
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 67/322 (20%), Positives = 120/322 (37%), Gaps = 66/322 (20%)
Query: 476 VFNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIASDQHPNI 529
+ +KE+ +G V G+ A K R + L EI L + P +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 530 VRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + V + + L LE + L + + +++E +
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCL-------------PELAEMVSENDVI---- 134
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCA 647
++ + I+ G+ +LH+ ++H DLKPQN+L S
Sbjct: 135 ---------------------RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K+ D G+S+++ L + G+ + APE L T A D++++G I + +T
Sbjct: 174 KIVDFGMSRKIGHA-CELREIM---GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
Query: 708 GKHP--YGES----FERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 757
GE + NI + D + E + A D LL NP+ RP A+
Sbjct: 230 --TSPFVGEDNQETYL---NISQVNVD-YSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283
Query: 758 NVLNHPFFWTADTRLSFLRDVS 779
L+H + D F + +
Sbjct: 284 ICLSHSWLQQWDFENLFHPEET 305
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 64/348 (18%), Positives = 118/348 (33%), Gaps = 68/348 (19%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 527
+E+ G V G A K + + V+ +EI+ ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 528 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
N++ + V ++ V L LE + L D + S E+ E
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEE------------EAT---- 118
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSF 645
+ I+ G+++LH + H DLKP+N+++ K+
Sbjct: 119 -----------------------SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155
Query: 646 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
KL D G++ ++ +G+ + APE + D++S+G I +
Sbjct: 156 PHIKLIDFGLAHEIEDG-VEFKNI---FGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 705 ITGGKHP--YGESFERD-ANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 757
++G G++ + ANI D F E H A D +LL R Q
Sbjct: 212 LSG--ASPFLGDTKQETLANITSVSYD-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQ 268
Query: 758 NVLNHPFF--WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 803
L HP+ + V + + + + ++L
Sbjct: 269 EALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRRRWKLSFSIVSLC 316
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 62/311 (19%), Positives = 110/311 (35%), Gaps = 64/311 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHPNI 529
+E+ G V G+ A K RL + V+ +EI+ + +HPNI
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 530 VRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + + ++ V L LE + L D + S E E
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTED------------EAT------ 111
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKSFC 646
+ + I+ G+ +LH + H DLKP+N+++ +
Sbjct: 112 ---------------------QFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 150
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
KL D GI+ +++ + +G+ + APE + D++S+G I + ++
Sbjct: 151 IKLIDFGIAHKIEAG-NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 206
Query: 707 GGKHP--YGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVL 760
G GE+ + + F E+ A D RLL +P R L
Sbjct: 207 G--ASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSL 264
Query: 761 NHPFFWTADTR 771
H + R
Sbjct: 265 EHSWIKAIRRR 275
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 70/365 (19%), Positives = 131/365 (35%), Gaps = 73/365 (20%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 535
K + GS G V + E G+ A+K+ V +E+ ++ H NI++
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKK-VLQDPRYKNRELD-IMKVLDHVNIIKLVDYFY 70
Query: 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT--K 593
+ + + + + + + LN + + + +T K
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI----MEYVPDTLHK 126
Query: 594 DIELWKANGHP---------SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
++ + +G QL + + +H +G+ HRD+KPQN+L+ +
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLGICHRDIKPQNLLV--NSK 177
Query: 645 FCA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL 701
KL D G +K+L + + Y S + +APE +L + T +IDL+S+GC+
Sbjct: 178 DNTLKLCDFGSAKKLIPS-----EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 702 FFCITG-----GKH--------------PYGESFERDANIVKDRK----------DLFLV 732
I G G+ P E R + + +
Sbjct: 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPE 292
Query: 733 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSK 792
A+DL ++L PDLR + HPFF LR+ + +
Sbjct: 293 GTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF-------DHLRNSYESEVKNNSNFPHG 345
Query: 793 LLRAL 797
+ + +
Sbjct: 346 VNQNI 350
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 65/296 (21%), Positives = 104/296 (35%), Gaps = 63/296 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNI 529
+ + I GS GTV +G + G VAVK L T E+ L +H NI
Sbjct: 26 ITVGQRIGSGSFGTV-YKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVL-RKTRHVNI 82
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + G S + + + C SL ++ FE +
Sbjct: 83 LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMK--------------------- 120
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+L+ + R G+ +LH +IHRDLK N+ + + K
Sbjct: 121 ------------------KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL--HEDNTVK 160
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCI 705
+ D G++ + S Q GS W APE + + D+++ G +L+ +
Sbjct: 161 IGDFGLA-TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 706 TGGKHPYGESFERDANIV----KDRKDLFLV--EHIPEAV-DLFTRLLDPNPDLRP 754
T G+ PY RD I + P+ + L L D RP
Sbjct: 220 T-GQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 73/306 (23%), Positives = 123/306 (40%), Gaps = 77/306 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNIVRW 532
K I KG+ V L + GR VA+K + KT + +E++ + HPNIV+
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM-KILNHPNIVKL 79
Query: 533 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ V + +YL +E + + D + V G +E E R
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKE------------KEAR--------- 117
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
R IVS + + H+ ++HRDLK +N+L+ D K++D
Sbjct: 118 ------------------SKFRQIVSAVQYCHQKRIVHRDLKAENLLL--DADMNIKIAD 157
Query: 652 MGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCI 705
G S C G+ + APE L QG++ +D++SLG IL+ +
Sbjct: 158 FGFSNEFTVGGKLDAFC--------GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 706 TGGKHPYGESFERDANIVKDRKDLFLVE-HIP-----EAVDLFTRLLDPNPDLRPKAQNV 759
+ G P F+ N+ + R+ + + IP + +L R L NP R + +
Sbjct: 209 S-GSLP----FD-GQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262
Query: 760 LNHPFF 765
+ +
Sbjct: 263 MKDRWI 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 62/346 (17%), Positives = 115/346 (33%), Gaps = 64/346 (18%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 527
+E+ G V G A K + + V +EI+ ++ HP
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 528 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NI+ + V ++ V L LE + L D + S E+ E
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEE------------EAT---- 118
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSF 645
+ I+ G+++LH + H DLKP+N++ + K+
Sbjct: 119 -----------------------SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPI 155
Query: 646 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
KL D G++ ++ G+ + APE + D++S+G I +
Sbjct: 156 PHIKLIDFGLAHEIEDG-VEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 211
Query: 705 ITGGKHP-YGESFERDANIVKDRKDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQNV 759
++ G P G++ + + F E A D +LL R Q
Sbjct: 212 LS-GASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 760 LNHPFF--WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 803
L HP+ + V + + + + + ++L
Sbjct: 271 LRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLC 316
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 66/319 (20%), Positives = 113/319 (35%), Gaps = 75/319 (23%)
Query: 465 RVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH-------HDVALK- 515
+G K + G+ G V + E + V VK + K D L
Sbjct: 17 ACEGEYSQKYSTM-SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGK 75
Query: 516 ---EIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS---LNDLIYVLSGSFEEQLN 569
EI L + +H NI++ + +Q F L +E+ S L I +E
Sbjct: 76 VTLEIAIL-SRVEHANIIKVLDIFENQGFFQLVMEKH-GSGLDLFAFI-DRHPRLDE--- 129
Query: 570 AKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629
+ R +VS + +L +IH
Sbjct: 130 ---------PLAS---------------------------YIFRQLVSAVGYLRLKDIIH 153
Query: 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQT 689
RD+K +N++I + F KL D G + L+ T G+ + APE +L G
Sbjct: 154 RDIKDENIVI--AEDFTIKLIDFGSAAYLERG-KLFY---TFCGTIEYCAPE-VLMGNPY 206
Query: 690 R--AIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLL 746
R ++++SLG L+ + ++P F V + + E + L + LL
Sbjct: 207 RGPELEMWSLGVTLYTLVF-EENP----FCELEETV--EAAIHPPYLVSKELMSLVSGLL 259
Query: 747 DPNPDLRPKAQNVLNHPFF 765
P P+ R + ++ P+
Sbjct: 260 QPVPERRTTLEKLVTDPWV 278
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 78/356 (21%), Positives = 125/356 (35%), Gaps = 117/356 (32%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVR----WY 533
K I GS G V + G VA+K+ V +E+Q ++ H NIVR +Y
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKK-VLQDKRFKNRELQ-IMRKLDHCNIVRLRYFFY 117
Query: 534 GVESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+D VYL+L + ++ + S + L + ++L
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRA-----------KQTLPVIYVKLY----- 161
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
QL + L+++H G+ HRD+KPQN+L+ D + KL D
Sbjct: 162 -------------MYQLFR-------SLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCD 200
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI--------- 700
G +K+L + Y S + +APE + T +ID++S GC+
Sbjct: 201 FGSAKQLVRG-----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 255
Query: 701 LF------------FCITG----------------------GKHPYGESFERDANIVKDR 726
+F + G HP+ + F
Sbjct: 256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP----- 310
Query: 727 KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRV 782
PEA+ L +RLL+ P R H FF LRD + ++
Sbjct: 311 ---------PEAIALCSRLLEYTPTARLTPLEACAHSFF-------DELRDPNVKL 350
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 8e-23
Identities = 60/307 (19%), Positives = 114/307 (37%), Gaps = 68/307 (22%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVK-----RLVKTHHDVALKEIQNLIA---SDQHP 527
+E+ G V G A K R + V+ ++I+ ++ QHP
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 528 NIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
N++ + V ++ V L LE L D + S E
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFL-AEKESLTE-------------------- 113
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS--KDKS 644
++ + + I++G+ +LH + + H DLKP+N+++
Sbjct: 114 ------EEA-------------TEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 154
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
K+ D G++ ++ + G+ + APE + D++S+G I +
Sbjct: 155 PRIKIIDFGLAHKIDFG-NEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 705 ITGGKHP--YGESFERD--ANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 756
++G G++ +++ AN+ + F E+ A D RLL +P R
Sbjct: 211 LSG--ASPFLGDT-KQETLANVSAVNYE-FEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 757 QNVLNHP 763
Q+ L HP
Sbjct: 267 QDSLQHP 273
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 77/339 (22%), Positives = 129/339 (38%), Gaps = 75/339 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA---LKEIQNLIASDQHPNIVRWYG 534
K + G NG V + + + VA+K++V T L+EI+ +I H NIV+ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK-IIRRLDHDNIVKVFE 75
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ LN +Y++ E L + L E RL
Sbjct: 76 ILGPSGSQLTDDVGSLTELNS-VYIVQEYMETDLANVLE-QGPLLEEHARLF-------- 125
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMG 653
++ QLL+ GL ++H ++HRDLKP N+ I + K+ D G
Sbjct: 126 --MY--------QLLR-------GLKYIHSANVLHRDLKPANLFI--NTEDLVLKIGDFG 166
Query: 654 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITG---- 707
++ R+ + + + W ++P LL T+AID+++ GCI +TG
Sbjct: 167 LA-RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLF 225
Query: 708 -GKH--------------PYGESFERDANIVKD---------RKDL--FLVEHIPEAVDL 741
G H + E + +++ K L L EAVD
Sbjct: 226 AGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDF 285
Query: 742 FTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 780
++L +P R A+ L+HP+ +S D
Sbjct: 286 LEQILTFSPMDRLTAEEALSHPY-------MSIYSFPMD 317
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 47/301 (15%), Positives = 98/301 (32%), Gaps = 68/301 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQHPNI 529
+ + I KG G V G + G VA++ + + +E+ +H N+
Sbjct: 35 LEIGELIGKGRFGQV-YHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAY-RQTRHENV 91
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
V + G + + C +L ++ +
Sbjct: 92 VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVN--------------------- 130
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ ++ ++IV G+ +LH G++H+DLK +NV K
Sbjct: 131 ------------------KTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK---VV 169
Query: 649 LSDMGIS--KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ----------TRAIDLFS 696
++D G+ + + G APE +++ ++ D+F+
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQLSPDTEEDKLPFSKHSDVFA 228
Query: 697 LGCILFFCITGGKHPY-GESFERDANIV--KDRKDLFLVEHIPEAVDLFTRLLDPNPDLR 753
LG I + + P+ + E + + +L + E D+ + R
Sbjct: 229 LGTIWYELHA-REWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
Query: 754 P 754
P
Sbjct: 288 P 288
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 74/334 (22%), Positives = 140/334 (41%), Gaps = 80/334 (23%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVALKEIQNLIASDQHPNIVRWYGVE 536
+++ +GS G+V + E G+ VA+K++ V++ +KEI + D P++V++YG
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVKYYGSY 93
Query: 537 SDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
+++ +E C S++D+I + + + E
Sbjct: 94 FKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED---------------------------- 125
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
++ + + + GL +LH + IHRD+K N+L++ + AKL+D G++
Sbjct: 126 -----------EIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVA 172
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----GKH 710
+L M+ + T G+ W APE + + D++SLG IT GK
Sbjct: 173 GQLTDTMA---KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLG------ITAIEMAEGKP 223
Query: 711 PYGESFERDANIVKDRKDLFLVEHIP------------EAVDLFTRLLDPNPDLRPKAQN 758
PY + + + +F++ P D + L +P+ R A
Sbjct: 224 PYAD--------IHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
Query: 759 VLNHPFFWTADTRLSFLRDVSDRVELEDRESDSK 792
+L HPF +A +S LRD+ + +
Sbjct: 276 LLQHPFVRSAKG-VSILRDLINEAMDVKLKRQES 308
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-22
Identities = 66/327 (20%), Positives = 124/327 (37%), Gaps = 84/327 (25%)
Query: 497 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551
GR VA+K+ +++ D +A++EI L+ +H N+V V + YL E
Sbjct: 50 GRIVAIKKFLESDDDKMVKKIAMREI-KLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH 108
Query: 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611
++ D + E N L+ ++ L+ Q++
Sbjct: 109 TILDDL--------------ELFPNGLDYQVVQKY----------LF--------QIIN- 135
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG 671
G+ H +IHRD+KP+N+L+S+ KL D G ++ L
Sbjct: 136 ------GIGFCHSHNIIHRDIKPENILVSQSGVV--KLCDFGFARTLAAPGEVYDD---- 183
Query: 672 YGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI---------LF---------FCI------ 705
++ W +APE L+ + +A+D++++GC+ LF + I
Sbjct: 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243
Query: 706 -TGGKHPYGESFE--RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQN 758
+ + ++ L P +DL + L +PD RP
Sbjct: 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303
Query: 759 VLNHPFFWTADTRLSFLRDVSDRVELE 785
+L+H FF F +++ +V+ +
Sbjct: 304 LLHHDFFQMDGFAERFSQELQLKVQKD 330
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 5e-22
Identities = 74/312 (23%), Positives = 108/312 (34%), Gaps = 91/312 (29%)
Query: 497 GRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550
VA+KR V+ D AL+EI L+ +H NIVR + V + L E C
Sbjct: 27 HEIVALKR-VRLDDDDEGVPSSALREI-CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84
Query: 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610
L +G + V+ L QLLK
Sbjct: 85 QDLKKYFDSCNGDLDP------------EIVKSFLF--------------------QLLK 112
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-A 669
GL H ++HRDLKPQN+LI+++ KL++ G+++ + C +
Sbjct: 113 -------GLGFCHSRNVLHRDLKPQNLLINRNG--ELKLANFGLARAFGIPVRCYSAEVV 163
Query: 670 TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GESFERD------ 719
T W + P+ L + + +ID++S GCI G+ P G D
Sbjct: 164 T-----LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR-PLFPGND-VDDQLKRIF 216
Query: 720 --------------------ANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPK 755
LV +P DL LL NP R
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 756 AQNVLNHPFFWT 767
A+ L HP+F
Sbjct: 277 AEEALQHPYFSD 288
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-22
Identities = 77/324 (23%), Positives = 119/324 (36%), Gaps = 81/324 (25%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV--- 535
K I GS G V E VA+K+ V +E+Q ++ +HPN+V
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKK-VLQDKRFKNRELQ-IMRIVKHPNVVDLKAFFYS 103
Query: 536 ---ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ D+ F+ L LE ++ + + + + I+L
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYA-----------KLKQTMPMLLIKLY------ 146
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
QLL+ L+++H IG+ HRD+KPQN+L+ KL D
Sbjct: 147 ------------MYQLLR-------SLAYIHSIGICHRDIKPQNLLLDPPSGVL-KLIDF 186
Query: 653 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL--------F 702
G +K L + Y S + +APE + T ID++S GC++
Sbjct: 187 GSAKILIAG-----EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPL 241
Query: 703 FCITGGKH-----------PYGESFERDANIVKDRK----------DLFLVEHIPEAVDL 741
F G P E + + K +F P+A+DL
Sbjct: 242 FPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDL 301
Query: 742 FTRLLDPNPDLRPKAQNVLNHPFF 765
+RLL+ P R A L HPFF
Sbjct: 302 ISRLLEYTPSARLTAIEALCHPFF 325
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 6e-22
Identities = 74/389 (19%), Positives = 133/389 (34%), Gaps = 76/389 (19%)
Query: 400 EHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFT 459
H + + + + N +S N + + L
Sbjct: 7 HHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDI 66
Query: 460 D----LIDDRVDGRRIGKL-----VVFNKEIAKGSNGTVVL-EGNYEGRSVAVK----RL 505
D R+ + G + V + + G G V E G +A K R
Sbjct: 67 PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG 126
Query: 506 VKTHHDVALKEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS-LNDLIYVLS 561
+K +V EI L H N+++ Y ++ + L +E L D I S
Sbjct: 127 MKDKEEV-KNEISVMNQL----DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES 181
Query: 562 GSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621
+ E D + + I G+ H
Sbjct: 182 YNLTE--------------------------LDT-------------ILFMKQICEGIRH 202
Query: 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPE 681
+H++ ++H DLKP+N+L + K+ D G+++R + + +G+ + APE
Sbjct: 203 MHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR----EKLKVNFGTPEFLAPE 258
Query: 682 QLLQGRQTRAIDLFSLGCILFFCITGGKHP-YGESFERD--ANIVKDRKDLFLVE---HI 735
+ + D++S+G I + ++ G P G++ + + NI+ R D E I
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDN-DAETLNNILACRWD-LEDEEFQDI 315
Query: 736 -PEAVDLFTRLLDPNPDLRPKAQNVLNHP 763
EA + ++LL R A L HP
Sbjct: 316 SEEAKEFISKLLIKEKSWRISASEALKHP 344
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 7e-22
Identities = 70/350 (20%), Positives = 122/350 (34%), Gaps = 88/350 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKR--LVKTHHDVALKEIQNLI---ASDQHPNIVRW 532
+EI GS G V + VA+K+ + ++I + +HPN +++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G + +L +E C S +DL+ V +E
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV------------------------- 154
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
++ VT + GL++LH +IHRD+K N+L+S+ KL D
Sbjct: 155 --------------EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDF 198
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTR---AIDLFSLGCILFFCITG-- 707
G + S + + G+ W APE +L + + +D++SLG IT
Sbjct: 199 GSA-------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG------ITCIE 245
Query: 708 ---GKHPYGESFERDANIVKDRKDLFLV-----------EHIPEAVDLFTRLLDPNPDLR 753
K P + L+ + + L P R
Sbjct: 246 LAERKPPLFN--------MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDR 297
Query: 754 PKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 803
P ++ +L H F + + D+ R + RE D+ R ++ I
Sbjct: 298 PTSEVLLKHRFVLRE-RPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQ 346
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 62/309 (20%), Positives = 107/309 (34%), Gaps = 88/309 (28%)
Query: 476 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYG 534
V ++ + G NG V+ A+K L A +E++ + Q P+IVR
Sbjct: 21 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVD 78
Query: 535 V----ESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V + + + + +E L I +++ E
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTE--------- 116
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL-ISKDKSFCAK 648
++ +++++K I + +LH I + HRD+KP+N+L SK + K
Sbjct: 117 ---RE----------ASEIMK---SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF--CIT 706
L+D G A E + ++ D++SLG I++ C
Sbjct: 161 LTDFGF------------------------AKE-TTGEKYDKSCDMWSLGVIMYILLC-- 193
Query: 707 GGKHP-YGESFERDANIVKDR----KDLFLVE---HI-PEAVDLFTRLLDPNPDLRPKAQ 757
G P Y + +K R + F + E L LL P R
Sbjct: 194 -GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 252
Query: 758 NVLNHPFFW 766
+NHP W
Sbjct: 253 EFMNHP--W 259
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 1e-21
Identities = 72/330 (21%), Positives = 128/330 (38%), Gaps = 92/330 (27%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYG 534
I +G+ G V N G + A+K+ ++ + ++EI +++ +H NIV+ Y
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKK-IRLEKEDEGIPSTTIREI-SILKELKHSNIVKLYD 67
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V + + L E L L+ V G E + LL
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLES------------VTAKSFLL-------- 107
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
QLL G+++ H+ ++HRDLKPQN+LI+++ K++D G+
Sbjct: 108 ------------QLLN-------GIAYCHDRRVLHRDLKPQNLLINREG--ELKIADFGL 146
Query: 655 SKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 711
++ + T T W +AP+ L+ ++ + ID++S+GCI + G P
Sbjct: 147 ARAFGIPVRKYTHEIVT-----LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG--TP 199
Query: 712 Y--GESFERD--ANIVK-----------------DRKDLF-------LVEHIP----EAV 739
G S E D I + F + +
Sbjct: 200 LFPGVS-EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI 258
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769
DL +++L +P+ R A+ L H +F +
Sbjct: 259 DLLSKMLKLDPNQRITAKQALEHAYFKENN 288
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 78/342 (22%), Positives = 128/342 (37%), Gaps = 96/342 (28%)
Query: 479 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHDVALKEIQNLI---ASDQHPNI 529
++I KGS G V ++G VA+K + + +++IQ I + P +
Sbjct: 28 EKIGKGSFGEV-----FKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++YG +++ +E S DL+ + L+E +I
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSALDLL----------------EPGPLDETQIAT--- 123
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ R+I+ GL +LH IHRD+K NVL+S+ K
Sbjct: 124 ----------------------ILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VK 159
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG- 707
L+D G++ +L + T G+ W APE + Q D++SLG IT
Sbjct: 160 LADFGVAGQLTDTQI---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG------ITAI 210
Query: 708 ----GKHPYGESFERDANIVKDRKDLFLVEHIP-------------EAVDLFTRLLDPNP 750
G+ P+ E + K LFL IP + L+ P
Sbjct: 211 ELARGEPPHSE--------LHPMKVLFL---IPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 751 DLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSK 792
RP A+ +L H F + S+L ++ DR + E
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHD 301
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-21
Identities = 75/356 (21%), Positives = 127/356 (35%), Gaps = 109/356 (30%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV--------------ALKEIQNLIASD 524
+ I+ GS G V + EG VA+KR+ T D L+EI+ L+
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR-LLNHF 86
Query: 525 QHPNIVRWYGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
HPNI+ + + +YL E L +I+ +++
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH--------------DQRIVIS 132
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
I+ ++ +L GL LHE G++HRDL P N+L+
Sbjct: 133 PQHIQYF----------MY--------HILL-------GLHVLHEAGVVHRDLHPGNILL 167
Query: 640 SKDKSFCA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFS 696
+ + + D +++ D N T Y + W +APE ++Q + T+ +D++S
Sbjct: 168 ADN---NDITICDFNLAREDTAD-----ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWS 219
Query: 697 LGCILFFCITG-----GKH-------------------------PYGESFERDANIVKDR 726
GC++ G P + R++
Sbjct: 220 AGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPA 279
Query: 727 KDLFLV--EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 780
+ V P A+DL ++L+ NP R + L HP+F L D D
Sbjct: 280 RAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF-------ESLFDPLD 328
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 66/328 (20%), Positives = 124/328 (37%), Gaps = 85/328 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
+I +GS G V N + G+ VA+K+ +++ D +AL+EI ++ +HPN+V
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREI-RMLKQLKHPNLVNL 67
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + ++L E C ++ + ++ + E ++ +
Sbjct: 68 LEVFRRKRRLHLVFEYCDHTVLHEL--------------DRYQRGVPEHLVKSI------ 107
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
W Q L+ ++ H+ IHRD+KP+N+LI+K KL D
Sbjct: 108 ----TW--------QTLQ-------AVNFCHKHNCIHRDVKPENILITKHSVI--KLCDF 146
Query: 653 GISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI---------L 701
G ++ L G ++ W ++PE L+ Q +D++++GC+ L
Sbjct: 147 GFARLLTGPSDYYDD----EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL 202
Query: 702 F---------FCI-------TGGKHPYGESFE--RDANIVKDRKDLFLVEHIP----EAV 739
+ + I + + I L P A+
Sbjct: 203 WPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL 262
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFFWT 767
L L +P R + +L+HP+F
Sbjct: 263 GLLKGCLHMDPTERLTCEQLLHHPYFEN 290
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 87/355 (24%), Positives = 127/355 (35%), Gaps = 107/355 (30%)
Query: 479 KEIAKGSNGTVVLEGNYEGR------SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 530
+ + G+ G V Y+GR A+K + T + +EI L H NI
Sbjct: 30 ELVGNGTYGQV-----YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 531 RWYG------VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
+YG D ++L +E C S+ DLI K N L E I
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-------------KNTKGNTLKEEWI 131
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+ R+I+ GLSHLH+ +IHRD+K QNVL++++
Sbjct: 132 AY-------------------------ICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 166
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLG 698
KL D G+S +L + + T G+ W APE + A DL+SLG
Sbjct: 167 E--VKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221
Query: 699 CILFFCITG-----GKHPYGESFERDANIVKDRKDLFLVEHIP--------------EAV 739
IT G P + + + LFL IP +
Sbjct: 222 ------ITAIEMAEGAPPLCD--------MHPMRALFL---IPRNPAPRLKSKKWSKKFQ 264
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR---LSFLRDVSDRVELEDRESDS 791
L N RP + ++ HPF L+D DR + + E D
Sbjct: 265 SFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGEKDE 319
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 71/316 (22%), Positives = 129/316 (40%), Gaps = 78/316 (24%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 521
R IG ++ + + +GS G V L +Y+ + VA+K + + D+ ++ EI L
Sbjct: 6 RHIGPYII-RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL- 63
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+HP+I++ Y V + + + +E L D I V E +E
Sbjct: 64 KLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VEKKRMTE------------DEG 110
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
R + + I+ + + H ++HRDLKP+N+L+
Sbjct: 111 R---------------------------RFFQQIICAIEYCHRHKIVHRDLKPENLLL-- 141
Query: 642 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 695
D + K++D G+S + SC GS + APE ++ G+ +D++
Sbjct: 142 DDNLNVKIADFGLSNIMTDGNFLKTSC--------GSPNYAAPE-VINGKLYAGPEVDVW 192
Query: 696 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 749
S G +L+ + G+ P F+ D I K + + + P A L R++ +
Sbjct: 193 SCGIVLYVMLV-GRLP----FD-DEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVAD 246
Query: 750 PDLRPKAQNVLNHPFF 765
P R Q + P+F
Sbjct: 247 PMQRITIQEIRRDPWF 262
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-21
Identities = 67/313 (21%), Positives = 107/313 (34%), Gaps = 92/313 (29%)
Query: 497 GRSVAVKRLVKTHHDV---------ALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547
+ VA+K+ +K H AL+EI L+ HPNI+ + + L +
Sbjct: 35 NQIVAIKK-IKLGHRSEAKDGINRTALREI-KLLQELSHPNIIGLLDAFGHKSNISLVFD 92
Query: 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQ 607
L +I S + ++ +L
Sbjct: 93 FMETDLEVIIKDNSLVLTP------------SHIKAYML--------------------M 120
Query: 608 LLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQ 667
L+ GL +LH+ ++HRDLKP N+L+ ++ KL+D G++K T
Sbjct: 121 TLQ-------GLEYLHQHWILHRDLKPNNLLLDENG--VLKLADFGLAKSFGSPNRAYTH 171
Query: 668 N-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GES------- 715
T W +APE L R +D++++GCIL + P+ G+S
Sbjct: 172 QVVT-----RWYRAPELLFGARMYGVGVDMWAVGCILAELLLR--VPFLPGDSDLDQLTR 224
Query: 716 -FE----------------RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRP 754
FE D K + L + +DL L NP R
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284
Query: 755 KAQNVLNHPFFWT 767
A L +F
Sbjct: 285 TATQALKMKYFSN 297
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 85/348 (24%), Positives = 139/348 (39%), Gaps = 105/348 (30%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ + G+ G V + G VA+K+L + A +E++ L+ +H N++
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGL 89
Query: 533 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
V E+ DF YL + L L+ L E RI+ L
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK----------------HEKLGEDRIQFL 133
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
++ Q+LK GL ++H G+IHRDLKP N+ +++D C
Sbjct: 134 ----------VY--------QMLK-------GLRYIHAAGIIHRDLKPGNLAVNED---C 165
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 703
K+ D G++++ +M TGY + W +APE +L + T+ +D++S+GCI+
Sbjct: 166 ELKILDFGLARQADSEM-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAE 218
Query: 704 CITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLV 732
ITG G P E +R + ++KD L
Sbjct: 219 MITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILT 278
Query: 733 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 780
P AV+L ++L + + R A L HP+F L D D
Sbjct: 279 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF-------ESLHDTED 319
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 6e-21
Identities = 65/305 (21%), Positives = 119/305 (39%), Gaps = 70/305 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL----KEIQNLIASDQHPNIVRWY 533
+ + +G+ G V L N +VAVK + KEI H N+V++Y
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFY 71
Query: 534 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G + + YL LE C+ L D I E + +
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE------------PDAQ---------- 108
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ +++G+ +LH IG+ HRD+KP+N+L+ D+ K+SD
Sbjct: 109 -----------------RFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDF 149
Query: 653 GISK--RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGG 708
G++ R L G+ + APE LL+ R+ +D++S G +L + G
Sbjct: 150 GLATVFRYNNRERLLN---KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLA-G 204
Query: 709 KHPYGESFERDANIVKDRKDLFLVE-------HI-PEAVDLFTRLLDPNPDLRPKAQNVL 760
+ P +++ ++ ++ D + I + L ++L NP R ++
Sbjct: 205 ELP----WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 761 NHPFF 765
++
Sbjct: 261 KDRWY 265
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 76/333 (22%), Positives = 137/333 (41%), Gaps = 91/333 (27%)
Query: 481 IAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVRWYG 534
+ +G+ G V + +GR VA+KR ++ + A++EI +L+ HPNIV
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKR-IRLDAEDEGIPSTAIREI-SLLKELHHPNIVSLID 86
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V + + L E L ++ ++ ++++I L
Sbjct: 87 VIHSERCLTLVFEFMEKDLKKVLDENKTGLQD------------SQIKIYLY-------- 126
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
QLL+ G++H H+ ++HRDLKPQN+LI+ D KL+D G+
Sbjct: 127 ------------QLLR-------GVAHCHQHRILHRDLKPQNLLINSDG--ALKLADFGL 165
Query: 655 SKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 711
++ + T T W +AP+ L+ ++ + ++D++S+GCI ITG P
Sbjct: 166 ARAFGIPVRSYTHEVVT-----LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG--KP 218
Query: 712 Y--GES--------FE----------------RDANIV--KDRKDLFLVEHIP----EAV 739
G + F + + IP E +
Sbjct: 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGI 278
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRL 772
DL + +L +P+ R A++ +NHP+F D ++
Sbjct: 279 DLLSNMLCFDPNKRISARDAMNHPYFKDLDPQI 311
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 76/316 (24%), Positives = 130/316 (41%), Gaps = 77/316 (24%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 521
+IG V+ + G+ G V + + G VAVK L + DV K EIQNL
Sbjct: 8 VKIGHYVL-GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL- 65
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+HP+I++ Y V S ++ +E YV G + + + + E+
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVME----------YVSGGELFDYICKHGR----VEEM 111
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
R ++ + I+S + + H ++HRDLKP+NVL+
Sbjct: 112 EAR-------------------------RLFQQILSAVDYCHRHMVVHRDLKPENVLL-- 144
Query: 642 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 695
D AK++D G+S + SC GS + APE ++ GR +D++
Sbjct: 145 DAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPE-VISGRLYAGPEVDIW 195
Query: 696 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 749
S G IL+ + G P F+ D ++ K ++ E++ L +L +
Sbjct: 196 SCGVILYALLC-GTLP----FD-DEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVD 249
Query: 750 PDLRPKAQNVLNHPFF 765
P R +++ H +F
Sbjct: 250 PLKRATIKDIREHEWF 265
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 75/346 (21%), Positives = 131/346 (37%), Gaps = 97/346 (28%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 533
I +G+ G V + VA+K++ H L+EI+ ++ +H NI+
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRFRHENIIGIN 91
Query: 534 GV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ + + VY+ + L L+ + L+ I
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMETDLYKLLK----------------TQHLSNDHICYF-- 133
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA- 647
L+ Q+L+ GL ++H ++HRDLKP N+L++ C
Sbjct: 134 --------LY--------QILR-------GLKYIHSANVLHRDLKPSNLLLNTT---CDL 167
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCI 705
K+ D G++ R+ T T Y ++ W +APE +L + T++ID++S+GCIL +
Sbjct: 168 KICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 706 TG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLVEH 734
+ GKH P E N+ K++
Sbjct: 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA 286
Query: 735 IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 780
+A+DL ++L NP R + + L HP+ D SD
Sbjct: 287 DSKALDLLDKMLTFNPHKRIEVEQALAHPYL-------EQYYDPSD 325
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-20
Identities = 69/333 (20%), Positives = 121/333 (36%), Gaps = 90/333 (27%)
Query: 497 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551
VA+K ++ H+ A++E+ +L+ +H NIV + + + + L E
Sbjct: 27 DNLVALKE-IRLEHEEGAPCTAIREV-SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84
Query: 552 SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKV 611
L + + V++ L QLL+
Sbjct: 85 DLKQYLDDCGNIINM------------HNVKLFLF--------------------QLLR- 111
Query: 612 TRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-AT 670
GL++ H ++HRDLKPQN+LI++ KL+D G+++ T
Sbjct: 112 ------GLAYCHRQKVLHRDLKPQNLLINERG--ELKLADFGLARAKSIPTKTYDNEVVT 163
Query: 671 GYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GES--------FE- 717
W + P+ LL + ID++ +GCI + TG P G + F
Sbjct: 164 -----LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG--RPLFPGSTVEEQLHFIFRI 216
Query: 718 ---------------RDANIVK--DRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 756
+ + L+ H P + DL T+LL R A
Sbjct: 217 LGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA 276
Query: 757 QNVLNHPFFWTADTRLSFLRDVSDRVELEDRES 789
++ + HPFF + R+ L D + L++ +
Sbjct: 277 EDAMKHPFFLSLGERIHKLPDTTSIFALKEIQL 309
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 69/325 (21%), Positives = 116/325 (35%), Gaps = 84/325 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIA---SDQHPNIVRWYG 534
+I +GS G V L GR VAVK + + + N + QH N+V Y
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKM-MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+ +++ +E +L D++ LNE +I
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIV----------------SQVRLNEEQIAT-------- 145
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
V ++ L++LH G+IHRD+K ++L++ D KLSD G
Sbjct: 146 -----------------VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFG 186
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----G 708
++ D+ + + G+ W APE + + +D++SLG I G
Sbjct: 187 FCAQISKDVP---KRKSLVGTPYWMAPEVISRSLYATEVDIWSLG------IMVIEMVDG 237
Query: 709 KHPYGESFERDANIVKDRKDLFLV------------EHIPEAVDLFTRLLDPNPDLRPKA 756
+ PY + + + + P D R+L +P R A
Sbjct: 238 EPPYFS--------DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATA 289
Query: 757 QNVLNHPFFWTADTRLSFLRDVSDR 781
Q +L+HPF L +
Sbjct: 290 QELLDHPFLLQTGL-PECLVPLIQL 313
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 67/321 (20%), Positives = 107/321 (33%), Gaps = 98/321 (30%)
Query: 497 GRSVAVKRLVKTHHD---------VALKEIQNL--IASDQHPNIVRWYGVESDQDF---- 541
G VA+K V+ + ++E+ L + + +HPN+VR V +
Sbjct: 34 GHFVALKS-VRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREI 92
Query: 542 -VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKA 600
V L E +QD L ++ L
Sbjct: 93 KVTLVFEHV----------------------DQD----------LRTYLDKAPPPGL--- 117
Query: 601 NGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQG 660
P+ + + R + GL LH ++HRDLKP+N+L++ KL+D G++ R+
Sbjct: 118 ---PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG--TVKLADFGLA-RIYS 171
Query: 661 DMSCLTQN-ATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY--GES- 715
LT T W +APE LLQ +D++S+GCI + P G S
Sbjct: 172 YQMALTPVVVT-----LWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR--RKPLFCGNSE 224
Query: 716 -------FE----------------RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDP 748
F+ + +P L +L
Sbjct: 225 ADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPR-PVQSVVPEMEESGAQLLLEMLTF 283
Query: 749 NPDLRPKAQNVLNHPFFWTAD 769
NP R A L H + +
Sbjct: 284 NPHKRISAFRALQHSYLHKDE 304
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 65/305 (21%), Positives = 119/305 (39%), Gaps = 70/305 (22%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVAL----KEIQNLIASDQHPNIVRWY 533
+ + +G+ G V L N +VAVK + KEI H N+V++Y
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICIN-KMLNHENVVKFY 71
Query: 534 GVESDQDFVYLSLERCTCS-LNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
G + + YL LE C+ L D I E + +
Sbjct: 72 GHRREGNIQYLFLEYCSGGELFDRI-EPDIGMPE------------PDAQ---------- 108
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ +++G+ +LH IG+ HRD+KP+N+L+ D+ K+SD
Sbjct: 109 -----------------RFFHQLMAGVVYLHGIGITHRDIKPENLLL--DERDNLKISDF 149
Query: 653 GISK--RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGG 708
G++ R L G+ + APE LL+ R+ +D++S G +L + G
Sbjct: 150 GLATVFRYNNRERLLN---KMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLA-G 204
Query: 709 KHPYGESFERDANIVKDRKDLFLVE-------HI-PEAVDLFTRLLDPNPDLRPKAQNVL 760
+ P +++ ++ ++ D + I + L ++L NP R ++
Sbjct: 205 ELP----WDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 761 NHPFF 765
++
Sbjct: 261 KDRWY 265
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 62/344 (18%), Positives = 111/344 (32%), Gaps = 99/344 (28%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQ---NLIASDQHPNIVRWYG 534
E+ G+ G V + G +A K + +I ++ P IV +YG
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 535 VESDQDFVYLSLERC-TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+ + +E SL D + +G EQ
Sbjct: 99 AFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQ-------------------------- 131
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-LIHRDLKPQNVLISKDKSFCAKLSDM 652
L KV+ ++ GL++L E ++HRD+KP N+L++ KL D
Sbjct: 132 -------------ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDF 176
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
G+S +L M+ + G+ + +PE+L + D++S+G L G++P
Sbjct: 177 GVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV-GRYPI 230
Query: 713 -------------------------------GESFERDANIVKDRKDLFLVEHI------ 735
+ + L+++I
Sbjct: 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP 290
Query: 736 --------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTR 771
E D + L NP R + ++ H F +D
Sbjct: 291 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 69/325 (21%), Positives = 123/325 (37%), Gaps = 84/325 (25%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLI---ASDQHPNIVRWYG 534
++I +G++GTV + G+ VA+++ + + I N I +++PNIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
D +++ +E SL D++ ++E +I
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV----------------TETCMDEGQIAA-------- 120
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
V R+ + L LH +IHRD+K N+L+ D S KL+D G
Sbjct: 121 -----------------VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFG 161
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG-----G 708
++ + S + +T G+ W APE + + +D++SLG I G
Sbjct: 162 FCAQITPEQS---KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG------IMAIEMIEG 212
Query: 709 KHPYGESFERDANIVKDRKDLFLV------------EHIPEAVDLFTRLLDPNPDLRPKA 756
+ PY + L+L+ + D R L+ + + R A
Sbjct: 213 EPPYLN--------ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSA 264
Query: 757 QNVLNHPFFWTADTRLSFLRDVSDR 781
+ +L H F A LS L +
Sbjct: 265 KELLQHQFLKIAKP-LSSLTPLIAA 288
|
| >2be1_A Serine/threonine-protein kinase/endoribonuclease; transcription; 2.98A {Saccharomyces cerevisiae} Length = 339 | Back alignment and structure |
|---|
Score = 92.5 bits (229), Expect = 2e-20
Identities = 38/201 (18%), Positives = 77/201 (38%), Gaps = 30/201 (14%)
Query: 49 DVALVAALDGTIHLVDTKLGKIRWSF--GTGRPIYSSYQASFNSNASEFYLDVDEDWELY 106
D+ + A ++G +H VD + G I WS +P+ + S ++ D +Y
Sbjct: 11 DILIAADVEGGLHAVDRRNGHIIWSIEPENFQPLIEIQEPSRLETYETLIIEPFGDGNIY 70
Query: 107 FHSKRFGKMKKLSSSAEEYIRRMPYISK-------------DGGVTLGAMKTSVFLVDVK 153
+ + G ++KL S + + P K D V G+M+T ++ +++
Sbjct: 71 YFNAHQG-LQKLPLSIRQLVSTSPLHLKTNIVVNDSGKIVEDEKVYTGSMRTIMYTINML 129
Query: 154 SGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVL 213
+G ++ + G QS + + E ++ I +T + L
Sbjct: 130 NGEIISAFGPGSKNGYFGSQSVDCSPEEKIKLQEC------------ENMIVIGKTIFEL 177
Query: 214 QSTSQDSGEVLWNVAYADFKA 234
S D +NV Y+ ++
Sbjct: 178 GIHSYDGAS--YNVTYSTWQQ 196
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 79/315 (25%), Positives = 121/315 (38%), Gaps = 91/315 (28%)
Query: 497 GRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTC 551
G VA+K VK + A++EI +L+ +H NIVR Y V ++ + L E
Sbjct: 30 GVYVALKE-VKLDSEEGTPSTAIREI-SLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87
Query: 552 SLNDLIYVLSGSFEEQLNAKEQDSNL-LNEVRIRLLPVMENTKDIELWKANGHPSAQLLK 610
L + + L LN V+ QLL+
Sbjct: 88 DLKKYM--------DSRTVGNTPRGLELNLVKYFQW--------------------QLLQ 119
Query: 611 VTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQN-A 669
GL+ HE ++HRDLKPQN+LI+K KL D G+++ ++ +
Sbjct: 120 -------GLAFCHENKILHRDLKPQNLLINKRG--QLKLGDFGLARAFGIPVNTFSSEVV 170
Query: 670 TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY--GES--------FE 717
T W +AP+ L+ R + +ID++S GCIL ITG P G + F+
Sbjct: 171 T-----LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG--KPLFPGTNDEEQLKLIFD 223
Query: 718 ----------------RDANIV------KDRKDLFLVEHIP----EAVDLFTRLLDPNPD 751
N +D + + +D LL NPD
Sbjct: 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283
Query: 752 LRPKAQNVLNHPFFW 766
+R A+ L+HP+F
Sbjct: 284 MRLSAKQALHHPWFA 298
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
+V L +L +IHRD+KP N+L+ D+ ++D I+ L + TQ T G+
Sbjct: 124 LVMALDYLQNQRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRE----TQITTMAGT 177
Query: 675 SGWQAPEQLLQGRQ---TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFL 731
+ APE + + A+D +SLG + + G+ PY R + K+ F
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR-GRRPY---HIRSSTSSKEIVHTFE 233
Query: 732 VEHI-------PEAVDLFTRLLDPNPDLR-PKAQNVLNHPFF 765
+ E V L +LL+PNPD R + +V N P+
Sbjct: 234 TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 74/348 (21%), Positives = 136/348 (39%), Gaps = 105/348 (30%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ G+ G+V + + G VAVK+L + + +E++ L+ +H N++
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGL 93
Query: 533 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
V S ++F VYL LN+++ L + ++ L
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----------------CQKLTDDHVQFL 137
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
++ Q+L+ GL ++H +IHRDLKP N+ +++D C
Sbjct: 138 ----------IY--------QILR-------GLKYIHSADIIHRDLKPSNLAVNED---C 169
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 703
K+ D G+++ +M TGY ++ W +APE +L + +D++S+GCI+
Sbjct: 170 ELKILDFGLARHTADEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 222
Query: 704 CITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FLV 732
+TG G P E ++ ++ + + +
Sbjct: 223 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 282
Query: 733 EHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 780
P AVDL ++L + D R A L H +F + D D
Sbjct: 283 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYF-------AQYHDPDD 323
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 60/337 (17%), Positives = 106/337 (31%), Gaps = 94/337 (27%)
Query: 476 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ-NLIASDQHPNIVRWYG 534
+ I +G G V +G+ + R VAVK + + E + +H NI R+
Sbjct: 16 KLLELIGRGRYGAV-YKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 535 VESDQDFVYLSLERCTCSLNDLI--YVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ + +E L+ Y +GS + L+ D
Sbjct: 75 GDE-RVTADGRMEYL------LVMEYYPNGSLXKYLSLHTSDWV---------------- 111
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHE---------IGLIHRDLKPQNVLISKDK 643
++ + GL++LH + HRDL +NVL+
Sbjct: 112 --------------SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV--KN 155
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY-----GSSGWQAPEQLLQGR--------QTR 690
+SD G+S RL G+ G+ + APE +L+G +
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALK 214
Query: 691 AIDLFSLGCIL------------FFCITGGKHPYGESFERDANIVKDRKDLFLVEH---- 734
+D+++LG I + + + +D + L E
Sbjct: 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTF-EDMQVLVSREKQRPK 273
Query: 735 IPEAVDLFTRLL-----------DPNPDLRPKAQNVL 760
PEA + + D + + R AQ
Sbjct: 274 FPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAE 310
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 82/335 (24%), Positives = 131/335 (39%), Gaps = 89/335 (26%)
Query: 479 KEIAKGSNGTVVLEGNYEGR------SVAVKR--LVKTHHDVAL--KEIQNLIASDQHPN 528
+ I G+ V VA+KR L K + KEIQ + HPN
Sbjct: 21 EVIGSGATAVV-----QAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPN 74
Query: 529 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
IV +Y +D ++L ++ + S+ D+I + + E S +L+E I
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDII-------KHIVAKGEHKSGVLDESTIAT-- 125
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+ R+++ GL +LH+ G IHRD+K N+L+ +D S
Sbjct: 126 -----------------------ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--V 160
Query: 648 KLSDMGISKRL--QGDMSCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLFSLGCILFF 703
+++D G+S L GD++ T G+ W APE + Q R +A D++S G
Sbjct: 161 QIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA-DIWSFG----- 214
Query: 704 CITG-----GKHPYGE----------------SFERDANIVKDRKDLFLVEHIPEAVDLF 742
IT G PY + S E + K +
Sbjct: 215 -ITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY-----GKSFRKMI 268
Query: 743 TRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRD 777
+ L +P+ RP A +L H FF A + FL++
Sbjct: 269 SLCLQKDPEKRPTAAELLRHKFFQKAKNK-EFLQE 302
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 6e-20
Identities = 71/317 (22%), Positives = 113/317 (35%), Gaps = 93/317 (29%)
Query: 497 GRSVAVKRLVKTHHDV------ALKEIQNL--IASDQHPNIVRWYGV-----ESDQDFVY 543
GR VA+KR V+ ++E+ L + + +HPN+VR + V + +
Sbjct: 37 GRFVALKR-VRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGH 603
L E +QD L ++ + +
Sbjct: 96 LVFEHV----------------------DQD----------LTTYLDKVPEPGV------ 117
Query: 604 PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS 663
P+ + + ++ GL LH ++HRDLKPQN+L++ KL+D G++ R+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG--QIKLADFGLA-RIYSFQM 174
Query: 664 CLTQN-ATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY--GES---- 715
LT T W +APE LLQ +DL+S+GCI + P G S
Sbjct: 175 ALTSVVVT-----LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR--RKPLFRGSSDVDQ 227
Query: 716 ----FE----------------RDANIVKDRKDLF--LVEHI-PEAVDLFTRLLDPNPDL 752
+ V I DL + L NP
Sbjct: 228 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAK 287
Query: 753 RPKAQNVLNHPFFWTAD 769
R A + L+HP+F +
Sbjct: 288 RISAYSALSHPYFQDLE 304
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 69/324 (21%), Positives = 115/324 (35%), Gaps = 77/324 (23%)
Query: 463 DDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVA--LKEIQN 519
D + K+I G+ G L + VAVK + + +EI N
Sbjct: 11 LDMPIMHDSDRYDF-VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN 69
Query: 520 LIASDQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLL 578
S +HPNIVR+ V + + +E + L + I +G F E
Sbjct: 70 H-RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERI-CNAGRFSE------------ 115
Query: 579 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 638
+E R + ++SG+S+ H + + HRDLK +N L
Sbjct: 116 DEAR---------------------------FFFQQLLSGVSYCHSMQICHRDLKLENTL 148
Query: 639 ISKDKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAI 692
+ + K+ D G SK + G+ + APE +L ++ +
Sbjct: 149 LDGSPAPRLKICDFGYSKSSVLHSQPKSTV--------GTPAYIAPE-VLLRQEYDGKIA 199
Query: 693 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE----HIP-------EAVDL 741
D++S G L+ + G +P FE RK + + IP E L
Sbjct: 200 DVWSCGVTLYVMLV-GAYP----FEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHL 254
Query: 742 FTRLLDPNPDLRPKAQNVLNHPFF 765
+R+ +P R + H +F
Sbjct: 255 ISRIFVADPATRISIPEIKTHSWF 278
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 8e-20
Identities = 76/350 (21%), Positives = 126/350 (36%), Gaps = 98/350 (28%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNL--IASDQHPNIVRWYGV 535
+ +G+ GTV L G SVA+K+ V +E+Q + +A HPNIV+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKK-VIQDPRFRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 536 -----ESDQDFVYLSL--ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
E D+ +YL++ E +L+ ++ + I++
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPDTLHRCC--------RNYYRRQVA---PPPILIKVF-- 134
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE--IGLIHRDLKPQNVLISKDKSFC 646
QL++ + LH + + HRD+KP NVL+ +++
Sbjct: 135 ----------------LFQLIR-------SIGCLHLPSVNVCHRDIKPHNVLV--NEADG 169
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILFF 703
KL D G +K+L + Y S + +APE + + T A+D++S+GCI
Sbjct: 170 TLKLCDFGSAKKLSPS-----EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAE 224
Query: 704 CITG-----GKH--------------PYGESFERDANIVKDRKDLFLVEH---------- 734
+ G G + P E + D
Sbjct: 225 MMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHS 284
Query: 735 ---IPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDR 781
EA DL + LL P+ R K L HP+F L D + +
Sbjct: 285 LKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF-------DELHDPATK 327
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 75/340 (22%), Positives = 122/340 (35%), Gaps = 93/340 (27%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRL-VKTHHDVAL--KEIQNLIASDQHPNIVRWYG 534
E+ G+ G V N E G A K + K+ ++ EI+ L D HP IV+ G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLLG 83
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+++ +E C +++ ++ L E
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------------------------- 117
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+ V R ++ L+ LH +IHRDLK NVL++ + +L+D G
Sbjct: 118 -------------QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFG 162
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRA-----IDLFSLGCILFFCITG- 707
+S + + + + G+ W APE ++ D++SLG IT
Sbjct: 163 VSAKNLKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG------ITLI 213
Query: 708 ----GKHPYGESFERDANIVKDRKDLFLVEHIP---------------EAVDLFTRLLDP 748
+ P+ E + + L I E D LD
Sbjct: 214 EMAQIEPPHHE--------LNPMRVLLK---IAKSDPPTLLTPSKWSVEFRDFLKIALDK 262
Query: 749 NPDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRE 788
NP+ RP A +L HPF + T LR++ + E E
Sbjct: 263 NPETRPSAAQLLEHPFVSSI-TSNKALRELVAEAKAEVME 301
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 75/340 (22%), Positives = 125/340 (36%), Gaps = 106/340 (31%)
Query: 481 IAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDV------ALKEIQNLIASDQHPN 528
+ +G+ G V Y+ VA+KR ++ H+ A++E+ +L+ QH N
Sbjct: 42 LGEGTYGEV-----YKAIDTVTNETVAIKR-IRLEHEEEGVPGTAIREV-SLLKELQHRN 94
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL-LNEVRIRLLP 587
I+ V ++L E L + D N ++ I+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAENDLKKYM----------------DKNPDVSMRVIKSF- 137
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF-- 645
QL+ G++ H +HRDLKPQN+L+S +
Sbjct: 138 -----------------LYQLIN-------GVNFCHSRRCLHRDLKPQNLLLSVSDASET 173
Query: 646 -CAKLSDMGISKRLQGDMSCLTQN-ATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCI- 700
K+ D G+++ + T T W + PE LL R + ++D++S+ CI
Sbjct: 174 PVLKIGDFGLARAFGIPIRQFTHEIIT-----LWYRPPEILLGSRHYSTSVDIWSIACIW 228
Query: 701 --------LF------------FCITG----------GKHP-YGESFERDANIVKDRKDL 729
LF F + G P + +SF + K K +
Sbjct: 229 AEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRG--KTLKRV 286
Query: 730 FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769
E +DL T +L+ +P R A+N L HP+F D
Sbjct: 287 LGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND 326
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 82/348 (23%), Positives = 143/348 (41%), Gaps = 77/348 (22%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTH---HDVALK---EIQNLI 521
+IG ++ + G+ G V + + G VAVK L + DV K EIQNL
Sbjct: 13 VKIGHYIL-GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL- 70
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+HP+I++ Y V S +++ +E YV G + + + L+E
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVME----------YVSGGELFDYICKNGR----LDEK 116
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
R ++ + I+SG+ + H ++HRDLKP+NVL+
Sbjct: 117 ESR-------------------------RLFQQILSGVDYCHRHMVVHRDLKPENVLL-- 149
Query: 642 DKSFCAKLSDMGISKRLQGDM----SCLTQNATGYGSSGWQAPEQLLQGRQ--TRAIDLF 695
D AK++D G+S + SC GS + APE ++ GR +D++
Sbjct: 150 DAHMNAKIADFGLSNMMSDGEFLRTSC--------GSPNYAAPE-VISGRLYAGPEVDIW 200
Query: 696 SLGCILFFCITGGKHPYGESFERDANIVKDRK-----DLFLVEHI-PEAVDLFTRLLDPN 749
S G IL+ + G P F+ D ++ K + +++ P + L +L +
Sbjct: 201 SSGVILYALLC-GTLP----FD-DDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVD 254
Query: 750 PDLRPKAQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKLLRAL 797
P R +++ H +F + F D S + D E+ ++
Sbjct: 255 PMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKF 302
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 78/363 (21%), Positives = 127/363 (34%), Gaps = 121/363 (33%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
K++ KG+ G V + G VAVK++ + +EI L H NIV
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 533 YGV---ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V ++D+D VYL + L+ +I +N+L V + +
Sbjct: 75 LNVLRADNDRD-VYLVFDYMETDLHAVIR----------------ANILEPVHKQYV--- 114
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-K 648
++ QL+K + +LH GL+HRD+KP N+L++ + C K
Sbjct: 115 -------VY--------QLIK-------VIKYLHSGGLLHRDMKPSNILLNAE---CHVK 149
Query: 649 LSDMGISKRLQGDMSCLTQNA-----------------TGYGSSGW-QAPEQLLQGRQ-T 689
++D G+S+ T Y ++ W +APE LL + T
Sbjct: 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209
Query: 690 RAIDLFSLGCI---------LF------------FCITG--------------------- 707
+ ID++SLGCI +F +
Sbjct: 210 KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIES 269
Query: 708 ----GKHPYGESFERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNH 762
+ + + EA+DL +LL NP+ R A + L H
Sbjct: 270 LKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329
Query: 763 PFF 765
PF
Sbjct: 330 PFV 332
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 77/334 (23%), Positives = 129/334 (38%), Gaps = 101/334 (30%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ G+ G+V + G VA+K+L + A +E+ L+ QH N++
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL-LLKHMQHENVIGL 88
Query: 533 YGV-------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
V + D YL + L ++ E +I+
Sbjct: 89 LDVFTPASSLRNFYD-FYLVMPFMQTDLQKIMG----------------LKFSEE-KIQY 130
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L ++ Q+LK GL ++H G++HRDLKP N+ +++D
Sbjct: 131 L----------VY--------QMLK-------GLKYIHSAGVVHRDLKPGNLAVNED--- 162
Query: 646 CA-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCILF 702
C K+ D G+++ +M TGY + W +APE +L + +D++S+GCI+
Sbjct: 163 CELKILDFGLARHADAEM-------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215
Query: 703 FCITG-----GKH--------------PYGESFERDANI----------VKDRKDL--FL 731
+TG GK P E ++ + RKD
Sbjct: 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF 275
Query: 732 VEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
P+A DL ++L+ + D R A L HPFF
Sbjct: 276 PRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 72/325 (22%), Positives = 113/325 (34%), Gaps = 103/325 (31%)
Query: 497 GRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVRWYGV--------ESDQDFV 542
G+ VA+K+ V ++ AL+EI+ L H N+V + + +
Sbjct: 42 GQKVALKK-VLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSI 99
Query: 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQD-SNLLNEVRIRLLPVMENTKDIELWKAN 601
YL + C E D + LL+ V ++ K +
Sbjct: 100 YLVFDFC----------------------EHDLAGLLSNVLVKFTL--SEIKRVMQ---- 131
Query: 602 GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGD 661
LL GL ++H ++HRD+K NVLI++D KL+D G+++
Sbjct: 132 -----MLLN-------GLYYIHRNKILHRDMKAANVLITRDG--VLKLADFGLARAFSLA 177
Query: 662 MSCLTQNATG------YGSSGWQAPEQLLQGRQ-TRAIDLFSLGCI---------LF--- 702
+ T Y + PE LL R IDL+ GCI +
Sbjct: 178 KNSQPNRYTNRVVTLWY-----RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 232
Query: 703 ---------FCITG----------GKHPYGESFERDANIVKDRKDLF-LVEHIPEAVDLF 742
+ G + E E + KD P A+DL
Sbjct: 233 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 292
Query: 743 TRLLDPNPDLRPKAQNVLNHPFFWT 767
+LL +P R + + LNH FFW+
Sbjct: 293 DKLLVLDPAQRIDSDDALNHDFFWS 317
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-19
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 18/161 (11%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+ GL H+H +++RDLKP N+L+ D+ ++SD+G++ + G+
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILL--DEHGHVRISDLGLACDFSKK-----KPHASVGT 353
Query: 675 SGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDR---KDLF 730
G+ APE L +G + D FSLGC+LF + G P+ + +D + + +
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 731 LVEHI-PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFF 765
L + PE L LL + + R AQ V PFF
Sbjct: 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 3e-19
Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
IVSGL HLH+ +I+RDLKP+NVL+ D ++SD+G++ + T+ G+
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLL--DDDGNVRISDLGLAVE---LKAGQTKTKGYAGT 352
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERDANIVKDR---KDL 729
G+ APE LL ++D F+LG L+ I + + +K R + +
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAA--RGPFRARGEKVENKELKQRVLEQAV 410
Query: 730 FLVEHI-PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTAD 769
+ P + D LL +P+ R + HP F
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-19
Identities = 56/249 (22%), Positives = 100/249 (40%), Gaps = 61/249 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 530
+ ++ G G V EG ++ S VAVK L + +V LKE + +HPN+V
Sbjct: 222 ITMKHKLGGGQYG-EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVM-KEIKHPNLV 279
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ GV + + Y+ E ++ G+ + L +E + +
Sbjct: 280 QLLGVCTREPPFYIITE----------FMTYGNLLDYL--RECNRQEV------------ 315
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ LL + I S + +L + IHR+L +N L+ ++ K++
Sbjct: 316 -------------SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGEN--HLVKVA 360
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 703
D G+S+ + GD Y + W APE L + + D+++ G +L+
Sbjct: 361 DFGLSRLMTGDT---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 411
Query: 704 CITGGKHPY 712
T G PY
Sbjct: 412 IATYGMSPY 420
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 6e-19
Identities = 71/373 (19%), Positives = 128/373 (34%), Gaps = 103/373 (27%)
Query: 462 IDDRVDGRRIGKLVVFNKEIAKGSNGT--VVLEG----NYEGRSVAVKRLVKTHHDV-AL 514
++ R +F E K GT V + + + A+K++ T + A
Sbjct: 7 FKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC 66
Query: 515 KEIQNLIASDQHPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKE 572
+EI L+ +HPN++ V V+L + E
Sbjct: 67 REIA-LLRELKHPNVISLQKVFLSHADRKVWLLFDYA----------------------E 103
Query: 573 QDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLK-VTRDIVSGLSHLHEIGLIHRD 631
D L +++ + + K ++K + I+ G+ +LH ++HRD
Sbjct: 104 HD----------LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRD 153
Query: 632 LKPQNVLISKDKSF--CAKLSDMGISKRLQGDMSCLTQNATG-----YGSSGWQAPEQLL 684
LKP N+L+ + K++DMG ++ + L Y +APE LL
Sbjct: 154 LKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY-----RAPELLL 208
Query: 685 QGRQ-TRAIDLFSLGCI---------LF---------------------FCITG------ 707
R T+AID++++GCI +F F + G
Sbjct: 209 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD 268
Query: 708 ----GKHPYGESFE---RDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKA 756
K P + R ++ +H +A L +LL +P R +
Sbjct: 269 WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328
Query: 757 QNVLNHPFFWTAD 769
+ + P+F
Sbjct: 329 EQAMQDPYFLEDP 341
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 8e-19
Identities = 69/354 (19%), Positives = 133/354 (37%), Gaps = 105/354 (29%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWY 533
+ +G+ G V + G VA+K++ + L+EI+ ++ +H NI+ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIK-ILKHFKHENIITIF 75
Query: 534 GV------ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+ E+ + VY+ E L+ +I + +L++ I+
Sbjct: 76 NIQRPDSFENFNE-VYIIQELMQTDLHRVI----------------STQMLSDDHIQYF- 117
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
++ Q L+ + LH +IHRDLKP N+LI+ + C
Sbjct: 118 ---------IY--------QTLR-------AVKVLHGSNVIHRDLKPSNLLINSN---CD 150
Query: 648 -KLSDMGISKRLQGDMSCLTQNA------TGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLG 698
K+ D G+++ + + ++ + ++ W +APE +L + +RA+D++S G
Sbjct: 151 LKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG 210
Query: 699 CILFFCITG-----GKH--------------PYGESF------ERDANIV-----KDRKD 728
CIL G+ P+ ++ R +
Sbjct: 211 CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAP 270
Query: 729 L--FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 780
L P+ +DL R+L +P R A+ L HP+ D +D
Sbjct: 271 LEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL-------QTYHDPND 317
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 3e-18
Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-G 673
I GL LH +++RDLKP+N+L+ D ++SD+G++ + Q G G
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILL--DDHGHIRISDLGLAVHVPEG-----QTIKGRVG 347
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERDANIVKDR---KD 728
+ G+ APE + R T + D ++LGC+L+ I G + V+
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG--QSPFQQRKKKIKREEVERLVKEVP 405
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR-----PKAQNVLNHPFFWTAD 769
E P+A L ++LL +P R A+ V HP F +
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 56/257 (21%), Positives = 96/257 (37%), Gaps = 52/257 (20%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+ F K + G+ G VV L + +VAVK L + H + E++ L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
H NIV G + + E Y G +LLN +R +
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITE----------YCCYG-------------DLLNFLRRK 121
Query: 585 LLPVMENTKDIELWKANGHP--SAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
+ + + + + LL + + G++ L IHRDL +N+L++
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 695
+ K+ D G+++ ++ D + Y G W APE + T D++
Sbjct: 182 R--ITKICDFGLARDIKNDSN--------YVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 696 SLGCILFFCITGGKHPY 712
S G L+ + G PY
Sbjct: 232 SYGIFLWELFSLGSSPY 248
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 74/312 (23%), Positives = 123/312 (39%), Gaps = 78/312 (25%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNIVR 531
K + GS G V+L + G A+K L K V LK+I+ ++ + P +V+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDK-QKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
D +Y+ +E YV G L + +E R
Sbjct: 106 LEFSFKDNSNLYMVME----------YVAGGEMFSHL----RRIGRFSEPHARFY----- 146
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+AQ IV +LH + LI+RDLKP+N+LI D+ +++D
Sbjct: 147 -------------AAQ-------IVLTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTD 184
Query: 652 MGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
G +KR++G C G+ APE +L +A+D ++LG +++ G
Sbjct: 185 FGFAKRVKGRTWTLC--------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG-- 234
Query: 710 HP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR-----PKAQ 757
+P + + +E IV + + H + DL LL + R
Sbjct: 235 YPPFFADQPIQIYE---KIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVN 289
Query: 758 NVLNHPFFWTAD 769
++ NH +F T D
Sbjct: 290 DIKNHKWFATTD 301
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 61/251 (24%), Positives = 98/251 (39%), Gaps = 63/251 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRL--VKTHHDVA--LKEIQNLIASDQHPN 528
+V ++I +G+ G V G + VAVK A L+E + ++ HPN
Sbjct: 116 LVLGEQIGRGNFG-EVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEAR-ILKQYSHPN 173
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
IVR GV + + +Y+ +E V G F L + + + L
Sbjct: 174 IVRLIGVCTQKQPIYIVME----------LVQGGDFLTFL--RTEGARL----------- 210
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
LL++ D +G+ +L IHRDL +N L+++ K
Sbjct: 211 ---------------RVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN--VLK 253
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCIL 701
+SD G+S+ + S G W APE L GR + D++S G +L
Sbjct: 254 ISDFGMSREEADGVY--------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305
Query: 702 FFCITGGKHPY 712
+ + G PY
Sbjct: 306 WETFSLGASPY 316
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 59/247 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 531
+ F +EI G G +V G + + VA+K + + ++E + ++ HP +V+
Sbjct: 10 LTFVQEIGSGQFG-LVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQ 67
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
YGV +Q + L E ++ G + L + Q
Sbjct: 68 LYGVCLEQAPICLVTE----------FMEHGCLSDYL--RTQRGLF-------------- 101
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+ LL + D+ G+++L E +IHRDL +N L+ ++ K+SD
Sbjct: 102 ------------AAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGEN--QVIKVSD 147
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
G+++ + D S+G W +PE R + D++S G +++
Sbjct: 148 FGMTRFVLDD--------QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 199
Query: 706 TGGKHPY 712
+ GK PY
Sbjct: 200 SEGKIPY 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 23/170 (13%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
IV L HLH++G+I+RD+K +N+L+ D + L+D G+SK D + G+
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILL--DSNGHVVLTDFGLSKEFVADETERAY--DFCGT 223
Query: 675 SGWQAPEQLLQGRQ--TRAIDLFSLGCILFFCITGGKHP--YGESFERDA-----NIVKD 725
+ AP+ + G +A+D +SLG +++ +TG + + I+K
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG--ASPFTVDGEKNSQAEISRRILKS 281
Query: 726 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 769
+ + + A DL RLL +P R P+ A + H FF +
Sbjct: 282 --EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 57/255 (22%), Positives = 92/255 (36%), Gaps = 43/255 (16%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+ F K + G+ G V+ + VAVK L + + E++ +
Sbjct: 47 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
H NIV G + +YL E Y G L +K + +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFE----------YCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+ E L LL + G+ L +HRDL +NVL++ K
Sbjct: 157 QKRLEEEEDLNVL------TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK- 209
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G+++ + D + Y G W APE L +G T D++S
Sbjct: 210 -VVKICDFGLARDIMSDSN--------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260
Query: 698 GCILFFCITGGKHPY 712
G +L+ + G +PY
Sbjct: 261 GILLWEIFSLGVNPY 275
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 73/346 (21%), Positives = 126/346 (36%), Gaps = 67/346 (19%)
Query: 391 QVKSKKQNEEHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGN 450
+++ + K+ RR + T ++E ++ N V T LS
Sbjct: 4 SHHHHHHSQDPPAVHKLTKRIPLRR----QVTVSAESSSSMNSNTPLVRITTRLSSTADT 59
Query: 451 GEKFLLTFTDLIDDR---VDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRS-------- 499
++ +L +D ++ K + +G G VV G
Sbjct: 60 PMLAGVSEYELPEDPKWEFPRDKL----TLGKPLGEGCFGQVV-MAEAVGIDKDKPKEAV 114
Query: 500 -VAVKRLVKTHHDVA----LKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLN 554
VAVK L + + E++ + +H NI+ G + +Y+ +E
Sbjct: 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE------- 167
Query: 555 DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614
Y G NL +R R P ME + DI L+ T
Sbjct: 168 ---YASKG-------------NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 672
+ G+ +L IHRDL +NVL++++ K++D G+++ D+ N Y
Sbjct: 212 LARGMEYLASQKCIHRDLAARNVLVTENN--VMKIADFGLAR----DI-----NNIDYYK 260
Query: 673 -GSSG-----WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
++G W APE L T D++S G +++ T G PY
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 531
+ ++ +G G V G + G VA+K L + L+E Q + +H +V+
Sbjct: 186 LRLEVKLGQGCFG-EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM-KKLRHEKLVQ 243
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
Y V S++ +Y+ E Y+ GS + L K + L
Sbjct: 244 LYAVVSEEP-IYIVTE----------YMSKGSLLDFL--KGETGKYL------------- 277
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D
Sbjct: 278 ------------RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVAD 323
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFC 704
G+++ ++ + Y + W APE L GR T D++S G +L
Sbjct: 324 FGLARLIEDNE---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 705 ITGGKHPY 712
T G+ PY
Sbjct: 375 TTKGRVPY 382
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 2e-17
Identities = 56/248 (22%), Positives = 101/248 (40%), Gaps = 61/248 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 531
+ ++ +G G V G + G VA+K L + L+E Q + +H +V+
Sbjct: 269 LRLEVKLGQGCFG-EVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVM-KKLRHEKLVQ 326
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
Y V S++ +Y+ E Y+ GS + L K + L
Sbjct: 327 LYAVVSEEP-IYIVTE----------YMSKGSLLDFL--KGETGKYL------------- 360
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D
Sbjct: 361 ------------RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVAD 406
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFFC 704
G+++ ++ + Y + W APE L GR T D++S G +L
Sbjct: 407 FGLARLIEDNE---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457
Query: 705 ITGGKHPY 712
T G+ PY
Sbjct: 458 TTKGRVPY 465
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 61/335 (18%), Positives = 105/335 (31%), Gaps = 101/335 (30%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 535
+++ +G V N V VK L +EI+ L PNI+ +
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 101
Query: 536 -ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ + L L+ ++R +
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQLYQTLT----------------DYDIRFYMY-------- 137
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA-KLSDMG 653
++LK L + H +G++HRD+KP NV+I D +L D G
Sbjct: 138 ------------EILK-------ALDYCHSMGIMHRDVKPHNVMI--DHEHRKLRLIDWG 176
Query: 654 ISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQ-TRAIDLFSLGCIL---------F 702
++ +S + + PE L+ + ++D++SLGC+L F
Sbjct: 177 LA-EFYHPGQEY----NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
Query: 703 FCITGGKH--------------PYGESFERDANIVKDR--------------KDLFLVEH 734
F G + NI D + E+
Sbjct: 232 FH---GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSEN 288
Query: 735 I----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
PEA+D +LL + R A+ + HP+F
Sbjct: 289 QHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 3e-17
Identities = 67/400 (16%), Positives = 111/400 (27%), Gaps = 110/400 (27%)
Query: 479 KEIAKGSNGT-VVLEGNYE--GRSVAVKRL-----VKTHHDVALKEIQNLIASDQHPNIV 530
I KG V Y+ G V V+R+ E+ + HPNIV
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIV 89
Query: 531 RWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ + +++ S DLI + +NE+ I
Sbjct: 90 PYRATFIADNELWVVTSFMAYGSAKDLI-------------CTHFMDGMNELAIAY---- 132
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+ + ++ L ++H +G +HR +K ++LIS D L
Sbjct: 133 ---------------------ILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYL 169
Query: 650 SDMGISKRLQGDMSCL-TQNATGYGSSG---WQAPEQLLQGRQ--TRAIDLFSLGC---- 699
S + + + + S W +PE L Q Q D++S+G
Sbjct: 170 SGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
Query: 700 ---------------ILFFCITGG--------KHPYGESFERDANIVKDRKDLFLVEHIP 736
+L + G P E + V + +
Sbjct: 230 LANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTST 289
Query: 737 EAVDLFTRLLDP-------------------NPDLRPKAQNVLNHPFFWTA-DTRLSFLR 776
P NPD RP A +LNH FF L
Sbjct: 290 PRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALP 349
Query: 777 DVSDRVELEDRESDSKLLRALEGIALVALN------GKWD 810
++ V + + GI + N W+
Sbjct: 350 ELLRPVT-PITNFEGSQSQDHSGIFGLVTNLEELEVDDWE 388
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 50/252 (19%)
Query: 475 VVFNKEIAKGSNGTVV---LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQHP 527
+ F I +G+ G V+ ++ + A+KR+ + E++ L HP
Sbjct: 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NI+ G + ++YL++E Y G NLL+ +R +
Sbjct: 87 NIINLLGACEHRGYLYLAIE----------YAPHG-------------NLLDFLRKSRVL 123
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+ I A+ S QLL D+ G+ +L + IHRDL +N+L+ ++ A
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY--VA 181
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCI 700
K++D G L++ Y W A E L T D++S G +
Sbjct: 182 KIADFG-----------LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 230
Query: 701 LFFCITGGKHPY 712
L+ ++ G PY
Sbjct: 231 LWEIVSLGGTPY 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 56/259 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA----LKEIQNLI 521
+ K + +G+ G VV G VAVK L + + E++ +
Sbjct: 37 LTLGKPLGEGAFGQVV-MAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 95
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+H NI+ G + +Y+ +E Y G NL +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVE----------YASKG-------------NLREYL 132
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
R R P ME + DI L+ T + G+ +L IHRDL +NVL+++
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAID 693
+ K++D G+++ D+ N Y ++G W APE L T D
Sbjct: 193 NNV--MKIADFGLAR----DI-----NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 694 LFSLGCILFFCITGGKHPY 712
++S G +++ T G PY
Sbjct: 242 VWSFGVLMWEIFTLGGSPY 260
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 71/257 (27%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR---------SVAVKRLVKTHHDVA----LKEIQNLI 521
+ +K + G G V GR SVA+K L + + L E ++
Sbjct: 47 ISIDKVVGAGEFGEV-----CSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS-IM 100
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
HPNI+R GV + V + E Y+ +GS + L ++ D+
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTE----------YMENGSLDSFL--RKHDAQF---- 144
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
QL+ + R I SG+ +L ++G +HRDL +N+LI+
Sbjct: 145 ----------------------TVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLF 695
+ K+SD G+ + L+ D Y + G W +PE + + T A D++
Sbjct: 183 N--LVCKVSDFGLGRVLEDDPE------AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVW 234
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ ++ G+ PY
Sbjct: 235 SYGIVLWEVMSYGERPY 251
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 57/249 (22%), Positives = 101/249 (40%), Gaps = 61/249 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS--VAVKRLVKTHHDVA--LKEIQNLIASDQHPNIV 530
+ ++ G G V EG ++ S VAVK L + +V LKE ++ +HPN+V
Sbjct: 15 ITMKHKLGGGQYG-EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLV 72
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ GV + + Y+ E ++ G+ + L +E + +
Sbjct: 73 QLLGVCTREPPFYIITE----------FMTYGNLLDYL--RECNRQEV------------ 108
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ LL + I S + +L + IHRDL +N L+ ++ K++
Sbjct: 109 -------------SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN--HLVKVA 153
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLGCILFF 703
D G+S+ + GD Y + W APE L + + D+++ G +L+
Sbjct: 154 DFGLSRLMTGDT---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 704 CITGGKHPY 712
T G PY
Sbjct: 205 IATYGMSPY 213
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 50/257 (19%), Positives = 91/257 (35%), Gaps = 53/257 (20%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+ K + +G+ G V+ ++ R+VAVK L + + E++ LI
Sbjct: 29 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 525 QHPNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
H N+V G + + + +E + G NL +R
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVE----------FCKFG-------------NLSTYLRS 125
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+ + E + L+ + + G+ L IHRDL +N+L+S+
Sbjct: 126 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 695
K+ D G+++ D+ W APE + T D++
Sbjct: 186 --VVKICDFGLAR----DI-----YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 234
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ + G PY
Sbjct: 235 SFGVLLWEIFSLGASPY 251
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 6e-17
Identities = 76/358 (21%), Positives = 131/358 (36%), Gaps = 114/358 (31%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
K I G+ G V + R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIIGL 89
Query: 533 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
V +S ++F VY+ +E +L +I + + L+ R+ L
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDANLCQVI--------------QME---LDHERMSYL 132
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
L+ Q+L G+ HLH G+IHRDLKP N+++ D C
Sbjct: 133 ----------LY--------QMLC-------GIKHLHSAGIIHRDLKPSNIVVKSD---C 164
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFC 704
K+ D G+++ T Y + + +APE +L +D++S+GCI+
Sbjct: 165 TLKILDFGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 705 ITG-----GKHPY------------------------------------GESFERD-ANI 722
I G G G SFE+ ++
Sbjct: 220 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDV 279
Query: 723 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLRDVSD 780
+ +A DL +++L + R L HP+ ++ D S+
Sbjct: 280 LFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY-------INVWYDPSE 330
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 54/247 (21%), Positives = 100/247 (40%), Gaps = 59/247 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEG-RSVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 531
+ F KE+ G G VV G + G VA+K + + D ++E + ++ + H +V+
Sbjct: 26 LTFLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMNLSHEKLVQ 83
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
YGV + Q +++ E Y+ +G L +E
Sbjct: 84 LYGVCTKQRPIFIITE----------YMANGCLLNYL--REMRHRF-------------- 117
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+ QLL++ +D+ + +L +HRDL +N L++ K+SD
Sbjct: 118 ------------QTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ--GVVKVSD 163
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
G+S+ + D S G W PE L+ + + D+++ G +++
Sbjct: 164 FGLSRYVLDD--------EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
Query: 706 TGGKHPY 712
+ GK PY
Sbjct: 216 SLGKMPY 222
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 9e-17
Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 59/247 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVK--THHDVALKEIQNLIASDQHPNIVR 531
+ KE+ G G VV G ++G+ VAVK + + D +E Q + HP +V+
Sbjct: 10 ITLLKELGSGQFG-VVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQ-TMMKLSHPKLVK 67
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+YGV S + +Y+ E Y+ +G L + +
Sbjct: 68 FYGVCSKEYPIYIVTE----------YISNGCLLNYLRSHGKGLEP-------------- 103
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+QLL++ D+ G++ L IHRDL +N L+ +D C K+SD
Sbjct: 104 --------------SQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD--LCVKVSD 147
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
G+++ + D S G W APE + + D+++ G +++
Sbjct: 148 FGMTRYVLDD--------QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
Query: 706 TGGKHPY 712
+ GK PY
Sbjct: 200 SLGKMPY 206
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 48/179 (26%), Positives = 71/179 (39%), Gaps = 24/179 (13%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 671
+V L +H +G IHRD+KP N+L+ DKS KL+D G ++ + A G
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 234
Query: 672 YGSSGWQAPEQLL----QGRQTRAIDLFSLGCILFFCITGGKHP--YGES-FERDANIVK 724
Y +PE L G R D +S+G L+ + G Y +S + I+
Sbjct: 235 Y-----ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFYADSLVGTYSKIMN 287
Query: 725 DRKDLFLVEHI---PEAVDLFTRLL-DPNPDLRPK-AQNVLNHPFFWTADTRLSFLRDV 778
+ L + EA +L L D L + + H FF LRD
Sbjct: 288 HKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDT 346
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 34/314 (10%), Positives = 72/314 (22%), Gaps = 109/314 (34%)
Query: 466 VDGR-RIGKLVVFNKEIAKGSNGTV------VLEGNYEGRSVAVKRLVKTHHDVALKEIQ 518
+GR R+ L R VA+ V + +Q
Sbjct: 29 ANGRYRLLIF------HGGVPPLQFWQALDTAL-----DRQVALT-FVDPQGVLPDDVLQ 76
Query: 519 NLI------ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKE 572
+ + P + R V + + E ++ GS +E +
Sbjct: 77 ETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE----------WIRGGSLQEVADT-- 124
Query: 573 QDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDL 632
P ++ + + + H G+
Sbjct: 125 -----------SPSP------------------VGAIRAMQSLAAAADAAHRAGVALSID 155
Query: 633 KPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI 692
P V +S D L+
Sbjct: 156 HPSRVRVSIDGD--VVLAYPATM-----------------------PDA-------NPQD 183
Query: 693 DLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF--------LVEHIPEAVD-LFT 743
D+ +G L+ + + P E+ + + +D + IP + +
Sbjct: 184 DIRGIGASLYALLV-NRWPLPEA-GVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAA 241
Query: 744 RLLDPNPDLRPKAQ 757
R + + +R +
Sbjct: 242 RSVQGDGGIRSAST 255
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 47/167 (28%), Positives = 79/167 (47%), Gaps = 24/167 (14%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
IVS L +LH +++RD+K +N+++ KD K++D G+ K +S T G+
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKD-GHI-KITDFGLCKE---GISDGATMKTFCGT 168
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE L RA+D + LG +++ + G Y + FE I+ + +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG--RLPFYNQDHERLFE---LILME--E 221
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 769
+ + PEA L LL +P R P A+ V+ H FF + +
Sbjct: 222 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 62/258 (24%), Positives = 104/258 (40%), Gaps = 72/258 (27%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR----------SVAVKRLVKTHHDVA----LKEIQNL 520
V K I G G V Y+G VA+K L + + L E +
Sbjct: 46 VTRQKVIGAGEFGEV-----YKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG-I 99
Query: 521 IASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNE 580
+ H NI+R GV S + + E Y+ +G+ ++ L +E+D
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITE----------YMENGALDKFL--REKDGEF--- 144
Query: 581 VRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS 640
QL+ + R I +G+ +L + +HRDL +N+L++
Sbjct: 145 -----------------------SVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN 181
Query: 641 KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDL 694
+ K+SD G+S+ L+ D Y +SG W APE + + T A D+
Sbjct: 182 SN--LVCKVSDFGLSRVLEDDPE------ATYTTSGGKIPIRWTAPEAISYRKFTSASDV 233
Query: 695 FSLGCILFFCITGGKHPY 712
+S G +++ +T G+ PY
Sbjct: 234 WSFGIVMWEVMTYGERPY 251
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 58/253 (22%), Positives = 99/253 (39%), Gaps = 63/253 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 525
+ K I G +G V G VA+K L + + L E ++
Sbjct: 51 IHIEKIIGSGDSG-EVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS-IMGQFD 108
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HPNI+R GV + + E Y+ +GS + L + D
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTE----------YMENGSLDTFL--RTHDGQF-------- 148
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
QL+ + R + +G+ +L ++G +HRDL +NVL+ +
Sbjct: 149 ------------------TIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN--L 188
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
K+SD G+S+ L+ D Y ++G W APE + + A D++S G
Sbjct: 189 VCKVSDFGLSRVLEDD------PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGV 242
Query: 700 ILFFCITGGKHPY 712
+++ + G+ PY
Sbjct: 243 VMWEVLAYGERPY 255
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 55/167 (32%), Positives = 83/167 (49%), Gaps = 24/167 (14%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I L HLH+ G+I+RDLKP+N+++ + KL+D G+ K + T T G+
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIML--NHQGHVKLTDFGLCKE---SIHDGTVTHTFCGT 184
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE L++ RA+D +SLG +++ +TG P GE+ + I+K
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG--APPFTGENRKKTID---KILKC--K 237
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 769
L L ++ EA DL +LL N R P A V HPFF +
Sbjct: 238 LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 66/314 (21%), Positives = 121/314 (38%), Gaps = 78/314 (24%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQ------NLIASDQHPNI 529
+ + GS G V L + GR A+K L K V LK+++ +++ HP I
Sbjct: 10 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKK-EIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+R +G D +++ ++ Y+ G L + S +
Sbjct: 69 IRMWGTFQDAQQIFMIMD----------YIEGGELFSLL----RKSQRFPNPVAKFY--- 111
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+A+ + L +LH +I+RDLKP+N+L+ DK+ K+
Sbjct: 112 ---------------AAE-------VCLALEYLHSKDIIYRDLKPENILL--DKNGHIKI 147
Query: 650 SDMGISKRLQGDMS--CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
+D G +K + C G+ + APE + ++ID +S G +++ + G
Sbjct: 148 TDFGFAKYVPDVTYTLC--------GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
Query: 708 GKHP--YGES----FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLR-----PK 755
+ Y + +E I+ L + DL +RL+ + R
Sbjct: 200 --YTPFYDSNTMKTYE---KILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNG 252
Query: 756 AQNVLNHPFFWTAD 769
++V NHP+F
Sbjct: 253 TEDVKNHPWFKEVV 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 22/171 (12%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I L++LHE G+I+RDLK NVL+ + KL+D G+ K + +T G+
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHI-KLTDYGMCKE---GLRPGDTTSTFCGT 173
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---L 731
+ APE L ++D ++LG ++F + G+ P+ D LF L
Sbjct: 174 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVIL 232
Query: 732 VEHI-------PEAVDLFTRLLDPNPDLR----PK--AQNVLNHPFFWTAD 769
+ I +A + L+ +P R P+ ++ HPFF D
Sbjct: 233 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 48/175 (27%), Positives = 72/175 (41%), Gaps = 30/175 (17%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 671
IV + +H +G +HRD+KP N+L+ D+ +L+D G +L+ D + + A G
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILL--DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD 228
Query: 672 YGSSGWQAPEQLL-------QGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-AN 721
Y +PE L G D ++LG + G Y +S
Sbjct: 229 Y-----LSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG--QTPFYADSTAETYGK 281
Query: 722 IVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLR---PKAQNVLNHPFFWTAD 769
IV ++ L L EA D RLL P+ R A + HPFF+ D
Sbjct: 282 IVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLD 335
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-16
Identities = 52/247 (21%), Positives = 95/247 (38%), Gaps = 59/247 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 531
+ K++ G G V Y VAVK + V L E + + QH +V+
Sbjct: 190 LKLEKKLGAGQFG-EVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVM-KTLQHDKLVK 247
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ V + ++ +Y+ E ++ GS + L K + +
Sbjct: 248 LHAVVT-KEPIYIITE----------FMAKGSLLDFL--KSDEGSKQ------------- 281
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
P +L+ + I G++ + + IHRDL+ N+L+S K++D
Sbjct: 282 ------------PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS--LVCKIAD 327
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
G+++ ++ + G W APE + G T D++S G +L +
Sbjct: 328 FGLARVIEDN--------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
Query: 706 TGGKHPY 712
T G+ PY
Sbjct: 380 TYGRIPY 386
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 64/253 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 525
K + G+ GTV +G + VA+K L + A KEI ++AS
Sbjct: 17 FKKIKVLGSGAFGTVY-KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
+P++ R G+ V L + + G LL+ VR
Sbjct: 76 NPHVCRLLGICLTST-VQLITQ----------LMPFGC-------------LLDYVR--- 108
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
E+ +I S LL I G+++L + L+HRDL +NVL+
Sbjct: 109 ----EHKDNI--------GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--Q 154
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
K++D G++K L + Y + G W A E +L T D++S G
Sbjct: 155 HVKITDFGLAKLLGAEEKE-------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
Query: 700 ILFFCITGGKHPY 712
++ +T G PY
Sbjct: 208 TVWELMTFGSKPY 220
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 3e-16
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 30/170 (17%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 672
+ L HLH +G+I+RDLKP+N+L+ D+ KL+D G+SK + Y
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILL--DEEGHIKLTDFGLSKE------SIDHEKKAYSF 186
Query: 673 -GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKD 725
G+ + APE + + T++ D +S G ++F +TG G+ I+K
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG--TLPFQGKDRKETMT---MILKA 241
Query: 726 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 769
L + + + PEA L L NP R P + + H FF T D
Sbjct: 242 --KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 55/258 (21%), Positives = 97/258 (37%), Gaps = 67/258 (25%)
Query: 473 KLVVFNKEIAKGSNGTVVLEGNYEGRS----VAVKRL-----VKTHHDVALKEIQNLIAS 523
L + +KE+ G+ G V +G Y+ + VAVK L D L E ++
Sbjct: 17 LLTLEDKELGSGNFG-TVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQ 74
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
+P IVR G+ + + L +E G L ++
Sbjct: 75 LDNPYIVRMIGI-CEAESWMLVME----------MAELGP-------------LNKYLQ- 109
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+ ++++ + G+ +L E +HRDL +NVL+
Sbjct: 110 ---------------QNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH 154
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 696
AK+SD G+SK L+ D + Y + W APE + + + D++S
Sbjct: 155 --YAKISDFGLSKALRADENY-------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWS 205
Query: 697 LGCILFFCITGGKHPYGE 714
G +++ + G+ PY
Sbjct: 206 FGVLMWEAFSYGQKPYRG 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 65/276 (23%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA---LKEIQNLIASDQH 526
+ + ++ KG+ G+V L G+ G VAVK+L + D +EIQ ++ +
Sbjct: 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQ-ILKALHS 83
Query: 527 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
IV++ GV + + L +E Y+ SG + L + + L
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVME----------YLPSGCLRDFL--QRHRARL------- 124
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+++LL + I G+ +L +HRDL +N+L+ +
Sbjct: 125 -------------------DASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESE-- 163
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 697
K++D G++K L D Y W APE L +R D++S
Sbjct: 164 AHVKIADFGLAKLLPLDKDY-------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSF 216
Query: 698 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
G +L+ T S E + +R L
Sbjct: 217 GVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 61/246 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIVRWY 533
+ + I KG G V+ G+Y G VAVK + A L E ++ +H N+V+
Sbjct: 23 LKLLQTIGKGEFG-DVMLGDYRGNKVAVKCIKNDATAQAFLAEAS-VMTQLRHSNLVQLL 80
Query: 534 GVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
GV ++ +Y+ E Y+ GS + L + + ++L
Sbjct: 81 GVIVEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVL-------------- 114
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
LLK + D+ + +L +HRDL +NVL+S+D AK+SD
Sbjct: 115 -----------GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDF 161
Query: 653 GISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
G++K W APE L + + + D++S G +L+ +
Sbjct: 162 GLTKEAS------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
Query: 707 GGKHPY 712
G+ PY
Sbjct: 210 FGRVPY 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 59/259 (22%), Positives = 100/259 (38%), Gaps = 56/259 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA----LKEIQNLI 521
+V K + +G+ G VV G VAVK L + + E++ +
Sbjct: 71 LVLGKPLGEGAFGQVV-LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 129
Query: 522 ASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
+H NI+ G + +Y+ +E Y G NL +
Sbjct: 130 MIGKHKNIINLLGACTQDGPLYVIVE----------YASKG-------------NLREYL 166
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK 641
+ R P +E + + S L+ + G+ +L IHRDL +NVL+++
Sbjct: 167 QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 226
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAID 693
D K++D G+++ D+ + Y ++G W APE L T D
Sbjct: 227 DN--VMKIADFGLAR----DI-----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 694 LFSLGCILFFCITGGKHPY 712
++S G +L+ T G PY
Sbjct: 276 VWSFGVLLWEIFTLGGSPY 294
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 4e-16
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 22/171 (12%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I L++LHE G+I+RDLK NVL+ + KL+D G+ K + +T G+
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHI-KLTDYGMCKE---GLRPGDTTSTFCGT 216
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIVKDRKDLF---L 731
+ APE L ++D ++LG ++F + G+ P+ D LF L
Sbjct: 217 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-GRSPFDIVGSSDNPDQNTEDYLFQVIL 275
Query: 732 VEHI-------PEAVDLFTRLLDPNPDLR----PK--AQNVLNHPFFWTAD 769
+ I +A + L+ +P R P+ ++ HPFF D
Sbjct: 276 EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 5e-16
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 26/168 (15%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATG--- 671
+V + +H++ +HRD+KP N+L+ D + +L+D G +L D + + A G
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 672 YGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-ANIV 723
Y +PE L +GR D +SLG ++ + G Y ES I+
Sbjct: 242 Y-----ISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG--ETPFYAESLVETYGKIM 294
Query: 724 KDRKDLFLVEHI----PEAVDLFTRLLDPNPD-L-RPKAQNVLNHPFF 765
++ + A DL RL+ L + ++ HPFF
Sbjct: 295 NHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 59/246 (23%), Positives = 98/246 (39%), Gaps = 61/246 (24%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA-LKEIQNLIASDQHPNIVRWY 533
+ + I KG G V+ G+Y G VAVK + A L E + +H N+V+
Sbjct: 195 LKLLQTIGKGEFG-DVMLGDYRGNKVAVKCIKNDATAQAFLAEASVM-TQLRHSNLVQLL 252
Query: 534 GVES-DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
GV ++ +Y+ E Y+ GS + L + + ++L
Sbjct: 253 GVIVEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVL-------------- 286
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
LLK + D+ + +L +HRDL +NVL+S+D AK+SD
Sbjct: 287 -----------GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDF 333
Query: 653 GISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
G++K W APE L + + + D++S G +L+ +
Sbjct: 334 GLTKEAS------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
Query: 707 GGKHPY 712
G+ PY
Sbjct: 382 FGRVPY 387
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-16
Identities = 59/257 (22%), Positives = 93/257 (36%), Gaps = 56/257 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEG-------RSVAVKRLVKTHHDVA----LKEIQNLIAS 523
+ F K + G+ G VV E G VAVK L T H + E++ +
Sbjct: 48 LQFGKTLGAGAFGKVV-EATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL 106
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
QH NIV G + V + E C L + + S E +S
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA----- 161
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
+ LL + + G++ L IHRD+ +NVL++
Sbjct: 162 ---------------------STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 695
AK+ D G+++ + D + Y G W APE + T D++
Sbjct: 201 H--VAKIGDFGLARDIMNDSN--------YIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ + G +PY
Sbjct: 251 SYGILLWEIFSLGLNPY 267
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 5e-16
Identities = 67/363 (18%), Positives = 125/363 (34%), Gaps = 61/363 (16%)
Query: 358 HAFVEGFRSYIQSFIVLFIALCPIIGFLFYHSKQVKSKKQNEEHITKTGIPKKKKSRRPG 417
VE + I CP + + H + P+++
Sbjct: 233 WQLVEYLKLKADGLIYCLKEACPNSS---ASNASGAAAPTLPAHPSTLTHPQRRIDTLNS 289
Query: 418 YNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFTDLIDDRVDGRRIGKLVVF 477
+ T ++ + +T + E+ L D L++
Sbjct: 290 -DGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRD--------NLLIA 340
Query: 478 NKEIAKGSNGTVVLEGNYEGRS----VAVKRLVKTHHDVALKEIQ---NLIASDQHPNIV 530
+ E+ G+ G+V +G Y R VA+K L + +E+ ++ +P IV
Sbjct: 341 DIELGCGNFGSV-RQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R GV + + L +E G + L + +
Sbjct: 400 RLIGVCQAEA-LMLVME----------MAGGGPLHKFL--VGKREEI------------- 433
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
P + + ++ + G+ +L E +HR+L +NVL+ AK+S
Sbjct: 434 -------------PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH--YAKIS 478
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G+SK L D S T + G W APE + + + D++S G ++ ++ G+
Sbjct: 479 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
Query: 711 PYG 713
PY
Sbjct: 539 PYK 541
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 6e-16
Identities = 72/343 (20%), Positives = 124/343 (36%), Gaps = 107/343 (31%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
K I G+ G V + R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISL 126
Query: 533 YGV----ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
V ++ ++F VYL +E +L +I L+ R+ L
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDANLCQVI-----------------QMELDHERMSYL 169
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
Q+L G+ HLH G+IHRDLKP N+++ D C
Sbjct: 170 ------------------LYQMLC-------GIKHLHSAGIIHRDLKPSNIVVKSD---C 201
Query: 647 A-KLSDMGISKRLQGDMSCLTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFC 704
K+ D G++ R G + T Y + + +APE +L +D++S+GCI+
Sbjct: 202 TLKILDFGLA-RTAGTSFMM----TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 705 ITG-----GKH--------------PYGESFER---DA--------------------NI 722
+ G+ P E ++ +
Sbjct: 257 VRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDS 316
Query: 723 VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+ +A DL +++L +P R + L HP+
Sbjct: 317 LFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-16
Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 29/169 (17%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY-- 672
I S L +LH + +++RDLKP+N+L+ D L+D G+ K + N+T
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILL--DSQGHIVLTDFGLCKE------NIEHNSTTSTF 199
Query: 673 -GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKD 725
G+ + APE L + R +D + LG +L+ + G P Y + ++ NI+
Sbjct: 200 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG--LPPFYSRNTAEMYD---NILNK 254
Query: 726 RKDLFLVEHI-PEAVDLFTRLLDPNPDLR----PKAQNVLNHPFFWTAD 769
L L +I A L LL + R + +H FF +
Sbjct: 255 --PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 63/257 (24%), Positives = 105/257 (40%), Gaps = 47/257 (18%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+V K + +G G VV L+G +VAVK L + L E N++
Sbjct: 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEF-NVLKQV 83
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQL-NAKEQDSNLLNEVRI 583
HP++++ YG S + L +E Y GS L +++ L
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVE----------YAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
R +++ + L L+ I G+ +L E+ L+HRDL +N+L+++ +
Sbjct: 134 RNSSSLDHPDERAL------TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR 187
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 695
K+SD G+S+ D+ S G W A E L T D++
Sbjct: 188 --KMKISDFGLSR----DV-----YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ +T G +PY
Sbjct: 237 SFGVLLWEIVTLGGNPY 253
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 1e-15
Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I GL L G+I+RDLK NV++ + K++D G+ K ++ T G+
Sbjct: 130 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHI-KIADFGMCKE---NIWDGVTTKTFCGT 184
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE + +++D ++ G +L+ + G GE F+ +I++ +
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG--QAPFEGEDEDELFQ---SIMEH--N 237
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 769
+ + + EAV + L+ +P R P+ +++ H FF D
Sbjct: 238 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 53/257 (20%), Positives = 101/257 (39%), Gaps = 61/257 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 523
+ ++E+ +GS G V EG +G VA+K + + L E ++
Sbjct: 27 ITMSRELGQGSFGMVY-EGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKE 84
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
++VR GV S + +E + G +L + +R
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIME----------LMTRG-------------DLKSYLRS 121
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+ N ++++++ +I G+++L+ +HRDL +N ++++D
Sbjct: 122 LRPAMANNPVLAPP------SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED- 174
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 695
F K+ D G+++ + T Y G G W +PE L G T D++
Sbjct: 175 -FTVKIGDFGMTRDIY---------ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 224
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ T + PY
Sbjct: 225 SFGVVLWEIATLAEQPY 241
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 20/163 (12%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+ GL LH G+++RDLK N+L+ KD K++D G+ K +M + T G+
Sbjct: 127 IILGLQFLHSKGIVYRDLKLDNILLDKD-GHI-KIADFGMCKE---NMLGDAKTNTFCGT 181
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE LL + ++D +S G +L+ + G +G+ F +I D +
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG--QSPFHGQDEEELFH---SIRMD--N 234
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLRPKAQN-VLNHPFFWTAD 769
F + EA DL +L P+ R + + HP F +
Sbjct: 235 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 19/165 (11%)
Query: 615 IVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYG 673
IVS L +LH E +++RDLK +N+++ DK K++D G+ K + T G
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLML--DKDGHIKITDFGLCKE---GIKDGATMKTFCG 311
Query: 674 SSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGESFERD-ANIVKDRKDLF 730
+ + APE L RA+D + LG +++ + G Y + E+ I+ + ++
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG--RLPFYNQDHEKLFELILME--EIR 367
Query: 731 LVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 769
+ PEA L + LL +P R + A+ ++ H FF
Sbjct: 368 FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 57/257 (22%), Positives = 94/257 (36%), Gaps = 60/257 (23%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASD 524
+ +++ +G G V L + G VAVK L K +EI ++ +
Sbjct: 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEID-ILRTL 90
Query: 525 QHPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
H +I+++ G ++ + L +E YV GS + L
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVME----------YVPLGSLRDYL-------------- 126
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
+ AQLL + I G+++LH IHRDL +NVL+ D
Sbjct: 127 ----------------PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDND 170
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSS--GWQAPEQLLQGRQTRAIDLFSLGCI 700
K+ D G++K + G S W APE L + + A D++S G
Sbjct: 171 --RLVKIGDFGLAKAVPEGHEYYR--VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226
Query: 701 LFFCITGGKHPYGESFE 717
L+ +T +
Sbjct: 227 LYELLTHCDSSQSPPTK 243
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 25/168 (14%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I+S L LH+ G+I+RDLK NVL+ + C KL+D G+ K + AT G+
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHC-KLADFGMCKE---GICNGVTTATFCGT 187
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE L + A+D +++G +L+ + G H E+ FE I+ D +
Sbjct: 188 PDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG--HAPFEAENEDDLFE---AILND--E 240
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR------PKAQNVLNHPFFWTAD 769
+ + +A + + NP +R +L HPFF D
Sbjct: 241 VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 67/294 (22%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA---LKEIQNLIASDQH 526
+ F +++ KG+ G+V + + G VAVK+L + + +EI+ ++ S QH
Sbjct: 12 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE-ILKSLQH 70
Query: 527 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
NIV++ GV + + + L +E Y+ GS + L ++ +
Sbjct: 71 DNIVKYKGVCYSAGRRNLKLIME----------YLPYGSLRDYL--QKHKERI------- 111
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+LL+ T I G+ +L IHRDL +N+L+ +
Sbjct: 112 -------------------DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-- 150
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G++K L D + W APE L + + + A D++S
Sbjct: 151 NRVKIGDFGLTKVLPQDKEF-------FKVKEPGESPIFWYAPESLTESKFSVASDVWSF 203
Query: 698 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
G +L+ T + E I D++ +V H+ E + RL P PD
Sbjct: 204 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--PRPD 255
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 64/327 (19%), Positives = 117/327 (35%), Gaps = 70/327 (21%)
Query: 400 EHITKTGIPKKKKSRRPGYNRNTTNSEKMQNIIPNESKVGETDGLSHITGNGEKFLLTFT 459
I +K+ R + + + Q + + V ETD + I + T+T
Sbjct: 323 GATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEED----TYT 378
Query: 460 DLIDDRVDGRRIGKLVVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVAL 514
+ +R + + + I +G G V +G Y VA+K D
Sbjct: 379 MPSTRDYEIQR--ERIELGRCIGEGQFGDVH-QGIYMSPENPAMAVAIKTCKNCTSDSVR 435
Query: 515 KEIQ---NLIASDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAK 571
++ + HP+IV+ GV ++ V++ +E G L +
Sbjct: 436 EKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIME----------LCTLGELRSFL--Q 482
Query: 572 EQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRD 631
+ +L A L+ + + L++L +HRD
Sbjct: 483 VRKFSL--------------------------DLASLILYAYQLSTALAYLESKRFVHRD 516
Query: 632 LKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQ 685
+ +NVL+S + C KL D G+S+ ++ T Y +S W APE +
Sbjct: 517 IAARNVLVSSN--DCVKLGDFGLSRYMEDS--------TYYKASKGKLPIKWMAPESINF 566
Query: 686 GRQTRAIDLFSLGCILFFCITGGKHPY 712
R T A D++ G ++ + G P+
Sbjct: 567 RRFTSASDVWMFGVCMWEILMHGVKPF 593
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 45/256 (17%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+ + ++I +G+ G V L VAVK L + +E L+A
Sbjct: 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEF 107
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
+PNIV+ GV + + L E Y+ G E L + +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFE----------YMAYGDLNEFLRSMSPHTVCSLSHSDL 157
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
++ A+ L + R + +G+++L E +HRDL +N L+ ++
Sbjct: 158 STRARVSSPGPPPL-----SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-- 210
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLFS 696
K++D G+S+ + + Y + W PE + R T D+++
Sbjct: 211 MVVKIADFGLSRNIY---------SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 261
Query: 697 LGCILFFCITGGKHPY 712
G +L+ + G PY
Sbjct: 262 YGVVLWEIFSYGLQPY 277
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 54/256 (21%), Positives = 98/256 (38%), Gaps = 63/256 (24%)
Query: 473 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 525
L++ + E+ G+ G+V V + VA+K L + ++E Q ++
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLD 68
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
+P IVR GV + + L +E G + L + +
Sbjct: 69 NPYIVRLIGV-CQAEALMLVME----------MAGGGPLHKFL--VGKREEI-------- 107
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
P + + ++ + G+ +L E +HRDL +NVL+
Sbjct: 108 ------------------PVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-- 147
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSLG 698
AK+SD G+SK L D S Y + W APE + + + D++S G
Sbjct: 148 YAKISDFGLSKALGADDSY-------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYG 200
Query: 699 CILFFCITGGKHPYGE 714
++ ++ G+ PY +
Sbjct: 201 VTMWEALSYGQKPYKK 216
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 3e-15
Identities = 40/167 (23%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGS 674
I GL L G+I+RDLK NV++ + K++D G+ K ++ T G+
Sbjct: 451 IAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHI-KIADFGMCKE---NIWDGVTTKTFCGT 505
Query: 675 SGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP--YGES----FERDANIVKDRKD 728
+ APE + +++D ++ G +L+ + G GE F+ +I++ +
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG--QAPFEGEDEDELFQ---SIMEH--N 558
Query: 729 LFLVEHI-PEAVDLFTRLLDPNPDLR----PK-AQNVLNHPFFWTAD 769
+ + + EAV + L+ +P R P+ +++ H FF D
Sbjct: 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 53/256 (20%), Positives = 97/256 (37%), Gaps = 53/256 (20%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 523
V F +E+ + G V +G+ G + VA+K L E L A
Sbjct: 11 VRFMEELGEDRFGKVY-KGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM-LRAR 68
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
QHPN+V GV + + + ++ F + +L + +
Sbjct: 69 LQHPNVVCLLGV---------------VTKDQPLSMI---FSYCSH-----GDLHEFLVM 105
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
R + D + + + + I +G+ +L ++H+DL +NVL+
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK- 164
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 696
K+SD+G+ + + A Y G W APE ++ G+ + D++S
Sbjct: 165 -LNVKISDLGLFREV--------YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 215
Query: 697 LGCILFFCITGGKHPY 712
G +L+ + G PY
Sbjct: 216 YGVVLWEVFSYGLQPY 231
|
| >2hz6_A Endoplasmic reticulum to nucleus signalling 1 isoform 1 variant; triangular beta-sheet cluster, signaling protein; 3.10A {Homo sapiens} Length = 369 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 3e-15
Identities = 37/187 (19%), Positives = 68/187 (36%), Gaps = 34/187 (18%)
Query: 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFH 108
+ V+ LDG++H V + G I+W+ + + F D D LY
Sbjct: 10 TLLFVSTLDGSLHAVSKRTGSIKWTLKEDPVLQVPTHVEEPA----FLPD-PNDGSLYTL 64
Query: 109 SKRFGK-MKKLSSSAEEYIRRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSA 167
+ + + KL + E ++ P S DG + +G + +++D+ +G
Sbjct: 65 GSKNNEGLTKLPFTIPELVQASPCRSSDGILYMGKKQDIWYVIDLLTGEKQQT------- 117
Query: 168 STPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDYVLQSTSQDSGEVLWNV 227
S + P L+Y+ RT+Y + + E+ WN
Sbjct: 118 ----LSSAFADSLSPSTS-----------------LLYLGRTEYTITMYDTKTRELRWNA 156
Query: 228 AYADFKA 234
Y D+ A
Sbjct: 157 TYFDYAA 163
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 70/294 (23%), Positives = 119/294 (40%), Gaps = 67/294 (22%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRL---VKTHHDVALKEIQNLIASDQH 526
+ F +++ KG+ G+V + + G VAVK+L + H +EI+ ++ S QH
Sbjct: 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIE-ILKSLQH 101
Query: 527 PNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
NIV++ GV + + + L +E Y+ GS + L ++ +
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIME----------YLPYGSLRDYL--QKHKERI------- 142
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKS 644
+LL+ T I G+ +L IHRDL +N+L+ +
Sbjct: 143 -------------------DHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENE-- 181
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 697
K+ D G++K L D Y W APE L + + + A D++S
Sbjct: 182 NRVKIGDFGLTKVLPQDKEY-------YKVKEPGESPIFWYAPESLTESKFSVASDVWSF 234
Query: 698 GCILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPD 751
G +L+ T + E I D++ +V H+ E + RL P PD
Sbjct: 235 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRL--PRPD 286
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 60/247 (24%), Positives = 95/247 (38%), Gaps = 59/247 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR-SVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 531
+ + + G G V G Y G VAVK L + L E L+ QH +VR
Sbjct: 15 LKLVERLGAGQFG-EVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVR 72
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
Y V + Q+ +Y+ E Y+ +GS + L K L
Sbjct: 73 LYAVVT-QEPIYIITE----------YMENGSLVDFL--KTPSGIKLT------------ 107
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+LL + I G++ + E IHRDL+ N+L+S K++D
Sbjct: 108 -------------INKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT--LSCKIAD 152
Query: 652 MGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
G+++ ++ + G W APE + G T D++S G +L +
Sbjct: 153 FGLARLIEDN--------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
Query: 706 TGGKHPY 712
T G+ PY
Sbjct: 205 THGRIPY 211
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 6e-15
Identities = 53/283 (18%), Positives = 101/283 (35%), Gaps = 55/283 (19%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHD----VALKEIQNLIASD 524
+ K + +G+ G V+ ++ R+VAVK L + + E++ LI
Sbjct: 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 83
Query: 525 QHPNIVRWYGVESDQDF-VYLSLERCTC-SLNDLI---------YVLSGSFEEQLNAKEQ 573
H N+V G + + + +E C +L+ + Y G+ Q
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 574 DSNLLNEVRIRLLPVMENTKDIELWKANGH-----------------PSAQLLKVTRDIV 616
+ + R+ + +++ + L+ + +
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVA 203
Query: 617 SGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG 676
G+ L IHRDL +N+L+S+ K+ D G+++ + D Y G
Sbjct: 204 KGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPD--------YVRKG 253
Query: 677 -------WQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
W APE + T D++S G +L+ + G PY
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 59/252 (23%), Positives = 99/252 (39%), Gaps = 46/252 (18%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRL-VKTHHDVA--LKEIQNLIASDQ 525
+V +E+ +G+ G V L + VAVK L T +E + L+ + Q
Sbjct: 17 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE-LLTNLQ 75
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H +IV++YGV D D + + E Y+ G +L +R
Sbjct: 76 HEHIVKFYGVCGDGDPLIMVFE----------YMKHG-------------DLNKFLRAHG 112
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
M +Q+L + I SG+ +L +HRDL +N L+ +
Sbjct: 113 PDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN--L 170
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 700
K+ D G+S+ + + + G W PE ++ + T D++S G I
Sbjct: 171 LVKIGDFGMSRDVY------STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 224
Query: 701 LFFCITGGKHPY 712
L+ T GK P+
Sbjct: 225 LWEIFTYGKQPW 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 60/257 (23%), Positives = 98/257 (38%), Gaps = 57/257 (22%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-------VAVKRLVKTHHDVA----LKEIQNLIAS 523
+V E+ +G+ G V VAVK L K + A +E + L+
Sbjct: 43 IVLKWELGEGAFGKVF-LAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAE-LLTM 99
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
QH +IVR++GV ++ + + E Y+ G LN
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFE----------YMRHGD--------------LNRFLR 135
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
P + E QLL V + +G+ +L + +HRDL +N L+ +
Sbjct: 136 SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG- 194
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 695
K+ D G+S+ + +T Y G W PE +L + T D++
Sbjct: 195 -LVVKIGDFGMSRDIY---------STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVW 244
Query: 696 SLGCILFFCITGGKHPY 712
S G +L+ T GK P+
Sbjct: 245 SFGVVLWEIFTYGKQPW 261
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 70/314 (22%), Positives = 128/314 (40%), Gaps = 77/314 (24%)
Query: 477 FNKE--IAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 528
F+ + I G G V VL +G VA+KR ++E + ++ +HP+
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLR---DGAKVALKRRTPESSQ-GIEEFETEIETLSFCRHPH 96
Query: 529 IVRWYG--VESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
+V G E ++ +Y + Y+ +G+ + L + + ++
Sbjct: 97 LVSLIGFCDERNEMILIY---K----------YMENGNLKRHLYGSDLPTMSMS------ 137
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
W+ Q L++ GL +LH +IHRD+K N+L+ D++F
Sbjct: 138 ------------WE-------QRLEICIGAARGLHYLHTRAIIHRDVKSINILL--DENF 176
Query: 646 CAKLSDMGISK-RLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704
K++D GISK + D + L+ G+ G+ PE ++GR T D++S G +LF
Sbjct: 177 VPKITDFGISKKGTELDQTHLSTVVK--GTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEV 234
Query: 705 ITGGKHPYGESFERD-ANIV-------KDRK-----DLFLVEHIPE-----AVDLFTRLL 746
+ + +S R+ N+ + + D L + I D + L
Sbjct: 235 LC-ARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCL 293
Query: 747 DPNPDLRPKAQNVL 760
+ + RP +VL
Sbjct: 294 ALSSEDRPSMGDVL 307
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 49/259 (18%), Positives = 90/259 (34%), Gaps = 70/259 (27%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS---------VAVKRLVKTHHDVA---LKEIQNLIA 522
++FN+ + +G+ + +G V +K L K H + + + +++
Sbjct: 10 LIFNESLGQGTFTKIF-KGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS-MMS 67
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
H ++V YGV D L E +V GS + L K+ + +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQE----------FVKFGSLDTYL--KKNKNCI----- 110
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
L+V + + + + L E LIH ++ +N+L+ ++
Sbjct: 111 ---------------------NILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIRE 149
Query: 643 KSF------CAKLSDMGISKRLQGDMSCLTQNATGYGSS--GWQAPEQLLQGRQ-TRAID 693
+ KLSD GIS + W PE + + A D
Sbjct: 150 EDRKTGNPPFIKLSDPGISITVLPK---------DILQERIPWVPPECIENPKNLNLATD 200
Query: 694 LFSLGCILFFCITGGKHPY 712
+S G L+ +GG P
Sbjct: 201 KWSFGTTLWEICSGGDKPL 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 77.6 bits (190), Expect = 1e-14
Identities = 81/518 (15%), Positives = 157/518 (30%), Gaps = 153/518 (29%)
Query: 425 SEKMQNIIPNESKVGETDGLSHITGNG---EKFLLTFTDLIDDRVDG--RRIGKLVVFN- 478
+ ++I+ E E D HI + L F L+ + + + + +++ N
Sbjct: 39 QDMPKSILSKE----EID---HIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY 91
Query: 479 ----KEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHHDVALKEIQNLIASDQ- 525
I ++ Y V K V +++ + +
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPY--LKLRQALLELRP 149
Query: 526 HPNIV-----------------RWYGVESDQDF-VY-LSLERCTCS------LNDLIYVL 560
N++ Y V+ DF ++ L+L+ C L L+Y +
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQI 209
Query: 561 SGSFEEQLNAKEQDSNLLNEVRIRL------------LPVMENTKDIELWKA-NGHPSAQ 607
++ + + ++ ++ L L V+ N ++ + W A N +
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS--CK 267
Query: 608 LLKVTRD--IVSGLSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMS 663
+L TR + LS H L ++ ++ D+ K D
Sbjct: 268 ILLTTRFKQVTDFLSAATT---THISLDHHSMTLTPDEVKSLLLKYLDC--------RPQ 316
Query: 664 CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFERDANIV 723
L P ++L + L I ES RD
Sbjct: 317 DL--------------PREVLT------TNPRRLSII------------AESI-RDGLAT 343
Query: 724 KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADTRLS-FLRDV---- 778
D + + ++ +L+P + R F RLS F
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEPA-EYR---------KMFD----RLSVFPPSAHIPT 389
Query: 779 -------SDRVELEDRESDSKLLRALEGIALVALNGKWDEKMETKFIENIGRYRRYKYDN 831
D ++ + +KL + +LV K K T I +I + K +N
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKY----SLVE---KQP-KESTISIPSIYLELKVKLEN 441
Query: 832 VRDLLRVIRNKSNHFRELPQDIQELLGSHPEG-FYNYF 868
L R I + N + D +L+ + + FY++
Sbjct: 442 EYALHRSIVDHYNIPKTFDSD--DLIPPYLDQYFYSHI 477
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 8e-09
Identities = 81/613 (13%), Positives = 179/613 (29%), Gaps = 155/613 (25%)
Query: 231 DFKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVE-SHLPCHTQMTASVYRL-------R 282
F F C++V ++ ++ E H+ + RL +
Sbjct: 28 AFVDNFDCKDV------------QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQ 75
Query: 283 DNSLPEFL-SVIGKVAGWI-----------SLPGSSQNSLLGPVDRNSPLFLPDKVDRPP 330
+ + +F+ V+ ++ S+ + ++ +F V R
Sbjct: 76 EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQ 135
Query: 331 L------ALPSTETEIPWTL--GMPG-G-SV--SEINKKHAFVEGFRSYIQSFIVLFIAL 378
AL L G+ G G + ++ + F + ++ L
Sbjct: 136 PYLKLRQALLELRPA-KNVLIDGVLGSGKTWVALDVCLSYKVQCKM-----DFKIFWLNL 189
Query: 379 ----CP--IIGFL--FYHSKQVKSKKQNEEHITKTGIP----KKKKSR---RPGYNR--- 420
P ++ L + + + +H + + + + R Y
Sbjct: 190 KNCNSPETVLEMLQKLLY-QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLL 248
Query: 421 ---NTTNSEKMQ--NIIPNESKVGETDGLSHITGNGEKFLLTFTDL-IDDRVDGRRIGKL 474
N N++ N+ K+ LLT + D + +
Sbjct: 249 VLLNVQNAKAWNAFNL---SCKI----------------LLTTRFKQVTDFLSAATTTHI 289
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRSVA-VKRLVKTHHDVALKEIQNLIASDQHPNIVRWY 533
+ + + + L Y + R V T + L ++IA + W
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL----SIIAESIRDGLATW- 344
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
++ +++ ++ L +I S L E + + + + P +
Sbjct: 345 -----DNWKHVNCDK----LTTII----ESSLNVLEPAEY-RKMFDRLSV--FP--PSAH 386
Query: 594 DIE------LWKANGHPS------AQLLK---VTRDIVSGLSHLHEIGLIHRDLKPQNVL 638
I +W + S +L K V + + I+ +LK +
Sbjct: 387 -IPTILLSLIW-FDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS---IYLELKVK--- 438
Query: 639 ISKDKSFCAKLSDM-GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697
+ + + + D I K D + Y L + LF +
Sbjct: 439 LENEYALHRSIVDHYNIPKTFDSD-DLIPPYLDQY--FYSHIGHHLKNIEHPERMTLFRM 495
Query: 698 GCILF--FCITGGK--HPYGESFERDANIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDL 752
+F F K H ++ +I+ + L F +I + + RL++ D
Sbjct: 496 ---VFLDFRFLEQKIRHD-STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDF 551
Query: 753 RPK-AQNVLNHPF 764
PK +N++ +
Sbjct: 552 LPKIEENLICSKY 564
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 54/253 (21%), Positives = 93/253 (36%), Gaps = 66/253 (26%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 525
+ + I +G G V +G Y VA+K D L+E +
Sbjct: 17 IELGRCIGEGQFGDVH-QGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL-TMRQFD 74
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HP+IV+ GV ++ V++ +E G L + + +L
Sbjct: 75 HPHIVKLIGVITENP-VWIIME----------LCTLGELRSFL--QVRKYSL-------- 113
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
A L+ + + L++L +HRD+ +NVL+S +
Sbjct: 114 ------------------DLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN--D 153
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
C KL D G+S+ ++ T Y +S W APE + R T A D++ G
Sbjct: 154 CVKLGDFGLSRYMEDS--------TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205
Query: 700 ILFFCITGGKHPY 712
++ + G P+
Sbjct: 206 CMWEILMHGVKPF 218
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 41/228 (17%), Positives = 71/228 (31%), Gaps = 58/228 (25%)
Query: 596 ELWKAN---GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
E K N +P + + + L LHE L H DLKP+N+L +
Sbjct: 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169
Query: 653 GISKRLQGDM---------SCL-TQNATGYGSSG-WQAPEQLLQGRQTRAIDLFSLGCIL 701
++ + + ++ T ++ ++ PE +L+ + D++S+GCIL
Sbjct: 170 SCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229
Query: 702 ------------------------------------------FFCITGGKHPYGESFERD 719
F+
Sbjct: 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYV 289
Query: 720 ANIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
K K L + + + DL R+L+ +P R L HPFF
Sbjct: 290 KENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 61/253 (24%), Positives = 97/253 (38%), Gaps = 64/253 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 525
K + G+ GTV +G + VA+K L + A KEI ++AS
Sbjct: 17 FKKIKVLGSGAFGTVY-KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
+P++ R G+ V L + + G LL+ VR
Sbjct: 76 NPHVCRLLGICLTST-VQLITQ----------LMPFGC-------------LLDYVR--- 108
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
E+ +I S LL I G+++L + L+HRDL +NVL+
Sbjct: 109 ----EHKDNI--------GSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--Q 154
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
K++D G++K L + Y + G W A E +L T D++S G
Sbjct: 155 HVKITDFGLAKLLGAEEKE-------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGV 207
Query: 700 ILFFCITGGKHPY 712
++ +T G PY
Sbjct: 208 TVWELMTFGSKPY 220
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 42/228 (18%), Positives = 77/228 (33%), Gaps = 58/228 (25%)
Query: 596 ELWKANGH---PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ K NG + K+ I ++ LH L H DLKP+N+L + A +
Sbjct: 105 DFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 653 GISKRLQGDM---------SCL-TQNATGYGSSG-WQAPEQLLQGRQTRAIDLFSLGCIL 701
+R + + ++ + S+ ++APE +L ++ D++S+GCIL
Sbjct: 165 KRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCIL 224
Query: 702 ------------------------------------------FFCITGGKHPYGESFERD 719
F + +
Sbjct: 225 IEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV 284
Query: 720 ANIVKDRKDLFLVEHI--PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+ K K+ L + + DL ++L+ +P R + L HPFF
Sbjct: 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 51/257 (19%), Positives = 88/257 (34%), Gaps = 70/257 (27%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRL-------VKTHHDVALKEIQNLIA 522
+ +++ GS G V G ++ S VAVK L + D ++E+ +
Sbjct: 20 LRLLEKLGDGSFGVV-RRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF-IREVN-AMH 76
Query: 523 SDQHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
S H N++R YGV + + E GS ++L ++ +
Sbjct: 77 SLDHRNLIRLYGVVLTPP-MKMVTE----------LAPLGSLLDRL--RKHQGHF----- 118
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
L + + G+ +L IHRDL +N+L++
Sbjct: 119 ---------------------LLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR 157
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLF 695
K+ D G+ + L + Y W APE L + A D +
Sbjct: 158 D--LVKIGDFGLMRALPQNDDH-------YVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208
Query: 696 SLGCILFFCITGGKHPY 712
G L+ T G+ P+
Sbjct: 209 MFGVTLWEMFTYGQEPW 225
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-14
Identities = 61/273 (22%), Positives = 108/273 (39%), Gaps = 70/273 (25%)
Query: 477 FNKE--IAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 528
F+ + + +G G V L +G VAVKRL + + Q +I+ H N
Sbjct: 32 FSNKNILGRGGFGKVYKGRLA---DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 529 IVRWYG--VESDQDFVYLSLERCTCSLNDLIY--VLSGSFEEQLNAKEQDSNLLNEVRIR 584
++R G + + R L+Y + +GS L + + L+
Sbjct: 89 LLRLRGFCMTPTE--------RL------LVYPYMANGSVASCLRERPESQPPLD----- 129
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE---IGLIHRDLKPQNVLISK 641
W ++ GL++LH+ +IHRD+K N+L+
Sbjct: 130 -------------WPKR-------QRIALGSARGLAYLHDHCDPKIIHRDVKAANILL-- 167
Query: 642 DKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700
D+ F A + D G++K + + + T G+ G APE L G+ + D+F G +
Sbjct: 168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVR---GTIGHIAPEYLSTGKSSEKTDVFGYGVM 224
Query: 701 LFFCITGGKHPYGESFERDANIVKDRKDLFLVE 733
L IT G+ + D + + D+ L++
Sbjct: 225 LLELIT-GQRAF------DLARLANDDDVMLLD 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 69/336 (20%), Positives = 119/336 (35%), Gaps = 64/336 (19%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASD 524
+ + + G+ G V + + VAVK L + + L E +I+
Sbjct: 32 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL-IISKF 90
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
H NIVR GV ++ +E + G +L + +R
Sbjct: 91 NHQNIVRCIGVSLQSLPRFILME----------LMAGG-------------DLKSFLR-E 126
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDK 643
P + + LL V RDI G +L E IHRD+ +N L++
Sbjct: 127 TRPRPSQPSSLAM--------LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTRAIDLF 695
AK+ D G+++ + Y G W PE ++G T D +
Sbjct: 179 GRVAKIGDFGMARDIYR---------ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229
Query: 696 SLGCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLR 753
S G +L+ + G PY +S + V + ++ P V + T+ P+ R
Sbjct: 230 SFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
Query: 754 PKAQNVLNHPFFWTADTR-LSFLRDVSDRVELEDRE 788
P +L + T D ++ + +E+ E
Sbjct: 290 PNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 325
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 69/334 (20%), Positives = 119/334 (35%), Gaps = 60/334 (17%)
Query: 475 VVFNKEIAKGSNGTVV------LEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQ 525
+ + + G+ G V + + VAVK L + + + +I+
Sbjct: 73 ITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 132
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H NIVR GV ++ LE + G +L + +R
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLE----------LMAGG-------------DLKSFLR-ET 168
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLIS-KDKS 644
P + + LL V RDI G +L E IHRD+ +N L++
Sbjct: 169 RPRPSQPSSLAM--------LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
Query: 645 FCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFSL 697
AK+ D G+++ + A Y G W PE ++G T D +S
Sbjct: 221 RVAKIGDFGMARDI--------YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF 272
Query: 698 GCILFFCITGGKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPK 755
G +L+ + G PY +S + V + ++ P V + T+ P+ RP
Sbjct: 273 GVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPN 332
Query: 756 AQNVLNHPFFWTADTR-LSFLRDVSDRVELEDRE 788
+L + T D ++ + +E+ E
Sbjct: 333 FAIILERIEYCTQDPDVINTALPIEYGPLVEEEE 366
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 6e-14
Identities = 51/253 (20%), Positives = 94/253 (37%), Gaps = 66/253 (26%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA----LKEIQNLIASDQ 525
VV N+ + +G G V EG Y VAVK K + E ++ +
Sbjct: 14 VVLNRILGEGFFGEV-YEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV-IMKNLD 71
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HP+IV+ G+ ++ ++ +E G L + +L
Sbjct: 72 HPHIVKLIGIIEEEP-TWIIME----------LYPYGELGHYLERNKNSLKVL------- 113
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L+ + I +++L I +HRD+ +N+L++
Sbjct: 114 ---------------------TLVLYSLQICKAMAYLESINCVHRDIAVRNILVASP--E 150
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
C KL D G+S+ ++ + Y +S W +PE + R T A D++
Sbjct: 151 CVKLGDFGLSRYIEDE--------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAV 202
Query: 700 ILFFCITGGKHPY 712
++ ++ GK P+
Sbjct: 203 CMWEILSFGKQPF 215
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-14
Identities = 60/255 (23%), Positives = 102/255 (40%), Gaps = 76/255 (29%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
I +GS G V L + ++VA+K++ + D+ L+EI ++ + I+R
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT-ILNRLKSDYIIRL 90
Query: 533 YGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
Y + + F +Y+ LE L L L E I+ +
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADSDLKKLFKT---------------PIFLTEEHIKTI- 134
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
L+ LL G + +HE G+IHRDLKP N L+++D C+
Sbjct: 135 ---------LY--------NLLL-------GENFIHESGIIHRDLKPANCLLNQD---CS 167
Query: 648 -KLSDMGISKRLQGDMSCLTQNA------------------TGYGSSGW-QAPEQLLQGR 687
K+ D G+++ + + N T + + W +APE +L
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE 227
Query: 688 Q-TRAIDLFSLGCIL 701
T++ID++S GCI
Sbjct: 228 NYTKSIDIWSTGCIF 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 62/266 (23%), Positives = 98/266 (36%), Gaps = 66/266 (24%)
Query: 475 VVFNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQ 525
+ +++ +G G V L EG+ G VAVK L KEI+ ++ +
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIE-ILRNLY 81
Query: 526 HPNIVRWYGV--ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
H NIV++ G+ E + + L +E ++ SGS +E L + NL
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIME----------FLPSGSLKEYLPKNKNKINL------ 125
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
Q LK I G+ +L +HRDL +NVL+ +
Sbjct: 126 ----------------------KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESE- 162
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAIDLFS 696
K+ D G++K ++ D Y W APE L+Q + A D++S
Sbjct: 163 -HQVKIGDFGLTKAIETDKE-------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWS 214
Query: 697 LGCILFFCITGGKHPYGESFERDANI 722
G L +T I
Sbjct: 215 FGVTLHELLTYCDSDSSPMALFLKMI 240
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 51/234 (21%), Positives = 75/234 (32%), Gaps = 72/234 (30%)
Query: 596 ELWKAN---GHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
EL K N G + K I+ L LH+ +IH DLKP+N+L+ + K+ D
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
Query: 653 GISKRLQGDMSC-LTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCIL--------- 701
G S SC Q Y S + +APE +L R ID++SLGCIL
Sbjct: 247 G-S-------SCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL 298
Query: 702 ---------------------------------FFCITGGKH--------------PYGE 714
F G G
Sbjct: 299 LPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGR 358
Query: 715 SFERDANIVKDRKDLFLVEHIPEA---VDLFTRLLDPNPDLRPKAQNVLNHPFF 765
S + ++ + +D + L+ +P +R L HP+
Sbjct: 359 SRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 53/253 (20%), Positives = 90/253 (35%), Gaps = 64/253 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS------VAVKRLVKTHHDVALKEIQ---NLIASDQ 525
+ K + G GTV +G + V +K + + + + I S
Sbjct: 15 LRKLKVLGSGVFGTVH-KGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
H +IVR G+ + L + Y+ GS LL+ VR
Sbjct: 74 HAHIVRLLGLCPGSS-LQLVTQ----------YLPLGS-------------LLDHVR--- 106
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
++ + LL I G+ +L E G++HR+L +NVL+
Sbjct: 107 ----QHRGAL--------GPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSP--S 152
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG------WQAPEQLLQGRQTRAIDLFSLGC 699
+++D G++ L D S W A E + G+ T D++S G
Sbjct: 153 QVQVADFGVADLLPPD-------DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGV 205
Query: 700 ILFFCITGGKHPY 712
++ +T G PY
Sbjct: 206 TVWELMTFGAEPY 218
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 9e-13
Identities = 56/260 (21%), Positives = 97/260 (37%), Gaps = 81/260 (31%)
Query: 479 KEIAKGSNGTVVLEGNYE-GRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
I GS G V + R VA+K++++ D+ L+EI ++ H ++V+
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIA-ILNRLNHDHVVKV 117
Query: 533 YGV---ESDQDF--VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+ + + F +Y+ LE L L E+ I+ L
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADSDFKKLFRT---------------PVYLTELHIKTL- 161
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
L+ LL G+ ++H G++HRDLKP N L+++D C+
Sbjct: 162 ---------LY--------NLLV-------GVKYVHSAGILHRDLKPANCLVNQD---CS 194
Query: 648 -KLSDMGISKRLQGDMSCLTQNATGYGSSGWQ------------------------APEQ 682
K+ D G+++ + + +Q APE
Sbjct: 195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL 254
Query: 683 LLQGRQ-TRAIDLFSLGCIL 701
+L T AID++S+GCI
Sbjct: 255 ILLQENYTEAIDVWSIGCIF 274
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 39/236 (16%), Positives = 72/236 (30%), Gaps = 66/236 (27%)
Query: 596 ELWKANGH---PSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
E+ N + + +I+ L++L ++ L H DLKP+N+L+ + ++
Sbjct: 124 EIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 653 GISKRLQGDMSCLTQNATG---YGSSGWQ--------------APEQLLQGRQTRAIDLF 695
++ + + +G + ++ APE +L + D++
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMW 243
Query: 696 SLGCILFFCITG--------------------GK-------------------------- 709
S GC+L TG
Sbjct: 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303
Query: 710 HPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
P S VK L+ + D +L +P LRP +L H F
Sbjct: 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 9e-13
Identities = 63/281 (22%), Positives = 107/281 (38%), Gaps = 84/281 (29%)
Query: 490 VLEGNYEGRSVAVKRLVKTHHDVA--------LKEIQNLIASDQHPNIVRWYG--VESDQ 539
V +G +VAVK+L D+ +EI ++A QH N+V G + D
Sbjct: 47 VYKGYVNNTTVAVKKL-AAMVDITTEELKQQFDQEI-KVMAKCQHENLVELLGFSSDGDD 104
Query: 540 DFVYLSLERCTCSLNDLIY--VLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597
C L+Y + +GS ++L+ + L +R
Sbjct: 105 --------LC------LVYVYMPNGSLLDRLSCLDGTPPLSWHMR--------------- 135
Query: 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
K+ + +G++ LHE IHRD+K N+L+ D++F AK+SD G+++
Sbjct: 136 -----------CKIAQGAANGINFLHENHHIHRDIKSANILL--DEAFTAKISDFGLAR- 181
Query: 658 LQGDMSCLTQNAT------GYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
+ T + Y APE L+G T D++S G +L ITG
Sbjct: 182 -ASEKFAQTVMTSRIVGTTAY-----MAPE-ALRGEITPKSDIYSFGVVLLEIITGLP-- 232
Query: 712 YGESFERDANIVKDRKDLFLVEH---IPEAVDLFTRLLDPN 749
+ + R+ L++ I + +D
Sbjct: 233 ---------AVDEHREPQLLLDIKEEIEDEEKTIEDYIDKK 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 48/252 (19%), Positives = 84/252 (33%), Gaps = 59/252 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEIQN---LIASDQH 526
V FN+ I +G G V G AVK L + + + ++ H
Sbjct: 91 VHFNEVIGRGHFGCVY-HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 149
Query: 527 PNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
PN++ G+ + + L Y+ G + + + N
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLP----------YMKHGDLRNFI--RNETHNP-------- 189
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L+ + G+ L +HRDL +N ++ + F
Sbjct: 190 ------------------TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK--F 229
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 700
K++D G+++ + N TG W A E L + T D++S G +
Sbjct: 230 TVKVADFGLARDMYDKEFDSVHNKTG----AKLPVKWMALESLQTQKFTTKSDVWSFGVL 285
Query: 701 LFFCITGGKHPY 712
L+ +T G PY
Sbjct: 286 LWELMTRGAPPY 297
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 45/227 (19%), Positives = 84/227 (37%), Gaps = 64/227 (28%)
Query: 596 ELWKANGH---PSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISK----DKSFCA 647
L K H P + ++++ ++ GL ++H G+IH D+KP+NVL+ +
Sbjct: 118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 177
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQ-APEQLLQGRQTRAIDLFSLGCILFFCIT 706
K++D+G + ++ T + +PE LL D++S C++F IT
Sbjct: 178 KIADLGNA-------CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
Query: 707 G-----GKHPYGESFERD--ANIV-----------------------------------K 724
G + + + D A I+
Sbjct: 231 GDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFW 290
Query: 725 DRKDL------FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+D+ F + E D + +L +P R A ++NHP+
Sbjct: 291 PLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 47/252 (18%), Positives = 86/252 (34%), Gaps = 59/252 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVALKEIQ---NLIASDQH 526
++ I KG G V G Y ++ A+K L + ++ L+ H
Sbjct: 23 THSDRVIGKGHFGVVY-HGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH 81
Query: 527 PNIVRWYGVESDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
PN++ G+ + ++ L Y+ G + + + N
Sbjct: 82 PNVLALIGIMLPPEGLPHVLLP----------YMCHGDLLQFI--RSPQRNP-------- 121
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L+ + G+ +L E +HRDL +N ++ + F
Sbjct: 122 ------------------TVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES--F 161
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 700
K++D G+++ + Q W A E L R T D++S G +
Sbjct: 162 TVKVADFGLARDILDREYYSVQQHRH----ARLPVKWTALESLQTYRFTTKSDVWSFGVL 217
Query: 701 LFFCITGGKHPY 712
L+ +T G PY
Sbjct: 218 LWELLTRGAPPY 229
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 51/262 (19%), Positives = 94/262 (35%), Gaps = 70/262 (26%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRL---VKTHHDVA--LKEIQNLIASD 524
+ + KG G+V E + VAVK L + D+ L+E +
Sbjct: 25 FTLGRMLGKGEFGSVR-EAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAA-CMKEF 82
Query: 525 QHPNIVRWYGVESDQD------FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLL 578
HP++ + GV + L ++ G +L
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILP----------FMKHG-------------DLH 119
Query: 579 NEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVL 638
+ + EN ++ P L++ DI G+ +L IHRDL +N +
Sbjct: 120 AFLLASRIG--ENPFNL--------PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169
Query: 639 ISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGY---GSSG-----WQAPEQLLQGRQTR 690
+++D ++D G+S+++ + Y G + W A E L T
Sbjct: 170 LAED--MTVCVADFGLSRKIY---------SGDYYRQGCASKLPVKWLALESLADNLYTV 218
Query: 691 AIDLFSLGCILFFCITGGKHPY 712
D+++ G ++ +T G+ PY
Sbjct: 219 HSDVWAFGVTMWEIMTRGQTPY 240
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 47/252 (18%), Positives = 85/252 (33%), Gaps = 59/252 (23%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR-----SVAVKRLVKTHHDVALKEIQN---LIASDQH 526
V FN+ I +G G V G AVK L + + + ++ H
Sbjct: 27 VHFNEVIGRGHFGCVY-HGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 85
Query: 527 PNIVRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
PN++ G+ + + L Y+ G + + + N
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLP----------YMKHGDLRNFI--RNETHNP-------- 125
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L+ + G+ +L +HRDL +N ++ + F
Sbjct: 126 ------------------TVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEK--F 165
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSG-----WQAPEQLLQGRQTRAIDLFSLGCI 700
K++D G+++ DM + + W A E L + T D++S G +
Sbjct: 166 TVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVL 221
Query: 701 LFFCITGGKHPY 712
L+ +T G PY
Sbjct: 222 LWELMTRGAPPY 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 54/260 (20%), Positives = 90/260 (34%), Gaps = 67/260 (25%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGRS-----VAVKRLVKTHHDVA-----LKEIQNLIASD 524
++ K + +G G+V+ EGN + VAVK + + L E +
Sbjct: 36 LILGKILGEGEFGSVM-EGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAA-CMKDF 93
Query: 525 QHPNIVRWYGVESDQD-----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLN 579
HPN++R GV + + L ++ G +L
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILP----------FMKYG-------------DLHT 130
Query: 580 EVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI 639
+ L T + P LLK DI G+ +L +HRDL +N ++
Sbjct: 131 YLLYSRLE----TGPKHI------PLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSG-------WQAPEQLLQGRQTRAI 692
D ++D G+SK++ + Y W A E L T
Sbjct: 181 RDD--MTVCVADFGLSKKI--------YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKS 230
Query: 693 DLFSLGCILFFCITGGKHPY 712
D+++ G ++ T G PY
Sbjct: 231 DVWAFGVTMWEIATRGMTPY 250
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 59/243 (24%), Positives = 92/243 (37%), Gaps = 60/243 (24%)
Query: 478 NKEIAKGSNGTVVLEGNYE-GRSVAVK--RLVKTHHDVALKEIQNL------IASDQHPN 528
+ I KGS G VV + VA+K + K + A E++ L ++
Sbjct: 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY-Y 117
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
IV ++ + L E + +L DL+ + + ++ R
Sbjct: 118 IVHLKRHFMFRNHLCLVFEMLSYNLYDLL-------------RNTNFRGVSLNLTR---- 160
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH--EIGLIHRDLKPQNVLISKDKSFC 646
K + + + L L E+ +IH DLKP+N+L+ K
Sbjct: 161 ---------------------KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199
Query: 647 AKLSDMGISKRLQGDMSC-LTQNATGYGSSGW-QAPEQLLQGRQTRAIDLFSLGCILFFC 704
K+ D G SC L Q Y S + ++PE LL AID++SLGCIL
Sbjct: 200 IKIVDFG--------SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEM 251
Query: 705 ITG 707
TG
Sbjct: 252 HTG 254
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 38/195 (19%), Positives = 69/195 (35%), Gaps = 48/195 (24%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHP 527
+G K+I G+ G + L N Y VA+K +K+ E +
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 528 NI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
I V ++G + + LE SL DL + +F
Sbjct: 66 GIPQVYYFGPC--GKYNAMVLELLGPSLEDLFDLCDRTF--------------------- 102
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ K + L + ++S + ++H LI+RD+KP+N LI + +
Sbjct: 103 -----SLKTV-------------LMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNK 144
Query: 646 CAK---LSDMGISKR 657
+ + D ++K
Sbjct: 145 TQQVIHIIDFALAKE 159
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 45/261 (17%), Positives = 77/261 (29%), Gaps = 90/261 (34%)
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLIS------------- 640
I G P + K+ + ++ GL +LH + +IH D+KP+N+L+S
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194
Query: 641 --------------KDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQ-------- 678
+ A + ++ + L G++ W
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI 254
Query: 679 ------APEQLLQGRQTRAIDLFSLGCILFFCITG------------------------- 707
+ E L+ D++S C+ F TG
Sbjct: 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314
Query: 708 -GKHPY---------GESFERDANIVKDR--KDLFLVEHIPE-----------AVDLFTR 744
GK P E F + ++ K L E + E D
Sbjct: 315 LGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLP 374
Query: 745 LLDPNPDLRPKAQNVLNHPFF 765
+L+ P+ R A L HP+
Sbjct: 375 MLELIPEKRATAAECLRHPWL 395
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 37/203 (18%), Positives = 69/203 (33%), Gaps = 55/203 (27%)
Query: 463 DDRVDGR-RIGKLVVFNKEIAKGSNGTVVLEGNYE-GRSVAVKR-LVKTHHDVALKEIQN 519
++ V ++G+ I +GS G + N + VA+K ++ E +
Sbjct: 5 NNVVGVHYKVGR------RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 58
Query: 520 LIASDQHPNI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNL 577
I V ++G E L ++ SL DL+ + F
Sbjct: 59 YKLLAGCTGIPNVYYFGQE--GLHNVLVIDLLGPSLEDLLDLCGRKF------------- 103
Query: 578 LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNV 637
+ K + + +++ + +HE L++RD+KP N
Sbjct: 104 -------------SVKTV-------------AMAAKQMLARVQSIHEKSLVYRDIKPDNF 137
Query: 638 LISKDKSFCAK---LSDMGISKR 657
LI + S A + D G+ K
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVKF 160
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 42/240 (17%), Positives = 76/240 (31%), Gaps = 24/240 (10%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVK-------RLVKTHHDVALKEIQNLIASDQHPNIVR 531
++I +G G V + VA+K LV H +EI I + +++
Sbjct: 26 EKIGEGVFGEVFQ-TIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 532 WYGVESDQDFVYL-SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ F+ L S+ S L+ + + + + ++ ++ E
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 591 N-TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE-IGLIHRDLKPQNVLISKDKSFCAK 648
D+E + A + + + L+ + HRDL NVL+ K+ K
Sbjct: 145 FGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL--KKTSLKK 202
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSG-----------WQAPEQLLQGRQTRAIDLFSL 697
L K L + Y S E L G D++ L
Sbjct: 203 LHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 45/194 (23%), Positives = 69/194 (35%), Gaps = 46/194 (23%)
Query: 469 RRIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKR-LVKTHHDVALKEIQNLIASDQH 526
R+G ++I GS G + L G VA+K VKT H E +
Sbjct: 5 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG 64
Query: 527 PNI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
I +RW G E D+ + +E SL DL S F
Sbjct: 65 VGIPTIRWCGAE--GDYNVMVMELLGPSLEDLFNFCSRKF-------------------- 102
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISK-DK 643
+ K + L + ++S + ++H IHRD+KP N L+ K
Sbjct: 103 ------SLKTV-------------LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKK 143
Query: 644 SFCAKLSDMGISKR 657
+ D G++K+
Sbjct: 144 GNLVYIIDFGLAKK 157
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 16/63 (25%), Positives = 30/63 (47%), Gaps = 1/63 (1%)
Query: 596 ELWKANGHPSAQL-LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
++ NG L++ ++ L ++HE +H D+K N+L+ L+D G+
Sbjct: 140 KISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGL 199
Query: 655 SKR 657
S R
Sbjct: 200 SYR 202
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 11/49 (22%), Positives = 23/49 (46%)
Query: 609 LKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
L+V ++ L LHE +H ++ +N+ + + L+ G + R
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 44/193 (22%), Positives = 70/193 (36%), Gaps = 46/193 (23%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKR-LVKTHHDVALKEIQNLIASDQHP 527
R+G ++I GS G + L N VA+K VKT H L E +
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGT 63
Query: 528 NI--VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
I VRW+GVE D+ L ++ SL DL S
Sbjct: 64 GIPNVRWFGVE--GDYNVLVMDLLGPSLEDLFNFCSRKL--------------------- 100
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ K + L + +++ + +H +HRD+KP N L+ +
Sbjct: 101 -----SLKTV-------------LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142
Query: 646 -CAKLSDMGISKR 657
+ D G++K+
Sbjct: 143 NQVYIIDFGLAKK 155
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 13/43 (30%), Positives = 23/43 (53%)
Query: 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
I+ L ++HE +H D+K N+L++ L D G++ R
Sbjct: 161 ILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 902 | ||||
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-45 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-42 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-41 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-41 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-38 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-38 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-37 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-37 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-36 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-35 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-35 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-35 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-34 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-34 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-34 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-32 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-31 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-30 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-29 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-28 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-08 |
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-45
Identities = 61/300 (20%), Positives = 102/300 (34%), Gaps = 34/300 (11%)
Query: 477 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVA----LKEIQNLIASDQH 526
F K + G+ G V+ VAVK L + + E++ + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 527 PNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
NIV G + +YL E C L + + F E E L E + +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
L LL + G+ L +HRDL +NVL+
Sbjct: 161 LTF-----------------EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV--THGK 201
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
K+ D G+++ + D S W APE L +G T D++S G +L+
Sbjct: 202 VVKICDFGLARDIMSD-SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 706 TGGKHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 762
+ G +PY ++++ + + E + + RP N+ +
Sbjct: 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 1e-42
Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 54/294 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD------VALKEIQNLIASDQHPNIVR 531
+ + KG G V L +A+K L K + +E++ + + +HPNI+R
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE-IQSHLRHPNILR 70
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
YG D VYL LE F+EQ
Sbjct: 71 LYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQ------------------------ 106
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+ ++ + LS+ H +IHRD+KP+N+L+ + K++D
Sbjct: 107 ---------------RTATYITELANALSYCHSKRVIHRDIKPENLLL--GSAGELKIAD 149
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G S T G+ + PE + +DL+SLG + + + G
Sbjct: 150 FGWSVHAPSSRRT-----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 204
Query: 712 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
+++ + + F A DL +RLL NP RP + VL HP+
Sbjct: 205 EANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 156 bits (396), Expect = 1e-42
Identities = 59/297 (19%), Positives = 108/297 (36%), Gaps = 55/297 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 534
+E+ G+ G V G + A K ++ H + KEIQ + + +HP +V +
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTM-SVLRHPTLVNLHD 90
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
D + + + E + L + + E
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED-------------------------- 124
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+ ++ R + GL H+HE +H DLKP+N++ + +S KL D G
Sbjct: 125 -------------EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 171
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 712
++ L S G++ + APE D++S+G + + ++ G P+
Sbjct: 172 LTAHLDPKQSVKVT----TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFG 226
Query: 713 GESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
GE+ + VK + D +LL +P+ R L HP+
Sbjct: 227 GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 283
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 8e-42
Identities = 71/335 (21%), Positives = 125/335 (37%), Gaps = 64/335 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV------ALKEIQNLIASDQHPNIVR 531
+EI GS G V VA+K++ + +KE++ + +HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQ 79
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ G + +L +E C S +DL+ V +E
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEV------------------------ 115
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
++ VT + GL++LH +IHRD+K N+L+S+ KL D
Sbjct: 116 ---------------EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP--GLVKLGD 158
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFFCITGG 708
G + + + G+ W APE +L +G+ +D++SLG
Sbjct: 159 FGSASI-------MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-R 210
Query: 709 KHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
K P A +I ++ H + L P RP ++ +L H F
Sbjct: 211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
Query: 766 WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGI 800
+ + + D+ R + RE D+ R ++ I
Sbjct: 271 -LRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKI 304
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 8e-42
Identities = 65/307 (21%), Positives = 116/307 (37%), Gaps = 58/307 (18%)
Query: 473 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALK-----EIQNLIASD 524
L + +KE+ G+ GTV + ++VAVK L +D ALK E ++
Sbjct: 7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQL 65
Query: 525 QHPNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRI 583
+P IVR G+ + + L +E LN +
Sbjct: 66 DNPYIVRMIGICEAESW-MLVMEMAELGPLNKYL-------------------------- 98
Query: 584 RLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDK 643
+ ++++ + G+ +L E +HRDL +NVL+
Sbjct: 99 --------------QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ- 143
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
AK+SD G+SK L+ D + G W APE + + + D++S G +++
Sbjct: 144 -HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWE 202
Query: 704 CITGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNV-- 759
+ G+ PY G +++ + + P E DL + + RP V
Sbjct: 203 AFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262
Query: 760 -LNHPFF 765
L + ++
Sbjct: 263 RLRNYYY 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 9e-42
Identities = 65/296 (21%), Positives = 116/296 (39%), Gaps = 57/296 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 534
++I +G++GTV G+ VA++++ ++ + EI ++ +++PNIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLD 84
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
D +++ +E SL D++
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVT----------------------------------- 109
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+ V R+ + L LH +IHRD+K N+L+ D S KL+D G
Sbjct: 110 ------ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFG 161
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYG 713
++ + S + T G+ W APE + + +D++SLG + I G+ PY
Sbjct: 162 FCAQITPEQSKRS---TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYL 217
Query: 714 ESFERDA---NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
A +L E + D R LD + + R A+ +L H F
Sbjct: 218 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 63/301 (20%), Positives = 106/301 (35%), Gaps = 60/301 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV---ALKEIQNLIASDQHPNIVRWYG 534
E+ G+ G V + A K + + + EI L AS HPNIV+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDIL-ASCDHPNIVKLLD 76
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
++ +++ +E C +++ ++ L E
Sbjct: 77 AFYYENNLWILIEFCAGGAVDAVMLELERPLTES-------------------------- 110
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
Q+ V + + L++LH+ +IHRDLK N+L + D KL+D G
Sbjct: 111 -------------QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD--GDIKLADFG 155
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFFCITGG 708
+S + + + G+ W APE ++ D++SLG L
Sbjct: 156 VSAKNTRTIQRRD---SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE-I 211
Query: 709 KHPYGESFERDA--NIVK-DRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
+ P+ E I K + L D + L+ N D R +L HPF
Sbjct: 212 EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271
Query: 765 F 765
Sbjct: 272 V 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 57/295 (19%), Positives = 112/295 (37%), Gaps = 50/295 (16%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 534
+ + +G+ G V L +VAVK + + I+ + H N+V++YG
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ + YL LE Y G +++
Sbjct: 71 HRREGNIQYLFLE----------YCSGGELFDRIEPD----------------------- 97
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
G P + +++G+ +LH IG+ HRD+KP+N+L+ + K+SD G+
Sbjct: 98 ------IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER--DNLKISDFGL 149
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGGKHPYG 713
+ + + N G+ + APE L + +D++S G +L + G
Sbjct: 150 ATVFRYNNRERLLN-KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208
Query: 714 ES--FERDANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
S + ++ + + L + I + L ++L NP R ++ ++
Sbjct: 209 PSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 60/309 (19%), Positives = 108/309 (34%), Gaps = 54/309 (17%)
Query: 473 KLVVFNKEIAKGSNGTV---VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 526
L++ + E+ G+ G+V V + VA+K L + +E+ ++ +
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68
Query: 527 PNIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
P IVR GV + L +E L+ +
Sbjct: 69 PYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVS------------------ 109
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ ++ + G+ +L E +HRDL +NVL+
Sbjct: 110 ---------------------NVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR--H 146
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
AK+SD G+SK L D S T + G W APE + + + D++S G ++ +
Sbjct: 147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 206
Query: 706 TGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNV---L 760
+ G+ PY ++ K + P E L + + RP V +
Sbjct: 207 SYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
Query: 761 NHPFFWTAD 769
++ A
Sbjct: 267 RACYYSLAS 275
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 64/310 (20%), Positives = 111/310 (35%), Gaps = 64/310 (20%)
Query: 472 GKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA-----LKEIQNLIASDQ 525
G+ + F+ EI +GS TV VA L + +E + ++ Q
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE-MLKGLQ 66
Query: 526 HPNIVRWYGV----ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEV 581
HPNIVR+Y + + L E + SG+ + L
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTE----------LMTSGTLKTYLK------------ 104
Query: 582 RIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG--LIHRDLKPQNVLI 639
+ L R I+ GL LH +IHRDLK N+ I
Sbjct: 105 -----------------RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147
Query: 640 SKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699
+ + K+ D+G++ + + G+ + APE + + ++D+++ G
Sbjct: 148 T-GPTGSVKIGDLGLATLKRASFA-----KAVIGTPEFMAPEMY-EEKYDESVDVYAFGM 200
Query: 700 ILFFCITGGKHPYGESFERDA---NIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPK 755
+ T ++PY E + K + PE ++ + N D R
Sbjct: 201 CMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 259
Query: 756 AQNVLNHPFF 765
+++LNH FF
Sbjct: 260 IKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-40
Identities = 64/300 (21%), Positives = 111/300 (37%), Gaps = 55/300 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
I GS G +G+ + K L + + E+ L+ +HPNIVR+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN-LLRELKHPNIVRY 68
Query: 533 YGVESDQ--DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
Y D+ +Y+ +E Y G + ++ L+E
Sbjct: 69 YDRIIDRTNTTLYIVME----------YCEGGDLASVITKGTKERQYLDE---------- 108
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG-----LIHRDLKPQNVLISKDKSF 645
+L+V + L H ++HRDLKP NV + D
Sbjct: 109 ---------------EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--DGKQ 151
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
KL D G+++ L D S G+ + +PEQ+ + D++SLGC+L+
Sbjct: 152 NVKLGDFGLARILNHDTSFAK---AFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC 208
Query: 706 TGGKHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPF 764
S + A +++ K + E ++ TR+L+ RP + +L +P
Sbjct: 209 ALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 4e-40
Identities = 64/295 (21%), Positives = 112/295 (37%), Gaps = 29/295 (9%)
Query: 477 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHP 527
+ ++I +G+ G V VAVK L + + Q L+A +P
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
NIV+ GV + + L E Y+ G E L + + V
Sbjct: 77 NIVKLLGVCAVGKPMCLLFE----------YMAYGDLNEFLRSMSPHT-----VCSLSHS 121
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+ + A+ L + R + +G+++L E +HRDL +N L+ ++
Sbjct: 122 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVV 179
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K++D G+S+ + + W PE + R T D+++ G +L+ +
Sbjct: 180 KIADFGLSRNIYSA-DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238
Query: 708 GKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVL 760
G PY G + E V+D L E+ P E +L P RP ++
Sbjct: 239 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 7e-40
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 49/289 (16%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVE 536
+ I KG G V+L G+Y G VAVK + A +++ +H N+V+ GV
Sbjct: 11 LLQTIGKGEFGDVML-GDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 537 SDQD-FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
++ +Y+ E Y+ GS + L + + ++L
Sbjct: 70 VEEKGGLYIVTE----------YMAKGSLVDYL--RSRGRSVLGG--------------- 102
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGIS 655
LLK + D+ + +L +HRDL +NVL+S+D AK+SD G++
Sbjct: 103 ----------DCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDFGLT 150
Query: 656 KRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-GE 714
K TG W APE L + + + D++S G +L+ + G+ PY
Sbjct: 151 KEASSTQD------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204
Query: 715 SFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 762
+ V+ + + P ++ + +RP +
Sbjct: 205 PLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 62/295 (21%), Positives = 108/295 (36%), Gaps = 49/295 (16%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYG 534
+ + G G V + VAVK L + D L E L+ QH +VR Y
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVRLYA 75
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V + + +Y+ E Y+ +GS + L
Sbjct: 76 VVTQEP-IYIITE----------YMENGSLVDFLKTP----------------------- 101
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+LL + I G++ + E IHRDL+ N+L+ + K++D G+
Sbjct: 102 ----SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV--SDTLSCKIADFGL 155
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 713
++ ++ + + W APE + G T D++S G +L +T G+ PY G
Sbjct: 156 ARLIEDNEYTARE--GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 714 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLN--HPFF 765
+ ++ + ++ P E L P+ RP + + FF
Sbjct: 214 MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 147 bits (371), Expect = 3e-39
Identities = 62/297 (20%), Positives = 105/297 (35%), Gaps = 55/297 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYG 534
+E+ G+ G V GR K + + EI ++ HP ++ +
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS-IMNQLHHPKLINLHD 93
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
D+ + L LE + L D I E
Sbjct: 94 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSE--------------------------- 126
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
A+++ R GL H+HE ++H D+KP+N++ K+ K+ D G
Sbjct: 127 ------------AEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 174
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 712
++ +L D AT + APE + + D++++G + + ++ G P+
Sbjct: 175 LATKLNPDEIVKVTTATAE----FAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFA 229
Query: 713 GESFERDANIVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
GE VK F + PEA D LL P R + L HP+
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 4e-39
Identities = 57/291 (19%), Positives = 110/291 (37%), Gaps = 49/291 (16%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYG 534
F KE+ G G V VA+K + + D ++E + ++ + H +V+ YG
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAK-VMMNLSHEKLVQLYG 66
Query: 535 VESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
V + Q +++ E L + + + F+ Q
Sbjct: 67 VCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ-------------------------- 100
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
QLL++ +D+ + +L +HRDL +N L+ + K+SD G
Sbjct: 101 -------------QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV--NDQGVVKVSDFG 145
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY- 712
+S+ + D T + W PE L+ + + D+++ G +++ + GK PY
Sbjct: 146 LSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203
Query: 713 GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 762
+ A + L+ E V + D RP + +L++
Sbjct: 204 RFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 5e-39
Identities = 57/290 (19%), Positives = 101/290 (34%), Gaps = 47/290 (16%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVRWYG 534
F +EI G G V L VA+K + + ++E + ++ HP +V+ YG
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQLYG 67
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V +Q + L E D
Sbjct: 68 VCLEQAPICLVFEFMEHGCLS--------------------------------------D 89
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+ + LL + D+ G+++L E +IHRDL +N L+ ++ K+SD G+
Sbjct: 90 YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV--GENQVIKVSDFGM 147
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 713
++ + D T + W +PE R + D++S G +++ + GK PY
Sbjct: 148 TRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
Query: 714 ESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 762
S + L+ + P+ RP +L
Sbjct: 206 RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 6e-39
Identities = 50/296 (16%), Positives = 106/296 (35%), Gaps = 54/296 (18%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVAL--KEIQNLIASDQHPNIVRWYGV 535
+++ +G G V ++ K + D L KEI L +H NI+ +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISIL-NIARHRNILHLHES 69
Query: 536 ESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ + + E + + + I + E+
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNER--------------------------- 102
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+++ + L LH + H D++P+N++ +S K+ + G
Sbjct: 103 ------------EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 713
+++ + + + + APE + A D++SLG +++ ++ G +P+
Sbjct: 151 ARQ----LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLA 205
Query: 714 ESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
E+ ++ + + + F E EA+D RLL R A L HP+
Sbjct: 206 ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-38
Identities = 66/297 (22%), Positives = 114/297 (38%), Gaps = 37/297 (12%)
Query: 477 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHH----DVALKEIQNLIASDQH 526
F K + G+ G VV + +VAVK L + H + + E++ L H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 527 PNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NIV G + + E Y G L +++DS + ++ ++
Sbjct: 87 MNIVNLLGACTIGGPTLVITE----------YCCYGDLLNFLR-RKRDSFICSKTSPAIM 135
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
E D+E LL + + G++ L IHRDL +N+L++
Sbjct: 136 EDDELALDLE----------DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RI 183
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
K+ D G+++ ++ D S W APE + T D++S G L+ +
Sbjct: 184 TKICDFGLARDIKND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
Query: 707 GGKHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVL 760
G PY ++K+ + EH P E D+ D +P RP + ++
Sbjct: 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 62/302 (20%), Positives = 111/302 (36%), Gaps = 42/302 (13%)
Query: 476 VFNKEIAKGSNGTVVL--------EGNYEGRSVAVKRLVKTHHDVALK----EIQNLIAS 523
V K + +G+ G VVL + VAVK L + L E++ +
Sbjct: 16 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 524 DQHPNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVR 582
+H NI+ G + +Y+ +E + +L + + +
Sbjct: 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL------------------------Q 111
Query: 583 IRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD 642
R P +E + + S L+ + G+ +L IHRDL +NVL+++D
Sbjct: 112 ARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171
Query: 643 KSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
K++D G+++ + G W APE L T D++S G +L+
Sbjct: 172 --NVMKIADFGLARDIHHIDYYKKTT-NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 228
Query: 703 FCITGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVL 760
T G PY G E ++K+ + + E + P RP + ++
Sbjct: 229 EIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 288
Query: 761 NH 762
Sbjct: 289 ED 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-38
Identities = 72/338 (21%), Positives = 121/338 (35%), Gaps = 60/338 (17%)
Query: 471 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNI 529
I V ++ + G NG V+ A+K L A +E++ + Q P+I
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK--ARREVELHWRASQCPHI 67
Query: 530 VRWYGV----ESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIR 584
VR V + + + + +E L I +++ E
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-------------QDRGDQAFTEREAS 114
Query: 585 LLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDK 643
++ + I + +LH I + HRD+KP+N+L SK
Sbjct: 115 -------------------------EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRP 149
Query: 644 SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703
+ KL+D G +K S T T Y + APE L + ++ D++SLG I++
Sbjct: 150 NAILKLTDFGFAKETTSHNSLTTPCYTPY----YVAPEVLGPEKYDKSCDMWSLGVIMYI 205
Query: 704 CITGGKHPYGESFERDANIVKDR--------KDLFLVEHIPEAVDLFTRLLDPNPDLRPK 755
+ G Y + +K R + E E L LL P R
Sbjct: 206 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 265
Query: 756 AQNVLNHPFFWTADTRLSFLRDVSDRVELEDRESDSKL 793
+NHP+ T++ + RV ED+E +
Sbjct: 266 ITEFMNHPWI-MQSTKVPQTPLHTSRVLKEDKERWEDV 302
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 61/295 (20%), Positives = 105/295 (35%), Gaps = 50/295 (16%)
Query: 477 FNKEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPN 528
K I G G V + VA+K L + + + ++ H N
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 70
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
I+R GV S + + E D
Sbjct: 71 IIRLEGVISKYKPMMIITEYMENGALD--------------------------------- 97
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
K QL+ + R I +G+ +L + +HRDL +N+L+ + + K
Sbjct: 98 -----KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV--NSNLVCK 150
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
+SD G+S+ L+ D + G W APE + + T A D++S G +++ +T G
Sbjct: 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 210
Query: 709 KHPYGESFERDA-NIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN 761
+ PY E + + D L P A+ L + RPK ++++
Sbjct: 211 ERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 141 bits (357), Expect = 6e-38
Identities = 58/297 (19%), Positives = 108/297 (36%), Gaps = 51/297 (17%)
Query: 477 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 529
+ I G G V VA+K L + + ++ + ++ HPN+
Sbjct: 30 IEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV 89
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ GV + V + E D
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLR------------------------------ 119
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
QL+ + R I +G+ +L ++ +HRDL +N+L+ + + K+
Sbjct: 120 --------QNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV--NSNLVCKV 169
Query: 650 SDMGISKRLQGDMSCLTQNATG--YGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
SD G+S+ L+ D S T + W APE + + T A D++S G +++ ++
Sbjct: 170 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSY 229
Query: 708 GKHPY-GESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 762
G+ PY + + N ++ L P A+ L + + RPK ++N
Sbjct: 230 GERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-38
Identities = 64/340 (18%), Positives = 108/340 (31%), Gaps = 95/340 (27%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 534
E+ G+ G V G +A K + +I ++ P IV +YG
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ + +E ++ GS ++ L
Sbjct: 72 AFYSDGEISICME----------HMDGGSLDQVL-------------------------- 95
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEI-GLIHRDLKPQNVLISKDKSFCAKLSDMG 653
KA P L KV+ ++ GL++L E ++HRD+KP N+L++ KL D G
Sbjct: 96 ---KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR--GEIKLCDFG 150
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG------ 707
+S +L M+ + G+ + +PE+L + D++S+G L G
Sbjct: 151 VSGQLIDSMAN-----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
Query: 708 -------------------------------------GKHPYGESFERDANIVKDRKDLF 730
P FE IV +
Sbjct: 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKL 265
Query: 731 LVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769
E D + L NP R + ++ H F +D
Sbjct: 266 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 69/329 (20%), Positives = 119/329 (36%), Gaps = 53/329 (16%)
Query: 479 KEIAKGSNGTVVL-----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIV 530
K + G+ GTV EG VA+K L + A KEI + ++AS +P++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
R G+ ++ L D +
Sbjct: 75 RLLGICLTSTVQLITQLMPFGCLLDYVR-------------------------------- 102
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
+ S LL I G+++L + L+HRDL +NVL+ K++
Sbjct: 103 -------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV--KTPQHVKIT 153
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G++K L + G W A E +L T D++S G ++ +T G
Sbjct: 154 DFGLAKLLGAEEKEYHAE-GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
Query: 711 PY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768
PY G ++I++ + L + + + + D RPK + ++
Sbjct: 213 PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
Query: 769 DTRLSFLRDVSDRVELEDRESDSKLLRAL 797
D + + +R+ L +DS RAL
Sbjct: 273 DPQRYLVIQGDERMHLPS-PTDSNFYRAL 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-37
Identities = 67/295 (22%), Positives = 113/295 (38%), Gaps = 38/295 (12%)
Query: 477 FNKEIAKGSNGTV---VLEGNYEGRSVAVKRL----VKTHHDVALKEIQNLIASDQHPNI 529
F I +G+ G V ++ + A+KR+ K H E++ L HPNI
Sbjct: 14 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ G + ++YL++E NLL+ +R +
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHG-----------------------NLLDFLRKSRVLET 110
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+ I A+ S QLL D+ G+ +L + IHRDL +N+L+ +++ AK+
Sbjct: 111 DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV--GENYVAKI 168
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709
+D G+S+ + G W A E L T D++S G +L+ ++ G
Sbjct: 169 ADFGLSR----GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 710 HPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 762
PY G + + L + E DL + P RP +L
Sbjct: 225 TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-37
Identities = 74/303 (24%), Positives = 124/303 (40%), Gaps = 58/303 (19%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIV 530
F K + +GS TVVL R A+K L K H + +++++ HP V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 531 RWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVME 590
+ Y D + +Y L Y +G + +
Sbjct: 72 KLYFTFQDDEKLYFGLS----------YAKNGELLKYI---------------------- 99
Query: 591 NTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLS 650
K T +IVS L +LH G+IHRDLKP+N+L+++D +++
Sbjct: 100 -------RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED--MHIQIT 150
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G +K + S + + G++ + +PE L + ++ DL++LGCI++ + G
Sbjct: 151 DFGTAK-VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLP 208
Query: 711 PYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ------NVLNH 762
P+ E I+K D F + P+A DL +LL + R + + H
Sbjct: 209 PFRAGNEYLIFQKIIKLEYD-FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
Query: 763 PFF 765
PFF
Sbjct: 268 PFF 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 3e-37
Identities = 65/306 (21%), Positives = 111/306 (36%), Gaps = 67/306 (21%)
Query: 475 VVFNKEIAKGSNGTVVLEGNYEGR---SVAVKRLVKTHHD-VALKEIQN---LIASDQHP 527
+ + I GS GTV Y+G+ VAVK L T L+ +N ++ +H
Sbjct: 10 ITVGQRIGSGSFGTV-----YKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 528 NIVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
NI+ + G + + + C SL ++++ FE
Sbjct: 65 NILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMI------------------- 104
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
+L+ + R G+ +LH +IHRDLK N+ + +D
Sbjct: 105 --------------------KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHED--LT 142
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL---QGRQTRAIDLFSLGCILFF 703
K+ D G++ ++ S Q GS W APE + + + D+++ G +L+
Sbjct: 143 VKIGDFGLA-TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYE 201
Query: 704 CITGGKHPYGESFERDA--NIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPKA 756
+T G+ PY RD +V + + L L D RP
Sbjct: 202 LMT-GQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLF 260
Query: 757 QNVLNH 762
+L
Sbjct: 261 PQILAS 266
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (351), Expect = 5e-37
Identities = 73/338 (21%), Positives = 136/338 (40%), Gaps = 57/338 (16%)
Query: 477 FNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRW 532
F + G+ V+L E + VA+K + K + ++N ++ +HPNIV
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 533 YGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+ +YL ++ + L D I
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIV--------------------------------- 99
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFCAKLS 650
+ + ++ ++ + +LH++G++HRDLKP+N+L S D+ +S
Sbjct: 100 -------EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 152
Query: 651 DMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710
D G+SK + +T G+ G+ APE L Q ++A+D +S+G I + + G
Sbjct: 153 DFGLSKMEDPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG-YP 207
Query: 711 PYGESFERD--ANIVKDRKDLF--LVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
P+ + + I+K + + I A D L++ +P+ R + L HP+
Sbjct: 208 PFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267
Query: 766 WTADTRLSFLRDVSDRVELEDRESDSKLLRALEGIALV 803
DT L S +++ + SK +A A+V
Sbjct: 268 -AGDTALDKNIHQSVSEQIKKNFAKSKWKQAFNATAVV 304
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 6e-37
Identities = 52/297 (17%), Positives = 105/297 (35%), Gaps = 51/297 (17%)
Query: 477 FNKEIAKGSNGTV----VLEGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 529
FN+ I +G G V +L+ + + AVK L + + + ++ HPN+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 530 VRWYGVESDQDF-VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
+ G+ + + L
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLR--------------------------------- 117
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
+ + + L+ + G+ L +HRDL +N ++ D+ F K
Sbjct: 118 -----NFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML--DEKFTVK 170
Query: 649 LSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
++D G+++ + N TG W A E L + T D++S G +L+ +T
Sbjct: 171 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 230
Query: 708 GKHPYGESFERD-ANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLNH 762
G PY + D + + L E+ P+ + ++ + P ++RP +++
Sbjct: 231 GAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 9e-37
Identities = 63/299 (21%), Positives = 112/299 (37%), Gaps = 54/299 (18%)
Query: 476 VFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPN 528
+ +K + KGS G V L E + A+K L K + + E + L + +HP
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 529 IVRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+ + ++ ++ +E L I Q + + R
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHI---------------QSCHKFDLSRAT--- 106
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+I+ GL LH G+++RDLK N+L+ KD
Sbjct: 107 ----------------------FYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD--GHI 142
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K++D G+ K + T G+ + APE LL + ++D +S G +L+ + G
Sbjct: 143 KIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199
Query: 708 GKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN-VLNHPFF 765
+G+ E + ++ + EA DL +L P+ R + + HP F
Sbjct: 200 QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 1e-36
Identities = 58/295 (19%), Positives = 110/295 (37%), Gaps = 49/295 (16%)
Query: 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV--ALKEIQNLIASDQHPNIVRWYG 534
++ +G G V + VA+K L L+E Q ++ +H +V+ Y
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYA 79
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
V S++ +Y+ E +
Sbjct: 80 VVSEEP-IYIVTEYMSKGSLLDFL------------------------------------ 102
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+ QL+ + I SG++++ + +HRDL+ N+L+ ++ K++D G+
Sbjct: 103 -KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV--GENLVCKVADFGL 159
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-G 713
++ ++ + Q W APE L GR T D++S G +L T G+ PY G
Sbjct: 160 ARLIEDNEYTARQ--GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217
Query: 714 ESFERDANIVKDRKDLFLVEHIPEAV-DLFTRLLDPNPDLRPKAQNVLN--HPFF 765
+ V+ + PE++ DL + P+ RP + + +F
Sbjct: 218 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (340), Expect = 7e-36
Identities = 63/310 (20%), Positives = 106/310 (34%), Gaps = 68/310 (21%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV------------ALKEIQNLIASDQ 525
+ + +G + V + AVK + T LKE+ L
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 526 HPNIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
HPNI++ F +L + + G + L K L+E R
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFD----------LMKKGELFDYLTEKVT----LSEKETR- 113
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
K+ R ++ + LH++ ++HRDLKP+N+L+ D +
Sbjct: 114 ------------------------KIMRALLEVICALHKLNIVHRDLKPENILLDDDMN- 148
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ------TRAIDLFSLGC 699
KL+D G S +L G+ + APE + + +D++S G
Sbjct: 149 -IKLTDFGFSCQLDPGEKLREV----CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203
Query: 700 ILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHI----PEAVDLFTRLLDPNPDLRPK 755
I++ + G + ++ F DL +R L P R
Sbjct: 204 IMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT 263
Query: 756 AQNVLNHPFF 765
A+ L HPFF
Sbjct: 264 AEEALAHPFF 273
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 1e-35
Identities = 58/300 (19%), Positives = 105/300 (35%), Gaps = 40/300 (13%)
Query: 477 FNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTH----HDVALKEIQNLIASDQH 526
K + +G+ G V+ + R+VAVK L + H + E++ LI H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 527 PNIVRWYGV-ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
N+V G + + +E C + NL +R +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFC-----------------------KFGNLSTYLRSKR 113
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
+ E + L+ + + G+ L IHRDL +N+L+S+
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--N 171
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
K+ D G+++ + D + W APE + T D++S G +L+
Sbjct: 172 VVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 706 TGGKHPYGESFERD--ANIVKDRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPKAQNVLNH 762
+ G PY + +K+ + ++ PE P RP ++ H
Sbjct: 231 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 136 bits (342), Expect = 2e-35
Identities = 70/318 (22%), Positives = 115/318 (36%), Gaps = 64/318 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQ--NLIASDQHPNI 529
+ I +G G V G+ A+K L K +AL E +L+++ P I
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
V D + L+ + G L+
Sbjct: 70 VCMSYAFHTPDKLSFILD----------LMNGGDLHYHLSQHGV---------------- 103
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
A + +I+ GL H+H +++RDLKP N+L+ D+ ++
Sbjct: 104 -------------FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGHVRI 148
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG 708
SD+G++ + G+ G+ APE L +G + D FSLGC+LF + G
Sbjct: 149 SDLGLACDFSKKKPHAS-----VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
Query: 709 KHPYGESFERDANIVK--DRKDLFLVEHI-PEAVDLFTRLLDPNPDLRPK-----AQNVL 760
+ I + + L + PE L LL + + R AQ V
Sbjct: 204 SPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 263
Query: 761 NHPFFWTADTRLSFLRDV 778
PFF + D ++ FL+
Sbjct: 264 ESPFFRSLDWQMVFLQKY 281
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 3e-35
Identities = 59/308 (19%), Positives = 114/308 (37%), Gaps = 51/308 (16%)
Query: 476 VFNKEIAKGSNGTVVL------EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQH 526
++E+ +GS G V + VA+K + + E N ++
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 527 PNIVRWYGVESDQDFVYLSLERCT-CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRL 585
++VR GV S + +E T L + L +
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL---------- 132
Query: 586 LPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSF 645
++++++ +I G+++L+ +HRDL +N ++++D F
Sbjct: 133 --------------------SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--F 170
Query: 646 CAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705
K+ D G+++ + + + G W +PE L G T D++S G +L+
Sbjct: 171 TVKIGDFGMTRDIY-ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 229
Query: 706 TGGKHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLN-- 761
T + PY G S E+ V + L ++ P +L NP +RP +++
Sbjct: 230 TLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
Query: 762 ----HPFF 765
P F
Sbjct: 290 KEEMEPGF 297
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 60/300 (20%), Positives = 101/300 (33%), Gaps = 64/300 (21%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVK---------THHDVALKEIQNLIA-SDQHP 527
+ G G+V + VA+K + K + E+ L S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
++R D L LER + ++ + L E R
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI-------------TERGALQEELAR--- 113
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
++ + H H G++HRD+K +N+LI ++
Sbjct: 114 ----------------------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GEL 150
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCIT 706
KL D G L+ + G+ + PE + R R+ ++SLG +L+ +
Sbjct: 151 KLIDFGSGALLKDTVYT-----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205
Query: 707 GGKHPYGESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
G P FE D I+ R +F + + E L L P RP + + NHP+
Sbjct: 206 G-DIP----FEHDEEII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 3e-35
Identities = 57/296 (19%), Positives = 105/296 (35%), Gaps = 54/296 (18%)
Query: 477 FNKEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNI 529
+ I +G G V +VA+K D ++ + HP+I
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 530 VRWYGVESDQDFVYLSLERCTC-SLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
V+ GV ++ + V++ +E CT L + V S +
Sbjct: 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDL---------------------- 107
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
A L+ + + L++L +HRD+ +NVL+ + C K
Sbjct: 108 -----------------ASLILYAYQLSTALAYLESKRFVHRDIAARNVLV--SSNDCVK 148
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
L D G+S+ ++ G W APE + R T A D++ G ++ + G
Sbjct: 149 LGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 206
Query: 709 KHPY-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 762
P+ G +++ + L + + P L T+ +P RP+ +
Sbjct: 207 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 58/297 (19%), Positives = 97/297 (32%), Gaps = 55/297 (18%)
Query: 479 KEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPN 528
+++ GS G V + + SVAVK L D ++E+ + S H N
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN-AMHSLDHRN 72
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++R YGV ++ SL D + G F
Sbjct: 73 LIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLL---------------------- 110
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAK 648
L + + G+ +L IHRDL +N+L+ K
Sbjct: 111 -----------------GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL--ATRDLVK 151
Query: 649 LSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708
+ D G+ + L + W APE L + A D + G L+ T G
Sbjct: 152 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 211
Query: 709 KHPYGESFERDA--NIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 762
+ P+ I K+ + L E P + ++ + P+ RP + +
Sbjct: 212 QEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (332), Expect = 2e-34
Identities = 59/299 (19%), Positives = 112/299 (37%), Gaps = 60/299 (20%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 531
+ + GS G V L + GR A+K L K + E +++ HP I+R
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL-MLSIVTHPFIIR 68
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
+G D +++ ++ +
Sbjct: 69 MWGTFQDAQQIFMIMDYIEGGELFSLL--------------------------------- 95
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
K+ P+ ++ L +LH +I+RDLKP+N+L+ DK+ K++D
Sbjct: 96 ------RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL--DKNGHIKITD 147
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G +K + T G+ + APE + ++ID +S G +++ + G
Sbjct: 148 FGFAKYVPDVTY------TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 201
Query: 712 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFF 765
Y + + + + + F + DL +RL+ + R ++V NHP+F
Sbjct: 202 YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (329), Expect = 2e-34
Identities = 67/318 (21%), Positives = 112/318 (35%), Gaps = 57/318 (17%)
Query: 475 VVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA--LKEIQNLIASDQHPNIVR 531
+ ++ G G V +VAVK L + +V LKE ++ +HPN+V+
Sbjct: 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQ 77
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
GV + + Y+ E T E
Sbjct: 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV------------------------- 112
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
+ LL + I S + +L + IHRDL +N L+ ++ K++D
Sbjct: 113 ------------SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV--GENHLVKVAD 158
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G+S+ + GD A W APE L + + D+++ G +L+ T G P
Sbjct: 159 FGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216
Query: 712 Y-GESFERDANIVKDRKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLN--HPFFWT 767
Y G + +++ + E P + +L NP RP + F
Sbjct: 217 YPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
Query: 768 ADTRLSFLRDVSDRVELE 785
+ +SD VE E
Sbjct: 277 S--------SISDEVEKE 286
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 7e-34
Identities = 59/309 (19%), Positives = 108/309 (34%), Gaps = 60/309 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVA---------LKEIQNLIASDQHPN 528
+E+ G V G A K + K + +E+ L QHPN
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL-KEIQHPN 74
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
++ + V ++ V L LE S E+
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE--------------------- 113
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD--KSFC 646
+ + + I++G+ +LH + + H DLKP+N+++
Sbjct: 114 ------------------EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 155
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
K+ D G++ ++ + +G+ + APE + D++S+G I + ++
Sbjct: 156 IKIIDFGLAHKIDFG----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
Query: 707 GGKHPYGESFERDANIVKDRKDLFLVEHIP----EAVDLFTRLLDPNPDLRPKAQNVLNH 762
G G++ + V F E+ A D RLL +P R Q+ L H
Sbjct: 212 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 763 PFFWTADTR 771
P+ DT+
Sbjct: 272 PWIKPKDTQ 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 5e-33
Identities = 64/299 (21%), Positives = 107/299 (35%), Gaps = 57/299 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 531
K + KG+ G V+L GR A+K L K + E + L + +HP +
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL-QNTRHPFLTA 69
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
D + +E
Sbjct: 70 LKYAFQTHDRLCFVMEYANG---------------------------------------G 90
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
L + + +IVS L +LH +++RD+K +N+++ DK K++D
Sbjct: 91 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML--DKDGHIKITD 148
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G+ K D + + G+ + APE L RA+D + LG +++ + G
Sbjct: 149 FGLCKEGISDGATMKTFC---GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205
Query: 712 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFF 765
Y + ER ++ + F PEA L LL +P R A+ V+ H FF
Sbjct: 206 YNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (319), Expect = 7e-33
Identities = 58/314 (18%), Positives = 99/314 (31%), Gaps = 57/314 (18%)
Query: 470 RIGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRL-VKTHHDVALKEIQNLIASDQHP 527
R+G ++I GS G + L G VA+K VKT H E +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 63
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
I ++ D+ + +E SL DL S F +
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLK-------------------- 103
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLI-SKDKSFC 646
+L + ++S + ++H IHRD+KP N L+ K
Sbjct: 104 -------------------TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL 144
Query: 647 AKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702
+ D G++K+ + + +N G++ + + L Q+R DL SLG +L
Sbjct: 145 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM 204
Query: 703 FCITGGKHPYGESFERDANIVKDRKDLFLVEHI--------PEAVDLFTRLLDPNPDLRP 754
+ G G + + + I E D +P
Sbjct: 205 YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKP 264
Query: 755 KAQ---NVLNHPFF 765
+ + F
Sbjct: 265 DYSYLRQLFRNLFH 278
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-32
Identities = 58/324 (17%), Positives = 116/324 (35%), Gaps = 76/324 (23%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQN---LIASDQHPNIVRWYG 534
I +G+ G V N VA+K++ H + ++ +H NI+
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD 594
+ + +Y+++ +
Sbjct: 74 IIRAPTIEQM----------KDVYLVTH--------------------------LMGADL 97
Query: 595 IELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+L K + + I+ GL ++H ++HRDLKP N+L++ K+ D G+
Sbjct: 98 YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGL 155
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY- 712
++ D + ++APE +L + T++ID++S+GCIL ++ + +
Sbjct: 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-NRPIFP 214
Query: 713 ---------------GESFERDANIVKDRKDLFLVEHIP----------------EAVDL 741
G + D N + + K + +P +A+DL
Sbjct: 215 GKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL 274
Query: 742 FTRLLDPNPDLRPKAQNVLNHPFF 765
++L NP R + + L HP+
Sbjct: 275 LDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 3e-32
Identities = 71/335 (21%), Positives = 121/335 (36%), Gaps = 82/335 (24%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
++I +G+ G V G VA+K++ A++EI L+ HPNIV+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKL 66
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V ++ +YL E L +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFM----------------------------------- 91
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ G P + ++ GL+ H ++HRDLKPQN+LI+ + KL+D
Sbjct: 92 ---DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE--GAIKLADF 146
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 711
G+++ + T + ++APE LL + + A+D++SLGCI +T +
Sbjct: 147 GLARAFGVPVRTYTHEV---VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202
Query: 712 YGESFERD--ANIVKDRKDLFLVEHI----------------------------PEAVDL 741
+ E D I + V + L
Sbjct: 203 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL 262
Query: 742 FTRLLDPNPDLRPKAQNVLNHPFFWTADTRLSFLR 776
+++L +P+ R A+ L HPFF + LR
Sbjct: 263 LSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 9e-32
Identities = 64/329 (19%), Positives = 119/329 (36%), Gaps = 74/329 (22%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+I +G+ G V G+ VA+K+++ + AL+EI+ L +H N+V
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKIL-QLLKHENVVNL 74
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ + Y + + D +
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDF-------------------------------CEHDL 103
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ +++ +V + +++GL ++H ++HRD+K NVLI++D KL+D
Sbjct: 104 AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADF 161
Query: 653 GISKRLQ-GDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKH 710
G+++ S + + ++ PE LL R IDL+ GCI+ T
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
Query: 711 PYGESFERDANIVKD--------------------------------RKDLFLVEHIPEA 738
G + + ++ + L P A
Sbjct: 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281
Query: 739 VDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767
+DL +LL +P R + + LNH FFW+
Sbjct: 282 LDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 123 bits (309), Expect = 1e-31
Identities = 46/308 (14%), Positives = 93/308 (30%), Gaps = 56/308 (18%)
Query: 471 IGKLVVFNKEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALK-EIQNLIASDQHPN 528
+G + I +GS G + + VA+K + L+ E +
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 529 IVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPV 588
I Y + L ++ SL DL+ + F +
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVK--------------------- 101
Query: 589 MENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKD---KSF 645
+ + +++ + +HE L++RD+KP N LI + +
Sbjct: 102 ------------------TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN 143
Query: 646 CAKLSDMGISKRLQGDMS----CLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701
+ D G+ K + ++ + G++ + + L Q+R DL +LG +
Sbjct: 144 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203
Query: 702 FFCITGGKHPYGESFERDANIVKDRKDLF-------LVEHIPEAV-DLFTRLLDPNPDLR 753
+ + G G + + + L PE + D
Sbjct: 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
Query: 754 PKAQNVLN 761
P +
Sbjct: 264 PDYDYLQG 271
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (308), Expect = 1e-31
Identities = 61/302 (20%), Positives = 106/302 (35%), Gaps = 59/302 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 531
+ + G V L R VAVK L + +E QN A+ HP IV
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA-AALNHPAIVA 71
Query: 532 WYGVESDQD----FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
Y + Y+ +E I G +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK-------------------- 111
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
+ ++V D L+ H+ G+IHRD+KP N++I +
Sbjct: 112 -------------------RAIEVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAV 150
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
K+ D GI++ + + +TQ A G++ + +PEQ D++SLGC+L+ +T
Sbjct: 151 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT- 209
Query: 708 GKHPYGESFERDA--NIVKD--RKDLFLVEHIP-EAVDLFTRLLDPNPDLRPKAQNVLNH 762
G+ P+ V++ E + + + + L NP+ R + +
Sbjct: 210 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269
Query: 763 PF 764
Sbjct: 270 DL 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 2e-31
Identities = 61/327 (18%), Positives = 104/327 (31%), Gaps = 83/327 (25%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH--------HDVALKEIQNLIASDQHPNI 529
+ +G TV + VA+K++ H + AL+EI+ L+ HPNI
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQELSHPNI 62
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ + + L + L +I S
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS---------------------- 100
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKL 649
+ + GL +LH+ ++HRDLKP N+L+ ++ KL
Sbjct: 101 -----------------HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN--GVLKL 141
Query: 650 SDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGG 708
+D G++K T + ++APE L R +D++++GCIL +
Sbjct: 142 ADFGLAKSFGSPNRAYTHQV---VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
Query: 709 KHPYGESFERDANIVKDRKDLFLVEHIP----------------------------EAVD 740
G+S + + E P + +D
Sbjct: 199 PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLD 258
Query: 741 LFTRLLDPNPDLRPKAQNVLNHPFFWT 767
L L NP R A L +F
Sbjct: 259 LIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-31
Identities = 70/331 (21%), Positives = 122/331 (36%), Gaps = 83/331 (25%)
Query: 479 KEIAKGSNGTVVL--EGNYEGRSVAVKRLVKTHHD-----VALKEIQNL--IASDQHPNI 529
EI +G+ G V + GR VA+KR+ + ++E+ L + + +HPN+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 530 VRWYGVESDQDF---VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLL 586
VR + V + L+L + Y
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY---------------------------- 104
Query: 587 PVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFC 646
++ G P+ + + ++ GL LH ++HRDLKPQN+L++
Sbjct: 105 --------LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI- 155
Query: 647 AKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706
KL+D G+++ M+ + + ++APE LLQ +DL+S+GCI
Sbjct: 156 -KLADFGLARIYSFQMALTSV----VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 210
Query: 707 GGKHPY--------------------------GESFERDANIVKDRKDL--FLVEHIPEA 738
K + + R A K + + F+ +
Sbjct: 211 -RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELG 269
Query: 739 VDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769
DL + L NP R A + L+HP+F +
Sbjct: 270 KDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 57/328 (17%), Positives = 104/328 (31%), Gaps = 77/328 (23%)
Query: 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQ-NLIASDQHPNI 529
I + +V + I KG G V G + G VAVK +E + +H NI
Sbjct: 1 IARTIVLQESIGKGRFGEVWR-GKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI 59
Query: 530 VRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVM 589
+ + ++ + + L + Y GS + LN
Sbjct: 60 LGFIAADNKDNGTWTQLWLVSD------YHEHGSLFDYLNRY------------------ 95
Query: 590 ENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI--------GLIHRDLKPQNVLISK 641
++K+ SGL+HLH + HRDLK +N+L+
Sbjct: 96 ------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV-- 141
Query: 642 DKSFCAKLSDMGISKRLQGDMSCLTQNATGY-GSSGWQAPEQLL------QGRQTRAIDL 694
K+ ++D+G++ R + G+ + APE L + D+
Sbjct: 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 695 FSLGCILFFCITG---------GKHPYGESFERDANIVKDRK-------------DLFLV 732
+++G + + + PY + D ++ + RK
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261
Query: 733 EHIPEAVDLFTRLLDPNPDLRPKAQNVL 760
E + + N R A +
Sbjct: 262 EALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-30
Identities = 76/353 (21%), Positives = 124/353 (35%), Gaps = 81/353 (22%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGV-- 535
K I GS G V + G VA+K++++ +E+Q ++ H NIVR
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ-IMRKLDHCNIVRLRYFFY 83
Query: 536 --ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
+D VYL+L S +Q L + ++
Sbjct: 84 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT---------LPVIYVK--------- 125
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+ L+++H G+ HRD+KPQN+L+ D + KL D G
Sbjct: 126 ----------------LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFG 168
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHPY 712
+K+L ++ + Y ++APE + T +ID++S GC+L + G+ +
Sbjct: 169 SAKQLVRGEPNVSYICSRY----YRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIF 223
Query: 713 GESFERD--ANIVK----------------------------DRKDLFLVEHIPEAVDLF 742
D I+K +F PEA+ L
Sbjct: 224 PGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC 283
Query: 743 TRLLDPNPDLRPKAQNVLNHPFF---WTADTRLSFLRDVSDRVELEDRESDSK 792
+RLL+ P R H FF + +L RD +E S
Sbjct: 284 SRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 336
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 118 bits (295), Expect = 6e-30
Identities = 63/323 (19%), Positives = 122/323 (37%), Gaps = 82/323 (25%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWY 533
++I +G+ G V N G + A+K++ D ++EI ++ +H NIV+ Y
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSNIVKLY 66
Query: 534 GVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTK 593
V + + L E L L+ V G E
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV-------------------------- 100
Query: 594 DIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMG 653
+++G+++ H+ ++HRDLKPQN+LI+++ K++D G
Sbjct: 101 -------------TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFG 145
Query: 654 ISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHPY 712
+++ + + + ++AP+ L+ + + ID++S+GCI + G +
Sbjct: 146 LARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLF 201
Query: 713 GESFERD--ANIVK----------------------------DRKDLFLVEHIPEAVDLF 742
E D I + + FL +DL
Sbjct: 202 PGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLL 261
Query: 743 TRLLDPNPDLRPKAQNVLNHPFF 765
+++L +P+ R A+ L H +F
Sbjct: 262 SKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 66/323 (20%), Positives = 105/323 (32%), Gaps = 80/323 (24%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
++I +G+ GTV + VA+KR+ D AL+EI L +H NIVR
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL-KELKHKNIVRL 66
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
+ V + L E C L +G + +
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE------------------------- 101
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ ++ GL H ++HRDLKPQN+LI+++ KL++
Sbjct: 102 --------------IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL--KLANF 145
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
G+++ + C + + +ID++S GCI G+ +
Sbjct: 146 GLARAFGIPVRCYSA--EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203
Query: 713 ----------------GESFERDANIVKDRKDLFLVEHIP--------------EAVDLF 742
G E + D P DL
Sbjct: 204 PGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLL 263
Query: 743 TRLLDPNPDLRPKAQNVLNHPFF 765
LL NP R A+ L HP+F
Sbjct: 264 QNLLKCNPVQRISAEEALQHPYF 286
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 3e-29
Identities = 59/330 (17%), Positives = 103/330 (31%), Gaps = 83/330 (25%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES 537
+++ +G V V VK L +EI+ L PNI+ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVK 100
Query: 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIEL 597
D +L + D + L + IR
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLYQT---------------LTDYDIR------------- 132
Query: 598 WKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657
+I+ L + H +G++HRD+KP NV+I + +L D G+++
Sbjct: 133 ------------FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL-RLIDWGLAEF 179
Query: 658 LQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPYGESFE 717
+ A+ Y + ++D++SLGC+L I + +
Sbjct: 180 YHPGQEYNVRVASRY---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
Query: 718 RD--ANIVKDRKDLFLVEHI------------------------------------PEAV 739
D I K L ++I PEA+
Sbjct: 237 YDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 296
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769
D +LL + R A+ + HP+F+T
Sbjct: 297 DFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-29
Identities = 64/308 (20%), Positives = 108/308 (35%), Gaps = 63/308 (20%)
Query: 479 KEIAKGSNGTVVL----EGNYEGRSVAVKRLVKTH-------HDVALKEIQNLIASDQHP 527
K + G+ G V L G+ G+ A+K L K + E Q L Q P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 528 NIVRWYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLP 587
+V + + ++L L+
Sbjct: 90 FLVTLHYAFQTETKLHLILDYI-------------------------------------- 111
Query: 588 VMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCA 647
L + ++ +IV L HLH++G+I+RD+K +N+L+ +
Sbjct: 112 -NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN--GHV 168
Query: 648 KLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707
L+D G+SK D + + G + +A+D +SLG +++ +T
Sbjct: 169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT- 227
Query: 708 GKHPYGESFERDANIVKDRKDLFLVEHIP-----EAVDLFTRLLDPNPDLRPK-----AQ 757
G P+ E+++ R+ L P A DL RLL +P R A
Sbjct: 228 GASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
Query: 758 NVLNHPFF 765
+ H FF
Sbjct: 288 EIKEHLFF 295
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 9e-28
Identities = 65/326 (19%), Positives = 122/326 (37%), Gaps = 84/326 (25%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ + G+ G V G VA+K+L + A +E++ L+ +H N++
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGL 82
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + + + + L+ G+ +
Sbjct: 83 LDVFTPDETLDDFTDFY------LVMPFMGTDLGK------------------------- 111
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
L K ++ + ++ GL ++H G+IHRDLKP N+ +++D K+ D
Sbjct: 112 ----LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED--CELKILDF 165
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-QGRQTRAIDLFSLGCILFFCITGGKHP 711
G++++ +M+ + ++APE +L R T+ +D++S+GCI+ IT GK
Sbjct: 166 GLARQADSEMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT-GKTL 218
Query: 712 YGESFERDA--------------------------------NIVKDRKDLFLVEHIPEAV 739
+ S D + K L P AV
Sbjct: 219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV 278
Query: 740 DLFTRLLDPNPDLRPKAQNVLNHPFF 765
+L ++L + + R A L HP+F
Sbjct: 279 NLLEKMLVLDAEQRVTAGEALAHPYF 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 113 bits (283), Expect = 9e-28
Identities = 63/312 (20%), Positives = 110/312 (35%), Gaps = 60/312 (19%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVR 531
K + GS G V+L + G A+K L K + L E + ++ + P +V+
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR-ILQAVNFPFLVK 105
Query: 532 WYGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMEN 591
D +Y+ +E
Sbjct: 106 LEFSFKDNSNLYMVMEYVAG---------------------------------------G 126
Query: 592 TKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSD 651
L + IV +LH + LI+RDLKP+N+LI + ++D
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ--VTD 184
Query: 652 MGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHP 711
G +KR++G T G+ APE +L +A+D ++LG +++ G
Sbjct: 185 FGFAKRVKGRTW------TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238
Query: 712 YGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNP-----DLRPKAQNVLNHPFFW 766
+ + + + K F + DL LL + +L+ ++ NH +F
Sbjct: 239 FADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
Query: 767 TADTRLSFLRDV 778
T D + R V
Sbjct: 299 TTDWIAIYQRKV 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-25
Identities = 57/325 (17%), Positives = 110/325 (33%), Gaps = 82/325 (25%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHDV-----ALKEIQNLIASDQHPNIVRW 532
+ G+ G+V G VAVK+L + + +E++ L+ +H N++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGL 82
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + + + L+ +
Sbjct: 83 LDVFTPARSLE-----------------------------------EFNDVYLVTHLMGA 107
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
+ K + + I+ GL ++H +IHRDLKP N+ + ++ K+ D
Sbjct: 108 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV--NEDCELKILDF 165
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCITGGKHP 711
G+++ +M+ + ++APE +L + +D++S+GCI+ +TG
Sbjct: 166 GLARHTDDEMT------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 712 YGESFERDANIVKDRKDLFLVEHI-------------------------------PEAVD 740
G ++ E + P AVD
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 279
Query: 741 LFTRLLDPNPDLRPKAQNVLNHPFF 765
L ++L + D R A L H +F
Sbjct: 280 LLEKMLVLDSDKRITAAQALAHAYF 304
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.3 bits (241), Expect = 2e-22
Identities = 61/370 (16%), Positives = 119/370 (32%), Gaps = 95/370 (25%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRW 532
K I G+ G V R+VA+K+L + + A +E+ L+ H NI+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISL 81
Query: 533 YGVESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENT 592
V + Q + + + ++ + + +
Sbjct: 82 LNVFTPQKTLEEFQDVYLV-----MELMDANLCQVIQ----------------------- 113
Query: 593 KDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDM 652
++ + ++ G+ HLH G+IHRDLKP N+++ D + +
Sbjct: 114 --------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 653 GISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY 712
+ M+ + ++APE +L +D++S+GCI+ + K +
Sbjct: 166 ARTAGTSFMMTPYV------VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILF 218
Query: 713 GESFERD---------------------------------------ANIVKDRKDLFLVE 733
D + D E
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278
Query: 734 HI----PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF--WTADTRLSFLRDVSDRVELEDR 787
H +A DL +++L +P R + L HP+ W + +L++R
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDER 338
Query: 788 ESDSKLLRAL 797
E + + L
Sbjct: 339 EHTIEEWKEL 348
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 95.1 bits (235), Expect = 2e-21
Identities = 56/340 (16%), Positives = 111/340 (32%), Gaps = 80/340 (23%)
Query: 479 KEIAKGSNGTVVL-EGNYEGRSVAVKRL--VKTHHDVALKEIQNLIASDQHPNIVRWYGV 535
+++ G TV L + VA+K + K + + A EI+ L+ + + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIK-LLQRVNDADNTKEDSM 77
Query: 536 ESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDI 595
++ L + N ++ V + + I
Sbjct: 78 GANHILKLLDHFN-----------------------HKGPNGVHVVMVFEVLGENLLALI 114
Query: 596 ELWKANGHPSAQLLKVTRDIVSGLSHLH-EIGLIHRDLKPQNVLISKDKSFCAKLSDMGI 654
+ ++ G P + ++++ ++ GL ++H G+IH D+KP+NVL+ L + I
Sbjct: 115 KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIV-DSPENLIQIKI 173
Query: 655 SKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKHPY-- 712
+ + +++PE LL D++S C++F ITG +
Sbjct: 174 ADLGNACWYD-EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG-DFLFEP 231
Query: 713 --------------------GESFERDANIVKDRKDLFLVEHI----------------- 735
GE K + F +
Sbjct: 232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291
Query: 736 ----------PEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765
E D + +L +P R A ++NHP+
Sbjct: 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 331
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 53.6 bits (128), Expect = 1e-08
Identities = 27/185 (14%), Positives = 55/185 (29%), Gaps = 33/185 (17%)
Query: 479 KEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD 538
K + +G V + + VK V+ D
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKV---------------GHTSFKKVKEKRDYGD 50
Query: 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELW 598
F L++ L + + + + N + +ME EL+
Sbjct: 51 LHFSVLAIRSARNEFRALQKLQGLAVPKVY---AWEGNAV---------LMELIDAKELY 98
Query: 599 KANGHPSAQLLKVTRDIVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRL 658
+ ++L I+ ++ + G++H DL NVL+S+ + D S +
Sbjct: 99 RVRVENPDEVL---DMILEEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFPQSVEV 152
Query: 659 QGDMS 663
+
Sbjct: 153 GEEGW 157
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 902 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 98.72 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 97.58 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.1 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 97.07 | |
| d1kb0a2 | 573 | Quinoprotein alcohol dehydrogenase, N-terminal dom | 96.8 | |
| d1kv9a2 | 560 | Quinoprotein alcohol dehydrogenase, N-terminal dom | 96.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 96.67 | |
| d1flga_ | 582 | Ethanol dehydrogenase {Pseudomonas aeruginosa [Tax | 96.65 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.49 | |
| d2ad6a1 | 571 | Methanol dehydrogenase, heavy chain {Methylophilus | 96.3 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 96.21 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 96.02 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 95.85 | |
| d1flga_ | 582 | Ethanol dehydrogenase {Pseudomonas aeruginosa [Tax | 95.55 | |
| d2ad6a1 | 571 | Methanol dehydrogenase, heavy chain {Methylophilus | 95.4 | |
| d1w6sa_ | 596 | Methanol dehydrogenase, heavy chain {Methylobacter | 95.15 | |
| d1w6sa_ | 596 | Methanol dehydrogenase, heavy chain {Methylobacter | 94.81 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 94.59 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 94.26 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 93.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 93.83 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 93.62 | |
| d1kb0a2 | 573 | Quinoprotein alcohol dehydrogenase, N-terminal dom | 93.32 | |
| d1kv9a2 | 560 | Quinoprotein alcohol dehydrogenase, N-terminal dom | 92.06 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 92.04 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 91.9 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 91.15 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.66 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 90.21 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 90.04 | |
| d1hzua2 | 426 | C-terminal (heme d1) domain of cytochrome cd1-nitr | 89.28 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 87.63 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 87.5 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 86.96 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 85.9 | |
| d1qksa2 | 432 | C-terminal (heme d1) domain of cytochrome cd1-nitr | 85.44 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.79 Aligned_cols=246 Identities=28% Similarity=0.425 Sum_probs=203.5
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCC------CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
Q ss_conf 2299946644039659999985-389499999931587------069999999999918999755741434686512655
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~------~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV 545 (902)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|+. +++.++|||||++++++.+++..|+|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE-IQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHH-HHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999-99856888888599999989998999
Q ss_pred ECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 21346881247988359856774331025611488976402343430247777517999899999999620123421103
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~ 625 (902)
|||| ++|+|.+++. +...+++..+..|+.||+.||+|||++
T Consensus 85 mEy~----------~~g~L~~~l~-----------------------------~~~~l~e~~~~~i~~qi~~al~~lH~~ 125 (263)
T d2j4za1 85 LEYA----------PLGTVYRELQ-----------------------------KLSKFDEQRTATYITELANALSYCHSK 125 (263)
T ss_dssp EECC----------TTCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEC----------CCCCHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 8504----------7985898875-----------------------------048999999999999999999999988
Q ss_pred CCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 62134445611685369992388814786201248776553464588986545701100299998521465679999999
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ell 705 (902)
+|+||||||+|||++.++. +||+|||+|+..... ......||+.|||||++.+..++.++|||||||++|||+
T Consensus 126 ~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell 198 (263)
T d2j4za1 126 RVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPSS-----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 198 (263)
T ss_dssp TCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCCC-----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred CEEEEEECCCCCEECCCCC--EEECCCCEEEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 9465220234414668998--711555633544888-----523557887634999975899893144046759999983
Q ss_pred HCCCCCCCCC-HHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 3899999983-566788974113332236995799999800599999996988897297777
Q 002601 706 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 706 tG~~~Pf~~~-~~~~~~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~ 766 (902)
+| .+||... .......+......++...++++.+||.+||+.||.+|||++|+++||||.
T Consensus 199 ~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~ 259 (263)
T d2j4za1 199 VG-KPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 259 (263)
T ss_dssp HS-SCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred CC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 29-99988899999999997189999866899999999997647976890999997190707
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.16 Aligned_cols=252 Identities=26% Similarity=0.373 Sum_probs=208.8
Q ss_pred CEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCC------CCHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
Q ss_conf 229994664403965999998-538949999993158------7069999999999918999755741434686512655
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~------~~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV 545 (902)
++|.+.+.||+|+||+||++. ..+|+.||||++.+. ......+|+. +++.++|||||++++++.+.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESR-VLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 74289889831768499999998999899999981565449799999999999-99867999887787640356421110
Q ss_pred ECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 21346881247988359856774331025611488976402343430247777517999899999999620123421103
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~ 625 (902)
|| |+++|+|..++. +.+.+++..++.++.|++.||+|||++
T Consensus 84 ~e----------y~~gg~L~~~~~-----------------------------~~~~~~e~~~~~~~~qil~al~ylH~~ 124 (337)
T d1o6la_ 84 ME----------YANGGELFFHLS-----------------------------RERVFTEERARFYGAEIVSALEYLHSR 124 (337)
T ss_dssp EE----------CCTTCBHHHHHH-----------------------------HHSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------CCCCCCHHHHHH-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 00----------357986055553-----------------------------256775999999999996521134315
Q ss_pred CCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 62134445611685369992388814786201248776553464588986545701100299998521465679999999
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ell 705 (902)
+|+||||||+|||++.++. +||+|||+|+...... ......+||+.|+|||++.+..++.++||||+||++|||+
T Consensus 125 ~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~---~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml 199 (337)
T d1o6la_ 125 DVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDG---ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTT---CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHEEECCCCC--EEEEECCCCCCCCCCC---CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHH
T ss_conf 9622464777847658998--8882056520035678---6205510088996666504898883331022306788998
Q ss_pred HCCCCCCC-CCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCC-----HHHHHCCCCCCCCCH
Q ss_conf 38999999-835667889741133322369957999998005999999969-----888972977778300
Q 002601 706 TGGKHPYG-ESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADT 770 (902)
Q Consensus 706 tG~~~Pf~-~~~~~~~~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt-----~~elL~HPfF~~~~~ 770 (902)
+| .+||. .........+......++...++++++||.+||++||.+|++ ++++++||||.+.++
T Consensus 200 ~G-~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~ 269 (337)
T d1o6la_ 200 CG-RLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINW 269 (337)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCH
T ss_pred HC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCH
T ss_conf 78-99999969999999985289989866899999999866638934422565234999972915036999
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.66 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=201.4
Q ss_pred CEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCC---CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECC
Q ss_conf 229994664403965999998-5389499999931587---069999999999918999755741434686512655213
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~---~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~ 548 (902)
+.|.+.+.||+|+||+||+|. ..+|+.||||++.... .+...+|+. +++.++|||||++++++.+.+..|+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEIL-VMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCEEEEEEEE
T ss_conf 05388789812858299999998999899999984301727999999999-99867999880585779889998999970
Q ss_pred CCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 46881247988359856774331025611488976402343430247777517999899999999620123421103621
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~Ii 628 (902)
| ++|+|.+++. .+++++..++.|+.|++.||+|||+++|+
T Consensus 99 ~----------~gg~L~~~~~------------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ii 138 (293)
T d1yhwa1 99 L----------AGGSLTDVVT------------------------------ETCMDEGQIAAVCRECLQALEFLHSNQVI 138 (293)
T ss_dssp C----------TTCBHHHHHH------------------------------HSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred C----------CCCCHHHHHH------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 3----------7980898864------------------------------15999999999999999999999987972
Q ss_pred CCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 34445611685369992388814786201248776553464588986545701100299998521465679999999389
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~elltG~ 708 (902)
||||||+|||++.++. +||+|||+|+.+.... ......+||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 139 HrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG- 212 (293)
T d1yhwa1 139 HRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQ---SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG- 212 (293)
T ss_dssp CCCCSGGGEEECTTCC--EEECCCTTCEECCSTT---CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHS-
T ss_pred CCCCCHHHEEECCCCC--EEECCCHHHEEECCCC---CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHC-
T ss_conf 2677688868878996--8642515641321366---644444447773682664479988012031372999998048-
Q ss_pred CCCCCCCHHH-HH-HHHHHCC--CCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 9999983566-78-8974113--33223699579999980059999999698889729777783
Q 002601 709 KHPYGESFER-DA-NIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 709 ~~Pf~~~~~~-~~-~i~~~~~--~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
.+||.+.... .. .+..... ...+...++++++||.+||+.||.+|||+.|+++||||...
T Consensus 213 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 213 EPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp SCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 8998997999999999857999888855379999999999866996689099999649965778
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.21 Aligned_cols=252 Identities=23% Similarity=0.369 Sum_probs=200.4
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCCC----HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEC
Q ss_conf 2299946644039659999985-3894999999315870----6999999999991899975574143468651265521
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~~----~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E 547 (902)
++|.+.+.||+|+||+||+|.. .+|+.||||++..... +...+|+. +++.++|||||++++++.+++..|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIC-INKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHH-HHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHH-HHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 460899897217480999999999997999999845664127999999999-9985799888469654046743679886
Q ss_pred CCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 34688124798835985677433102561148897640234343024777751799989999999962012342110362
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~I 627 (902)
|| .+|+|.+++.. ...+++..++.++.|++.||+|||+++|
T Consensus 84 y~----------~gg~L~~~l~~-----------------------------~~~l~e~~~~~i~~qi~~al~ylH~~~I 124 (271)
T d1nvra_ 84 YC----------SGGELFDRIEP-----------------------------DIGMPEPDAQRFFHQLMAGVVYLHGIGI 124 (271)
T ss_dssp CC----------TTEEGGGGSBT-----------------------------TTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CC----------CCCCHHHHHHC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 45----------89808999753-----------------------------7999999999999999999999997598
Q ss_pred CCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCC-CCCCHHHHHHHHHHHHHH
Q ss_conf 1344456116853699923888147862012487765534645889865457011002999-985214656799999993
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 iHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGvIL~ellt 706 (902)
+||||||+|||++.++. +||+|||+|+....... .......+||+.|||||++.+..+ +.++||||+||++|||++
T Consensus 125 iHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~ 201 (271)
T d1nvra_ 125 THRDIKPENLLLDERDN--LKISDFGLATVFRYNNR-ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201 (271)
T ss_dssp ECSCCCGGGEEECTTCC--EEECCCTTCEECEETTE-ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHEEECCCCC--EEECCCHHHEEECCCCC-CCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHH
T ss_conf 35754689978878998--79832314224046886-5311132557474287286189999971016173799999982
Q ss_pred CCCCCCCCCHHHHH--HHHHHC--CCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 89999998356678--897411--333223699579999980059999999698889729777783
Q 002601 707 GGKHPYGESFERDA--NIVKDR--KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 707 G~~~Pf~~~~~~~~--~i~~~~--~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
| .+||........ ...... ........++++.+|+.+||+.||.+|||++|+++||||...
T Consensus 202 G-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 202 G-ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp S-SCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred C-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9-9788889859999999863888788644699999999999767996689099999619845859
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=377.99 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=203.6
Q ss_pred CCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCCH---HHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEC
Q ss_conf 5229994664403965999998-538949999993158706---999999999991899975574143468651265521
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~~---~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E 547 (902)
-+.|.+.+.||+|+||+||++. ..+|+.||||++...... ...+|+. ++..++|||||++++++.+.+.+|+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQ-TMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHH-HHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 657589889840768199999988999899999984524316999999999-9986799799929999998999999998
Q ss_pred CCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 34688124798835985677433102561148897640234343024777751799989999999962012342110362
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~I 627 (902)
|+.+|+|.+++... .+.+++..+..|+.||+.||+|||+++|
T Consensus 104 ----------~~~gg~L~~~l~~~----------------------------~~~l~e~~~~~i~~qi~~aL~ylH~~~i 145 (350)
T d1koaa2 104 ----------FMSGGELFEKVADE----------------------------HNKMSEDEAVEYMRQVCKGLCHMHENNY 145 (350)
T ss_dssp ----------CCCSCBHHHHHTCT----------------------------TSCBCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ----------CCCCCCHHHHHHHH----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf ----------57998899999762----------------------------3789999999999999999999975697
Q ss_pred CCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 13444561168536999238881478620124877655346458898654570110029999852146567999999938
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 iHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~elltG 707 (902)
+||||||+|||++.+....+||+|||+|+.+.... ...+..||+.|||||++.+..++.++||||+||++|+|++|
T Consensus 146 iHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ----SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp ECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS----CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred EEEEECHHHEEECCCCCCEEEEEECCHHEECCCCC----CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHC
T ss_conf 60001546736416889869995452104425654----32000686242188997589987267655465999999859
Q ss_pred CCCCCCCCH-HHHHH-HHHHCC---CCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 999999835-66788-974113---332236995799999800599999996988897297777830
Q 002601 708 GKHPYGESF-ERDAN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 708 ~~~Pf~~~~-~~~~~-i~~~~~---~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
.+||.... ..... +..... .......++++++||.+||+.||.+|||++|+++||||....
T Consensus 222 -~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 222 -LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp -SCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf -899899799999999984788989422358999999999997568966790899986291328898
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.85 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=205.4
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCC------CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEE
Q ss_conf 52299946644039659999985-389499999931587------06999999999991899975574143468651265
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~------~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyL 544 (902)
.++|.+.+.||+|+||+||+|.. .+|+.||||++.+.. .+...+|+. +++.++|||||++++++.+++..|+
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD-VMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCEEEE
T ss_conf 987789889850879099999998999799999986577557778999999999-9987688886179999998998899
Q ss_pred EECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 52134688124798835985677433102561148897640234343024777751799989999999962012342110
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs 624 (902)
|||||. +|+|.+++. ..+.+++..++.++.|++.||+|||+
T Consensus 86 vmEy~~----------gg~L~~~~~-----------------------------~~~~l~e~~~~~~~~qi~~al~ylH~ 126 (288)
T d1uu3a_ 86 GLSYAK----------NGELLKYIR-----------------------------KIGSFDETCTRFYTAEIVSALEYLHG 126 (288)
T ss_dssp EECCCT----------TEEHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEECCC----------CCCHHHHHH-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHCC
T ss_conf 997048----------987777653-----------------------------15999999999999999999976216
Q ss_pred CCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 36213444561168536999238881478620124877655346458898654570110029999852146567999999
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~el 704 (902)
.+|+||||||+|||++.++. +||+|||+|+.+..... .......+||+.|||||++.+..++.++||||+||++|||
T Consensus 127 ~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~-~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyel 203 (288)
T d1uu3a_ 127 KGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESK-QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQL 203 (288)
T ss_dssp TTEECSCCSGGGEEECTTSC--EEECCCTTCEECC-----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CCEECCCCCCCCCCCCCCCE--EEECCCCCCEECCCCCC-CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHH
T ss_conf 50884767741236688853--88603210242256776-4333555677552584400268989666230456999998
Q ss_pred HHCCCCCCCCCHH-HHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHH------HHCCCCCCCCC
Q ss_conf 9389999998356-67889741133322369957999998005999999969888------97297777830
Q 002601 705 ITGGKHPYGESFE-RDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN------VLNHPFFWTAD 769 (902)
Q Consensus 705 ltG~~~Pf~~~~~-~~~~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~e------lL~HPfF~~~~ 769 (902)
++| .+||..... .....+......++...++++++||.+||+.||.+|||++| +++||||.+.+
T Consensus 204 l~g-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 204 VAG-LPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp HHS-SCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred HHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCC
T ss_conf 038-89989959999999997189999854799999999998557976891978973778987697647899
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=373.75 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=203.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCC------CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
Q ss_conf 2299946644039659999985-389499999931587------069999999999918999755741434686512655
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~------~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV 545 (902)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .+...+|+ .+++.++|||||++++++.+.+..|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDER-LMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHH-HHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHH-HHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf 4708888972076808999999899979999998457754889999999999-999863696753303568528800567
Q ss_pred ECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 21346881247988359856774331025611488976402343430247777517999899999999620123421103
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~ 625 (902)
||||. +|++...+. ....+++..+..++.|++.||+|||++
T Consensus 83 mE~~~----------gg~l~~~~~-----------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~ 123 (316)
T d1fota_ 83 MDYIE----------GGELFSLLR-----------------------------KSQRFPNPVAKFYAAEVCLALEYLHSK 123 (316)
T ss_dssp ECCCC----------SCBHHHHHH-----------------------------HTSSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEECC----------CCCCCCCCC-----------------------------CCCCCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 65037----------863223432-----------------------------222111007999999998765541247
Q ss_pred CCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 62134445611685369992388814786201248776553464588986545701100299998521465679999999
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ell 705 (902)
+|+||||||+|||++.++. +||+|||+|+..... ..+.+||+.|||||++.+..++.++||||+||++|+|+
T Consensus 124 ~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyeml 195 (316)
T d1fota_ 124 DIIYRDLKPENILLDKNGH--IKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 195 (316)
T ss_dssp TEECCCCCGGGEEECTTSC--EEECCCSSCEECSSC------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHH
T ss_pred CEECCCCCCHHEEECCCCC--EEEECCCCCEEECCC------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHH
T ss_conf 6770556810503868998--898317521671245------64345763435999983899980430465333689997
Q ss_pred HCCCCCCCCCH-HHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCC-----CHHHHHCCCCCCCCCHH
Q ss_conf 38999999835-66788974113332236995799999800599999996-----98889729777783001
Q 002601 706 TGGKHPYGESF-ERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADTR 771 (902)
Q Consensus 706 tG~~~Pf~~~~-~~~~~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rp-----t~~elL~HPfF~~~~~~ 771 (902)
+| .+||.+.. ......+......++...++++.+++.+||+.||.+|+ +++++++||||.+.++.
T Consensus 196 tG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 196 AG-YTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp HS-SCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHH
T ss_conf 59-899999699999999970898899778999999999995449976664310219999819351467989
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=376.44 Aligned_cols=255 Identities=22% Similarity=0.326 Sum_probs=203.6
Q ss_pred CCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCCH---HHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
Q ss_conf 15229994664403965999998-538949999993158706---99999999999189997557414346865126552
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD---VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~~---~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~ 546 (902)
+.+.|.+.+.||+|+||+||+|. ..+|+.||||++...... ...+|+. ++..++|||||++++++.+++.+|+||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEIS-IMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHH-HHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 5403599899931778299999998999799999988726467999999999-998679979891999999899999999
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 13468812479883598567743310256114889764023434302477775179998999999996201234211036
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~ 626 (902)
||| .+|+|.+++... ...+++..++.|+.||+.||+|||+++
T Consensus 106 E~~----------~gg~L~~~~~~~----------------------------~~~l~e~~~~~i~~qi~~aL~ylH~~~ 147 (352)
T d1koba_ 106 EFL----------SGGELFDRIAAE----------------------------DYKMSEAEVINYMRQACEGLKHMHEHS 147 (352)
T ss_dssp ECC----------CCCBHHHHTTCT----------------------------TCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ECC----------CCCHHHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 828----------998088889863----------------------------899899999999999999999999779
Q ss_pred CCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 21344456116853699923888147862012487765534645889865457011002999985214656799999993
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ellt 706 (902)
|+||||||+|||++......+||+|||+|+.+.... ...+..||+.|+|||++.+..++.++||||+||++|+|++
T Consensus 148 iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt 223 (352)
T d1koba_ 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE----IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223 (352)
T ss_dssp EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS----CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCCC----CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 265131445531134678848995256303437887----2010047645348999747998976333898999999996
Q ss_pred CCCCCCCCCHH-HHHHHHHHCCCC----CCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 89999998356-678897411333----2236995799999800599999996988897297777830
Q 002601 707 GGKHPYGESFE-RDANIVKDRKDL----FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 707 G~~~Pf~~~~~-~~~~i~~~~~~~----~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
| .+||.+... .....+...... .....++++.+||.+||+.||.+|||+.|+++||||....
T Consensus 224 G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 224 G-LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp S-CCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred C-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 8-899899799999999984788989300247999999999997569966891899996097348882
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.71 Aligned_cols=248 Identities=24% Similarity=0.350 Sum_probs=196.1
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCCC----HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
Q ss_conf 52299946644039659999985-3894999999315870----699999999999189997557414346865126552
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~~----~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~ 546 (902)
.+.|...+.||+|+||+||++.. .+|+.||+|++..... ....+|+. +++.++|||||++++++.+.+.+|+||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ-VLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGG-GGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 5688897897127780999999989996999999875409789999999999-998679999994999999899999999
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCC-
Q ss_conf 1346881247988359856774331025611488976402343430247777517999899999999620123421103-
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI- 625 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~- 625 (902)
|| +.+|+|.+++. +.+.+++..+..++.|++.||.|||+.
T Consensus 84 Ey----------~~gg~L~~~l~-----------------------------~~~~l~~~~~~~~~~qil~aL~yLH~~~ 124 (322)
T d1s9ja_ 84 EH----------MDGGSLDQVLK-----------------------------KAGRIPEQILGKVSIAVIKGLTYLREKH 124 (322)
T ss_dssp EC----------CTTEEHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EC----------CCCCCHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 76----------79986899874-----------------------------2499999999999999999999999859
Q ss_pred CCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 62134445611685369992388814786201248776553464588986545701100299998521465679999999
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ell 705 (902)
+|+||||||+|||++.++. +||+|||+|+..... ...+.+||+.|||||++.+..++.++||||+||++|||+
T Consensus 125 ~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~-----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell 197 (322)
T d1s9ja_ 125 KIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLIDS-----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197 (322)
T ss_dssp CCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHHH-----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH
T ss_pred CEECCCCCHHHEEECCCCC--EEEEECCCCCCCCCC-----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 9971445779946878998--999548776256788-----621113771411946875899894888998999999999
Q ss_pred HCCCCCCCCCHHHHHHH--------------------------------------------HHHCCCC-CCCCCCHHHHH
Q ss_conf 38999999835667889--------------------------------------------7411333-22369957999
Q 002601 706 TGGKHPYGESFERDANI--------------------------------------------VKDRKDL-FLVEHIPEAVD 740 (902)
Q Consensus 706 tG~~~Pf~~~~~~~~~i--------------------------------------------~~~~~~~-~~~~~~~e~~d 740 (902)
+| .+||.......... ....... .....++++.|
T Consensus 198 ~G-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 276 (322)
T d1s9ja_ 198 VG-RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 276 (322)
T ss_dssp HS-SCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHH
T ss_pred HC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHH
T ss_conf 88-89989988789999998875177545774212333221111222354134778876650268766764448999999
Q ss_pred HHHCCCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 998005999999969888972977778
Q 002601 741 LFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 741 LI~~lL~~dP~~Rpt~~elL~HPfF~~ 767 (902)
||.+||+.||.+|||++|+++||||..
T Consensus 277 li~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 277 FVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred HHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 999986899467908999960986476
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=376.01 Aligned_cols=257 Identities=26% Similarity=0.392 Sum_probs=202.3
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCC------CHHHHHHH--HHHHHHCCCCCEEEECCCCCCCCCEE
Q ss_conf 2299946644039659999985-389499999931587------06999999--99999189997557414346865126
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEI--QNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~------~~~~~~Ei--~~ll~~l~HpNIVrL~g~~~d~~~ly 543 (902)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .....+|. ..++...+|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 55213468812479883598567743310256114889764023434302477775179998999999996201234211
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+|||| +++|+|.+++.. ...+++..++.++.||+.||+|||
T Consensus 84 ivmE~----------~~gg~L~~~l~~-----------------------------~~~~~e~~~~~~~~qi~~aL~ylH 124 (364)
T d1omwa3 84 FILDL----------MNGGDLHYHLSQ-----------------------------HGVFSEADMRFYAAEIILGLEHMH 124 (364)
T ss_dssp EEECC----------CCSCBHHHHHHH-----------------------------HCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------CCCCCHHHHHHH-----------------------------CCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 99991----------489838999873-----------------------------255327899999999999999999
Q ss_pred CCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCC-CCCCCCCHHHHHHHHHH
Q ss_conf 03621344456116853699923888147862012487765534645889865457011002-99998521465679999
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILF 702 (902)
Q Consensus 624 s~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvIL~ 702 (902)
+++|+||||||+|||++.++. +||+|||+|+.+... .....+||+.|+|||++.. ..++.++|||||||++|
T Consensus 125 ~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~-----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvily 197 (364)
T d1omwa3 125 NRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 197 (364)
T ss_dssp HTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS-----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHH
T ss_pred HCCCCCEEECCCEEEECCCCC--EEEEEECEEEECCCC-----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 779622044422167858896--798220102333788-----6433113455421687603899984410467789999
Q ss_pred HHHHCCCCCCCCCHHHH-H---HHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCC-----HHHHHCCCCCCCCCHHHH
Q ss_conf 99938999999835667-8---89741133322369957999998005999999969-----888972977778300133
Q 002601 703 FCITGGKHPYGESFERD-A---NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPK-----AQNVLNHPFFWTADTRLS 773 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-~---~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt-----~~elL~HPfF~~~~~~~~ 773 (902)
||++| .+||....... . ..........+...++++.+||.+||+.||.+||| ++++++||||.+.++..-
T Consensus 198 emltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~ 276 (364)
T d1omwa3 198 KLLRG-HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276 (364)
T ss_dssp HHHHS-SCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred HHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHHH
T ss_conf 99859-99888899899999998604688878877899999999998566988808874357999974910237898799
Q ss_pred HHH
Q ss_conf 553
Q 002601 774 FLR 776 (902)
Q Consensus 774 ~l~ 776 (902)
+.+
T Consensus 277 ~~~ 279 (364)
T d1omwa3 277 FLQ 279 (364)
T ss_dssp HTT
T ss_pred HCC
T ss_conf 628
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=374.30 Aligned_cols=249 Identities=26% Similarity=0.353 Sum_probs=205.7
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCC------CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
Q ss_conf 2299946644039659999985-389499999931587------069999999999918999755741434686512655
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~------~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV 545 (902)
+.|.+.+.||+|+||+||++.. .+|+.||||++.+.. .+...+|+. ++..++|||||++++++.+.+..|+|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR-ILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHH-HHHHCCCCCEEECCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999-99974877274034444322222322
Q ss_pred ECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 21346881247988359856774331025611488976402343430247777517999899999999620123421103
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~ 625 (902)
+| |+.+|++..++. +.+.+++..++.|+.||+.||.|||++
T Consensus 120 ~e----------~~~~g~l~~~l~-----------------------------~~~~l~e~~~~~i~~qi~~aL~yLH~~ 160 (350)
T d1rdqe_ 120 ME----------YVAGGEMFSHLR-----------------------------RIGRFSEPHARFYAAQIVLTFEYLHSL 160 (350)
T ss_dssp EE----------CCTTCBHHHHHH-----------------------------HHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CC----------CCCCCCHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 22----------334662266675-----------------------------158989999999999999989999859
Q ss_pred CCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 62134445611685369992388814786201248776553464588986545701100299998521465679999999
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ell 705 (902)
+|+||||||+|||++.++. +||+|||+|+.+... ..+..||+.|||||++.+..++.++|||||||++|||+
T Consensus 161 ~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~~------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyeml 232 (350)
T d1rdqe_ 161 DLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKGR------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232 (350)
T ss_dssp TEECCCCSGGGEEECTTSC--EEECCCTTCEECSSC------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CEECCCCCHHHCCCCCCCC--EEEEECEEEEECCCC------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHH
T ss_conf 9861767999936077897--886101033322566------64336763567889971799885331145007899997
Q ss_pred HCCCCCCCCC-HHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCC-----CHHHHHCCCCCCCCCH
Q ss_conf 3899999983-566788974113332236995799999800599999996-----9888972977778300
Q 002601 706 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTADT 770 (902)
Q Consensus 706 tG~~~Pf~~~-~~~~~~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rp-----t~~elL~HPfF~~~~~ 770 (902)
+| .+||... .......+.......+...++++.++|.+||+.||.+|+ +++++++||||.+.++
T Consensus 233 tG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~ 302 (350)
T d1rdqe_ 233 AG-YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW 302 (350)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred HC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCH
T ss_conf 58-89989959999999986179889766899999999998340998606553454999971905158998
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.51 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=207.9
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCC------CCHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
Q ss_conf 2299946644039659999985-38949999993158------7069999999999918999755741434686512655
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKT------HHDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~------~~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV 545 (902)
+.|.+.+.||+|+||+||+|.. .+|+.||||++.+. ......+|+..+...++|||||++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred ECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 21346881247988359856774331025611488976402343430247777517999899999999620123421103
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~ 625 (902)
|| |+.+|+|.+++.. ...+++..++.++.||+.||+|||++
T Consensus 82 mE----------y~~~g~L~~~i~~-----------------------------~~~~~e~~~~~~~~qi~~al~ylH~~ 122 (320)
T d1xjda_ 82 ME----------YLNGGDLMYHIQS-----------------------------CHKFDLSRATFYAAEIILGLQFLHSK 122 (320)
T ss_dssp EE----------CCTTCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------ECCCCCHHHHHHC-----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 75----------0379808998640-----------------------------47899999999999999999999868
Q ss_pred CCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 62134445611685369992388814786201248776553464588986545701100299998521465679999999
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ell 705 (902)
+|+||||||+|||++.++. +||+|||+|+...... .......||+.|+|||++.+..++.++||||+||++|+|+
T Consensus 123 ~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyeml 197 (320)
T d1xjda_ 123 GIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGD---AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML 197 (320)
T ss_dssp TCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTT---CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred CEEECCCCCCCEEECCCCC--EECCCCCHHHHCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 9340347654044448996--3015553023235665---3345457877768999982799883232011227898987
Q ss_pred HCCCCCCCCC-HHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHH-HHHCCCCCCCCC
Q ss_conf 3899999983-566788974113332236995799999800599999996988-897297777830
Q 002601 706 TGGKHPYGES-FERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQ-NVLNHPFFWTAD 769 (902)
Q Consensus 706 tG~~~Pf~~~-~~~~~~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~-elL~HPfF~~~~ 769 (902)
+| .+||... .......+......++...++++.+||.+||+.||.+||++. ++++||||.+.+
T Consensus 198 tG-~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 198 IG-QSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp HS-SCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred HC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHHCCCC
T ss_conf 38-899999899999999971899897567999999999965448987838899998090131589
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=377.87 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=202.0
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCCC----HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEE
Q ss_conf 0152299946644039659999985-3894999999315870----6999999999991899975574143468651265
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~~----~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyL 544 (902)
.+.+.|.+.+.||+|+||+||++.. .+|+.||||++.+... ....+|+. ++..++|||||++++++.+++.+|+
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA-VLHKIKHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHH-HHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 776666998899406583999999999998999999815773128999999999-9986799899919899998998889
Q ss_pred EECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 52134688124798835985677433102561148897640234343024777751799989999999962012342110
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs 624 (902)
|||||. +|+|.+++. ..+.+++..+..++.|++.||+|||+
T Consensus 85 vmE~~~----------gg~L~~~l~-----------------------------~~~~l~e~~~~~~~~qi~~al~ylH~ 125 (307)
T d1a06a_ 85 IMQLVS----------GGELFDRIV-----------------------------EKGFYTERDASRLIFQVLDAVKYLHD 125 (307)
T ss_dssp EECCCC----------SCBHHHHHH-----------------------------TCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEECCC----------CCCHHHHHH-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf 885268----------984888653-----------------------------03678878999999999999875241
Q ss_pred CCCCCCCCCCCEEEECC-CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 36213444561168536-99923888147862012487765534645889865457011002999985214656799999
Q 002601 625 IGLIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 625 ~~IiHrDLKp~NILL~~-d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~e 703 (902)
++|+||||||+|||+.. +....+||+|||+|+..... ....+.+||+.|||||++.+..++.++||||+||++||
T Consensus 126 ~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~----~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilye 201 (307)
T d1a06a_ 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYI 201 (307)
T ss_dssp TTCCCSCCCGGGEEESSSSTTCCEEECCC----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred CEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECCCC----CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHH
T ss_conf 30556870463001104688824998315435872589----70440032842259188737999807873451599999
Q ss_pred HHHCCCCCCCCCHHHH-H-HHHHHCCC---CCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 9938999999835667-8-89741133---3223699579999980059999999698889729777783
Q 002601 704 CITGGKHPYGESFERD-A-NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~-~-~i~~~~~~---~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
|++| .+||.+..... . .+...... ......++++.+||.+||+.||.+|||++|+++||||.+.
T Consensus 202 ll~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 202 LLCG-YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp HHHS-SCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred HHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9859-79999989999999986168777876666789999999999760897579189998629844799
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.10 Aligned_cols=257 Identities=22% Similarity=0.333 Sum_probs=205.1
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCC---------CHHHHHHHHHHHHHCCCCCEEEECCCCCC
Q ss_conf 20152299946644039659999985-389499999931587---------06999999999991899975574143468
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH---------HDVALKEIQNLIASDQHPNIVRWYGVESD 538 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~---------~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d 538 (902)
+.+.+.|.+.+.||+|+||+||+|.. .+|+.||||++.+.. .+...+|+. ++..++|||||++++++.+
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS-ILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHH-HHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEE
T ss_conf 885567798279811789599999999999899999987566321340689999999999-9986799899938899997
Q ss_pred CCCEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCC
Q ss_conf 65126552134688124798835985677433102561148897640234343024777751799989999999962012
Q 002601 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 539 ~~~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
.+..|+||||| .+|+|.+++.. ...+++..++.++.|++.|
T Consensus 85 ~~~~~iv~E~~----------~gg~L~~~i~~-----------------------------~~~l~~~~~~~~~~qi~~a 125 (293)
T d1jksa_ 85 KTDVILILELV----------AGGELFDFLAE-----------------------------KESLTEEEATEFLKQILNG 125 (293)
T ss_dssp SSEEEEEEECC----------CSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEECC----------CCCCCCCHHCC-----------------------------CCCCCHHHHHHHHHHHHHH
T ss_conf 99899999867----------78643100103-----------------------------5642155789999999999
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCC--CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHH
Q ss_conf 34211036213444561168536999--2388814786201248776553464588986545701100299998521465
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKS--FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFS 696 (902)
Q Consensus 619 L~yLHs~~IiHrDLKp~NILL~~d~~--~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwS 696 (902)
|+|||+.+|+||||||+|||++.++. ..+|++|||+|+...... ...+..||+.|+|||++.+..++.++||||
T Consensus 126 l~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~----~~~~~~~t~~y~APE~~~~~~~~~~~DiwS 201 (293)
T d1jksa_ 126 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN----EFKNIFGTPEFVAPEIVNYEPLGLEADMWS 201 (293)
T ss_dssp HHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC----BCSCCCCCGGGCCHHHHTTCCBCTHHHHHH
T ss_pred HHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHCCCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCHH
T ss_conf 8766625422113330127982589866646964334421057776----312247777430999981899997665221
Q ss_pred HHHHHHHHHHCCCCCCCCCHH-HHHH-HHHHCC---CCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCCCH
Q ss_conf 679999999389999998356-6788-974113---3322369957999998005999999969888972977778300
Q 002601 697 LGCILFFCITGGKHPYGESFE-RDAN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTADT 770 (902)
Q Consensus 697 lGvIL~elltG~~~Pf~~~~~-~~~~-i~~~~~---~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~~~ 770 (902)
+||++|||++| .+||..... .... +..... ...+...++++++||.+||+.||.+|||++++++||||+..+.
T Consensus 202 lGvilyell~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 279 (293)
T d1jksa_ 202 IGVITYILLSG-ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 279 (293)
T ss_dssp HHHHHHHHHHS-SCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred HHHHHHHHHCC-CCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCCH
T ss_conf 40999999708-8998899999999999816888870104788999999999986389668919999961904188870
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.31 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=200.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCCC---HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECC
Q ss_conf 2299946644039659999985-3894999999315870---69999999999918999755741434686512655213
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH---DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~~---~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~ 548 (902)
+.|.+.+.||+|+||+||++.. .+|+.||||++..... +...+|+. +++.++|||||++++++.+.+..|+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID-ILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHH-HHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHH-HHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 37598479930778199999999999399999987289999999999999-99867999988498898009958999962
Q ss_pred CCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 46881247988359856774331025611488976402343430247777517999899999999620123421103621
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~Ii 628 (902)
| ++|+|.+++.. ..+++++..+..++.|++.||+|||+++|+
T Consensus 91 ~----------~~g~L~~~~~~----------------------------~~~~l~e~~~~~i~~qi~~gL~ylH~~~iv 132 (288)
T d2jfla1 91 C----------AGGAVDAVMLE----------------------------LERPLTESQIQVVCKQTLDALNYLHDNKII 132 (288)
T ss_dssp C----------TTEEHHHHHHH----------------------------HTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred C----------CCCCHHHHHHH----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
T ss_conf 7----------99818899986----------------------------289999999999999999999999988988
Q ss_pred CCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHC-----CCCCCCCCHHHHHHHHHHH
Q ss_conf 34445611685369992388814786201248776553464588986545701100-----2999985214656799999
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLL-----QGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~-----~~~~t~ksDVwSlGvIL~e 703 (902)
||||||+|||++.++. +||+|||+|+...... ....+.+||+.|||||++. ...++.++|||||||++||
T Consensus 133 HrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye 207 (288)
T d2jfla1 133 HRDLKAGNILFTLDGD--IKLADFGVSAKNTRTI---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207 (288)
T ss_dssp CCCCSGGGEEECTTSC--EEECCCTTCEECHHHH---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred EEECCHHHEEECCCCC--EEEEECHHHHCCCCCC---CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 7140700314878999--8997161230357786---4100102562647999983202578888806657878999999
Q ss_pred HHHCCCCCCCCCHHH-HH-HHHHHCC--CCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 993899999983566-78-8974113--33223699579999980059999999698889729777783
Q 002601 704 CITGGKHPYGESFER-DA-NIVKDRK--DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 704 lltG~~~Pf~~~~~~-~~-~i~~~~~--~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
|++| .+||.+.... .. .+..... ...+...++++.+||.+||+.||.+|||++|+++||||...
T Consensus 208 mltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 208 MAEI-EPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp HHHS-SCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred HHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 8208-8999998999999999707998777656699999999999766996689199999629231889
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.58 Aligned_cols=246 Identities=28% Similarity=0.390 Sum_probs=193.3
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCC----CCC
Q ss_conf 52299946644039659999985-3894999999315870-----6999999999991899975574143468----651
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD----QDF 541 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~~-----~~~~~Ei~~ll~~l~HpNIVrL~g~~~d----~~~ 541 (902)
++.+.+.++||+|+||+||++.. .+++.||+|++..... +...+|+. +++.++|||||++++++.+ .+.
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE-MLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHH-HHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCCCCCE
T ss_conf 87788516970082849999999999959999998512279899999999999-99857999850699998403345888
Q ss_pred EEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 26552134688124798835985677433102561148897640234343024777751799989999999962012342
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
+|+||| |+++|+|.+++.. ...+++..++.++.||+.||+|
T Consensus 87 ~~ivmE----------~~~~g~L~~~l~~-----------------------------~~~~~~~~~~~~~~qi~~gl~y 127 (270)
T d1t4ha_ 87 IVLVTE----------LMTSGTLKTYLKR-----------------------------FKVMKIKVLRSWCRQILKGLQF 127 (270)
T ss_dssp EEEEEE----------CCCSCBHHHHHHH-----------------------------HSSCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEE----------CCCCCCHHHHHHC-----------------------------CCCCCHHHHHHHHHHHHHHHHH
T ss_conf 999995----------7898948999751-----------------------------3554699999999999999999
Q ss_pred CCCCC--CCCCCCCCCEEEECC-CCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHH
Q ss_conf 11036--213444561168536-999238881478620124877655346458898654570110029999852146567
Q 002601 622 LHEIG--LIHRDLKPQNVLISK-DKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 622 LHs~~--IiHrDLKp~NILL~~-d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlG 698 (902)
||+++ |+||||||+|||++. ++. +||+|||+|+..... .....+||+.|||||++.+ .++.++||||||
T Consensus 128 LH~~~~~IiHrDiKp~NILl~~~~~~--~Kl~DFGla~~~~~~-----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlG 199 (270)
T d1t4ha_ 128 LHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKRAS-----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFG 199 (270)
T ss_dssp HHTSSSCCCCSCCCGGGEEESSTTSC--EEECCTTGGGGCCTT-----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHH
T ss_pred HHHCCCCEEECCCCHHHCEEECCCCC--EEEEECCCCEECCCC-----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHH
T ss_conf 99789979968767435116679998--898005765423687-----6677553813008988478-999867110079
Q ss_pred HHHHHHHHCCCCCCCCCH--HHHHHHHHH-CC-CCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 999999938999999835--667889741-13-332236995799999800599999996988897297777
Q 002601 699 CILFFCITGGKHPYGESF--ERDANIVKD-RK-DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFW 766 (902)
Q Consensus 699 vIL~elltG~~~Pf~~~~--~~~~~i~~~-~~-~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~ 766 (902)
|++|||++| .+||.+.. ......+.. .. ..+....++++.++|.+||+.||++|||++|+++||||+
T Consensus 200 vilyel~~g-~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 200 MCMLEMATS-EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHHHS-SCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHHHHHC-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 999999878-89998765599999999738998656755789999999997637975892999996775409
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=375.23 Aligned_cols=245 Identities=24% Similarity=0.343 Sum_probs=195.6
Q ss_pred CEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCC------HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
Q ss_conf 229994664403965999998-53894999999315870------69999999999918999755741434686512655
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLS 545 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~------~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV 545 (902)
+.|...+.||+|+||+||+|. ..+|+.||||++..... ....+|+. ++..++|||||++++++.+.+..|+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR-FLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999-99977899982389999989988999
Q ss_pred ECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 21346881247988359856774331025611488976402343430247777517999899999999620123421103
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~ 625 (902)
||||.++. +..++ ....++++..++.++.||+.||+|||++
T Consensus 94 ~E~~~~g~----------l~~~~-----------------------------~~~~~l~e~~~~~i~~qi~~aL~yLH~~ 134 (309)
T d1u5ra_ 94 MEYCLGSA----------SDLLE-----------------------------VHKKPLQEVEIAAVTHGALQGLAYLHSH 134 (309)
T ss_dssp EECCSEEH----------HHHHH-----------------------------HHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCC----------HHHHH-----------------------------HHCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 98069994----------57899-----------------------------7379999999999999999999999868
Q ss_pred CCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCC---CCCCCCCHHHHHHHHHH
Q ss_conf 621344456116853699923888147862012487765534645889865457011002---99998521465679999
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILF 702 (902)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDVwSlGvIL~ 702 (902)
+|+||||||+|||++.++. +||+|||+|+..... ....||+.|||||++.+ +.++.++|||||||++|
T Consensus 135 ~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~~-------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvily 205 (309)
T d1u5ra_ 135 NMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCI 205 (309)
T ss_dssp TCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSSB-------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHH
T ss_pred CEECCCCCCCEEEECCCCC--EEEEECCCCCCCCCC-------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf 9766678842179879997--898443653346778-------7313476636889983467888672145455899999
Q ss_pred HHHHCCCCCCCCCHHH-H-HHHHHHCCCC-CCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 9993899999983566-7-8897411333-22369957999998005999999969888972977778
Q 002601 703 FCITGGKHPYGESFER-D-ANIVKDRKDL-FLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 703 elltG~~~Pf~~~~~~-~-~~i~~~~~~~-~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~ 767 (902)
||++| .+||.+.... . ..+....... .....++++.+||.+||+.||.+|||++++++||||..
T Consensus 206 el~~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 206 ELAER-KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp HHHHS-SCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred HHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 99878-89999979999999998289998887888999999999977379657918999971997537
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.63 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=201.3
Q ss_pred CEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCCH-----HHHHHHHHHHHHCCCCCEEEECCCCCC--CCCEEE
Q ss_conf 229994664403965999998-538949999993158706-----999999999991899975574143468--651265
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD-----VALKEIQNLIASDQHPNIVRWYGVESD--QDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~~-----~~~~Ei~~ll~~l~HpNIVrL~g~~~d--~~~lyL 544 (902)
++|.+.+.||+|+||+||++. ..+|+.||||++...... ...+|+. ++..++|||||++++++.+ .+.+|+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN-LLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHH-HTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 3379967983088919999999999979999998746579799999999999-999778999824899999178998999
Q ss_pred EECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 52134688124798835985677433102561148897640234343024777751799989999999962012342110
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs 624 (902)
|||| +++|+|.+++.... .....+++..++.++.|++.||+|||+
T Consensus 83 vmEy----------~~~g~L~~~i~~~~-------------------------~~~~~l~e~~~~~i~~qi~~al~ylH~ 127 (269)
T d2java1 83 VMEY----------CEGGDLASVITKGT-------------------------KERQYLDEEFVLRVMTQLTLALKECHR 127 (269)
T ss_dssp EEEC----------CTTEEHHHHHHHHH-------------------------HHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEC----------CCCCCHHHHHHHCC-------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf 9956----------89993899998515-------------------------457899999999999999999999997
Q ss_pred CC-----CCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHH
Q ss_conf 36-----2134445611685369992388814786201248776553464588986545701100299998521465679
Q 002601 625 IG-----LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGC 699 (902)
Q Consensus 625 ~~-----IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGv 699 (902)
.+ |+||||||+|||++.++. +||+|||+|+.+..... .....+||+.|||||++.+..++.++|||||||
T Consensus 128 ~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGv 202 (269)
T d2java1 128 RSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTS---FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGC 202 (269)
T ss_dssp HCC---------CCGGGEEECTTSC--EEECCHHHHHHC--------------CCCSCCCHHHHTTCCCCHHHHHHHHHH
T ss_pred HCCCCCCEEECCCCHHHCCCCCCCC--EEEEECCCEEECCCCCC---CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCH
T ss_conf 1677887885867654257478885--79800100032245777---556677882327999983999993898875278
Q ss_pred HHHHHHHCCCCCCCCCHHHH-H-HHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCC
Q ss_conf 99999938999999835667-8-897411333223699579999980059999999698889729777
Q 002601 700 ILFFCITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 700 IL~elltG~~~Pf~~~~~~~-~-~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF 765 (902)
++|||++| .+||....... . .+........+...++++.+||.+||+.||.+|||++|+++|||.
T Consensus 203 ilyel~tg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 203 LLYELCAL-MPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHS-SCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCCCC
T ss_conf 99998018-89989989999999997189988974359999999999767995579189999729819
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.18 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=203.6
Q ss_pred CCEEEEEEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECCC
Q ss_conf 52299946644039659999985389499999931587--0699999999999189997557414346865126552134
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrL~~~~--~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~c 549 (902)
.+.|.+.+.||+|+||+||+|...++..||||++.... .+...+|+. ++..++|||||+++|++.+ +..|+|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~~~g~~~~-~~~~iv~E-- 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEAN-LMKQLQHQRLVRLYAVVTQ-EPIYIITE-- 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECS-SSCEEEEE--
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHH-HHHHCCCCCEEEEEEEECC-CCEEEEEE--
T ss_conf 8993886798107982899999999999999998647688899999999-9986799988578731045-97699999--
Q ss_pred CCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 68812479883598567743310256114889764023434302477775179998999999996201234211036213
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~IiH 629 (902)
|+++|+|.+++... ....+++..+++|+.||+.||+|||+++|+|
T Consensus 88 --------y~~~g~L~~~~~~~---------------------------~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivH 132 (272)
T d1qpca_ 88 --------YMENGSLVDFLKTP---------------------------SGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132 (272)
T ss_dssp --------CCTTCBHHHHTTSH---------------------------HHHTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred --------ECCCCCHHHHHHHC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf --------57898288887514---------------------------7898878899999999999999997489546
Q ss_pred CCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 44456116853699923888147862012487765534645889865457011002999985214656799999993899
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~elltG~~ 709 (902)
|||||+||||+.++. +||+|||+|+.+..... .......||+.|||||++..+.++.++|||||||++|||+||+.
T Consensus 133 rDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~ 208 (272)
T d1qpca_ 133 RDLRAANILVSDTLS--CKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208 (272)
T ss_dssp SCCSGGGEEECTTSC--EEECCCTTCEECSSSCE--ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTC
T ss_pred CCCCHHHEEEECCCC--EEECCCCCEEECCCCCC--CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 756422515620244--04234101477358864--42035677444458289837999824564525799999996898
Q ss_pred CCCCCCHHHHH--HHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHC--CCCCC
Q ss_conf 99998356678--89741133322369957999998005999999969888972--97777
Q 002601 710 HPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN--HPFFW 766 (902)
Q Consensus 710 ~Pf~~~~~~~~--~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~--HPfF~ 766 (902)
+|+........ .+........+...++++.+++.+||+.||++|||++++++ |+||.
T Consensus 209 ~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 209 IPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 8888889999999997068888965571999999999758897689399999998611321
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.86 Aligned_cols=253 Identities=19% Similarity=0.281 Sum_probs=203.3
Q ss_pred CCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCCH--HHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEC
Q ss_conf 15229994664403965999998-538949999993158706--999999999991899975574143468651265521
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD--VALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~~--~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E 547 (902)
+-+.|.+.+.||+|+||+||++. ..+|+.||||.+.....+ ...+|+. ++..++|||||++++++.+++.+|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~-il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEIS-ILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHH-HHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHH-HHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 701058878983177839999999899969999997578665999999999-9985799798909899988998899995
Q ss_pred CCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 34688124798835985677433102561148897640234343024777751799989999999962012342110362
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~I 627 (902)
||. +|+|.+++... ...+++..+..|+.||+.||+|||+++|
T Consensus 82 ~~~----------gg~L~~~i~~~----------------------------~~~l~e~~~~~i~~qi~~al~yLH~~~i 123 (321)
T d1tkia_ 82 FIS----------GLDIFERINTS----------------------------AFELNEREIVSYVHQVCEALQFLHSHNI 123 (321)
T ss_dssp CCC----------CCBHHHHHTSS----------------------------SCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCC----------CCCHHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 389----------98088998753----------------------------8999999999999999999999987699
Q ss_pred CCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 13444561168536999238881478620124877655346458898654570110029999852146567999999938
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 628 iHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~elltG 707 (902)
+||||||+|||++.++...+||+|||+++...... ......||+.|+|||.+.+..++.++||||+||++|+|++|
T Consensus 124 iHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~----~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G 199 (321)
T d1tkia_ 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199 (321)
T ss_dssp ECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC----EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCCC----CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHC
T ss_conf 75135544434437885189976441110034677----53212233222340210487778401130279999999828
Q ss_pred CCCCCCCCHHH-HHH-HHHHCCC---CCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 99999983566-788-9741133---322369957999998005999999969888972977778
Q 002601 708 GKHPYGESFER-DAN-IVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 708 ~~~Pf~~~~~~-~~~-i~~~~~~---~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~ 767 (902)
.+||...... ... +...... ......++++++||.+||+.||.+|||+.|+++||||..
T Consensus 200 -~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 200 -INPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -SCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf -9999998999999999838999880223678999999999986699668909999963996566
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.02 Aligned_cols=247 Identities=23% Similarity=0.378 Sum_probs=202.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECCCC
Q ss_conf 2299946644039659999985389499999931587--06999999999991899975574143468651265521346
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrL~~~~--~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~c~ 550 (902)
+.|.+.+.||+|+||+||+|...++..||||++.... .+...+|+. ++..++|||||+++|+|.+.+..|+|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~-~l~~l~HpnIv~~~g~~~~~~~~~lv~E--- 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAE-VMMKLSHPKLVQLYGVCLEQAPICLVFE--- 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSCEEEEE---
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHH-HHHHCCCCCCCCCCCEECCCCCEEEEEE---
T ss_conf 995888898208882999999889999999998788676899999999-9996689975653524315993379998---
Q ss_pred CCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 88124798835985677433102561148897640234343024777751799989999999962012342110362134
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~IiHr 630 (902)
|+++|+|.+++... ...+++..++.|+.|++.||+|||+.+|+||
T Consensus 81 -------~~~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qia~gl~~lH~~~iiHr 125 (263)
T d1sm2a_ 81 -------FMEHGCLSDYLRTQ----------------------------RGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125 (263)
T ss_dssp -------CCTTCBHHHHHHTT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCT
T ss_pred -------ECCCCCHHHHHHCC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCEEEC
T ss_conf -------36999189975201----------------------------3478899999999999998776531643104
Q ss_pred CCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 44561168536999238881478620124877655346458898654570110029999852146567999999938999
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~elltG~~~ 710 (902)
||||+|||++.++. +||+|||+|+....... .......||+.|+|||++....++.++|||||||++|||+|++.+
T Consensus 126 DlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~ 201 (263)
T d1sm2a_ 126 DLAARNCLVGENQV--IKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 201 (263)
T ss_dssp TCSGGGEEECGGGC--EEECSCC--------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCHHHEEECCCCC--EEECCCCHHEECCCCCC--EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCC
T ss_conf 43153266668877--68655321002368873--350430017666785786079998403321059999999878988
Q ss_pred CCCCCHHHH-H-HHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 999835667-8-897411333223699579999980059999999698889729
Q 002601 711 PYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 711 Pf~~~~~~~-~-~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
|+....... . .+........+...++++.+++.+||+.||++|||++++++|
T Consensus 202 ~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 202 PYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp TTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 877899999999998068889954367999999999765797689199999999
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.90 Aligned_cols=252 Identities=22% Similarity=0.337 Sum_probs=197.0
Q ss_pred CEEEE-EEEECCCCCEEEEEEE-EECCCEEEEEEECCCCCHHHHHHHHHHHHHCCCCCEEEECCCCCC----CCCEEEEE
Q ss_conf 22999-4664403965999998-538949999993158706999999999991899975574143468----65126552
Q 002601 473 KLVVF-NKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVESD----QDFVYLSL 546 (902)
Q Consensus 473 ~~~~~-~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d----~~~lyLV~ 546 (902)
+.|.+ ++.||+|+||+||+|. ..+++.||||++.+. ....+|+..++...+|||||++++++.+ +..+|+||
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivm 88 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEEE
T ss_conf 48798107965454869999998899989999998974--7799999999986699997829899950346897899999
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 13468812479883598567743310256114889764023434302477775179998999999996201234211036
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~ 626 (902)
||| ++|+|.+++.... ...+++..++.|+.|++.||+|||+.+
T Consensus 89 Ey~----------~gg~L~~~i~~~~---------------------------~~~l~e~~~~~i~~qi~~al~ylH~~~ 131 (335)
T d2ozaa1 89 ECL----------DGGELFSRIQDRG---------------------------DQAFTEREASEIMKSIGEAIQYLHSIN 131 (335)
T ss_dssp ECC----------CSEEHHHHHHSCS---------------------------CCCEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ECC----------CCCCHHHHHHHCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 778----------9984999998627---------------------------877579999999999999999999769
Q ss_pred CCCCCCCCCEEEECCCC-CCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 21344456116853699-92388814786201248776553464588986545701100299998521465679999999
Q 002601 627 LIHRDLKPQNVLISKDK-SFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 627 IiHrDLKp~NILL~~d~-~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ell 705 (902)
|+||||||+|||++.++ ...+||+|||+|+...... .....+||+.|||||++.+..++.++|||||||++|+|+
T Consensus 132 iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll 207 (335)
T d2ozaa1 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN----SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 207 (335)
T ss_dssp EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC----CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCC----CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHH
T ss_conf 8644410022011355556631135455123336888----643226775637927774898888888876451677886
Q ss_pred HCCCCCCCCCHHHH-H-HH---HHHCCCCC----CCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 38999999835667-8-89---74113332----23699579999980059999999698889729777783
Q 002601 706 TGGKHPYGESFERD-A-NI---VKDRKDLF----LVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 706 tG~~~Pf~~~~~~~-~-~i---~~~~~~~~----~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
|| .+||.+..... . .+ +......+ ....++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 208 tg-~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 208 CG-YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp TS-SCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred HC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCC
T ss_conf 58-899889887788999999985388888985434699999999999756996579099999709876178
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=357.35 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=199.4
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCCC------------HHHHHHHHHHHHHCCCCCEEEECCCCCC
Q ss_conf 52299946644039659999985-3894999999315870------------6999999999991899975574143468
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH------------DVALKEIQNLIASDQHPNIVRWYGVESD 538 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~~------------~~~~~Ei~~ll~~l~HpNIVrL~g~~~d 538 (902)
.++|.+.+.||+|+||+||++.. .+|+.||||++.+... +...+|+..+.....|||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCC
Q ss_conf 65126552134688124798835985677433102561148897640234343024777751799989999999962012
Q 002601 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 539 ~~~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
++..||||| |+++|+|.+++. ....+++..++.++.||+.|
T Consensus 82 ~~~~~ivmE----------~~~~g~L~~~l~-----------------------------~~~~l~e~~~~~~~~qi~~a 122 (277)
T d1phka_ 82 NTFFFLVFD----------LMKKGELFDYLT-----------------------------EKVTLSEKETRKIMRALLEV 122 (277)
T ss_dssp SSEEEEEEE----------CCTTCBHHHHHH-----------------------------HHSSCCHHHHHHHHHHHHHH
T ss_pred CCCEEEEEE----------CCCCCHHHHHHH-----------------------------HCCCCCHHHHHHHHHHHHHH
T ss_conf 760599997----------689866899998-----------------------------65999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCC------CCCCCCC
Q ss_conf 3421103621344456116853699923888147862012487765534645889865457011002------9999852
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ------GRQTRAI 692 (902)
Q Consensus 619 L~yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~------~~~t~ks 692 (902)
|+|||+++|+||||||+|||++.++. +||+|||+|+...... .....+||+.|+|||++.. ..++.++
T Consensus 123 l~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~ 196 (277)
T d1phka_ 123 ICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGE----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEV 196 (277)
T ss_dssp HHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTC----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHH
T ss_pred HHHHHHCCCCCCCCCCCEEEECCCCC--EEECCCHHEEECCCCC----CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHH
T ss_conf 99998759943234625489868998--3871240316726887----21345246788898886053445678899233
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHHH-HH-HHHHCC---CCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCC
Q ss_conf 146567999999938999999835667-88-974113---3322369957999998005999999969888972977778
Q 002601 693 DLFSLGCILFFCITGGKHPYGESFERD-AN-IVKDRK---DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWT 767 (902)
Q Consensus 693 DVwSlGvIL~elltG~~~Pf~~~~~~~-~~-i~~~~~---~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~ 767 (902)
||||+||++|+|++| .+||.+..... .. +..... .......++++++|+.+||++||.+||+++|+++||||..
T Consensus 197 DiwslGvilyeml~g-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 197 DMWSTGVIMYTLLAG-SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred EECCCCHHHHHHCCC-CCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf 185656023103228-8898899999999999818988898543468999999999976589668919999973978797
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.01 Aligned_cols=271 Identities=23% Similarity=0.295 Sum_probs=201.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEEEC------CCEEEEEEECCCC----CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCE
Q ss_conf 229994664403965999998538------9499999931587----069999999999918999755741434686512
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYE------GRSVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~------g~~VAVKrL~~~~----~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~l 542 (902)
+.|.+.+.||+|+||+||+|.... ...||||++.... .....+|+..+....+|||||+++|++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
T ss_conf 99397019830788199999985788554204999999663358789999999999999715899686877888629958
Q ss_pred EEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 65521346881247988359856774331025611488976402343430247777517999899999999620123421
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+||| |+++|+|.++++.......... . ................+++..++.|+.|++.||+||
T Consensus 117 ~lv~E----------y~~~g~L~~~l~~~~~~~~~~~---~---~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yL 180 (325)
T d1rjba_ 117 YLIFE----------YCCYGDLLNYLRSKREKFSEDE---I---EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180 (325)
T ss_dssp EEEEE----------CCTTCBHHHHHHTTTTCC---------------------------CCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------CCCCCCHHHHHHHCCCCCCCHH---H---HHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 99997----------2799959999986257775102---2---100001222001257789999999999999999999
Q ss_pred CCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 10362134445611685369992388814786201248776553464588986545701100299998521465679999
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 Hs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ 702 (902)
|+++|+||||||+|||++.++. +||+|||+|+........ ....+..||+.|||||++..+.++.++|||||||++|
T Consensus 181 H~~~IiHRDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~ 257 (325)
T d1rjba_ 181 EFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLW 257 (325)
T ss_dssp HHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHCCEEECCCCHHCCCCCCCCE--EEEEECCCCCCCCCCCCE-EEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHH
T ss_conf 7399050527032144345982--898514222204577861-5623435787657838872799996330300039999
Q ss_pred HHHHCCCCCCCCCHH--HHHHHHHHC-CCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 999389999998356--678897411-333223699579999980059999999698889729
Q 002601 703 FCITGGKHPYGESFE--RDANIVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 703 elltG~~~Pf~~~~~--~~~~i~~~~-~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
||+|+|.+||.+... ....++... ....+...++++.+||.+||+.||++|||++|+++|
T Consensus 258 emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 258 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 998389999999898999999985699899887678999999999758896689399999999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=361.99 Aligned_cols=247 Identities=23% Similarity=0.320 Sum_probs=199.7
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCC--CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECCC
Q ss_conf 2299946644039659999985-389499999931587--0699999999999189997557414346865126552134
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~--~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~c 549 (902)
+.|.+.+.||+|+||+||+|.. .+|+.||||++.... .+...+|+. +++.++|||||+++|+|.+.+..|+|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~iv~E-- 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAA-VMKEIKHPNLVQLLGVCTREPPFYIITE-- 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHH-HHHHCCCTTBCCEEEEECSSSSCEEEEE--
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCCHHHHHHHHHH-HHHHCCCCCEECCCCCEEECCEEEEEEE--
T ss_conf 9939865982088808999999999969999997776103999999999-9986799988267752745785478763--
Q ss_pred CCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 68812479883598567743310256114889764023434302477775179998999999996201234211036213
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~IiH 629 (902)
|+++|+|..++.... ...+++..++.|+.|++.||+|||+++|+|
T Consensus 94 --------~~~~g~l~~~l~~~~---------------------------~~~~~~~~~~~i~~qi~~gL~yLH~~~iiH 138 (287)
T d1opja_ 94 --------FMTYGNLLDYLRECN---------------------------RQEVSAVVLLYMATQISSAMEYLEKKNFIH 138 (287)
T ss_dssp --------CCTTCBHHHHHHHSC---------------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred --------CCCCCCHHHHHHHCC---------------------------CCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf --------146760677753035---------------------------541579999999999999788898789305
Q ss_pred CCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 44456116853699923888147862012487765534645889865457011002999985214656799999993899
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGK 709 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~elltG~~ 709 (902)
|||||+|||++.++. +||+|||+|+........ ......|++.|+|||++..+.++.++|||||||++|||++|+.
T Consensus 139 rDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~ 214 (287)
T d1opja_ 139 RDLAARNCLVGENHL--VKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 214 (287)
T ss_dssp SCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSE--EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCCCCEEEECCCCC--EEECCCCCEEECCCCCCE--EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 760457689989992--898324454653788722--1035566546669278727999810430217899999986799
Q ss_pred CCCCCCHHHH-HHHHHH-CCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHC
Q ss_conf 9999835667-889741-133322369957999998005999999969888972
Q 002601 710 HPYGESFERD-ANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 710 ~Pf~~~~~~~-~~i~~~-~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~ 761 (902)
+|+....... ...+.. .....+...++++.+|+.+||+.||.+|||++++++
T Consensus 215 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 215 SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 887742599999998558888887433099999999975779768939999999
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=359.84 Aligned_cols=250 Identities=26% Similarity=0.373 Sum_probs=198.1
Q ss_pred CCEEEEEEEECCCCCEEEEEEEEE-CC---CEEEEEEECCCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCCEE
Q ss_conf 522999466440396599999853-89---49999993158706----99999999999189997557414346865126
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGNY-EG---RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~~-~g---~~VAVKrL~~~~~~----~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~ly 543 (902)
.+.|.+.+.||+|+||+||+|... ++ ..||||++...... ...+|+. +++.++|||||+++|++.+.+..|
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS-IMGQFDHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHH-HHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 0042785698027882999999957997889999999784459899999999999-998579988861899996288779
Q ss_pred EEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 55213468812479883598567743310256114889764023434302477775179998999999996201234211
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+||| |+++|+|.+++... ...+++..+++|+.||+.||+|||
T Consensus 104 iv~E----------y~~~g~L~~~~~~~----------------------------~~~l~~~~~~~i~~qia~gl~yLH 145 (299)
T d1jpaa_ 104 IITE----------FMENGSLDSFLRQN----------------------------DGQFTVIQLVGMLRGIAAGMKYLA 145 (299)
T ss_dssp EEEE----------CCTTEEHHHHHHTT----------------------------TTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------ECCCCCCEEEECCC----------------------------CCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 9997----------22798530021045----------------------------679999999999999999889885
Q ss_pred CCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 0362134445611685369992388814786201248776553--46458898654570110029999852146567999
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLT--QNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 624 s~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL 701 (902)
+++|+||||||+|||++.++. +||+|||+|+.+........ ......||+.|||||++..+.++.++|||||||++
T Consensus 146 ~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 146 DMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp HTTCCCSCCCGGGEEECTTCC--EEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred HCCCCCCCCCCCEEEECCCCC--EEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHH
T ss_conf 279835761504489889991--998884431575677776536502566688300387888369978612144535789
Q ss_pred HHHHHCCCCCCCCCHHHH-HH-HHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 999938999999835667-88-97411333223699579999980059999999698889729
Q 002601 702 FFCITGGKHPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~~~-~~-i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
|||+|++.+||.+..... .. +........+...++++.+++.+||+.||.+|||+.+++++
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 999867999999999999999997378899974226999999999758797689299999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.94 Aligned_cols=244 Identities=25% Similarity=0.348 Sum_probs=194.0
Q ss_pred EEECCCCCEEEEEEEEE---CCCEEEEEEECCCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECCCC
Q ss_conf 66440396599999853---894999999315870-----6999999999991899975574143468651265521346
Q 002601 479 KEIAKGSNGTVVLEGNY---EGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~---~g~~VAVKrL~~~~~-----~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~c~ 550 (902)
++||+|+||+||+|... .++.||||++..... +...+|+. ++..++|||||+++|+|.+ +..|+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~g~~~~-~~~~lvmE--- 87 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN-VMQQLDNPYIVRMIGICEA-ESWMLVME--- 87 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHH-HHHTCCCTTBCCEEEEEES-SSEEEEEE---
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHH-HHHHCCCCCCCEEEEEECC-CCEEEEEE---
T ss_conf 783458782999999816973859999998801089899999999999-9986799898527777505-97799997---
Q ss_pred CCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 88124798835985677433102561148897640234343024777751799989999999962012342110362134
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~IiHr 630 (902)
|+++|+|.+++.. ...+++..++.|+.||+.||+|||+++|+||
T Consensus 88 -------~~~~g~L~~~l~~-----------------------------~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHr 131 (277)
T d1xbba_ 88 -------MAELGPLNKYLQQ-----------------------------NRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131 (277)
T ss_dssp -------CCTTEEHHHHHHH-----------------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred -------CCCCCCHHHHHHH-----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf -------4788968999752-----------------------------2578999999999999999766874795567
Q ss_pred CCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 44561168536999238881478620124877655346458898654570110029999852146567999999938999
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~elltG~~~ 710 (902)
||||+|||++.++. +||+|||+|+.+..............||+.|||||++....++.++|||||||++|||+|.|.+
T Consensus 132 DlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~ 209 (277)
T d1xbba_ 132 DLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 209 (277)
T ss_dssp CCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCHHHCCCCCCC--CCCCCHHHHHHCCCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCC
T ss_conf 77611310235675--1234134533134323443224456778420391665379998434430340313289658999
Q ss_pred CCCCCHHHH-HH-HHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHH---CCCCC
Q ss_conf 999835667-88-974113332236995799999800599999996988897---29777
Q 002601 711 PYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL---NHPFF 765 (902)
Q Consensus 711 Pf~~~~~~~-~~-i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL---~HPfF 765 (902)
||.+..... .. +........+...++++.+++.+||+.||.+|||+++++ +|+|+
T Consensus 210 Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 210 PYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHH
T ss_conf 999989999999998289999986567999999999758897689098999998528875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.42 Aligned_cols=246 Identities=23% Similarity=0.300 Sum_probs=191.7
Q ss_pred EEEECCCCCEEEEEEEE-ECCCEEEEEEECCCCC--------HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECC
Q ss_conf 46644039659999985-3894999999315870--------69999999999918999755741434686512655213
Q 002601 478 NKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH--------DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~~--------~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~ 548 (902)
.+.||+|+||+||+|.. .+|+.||||++..... ....+|+. ++..++|||||++++++.+++..|+||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK-LLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHH-HHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHH-HHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 63851272829999999999969999998420212456799999999999-99867999986898542258740220455
Q ss_pred CCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 46881247988359856774331025611488976402343430247777517999899999999620123421103621
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~Ii 628 (902)
|.+++...+.. ....+++..+..++.||+.||+|||+++|+
T Consensus 82 ~~~~~~~~~~~---------------------------------------~~~~l~~~~~~~~~~qil~aL~~lH~~~ii 122 (299)
T d1ua2a_ 82 METDLEVIIKD---------------------------------------NSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122 (299)
T ss_dssp CSEEHHHHHTT---------------------------------------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HCCHHHHHHHH---------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCEE
T ss_conf 34507765541---------------------------------------266778999999999999999886316355
Q ss_pred CCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCC-CCCCCCHHHHHHHHHHHHHHC
Q ss_conf 3444561168536999238881478620124877655346458898654570110029-999852146567999999938
Q 002601 629 HRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCITG 707 (902)
Q Consensus 629 HrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvIL~elltG 707 (902)
||||||+|||++.++. +||+|||+|+...... ......+||+.|+|||++... .++.++||||+||++|||++|
T Consensus 123 HrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 197 (299)
T d1ua2a_ 123 HRDLKPNNLLLDENGV--LKLADFGLAKSFGSPN---RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR 197 (299)
T ss_dssp CCCCCGGGEEECTTCC--EEECCCGGGSTTTSCC---CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCEEEECCCCC--CCCCCCCCCCCCCCCC---CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHC
T ss_conf 0357762588537784--1146576100057875---5433020473336399972677888056436304289999859
Q ss_pred CCCCCCCCHHHH-H-HHHHHCC---------------------------CCCCCCCCHHHHHHHHCCCCCCCCCCCCHHH
Q ss_conf 999999835667-8-8974113---------------------------3322369957999998005999999969888
Q 002601 708 GKHPYGESFERD-A-NIVKDRK---------------------------DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQN 758 (902)
Q Consensus 708 ~~~Pf~~~~~~~-~-~i~~~~~---------------------------~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~e 758 (902)
.+||......+ . .+..... .......++++.+||.+||+.||++|||++|
T Consensus 198 -~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e 276 (299)
T d1ua2a_ 198 -VPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 276 (299)
T ss_dssp -SCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHH
T ss_pred -CCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf -6999999999999999985189972545210002134430347898867856568999999999976389456908999
Q ss_pred HHCCCCCCCCC
Q ss_conf 97297777830
Q 002601 759 VLNHPFFWTAD 769 (902)
Q Consensus 759 lL~HPfF~~~~ 769 (902)
+|+||||++..
T Consensus 277 ~L~Hp~f~~~p 287 (299)
T d1ua2a_ 277 ALKMKYFSNRP 287 (299)
T ss_dssp HHTSGGGTSSS
T ss_pred HHCCHHHCCCC
T ss_conf 96799657899
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.99 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=197.6
Q ss_pred CEEEEEE-EECCCCCEEEEEEEE---ECCCEEEEEEECCCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEE
Q ss_conf 2299946-644039659999985---38949999993158706----999999999991899975574143468651265
Q 002601 473 KLVVFNK-EIAKGSNGTVVLEGN---YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~-~LG~GsfGtVy~a~~---~~g~~VAVKrL~~~~~~----~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyL 544 (902)
+.+.+.+ +||+|+||+||+|.. .++..||||++...... ...+|+. ++..++|||||+++|++.+ +..|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~-il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ-IMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHH-HHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 471887848730608099999996089768999999882039789999999999-9986799888068656036-80799
Q ss_pred EECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 52134688124798835985677433102561148897640234343024777751799989999999962012342110
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs 624 (902)
||| |+++|+|.+++... ...+++..+.+++.|++.||+|||+
T Consensus 86 vmE----------~~~~g~L~~~l~~~----------------------------~~~l~~~~~~~i~~qi~~gL~ylH~ 127 (285)
T d1u59a_ 86 VME----------MAGGGPLHKFLVGK----------------------------REEIPVSNVAELLHQVSMGMKYLEE 127 (285)
T ss_dssp EEE----------CCTTEEHHHHHTTC----------------------------TTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------ECCCCCHHHHHHCC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf 998----------07899689975212----------------------------5699999999999999998789986
Q ss_pred CCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 36213444561168536999238881478620124877655346458898654570110029999852146567999999
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~el 704 (902)
++|+||||||+|||++.++. +||+|||+|+.+..............||+.|+|||++..+.++.++|||||||++|||
T Consensus 128 ~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~ 205 (285)
T d1u59a_ 128 KNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 205 (285)
T ss_dssp TTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CCEECCCCCHHHEEECCCCC--EEECCCHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHH
T ss_conf 88105767646604546885--4203313421155434321135621137433586887279999541232201789999
Q ss_pred HHCCCCCCCCCHHHH-H-HHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHH---HCCCCC
Q ss_conf 938999999835667-8-897411333223699579999980059999999698889---729777
Q 002601 705 ITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV---LNHPFF 765 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~-~-~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~el---L~HPfF 765 (902)
+|.|.+||.+....+ . .+........+...++++.+++.+||+.||++||++.++ |+|+|+
T Consensus 206 lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 206 LSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp HTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 938999999979999999998189999997678999999999757797689099999999999999
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.91 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=195.9
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECC-----CEEEEEEECCCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCCEE
Q ss_conf 2299946644039659999985389-----49999993158706----99999999999189997557414346865126
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEG-----RSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g-----~~VAVKrL~~~~~~----~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~ly 543 (902)
..|...+.||+|+||+||+|..... ..||||++.....+ ...+|+. ++..++|||||+++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~-il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG-IMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 9968615981177909999999689987879999999884459689999999999-998568987832367783388038
Q ss_pred EEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 55213468812479883598567743310256114889764023434302477775179998999999996201234211
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+|+|+|. +|++.+.+.. ....+++..+..++.|++.||+|||
T Consensus 86 ~v~e~~~----------~~~l~~~~~~----------------------------~~~~~~~~~~~~i~~~i~~gl~~lH 127 (283)
T d1mqba_ 86 IITEYME----------NGALDKFLRE----------------------------KDGEFSVLQLVGMLRGIAAGMKYLA 127 (283)
T ss_dssp EEEECCT----------TEEHHHHHHH----------------------------TTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECC----------CCCCHHHHHC----------------------------CCCCCCHHHHHHHHHHHHHHHHHCC
T ss_conf 9997213----------5740222102----------------------------3454208999999999998541212
Q ss_pred CCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 03621344456116853699923888147862012487765534645889865457011002999985214656799999
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 s~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~e 703 (902)
+.+|+||||||+|||++.++. +||+|||+|+.+..............||+.|||||++..+.++.++|||||||++||
T Consensus 128 ~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~e 205 (283)
T d1mqba_ 128 NMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205 (283)
T ss_dssp HTTCCCSCCCGGGEEECTTCC--EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCCEEEECCCCE--EEECCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHH
T ss_conf 123425765644278889984--998455103003578765267426777734348888704999973556344898999
Q ss_pred HHHCCCCCCCCCHHHH-HH-HHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHC
Q ss_conf 9938999999835667-88-9741133322369957999998005999999969888972
Q 002601 704 CITGGKHPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 704 lltG~~~Pf~~~~~~~-~~-i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~ 761 (902)
|++++.+|+....... .. +........+...++++.+++.+||+.||.+||++.++++
T Consensus 206 l~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 206 VMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHCCCCCCCCCCHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 996798865568999999998635789985045799999999977679768939999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.63 Aligned_cols=254 Identities=24% Similarity=0.390 Sum_probs=205.5
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEECCCCC--HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECCCC
Q ss_conf 22999466440396599999853894999999315870--6999999999991899975574143468651265521346
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH--DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrL~~~~~--~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~c~ 550 (902)
++|.+.+.||+|+||+||++...++..||||++..... +...+|+. ++..++|||||+++|+|.+ +..|+|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~-~l~~l~h~nIv~~~g~~~~-~~~~lv~E--- 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQ-VMKKLRHEKLVQLYAVVSE-EPIYIVTE--- 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHH-HHHHCCCTTBCCEEEEECS-SSCEEEEC---
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHHH-HHHHCCCCCEEEEEEEEEC-CCEEEEEE---
T ss_conf 997984699307980999999999999999998804488899999999-9986666788689999823-97599999---
Q ss_pred CCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 88124798835985677433102561148897640234343024777751799989999999962012342110362134
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~IiHr 630 (902)
|+++|++..++... ....+++..++.|+.||+.||+|||+.+|+||
T Consensus 92 -------y~~~g~l~~~~~~~---------------------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~ 137 (285)
T d1fmka3 92 -------YMSKGSLLDFLKGE---------------------------TGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 137 (285)
T ss_dssp -------CCTTCBHHHHHSHH---------------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -------ECCCCCHHHHHHHC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHHHHEECC
T ss_conf -------44799435420000---------------------------35530599999999999999998754114335
Q ss_pred CCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 44561168536999238881478620124877655346458898654570110029999852146567999999938999
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~elltG~~~ 710 (902)
||||+|||++.++. +||+|||+|+....... .......||+.|+|||++..+.++.++|||||||++|||++|+.+
T Consensus 138 DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p 213 (285)
T d1fmka3 138 DLRAANILVGENLV--CKVADFGLARLIEDNEY--TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 213 (285)
T ss_dssp CCSGGGEEECGGGC--EEECCCCTTC----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCCEEEEECCCCC--EEECCCCHHHHCCCCCC--EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCC
T ss_conf 31230799989992--99844255542568873--352454556654580898379989177413235899999868999
Q ss_pred CCCCCHHHH-HH-HHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHC--CCCCCCCC
Q ss_conf 999835667-88-9741133322369957999998005999999969888972--97777830
Q 002601 711 PYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN--HPFFWTAD 769 (902)
Q Consensus 711 Pf~~~~~~~-~~-i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~--HPfF~~~~ 769 (902)
|+....... .. +........+...++++.++|.+||+.||++||++++++. |+||.+.+
T Consensus 214 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 214 PYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp SSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCCC
T ss_conf 998888999999998268999983237999999999756697589199999998766623899
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.03 Aligned_cols=253 Identities=27% Similarity=0.407 Sum_probs=194.4
Q ss_pred CCEEEEEEEECCCCCEEEEEEEE-EC-CCEEEEEEECCCC-----CHHHHHHHHHH--HHHCCCCCEEEECCCCC-----
Q ss_conf 52299946644039659999985-38-9499999931587-----06999999999--99189997557414346-----
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEGN-YE-GRSVAVKRLVKTH-----HDVALKEIQNL--IASDQHPNIVRWYGVES----- 537 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~~-~~-g~~VAVKrL~~~~-----~~~~~~Ei~~l--l~~l~HpNIVrL~g~~~----- 537 (902)
.++|.+.++||+|+||+||+|.. .+ ++.||||++.... .....+|+..+ +...+|||||++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred CCCCEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHC
Q ss_conf 86512655213468812479883598567743310256114889764023434302477775179998999999996201
Q 002601 538 DQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (902)
Q Consensus 538 d~~~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~ 617 (902)
.....|+++|+|.+++..+... .....+++..++.++.|++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~~~~~~qi~~ 127 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--------------------------------------VPEPGVPTETIKDMMFQLLR 127 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--------------------------------------SCTTCSCHHHHHHHHHHHHH
T ss_pred CCCEEEEEEEECCCCCHHHHHH--------------------------------------CCCCCCCHHHHHHHHHHHHH
T ss_conf 6746999997405871444443--------------------------------------03789998999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHH
Q ss_conf 23421103621344456116853699923888147862012487765534645889865457011002999985214656
Q 002601 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (902)
Q Consensus 618 gL~yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSl 697 (902)
||+|||+++|+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.++||||+
T Consensus 128 aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~~~~~----~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSl 201 (305)
T d1blxa_ 128 GLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 201 (305)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGG----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHHHHHCCEEECCCCCCEEEECCCCC--EEECCHHHHHHHCCC----CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCH
T ss_conf 999997588983579862789858997--542100010110023----45777654851148310017988811100032
Q ss_pred HHHHHHHHHCCCCCCCCCHHHH-H-HHHHHC--------------------------CCCCCCCCCHHHHHHHHCCCCCC
Q ss_conf 7999999938999999835667-8-897411--------------------------33322369957999998005999
Q 002601 698 GCILFFCITGGKHPYGESFERD-A-NIVKDR--------------------------KDLFLVEHIPEAVDLFTRLLDPN 749 (902)
Q Consensus 698 GvIL~elltG~~~Pf~~~~~~~-~-~i~~~~--------------------------~~~~~~~~~~e~~dLI~~lL~~d 749 (902)
||++|||++| .+||....... . .+.... ...+....++++.+||.+||+.|
T Consensus 202 G~il~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 280 (305)
T d1blxa_ 202 GCIFAEMFRR-KPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 280 (305)
T ss_dssp HHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCC
T ss_conf 8999999878-799899898999999998407996110532111103330223456454404458999999999987489
Q ss_pred CCCCCCHHHHHCCCCCCCCC
Q ss_conf 99996988897297777830
Q 002601 750 PDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 750 P~~Rpt~~elL~HPfF~~~~ 769 (902)
|.+|||+.|+++||||++-+
T Consensus 281 P~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 281 PAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TTTSCCHHHHHTSGGGTTCC
T ss_pred HHHCCCHHHHHCCHHHCCCH
T ss_conf 66791899996696340752
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.78 Aligned_cols=247 Identities=22% Similarity=0.343 Sum_probs=200.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECCCC
Q ss_conf 2299946644039659999985389499999931587--06999999999991899975574143468651265521346
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrL~~~~--~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~c~ 550 (902)
+.|.+.++||+|+||+||++...+++.||||++.+.. .+...+|+ .++..++|||||+++|+|.+++.+++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev-~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey-- 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA-KVMMNLSHEKLVQLYGVCTKQRPIFIITEY-- 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHH-HHHHTCCCTTBCCEEEEECCSSSEEEEEEC--
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCCHHHHHHHH-HHHHHCCCCCEEEEEEEEEECCCEEEEEEC--
T ss_conf 99799689820788399999988998999999874757789999999-999966898601588998507816999970--
Q ss_pred CCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 88124798835985677433102561148897640234343024777751799989999999962012342110362134
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~IiHr 630 (902)
+.+|++..++... ...+++..+.+++.|+++||+|||+.+|+||
T Consensus 81 --------~~~g~l~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~ 124 (258)
T d1k2pa_ 81 --------MANGCLLNYLREM----------------------------RHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124 (258)
T ss_dssp --------CTTEEHHHHHHSG----------------------------GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCS
T ss_pred --------CCCCCHHHHHHCC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf --------4899388864102----------------------------4677689999999999999998754684346
Q ss_pred CCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 44561168536999238881478620124877655346458898654570110029999852146567999999938999
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~elltG~~~ 710 (902)
||||+|||++.++. +||+|||+|+....... .......||+.|+|||++....++.++|||||||++|||+|+++.
T Consensus 125 dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~ 200 (258)
T d1k2pa_ 125 DLAARNCLVNDQGV--VKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 200 (258)
T ss_dssp CCSGGGEEECTTCC--EEECCCSSCCBCSSSSC--CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCEEEEECCCCC--EEECCCHHHEECCCCCC--EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCC
T ss_conf 65413588769984--79886144202357872--252465788775780786379988521033643246739755999
Q ss_pred CCCCCHHHHH--HHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 9998356678--897411333223699579999980059999999698889729
Q 002601 711 PYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 711 Pf~~~~~~~~--~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
||......+. .+........+...++++.+|+.+||+.||++|||++++++|
T Consensus 201 Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 201 PYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 988999999999998079789965465999999999766897689399999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.85 Aligned_cols=255 Identities=24% Similarity=0.363 Sum_probs=195.4
Q ss_pred CCCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCC----
Q ss_conf 015229994664403965999998-538949999993158706----99999999999189997557414346865----
Q 002601 470 RIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD---- 540 (902)
Q Consensus 470 ~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~~----~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~---- 540 (902)
.++..|...+.||+|+||+||+|. ..+|+.||||++.+.... ...+|+. ++..++|||||++++++....
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~-il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK-ILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHH-HHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred CCCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHH-HHHHCCCCCCCCEEEEEEECCCCCC
T ss_conf 738985997899406480999999999994999999803109589999999999-9997689898858889950564554
Q ss_pred -CEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCC
Q ss_conf -1265521346881247988359856774331025611488976402343430247777517999899999999620123
Q 002601 541 -FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGL 619 (902)
Q Consensus 541 -~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL 619 (902)
..|++++++.++|.+++. .+++++..++.++.|++.||
T Consensus 84 ~~~~l~~~~~~g~L~~~l~-----------------------------------------~~~l~~~~i~~i~~qil~al 122 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLK-----------------------------------------TQHLSNDHICYFLYQILRGL 122 (345)
T ss_dssp CCEEEEEECCCEEHHHHHH-----------------------------------------HCCCCHHHHHHHHHHHHHHH
T ss_pred CEEEEEEEECCCCHHHHHH-----------------------------------------CCCCCHHHHHHHHHHHHHHH
T ss_conf 1499999625986566440-----------------------------------------58999999999999999999
Q ss_pred CCCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCC-CCCCCCCHHHHHH
Q ss_conf 421103621344456116853699923888147862012487765534645889865457011002-9999852146567
Q 002601 620 SHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLG 698 (902)
Q Consensus 620 ~yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlG 698 (902)
+|||+++|+||||||+|||++.++. +||+|||+|+...............+||+.|+|||++.. ..++.++||||+|
T Consensus 123 ~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG 200 (345)
T d1pmea_ 123 KYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVG 200 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHH
T ss_pred HHHHHCCCCCCCCCCCEEEECCCCC--EEECCCCCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCC
T ss_conf 9999789867778764378879997--78754570565047776410101102652000387860478887410100467
Q ss_pred HHHHHHHHCCCCCCCCCHHHHH-HHH-H-----------------------HC--C-----CCCCCCCCHHHHHHHHCCC
Q ss_conf 9999999389999998356678-897-4-----------------------11--3-----3322369957999998005
Q 002601 699 CILFFCITGGKHPYGESFERDA-NIV-K-----------------------DR--K-----DLFLVEHIPEAVDLFTRLL 746 (902)
Q Consensus 699 vIL~elltG~~~Pf~~~~~~~~-~i~-~-----------------------~~--~-----~~~~~~~~~e~~dLI~~lL 746 (902)
|++|+|++| .+||........ ... . .. . .......++++++|+.+||
T Consensus 201 ~il~eml~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L 279 (345)
T d1pmea_ 201 CILAEMLSN-RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKML 279 (345)
T ss_dssp HHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHS
T ss_pred CEEHHHHHC-CCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHC
T ss_conf 013377669-7997888889999987652069975664234332222024467755778777837899999999999976
Q ss_pred CCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 99999996988897297777830
Q 002601 747 DPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 747 ~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
+.||.+|||++++++||||....
T Consensus 280 ~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 280 TFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 48956790899986198655588
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.77 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=198.8
Q ss_pred CEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCC-----CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
Q ss_conf 229994664403965999998-5389499999931587-----0699999999999189997557414346865126552
Q 002601 473 KLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~-----~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~ 546 (902)
+.|...+.||+|+||+||+|. ..+|+.||||++.... .....+|+. +++.++|||||++++++.+.+..|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS-LLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHH-HHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 9977651772376809999999999979999998022257589999999999-998679983887445332243203788
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 13468812479883598567743310256114889764023434302477775179998999999996201234211036
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~ 626 (902)
|+|.+++.+++.. ....++++..+..++.|++.||+|||+.+
T Consensus 81 e~~~~~~~~~~~~--------------------------------------~~~~~l~e~~~~~~~~qil~~L~yLH~~~ 122 (298)
T d1gz8a_ 81 EFLHQDLKKFMDA--------------------------------------SALTGIPLPLIKSYLFQLLQGLAFCHSHR 122 (298)
T ss_dssp ECCSEEHHHHHHH--------------------------------------TTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EECCCCHHHHHHH--------------------------------------HCCCCCCHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 6237744555442--------------------------------------02568888999999999999999865288
Q ss_pred CCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCC-CCCCCHHHHHHHHHHHHH
Q ss_conf 2134445611685369992388814786201248776553464588986545701100299-998521465679999999
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDVwSlGvIL~ell 705 (902)
|+||||||+|||++.++. +||+|||+|+...... .......||+.|+|||++.... ++.++||||+||++|+|+
T Consensus 123 IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~---~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~ 197 (298)
T d1gz8a_ 123 VLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPV---RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197 (298)
T ss_dssp CCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCS---BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred EECCCCCCHHEEECCCCC--CEECCCCCCEECCCCC---CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHH
T ss_conf 992135711401134676--2103578613436886---41001036521541122136657774221033331342796
Q ss_pred HCCCCCCCCCHHHH--HHHHHHCC-----------------C-----------CCCCCCCHHHHHHHHCCCCCCCCCCCC
Q ss_conf 38999999835667--88974113-----------------3-----------322369957999998005999999969
Q 002601 706 TGGKHPYGESFERD--ANIVKDRK-----------------D-----------LFLVEHIPEAVDLFTRLLDPNPDLRPK 755 (902)
Q Consensus 706 tG~~~Pf~~~~~~~--~~i~~~~~-----------------~-----------~~~~~~~~e~~dLI~~lL~~dP~~Rpt 755 (902)
+| +.||....... ..+..... . ......++++.+|+.+||+.||.+|||
T Consensus 198 ~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 276 (298)
T d1gz8a_ 198 TR-RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS 276 (298)
T ss_dssp HS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HC-CCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 68-79989889999999999832898333144422242124345432222044416678999999999976399557918
Q ss_pred HHHHHCCCCCCCCCH
Q ss_conf 888972977778300
Q 002601 756 AQNVLNHPFFWTADT 770 (902)
Q Consensus 756 ~~elL~HPfF~~~~~ 770 (902)
++|+++||||.+...
T Consensus 277 ~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 277 AKAALAHPFFQDVTK 291 (298)
T ss_dssp HHHHHTSGGGTTCCC
T ss_pred HHHHHCCHHHCCCCC
T ss_conf 999967870146999
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.03 Aligned_cols=247 Identities=21% Similarity=0.270 Sum_probs=195.3
Q ss_pred CCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCC---------CHHHHHHHHHHHHH-CCCCCEEEECCCCCCCC
Q ss_conf 5229994664403965999998-5389499999931587---------06999999999991-89997557414346865
Q 002601 472 GKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH---------HDVALKEIQNLIAS-DQHPNIVRWYGVESDQD 540 (902)
Q Consensus 472 ~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~---------~~~~~~Ei~~ll~~-l~HpNIVrL~g~~~d~~ 540 (902)
..+|.+.+.||+|+||+||+|. ..+|+.||||++.+.. .....+|+..+... ..|||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCC
Q ss_conf 12655213468812479883598567743310256114889764023434302477775179998999999996201234
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
..|+|||+|.+. +++.+++ .+...+++..++.++.|++.||+
T Consensus 83 ~~~lv~e~~~~~---------~~l~~~~-----------------------------~~~~~l~e~~~~~~~~qi~~al~ 124 (273)
T d1xwsa_ 83 SFVLILERPEPV---------QDLFDFI-----------------------------TERGALQEELARSFFWQVLEAVR 124 (273)
T ss_dssp EEEEEEECCSSE---------EEHHHHH-----------------------------HHHCSCCHHHHHHHHHHHHHHHH
T ss_pred EEEEEEEECCCC---------CHHHHHH-----------------------------HCCCCCCHHHHHHHHHHHHHHHH
T ss_conf 689999833686---------2289998-----------------------------61589999999999999999999
Q ss_pred CCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCC-CCCCHHHHHHH
Q ss_conf 21103621344456116853699923888147862012487765534645889865457011002999-98521465679
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQ-TRAIDLFSLGC 699 (902)
Q Consensus 621 yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-t~ksDVwSlGv 699 (902)
|||+.+|+||||||+|||++.+. ..+||+|||+|+..... ...+..||+.|+|||++....+ +.++||||+||
T Consensus 125 ~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~~~-----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGv 198 (273)
T d1xwsa_ 125 HCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLKDT-----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 198 (273)
T ss_dssp HHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCSS-----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHH
T ss_pred HHHHCCCCCCCCCCCCEEEECCC-CEEEECCCCCCEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEE
T ss_conf 99877975566761114774478-84897754653532444-----5566565877479999848997886533255403
Q ss_pred HHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 999999389999998356678897411333223699579999980059999999698889729777783
Q 002601 700 ILFFCITGGKHPYGESFERDANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 700 IL~elltG~~~Pf~~~~~~~~~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
++|||++| .+||..... +. .....++...++++.+||.+||+.||++|||++|+++||||.+.
T Consensus 199 ilyell~g-~~Pf~~~~~----i~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 199 LLYDMVCG-DIPFEHDEE----II-RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHHHHHHS-SCSCCSHHH----HH-HCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred EEHHHHHC-CCCCCCCHH----HH-HCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 45367568-899887367----76-15447787799999999999760897589399998539866788
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.80 Aligned_cols=247 Identities=27% Similarity=0.427 Sum_probs=194.9
Q ss_pred CCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCCCC----
Q ss_conf 15229994664403965999998-53894999999315870-----699999999999189997557414346865----
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQD---- 540 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~-----~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~---- 540 (902)
+.+.|...+.||+|+||+||+|. ..+|+.||||++.+... ....+|+. +++.++|||||++++++.+.+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR-LLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHH-HHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEECCCCCCCC
T ss_conf 477189988980177819999999999989999998522259699999999999-9986689875479998635765555
Q ss_pred --CEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCC
Q ss_conf --126552134688124798835985677433102561148897640234343024777751799989999999962012
Q 002601 541 --FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 541 --~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
.+|+|||+|+.+|..++ +...+++..++.++.|++.|
T Consensus 95 ~~~~~lv~e~~~~~l~~~~-----------------------------------------~~~~l~~~~~~~~~~qi~~a 133 (346)
T d1cm8a_ 95 FTDFYLVMPFMGTDLGKLM-----------------------------------------KHEKLGEDRIQFLVYQMLKG 133 (346)
T ss_dssp CCCCEEEEECCSEEHHHHH-----------------------------------------HHCCCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEECCCCCHHHHH-----------------------------------------HHCCCCHHHHHHHHHHHHHH
T ss_conf 4159999840552189998-----------------------------------------74022699999999999999
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCC-CCCCCCHHHHH
Q ss_conf 34211036213444561168536999238881478620124877655346458898654570110029-99985214656
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSL 697 (902)
Q Consensus 619 L~yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSl 697 (902)
|+|||+++|+||||||+|||++.++. +|++|||+|+..... .....||+.|+|||++.+. .++.++||||+
T Consensus 134 L~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 205 (346)
T d1cm8a_ 134 LRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADSE------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSV 205 (346)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSS------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCHHHCCCCCC--CCCCCCCCEECCCCC------CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCC
T ss_conf 99987378764566851111210012--211343102206876------3102455333588998178789965010300
Q ss_pred HHHHHHHHHCCCCCCCCCHHHHH-H-HHH-----------------------HC-------CCCCCCCCCHHHHHHHHCC
Q ss_conf 79999999389999998356678-8-974-----------------------11-------3332236995799999800
Q 002601 698 GCILFFCITGGKHPYGESFERDA-N-IVK-----------------------DR-------KDLFLVEHIPEAVDLFTRL 745 (902)
Q Consensus 698 GvIL~elltG~~~Pf~~~~~~~~-~-i~~-----------------------~~-------~~~~~~~~~~e~~dLI~~l 745 (902)
||++|+|++| .+||........ . +.. .. ........++++.|||.+|
T Consensus 206 Gvil~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m 284 (346)
T d1cm8a_ 206 GCIMAEMITG-KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284 (346)
T ss_dssp HHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHH
T ss_conf 3899999978-699888976899999985037884888865300034433115786665566775568999999999997
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 59999999698889729777783
Q 002601 746 LDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 746 L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
|+.||.+|||+.|+|+||||+..
T Consensus 285 L~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 285 LVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 72995579299999639623758
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=347.06 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=193.8
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCCCHHHHHHHHHHHHHCCCCCEEEECCCCC--CCCCEEEEECCC
Q ss_conf 2299946644039659999985-3894999999315870699999999999189997557414346--865126552134
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES--DQDFVYLSLERC 549 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~~~~~~~Ei~~ll~~l~HpNIVrL~g~~~--d~~~lyLV~E~c 549 (902)
++|.+.++||+|+||+||+|.. .+|+.||||++.+.......+|+..+.....||||+++++++. +...+++|||+|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~ 114 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEEEEC
T ss_conf 67189789831748199999988999799999988899999999999998515799876799999816877126888631
Q ss_pred CCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 68812479883598567743310256114889764023434302477775179998999999996201234211036213
Q 002601 550 TCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIH 629 (902)
Q Consensus 550 ~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~IiH 629 (902)
.+ |+|.... +.+++..++.++.||+.||+|||+++|+|
T Consensus 115 ~~----------~~L~~~~--------------------------------~~l~e~~i~~i~~qil~aL~~LH~~gIvH 152 (328)
T d3bqca1 115 NN----------TDFKQLY--------------------------------QTLTDYDIRFYMYEILKALDYCHSMGIMH 152 (328)
T ss_dssp CS----------CBGGGTT--------------------------------TSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CC----------CCHHHHH--------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 79----------8589974--------------------------------68999999999999999998876433443
Q ss_pred CCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCC-CCCCCHHHHHHHHHHHHHHCC
Q ss_conf 4445611685369992388814786201248776553464588986545701100299-998521465679999999389
Q 002601 630 RDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCITGG 708 (902)
Q Consensus 630 rDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDVwSlGvIL~elltG~ 708 (902)
|||||+|||++.++. .+||+|||+|+...... .....+||+.|+|||.+.... ++.++||||+||++|+|++|
T Consensus 153 rDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g- 226 (328)
T d3bqca1 153 RDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFR- 226 (328)
T ss_dssp CCCSGGGEEEETTTT-EEEECCGGGCEECCTTC----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHT-
T ss_pred CCCCCCCEEECCCCC-EEEECCCCCCEECCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC-
T ss_conf 456441237748998-36641565426646887----444322486424761026888888452323354555876048-
Q ss_pred CCCCCCCH-HHH--HHHHH------------H------------------------CCCCCCCCCCHHHHHHHHCCCCCC
Q ss_conf 99999835-667--88974------------1------------------------133322369957999998005999
Q 002601 709 KHPYGESF-ERD--ANIVK------------D------------------------RKDLFLVEHIPEAVDLFTRLLDPN 749 (902)
Q Consensus 709 ~~Pf~~~~-~~~--~~i~~------------~------------------------~~~~~~~~~~~e~~dLI~~lL~~d 749 (902)
..||.... ... ..+.. . .........++++.|||.+||+.|
T Consensus 227 ~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 306 (328)
T d3bqca1 227 KEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYD 306 (328)
T ss_dssp CSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSS
T ss_pred CCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 89998876018999999998788415555542254447430000033343311211552112448999999999986699
Q ss_pred CCCCCCHHHHHCCCCCCCCC
Q ss_conf 99996988897297777830
Q 002601 750 PDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 750 P~~Rpt~~elL~HPfF~~~~ 769 (902)
|.+|||++|+|+||||++..
T Consensus 307 P~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 307 HQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp GGGSCCHHHHHTSGGGTTSC
T ss_pred HHHCCCHHHHHCCCCCCCCC
T ss_conf 56890899996493558879
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.63 Aligned_cols=251 Identities=27% Similarity=0.362 Sum_probs=192.2
Q ss_pred EEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCCCHHHHHHHHHHHHHCCCCCEEEECCCCC------CCCCEEEEE
Q ss_conf 299946644039659999985-3894999999315870699999999999189997557414346------865126552
Q 002601 474 LVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHHDVALKEIQNLIASDQHPNIVRWYGVES------DQDFVYLSL 546 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~~~~~~~Ei~~ll~~l~HpNIVrL~g~~~------d~~~lyLV~ 546 (902)
.|...++||+|+||+||+|.. .+|+.||||++.+.. ....+|+. ++..++|||||++++++. +..++|+||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~-il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQ-IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHH-HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCC-HHHHHHHH-HHHHCCCCCCCCEEEEEEECCCCCCCEEEEEEE
T ss_conf 7675169821768399999999999799999988160-68999999-998668989873878997447657731899998
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 13468812479883598567743310256114889764023434302477775179998999999996201234211036
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~ 626 (902)
|||++++.+.+. +. ......+++..++.|+.|++.||+|||+++
T Consensus 99 Ey~~~~~~~~l~----------~~--------------------------~~~~~~l~~~~~~~i~~qil~aL~yLH~~~ 142 (350)
T d1q5ka_ 99 DYVPETVYRVAR----------HY--------------------------SRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142 (350)
T ss_dssp ECCSEEHHHHHH----------HH--------------------------HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred ECCCCCCHHHHH----------HH--------------------------HHCCCCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 416886078888----------63--------------------------103689999999999999999999998668
Q ss_pred CCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCC-CCCCCCCHHHHHHHHHHHHH
Q ss_conf 21344456116853699923888147862012487765534645889865457011002-99998521465679999999
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ-GRQTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~t~ksDVwSlGvIL~ell 705 (902)
|+||||||+|||++.++. .+||+|||+|+...... ...+.+||+.|+|||.+.. ..++.++||||+||++|||+
T Consensus 143 IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~ 217 (350)
T d1q5ka_ 143 ICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGE----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217 (350)
T ss_dssp EECCCCCGGGEEECTTTC-CEEECCCTTCEECCTTS----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCEEEEECCCC-CEEEECCCCHHHCCCCC----CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHH
T ss_conf 764578860378735897-11673366054404776----5320025555568277640468882100024652778550
Q ss_pred HCCCCCCCCCHHHH-H-HHHHHC----------------------------CCCCCCCCCHHHHHHHHCCCCCCCCCCCC
Q ss_conf 38999999835667-8-897411----------------------------33322369957999998005999999969
Q 002601 706 TGGKHPYGESFERD-A-NIVKDR----------------------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPK 755 (902)
Q Consensus 706 tG~~~Pf~~~~~~~-~-~i~~~~----------------------------~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt 755 (902)
+| .+||....... . .+.... ........++++.+|+.+||+.||.+|||
T Consensus 218 ~g-~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 296 (350)
T d1q5ka_ 218 LG-QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296 (350)
T ss_dssp HT-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HC-CCCCCCCCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 28-79989879999999999974898177654306210110355445674444315689999999999976589557929
Q ss_pred HHHHHCCCCCCCC
Q ss_conf 8889729777783
Q 002601 756 AQNVLNHPFFWTA 768 (902)
Q Consensus 756 ~~elL~HPfF~~~ 768 (902)
+.|+++||||...
T Consensus 297 a~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 297 PLEACAHSFFDEL 309 (350)
T ss_dssp HHHHHTSGGGGGG
T ss_pred HHHHHCCHHHCCC
T ss_conf 9999669845246
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.19 Aligned_cols=264 Identities=21% Similarity=0.303 Sum_probs=200.8
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE------CCCEEEEEEECCCCC----HHHHHHHHHHHHHCCCCCEEEECCCCCC-CCC
Q ss_conf 22999466440396599999853------894999999315870----6999999999991899975574143468-651
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHH----DVALKEIQNLIASDQHPNIVRWYGVESD-QDF 541 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrL~~~~~----~~~~~Ei~~ll~~l~HpNIVrL~g~~~d-~~~ 541 (902)
+.|.+.+.||+|+||.||+|... +++.||||++..... ....+|+..+....+|+|||++++++.+ ++.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCE
T ss_conf 99798449841678399999986777555783999999860017178999999999988614998499741154047975
Q ss_pred EEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 26552134688124798835985677433102561148897640234343024777751799989999999962012342
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
+++||| |+++|+|.++++.......... .....-....+++..++.++.||+.||+|
T Consensus 93 ~~iv~E----------~~~~g~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qi~~gl~y 149 (299)
T d1ywna1 93 LMVIVE----------FCKFGNLSTYLRSKRNEFVPYK-------------VAPEDLYKDFLTLEHLICYSFQVAKGMEF 149 (299)
T ss_dssp CEEEEE----------CCTTCBHHHHHHHTGGGBCC------------------------CBCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEE----------ECCCCCHHHHHHHCCCCCCCCC-------------CCHHHHHCCCCCHHHHHHHHHHHHHHHHH
T ss_conf 799998----------4589929999985366666532-------------22023321468999999999999999998
Q ss_pred CCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 11036213444561168536999238881478620124877655346458898654570110029999852146567999
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 622 LHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL 701 (902)
||+++|+||||||+|||++.++. +||+|||+|+....... ........||+.|||||++.++.++.++|||||||++
T Consensus 150 lH~~~ivHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil 226 (299)
T d1ywna1 150 LASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226 (299)
T ss_dssp HHHTTCCCSCCCGGGEEECGGGC--EEECC------CCSCTT-SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHCCCCCCCCCCCCEEECCCCC--EEECCCCCHHHCCCCCC-CCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHH
T ss_conf 87379717867731065779982--89845752001135665-2224751667210203686468899663221367899
Q ss_pred HHHHHCCCCCCCCCHH--HHHHHH-HHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 9999389999998356--678897-411333223699579999980059999999698889729
Q 002601 702 FFCITGGKHPYGESFE--RDANIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~--~~~~i~-~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
|||++++.+||..... .....+ .......+...++++.+++.+||+.||.+|||++++++|
T Consensus 227 ~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 227 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 9998688999989998999999996389888886578999999999767796679199999999
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.91 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=194.1
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCC-----CHHHHHHHHHHHHHCCCCCEEEECCCCCC--------
Q ss_conf 2299946644039659999985-389499999931587-----06999999999991899975574143468--------
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESD-------- 538 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~-----~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d-------- 538 (902)
.+|.+.++||+|+||+||+|.. .+|+.||||++.... .....+|+. +++.++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIK-ILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHH-HHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHH-HHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 7988999972274829999999899979999998422246378999999999-999835999660676540246544445
Q ss_pred CCCEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCC
Q ss_conf 65126552134688124798835985677433102561148897640234343024777751799989999999962012
Q 002601 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 539 ~~~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
.+..|+|||+|..++.... . .....+++..++.++.|++.|
T Consensus 89 ~~~~~iv~e~~~~~~~~~~----------~-----------------------------~~~~~~~~~~~~~i~~qil~~ 129 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL----------S-----------------------------NVLVKFTLSEIKRVMQMLLNG 129 (318)
T ss_dssp --CEEEEEECCCEEHHHHH----------T-----------------------------CTTCCCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEECCCCCCCCHH----------H-----------------------------HCCCCCCCHHHHHHHHHHHHH
T ss_conf 7638999853578741012----------2-----------------------------203443308999999999999
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCHHHCCC-CCCCCCHHHH
Q ss_conf 342110362134445611685369992388814786201248776-55346458898654570110029-9998521465
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMS-CLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFS 696 (902)
Q Consensus 619 L~yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~-~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwS 696 (902)
|.|||+.+|+||||||+|||++.++. +||+|||+|+....... ........+||+.|+|||++... .++.++||||
T Consensus 130 l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwS 207 (318)
T d3blha1 130 LYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207 (318)
T ss_dssp HHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHCCCCEEECCCCCHHEEECCCCC--EEEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCC
T ss_conf 98852299885676722203668996--8763135002235544432113566024978742899707999891787006
Q ss_pred HHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCCCC--------------------------------CCCCCHHHHHHHH
Q ss_conf 67999999938999999835667-88974113332--------------------------------2369957999998
Q 002601 697 LGCILFFCITGGKHPYGESFERD-ANIVKDRKDLF--------------------------------LVEHIPEAVDLFT 743 (902)
Q Consensus 697 lGvIL~elltG~~~Pf~~~~~~~-~~i~~~~~~~~--------------------------------~~~~~~e~~dLI~ 743 (902)
+||++|||++| .+||.+..... ...+....... ....++++.|||.
T Consensus 208 lGvil~el~~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~ 286 (318)
T d3blha1 208 AGCIMAEMWTR-SPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286 (318)
T ss_dssp HHHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHH
T ss_pred CCCEEEEHHHC-CCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHH
T ss_conf 78646617448-79989989999999999841899825534432034443320133445550334044459989999999
Q ss_pred CCCCCCCCCCCCHHHHHCCCCCCCCC
Q ss_conf 00599999996988897297777830
Q 002601 744 RLLDPNPDLRPKAQNVLNHPFFWTAD 769 (902)
Q Consensus 744 ~lL~~dP~~Rpt~~elL~HPfF~~~~ 769 (902)
+||+.||++|||++|+++||||+...
T Consensus 287 ~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 287 KLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred HHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 98738965890999997495015699
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.86 Aligned_cols=244 Identities=23% Similarity=0.319 Sum_probs=186.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEECCCC----C-HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEC
Q ss_conf 2299946644039659999985389499999931587----0-6999999999991899975574143468651265521
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH----H-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrL~~~~----~-~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E 547 (902)
..|.+.+.||+|+||+||+|... ..||||++.... . ....+|+ .++..++|||||+++|++.+ +.+|+|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEV-GVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHH-HHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 51899889830788589999999--9899999973469989999999999-99984799878645679715-58999996
Q ss_pred CCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 34688124798835985677433102561148897640234343024777751799989999999962012342110362
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~I 627 (902)
|+++|+|.++++.. ...+++..++.|+.||+.||+|||+++|
T Consensus 84 ----------y~~~g~L~~~l~~~----------------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~i 125 (276)
T d1uwha_ 84 ----------WCEGSSLYHHLHII----------------------------ETKFEMIKLIDIARQTAQGMDYLHAKSI 125 (276)
T ss_dssp ----------CCCEEEHHHHHHTS----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ----------CCCCCCHHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCE
T ss_conf ----------58998889998523----------------------------5789999999999999999888750999
Q ss_pred CCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCC---CCCCCCCHHHHHHHHHHHH
Q ss_conf 1344456116853699923888147862012487765534645889865457011002---9999852146567999999
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQ---GRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 628 iHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~---~~~t~ksDVwSlGvIL~el 704 (902)
+||||||+|||++.++. +||+|||+|+....... ........||+.|||||++.. ..++.++|||||||++|||
T Consensus 126 vHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el 202 (276)
T d1uwha_ 126 IHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSG-SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202 (276)
T ss_dssp CCSCCCGGGEEEETTSS--EEECCCCCSCC-------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHH
T ss_pred ECCCCCHHHEEECCCCC--EEECCCCCEEECCCCCC-CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 51614789979818997--88750022133355677-6312566557431799999505689999531516359999999
Q ss_pred HHCCCCCCCCCHHH--HHHHHHHCC-----CCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 93899999983566--788974113-----33223699579999980059999999698889729
Q 002601 705 ITGGKHPYGESFER--DANIVKDRK-----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 705 ltG~~~Pf~~~~~~--~~~i~~~~~-----~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
+|| ..||.+.... ....+.... ...+...++++.+++.+||+.||.+|||++++++|
T Consensus 203 ~tg-~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 203 MTG-QLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHS-SCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHC-CCCCCCCCHHHHHHHHHHCCCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 978-8998998969999999965888986000365554999999999758897689299999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.74 Aligned_cols=248 Identities=23% Similarity=0.289 Sum_probs=193.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCC----EEEEEEECCCC----CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEE
Q ss_conf 2299946644039659999985-3894----99999931587----0699999999999189997557414346865126
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGR----SVAVKRLVKTH----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVY 543 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~----~VAVKrL~~~~----~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~ly 543 (902)
.+|.+.+.||+|+||+||+|.. .+|+ .||||++.... .....+|+. ++..++|||||+++|+|.+++ .+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~HpnIv~l~g~~~~~~-~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY-VMASVDNPHVCRLLGICLTST-VQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHH-HHHHCCCTTBCCEEEEEESSS-EE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEECCC-EE
T ss_conf 9997831982089929999999589988989999999651349799999999999-998679988815899996198-36
Q ss_pred EEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCC
Q ss_conf 55213468812479883598567743310256114889764023434302477775179998999999996201234211
Q 002601 544 LSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLH 623 (902)
Q Consensus 544 LV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLH 623 (902)
+++| ++.+|+|.+.+.. ....+++..+++|+.||+.||+|||
T Consensus 87 ~v~e----------~~~~~~l~~~~~~----------------------------~~~~~~~~~~~~i~~qi~~gl~yLH 128 (317)
T d1xkka_ 87 LITQ----------LMPFGCLLDYVRE----------------------------HKDNIGSQYLLNWCVQIAKGMNYLE 128 (317)
T ss_dssp EEEE----------CCTTCBHHHHHHH----------------------------TSSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEEE----------ECCCCCCCCCCCC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHH
T ss_conf 9998----------4268740101113----------------------------3457999999999999999999998
Q ss_pred CCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHH
Q ss_conf 03621344456116853699923888147862012487765534645889865457011002999985214656799999
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFF 703 (902)
Q Consensus 624 s~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~e 703 (902)
+++|+||||||+|||++.++. +||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++||
T Consensus 129 ~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~e 205 (317)
T d1xkka_ 129 DRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKE-YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWE 205 (317)
T ss_dssp HTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTCC---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred HCCCCCCCCHHHCCEECCCCC--EEEECCCCCEECCCCCCC-CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHH
T ss_conf 769504762120311679987--586025522233544453-22365105864467088746999835654407999999
Q ss_pred HHHCCCCCCCCCHHH-HHHHHHH-CCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCC
Q ss_conf 993899999983566-7889741-13332236995799999800599999996988897297
Q 002601 704 CITGGKHPYGESFER-DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHP 763 (902)
Q Consensus 704 lltG~~~Pf~~~~~~-~~~i~~~-~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HP 763 (902)
|+|++.+||...... ....+.. .....+...++++.+++.+||+.||.+|||+.+++.|.
T Consensus 206 l~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 206 LMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 99779999999998999999975998999855689999999984789934691999999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=345.44 Aligned_cols=270 Identities=21% Similarity=0.272 Sum_probs=202.5
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE------CCCEEEEEEECCCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCCE
Q ss_conf 22999466440396599999853------8949999993158706----9999999999918999755741434686512
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrL~~~~~~----~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~l 542 (902)
+.|.+.+.||+|+||+||+|... +++.||||++...... ...+|+. +++.++||||++++++|.+.+..
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA-LMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHH-HHHHCCCCCCCCCEEEECCCCCE
T ss_conf 89388679820788399999988876577882999999882108579999999999-99966899765524666059803
Q ss_pred EEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 65521346881247988359856774331025611488976402343430247777517999899999999620123421
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
++++| |+.+|+|.+++............+. ...............+++..++.|+.|++.||+||
T Consensus 92 ~~v~e----------~~~~g~L~~~l~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yl 156 (301)
T d1lufa_ 92 CLLFE----------YMAYGDLNEFLRSMSPHTVCSLSHS-----DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL 156 (301)
T ss_dssp EEEEE----------CCTTCBHHHHHHHTCC---------------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------ECCCCCHHHHHHHCCCCCCCCCCCC-----CCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHC
T ss_conf 89998----------1589929999985275542100001-----11001210346788989999999999999985541
Q ss_pred CCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 10362134445611685369992388814786201248776553464588986545701100299998521465679999
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 Hs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ 702 (902)
|+.+|+||||||+|||++.++. +||+|||+|+....... .....+..|++.|+|||++....++.++|||||||++|
T Consensus 157 H~~~ivHrDlKp~NILld~~~~--~Kl~DFGls~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ 233 (301)
T d1lufa_ 157 SERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADY-YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233 (301)
T ss_dssp HHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGC-BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred CCCCEEEEEECCCCEEECCCCC--EEECCCHHHEECCCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHH
T ss_conf 3578685488401168989992--89833144211367764-11157777676767989972688980563025236299
Q ss_pred HHHHCCCCCCCCCHHHH-H-HHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHC
Q ss_conf 99938999999835667-8-89741133322369957999998005999999969888972
Q 002601 703 FCITGGKHPYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-~-~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~ 761 (902)
||++|+.+||....... . .+........+...++++.+++.+||+.||.+|||+.++++
T Consensus 234 ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 234 EIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9980689999998999999999739978887325299999999974889657939999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.60 Aligned_cols=243 Identities=27% Similarity=0.393 Sum_probs=199.0
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHH-HHHHHHHHHHHCCCCCEEEECCCCCC-CCCEEEEECCCC
Q ss_conf 2299946644039659999985389499999931587069-99999999991899975574143468-651265521346
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDV-ALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLSLERCT 550 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrL~~~~~~~-~~~Ei~~ll~~l~HpNIVrL~g~~~d-~~~lyLV~E~c~ 550 (902)
++|.+.+.||+|+||.||++.. .|..||||++++..... ..+|+ .+++.++|||||+++|+|.+ .+.+|+|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~~~~~~~E~-~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e--- 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQAFLAEA-SVMTQLRHSNLVQLLGVIVEEKGGLYIVTE--- 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC--HHHHHTH-HHHTTCCCTTBCCEEEEECCC--CCEEEEC---
T ss_pred HHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEEECCCCEEEEEE---
T ss_conf 9948857982079808999999-99099999988577799999999-999867898985498788723892899996---
Q ss_pred CCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 88124798835985677433102561148897640234343024777751799989999999962012342110362134
Q 002601 551 CSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLIHR 630 (902)
Q Consensus 551 ~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~IiHr 630 (902)
|+++|+|.++++... ...+++..+++|+.|++.||+|||+.+|+||
T Consensus 82 -------y~~~g~L~~~l~~~~---------------------------~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~ 127 (262)
T d1byga_ 82 -------YMAKGSLVDYLRSRG---------------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 127 (262)
T ss_dssp -------CCTTEEHHHHHHHHH---------------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -------CCCCCCHHHHHHHCC---------------------------CCCCCHHHHHHHHHHHHHHCCCCCCCCEECC
T ss_conf -------369998999987457---------------------------8888999999999999852321133765536
Q ss_pred CCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 44561168536999238881478620124877655346458898654570110029999852146567999999938999
Q 002601 631 DLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFCITGGKH 710 (902)
Q Consensus 631 DLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~elltG~~~ 710 (902)
||||+|||++.++. +|++|||+++..... .....++..|+|||++.++.++.++|||||||++|||+|++.+
T Consensus 128 dlkp~Nil~~~~~~--~kl~dfg~s~~~~~~------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~ 199 (262)
T d1byga_ 128 DLAARNVLVSEDNV--AKVSDFGLTKEASST------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 199 (262)
T ss_dssp CCSGGGEEECTTSC--EEECCCCC------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCHHHHEECCCCC--EEECCCCCCEECCCC------CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCC
T ss_conf 66567601468997--763245600344787------7655666467781787279888588777579999999978999
Q ss_pred CCCCCHHHH-H-HHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 999835667-8-897411333223699579999980059999999698889729
Q 002601 711 PYGESFERD-A-NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 711 Pf~~~~~~~-~-~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
||......+ . .+........+...++++.++|.+||+.||.+|||+.+++++
T Consensus 200 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 200 PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp SCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 999999999999998089999976579999999999756697689399999999
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=341.13 Aligned_cols=248 Identities=25% Similarity=0.418 Sum_probs=197.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEEECCCEEEEEEECCCC-----CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEC
Q ss_conf 2299946644039659999985389499999931587-----06999999999991899975574143468651265521
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH-----HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLE 547 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrL~~~~-----~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E 547 (902)
++|...++||+|+||+||+|...+|+.||||++.... .....+|+. +++.++|||||++++++.+.+..|+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREIS-ILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHH-GGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf 996343187227781899999689999999998123268589999999999-9986799868766012046773158997
Q ss_pred CCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 34688124798835985677433102561148897640234343024777751799989999999962012342110362
Q 002601 548 RCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGL 627 (902)
Q Consensus 548 ~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~I 627 (902)
+|.+++...+.. ..+.+++..+..++.|++.||+|||+.+|
T Consensus 81 ~~~~~~~~~~~~---------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~I 121 (286)
T d1ob3a_ 81 HLDQDLKKLLDV---------------------------------------CEGGLESVTAKSFLLQLLNGIAYCHDRRV 121 (286)
T ss_dssp CCSEEHHHHHHT---------------------------------------STTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEHHHHHHHHHH---------------------------------------HCCCCCHHHHHHHHHHHHHHHHHHCCCCE
T ss_conf 400456789986---------------------------------------04775144568999999999998605748
Q ss_pred CCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCC-CCCCCCHHHHHHHHHHHHHH
Q ss_conf 13444561168536999238881478620124877655346458898654570110029-99985214656799999993
Q 002601 628 IHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG-RQTRAIDLFSLGCILFFCIT 706 (902)
Q Consensus 628 iHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~t~ksDVwSlGvIL~ellt 706 (902)
+||||||+|||++.++. +|++|||.|....... .......|++.|+|||.+... .++.++||||+||++|||++
T Consensus 122 vHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~---~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~ 196 (286)
T d1ob3a_ 122 LHRDLKPQNLLINREGE--LKIADFGLARAFGIPV---RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196 (286)
T ss_dssp CCSCCCGGGEEECTTSC--EEECCTTHHHHHCC------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred EECCCCCCEEEECCCCC--EEECCCCCCEECCCCC---CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHH
T ss_conf 82678775056868997--8732366430114676---541010243110137887178888841002111758999977
Q ss_pred CCCCCCCCCHHHHH--HHHHHC----------------------------CCCCCCCCCHHHHHHHHCCCCCCCCCCCCH
Q ss_conf 89999998356678--897411----------------------------333223699579999980059999999698
Q 002601 707 GGKHPYGESFERDA--NIVKDR----------------------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPKA 756 (902)
Q Consensus 707 G~~~Pf~~~~~~~~--~i~~~~----------------------------~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~ 756 (902)
| .+||.+....+. ++.... ........++++.|||.+||+.||++|||+
T Consensus 197 G-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~ 275 (286)
T d1ob3a_ 197 G-TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275 (286)
T ss_dssp S-SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred C-CCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 9-799898898999999998638997110421233322143333356764666512589999999999866896689099
Q ss_pred HHHHCCCCCC
Q ss_conf 8897297777
Q 002601 757 QNVLNHPFFW 766 (902)
Q Consensus 757 ~elL~HPfF~ 766 (902)
+|+++||||.
T Consensus 276 ~ell~Hp~f~ 285 (286)
T d1ob3a_ 276 KQALEHAYFK 285 (286)
T ss_dssp HHHHTSGGGG
T ss_pred HHHHCCCCCC
T ss_conf 9985692207
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.00 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=199.7
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE-CCC--EEEEEEECCCC----CHHHHHHHHHHHHHC-CCCCEEEECCCCCCCCCEEE
Q ss_conf 22999466440396599999853-894--99999931587----069999999999918-99975574143468651265
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY-EGR--SVAVKRLVKTH----HDVALKEIQNLIASD-QHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~-~g~--~VAVKrL~~~~----~~~~~~Ei~~ll~~l-~HpNIVrL~g~~~d~~~lyL 544 (902)
+.|.+.+.||+|+||+||+|... +|. .||||++.... .+...+|+. ++..+ +|||||+++|++.+++.+|+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~-~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE-VLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHH-HHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHH-HHHHCCCCCCEEEEEEEEECCCEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999-99862289988367888841873699
Q ss_pred EECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 52134688124798835985677433102561148897640234343024777751799989999999962012342110
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs 624 (902)
||| |+++|+|.++++.......... ..........+++..+.+++.||+.||.|||+
T Consensus 89 V~e----------y~~~g~L~~~l~~~~~~~~~~~-------------~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~ 145 (309)
T d1fvra_ 89 AIE----------YAPHGNLLDFLRKSRVLETDPA-------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQ 145 (309)
T ss_dssp EEC----------CCTTCBHHHHHHTTCHHHHCHH-------------HHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEE----------ECCCCCHHHHHHHCCCCCCCHH-------------HHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC
T ss_conf 998----------0289869999864035555512-------------31012345789999999999999999876630
Q ss_pred CCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 36213444561168536999238881478620124877655346458898654570110029999852146567999999
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~el 704 (902)
.+|+||||||+|||++.++. +||+|||+|+...... ......||..|+|||.+..+.++.++|||||||++|||
T Consensus 146 ~~iiHrDlkp~NIL~~~~~~--~kl~DfG~a~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~el 219 (309)
T d1fvra_ 146 KQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVYV----KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219 (309)
T ss_dssp TTEECSCCSGGGEEECGGGC--EEECCTTCEESSCEEC----CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCEEEECCCCC--EEECCCCCCCCCCCCC----CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHH
T ss_conf 89545550520489868876--3874344322444223----45530137755553875269999622153138899999
Q ss_pred HHCCCCCCCCCHHHH-HHH-HHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 938999999835667-889-7411333223699579999980059999999698889729
Q 002601 705 ITGGKHPYGESFERD-ANI-VKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~-~~i-~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
++|+.+||....... ... ........+...++++.+||.+||+.||++|||++++++|
T Consensus 220 l~~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 220 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HTTSCCTTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 836899999999999999998268888876678999999999767896689499999999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.56 Aligned_cols=263 Identities=22% Similarity=0.337 Sum_probs=202.7
Q ss_pred CEEEEEEEECCCCCEEEEEEEEEC--------CCEEEEEEECCCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCC
Q ss_conf 229994664403965999998538--------949999993158706----99999999999189997557414346865
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQD 540 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~--------g~~VAVKrL~~~~~~----~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~ 540 (902)
+.|.+.+.||+|+||.||++.... +..||||++.+.... ...+|+..+....+|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286889999999999998139996973465220188
Q ss_pred CEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCC
Q ss_conf 12655213468812479883598567743310256114889764023434302477775179998999999996201234
Q 002601 541 FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLS 620 (902)
Q Consensus 541 ~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~ 620 (902)
..++||| |+.+|+|.+++.......... ...........+++..+++++.|++.||+
T Consensus 93 ~~~~v~e----------~~~~g~l~~~i~~~~~~~~~~-------------~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 149 (299)
T d1fgka_ 93 PLYVIVE----------YASKGNLREYLQARRPPGLEY-------------SYNPSHNPEEQLSSKDLVSCAYQVARGME 149 (299)
T ss_dssp SCEEEEC----------CCTTCBHHHHHHTTSCC-------------------------CCCCCHHHHHHHHHHHHHHHH
T ss_pred EEEEEEE----------CCCCCCHHHHHHHHCCCCCCC-------------CCCCCCCCCCCCCHHHHHHHHHHHHHHHH
T ss_conf 6899997----------369990999998606776432-------------22334574346799999999999999998
Q ss_pred CCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHH
Q ss_conf 21103621344456116853699923888147862012487765534645889865457011002999985214656799
Q 002601 621 HLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (902)
Q Consensus 621 yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvI 700 (902)
|||+.+|+||||||+|||++.++. +||+|||+++........ .......|++.|+|||++.++.++.++|||||||+
T Consensus 150 ylH~~~ivHrDiKp~NiLl~~~~~--~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvv 226 (299)
T d1fgka_ 150 YLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226 (299)
T ss_dssp HHHHTTCCCSCCSGGGEEECTTCC--EEECSTTCCCCGGGCCTT-CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHCCEEEEEECCCCEEECCCCC--EEECCCHHHCCCCCCCCC-CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHH
T ss_conf 766379786302210224547897--676221110113555554-31466788846632667517988825554775888
Q ss_pred HHHHHHCCCCCCCCCHHHHH-HHH-HHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHC
Q ss_conf 99999389999998356678-897-41133322369957999998005999999969888972
Q 002601 701 LFFCITGGKHPYGESFERDA-NIV-KDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~~~~-~i~-~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~ 761 (902)
+|||++++.+||.+...... ..+ .......+...++++.+||.+||+.||.+|||+.++++
T Consensus 227 l~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 227 LWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 887401798989999999999999728888987435299999999976679767939999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.21 Aligned_cols=246 Identities=23% Similarity=0.356 Sum_probs=195.3
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE----CCCEEEEEEECCCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEE
Q ss_conf 22999466440396599999853----8949999993158706----999999999991899975574143468651265
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY----EGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~----~g~~VAVKrL~~~~~~----~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyL 544 (902)
+.|.+.+.||+|+||+||+|... .+..||||++.....+ ...+|+ .++..++|||||+++|++.+ +..|+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~l~~~~~~-~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA-LTMRQFDHPHIVKLIGVITE-NPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHH-HHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEEC-CEEEE
T ss_conf 99698779930788299999993699644999999936566879999999999-99986899998569889953-74799
Q ss_pred EECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCC
Q ss_conf 52134688124798835985677433102561148897640234343024777751799989999999962012342110
Q 002601 545 SLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE 624 (902)
Q Consensus 545 V~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs 624 (902)
|||+| .+|++..++.. ....+++..++.++.||+.||+|||+
T Consensus 85 v~E~~----------~~g~l~~~~~~----------------------------~~~~l~~~~~~~~~~qi~~gl~ylH~ 126 (273)
T d1mp8a_ 85 IMELC----------TLGELRSFLQV----------------------------RKYSLDLASLILYAYQLSTALAYLES 126 (273)
T ss_dssp EEECC----------TTEEHHHHHHH----------------------------TTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEC----------CCCCHHHHHHC----------------------------CCCCCCHHHHHHHHHHHHHHHHHHCC
T ss_conf 99840----------69807765422----------------------------47899999999999999877523022
Q ss_pred CCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 36213444561168536999238881478620124877655346458898654570110029999852146567999999
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~el 704 (902)
.+|+||||||+|||++.++. +||+|||+|+....... .......||+.|+|||++....++.++|||||||++|||
T Consensus 127 ~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~--~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~ 202 (273)
T d1mp8a_ 127 KRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEI 202 (273)
T ss_dssp TTCCCSCCSGGGEEEEETTE--EEECC---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHH
T ss_pred CCEECCCCCHHHEEECCCCC--EEECCCHHHEECCCCCC--EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHH
T ss_conf 67441410265532067896--78765034213367762--330540058310326675169988745244424789999
Q ss_pred HHCCCCCCCCCHHHHH--HHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 9389999998356678--897411333223699579999980059999999698889729
Q 002601 705 ITGGKHPYGESFERDA--NIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~~--~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
++++.+||........ .+........+...++++.+||.+||+.||.+|||+.++++|
T Consensus 203 lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 203 LMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 826999988899999999998189998987779999999999768797689299999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.96 Aligned_cols=247 Identities=20% Similarity=0.321 Sum_probs=193.0
Q ss_pred EEEEEEECCCCCEEEEEEEEEC----CCEEEEEEECCCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCC-CCCEEEE
Q ss_conf 9994664403965999998538----949999993158706----999999999991899975574143468-6512655
Q 002601 475 VVFNKEIAKGSNGTVVLEGNYE----GRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESD-QDFVYLS 545 (902)
Q Consensus 475 ~~~~~~LG~GsfGtVy~a~~~~----g~~VAVKrL~~~~~~----~~~~Ei~~ll~~l~HpNIVrL~g~~~d-~~~lyLV 545 (902)
+.++++||+|+||+||+|...+ ...||||++.+.... ...+|+ .++..++|||||+++|++.+ ++..++|
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~-~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG-IIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHH-HHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 526669813688099999997799879999999988436978999999999-9998678999867867898069943899
Q ss_pred ECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 21346881247988359856774331025611488976402343430247777517999899999999620123421103
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~ 625 (902)
|| |+.+|+|.++++... ...++..+++++.|++.||.|||+.
T Consensus 108 ~E----------~~~~g~l~~~~~~~~----------------------------~~~~~~~~~~i~~qia~gL~~lH~~ 149 (311)
T d1r0pa_ 108 LP----------YMKHGDLRNFIRNET----------------------------HNPTVKDLIGFGLQVAKGMKFLASK 149 (311)
T ss_dssp EE----------CCTTCBHHHHHHCTT----------------------------CCCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred EE----------EEECCCHHHHHCCCC----------------------------CCCHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 98----------740674144210134----------------------------5404899999999988765200336
Q ss_pred CCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 6213444561168536999238881478620124877655-346458898654570110029999852146567999999
Q 002601 626 GLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILFFC 704 (902)
Q Consensus 626 ~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~el 704 (902)
+|+||||||+|||++.++. +||+|||+++......... .......||+.|+|||++..+.++.++||||||+++|||
T Consensus 150 ~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El 227 (311)
T d1r0pa_ 150 KFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227 (311)
T ss_dssp TCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHEEECCCCC--EEEECCCCHHHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHH
T ss_conf 7625776687576779998--89910652322556655531002565556455676887437999745746619999999
Q ss_pred HHCCCCCCCCCHHHH--HHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 938999999835667--8897411333223699579999980059999999698889729
Q 002601 705 ITGGKHPYGESFERD--ANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 705 ltG~~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
++|+.+|+......+ ..+........+...++++.+++.+||+.||++||++.|+++|
T Consensus 228 ~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 228 MTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 978999988899999999998089889964475999999999768897689399999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.85 Aligned_cols=257 Identities=19% Similarity=0.288 Sum_probs=201.5
Q ss_pred CEEEEEEEECCCCCEEEEEEEEE------CCCEEEEEEECCCCCHH----HHHHHHHHHHHCCCCCEEEECCCCCCCCCE
Q ss_conf 22999466440396599999853------89499999931587069----999999999918999755741434686512
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNY------EGRSVAVKRLVKTHHDV----ALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~------~g~~VAVKrL~~~~~~~----~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~l 542 (902)
+.|.+.+.||+|+||+||+|... ++..||||++.+..... ..+|+. ++..++|||||+++|+|.+.+..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS-VMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHH-HGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEECCCCE
T ss_conf 99188359820788189999987864477896899999870128689999999999-99976999884125478428810
Q ss_pred EEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 65521346881247988359856774331025611488976402343430247777517999899999999620123421
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
++||| |+.+|+|.++++....... ..-....+++..+.+++.|+++||.||
T Consensus 99 ~lv~e----------~~~~g~l~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~ia~gl~~L 149 (308)
T d1p4oa_ 99 LVIME----------LMTRGDLKSYLRSLRPAMA-------------------NNPVLAPPSLSKMIQMAGEIADGMAYL 149 (308)
T ss_dssp EEEEE----------CCTTCBHHHHHHHHHHHHH-------------------HCTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEE----------ECCCCCHHHHHHHCCCCCC-------------------CCCCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 67776----------0489988999875033211-------------------344468879999999999999999987
Q ss_pred CCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 10362134445611685369992388814786201248776553464588986545701100299998521465679999
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 Hs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ 702 (902)
|+++|+||||||+|||++.++. +||+|||+|+.+...... .......||+.|+|||.+.++.++.++|||||||++|
T Consensus 150 H~~~ivHrDlk~~NiLld~~~~--~Kl~DFGla~~~~~~~~~-~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 150 NANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp HHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHCCEEECEECCCCEEECCCCE--EEEEECCCCEECCCCCCE-EECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHH
T ss_conf 6479654328677540359964--999424542023577630-3134023163237888873699883334443789999
Q ss_pred HHHHCCCCCCCCCHHHH-HH-HHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCC
Q ss_conf 99938999999835667-88-97411333223699579999980059999999698889729
Q 002601 703 FCITGGKHPYGESFERD-AN-IVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNH 762 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-~~-i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~H 762 (902)
||+||+.+||....... .. +........+...++++.+++.+||+.||.+|||+.+++++
T Consensus 227 El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 99968999999989999999998088888863353999999999757796589399999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.13 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=192.6
Q ss_pred CCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCC------
Q ss_conf 15229994664403965999998-53894999999315870-----6999999999991899975574143468------
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESD------ 538 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~-----~~~~~Ei~~ll~~l~HpNIVrL~g~~~d------ 538 (902)
+-+.|...++||+|+||+||+|. ..+|+.||||++.+... ....+|+. +++.++|||||++++++..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~-il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEECCCCCCC
T ss_conf 337759988962175859999999999989999998823369799999999999-9986489876489989702564345
Q ss_pred CCCEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCC
Q ss_conf 65126552134688124798835985677433102561148897640234343024777751799989999999962012
Q 002601 539 QDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 539 ~~~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
.+..|+|||||.+++.+.+ ...+++..++.++.|++.|
T Consensus 94 ~~~~~iv~Ey~~~~l~~~~------------------------------------------~~~~~~~~i~~~~~qil~g 131 (355)
T d2b1pa1 94 FQDVYLVMELMDANLCQVI------------------------------------------QMELDHERMSYLLYQMLCG 131 (355)
T ss_dssp CCEEEEEEECCSEEHHHHH------------------------------------------TSCCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEECCCHHHHHHH------------------------------------------HCCCCHHHHHHHHHHHHHH
T ss_conf 7626999841446778765------------------------------------------0389999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHH
Q ss_conf 34211036213444561168536999238881478620124877655346458898654570110029999852146567
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLG 698 (902)
Q Consensus 619 L~yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlG 698 (902)
|+|||+.||+||||||+|||++.++. +|++|||+++..... .......||+.|+|||++.+..++.++||||+|
T Consensus 132 l~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~----~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG 205 (355)
T d2b1pa1 132 IKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205 (355)
T ss_dssp HHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-------------------CCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCC--EEEECHHHHHCCCCC----CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
T ss_conf 98865221124567763211365443--132010232114666----553322146555581331477778774333566
Q ss_pred HHHHHHHHCCCCCCCCCHHHH-H-HHHH----------------------HCCC-------------------CCCCCCC
Q ss_conf 999999938999999835667-8-8974----------------------1133-------------------3223699
Q 002601 699 CILFFCITGGKHPYGESFERD-A-NIVK----------------------DRKD-------------------LFLVEHI 735 (902)
Q Consensus 699 vIL~elltG~~~Pf~~~~~~~-~-~i~~----------------------~~~~-------------------~~~~~~~ 735 (902)
|++|+|++| .+||....... . .+.. .... ......+
T Consensus 206 ~~l~ell~g-~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 284 (355)
T d2b1pa1 206 CIMGEMVRH-KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284 (355)
T ss_dssp HHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHH
T ss_pred CHHHHHHHC-CCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 257898659-8998889778899999972058987999876566777764175435666421264333543210133379
Q ss_pred HHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 579999980059999999698889729777783
Q 002601 736 PEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 736 ~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
+++.+||.+||+.||++|||++|+|+||||...
T Consensus 285 ~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 285 SQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 999999999876994579089999669420878
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.47 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=200.8
Q ss_pred CEEEEEEEECCCCCEEEEEEEE------ECCCEEEEEEECCCCCH----HHHHHHHHHHHHCCCCCEEEECCCCCCCCCE
Q ss_conf 2299946644039659999985------38949999993158706----9999999999918999755741434686512
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN------YEGRSVAVKRLVKTHHD----VALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~------~~g~~VAVKrL~~~~~~----~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~l 542 (902)
+.|.+++.||+|+||.||+|.. .+++.||||++...... ...+|+..+....+|||||+++|+|.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 99698549820688299999980664477886999999874248779999999999987626999887899898319978
Q ss_pred EEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 65521346881247988359856774331025611488976402343430247777517999899999999620123421
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
|+||||| ++|+|.++++.......... ............+++..+.+++.||+.||+||
T Consensus 103 ~lvmE~~----------~~g~l~~~l~~~~~~~~~~~-----------~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~L 161 (311)
T d1t46a_ 103 LVITEYC----------CYGDLLNFLRRKRDSFICSK-----------TSPAIMEDDELALDLEDLLSFSYQVAKGMAFL 161 (311)
T ss_dssp EEEEECC----------TTEEHHHHHHHTTTTC-------------------------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred EEEEECC----------CCCCHHHHHHHCCCCCCCCC-----------CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 9999737----------99879999985356654444-----------45332223345889999999999999999988
Q ss_pred CCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 10362134445611685369992388814786201248776553464588986545701100299998521465679999
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 Hs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ 702 (902)
|+++|+||||||+|||++.++. +|++|||+++........ .......||+.|+|||++..+.++.++|||||||++|
T Consensus 162 H~~~ivHrDLKp~NIl~~~~~~--~ki~DfG~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ 238 (311)
T d1t46a_ 162 ASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238 (311)
T ss_dssp HHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HHCCEEECCCCCCCCCCCCCCC--CCCCCCCHHEECCCCCCC-EEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHH
T ss_conf 7579266624102100002575--210234010233678861-5862013596876778861799997400102589999
Q ss_pred HHHHCCCCCCCCCHHH--HHHHHHH-CCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHC
Q ss_conf 9993899999983566--7889741-133322369957999998005999999969888972
Q 002601 703 FCITGGKHPYGESFER--DANIVKD-RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 703 elltG~~~Pf~~~~~~--~~~i~~~-~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~ 761 (902)
||+|++.+|+...... ...++.. .....+...++++.+||.+||+.||.+|||++++++
T Consensus 239 ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99858998877899899999998668988985436599999999975779657929999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=338.06 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=196.5
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCC------HHHHHHHHHHHHHCCCCCEEEECCCCCCCC-
Q ss_conf 2015229994664403965999998-53894999999315870------699999999999189997557414346865-
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH------DVALKEIQNLIASDQHPNIVRWYGVESDQD- 540 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~------~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~- 540 (902)
..+.++|.+.+.||+|+||+||+|. ..+|+.||||++.+... ....+|+. ++..++|||||++++++.+.+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~-~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ-NAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHH-HHHTCCCTTBCCEEEEEEEECS
T ss_pred CCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHH-HHHHCCCCCCCCCCCEEEECCC
T ss_conf 570620698689960899299999999999899999985566469899999999999-9985699988731143543268
Q ss_pred ---CEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHC
Q ss_conf ---12655213468812479883598567743310256114889764023434302477775179998999999996201
Q 002601 541 ---FVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (902)
Q Consensus 541 ---~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~ 617 (902)
..|+|||||. +|+|..++. ..+.+++..++.|+.|++.
T Consensus 82 ~~~~~~lvmE~~~----------g~~L~~~~~-----------------------------~~~~l~~~~~~~i~~qi~~ 122 (277)
T d1o6ya_ 82 AGPLPYIVMEYVD----------GVTLRDIVH-----------------------------TEGPMTPKRAIEVIADACQ 122 (277)
T ss_dssp SSEEEEEEEECCC----------EEEHHHHHH-----------------------------HHCSCCHHHHHHHHHHHHH
T ss_pred CCCEEEEEEECCC----------CCEEHHHHC-----------------------------CCCCCCHHHHHHHHHHHHH
T ss_conf 8766999997788----------987101120-----------------------------3589999999999999999
Q ss_pred CCCCCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHH
Q ss_conf 23421103621344456116853699923888147862012487765534645889865457011002999985214656
Q 002601 618 GLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSL 697 (902)
Q Consensus 618 gL~yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSl 697 (902)
||+|||+.+|+||||||+|||++.++. .+++|||.+................+||+.|+|||++.+..++.++||||+
T Consensus 123 al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSl 200 (277)
T d1o6ya_ 123 ALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSL 200 (277)
T ss_dssp HHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCCCCCCCCCCCCC--CEEEHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCC
T ss_conf 999998579527634675566575432--010034443221235443333464257624369999839999966320265
Q ss_pred HHHHHHHHHCCCCCCCCCHHHHH--HHHHHCCC---CCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCC
Q ss_conf 79999999389999998356678--89741133---3223699579999980059999999698889729777
Q 002601 698 GCILFFCITGGKHPYGESFERDA--NIVKDRKD---LFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFF 765 (902)
Q Consensus 698 GvIL~elltG~~~Pf~~~~~~~~--~i~~~~~~---~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF 765 (902)
||++|||+|| .+||........ .++..... ......++++.++|.+||++||.+||+..+.+.|+|.
T Consensus 201 GvilyelltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 201 GCVLYEVLTG-EPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHHHHS-SCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHH
T ss_conf 2899999769-79989969999999998469999710034789999999999866797677739999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.21 Aligned_cols=253 Identities=26% Similarity=0.374 Sum_probs=197.6
Q ss_pred CEEEEEEEECCCCCEEEEEEEE----ECCCEEEEEEECCCC-------CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCC
Q ss_conf 2299946644039659999985----389499999931587-------06999999999991899975574143468651
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN----YEGRSVAVKRLVKTH-------HDVALKEIQNLIASDQHPNIVRWYGVESDQDF 541 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~----~~g~~VAVKrL~~~~-------~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~ 541 (902)
++|.+.+.||+|+||+||++.. .+|+.||||++.+.. .+...+|+..+.....||||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 26552134688124798835985677433102561148897640234343024777751799989999999962012342
Q 002601 542 VYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 542 lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
.|+++| |+.+|+|.+++.. ...+++..+..++.|++.||+|
T Consensus 104 ~~~v~e----------~~~~~~L~~~i~~-----------------------------~~~~~e~~~~~~~~Qi~~al~~ 144 (322)
T d1vzoa_ 104 LHLILD----------YINGGELFTHLSQ-----------------------------RERFTEHEVQIYVGEIVLALEH 144 (322)
T ss_dssp EEEEEC----------CCCSCBHHHHHHH-----------------------------HSCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEEEE----------CCCCCHHHHHHHH-----------------------------CCCCCHHHHHHHHHHHHHHHHH
T ss_conf 001231----------2341179999873-----------------------------0454378888889999999988
Q ss_pred CCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCC--CCCCCCHHHHHHH
Q ss_conf 11036213444561168536999238881478620124877655346458898654570110029--9998521465679
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQG--RQTRAIDLFSLGC 699 (902)
Q Consensus 622 LHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~t~ksDVwSlGv 699 (902)
||+.+|+||||||+|||++.++. +||+|||+|+....... ....+..|++.|+|||.+... .++.++||||+||
T Consensus 145 lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~~~~--~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~ 220 (322)
T d1vzoa_ 145 LHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGV 220 (322)
T ss_dssp HHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHH
T ss_pred HHCCCEEECCCCCCCEEECCCCC--EEEEECCCHHHHCCCCC--CCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHH
T ss_conf 51499896547732012469998--88741320222034444--322122233333106876057768871325177779
Q ss_pred HHHHHHHCCCCCCCCCHHH-----HHHHHHHCCCCCCCCCCHHHHHHHHCCCCCCCCCCC-----CHHHHHCCCCCCCCC
Q ss_conf 9999993899999983566-----788974113332236995799999800599999996-----988897297777830
Q 002601 700 ILFFCITGGKHPYGESFER-----DANIVKDRKDLFLVEHIPEAVDLFTRLLDPNPDLRP-----KAQNVLNHPFFWTAD 769 (902)
Q Consensus 700 IL~elltG~~~Pf~~~~~~-----~~~i~~~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rp-----t~~elL~HPfF~~~~ 769 (902)
++|+|++| .+||...... ............+...++++.+++.+||++||.+|| +++|+++||||...+
T Consensus 221 iLyelltG-~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 221 LMYELLTG-ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp HHHHHHHS-SCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred HHHHHHHC-CCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCC
T ss_conf 99999768-99988887777999999833568998865479999999999744589881999745099997497234899
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.06 Aligned_cols=250 Identities=25% Similarity=0.335 Sum_probs=193.2
Q ss_pred CEEEEEEEECCCCCEEEEEEEE-ECCCEEEEEEECCCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
Q ss_conf 2299946644039659999985-3894999999315870-----699999999999189997557414346865126552
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGN-YEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSL 546 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~-~~g~~VAVKrL~~~~~-----~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~ 546 (902)
++|...++||+|+||+||+|.. .+|+.||||+++.... ....+|+. +++.++|||||++++++.+.+..++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREIC-LLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHH-HHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHH-HHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 9978626971286819999999999969999998032178689999999999-998567578882135444443115886
Q ss_pred CCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 13468812479883598567743310256114889764023434302477775179998999999996201234211036
Q 002601 547 ERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIG 626 (902)
Q Consensus 547 E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~ 626 (902)
|+|.+... ..++. ..+.+++..+..++.|++.||+|||+++
T Consensus 81 ~~~~~~~l----------~~~~~-----------------------------~~~~~~~~~~~~~~~q~~~aL~~lH~~~ 121 (292)
T d1unla_ 81 EFCDQDLK----------KYFDS-----------------------------CNGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp ECCSEEHH----------HHHHH-----------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EECCCCCC----------CCCCC-----------------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 30233222----------11212-----------------------------3565403678999999999987743399
Q ss_pred CCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCC-CCCCCHHHHHHHHHHHHH
Q ss_conf 2134445611685369992388814786201248776553464588986545701100299-998521465679999999
Q 002601 627 LIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSLGCILFFCI 705 (902)
Q Consensus 627 IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDVwSlGvIL~ell 705 (902)
|+||||||+|||++.++. +||+|||.|+....... ......+++.|+|||++.... ++.++||||+||++|||+
T Consensus 122 IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell 196 (292)
T d1unla_ 122 VLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVR---CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196 (292)
T ss_dssp EECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCS---CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHT
T ss_pred EEEECCCCCCCCCCCCCC--EEEEECCHHHCCCCCCC---CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHH
T ss_conf 860014676121133782--66520460110468875---1001034431014667506988880444026541889985
Q ss_pred HCCCCCCCCCHHHH-HHHHHHC-----------------------------CCCCCCCCCHHHHHHHHCCCCCCCCCCCC
Q ss_conf 38999999835667-8897411-----------------------------33322369957999998005999999969
Q 002601 706 TGGKHPYGESFERD-ANIVKDR-----------------------------KDLFLVEHIPEAVDLFTRLLDPNPDLRPK 755 (902)
Q Consensus 706 tG~~~Pf~~~~~~~-~~i~~~~-----------------------------~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt 755 (902)
+|+.++|......+ ...+... ........++++.+|+.+||+.||.+|||
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s 276 (292)
T d1unla_ 197 NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276 (292)
T ss_dssp TTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred HCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 18999988999999999998611899735513443222113344454431043306568999999999986499668909
Q ss_pred HHHHHCCCCCCC
Q ss_conf 888972977778
Q 002601 756 AQNVLNHPFFWT 767 (902)
Q Consensus 756 ~~elL~HPfF~~ 767 (902)
++|+|+||||..
T Consensus 277 a~e~L~Hp~f~~ 288 (292)
T d1unla_ 277 AEEALQHPYFSD 288 (292)
T ss_dssp HHHHTTSGGGSS
T ss_pred HHHHHCCHHHCC
T ss_conf 999964953407
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.54 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=187.5
Q ss_pred CCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCC-----HHHHHHHHHHHHHCCCCCEEEECCCCCCC-----
Q ss_conf 15229994664403965999998-53894999999315870-----69999999999918999755741434686-----
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-----DVALKEIQNLIASDQHPNIVRWYGVESDQ----- 539 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~-----~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~----- 539 (902)
+.++|...+.||+|+||+||+|. ..+|+.||||++.+... ....+|+. ++..++|||||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~-il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR-LLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHH-HHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHH-HHHHCCCCCEEEEEEEEEECCCCCC
T ss_conf 898718888983178839999999999979999998820028689999999999-9986689874259999963464566
Q ss_pred -CCEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCC
Q ss_conf -5126552134688124798835985677433102561148897640234343024777751799989999999962012
Q 002601 540 -DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSG 618 (902)
Q Consensus 540 -~~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~g 618 (902)
...|++++++.++|. +++. .+++++..++.++.||+.|
T Consensus 95 ~~~~~i~~~~~gg~L~-----------~~~~------------------------------~~~l~e~~~~~i~~qil~a 133 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLN-----------NIVK------------------------------CQKLTDDHVQFLIYQILRG 133 (348)
T ss_dssp CCCCEEEEECCSEEHH-----------HHHT------------------------------TCCCCHHHHHHHHHHHHHH
T ss_pred CCEEEEEEEECCCCHH-----------HHCC------------------------------CCCCCHHHHHHHHHHHHHH
T ss_conf 8649999962588623-----------2002------------------------------2453099999999999999
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCC-CCCCCHHHHH
Q ss_conf 342110362134445611685369992388814786201248776553464588986545701100299-9985214656
Q 002601 619 LSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGR-QTRAIDLFSL 697 (902)
Q Consensus 619 L~yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~t~ksDVwSl 697 (902)
|+|||+++|+||||||+|||++.++. +|++|||+|..... ...+..|++.|+|||+..... ++.++||||+
T Consensus 134 L~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~~------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSl 205 (348)
T d2gfsa1 134 LKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDD------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 205 (348)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCTG------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHH
T ss_pred HHHHHHCCCCCCCCCCCCCCCCCCCC--CCCCCCCHHCCCCC------CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHH
T ss_conf 99997388765166776334554322--00132100012575------44443454355583553377567855124320
Q ss_pred HHHHHHHHHCCCCCCCCCHHHH-HH-HHHHCCC------------------------------CCCCCCCHHHHHHHHCC
Q ss_conf 7999999938999999835667-88-9741133------------------------------32236995799999800
Q 002601 698 GCILFFCITGGKHPYGESFERD-AN-IVKDRKD------------------------------LFLVEHIPEAVDLFTRL 745 (902)
Q Consensus 698 GvIL~elltG~~~Pf~~~~~~~-~~-i~~~~~~------------------------------~~~~~~~~e~~dLI~~l 745 (902)
||++|+|++| .+||....... .. +...... ......++++.|||.+|
T Consensus 206 Gv~l~~ll~g-~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m 284 (348)
T d2gfsa1 206 GCIMAELLTG-RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 284 (348)
T ss_dssp HHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHH
T ss_pred HHHHHHHHHC-CCCCCCCCHHHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHH
T ss_conf 5899999768-899788988999999997307997577320010244544430355787555662678999999999997
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf 59999999698889729777783
Q 002601 746 LDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 746 L~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
|+.||.+|||++|+|+||||...
T Consensus 285 L~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 285 LVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp SCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 75883459389998559954879
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.12 Aligned_cols=247 Identities=23% Similarity=0.287 Sum_probs=193.4
Q ss_pred CEEEEEEEECCCCCEEEEEEEEEC--C--CEEEEEEECCCC------CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCE
Q ss_conf 229994664403965999998538--9--499999931587------069999999999918999755741434686512
Q 002601 473 KLVVFNKEIAKGSNGTVVLEGNYE--G--RSVAVKRLVKTH------HDVALKEIQNLIASDQHPNIVRWYGVESDQDFV 542 (902)
Q Consensus 473 ~~~~~~~~LG~GsfGtVy~a~~~~--g--~~VAVKrL~~~~------~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~l 542 (902)
++|.+.+.||+|+||+||+|.... + ..||||++.+.. .+...+|+ .++..++|||||+++|++.+ +..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei-~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV-NAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHH-HHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHH-HHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf 8919978980388839999999889990799999999835557989999999999-99986899998789877740-100
Q ss_pred EEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 65521346881247988359856774331025611488976402343430247777517999899999999620123421
Q 002601 543 YLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHL 622 (902)
Q Consensus 543 yLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yL 622 (902)
++|||+| .+|++.+.+... ...+++..+++++.|++.||+||
T Consensus 86 ~lv~e~~----------~~~~l~~~~~~~----------------------------~~~l~~~~~~~~~~qi~~gl~yl 127 (273)
T d1u46a_ 86 KMVTELA----------PLGSLLDRLRKH----------------------------QGHFLLGTLSRYAVQVAEGMGYL 127 (273)
T ss_dssp EEEEECC----------TTCBHHHHHHHH----------------------------GGGSCHHHHHHHHHHHHHHHHHH
T ss_pred HEEEEEE----------CCCCHHHHHHCC----------------------------CCCCCHHHHHHHHHHHHHHHHHH
T ss_conf 1146542----------386125444212----------------------------68999999999999999999875
Q ss_pred CCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 10362134445611685369992388814786201248776553464588986545701100299998521465679999
Q 002601 623 HEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCILF 702 (902)
Q Consensus 623 Hs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL~ 702 (902)
|+++|+||||||+|||++.++. +||+|||+++................|+..|+|||++.+..++.++|||||||++|
T Consensus 128 H~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~ 205 (273)
T d1u46a_ 128 ESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205 (273)
T ss_dssp HHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred HHCCEEEEEECHHHHCCCCCCC--EEECCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 2178752056688815655654--33256115553035887526547632573107999983799994215661489999
Q ss_pred HHHHCCCCCCCCCHHHH-HH-HHHHC-CCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHC
Q ss_conf 99938999999835667-88-97411-33322369957999998005999999969888972
Q 002601 703 FCITGGKHPYGESFERD-AN-IVKDR-KDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLN 761 (902)
Q Consensus 703 elltG~~~Pf~~~~~~~-~~-i~~~~-~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~ 761 (902)
||+|+|.+||.+..... .. +.... ....+...++++.+|+.+||+.||++|||++++++
T Consensus 206 emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99968999999969999999998479999985445399999999976889667929999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.57 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=184.9
Q ss_pred CCCEEEEEEEECCCCCEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHH-HHHCCCCCEEEECCCCCCCC----CEEEE
Q ss_conf 15229994664403965999998538949999993158706999999999-99189997557414346865----12655
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNL-IASDQHPNIVRWYGVESDQD----FVYLS 545 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~~~~g~~VAVKrL~~~~~~~~~~Ei~~l-l~~l~HpNIVrL~g~~~d~~----~lyLV 545 (902)
|.+.+++.++||+|+||+||++. .+|+.||||++.........+|.+.+ +..++|||||+++|+|.+.+ .+|+|
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~-~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEE-ETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEE-ECCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 98689998898207881999999-99989999998720046799999999996279986832688998379860489999
Q ss_pred ECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCC-
Q ss_conf 2134688124798835985677433102561148897640234343024777751799989999999962012342110-
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHE- 624 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs- 624 (902)
|| |+.+|+|.++++. ..+++..+++++.|++.||+|||+
T Consensus 80 ~E----------y~~~g~L~~~l~~------------------------------~~l~~~~~~~~~~~ia~gl~~lH~~ 119 (303)
T d1vjya_ 80 SD----------YHEHGSLFDYLNR------------------------------YTVTVEGMIKLALSTASGLAHLHME 119 (303)
T ss_dssp EE----------CCTTCBHHHHHHH------------------------------CCBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred EE----------CCCCCCHHHHHHC------------------------------CCCCHHHHHHHHHHHHHHHHHHHHH
T ss_conf 96----------4669898999865------------------------------8999899999999999999998876
Q ss_pred -------CCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCHHHCCCC------CCC
Q ss_conf -------36213444561168536999238881478620124877655-3464588986545701100299------998
Q 002601 625 -------IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCL-TQNATGYGSSGWQAPEQLLQGR------QTR 690 (902)
Q Consensus 625 -------~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~------~t~ 690 (902)
++|+||||||+|||++.++. +||+|||+++......... ......+||+.|+|||++.... ++.
T Consensus 120 ~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~ 197 (303)
T d1vjya_ 120 IVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 197 (303)
T ss_dssp BCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHH
T ss_pred HHHHCCCCCEECCCCCCCCEEECCCCC--EEEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf 652046898661531731357868877--688763866234677762001355250354767822105654546777675
Q ss_pred CCHHHHHHHHHHHHHHCCCCCCCCCH----------------HHHHHHHHH-CC-CCCCCC-----CCHHHHHHHHCCCC
Q ss_conf 52146567999999938999999835----------------667889741-13-332236-----99579999980059
Q 002601 691 AIDLFSLGCILFFCITGGKHPYGESF----------------ERDANIVKD-RK-DLFLVE-----HIPEAVDLFTRLLD 747 (902)
Q Consensus 691 ksDVwSlGvIL~elltG~~~Pf~~~~----------------~~~~~i~~~-~~-~~~~~~-----~~~e~~dLI~~lL~ 747 (902)
++|||||||++|||+|| .+|++... ......... .. ...+.. ...++.+++.+||+
T Consensus 198 k~Di~S~Gvvl~el~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~ 276 (303)
T d1vjya_ 198 RADIYAMGLVFWEIARR-CSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276 (303)
T ss_dssp HHHHHHHHHHHHHHHHT-BCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCC
T ss_pred CHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC
T ss_conf 01220159999999628-99887663112410122556430999999875024688877655776899999999999760
Q ss_pred CCCCCCCCHHHHHCC
Q ss_conf 999999698889729
Q 002601 748 PNPDLRPKAQNVLNH 762 (902)
Q Consensus 748 ~dP~~Rpt~~elL~H 762 (902)
.||.+|||+.|++++
T Consensus 277 ~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 277 ANGAARLTALRIKKT 291 (303)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CCHHHCCCHHHHHHH
T ss_conf 698589599999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=319.90 Aligned_cols=255 Identities=21% Similarity=0.254 Sum_probs=191.6
Q ss_pred CCCCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCC-HHHHHHHHHHHHHCCCCC-EEEECCCCCCCCCEEEE
Q ss_conf 2015229994664403965999998-53894999999315870-699999999999189997-55741434686512655
Q 002601 469 RRIGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH-DVALKEIQNLIASDQHPN-IVRWYGVESDQDFVYLS 545 (902)
Q Consensus 469 ~~i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~-~~~~~Ei~~ll~~l~HpN-IVrL~g~~~d~~~lyLV 545 (902)
-++|+.|.+.+.||+|+||+||+|. ..+|+.||||++..... ....+|+. ++..++|+| |+.+.++..+.+..++|
T Consensus 3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~-i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK-IYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHH-HHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEECCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCCHHHHHHHH-HHHHCCCCCCCCEEEEEEECCCEEEEE
T ss_conf 7188889996898507880999999988998999999721005888999999-999703899601799999519877899
Q ss_pred ECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 21346881247988359856774331025611488976402343430247777517999899999999620123421103
Q 002601 546 LERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEI 625 (902)
Q Consensus 546 ~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~ 625 (902)
||+|.+++.+.+. .....+++..+..++.|++.||+|||++
T Consensus 82 me~~~~~l~~~~~---------------------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 122 (299)
T d1ckia_ 82 MELLGPSLEDLFN---------------------------------------FCSRKFSLKTVLLLADQMISRIEYIHSK 122 (299)
T ss_dssp EECCCCBHHHHHH---------------------------------------HTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEECCCCHHHHHH---------------------------------------HCCCCCCHHHHHHHHHHHHHHHHHHHHC
T ss_conf 9873871333244---------------------------------------3068876899999999999999999979
Q ss_pred CCCCCCCCCCEEEECCC-CCCEEEECCCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHH
Q ss_conf 62134445611685369-9923888147862012487765----534645889865457011002999985214656799
Q 002601 626 GLIHRDLKPQNVLISKD-KSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCI 700 (902)
Q Consensus 626 ~IiHrDLKp~NILL~~d-~~~~vKLsDFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvI 700 (902)
+|+||||||+|||++.. ....+||+|||+|+.+...... ........||+.|||||++.+..++.++|||||||+
T Consensus 123 ~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~ 202 (299)
T d1ckia_ 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 202 (299)
T ss_dssp TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHH
T ss_pred CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHH
T ss_conf 94426678766064335777615650467513425544554100013577678735329999918998983218861778
Q ss_pred HHHHHHCCCCCCCCCHHHHH-----HHHH----HCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHH---HCCCC
Q ss_conf 99999389999998356678-----8974----11333223699579999980059999999698889---72977
Q 002601 701 LFFCITGGKHPYGESFERDA-----NIVK----DRKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNV---LNHPF 764 (902)
Q Consensus 701 L~elltG~~~Pf~~~~~~~~-----~i~~----~~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~el---L~HPf 764 (902)
+|||++| .+||........ .... ..........++++.+++.+||..+|.+||+++++ ++|+|
T Consensus 203 l~el~tg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 203 LMYFNLG-SLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHHHHHS-SCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHC-CCCCCCCCHHHHHHHHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9999849-87665530577999999852356789835753478899999999984399557919999999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-45 Score=310.79 Aligned_cols=250 Identities=17% Similarity=0.214 Sum_probs=190.7
Q ss_pred CCCEEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCC-CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECC
Q ss_conf 15229994664403965999998-5389499999931587-069999999999918999755741434686512655213
Q 002601 471 IGKLVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTH-HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLER 548 (902)
Q Consensus 471 i~~~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~-~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~ 548 (902)
+++.|.+.+.||+|+||+||+|. ..+|+.||||++.... .....+|+..+.....|+|++.+++++.+....|+|||+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 89806997998417882999999988997999999750258299999999999964899987799996018811799996
Q ss_pred CCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 46881247988359856774331025611488976402343430247777517999899999999620123421103621
Q 002601 549 CTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSHLHEIGLI 628 (902)
Q Consensus 549 c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~yLHs~~Ii 628 (902)
|.++|.+++.. ....+++..+..++.|++.||+|||+.+|+
T Consensus 83 ~~~~l~~~~~~---------------------------------------~~~~~~~~~~~~i~~q~~~~l~~lH~~gii 123 (293)
T d1csna_ 83 LGPSLEDLLDL---------------------------------------CGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123 (293)
T ss_dssp CCCBHHHHHHH---------------------------------------TTTCCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred CCCCHHHHHHH---------------------------------------HCCCHHHHHHHHHHHHHHHHHHHHHHCCCE
T ss_conf 48887999975---------------------------------------203110689999999999999999977966
Q ss_pred CCCCCCCEEEECCC---CCCEEEECCCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCHHHCCCCCCCCCHHHHHHHHH
Q ss_conf 34445611685369---9923888147862012487765----5346458898654570110029999852146567999
Q 002601 629 HRDLKPQNVLISKD---KSFCAKLSDMGISKRLQGDMSC----LTQNATGYGSSGWQAPEQLLQGRQTRAIDLFSLGCIL 701 (902)
Q Consensus 629 HrDLKp~NILL~~d---~~~~vKLsDFGla~~~~~~~~~----~~~~~~~~GT~~Y~APE~l~~~~~t~ksDVwSlGvIL 701 (902)
||||||+|||++.+ ....+||+|||+|+........ .......+||+.|||||++.+..++.++|||||||++
T Consensus 124 HrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (293)
T d1csna_ 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203 (293)
T ss_dssp CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred ECCCCCCCEEECCCCCCCCCCEEECCCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHH
T ss_conf 26677131523475434479568723660577146766541110246762775102679896488888699989831999
Q ss_pred HHHHHCCCCCCCCCHH----HHH-HHHHHCC----CCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHH
Q ss_conf 9999389999998356----678-8974113----332236995799999800599999996988897
Q 002601 702 FFCITGGKHPYGESFE----RDA-NIVKDRK----DLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVL 760 (902)
Q Consensus 702 ~elltG~~~Pf~~~~~----~~~-~i~~~~~----~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL 760 (902)
|||++| ..||..... ... .+..... .......++++.+++..|+..+|..||+++.+.
T Consensus 204 ~elltg-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 204 MYFLRG-SLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHS-SCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HHHHHC-CCCCCCCCCHHHHHHHHHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf 999869-8767885302199999999705679995896579989999999998439930085999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.4e-45 Score=303.85 Aligned_cols=251 Identities=22% Similarity=0.329 Sum_probs=181.5
Q ss_pred EEEEEEEECCCCCEEEEEEE-EECCCEEEEEEECCCCC--HHHHHHHHHHHHH-----------CCCCCEEEECCCCCCC
Q ss_conf 29994664403965999998-53894999999315870--6999999999991-----------8999755741434686
Q 002601 474 LVVFNKEIAKGSNGTVVLEG-NYEGRSVAVKRLVKTHH--DVALKEIQNLIAS-----------DQHPNIVRWYGVESDQ 539 (902)
Q Consensus 474 ~~~~~~~LG~GsfGtVy~a~-~~~g~~VAVKrL~~~~~--~~~~~Ei~~ll~~-----------l~HpNIVrL~g~~~d~ 539 (902)
+|.+.++||+|+||+||+|. ..+|+.||||++.+... +...+|+.. +.. ..|+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~-l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKL-LQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHH-HHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCCCHHHHHHHHHH-HHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 5799899750778189999999999799999983431336899999999-998401455555422767647899876312
Q ss_pred --CCEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHC
Q ss_conf --512655213468812479883598567743310256114889764023434302477775179998999999996201
Q 002601 540 --DFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVS 617 (902)
Q Consensus 540 --~~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~ 617 (902)
...+++++++.+.... .... .......+++..+..++.|++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~---------~~~~---------------------------~~~~~~~~~~~~i~~i~~qil~ 136 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENL---------LALI---------------------------KKYEHRGIPLIYVKQISKQLLL 136 (362)
T ss_dssp ETTEEEEEEEECCCCEEH---------HHHH---------------------------HHTTTSCCCHHHHHHHHHHHHH
T ss_pred CCCCEEEEEEECCCCCCC---------CCCC---------------------------CCCCCCCCCHHHHHHHHHHHHH
T ss_conf 565202343200035420---------0000---------------------------1223467868999999999999
Q ss_pred CCCCCCC-CCCCCCCCCCCEEEECCCCC----CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCC
Q ss_conf 2342110-36213444561168536999----238881478620124877655346458898654570110029999852
Q 002601 618 GLSHLHE-IGLIHRDLKPQNVLISKDKS----FCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAPEQLLQGRQTRAI 692 (902)
Q Consensus 618 gL~yLHs-~~IiHrDLKp~NILL~~d~~----~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~t~ks 692 (902)
||+|||+ .+|+||||||+|||++.++. ..++++|||.|...... ....+||+.|+|||++....++.++
T Consensus 137 al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~ 210 (362)
T d1q8ya_ 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGAPWGCGA 210 (362)
T ss_dssp HHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTCCCCTHH
T ss_pred HHHHHHHHCCCCCCCCCHHHEEEECCCCCCCCCEEEEEECCCCCCCCCC------CCCCCCCCCCCCHHHCCCCCCCCCC
T ss_conf 9888764058646567705705630576564430567531442123445------4223665210571321466777643
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHH-----------H----------------------------
Q ss_conf 14656799999993899999983566--------788974-----------1----------------------------
Q 002601 693 DLFSLGCILFFCITGGKHPYGESFER--------DANIVK-----------D---------------------------- 725 (902)
Q Consensus 693 DVwSlGvIL~elltG~~~Pf~~~~~~--------~~~i~~-----------~---------------------------- 725 (902)
||||+||++++|++| +.||...... ....+. .
T Consensus 211 DiwSlG~il~el~~g-~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (362)
T d1q8ya_ 211 DIWSTACLIFELITG-DFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289 (362)
T ss_dssp HHHHHHHHHHHHHHS-SCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHH
T ss_pred CCCCHHHHHHHHHHC-CCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHH
T ss_conf 201237899999878-8998987554321026899999998379987886245322000132012202432357764442
Q ss_pred --CCCCCCCCCCHHHHHHHHCCCCCCCCCCCCHHHHHCCCCCCCC
Q ss_conf --1333223699579999980059999999698889729777783
Q 002601 726 --RKDLFLVEHIPEAVDLFTRLLDPNPDLRPKAQNVLNHPFFWTA 768 (902)
Q Consensus 726 --~~~~~~~~~~~e~~dLI~~lL~~dP~~Rpt~~elL~HPfF~~~ 768 (902)
.........++++.|||.+||+.||.+|||++|+|+||||.+.
T Consensus 290 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 100015674358999999999877994579089999669340789
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=7.8e-23 Score=162.21 Aligned_cols=160 Identities=16% Similarity=0.070 Sum_probs=110.3
Q ss_pred EEEEEECCCCCEEEEEEEEECCCEEEEEEECCCCC---------------------HHHHHHHHHHHHHCCCCCEEEECC
Q ss_conf 99466440396599999853894999999315870---------------------699999999999189997557414
Q 002601 476 VFNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTHH---------------------DVALKEIQNLIASDQHPNIVRWYG 534 (902)
Q Consensus 476 ~~~~~LG~GsfGtVy~a~~~~g~~VAVKrL~~~~~---------------------~~~~~Ei~~ll~~l~HpNIVrL~g 534 (902)
.++++||+|+||+||+|...+|+.||||+++.... ....+|.. .+..+.|.+++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR-ALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHH-HHHHTTTSSSCCEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHH-HHHHCCCCCCCEEEE
T ss_conf 2277802485659999997999999999986044346665565630008889999997789999-999816999144998
Q ss_pred CCCCCCCEEEEECCCCCCHHHHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHH
Q ss_conf 34686512655213468812479883598567743310256114889764023434302477775179998999999996
Q 002601 535 VESDQDFVYLSLERCTCSLNDLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRD 614 (902)
Q Consensus 535 ~~~d~~~lyLV~E~c~~sL~dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~q 614 (902)
+. ..+++||++.+.. +.. ++.....+++.|
T Consensus 82 ~~----~~~lvme~~~~~~----------~~~------------------------------------l~~~~~~~i~~q 111 (191)
T d1zara2 82 WE----GNAVLMELIDAKE----------LYR------------------------------------VRVENPDEVLDM 111 (191)
T ss_dssp EE----TTEEEEECCCCEE----------GGG------------------------------------CCCSCHHHHHHH
T ss_pred EC----CCEEEEEEECCCC----------CCC------------------------------------HHHHHHHHHHHH
T ss_conf 62----8889999504565----------420------------------------------------015789999999
Q ss_pred HHCCCCCCCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------HHHCCCCC
Q ss_conf 201234211036213444561168536999238881478620124877655346458898654570------11002999
Q 002601 615 IVSGLSHLHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKRLQGDMSCLTQNATGYGSSGWQAP------EQLLQGRQ 688 (902)
Q Consensus 615 Ia~gL~yLHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~GT~~Y~AP------E~l~~~~~ 688 (902)
++.||+|||+.+|+||||||+|||+++++ ++|+|||+|+....... ..|... +. ..+.|
T Consensus 112 l~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~~~~~~~-----------~~~l~rd~~~~~~~-f~r~y 176 (191)
T d1zara2 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVEVGEEGW-----------REILERDVRNIITY-FSRTY 176 (191)
T ss_dssp HHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEETTSTTH-----------HHHHHHHHHHHHHH-HHHHH
T ss_pred HHHHHHHHHHCCEEECCCCHHHEEEECCC---EEEEECCCCCCCCCCCC-----------HHHHHHHHHHHHHH-HCCCC
T ss_conf 99999998268889836890361142898---99987788430899870-----------99998779999999-75789
Q ss_pred CCCCHHHHHHHHH
Q ss_conf 9852146567999
Q 002601 689 TRAIDLFSLGCIL 701 (902)
Q Consensus 689 t~ksDVwSlGvIL 701 (902)
..++|+||..--+
T Consensus 177 ~~~~d~~s~~~~~ 189 (191)
T d1zara2 177 RTEKDINSAIDRI 189 (191)
T ss_dssp CCCCCHHHHHHHH
T ss_pred CCCCCHHHHHHHH
T ss_conf 9844689999987
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=98.72 E-value=4e-09 Score=73.72 Aligned_cols=80 Identities=6% Similarity=-0.042 Sum_probs=65.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH-HCCC-CCCCCCCCCCCCCCCCCC----CCCCCCCCCCCCCCC
Q ss_conf 6777534578977565334663233468847321100-0048-876423347854354789----998988876988999
Q 002601 244 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISL----PGSSQNSLLGPVDRN 317 (902)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~~-L~~l-~L~~LNlsnN~fsG~IP~----~~~~~~sf~GN~~lc 317 (902)
.++++++.+..+ .+....+|+.+.+.+|+|+|.||. +..+ .|+.|||++|+|+|.||. +.....+|.||..+|
T Consensus 227 ~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~ 305 (313)
T d1ogqa_ 227 HLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp ECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEE
T ss_pred CCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 222222222222-2224554444447657066608768847999998979588351668986667998978868895001
Q ss_pred CCCCCCC
Q ss_conf 8898899
Q 002601 318 SPLFLPD 324 (902)
Q Consensus 318 g~~~~P~ 324 (902)
|.++|+|
T Consensus 306 g~plp~c 312 (313)
T d1ogqa_ 306 GSPLPAC 312 (313)
T ss_dssp STTSSCC
T ss_pred CCCCCCC
T ss_conf 9898898
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=97.58 E-value=1.6e-05 Score=50.52 Aligned_cols=57 Identities=11% Similarity=0.068 Sum_probs=26.2
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCC-CCCCCCCCH-HCCC-CCCCCCCCCCCCCCCCC
Q ss_conf 77753457--8977565334663233468-847321100-0048-87642334785435478
Q 002601 245 FSGYHFNS--GSELGMDLIGDVESHLPCH-TQMTASVYR-LRDN-SLPEFLSVIGKVAGWIS 301 (902)
Q Consensus 245 ~~~~~~~~--~~~~~~~~~~~l~~~~l~n-N~lsG~I~~-L~~l-~L~~LNlsnN~fsG~IP 301 (902)
+++++.++ ++|..+..+.+|+.+.+.+ |+|+|.||. +.++ .|+.||+++|+++|.++
T Consensus 57 L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~ 118 (313)
T d1ogqa_ 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118 (313)
T ss_dssp EECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECC
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
T ss_conf 98998888887984784675335202026543330024311454200110203564344332
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.54 E-value=0.00013 Score=44.62 Aligned_cols=75 Identities=11% Similarity=-0.026 Sum_probs=44.3
Q ss_pred EEEEECCCCCEEEEEEEEECCCEEEEEEECCCC---CHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECCCCCC
Q ss_conf 946644039659999985389499999931587---0699999999999189997557414346865126552134688
Q 002601 477 FNKEIAKGSNGTVVLEGNYEGRSVAVKRLVKTH---HDVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERCTCS 552 (902)
Q Consensus 477 ~~~~LG~GsfGtVy~a~~~~g~~VAVKrL~~~~---~~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~c~~s 552 (902)
..+..+.++...||+.. .++..+.+|+..... .....+|...+.....+--+.+++.++.+.+..++||++..+.
T Consensus 18 ~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~ 95 (263)
T d1j7la_ 18 CVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp EEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred EEECCCCCCCCCEEEEE-ECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCC
T ss_conf 99767899877189999-0898699998488765325569999999998760699872899975089649999860433
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.42 E-value=0.00022 Score=43.09 Aligned_cols=171 Identities=12% Similarity=0.118 Sum_probs=80.5
Q ss_pred EECCCC-CEEEEEEEEECCCEEEEEEECCCCCHHHHHHHHHH--HHHCCCCCEEEECCCCCCCCCEEEEECCCCCC-HHH
Q ss_conf 644039-65999998538949999993158706999999999--99189997557414346865126552134688-124
Q 002601 480 EIAKGS-NGTVVLEGNYEGRSVAVKRLVKTHHDVALKEIQNL--IASDQHPNIVRWYGVESDQDFVYLSLERCTCS-LND 555 (902)
Q Consensus 480 ~LG~Gs-fGtVy~a~~~~g~~VAVKrL~~~~~~~~~~Ei~~l--l~~l~HpNIVrL~g~~~d~~~lyLV~E~c~~s-L~d 555 (902)
.+..|. .+.||+....++..+.+|.-..........|...+ +.. ..-.+.++++++.+.+..++||+++++. +.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~-~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~ 95 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLAT-TGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS 95 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHT-TTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHHHHHHHHHHHHHHHH-CCCCCCCEEEECCCCCCEEEEEEEEECCCCCC
T ss_conf 76786547758999938987899995896677689999999999986-59998861322245661599987441355432
Q ss_pred H------HHHHCCCHHHHHHHHHCCCC----H----HHHHHHHHCCCCCCCHHHHHHHHCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 7------98835985677433102561----1----48897640234343024777751799989999999962012342
Q 002601 556 L------IYVLSGSFEEQLNAKEQDSN----L----LNEVRIRLLPVMENTKDIELWKANGHPSAQLLKVTRDIVSGLSH 621 (902)
Q Consensus 556 l------iy~~~GsL~~~L~~~~~~~~----~----l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~I~~qIa~gL~y 621 (902)
. ....-|..-..||....... . ...+..+............ ...... ........+...+..
T Consensus 96 ~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 96 SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD-EEHQGL---APAELFARLKARMPD 171 (255)
T ss_dssp SCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC-GGGTTC---CHHHHHHHHHHTCCS
T ss_pred CCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCC-CHHHHH---HHHHHHHHHHHHCCC
T ss_conf 2126899999999999987368854488755412468899999987541101134-011213---799999999871876
Q ss_pred CCCCCCCCCCCCCCEEEECCCCCCEEEECCCCCCCC
Q ss_conf 110362134445611685369992388814786201
Q 002601 622 LHEIGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (902)
Q Consensus 622 LHs~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~ 657 (902)
.....++|+|+.|.|||++.++ .+.|+||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~--~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGR--FSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTE--EEEECCCTTCEE
T ss_pred CCCCEEEECCCCCCCEEEECCC--EEEEEECHHCCC
T ss_conf 5795678678887635773796--589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.10 E-value=0.0011 Score=38.58 Aligned_cols=72 Identities=22% Similarity=0.227 Sum_probs=43.0
Q ss_pred EEEECCCCCEEEEEEEEE-CCCEEEEEEECC------C----CCHHHHHHHHHHHHHCCC--CCEEEECCCCCCCCCEEE
Q ss_conf 466440396599999853-894999999315------8----706999999999991899--975574143468651265
Q 002601 478 NKEIAKGSNGTVVLEGNY-EGRSVAVKRLVK------T----HHDVALKEIQNLIASDQH--PNIVRWYGVESDQDFVYL 544 (902)
Q Consensus 478 ~~~LG~GsfGtVy~a~~~-~g~~VAVKrL~~------~----~~~~~~~Ei~~ll~~l~H--pNIVrL~g~~~d~~~lyL 544 (902)
.+.||.|..-.||+.... +++.|.||.-.. . ..+....|...+.....+ ..+.+.+++ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EECCCCC
Q ss_conf 5213468
Q 002601 545 SLERCTC 551 (902)
Q Consensus 545 V~E~c~~ 551 (902)
|||++.+
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEECCCC
T ss_conf 8713577
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.07 E-value=0.0006 Score=40.29 Aligned_cols=84 Identities=13% Similarity=-0.031 Sum_probs=57.8
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH-HCCC-CCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 0344432001346777534578977565334663233468847321100-0048-8764233478543547899989888
Q 002601 232 FKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNS 309 (902)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~~-L~~l-~L~~LNlsnN~fsG~IP~~~~~~~s 309 (902)
|......+.+ .++++.+..-.+..+..+.+++.+.+.+|++++..+. +..+ .|+.||+++|+++ .||...++..+
T Consensus 120 ~~~l~~l~~L--~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~ 196 (266)
T d1p9ag_ 120 LRGLGELQEL--YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196 (266)
T ss_dssp TTTCTTCCEE--ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCC
T ss_pred CCCCCCCCCC--CCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCC
T ss_conf 2222111122--12434210221233322111000000015652237200134212423430139785-56866777888
Q ss_pred CC-----CCCCCCC
Q ss_conf 76-----9889998
Q 002601 310 LL-----GPVDRNS 318 (902)
Q Consensus 310 f~-----GN~~lcg 318 (902)
+. ||+|.|.
T Consensus 197 L~~L~L~~Np~~Cd 210 (266)
T d1p9ag_ 197 LPFAFLHGNPWLCN 210 (266)
T ss_dssp CSEEECCSCCBCCS
T ss_pred CCEEEECCCCCCCC
T ss_conf 99998369998788
|
| >d1kb0a2 b.70.1.1 (A:1-573) Quinoprotein alcohol dehydrogenase, N-terminal domain {Comamonas testosteroni [TaxId: 285]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Quinoprotein alcohol dehydrogenase, N-terminal domain species: Comamonas testosteroni [TaxId: 285]
Probab=96.80 E-value=0.0074 Score=33.25 Aligned_cols=111 Identities=16% Similarity=0.229 Sum_probs=67.5
Q ss_pred CCEEEEECCCEEEEEECCCCEEEEEECCCCCCCCCCCCCCCC---CCC----EEEEECCCCCEEEEECCCCCCEEE-EC-
Q ss_conf 612788127529999526851456515899832344457789---872----388851998318983035684577-03-
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNS---NAS----EFYLDVDEDWELYFHSKRFGKMKK-LS- 119 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----~~~~~~~~~~~~~~~~~~~~~~~~-~~- 119 (902)
++.-+.+.+|.++++|-.+|+.+|+|....+..+........ ... ..|.. ..|..||--+..-|++.- ..
T Consensus 78 g~vyv~t~~~~v~AlDa~TG~~~W~~~~~~~~~~~~~~~~~~~~~g~~~~~~~v~~~-t~~g~l~alda~tG~~~W~~~~ 156 (573)
T d1kb0a2 78 GIMYVSASWSVVHAIDTRTGNRIWTYDPQIDRSTGFKGCCDVVNRGVALWKGKVYVG-AWDGRLIALDAATGKEVWHQNT 156 (573)
T ss_dssp TEEEEECGGGCEEEEETTTTEEEEEECCCCCGGGGGGSSSCSCCCCCEEETTEEEEE-CTTSEEEEEETTTCCEEEEEET
T ss_pred CEEEEECCCCEEEEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCEEEE-ECCCCEEEECCCCCCCEECCCC
T ss_conf 999997899969999589998587867988765333345665666523878818997-3365406661624300101467
Q ss_pred --CCHHHHH-HHCCCCCCCCCEEEECEE------EEEEEEECCCCCEEEEE
Q ss_conf --6988898-637411048813440203------45899973446078510
Q 002601 120 --SSAEEYI-RRMPYISKDGGVTLGAMK------TSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 120 --~~~~~~~-~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 161 (902)
-...++. .-+|.+ .++.|++|..- -.+.+.|++||+++-.+
T Consensus 157 ~~~~~~~~~~~~~p~v-~~~~vivg~~~~~~~~~G~v~a~D~~TG~~~W~~ 206 (573)
T d1kb0a2 157 FEGQKGSLTITGAPRV-FKGKVIIGNGGAEYGVRGYITAYDAETGERKWRW 206 (573)
T ss_dssp TTTCCSSCBCCSCCEE-ETTEEEECCBCTTTCCBCEEEEEETTTCCEEEEE
T ss_pred CCCCCCEEEEECCEEE-EECCEEEEECCCCCCCCCEEEEEECCCCCCEEEE
T ss_conf 5687650786010279-7062799213445543221899856886510255
|
| >d1kv9a2 b.70.1.1 (A:1-560) Quinoprotein alcohol dehydrogenase, N-terminal domain {Pseudomonas putida, hk5 [TaxId: 303]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Quinoprotein alcohol dehydrogenase, N-terminal domain species: Pseudomonas putida, hk5 [TaxId: 303]
Probab=96.75 E-value=0.0098 Score=32.47 Aligned_cols=112 Identities=17% Similarity=0.149 Sum_probs=66.4
Q ss_pred CCEEEEECCCEEEEEECCCCEEEEEECCCCCCCCCCCCC---CCCCCC---EEEEECCCCCEEEEECCCCCCEEEECCC-
Q ss_conf 612788127529999526851456515899832344457---789872---3888519983189830356845770369-
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQAS---FNSNAS---EFYLDVDEDWELYFHSKRFGKMKKLSSS- 121 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 121 (902)
++..|.+.+|.+|++|-.+|+.+|+|..+.+........ .+.... -..+-...|..||--+...|++.--...
T Consensus 67 g~vyv~t~~~~v~AlDa~tG~~lW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~~~~~g~l~Alda~tG~~~w~~~~~ 146 (560)
T d1kv9a2 67 GVIYTSMSWSRVIAVDAASGKELWRYDPEVAKVKARTSCCDAVNRGVALWGDKVYVGTLDGRLIALDAKTGKAIWSQQTT 146 (560)
T ss_dssp TEEEEEEGGGEEEEEETTTCCEEEEECCCCCGGGGGGCTTCSCCCCCEEEBTEEEEECTTSEEEEEETTTCCEEEEEECS
T ss_pred CEEEEECCCCEEEEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCEECCEEEEEECCCEEEEEECCCCCEEECCCCC
T ss_conf 99999789995999968999879887798776445443224653575046884999738987999977789577305766
Q ss_pred ---HHHHHHHCCCCCCCCCEEEECEE------EEEEEEECCCCCEEEEE
Q ss_conf ---88898637411048813440203------45899973446078510
Q 002601 122 ---AEEYIRRMPYISKDGGVTLGAMK------TSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 122 ---~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 161 (902)
..-.+..+|.+ .+|.|+.|... -.+.+.|++||+++-.+
T Consensus 147 ~~~~~~~~~~~p~v-~~~~vivg~~~~~~~~~G~v~a~D~~TG~~~W~~ 194 (560)
T d1kv9a2 147 DPAKPYSITGAPRV-VKGKVIIGNGGAEYGVRGFVSAYDADTGKLAWRF 194 (560)
T ss_dssp CTTSSCBCCSCCEE-ETTEEEECCBCTTTCCBCEEEEEETTTCCEEEEE
T ss_pred CCCCCEEEEEEEEE-ECCCCCCCCCCEECCCCCEEEEEECCCCEEEEEE
T ss_conf 75540454320045-0685103653110013553899977886277664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=96.67 E-value=0.0017 Score=37.43 Aligned_cols=63 Identities=2% Similarity=-0.049 Sum_probs=34.9
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-HHCCC-CCCCCCCCCCCCCCCCC
Q ss_conf 3200134677753457897756533466323346884732110-00048-87642334785435478
Q 002601 237 RCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 301 (902)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~-~L~~l-~L~~LNlsnN~fsG~IP 301 (902)
.=++| .++++++..-.+..+..+..|+.+.+.+|++++-.+ .+.++ .|+.|++++|++++-.|
T Consensus 55 ~L~~L--~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~ 119 (192)
T d1w8aa_ 55 HLVKL--ELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMP 119 (192)
T ss_dssp TCCEE--ECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECT
T ss_pred EEEEE--ECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCH
T ss_conf 27213--013632212121222112222101003553443497998079746552457745353597
|
| >d1flga_ b.70.1.1 (A:) Ethanol dehydrogenase {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Ethanol dehydrogenase species: Pseudomonas aeruginosa [TaxId: 287]
Probab=96.65 E-value=0.016 Score=31.11 Aligned_cols=32 Identities=28% Similarity=0.434 Sum_probs=27.7
Q ss_pred CCEEEEECCCEEEEEECCCCEEEEEECCCCCC
Q ss_conf 61278812752999952685145651589983
Q 002601 49 DVALVAALDGTIHLVDTKLGKIRWSFGTGRPI 80 (902)
Q Consensus 49 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (902)
++.-+.+.+|.||++|-.+|+.+|+|....|.
T Consensus 69 g~vy~~t~~~~v~AlDa~TG~~lW~~~~~~~~ 100 (582)
T d1flga_ 69 GVIYVTASYSRLFALDAKTGKRLWTYNHRLPD 100 (582)
T ss_dssp TEEEEEETTTEEEEEESSSCCEEEEEECCCCT
T ss_pred CEEEEECCCCEEEEEECCCCCEEEEECCCCCC
T ss_conf 99999689995999968999868887688987
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.49 E-value=0.0022 Score=36.61 Aligned_cols=165 Identities=17% Similarity=0.179 Sum_probs=72.8
Q ss_pred CEEEEEEEEECCCEEEEEEECCCC--CHHHHHHHHHH--HHHC--CCCCEEEECC--CCCCCCCEEEEECCCCCCHH---
Q ss_conf 659999985389499999931587--06999999999--9918--9997557414--34686512655213468812---
Q 002601 486 NGTVVLEGNYEGRSVAVKRLVKTH--HDVALKEIQNL--IASD--QHPNIVRWYG--VESDQDFVYLSLERCTCSLN--- 554 (902)
Q Consensus 486 fGtVy~a~~~~g~~VAVKrL~~~~--~~~~~~Ei~~l--l~~l--~HpNIVrL~g--~~~d~~~lyLV~E~c~~sL~--- 554 (902)
.=.||+....+|..|++|...... ......|..-+ +... ..+..+..-+ .....+..+.+++++.+...
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred CCEEEEEECCCCCEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf 20269998389997999984787788999999999999998559987875206898056653479999865277688999
Q ss_pred -HHHHHHCCCHHHHHHHHHCCCCHHHHHHHHHCCCCCCCHH--HHHHHHCCCCH---HHHHHHHHHHHCCCCCC-C---C
Q ss_conf -4798835985677433102561148897640234343024--77775179998---99999999620123421-1---0
Q 002601 555 -DLIYVLSGSFEEQLNAKEQDSNLLNEVRIRLLPVMENTKD--IELWKANGHPS---AQLLKVTRDIVSGLSHL-H---E 624 (902)
Q Consensus 555 -dliy~~~GsL~~~L~~~~~~~~~l~~~~~~~~~~~~~~~~--~~~~~~~~l~~---~~~~~I~~qIa~gL~yL-H---s 624 (902)
.-.+..-|.+-..+|.......... +. ..+....... ........++. ......+..+...+.-+ . .
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~--r~-~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIH--RP-TIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSS--SC-BCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCC--CC-CCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999998999999886303578655--67-7897887665689998747699889899999999999999984545687
Q ss_pred CCCCCCCCCCCEEEECCCCCCEEEECCCCCCCC
Q ss_conf 362134445611685369992388814786201
Q 002601 625 IGLIHRDLKPQNVLISKDKSFCAKLSDMGISKR 657 (902)
Q Consensus 625 ~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~~ 657 (902)
.+++|+|+.+.|||++. . ..+.||+-|..
T Consensus 192 ~~liHgDlh~~NvL~~~--~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD--G--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESS--S--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEEC--C--CEEEECHHCCC
T ss_conf 12024788804287838--9--35886520146
|
| >d2ad6a1 b.70.1.1 (A:1-571) Methanol dehydrogenase, heavy chain {Methylophilus methylotrophus, w3a1 [TaxId: 17]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Methanol dehydrogenase, heavy chain species: Methylophilus methylotrophus, w3a1 [TaxId: 17]
Probab=96.30 E-value=0.026 Score=29.76 Aligned_cols=111 Identities=14% Similarity=0.233 Sum_probs=65.1
Q ss_pred CCEEEEEC-CCEEEEEEC-CCCEEEEEECCCCCCCCCCCCCC---CCCC----CEEEEECCCCCEEEEECCCCCCEEE--
Q ss_conf 61278812-752999952-68514565158998323444577---8987----2388851998318983035684577--
Q 002601 49 DVALVAAL-DGTIHLVDT-KLGKIRWSFGTGRPIYSSYQASF---NSNA----SEFYLDVDEDWELYFHSKRFGKMKK-- 117 (902)
Q Consensus 49 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~-- 117 (902)
++..|.+- +|.++++|- .+|+.+|+|..+.+.-++..... +... ..+|.. ..|+.||--+.+.|++.-
T Consensus 63 g~vyv~t~~~~~v~Alda~~tG~~~W~~~~~~~~~~~~~~~~~~~~rg~a~~~~~i~~~-~~~g~l~alda~tG~~~w~~ 141 (571)
T d2ad6a1 63 DMMYVHSAFPNNTYALNLNDPGKIVWQHKPKQDASTKAVMCCDVVDRGLAYGAGQIVKK-QANGHLLALDAKTGKINWEV 141 (571)
T ss_dssp TEEEEECSTTTCEEEEETTCTTSEEEEECCCCCGGGGGGCTTCSCCCCCEEETTEEEEE-CTTSEEEEEETTTCCEEEEE
T ss_pred CEEEEECCCCCEEEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCEEEEE-ECCCCEEEEEHHHHHHHCCC
T ss_conf 99999428799599994899986688835888865442002476888626508869999-17975782100211220234
Q ss_pred -EC-CCHHHHHHHCCCCCCCCCEEEECE------EEEEEEEECCCCCEEEEE
Q ss_conf -03-698889863741104881344020------345899973446078510
Q 002601 118 -LS-SSAEEYIRRMPYISKDGGVTLGAM------KTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 118 -~~-~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 161 (902)
+. ....-.+..+|.+ .++.|+.|.. +-.+.+.||.||+++-.+
T Consensus 142 ~~~~~~~~~~~t~~p~v-~~~~vivg~~~~~~~~~G~v~a~D~~TG~~~W~~ 192 (571)
T d2ad6a1 142 EVCDPKVGSTLTQAPFV-AKDTVLMGCSGAELGVRGAVNAFDLKTGELKWRA 192 (571)
T ss_dssp ECCCGGGTCBCCSCCEE-ETTEEEEECBCGGGTCCCEEEEEETTTCCEEEEE
T ss_pred CCCCCCCCCCEEECCEE-ECCEEEEEECCCCCCCCCCEEEEECCCCCEEEEE
T ss_conf 44554432414536757-5885888502344234674799988898588997
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.21 E-value=0.0044 Score=34.75 Aligned_cols=63 Identities=11% Similarity=0.008 Sum_probs=42.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCH-HCCC-CCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCC
Q ss_conf 77565334663233468847321100-0048-87642334785435478999898887-----69889998
Q 002601 255 ELGMDLIGDVESHLPCHTQMTASVYR-LRDN-SLPEFLSVIGKVAGWISLPGSSQNSL-----LGPVDRNS 318 (902)
Q Consensus 255 ~~~~~~~~~l~~~~l~nN~lsG~I~~-L~~l-~L~~LNlsnN~fsG~IP~~~~~~~sf-----~GN~~lcg 318 (902)
+..+..+.+|+.+.+.+|++++--+. +..+ .|+.|++++|+++ .||...+...++ .||++.|.
T Consensus 49 ~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~ 118 (156)
T d2ifga3 49 LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCS 118 (156)
T ss_dssp GGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCCCC
T ss_pred CHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 212256666672162021247742011124554333322678785-1574563353212433579863388
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=96.02 E-value=0.004 Score=35.00 Aligned_cols=46 Identities=17% Similarity=0.248 Sum_probs=35.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCCCCCCCCCCCCCC
Q ss_conf 75653346632334688473211000048-876423347854354789
Q 002601 256 LGMDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISL 302 (902)
Q Consensus 256 ~~~~~~~~l~~~~l~nN~lsG~I~~L~~l-~L~~LNlsnN~fsG~IP~ 302 (902)
.+++++.+|+.+-+.+|++++ |+.+.++ .|+.|++++|++++..|+
T Consensus 60 ~gl~~L~nL~~L~Ls~N~l~~-l~~l~~L~~L~~L~L~~n~i~~i~~l 106 (384)
T d2omza2 60 DGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQIADITPL 106 (384)
T ss_dssp TTGGGCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCCGGG
T ss_pred CCCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 242458999989681881798-86334771101030134333222211
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.85 E-value=0.0016 Score=37.60 Aligned_cols=58 Identities=12% Similarity=0.112 Sum_probs=29.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-HHCCC-CCCCCCCCCCCCCCCCC
Q ss_conf 677753457897756533466323346884732110-00048-87642334785435478
Q 002601 244 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 301 (902)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~-~L~~l-~L~~LNlsnN~fsG~IP 301 (902)
.++++++..-.+..+..+.+|+.+.+.+|++++..| .+..+ .|+.||+++|++++-.|
T Consensus 159 ~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~ 218 (284)
T d1ozna_ 159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (284)
T ss_dssp ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred CCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf 314176566256665465634131421143466281676653200023333352210000
|
| >d1flga_ b.70.1.1 (A:) Ethanol dehydrogenase {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Ethanol dehydrogenase species: Pseudomonas aeruginosa [TaxId: 287]
Probab=95.55 E-value=0.018 Score=30.81 Aligned_cols=32 Identities=25% Similarity=0.449 Sum_probs=15.0
Q ss_pred CCCCCCCCCEEEECEEEEEEEEECCCCCEEEEE
Q ss_conf 741104881344020345899973446078510
Q 002601 129 MPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (902)
+|-+ .||.|++++-...++++||+||.++-.|
T Consensus 63 tPiv-~~g~vy~~t~~~~v~AlDa~TG~~lW~~ 94 (582)
T d1flga_ 63 QAIV-SDGVIYVTASYSRLFALDAKTGKRLWTY 94 (582)
T ss_dssp CCEE-ETTEEEEEETTTEEEEEESSSCCEEEEE
T ss_pred CCEE-ECCEEEEECCCCEEEEEECCCCCEEEEE
T ss_conf 8989-8999999689995999968999868887
|
| >d2ad6a1 b.70.1.1 (A:1-571) Methanol dehydrogenase, heavy chain {Methylophilus methylotrophus, w3a1 [TaxId: 17]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Methanol dehydrogenase, heavy chain species: Methylophilus methylotrophus, w3a1 [TaxId: 17]
Probab=95.40 E-value=0.028 Score=29.52 Aligned_cols=140 Identities=16% Similarity=0.178 Sum_probs=73.1
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCEEEEECCC-CCCEE-EECCCHHHH---------HHHCCCCCCCC
Q ss_conf 51456515899832344457789872388851998318983035-68457-703698889---------86374110488
Q 002601 68 GKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKR-FGKMK-KLSSSAEEY---------IRRMPYISKDG 136 (902)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~---------~~~~~~~~~~~ 136 (902)
=+..|+|.+|..- ..|+++.-.---+|.....+..+|--+.+ .|+.+ ++....+.- +.|.+-+ .+|
T Consensus 40 L~~aW~~~~g~~~--~~~~tP~v~~g~vyv~t~~~~~v~Alda~~tG~~~W~~~~~~~~~~~~~~~~~~~~rg~a~-~~~ 116 (571)
T d2ad6a1 40 VKAAWSFSTGVLN--GHEGAPLVIGDMMYVHSAFPNNTYALNLNDPGKIVWQHKPKQDASTKAVMCCDVVDRGLAY-GAG 116 (571)
T ss_dssp CEEEEEEECSCCS--CCCSCCEEETTEEEEECSTTTCEEEEETTCTTSEEEEECCCCCGGGGGGCTTCSCCCCCEE-ETT
T ss_pred CEEEEEEECCCCC--CCCCCCEEECCEEEEECCCCCEEEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEE-ECC
T ss_conf 3289999689999--8642998999999994287995999948999866888358888654420024768886265-088
Q ss_pred CEEEECEEEEEEEEECCCCCEEEEE-CCCC----CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEEEEEE
Q ss_conf 1344020345899973446078510-1689----8899887888883121147863111232245664441367986301
Q 002601 137 GVTLGAMKTSVFLVDVKSGRVVDNY-VLDF----SASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYIMRTDY 211 (902)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (902)
.|+.++-.-.++++||+||.++-.+ ..|. ....++.- .++...+........ .+=
T Consensus 117 ~i~~~~~~g~l~alda~tG~~~w~~~~~~~~~~~~~t~~p~v----------~~~~vivg~~~~~~~----------~~G 176 (571)
T d2ad6a1 117 QIVKKQANGHLLALDAKTGKINWEVEVCDPKVGSTLTQAPFV----------AKDTVLMGCSGAELG----------VRG 176 (571)
T ss_dssp EEEEECTTSEEEEEETTTCCEEEEEECCCGGGTCBCCSCCEE----------ETTEEEEECBCGGGT----------CCC
T ss_pred EEEEEECCCCEEEEEHHHHHHHCCCCCCCCCCCCCEEECCEE----------ECCEEEEEECCCCCC----------CCC
T ss_conf 699991797578210021122023444554432414536757----------588588850234423----------467
Q ss_pred EEECCCCCCCCEEEEEECC
Q ss_conf 3201368877179986221
Q 002601 212 VLQSTSQDSGEVLWNVAYA 230 (902)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~ 230 (902)
++..+-.+.|+.+|.....
T Consensus 177 ~v~a~D~~TG~~~W~~~t~ 195 (571)
T d2ad6a1 177 AVNAFDLKTGELKWRAFAT 195 (571)
T ss_dssp EEEEEETTTCCEEEEEESS
T ss_pred CEEEEECCCCCEEEEEECC
T ss_conf 4799988898588997046
|
| >d1w6sa_ b.70.1.1 (A:) Methanol dehydrogenase, heavy chain {Methylobacterium extorquens [TaxId: 408]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Methanol dehydrogenase, heavy chain species: Methylobacterium extorquens [TaxId: 408]
Probab=95.15 E-value=0.073 Score=26.85 Aligned_cols=109 Identities=16% Similarity=0.136 Sum_probs=60.8
Q ss_pred EEEEC-CCEEEEEEC-CCCEEEEEECCCCCCCCCCCCCC---CCCCCE---------EEEECCCCCEEEEECCCCCCEEE
Q ss_conf 78812-752999952-68514565158998323444577---898723---------88851998318983035684577
Q 002601 52 LVAAL-DGTIHLVDT-KLGKIRWSFGTGRPIYSSYQASF---NSNASE---------FYLDVDEDWELYFHSKRFGKMKK 117 (902)
Q Consensus 52 ~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 117 (902)
.|.+. ++.++++|- .+|+.+|+|....+.-....+.. +.-.+| .++-...|.-||--+..-|++.-
T Consensus 66 y~~t~~~~~v~a~d~~~tG~~~W~~~~~~~~~~~~~~~~~~~~RGv~~~~~~~~~~~~v~~~t~dg~l~Alda~tG~~~w 145 (596)
T d1w6sa_ 66 YIHTSFPNNTFALGLDDPGTILWQDKPKQNPAARAVACCDLVNRGLAYWPGDGKTPALILKTQLDGNVAALNAETGETVW 145 (596)
T ss_dssp EEECSTTTCEEEEETTCTTSEEEEECCCCCGGGGGGCSSCSCCCCCEEECCCSSSCCEEEEECTTSEEEEEETTTCCEEE
T ss_pred EEEECCCCCEEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCEEEEEEECCCCEEEECCCCCCEEC
T ss_conf 99517899689995799887788703878864343213566665169832799886299998079876854365684102
Q ss_pred EC----CCHHHHHHHCCCCCCCCCEEEECE------EEEEEEEECCCCCEEEEE
Q ss_conf 03----698889863741104881344020------345899973446078510
Q 002601 118 LS----SSAEEYIRRMPYISKDGGVTLGAM------KTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 118 ~~----~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~ 161 (902)
-- ......+.-+|.+ .++.|++|.- +-.+.+.||.||.++-.+
T Consensus 146 ~~~~~d~~~~~~~t~~P~v-~~~~vivg~~~~e~~~~G~v~A~Da~TG~~~W~~ 198 (596)
T d1w6sa_ 146 KVENSDIKVGSTLTIAPYV-VKDKVIIGSSGAELGVRGYLTAYDVKTGEQVWRA 198 (596)
T ss_dssp EEECCCGGGTCBCCSCCEE-ETTEEEECCBCGGGTCCCEEEEEETTTCCEEEEE
T ss_pred CCCCCCCCCCCCCCCCCCE-ECCEEEEEECCCCCCCCCCEEEEECCCCCEEEEE
T ss_conf 3101465556422458817-7775899302344433573289887888577886
|
| >d1w6sa_ b.70.1.1 (A:) Methanol dehydrogenase, heavy chain {Methylobacterium extorquens [TaxId: 408]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Methanol dehydrogenase, heavy chain species: Methylobacterium extorquens [TaxId: 408]
Probab=94.81 E-value=0.039 Score=28.61 Aligned_cols=139 Identities=15% Similarity=0.148 Sum_probs=68.0
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCEEEEECC-CCCCEE-EECCCHHHHHH-HCCC---------CCCC
Q ss_conf 5145651589983234445778987238885199831898303-568457-70369888986-3741---------1048
Q 002601 68 GKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSK-RFGKMK-KLSSSAEEYIR-RMPY---------ISKD 135 (902)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~-~~~~---------~~~~ 135 (902)
=+.-|+|.+|.. ...|+|+.---.-+|+....+..+|.-+- ..|++. ++......-.+ .+.| ...+
T Consensus 40 L~~aW~~~~~~~--~~~~~tPiv~~g~ly~~t~~~~~v~a~d~~~tG~~~W~~~~~~~~~~~~~~~~~~~~RGv~~~~~~ 117 (596)
T d1w6sa_ 40 LRPAWTFSTGLL--NGHEGAPLVVDGKMYIHTSFPNNTFALGLDDPGTILWQDKPKQNPAARAVACCDLVNRGLAYWPGD 117 (596)
T ss_dssp EEEEEEEECSCC--SCCCSCCEEETTEEEEECSTTTCEEEEETTCTTSEEEEECCCCCGGGGGGCSSCSCCCCCEEECCC
T ss_pred CEEEEEEECCCC--CCCEECCEEECCEEEEEECCCCCEEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCC
T ss_conf 218999978999--985419989999999951789968999579988778870387886434321356666516983279
Q ss_pred C----CEEEECEEEEEEEEECCCCCEEEEE-CCCC-----CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 8----1344020345899973446078510-1689-----8899887888883121147863111232245664441367
Q 002601 136 G----GVTLGAMKTSVFLVDVKSGRVVDNY-VLDF-----SASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVY 205 (902)
Q Consensus 136 ~----~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (902)
+ .|+.+...-.++++||+||..+-.+ ..|. .++.|. ++++...+-....+..
T Consensus 118 ~~~~~~v~~~t~dg~l~Alda~tG~~~w~~~~~d~~~~~~~t~~P~-----------v~~~~vivg~~~~e~~------- 179 (596)
T d1w6sa_ 118 GKTPALILKTQLDGNVAALNAETGETVWKVENSDIKVGSTLTIAPY-----------VVKDKVIIGSSGAELG------- 179 (596)
T ss_dssp SSSCCEEEEECTTSEEEEEETTTCCEEEEEECCCGGGTCBCCSCCE-----------EETTEEEECCBCGGGT-------
T ss_pred CCCCEEEEEEECCCCEEEECCCCCCEECCCCCCCCCCCCCCCCCCC-----------EECCEEEEEECCCCCC-------
T ss_conf 9886299998079876854365684102310146555642245881-----------7777589930234443-------
Q ss_pred EEEEEEEEECCCCCCCCEEEEEEC
Q ss_conf 986301320136887717998622
Q 002601 206 IMRTDYVLQSTSQDSGEVLWNVAY 229 (902)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~ 229 (902)
..=++..+-++.|..+|..-.
T Consensus 180 ---~~G~v~A~Da~TG~~~W~~~t 200 (596)
T d1w6sa_ 180 ---VRGYLTAYDVKTGEQVWRAYA 200 (596)
T ss_dssp ---CCCEEEEEETTTCCEEEEEES
T ss_pred ---CCCCEEEEECCCCCEEEEEEC
T ss_conf ---357328988788857788653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.74 E-value=0.089 Score=26.30 Aligned_cols=69 Identities=14% Similarity=0.043 Sum_probs=37.1
Q ss_pred EEECCCCCEEEEEEEEEC--------CCEEEEEEECCCCC-HHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEECCC
Q ss_conf 664403965999998538--------94999999315870-699999999999189997557414346865126552134
Q 002601 479 KEIAKGSNGTVVLEGNYE--------GRSVAVKRLVKTHH-DVALKEIQNLIASDQHPNIVRWYGVESDQDFVYLSLERC 549 (902)
Q Consensus 479 ~~LG~GsfGtVy~a~~~~--------g~~VAVKrL~~~~~-~~~~~Ei~~ll~~l~HpNIVrL~g~~~d~~~lyLV~E~c 549 (902)
+.|+.|--=.+|+....+ ...|.+++.-.... ....+|...+.....+.-..++++++.+ .+|+|+.
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEEEE
T ss_conf 991785334348999688775445789817999659961165899999999999757999808998189----5699973
Q ss_pred CC
Q ss_conf 68
Q 002601 550 TC 551 (902)
Q Consensus 550 ~~ 551 (902)
.+
T Consensus 124 ~g 125 (395)
T d1nw1a_ 124 PS 125 (395)
T ss_dssp CE
T ss_pred CC
T ss_conf 45
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=94.59 E-value=0.03 Score=29.31 Aligned_cols=63 Identities=10% Similarity=-0.017 Sum_probs=42.0
Q ss_pred HCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCC-HHCCC-CCCCCCCCCCCCCCCCCCC
Q ss_conf 00134677753457-897756533466323346884732110-00048-8764233478543547899
Q 002601 239 QEVGKSFSGYHFNS-GSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISLP 303 (902)
Q Consensus 239 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~l~nN~lsG~I~-~L~~l-~L~~LNlsnN~fsG~IP~~ 303 (902)
++| .+|+|.++. ..+..+..+.+|+.+.+.+|++++.++ .+..+ .|+.|++++|++++-.|..
T Consensus 32 ~~L--~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~ 97 (192)
T d1w8aa_ 32 TEL--LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKM 97 (192)
T ss_dssp SEE--ECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSS
T ss_pred CEE--EECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHH
T ss_conf 889--848987755302002578762721301363221212122211222210100355344349799
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=94.26 E-value=0.029 Score=29.40 Aligned_cols=51 Identities=8% Similarity=-0.000 Sum_probs=22.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-HHCCC-CCCCCCCCCCCCCC
Q ss_conf 77753457897756533466323346884732110-00048-87642334785435
Q 002601 245 FSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAG 298 (902)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~-~L~~l-~L~~LNlsnN~fsG 298 (902)
+|+++.+.-. +++.+.+|+.+.+.+|+++ .|| .+..+ .|+.||+++|++++
T Consensus 5 Ls~n~l~~l~--~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~ 57 (124)
T d1dcea3 5 LAHKDLTVLC--HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 57 (124)
T ss_dssp CTTSCCSSCC--CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCCC--CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 6899898871--0105898898979787168-652156554313545324321123
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=93.92 E-value=0.029 Score=29.44 Aligned_cols=41 Identities=7% Similarity=0.067 Sum_probs=22.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCCCCCCCCCCC
Q ss_conf 653346632334688473211000048-876423347854354
Q 002601 258 MDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGW 299 (902)
Q Consensus 258 ~~~~~~l~~~~l~nN~lsG~I~~L~~l-~L~~LNlsnN~fsG~ 299 (902)
+..+.+|+.+.+.+|++++ |+.++.+ .|+.||+++|++++-
T Consensus 169 l~~l~~L~~L~Ls~n~l~~-l~~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp GTTCTTCCEEECCSSCCCC-CGGGGGCTTCCEEECTTSCCCBC
T ss_pred HCCCCCCEECCCCCCCCCC-CHHHCCCCCCCEEECCCCCCCCC
T ss_conf 0564633564458884177-85344799999897959968998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=93.83 E-value=0.057 Score=27.56 Aligned_cols=41 Identities=10% Similarity=0.016 Sum_probs=26.9
Q ss_pred CCCCCCCCCCCCCCCCCC-HHCCC-CCCCCCCCCCCCCCCCCC
Q ss_conf 466323346884732110-00048-876423347854354789
Q 002601 262 GDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWISL 302 (902)
Q Consensus 262 ~~l~~~~l~nN~lsG~I~-~L~~l-~L~~LNlsnN~fsG~IP~ 302 (902)
.+++.+-+.+|+++.--+ .+.++ .|+.|++++|+++.-.|.
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~ 73 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHH
T ss_conf 9979897849918986965760465652311234434452356
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.62 E-value=0.018 Score=30.81 Aligned_cols=35 Identities=9% Similarity=-0.044 Sum_probs=14.0
Q ss_pred CCCCCCCCCCCCCCCCC-HHCCC-CCCCCCCCCCCCC
Q ss_conf 66323346884732110-00048-8764233478543
Q 002601 263 DVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVA 297 (902)
Q Consensus 263 ~l~~~~l~nN~lsG~I~-~L~~l-~L~~LNlsnN~fs 297 (902)
+++.+.+.+|++++.-+ .+.++ .|+.|++++|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~ 68 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf 8898988499289859778634565522135665444
|
| >d1kb0a2 b.70.1.1 (A:1-573) Quinoprotein alcohol dehydrogenase, N-terminal domain {Comamonas testosteroni [TaxId: 285]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Quinoprotein alcohol dehydrogenase, N-terminal domain species: Comamonas testosteroni [TaxId: 285]
Probab=93.32 E-value=0.14 Score=25.09 Aligned_cols=88 Identities=23% Similarity=0.309 Sum_probs=44.3
Q ss_pred HHCCCCCCCCCEEEECEEEEEEEEECCCCCEEEEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf 63741104881344020345899973446078510168988998878888831211478631112322456644413679
Q 002601 127 RRMPYISKDGGVTLGAMKTSVFLVDVKSGRVVDNYVLDFSASTPGFQSDENKHVVPVDGYEELVESGVGNLKRIRQLVYI 206 (902)
Q Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (902)
.-+|-+ .||.+++++-.-.++++||+||.++-.|......... .... ...+..++.- -+-.+++
T Consensus 70 ~stPiv-~~g~vyv~t~~~~v~AlDa~TG~~~W~~~~~~~~~~~-~~~~-----------~~~~~~g~~~---~~~~v~~ 133 (573)
T d1kb0a2 70 EATPVV-VDGIMYVSASWSVVHAIDTRTGNRIWTYDPQIDRSTG-FKGC-----------CDVVNRGVAL---WKGKVYV 133 (573)
T ss_dssp CCCCEE-ETTEEEEECGGGCEEEEETTTTEEEEEECCCCCGGGG-GGSS-----------SCSCCCCCEE---ETTEEEE
T ss_pred EECCEE-ECCEEEEECCCCEEEEEECCCCCEEEEECCCCCCCCC-CCCC-----------CCCCCCCCEE---ECCCEEE
T ss_conf 779999-9999999789996999958999858786798876533-3345-----------6656665238---7881899
Q ss_pred EEEEEEEECCCCCCCCEEEEEECC
Q ss_conf 863013201368877179986221
Q 002601 207 MRTDYVLQSTSQDSGEVLWNVAYA 230 (902)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~ 230 (902)
.-.|..|-.+-+..|..+|.....
T Consensus 134 ~t~~g~l~alda~tG~~~W~~~~~ 157 (573)
T d1kb0a2 134 GAWDGRLIALDAATGKEVWHQNTF 157 (573)
T ss_dssp ECTTSEEEEEETTTCCEEEEEETT
T ss_pred EECCCCEEEECCCCCCCEECCCCC
T ss_conf 733654066616243001014675
|
| >d1kv9a2 b.70.1.1 (A:1-560) Quinoprotein alcohol dehydrogenase, N-terminal domain {Pseudomonas putida, hk5 [TaxId: 303]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: Quinoprotein alcohol dehydrogenase-like family: Quinoprotein alcohol dehydrogenase-like domain: Quinoprotein alcohol dehydrogenase, N-terminal domain species: Pseudomonas putida, hk5 [TaxId: 303]
Probab=92.06 E-value=0.21 Score=23.95 Aligned_cols=27 Identities=19% Similarity=0.384 Sum_probs=13.5
Q ss_pred CCCEEEECEEEEEEEEECCCCCEEEEE
Q ss_conf 881344020345899973446078510
Q 002601 135 DGGVTLGAMKTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (902)
++.|+.+.-.-.++++||+||..+-..
T Consensus 117 ~~~v~~~~~~g~l~Alda~tG~~~w~~ 143 (560)
T d1kv9a2 117 GDKVYVGTLDGRLIALDAKTGKAIWSQ 143 (560)
T ss_dssp BTEEEEECTTSEEEEEETTTCCEEEEE
T ss_pred CCEEEEEECCCEEEEEECCCCCEEECC
T ss_conf 884999738987999977789577305
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.04 E-value=0.055 Score=27.65 Aligned_cols=53 Identities=8% Similarity=-0.008 Sum_probs=27.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--HHCCCCCCCCCCCCCCCC
Q ss_conf 677753457897756533466323346884732110--000488764233478543
Q 002601 244 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY--RLRDNSLPEFLSVIGKVA 297 (902)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~--~L~~l~L~~LNlsnN~fs 297 (902)
.+++|....-.+.++..+.+|+.+.+.+|+++ .|+ .+..++|+.|+|++|.|.
T Consensus 62 ~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred EEECCCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCCCCCCCCCCC
T ss_conf 62021247742011124554333322678785-15745633532124335798633
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.90 E-value=0.15 Score=24.81 Aligned_cols=57 Identities=12% Similarity=0.100 Sum_probs=21.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-HHCCC-CCCCCCCCCCCCCCCCC
Q ss_conf 77753457897756533466323346884732110-00048-87642334785435478
Q 002601 245 FSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAGWIS 301 (902)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~-~L~~l-~L~~LNlsnN~fsG~IP 301 (902)
++++++..-.+..+.....|+.+.+.+|++++..+ .+.++ .|+.+++++|++++.+|
T Consensus 136 l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~ 194 (284)
T d1ozna_ 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (284)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred HCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCH
T ss_conf 00143144580574043405022314176566256665465634131421143466281
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=91.15 E-value=0.12 Score=25.48 Aligned_cols=66 Identities=9% Similarity=0.085 Sum_probs=51.2
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCCCCCCCCCCCCC
Q ss_conf 03444320013467775345789775653346632334688473211000048-87642334785435478
Q 002601 232 FKAEFRCQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWIS 301 (902)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~~L~~l-~L~~LNlsnN~fsG~IP 301 (902)
++..-.-+++ .+|+|... .+|.++..+.+|+.+.+.+|++++ ++.+..+ .|+.|++++|+++..-.
T Consensus 16 l~~l~~L~~L--~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N~i~~~~~ 82 (124)
T d1dcea3 16 LEQLLLVTHL--DLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQSAA 82 (124)
T ss_dssp GGGGTTCCEE--ECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCSSST
T ss_pred CCCCCCCCEE--ECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCC
T ss_conf 1058988989--79787168-652156554313545324321123-5741233555768888986588888
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.66 E-value=0.36 Score=22.39 Aligned_cols=31 Identities=32% Similarity=0.408 Sum_probs=25.1
Q ss_pred CCCCCCCCCCCCEEEECCCCCCEEEECCCCCCC
Q ss_conf 036213444561168536999238881478620
Q 002601 624 EIGLIHRDLKPQNVLISKDKSFCAKLSDMGISK 656 (902)
Q Consensus 624 s~~IiHrDLKp~NILL~~d~~~~vKLsDFGla~ 656 (902)
..++||+|+.+.||+++.+. ..-+.||+.|.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~--v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDE--LSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTE--EEEECCCTTCE
T ss_pred CCCCCCCCCCHHHHHCCCCC--CEEEECCCCCC
T ss_conf 45033378636564020454--12674222123
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=90.21 E-value=0.14 Score=24.99 Aligned_cols=56 Identities=14% Similarity=0.147 Sum_probs=39.5
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCCCCCCCCCC
Q ss_conf 20013467775345789775653346632334688473211000048-87642334785435
Q 002601 238 CQEVGKSFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAG 298 (902)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~~L~~l-~L~~LNlsnN~fsG 298 (902)
.+++ .++++....-. ++.++.+|+.+.+.+|++++ ++.+..+ .|+.|++++|++++
T Consensus 48 L~~L--~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~-l~~~~~l~~L~~L~l~~n~i~~ 104 (210)
T d1h6ta2 48 IDQI--IANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKVKD 104 (210)
T ss_dssp CCEE--ECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCC
T ss_pred CCEE--ECCCCCCCCCH--HHHHCCCCCEEECCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC
T ss_conf 4589--78279888744--47648998987698960258-6011358621201433333212
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=90.04 E-value=0.13 Score=25.32 Aligned_cols=67 Identities=10% Similarity=0.105 Sum_probs=47.5
Q ss_pred HHHHHHHCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCCCCCCCCCCCCCC
Q ss_conf 34443200134-67775345789775653346632334688473211000048-876423347854354789
Q 002601 233 KAEFRCQEVGK-SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGWISL 302 (902)
Q Consensus 233 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~~L~~l-~L~~LNlsnN~fsG~IP~ 302 (902)
++.-.+++|+. .+++++...-.+ +..+.+|+.+.+.+|++++ ++.+..+ .|+.|++++|.+++..+.
T Consensus 60 ~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~-i~~l~~l~~L~~L~~~~~~~~~~~~~ 128 (384)
T d2omza2 60 DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDIDPL 128 (384)
T ss_dssp TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCCCGGG
T ss_pred CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 242458999989681881798863--3477110103013433322-22111233433344332222222222
|
| >d1hzua2 b.70.2.1 (A:118-543) C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase {Pseudomonas aeruginosa [TaxId: 287]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase family: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase domain: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase species: Pseudomonas aeruginosa [TaxId: 287]
Probab=89.28 E-value=0.46 Score=21.68 Aligned_cols=110 Identities=14% Similarity=0.094 Sum_probs=73.6
Q ss_pred CCCEEEEE-CCCEEEEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCEEEEECCCCCCEEEEC----CCH
Q ss_conf 76127881-2752999952685145651589983234445778987238885199831898303568457703----698
Q 002601 48 PDVALVAA-LDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMKKLS----SSA 122 (902)
Q Consensus 48 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~ 122 (902)
.+..+|++ -||+|.+.|..+++.+..|..|.-. +...+..|-.++|.-. .|..+.+=+-.-++.+... ..-
T Consensus 31 ~~~~~V~~~~dg~v~vwD~~t~~~~~~l~~g~~~---~~vafSPDGk~l~~~~-~d~~v~vwd~~t~~~~~~~~i~~~~~ 106 (426)
T d1hzua2 31 PNLFSVTLRDAGQIALVDGDSKKIVKVIDTGYAV---HISRMSASGRYLLVIG-RDARIDMIDLWAKEPTKVAEIKIGIE 106 (426)
T ss_dssp GGEEEEEETTTTEEEEEETTTCSEEEEEECCSSE---EEEEECTTSCEEEEEE-TTSEEEEEETTSSSCEEEEEEECCSE
T ss_pred CEEEEEEECCCCEEEEEECCCCCEEEEEECCCCE---EEEEECCCCCEEEEEE-CCCCEEEEECCCCCEEEEEEEECCCC
T ss_conf 7089999759997999999999599999689980---3899989999999995-89988999756886048999867888
Q ss_pred HHHHHHCCCCCCCCC-EEEE-CEEEEEEEEECCCCCEEEEE
Q ss_conf 889863741104881-3440-20345899973446078510
Q 002601 123 EEYIRRMPYISKDGG-VTLG-AMKTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 123 ~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~ 161 (902)
.+-+..+|.+|-||. ++.+ +-..++-..|+.+|..+...
T Consensus 107 ~~~~~~s~~~spDG~~l~v~~~~~~~v~i~d~~~~~~~~~~ 147 (426)
T d1hzua2 107 ARSVESSKFKGYEDRYTIAGAYWPPQFAIMDGETLEPKQIV 147 (426)
T ss_dssp EEEEEECCSTTCTTTEEEEEEEESSEEEEEETTTCCEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEECCCCEEEEECCCCCCEEEEE
T ss_conf 76458850026889879996358976999857764125786
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=87.63 E-value=0.24 Score=23.47 Aligned_cols=42 Identities=17% Similarity=0.249 Sum_probs=26.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCCCCCCCCCCC
Q ss_conf 5653346632334688473211000048-876423347854354
Q 002601 257 GMDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAGW 299 (902)
Q Consensus 257 ~~~~~~~l~~~~l~nN~lsG~I~~L~~l-~L~~LNlsnN~fsG~ 299 (902)
++.++.+|+.+.+.+|++++.- .+..+ .|+.|++++|.+...
T Consensus 57 ~l~~l~nL~~L~Ls~N~l~~~~-~l~~l~~L~~L~l~~n~~~~~ 99 (199)
T d2omxa2 57 GVEYLNNLTQINFSNNQLTDIT-PLKNLTKLVDILMNNNQIADI 99 (199)
T ss_dssp TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCC
T ss_conf 0213788675754565566764-016775223111122222222
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=87.50 E-value=0.42 Score=21.91 Aligned_cols=54 Identities=2% Similarity=0.021 Sum_probs=29.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-HHCCC-CCCCCCCCCCCCCC
Q ss_conf 77753457897756533466323346884732110-00048-87642334785435
Q 002601 245 FSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVY-RLRDN-SLPEFLSVIGKVAG 298 (902)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~-~L~~l-~L~~LNlsnN~fsG 298 (902)
+++++...=.+..+..+.+|+.+.+.+|.++...| .+..+ .|+.|++++|+++.
T Consensus 38 Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~ 93 (305)
T d1xkua_ 38 LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE 93 (305)
T ss_dssp CCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSB
T ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCCC
T ss_conf 84991898696576046565231123443445235665279855783156875676
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.96 E-value=0.25 Score=23.42 Aligned_cols=39 Identities=5% Similarity=0.020 Sum_probs=17.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCCCCCCCCCC
Q ss_conf 53346632334688473211000048-87642334785435
Q 002601 259 DLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKVAG 298 (902)
Q Consensus 259 ~~~~~l~~~~l~nN~lsG~I~~L~~l-~L~~LNlsnN~fsG 298 (902)
..+.+|+.+-+.+|+++ .|+.+..+ .|+.|++++|+++.
T Consensus 38 ~~l~~L~~L~Ls~N~i~-~l~~~~~l~~L~~L~ls~N~i~~ 77 (162)
T d1a9na_ 38 ATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICR 77 (162)
T ss_dssp GGTTCCSEEECCSSCCC-EECCCCCCSSCCEEECCSSCCCE
T ss_pred CCCCCCCEEECCCCCCC-CCCCCCCCCCHHHHHCCCCCCCC
T ss_conf 04145998989799787-64774457613064310213457
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=85.90 E-value=0.33 Score=22.63 Aligned_cols=50 Identities=8% Similarity=0.078 Sum_probs=19.6
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCCCCCCCC
Q ss_conf 67775345789775653346632334688473211000048-876423347854
Q 002601 244 SFSGYHFNSGSELGMDLIGDVESHLPCHTQMTASVYRLRDN-SLPEFLSVIGKV 296 (902)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~l~~~~l~nN~lsG~I~~L~~l-~L~~LNlsnN~f 296 (902)
.++++.++.-.+ +..+.+|+.+.+.+|++++ |+.+.++ .|+.|++++|.+
T Consensus 74 ~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~ 124 (210)
T d1h6ta2 74 FLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGI 124 (210)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCC
T ss_pred ECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCC
T ss_conf 698960258601--1358621201433333212-22121222111223456532
|
| >d1qksa2 b.70.2.1 (A:136-567) C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase {Paracoccus denitrificans [TaxId: 266]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 8-bladed beta-propeller superfamily: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase family: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase domain: C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase species: Paracoccus denitrificans [TaxId: 266]
Probab=85.44 E-value=0.76 Score=20.27 Aligned_cols=107 Identities=10% Similarity=0.074 Sum_probs=75.1
Q ss_pred EEEEECCCEEEEEECCCCEEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCEEEEECCCCCCEE---EEC-CCHHHHH
Q ss_conf 278812752999952685145651589983234445778987238885199831898303568457---703-6988898
Q 002601 51 ALVAALDGTIHLVDTKLGKIRWSFGTGRPIYSSYQASFNSNASEFYLDVDEDWELYFHSKRFGKMK---KLS-SSAEEYI 126 (902)
Q Consensus 51 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~ 126 (902)
+..+.-||+|.++|..+++++=.|.+|.-. +...+..|-.|+|... .|..+.+=+-.-++.+ .++ ..-++-+
T Consensus 35 ~v~~~d~g~v~v~D~~t~~v~~~~~~g~~~---~~v~fSpDG~~l~~~s-~dg~v~~~d~~t~~~~~~~~i~~~~~~~~~ 110 (432)
T d1qksa2 35 SVTLRDAGQIALIDGSTYEIKTVLDTGYAV---HISRLSASGRYLFVIG-RDGKVNMIDLWMKEPTTVAEIKIGSEARSI 110 (432)
T ss_dssp EEEETTTTEEEEEETTTCCEEEEEECSSCE---EEEEECTTSCEEEEEE-TTSEEEEEETTSSSCCEEEEEECCSEEEEE
T ss_pred EEEECCCCEEEEEECCCCCEEEEEECCCCE---EEEEECCCCCEEEEEC-CCCCEEEEEEECCCCEEEEEEECCCCCCCE
T ss_conf 999769997999989998399997379971---3799889999999982-899978998108981288998448898776
Q ss_pred HHCCCCCCCCC--EEEECEEEEEEEEECCCCCEEEEE
Q ss_conf 63741104881--344020345899973446078510
Q 002601 127 RRMPYISKDGG--VTLGAMKTSVFLVDVKSGRVVDNY 161 (902)
Q Consensus 127 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 161 (902)
..+|.+|-||. +..++..-++-..|+.||.++...
T Consensus 111 ~~s~~~SpDG~~l~vs~~~~~~v~i~d~~t~~~~~~~ 147 (432)
T d1qksa2 111 ETSKMEGWEDKYAIAGAYWPPQYVIMDGETLEPKKIQ 147 (432)
T ss_dssp EECCSTTCTTTEEEEEEEETTEEEEEETTTCCEEEEE
T ss_pred EEECCCCCCCCEEEEECCCCCEEEEEECCCCCCEEEE
T ss_conf 9843218888889998178982799907655422540
|